PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jasiewicz, A; Samochowiec, A; Samochowiec, J; Malecka, I; Suchanecka, A; Grzywacz, A				Jasiewicz, Andrzej; Samochowiec, Agnieszka; Samochowiec, Jerzy; Malecka, Iwona; Suchanecka, Aleksandra; Grzywacz, Anna			Suicidal Behavior and Haplotypes of the Dopamine Receptor Gene (DRD2) and ANKK1 Gene Polymorphisms in Patients with Alcohol Dependence - Preliminary Report	PLOS ONE			English	Article							ENVIRONMENTAL CONTRIBUTIONS; TAQ1A POLYMORPHISM; FAMILY-HISTORY; ASSOCIATION; RFLP; RISK; METAANALYSIS; INDIVIDUALS; POPULATION; GENOTYPE	Suicide is a significant public health issue and a major cause of death throughout the world. According to WHO it accounts for almost 2% of deaths worldwide. The etiology of suicidal behavior is complex but the results of many studies suggest that genetic determinants are of significant importance. In our study,-we have analyzed selected SNPs polymorphisms in the DRD2 and ANKK1 genes in patients with alcohol dependence syndrome (169 Caucasian subjects) including a subgroup of individuals (n=61) who have experienced at least one suicide attempt. The aim of the study was to verify if various haplotypes of selected genes, comprising Taq1A, Taq1B, and Taq1D single nucleotide polymorphisms (SNP), play any role in the development of alcohol dependence and suicidal behavior. The control group comprised 157 unrelated individuals matched for ethnicity, gender,-and age and included no individuals with mental disorders. All subjects were recruited in the North West region of Poland. The study showed that alcohol dependent subjects with a history of at least one suicidal attempt were characterized by a significantly higher frequency of the T-G-A2 haplotype when compared to individuals in whom alcohol dependence was not associated with suicidal behavior (p=0.006). It appears that studies based on identifying correlation between SNPs is the future for research on genetic risk factors that contribute to the development of alcohol addiction and other associated disorders. To sum up, there is a necessity to perform further research to explain dependencies between the dopaminergic system, alcohol use disorders and suicidal behavior.	[Jasiewicz, Andrzej; Samochowiec, Jerzy; Malecka, Iwona; Suchanecka, Aleksandra; Grzywacz, Anna] Pomeranian Med Univ, Dept Psychiat, Szczecin, Poland; [Samochowiec, Agnieszka] Univ Szczecin, Dept Clin Psychol, Inst Psychol, PL-70453 Szczecin, Poland	Pomeranian Medical University; University of Szczecin	Grzywacz, A (corresponding author), Pomeranian Med Univ, Dept Psychiat, Szczecin, Poland.	annagrzywacz@gazeta.pl	Suchanecka, Aleksandra/Q-2963-2017; Ma?ecka, Iwona/O-3247-2014; Grzywacz, Anna AG/O-3234-2014; Samochowiec, Jerzy/G-8175-2014; Suchanecka, Aleksandra/R-1892-2019; Samochowiec, Jerzy/GMX-0900-2022	Suchanecka, Aleksandra/0000-0002-7137-1429; Grzywacz, Anna AG/0000-0002-2633-520X; Samochowiec, Jerzy/0000-0003-1438-583X; Suchanecka, Aleksandra/0000-0002-7137-1429; Samochowiec, Jerzy/0000-0003-1438-583X; /0000-0001-9783-7234	Ministry of Science and Higher Education [NN 402466540]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Funding: This work was supported by Ministry of Science and Higher Education: NN 402466540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM K, 1993, ALCOHOL, V10, P59, DOI 10.1016/0741-8329(93)90054-R; BOHMAN M, 1984, ARCH GEN PSYCHIAT, V41, P872; Bondy B, MOLECULAR PSYCHIATRY, V11, P336; Brent DA, 2005, AM J MED GENET C, V133C, P13, DOI 10.1002/ajmg.c.30042; Brezo J, 2008, PSYCHIAT CLIN N AM, V31, P179, DOI 10.1016/j.psc.2008.01.008; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Courtet P, 2005, AM J MED GENET C, V133C, P25, DOI 10.1002/ajmg.c.30043; Finckh U, 1997, PHARMACOGENETICS, V7, P271, DOI 10.1097/00008571-199708000-00002; Gorwood P, 2001, EUR PSYCHIAT, V16, P410, DOI 10.1016/S0924-9338(01)00599-5; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Grzywacz A, 2012, THESIS; Hamajima Nobuyuki, 2002, J Epidemiol, V12, P297; HAUGE XY, 1991, GENOMICS, V10, P527, DOI 10.1016/0888-7543(91)90431-D; HEATH AC, 1994, ANN NY ACAD SCI, V708, P72, DOI 10.1111/j.1749-6632.1994.tb24699.x; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Johann M, 2005, AM J MED GENET B, V132B, P46, DOI 10.1002/ajmg.b.30085; Joiner TE, 2002, SUICIDE LIFE-THREAT, V32, P329, DOI 10.1521/suli.32.3.329.22167; Karaoguz MY, 2004, KOREAN J GENETIC, V26, P149; KENDLER KS, 1994, AM J PSYCHIAT, V151, P707; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; KONDRICHIN SV, 1995, LANCET, V346, P1632; London ED, 2009, PSYCHIAT RES-NEUROIM, V174, P163, DOI 10.1016/j.pscychresns.2009.07.008; Lu RB, 2001, ALCOHOL CLIN EXP RES, V25, P177, DOI 10.1097/00000374-200102000-00004; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Marusic A, 2005, AM J MED GENET C, V133C, P43, DOI 10.1002/ajmg.c.30045; McGuffin P, 2001, Crisis, V22, P61, DOI 10.1027//0227-5910.22.2.61; Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble EP, 1998, ALCOHOL, V16, P33, DOI 10.1016/S0741-8329(97)00175-4; NOBLE EP, 1993, DRUG ALCOHOL DEPEN, V33, P271, DOI 10.1016/0376-8716(93)90113-5; Paredes B, 2008, EMERGENCIAS, V20, P93; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Preuss UW, 2007, ALCOHOL ALCOHOLISM, V42, P258, DOI 10.1093/alcalc/agm030; Preuss UW, 2002, ALCOHOL CLIN EXP RES, V26, P471, DOI 10.1111/j.1530-0277.2002.tb02563.x; Preuss UW, 2001, BIOL PSYCHIAT, V50, P636, DOI 10.1016/S0006-3223(01)01196-9; Robinson JD, 2007, PHARMACOGENOMICS J, V7, P266, DOI 10.1038/sj.tpj.6500427; SCHUCKIT MA, 1986, J STUD ALCOHOL, V47, P78, DOI 10.15288/jsa.1986.47.78; Schuckit MA, 2008, J STUD ALCOHOL DRUGS, V69, P571, DOI 10.15288/jsad.2008.69.571; Schuckit MA, 2009, J SUBST ABUSE TREAT, V36, pS5, DOI 10.1016/j.jsat.2008.05.012; SMITH SS, 1992, ARCH GEN PSYCHIAT, V49, P723; Suchanecka A, 2011, PSYCHIATR POL, V45, P349; Suda A, 2009, NEUROPSYCHOBIOLOGY, V59, P130, DOI 10.1159/000213566; Szekely A, 2011, GENES BRAIN BEHAV, V10, P129, DOI 10.1111/j.1601-183X.2010.00645.x; Wang F, 2013, HUM GENET, V132, P347, DOI 10.1007/s00439-012-1251-6; Wojnar M, 2007, ARCH PSYCHIATR PSYCH, V9, P13; World Health Organization, 2006, WORLD HEALTH REPORT; Zill P, 2007, NEUROPSYCHOPHARMACOL, V32, P1687, DOI 10.1038/sj.npp.1301318	48	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111798	10.1371/journal.pone.0111798	http://dx.doi.org/10.1371/journal.pone.0111798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415204	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600008
J	Ruffell, J; Didham, RK; Barrett, P; Gorman, N; Pike, R; Hickey-Elliott, A; Sievwright, K; Armstrong, DP				Ruffell, Jay; Didham, Raphael K.; Barrett, Paul; Gorman, Nic; Pike, Rhonda; Hickey-Elliott, Andree; Sievwright, Karin; Armstrong, Doug P.			Discriminating the Drivers of Edge Effects on Nest Predation: Forest Edges Reduce Capture Rates of Ship Rats (Rattus rattus), a Globally Invasive Nest Predator, by Altering Vegetation Structure	PLOS ONE			English	Article							HABITAT FRAGMENTATION; BLACK RATS; ISLAND; BIRDS; POPULATIONS; SUCCESS; CONSEQUENCES; MICROCLIMATE; VIABILITY; RESPONSES	Forest edges can strongly affect avian nest success by altering nest predation rates, but this relationship is inconsistent and context dependent. There is a need for researchers to improve the predictability of edge effects on nest predation rates by examining the mechanisms driving their occurrence and variability. In this study, we examined how the capture rates of ship rats, an invasive nest predator responsible for avian declines globally, varied with distance from the forest edge within forest fragments in a pastoral landscape in New Zealand. We hypothesised that forest edges would affect capture rates by altering vegetation structure within fragments, and that the strength of edge effects would depend on whether fragments were grazed by livestock. We measured vegetation structure and rat capture rates at 488 locations ranging from 0-212 m from the forest edge in 15 forest fragments, seven of which were grazed. Contrary to the vast majority of previous studies of edge effects on nest predation, ship rat capture rates increased with increasing distance from the forest edge. For grazed fragments, capture rates were estimated to be 78% lower at the forest edge than 118 m into the forest interior (the farthest distance for grazed fragments). This relationship was similar for ungrazed fragments, with capture rates estimated to be 51% lower at the forest edge than 118 m into the forest interior. A subsequent path analysis suggested that these 'reverse' edge effects were largely or entirely mediated by changes in vegetation structure, implying that edge effects on ship rats can be predicted from the response of vegetation structure to forest edges. We suggest the occurrence, strength, and direction of edge effects on nest predation rates may depend on edge-driven changes in local habitat when the dominant predator is primarily restricted to forest patches.	[Ruffell, Jay; Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO, Ctr Environm & Life Sci, Perth, WA, Australia; [Barrett, Paul; Gorman, Nic; Pike, Rhonda; Hickey-Elliott, Andree; Sievwright, Karin; Armstrong, Doug P.] Massey Univ, Wildlife Ecol Grp, Palmerston North, New Zealand	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Massey University	Ruffell, J (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	ruffell.jay@gmail.com	Didham, Raphael K/B-5953-2011		Marsden Fund [MAU0707]; Australian Research Council Future Fellowship [FT100100040]; Hackett Postgraduate Research Scholarship from the University of Western Australia	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Australian Research Council Future Fellowship(Australian Research Council); Hackett Postgraduate Research Scholarship from the University of Western Australia	The research was funded by Marsden Fund Grant MAU0707 to DPA and A.R.E Sinclair. RKD was supported during the writing of this manuscript by an Australian Research Council Future Fellowship FT100100040. JR was supported by a Hackett Postgraduate Research Scholarship from the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1988, ECOLOGY, V69, P544, DOI 10.2307/1940455; Andren Henrik, 1995, IALE Studies in Landscape Ecology, V2, P225; Armstrong DP, 2006, J WILDLIFE MANAGE, V70, P1020, DOI 10.2193/0022-541X(2006)70[1020:ETVOAR]2.0.CO;2; Armstrong DP, 2014, CONSERV BIOL, V28, P713, DOI 10.1111/cobi.12256; Barton K., 2013, MUMIN MULTIMODEL INF; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beausoleil N, 2010, HUMANE ARE OUR PEST; Bryant D., 1997, LAST FRONTIER FOREST; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Christie JE, 2009, DOC RES DEV SERIES, V305; Cox WA, 2012, LANDSCAPE ECOL, V27, P659, DOI 10.1007/s10980-012-9711-x; Day JW, 2009, BIOSCIENCE, V59, P321, DOI 10.1525/bio.2009.59.4.10; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Delgado JD, 2001, ECOGRAPHY, V24, P539, DOI 10.1034/j.1600-0587.2001.d01-209.x; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; DOWDING JE, 1994, NEW ZEAL J ECOL, V18, P19; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Falk KJ, 2011, LANDSCAPE ECOL, V26, P239, DOI 10.1007/s10980-010-9543-5; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Getzlaff CL, 2013, NEW ZEAL J ECOL, V37, P232; Gillies C, 2013, USING TRACKING TUNNE; Githiru M, 2005, BIOL CONSERV, V123, P189, DOI 10.1016/j.biocon.2004.11.006; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 2008, J WILDLIFE MANAGE, V72, P14, DOI 10.2193/2007-307; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; Hartley MJ, 1998, CONSERV BIOL, V12, P465, DOI 10.1046/j.1523-1739.1998.96373.x; Hobbs RJ, 2001, CONSERV BIOL, V15, P1522, DOI 10.1046/j.1523-1739.2001.01092.x; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Humphrey JW, 1999, FOREST ECOL MANAG, V113, P11, DOI 10.1016/S0378-1127(98)00413-7; Innes J, 1999, BIOL CONSERV, V87, P201, DOI 10.1016/S0006-3207(98)00053-6; Innes J, 2004, NEW ZEAL J ECOL, V28, P73; Innes J, 2001, J ROYAL SOC NZ, V31, P101; Innes J, 2010, NEW ZEAL J ECOL, V34, P227; Innes J, 2010, NEW ZEAL J ECOL, V34, P86; Jouventin P, 2003, POLAR BIOL, V26, P371, DOI 10.1007/s00300-003-0497-9; King CM, 1996, NEW ZEAL J ECOL, V20, P215; Lahti DC, 2009, ANIM CONSERV, V12, P279, DOI 10.1111/j.1469-1795.2009.00286.x; Lahti DC, 2001, BIOL CONSERV, V99, P365, DOI 10.1016/S0006-3207(00)00222-6; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; Macfarland CG, 1974, BIOL CONSERV, V6, P118, DOI DOI 10.1016/0006-3207(74)90024-X; Major RE, 1996, IBIS, V138, P298, DOI 10.1111/j.1474-919X.1996.tb04342.x; Martin JL, 2000, CONSERV BIOL, V14, P1452, DOI 10.1046/j.1523-1739.2000.99190.x; Martin JL, 2003, OIKOS, V102, P641, DOI 10.1034/j.1600-0706.2003.12040.x; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; Monteiro LR, 1996, BIOL CONSERV, V78, P319, DOI 10.1016/S0006-3207(96)00037-7; Moors P.J., 1992, Bird Conservation International, V2, P93; Morgan DKJ, 2009, NEW ZEAL J ZOOL, V36, P23, DOI 10.1080/03014220909510136; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Newton I., 1998, POPULATION LIMITATIO; NOUR N, 1993, ECOGRAPHY, V16, P111, DOI 10.1111/j.1600-0587.1993.tb00063.x; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; Pinheiro J, 2020, R PACKAGE VERSION 31; Pryde MA, 2005, BIOL CONSERV, V126, P175, DOI 10.1016/j.biocon.2005.05.006; R Core Team, 2012, R LANG ENV STAT COMP; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Smale MC, 2008, NEW ZEAL J ECOL, V32, P57; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Spanhove T, 2009, ANIM CONSERV, V12, P267, DOI 10.1111/j.1469-1795.2009.00249.x; Steffens KE, 2005, NEW ZEAL J ECOL, V29, P221; Storch I, 2005, LANDSCAPE ECOL, V20, P927, DOI 10.1007/s10980-005-7005-2; Tewksbury JJ, 2006, ECOLOGY, V87, P759, DOI 10.1890/04-1790; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Thompson FR, 2002, STUD AVIAN BIOL-SER, P8; TOWNS DR, 1994, NEW ZEAL J ZOOL, V21, P325, DOI 10.1080/03014223.1994.9518003; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8; Zuur Alain F., 2009, P1	69	14	15	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113098	10.1371/journal.pone.0113098	http://dx.doi.org/10.1371/journal.pone.0113098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412340	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000025
J	Seinige, D; von Kockritz-Blickwede, M; Krischek, C; Klein, G; Kehrenberg, C				Seinige, Diana; von Koeckritz-Blickwede, Maren; Krischek, Carsten; Klein, Guenter; Kehrenberg, Corinna			Influencing Factors and Applicability of the Viability EMA-qPCR for a Detection and Quantification of Campylobacter Cells from Water Samples	PLOS ONE			English	Article							REAL-TIME PCR; PROPIDIUM MONOAZIDE; ETHIDIUM MONOAZIDE; VIABLE CAMPYLOBACTER; SALMONELLA-ENTERICA; CHICKEN CARCASSES; ESCHERICHIA-COLI; DRINKING-WATER; JEJUNI; OUTBREAK	In recent years, increasing numbers of human campylobacteriosis cases caused by contaminated water have been reported. As the culture-based detection of Campylobacter is time consuming and can yield false-negative results, the suitability of a quantitative real-time PCR method in combination with an ethidium monoazide pretreatment of samples (EMA-qPCR) for the rapid, quantitative detection of viable Campylobacter cells from water samples was investigated. EMA-qPCR has been shown to be a promising rapid method for the detection of viable Campylobacter spp. from food samples. Application of membrane filtration and centrifugation, two methods frequently used for the isolation of bacteria from water, revealed a mean loss of up to 1.08 log(10) cells/ml from spiked samples. Both methods used alone lead to a loss of dead bacteria and accumulation of viable bacteria in the sample as shown by fluorescence microscopy. After filtration of samples, no significant differences could be detected in subsequent qPCR experiments with and without EMA pretreatment compared to culture-based enumeration. High correlations (R-2=0.942 without EMA, R-2=0.893 with EMA) were obtained. After centrifugation of samples, qPCR results overestimated Campylobacter counts, whereas results from both EMA-qPCR and the reference method were comparable. As up to 81.59% of nonviable cells were detected in pond water, EMA-qPCR failed to detect correct quantities of viable cells. However, analyses of spiked tap water samples revealed a high correlation (R-2=0.863) between results from EMA-qPCR and the reference method. After membrane filtration, EMA-qPCR was successfully applied to Campylobacter field isolates, and results indicated an advantage over qPCR by analysing defined mixtures of viable and nonviable cells. In conclusion, EMA-qPCR is a suitable method to detect viable Campylobacter from water samples, but the isolation technique and the type/quality of the water sample impact the results.	[Seinige, Diana; Krischek, Carsten; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Inst Physiol Chem, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Klein, Günter/G-5321-2013; Krischek, Carsten/C-5660-2015; Kehrenberg, Corinna/GSI-9835-2022	Klein, Günter/0000-0003-1931-2701; 	Sanitatsamt der Bundeswehr [M/SAB X/9A006]	Sanitatsamt der Bundeswehr	This study was supported by the Sanitatsamt der Bundeswehr (grant M/SAB X/9A006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulreesh HH, 2005, WATER RES, V39, P2877, DOI 10.1016/j.watres.2005.05.004; Alexandrino M, 2004, WATER RES, V38, P1340, DOI 10.1016/j.watres.2003.10.036; [Anonymous], 2005, 17995 ISO; Bae S, 2012, APPL ENVIRON MICROB, V78, P922, DOI 10.1128/AEM.05157-11; Banihashemi A, 2012, J APPL MICROBIOL, V113, P863, DOI 10.1111/j.1365-2672.2012.05382.x; Blackburn Brian G., 2004, Morbidity and Mortality Weekly Report, V53, P23; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Delgado-Viscogliosi P, 2009, APPL ENVIRON MICROB, V75, P3502, DOI 10.1128/AEM.02878-08; Devane ML, 2014, SCI TOTAL ENVIRON, V485, P666, DOI 10.1016/j.scitotenv.2014.03.027; Edge TA, 2013, APPL ENVIRON MICROB, V79, P5799, DOI 10.1128/AEM.00870-13; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Evans MR, 2003, EMERG INFECT DIS, V9, P1219; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Gubbels SM, 2012, SCAND J INFECT DIS, V44, P586, DOI 10.3109/00365548.2012.655773; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; Hein I, 2007, J MICROBIOL METH, V71, P336, DOI 10.1016/j.mimet.2007.09.005; Hellein KN, 2012, J MICROBIOL METH, V89, P76, DOI 10.1016/j.mimet.2012.01.015; Hellein KN, 2011, J WATER HEALTH, V9, P695, DOI 10.2166/wh.2011.154; Jokinen C, 2011, WATER RES, V45, P1247, DOI 10.1016/j.watres.2010.10.001; Josefsen MH, 2010, APPL ENVIRON MICROB, V76, P5097, DOI 10.1128/AEM.00411-10; Karagiannis I, 2010, EPIDEMIOL INFECT, V138, P1726, DOI 10.1017/S0950268810002116; Khan IUH, 2014, WATER RES, V61, P243, DOI 10.1016/j.watres.2014.05.027; Khan IUH, 2009, J MICROBIOL METH, V79, P307, DOI 10.1016/j.mimet.2009.09.024; Kramer N, 2011, INT J FOOD MICROBIOL, V145, pS86, DOI 10.1016/j.ijfoodmicro.2010.08.026; Kuusi M, 2005, EPIDEMIOL INFECT, V133, P593, DOI 10.1017/S0950268805003808; Melero B, 2011, FOOD MICROBIOL, V28, P1353, DOI 10.1016/j.fm.2011.06.006; O'Reilly CE, 2007, CLIN INFECT DIS, V44, P506, DOI 10.1086/511043; Pacholewicz E, 2013, J MICROBIOL METH, V95, P32, DOI 10.1016/j.mimet.2013.06.003; Pitkanen T, 2013, J MICROBIOL METH, V95, P39, DOI 10.1016/j.mimet.2013.06.008; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Seinige D, 2014, APPL ENVIRON MICROB, V80, P2186, DOI 10.1128/AEM.03962-13; Smith A, 2006, EPIDEMIOL INFECT, V134, P1141, DOI 10.1017/S0950268806006406; Taylor EV, 2013, EPIDEMIOL INFECT, V141, P987, DOI 10.1017/S0950268812001744; Tissier A, 2012, APPL ENVIRON MICROB, V78, P839, DOI 10.1128/AEM.06754-11; Van Dyke MI, 2010, J APPL MICROBIOL, V109, P1053, DOI 10.1111/j.1365-2672.2010.04730.x	35	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113812	10.1371/journal.pone.0113812	http://dx.doi.org/10.1371/journal.pone.0113812			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412499	gold, Green Submitted, Green Published			2022-12-27	WOS:000345253000081
J	Chen, TC; Sung, ML; Kuo, HC; Chien, SJ; Yen, CK; Chen, CN				Chen, Te-Chuan; Sung, Mao-Ling; Kuo, Hsing-Chun; Chien, Shao-Ju; Yen, Chia-Kuang; Chen, Cheng-Nan			Differential Regulation of Human Aortic Smooth Muscle Cell Proliferation by Monocyte-Derived Macrophages from Diabetic Patients	PLOS ONE			English	Article							NEOINTIMAL HYPERPLASIA; INSULIN-RESISTANCE; ATHEROSCLEROSIS; GROWTH; GLUCOSE; EXPRESSION; DISEASE; COMPLICATIONS; ACCUMULATION; INHIBITION	Macrophage accumulation in the arterial wall and smooth muscle cell (SMC) proliferation are features of type 2 diabetes mellitus (DM) and its vascular complications. However, the effects of diabetic monocyte-derived macrophages on vascular SMC proliferation are not clearly understood. In the present study, we investigated the pro-proliferative effect of macrophages isolated from DM patients on vascular SMCs. Macrophage-conditioned media (MCM) were prepared from macrophages isolated from DM patients. DM-MCM treatment induced HASMC proliferation, decreased p21(Cip1) and p27(Kip1) expressions, and increased microRNA (miR)-17-5p and miR-221 expressions. Inhibition of either miR-17-5p or miR-221 inhibited DM-MCM-induced cell proliferation. Inhibition of miR-17-5p abolished DM-MCM-induced p21(Cip1) down-regulation; and inhibition of miR-221 attenuated the DM-MCM-induced p27(Kip1) down-regulation. Furthermore, blocking assays demonstrated that PDGF-CC in DM-MCM is the major mediators of cell proliferation in SMCs. In conclusion, our present data support the hypothesis that SMC proliferation stimulated by macrophages may play critical roles in vascular complications in DM patients and suggest a new mechanism by which arterial disease is accelerated in diabetes.	[Chen, Te-Chuan] Kaohsiung Chang Gung Mem Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Te-Chuan] Chang Gung Univ Coll Med, Kaohsiung, Taiwan; [Sung, Mao-Ling; Yen, Chia-Kuang] St Martin De Porres Hosp, Dept Cardiol, Chiayi, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Inst Nursing, Taoyuan, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Dept Nursing, Taoyuan, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Chien, Shao-Ju] Chang Gung Univ Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Div Pediat Cardiol, Kaohsiung, Taiwan; [Chen, Cheng-Nan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; National Chiayi University	Chen, CN (corresponding author), Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	cnchen@mail.ncyu.edu.tw			Chang Gung Memorial Hospital-Kaohsiung Medical Center [CZRPG880253, CMRPF6A0073, CMRPG891581, CMRPG6C0071, CMRPG6C0011, EZRPF6C0011]; Chang Gung Memorial Hospital; Chang Gung University of Science and Technology, Chia-Yi Campus, Taiwan; National Science Council, Taiwan [NSC101-2320-B-415-003-MY3, NSC102-2314-B-750-001, NSC101-2622-B-255-001-CC3, NSC102-2313-B-255-002]	Chang Gung Memorial Hospital-Kaohsiung Medical Center(Chang Gung Memorial Hospital); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University of Science and Technology, Chia-Yi Campus, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Grants CZRPG880253, CMRPF6A0073, CMRPG891581, CMRPG6C0071, CMRPG6C0011 and EZRPF6C0011 from Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung Memorial Hospital, and Chang Gung University of Science and Technology, Chia-Yi Campus, Taiwan, and by the National Science Council, Taiwan (NSC101-2320-B-415-003-MY3, NSC102-2314-B-750-001, NSC101-2622-B-255-001-CC3, NSC102-2313-B-255-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Askari B, 2002, J BIOL CHEM, V277, P36338, DOI 10.1074/jbc.M205112200; Askari B, 2002, HISTOL HISTOPATHOL, V17, P1317, DOI 10.14670/HH-17.1317; Ballarino M, 2013, ONCOGENE, V32, P4646, DOI 10.1038/onc.2012.490; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Cai QK, 2004, AM J PHYSIOL-CELL PH, V287, pC707, DOI 10.1152/ajpcell.00170.2004; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Chen TC, 2011, J BIOL CHEM, V286, P25564, DOI 10.1074/jbc.M111.230540; Chiang JK, 2011, J CELL PHYSIOL, V226, P1017, DOI 10.1002/jcp.22415; Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Findeisen HM, 2011, ARTERIOSCL THROM VAS, V31, P851, DOI 10.1161/ATVBAHA.110.221952; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Indolfi C, 2001, CIRCULATION, V103, P2980, DOI 10.1161/01.CIR.103.24.2980; Jeong IK, 2011, EXP MOL MED, V43, P684, DOI 10.3858/emm.2011.43.12.079; Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee MJ, 2012, ARTERIOSCL THROM VAS, V32, P2733, DOI 10.1161/ATVBAHA.112.300230; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Liang CP, 2007, CIRC RES, V100, P1546, DOI 10.1161/CIRCRESAHA.107.152165; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Matsumoto T, 2010, AM J PHYSIOL-HEART C, V298, pH731, DOI 10.1152/ajpheart.01157.2009; Osorio Joana, 2010, Nat Rev Cardiol, V7, P666, DOI 10.1038/nrcardio.2010.176; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peiro C, 2001, BRIT J PHARMACOL, V133, P967, DOI 10.1038/sj.bjp.0704184; Proudfoot D, 1999, ATHEROSCLEROSIS, V145, P157, DOI 10.1016/S0021-9150(99)00028-3; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Robinson HC, 2012, CURR OPIN LIPIDOL, V23, P405, DOI 10.1097/MOL.0b013e32835719a1; Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Sun YF, 2013, CARDIOVASC RES, V100, P272, DOI 10.1093/cvr/cvt172; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Yu S, 2012, J CELL BIOCHEM, V113, P2671	39	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113752	10.1371/journal.pone.0113752	http://dx.doi.org/10.1371/journal.pone.0113752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409512	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200152
J	Gutierrez-Rodrigues, F; Santana-Lemos, BA; Scheucher, PS; Alves-Paiva, RM; Calado, RT				Gutierrez-Rodrigues, Fernanda; Santana-Lemos, Barbara A.; Scheucher, Priscila S.; Alves-Paiva, Raquel M.; Calado, Rodrigo T.			Direct Comparison of Flow-FISH and qPCR as Diagnostic Tests for Telomere Length Measurement in Humans	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; BREAST-CANCER RISK; APLASTIC-ANEMIA; SOUTHERN BLOTS; CYTOMETRY; DISEASE; CELLS; ASSOCIATION; SURVIVAL	Telomere length measurement is an essential test for the diagnosis of telomeropathies, which are caused by excessive telomere erosion. Commonly used methods are terminal restriction fragment (TRF) analysis by Southern blot, fluorescence in situ hybridization coupled with flow cytometry (flow-FISH), and quantitative PCR (qPCR). Although these methods have been used in the clinic, they have not been comprehensively compared. Here, we directly compared the performance of flow-FISH and qPCR to measure leukocytes' telomere length of healthy individuals and patients evaluated for telomeropathies, using TRF as standard. TRF and flow-FISH showed good agreement and correlation in the analysis of healthy subjects (R-2 = 0.60; p < 0.0001) and patients (R-2 = 0.51; p < 0.0001). In contrast, the comparison between TRF and qPCR yielded modest correlation for the analysis of samples of healthy individuals (R-2 = 0.35; p < 0.0001) and low correlation for patients (R-2 = 0.20; p = 0.001); Bland-Altman analysis showed poor agreement between the two methods for both patients and controls. Quantitative PCR and flow-FISH modestly correlated in the analysis of healthy individuals (R-2 = 0.33; p < 0.0001) and did not correlate in the comparison of patients' samples (R-2 = 0.1, p = 0.08). Intra-assay coefficient of variation (CV) was similar for flow-FISH (10.8 +/- 67.1%) and qPCR (9.5 +/- 67.4%; p = 0.35), but the inter-assay CV was lower for flow-FISH (9.6 +/- 67.6% vs. 16 +/- 619.5%; p=0.02). Bland-Altman analysis indicated that flow-FISH was more precise and reproducible than qPCR. Flow-FISH and qPCR were sensitive (both 100%) and specific (93% and 89%, respectively) to distinguish very short telomeres. However, qPCR sensitivity (40%) and specificity (63%) to detect telomeres below the tenth percentile were lower compared to flow-FISH (80% sensitivity and 85% specificity). In the clinical setting, flow-FISH was more accurate, reproducible, sensitive, and specific in the measurement of human leukocyte's telomere length in comparison to qPCR. In conclusion, flow-FISH appears to be a more appropriate method for diagnostic purposes.	[Gutierrez-Rodrigues, Fernanda; Santana-Lemos, Barbara A.; Scheucher, Priscila S.; Alves-Paiva, Raquel M.; Calado, Rodrigo T.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Internal Med, Sao Paulo, Brazil; [Gutierrez-Rodrigues, Fernanda; Santana-Lemos, Barbara A.; Scheucher, Priscila S.; Alves-Paiva, Raquel M.; Calado, Rodrigo T.] Sao Paulo Res Fdn FAPESP, Ctr Cell Based Therapy, Sao Paulo, Brazil	Universidade de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Calado, RT (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Internal Med, Sao Paulo, Brazil.	rtcalado@fmrp.usp.br	Scheucher, Priscila S/F-1599-2013; SANTANA, BARBARA A/T-3867-2017; Gutierrez-Rodrigues, Fernanda/AAU-4947-2020; Calado, Rodrigo T./G-2619-2011; CTC USP, CEPID 13 18/J-8951-2014	Scheucher, Priscila S/0000-0003-3111-8506; SANTANA, BARBARA A/0000-0001-7361-0764; Calado, Rodrigo T./0000-0002-7966-6029; CTC USP, CEPID 13 18/0000-0002-7123-9524	Sao Paulo Research Foundation (FAPESP) [13/08135-2]; FAPESP [2011/16177-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP; grant number, 13/08135-2). FGR was a recipient of a FAPESP scholarship (grant number, 2011/16177-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Baerlocher GM, 2002, CYTOMETRY, V47, P89, DOI 10.1002/cyto.10053; Baird DM, 2005, EXP GERONTOL, V40, P363, DOI 10.1016/j.exger.2005.02.008; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calado RT, 2012, LEUKEMIA, V26, P700, DOI 10.1038/leu.2011.272; Calado Rodrigo T, 2009, Hematology Am Soc Hematol Educ Program, P338, DOI 10.1182/asheducation-2009.1.338; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Elbers CC, 2014, J GERONTOL A-BIOL, V69, P527, DOI 10.1093/gerona/glt121; Gadalla SM, 2011, BLOOD REV, V25, P261, DOI 10.1016/j.blre.2011.06.004; Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651; Kapoor Veena, 2004, Methods Mol Biol, V263, P385; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nishio N, 2010, INT J HEMATOL, V92, P419, DOI 10.1007/s12185-010-0695-5; Pavesi E, 2009, PEDIATR BLOOD CANCER, V53, P411, DOI 10.1002/pbc.22107; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Scheinberg P, 2010, JAMA-J AM MED ASSOC, V304, P1358, DOI 10.1001/jama.2010.1376; Shen J, 2007, CANCER RES, V67, P5538, DOI 10.1158/0008-5472.CAN-06-3490; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	32	93	98	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113747	10.1371/journal.pone.0113747	http://dx.doi.org/10.1371/journal.pone.0113747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409313	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200150
J	Hleap, JS; Blouin, C				Hleap, Jose Sergio; Blouin, Christian			Inferring Meaningful Communities from Topology-Constrained Correlation Networks	PLOS ONE			English	Article							AMYLASE; CONSISTENCY; SELECTION; EVOLUTION; DATABASE; MODEL	Community structure detection is an important tool in graph analysis. This can be done, among other ways, by solving for the partition set which optimizes the modularity scores Q. Here it is shown that topological constraints in correlation graphs induce over-fragmentation of community structures. A refinement step to this optimization based on Linear Discriminant Analysis (LDA) and a statistical test for significance is proposed. In structured simulation constrained by topology, this novel approach performs better than the optimization of modularity alone. This method was also tested with two empirical datasets: the Roll-Call voting in the 110th US Senate constrained by geographic adjacency, and a biological dataset of 135 protein structures constrained by inter-residue contacts. The former dataset showed sub-structures in the communities that revealed a regional bias in the votes which transcend party affiliations. This is an interesting pattern given that the 110th Legislature was assumed to be a highly polarized government. The alpha-amylase catalytic domain dataset (biological dataset) was analyzed with and without topological constraints (inter-residue contacts). The results without topological constraints showed differences with the topology constrained one, but the LDA filtering did not change the outcome of the latter. This suggests that the LDA filtering is a robust way to solve the possible over-fragmentation when present, and that this method will not affect the results where there is no evidence of over-fragmentation.	[Hleap, Jose Sergio; Blouin, Christian] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Blouin, Christian] Dalhousie Univ, Dept Comp Sci, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Hleap, JS (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	jshleap@dal.ca		Hleap, Jose Sergio/0000-0003-2602-5276; Blouin, Christian/0000-0002-4434-4142	NSERC [120504858]; Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship	This study was funded by NSERC through the grant No. 120504858. This work was partially supported by The Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben Ali M, 2006, BIOCHEM J, V394, P51, DOI 10.1042/BJ20050726; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Burt RS, 2013, ANNU REV PSYCHOL, V64, P527, DOI 10.1146/annurev-psych-113011-143828; Cho WKT, 2010, J POLIT, V72, P124, DOI 10.1017/S002238160999051X; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Diestel R., 2012, GRADUATE TEXTS MATH, V173; Dobra A, 2004, J MULTIVARIATE ANAL, V90, P196, DOI 10.1016/j.jmva.2004.02.009; FARBER GK, 1993, CURR OPIN STRUC BIOL, V3, P409, DOI 10.1016/S0959-440X(05)80114-9; Fidelak J, 2010, EUR BIOPHYS J BIOPHY, V39, P1503, DOI 10.1007/s00249-010-0608-9; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Fortunato S., 2012, COMPUT COMPLEX THEOR, P490, DOI [10.1007/978-1-4614-1800-9_33, DOI 10.1007/978-1-4614-1800-9_33]; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Gorman SP, 2000, TELECOMMUN POLICY, V24, P113, DOI 10.1016/S0308-5961(00)00005-7; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Hleap Jose S., 2013, 5th International Conference on Bioinformatics and Computational Biology (BICOB-2013). Proceedings, P153; Hleap JS, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-20; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Jacob L., 2009, P 26 ANN INT C MACH, P26, DOI DOI 10.1145/1553374.1553431; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Keskin M, 2011, PHYSICA A, V390, P719, DOI 10.1016/j.physa.2010.10.041; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; Muller-Linow M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-44; Mukherjee S, 2011, BIOINFORMATICS, V27, P994, DOI 10.1093/bioinformatics/btr070; Murdoch D, 2013, ELLIPSE FUNCTIONS DR; Navia AF, 2010, ECOL MODEL, V221, P2918, DOI 10.1016/j.ecolmodel.2010.09.006; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Onnela JP, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036104; Rao C. R., 2009, LINEAR STAT INFERENC, V22; Reichardt J, 2009, UNDERST COMPLEX SYST, P147, DOI 10.1007/978-3-540-92267-4_7; Reichardt J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015102; Stanford NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079195; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Venables WN., 2002, MODERN APPL STAT S 4; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zhao P, 2006, J MACH LEARN RES, V7, P2541	49	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113438	10.1371/journal.pone.0113438	http://dx.doi.org/10.1371/journal.pone.0113438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409022	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200123
J	Kristensen, SL; Galloe, AM; Thuesen, L; Kelbaek, H; Thayssen, P; Havndrup, O; Hansen, PR; Bligaard, N; Saunamaki, K; Junker, A; Aaroe, J; Abildgaard, U; Jeppesen, JL				Kristensen, Soren Lund; Galloe, Anders M.; Thuesen, Leif; Kelbaek, Henning; Thayssen, Per; Havndrup, Ole; Hansen, Peter Riis; Bligaard, Niels; Saunamaki, Kari; Junker, Anders; Aaroe, Jens; Abildgaard, Ulrik; Jeppesen, Jorgen L.			Stent Thrombosis is the Primary Cause of ST-Segment Elevation Myocardial Infarction following Coronary Stent Implantation: A Five Year Follow-Up of the SORT OUT II Study	PLOS ONE			English	Article							SIROLIMUS-ELUTING STENTS; HIGH-RISK PATIENTS; CLINICAL-PRACTICE; INTERVENTION; TRIAL; PREDICTORS; COHORT	Background: The widespread use of coronary stents has exposed a growing population to the risk of stent thrombosis, but the importance in terms of risk of ST-segment elevation myocardial infarctions (STEMIs) remains unclear. Methods: We studied five years follow-up data for 2,098 all-comer patients treated with coronary stents in the randomized SORT OUT II trial (mean age 63.6 yrs. 74.8% men). Patients who following stent implantation were readmitted with STEMI were included and each patient was categorized ranging from definite-to ruled-out stent thrombosis according to the Academic Research Consortium definitions. Multivariate logistic regression was performed on selected covariates to assess odds ratios (ORs) for definite stent thrombosis. Results: 85 patients (4.1%), mean age 62.7 years, 77.1% men, were admitted with a total of 96 STEMIs, of whom 60 (62.5%) had definite stent thrombosis. Notably, definite stent thrombosis was more frequent in female than male STEMI patients (81.8% vs. 56.8%, p=0.09), and in very late STEMIs (p=0.06). Female sex (OR 3.53 [1.01-12.59]) and clopidogrel (OR 4.43 [1.03-19.01]) was associated with increased for definite stent thrombosis, whereas age, time since stent implantation, use of statins, initial PCI urgency (STEMI [primary PCI], NSTEMI/unstable angina [subacute PCI] or stable angina [elective PCI]), and glucose-lowering agents did not seem to influence risk of stent thrombosis. Conclusion: In a contemporary cohort of coronary stented patients, stent thrombosis was evident in more than 60% of subsequent STEMIs.	[Kristensen, Soren Lund; Galloe, Anders M.; Havndrup, Ole] Univ Copenhagen, Hosp Roskilde, Dept Cardiol, Roskilde, Denmark; [Kristensen, Soren Lund; Hansen, Peter Riis; Abildgaard, Ulrik] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Thuesen, Leif] Aarhus Univ, Hosp Herning, Dept Med, Herning, Denmark; [Kelbaek, Henning; Saunamaki, Kari] Copenhagen Univ Hosp, Rigshosp, Ctr Heart, Copenhagen, Denmark; [Thayssen, Per; Junker, Anders] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Bligaard, Niels] Univ Copenhagen, Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Aaroe, Jens] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Jeppesen, Jorgen L.] Univ Copenhagen, Glostrup Hosp, Dept Med, Glostrup, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; Aalborg University; Aalborg University Hospital; University of Copenhagen	Kristensen, SL (corresponding author), Univ Copenhagen, Hosp Roskilde, Dept Cardiol, Roskilde, Denmark.	slk@heart.dk	Kristensen, Søren Lund/J-5267-2019; Hansen, Peter Riis/AAR-7659-2020	Kristensen, Søren Lund/0000-0002-9759-7397; Saunamaki, Kari/0000-0001-5953-5243	Boston Scientific; Cordis; Johnson & Johnson company	Boston Scientific(Boston Scientific); Cordis; Johnson & Johnson company(Johnson & JohnsonJohnson & Johnson USA)	Boston Scientific and Cordis, a Johnson & Johnson company, supported the completion of the primary SORT OUT II study and event detection for a follow-up period of five years. They had no role in the design of the current substudy and did not provide support for its completion.	Bligaard N, 2014, SCAND CARDIOVASC J, V48, P148, DOI 10.3109/14017431.2014.883461; Brodie BR, 2012, J AM COLL CARDIOL, V60, P1989, DOI 10.1016/j.jacc.2012.07.043; Chechi T, 2008, J AM COLL CARDIOL, V51, P2396, DOI 10.1016/j.jacc.2008.01.070; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; D'Ascenzo F, 2012, INT J CARDIOL, V2, P575; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Ergelen M, 2010, AM HEART J, V159, P672, DOI 10.1016/j.ahj.2009.12.032; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Li J, 2013, EUR HEART J, V34, P1375, DOI 10.1093/eurheartj/eht005; Lindhardsen J, 2012, ANN RHEUM DIS, V71, P1496, DOI 10.1136/annrheumdis-2011-200806; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Parodi G, 2009, AM J CARDIOL, V103, P913, DOI 10.1016/j.amjcard.2008.12.006; Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055	18	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113399	10.1371/journal.pone.0113399	http://dx.doi.org/10.1371/journal.pone.0113399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409336	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200110
J	Spence, S; Delve, J; Stamp, E; Matthews, JNS; White, M; Adamson, AJ				Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; Matthews, John N. S.; White, Martin; Adamson, Ashley J.			Did School Food and Nutrient-Based Standards in England Impact on 11-12Y Olds Nutrient Intake at Lunchtime and in Total Diet? Repeat Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDREN; OBESITY; CHILDHOOD; PREVALENCE; ADULTHOOD; QUALITY; WEIGHTS; LUNCHES; TRENDS	Introduction: In September 2009, middle and secondary schools in England were required to comply with food and nutrient-based standards for school food. We examined the impact of this policy change on children's lunchtime and total dietary intake. Methods: We undertook repeat cross-sectional surveys in six Northumberland middle schools in 1999-2000 and 2009-10. Dietary data were collected from 11-12 y olds (n = 298 in 1999-2000; n = 215 in 2009-10). Children completed two consecutive 3-day food diaries, each followed by an interview. Linear mixed effect models examined the effect of year, lunch type and level of socio-economic deprivation on children's mean total dietary intake. Results: We found both before and after the introduction of the food and nutrient-based standards children consuming a school lunch, had a lower per cent energy from saturated fat (20.5%; p = 0.02), and a lower intake of sodium (-143 mg; p = 0.02), and calcium (-81 mg; p = 0.001) in their total diet, compared with children consuming a home-packed lunch. We found no evidence that lunch type was associated with mean energy, or absolute amounts of NSP, vitamin C and iron intake. There was marginal evidence of an association between lunch type and percent energy NMES (p = 0.06). In 1999-2000, children consuming a school lunch had a higher per cent energy from fat in their total diet compared with children consuming a home-packed lunch (2.8%), whereas by 2009-10, they had slightly less (-0.2%) (year by lunch type interaction p<0.001; change in mean differences -3%). Conclusions: We found limited evidence of an impact of the school food and nutrient-based standards on total diet among 11-12 year olds. Such policies may need to be supported by additional measures, including guidance on individual food choice, and the development of wider supportive environments in school and beyond the school gates.	[Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; White, Martin; Adamson, Ashley J.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; White, Martin; Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Matthews, John N. S.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [White, Martin; Adamson, Ashley J.] UKCRC Ctr Translat Res Publ Hlth, Fuse, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Adamson, AJ (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ashley.adamson@ncl.ac.uk		White, Martin/0000-0002-1861-6757; Spence, Suzanne/0000-0002-7089-7197; Adamson, Ashley/0000-0003-3735-2846	Department of Health (DH) Policy Research Programme; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under UKCRC; National Institute of Health Research as an NIHR; Economic and Social Research Council [ES/G007462/1, ES/G007470/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MR/K02325X/1B, MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001] Funding Source: researchfish; ESRC [ES/G007470/1, ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI	Department of Health (DH) Policy Research Programme; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under UKCRC; National Institute of Health Research as an NIHR; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken as part of the research programme of the Public Health Research Consortium (PHRC). The Public Health Research Consortium is funded by the Department of Health (DH) Policy Research Programme. The views expressed in this publication are those of the authors and not necessarily those of DH. Information about the wider programme of the PHRC is available from http://phrc.lshtm.ac.uk/. The funders had no role in the study design, data collection or analysis, interpretation of findings, writing of, or the decision to submit for publication. All authors had access to data, and take responsibility for the integrity of the data and the accuracy of the data analysis. MW is director and AJA is associate director of Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UKCRC, is gratefully acknowledged. AJA is funded by the National Institute of Health Research as an NIHR Research Professor. Opinions expressed are not necessarily those of the funders.	Adamson A, 2011, PROCESS IMPACT CHANG; Adamson AJ, 1996, J HUM NUTR DIET, V9, P55, DOI 10.1046/j.1365-277X.1996.00441.x; Adamson AJ, 1992, BR J NUTR, V68, P543; Bates B, 2011, NATL DIET NUTR SURVE; Bates B, 2008, NAT DIET NUTR SURV H; Bates CJ, 2000, NATL DIET NUTR SURVE; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Craigie AM, 2009, OBESITY FACTS, V2, P150, DOI 10.1159/000218092; Department of Health, 1991, DIET REF VAL FOOD EN; Department of Health, 2005, CHOOS BETT DIET FOOD; Department of Health, 2004, CHOOS HLTH MAK HLTH; Evans CEL, 2010, BRIT J NUTR, V104, P474, DOI 10.1017/S0007114510001601; Fletcher A, 2014, SOCIOLOGY, V48, P500, DOI 10.1177/0038038513500102; Fletcher ES, 2004, BRIT J NUTR, V92, P321, DOI 10.1079/BJN20041199; Food Standards Agency, 2002, MCCANCE WIDD COMP FO; Foster E., 2010, YOUNG PERSONS FOOD A; Fung C, 2013, PREV MED, V57, P934, DOI 10.1016/j.ypmed.2013.07.016; Golley R, 2011, PUBLIC HEALTH NUTR, V14, P271, DOI 10.1017/S1368980010002120; HACKETT AF, 1984, ANN HUM BIOL, V11, P545, DOI 10.1080/03014468400007461; HACKETT AF, 1983, HUM NUTR-APPL NUTR, V37, P293; HACKETT AF, 1985, HUM NUTR-APPL NUTR, V39A, P167; HACKETT AF, 1984, BRIT J NUTR, V51, P67, DOI 10.1079/BJN19840010; Haroun D, 2011, PUBLIC HEALTH NUTR, V14, P209, DOI 10.1017/S1368980010002132; Harrison F, 2013, PUBLIC HEALTH NUTR, V16, P1132, DOI 10.1017/S1368980011002321; Hur I., 2011, ICAN: Infant, Child & Adolescent Nutrition, V3, P70; Kitchen S, 2013, SCH FOOD HEAD TEACH; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Nelson M, 2011, STAT REL TAK SCH LUN; Pearce J, 2013, J HUM NUTR DIET, V26, P553, DOI 10.1111/jhn.12067; Pearce J, 2013, PUBLIC HEALTH NUTR, V16, P1126, DOI 10.1017/S1368980012003928; Pearce J, 2011, PUBLIC HEALTH NUTR, V14, P1507, DOI 10.1017/S1368980010003605; Pockett RD, 2011, CURR MED RES OPIN, V27, P777, DOI 10.1185/03007995.2011.555757; Prynne CJ, 2013, PUBLIC HEALTH NUTR, V16, P1118, DOI 10.1017/S1368980011002205; Rees GA, 2008, J HUM NUTR DIET, V21, P420, DOI 10.1111/j.1365-277X.2008.00885.x; Rogers IS, 2007, EUR J CLIN NUTR, V61, P856, DOI 10.1038/sj.ejcn.1602592; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Ruag-Gunn AJ, 2007, PUBLIC HEALTH NUTR, V10, P354, DOI 10.1017/S1368980007249729; School Food Trust, GUID INTR GOV FOOD B; Spence S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078298; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029; Stevens L, 2011, SECONDARY SCH FOOD S; Stevens L, 2013, PUBLIC HEALTH NUTR, V16, P1037, DOI 10.1017/S1368980013000852; Taylor JP, 2012, PUBLIC HEALTH NUTR, V15, P2259, DOI 10.1017/S1368980012000699; The Health and Social Care Information Centre, 2012, NAT CHILD MEAS PROGR; Wills W, 2005, HEALTH EDUC RES, V20, P458, DOI 10.1093/her/cyg132	48	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112648	10.1371/journal.pone.0112648	http://dx.doi.org/10.1371/journal.pone.0112648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409298	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200030
J	Yamaji, K; Suzuki, Y; Suzuki, H; Satake, K; Horikoshi, S; Novak, J; Tomino, Y				Yamaji, Kenji; Suzuki, Yusuke; Suzuki, Hitoshi; Satake, Kenji; Horikoshi, Satoshi; Novak, Jan; Tomino, Yasuhiko			The Kinetics of Glomerular Deposition of Nephritogenic IgA	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; ABERRANTLY GLYCOSYLATED IGA1; IMMUNE-COMPLEXES; BONE-MARROW; GLOMERULONEPHRITIS; MODEL; SUSCEPTIBILITY; PATHOGENESIS; ACTIVATION; CLEARANCE	Whether IgA nephropathy is attributable to mesangial IgA is unclear as there is no correlation between intensity of deposits and extent of glomerular injury and no clear mechanism explaining how these mesangial deposits induce hematuria and subsequent proteinuria. This hinders the development of a specific therapy. Thus, precise events during deposition still remain clinical challenge to clarify. Since no study assessed induction of IgA nephropathy by nephritogenic IgA, we analyzed sequential events involving nephritogenic IgA from IgA nephropathy-prone mice by real-time imaging systems. Immunofluorescence and electron microscopy showed that serum IgA from susceptible mice had strong affinity to mesangial, subepithelial, and subendothelial lesions, with effacement/actin aggregation in podocytes and arcade formation in endothelial cells. The deposits disappeared 24-h after single IgA injection. The data were supported by a fluorescence molecular tomography system and real-time and 3D in vivo imaging. In vivo imaging showed that IgA from the susceptible mice began depositing along the glomerular capillary from 1 min and accumulated until 2-h on the first stick in a focal and segmental manner. The findings indicate that glomerular IgA depositions in IgAN may be expressed under the balance between deposition and clearance. Since nephritogenic IgA showed mesangial as well as focal and segmental deposition along the capillary with acute cellular activation, all glomerular cellular elements are a plausible target for injury such as hematuria.	[Yamaji, Kenji; Suzuki, Yusuke; Suzuki, Hitoshi; Satake, Kenji; Horikoshi, Satoshi; Tomino, Yasuhiko] Juntendo Univ, Sch Med, Div Nephrol, Dept Internal Med, Tokyo 113, Japan; [Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Juntendo University; University of Alabama System; University of Alabama Birmingham	Tomino, Y (corresponding author), Juntendo Univ, Sch Med, Div Nephrol, Dept Internal Med, Tokyo 113, Japan.	yasu@juntendo.ac.jp			Ministry of Health, Labor and Welfare of Japan; Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgA Nephropathy in Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgA Nephropathy in Japan	A part of this study was supported by research funds from Grant-in-Aids for Progressive Renal Disease Research, Research on intractable disease, from the Ministry of Health, Labor and Welfare of Japan, a grant from Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program and a grant from the Study Group on IgA Nephropathy in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2007, CONTRIB NEPHROL, V157, P164, DOI 10.1159/000102462; Aizawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095365; Moreno JA, 2012, NEPHROL DIAL TRANSPL, V27, P28, DOI 10.1093/ndt/gfr749; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BAKE AWLV, 1989, NEPHROLOGIE, V10, P141; Barratt J, 2007, SEMIN IMMUNOPATHOL, V29, P427, DOI 10.1007/s00281-007-0089-9; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; BOYCE NW, 1987, KIDNEY INT, V31, P8, DOI 10.1038/ki.1987.2; CAMERON JS, 1982, CLIN NEPHROL, V18, P55; DAMICO G, 1987, Q J MED, V64, P709; Devi S, 2013, NAT MED, V19, P107, DOI 10.1038/nm.3024; Donadio JV, 1997, J AM SOC NEPHROL, V8, P1324; GALLA JH, 1995, KIDNEY INT, V47, P377, DOI 10.1038/ki.1995.50; Hashimoto A, 2012, AM J PATHOL, V181, P1338, DOI 10.1016/j.ajpath.2012.06.038; HEBERT LA, 1988, AM J KIDNEY DIS, V12, P388, DOI 10.1016/S0272-6386(88)80031-3; Hiki Y, 1999, J AM SOC NEPHROL, V10, P760; Iwata Y, 2006, INTERNAL MED, V45, P1291, DOI 10.2169/internalmedicine.45.1837; JULIAN BA, 1991, AM J KIDNEY DIS, V17, P472, DOI 10.1016/S0272-6386(12)80643-3; Kajiyama T, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819646; Kobayashi I, 2002, NEPHROL DIAL TRANSPL, V17, P2108, DOI 10.1093/ndt/17.12.2108; Maiguma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090558; MONTEIRO RC, 1985, KIDNEY INT, V28, P666, DOI 10.1038/ki.1985.181; Nakata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089707; Nakata J, 2013, NEPHROL DIAL TRANSPL, V28, P320, DOI 10.1093/ndt/gfs467; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Okazaki K, 2012, J AM SOC NEPHROL, V23, P1364, DOI 10.1681/ASN.2011121160; RIFAI A, 1987, KIDNEY INT, V31, P1, DOI 10.1038/ki.1987.1; RIFAI A, 1983, J IMMUNOL, V130, P1826; RIFAI A, 1984, J EXP MED, V160, P125, DOI 10.1084/jem.160.1.125; ROCCATELLO D, 1992, LAB INVEST, V66, P86; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Suzuki H, 2007, KIDNEY INT, V72, P319, DOI 10.1038/sj.ki.5002300; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; Suzuki Y, 2002, J IMMUNOL, V169, P4136, DOI 10.4049/jimmunol.169.8.4136; Suzuki Y, 2014, CLIN EXP NEPHROL; Suzuki Y, 2008, SEMIN NEPHROL, V28, P66, DOI 10.1016/j.semnephrol.2007.10.008; Suzuki Y, 2007, CONTRIB NEPHROL, V157, P70, DOI 10.1159/000102307; WARD DM, 1986, KIDNEY INT, V30, P706, DOI 10.1038/ki.1986.244; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Zuo N, 2011, NEPHROL DIAL TRANSPL, V26, P2127, DOI 10.1093/ndt/gfq687	45	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113005	10.1371/journal.pone.0113005	http://dx.doi.org/10.1371/journal.pone.0113005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409466	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200056
J	Dong, P; Zhang, SY; Cai, MH; Kang, N; Hu, Y; Cui, LX; Zhang, JM; He, W				Dong, Peng; Zhang, Siya; Cai, Menghua; Kang, Ning; Hu, Yu; Cui, Lianxian; Zhang, Jianmin; He, Wei			Global Characterization of Differential Gene Expression Profiles in Mouse V gamma 1(+) and V gamma 4(+) gamma delta T Cells	PLOS ONE			English	Article							COXSACKIEVIRUS B3-INDUCED MYOCARDITIS; TRANSCRIPTION FACTOR; AIRWAY HYPERREACTIVITY; PROTECTIVE ROLE; TUMOR-IMMUNITY; INTERLEUKIN 22; TH1 CELLS; TGF-BETA; SUBSETS; MICE	Peripheral gamma delta T cells in mice are classified into two major subpopulations, V gamma 1+ and V gamma 4+, based on the composition of T cell receptors. However, their intrinsic differences remain unclear. In this study, we analyzed gene expression profiles of the two subsets using Illumina HiSeq 2000 Sequencer. We identified 1995 transcripts related to the activation of V gamma 1+ gamma delta T cells, and 2158 transcripts related to the activation of V gamma 4+ gamma delta T cells. We identified 24 transcripts differentially expressed between the two subsets in resting condition, and 20 after PMA/Ionomycin treatment. We found that both cell types maintained phenotypes producing IFN-gamma, TNF-alpha, TGF-beta and IL-10. However, V gamma 1+ gamma delta T cells produced more Th2 type cytokines, such as IL-4 and IL-5, while V gamma 4+ gamma delta T cells preferentially produced IL-17. Our study provides a comprehensive gene expression profile of mouse peripheral V gamma 1+ and V gamma 4+ gamma delta T cells that describes the inherent differences between them.	[Dong, Peng; Zhang, Siya; Cai, Menghua; Kang, Ning; Hu, Yu; Cui, Lianxian; Zhang, Jianmin; He, Wei] Chinese Acad Med Sci, Dept Immunol, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Dong, Peng; Zhang, Siya; Cai, Menghua; Kang, Ning; Hu, Yu; Cui, Lianxian; Zhang, Jianmin; He, Wei] Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China; [Zhang, Jianmin] Johns Hopkins Univ, Sch Med, Dept Neurol, Neuroregenerat & Stem Cell Programs,Inst Cell Eng, Baltimore, MD 21205 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Johns Hopkins University	Zhang, JM (corresponding author), Chinese Acad Med Sci, Dept Immunol, Inst Basic Med Sci, Beijing 100730, Peoples R China.	jzhang42@gmail.com; heweiimu@public.bta.net.cn			Health Research Special Program, Ministry of Science and Technology of the People's Republic of China [20130217]	Health Research Special Program, Ministry of Science and Technology of the People's Republic of China	This study was supported by the Health Research Special Program, Ministry of Science and Technology of the People's Republic of China (Grant No. 20130217). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Hahn YS, 2004, J IMMUNOL, V172, P2894, DOI 10.4049/jimmunol.172.5.2894; Hahn YS, 2003, J IMMUNOL, V171, P3170, DOI 10.4049/jimmunol.171.6.3170; Hao JL, 2011, J IMMUNOL, V187, P4979, DOI 10.4049/jimmunol.1101389; He WF, 2010, J IMMUNOL, V185, P126, DOI 10.4049/jimmunol.0903767; Hedges JF, 2003, J LEUKOCYTE BIOL, V73, P306, DOI 10.1189/jlb.0902453; Huang YF, 2009, J IMMUNOL, V183, P849, DOI 10.4049/jimmunol.0804104; Huber S, 2002, J VIROL, V76, P6487, DOI 10.1128/JVI.76.13.6487-6494.2002; Huber SA, 2000, J IMMUNOL, V165, P4174, DOI 10.4049/jimmunol.165.8.4174; Huber SA, 2002, J VIROL, V76, P10785, DOI 10.1128/JVI.76.21.10785-10790.2002; Huber SA, 2001, J VIROL, V75, P5860, DOI 10.1128/JVI.75.13.5860-5869.2001; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten AM, 2009, NUCL RECEPT SIGNAL, V7, pe003; Jin N, 2009, J IMMUNOL, V182, P2002, DOI 10.4049/jimmunol.0803280; Kang N, 2009, IMMUNOL LETT, V125, P105, DOI 10.1016/j.imlet.2009.06.005; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Kress E, 2006, MOL IMMUNOL, V43, P2002, DOI 10.1016/j.molimm.2005.11.011; Lahn M, 2002, P NATL ACAD SCI USA, V99, P8850, DOI 10.1073/pnas.132519299; Lanca T, 2013, J IMMUNOL, V190, P6673, DOI 10.4049/jimmunol.1300434; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Li LB, 2007, BLOOD, V110, P1570, DOI 10.1182/blood-2007-01-070755; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matsuzaki G, 2002, EUR J IMMUNOL, V32, P928, DOI 10.1002/1521-4141(200204)32:4<928::AID-IMMU928>3.0.CO;2-I; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; Meissner N, 2003, J IMMUNOL, V170, P356, DOI 10.4049/jimmunol.170.1.356; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; O'Brien RL, 2000, J IMMUNOL, V165, P6472, DOI 10.4049/jimmunol.165.11.6472; O'Brien RL, 2010, GAMMADELTA T CELL SU, P193; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Resar LMS, 2010, CANCER RES, V70, P436, DOI 10.1158/0008-5472.CAN-09-1212; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Richards MH, 2000, MOL BIOL EVOL, V17, P146, DOI 10.1093/oxfordjournals.molbev.a026227; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Timerbaev A, 2012, CURR DRUG METAB, V13, P272, DOI 10.2174/138920012799320473; Tramonti D, 2006, EUR J IMMUNOL, V36, P1729, DOI 10.1002/eji.200635959; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Welte T, 2008, FEMS IMMUNOL MED MIC, V53, P275, DOI 10.1111/j.1574-695X.2008.00430.x; Xi Y, 2012, CANCER SCI, V103, P439, DOI 10.1111/j.1349-7006.2011.02159.x; Zhao N, 2011, J IMMUNOL, V187, P5007, DOI 10.4049/jimmunol.1101315	56	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112964	10.1371/journal.pone.0112964	http://dx.doi.org/10.1371/journal.pone.0112964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405356	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300066
J	Guan, WJ; Gao, YH; Xu, G; Lin, ZY; Tang, Y; Li, HM; Lin, ZM; Zheng, JP; Chen, RC; Zhong, NS				Guan, Wei-Jie; Gao, Yong-hua; Xu, Gang; Lin, Zhi-ya; Tang, Yan; Li, Hui-min; Lin, Zhi-min; Zheng, Jin-ping; Chen, Rong-chang; Zhong, Nan-shan			Characterization of Lung Function Impairment in Adults with Bronchiectasis	PLOS ONE			English	Article							PULMONARY-FUNCTION; PSEUDOMONAS-AERUGINOSA; FUNCTION DECLINE; EXACERBATIONS	Background: Characteristics of lung function impairment in bronchiectasis is not fully understood. Objectives: To determine the factors associated with lung function impairment and to compare changes in spirometry during bronchiectasis exacerbation and convalescence (1 week following 14-day antibiotic therapy). Methods: We recruited 142 patients with steady-state bronchiectasis, of whom 44 with acute exacerbations in the follow-up were included in subgroup analyses. Baseline measurements consisted of chest high-resolution computed tomography (HRCT), sputum volume, purulence and bacteriology, spirometry and diffusing capacity. Spirometry, but not diffusing capacity, was examined during acute exacerbations and convalescence. Results: In the final multivariate models, having bronchiectasis symptoms for 10 years or greater (OR = 4.75, 95% CI: 1.46-15.43, P = 0.01), sputum culture positive for Pseudomonas aeruginosa (OR = 4.93, 95% CI: 1.52-15.94, P<0.01) and HRCT total score being 12 or greater (OR = 7.77, 95% CI: 3.21-18.79, P<0.01) were the major variables associated with FEV1 being 50% pred or less; and the only variable associated with reduced DLCO was 4 or more bronchiectatic lobes (OR = 5.91, 95% CI: 2.20-17.23, P<0.01). Overall differences in FVC and FEV1 during exacerbations and convalescence were significant (P<0.05), whereas changes in other spirometric parameters were less notable. This applied even when stratified by the magnitude of FEV1 and DLCO reduction at baseline. Conclusion: Significant lung function impairment should raise alert of chest HRCT abnormality and sputum culture positive for Pseudomonas aeruginosa, in patients with predominantly mild to moderate steady-state bronchiectasis. Acute exacerbations elicited reductions in FVC and FEV1. Changes of other spirometric parameters were less significant during exacerbations.	[Guan, Wei-Jie; Lin, Zhi-ya; Tang, Yan; Li, Hui-min; Lin, Zhi-min; Zheng, Jin-ping; Chen, Rong-chang; Zhong, Nan-shan] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Gao, Yong-hua] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou 450052, Henan, Peoples R China; [Xu, Gang] Guangzhou First Peoples Hosp, Dept Geriatr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Zhengzhou University; South China University of Technology	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chenrc@vip.163.com; nanshan@vip.163.com	Guan, Wei-jie/K-8257-2019		Changjiang Scholars and Innovative Research Team in University [ITR0961]; National Key Technology R&D Program of the 12th National Five-year Development Plan [2012BAI05B01]; National Key Scientific Technology [2013BAI09B09]	Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); National Key Scientific Technology	This work received funding from Changjiang Scholars and Innovative Research Team in University ITR0961, The National Key Technology R&D Program of the 12th National Five-year Development Plan 2012BAI05B01 and National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer No. 2013BAI09B09 (to Profs. Zhong and Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai TR, 2007, EUR RESPIR J, V30, P452, DOI 10.1183/09031936.00165106; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; Evans SA, 1996, EUR RESPIR J, V9, P1601, DOI 10.1183/09031936.96.09081601; Haworth CS, 2014, AM J RESP CRIT CARE, V189, P975, DOI 10.1164/rccm.201312-2208OC; Ho PL, 1998, CHEST, V114, P1594, DOI 10.1378/chest.114.6.1594; IP M, 1993, RESPIRATION, V60, P45; Loubeyre P, 1996, CHEST, V109, P360, DOI 10.1378/chest.109.2.360; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; McDonnell MJ, 2015, RESP MED, V109, P716, DOI 10.1016/j.rmed.2014.07.021; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Roberts HR, 2000, THORAX, V55, P198, DOI 10.1136/thorax.55.3.198; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Rowan SA, 2014, AM J RESP CRIT CARE, V189, P586, DOI 10.1164/rccm.201310-1747OC; White Andrew J, 2005, COPD, V2, P419, DOI 10.1080/15412550500346477; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50	18	34	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113373	10.1371/journal.pone.0113373	http://dx.doi.org/10.1371/journal.pone.0113373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405614	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300110
J	Jah-Kabba, AMBM; Kukuk, GM; Hadizadeh, DR; Traber, F; Koscielny, A; Kabba, MS; Verrel, F; Schild, HH; Willinek, WA				Jah-Kabba, Ann-Marie Bintu Munda; Kukuk, Guido Matthias; Hadizadeh, Dariusch Reza; Traeber, Frank; Koscielny, Arne; Kabba, Mustapha Sundifu; Verrel, Frauke; Schild, Hans Heinz; Willinek, Winfried Albert			Mapping of Autogenous Saphenous Veins as an Imaging Adjunct to Peripheral MR Angiography in Patients with Peripheral Arterial Occlusive Disease and Peripheral Bypass Grafting: Prospective Comparison with Ultrasound and Intraoperative Findings	PLOS ONE			English	Article							POOL CONTRAST AGENT; MAGNETIC-RESONANCE ANGIOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; DIGITAL-SUBTRACTION-ANGIOGRAPHY; GADOFOSVESET TRISODIUM; INITIAL-EXPERIENCE; STEADY-STATE; GADOPENTETATE DIMEGLUMINE; FEMOROPOPLITEAL BYPASS; DUPLEX ULTRASOUND	Background: Mapping of the great saphenous vein is very important for planning of peripheral and coronary bypass surgery. This study investigated mapping of the great saphenous vein as an adjunct to peripheral MR angiography using a blood pool contrast agent in patients who were referred for evaluation of peripheral arterial occlusive disease and bypass surgery. Methods: 38 patients with peripheral arterial occlusive disease (21 men; mean age: 71 years, range, 44-88 years) underwent peripheral MR angiography using the blood pool contrast agent Gadofosveset trisodium. Apart from primary arterial assessment images were evaluated in order to determine great saphenous vein diameters at three levels: below the saphenofemoral junction, mid thigh and 10 cm above the knee joint (usability: diameter range:>3 and >10 mm at one level and >3.5 and >10 mm at a neighboring level). Duplex ultrasound was performed by an independent examiner providing diameter measurements at the same levels. Additionally, vessel usability was determined intraoperatively by the vascular surgeon during subsequent bypass surgery. Results: Mean venous diameters for MR angiography/duplex ultrasound were 5.4 +/- 2.6/5.5 +/- 2.8 mm (level 1), 4.7 +/- 2.7/ 4.6 +/- 2.9 mm (level 2) and 4.4 +/- 2.2/4.5 +/- 2.3 mm (level 3), respectively, without significant differences between the modalities (P = 0.207/0.806/0.518). Subsequent surgery was performed in 27/38 patients. A suitable saphenous vein was diagnosed in 25 and non-usability was diagnosed in 2 of the 27 patients based on MR angiography/duplex ultrasound, respectively. Usability was confirmed by intraoperative assessment in all of the 24 patients that received a venous bypass graft in subsequent bypass surgery. In 1 case, in which the great saphenous vein was assessed as useable by both MR angiography and duplex ultrasound, it was not used during subsequent bypass surgery due to the patients clinical condition and comorbidities. Conclusion: Simultaneous mapping of the great saphenous vein as an imaging adjunct to peripheral MR angiography with a blood pool contrast agent is an alternative to additive duplex ultrasound in patients undergoing subsequent peripheral bypass grafting.	[Jah-Kabba, Ann-Marie Bintu Munda; Kukuk, Guido Matthias; Hadizadeh, Dariusch Reza; Traeber, Frank; Schild, Hans Heinz; Willinek, Winfried Albert] Univ Bonn, Dept Radiol, Bonn, Germany; [Koscielny, Arne; Kabba, Mustapha Sundifu; Verrel, Frauke] Univ Bonn, Dept Surg, Bonn, Germany	University of Bonn; University of Bonn	Willinek, WA (corresponding author), Univ Bonn, Dept Radiol, Bonn, Germany.	Winfried.Willinek@ukb.uni-bonn.de	Hadizadeh, Dariusch/J-4947-2016; Koscielny, Arne/M-6185-2016	Hadizadeh, Dariusch/0000-0003-1802-6025; Traber, Frank/0000-0002-9713-3445				Anzidei M, 2009, RADIOLOGY, V251, P457, DOI 10.1148/radiol.2512081197; Aschauer M, 2003, MAGN RESON MED, V50, P993, DOI 10.1002/mrm.10607; Bonel HM, 2009, RADIOLOGY, V253, P879, DOI 10.1148/radiol.2533081627; Braverman Irwin M, 2010, F1000 Med Rep, V2, P84, DOI 10.3410/M2-84; Breitschaft Astrid, 2009, Med Monatsschr Pharm, V32, P377; BUCHBINDER D, 1987, AM SURGEON, V53, P368; BURNAND KG, 1985, ANN ROY COLL SURG, V67, P183; Chaikhouni Amer, 2010, Heart Views, V11, P31; Cohn JD, 2005, ANN THORAC SURG, V79, P2013, DOI 10.1016/j.athoracsur.2004.12.022; Collins R, 2007, HEALTH TECHNOL ASSES, V11, P1; Cowper SE, 2000, LANCET, V356, P1000, DOI 10.1016/S0140-6736(00)02694-5; Frydrychowicz A, 2010, ACAD RADIOL, V17, P1394, DOI 10.1016/j.acra.2010.05.022; Goyen M, 2006, EUR RADIOL, V16, pB9, DOI 10.1007/s10406-006-0162-9; Goyen M, 2007, FUTUR CARDIOL, V3, P19, DOI 10.2217/14796678.3.1.19; Goyen M, 2008, VASC HEALTH RISK MAN, V4, P1, DOI 10.2147/vhrm.2008.04.01.1; Grist TM, 1998, RADIOLOGY, V207, P539, DOI 10.1148/radiology.207.2.9577507; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hadizadeh DR, 2008, RADIOLOGY, V249, P701, DOI 10.1148/radiol.2492072033; Hadizadeh DR, 2012, AM J ROENTGENOL, V198, P1188, DOI 10.2214/AJR.11.7306; Hartmann M, 2006, EUR RADIOL, V16, pB15, DOI 10.1007/s10406-006-0163-8; HEAD HD, 1995, ANN THORAC SURG, V59, P144, DOI 10.1016/0003-4975(94)00796-A; Hoffmann U, 2002, J MAGN RESON IMAGING, V15, P429, DOI 10.1002/jmri.10082; Klessen C, 2007, INVEST RADIOL, V42, P659, DOI 10.1097/RLI.0b013e318063c635; Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027; Kos S, 2009, AM J ROENTGENOL, V192, P775, DOI 10.2214/AJR.08.1384; Kroft LJM, 1999, J MAGN RESON IMAGING, V10, P395, DOI 10.1002/(SICI)1522-2586(199909)10:3<395::AID-JMRI22>3.3.CO;2-G; Lauffer RB, 1998, RADIOLOGY, V207, P529, DOI 10.1148/radiology.207.2.9577506; Lemmer J H Jr, 1988, J Card Surg, V3, P237, DOI 10.1111/j.1540-8191.1988.tb00243.x; Lenhart M, 2002, ROFO-FORTSCHR RONTG, V174, P1289, DOI 10.1055/s-2002-34553; LEOPOLD PW, 1986, AM J SURG, V152, P206, DOI 10.1016/0002-9610(86)90243-6; LEOPOLD PW, 1989, BRIT J SURG, V76, P305, DOI 10.1002/bjs.1800760326; Luckraz Heyman, 2008, Interact Cardiovasc Thorac Surg, V7, P188, DOI 10.1510/icvts.2007.166645; Maki JH, 2009, J MAGN RESON IMAGING, V30, P1085, DOI 10.1002/jmri.21961; Marckmann P, 2006, J AM SOC NEPHROL, V17, P2359, DOI 10.1681/ASN.2006060601; MCSHANE MD, 1988, ANN ROY COLL SURG, V70, P147; MOSLEY JG, 1983, BRIT J SURG, V70, P673, DOI 10.1002/bjs.1800701111; Perreault P, 2003, RADIOLOGY, V229, P811, DOI 10.1148/radiol.2293021180; Pfeil A, 2012, EUR J RADIOL, V81, P547, DOI 10.1016/j.ejrad.2011.01.102; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; Puppinck P, 1997, J MAL VASCUL, V22, P162; Ruehm SG, 2002, ROFO-FORTSCHR RONTG, V174, P551, DOI 10.1055/s-2002-28317; Schanzer A, 2007, J VASC SURG, V46, P1180, DOI 10.1016/j.jvs.2007.08.033; SEEGER JM, 1987, ANN SURG, V205, P733, DOI 10.1097/00000658-198706000-00016; SHAH DM, 1986, J VASC SURG, V3, P273, DOI 10.1067/mva.1986.avs0030273; Tabrisky J, 1976, J Can Assoc Radiol, V27, P37; TOWNE JB, 1991, J CARDIOVASC SURG, V32, P192; Twine CP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001487.pub2; vanDijk LC, 1996, EUR J RADIOL, V23, P235, DOI 10.1016/S0720-048X(96)00776-0; VEITH FJ, 1979, SURGERY, V85, P253; WENGERTER KR, 1990, J VASC SURG, V11, P525, DOI 10.1067/mva.1990.18327	50	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112340	10.1371/journal.pone.0112340	http://dx.doi.org/10.1371/journal.pone.0112340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405867	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300028
J	Korotkova, N; Nauheimer, L; Ter-Voskanyan, H; Allgaier, M; Borsch, T				Korotkova, Nadja; Nauheimer, Lars; Ter-Voskanyan, Hasmik; Allgaier, Martin; Borsch, Thomas			Variability among the Most Rapidly Evolving Plastid Genomic Regions is Lineage-Specific: Implications of Pairwise Genome Comparisons in Pyrus (Rosaceae) and Other Angiosperms for Marker Choice	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; COMPLETE NUCLEOTIDE-SEQUENCES; GROUP-II INTRONS; PHYLOGENETIC UTILITY; HYPERVARIABLE REGIONS; SUBSECTION OENOTHERA; MOLECULAR EVOLUTION; DNA-SEQUENCES; IDENTIFICATION; GENES	Plastid genomes exhibit different levels of variability in their sequences, depending on the respective kinds of genomic regions. Genes are usually more conserved while noncoding introns and spacers evolve at a faster pace. While a set of about thirty maximum variable noncoding genomic regions has been suggested to provide universally promising phylogenetic markers throughout angiosperms, applications often require several regions to be sequenced for many individuals. Our project aims to illuminate evolutionary relationships and species-limits in the genus Pyrus (Rosaceae)-a typical case with very low genetic distances between taxa. In this study, we have sequenced the plastid genome of Pyrus spinosa and aligned it to the already available P. pyrifolia sequence. The overall p-distance of the two Pyrus genomes was 0.00145. The intergenic spacers between ndhC-trnV, trnR-atpA, ndhF-rpl32, psbM-trnD, and trnQ-rps16 were the most variable regions, also comprising the highest total numbers of substitutions, indels and inversions (potentially informative characters). Our comparative analysis of further plastid genome pairs with similar low p-distances from Oenothera (representing another rosid), Olea (asterids) and Cymbidium (monocots) showed in each case a different ranking of genomic regions in terms of variability and potentially informative characters. Only two intergenic spacers (ndhF-rpl32 and trnK-rps16) were consistently found among the 30 top-ranked regions. We have mapped the occurrence of substitutions and microstructural mutations in the four genome pairs. High AT content in specific sequence elements seems to foster frequent mutations. We conclude that the variability among the fastest evolving plastid genomic regions is lineage-specific and thus cannot be precisely predicted across angiosperms. The often lineage-specific occurrence of stem-loop elements in the sequences of introns and spacers also governs lineage-specific mutations. Sequencing whole plastid genomes to find markers for evolutionary analyses is therefore particularly useful when overall genetic distances are low.	[Korotkova, Nadja; Nauheimer, Lars; Borsch, Thomas] Free Univ Berlin, Inst Biol Bot Systemat Bot & Pflanzengeog, Berlin, Germany; [Korotkova, Nadja; Nauheimer, Lars; Borsch, Thomas] DCPS, Berlin, Germany; [Korotkova, Nadja; Ter-Voskanyan, Hasmik; Borsch, Thomas] Bot Garten & Bot Museum Berlin Dahlem, Berlin, Germany; [Ter-Voskanyan, Hasmik] Natl Acad Sci Republ Armenia, Inst Bot, Yerevan, Armenia; [Allgaier, Martin] Berlin Ctr Genom Biodivers Res BeGenDiv, Berlin, Germany	Free University of Berlin; National Academy of Sciences of Armenia; Institute of Botany after A.L. Takhtajyan - NAS RA	Borsch, T (corresponding author), Free Univ Berlin, Inst Biol Bot Systemat Bot & Pflanzengeog, Berlin, Germany.	t.borsch@bgbm.org	Korotkova, Nadja/ABD-2326-2021; Monaghan, Michael T/A-2589-2009	Korotkova, Nadja/0000-0003-0106-3209; Monaghan, Michael T/0000-0001-6200-2376	VolkswagenStiftung [AZ85021]	VolkswagenStiftung(Volkswagen)	The study was carried out as part of the project "Developing tools for conserving the plant diversity of the Transcaucasus" funded by VolkswagenStiftung (http://www.volkswagenstiftung.de/nc/en.html), grant number AZ85021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, MOL ECOL RESOUR, V13, P929, DOI 10.1111/1755-0998.12128; Akopian JA, 2007, FL RAST RASTITEL RES, V16, P15; Barniske AM, 2012, J SYST EVOL, V50, P85, DOI 10.1111/j.1759-6831.2012.00181.x; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Borsch T, 2007, INT J PLANT SCI, V168, P639, DOI 10.1086/513476; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Campagna Mary L., 1998, Transactions of the Illinois State Academy of Science, V91, P1; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cuizhi G, 2003, PYRUS FLORA CHINA EF, P173; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Erixon P, 2008, MOL PHYLOGENET EVOL, V48, P313, DOI 10.1016/j.ympev.2008.04.015; Fedorov AA, 1954, DEREVA KUSTARNIKI SS, P378; Fior S, 2013, NEW PHYTOL, V198, P579, DOI 10.1111/nph.12163; Gargano D, 2012, GENET RESOUR CROP EV, V59, P419, DOI 10.1007/s10722-011-9692-7; Goodson BE, 2006, TAXON, V55, P671, DOI 10.2307/25065643; Greiner S, 2008, MOL BIOL EVOL, V25, P2019, DOI 10.1093/molbev/msn149; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; Kallersjo M, 1998, PLANT SYST EVOL, V213, P259, DOI 10.1007/BF00985205; Katayama H, 2003, THEOR APPL GENET, V106, P303, DOI 10.1007/s00122-002-1003-4; Katayama H, 2012, TREE GENET GENOMES, V8, P313, DOI 10.1007/s11295-011-0442-y; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kelchner SA, 2002, AM J BOT, V89, P1651, DOI 10.3732/ajb.89.10.1651; Korotkova N, 2011, AM J BOT, V98, P1549, DOI 10.3732/ajb.1000502; Korotkova N, 2009, PLANT SYST EVOL, V282, P201, DOI 10.1007/s00606-008-0099-7; Krzywinski MI, 2009, GENOME RES; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068518; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtto A, 2009, ROSACEAE PRO PARTE M; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Lo EYY, 2012, MOL PHYLOGENET EVOL, V63, P230, DOI 10.1016/j.ympev.2011.10.005; Lohne C, 2007, BOT J LINN SOC, V154, P141, DOI 10.1111/j.1095-8339.2007.00659.x; Lohne C, 2005, MOL BIOL EVOL, V22, P317, DOI 10.1093/molbev/msi019; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Muller J., 2005, PHYDE PHYLOGENETIC D; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; PYLE AM, 2006, RNA WORLD, P449; Quandt D, 2004, MONOG SYST BOTAN, V98, P13; Quandt D, 2003, PLANT BIOLOGY, V5, P400, DOI 10.1055/s-2003-42715; Sarkinen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082266; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sang T, 1997, MOL BIOL EVOL, V14, P994, DOI 10.1093/oxfordjournals.molbev.a025716; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Storchova H, 2007, PLANT SYST EVOL, V268, P235, DOI 10.1007/s00606-007-0582-6; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Terakami S, 2012, TREE GENET GENOMES, V8, P841, DOI 10.1007/s11295-012-0469-8; Tesfaye K, 2007, GENOME, V50, P1112, DOI 10.1139/G07-088; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Wicke S, 2014, MOL BIOL EVOL, V31, P529, DOI 10.1093/molbev/mst261; Wuyun T, 2013, TREE GENET GENOMES, V9, P167, DOI 10.1007/s11295-012-0544-1; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Q, 2012, PLOS ONE, V7; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]	68	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112998	10.1371/journal.pone.0112998	http://dx.doi.org/10.1371/journal.pone.0112998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405773	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300069
J	Li, L; Tan, YH; Chen, XH; Xu, ZF; Yang, SY; Ren, FG; Guo, HX; Wang, XJ; Chen, Y; Li, GX; Wang, HW				Li, Li; Tan, Yanhong; Chen, Xiuhua; Xu, Zhifang; Yang, Siyao; Ren, Fanggang; Guo, Haixiu; Wang, Xiaojuan; Chen, Yi; Li, Guoxia; Wang, Hongwei			MDM4 Overexpressed in Acute Myeloid Leukemia Patients with Complex Karyotype and Wild-Type TP53	PLOS ONE			English	Article							POOR-PROGNOSIS; CELL-LINES; CYTOGENETIC ABNORMALITIES; MONOSOMAL KARYOTYPE; SPINDLE CHECKPOINT; P53 MUTATION; HUMAN CANCER; GENE; EXPRESSION; PROTEIN	Acute myeloid leukemia patients with complex karyotype (CK-AML) account for approximately 10-15% of adult AML cases, and are often associated with a poor prognosis. Except for about 70% of CK-AML patients with biallelic inactivation of TP53, the leukemogenic mechanism in the nearly 30% of CK-AML patients with wild-type TP53 has remained elusive. In this study, 15 cases with complex karyotype and wild-type TP53 were screened out of 140 de novo AML patients and the expression levels of MDM4, a main negative regulator of p53-signaling pathway, were detected. We ruled out mutations in genes associated with a poor prognosis of CK-AML, including RUNX1 or FLT3-ITD. The mRNA expression levels of the full-length of MDM4 (MDM4FL) and short isoform MDM4 (MDM4S) were elevated in CK-AML relative to normal karyotype AML (NK-AML) patients. We also explored the impact of MDM4 overexpression on the cell cycle, cell proliferation and the spindle checkpoint of HepG2 cells, which is a human cancer cell line with normal MDM4 and TP53 expression. The mitotic index and the expression of p21, BubR1 and Securin were all reduced following Nocodazole treatment. Moreover, karyotype analysis showed that MDM4 overexpression might lead to aneuploidy or polyploidy. These results suggest that MDM4 overexpression is related to CK-AML with wild-type TP53 and might play a pathogenic role by inhibiting p53-signal pathway.	[Li, Li; Tan, Yanhong; Chen, Xiuhua; Xu, Zhifang; Yang, Siyao; Ren, Fanggang; Wang, Xiaojuan; Chen, Yi; Li, Guoxia; Wang, Hongwei] Shanxi Med Univ, Dept Hematol, Hosp 2, Taiyuan, Shanxi, Peoples R China; [Li, Li; Guo, Haixiu] Shanxi Med Univ, Dept Biol, Sch Basic Med, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University	Wang, HW (corresponding author), Shanxi Med Univ, Dept Hematol, Hosp 2, Taiyuan, Shanxi, Peoples R China.	wanghw68@hotmail.com			Natural Science Fund of China [81241014]; Natural Science Fund of Shanxi Province [2014011039-2]; University of Shanxi Science and Technology Development Project [20121004]; Shanxi Medical Innovation Fund [C01201006]; Foundation for phD scientific research of Shanxi Medical University [03201309]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shanxi Province(Natural Science Foundation of Shanxi Province); University of Shanxi Science and Technology Development Project; Shanxi Medical Innovation Fund; Foundation for phD scientific research of Shanxi Medical University	This study was supported by Natural Science Fund (81241014) of China, Natural Science Fund (2014011039-2) of Shanxi Province, University of Shanxi Science and Technology Development Project (20121004), Shanxi Medical Innovation Fund (C01201006), and Foundation for phD scientific research of Shanxi Medical University (03201309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek KH, 2003, J LEUKOCYTE BIOL, V73, P850, DOI 10.1189/jlb.1202607; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Bista M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037518; Bowen D, 2009, LEUKEMIA, V23, P203, DOI 10.1038/leu.2008.173; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; DANOVA M, 1990, LEUKEMIA RES, V14, P417, DOI 10.1016/0145-2126(90)90027-7; Gogolin S, 2013, CANCER LETT, V331, P35, DOI 10.1016/j.canlet.2012.11.028; Greif PA, 2012, HAEMATOL-HEMATOL J, V97, P1909, DOI 10.3324/haematol.2012.064667; Haferlach C, 2008, LEUKEMIA, V22, P1539, DOI 10.1038/leu.2008.143; Harutyunyan A, 2011, NEW ENGL J MED, V364, P488, DOI 10.1056/NEJMc1012718; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Ikawa-Yoshida A, 2013, CANCER MED-US, V2, P447, DOI 10.1002/cam4.101; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Karess RE, 2013, INT REV CEL MOL BIO, V306, P223, DOI 10.1016/B978-0-12-407694-5.00006-7; Kim S, 2011, SEMIN CELL DEV BIOL, V22, P551, DOI 10.1016/j.semcdb.2011.03.008; Lenos K, 2012, CANCER RES, V72, P4074, DOI 10.1158/0008-5472.CAN-12-0215; Liu L, 2012, CANCER SCI, V103, P2056, DOI 10.1111/cas.12008; LUBBERT M, 1988, J EXP MED, V167, P873, DOI 10.1084/jem.167.3.873; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Pei DS, 2012, ONCOTARGET, V3, P228; Perrot A, 2011, BLOOD, V118, P679, DOI 10.1182/blood-2010-09-307264; Rallapalli R, 2003, J CELL BIOCHEM, V89, P563, DOI 10.1002/jcb.10535; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Yurlova L, 2014, J BIOMOL SCREEN, V19, P516, DOI 10.1177/1087057113518067; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zhi L, 2011, OLIGONUCLEOTIDES, V21, P21, DOI 10.1089/oli.2010.0254	32	18	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113088	10.1371/journal.pone.0113088	http://dx.doi.org/10.1371/journal.pone.0113088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405759	gold, Green Submitted, Green Published			2022-12-27	WOS:000347121300076
J	Silveira, LCL; Saito, CA; da Silva, M; Kremers, J; Bowmaker, JK; Lee, BB				Silveira, Luiz Carlos L.; Saito, Cezar A.; da Silva Filho, Manoel; Kremers, Jan; Bowmaker, James K.; Lee, Barry B.			Alouatta Trichromatic Color Vision: Cone Spectra and Physiological Responses Studied with Microspectrophotometry and Single Unit Retinal Electrophysiology	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; NEW-WORLD MONKEY; MACAQUE GANGLION-CELLS; CONTRAST GAIN-CONTROL; VISUAL RESPONSES; PRIMATE RETINA; EVOLUTION; SENSITIVITY; FRUGIVORY; GENES	The howler monkeys (Alouatta sp.) are the only New World primates to exhibit routine trichromacy. Both males and females have three cone photopigments. However, in contrast to Old World monkeys, Alouatta has a locus control region upstream of each opsin gene on the X-chromosome and this might influence the retinal organization underlying its color vision. Postmortem microspectrophotometry (MSP) was performed on the retinae of two male Alouatta to obtain rod and cone spectral sensitivities. The MSP data were consistent with only a single opsin being expressed in each cone and electrophysiological data were consistent with this primate expressing full trichromacy. To study the physiological organization of the retina underlying Alouatta trichromacy, we recorded from retinal ganglion cells of the same animals used for MSP measurements with a variety of achromatic and chromatic stimulus protocols. We found MC cells and PC cells in the Alouatta retina with similar properties to those previously found in the retina of other trichromatic primates. MC cells showed strong phasic responses to luminance changes and little response to chromatic pulses. PC cells showed strong tonic response to chromatic changes and small tonic response to luminance changes. Responses to other stimulus protocols (flicker photometry; changing the relative phase of red and green modulated lights; temporal modulation transfer functions) were also similar to those recorded in other trichromatic primates. MC cells also showed a pronounced frequency double response to chromatic modulation, and with luminance modulation response saturation accompanied by a phase advance between 10-20 Hz, characteristic of a contrast gain mechanism. This indicates a very similar retinal organization to Old-World monkeys. Cone-specific opsin expression in the presence of a locus control region for each opsin may call into question the hypothesis that this region exclusively controls opsin expression.	[Silveira, Luiz Carlos L.; Saito, Cezar A.; da Silva Filho, Manoel] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Silveira, Luiz Carlos L.] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Kremers, Jan] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Bowmaker, James K.] UCL, Inst Ophthalmol, Div Visual Sci, London, England; [Lee, Barry B.] SUNY Coll Optometry, New York, NY 10036 USA; [Lee, Barry B.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Universidade Federal do Para; Universidade Federal do Para; University of Erlangen Nuremberg; University of London; University College London; State University of New York (SUNY) System; SUNY Optometry; Max Planck Society	Silveira, LCL (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	luiz@ufpa.br	Kremers, Jan/X-3125-2019; da Silva Filho, Manoel/C-6684-2013; Saito, Cézar/Q-5274-2019	Kremers, Jan/0000-0002-9293-7380; Saito, Cézar/0000-0002-4931-1884	CNPq-PRONEX / FAPESPA / UFPA / FADESP [2268]; CNPq-PRONEX / FAPESPA [316799/2009]; FINEP IBN Net [1723]; Hertie Foundation	CNPq-PRONEX / FAPESPA / UFPA / FADESP; CNPq-PRONEX / FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP IBN Net(Financiadora de Inovacao e Pesquisa (Finep)); Hertie Foundation	This research was supported by the following grants: CNPq-PRONEX / FAPESPA / UFPA / FADESP #2268; CNPq-PRONEX / FAPESPA #316799/2009; FINEP IBN Net #1723. LCLS is a CNPq research fellow. JK was supported by the Hertie Foundation. The authors would like to thank Dr. Jose Augusto Pereira Carneiro Muniz of the Centro Nacional de Primatas (Ananindeua, Para, Brazil) for provision of animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AC, 2008, VISUAL NEUROSCI, V25, P243, DOI 10.1017/S0952523808080292; BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; BOWMAKER JK, 1991, J EXP BIOL, V156, P1; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Chan TL, 2001, J COMP NEUROL, V437, P219, DOI 10.1002/cne.1280; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; de Athaide LM, 2009, 20 INT COL VIS SOC I, P85; Dulai KS, 1999, GENOME RES, V9, P629; Fleagle JG, 1988, PRIMATE ADAPTATION E; Franco ECS, 2000, BRAIN BEHAV EVOLUT, V56, P276, DOI 10.1159/000047211; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hashemi-Nezhad M, 2008, VISION RES, V48, P2604, DOI 10.1016/j.visres.2008.02.017; Hunt DM, 1998, VISION RES, V38, P3299, DOI 10.1016/S0042-6989(97)00443-4; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Jacobs GH, 1996, NATURE, V382, P156, DOI 10.1038/382156a0; JACOBS GH, 1965, NATURE, V206, P487, DOI 10.1038/206487a0; Judd D. B., 1951, TECHNICAL COMMITTEE, P1; Kainz PM, 1998, VISION RES, V38, P3315, DOI 10.1016/S0042-6989(98)00078-9; Goulart PRK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062255; Kremers J, 1997, VISION RES, V37, P2171, DOI 10.1016/S0042-6989(97)00041-2; Kremers J, 2000, J OPT SOC AM A, V17, P517, DOI 10.1364/JOSAA.17.000517; Kremers J, 1997, VISION RES, V37, P2649, DOI 10.1016/S0042-6989(97)00090-4; Kremers Jan, 1999, P123; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; LEE BB, 1989, J PHYSIOL-LONDON, V414, P245, DOI 10.1113/jphysiol.1989.sp017686; Lee BB, 2000, J PHYSIOL-LONDON, V528, P573, DOI 10.1111/j.1469-7793.2000.00573.x; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; LIEBMAN PA, 1964, J OPT SOC AM, V54, P1451, DOI 10.1364/JOSA.54.001451; LINDSEY DT, 1986, J OPT SOC AM A, V3, P921, DOI 10.1364/JOSAA.3.000921; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; Martin PR, 2011, J PHYSIOL-LONDON, V589, P2795, DOI 10.1113/jphysiol.2010.194076; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; Matsushita Y, 2014, INT J PRIMATOL, V35, P71, DOI 10.1007/s10764-013-9705-9; Mollon J.D., 1989, FARBE, V35, P139; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; MOLLON JD, 1991, EVOLUTION EYE VISUAL, P306; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Polyak S., 1957, VERTEBRATE VISUAL SY; Regan BC, 1998, VISION RES, V38, P3321, DOI 10.1016/S0042-6989(97)00462-8; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Saito CA, 2004, ARVO ABSTR INV OPHTH, V45; Saito CA, 2005, ARVO ABSTR INV OPHTH, V46; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Silveira LCD, 2004, METH NE FRO NEUROSCI, P29; Silveira LCL, 1999, VISUAL NEUROSCI, V16, P333, DOI 10.1017/S0952523899162138; SILVEIRA LCL, 1989, VISION RES, V29, P1471, DOI 10.1016/0042-6989(89)90131-4; Silveira LCL, 1998, VISION RES, V38, P3329, DOI 10.1016/S0042-6989(97)00335-0; Silveira LCL, 2005, PRIMATE VISUAL SYSTEM: A COMPARATIVE APPROACH, P127; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; SMITH VC, 1992, J PHYSIOL-LONDON, V458, P191, DOI 10.1113/jphysiol.1992.sp019413; SNODDERLY DM, 1979, BEHAV SIGNIFICANCE C, P238; Solomon SG, 1999, J PHYSIOL-LONDON, V517, P907, DOI 10.1111/j.1469-7793.1999.0907s.x; Solomon SG, 2005, J NEUROSCI, V25, P4527, DOI 10.1523/JNEUROSCI.3921-04.2005; Stoner KE, 2005, AM J PRIMATOL, V67, P399, DOI 10.1002/ajp.20195; Szmajda BA, 2005, VISUAL NEUROSCI, V22, P395, DOI 10.1017/S0952523805224021; Usrey WM, 2000, J PHYSIOL-LONDON, V523, P755, DOI 10.1111/j.1469-7793.2000.00755.x; White AJR, 1998, J NEUROPHYSIOL, V80, P2063, DOI 10.1152/jn.1998.80.4.2063; White AJR, 2001, J PHYSIOL-LONDON, V533, P519, DOI 10.1111/j.1469-7793.2001.0519a.x; YEH T, 1995, J OPT SOC AM A, V12, P456, DOI 10.1364/JOSAA.12.000456; Yeh TY, 1995, J NEUROSCI, V15, P7892	68	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113321	10.1371/journal.pone.0113321	http://dx.doi.org/10.1371/journal.pone.0113321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405863	Green Published, gold			2022-12-27	WOS:000347121300105
J	Wang, Y; Nizkorodov, A; Riemenschneider, K; Lee, CSD; Olivares-Navarrete, R; Schwartz, Z; Boyan, BD				Wang, Yun; Nizkorodov, Alexandr; Riemenschneider, Kelsie; Lee, Christopher S. D.; Olivares-Navarrete, Rene; Schwartz, Zvi; Boyan, Barbara D.			Impaired Bone Formation in Pdia3 Deficient Mice	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GROWTH-PLATE CHONDROCYTES; PROTEIN-KINASE-C; KNOCKOUT MICE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; FRACTURE REPAIR; OSTEOBLASTS; CELLS; CAVEOLIN-1	1 alpha,25-dihydroxyvitamin D-3 [1 alpha,25(OH)(2)D-3] is crucial for normal skeletal development and bone homeostasis. Protein disulfide isomerase family A, member 3 (PDIA3) mediates 1 alpha,25(OH)(2)D-3 initiated-rapid membrane signaling in several cell types. To understand its role in regulating skeletal development, we generated Pdia3-deficient mice and examined the physiologic consequence of Pdia3-disruption in embryos and Pdia3(+/-) heterozygotes at different ages. No mice homozygous for the Pdia3-deletion were found at birth nor were there embryos after E12.5, indicating that targeted disruption of the Pdia3 gene resulted in early embryonic lethality. Pdia3-deficiency also resulted in skeletal manifestations as revealed by mu CT analysis of the tibias. In comparison to wild type mice, Pdia3 heterozygous mice displayed expanded growth plates associated with decreased tether formation. Histomorphometry also showed that the hypertrophic zone in Pdia3(+/-) mice was more cellular than seen in wild type growth plates. Metaphyseal trabecular bone in Pdia3(+/-) mice exhibited an age-dependent phenotype with lower BV/TV and trabecular numbers, which was most pronounced at 15 weeks of age. Bone marrow cells from Pdia3(+/-) mice exhibited impaired osteoblastic differentiation, based on reduced expression of osteoblast markers and mineral deposition compared to cells from wild type animals. Collectively, our findings provide in vivo evidence that PDIA3 is essential for normal skeletal development. The fact that the Pdia3(+/-) heterozygous mice share a similar growth plate and bone phenotype to nVdr knockout mice, suggests that PDIA3-mediated rapid membrane signaling might be an alternative mechanism responsible for 1 alpha,25(OH)(2)D-3's actions in regulating skeletal development.	[Wang, Yun; Nizkorodov, Alexandr; Riemenschneider, Kelsie; Lee, Christopher S. D.; Boyan, Barbara D.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Olivares-Navarrete, Rene; Schwartz, Zvi; Boyan, Barbara D.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA	University System of Georgia; Georgia Institute of Technology; Virginia Commonwealth University	Boyan, BD (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	bboyan@vcu.edu		Olivares-Navarrete, Rene/0000-0003-1232-9164	Price Gilbert, Jr. Foundation	Price Gilbert, Jr. Foundation	This study was funded by the Price Gilbert, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyay A, 2012, PEDIATR HEMAT ONCOL, V29, P691, DOI 10.3109/08880018.2012.727064; Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; Boyan BD, 2006, J BONE MINER RES, V21, P1637, DOI 10.1359/JBMR.060713; Boyan BD, 2012, STEROIDS, V77, P892, DOI 10.1016/j.steroids.2012.04.018; Boyan BD, 1999, STEROIDS, V64, P129, DOI 10.1016/S0039-128X(98)00099-3; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Brameld JM, 1998, P NUTR SOC, V57, P207, DOI 10.1079/PNS19980033; Chen JX, 2010, J BIOL CHEM, V285, P37041, DOI 10.1074/jbc.M110.157115; Chen J, 2009, CALCIFIED TISSUE INT, V85, P134, DOI 10.1007/s00223-009-9259-1; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Doroudi M, 2014, BBA-MOL CELL RES, V1843, P2365, DOI 10.1016/j.bbamcr.2014.06.006; Doroudi M, 2012, J STEROID BIOCHEM, V132, P48, DOI 10.1016/j.jsbmb.2012.03.001; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; JORGENSEN PH, 1991, BONE, V12, P353, DOI 10.1016/8756-3282(91)90022-B; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Kinney MA, 2012, INTEGR BIOL-UK, V4, P641, DOI 10.1039/c2ib00165a; Lee CSD, 2011, BONE, V49, P419, DOI 10.1016/j.bone.2011.05.004; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; MARTENS M, 1981, ARCH ORTHOP TRAUM SU, V98, P113, DOI 10.1007/BF00460798; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Nemere I, 2004, P NATL ACAD SCI USA, V101, P7392, DOI 10.1073/pnas.0402207101; Nemere I, 2010, J BIOL CHEM, V285, P31859, DOI 10.1074/jbc.M110.116954; Nemere K, 2005, STEROIDS, V70, P455, DOI 10.1016/j.steroids.2005.02.005; Nolan RL, 2006, J BIOCHEM BIOPH METH, V68, P127, DOI 10.1016/j.jbbm.2006.04.002; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Olivares-Navarrete R, 2012, STEM CELLS DEV, V21, P1726, DOI 10.1089/scd.2011.0411; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Schwartz Z, 2002, ENDOCRINOLOGY, V143, P2775, DOI 10.1210/en.143.7.2775; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098; Sooy K, 2005, J CELL BIOCHEM, V94, P81, DOI 10.1002/jcb.20313; St-Arnaud R, 2011, MOL CELL ENDOCRINOL, V347, P48, DOI 10.1016/j.mce.2011.05.018; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Vertino AM, 2005, J BIOL CHEM, V280, P14130, DOI 10.1074/jbc.M410720200; Wang Y, 2010, J STEROID BIOCHEM, V121, P257, DOI 10.1016/j.jsbmb.2010.05.004; Wilson JL, 2013, BIOTECHNOL BIOENG; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	41	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112708	10.1371/journal.pone.0112708	http://dx.doi.org/10.1371/journal.pone.0112708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405762	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300048
J	Agogo, GO; van der Voet, H; van't Veer, P; Ferrari, P; Leenders, M; Muller, DC; Sanchez-Cantalejo, E; Bamia, C; Braaten, T; Knuppel, S; Johansson, I; van Eeuwijk, FA; Boshuizen, H				Agogo, George O.; van der Voet, Hilko; van't Veer, Pieter; Ferrari, Pietro; Leenders, Max; Muller, David C.; Sanchez-Cantalejo, Emilio; Bamia, Christina; Braaten, Tonje; Knueppel, Sven; Johansson, Ingegerd; van Eeuwijk, Fred A.; Boshuizen, Hendriek			Use of Two-Part Regression Calibration Model to Correct for Measurement Error in Episodically Consumed Foods in a Single-Replicate Study Design: EPIC Case Study	PLOS ONE			English	Article							DIETARY SELF-REPORT; CANCER; DISEASE	In epidemiologic studies, measurement error in dietary variables often attenuates association between dietary intake and disease occurrence. To adjust for the attenuation caused by error in dietary intake, regression calibration is commonly used. To apply regression calibration, unbiased reference measurements are required. Short-term reference measurements for foods that are not consumed daily contain excess zeroes that pose challenges in the calibration model. We adapted twopart regression calibration model, initially developed for multiple replicates of reference measurements per individual to a single-replicate setting. We showed how to handle excess zero reference measurements by two-step modeling approach, how to explore heteroscedasticity in the consumed amount with variance-mean graph, how to explore nonlinearity with the generalized additive modeling (GAM) and the empirical logit approaches, and how to select covariates in the calibration model. The performance of two-part calibration model was compared with the one-part counterpart. We used vegetable intake and mortality data from European Prospective Investigation on Cancer and Nutrition (EPIC) study. In the EPIC, reference measurements were taken with 24-hour recalls. For each of the three vegetable subgroups assessed separately, correcting for error with an appropriately specified two-part calibration model resulted in about three fold increase in the strength of association with all-cause mortality, as measured by the log hazard ratio. Further found is that the standard way of including covariates in the calibration model can lead to over fitting the two-part calibration model. Moreover, the extent of adjusting for error is influenced by the number and forms of covariates in the calibration model. For episodically consumed foods, we advise researchers to pay special attention to response distribution, nonlinearity, and covariate inclusion in specifying the calibration model.	[Agogo, George O.; Boshuizen, Hendriek] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Agogo, George O.; van der Voet, Hilko; van Eeuwijk, Fred A.; Boshuizen, Hendriek] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [van't Veer, Pieter; Boshuizen, Hendriek] Univ Wageningen & Res Ctr, Dept Human Nutr, Wageningen, Netherlands; [Ferrari, Pietro] Int Agcy Res Canc, Nutr Epidemiol Grp, F-69372 Lyon, France; [Leenders, Max] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Muller, David C.] Int Agcy Res Canc, Genet Epidemiol Grp, F-69008 Lyon, France; [Sanchez-Cantalejo, Emilio] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez-Cantalejo, Emilio] CIBERESP, Barcelona, Spain; [Bamia, Christina] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Food & Nutr Policies, GR-11527 Athens, Greece; [Braaten, Tonje] Univ Tromso, Dept Community Med, N-9037 Tromso, Norway; [Knueppel, Sven] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Potsdam, Germany; [Johansson, Ingegerd] Umea Univ, Dept Odontol, Umea, Sweden	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Wageningen University & Research; World Health Organization; International Agency for Research on Cancer (IARC); Utrecht University; Utrecht University Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; UiT The Arctic University of Tromso; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Umea University	Agogo, GO (corresponding author), Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.	george.agogo@wur.nl	Knüppel, Sven/AAI-7195-2020; van der Voet, Hilko/W-8531-2019; Boshuizen, Hendriek C/B-3718-2014; van der Voet, Hilko/A-4073-2013; Muller, David C/V-8207-2017; Boshuizen, Hendriek/M-3415-2014	Knüppel, Sven/0000-0001-9006-9906; van der Voet, Hilko/0000-0003-0802-7382; van der Voet, Hilko/0000-0003-0802-7382; Muller, David C/0000-0002-2350-0417; Boshuizen, Hendriek/0000-0002-3916-9095; Agogo, George/0000-0002-7685-7743	Wageningen University and Research Centre, Biometris, AC WAGENINGEN	Wageningen University and Research Centre, Biometris, AC WAGENINGEN	The authors did not receive specific funding for this study. However, the publication cost will be covered by Wageningen University and Research Centre, Biometris, P.O. Box 100, 6700 AC WAGENINGEN should the paper be accepted for a publication.	Agudo A., 2004, MEASURING INTAKE FRU; Boshuizen HC, 2007, AM J EPIDEMIOL, V165, P398, DOI 10.1093/aje/kwk021; Cai W, 2008, SAS GLOBAL FORUM 200; Carroll RJ, 2006, MEASUREMENT ERROR NO; Cassell DL, 2007, DONT BE LOOPY RE SAM; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1970, ANAL BINARY DATA; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Ferrari P, 2004, AM J EPIDEMIOL, V160, P814, DOI 10.1093/aje/kwh280; Ferrari P, 2008, INT J EPIDEMIOL, V37, P368, DOI 10.1093/ije/dym242; Fraser GE, 2001, AM J EPIDEMIOL, V154, P836, DOI 10.1093/aje/154.9.836; Freedman LS, 2008, STAT MED, V27, P5195, DOI 10.1002/sim.3361; Geert Molenberghs MGK, 2007, MISSING DATA CLIN ST; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Hastie T., 1999, GEN ADDITIVE MODELS; Kaaks R, 2002, PUBLIC HEALTH NUTR, V5, P969, DOI 10.1079/PHN2002380; Kaaks RJ, 1997, AM J CLIN NUTR, V65, P1232; Keogh RH, 2013, STAT MED, V32, P3838, DOI 10.1002/sim.5803; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Kipnis V, 2001, AM J EPIDEMIOL, V153, P394, DOI 10.1093/aje/153.4.394; Kipnis V, 2009, BIOMETRICS, V65, P1003, DOI 10.1111/j.1541-0420.2009.01223.x; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; McCullagh P, 1989, GEN LINEAR MODELS, Vxix; Natarajan L, 2006, AM J EPIDEMIOL, V163, P770, DOI 10.1093/aje/kwj082; Natarajan L, 2010, AM J EPIDEMIOL, V172, P819, DOI 10.1093/aje/kwq216; Olsen MK, 2001, J AM STAT ASSOC, V96, P730, DOI 10.1198/016214501753168389; Raymond HM, 2010, GEN LINEAR MODELS AP; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rubin D. B., 2004, MULTIPLE IMPUTATION; Sainani KL, 2009, LINEARITY ASSESSMENT; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 2002, EUR J CLIN NUTR, V56, pS63, DOI 10.1038/sj.ejcn.1601430; Steyerberg EW, 2009, CLIN PREDICTION MODE, Vxxviii; Thoresen M, 2006, J STAT COMPUT SIM, V76, P475, DOI 10.1080/10629360500108897; Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003; Weiss J, 2006, STAT ANAL ECOLOGY 14; Willet W, 1998, NUTR EPIDEMIOLOGY; Wood S., 2012, MIXED GAM COMPUTATIO; Zhang SJ, 2011, ANN APPL STAT, V5, P1456, DOI 10.1214/10-AOAS446	40	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113160	10.1371/journal.pone.0113160	http://dx.doi.org/10.1371/journal.pone.0113160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402487	Green Published, gold			2022-12-27	WOS:000345158700122
J	Cook, GJ; Caudell, DL; Elford, HL; Pardee, TS				Cook, Guerry J.; Caudell, David L.; Elford, Howard L.; Pardee, Timothy S.			The Efficacy of the Ribonucleotide Reductase Inhibitor Didox in Preclinical Models of AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROGNOSTIC-FACTORS; DOSE CYTARABINE; CELLS; HYDROXYUREA; EXPRESSION; APOPTOSIS; CANCER; ACID; CHEMOTHERAPY	Acute Myeloid Leukemia (AML) is an aggressive malignancy which leads to marrow failure, and ultimately death. There is a desperate need for new therapeutics for these patients. Ribonucleotide reductase (RR) is the rate limiting enzyme in DNA synthesis. Didox (3,4-Dihydroxybenzohydroxamic acid) is a novel RR inhibitor noted to be more potent than hydroxyurea. In this report we detail the activity and toxicity of Didox in preclinical models of AML. RR was present in all AML cell lines and primary patient samples tested. Didox was active against all human and murine AML lines tested with IC50 values in the low micromolar range (mean IC50 37 mu M [range 25.89-52.70 mu M]). It was active against primary patient samples at concentrations that did not affect normal hematopoietic stem cells (HSCs). Didox exposure resulted in DNA damage and p53 induction culminating in apoptosis. In syngeneic, therapy-resistant AML models, single agent Didox treatment resulted in a significant reduction in leukemia burden and a survival benefit. Didox was well tolerated, as marrow from treated animals was morphologically indistinguishable from controls. Didox exposure at levels that impaired leukemia growth did not inhibit normal HSC engraftment. In summary, Didox was well tolerated and effective against preclinical models of AML.	[Cook, Guerry J.; Pardee, Timothy S.] Wake Forest Univ Hlth Sci, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27103 USA; [Caudell, David L.] Wake Forest Univ Hlth Sci, Dept Pathol, Comparat Med Sect, Winston Salem, NC USA; [Elford, Howard L.] Mol Hlth, Richmond, VA USA; [Pardee, Timothy S.] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University	Pardee, TS (corresponding author), Wake Forest Univ Hlth Sci, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27103 USA.	tspardee@wakehealth.edu		Pardee, Timothy/0000-0002-1186-6948	Doug Coley Foundation for Leukemia Research; Frances P. Tutwiler Fund; National Cancer Institute [P30CA012197, 1K08CA169809-01]; NATIONAL CANCER INSTITUTE [P30CA012197, K08CA169809] Funding Source: NIH RePORTER	Doug Coley Foundation for Leukemia Research; Frances P. Tutwiler Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Doug Coley Foundation for Leukemia Research, the Frances P. Tutwiler Fund, and the National Cancer Institute (award P30CA012197, 1K08CA169809-01; TSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimiuwu J, 2012, BLOOD, V119, P5229, DOI 10.1182/blood-2011-11-382226; Alibhai SMH, 2009, CANCER, V115, P2903, DOI 10.1002/cncr.24373; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Cory JG, 1989, INHIBITORS RIBONUCLE, Vix; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; ELFORD HL, 1979, CANCER RES, V39, P844; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Farag SS, 2006, BLOOD, V108, P63, DOI 10.1182/blood-2005-11-4354; Ferrara F, 2004, HAEMATOLOGICA, V89, P998; Gallaugher LD, 2009, COMPARATIVE MED, V59, P567; Garrido SM, 2001, EXP HEMATOL, V29, P448, DOI 10.1016/S0301-472X(01)00612-9; Gilliland D Gary, 2004, Hematology Am Soc Hematol Educ Program, P80; Grusch M, 2001, EXP HEMATOL, V29, P623, DOI 10.1016/S0301-472X(01)00624-5; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Horvath Z, 2004, CANCER CHEMOTH PHARM, V54, P139, DOI 10.1007/s00280-004-0795-0; Howlader N, 2011, SEER CANC STAT REV 1; Inayat MS, 2010, J INFLAMM-LOND, V7; KANTARJIAN HM, 1988, J CLIN ONCOL, V6, P232, DOI 10.1200/JCO.1988.6.2.232; Kaul DK, 2006, MICROCIRCULATION, V13, P489, DOI 10.1080/10739680600778456; Klisovic RB, 2008, CLIN CANCER RES, V14, P3889, DOI 10.1158/1078-0432.CCR-08-0109; Longo DL, 2012, HARRISONS PRINCIPLES; Macanas-Pirard P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037203; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Matsusaka S, 2007, CHEMOTHERAPY, V53, P36, DOI 10.1159/000098249; Mayhew CN, 1999, STEM CELLS, V17, P345, DOI 10.1002/stem.170345; Mayhew CN, 2002, ANTIVIR RES, V56, P167, DOI 10.1016/S0166-3542(02)00108-0; Nakano Y, 2000, EUR J HAEMATOL, V65, P23, DOI 10.1034/j.1600-0609.2000.90138.x; Okamura H, 2003, ACTA CYTOL, V47, P209, DOI 10.1159/000326506; Pardee TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043185; Raje N, 2006, BRIT J HAEMATOL, V135, P52, DOI 10.1111/j.1365-2141.2006.06261.x; Rollig C, 2010, BLOOD, V116, P971, DOI 10.1182/blood-2010-01-267302; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579; TAKEDA E, 1981, LIFE SCI, V28, P1007, DOI 10.1016/0024-3205(81)90746-3; VEALE D, 1988, BRIT J CANCER, V58, P70, DOI 10.1038/bjc.1988.164; Wang LM, 2012, CHINESE MED J-PEKING, V125, P2151, DOI 10.3760/cma.j.issn.0366-6999.2012.12.013; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112619	10.1371/journal.pone.0112619	http://dx.doi.org/10.1371/journal.pone.0112619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402485	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700058
J	Caruana, MV; Carvalho, S; Braun, DR; Presnyakova, D; Haslam, M; Archer, W; Bobe, R; Harris, JWK				Caruana, Matthew V.; Carvalho, Susana; Braun, David R.; Presnyakova, Darya; Haslam, Michael; Archer, Will; Bobe, Rene; Harris, John W. K.			Quantifying Traces of Tool Use: A Novel Morphometric Analysis of Damage Patterns on Percussive Tools	PLOS ONE			English	Article							PINNACLE POINT 13B; STONE TOOLS; EDGE DAMAGE; BED-II; TECHNOLOGY; MIDDLE; CHIMPANZEES; STRATEGIES; SPHEROIDS; ARTIFACTS	Percussive technology continues to play an increasingly important role in understanding the evolution of tool use. Comparing the archaeological record with extractive foraging behaviors in nonhuman primates has focused on percussive implements as a key to investigating the origins of lithic technology. Despite this, archaeological approaches towards percussive tools have been obscured by a lack of standardized methodologies. Central to this issue have been the use of qualitative, non-diagnostic techniques to identify percussive tools from archaeological contexts. Here we describe a new morphometric method for distinguishing anthropogenically-generated damage patterns on percussive tools from naturally damaged river cobbles. We employ a geomatic approach through the use of three-dimensional scanning and geographical information systems software to statistically quantify the identification process in percussive technology research. This will strengthen current technological analyses of percussive tools in archaeological frameworks and open new avenues for translating behavioral inferences of early hominins from percussive damage patterns.	[Caruana, Matthew V.] Univ Witwatersrand, Sch Archaeol Geog & Environm Studies, ZA-2050 Johannesburg, South Africa; [Carvalho, Susana; Braun, David R.; Bobe, Rene] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Carvalho, Susana; Bobe, Rene] Univ Algarve, Interdisciplinary Ctr Archaeol & Evolut Human Beh, Faro, Portugal; [Braun, David R.; Archer, Will] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Presnyakova, Darya] Univ Tubingen, Abt Altere Urgeschichte & Quartarokol, Tubingen, Germany; [Haslam, Michael] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Harris, John W. K.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ USA; [Harris, John W. K.] Natl Museums Kenya, Nairobi, Kenya	University of Witwatersrand; George Washington University; Universidade do Algarve; Max Planck Society; Eberhard Karls University of Tubingen; University of Oxford; Rutgers State University New Brunswick	Caruana, MV (corresponding author), Univ Witwatersrand, Sch Archaeol Geog & Environm Studies, ZA-2050 Johannesburg, South Africa.	hominin500@gmail.com	Caruana, Matthew/AAB-7528-2022	Caruana, Matthew/0000-0002-2095-5360; Archer, Will/0000-0003-1174-0605; Bobe, Rene/0000-0001-9059-2203; Carvalho, Susana/0000-0003-4542-3720; Haslam, Michael/0000-0001-8234-7806	Palaeontological Scientific Trust; National Research Foundation; National Science Foundation [BCS-1128170, BCS-0924476]; Integrative Graduate Education and Research Traineeship Program [DGE-0801634]; George Washington University's Selective Excellence Fund; George Washington University Columbian College Facilitating Fund; Clare Hall College [JRF]; Newnham College [Gibbs Travelling Fellowship] Cambridge; European Research Council [283959]	Palaeontological Scientific Trust; National Research Foundation; National Science Foundation(National Science Foundation (NSF)); Integrative Graduate Education and Research Traineeship Program(National Science Foundation (NSF)); George Washington University's Selective Excellence Fund; George Washington University Columbian College Facilitating Fund; Clare Hall College [JRF]; Newnham College [Gibbs Travelling Fellowship] Cambridge; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Palaeontological Scientific Trust (MVC), National Research Foundation (MVC), National Science Foundation's Biological Anthropology Program [BCS-1128170, -0924476] (DRB), Integrative Graduate Education and Research Traineeship Program [DGE-0801634] (DRB), The George Washington University's Selective Excellence Fund (DRB), The George Washington University Columbian College Facilitating Fund (DRB), Clare Hall College [JRF] (SC), Newnham College [Gibbs Travelling Fellowship] Cambridge (SC), and the European Research Council [Grant #283959; Primate Archaeology] (SC MH). The European Research Council [Grant #283959; Primate Archaeology] funded the collection of materials and three dimensional scanning. All other funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Ashley GM, 2011, GEOARCHAEOLOGY, V26, P809, DOI 10.1002/gea.20374; Barsky D, 2011, J AFR ARCHAEOL, V9, P207, DOI 10.3213/2191-5784-10196; Barthelme J. W, 1977, AZANIA, V12, P33, DOI DOI 10.1080/00672707709511246; BEATTY H, 1951, J MAMMAL, V32, P118, DOI 10.1093/jmammal/32.1.118; BINFORD LR, 1981, BONES ANCIENT MAN MO; Boshier A.K., 1965, S AFRICAN ARCHAEOLOG, V20, P131; Braun DR, 2009, ARCHAEOMETRY, V51, P26, DOI 10.1111/j.1475-4754.2008.00393.x; Caruana MV, PERCUSSIVE DAM UNPUB; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; Chavaillon J., 1979, B SOC PREHISTORIQUE, V76, P230, DOI [10.3406/bspf.1979.5213, DOI 10.3406/BSPF.1979.5213]; Chavaillon J., 2004, J SCI EXPLOR; Clark J.D., 1993, TRANSVAAL MUSEUM MON, P167; De Beaune S, 1989, GALLIA PREHISTOIRE, V31, P27, DOI DOI 10.3406/GALIP.1989.2264; De la Torre I, 2010, ENTRE MARTEAU ENCLUM, P13; de la Torre I, 2013, J ARCHAEOL SCI, V40, P313, DOI 10.1016/j.jas.2012.08.007; De Reu J, 2013, GEOMORPHOLOGY, V186, P39, DOI 10.1016/j.geomorph.2012.12.015; Deer W. A., 1992, INTRO ROCK FORMING M; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Fragaszy D, 2004, AM J PRIMATOL, V64, P359, DOI 10.1002/ajp.20085; Gallotti R, 2013, J HUM EVOL, V65, P594, DOI 10.1016/j.jhevol.2013.07.001; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Gumert MD, 2013, P R SOC B, V368, P1; HARRIS JWK, 1976, NATURE, V262, P102, DOI 10.1038/262102a0; Haslam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072872; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hernandez-Aguilar RA, 2007, P NATL ACAD SCI USA, V104, P19210, DOI 10.1073/pnas.0707929104; Hernandez-Aguilar RA, 2009, J HUM EVOL, V57, P350, DOI 10.1016/j.jhevol.2009.03.007; HUDSON C, 1976, SE INDIANS; Isaac G.Ll., 1997, KOOBI RES PROJECT, P262; Kimura Y, 2002, J HUM EVOL, V43, P291, DOI 10.1006/jhev.2002.0576; KORTLANDT A, 1987, PRIMATES, V28, P473, DOI 10.1007/BF02380862; Leakey M.D., 1971, OLDUVAI GORGE, V3, P1960; Lee R. B., 1979, KUNG SAN MEN WOMEN W; Maccurdy GG, 1914, AM ANTHROPOL, V16, P157, DOI 10.1525/aa.1914.16.2.02a00000; Mackay A, 2008, J ARCHAEOL SCI, V35, P614, DOI 10.1016/j.jas.2007.05.013; Malaivijitnond S, 2007, AM J PRIMATOL, V69, P227, DOI 10.1002/ajp.20342; McCarthy FD., 1946, STONE IMPLEMENTS AUS; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew William C., 1993, P143; MCGUIRE J. D, 1891, AM ANTHROPOL, V44, P301; McPherron SP, 2014, J ARCHAEOL SCI, V49, P70, DOI 10.1016/j.jas.2014.04.003; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Mora R, 2005, J ANTHROPOL ARCHAEOL, V24, P179, DOI 10.1016/j.jaa.2004.12.001; Ndiema EK, 2011, MOBILITY SUSISTENCE; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Passmore AD, 1921, P PREHIST SOC E ANGL, V3, P444; Potts R., 1988, EARLY HOMINID ACTIVI; PRASAD KN, 1982, J HUM EVOL, V11, P101, DOI 10.1016/S0047-2484(82)80034-1; Sahnouni M, 1997, J ARCHAEOL SCI, V24, P701, DOI 10.1006/jasc.1996.0152; Schoville B.J., 2010, VIS VIS EXPLOR ANTHR, V10, P34; Schoville BJ, 2010, J HUM EVOL, V59, P378, DOI 10.1016/j.jhevol.2010.07.015; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Shott MJ, 2007, J ARCHAEOL SCI, V34, P1016, DOI 10.1016/j.jas.2006.09.009; Slaght JC, 2013, ORYX, V47, P553, DOI 10.1017/S0030605312000956; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; SUGIYAMA Y, 1979, Primates, V20, P513, DOI 10.1007/BF02373433; Tagil Sermin, 2008, Journal of Applied Sciences, V8, P910, DOI 10.3923/jas.2008.910.921; Thompson E, 2010, J HUM EVOL, V59, P358, DOI 10.1016/j.jhevol.2010.07.009; Van Riet Lowe C, 1952, PLEISTOCENE GEOLOG 2; VISALBERGHI E, 1990, FOLIA PRIMATOL, V54, P146, DOI 10.1159/000156438; Wilkins J, 2012, J ARCHAEOL SCI, V39, P1883, DOI 10.1016/j.jas.2012.01.031; WILLOUGHBY PR, 1985, WORLD ARCHAEOL, V17, P44, DOI 10.1080/00438243.1985.9979949; Yellen J.E., 1977, STUDIES ARCHEOLOGY	69	38	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113856	10.1371/journal.pone.0113856	http://dx.doi.org/10.1371/journal.pone.0113856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AX4MM	25415303	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600081
J	Ding, YZ; Yuan, ST; Liu, XY; Mao, PA; Zhao, C; Huang, Q; Zhang, RH; Fang, Y; Song, QL; Yuan, DQ; Xie, P; Liu, Y; Liu, QH				Ding, Yuzhi; Yuan, Songtao; Liu, Xiaoyi; Mao, Pingan; Zhao, Chen; Huang, Qiong; Zhang, Rihua; Fang, Yuan; Song, Qinglu; Yuan, Dongqing; Xie, Ping; Liu, Yun; Liu, Qinghuai			Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy	PLOS ONE			English	Article							RETINAL BARRIER BREAKDOWN; OXIDATIVE STRESS; NEURAL APOPTOSIS; POLYOL PATHWAY; GANGLION-CELLS; EARLY-STAGE; EXPRESSION; RATS; STREPTOZOTOCIN; MECHANISMS	Objectives: Diabetic retinopathy (DR) is a common diabetic eye disease which is well-known as the result of microvascular retinal changes. Although the potential biological functions of astragaloside IV (AS IV) have long been described in traditional system of medicine, its protective effect on DR remains unclear. This study aims to investigate the function and mechanism of AS IV on type 2 diabetic db/db mice. Methods: Db/db mice were treated with AS IV (4.5 mg/kg or 9 mg/kg) or physiological saline by oral gavage for 20 weeks along with db/m mice. In each group, retinal ganglion cell (RGC) function was measured by pattern electroretinogram (ERG) and apoptosis was determined by Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Blood and retina aldose reductase (AR) activity were quantified by chemiluminescence analysis. The expressions of phosporylated-ERK1/2, NF-kappa B were determined by Western blot analysis. Furthermore, the expression of related downstream proteins were quantified by Label-based Mouse Antibody Array. Results: Administration of AS IV significantly improved the amplitude in pattern ERG and reduced the apoptosis of RGCs. in db/db mice. Furthermore, downregulation of AR activity, ERK1/2 phosphorylation, NF-kappa B and related cytokine were observed in AS IV treatment group. Conclusions: Our study indicated that AS IV, as an inhibitor of AR, could prevent the activation of ERK1/2 phosporylation and NF-kappa B and further relieve the RGCs disfunction in db/db mice with DR. It has provided a basis for investigating the clinical efficacy of AR inhibitors in preventing DR.	[Ding, Yuzhi; Yuan, Songtao; Liu, Xiaoyi; Zhao, Chen; Fang, Yuan; Song, Qinglu; Yuan, Dongqing; Xie, Ping; Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Mao, Pingan] 2 Peoples Hosp Changzhou, Dept Ophthalmol, Changzhou, Peoples R China; [Huang, Qiong; Zhang, Rihua; Liu, Yun] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Liu, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuyun@njmu.edu.cn; liuqh@njmu.edu.cn		Xie, Ping/0000-0003-4257-8970; Liu, Qinghuai/0000-0003-1605-1964	National Basic Research Program of China (973 Program) [2013CB967500]; National Natural Science Foundation of China [81270952, 81070684, 81170855, 81070743]; Jiangsu Province's Key Provincial Talents Program [BE 2011802]; Jiangsu Science & Technology Pillar Program [BE 2011802]; Jiangsu Provincial Special Program of Medical Science [BL2014089]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Provincial Talents Program; Jiangsu Science & Technology Pillar Program; Jiangsu Provincial Special Program of Medical Science	This work was supported by grants from the National Basic Research Program of China (973 Program, No. 2013CB967500), the National Natural Science Foundation of China (Nos. 81270952, 81070684, 81170855, 81070743), the Jiangsu Province's Key Provincial Talents Program (BE 2011802), Jiangsu Science & Technology Pillar Program (BE 2011802), and Jiangsu Provincial Special Program of Medical Science (BL2014089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2004, INVEST OPHTH VIS SCI, V45, P2760, DOI 10.1167/iovs.03-1392; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Basavarajappa HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095694; Bearse MA, 2004, INVEST OPHTH VIS SCI, V45, P3259, DOI 10.1167/iovs.04-0308; Bogdanov P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097302; Chang KC, 2014, INVEST OPHTH VIS SCI, V55, P2853, DOI 10.1167/iovs.13-13487; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Clements RS, 1998, J DIABETES COMPLICAT, V12, P28, DOI 10.1016/S1056-8727(97)00051-2; Dong N, 2014, MOL VIS, V20, P616; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gui DK, 2013, CYTOKINE, V61, P970, DOI 10.1016/j.cyto.2013.01.008; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Han Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P1809, DOI 10.1001/archopht.122.12.1809; Huang Ruochun, 2010, Cancer Genomics & Proteomics, V7, P129; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Ji Y, 2011, INT J MOL SCI, V12, P4722, DOI 10.3390/ijms12074722; Kim J, 2014, EUR REV MED PHARMACO, V18, P1573; Kim JH, 2010, AM J PATHOL, V176, P1517, DOI 10.2353/ajpath.2010.090398; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Kuzumoto Y, 2006, DIABETOLOGIA, V49, P3085, DOI 10.1007/s00125-006-0400-7; Li GY, 2009, EXP EYE RES, V89, P581, DOI 10.1016/j.exer.2009.06.004; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Lv L, 2010, PHYTOTHER RES, V24, P219, DOI 10.1002/ptr.2915; Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; Motomura K, 2009, J AGR FOOD CHEM, V57, P7666, DOI 10.1021/jf9007168; NAESER P, 1987, ACTA OPHTHALMOL, V65, P693; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Noh HL, 2009, J PHARMACOL EXP THER, V328, P496, DOI 10.1124/jpet.108.136283; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Romero-Aroca P, 2010, CLIN OPHTHALMOL, V4, P1481, DOI 10.2147/OPTH.S14521; Sango K, 2006, J NEUROCHEM, V98, P446, DOI 10.1111/j.1471-4159.2006.03885.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tang L, 2011, EXP BIOL MED, V236, P1051, DOI 10.1258/ebm.2011.010400; Tesch GH, 2011, AM J PHYSIOL-RENAL, V300, pF301, DOI 10.1152/ajprenal.00607.2010; Tiwari AK, 2014, PHARMACOGN MAG, V10, P383, DOI 10.4103/0973-1296.133290; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vanden-Berghe W, 1995, SCIENCE, V270, P2008; Wang SG, 2009, BIOL PHARM BULL, V32, P132, DOI 10.1248/bpb.32.132; Xiao CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030343; Yin XX, 2004, J PHARMACOL SCI, V95, P256, DOI 10.1254/jphs.FP0030597; Yu JX, 2006, CAN J PHYSIOL PHARM, V84, P579, DOI 10.1139/Y06-015; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang A, 2002, DIABETES, V51, P3499; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136	57	28	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112207	10.1371/journal.pone.0112207	http://dx.doi.org/10.1371/journal.pone.0112207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411784	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000010
J	Hashim, H; Azmin, S; Razlan, H; Yahya, NW; Tan, HJ; Manaf, MRA; Ibrahim, NM				Hashim, Hasriza; Azmin, Shahrul; Razlan, Hamizah; Yahya, Nafisah Wan; Tan, Hui Jan; Manaf, M. Rizal Abdul; Ibrahim, Norlinah Mohamed			Eradication of Helicobacter pylori Infection Improves Levodopa Action, Clinical Symptoms and Quality of Life in Patients with Parkinson's Disease	PLOS ONE			English	Article							C-13-UREA BREATH TEST; IDIOPATHIC PARKINSONISM; GASTROINTESTINAL-TRACT; MOTOR FLUCTUATIONS; ACID-SECRETION; PATHOGENESIS; INFLAMMATION; GASTRITIS; ETIOLOGY; INTERLEUKIN-1-BETA	Background: Previous studies have demonstrated a higher prevalence of Helicobacter pylori (H. pylori) infection in patients with Parkinson's disease (PD) compared to controls. H. pylori infection affects levodopa absorption and its eradication significantly improves clinical response to levodopa. Here, we studied the prevalence of H. pylori infection and its eradication effects among our PD patients. Methods: A prospective study involving idiopathic PD patients on levodopa therapy. C-13-urea breath test (UBT) was used to detect H. pylori. UBT-positive patients were given standard eradication therapy and followed up at 6 and 12 weeks in an open label single arm design. Repeat UBT was performed at 12 weeks. The UPDRS, PD NMQ, PD NMSS and PDQ-39 were administered at baseline and post-eradication (6 and 12 weeks). Levodopa 'onset' time and ON-duration were recorded. Results: Of 82 patients recruited, 27 (32.9%) had positive UBT. H. pylori-positive patients had significantly poorer total UPDRS (p = 0.005) and PDQ39 (p<0.0001) scores compared to H. pylori-negative patients. At 12 weeks post-eradication, the mean levodopa onset time shortened by 14 minutes (p = 0.011). The mean ON duration time increased by 56 minutes at week 6 (p = 0.041) and 38 minutes at week 12 (p = 0.035). The total UPDRS scores (p<0.0001), scores for parts II (p = 0.001), III (p<0.0001) and IV (p = 0.009) were significantly better. The total PDQ-39 scores (p = 0.001) and subdomains mobility (p = 0.002), ADL (p = 0.001), emotional well being (p = 0.026) and stigma (p = 0.034) significantly improved. The PD NMSQ did not show significant improvement. Conclusions: H. pylori eradication improved levodopa onset time, ON duration, motor severity and quality of life parameters. Screening and eradication of H. pylori is inexpensive and should be recommended in PD patients, particularly those with erratic response to levodopa.	[Hashim, Hasriza; Azmin, Shahrul; Razlan, Hamizah; Yahya, Nafisah Wan; Tan, Hui Jan; Ibrahim, Norlinah Mohamed] UKM Med Ctr, Dept Med, Neurol Unit, Kuala Lumpur, Malaysia; [Manaf, M. Rizal Abdul] UKM Med Ctr, Dept Community Hlth, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Ibrahim, NM (corresponding author), UKM Med Ctr, Dept Med, Neurol Unit, Kuala Lumpur, Malaysia.	norlinah@ppukm.ukm.edu.my	Manaf, Rizal Abdul/C-3030-2017	Abdul Manaf, Mohd Rizal/0000-0002-0813-8376	Universiti Kebangsaan Malaysia Fundamental Research Grant Scheme	Universiti Kebangsaan Malaysia Fundamental Research Grant Scheme	This study was funded by the Universiti Kebangsaan Malaysia Fundamental Research Grant Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Razak MR, 2012, NEUROLOGY ASIA, V17, P3; Altschuler E, 1996, MED HYPOTHESES, V47, P413, DOI 10.1016/S0306-9877(96)90223-6; Annibale B, 2002, ALIMENT PHARM THER, V16, P1723, DOI 10.1046/j.1365-2036.2002.01336.x; Asadi-Pooya AA, 2012, SEIZURE-EUR J EPILEP, V21, P21, DOI 10.1016/j.seizure.2011.08.011; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Bjarnason IT, 2005, HELICOBACTER, V10, P276, DOI 10.1111/j.1523-5378.2005.00330.x; Chapuis S, 2005, MOVEMENT DISORD, V20, P224, DOI 10.1002/mds.20279; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Dobbs RJ, 2005, HELICOBACTER, V10, P267, DOI 10.1111/j.1523-5378.2005.00331.x; Doherty NC, 2009, HELICOBACTER, V14, P223, DOI 10.1111/j.1523-5378.2009.00682.x; El-Omar EM, 2001, GUT, V48, P743, DOI 10.1136/gut.48.6.743; Feldman M, 1998, AM J PHYSIOL-GASTR L, V274, pG1011, DOI 10.1152/ajpgi.1998.274.6.G1011; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Graham DY, 2000, GASTROENTEROL CLIN N, V29, P885, DOI 10.1016/S0889-8553(05)70156-4; Hamlet A, 1999, GASTROENTEROLOGY, V116, P259, DOI 10.1016/S0016-5085(99)70121-6; Kalach N, 1998, J PEDIATR GASTR NUTR, V26, P291, DOI 10.1097/00005176-199803000-00010; Kankkunen T, 2002, EUR J PHARM SCI, V16, P273, DOI 10.1016/S0928-0987(02)00113-6; Lee WY, 2008, MOVEMENT DISORD, V23, P1696, DOI 10.1002/mds.22190; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Miyaji H, 1999, ALIMENT PHARM THERAP, V13, P1303; Nafisah WY, 2013, J PARKINSONISM RESTL, V3, P63, DOI 10.2147/JPRLS.S50491; Narozanska E, 2014, CLIN NEUROPHARMACOL, V37, P96, DOI 10.1097/WNF.0000000000000037; Ozturk A, 2007, SEIZURE-EUR J EPILEP, V16, P147, DOI 10.1016/j.seizure.2006.10.015; Pierantozzi M, 2006, NEUROLOGY, V66, P1824, DOI 10.1212/01.wnl.0000221672.01272.ba; Pierantozzi M, 2001, ANN NEUROL, V50, P686, DOI 10.1002/ana.1267; Rees K, 2011, COCHRANE DATABASE SY, V11; SALIM AS, 1993, INTERNAL MED, V32, P359, DOI 10.2169/internalmedicine.32.359; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Slawek J, 2005, PARKINSONISM RELAT D, V11, P465, DOI 10.1016/j.parkreldis.2005.04.006; STRANG R R, 1965, Med J Aust, V1, P842; Takashima M, 2001, GUT, V48, P765, DOI 10.1136/gut.48.6.765; Thor P, 1996, J PHYSIOL PHARMACOL, V47, P469; Weller C, 2005, HELICOBACTER, V10, P288, DOI 10.1111/j.1523-5378.2005.00329.x; Zagari RM, 2005, HELICOBACTER, V10, P615, DOI 10.1111/j.1523-5378.2005.00358.x	35	69	83	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112330	10.1371/journal.pone.0112330	http://dx.doi.org/10.1371/journal.pone.0112330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411976	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000012
J	Gomes, L; Fernando, S; Fernando, RH; Wickramasinghe, N; Shyamali, NLA; Ogg, GS; Malavige, GN				Gomes, Laksiri; Fernando, Samitha; Fernando, Randika Heshan; Wickramasinghe, Nilanka; Shyamali, Narangoda Liyanage Ajantha; Ogg, Graham S.; Malavige, Gathsaurie Neelika			Sphingosine 1-Phosphate in Acute Dengue Infection	PLOS ONE			English	Article							INFLUENZA-VIRUS INFECTION; RECEPTOR AGONIST THERAPY; HUMAN ENDOTHELIAL-CELLS; HEMORRHAGIC-FEVER; CYTOKINE STORM; T-CELLS; PERMEABILITY; PROTECTION; ANTIBODIES; RESPONSES	Background: Vascular leak is the hallmark of severe dengue infections and leads to complications such as shock and multi-organ failure. Although many mediators have been implicated in the vascular leak in dengue, the role of sphingosine 1 phosphate (S1P) has not been investigated. Metholodology/Principal findings: As S1P has been shown to be important in barrier integrity, we assessed the S1P levels in 28 patients with acute dengue and 12 healthy individuals. The S1P levels were significantly lower in patients with acute dengue (p = 0.002) and the levels in patients with grade IV dengue haemorrhagic fever (DHF) were significantly lower than those with dengue fever (p = 0.005). We then investigated the kinetics of S1P levels throughout the course of the illness in another 32 patients in serum samples obtained twice a day. We found that S1P levels were low throughout the course of illness and S1P levels were <0.5 mu M in 12/23 patients with DHF when compared to 1/9 with DF. Conclusions/Significance: As S1P has shown to be important in the endothelial barrier integrity and increases transendothelial resistance, low levels of S1P in acute dengue infection are likely to contribute to increased vascular permeability.	[Gomes, Laksiri; Fernando, Samitha; Fernando, Randika Heshan; Wickramasinghe, Nilanka; Malavige, Gathsaurie Neelika] Univ Sri Jayawardanapura, Fac Med Sci, Dept Microbiol, Ctr Dengue Res, Gangodawila, Sri Lanka; [Shyamali, Narangoda Liyanage Ajantha] Oxford NIHR Biomed Res Ctr, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Shyamali, Narangoda Liyanage Ajantha] Univ Oxford, Oxford, England; [Ogg, Graham S.; Malavige, Gathsaurie Neelika] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England	University Sri Jayewardenepura; University of Oxford; University of Oxford; University of Oxford	Malavige, GN (corresponding author), Univ Sri Jayawardanapura, Fac Med Sci, Dept Microbiol, Ctr Dengue Res, Gangodawila, Sri Lanka.	gathsaurie.malavige@ndm.ox.ac.uk	Malavige, Gathsaurie/J-5483-2015	Malavige, Gathsaurie/0000-0001-9201-0449; Fernando, Bentotage/0000-0002-5613-5807; Ogg, Graham/0000-0002-3097-045X	Centre for Dengue Research, University of Sri Jayawardenapura; Medical Research Council, UK; MRC [MC_UU_12010/5] Funding Source: UKRI; Medical Research Council [MC_UU_12010/5] Funding Source: researchfish	Centre for Dengue Research, University of Sri Jayawardenapura; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to the Centre for Dengue Research, University of Sri Jayawardenapura and the Medical Research Council, UK for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appanna R, 2012, AM J TROP MED HYG, V87, P936, DOI 10.4269/ajtmh.2012.11-0606; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brasier AR, 2012, AM J TROP MED HYG, V86, P341, DOI 10.4269/ajtmh.2012.11-0469; Darwish I, 2013, VIRULENCE, V4, P572, DOI 10.4161/viru.25740; Dewi BE, 2008, J GEN VIROL, V89, P642, DOI 10.1099/vir.0.83356-0; Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192; Finney CAM, 2011, MOL MED, V17, P717, DOI 10.2119/molmed.2010.00214; Jayaratne S D, 2012, BMC Res Notes, V5, P645, DOI 10.1186/1756-0500-5-645; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Lundblad C, 2013, ACTA ANAESTH SCAND, V57, P713, DOI 10.1111/aas.12130; Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023; Malavige GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050387; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Ntranos A, 2014, J NEUROIMMUNOL, V270, P13, DOI 10.1016/j.jneuroim.2014.03.007; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sang CT, 1998, CLIN DIAGN LAB IMMUN, V5, P7, DOI 10.1128/CDLI.5.1.7-10.1998; Schaphorst KL, 2003, AM J PHYSIOL-LUNG C, V285, pL258, DOI 10.1152/ajplung.00311.2002; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Srikiatkhachorn A, 2007, J VIROL, V81, P1592, DOI 10.1128/JVI.01642-06; Srikiatkhachorn A, 2014, ANTIVIR RES, V109, P160, DOI 10.1016/j.antiviral.2014.07.005; Teijaro JR, 2014, VIROLOGY, V452, P152, DOI 10.1016/j.virol.2014.01.003; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Walsh KB, 2014, J VIROL, V88, P6281, DOI 10.1128/JVI.00464-14; Walsh KB, 2011, IMMUNOL RES, V51, P15, DOI 10.1007/s12026-011-8240-z; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wei HY, 2003, J GEN VIROL, V84, P3095, DOI 10.1099/vir.0.19308-0; Whitehorn J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001716; Who, 2011, COMP GUID PREV CONTR; World Health Organization, 2009, DENG GUID DIAGN PREV	33	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113394	10.1371/journal.pone.0113394	http://dx.doi.org/10.1371/journal.pone.0113394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409037	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200108
J	Kang, MY; Kim, HR				Kang, Mo-Yeol; Kim, Hyoung-Ryoul			Association between Voluntary/Involuntary Job Loss and the Development of Stroke or Cardiovascular Disease: A Prospective Study of Middle-Aged to Older Workers in a Rapidly Developing Asian Country	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; RETIREMENT SURVEY; MENTAL-HEALTH; ALCOHOL-CONSUMPTION; FOLLOW-UP; UNEMPLOYMENT; RISK; MORTALITY; GENDER; HOSPITALIZATION	Background: The aim of this research was to investigate the association between job loss and the development of stroke or cardiovascular disease among middle-aged to older individuals in Korea. We also examined how this relationship was modified by gender and the nature of the job loss. Methods: This study used samples from the first-to fourth-wave datasets from the Korean Longitudinal Study of Aging (KLoSA), which were collected in 2006, 2008, 2010, and 2012. The study collected data from a total of 10,254 subjects aged >= 45 years at baseline. After applying exclusion criteria, the final sample size for analysis consisted of 4,000 individuals. Information about employment status, development of stroke or cardiovascular disease, and covariates (age, income level, and behavioral factors) was obtained. Cox proportional hazards models were used to evaluate the association between voluntary/involuntary job loss and the development of stroke or cardiovascular disease. We performed these analyses separately according to disease, gender, and the nature of the job loss. Results: Involuntary job loss significantly increased the risk of stroke or cardiovascular disease among males (adjusted hazard ratio [HR] = 3.560, 95% confidence interval [CI] = 2.055-6.168). Voluntary retirement also increased the risk of cardiovascular disease or stroke among males (adjusted HR = 2.879, 95% CI = 1.533-5.409). Job loss was more closely associated with stroke than with cardiovascular disease (stroke, adjusted HR = 6.208, 95% CI = 2.417-15.943; cardiovascular disease, adjusted HR = 2.768, 95% CI = 1.402-5.465). Conclusion: Our findings suggest that both voluntary retirement and involuntary job loss increase the risk for stroke or cardiovascular disease in middle-aged to older individuals, especially males.	[Kang, Mo-Yeol] Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan, South Korea; [Kang, Mo-Yeol] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Hyoung-Ryoul] Catholic Univ Korea, Coll Med, Dept Occupat & Environm Med, Seoul, South Korea	Seoul National University (SNU); Catholic University of Korea	Kim, HR (corresponding author), Catholic Univ Korea, Coll Med, Dept Occupat & Environm Med, Seoul, South Korea.	cyclor@catholic.ac.kr						Artazcoz L, 2004, AM J PUBLIC HEALTH, V94, P82, DOI 10.2105/AJPH.94.1.82; Bolton KL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-77; BRACKBILL RM, 1995, BRIT MED J, V310, P568, DOI 10.1136/bmj.310.6979.568; Broman CL, 1995, AM J COMMUN PSYCHOL, V23, P813, DOI 10.1007/BF02507017; Browning M, 2012, J HEALTH ECON, V31, P599, DOI 10.1016/j.jhealeco.2012.03.001; BUNN AR, 1979, AM J PUBLIC HEALTH, V69, P772, DOI 10.2105/AJPH.69.8.772; Buxton JW, 2005, SOC PSYCH PSYCH EPID, V40, P99, DOI 10.1007/s00127-005-0866-5; Dupre ME, 2012, ARCH INTERN MED, V172, P1731, DOI 10.1001/2013.jamainternmed.447; Ekerdt DJ, 2000, RES AGING, V22, P3, DOI 10.1177/0164027500221001; Eliason M, 2009, SOC SCI MED, V68, P1396, DOI 10.1016/j.socscimed.2009.01.021; ENSMINGER ME, 1988, SOC SCI MED, V27, P239, DOI 10.1016/0277-9536(88)90127-X; Falba T, 2005, ADDICTION, V100, P1330, DOI 10.1111/j.1360-0443.2005.01150.x; FRANKS PJ, 1991, J EPIDEMIOL COMMUN H, V45, P16, DOI 10.1136/jech.45.1.16; Gallo WT, 2006, INT ARCH OCC ENV HEA, V80, P109, DOI 10.1007/s00420-006-0108-5; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Gallo WT, 2004, AM J IND MED, V45, P408, DOI 10.1002/ajim.20004; Gallo WT, 2001, J GERONTOL B-PSYCHOL, V56, pS3, DOI 10.1093/geronb/56.1.S3; Garcy AM, 2012, SOC SCI MED, V74, P1911, DOI 10.1016/j.socscimed.2012.01.034; IVERSEN L, 1986, SOC SCI MED, V22, P107, DOI 10.1016/0277-9536(86)90314-X; Kim JE, 2002, J GERONTOL B-PSYCHOL, V57, pP212, DOI 10.1093/geronb/57.3.P212; Kornerup H, 2010, EUR J CARDIOV PREV R, V17, P113, DOI 10.1097/HJR.0b013e3283359c18; Lundin A, 2014, OCCUPATIONAL ENV MED; Mandal B, 2007, RETIREMENT MENTA JUN; Marshall VW, 2001, RES AGING, V23, P379, DOI 10.1177/0164027501234001; Moon JR, 2012, SOC SCI MED, V75, P526, DOI 10.1016/j.socscimed.2012.04.004; OECD (Organisation for Economic Co-operation and Development), STATEXTRACTS LABR FO; Olesen K, 2014, INT J EPIDEMIOL, V43, P160, DOI 10.1093/ije/dyt260; Park S, 2012, J PREVENTIVE MED PUB, V45, P188, DOI DOI 10.3961/JPMPH.2012.45.3.188; SALOKANGAS RKR, 1991, PSYCHOTHER PSYCHOSOM, V55, P100, DOI 10.1159/000288415; Statistics Korea, 2011, STAT ELD; Stephens M, 2004, REV ECON STAT, V86, P253, DOI 10.1162/003465304323023796; van Rijn R., 2013, OCCUPATIONAL ENV MED; Westerlund H., 2010, BMJ, V341; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; YEUNG WJJ, 1998, J FAMILY EC ISSUES, V0019	35	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113495	10.1371/journal.pone.0113495	http://dx.doi.org/10.1371/journal.pone.0113495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409032	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200128
J	Santos, BA; Tabarelli, M; Melo, FPL; Camargo, JLC; Andrade, A; Laurance, SG; Laurance, WF				Santos, Braulio A.; Tabarelli, Marcelo; Melo, Felipe P. L.; Camargo, Jose L. C.; Andrade, Ana; Laurance, Susan G.; Laurance, William F.			Phylogenetic Impoverishment of Amazonian Tree Communities in an Experimentally Fragmented Forest Landscape	PLOS ONE			English	Article							ATLANTIC FOREST; NONRANDOM EXTINCTION; DIVERSITY; FIRE; CONSERVATION; PHYLOCOM; ECOLOGY; HISTORY; EROSION; STAND	Amazonian rainforests sustain some of the richest tree communities on Earth, but their ecological and evolutionary responses to human threats remain poorly known. We used one of the largest experimental datasets currently available on tree dynamics in fragmented tropical forests and a recent phylogeny of angiosperms to test whether tree communities have lost phylogenetic diversity since their isolation about two decades previously. Our findings revealed an overall trend toward phylogenetic impoverishment across the experimentally fragmented landscape, irrespective of whether tree communities were in 1-ha, 10-ha, or 100-ha forest fragments, near forest edges, or in continuous forest. The magnitude of the phylogenetic diversity loss was low (< 2% relative to before-fragmentation values) but widespread throughout the study landscape, occurring in 32 of 40 1-ha plots. Consistent with this loss in phylogenetic diversity, we observed a significant decrease of 50% in phylogenetic dispersion since forest isolation, irrespective of plot location. Analyses based on tree genera that have significantly increased (28 genera) or declined (31 genera) in abundance and basal area in the landscape revealed that increasing genera are more phylogenetically related than decreasing ones. Also, the loss of phylogenetic diversity was greater in tree communities where increasing genera proliferated and decreasing genera reduced their importance values, suggesting that this taxonomic replacement is partially underlying the phylogenetic impoverishment at the landscape scale. This finding has clear implications for the current debate about the role human-modified landscapes play in sustaining biodiversity persistence and key ecosystem services, such as carbon storage. Although the generalization of our findings to other fragmented tropical forests is uncertain, it could negatively affect ecosystem productivity and stability and have broader impacts on coevolved organisms.	[Santos, Braulio A.] Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58051900 Joao Pessoa, Paraiba, Brazil; [Tabarelli, Marcelo; Melo, Felipe P. L.] Univ Fed Pernambuco, Dept Bot, BR-50670901 Recife, PE, Brazil; [Camargo, Jose L. C.; Andrade, Ana] Natl Inst Amazonian Res INPA, Biol Dynam Forest Fragment Project, BR-69011970 Manaus, Amazonas, Brazil; [Laurance, Susan G.; Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia; [Laurance, Susan G.; Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia	Universidade Federal da Paraiba; Universidade Federal de Pernambuco; Institute Nacional de Pesquisas da Amazonia; James Cook University; James Cook University	Santos, BA (corresponding author), Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58051900 Joao Pessoa, Paraiba, Brazil.	braulio@dse.ufpb.br	Tabarelli, Marcelo/F-1088-2010; Laurance, William F/B-2709-2012; Laurance, Susan/G-6021-2011; Melo, Felipe P.L./B-7720-2008; Santos, Bráulio A./M-2582-2013; Camargo, José Luís C/C-3137-2015	Tabarelli, Marcelo/0000-0001-7573-7216; Laurance, William F/0000-0003-4430-9408; Laurance, Susan/0000-0002-2831-2933; Melo, Felipe P.L./0000-0002-1271-3214; Santos, Bráulio A./0000-0001-6046-4024; Campana Camargo, Jose Luis/0000-0003-0370-9878	Instituto Nacional de Pesquisas da Amazonia (INPA); Smithsonian Institution; US National Science Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); NASA-LBA program; US-AID; Blue Moon Fund; Marisla Foundation; CNPq; Mellon Foundation	Instituto Nacional de Pesquisas da Amazonia (INPA); Smithsonian Institution(Smithsonian Institution); US National Science Foundation(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NASA-LBA program(National Aeronautics & Space Administration (NASA)); US-AID(United States Agency for International Development (USAID)); Blue Moon Fund; Marisla Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Mellon Foundation	The Instituto Nacional de Pesquisas da Amazonia (INPA), Smithsonian Institution, US National Science Foundation, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), NASA-LBA program, US-AID, Mellon Foundation, Blue Moon Fund, and Marisla Foundation generously supported the Biological Dynamics of Forest Fragment Project. BAS, FPLM and MT are thankful to CNPq for postdoctoral fellowship and research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Arroyo-Rodriguez V, 2012, J ECOL, V100, P702, DOI 10.1111/j.1365-2745.2011.01952.x; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Barlow J, 2012, BIOL CONSERV, V151, P45, DOI 10.1016/j.biocon.2011.10.013; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bouroncle C, 2011, BIOTROPICA, V43, P562, DOI 10.1111/j.1744-7429.2011.00750.x; Briant G, 2010, BIOL CONSERV, V143, P2763, DOI 10.1016/j.biocon.2010.07.024; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cadotte MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019363; Cavender-Bares J, 2012, ECOLOGY, V93, pS1, DOI 10.1890/12-0092.1; Cavender-Bares J, 2012, ECOLOGY, V93, pS52, DOI 10.1890/11-0502.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Cianciaruso MV, 2012, PERSPECT PLANT ECOL, V14, P205, DOI 10.1016/j.ppees.2011.11.004; D'Angelo SA, 2004, J TROP ECOL, V20, P243, DOI 10.1017/S0266467403001032; Gastauer M, 2013, ECOL INFORM, V15, P85, DOI 10.1016/j.ecoinf.2013.03.005; Grafen A., 2002, MODERN STAT LIFE SCI; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Hernandez-Ruedas MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098931; Laurance SGW, 2010, BIOTROPICA, V42, P429, DOI 10.1111/j.1744-7429.2009.00611.x; Susan GWL, 2009, J VEG SCI, V20, P323, DOI 10.1111/j.1654-1103.2009.01044.x; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; LAURANCE WF, 2006, EMERGING THREATS TRO; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lessard JP, 2009, ECOLOGY, V90, P2664, DOI 10.1890/09-0503.1; Letcher SG, 2012, PERSPECT PLANT ECOL, V14, P79, DOI 10.1016/j.ppees.2011.09.005; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Lopes AV, 2009, BIOL CONSERV, V142, P1154, DOI 10.1016/j.biocon.2009.01.007; Magurran A.E., 2004, MEASURING BIOL DIVER; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Michalski F, 2007, BIOTROPICA, V39, P691, DOI 10.1111/j.1744-7429.2007.00318.x; Norden N, 2012, ECOLOGY, V93, pS70, DOI 10.1890/10-2179.1; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Pausas JG, 2010, BIOSCIENCE, V60, P614, DOI 10.1525/bio.2010.60.8.7; Piperno DR, 1996, QUATERNARY RES, V45, P202, DOI 10.1006/qres.1996.0020; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Ros M, 2012, DIVERS DISTRIB, V18, P377, DOI 10.1111/j.1472-4642.2011.00834.x; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Santos GGA, 2012, BIOTROPICA, V44, P771, DOI 10.1111/j.1744-7429.2012.00882.x; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Verdu M, 2007, J ECOL, V95, P1316, DOI 10.1111/j.1365-2745.2007.01300.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Youssef NH, 2012, APPL ENVIRON MICROB, V78, P1332, DOI 10.1128/AEM.07420-11	58	29	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113109	10.1371/journal.pone.0113109	http://dx.doi.org/10.1371/journal.pone.0113109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409011	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200068
J	Wijemanne, P; Moxley, RA				Wijemanne, Prageeth; Moxley, Rodney A.			Glucose Significantly Enhances Enterotoxigenic Escherichia coli Adherence to Intestinal Epithelial Cells through Its Effects on Heat-Labile Enterotoxin Production	PLOS ONE			English	Article							STIMULATES PROLIFERATION; SECRETORY PATHWAY; VIRULENCE GENES; WEANED PIGS; YOUNG-PIGS; DISEASE; PREVALENCE; REPRESSION; VISCOSITY; VESICLES	The present study tested whether exposure of enterotoxigenic Escherichia coli (ETEC) to glucose at different concentrations in the media results in increased bacterial adherence to host cells through increased heat-labile enterotoxin (LT) production, thereby suggesting the effects are physiological. Porcine-origin ETEC strains grown in Casamino acid yeast extract medium containing different concentrations of glucose were washed and inoculated onto IPEC-J2 porcine intestinal epithelial cells to test for effects on adherence and host cell cAMP concentrations. Consistent with previous studies, all LT+ strains had higher ETEC adherence to IPEC-J2 cells than did LT- strains. Adherence of the LT- but not the LT+ strains was increased by pre-incubating the IPEC-J2 cells with LT and decreased by co-incubation with GM1 ganglioside in a dose-dependent manner (P<0.05). To determine whether the glucose concentration of the cell culture media has an effect on adherence, IPEC-J2 cells were inoculated with LT+ or LT- strains in cell culture media containing a final glucose concentration of 0, 0.25, 0.5, 1.0 or 2.0%, and incubated for 4 h. Only media containing 0.25% glucose resulted in increased adherence and cAMP levels, and this was limited to IPEC-J2 cells inoculated with LT+ strains. This study supports the hypothesis that glucose, at a concentration optimal for LT expression, enhances bacterial adherence through the promotion of LT production. Hence, these results establish the physiological relevance of the effects of glucose on LT production and provide a basis for how glucose intake may influence the severity of ETEC infection.	[Wijemanne, Prageeth; Moxley, Rodney A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Moxley, RA (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA.	rmoxley1@unl.edu		Moxley, Rodney/0000-0002-5377-7716	United States Department of Agriculture [NC-1202, NEB-39-167]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture, Multi-State Project NC-1202, NEB-39-167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflen KP, 2006, INFECT IMMUN, V74, P869; Argenzio R. A., 2004, Dukes' physiology of domestic animals, P405; BAYLEY HS, 1970, J ANIM SCI, V30, P394, DOI 10.2527/jas1970.303394x; Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; Bodero MD, 2009, INFECT IMMUN, V77, P791, DOI 10.1128/IAI.00928-08; BUSQUE P, 1995, MICROBIOL-SGM, V141, P1621, DOI 10.1099/13500872-141-7-1621; CHEN TM, 1985, INFECT IMMUN, V47, P5, DOI 10.1128/IAI.47.1.5-10.1985; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; Erume J, 2008, INFECT IMMUN, V76, P3141, DOI 10.1128/IAI.01743-07; Erume J, 2013, VET MICROBIOL, V161, P315, DOI 10.1016/j.vetmic.2012.07.048; Fekete PZ, 2013, VET MICROBIOL, V164, P330, DOI 10.1016/j.vetmic.2013.02.019; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; GILLIGAN PH, 1979, INFECT IMMUN, V23, P99, DOI 10.1128/IAI.23.1.99-107.1979; Hegde A, 2009, INDIAN J MED MICROBI, V27, P325, DOI 10.4103/0255-0857.55446; HOHMANN A, 1975, INFECT IMMUN, V12, P866, DOI 10.1128/IAI.12.4.866-880.1975; Hopwood DE, 2002, BRIT J NUTR, V88, P523, DOI 10.1079/BJN2002694; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; KUNKEL SL, 1979, INFECT IMMUN, V23, P652, DOI 10.1128/IAI.23.3.652-659.1979; McDonald DE, 2001, BRIT J NUTR, V86, P487, DOI 10.1079/BJN2001416; Moxley RA, 1998, INFECT IMMUN, V66, P5031, DOI 10.1128/IAI.66.10.5031-5035.1998; Mudrak B, 2010, TOXINS, V2, P1445, DOI 10.3390/toxins2061445; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; PICKEN RN, 1983, INFECT IMMUN, V42, P269, DOI 10.1128/IAI.42.1.269-275.1983; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; SMITH HW, 1968, J MED MICROBIOL, V1, P45, DOI 10.1099/00222615-1-1-45; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; Walker RI, 2007, VACCINE, V25, P2545, DOI 10.1016/j.vaccine.2006.12.028; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018	33	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113230	10.1371/journal.pone.0113230	http://dx.doi.org/10.1371/journal.pone.0113230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409235	Green Published, gold			2022-12-27	WOS:000345533200079
J	Yoshimori, M; Imadome, KI; Komatsu, H; Wang, LD; Saitoh, Y; Yamaoka, S; Fukuda, T; Kurata, M; Koyama, T; Shimizu, N; Fujiwara, S; Miura, O; Arai, A				Yoshimori, Mayumi; Imadome, Ken-Ichi; Komatsu, Honami; Wang, Ludan; Saitoh, Yasunori; Yamaoka, Shoji; Fukuda, Tetsuya; Kurata, Morito; Koyama, Takatoshi; Shimizu, Norio; Fujiwara, Shigeyoshi; Miura, Osamu; Arai, Ayako			CD137 Expression Is Induced by Epstein-Barr Virus Infection through LMP1 in T or NK Cells and Mediates Survival Promoting Signals	PLOS ONE			English	Article							DENDRITIC CELLS; KINASE PATHWAY; EBV INFECTION; 4-1BB LIGAND; CD40 LIGAND; ACTIVATION; LYMPHOMAS; ANTIGEN; ESTABLISHMENT; LYMPHOCYTES	To clarify the mechanism for development of Epstein-Barr virus (EBV)-positive T-or NK-cell neoplasms, we focused on the costimulatory receptor CD137. We detected high expression of CD137 gene and its protein on EBV-positive T-or NK-cell lines as compared with EBV-negative cell lines. EBV-positive cells from EBV-positive T-or NK-cell lymphoproliferative disorders (EBV-T/NK-LPDs) patients also had significantly higher CD137 gene expression than control cells from healthy donors. In the presence of IL-2, whose concentration in the serum of EBV-T/NK-LPDs was higher than that of healthy donors, CD137 protein expression was upregulated in the patients' cells whereas not in control cells from healthy donors. In vitro EBV infection of MOLT4 cells resulted in induction of endogenous CD137 expression. Transient expression of LMP1, which was enhanced by IL-2 in EBV-T/NK-LPDs cells, induced endogenous CD137 gene expression in T and NK-cell lines. In order to examine in vivo CD137 expression, we used EBV-T/NK-LPDs xenograft models generated by intravenous injection of patients' cells. We identified EBV-positive and CD8-positive T cells, as well as CD137 ligand-positive cells, in their tissue lesions. In addition, we detected CD137 expression on the EBV infected cells from the lesions of the models by immune-fluorescent staining. Finally, CD137 stimulation suppressed etoposide-induced cell death not only in the EBV-positive T-or NK-cell lines, but also in the patients' cells. These results indicate that upregulation of CD137 expression through LMP1 by EBV promotes cell survival in T or NK cells leading to development of EBV-positive T/NK-cell neoplasms.	[Yoshimori, Mayumi; Komatsu, Honami; Wang, Ludan; Fukuda, Tetsuya; Miura, Osamu; Arai, Ayako] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan; [Yoshimori, Mayumi; Komatsu, Honami; Koyama, Takatoshi] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Lab Mol Genet Hematol, Tokyo, Japan; [Imadome, Ken-Ichi; Fujiwara, Shigeyoshi] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo, Japan; [Saitoh, Yasunori; Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Virol, Tokyo, Japan; [Kurata, Morito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan; [Shimizu, Norio] Tokyo Med & Dent Univ, Med Res Inst, Dept Virol, Div Med Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Arai, A (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan.	ara.hema@tmd.ac.jp	Kurata, Morito/AAD-3172-2019	Kurata, Morito/0000-0002-1242-6709; Miura, Osamu/0000-0002-0981-3054	Ministry of Health, Labor, and Welfare of Japan [H22-Nanchi-080]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23591375]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan (H22-Nanchi-080) as well as a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23591375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1994, EUR J IMMUNOL, V24, P2219, DOI 10.1002/eji.1830240943; Anderson MW, 2012, AM J PATHOL, V181, P795, DOI 10.1016/j.ajpath.2012.05.015; Arai A, 2011, INT J HEMATOL, V93, P602, DOI 10.1007/s12185-011-0831-x; Chan JC, 2008, WHO CLASSIFICATION T, P285; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Fox CP, 2010, CLIN INFECT DIS, V51, P66, DOI 10.1086/653424; Hentschel N, 2006, EUR J HAEMATOL, V77, P91, DOI 10.1111/j.1600-0609.2006.00679.x; Imadome KI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002326; Imadome KI, 2005, J INFECT DIS, V192, P1340, DOI 10.1086/466530; Imadome KI, 2003, P NATL ACAD SCI USA, V100, P7836, DOI 10.1073/pnas.1231363100; Iwasaki Y, 1998, J VIROL, V72, P8321, DOI 10.1128/JVI.72.10.8321-8326.1998; Jung HW, 2004, EXP MOL MED, V36, P13, DOI 10.1038/emm.2004.2; Kasahara Y, 2001, BLOOD, V98, P1882, DOI 10.1182/blood.V98.6.1882; Kawa K, 2011, BONE MARROW TRANSPL, V46, P77, DOI 10.1038/bmt.2010.122; Kaye KM, 1999, J VIROL, V73, P10525, DOI 10.1128/JVI.73.12.10525-10530.1999; Kim JO, 2003, FEBS LETT, V541, P163, DOI 10.1016/S0014-5793(03)00326-0; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kimura H, 2006, REV MED VIROL, V16, P251, DOI 10.1002/rmv.505; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Kutz H, 2008, VIROLOGY, V371, P246, DOI 10.1016/j.virol.2007.09.044; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Lee SW, 2008, NAT IMMUNOL, V9, P917, DOI 10.1038/ni.1632; MacCallum CJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000413; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Middendorp S, 2009, BLOOD, V114, P2280, DOI 10.1182/blood-2009-03-208215; MIKI T, 1994, BLOOD, V83, P217; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Nakaima Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064425; Narazaki H, 2010, BLOOD, V115, P1941, DOI 10.1182/blood-2008-12-192591; Nosaka Y, 1999, J BIOL CHEM, V274, P30154, DOI 10.1074/jbc.274.42.30154; Ohga S, 2001, J INFECT DIS, V183, P1, DOI 10.1086/317653; Okano M, 2005, AM J HEMATOL, V80, P64, DOI 10.1002/ajh.20398; Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35; Pichler K, 2008, BLOOD, V111, P4741, DOI 10.1182/blood-2007-10-115220; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; Quintanilla-Marinez L, 2008, WHO CLASSIFICATION T, P278; REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302; Salih HR, 2000, J IMMUNOL, V165, P2903, DOI 10.4049/jimmunol.165.5.2903; Salih HR, 2001, J IMMUNOL, V167, P4059, DOI 10.4049/jimmunol.167.7.4059; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shao Z, 2011, J LEUKOCYTE BIOL, V89, P21, DOI 10.1189/jlb.0510315; Shirakata M, 2001, J VIROL, V75, P5059, DOI 10.1128/JVI.75.11.5059-5068.2001; SINCLAIR AJ, 1994, EMBO J, V13, P3321, DOI 10.1002/j.1460-2075.1994.tb06634.x; Song ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023239; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Takahara M, 2006, INT J CANCER, V119, P2775, DOI 10.1002/ijc.22139; Tan JT, 2000, TRANSPLANTATION, V70, P175; Yamaguchi M, 2012, J CLIN ONCOL; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Zhang Y, 2003, BRIT J HAEMATOL, V121, P805, DOI 10.1046/j.1365-2141.2003.04359.x	56	25	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112564	10.1371/journal.pone.0112564	http://dx.doi.org/10.1371/journal.pone.0112564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409517	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200027
J	Hatton, SN; Lagopoulos, J; Hermens, DF; Hickie, IB; Scott, E; Bennett, MR				Hatton, Sean N.; Lagopoulos, Jim; Hermens, Daniel F.; Hickie, Ian B.; Scott, Elizabeth; Bennett, Maxwell R.			Short Association Fibres of the Insula-Temporoparietal Junction in Early Psychosis: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							AUDITORY VERBAL HALLUCINATIONS; SUPERFICIAL WHITE-MATTER; HOMO-SAPIENS PAYS; BRAIN IMAGES; YOUNG-PEOPLE; SCHIZOPHRENIA; MRI; NEUROANATOMY; LANGUAGE; ABNORMALITIES	Evidence shows that there are reductions in gray matter volume (GMV) and changes in long association white matter fibres within the left insula-temporoparietal junction (TPJ) during the early stages of psychotic disorders but less is known about short association fibres (sAFs). In this study we sought to characterise the changes in sAFs and associated volumetric changes of the left insula-TPJ during the early stages of psychosis. Magnetic resonance imaging was obtained from a sample of young people with psychosis (n = 42) and healthy controls (n = 45), and cortical parcellations of the left insula-TPJ were used as seeding masks to reconstruct 13 sAFs. Compared to healthy counterparts, the psychosis group showed significant reductions in fractional anisotropy (FA) in the sAFs connecting the superior (STG) and middle temporal gyri (MTG) and as well as reduced GMV within the inferior temporal gyrus and increased white matter volume (WMV) within Heschl's gyrus (HG). Furthermore, adolescent-onset psychosis subjects (onset 18 year or earlier) showed FA reductions in the STG-HG sAF when compared to adult-onset subjects, but this was not associated with changes in GMV nor WMV of the STG or HG. These findings suggest that during the early stages of psychosis, changes in sAFs and associated cortical GMV and WMV appear to occur independently, however age of onset of a psychotic syndrome/disorder influences the pattern of neuroanatomical abnormalities.	[Hatton, Sean N.; Lagopoulos, Jim; Hermens, Daniel F.; Hickie, Ian B.; Scott, Elizabeth; Bennett, Maxwell R.] Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia	University of Sydney	Hatton, SN (corresponding author), Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia.	sean.hatton@sydney.edu.au	Hatton, Sean/U-5993-2019; Hatton, Sean/ABF-2549-2020; Hickie, Ian B/K-8975-2015	Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Hatton, Sean/0000-0002-9149-8726	National Health & Medical Research Council funding sources: Program Grant [566529]; Centres of Clinical Research Excellence Grant [264611]; Australia Fellowship [464914]; Clinical Research Fellowship [402864]; Australian Postgraduate Award; NSW Health, Mental Health and Drug Alcohol Office; NHMRC Australia Fellowship; National Health and Medical Research Council Australia Fellowship [464914]	National Health & Medical Research Council funding sources: Program Grant; Centres of Clinical Research Excellence Grant; Australia Fellowship; Clinical Research Fellowship; Australian Postgraduate Award(Australian Government); NSW Health, Mental Health and Drug Alcohol Office; NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the following National Health & Medical Research Council funding sources: Program Grant (No. 566529), Centres of Clinical Research Excellence Grant (No. 264611), Australia Fellowship (No. 464914) and Clinical Research Fellowship (No. 402864). Sean Hatton is supported by an Australian Postgraduate Award (APA). Dr Daniel Hermens is currently supported by a grant from the NSW Health, Mental Health and Drug & Alcohol Office as well as an NHMRC Australia Fellowship (awarded to Professor Hickie). Professor Ian B Hickie is supported by a National Health and Medical Research Council Australia Fellowship (No. 464914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2012, SCHIZOPHRENIA BULL, V38, P695, DOI 10.1093/schbul/sbs066; American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Chance SA, 2008, BRAIN, V131, P3178, DOI 10.1093/brain/awn211; Crow TJ, 2008, SCHIZOPHR RES, V102, P31, DOI 10.1016/j.schres.2008.03.010; Crow TJ, 2000, BRAIN RES REV, V31, P118, DOI 10.1016/S0165-0173(99)00029-6; Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hatton SN, 2013, INT J BIPOLAR DISORD, V1, DOI 10.1186/2194-7511-1-3; Hatton SN, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-45; Hatton SN, 2014, J PSYCHIATR NEUROSCI, V39; Hubl D, 2010, NEUROPSYCHOBIOLOGY, V61, P1, DOI 10.1159/000258637; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kuroki N, 2006, AM J PSYCHIAT, V163, P2103, DOI 10.1176/appi.ajp.163.12.2103; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meynert T, 1869, S STRICKER HDB LEHRE; Modinos G, 2013, CORTEX, V49, P1046, DOI 10.1016/j.cortex.2012.01.009; Nazeri A, 2013, NEUROPSYCHOPHARMACOL, V38, P1954, DOI 10.1038/npp.2013.93; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Phillips OR, 2011, BIOL PSYCHIAT, V70, P680, DOI 10.1016/j.biopsych.2011.03.039; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Scott EM, 2013, J AFFECT DISORDERS, V144, P208, DOI 10.1016/j.jad.2012.06.031; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; Smiley JF, 2012, SCHIZOPHR RES, V136, P43, DOI 10.1016/j.schres.2012.01.006; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Tozer DJ, 2012, NEUROIMAGE, V59, P3094, DOI 10.1016/j.neuroimage.2011.10.088; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D., 2001, WECHSLER TEST ADULT; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yushkevich PA, 2009, NEUROIMAGE, V45, pS99, DOI 10.1016/j.neuroimage.2008.10.051; Zhang FF, 2014, SCHIZOPHR RES, V159, P31, DOI 10.1016/j.schres.2014.07.050; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang SW, 2011, NEUROIMAGE, V54, P974, DOI 10.1016/j.neuroimage.2010.09.008; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112842	10.1371/journal.pone.0112842	http://dx.doi.org/10.1371/journal.pone.0112842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405994	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300057
J	Vetreno, RP; Broadwater, M; Liu, W; Spear, LP; Crews, FT				Vetreno, Ryan P.; Broadwater, Margaret; Liu, Wen; Spear, Linda P.; Crews, Fulton T.			Adolescent, but Not Adult, Binge Ethanol Exposure Leads to Persistent Global Reductions of Choline Acetyltransferase Expressing Neurons in Brain	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; EFFERENT CONNECTIONS; PARADOXICAL SLEEP; DOPAMINE RELEASE; MEDIAL HABENULA; NUCLEUS; LESIONS; DRINKING; NICOTINE; RAT	During the adolescent transition from childhood to adulthood, notable maturational changes occur in brain neurotransmitter systems. The cholinergic system is composed of several distinct nuclei that exert neuromodulatory control over cognition, arousal, and reward. Binge drinking and alcohol abuse are common during this stage, which might alter the developmental trajectory of this system leading to long-term changes in adult neurobiology. In Experiment 1, adolescent intermittent ethanol (AIE; 5.0 g/kg, i.g., 2-day on/2-day off from postnatal day [P] 25 to P55) treatment led to persistent, global reductions of choline acetyltransferase (ChAT) expression. Administration of the Toll-like receptor 4 agonist lipopolysaccharide to young adult rats (P70) produced a reduction in ChAT+ IR that mimicked AIE. To determine if the binge ethanol-induced ChAT decline was unique to the adolescent, Experiment 2 examined ChAT+ IR in the basal forebrain following adolescent (P28-P48) and adult (P70-P90) binge ethanol exposure. Twenty-five days later, ChAT expression was reduced in adolescent, but not adult, binge ethanol-exposed animals. In Experiment 3, expression of ChAT and vesicular acetylcholine transporter expression was found to be significantly reduced in the alcoholic basal forebrain relative to moderate drinking controls. Together, these data suggest that adolescent binge ethanol decreases adult ChAT expression, possibly through neuroimmune mechanisms, which might impact adult cognition, arousal, or reward sensitivity.	[Vetreno, Ryan P.; Liu, Wen; Crews, Fulton T.] Univ N Carolina, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Broadwater, Margaret; Spear, Linda P.] SUNY Binghamton, Dept Psychol, Ctr Dev & Behav Neurosci, Binghamton, NY 13902 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Vetreno, RP (corresponding author), Univ N Carolina, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.	rvetreno@email.unc.edu	Crews, Fulton/T-1181-2019	Crews, Fulton/0000-0003-2393-4976	National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse [AA019767, AA11605, AA007573, AA021040, AA018026]; Neurobiology of Adolescent Drinking in Adulthood (NADIA) [AA020023, AA020024, AA020022]; Bowles Center for Alcohol Studies; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA021040, U01AA019972, T32AA007573, P60AA011605, U24AA020022, P50AA011605, R01AA018026, U01AA020023, U54AA019767, U24AA020024] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Neurobiology of Adolescent Drinking in Adulthood (NADIA); Bowles Center for Alcohol Studies; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by the National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse (AA019767, AA11605, AA007573, AA021040, and AA018026), the Neurobiology of Adolescent Drinking in Adulthood (NADIA [AA020023, AA020024, and AA020022]), and the Bowles Center for Alcohol Studies. The NIH, NIAAA, NADIA, and Bowles Center for Alcohol Studies had no further role in the study design, collection, analysis, and interpretation of data, writing of the report, or decision to submit the article for publication.	ARENDT T, 1989, NEUROSCIENCE, V33, P435, DOI 10.1016/0306-4522(89)90397-7; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Bah TM, 2010, SLEEP, V33, P1703, DOI 10.1093/sleep/33.12.1703; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Benarroch EE, 2013, NEUROLOGY, V80, P1148, DOI 10.1212/WNL.0b013e3182886a76; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Broadwater M, 2013, BEHAV BRAIN RES, V256, P10, DOI 10.1016/j.bbr.2013.08.013; Cabrera SM, 2006, BEHAV NEUROSCI, V120, P298, DOI 10.1037/0735-7044.120.2.298; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Carlson J, 2000, NEUROPHARMACOLOGY, V39, P2792, DOI 10.1016/S0028-3908(00)00141-6; Carlson J, 2001, BRAIN RES, V906, P127, DOI 10.1016/S0006-8993(01)02570-7; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Criado JR, 2008, ALCOHOL, V42, P631, DOI 10.1016/j.alcohol.2008.08.001; De Rosa E, 2004, NEURON, V41, P825, DOI 10.1016/S0896-6273(04)00080-7; Dedova I, 2009, INT J MOL SCI, V10, P366, DOI 10.3390/ijms10010366; Ehlers CL, 2011, NEUROSCIENCE, V199, P333, DOI 10.1016/j.neuroscience.2011.10.011; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003; Guo KH, 2010, NEUROCHEM INT, V56, P694, DOI 10.1016/j.neuint.2010.02.005; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hingson R, 2001, PEDIATRICS, V108, P872, DOI 10.1542/peds.108.4.872; Johnston L., 2009, MONITORING FUTURE NA, VI; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Knox D, 2006, BEHAV NEUROSCI, V120, P307, DOI 10.1037/0735-7044.120.2.307; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; LEVEY AI, 1983, J NEUROSCI, V3, P1; Ma M, 2012, J NEUROSCI, V32, P10105, DOI 10.1523/JNEUROSCI.0058-12.2012; MCMILLIAN M, 1995, BIOCHEM BIOPH RES CO, V215, P572, DOI 10.1006/bbrc.1995.2503; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Oda Y, 2000, HISTOL HISTOPATHOL, V15, P825, DOI 10.14670/HH-15.825; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; POTTHOFF AD, 1983, PHARMACOL BIOCHEM BE, V18, P489, DOI 10.1016/0091-3057(83)90269-1; Power AE, 2002, BEHAV BRAIN RES, V134, P307, DOI 10.1016/S0166-4328(02)00046-3; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Roehrs T, 2001, SLEEP MED REV, V5, P287, DOI 10.1053/smrv.2001.0162; Rupp CI, 2003, ALCOHOL CLIN EXP RES, V27, P432, DOI 10.1097/01.ALC.0000057945.57330.2C; Sher KJ, 1999, DEV PSYCHOPATHOL, V11, P933, DOI 10.1017/S0954579499002394; Silveri MM, 1998, ALCOHOL CLIN EXP RES, V22, P670, DOI 10.1111/j.1530-0277.1998.tb04310.x; Slotkin TA, 2008, BRAIN RES BULL, V76, P522, DOI 10.1016/j.brainresbull.2008.03.001; Smith HR, 2005, NEUROSCIENCE, V132, P261, DOI 10.1016/j.neuroscience.2004.12.037; Spear LP, 2011, DEV COGN NEUROS-NETH, V1, P390, DOI 10.1016/j.dcn.2011.08.001; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Szutowicz A, 2006, METAB BRAIN DIS, V21, P149, DOI 10.1007/s11011-006-9007-4; Unal CT, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00021; Usunoff KG, 2007, BRAIN RES, V1133, P87, DOI 10.1016/j.brainres.2006.11.073; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Vetreno RP, 2013, NEUROBIOL DIS, V59, P52, DOI 10.1016/j.nbd.2013.07.002; WEBSTER HH, 1988, BRAIN RES, V458, P285, DOI 10.1016/0006-8993(88)90471-4; Windle M, 2008, PEDIATRICS, V121, pS273, DOI 10.1542/peds.2007-2243C; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	58	68	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113421	10.1371/journal.pone.0113421	http://dx.doi.org/10.1371/journal.pone.0113421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405505	Green Published, gold			2022-12-27	WOS:000347121300116
J	Xiang, L; Kong, W; Su, JT; Liang, J; Zhang, GY; Xie, LP; Zhang, RQ				Xiang, Liang; Kong, Wei; Su, Jingtan; Liang, Jian; Zhang, Guiyou; Xie, Liping; Zhang, Rongqing			Amorphous Calcium Carbonate Precipitation by Cellular Biomineralization in Mantle Cell Cultures of Pinctada fucata	PLOS ONE			English	Article							MATRIX PROTEIN SECRETION; PEARL OYSTER; PRECURSOR PHASE; SHELL FORMATION; MOLLUSK; TISSUE; NACRE; ARAGONITE; ABALONE; LAYER	The growth of molluscan shell crystals is generally thought to be initiated from the extrapallial fluid by matrix proteins, however, the cellular mechanisms of shell formation pathway remain unknown. Here, we first report amorphous calcium carbonate (ACC) precipitation by cellular biomineralization in primary mantle cell cultures of Pinctada fucata. Through real-time PCR and western blot analyses, we demonstrate that mantle cells retain the ability to synthesize and secrete ACCBP, Pif80 and nacrein in vitro. In addition, the cells also maintained high levels of alkaline phosphatase and carbonic anhydrase activity, enzymes responsible for shell formation. On the basis of polarized light microscopy and scanning electron microscopy, we observed intracellular crystals production by mantle cells in vitro. Fourier transform infrared spectroscopy and X-ray diffraction analyses revealed the crystals to be ACC, and de novo biomineralization was confirmed by following the incorporation of Sr into calcium carbonate. Our results demonstrate the ability of mantle cells to perform fundamental biomineralization processes via amorphous calcium carbonate, and these cells may be directly involved in pearl oyster shell formation.	[Xiang, Liang; Kong, Wei; Su, Jingtan; Liang, Jian; Zhang, Guiyou; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xiang, Liang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Lab Reprod Hlth, Shenzhen, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, U0831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090002110055]; Independent Research Projects of Tsinghua University [20111080964]; National Key Scientific and Technological Project [2011ZX08011]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Research Projects of Tsinghua University; National Key Scientific and Technological Project	This work was supported by the National Basic Research Program of China Grant 2010CB126405, http://www.973.gov.cn/English/Index.aspx, the National High Technology Research and Development Program of China 2010AA09Z405, http://www.most.gov.cn/eng/index.htm, the National Natural Science Foundation of China Grants 31172382 and U0831001 (Joint Fund with Guangdong) http://www.nsfc.gov.cn/Portal0/default124.htm, the Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20090002110055, and Independent Research Projects of Tsinghua University Grant 20111080964, and National Key Scientific and Technological Project 2011ZX08011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Auzoux-Bordenave S, 2010, J STRUCT BIOL, V171, P277, DOI 10.1016/j.jsb.2010.05.012; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Beniash E, 1999, J STRUCT BIOL, V125, P50, DOI 10.1006/jsbi.1998.4081; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Checa AG, 2005, BIOMATERIALS, V26, P1071, DOI 10.1016/j.biomaterials.2004.04.007; Collin R, 1998, J MORPHOL, V235, P77, DOI 10.1002/(SICI)1097-4687(199801)235:1<77::AID-JMOR6>3.0.CO;2-L; Domart-Coulon IJ, 2001, P NATL ACAD SCI USA, V98, P11885, DOI 10.1073/pnas.211439698; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang Z, 2008, MAR BIOL, V153, P745, DOI 10.1007/s00227-007-0851-5; Gardner LD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-455; Gaume B, 2011, MAR BIOL, V158, P341, DOI 10.1007/s00227-010-1562-x; Gong NP, 2008, CELL TISSUE RES, V333, P493, DOI 10.1007/s00441-008-0609-5; Gong NP, 2008, MAR BIOTECHNOL, V10, P457, DOI 10.1007/s10126-008-9081-1; Hasse B, 2000, CHEM-EUR J, V6, P3679, DOI 10.1002/1521-3765(20001016)6:20<3679::AID-CHEM3679>3.0.CO;2-#; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Jacob DE, 2008, GEOCHIM COSMOCHIM AC, V72, P5401, DOI 10.1016/j.gca.2008.08.019; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Koga N, 1998, THERMOCHIM ACTA, V318, P239, DOI 10.1016/S0040-6031(98)00348-7; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; McDougall C, 2011, CELLS TISSUES ORGANS, V194, P103, DOI 10.1159/000324213; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nassif N, 2005, P NATL ACAD SCI USA, V102, P12653, DOI 10.1073/pnas.0502577102; Natoli A, 2010, MICRON, V41, P359, DOI 10.1016/j.micron.2010.01.002; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; Poncet JM, 2000, MAR BIOTECHNOL, V2, P387; Rinkevich B, 2005, MAR BIOTECHNOL, V7, P429, DOI 10.1007/s10126-004-0108-y; Rousseau M, 2003, COMP BIOCHEM PHYS A, V135, P271, DOI 10.1016/S1095-6433(03)00070-9; Sud D, 2001, TISSUE CELL, V33, P154, DOI 10.1054/tice.2000.0166; Suja CP, 2007, AQUACULTURE, V271, P516, DOI 10.1016/j.aquaculture.2007.04.086; Suja CP, 2005, TISSUE CELL, V37, P1, DOI 10.1016/j.tice.2004.08.002; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Wang XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066522; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Yan ZG, 2011, ACTA OCEANOL SIN, V30, P87, DOI 10.1007/s13131-011-0094-7; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	43	38	39	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113150	10.1371/journal.pone.0113150	http://dx.doi.org/10.1371/journal.pone.0113150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405357	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300087
J	Jackson, D; McCrone, P; Mosweu, I; Siegert, R; Turner-Stokes, L				Jackson, Diana; McCrone, Paul; Mosweu, Iris; Siegert, Richard; Turner-Stokes, Lynne			Service Use and Costs for People with Long-Term Neurological Conditions in the First Year following Discharge from In-Patient Neuro-Rehabilitation: A Longitudinal Cohort Study	PLOS ONE			English	Article							ACQUIRED BRAIN-INJURY; INFORMAL CARE; STROKE; DEMENTIA; NEEDS	Background: Knowledge of the configuration and costs of community rehabilitation and support for people with long-term neurological conditions (LTNCs) is needed to inform future service development and resource allocation. In a multicentre prospective cohort study evaluating community service delivery during the year post-discharge from in-patient neuro-rehabilitation, a key objective was to determine service use, costs, and predictors of these costs. Methods: Patients consecutively admitted over one year to all nine London specialised (Level 1) in-patient neuro-rehabilitation units were recruited on discharge. They or their carers completed postal/web-based questionnaires at discharge and six and twelve months later, providing demographic data and measures of impairment, disability, service needs and provision. This paper describes health and social care service use, informal care and associated costs. Regression models using non-parametric boot-strapping identified predictors of costs over time. Results: Overall, 152 patients provided consistent data. Mean formal service costs fell significantly from 13,290 pound (sd 19,369) pound during the first six months to 9,335 pound (sd 19,036) pound from six-twelve months, (t = 2.35, P<0.05), mainly due to declining health service use. At six months, informal care was received on average for 8.2 hours/day, mean cost 14,615 pound (sd 23,305), comprising 52% of overall care costs. By twelve months, it had increased to 8.8 hours per day, mean cost 15,468 pound (sd 25,534) pound, accounting for 62% of overall care costs. Being younger and more disabled predicted higher formal care costs, explaining 32% and 30% of the variation in costs respectively at six and twelve months. Conclusion: Community services for people with LTNCs carry substantial costs that shift from health to social care over time, increasing the burden on families. Prioritising rehabilitation services towards those in greatest need could limit access to others needing on-going support to promote their independence and reduce their reliance on families. This argues for greater investment in future rehabilitation services.	[Jackson, Diana; Turner-Stokes, Lynne] Kings Coll London, Fac Life Sci & Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [McCrone, Paul; Mosweu, Iris] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London WC2R 2LS, England; [Siegert, Richard] AUT Univ, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Siegert, Richard] AUT Univ, Sch Rehabil & Occupat Studies, Ctr Person Ctr Res, Auckland, New Zealand; [Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, London, England	University of London; King's College London; University of London; King's College London; Auckland University of Technology; Auckland University of Technology; Imperial College London	Jackson, D (corresponding author), Kings Coll London, Fac Life Sci & Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.	diana.m.jackson@kcl.ac.uk	Mosweu, Iris/P-4391-2016; Siegert, Richard J./K-2030-2019; Turner-Stokes, Lynne/F-4418-2012	Mosweu, Iris/0000-0001-6797-2478; Turner-Stokes, Lynne/0000-0002-3302-9462; Siegert, Richard/0000-0002-3074-0929; McCrone, Paul/0000-0001-7001-4502	National Institute for Health Research Health Services and Delivery Research (NIHR HSDR) programme [08/1809/235]; Dunhill Medical Trust; Luff Foundation; National Institute for Health Research [08/1809/235] Funding Source: researchfish	National Institute for Health Research Health Services and Delivery Research (NIHR HSDR) programme(National Institute for Health Research (NIHR)); Dunhill Medical Trust(Dunhill Medical Trust); Luff Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research Health Services and Delivery Research (NIHR HS&DR) programme (project number 08/1809/235). Please visit the HS&DR website for more information. Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust and the Luff Foundation. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecham J., 2001, MEASURING MENTAL HLT, P200; Bernard S, 2008, INT J INTEGR CARE, V8, P1; Bernard S, 2010, 2399 SDO SOC POL RES; British Society of Rehabilitation Medicine, 2008, NEUR REH BRIEF PAP C; Campbell MK, 1999, QJM-INT J MED, V92, P177, DOI 10.1093/qjmed/92.3.177; Care Quality Commission, 2011, REV SERV PEOPL HAV H; Chard Sarah E, 2006, NeuroRx, V3, P525, DOI 10.1016/j.nurx.2006.07.002; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Curtis L, 2015, UNIT COSTS HLTH SOCI; Department of Health PbR - Finance and Costing team, 2011, 2009 10 REF COSTS; DH Long-term Conditions NSF Team, 2005, NAT SERV FRAM LONG T; Ferrarello F, 2011, J NEUROL NEUROSUR PS, V82, P136, DOI 10.1136/jnnp.2009.196428; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Harrington R, 2010, CLIN REHABIL, V24, P3, DOI 10.1177/0269215509347437; Jackson D, 2013, J REHABIL MED, V45, P653, DOI 10.2340/16501977-1178; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Kavanagh S, 1999, J PUBLIC HEALTH MED, V21, P385, DOI 10.1093/pubmed/21.4.385; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McCrone P., 2005, J MENTAL HLTH, V14, P37, DOI DOI 10.1080/09638230500048081; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; National Audit Office, 2011, SERV PEOPL NEUR COND; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; Schneider J, 2003, AGEING SOC, V23, P303, DOI 10.1017/S0144686X02001149; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Siegert RJ, 2014, CLIN REHABILITATION; Siegert RJ, 2013, FINAL REPORT NIHR SE; SIEGERT RJ, 2014, BMJ OPEN, V4; Sixsmith J, 2014, DISABIL REHABIL, V36, P563, DOI 10.3109/09638288.2013.804594; *STAT CORP, 2010, STAT STAT SOFTW REL; Teng J, 2003, STROKE, V34, P528, DOI 10.1161/01.STR.0000049767.14156.2C; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Turner-Stokes Lynne, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002353; Turner-Stokes L, 2014, DISABIL REHABIL, V36, P23, DOI 10.3109/09638288.2013.775360	39	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113056	10.1371/journal.pone.0113056	http://dx.doi.org/10.1371/journal.pone.0113056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25401992	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000345158700103
J	Sousa, MC; Mendes, R; Alvarez, I; Vaz, N; Gomez-Gesteira, M; Dias, JM				Sousa, Magda Catarina; Mendes, Renato; Alvarez, Ines; Vaz, Nuno; Gomez-Gesteira, Moncho; Dias, Joao Miguel			Unusual Circulation Patterns of the Rias Baixas Induced by Minho Freshwater Intrusion (NW of the Iberian Peninsula)	PLOS ONE			English	Article							GALICIAN RIAS; ESTUARINE-PLUME; NORTH-ATLANTIC; RIVER PLUME; SPAIN; HYDROGRAPHY; VARIABILITY; SALINITY; DYNAMICS; SYSTEM	The Minho River, situated 30 km south of the Rias Baixas, is the most important freshwater source flowing into the Western Galician coast (NW of the Iberian Peninsula). The buoyancy generated by the Minho estuarine plume can reverse the normal circulation pattern inside the Rias Baixas affecting the exchange between the Rias and the ocean, changing the input of nutrients. Nevertheless, this inversion of the circulation patterns is not a well-monitored phenomenon. The only published results based on in situ data related to the presence of the Minho River plume inside the Rias de Vigo and Pontevedra correspond to an event measured on spring 1998. In this case unexpectedly higher inflow surface current velocities were found at the Ria de Pontevedra, located further away from Minho River. Thus, the main aim of this study is to research the main factors inducing this unusual pattern on the circulation of the Rias de Vigo and Pontevedra. A numerical model implementation of MOHID previously developed, calibrated, and validated for this coastal area was used. Several scenarios were performed in order to explain the individual effect of the Minho River, rivers discharging into each Rias, and estuarine morphology changes. According to the model results, the Minho River discharge is a key factor in the establishment of the negative circulation, while small rivers inside the Rias slightly attenuate this circulation. The negative circulation was stronger in Ria de Pontevedra independently of the distance of this coastal system from the Minho River mouth, showing that morphologic estuarine features are the main factor justifying the different local circulation patterns.	[Sousa, Magda Catarina; Mendes, Renato; Alvarez, Ines; Vaz, Nuno; Dias, Joao Miguel] Univ Aveiro, Dept Fis, CESAM, P-3800 Aveiro, Portugal; [Alvarez, Ines; Gomez-Gesteira, Moncho] Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain	Universidade de Aveiro; Universidade de Vigo	Dias, JM (corresponding author), Univ Aveiro, Dept Fis, CESAM, Campus Santiago, P-3800 Aveiro, Portugal.	joao.dias@ua.pt	Mendes, Renato/D-5952-2015; Mendes, Renato/AAW-8775-2021; Vaz, Nuno AF/F-5552-2010; Gesteira, Moncho Gomez/R-9431-2019; Alvarez, Ines/F-9482-2016; Dias, João Miguel/F-3292-2010; Sousa, Magda C/L-7665-2014; Vaz, Nuno/GXH-8216-2022	Mendes, Renato/0000-0002-2964-9757; Mendes, Renato/0000-0002-2964-9757; Vaz, Nuno AF/0000-0002-8484-6948; Gesteira, Moncho Gomez/0000-0002-0661-9731; Alvarez, Ines/0000-0002-3837-1742; Dias, João Miguel/0000-0002-7613-6241; Sousa, Magda C/0000-0003-2575-3263; 	Portuguese Science Foundation (FCT) [SFRH/BD/79555/2011]; Ramon y Cajal program; Ciencia program; FCT; European Union (COMPETE) [Pest (C/MAR/LA0017/2013)]; European Union (QREN) [Pest (C/MAR/LA0017/2013)]; European Union (FEDER) [Pest (C/MAR/LA0017/2013)]; Xunta de Galicia [GR2013-001]; European Regional Development Fund (FEDER) [EM2013/003]; Galician Internal Basin Paleoclimatic Sedimentary Archives: Transport, Provenances, Hydrology and reliability [GALINCLIMARCH - CGL2010-16688/BTE]; Fundação para a Ciência e a Tecnologia [Incentivo/MAR/LA0017/2013] Funding Source: FCT	Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Ramon y Cajal program(Spanish Government); Ciencia program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union (COMPETE); European Union (QREN); European Union (FEDER)(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Regional Development Fund (FEDER)(European Commission); Galician Internal Basin Paleoclimatic Sedimentary Archives: Transport, Provenances, Hydrology and reliability; Fundação para a Ciência e a Tecnologia	RM has been supported by the Portuguese Science Foundation (FCT) through a doctoral grant (SFRH/BD/79555/2011). IA and NV are supported by the Ramon y Cajal and Ciencia 2008 programs, respectively. This work has been supported by FCT and by the European Union (COMPETE, QREN, FEDER) in the frame of the research project Pest (C/MAR/LA0017/2013) and partially supported by Xunta de Galicia under projects "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas: Grupos de Referencia Competitiva" (GR2013-001) co-funded by European Regional Development Fund (FEDER), EM2013/003, and "Galician Internal Basin Paleoclimatic Sedimentary Archives: Transport, Provenances, Hydrology and reliability (GALINCLIMARCH - CGL2010-16688/BTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez F, 2010, J EXP MAR BIOL ECOL, V382, P96, DOI 10.1016/j.jembe.2009.11.008; Alvarez I, 2006, J MARINE SYST, V60, P144, DOI 10.1016/j.jmarsys.2005.12.005; Alvarez I, 2005, J GEOPHYS RES-OCEANS, V110; Antonov J. I., 2010, WORLD OCEAN ATLAS 20, V2; Banas NS, 2004, J PHYS OCEANOGR, V34, P2413, DOI 10.1175/JPO2637.1; Chapra SC, 1997, SURFACE WATER QUALIT; Choi BJ, 2007, J PHYS OCEANOGR, V37, P1878, DOI 10.1175/JPO3081.1; Das A, 2012, ESTUAR COAST SHELF S, V111, P17, DOI 10.1016/j.ecss.2012.06.005; deCastro M, 2004, ESTUAR COAST SHELF S, V60, P301, DOI 10.1016/j.ecss.2004.01.006; deCastro M, 2006, ESTUAR COAST SHELF S, V70, P52, DOI 10.1016/j.ecss.2006.05.035; Garcia-Berdeal I, 2002, J GEOPHYS RES-OCEANS, V107; Genio L, 2008, J SEA RES, V59, P133, DOI 10.1016/j.seares.2007.09.001; Hickey BM, 2002, J GEOPHYS RES-OCEANS, V107; Jurisa JT, 2012, OCEAN DYNAM, V62, P771, DOI 10.1007/s10236-012-0527-7; Lee J, 2012, CONT SHELF RES, V41, P77, DOI 10.1016/j.csr.2012.04.006; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Lyard F, 2006, OCEAN DYNAM, V56, P394, DOI 10.1007/s10236-006-0086-x; Marques WC, 2009, CONT SHELF RES, V29, P556, DOI 10.1016/j.csr.2008.09.022; Monteiro PMS, 1999, ESTUAR COAST SHELF S, V49, P877, DOI 10.1006/ecss.1999.0550; MOURINO C, 1982, INVEST PESQ, V46, P459; NONN H, 1966, THESIS U STRASBOURG; PREGO R, 1992, ESTUAR COAST SHELF S, V34, P603, DOI 10.1016/S0272-7714(05)80065-4; Prego R, 2001, J GEOPHYS RES-OCEANS, V106, P19845, DOI 10.1029/2000JC000775; Rio-Barja FX, 1996, RIOS AUGAS GALICIA; RIOS AF, 1992, DEEP-SEA RES, V39, P645, DOI 10.1016/0198-0149(92)90093-9; Sordo I, 2001, ESTUAR COAST SHELF S, V53, P787, DOI 10.1006/ecss.2000.0788; Sousa MC, 2014, CONT SHELF RES, V85, P30, DOI 10.1016/j.csr.2014.06.004; Sousa MC, 2013, J COASTAL RES, P2059, DOI 10.2112/SI65-348.1; TENORE KR, 1995, J GEOPHYS RES-OCEANS, V100, P10943, DOI 10.1029/95JC00529; Valentim JM, 2013, ESTUAR COAST SHELF S, V130, P138, DOI 10.1016/j.ecss.2013.04.005; Varela RA, 2005, J MARINE SYST, V54, P97, DOI 10.1016/j.jmarsys.2004.07.006; Vaz N, 2014, J MARINE SYSTEMS, DOI [10.1016/j.jmarsys.2014.1005.1022, DOI 10.1016/J.JMARSYS.2014.1005.1022]; Warrick JA, 2011, CONT SHELF RES, V31, P85, DOI 10.1016/j.csr.2010.11.007; WONG KC, 1994, J GEOPHYS RES-OCEANS, V99, P12683, DOI 10.1029/94JC00569; WOOSTER WS, 1976, J MAR RES, V34, P131	35	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112587	10.1371/journal.pone.0112587	http://dx.doi.org/10.1371/journal.pone.0112587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402444	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700055
J	Taoka, M; Ishikawa, D; Nobe, Y; Ishikawa, H; Yamauchi, Y; Terukina, G; Nakayama, H; Hirota, K; Takahashi, N; Isobe, T				Taoka, Masato; Ishikawa, Daisuke; Nobe, Yuko; Ishikawa, Hideaki; Yamauchi, Yoshio; Terukina, Goro; Nakayama, Hiroshi; Hirota, Kouji; Takahashi, Nobuhiro; Isobe, Toshiaki			RNA Cytidine Acetyltransferase of Small-Subunit Ribosomal RNA: Identification of Acetylation Sites and the Responsible Acetyltransferase in Fission Yeast, Schizosaccharomyces pombe	PLOS ONE			English	Article							NUCLEOLAR PROTEIN; GENE; CLONING; NAT10; SEQUENCE; DATABASE	The eukaryotic small-subunit (SSU) ribosomal RNA (rRNA) has two evolutionarily conserved acetylcytidines. However, the acetylation sites and the acetyltransferase responsible for the acetylation have not been identified. We performed a comprehensive MS-based analysis covering the entire sequence of the fission yeast, Schizosaccharomyces pombe, SSU rRNA and identified two acetylcytidines at positions 1297 and 1815 in the 3' half of the rRNA. To identify the enzyme responsible for the cytidine acetylation, we searched for an S. pombe gene homologous to TmcA, a bacterial tRNA N-acetyltransferase, and found one potential candidate, Nat10. A temperature-sensitive strain of Nat10 with a mutation in the Walker A type ATP-binding motif abolished the cytidine acetylation in SSU rRNA, and the wild-type Nat10 supplemented to this strain recovered the acetylation, providing evidence that Nat10 is necessary for acetylation of SSU rRNA. The Nat10 mutant strain showed a slow-growth phenotype and was defective in forming the SSU rRNA from the precursor RNA, suggesting that cytidine acetylation is necessary for ribosome assembly.	[Taoka, Masato; Ishikawa, Daisuke; Nobe, Yuko; Yamauchi, Yoshio; Terukina, Goro; Hirota, Kouji; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Tokyo 158, Japan; [Taoka, Masato; Nobe, Yuko; Ishikawa, Hideaki; Yamauchi, Yoshio; Terukina, Goro; Nakayama, Hiroshi; Takahashi, Nobuhiro; Isobe, Toshiaki] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Ishikawa, Hideaki; Takahashi, Nobuhiro] Tokyo Univ Agr & Technol, United Grad Sch Agr, Dept Biotechnol, Tokyo, Japan; [Nakayama, Hiroshi] RIKEN Adv Sci Inst, Biomol Characterizat Team, Saitama, Japan	Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Tokyo University of Agriculture & Technology; RIKEN	Taoka, M (corresponding author), Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Tokyo 158, Japan.	mango@tmu.ac.jp; isobe-toshiaki@tmu.ac.jp	Ishikawa, Hideaki/J-2217-2016; Isobe, Toshiaki/Q-9279-2017; TAKAHASHI, Nobuhiro/G-1129-2013	Ishikawa, Hideaki/0000-0002-2989-8411; Taoka, Masato/0000-0001-5554-4951	Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency	Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency	This work was supported by Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BRUENGER E, 1993, FASEB J, V7, P196, DOI 10.1096/fasebj.7.1.8422966; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chimnaronk S, 2009, EMBO J, V28, P1362, DOI 10.1038/emboj.2009.69; Duveau F, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001230; ELDER RT, 1983, P NATL ACAD SCI-BIOL, V80, P2432, DOI 10.1073/pnas.80.9.2432; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Gutz H, 1974, SCHIZOSACCHAROMYCES; Hirota K, 2001, GENES CELLS, V6, P201, DOI 10.1046/j.1365-2443.2001.00415.x; Ikeuchi Y, 2008, EMBO J, V27, P2194, DOI 10.1038/emboj.2008.154; Ito S, 2014, J BIOL CHEM, V289, P26201, DOI 10.1074/jbc.M114.593996; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Kalis AK, 2010, GENETICS, V185, P523, DOI 10.1534/genetics.110.116038; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Konstantinidis TC, 2006, BIOCHEMISTRY-US, V45, P3525, DOI 10.1021/bi052505d; Larrieu D, 2014, SCIENCE, V344, P527, DOI 10.1126/science.1252651; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Liu HJ, 2007, MOL CELL BIOCHEM, V300, P249, DOI 10.1007/s11010-006-9390-5; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MCCARROLL R, 1983, BIOCHEMISTRY-US, V22, P5858, DOI 10.1021/bi00294a027; NAKAI C, 1994, FEBS LETT, V339, P67, DOI 10.1016/0014-5793(94)80386-2; Nakayama H, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp099; Noon KR, 1998, J BACTERIOL, V180, P2883, DOI 10.1128/JB.180.11.2883-2888.1998; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; Sambrook J., 2001, MOL CLONING LAB MANU; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Sherman F., 1986, METHODS YEAST GENETI; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Swaminathan S, 2006, MOL BIOL CELL, V17, P1472, DOI 10.1091/mbc.e05-07-0632; Taoka M, 2010, ANAL CHEM, V82, P7795, DOI 10.1021/ac101623j; Taoka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp732; THOMAS G, 1978, J BIOL CHEM, V253, P1101; Voigts-Hoffmann F, 2012, CURR OPIN STRUC BIOL, V22, P768, DOI 10.1016/j.sbi.2012.07.010; Wilson DN, 2012, COLD SPRING HARB PER, V4; Yamauchi Y, 2013, J CHROMATOGR A, V1312, P87, DOI 10.1016/j.chroma.2013.09.021; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445	40	15	17	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112156	10.1371/journal.pone.0112156	http://dx.doi.org/10.1371/journal.pone.0112156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402480	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700031
J	Adams, S; Teo, C; McDonald, KL; Zinger, A; Bustamante, S; Lim, CK; Sundaram, G; Braidy, N; Brew, BJ; Guillemin, GJ				Adams, Seray; Teo, Charles; McDonald, Kerrie L.; Zinger, Anna; Bustamante, Sonia; Lim, Chai K.; Sundaram, Gayathri; Braidy, Nady; Brew, Bruce J.; Guillemin, Gilles J.			Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology	PLOS ONE			English	Article							TUMORAL IMMUNE RESISTANCE; INDOLEAMINE 2,3-DIOXYGENASE; T-CELL; TRYPTOPHAN DEGRADATION; QUINOLINIC ACID; IDO EXPRESSION; BRAIN; METABOLISM; INHIBITION; AMINOTRANSFERASE	The kynurenine pathway (KP) is the principal route of L-tryptophan (TRP) catabolism leading to the production of kynurenine (KYN), the neuroprotectants, kynurenic acid (KYNA) and picolinic acid (PIC), the excitotoxin, quinolinic acid (QUIN) and the essential pyridine nucleotide, nicotinamide adenine dinucleotide (NAD+). The enzymes indoleamine 2,3-dioxygenase-1 (IDO-1), indoleamine 2,3dioxygenase- 2 (IDO-2) and tryptophan 2,3-dioxygenase (TDO-2) initiate the first step of the KP. IDO-1 and TDO-2 induction in tumors are crucial mechanisms implicated to play pivotal roles in suppressing anti-tumor immunity. Here, we report the first comprehensive characterisation of the KP in 1) cultured human glioma cells and 2) plasma from patients with glioblastoma (GBM). Our data revealed that interferon-gamma (IFN-c) stimulation significantly potentiated the expression of the KP enzymes, IDO-1 IDO-2, kynureninase (KYNU), kynurenine hydroxylase (KMO) and significantly down-regulated 2-amino-3-carboxymuconate semialdehyde decarboxylase (ACMSD) and kynurenine aminotransferase-I (KAT-I) expression in cultured human glioma cells. This significantly increased KP activity but significantly lowered the KYNA/KYN neuroprotective ratio in human cultured glioma cells. KP activation (KYN/TRP) was significantly higher, whereas the concentrations of the neuroreactive KP metabolites TRP, KYNA, QUIN and PIC and the KYNA/KYN ratio were significantly lower in GBM patient plasma (n518) compared to controls. These results provide further evidence for the involvement of the KP in glioma pathophysiology and highlight a potential role of KP products as novel and highly attractive therapeutic targets to evaluate for the treatment of brain tumors, aimed at restoring anti-tumor immunity and reducing the capacity for malignant cells to produce NAD+, which is necessary for energy production and DNA repair.	[Adams, Seray; Lim, Chai K.; Guillemin, Gilles J.] Macquarie Univ, Australian Sch Adv Med, MND & Neurodegenerat Dis Res Ctr, Sydney, NSW 2109, Australia; [Teo, Charles] Prince Wales Hosp, Ctr Minimally Invas Neurosurg, Sydney, NSW, Australia; [McDonald, Kerrie L.] Univ New S Wales, Lowy Canc Res Ctr, Cure Life Neuro Oncol Grp, Sydney, NSW, Australia; [Zinger, Anna] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Bustamante, Sonia] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Braidy, Nady] Univ New S Wales, Sch Psychiat, Ctr Healthy Brain Ageing, Sydney, NSW, Australia; [Sundaram, Gayathri; Brew, Bruce J.; Guillemin, Gilles J.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Guillemin, Gilles J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Guillemin, GJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, MND & Neurodegenerat Dis Res Ctr, Sydney, NSW 2109, Australia.	gilles.guillemin@mq.edu.au	Guillemin, Gilles J/C-3878-2015; Sundaram, Gayathri/AAN-3599-2020; Lim, Edwin/R-5001-2019	Guillemin, Gilles J/0000-0001-8105-4470; Lim, Edwin/0000-0003-3526-8405; Sundaram, Gayathri/0000-0001-8610-1598; Bustamante, sonia/0000-0002-5411-2919; Adams, Seray/0000-0002-3700-094X; Braidy, Nady/0000-0002-0497-5572; brew, bruce/0000-0003-0622-1392	Tour de Cure (Cure for Life Foundation); National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Peter Duncan Foundation; Curran Foundation	Tour de Cure (Cure for Life Foundation); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Peter Duncan Foundation; Curran Foundation	Funding: This work has been supported by the Tour de Cure (Cure for Life Foundation), the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), the Peter Duncan Foundation, and the Curran Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2012, CANCER RES, V72, P5649, DOI 10.1158/0008-5472.CAN-12-0549; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Braidy N, 2011, FEBS J, V278, P4425, DOI 10.1111/j.1742-4658.2011.08366.x; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Coggan SE, 2009, J NEUROCHEM, V108, P1220, DOI 10.1111/j.1471-4159.2009.05868.x; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Forouzandeh F, 2008, MOL CELL BIOCHEM, V309, P1, DOI 10.1007/s11010-007-9635-y; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gibbons HA, 2007, J NEUROSCI METH, V166, P89, DOI 10.1016/j.jneumeth.2007.07.005; Gomez GG, 2003, CANC CELL CULTURE ME; Grant RS, 2000, REDOX REP, V5, P101, DOI 10.1179/135100000101535357; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; IKEDA M, 1965, J BIOL CHEM, V240, P1395; Juhasz C, 2006, J CEREBR BLOOD F MET, V26, P345, DOI 10.1038/sj.jcbfm.9600199; Jung CS, 2011, HISTOL HISTOPATHOL, V26, P1327, DOI 10.14670/HH-26.1327; KAPOOR V, 1994, CLIN EXP PHARMACOL P, V21, P891, DOI 10.1111/j.1440-1681.1994.tb02460.x; Karanikas V, 2007, CANCER BIOL THER, V6, P1258; Locasale JW, 2012, MOL CELLULAR PROTEOM, P11; LONG CL, 1954, J BIOL CHEM, V211, P405; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; McLendon RE, 2003, CANCER-AM CANCER SOC, V98, P1745, DOI 10.1002/cncr.11666; Miyazaki T, 2009, J NEUROSURG, V111, P230, DOI 10.3171/2008.10.JNS081141; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Myint AM, 2011, BRAIN BEHAV IMMUN, V25, P1576, DOI 10.1016/j.bbi.2011.05.005; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; Ohshiro H, 2008, BIOCHEM BIOPH RES CO, V365, P344, DOI 10.1016/j.bbrc.2007.10.197; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; Phillips RS, 2011, BBA-PROTEINS PROTEOM, V1814, P1481, DOI 10.1016/j.bbapap.2010.12.003; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Sahm F, 2013, CANCER RES, V73, P3225, DOI 10.1158/0008-5472.CAN-12-3831; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Smythe GA, 2003, ADV EXP MED BIOL, V527, P705; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki Y, 2012, CLIN VACCINE IMMUNOL, V19, P436, DOI 10.1128/CVI.05402-11; Urakawa H, 2009, CLIN EXP METASTAS, V26, P1005, DOI 10.1007/s10585-009-9290-7; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Van Gool AR, 2008, PSYCHIAT CLIN NEUROS, V62, P597, DOI 10.1111/j.1440-1819.2008.01854.x; Wainwright DA, 2012, CLIN CANCER RES, V18, P6110, DOI 10.1158/1078-0432.CCR-12-2130; Wejksza K, 2005, NEUROCHEM RES, V30, P963, DOI 10.1007/s11064-005-6178-z; WERNERFELMAYER G, 1990, CANCER RES, V50, P2863; WERNERFELMAYER G, 1989, BIOCHIM BIOPHYS ACTA, V1012, P140, DOI 10.1016/0167-4889(89)90087-6; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034	57	84	88	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112945	10.1371/journal.pone.0112945	http://dx.doi.org/10.1371/journal.pone.0112945			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415278	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600021
J	de Kwaasteniet, BP; Pinto, C; Ruhe, EHG; van Wingen, GA; Booij, J; Denys, D				de Kwaasteniet, Bart P.; Pinto, Chedwa; Ruhe, Eric H. G.; van Wingen, Guido A.; Booij, Jan; Denys, Damiaan			Striatal Dopamine D-2/3 Receptor Availability in Treatment Resistant Depression	PLOS ONE			English	Article							MAJOR DEPRESSION; ENDOGENOUS DOPAMINE; BRAIN METABOLISM; DOUBLE-BLIND; PRAMIPEXOLE; BINDING; D-1; ANTIDEPRESSANT; METAANALYSIS; RELEASE	Several studies demonstrated improvement of depressive symptoms in treatment resistant depression (TRD) after administering dopamine agonists which suggest abnormal dopaminergic neurotransmission in TRD. However, the role of dopaminergic signaling through measurement of striatal dopamine D-2/3 receptor (D2/3R) binding has not been investigated in TRD subjects. We used [I-123] IBZM single photon emission computed tomography (SPECT) to investigate striatal D2/3R binding in TRD. We included 6 severe TRD patients, 11 severe TRD patients on antipsychotics (TRD AP group) and 15 matched healthy controls. Results showed no significant difference (p = 0.75) in striatal D2/3R availability was found between TRD patients and healthy controls. In the TRD AP group D2/3R availability was significantly decreased (reflecting occupancy of D2/3Rs by antipsychotics) relative to TRD patients and healthy controls (p < 0.001) but there were no differences in clinical symptoms between TRD AP and TRD patients. This preliminary study therefore does not provide evidence for large differences in D2/3 availability in severe TRD patients and suggests this TRD subgroup is not characterized by altered dopaminergic transmission. Atypical antipsychotics appear to have no clinical benefit in severe TRD patients who remain depressed, despite their strong occupancy of D2/3Rs.	[de Kwaasteniet, Bart P.; Ruhe, Eric H. G.; van Wingen, Guido A.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [de Kwaasteniet, Bart P.; Ruhe, Eric H. G.; van Wingen, Guido A.; Booij, Jan; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Pinto, Chedwa] MC Groep, Dept Psychiat, Lelystad, Netherlands; [Booij, Jan] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Inst Neurosci, Amsterdam, Netherlands; [Ruhe, Eric H. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat Mood & Anxiety Disorders, Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Groningen	de Kwaasteniet, BP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.p.dekwaasteniet@amc.nl	Booij, Jan/AAD-7159-2019; van Wingen, Guido/AAK-8462-2021; Ruhe, Henricus G/K-8764-2012	van Wingen, Guido/0000-0003-3076-5891; Ruhe, Henricus G/0000-0001-6072-0358	NWO/ZonMW VENI-Grant [016.126.059]	NWO/ZonMW VENI-Grant	Dr. H.G. Ruhe is supported by a NWO/ZonMW VENI-Grant #016.126.059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1999, SYNAPSE, V32, P93, DOI 10.1002/(SICI)1098-2396(199905)32:2<93::AID-SYN3>3.0.CO;2-C; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Booij J, 1997, EUR J NUCL MED, V24, P674, DOI 10.1007/s002590050105; Booij J, 1997, J NEUROL NEUROSUR PS, V62, P133, DOI 10.1136/jnnp.62.2.133; Boot E, 2010, J PSYCHOPHARMACOL, V24, P1525, DOI 10.1177/0269881109104854; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Corya SA, 2006, DEPRESS ANXIETY, V23, P364, DOI 10.1002/da.20130; Cusin C, 2013, J CLIN PSYCHIAT, V74, pE636, DOI 10.4088/JCP.12m08093; Devoto P, 2004, EUR J PHARMACOL, V487, P105, DOI 10.1016/j.ejphar.2004.01.018; DHAENEN HA, 1994, BIOL PSYCHIAT, V35, P128, DOI 10.1016/0006-3223(94)91202-5; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ebert D, 1996, PSYCHOPHARMACOLOGY, V126, P91, DOI 10.1007/BF02246416; Farahani A, 2012, J CLIN PSYCHIAT, V73, P486, DOI 10.4088/JCP.11r07324; Fekadu A, 2009, J CLIN PSYCHIAT, V70, P177, DOI 10.4088/JCP.08m04309; First M.B., 2012, STRUCTURED CLIN INTE; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Greden John F., 2001, Journal of Clinical Psychiatry, V62, P26; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hori H, 2012, SCI WORLD J, DOI 10.1100/2012/372474; Ikemoto S, 1997, J NEUROSCI, V17, P8580; Inoue T, 2010, PROG NEURO-PSYCHOPH, V34, P1446, DOI 10.1016/j.pnpbp.2010.07.035; Izumi T, 2000, J AFFECT DISORDERS, V61, P127, DOI 10.1016/S0165-0327(99)00199-8; Kaasinen V, 2004, NEUROREPORT, V15, P281, DOI 10.1097/00001756-200402090-00014; Kapur S, 1999, AM J PSYCHIAT, V156, P286; Konarski JZ, 2007, PSYCHIAT RES-NEUROIM, V155, P203, DOI 10.1016/j.pscychresns.2007.02.001; Lattanzi L, 2002, BIPOLAR DISORD, V4, P307, DOI 10.1034/j.1399-5618.2002.01171.x; Leentjens AFG, 2009, CLIN THER, V31, P89, DOI 10.1016/j.clinthera.2009.01.012; Martinot MLP, 2011, NEUROPSYCHOPHARMACOL, V36, P2710, DOI 10.1038/npp.2011.161; Meyer JH, 2006, AM J PSYCHIAT, V163, P1594, DOI 10.1176/appi.ajp.163.9.1594; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nakayama K, 2004, BRAIN RES BULL, V63, P237, DOI 10.1016/j.brainresbull.2004.02.007; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; NEVO I, 1995, NEUROCHEM INT, V26, P305, DOI 10.1016/0197-0186(94)00139-L; Palner M, 2010, NUCL MED BIOL, V37, P837, DOI 10.1016/j.nucmedbio.2010.04.193; Parsey RV, 2001, BIOL PSYCHIAT, V50, P313, DOI 10.1016/S0006-3223(01)01089-7; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Plaven-Sigray P, 2014, NEUROIMAGE, V102, P590, DOI 10.1016/j.neuroimage.2014.08.018; RINNE JO, 1993, J CEREBR BLOOD F MET, V13, P310, DOI 10.1038/jcbfm.1993.39; Ruhe HG, 2012, J AFFECT DISORDERS, V137, P35, DOI 10.1016/j.jad.2011.02.020; Ruhe HG, 2014, MOL IMAGING DEPRESSI, P93; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Shah PJ, 1997, PSYCHOL MED, V27, P1247, DOI 10.1017/S0033291797005382; Smoski MJ, 2009, J AFFECT DISORDERS, V118, P69, DOI 10.1016/j.jad.2009.01.034; Tauscher J, 2004, AM J PSYCHIAT, V161, P1620, DOI 10.1176/appi.ajp.161.9.1620; Trainor BC, 2011, HORM BEHAV, V60, P457, DOI 10.1016/j.yhbeh.2011.08.013; Ustun TB, 2002, BRIT J PSYCHIAT, V181, P181, DOI 10.1192/bjp.181.3.181; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Wijkstra J, 2013, COCHRANE DB SYST REV, V11; Yamada M, 2004, NEUROTOXICOLOGY, V25, P215, DOI 10.1016/S0161-813X(03)00097-4; Yang YK, 2008, PSYCHIAT RES-NEUROIM, V162, P230, DOI 10.1016/j.pscychresns.2007.08.008	50	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113612	10.1371/journal.pone.0113612	http://dx.doi.org/10.1371/journal.pone.0113612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411966	gold, Green Submitted, Green Published			2022-12-27	WOS:000345253000066
J	Forcey, DS; Walker, SM; Vodstrcil, LA; Fairley, CK; Bilardi, JE; Law, M; Hocking, JS; Fethers, KA; Petersen, S; Bellhouse, C; Chen, MY; Bradshaw, CS				Forcey, Dana S.; Walker, Sandra M.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Bilardi, Jade E.; Law, Matthew; Hocking, Jane S.; Fethers, Katherine A.; Petersen, Susan; Bellhouse, Clare; Chen, Marcus Y.; Bradshaw, Catriona S.			Factors Associated with Participation and Attrition in a Longitudinal Study of Bacterial Vaginosis in Australian Women Who Have Sex with Women	PLOS ONE			English	Article							VAGINAL MICROBIOME; GRAM STAIN; LESBIANS; HEALTH; RETENTION; PREVALENCE; EXPERIENCE; DIAGNOSIS	Objective: A number of social and sexual risk factors for bacterial vaginosis (BV) have been described. It is important to understand whether these factors are associated with non-participation or attrition of participants from longitudinal studies in order to examine potential for recruitment or attrition bias. We describe factors associated with participation and attrition in a 24-month prospective cohort study, investigating incident BV among Australian women who have sex with women. Study Design and Setting: Participants negative for prevalent BV were offered enrolment in a longitudinal cohort study. Participants self-collected vaginal samples and completed questionnaires 3-monthly to endpoint (BV-positive/BV-negative by 24 months). Factors associated with participation in the cohort study were examined by logistic regression and factors associated with attrition from the cohort were examined by Cox regression. Results: The cross-sectional study recruited 457 women. 334 BV-negative women were eligible for the cohort and 298 (89%, 95%CI 85, 92) enrolled. Lower educational levels (aOR 2.72, 95%CI 1.09, 6.83), smoking (aOR 2.44, 95%CI 1.13, 5.27), past BV symptoms (aOR 3.42, 95%CI 1.16, 10.10) and prior genital warts (aOR 2.71, 95%CI 1.14, 6.46) were associated with non-participation; a partner co-enrolling increased participation (aOR 3.73, 95%CI 1.43, 9.70). 248 participants (83%, 95%CI 78, 87) were retained to study endpoint (BV-negative at 24 months or BV-positive at any stage). Attrition was associated being <30 yrs (aHR 2.15, 95%CI 1.13, 4.10) and a male partner at enrolment (aHR 6.12, 95%CI 1.99, 18.82). Conclusion: We achieved high participation and retention levels in a prospective cohort study and report factors influencing participation and retention of participants over a 24-month study period, which will assist in the design and implementation of future cohort studies in sexual health and disease.	[Forcey, Dana S.; Walker, Sandra M.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Bilardi, Jade E.; Fethers, Katherine A.; Petersen, Susan; Bellhouse, Clare; Chen, Marcus Y.; Bradshaw, Catriona S.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Forcey, Dana S.; Walker, Sandra M.; Vodstrcil, Lenka A.; Hocking, Jane S.; Bradshaw, Catriona S.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic 3053, Australia; [Fairley, Christopher K.; Bilardi, Jade E.; Chen, Marcus Y.; Bradshaw, Catriona S.] Monash Univ, Alfred Ctr, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Law, Matthew] Univ New S Wales, Kirby Inst, Darlinghurst, NSW, Australia	University of Melbourne; Monash University; University of New South Wales Sydney; Kirby Institute	Forcey, DS (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia.	dforcey@student.unimelb.edu.au; CBradshaw@mshc.org.au	Vodstrcil, Lenka/AAF-8722-2020; Vodstrcil, Lenka/AAC-1896-2019; Hocking, Jane/AAD-5203-2021	Vodstrcil, Lenka/0000-0003-3679-9195; Hocking, Jane/0000-0001-9329-8501; bradshaw, catriona/0000-0002-6643-5678; Law, Matthew/0000-0002-3540-8837; Christopher, Fairley/0000-0001-9081-1664; Bilardi, Jade/0000-0003-0461-2605	Australian National Health and Medical Research Council [APP57431]; Early Careers Fellowship [ERC1013135]; Lesbian Health Research Grant from the Australian Lesbian Medical Association; AIDS Council of New South Wales	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Early Careers Fellowship; Lesbian Health Research Grant from the Australian Lesbian Medical Association; AIDS Council of New South Wales	This work was supported by the Australian National Health and Medical Research Council (program grant APP57431) and Early Careers Fellowship grant ERC1013135 to J.E.B. This work is also supported by a 2007 Lesbian Health Research Grant from the Australian Lesbian Medical Association and the AIDS Council of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAT STAT SOFTW REL; [Anonymous], 2013, ANT GEN SEX TRANSM I; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249; Bradshaw CS, 2013, J INFECT DIS, V29, P29; Brotman RM, 2008, CLIN INFECT DIS, V47, P44, DOI 10.1086/588662; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Brown BA, 2000, J WOMEN HEALTH GEN-B, V9, P625, DOI 10.1089/15246090050118152; Browne K., 2005, INT J SOC RES METHOD, V8, P47, DOI DOI 10.1080/1364557032000081663; Chen KF, 2011, J CLIN EPIDEMIOL, V64, P1144, DOI 10.1016/j.jclinepi.2010.08.007; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Gajer P, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003605; Grulich AE, 2003, AUST NZ J PUBL HEAL, V27, P155, DOI 10.1111/j.1467-842X.2003.tb00803.x; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; McCaffrey M, 1999, INT J STD AIDS, V10, P305, DOI 10.1258/0956462991914168; McNair Ruth, 2005, Sex Health, V2, P209, DOI 10.1071/SH04046; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Meyer IH, 2009, J COUNS PSYCHOL, V56, P23, DOI 10.1037/a0014587; Mooney-Somers J, 2012, WOMEN CONTACT SYDNEY; Muzny CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080254; Muzny CA, 2013, SEX TRANSM DIS, V40, P751, DOI 10.1097/OLQ.0000000000000004; Nelson DB, 2003, J CLIN EPIDEMIOL, V56, P862, DOI 10.1016/S0895-4356(03)00073-8; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Power J, 2009, CULT HEALTH SEX, V11, P67, DOI 10.1080/13691050802541674; Purwar M, 2001, J OBSTET GYNAECOL RE, V27, P175, DOI 10.1111/j.1447-0756.2001.tb01248.x; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Ribisl KM, 1996, EVAL PROGRAM PLANN, V19, P1, DOI 10.1016/0149-7189(95)00037-2; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P138, DOI 10.1111/j.1467-842X.2003.tb00801.x; Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Strauss Robert A, 2005, Infect Dis Obstet Gynecol, V13, P31; Sullivan C. M., 1996, J APPL BEHAV SCI, V32, P262, DOI [10.1177/0021886396323002, DOI 10.1177/0021886396323002]; SWEET RL, 1995, CLIN INFECT DIS, V20, pS271, DOI 10.1093/clinids/20.Supplement_2.S271; Tchamouroff SE, 2000, SEX TRANSM INFECT, V76, P144, DOI 10.1136/sti.76.2.144-a; Young AF, 2006, AUST NZ J PUBL HEAL, V30, P353, DOI 10.1111/j.1467-842X.2006.tb00849.x	40	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113452	10.1371/journal.pone.0113452	http://dx.doi.org/10.1371/journal.pone.0113452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25412421	Green Published, gold			2022-12-27	WOS:000345253000053
J	Lesutiene, J; Gorokhova, E; Stankeviciene, D; Bergman, E; Greenberg, L				Lesutiene, Jurate; Gorokhova, Elena; Stankeviciene, Daiva; Bergman, Eva; Greenberg, Larry			Light Increases Energy Transfer Efficiency in a Boreal Stream	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN-DEPOSITION; NUTRIENT ENRICHMENT; ECOLOGICAL STOICHIOMETRY; ELEMENTAL COMPOSITION; PERIPHYTON BIOMASS; SPATIAL VARIATION; ORGANIC-CARBON; PHOSPHORUS; LIMITATION; RESPONSES	Periphyton communities of a boreal stream were exposed to different light and nutrient levels to estimate energy transfer efficiency from primary to secondary producers using labeling with inorganic C-13. In a one-day field experiment, periphyton grown in fast-flow conditions and dominated by opportunistic green algae were exposed to light levels corresponding to sub-saturating (forest shade) and saturating (open stream section) irradiances, and to N and P nutrient additions. In a two-week laboratory experiment, periphyton grown in low-flow conditions and dominated by slowly growing diatoms were incubated under two sub-saturating light and nutrient enrichment levels as well as grazed and non-grazed conditions. Light had significant positive effect on C-13 uptake by periphyton. In the field experiment, P addition had a positive effect on C-13 uptake but only at sub-saturating light levels, whereas in the laboratory experiment nutrient additions had no effect on the periphyton biomass, C-13 uptake, biovolume and community composition. In the laboratory experiment, the grazer (caddisfly) effect on periphyton biomass specific C-13 uptake and nutrient content was much stronger than the effects of light and nutrients. In particular, grazers significantly reduced periphyton biomass and increased biomass specific C-13 uptake and C: nutrient ratios. The energy transfer efficiency, estimated as a ratio between C-13 uptake by caddisfly and periphyton, was positively affected by light conditions, whereas the nutrient effect was not significant. We suggest that the observed effects on energy transfer were related to the increased diet contribution of highly palatable green algae, stimulated by higher light levels. Also, high heterotrophic microbial activity under low light levels would facilitate energy loss through respiration and decrease overall trophic transfer efficiency. These findings suggest that even a small increase in light intensity could result in community-wide effects on periphyton in boreal streams, with a subsequent increase in energy transfer and system productivity.	[Lesutiene, Jurate] Klaipeda Univ, Marine Sci & Technol Ctr, Klaipeda, Lithuania; [Lesutiene, Jurate; Bergman, Eva; Greenberg, Larry] Karlstad Univ, Dept Biol, Karlstad, Sweden; [Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Stankeviciene, Daiva] Nat Res Ctr, Inst Ecol, Vilnius, Lithuania	Klaipeda University; Karlstad University; Stockholm University; Nature Research Center - Lithuania	Lesutiene, J (corresponding author), Klaipeda Univ, Marine Sci & Technol Ctr, Klaipeda, Lithuania.	jurate.lesutiene@jmtc.ku.lt	Bergman, Eva/R-8464-2016; Gorokhova, Elena/E-7105-2018; Bergman, Eva/AAR-8368-2021	Bergman, Eva/0000-0003-2220-1615; Gorokhova, Elena/0000-0002-4192-6956; Bergman, Eva/0000-0003-2220-1615; Lesutiene, Jurate/0000-0002-9636-8218	Department of Biology at Karlstad University; Isotope Ecology Network in the Baltic Sea region - Swedish Institute	Department of Biology at Karlstad University; Isotope Ecology Network in the Baltic Sea region - Swedish Institute	This work was financially supported by the Department of Biology at Karlstad University (postdoctoral felloship provided for J. Lesutiene.), and Isotope Ecology Network in the Baltic Sea region funded by the Swedish Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2008, HYDROL PROCESS, V22, P1965, DOI 10.1002/hyp.6779; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Bergstrom AK, 2005, LIMNOL OCEANOGR, V50, P987, DOI 10.4319/lo.2005.50.3.0987; Bernhardt ES, 2003, P NATL ACAD SCI USA, V100, P10304, DOI 10.1073/pnas.1233676100; BIGGS BJF, 1989, FRESHWATER BIOL, V22, P209, DOI 10.1111/j.1365-2427.1989.tb01096.x; Bunn SE, 1999, FRESHWATER BIOL, V41, P333, DOI 10.1046/j.1365-2427.1999.00434.x; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Cummins K.W., 1984, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P1818; Dickman EM, 2008, P NATL ACAD SCI USA, V105, P18408, DOI 10.1073/pnas.0805566105; England LE, 2004, FRESHWATER BIOL, V49, P721, DOI 10.1111/j.1365-2427.2004.01219.x; Evans-White MA, 2005, FRESHWATER BIOL, V50, P1853, DOI 10.1111/j.1365-2427.2005.01452.x; Faerovig PJ, 2003, FRESHWATER BIOL, V48, P1782, DOI 10.1046/j.1365-2427.2003.01128.x; Fanta SE, 2010, FRESHWATER BIOL, V55, P931, DOI 10.1111/j.1365-2427.2009.02309.x; Frost PC, 2005, FRESHWATER BIOL, V50, P1800, DOI 10.1111/j.1365-2427.2005.01449.x; Frost PC, 2002, FRESHWATER BIOL, V47, P173, DOI 10.1046/j.1365-2427.2002.00796.x; Frost PJ, 2002, J MANAGE INQUIRY, V11, P21, DOI 10.1177/1056492602111007; Gothe E, 2009, FUND APPL LIMNOL, V175, P281, DOI 10.1127/1863-9135/2009/0175-0281; Greenwood JL, 2005, CAN J FISH AQUAT SCI, V62, P2033, DOI 10.1139/F05-117; Hamilton SK, 2001, BIOGEOCHEMISTRY, V54, P297, DOI 10.1023/A:1010635524108; Hesselsoe M, 2005, APPL ENVIRON MICROB, V71, P646, DOI 10.1128/AEM.71.2.646-655.2005; Hessen DO, 2009, LIMNOL OCEANOGR, V54, P2520, DOI 10.4319/lo.2009.54.6_part_2.2520; Hill Walter, 1996, P121, DOI 10.1016/B978-012668450-6/50034-5; Hill WR, 2008, FRESHWATER BIOL, V53, P215, DOI 10.1111/j.1365-2427.2007.01885.x; Hill WR, 2006, LIMNOL OCEANOGR, V51, P2360, DOI 10.4319/lo.2006.51.5.2360; Hill WR, 2009, LIMNOL OCEANOGR, V54, P368, DOI 10.4319/lo.2009.54.1.0368; Hillebrand H, 2004, OIKOS, V106, P93, DOI 10.1111/j.0030-1299.2004.13166.x; Hillebrand H, 2008, OECOLOGIA, V155, P619, DOI 10.1007/s00442-007-0930-9; Johnson SL, 2000, CAN J FISH AQUAT SCI, V57, P30, DOI 10.1139/cjfas-57-S2-30; Kahlert M, 2001, THESIS ACTA U UPSALI; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; Lang DA, 2012, FRESHW SCI, V31, P1096, DOI 10.1899/12-031.1; Larned ST, 2004, LIMNOL OCEANOGR, V49, P1992, DOI 10.4319/lo.2004.49.6.1992; Lepori F, 2006, CAN J FISH AQUAT SCI, V63, P2478, DOI 10.1139/F06-142; Liess A, 2004, ARCH HYDROBIOL, V159, P433, DOI 10.1127/0003-9136/2004/0159-0433; Liess A, 2009, FRESHWATER BIOL, V54, P1759, DOI 10.1111/j.1365-2427.2009.02222.x; Malzahn AM, 2010, OECOLOGIA, V162, P35, DOI 10.1007/s00442-009-1458-y; Mulholland PJ, 2010, J N AM BENTHOL SOC, V29, P100, DOI 10.1899/08-035.1; Olenina I., 2006, HELCON BALTIC SEA EN, P144; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; PETERSON CG, 1987, FRESHWATER BIOL, V18, P455, DOI 10.1111/j.1365-2427.1987.tb01330.x; Peterson CG, 1998, FRESHWATER BIOL, V40, P607, DOI 10.1046/j.1365-2427.1998.00358.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Richardson JS, 2004, ARCH HYDROBIOL, V159, P309, DOI 10.1127/0003-9136/2004/0159-0309; Rier ST, 2006, J PHYCOL, V42, P560, DOI 10.1111/j.1529-8817.2006.00225.x; Rober AR, 2011, J N AM BENTHOL SOC, V30, P787, DOI 10.1899/10-166R.1; Roberts S, 2004, J PHYCOL, V40, P1004, DOI 10.1111/j.1529-8817.2004.03333.x; Rosemond AD, 2000, CAN J FISH AQUAT SCI, V57, P66, DOI 10.1139/cjfas-57-1-66; Scott JT, 2008, J N AM BENTHOL SOC, V27, P332, DOI 10.1899/07-108.1; Simon D, 1998, WATER RES, V32, P2220, DOI 10.1016/S0043-1354(97)00452-1; Smucker NJ, 2013, FRESHW SCI, V32, P230, DOI 10.1899/11-171.1; Stelzer RS, 2001, LIMNOL OCEANOGR, V46, P356, DOI 10.4319/lo.2001.46.2.0356; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; Stevenson R. Jan, 2003, P775, DOI 10.1016/B978-012741550-5/50024-6; Taulbee WK, 2005, ARCH HYDROBIOL, V164, P449, DOI 10.1127/0003-9136/2005/0164-0449; Taylor JM, 2012, FRESHW SCI, V31, P451, DOI 10.1899/11-055.1; Temnerud J, 2007, J HYDROL, V342, P72, DOI 10.1016/j.jhydrol.2007.05.015; Tibbets TM, 2008, FUNCT ECOL, V22, P109, DOI 10.1111/j.1365-2435.2007.01342.x; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Veraart AJ, 2008, J PHYCOL, V44, P564, DOI 10.1111/j.1529-8817.2008.00503.x; Von Schiller D, 2007, FRESHWATER BIOL, V52, P891, DOI 10.1111/j.1365-2427.2007.01742.x; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Wilkerson E, 2010, CAN J FISH AQUAT SCI, V67, P177, DOI 10.1139/F09-162	64	5	5	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113675	10.1371/journal.pone.0113675	http://dx.doi.org/10.1371/journal.pone.0113675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412343	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000070
J	Rezgui, R; Lestini, R; Kuhn, J; Fave, X; McLeod, L; Myllykallio, H; Alexandrou, A; Bouzigues, C				Rezgui, Rachid; Lestini, Roxane; Kuehn, Joelle; Fave, Xenia; McLeod, Lauren; Myllykallio, Hannu; Alexandrou, Antigoni; Bouzigues, Cedric			Differential Interaction Kinetics of a Bipolar Structure-Specific Endonuclease with DNA Flaps Revealed by Single-Molecule Imaging	PLOS ONE			English	Article							CONFORMATIONAL DYNAMICS; STRANDED-DNA; PROTEIN; SPECTROSCOPY; REPAIR; PCNA; RECOGNITION; MECHANISM; BINDING; DAMAGE	As DNA repair enzymes are essential for preserving genome integrity, understanding their substrate interaction dynamics and the regulation of their catalytic mechanisms is crucial. Using single-molecule imaging, we investigated the association and dissociation kinetics of the bipolar endonuclease NucS from Pyrococcus abyssi (Pab) on 59 and 39-flap structures under various experimental conditions. We show that association of the PabNucS with ssDNA flaps is largely controlled by diffusion in the NucS-DNA energy landscape and does not require a free 5' or 3' extremity. On the other hand, NucS dissociation is independent of the flap length and thus independent of sliding on the single-stranded portion of the flapped DNA substrates. Our kinetic measurements have revealed previously unnoticed asymmetry in dissociation kinetics from these substrates that is markedly modulated by the replication clamp PCNA. We propose that the replication clamp PCNA enhances the cleavage specificity of NucS proteins by accelerating NucS loading at the ssDNA/dsDNA junctions and by minimizing the nuclease interaction time with its DNA substrate. Our data are also consistent with marked reorganization of ssDNA and nuclease domains occurring during NucS catalysis, and indicate that NucS binds its substrate directly at the ssDNA-dsDNA junction and then threads the ssDNA extremity into the catalytic site. The powerful techniques used here for probing the dynamics of DNA-enzyme binding at the single-molecule have provided new insight regarding substrate specificity of NucS nucleases.	[Rezgui, Rachid; Lestini, Roxane; Kuehn, Joelle; Fave, Xenia; McLeod, Lauren; Myllykallio, Hannu; Alexandrou, Antigoni; Bouzigues, Cedric] Ecole Polytech, Inserm U696, CNRS UMR Unite Mixte Rech 7645, Lab Opt & Biosci, Palaiseau, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris	Bouzigues, C (corresponding author), Ecole Polytech, Inserm U696, CNRS UMR Unite Mixte Rech 7645, Lab Opt & Biosci, Palaiseau, France.	cedric.bouzigues@polytechnique.edu	Lestini, Roxane/R-9285-2017; Myllykallio, Hannu/Y-5462-2019	Lestini, Roxane/0000-0001-7377-4734; Ray, Xenia/0000-0003-0150-0843; Myllykallio, Hannu/0000-0002-0541-1197; Alexandrou, Antigoni/0000-0003-3727-6863				Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Craggs TD, 2013, NUCL ACIDS RES; Creze C, 2012, J BIOL CHEM, V287, P15648, DOI 10.1074/jbc.M112.346361; Facista Alexander, 2012, Genome Integr, V3, P3, DOI 10.1186/2041-9414-3-3; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Iizuka R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022253; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Kuznetsova S, 2008, P NATL ACAD SCI USA, V105, P3250, DOI 10.1073/pnas.0707736105; Lia G, 2012, SCIENCE, V335, P328, DOI 10.1126/science.1210400; Lu HP, 2001, J AM CHEM SOC, V123, P9184, DOI 10.1021/ja0058942; Macklin JJ, 1996, SCIENCE, V272, P255, DOI 10.1126/science.272.5259.255; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Ren B, 2009, EMBO J, V28, P2479, DOI 10.1038/emboj.2009.192; Roberts JA, 2005, J BIOL CHEM, V280, P5924, DOI 10.1074/jbc.M412766200; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Schurtenberger P, 1998, J MOL BIOL, V275, P123, DOI 10.1006/jmbi.1997.1435; Segers-Nolten GMJ, 2002, NUCLEIC ACIDS RES, V30, P4720, DOI 10.1093/nar/gkf599; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; van Oijen AM, 2010, CURRENT OPINION BIOT, V22, P1; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xie SN, 2001, SINGLE MOL, V2, P229, DOI 10.1002/1438-5171(200112)2:4<229::AID-SIMO229>3.0.CO;2-9; Zhang W, 2011, LANGMUIR, V27, P15008, DOI 10.1021/la203752y; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	37	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113493	10.1371/journal.pone.0113493	http://dx.doi.org/10.1371/journal.pone.0113493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412080	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000058
J	Dureja, C; Mahajan, S; Raychaudhuri, S				Dureja, Chetna; Mahajan, Sakshi; Raychaudhuri, Saumya			Phylogenetic Distribution and Prevalence of Genes Encoding Class I Integrons and CTX-M-15 Extended-Spectrum beta-Lactamases in Escherichia coli Isolates from Healthy Humans in Chandigarh, India	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE GENES; ANTIBIOTIC-RESISTANCE; FLUOROQUINOLONE RESISTANCE; RISK-FACTORS; COMMENSAL; ENTEROBACTERIACEAE; KLEBSIELLA; STRAINS; DISSEMINATION; ASSOCIATION	Escherichia coli is generally considered as a commensal inhabitant of gastrointestinal tract of humans and animals. The aim of this study was to gain insight on the distribution of phylotypes and presence of genes encoding integrons, extended beta-lactamases and resistance to other antimicrobials in the commensal E. coli isolates from healthy adults in Chandigarh, India. PCR and DNA sequencing were used for phylogenetic classification, detections of integrase genes, gene cassettes within the integron and extended beta-lactamases. The genetic structure of E. coli revealed a non-uniform distribution of isolates among the seven phylogenetic groups with significant representation of group A. Integron-encoded integrases were detected in 25 isolates with class 1 integron-encoded int/1 integrase being in the majority (22 isolates). The gene cassettes identified were those for trimethoprim, streptomycin, spectinomycin and streptothricin. The dfrA12-orfF-aadA2 was the most commonly found gene cassette in int/1 positive isolates. Phenotypic assay for screening the potential ESBL producers suggested 16 isolates to be ESBL producers. PCR detection using gene-specific primers showed that 15 out of these 16 ESBL-producing E. coli harboured the bla(CTX-M-15) gene. Furthermore, molecular studies helped in characterizing the genes responsible for tetracycline, chloramphenicol and sulphonamides resistance. Collectively, our study outlines the intra-species phylogenetic structure and highlights the prevalence of class 1 integron and bla(CTX-M-15) in commensal E. coli isolates of healthy adults in Chandigarh, India. Our findings further reinforce the relevance of commensal E. coli strains on the growing burden of antimicrobial resistance.	[Dureja, Chetna; Mahajan, Sakshi; Raychaudhuri, Saumya] CSIR, Inst Microbial Technol, Div Mol Biol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raychaudhuri, S (corresponding author), CSIR, Inst Microbial Technol, Div Mol Biol, Chandigarh 160036, India.	saumya@rocketmail.com	Raychaudhuri, Saumya/AFL-0368-2022		CSIR Network project Human Microbiom [HUM-CSIR-BSC-0119A]	CSIR Network project Human Microbiom	CSIR Network project Human Microbiome (HUM-CSIR-BSC-0119A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes P, 2007, ANTIMICROB AGENTS CH, V51, P1545, DOI 10.1128/AAC.01275-06; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Bailey JK, 2010, J CLIN MICROBIOL, V48, P3455, DOI 10.1128/JCM.00760-10; Ben Nasr A, 2013, ANTIMICROB AGENTS CH, V57, P4089, DOI 10.1128/AAC.00536-13; Blahna MT, 2006, J ANTIMICROB CHEMOTH, V57, P666, DOI 10.1093/jac/dkl020; Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x; Bryan A, 2004, APPL ENVIRON MICROB, V70, P2503, DOI 10.1128/AEM.70.4.2503-2507.2004; Cao V, 2002, ANTIMICROB AGENTS CH, V46, P3739, DOI 10.1128/AAC.46.12.3739-3743.2002; Chang CY, 2011, J MED MICROBIOL, V60, P197, DOI 10.1099/jmm.0.022517-0; Chang LL, 2004, J ANTIMICROB CHEMOTH, V53, P518, DOI 10.1093/jac/dkh094; Ciccozzi M, 2013, NEW MICROBIOL, V36, P385; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUS S, V32; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Gundogdu A, 2011, J MED MICROBIOL, V60, P1633, DOI 10.1099/jmm.0.034140-0; Jemima SA, 2008, INDIAN J MED RES, V128, P313; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Jouini A, 2010, J CHEMOTHERAPY, V22, P318, DOI 10.1179/joc.2010.22.5.318; Kang HY, 2005, J ANTIMICROB CHEMOTH, V55, P639, DOI 10.1093/jac/dki076; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Katsandri A, 2008, J CHEMOTHERAPY, V20, P452, DOI 10.1179/joc.2008.20.4.452; Lautenbach E, 2001, CLIN INFECT DIS, V33, P1288, DOI 10.1086/322667; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; Li B, 2010, APPL ENVIRON MICROB, V76, P6698, DOI 10.1128/AEM.00707-10; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Muzaheed, 2008, J ANTIMICROB CHEMOTH, V61, P1393, DOI 10.1093/jac/dkn109; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P2720, DOI 10.1128/AAC.00026-07; Pitout JDD, 2007, ANTIMICROB AGENTS CH, V51, P1281, DOI 10.1128/AAC.01377-06; Raghunath D, 2008, J BIOSCIENCES, V33, P593, DOI 10.1007/s12038-008-0077-9; Rakotonirina HC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-85; Rao PNS, 2008, INDIAN J PATHOL MICR, V51, P497, DOI 10.4103/0377-4929.43739; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Seidman JC, 2009, EPIDEMIOL INFECT, V137, P879, DOI 10.1017/S0950268808001519; Skurnik D, 2005, ANTIMICROB AGENTS CH, V49, P3062, DOI 10.1128/AAC.49.7.3062-3065.2005; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; van Essen-Zandbergen A, 2007, J ANTIMICROB CHEMOTH, V59, P746, DOI 10.1093/jac/dkl549; Wilkerson C, 2004, ANTIMICROB AGENTS CH, V48, P1066, DOI 10.1128/AAC.48.3.1066-1067.2004; Yu HS, 2003, J CLIN MICROBIOL, V41, P5429, DOI 10.1128/JCM.41.12.5429-5433.2003	43	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112551	10.1371/journal.pone.0112551	http://dx.doi.org/10.1371/journal.pone.0112551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409321	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200025
J	Freimann, R; Burgmann, H; Findlay, SEG; Robinson, CT				Freimann, Remo; Buergmann, Helmut; Findlay, Stuart E. G.; Robinson, Christopher T.			Spatio-Temporal Patterns of Major Bacterial Groups in Alpine Waters	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DISSOLVED ORGANIC-CARBON; MICROBIAL COMMUNITIES; VAL ROSEG; RIVER; BIOGEOGRAPHY; BIOFILM; ECOLOGY; FLUXES; PROBES	Glacial alpine landscapes are undergoing rapid transformation due to changes in climate. The loss of glacial ice mass has directly influenced hydrologic characteristics of alpine floodplains. Consequently, hyporheic sediment conditions are likely to change in the future as surface waters fed by glacial water (kryal) become groundwater dominated (krenal). Such environmental shifts may subsequently change bacterial community structure and thus potential ecosystem functioning. We quantitatively investigated the structure of major bacterial groups in glacial and groundwater-fed streams in three alpine floodplains during different hydrologic periods. Our results show the importance of several physico-chemical variables that reflect local geological characteristics as well as water source in structuring bacterial groups. For instance, Alpha-, Betaproteobacteria and Cytophaga-Flavobacteria were influenced by pH, conductivity and temperature as well as by inorganic and organic carbon compounds, whereas phosphorous compounds and nitrate showed specific influence on single bacterial groups. These results can be used to predict future bacterial group shifts, and potential ecosystem functioning, in alpine landscapes under environmental transformation.	[Freimann, Remo] ETH, Inst Mol Hlth Sci, Zurich, Switzerland; [Freimann, Remo; Robinson, Christopher T.] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Freimann, Remo; Robinson, Christopher T.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Buergmann, Helmut] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Surface Waters Res & Management, Kastanienbaum, Switzerland; [Findlay, Stuart E. G.] Cary Inst Ecosyst Studies, Millbrook, NY USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Cary Institute of Ecosystem Studies	Freimann, R (corresponding author), ETH, Inst Mol Hlth Sci, Zurich, Switzerland.	remofreimann@gmail.com		Freimann, Remo/0000-0002-8955-2842; Burgmann, Helmut/0000-0002-5651-5906	Swiss National Science Foundation [31003A-119735]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding provided by Swiss National Science Foundation (No. 31003A-119735) to CR HB SF RF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato P, 2007, FEMS MICROBIOL ECOL, V59, P255, DOI 10.1111/j.1574-6941.2006.00198.x; Araya R, 2003, FEMS MICROBIOL ECOL, V43, P111, DOI 10.1111/j.1574-6941.2003.tb01050.x; Battin TJ, 1999, WATER RESOUR RES, V35, P3159, DOI 10.1029/1999WR900144; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Besemer K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1760; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Brablcova L, 2013, FOLIA MICROBIOL, V58, P235, DOI 10.1007/s12223-012-0201-y; Brummer IHM, 2000, APPL ENVIRON MICROB, V66, P3078, DOI 10.1128/AEM.66.7.3078-3082.2000; Comte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025266; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Freimann R, 2013, ISME J, V7, P2361, DOI 10.1038/ismej.2013.114; Freimann R, 2013, LIMNOL OCEANOGR, V58, P951, DOI 10.4319/lo.2013.58.3.0951; HENDRICKS SP, 1993, J N AM BENTHOL SOC, V12, P70, DOI 10.2307/1467687; Hood E, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001738; Horton P, 2006, HYDROL PROCESS, V20, P2091, DOI 10.1002/hyp.6197; Kloep F, 2006, FEMS MICROBIOL ECOL, V56, P79, DOI 10.1111/j.1574-6941.2006.00049.x; Legendre P, 2011, METHODS ECOL EVOL, V2, P269, DOI 10.1111/j.2041-210X.2010.00078.x; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1999, MICROB ECOL, V37, P225, DOI 10.1007/s002489900148; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Neef Alexander, 1997, Zentralblatt fuer Hygiene und Umweltmedizin, V199, P410; Pernthaler A, 2004, MOL MICROBIAL ECOLOG, V2, P711; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Pollard PC, 2011, LIMNOL OCEANOGR, V56, P1115, DOI 10.4319/lo.2011.56.3.1115; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; R Core Team, 2021, R LANGUAGE ENV STAT; SCHOFIELD R. K., 1955, SOIL SCI SOC AMER PROC, V19, P164; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tockner K, 2002, LIMNOL OCEANOGR, V47, P266, DOI 10.4319/lo.2002.47.1.0266; Tockner K, 1997, ARCH HYDROBIOL, V140, P433; WARD JV, 1994, FRESHWATER BIOL, V32, P277, DOI 10.1111/j.1365-2427.1994.tb01126.x; Xiang SR, 2009, APPL ENVIRON MICROB, V75, P7287, DOI 10.1128/AEM.00915-09; Zeder M, 2009, CYTOM PART A, V75A, P781, DOI 10.1002/cyto.a.20770	38	10	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113524	10.1371/journal.pone.0113524	http://dx.doi.org/10.1371/journal.pone.0113524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409508	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200132
J	Gangisetty, O; Bekdash, R; Maglakelidze, G; Sarkar, DK				Gangisetty, Omkaram; Bekdash, Rola; Maglakelidze, George; Sarkar, Dipak K.			Fetal Alcohol Exposure Alters Proopiomelanocortin Gene Expression and Hypothalamic-Pituitary-Adrenal Axis Function via Increasing MeCP2 Expression in the Hypothalamus	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; ASSOCIATION; STRESS; NEURONS; COMPLEX; SYSTEM; FAMILY	Proopiomelanocortin (POMC) is a precursor gene of the neuropeptide beta-endorphin in the hypothalamus and is known to regulate various physiological functions including stress response. Several recent reports showed that fetal alcohol exposure programs the hypothalamus to produce lower levels of POMC gene transcripts and to elevate the hypothalamic-pituitary-adrenal (HPA) axis response to stressful stimuli. We investigated the role of methyl CpG binding protein (MeCP2) in the effects of prenatal ethanol on POMC gene expression and hypothalamic-pituitary-adrenal (HPA) axis function. Pregnant Sprague Dawley rats were fed between GD 7 and 21 with a liquid diet containing 6.7% alcohol, pair-fed with isocaloric liquid diet, or fed ad libitum with rat chow, and their male offsprings were used at 60 days after birth in this study. Fetal alcohol exposure reduced the level of POMC mRNA, but increased the level of DNA methylation of this gene in the arcuate nucleus (ARC) of the hypothalamus where the POMC neuronal cell bodies are located. Fetal alcohol exposed rats showed a significant increase in MeCP2 protein levels in POMC cells, MeCP2 gene transcript levels as well as increased MeCP2 protein binding on the POMC promoter in the arcuate nucleus. Lentiviral delivery of MeCP2 shRNA into the third ventricle efficiently reduced MeCP2 expression and prevented the effect of prenatal ethanol on POMC gene expression in the arcuate nucleus. MeCP2-shRNA treatment also normalized the prenatal ethanol-induced increase in corticotropin releasing hormone (CRH) gene expression in the hypothalamus and elevated plasma adrenocorticotrophic hormone (ACTH) and corticosterone hormone responses to lipopolysaccharide (LPS) challenge. These results suggest that fetal alcohol programming of POMC gene may involve recruitment of MeCP2 on to the methylated promoter of the POMC gene to suppress POMC transcript levels and contribute to HPA axis dysregulation.	[Gangisetty, Omkaram; Bekdash, Rola; Maglakelidze, George; Sarkar, Dipak K.] Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Sarkar, DK (corresponding author), Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08903 USA.	sarkar@aesop.rutgers.edu	Sarkar, Dipak K/O-7942-2017	Sarkar, Dipak K/0000-0003-3237-9871; Gangisetty, Omkaram/0000-0001-6280-0642	National Institutes of Health [R37AA08757]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA008757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a National Institutes of Health Grant R37AA08757 to DS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjona A, 2006, ALCOHOL CLIN EXP RES, V30, P1039, DOI 10.1111/j.1530-0277.2006.00117.x; Baker M, 2005, DIABETES, V54, P2492, DOI 10.2337/diabetes.54.8.2492; Ballestar E, 2005, HUM GENET, V116, P91, DOI 10.1007/s00439-004-1200-0; Bekdash RA, 2013, ALCOHOL CLIN EXP RES, V37, P1133, DOI 10.1111/acer.12082; Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boyadjieva NI, 2009, ALCOHOL CLIN EXP RES, V33, P931, DOI 10.1111/j.1530-0277.2009.00911.x; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Govorko D, 2012, BIOL PSYCHIAT, V72, P378, DOI 10.1016/j.biopsych.2012.04.006; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Itoh M, 2007, J NEUROPATH EXP NEUR, V66, P117, DOI 10.1097/nen.0b013e3180302078; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kelley ML, 2010, AM J ORTHOPSYCHIAT, V80, P204, DOI 10.1111/j.1939-0025.2010.01024.x; Latino-Martel P, 2010, CANCER EPIDEM BIOMAR, V19, P1238, DOI 10.1158/1055-9965.EPI-09-1110; LISSONI P, 1987, BRIT J CANCER, V56, P834, DOI 10.1038/bjc.1987.300; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; Lopez-Serra L, 2008, ONCOGENE, V27, P3556, DOI 10.1038/sj.onc.1211022; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; MILLER MW, 1992, BRAIN RES, V595, P17, DOI 10.1016/0006-8993(92)91447-M; Mountjoy KG, 2010, BIOCHEM J, V428, P305, DOI 10.1042/BJ20091957; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Newell-Price J, 2003, J ENDOCRINOL, V177, P365, DOI 10.1677/joe.0.1770365; Newell-Price J, 2001, MOL ENDOCRINOL, V15, P338, DOI 10.1210/me.15.2.338; Plagemann A, 1999, J NEUROENDOCRINOL, V11, P541; PLOTSKY PM, 1991, J NEUROENDOCRINOL, V3, P1, DOI 10.1111/j.1365-2826.1991.tb00231.x; Raffin-Sanson ML, 2003, EUR J ENDOCRINOL, V149, P79, DOI 10.1530/eje.0.1490079; Rizzato C, 2011, J DERMATOL SCI, V63, P47, DOI 10.1016/j.jdermsci.2011.03.006; Sarkar DK, 2007, ENDOCRINOLOGY, V148, P2828, DOI 10.1210/en.2006-1606; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Smart JL, 2007, ENDOCRINOLOGY, V148, P647, DOI 10.1210/en.2006-0990; Sutton BS, 2005, OBES RES, V13, P1491, DOI 10.1038/oby.2005.180; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wynne O., 2013, HDB PSYCHONEUROIMMUN, P198; Xuei XL, 2007, AM J MED GENET B, V144B, P877, DOI 10.1002/ajmg.b.30531; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	46	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113228	10.1371/journal.pone.0113228	http://dx.doi.org/10.1371/journal.pone.0113228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409090	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200078
J	Nieman, DC; Scherr, J; Luo, BB; Meaney, MP; Dreau, D; Sha, W; Dew, DA; Henson, DA; Pappan, KL				Nieman, David C.; Scherr, Johannes; Luo, Beibei; Meaney, Mary Pat; Dreau, Didier; Sha, Wei; Dew, Dustin A.; Henson, Dru A.; Pappan, Kirk L.			Influence of Pistachios on Performance and Exercise-Induced Inflammation, Oxidative Stress, Immune Dysfunction, and Metabolite Shifts in Cyclists: A Randomized, Crossover Trial	PLOS ONE			English	Article							LINOLEIC-ACID; METABOLOMICS; PLASMA; QUANTIFICATION; MYOINOSITOL; RAFFINOSE; RESPONSES	Objectives: Pistachio nut ingestion (3 oz./d, two weeks) was tested for effects on exercise performance and 21-h postexercise recovery from inflammation, oxidative stress, immune dysfunction, and metabolite shifts. Methods: Using a randomized, crossover approach, cyclists (N = 19) engaged in two 75-km time trials after 2-weeks pistachio or no pistachio supplementation, with a 2-week washout period. Subjects came to the lab in an overnight fasted state, and ingested water only or 3 oz. pistachios with water before and during exercise. Blood samples were collected 45 min pre-exercise, and immediately post-, 1.5-h post-, and 21-h post-exercise, and analyzed for plasma cytokines, Creactive protein (CRP), F-2-isoprostanes (F-2-IsoP), granulocyte phagocytosis (GPHAG) and oxidative burst activity (GOBA), and shifts in metabolites. Results: Performance time for the 75-km time trial was 4.8% slower under pistachio conditions (2.846 +/- 0.11 and 2.716 +/- 0.07 h, respectively, P = 0.034). Significant time effects were shown for plasma cytokines, CRP, F-2-IsoP, GPHAG, and GOBA, with few group differences. Metabolomics analysis revealed 423 detectable compounds of known identity, with significant interaction effects for 19 metabolites, especially raffinose, (12Z)-9,10-Dihydroxyoctadec-12-enoate (9,10-DiHOME), and sucrose. Dietary intake of raffinose was 2.196 +/- 0.15 and 0.356 +/- 0.08 mg/d during the pistachio and no pistachio periods, and metabolomics revealed that colon raffinose and sucrose translocated to the circulation during exercise due to increased gut permeability. The post-exercise increase in plasma raffinose correlated significantly with 9,10-DiHOME and other oxidative stress metabolites. Conclusions: In summary, 2-weeks pistachio nut ingestion was associated with reduced 75-km cycling time trial performance and increased post-exercise plasma levels of raffinose, sucrose, and metabolites related to leukotoxic effects and oxidative stress.	[Nieman, David C.; Meaney, Mary Pat; Dew, Dustin A.] Appalachian State Univ, Human Performance Lab, Kannapolis, NC 28081 USA; [Scherr, Johannes] Tech Univ Munich, Klinikum Rechts Isar, Dept Prevent & Sports Med, D-80290 Munich, Germany; [Luo, Beibei] Second Mil Med Univ, Dept Physiol, Shanghai 200433, Peoples R China; [Dreau, Didier] Univ N Carolina, Charlotte Res Inst, Charlotte, NC 28223 USA; [Dreau, Didier] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA; [Sha, Wei] Univ North Carolina Charlotte, Bioinformat Serv Div, Kannapolis, NC USA; [Henson, Dru A.] Appalachian State Univ, Dept Biol, Immunol Lab, Boone, NC 28608 USA; [Pappan, Kirk L.] Metabolon Inc, Durham, NC USA	University of North Carolina; Appalachian State University; Technical University of Munich; Naval Medical University; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; Appalachian State University; Metabolon	Nieman, DC (corresponding author), Appalachian State Univ, Human Performance Lab, North Carolina Res Campus, Kannapolis, NC 28081 USA.	niemandc@appstate.edu	Nieman, David/AAC-9739-2022; Pappan, Kirk/AAV-5946-2021	Nieman, David/0000-0002-8305-1860; Scherr, Johannes/0000-0001-9948-1024; Pappan, Kirk/0000-0002-2341-8798; Dreau, Didier/0000-0002-7094-650X	American Pistachio Growers	American Pistachio Growers	This work was supported by American Pistachio Growers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dreher ML, 2012, NUTR REV, V70, P234, DOI 10.1111/j.1753-4887.2011.00467.x; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Hellsten Y, 2001, FREE RADICAL BIO MED, V31, P1313, DOI 10.1016/S0891-5849(01)00631-1; Karner U, 2004, J EXP BOT, V55, P1981, DOI 10.1093/jxb/erh216; Kocyigit A, 2006, NUTR METAB CARDIOVAS, V16, P202, DOI 10.1016/j.numecd.2005.08.004; Lamprecht M, 2012, MED SPORT SCI, V59, P47, DOI 10.1159/000342169; Le Moyec L, 2012, ANAL BIOANAL CHEM, V404, P593, DOI 10.1007/s00216-012-6165-6; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; Liu YT, 2014, J AGR FOOD CHEM, V62, P1550, DOI 10.1021/jf4046864; Marchbank T, 2011, AM J PHYSIOL-GASTR L, V300, pG477, DOI 10.1152/ajpgi.00281.2010; Mastrofrancesco A, 2010, EXP DERMATOL, V19, P813, DOI 10.1111/j.1600-0625.2010.01107.x; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; McGhie TK, 2012, MOL NUTR FOOD RES, V56, P147, DOI 10.1002/mnfr.201100545; Moran JH, 1997, TOXICOL APPL PHARM, V146, P53, DOI 10.1006/taap.1997.8197; Nieman DC, 2008, NUTR REV, V66, P310, DOI 10.1111/j.1753-4887.2008.00038.x; Nieman David C, 2006, Res Sports Med, V14, P225, DOI 10.1080/15438620600854793; Nieman DC, 2014, AM J PHYSIOL-REG I, V307, pR68, DOI 10.1152/ajpregu.00092.2014; Nieman DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072215; Nieman DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037479; Nieman DC, 1997, J APPL PHYSIOL, V82, P1385, DOI 10.1152/jappl.1997.82.5.1385; Pennington JAT, 2005, BOWES CHURCHS FOOD V, P374; Sari I, 2010, NUTRITION, V26, P399, DOI 10.1016/j.nut.2009.05.023; SAUNDERS DR, 1981, AM J PHYSIOL, V241, pG397, DOI 10.1152/ajpgi.1981.241.5.G397; Schlemmer U, 2009, MOL NUTR FOOD RES, V53, pS330, DOI 10.1002/mnfr.200900099; Sisemore MF, 2001, ARCH BIOCHEM BIOPHYS, V392, P32, DOI 10.1006/abbi.2001.2434; Thompson DA, 2007, J BIOSCIENCES, V32, P279, DOI 10.1007/s12038-007-0028-x; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; van Zanten GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047212; Vinaixa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029052; Viswanathan S, 2003, J AM COLL NUTR, V22, P502, DOI 10.1080/07315724.2003.10719328; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; ZHANG WD, 1995, INT J LEGAL MED, V107, P174, DOI 10.1007/BF01428400	37	44	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113725	10.1371/journal.pone.0113725	http://dx.doi.org/10.1371/journal.pone.0113725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409020	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200148
J	Pavo, N; Jakab, A; Emmert, MY; Strebinger, G; Wolint, P; Zimmermann, M; Ankersmit, HJ; Hoerstrup, SP; Maurer, G; Gyongyosi, M				Pavo, Noemi; Jakab, Andras; Emmert, Maximilian Y.; Strebinger, Georg; Wolint, Petra; Zimmermann, Matthias; Ankersmit, Hendrik Jan; Hoerstrup, Simon P.; Maurer, Gerald; Gyoengyoesi, Mariann			Comparison of NOGA Endocardial Mapping and Cardiac Magnetic Resonance Imaging for Determining Infarct Size and Infarct Transmurality for Intramyocardial Injection Therapy Using Experimental Data	PLOS ONE			English	Article							MYOCARDIAL VIABILITY; NONISCHEMIC CARDIOMYOPATHY; SCAR; REGISTRATION; NAVIGATION; VOLTAGE; HEART	Objectives: We compared the accuracy of NOGA endocardial mapping for delineating transmural and non-transmural infarction to the results of cardiac magnetic resonance imaging (cMRI) with late gadolinium enhancement (LE) for guiding intramyocardial reparative substance delivery using data from experimental myocardial infarction studies. Methods: Sixty domestic pigs underwent diagnostic NOGA endocardial mapping and cMRI-LE 60 days after induction of closed-chest reperfused myocardial infarction. The infarct size was determined by LE of cMRI and by delineation of the infarct core on the unipolar voltage polar map. The sizes of the transmural and non-transmural infarctions were calculated from the cMRI transmurality map using signal intensity (SI) cut-offs of>75% and>25% and from NOGA bipolar maps using bipolar voltage cut-off values of<0.8 mV and <1.9 mV. Linear regression analysis and Bland- Altman plots were used to determine correlations and systematic differences between the two images. The overlapping ratios of the transmural and non-transmural infarcted areas were calculated. Results: Infarct size as determined by 2D NOGA unipolar voltage polar mapping correlated with the 3D cMRI-LE findings (r = 0.504, p<0.001) with a mean difference of 2.82% in the left ventricular (LV) surface between the two images. Polar maps of transmural cMRI and bipolar maps of NOGA showed significant association for determining of the extent of transmural infarction (r = 0.727, p<0.001, overlap ratio of 81.6 +/- 11.1%) and non-transmural infarction (r = 0.555, p<0.001, overlap ratio of 70.6 +/- 18.5%). NOGA overestimated the transmural scar size (6.81% of the LV surface) but slightly underestimated the size of the non-transmural infarction (-3.04% of the LV surface). Conclusions: By combining unipolar and bipolar voltage maps, NOGA endocardial mapping is useful for accurate delineation of the targeted zone for intramyocardial therapy and is comparable to cMRI-LE. This may be useful in patients with contraindications for cMRI who require targeted intramyocardial regenerative therapy.	[Pavo, Noemi; Strebinger, Georg; Maurer, Gerald; Gyoengyoesi, Mariann] Med Univ Vienna, Dept Cardiol, Vienna, Austria; [Jakab, Andras] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Emmert, Maximilian Y.; Wolint, Petra; Hoerstrup, Simon P.] Univ Zurich, Swiss Ctr Regenerat Med, Zurich, Switzerland; [Emmert, Maximilian Y.; Wolint, Petra; Hoerstrup, Simon P.] Univ Zurich Hosp, Div Surg Res, CH-8091 Zurich, Switzerland; [Emmert, Maximilian Y.; Wolint, Petra; Hoerstrup, Simon P.] Univ Zurich Hosp, Cardiovasc Surg Clin, CH-8091 Zurich, Switzerland; [Zimmermann, Matthias; Ankersmit, Hendrik Jan] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Ankersmit, Hendrik Jan] Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Medical University of Vienna	Gyongyosi, M (corresponding author), Med Univ Vienna, Dept Cardiol, Vienna, Austria.	mariann.gyongyosi@meduniwien.ac.at	Jakab, András/U-9436-2019; Zimmermann, Matthias/AAE-9681-2020	Jakab, András/0000-0001-6291-9889; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Zimmermann, Matthias/0000-0002-4610-7853; Maurer, Gerald/0000-0002-9043-7657	Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration, Vienna, Austria; Ludwig Boltzmann Institute Cluster of Cardiovascular Diseases; Swiss Centre for Regenerative Medicine, University of Zurich, Zurich, Switzerland	Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration, Vienna, Austria; Ludwig Boltzmann Institute Cluster of Cardiovascular Diseases; Swiss Centre for Regenerative Medicine, University of Zurich, Zurich, Switzerland	This study was sponsored by the Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration, Vienna, Austria; by the Ludwig Boltzmann Institute Cluster of Cardiovascular Diseases; and by the Swiss Centre for Regenerative Medicine, University of Zurich, Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LC, 2004, J AM COLL CARDIOL, V44, P2383, DOI 10.1016/j.jacc.2004.09.020; BenHaim SA, 1996, NAT MED, V2, P1393, DOI 10.1038/nm1296-1393; Callans DJ, 1999, CIRCULATION, V100, P1744, DOI 10.1161/01.CIR.100.16.1744; Codreanu A, 2008, J AM COLL CARDIOL, V52, P839, DOI 10.1016/j.jacc.2008.05.038; Cohen J.E., 1988, STAT POWER ANAL BEHA; Constantine G, 2004, LANCET, V363, P2162, DOI 10.1016/S0140-6736(04)16509-4; Desjardins B, 2013, CIRC-ARRHYTHMIA ELEC, V6, P891, DOI 10.1161/CIRCEP.113.000073; Desjardins B, 2009, HEART RHYTHM, V6, P644, DOI 10.1016/j.hrthm.2009.02.018; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fuchs S, 2001, AM J CARDIOL, V87, P874, DOI 10.1016/S0002-9149(00)01529-0; Gepstein L, 1997, CIRCULATION, V96, P3672; Graf S, 2004, J NUCL MED, V45, P1611; Gupta S, 2012, JACC-CARDIOVASC IMAG, V5, P207, DOI 10.1016/j.jcmg.2011.08.021; Gyongyosi M, 2011, NAT REV CARDIOL, V8, P393, DOI 10.1038/nrcardio.2011.64; Gyongyosi M, 2005, AM J CARDIOL, V95, P722, DOI 10.1016/j.amjcard.2004.11.022; Gyongyosi M, 2001, CIRCULATION, V104, P1005, DOI 10.1161/hc3401.095099; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Keck A, 2002, J AM COLL CARDIOL, V40, P1067, DOI 10.1016/S0735-1097(02)02118-6; Kornowski R, 1998, CIRCULATION, V98, P1837, DOI 10.1161/01.CIR.98.18.1837; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Perin EC, 2002, CIRCULATION, V106, P957, DOI 10.1161/01.CIR.0000026394.01888.18; Poon M, 2002, CURR OPIN CARDIOL, V17, P663, DOI 10.1097/00001573-200211000-00013; Psaltis PJ, 2009, J CARDIOVASC TRANSL, V2, P48, DOI 10.1007/s12265-008-9080-7; Sheehan FH, 2002, IEEE T MED IMAGING, V21, P1264, DOI 10.1109/TMI.2002.806320; Spears DA, 2012, HEART RHYTHM, V9, P1837, DOI 10.1016/j.hrthm.2012.07.022; Tokuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000215; van Slochteren FJ, 2012, EUR HEART J-CARD IMG, V13, P808, DOI 10.1093/ehjci/jes119; Vrtovec B, 2013, CIRCULATION, V128, pS42, DOI 10.1161/CIRCULATIONAHA.112.000230; Wiggers H, 2003, J AM COLL CARDIOL, V41, P843, DOI 10.1016/S0735-1097(02)02961-3; Wijnmaalen AP, 2011, EUR HEART J, V32, P104, DOI 10.1093/eurheartj/ehq345; Wolf T, 2001, J AM COLL CARDIOL, V37, P1590, DOI 10.1016/S0735-1097(01)01209-8	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113245	10.1371/journal.pone.0113245	http://dx.doi.org/10.1371/journal.pone.0113245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409528	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000345533200082
J	Wu, XQ; He, LS; Chen, FJ; He, XE; Cai, Y; Zhang, GP; Yi, Q; He, MX; Luo, JD				Wu, Xiaoqian; He, Lishan; Chen, Fajiang; He, Xiaoen; Cai, Yi; Zhang, Guiping; Yi, Quan; He, Meixiang; Luo, Jiandong			Impaired Autophagy Contributes to Adverse Cardiac Remodeling in Acute Myocardial Infarction	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-KINASE; HEART-FAILURE; CARDIOMYOCYTE DEATH; INFLAMMATION; INHIBITION; MODEL; PHOSPHORYLATION; DEGRADATION	Objective: Autophagy is activated in ischemic heart diseases, but its dynamics and functional roles remain unclear and controversial. In this study, we investigated the dynamics and role of autophagy and the mechanism(s), if any, during postinfarction cardiac remodeling. Methods and results: Acute myocardial infarction (AMI) was induced by ligating left anterior descending (LAD) coronary artery. Autophagy was found to be induced sharply 12-24 hours after surgery by testing LC3 modification and Electron microscopy. P62 degradation in the infarct border zone was increased from day 0.5 to day 3, and however, decreased from day 5 until day 21 after LAD ligation. These results indicated that autophagy was induced in the acute phase of AMI, and however, impaired in the latter phase of AMI. To investigate the significance of the impaired autophagy in the latter phase of AMI, we treated the mice with Rapamycin (an autophagy enhancer, 2.0 mg/kg/day) or 3-methyladenine (3MA, an autophagy inhibitor, 15 mg/kg/day) one day after LAD ligation until the end of experiment. The results showed that Rapamycin attenuated, while 3MA exacerbated, postinfarction cardiac remodeling and dysfunction respectively. In addition, Rapamycin protected the H9C2 cells against oxygen glucose deprivation in vitro. Specifically, we found that Rapamycin attenuated NF kappa B activation after LAD ligation. And the inflammatory response in the acute stage of AMI was significantly restrained with Rapamycin treatment. In vitro, inhibition of NF kappa B restored autophagy in a negative reflex. Conclusion: Sustained myocardial ischemia impairs cardiomyocyte autophagy, which is an essential mechanism that protects against adverse cardiac remodeling. Augmenting autophagy could be a therapeutic strategy for acute myocardial infarction.	[Wu, Xiaoqian; He, Lishan; Chen, Fajiang; He, Xiaoen; Cai, Yi; Zhang, Guiping; Yi, Quan; He, Meixiang; Luo, Jiandong] Guangzhou Med Univ, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Zhang, Guiping; Luo, Jiandong] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Guangzhou Key Lab Cardiovasc Dis, Guangzhou, Guangdong, Peoples R China; [Zhang, Guiping; Luo, Jiandong] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Wu, XQ (corresponding author), Guangzhou Med Univ, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	wuxiaoqian@gzhmu.edu.cn; luojiandong@gzhmu.edu.cn	Wu, X/I-7859-2019	wu, xiaoqian/0000-0002-4441-5772	National Natural Science Foundation of China [81001436, 81173062]; Education Administration Research Foundation of Guangzhou City [10A018G, 10A157]; Department of Education of Guangdong province [Yq2013134]; Science and Information Technology of Guangzhou [12C22021631]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Administration Research Foundation of Guangzhou City; Department of Education of Guangdong province(National Natural Science Foundation of Guangdong Province); Science and Information Technology of Guangzhou	This study was supported by grants from the National Natural Science Foundation of China (grant No. 81001436 to Dr. X Wu and grant No. 81173062 to Dr. J Luo), the Education Administration Research Foundation of Guangzhou City (grant No. 10A018G and 10A157 to Dr. X Wu), outstanding young scientist training program by Department of Education of Guangdong province (grant No. Yq2013134 to Dr. X Wu), and Science and Information Technology of Guangzhou (grant No. 12C22021631 to Dr. J Luo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Carmignac V, 2011, HUM MOL GENET, V20, P4891, DOI 10.1093/hmg/ddr427; Chen J, 2013, CIRCULATION, V128, P2577, DOI 10.1161/CIRCULATIONAHA.113.003668; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Hausleiter J, 2004, CIRCULATION, V110, P790, DOI 10.1161/01.CIR.0000138935.17503.35; Jundt F, 2005, BLOOD, V106, P1801, DOI 10.1182/blood-2004-11-4513; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mauriello A, 2005, J AM COLL CARDIOL, V45, P1585, DOI 10.1016/j.jacc.2005.01.054; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sala-Mercado JA, 2010, CIRCULATION, V122, pS179, DOI 10.1161/CIRCULATIONAHA.109.928242; Shan K, 1997, CURR OPIN CARDIOL, V12, P218, DOI 10.1097/00001573-199705000-00002; Shibata Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2068; Shinde AV, 2013, J MOL CELL CARDIOL; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Takemura G, 2006, AUTOPHAGY, V2, P212, DOI 10.4161/auto.2608; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060087; WEISMAN HF, 1988, CIRCULATION, V78, P186, DOI 10.1161/01.CIR.78.1.186; Wu XQ, 2013, MOL MED REP, V8, P1824, DOI 10.3892/mmr.2013.1708; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Xiao Q, 2012, CARDIOVASC RES, V95, P507, DOI 10.1093/cvr/cvs216; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhang HN, 2012, J CARDIOVASC PHARM, V60, P33, DOI 10.1097/FJC.0b013e3182567fef; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	42	105	116	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112891	10.1371/journal.pone.0112891	http://dx.doi.org/10.1371/journal.pone.0112891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409294	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200045
J	Zaman, N; Giannopoulos, PN; Chowdhury, S; Bonneil, E; Thibault, P; Wang, E; Trifiro, M; Paliouras, M				Zaman, Naif; Giannopoulos, Paresa N.; Chowdhury, Shafinaz; Bonneil, Eric; Thibault, Pierre; Wang, Edwin; Trifiro, Mark; Paliouras, Miltiadis			Proteomic-Coupled-Network Analysis of T877A-Androgen Receptor Interactomes Can Predict Clinical Prostate Cancer Outcomes between White (Non-Hispanic) and African-American Groups	PLOS ONE			English	Article							CELLULAR SIGNALING NETWORK; LIGAND-BINDING DOMAIN; ANDROGEN-RECEPTOR; LUNG-CANCER; CHROMATIN IMMUNOPRECIPITATION; MOLECULAR-DYNAMICS; RACIAL-DIFFERENCES; SOMATIC MUTATIONS; STRUCTURAL BASIS; GENE-EXPRESSION	The androgen receptor (AR) remains an important contributor to the neoplastic evolution of prostate cancer (CaP). CaP progression is linked to several somatic AR mutational changes that endow upon the AR dramatic gain-of-function properties. One of the most common somatic mutations identified is Thr877-to-Ala (T877A), located in the ligand-binding domain, that results in a receptor capable of promiscuous binding and activation by a variety of steroid hormones and ligands including estrogens, progestins, glucocorticoids, and several anti-androgens. In an attempt to further define somatic mutated AR gain-of-function properties, as a consequence of its promiscuous ligand binding, we undertook a proteomic/network analysis approach to characterize the protein interactome of the mutant T877A-AR in LNCaP cells under eight different ligand-specific treatments (dihydrotestosterone, mibolerone, R1881, testosterone, estradiol, progesterone, dexamethasone, and cyproterone acetate). In extending the analysis of our multi-ligand complexes of the mutant T877A-AR we observed significant enrichment of specific complexes between normal and primary prostatic tumors, which were furthermore correlated with known clinical outcomes. Further analysis of certain mutant T877A-AR complexes showed specific population preferences distinguishing primary prostatic disease between white (non-Hispanic) vs. African-American males. Moreover, these cancer-related AR-protein complexes demonstrated predictive survival outcomes specific to CaP, and not for breast, lung, lymphoma or medulloblastoma cancers. Our study, by coupling data generated by our proteomics to network analysis of clinical samples, has helped to define real and novel biological pathways in complicated gain-of-function AR complex systems.	[Zaman, Naif; Chowdhury, Shafinaz; Wang, Edwin] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ, Canada; [Giannopoulos, Paresa N.; Chowdhury, Shafinaz; Trifiro, Mark; Paliouras, Miltiadis] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ, Canada; [Trifiro, Mark; Paliouras, Miltiadis] McGill Univ, Dept Med, Dept Oncol, Montreal, PQ, Canada; [Trifiro, Mark; Paliouras, Miltiadis] McGill Univ, Div Expt Med, Montreal, PQ, Canada	National Research Council Canada; Lady Davis Institute; McGill University; Universite de Montreal; McGill University; McGill University	Paliouras, M (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada.	miltiadis.paliouras@mcgill.ca	Paliouras, Miltiadis/D-4567-2015; Wang, Edwin/Y-1553-2019	Paliouras, Miltiadis/0000-0003-1321-4414; Thibault, Pierre/0000-0001-5993-0331	Canadian Institutes for Health Research [MOP-106477]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca) operating grant MOP-106477 (M.T., M.P, E.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abern MR, 2013, PROSTATE CANCER P D, V16, P84, DOI 10.1038/pcan.2012.38; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Baca Sylvan C, 2012, Front Endocrinol (Lausanne), V3, P69, DOI 10.3389/fendo.2012.00069; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2014, UROL ONCOL, V32, P15; BEITEL LK, 1995, J MOL ENDOCRINOL, V15, P117, DOI 10.1677/jme.0.0150117; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bratt O, 1999, BRIT J CANCER, V81, P672, DOI 10.1038/sj.bjc.6690746; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen HL, 2010, ENDOCR-RELAT CANCER, V17, P857, DOI 10.1677/ERC-10-0081; Chornokur G, 2011, PROSTATE, V71, P985, DOI 10.1002/pros.21314; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Moissac D, 1999, J BIOL CHEM, V274, P29505, DOI 10.1074/jbc.274.41.29505; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Ding DC, 2004, PROSTATE, V58, P23, DOI 10.1002/pros.10316; Ellis SD, 2013, CANCER-AM CANCER SOC, V119, P2282, DOI 10.1002/cncr.28004; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fukagai Takashi, 2009, V472, P455, DOI 10.1007/978-1-60327-492-0_22; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Gaston KE, 2003, J UROLOGY, V170, P990, DOI 10.1097/01.ju.0000079761.56154.e5; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hieronymus H, 2012, NAT GENET, V44, P613, DOI 10.1038/ng.2301; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubert L, 2011, HUM MOL GENET, V20, P4822, DOI 10.1093/hmg/ddr421; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Kaiser U, 1996, INT J CANCER, V67, P357, DOI 10.1002/(SICI)1097-0215(19960729)67:3<357::AID-IJC9>3.0.CO;2-Q; Kearney P, 2003, J Bioinform Comput Biol, V1, P183, DOI 10.1142/S021972000300023X; Kim HS, 2011, PROSTATE CANCER P D, V14, P262, DOI 10.1038/pcan.2011.18; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Kubricht WS, 1999, UROLOGY, V54, P1035, DOI 10.1016/S0090-4295(99)00290-3; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lange EM, 2008, J HUM GENET, V53, P220, DOI 10.1007/s10038-007-0240-4; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1033; Lin YF, 2009, DNA REPAIR, V8, P878, DOI 10.1016/j.dnarep.2009.04.024; Lindner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071915; Long JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058350; Loriot Y, 2013, CANC RES, V73; Mahmoud AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078479; Marks LS, 2006, UROLOGY, V68, P337, DOI 10.1016/j.urology.2006.03.013; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Matias PM, 2002, J MED CHEM, V45, P1439, DOI 10.1021/jm011072j; McGhan LJ, 2014, ANN SURG ONCOL, V21, P361, DOI 10.1245/s10434-013-3260-7; Mikkonen L, 2010, MOL CELL ENDOCRINOL, V317, P14, DOI 10.1016/j.mce.2009.12.022; Mu XM, 2003, PROSTATE, V57, P129, DOI 10.1002/pros.10282; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Paliouras M, 2011, INTEGR BIOL-UK, V3, P1020, DOI 10.1039/c1ib00038a; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Park HS, 2013, TRANSL ONCOL, V6, P370, DOI 10.1593/tlo.13250; Parker Carol E., 2005, V301, P117; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Powell I J, 1998, Semin Urol Oncol, V16, P221; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; Ren QH, 2013, CANCER-AM CANCER SOC, V119, P2532, DOI 10.1002/cncr.28092; Rodriguez-Gonzalez G, 2009, J STEROID BIOCHEM, V113, P85, DOI 10.1016/j.jsbmb.2008.11.010; Russo D, 2013, EXPERT OPIN THER TAR, V17, P179, DOI 10.1517/14728222.2013.740013; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saba J, 2009, J PROTEOME RES, V8, P3355, DOI 10.1021/pr801106a; Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; van de Wijngaart DJ, 2010, J BIOL CHEM, V285, P5097, DOI 10.1074/jbc.M109.039958; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Venkatesan RN, 2006, DNA REPAIR, V5, P294, DOI 10.1016/j.dnarep.2005.10.012; Vera-Badillo FE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt319; Vogelstein B., 2002, GENETIC BASIS HUMAN; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wu AH, 2013, CANCER CAUSE CONTROL, V24, P1821, DOI 10.1007/s10552-013-0260-7; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Xu XL, 2013, GENE, V519, P343, DOI 10.1016/j.gene.2013.01.046; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158; Zhao XY, 1999, J UROLOGY, V162, P2192, DOI 10.1016/S0022-5347(05)68158-X; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287; Zhou JM, 2009, J MED CHEM, V52, P5546, DOI 10.1021/jm801218k	90	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113190	10.1371/journal.pone.0113190	http://dx.doi.org/10.1371/journal.pone.0113190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409505	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200077
J	Zengin, G; Uysal, A; Gunes, E; Aktumsek, A				Zengin, Gokhan; Uysal, Ahmet; Gunes, Erdogan; Aktumsek, Abdurrahman			Survey of Phytochemical Composition and Biological Effects of Three Extracts from a Wild Plant (Cotoneaster nummularia Fisch et Mey.): A Potential Source for Functional Food Ingredients and Drug Formulations	PLOS ONE			English	Article							TOTAL PHENOLIC CONTENT; ANTIOXIDANT ACTIVITY; FERULIC ACID; MEDICINAL-PLANTS; AQUEOUS EXTRACTS; ESSENTIAL OIL; IN-VITRO; L.; INHIBITORS; ANTICHOLINESTERASE	This study was focused on the analysis of the phenolic content, antioxidant, antibacterial, anti-cholinesterase, anti-tyrosinase, anti-amylase and anti-glucosidase activity of three solvent extracts from Cotoneaster nummularia. Moreover, water extract was tested in terms of mutagenic/anti-mutagenic effects. The antioxidant activities of these extracts were evaluated by DPPH, ABTS, O-2, metal chelating, phosphomolybdenum, beta-carotene/linoleic acid, ferric and cupric reducing power assays. Enzyme inhibitory activities were also examined with colorimetric methods. Generally, methanol and water extracts exhibited excellent biological activities. These extracts were rich in phenolic and flavonoid content. Furthermore, Cotoneaster extracts indicated appreciable antibacterial properties against human pathogen strains. HPLC analysis showed that ferulic acid, chlorogenic acid, (-) - epicatechin and (+)-catechin were the major phenolics in extracts tested. These data offer that these extracts from C. nummularia may be considered as a potential source of biological agents for developing functional foods or drug formulations.	[Zengin, Gokhan; Gunes, Erdogan; Aktumsek, Abdurrahman] Selcuk Univ, Fac Sci, Dept Biol, Konya, Turkey; [Uysal, Ahmet] Selcuk Univ, Vocat Sch Hlth Serv, Konya, Turkey	Selcuk University; Selcuk University	Uysal, A (corresponding author), Selcuk Univ, Vocat Sch Hlth Serv, Konya, Turkey.	ahuysal@selcuk.edu.tr	Zengin, Gokhan/K-9393-2015; Uysal, Ahmet/V-7909-2017; Zengin, Gokhan/GLS-8806-2022	Zengin, Gokhan/0000-0001-6548-7823; Uysal, Ahmet/0000-0002-9297-4050; Zengin, Gokhan/0000-0001-6548-7823				Adebiyi AO, 2009, PHARM BIOL, V47, P320, DOI 10.1080/13880200902748460; Aksoy L, 2013, SAUDI J BIOL SCI, V20, P235, DOI 10.1016/j.sjbs.2013.02.003; Aktumsek A, 2013, FOOD CHEM TOXICOL, V55, P290, DOI 10.1016/j.fct.2013.01.018; Apak R, 2006, INT J FOOD SCI NUTR, V57, P292, DOI 10.1080/09637480600798132; Berk S, 2011, AFR J BIOTECHNOL, V10, P8902; Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244; BUENING MK, 1981, CANCER RES, V41, P67; Cakilcioglu U, 2011, J ETHNOPHARMACOL, V137, P469, DOI 10.1016/j.jep.2011.05.046; Caponio F, 1999, FOOD CHEM, V64, P203, DOI 10.1016/S0308-8146(98)00146-0; Chakrabarti R, 2002, CURR SCI INDIA, V83, P1533; Chandini SK, 2008, FOOD CHEM, V107, P707, DOI 10.1016/j.foodchem.2007.08.081; Dalar A, 2013, IND CROP PROD, V44, P383, DOI 10.1016/j.indcrop.2012.11.037; Dasgupta N, 2004, FOOD CHEM, V88, P219, DOI 10.1016/j.foodchem.2004.01.036; DEAN BJ, 1985, MUTAT RES, V153, P57, DOI 10.1016/0165-1110(85)90005-3; EDENHARDER R, 1993, MUTAT RES, V287, P261, DOI 10.1016/0027-5107(93)90019-C; Eldeen IMS, 2005, J ETHNOPHARMACOL, V102, P457, DOI 10.1016/j.jep.2005.08.049; Erdogan-Orhan I, 2010, J SERB CHEM SOC, V75, P1491, DOI 10.2298/JSC100322115E; Fang L, 2008, BIOORG MED CHEM LETT, V18, P2905, DOI 10.1016/j.bmcl.2008.03.073; Gallegos-Tintore S, 2011, J SCI FOOD AGR, V91, P1618, DOI 10.1002/jsfa.4357; Ranilla LG, 2010, BIORESOURCE TECHNOL, V101, P4676, DOI 10.1016/j.biortech.2010.01.093; Goze I, 2009, J MED PLANTS RES, V3, P246; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Horn RC, 2003, MUTAGENESIS, V18, P113, DOI 10.1093/mutage/18.2.113; Jang HD, 2007, FOOD CHEM, V103, P749, DOI 10.1016/j.foodchem.2006.09.026; Javanmardi J, 2003, FOOD CHEM, V83, P547, DOI 10.1016/S0308-8146(03)00151-1; KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7; Karioti A, 2007, BIOORGAN MED CHEM, V15, P2708, DOI 10.1016/j.bmc.2007.01.035; Khan S, 2009, J ASIAN NAT PROD RES, V11, P44, DOI 10.1080/10286020802435745; Kinghorn AD, 2004, PLANTA MED, V70, P691, DOI 10.1055/s-2004-827198; Koc ZE, 2013, EXCLI J, V12, P396; Leonti M, 2012, GENET RESOUR CROP EV, V59, P1295, DOI 10.1007/s10722-012-9894-7; Mamiya T, 2008, NEUROSCI LETT, V430, P115, DOI 10.1016/j.neulet.2007.10.029; Manian R, 2008, FOOD CHEM, V107, P1000, DOI 10.1016/j.foodchem.2007.09.008; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Matthews VA, 1972, FLORA TURKEY E AEGEA, V4; Mitscher LA, 1996, MUTAT RES-FUND MOL M, V350, P143, DOI 10.1016/0027-5107(95)00099-2; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Nazir A, 2010, NAT SCI, V8, P57; Negi PS, 2003, FOOD CHEM, V80, P393, DOI 10.1016/S0308-8146(02)00279-0; Okombi S, 2006, BIOORG MED CHEM LETT, V16, P2252, DOI 10.1016/j.bmcl.2006.01.022; Oksana S., 2012, Journal of Medicinal Plants Research, V6, P2526; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Ozgen U, 2012, TURK J BIOL, V36, P93, DOI 10.3906/biy-1009-124; Pandey MR, 2007, OUR NAT, V4, P69; PARKE DV, 1991, CAN J PHYSIOL PHARM, V69, P537, DOI 10.1139/y91-081; Polat R, 2013, J ETHNOPHARMACOL, V148, P951, DOI 10.1016/j.jep.2013.05.050; Priya Darsini DT, 2013, FREE RADICAL ANTIOXI, V3, P62, DOI DOI 10.1016/J.FRA.2013.08.001; Rajaei A, 2010, FOOD CHEM TOXICOL, V48, P107, DOI 10.1016/j.fct.2009.09.023; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Roy S, 2013, ENDOCRINE, V44, P369, DOI 10.1007/s12020-012-9868-8; Saija A, 2000, INT J PHARM, V199, P39, DOI 10.1016/S0378-5173(00)00358-6; Sarikurkcu C, 2012, SPECTROSC LETT, V45, P352, DOI 10.1080/00387010.2012.666701; Sarikurkcu C, 2011, AFR J BIOTECHNOL, V10, P831; Shahwar D, 2010, J MED PLANTS RES, V4, P260; Skotti E, 2014, IND CROP PROD, V53, P46, DOI 10.1016/j.indcrop.2013.12.013; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Suhaj M, 2006, J FOOD COMPOS ANAL, V19, P531, DOI 10.1016/j.jfca.2004.11.005; Vladimir-Knezevic S, 2014, MOLECULES, V19, P767, DOI 10.3390/molecules19010767; Zengin G, 2014, IND CROP PROD, V53, P244, DOI 10.1016/j.indcrop.2013.12.043	61	89	89	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113527	10.1371/journal.pone.0113527	http://dx.doi.org/10.1371/journal.pone.0113527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409171	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200134
J	Adams, P; Kaewkungwal, J; Limphattharacharoen, C; Prakobtham, S; Pengsaa, K; Khusmith, S				Adams, Pornpimon; Kaewkungwal, Jaranit; Limphattharacharoen, Chanthima; Prakobtham, Sukanya; Pengsaa, Krisana; Khusmith, Srisin			Is Your Ethics Committee Efficient? Using "IRB Metrics'' as a Self-Assessment Tool for Continuous Improvement at the Faculty of Tropical Medicine, Mahidol University, Thailand	PLOS ONE			English	Article							BOARDS; TRIAL; VARIABILITY; RESEARCHERS; COUNTRIES	Tensions between researchers and ethics committees have been reported in several institutions. Some reports suggest researchers lack confidence in the quality of institutional review board (IRB) reviews, and that emphasis on strict procedural compliance and ethical issues raised by the IRB might unintentionally lead to delays in correspondence between researchers and ethics committees, and/or even encourage prevarication/equivocation, if researchers perceive committee concerns and criticisms unjust. This study systematically analyzed the efficiency of different IRB functions, and the relationship between efficiency and perceived quality of the decision-making process. The major purposes of this study were thus (1) to use the IRB Metrics developed by the Faculty of Tropical Medicine, Mahidol University, Thailand (FTM-EC) to assess the operational efficiency and perceived effectiveness of its ethics committees, and (2) to determine ethical issues that may cause the duration of approval process to be above the target limit of 60 days. Based on a literature review of definitions and methods used and proposed for use, in assessing aspects of IRB quality, an "IRB Metrics'' was developed to assess IRB processes using a structure-process-outcome measurement model. To observe trends in the indicators evaluated, data related to all protocols submitted to the two panels of the FTM-EC (clinical and non-clinical), between January 2010-September 2013, were extracted and analyzed. Quantitative information based on IRB Metrics structure-process-outcome illuminates different areas for internal-process improvement. Ethical issues raised with researchers by the IRB, which were associated with the duration of the approval process in protocol review, could be considered root causes of tensions between the parties. The assessment of IRB structure-process-outcome thus provides a valuable opportunity to strengthen relationships and reduce conflicts between IRBs and researchers, with positive outcomes for all parties involved in the conduct of human-subject research.	[Adams, Pornpimon; Limphattharacharoen, Chanthima; Prakobtham, Sukanya] Mahidol Univ, Fac Trop Med, Off Res Serv, Bangkok, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Pengsaa, Krisana] Mahidol Univ, Fac Trop Med, Dept Trop Pediat, Bangkok, Thailand; [Khusmith, Srisin] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Kaewkungwal, J (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.	jaranit.kae@mahidol.ac.th		Kaewkungwal, Jaranit/0000-0001-7916-8460				Abbott L, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.1.3; Adams P, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-33; Ahmed AH, 1996, J MED ETHICS, V22, P263, DOI 10.1136/jme.22.5.263; [Anonymous], 2011, GOV ARR RES ETH COMM; [Anonymous], 1980, EXPLORATIONS QUALITY; Association for the Accreditation of Human Research Protection Programs Inc, 2012, METR HRPP PERF; Association for the Accreditation of Human Research Protection Programs Inc, 2012, EV INSTR ACCR; Association for the Accreditation of Human Research Protection Programs Inc, 2001, AAHRPP ACCR STAND; Brozek U, 2013, THESIS U ILLINOIS CH; Candilis Philip J, 2006, IRB, V28, P1; Catania JA, 2008, J EMPIR RES HUM RES, V3, P57, DOI 10.1525/jer.2008.3.4.57; Citro CF, 2003, PROTECTING PARTICIPA; Clinical Research Resources Office (CRRO) Boston University, REG TOOLS RES; Coleman Carl H, 2008, BMC Med Ethics, V9, P6, DOI 10.1186/1472-6939-9-6; Cook Ann Freeman, 2011, IRB, V33, P14; Dodsworth N, 2008, GUIDANCE AUDITING QU; Dyrbye LN, 2007, ACAD MED, V82, P654, DOI 10.1097/ACM.0b013e318065be1e; Edwards SJL, 2007, INT J TECHNOL ASSESS, V23, P17, DOI 10.1017/S0266462307051525; Eissenberg T., 2004, IRBS PSYCHOL SCI ENS; Flynn KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054999; Food and Drug Administration (FDA), 2009, SELF EV CHECKL IRBS; Giles J, 2005, NATURE, V438, P136, DOI 10.1038/438136b; Guillemin M, 2012, J EMPIR RES HUM RES, V7, P38, DOI 10.1525/jer.2012.7.3.38; Halis M, 2007, SERB J MANAG, V2, P127; Health Research Authority, 2007, QUALITY ASSURANCE; Hirshon JM, 2002, ACAD EMERG MED, V9, P1417, DOI 10.1197/aemj.9.12.1417; Hyder AA, 2004, J MED ETHICS, V30, P68, DOI 10.1136/jme.2002.001933; Institution Review Board University of Missouri-Columbia, 2008, STAND OP PROC ASS AU; Johnson R. S., 1993, TQM LEADERSHIP QUALI; Kass NE, 2007, PLOS MED, V4, P26, DOI 10.1371/journal.pmed.0040003; Keith-Spiegel P, 2005, ETHICS BEHAV, V15, P339, DOI 10.1207/s15327019eb1504_5; Keith-Spiegel P, 2006, J EMPIR RES HUM RES, V1, P67, DOI 10.1525/jer.2006.1.1.67; Kipnis K, 2006, AM J BIOETHICS, V6, P18, DOI 10.1080/15265160600685580; Klitzman Robert, 2012, BMC Res Notes, V5, P347, DOI 10.1186/1756-0500-5-347; Klitzman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028773; Klitzman R, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-13; Koziatek S, 2012, IRB ADVISOR, V12, P89; Lantero D., 2011, J CLIN RES BEST PRAC, V7, P1; Lavori PW, 1999, CONTROL CLIN TRIALS, V20, P187, DOI 10.1016/S0197-2456(98)00064-6; Lidz CW, 2012, ACAD MED, V87, P969, DOI 10.1097/ACM.0b013e3182575e2e; Mayo Clinic Human Research Protection Program, 2012, ROL QUAL EV IRB MEMB; Nelson J., 2013, J CLIN RES BEST PRAC, V9, P1; Office of Research and Commercialization (ORC) University of Central Florida, 2012, CHECKL MIN QUAL IMPR; Pandiya Anvita, 2011, Perspect Clin Res, V2, P45, DOI 10.4103/2229-3485.80364; Repenshek M, 2010, CONTINUOUS QUALITY I; Research Compliance Office (RCO) Stanford University, 2014, SURV AND METR; Rikkert MGMO, 2005, EUR J NEUROL, V12, P212, DOI 10.1111/j.1468-1331.2004.00980.x; Schuppli CA, 2007, J MED ETHICS, V33, P294, DOI 10.1136/jme.2005.015057; Shaw DM, 2011, J MED ETHICS, V37, P706, DOI 10.1136/medethics-2011-100120; Shewhart W. A., 1986, EC CONTROL QUALITY M; Silverman H, 2001, CRIT CARE MED, V29, P235, DOI 10.1097/00003246-200102000-00002; Sleem H, 2010, J EMPIR RES HUM RES, V5, P85, DOI 10.1525/jer.2010.5.3.85; Stair TO, 2001, ACAD EMERG MED, V8, P636, DOI 10.1111/j.1553-2712.2001.tb00177.x; Sugarman J, 2004, J LAW MED ETHICS, V32, P226, DOI 10.1111/j.1748-720X.2004.tb00469.x; Sugarman J, 2004, JAMA-J AM MED ASSOC, V291, P494, DOI 10.1001/jama.291.4.494; Taylor Holly A, 2007, IRB, V29, P9; U.S. Department of Health & Human Services, 2005, IRBS AND ASS; U.S. Department of Health & Human Services, 2002, OHRP QA SELF ASS TOO; University of Michigan, 2013, U MICH IRB METR; Varga Orsolya, 2013, Animals (Basel), V3, P907, DOI 10.3390/ani3030907; Wayne State University Division of Research Research Compliance, 2014, IRB TIM APPR FULL BO; Whitney Simon N, 2008, Int J Med Sci, V5, P68; WHO/TDR, 2002, SURV EV ETH REV PRAC; WHO/TDR, 2000, OP GUID ETH COMM REV; Wichman Alison, 2006, IRB, V28, P7; Yanow D, 2008, PS-POLIT SCI POLIT, V41, P483, DOI 10.1017/S1049096508080864; Young M, 2013, IRB ADVISOR, V13, P13	67	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113356	10.1371/journal.pone.0113356	http://dx.doi.org/10.1371/journal.pone.0113356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25406085	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300107
J	Chen, HY; Yamagishi, J; Kishino, H				Chen, Hungyen; Yamagishi, Junko; Kishino, Hirohisa			Bayesian Inference of Baseline Fertility and Treatment Effects via a Crop Yield-Fertility Model	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; SOIL FERTILITY; AGRICULTURAL SUSTAINABILITY; CARBON SEQUESTRATION; DAIRY MANURE; WORLD FOOD; TILLAGE; QUALITY; MANAGEMENT; NITROGEN	To effectively manage soil fertility, knowledge is needed of how a crop uses nutrients from fertilizer applied to the soil. Soil quality is a combination of biological, chemical and physical properties and is hard to assess directly because of collective and multiple functional effects. In this paper, we focus on the application of these concepts to agriculture. We define the baseline fertility of soil as the level of fertility that a crop can acquire for growth from the soil. With this strict definition, we propose a new crop yield-fertility model that enables quantification of the process of improving baseline fertility and the effects of treatments solely from the time series of crop yields. The model was modified from Michaelis-Menten kinetics and measured the additional effects of the treatments given the baseline fertility. Using more than 30 years of experimental data, we used the Bayesian framework to estimate the improvements in baseline fertility and the effects of fertilizer and farmyard manure (FYM) on maize (Zea mays), barley (Hordeum vulgare), and soybean (Glycine max) yields. Fertilizer contributed the most to the barley yield and FYM contributed the most to the soybean yield among the three crops. The baseline fertility of the subsurface soil was very low for maize and barley prior to fertilization. In contrast, the baseline fertility in this soil approximated half-saturated fertility for the soybean crop. The long-term soil fertility was increased by adding FYM, but the effect of FYM addition was reduced by the addition of fertilizer. Our results provide evidence that longterm soil fertility under continuous farming was maintained, or increased, by the application of natural nutrients compared with the application of synthetic fertilizer.	[Chen, Hungyen; Kishino, Hirohisa] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yamagishi, Junko] Univ Tokyo, Inst Sustainable Agroecosyst Serv, Tokyo, Japan	University of Tokyo; University of Tokyo	Kishino, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	kishino@lbm.ab.a.u-tokyo.ac.jp	Kishino, Hirohisa/U-9311-2019	CHEN, Hungyen/0000-0003-3693-9354	Ministry of Education, Science and Culture (MEXT) [59440009]; Japan Society for the Promotion of Science (JSPS) [25280006]	Ministry of Education, Science and Culture (MEXT); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Grant-in-Aid for Scientific Research (grant number 59440009, PI: Wataru Sunohara) by the Ministry of Education, Science and Culture (MEXT, http://www.mext.go.jp) supported the initial phase (1984-1987) of the long-term fertilizer experiment. The University Farm continued the experiment until 2010 by the regular budget supplied by the University of Tokyo. This work was supported by Grants-in-Aid for Scientific Research (grant number 25280006) by the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/) to H. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N, 1999, P NATL ACAD SCI USA, V96, P5908, DOI 10.1073/pnas.96.11.5908; Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; Altieri MA, 2003, SOIL TILL RES, V72, P203, DOI 10.1016/S0167-1987(03)00089-8; Aref S, 1998, ADV AGRON, V62, P153; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Canali S, 2004, BIOL FERT SOILS, V40, P206, DOI 10.1007/s00374-004-0759-x; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Clark MS, 1998, AGRON J, V90, P662, DOI 10.2134/agronj1998.00021962009000050016x; Cong RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095142; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Denef K, 2004, SOIL SCI SOC AM J, V68, P1935, DOI 10.2136/sssaj2004.1935; Deng JM, 2012, P NATL ACAD SCI USA, V109, P15823, DOI 10.1073/pnas.1210955109; DRURY CF, 1995, CAN J PLANT SCI, V75, P355, DOI 10.4141/cjps95-060; Fan RQ, 2012, CAN J SOIL SCI, V92, P463, DOI 10.4141/CJSS2010-020; Fan TL, 2008, J PLANT NUTR SOIL SC, V171, P448, DOI 10.1002/jpln.200625192; Glover JD, 2012, NATURE, V489, P359, DOI 10.1038/489359a; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; HOLDREN JP, 1974, AM SCI, V62, P282; Huang S, 2010, GEODERMA, V154, P364, DOI 10.1016/j.geoderma.2009.11.009; International Benchmark Sites Network for Agrotechnology Transfer, 1993, IBSNAT DEC; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; JENKINSON DS, 1991, AGRON J, V83, P2, DOI 10.2134/agronj1991.00021962008300010008x; Khan AUH, 2007, BIORESOURCE TECHNOL, V98, P1972, DOI 10.1016/j.biortech.2006.07.041; Korschens M, 2013, ARCH AGRON SOIL SCI, V59, P1017, DOI 10.1080/03650340.2012.704548; [李菊梅 Li Jumei], 2005, [植物营养与肥料学报, Plant nutrition and fertitizer science], V11, P51; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Malhi SS, 2007, SOIL TILL RES, V96, P269, DOI 10.1016/j.still.2007.06.011; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McCown RL, 1996, AGR SYST, V50, P255, DOI 10.1016/0308-521X(94)00055-V; MERCIK S, 1985, PLANT SOIL, V83, P151, DOI 10.1007/BF02182725; Michaelis L, 1913, BIOCHEM Z, V49, P333; Min DH, 2003, COMMUN SOIL SCI PLAN, V34, P781, DOI 10.1081/CSS-120018975; MYERS RJK, 1984, FERT RES, V5, P95, DOI 10.1007/BF01049494; Neupane RP, 2001, AGR ECOSYST ENVIRON, V84, P157, DOI 10.1016/S0167-8809(00)00203-6; PEOPLES MB, 1995, PLANT SOIL, V174, P3, DOI 10.1007/BF00032239; Poulton PR, 1996, CAN J PLANT SCI, V76, P559, DOI 10.4141/cjps96-103; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasmussen PE, 1998, SCIENCE, V282, P893, DOI 10.1126/science.282.5390.893; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; SPIECKER H, 1995, PLANT SOIL, V168, P555, DOI 10.1007/BF00029368; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vanlauwe B, 2005, PLANT SOIL, V273, P337, DOI 10.1007/s11104-005-0194-2; Watson CA, 2002, SOIL USE MANAGE, V18, P264, DOI 10.1079/SUM2002127; Watson CA, 2002, SOIL USE MANAGE, V18, P239, DOI 10.1079/SUM2002131; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Yadvinder-Singh, 2004, SOIL SCI SOC AM J, V68, P854; Yanni YG, 2010, PLANT SOIL, V336, P129, DOI 10.1007/s11104-010-0454-7; Zhang H, 2009, J AGR SCI-CAMBRIDGE, V147, P31, DOI 10.1017/S0021859608008265; Zhu P, 2007, J PLANT NUTR SOIL SC, V170, P219, DOI 10.1002/jpln.200620635	56	5	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112785	10.1371/journal.pone.0112785	http://dx.doi.org/10.1371/journal.pone.0112785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405353	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300052
J	Hou, J; Huang, ZC; Li, HX; Liu, MQ; Zhang, W; Ma, N; Yang, LZ; Gu, F; Liu, Y; Jin, SH; Zhang, XC				Hou, Juan; Huang, Zhichao; Li, Hongxia; Liu, Mengqiu; Zhang, Wei; Ma, Ning; Yang, Lizhuang; Gu, Feng; Liu, Ying; Jin, Shenghua; Zhang, Xiaochu			Is the Excessive Use of Microblogs an Internet Addiction? Developing a Scale for Assessing the Excessive Use of Microblogs in Chinese College Students	PLOS ONE			English	Article							ONLINE SOCIAL NETWORKING; SELF-DISCLOSURE; ADOLESCENTS; COMPUTER	More and more college students are using microblogs, with some excessive users demonstrating addiction-like symptoms. However, there is currently no published scale available for use in assessing excessive use of these microblogs, a significant impediment to advancing this area of research. We collected data from 3,047 college students in China and developed a Microblog Excessive Use Scale (MEUS) for Chinese college students, comparing it with criteria used for assessing Internet addiction. Our diagnostic scale featured three factors, two of which-"withdrawal and health problem'' and "time management and performance''-are already included in Internet addiction assessment scales. The third factor, "social comfort,'' does not appear in Internet addiction assessment scales. Our study found that females have significantly higher MEUS scores than males, and that total MEUS scores positively correlated with scores from "self-disclosure'' and `` real social interaction'' scales. These findings differ from results obtained in previous investigations into Internet addiction. Our results indicate that some characteristics of the excessive use of microblogs are different to those of Internet addiction, suggesting that microblog overuse may not correspond exactly to the state of Internet addiction.	[Hou, Juan] Anhui Univ, Dept Philosophy, Hefei 230039, Anhui, Peoples R China; [Huang, Zhichao; Zhang, Wei; Ma, Ning; Yang, Lizhuang; Gu, Feng; Zhang, Xiaochu] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China; [Huang, Zhichao; Zhang, Wei; Ma, Ning; Yang, Lizhuang; Gu, Feng; Zhang, Xiaochu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Li, Hongxia; Jin, Shenghua] Beijing Normal Univ, Dept Psychol, Beijing 100875, Peoples R China; [Liu, Mengqiu; Liu, Ying] Anhui Med Univ, Anhui Prov Hosp, Hefei, Anhui, Peoples R China; [Zhang, Xiaochu] Univ Sci & Technol China, Sch Humanities & Social Sci, Hefei 230026, Anhui, Peoples R China	Anhui University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing Normal University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, XC (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China.	zxcustc@ustc.edu.cn	Zhang, Xiaochu/AEW-0582-2022; Yang, Li-Zhuang/AAJ-3623-2020; Yang, Li-Zhuang/F-3648-2016; Zhang, Xiaochu/AAG-8768-2022; Zhang, Xiaochu/O-9592-2014	Yang, Li-Zhuang/0000-0002-0192-4323; Yang, Li-Zhuang/0000-0002-0192-4323; Zhang, Xiaochu/0000-0002-7541-0130; Gu, Feng/0000-0002-5954-5596	Anhui Provincial Key Science Foundation for Outstanding Young Talent [2013SQRW007ZD]; Academic and Technology Leaders Introduction project of Anhui University [023032030063]; Social Science Planned Project of Anhui Province [AHSKQ2014D30]; National Natural Science Foundation of China [31171083, 31230032]; Fundamental Research Funds for the Central Universities of China [WK2070000033]; 100 Talents Program of The Chinese Academy of Sciences [BJ2070000047]; Natural Science Fund Project of Anhui Province [1208085MH179]	Anhui Provincial Key Science Foundation for Outstanding Young Talent; Academic and Technology Leaders Introduction project of Anhui University; Social Science Planned Project of Anhui Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); 100 Talents Program of The Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Fund Project of Anhui Province	This work was supported by grants from Anhui Provincial Key Science Foundation for Outstanding Young Talent (2013SQRW007ZD), Academic and Technology Leaders Introduction project of Anhui University (023032030063), and Social Science Planned Project of Anhui Province (AHSKQ2014D30). Also this work was supported by grants from the National Natural Science Foundation of China (31171083, 31230032), the Fundamental Research Funds for the Central Universities of China (WK2070000033), 100 Talents Program of The Chinese Academy of Sciences (BJ2070000047), and Natural Science Fund Project of Anhui Province (1208085MH179). The National Natural Science Foundation of China and Anhui Provincial Key Science Foundation for Outstanding Young Talent played a role in data collection and analysis. The Social Science Planned Project of Anhui Province and 100 Talents Program of The Chinese Academy played a role in the decision to publish. The Academic and Technology Leaders Introduction project of Anhui University, the Fundamental Research Funds for the Central Universities of China, and Natural Science Fund Project of Anhui Province played a role in the preparation of the manuscript.	Andreassen CS, 2012, PSYCHOL REP, V110, P501, DOI 10.2466/02.09.18.PR0.110.2.501-517; [Anonymous], 2014, PEOPLES DAILY O 0611; [Anonymous], 2012, 30 STAT REP CHIN INT; [Anonymous], 2010, RES REP CHAR MICR ME; Baike, 2010, WEIB KONG; Barbera LD, 2009, STUD HLTH TECHNOL IN, V144, P33; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Chang MK, 2008, COMPUT HUM BEHAV, V24, P2597, DOI 10.1016/j.chb.2008.03.001; Charlton JP, 2007, COMPUT HUM BEHAV, V23, P1531, DOI 10.1016/j.chb.2005.07.002; Chen D, 2009, CHINA J HLTH PSYCHOL, V17, P151; China Youth Association for Network Development (CYAND), 2009, DAT REP CHIN YOUTH I; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Consedine Nathan S, 2007, Cultur Divers Ethnic Minor Psychol, V13, P254, DOI 10.1037/1099-9809.13.3.254; Cornwell B, 2001, COMPUT HUM BEHAV, V17, P197, DOI 10.1016/S0747-5632(00)00040-6; Dai HQ, 2004, PSYCHOL ED MEASUREME, P118; Demetrovics Z, 2012, J BEHAV ADDICT, V1, P1, DOI 10.1556/JBA.1.2012.1.0; Demetrovics Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036417; Demetrovics Z, 2008, BEHAV RES METHODS, V40, P563, DOI 10.3758/BRM.40.2.563; Deters FG, 2013, SOC PSYCHOL PERS SCI, V4, P579, DOI 10.1177/1948550612469233; DINDIA K, 1992, PSYCHOL BULL, V112, P106, DOI 10.1037/0033-2909.112.1.106; Dong GH, 2012, PSYCHIAT RES-NEUROIM, V203, P153, DOI 10.1016/j.pscychresns.2012.02.001; EDGAR, 2013, FORM S 1 REG STAT; Gershuny J., 2000, CHANGING TIMES WORK; Goldberg I, 1995, INTERNET ADDICTIVE D, V2010; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Griffiths MD, 2014, NEUROPSYCHIATRY-LOND, V4, P1, DOI 10.2217/NPY.13.82; Griffiths MD, 2011, INT J GAME-BASED LEA, V1, P20, DOI 10.4018/ijgbl.2011100103; Hall A.S., 2001, J MENT HLTH COUNS, V23, P312, DOI DOI 10.1007/S11469-015-9622-6; Hilgard J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00608; HINSON JA, 1993, J COUNS DEV, V71, P465, DOI 10.1002/j.1556-6676.1993.tb02666.x; Hu Xiaomeng, 2010, Proceedings 2010 IEEE 2nd Symposium on Web Society (SWS 2010), P643, DOI 10.1109/SWS.2010.5607369; Huang HY, 2009, CYBERPSYCHOL BEHAV, V12, P675, DOI 10.1089/cpb.2009.0060; Iskender M, 2011, TURK ONLINE J EDUC T, V10, P215; Jia R., 2007, P 28 INT C INF SYST; Jiang X, 2012, CHINESE J SCH HLTH, V33, P225; JOURARD SM, 1958, J ABNORM SOC PSYCH, V56, P91, DOI 10.1037/h0043357; Kanai R, 2012, P ROY SOC B-BIOL SCI, V279, P1327, DOI 10.1098/rspb.2011.1959; Kang YH, 2012, CHINESE J SCH HLTH, V33, P99; Kelley TL, 1939, J EDUC PSYCHOL, V30, P17, DOI 10.1037/h0057123; Kittinger R, 2012, CYBERPSYCH BEH SOC N, V15, P324, DOI 10.1089/cyber.2010.0410; Koutamanis M, 2013, COMPUT HUM BEHAV, V29, P2265, DOI 10.1016/j.chb.2013.04.033; Kramer N.C., 2008, J MEDIA PSYCHOL-GER, V20, P106, DOI [DOI 10.1027/1864-1105.20.3.106, 10.1027/1864-1105.20.3.106]; Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528; Lenhart A., 2007, SOCIAL NETWORKING WE; Li YC, 2012, CHINESE J SCH HLTH, V33, P199; Liu CN, 2008, CHINESE J PREVENTION, V16, P159; Ma J, 2008, CHINESE J PREVENTION, V16, P161; Ma XH, 2012, PRESS CIRCLES, V3; Mazur E, 2010, J ADOLESCENT RES, V25, P124, DOI 10.1177/0743558409350498; Mesch GS, 2001, SOC SCI QUART, V82, P329, DOI 10.1111/0038-4941.00026; Mesquita G, 2007, ARQ NEURO-PSIQUIAT, V65, P428, DOI 10.1590/S0004-282X2007000300012; Ng BD, 2005, CYBERPSYCHOL BEHAV, V8, P110, DOI 10.1089/cpb.2005.8.110; Nie N. H., 2002, INTERNET EVERYDAY LI, P215, DOI DOI 10.1002/9780470774298.CH7; Pan XL, 2009, J GUANGDONG BAIYUN I, V16, P41; Parks MR, 1998, J SOC PERS RELAT, V15, P517, DOI 10.1177/0265407598154005; Parks MR, 1996, J COMMUN, V46, P80, DOI 10.1111/j.1460-2466.1996.tb01462.x; Peters CS, 2008, CYBERPSYCHOL BEHAV, V11, P480, DOI 10.1089/cpb.2007.0140; Pies Ronald, 2009, Psychiatry (Edgmont), V6, P31; Rainie L., 2010, WHO TWEETS; Sagolla D, 2009, TWITTER WAS BORN 140; Sanders CE, 2000, ADOLESCENCE, V35, P237; Shaffer H., 1997, ESTIMATING PREVALENC; Shaffer HJ, 2000, AM J ORTHOPSYCHIAT, V70, P162, DOI 10.1037/h0087741; Shapira NA, 2003, DEPRESS ANXIETY, V17, P207, DOI 10.1002/da.10094; Sprecher S, 2004, J SOC CLIN PSYCHOL, V23, P857, DOI 10.1521/jscp.23.6.857.54803; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Thadani DR, 2011, P 32 INT C INF SYST; Thelwall M, 2011, J AM SOC INF SCI TEC, V62, P406, DOI 10.1002/asi.21462; Turel O, 2011, MIS QUART, V35, P1043; Turkle S., 1995, LIFE SCREEN IDENTITY; Wang JX, 2011, 2011 CHINA SOCIAL PS; Weiser EB, 2001, CYBERPSYCHOL BEHAV, V4, P723, DOI 10.1089/109493101753376678; Widyanto L., 2006, INT J MENT HEALTH AD, V4, P31, DOI DOI 10.1007/S11469-006-9009-9; Wolniczak I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059087; Xifra J, 2010, PUBLIC RELAT REV, V36, P171, DOI 10.1016/j.pubrev.2010.02.005; Xinhua, 2011, CHIN MICR US POP TOP; Xuanhui L, 2001, CHINESE MENTAL HLTH, V15, P281; Xun Y, 2012, FUTURE IS NOW, V13; Yan MY, 2011, THESIS ANHUI MED U; Yao YH, 2007, CHINESE J SCH HLTH, V28, P475; Yellowlees PM, 2007, COMPUT HUM BEHAV, V23, P1447, DOI 10.1016/j.chb.2005.05.004; Yi FR, 2012, CHINA J HLTH PSYCHOL, V20, P233; Young K., 1998, CAUGHT NET RECOGNIZE; Young K. S., 1997, 105 ANN C AM PSYCH A, V15, P12; Young K, 2009, J CONTEMP PSYCHOTHER, V39, P241, DOI 10.1007/s10879-009-9120-x; Young KS, 2004, AM BEHAV SCI, V48, P402, DOI 10.1177/0002764204270278; Young KS, 1996, PSYCHOL REP, V79, P899, DOI 10.2466/pr0.1996.79.3.899; [俞宝龙 Yu Baolong], 2010, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V30, P476; Yu BL, 2010, J NANJING MED U NAT, V30, P501; Yu YW, 2007, SHANGHAI ARCH PSYCHI, V19, P1; ZHANG RP, 2011, CHINA J HLTH PSYCHOL, V19, P714; Zhang Z., 2011, TEACHER ED RES, V23, P44, DOI [10.13445/j.cnki.t.e.r.2011.02.012, DOI 10.13445/J.CNKI.T.E.R.2011.02.012]; Zhehui L., 2010, PSYCHOL DEV ED, V26, P618, DOI DOI 10.16187/J.CNKI.ISSN1001-4918.2010.06.010	94	9	10	8	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e110960	10.1371/journal.pone.0110960	http://dx.doi.org/10.1371/journal.pone.0110960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405928	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300008
J	Miller, CR; Lee, KH; Wichman, HA; Ytreberg, FM				Miller, Craig R.; Lee, Kuo Hao; Wichman, Holly A.; Ytreberg, F. Marty			Changing Folding and Binding Stability in a Viral Coat Protein: A Comparison between Substitutions Accessible through Mutation and Those Fixed by Natural Selection	PLOS ONE			English	Article							EXPERIMENTAL EVOLUTION; FORCE-FIELD; WEB SERVER; THERMODYNAMICS; PREDICTION; SEQUENCE; PHI-X174; VIRUS; BACTERIOPHAGE-PHI-X174; AGGREGATION	Previous studies have shown that most random amino acid substitutions destabilize protein folding (i.e. increase the folding free energy). No analogous studies have been carried out for protein-protein binding. Here we use a structure-based model of the major coat protein in a simple virus, bacteriophage phi X174, to estimate the free energy of folding of a single coat protein and binding of five coat proteins within a pentameric unit. We confirm and extend previous work in finding that most accessible substitutions destabilize both protein folding and protein-protein binding. We compare the pool of accessible substitutions with those observed among the phi X174-like wild phage and in experimental evolution with phi X174. We find that observed substitutions have smaller effects on stability than expected by chance. An analysis of adaptations at high temperatures suggests that selection favors either substitutions with no effect on stability or those that simultaneously stabilize protein folding and slightly destabilize protein binding. We speculate that these mutations might involve adjusting the rate of capsid assembly. At normal laboratory temperature there is little evidence of directional selection. Finally, we show that cumulative changes in stability are highly variable; sometimes they are well beyond the bounds of single substitution changes and sometimes they are not. The variation leads us to conclude that phenotype selection acts on more than just stability. Instances of larger cumulative stability change (never via a single substitution despite their availability) lead us to conclude that selection views stability at a local, not a global, level.	[Miller, Craig R.; Wichman, Holly A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Miller, Craig R.] Univ Idaho, Dept Math, Moscow, ID 83843 USA; [Miller, Craig R.; Lee, Kuo Hao; Wichman, Holly A.; Ytreberg, F. Marty] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Lee, Kuo Hao] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Kansas State University; Idaho; University of Idaho	Ytreberg, FM (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.	ytreberg@uidaho.edu	Miller, Craig/GWQ-5012-2022; Lee, Kuo Hao/H-9929-2019		National Institutes of Health [P20-RR016448-07S1, R01-GM076040, R21-GM083827]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076040, R21GM083827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KHL and FMY were supported by grant P20-RR016448-07S1 from the National Institutes of Health. CRM and HAW were supported by grant number R01-GM076040 from the National Institutes of Health. Computational resources were provided in part by grant R21-GM083827 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2007, GENETICS, V175, P255, DOI 10.1534/genetics.106.061754; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060401; Brown CJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-66; Bull JJ, 2000, MOL BIOL EVOL, V17, P942, DOI 10.1093/oxfordjournals.molbev.a026375; Bull JJ, 1997, GENETICS, V147, P1497; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cherwa JE, 2011, J MOL BIOL, V412, P387, DOI 10.1016/j.jmb.2011.07.070; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Crill WD, 2000, GENETICS, V154, P27; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dokland T, 1999, J MOL BIOL, V288, P595, DOI 10.1006/jmbi.1999.2699; Dokland T, 1998, ACTA CRYSTALLOGR D, V54, P878, DOI 10.1107/S0907444998002467; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Jha BK, 2004, J BIOL CHEM, V279, P23061, DOI 10.1074/jbc.M310676200; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Kronenberg ZN, 2010, ASYMMETRICAL ADAPTIO; Lee KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025640; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; MCKENNA R, 1992, ACTA CRYSTALLOGR B, V48, P499, DOI 10.1107/S0108768192001344; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Pace CN, 1998, J MOL BIOL, V279, P271, DOI 10.1006/jmbi.1998.1760; Pace CN, 2001, J MOL BIOL, V312, P393, DOI 10.1006/jmbi.2001.4956; Pepin KM, 2008, INFECT GENET EVOL, V8, P825, DOI 10.1016/j.meegid.2008.08.008; Pepin KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-85; Rain MW, 2001, MOL EVOLUTION 2 VIRU; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wichman HA, 2005, GENETICS, V170, P19, DOI 10.1534/genetics.104.034488; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731; Wichman HA, 2010, PHILOS T R SOC B, V365, P2495, DOI 10.1098/rstb.2010.0053; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	51	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112988	10.1371/journal.pone.0112988	http://dx.doi.org/10.1371/journal.pone.0112988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405628	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300068
J	Priyadarsini, S; Hjortdal, J; Sarker-Nag, A; Sejersen, H; Asara, JM; Karamichos, D				Priyadarsini, Shrestha; Hjortdal, Jesper; Sarker-Nag, Akhee; Sejersen, Henrik; Asara, John M.; Karamichos, Dimitrios			Gross Cystic Disease Fluid Protein-15/Prolactin-Inducible Protein as a Biomarker for Keratoconus Disease	PLOS ONE			English	Article							PROLACTIN-INDUCIBLE PROTEIN; HUMAN SEMINAL PLASMA; CORNEAL ALDEHYDE DEHYDROGENASE; IN-VITRO MODEL; OXIDATIVE STRESS; ZINC ALPHA-2-GLYCOPROTEIN; PATHOLOGICAL CORNEAS; COLLAGEN MATRICES; GENE-EXPRESSION; CELLS	Keratoconus (KC) is a bilateral degenerative disease of the cornea characterized by corneal bulging, stromal thinning, and scarring. The etiology of the disease is unknown. In this study, we identified a new biomarker for KC that is present in vivo and in vitro. In vivo, tear samples were collected from age-matched controls with no eye disease (n = 36) and KC diagnosed subjects (n = 17). Samples were processed for proteomics using LC-MS/MS. In vitro, cells were isolated from controls (Human Corneal Fibroblasts-HCF) and KC subjects (Human Keratoconus Cells-HKC) and stimulated with a Vitamin C (VitC) derivative for 4 weeks, and with one of the three transforming growth factor-beta (TGF-beta) isoforms. Samples were analyzed using realtime PCR and Western Blots. By using proteomics analysis, the Gross cystic disease fluid protein-15 (GCDFP-15) or prolactin-inducible protein (PIP) was found to be the best independent biomarker able to discriminate between KC and controls. The intensity of GCDFP-15/PIP was significantly higher in healthy subjects compared to KC-diagnosed. Similar findings were seen in vitro, using a 3D culture model. All three TGF-b isoforms significantly down-regulated the expression of GCDFP-15/PIP. Zinc-alpha-2-glycoprotein (AZGP1), a protein that binds to PIP, was identified by proteomics and cell culture to be highly regulated. In this study by different complementary techniques we confirmed the potential role of GCDFP-15/PIP as a novel biomarker for KC disease. It is likely that exploring the GCDFP-15/PIP-AZGP1 interactions will help better understand the mechanism of KC disease.	[Priyadarsini, Shrestha; Sarker-Nag, Akhee; Karamichos, Dimitrios] Univ Oklahoma, Dean McGee Eye Inst, Oklahoma City, OK 73106 USA; [Hjortdal, Jesper; Sejersen, Henrik] Aarhus Univ Hosp, Dept Ophthalmol, Aarhus C, Denmark; [Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct,Mass Spectrometry Core, Boston, MA 02215 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Karamichos, D (corresponding author), Univ Oklahoma, Dean McGee Eye Inst, Oklahoma City, OK 73106 USA.	dimitrios-karamichos@ouhsc.edu	karamichos, dimitrios/D-9651-2015		National Eye Institute [R01-EY023568]; Dana-Farber/Harvard Cancer Center [5P30CA006516];  [2P01CA120964]; NATIONAL CANCER INSTITUTE [P30CA006516, P01CA120964] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023568] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Dana-Farber/Harvard Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the following: 1) R01-EY023568, National Eye Institute, http://www.nei.nih.gov (D.K.); 2) 2P01CA120964 (J.M.A.); and 3) 5P30CA006516 Dana-Farber/Harvard Cancer Center Support Grant (J.M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarran C, 1997, Cont Lens Anterior Eye, V20, P129, DOI 10.1016/S1367-0484(97)80011-2; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; AUTIERO M, 1995, EUR J IMMUNOL, V25, P1461, DOI 10.1002/eji.1830250550; Behndig A, 2001, INVEST OPHTH VIS SCI, V42, P2293; Brizzi MF, 2002, DIABETES, V51, P3311, DOI 10.2337/diabetes.51.11.3311; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; Cabassi A, 2013, CURR OPIN CLIN NUTR, V16, P267, DOI 10.1097/MCO.0b013e32835f816c; Caputo E, 2003, BIOCHEMISTRY-US, V42, P6169, DOI 10.1021/bi034038a; Chung EH, 1999, INVEST OPHTH VIS SCI, V40, P1952; Daxer A, 1997, INVEST OPHTH VIS SCI, V38, P121; Espandar L, 2010, MIDDLE EAST AFR J OP, V17, P15, DOI 10.4103/0974-9233.61212; Fodor M, 2013, EYE CONTACT LENS, V39, P147, DOI 10.1097/ICL.0b013e318273b35f; Gallo A, 2013, J GENET SYNDR GENE T, V4; GONDHOWIARDJO TD, 1993, CORNEA, V12, P146, DOI 10.1097/00003226-199303000-00010; GONDHOWIARDJO TD, 1993, CORNEA, V12, P310, DOI 10.1097/00003226-199307000-00006; HAAGENSEN DE, 1990, ANN NY ACAD SCI, V586, P161, DOI 10.1111/j.1749-6632.1990.tb17804.x; Hassan MI, 2008, J SEP SCI, V31, P2318, DOI 10.1002/jssc.200700686; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; Hassan MI, 2008, J MOL BIOL, V384, P663, DOI 10.1016/j.jmb.2008.09.072; Hayes S, 2007, EXP EYE RES, V84, P423, DOI 10.1016/j.exer.2006.10.014; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Karamichos D, 2014, EXP EYE RES; Karamichos D, 2013, INVEST OPHTH VIS SCI, V54, P6612, DOI 10.1167/iovs.13-12861; Karamichos D, 2012, J FUNCT BIOMATER, V3, P760, DOI 10.3390/jfb3040760; Karamichos D, 2011, J FUNCT BIOMATER, V2, P213, DOI 10.3390/jfb2030213; Karamichos D, 2007, INVEST OPHTH VIS SCI, V48, P5030, DOI 10.1167/iovs.07-0443; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Karamichos D, 2009, CELL MOTIL CYTOSKEL, V66, P1, DOI 10.1002/cm.20326; Kenney M. Cristina, 2000, CLAO Journal, V26, P10; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Levy DE, 2000, ONCOGENE, V19, P2505, DOI 10.1038/sj.onc.1203480; MAGUIRE LJ, 1989, AM J OPHTHALMOL, V108, P107, DOI 10.1016/0002-9394(89)90001-9; Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253; Mirels L, 1998, J HISTOCHEM CYTOCHEM, V46, P1061, DOI 10.1177/002215549804600910; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; MURPHY LC, 1987, J BIOL CHEM, V262, P15236; Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Radner W, 1998, OPHTHALMIC RES, V30, P327, DOI 10.1159/000055492; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; Sawaguchi S, 1998, ARCH OPHTHALMOL-CHIC, V116, P62, DOI 10.1001/archopht.116.1.62; Sharma M, 2006, AM J OPHTHALMOL, V141, P891, DOI 10.1016/j.ajo.2005.12.027; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Sporl E, 2000, OPHTHALMOLOGE, V97, P203, DOI 10.1007/s003470050515; Udar N, 2009, CORNEA, V28, P902, DOI 10.1097/ICO.0b013e3181983a0c; UEYAMA H, 1991, BIOCHEM BIOPH RES CO, V177, P696, DOI 10.1016/0006-291X(91)91844-3; UEYAMA H, 1994, J BIOCHEM, V116, P677, DOI 10.1093/oxfordjournals.jbchem.a124579; Webhofer C, 2013, J PSYCHIATR RES, V47, P289, DOI 10.1016/j.jpsychires.2012.11.003; Wentz-Hunter K, 2001, MOL MED, V7, P470, DOI 10.1007/BF03401852; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	54	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113310	10.1371/journal.pone.0113310	http://dx.doi.org/10.1371/journal.pone.0113310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405607	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300103
J	Wang, ZJ; Chen, R; Wang, SH; Zhong, J; Wu, MN; Zhao, J; Duan, JC; Zhuo, ML; An, TT; Wang, YY; Bai, H; Wang, J				Wang, Zhijie; Chen, Rui; Wang, Shuhang; Zhong, Jia; Wu, Meina; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; An, Tongtong; Wang, Yuyan; Bai, Hua; Wang, Jie			Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR MUTATIONS; LUNG-CANCER PATIENTS; ACQUIRED-RESISTANCE; NONINVASIVE DETECTION; 1ST-LINE TREATMENT; OPEN-LABEL; GEFITINIB; ERLOTINIB; CHEMOTHERAPY	Background: Among advanced non-small cell lung cancer (NSCLC) patients with an acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI), about 50% carry the T790M mutation, but this frequency in EGFR-TKI-naive patients and dynamic change during therapy remains unclear. This study investigated the quantification and dynamic change of T790M mutation in plasma cell-free DNA (cf-DNA) of advanced NSCLC patients to assess the clinical outcomes of EGFR-TKI therapy. Materials and Methods: We retrospectively investigated 135 patients with advanced NSCLC who obtained progression-free survival (PFS) after EGFR-TKI for.6 months for their EGFR sensitive mutations and T790M mutation in matched pre-and post-TKI plasma samples, using denaturing high-performance liquid chromatography (DHPLC), amplification refractory mutation system (ARMS), and digital-PCR (D-PCR). Real-time PCR was performed to measure c-MET amplification. Results: Detection limit of D-PCR in assessing the T790M mutation was approximately 0.03%. D-PCR identified higher frequency of T790M than ARMS in pre-TKI (31.3% vs. 5.5%) and post-TKI (43.0% vs. 25.2%) plasma samples. Patients with pre-TKI T790M showed inferior PFS (8.9 vs. 12.1 months, p = 0.007) and overall survival (OS, 19.3 vs. 31.9 months, p = 0.001) compared with those without T790M. In patients harboring EGFR sensitive mutation, high quantities of pre-TKI T790M predicted poorer PFS (p = 0.001) on EGFR-TKI than low ones. Moreover, patients who experienced increased quantity of T790M during EGFR-TKI treatment showed superior PFS and OS compared with those with decreased changes (p = 0.044 and p = 0.015, respectively). Conclusion: Qualitative and quantitative T790M in plasma cf-DNA by D-PCR provided a non-invasive and sensitive assay to predict EGFR-TKI prognosis.	[Bai, Hua] Beijing Canc Hosp, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Thorac Med Oncol, Beijing, Peoples R China; Beijing Inst Canc Res, Beijing, Peoples R China	Peking University	Bai, H (corresponding author), Beijing Canc Hosp, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Thorac Med Oncol, Beijing, Peoples R China.	baihuahb@sina.com; zlhuxi@163.com	Duan, Jianchun/AAM-5765-2020	zhuo, minglei/0000-0003-2489-7791	National Natural Science Foundation Distinguished Young Scholars [81025012]; National Natural Science Foundation Key Program [81330062]; Education Ministry Innovative Research Team Program [IRT13003]; Peking University-Tsinghua University Joint Center; Wujieping Medicine Foundation [320.6750.1361, 320.6750.12192]	National Natural Science Foundation Distinguished Young Scholars; National Natural Science Foundation Key Program; Education Ministry Innovative Research Team Program; Peking University-Tsinghua University Joint Center; Wujieping Medicine Foundation	This work was supported by the National Natural Science Foundation Distinguished Young Scholars (81025012); the National Natural Science Foundation Key Program (81330062); Education Ministry Innovative Research Team Program (IRT13003); Peking University-Tsinghua University Joint Center for Life Sciences Clinical Investigator; and Wujieping Medicine Foundation (320.6750.1361 and 320.6750.12192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CANCER DISCOV, V3, pOF9, DOI [10.1158/2159-8290.CD-ND2013-025, DOI 10.1158/2159-8290.CD-ND2013-025]; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; CHMIELECKI J, 2009, AACR 100 ANN M DENV; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; Hata A, 2013, CANCER-AM CANCER SOC, V119, P4325, DOI 10.1002/cncr.28364; Huang Z, 2012, THORAC CANCER, V3, P334, DOI 10.1111/j.1759-7714.2012.00133.x; Kimura H, 2007, BRIT J CANCER, V97, P778, DOI 10.1038/sj.bjc.6603949; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Liu SV, 2014, EXPERT OPIN EMERG DR, V19, P51, DOI 10.1517/14728214.2014.873403; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok T, 2013, J CLIN ONCOL, V31; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ranson M, 2013, AZD9291 IRREVERSIBLE; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Wakelee HA, 2013, SERIAL MONITORING PL; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973; Wang SH, 2010, CLIN CANCER RES, V16, P1324, DOI 10.1158/1078-0432.CCR-09-2672; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Yang JC, 2013, ACTIVITY AFATINIB UN; Ye X, 2013, J THORAC ONCOL, V8, P1118, DOI 10.1097/JTO.0b013e31829f691f; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	34	15	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e110780	10.1371/journal.pone.0110780	http://dx.doi.org/10.1371/journal.pone.0110780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405807	Green Submitted, gold, Green Published			2022-12-27	WOS:000347121300007
J	Chen, N; Li, J; Li, D; Yang, YS; He, DF				Chen, Na; Li, Jia; Li, Dan; Yang, Yongsheng; He, Defu			Chronic Exposure to Perfluorooctane Sulfonate Induces Behavior Defects and Neurotoxicity through Oxidative Damages, In Vivo and In Vitro	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SERUM CONCENTRATIONS; NEONATAL EXPOSURE; LEARNING-BEHAVIOR; PFOS; NEMATODE; CHEMOTAXIS; TOXICITY; MICE; RATS	Perfluorooctane sulfonate (PFOS) is an emerging persistent pollutant which shows multiple adverse health effects. However, the neurotoxicity of PFOS and its mechanisms have not been fully elucidated. Using a combination of in vivo and in vitro methods, the present study provides a detailed description of PFOS-induced neurotoxicity. Results showed that the median lethal concentration of PFOS was 2.03 mM in Caenorhabditis elegans for 48 h exposure. 20 mM PFOS caused decrease of locomotor behaviors including forward movement, body bend and head thrash. Additionally, PFOS exposure reduced chemotaxis index of C. elegans, which indicates the decline of chemotaxis learning ability. Using green fluorescent protein (GFP) labelled transgenic strains, we found that PFOS caused down-regulated expression of a chemoreceptor gene, gcy-5, in ASE chemosensory neurons, but did not affect cholinergic neurons and dopaminergic neurons. In SH-SY5Y cells, 48 h exposure to 25 mu M and 50 mu M PFOS induced cell damage, apoptosis and the reactive oxygen species (ROS) generation. PFOS caused significant increases of lipid peroxidation and superoxide dismutase activity, but an actual decrease of glutathione peroxidase activity. Furthermore, antioxidant N-acetylcysteine rescued cells from PFOS-induced apoptosis via blocking ROS. Our results demonstrate that chronic exposure to PFOS can cause obvious neurotoxicity and behavior defects. Oxidative damage and anti-oxidative deficit are crucial mechanisms in neurotoxicity of PFOS.	[Chen, Na; Li, Jia; Li, Dan; Yang, Yongsheng; He, Defu] E China Normal Univ, Sch Ecol & Environm Sci, Toxicol Lab, Shanghai 200062, Peoples R China; [He, Defu] E China Normal Univ, Shanghai Key Lab Urban Ecol Proc & Ecorestorat, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	He, DF (corresponding author), E China Normal Univ, Sch Ecol & Environm Sci, Toxicol Lab, Shanghai 200062, Peoples R China.	dfhe@des.ecnu.edu.cn	Lang, Ming/HIK-0758-2022		National Science and Technology Major Project of China	National Science and Technology Major Project of China	This study was supported by National Science and Technology Major Project of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev G, 2002, BRAIN PATHOL, V12, P21; Andersen ME, 2006, TOXICOLOGY, V227, P156, DOI 10.1016/j.tox.2006.08.004; Ankley GT, 2004, ENVIRON TOXICOL CHEM, V23, P2745, DOI 10.1897/03-667; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bhhatarai B, 2010, CHEM RES TOXICOL, V23, P528, DOI 10.1021/tx900252h; BRENNER S, 1974, GENETICS, V77, P71; Calafat AM, 2007, ENVIRON SCI TECHNOL, V41, P2237, DOI 10.1021/es062686m; Chang SC, 2012, REPROD TOXICOL, V33, P428, DOI 10.1016/j.reprotox.2011.07.002; Chang SC, 2009, REPROD TOXICOL, V27, P387, DOI 10.1016/j.reprotox.2009.01.005; Chen JF, 2013, ENVIRON TOXICOL CHEM, V32, P201, DOI 10.1002/etc.2031; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; Dorts J, 2011, AQUAT TOXICOL, V103, P1, DOI 10.1016/j.aquatox.2011.01.015; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Fuentes S, 2007, TOXICOLOGY, V242, P123, DOI 10.1016/j.tox.2007.09.012; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Hansen KJ, 2002, ENVIRON SCI TECHNOL, V36, P1681, DOI 10.1021/es010780r; Harada KH, 2010, CHEMOSPHERE, V79, P314, DOI 10.1016/j.chemosphere.2010.01.027; Haug LS, 2009, ENVIRON SCI TECHNOL, V43, P2131, DOI 10.1021/es802827u; Hu XZ, 2009, ARCH TOXICOL, V83, P851, DOI 10.1007/s00204-009-0441-z; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P605, DOI 10.1016/j.bbrc.2011.09.010; Johansson N, 2008, NEUROTOXICOLOGY, V29, P160, DOI 10.1016/j.neuro.2007.10.008; Johansson N, 2009, TOXICOL SCI, V108, P412, DOI 10.1093/toxsci/kfp029; Joung K, 2010, HLTH TOXICOL, V25, P181; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kannan K, 2002, ENVIRON SCI TECHNOL, V36, P3210, DOI 10.1021/es020519q; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Kumsta C, 2011, ANTIOXID REDOX SIGN, V14, P1023, DOI 10.1089/ars.2010.3203; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lee HG, 2012, NEUROTOXICOLOGY, V33, P314, DOI 10.1016/j.neuro.2012.01.017; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lou IC, 2009, TOXICOL SCI, V107, P331, DOI 10.1093/toxsci/kfn234; Mao ZX, 2013, J APPL TOXICOL, V33, P1268, DOI 10.1002/jat.2785; Mariussen E, 2012, ARCH TOXICOL, V86, P1349, DOI 10.1007/s00204-012-0822-6; Martin JW, 2004, ENVIRON SCI TECHNOL, V38, P373, DOI 10.1021/es034727+; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Murakami S, 2005, NEUROBIOL AGING, V26, P899, DOI 10.1016/j.neurobiolaging.2004.08.007; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Olsen GW, 2012, ENVIRON SCI TECHNOL, V46, P6330, DOI 10.1021/es300604p; Onishchenko N, 2011, NEUROTOX RES, V19, P452, DOI 10.1007/s12640-010-9200-4; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Renner R, 2001, ENVIRON SCI TECHNOL, V35, p154A, DOI 10.1021/es012317k; Saeki S, 2001, J EXP BIOL, V204, P1757; Sato I, 2009, J TOXICOL SCI, V34, P569, DOI 10.2131/jts.34.569; Tominaga N, 2004, J HEALTH SCI, V50, P545, DOI 10.1248/jhs.50.545; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Tseng IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082657; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Wang SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069653; Wilhelm M, 2009, INT J HYG ENVIR HEAL, V212, P56, DOI 10.1016/j.ijheh.2007.11.002; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Xing HJ, 2012, CHEMOSPHERE, V88, P377, DOI 10.1016/j.chemosphere.2012.02.049; Xing XJ, 2009, J ENVIRON SCI, V21, P1684, DOI 10.1016/S1001-0742(08)62474-2; Zhang L, 2011, INT J TOXICOL, V30, P207, DOI 10.1177/1091581810387832	56	35	39	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113453	10.1371/journal.pone.0113453	http://dx.doi.org/10.1371/journal.pone.0113453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412474	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000054
J	Pufall, EL; Nyamukapa, C; Eaton, JW; Mutsindiri, R; Chawira, G; Munyati, S; Robertson, L; Gregson, S				Pufall, Erica L.; Nyamukapa, Constance; Eaton, Jeffrey W.; Mutsindiri, Reggie; Chawira, Godwin; Munyati, Shungu; Robertson, Laura; Gregson, Simon			HIV in Children in a General Population Sample in East Zimbabwe: Prevalence, Causes and Effects	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; OLDER CHILDREN; ADOLESCENTS; TIME; MAGNITUDE; MORTALITY; EXPOSURE; AFRICA	Background: There are an estimated half-million children living with HIV in sub-Saharan Africa. The predominant source of infection is presumed to be perinatal mother-to-child transmission, but general population data about paediatric HIV are sparse. We characterise the epidemiology of HIV in children in sub-Saharan Africa by describing the prevalence, possible source of infection, and effects of paediatric HIV in a southern African population. Methods: From 2009 to 2011, we conducted a household-based survey of 3389 children (aged 2-14 years) in Manicaland, eastern Zimbabwe (response rate: 73.5%). Data about socio-demographic correlates of HIV, risk factors for infection, and effects on child health were analysed using multi-variable logistic regression. To assess the plausibility of mother-to-child transmission, child HIV infection was linked to maternal survival and HIV status using data from a 12-year adult HIV cohort. Results: HIV prevalence was (2.2%, 95% CI: 1.6-2.8%) and did not differ significantly by sex, socio-economic status, location, religion, or child age. Infected children were more likely to be underweight (19.6% versus 10.0%, p = 0.03) or stunted (39.1% versus 30.6%, p = 0.04) but did not report poorer physical or psychological ill-health. Where maternal data were available, reported mothers of 61/62 HIV-positive children were deceased or HIV-positive. Risk factors for other sources of infection were not associated with child HIV infection, including blood transfusion, vaccinations, caring for a sick relative, and sexual abuse. The observed flat age-pattern of HIV prevalence was consistent with UNAIDS estimates which assumes perinatal mother-to-child transmission, although modelled prevalence was higher than observed prevalence. Only 19/73 HIV-positive children (26.0%) were diagnosed, but, of these, 17 were on antiretroviral therapy. Conclusions: Childhood HIV infection likely arises predominantly from mother-to-child transmission and is associated with poorer physical development. Overall antiretroviral therapy uptake was low, with the primary barrier to treatment appearing to be lack of diagnosis.	[Pufall, Erica L.; Nyamukapa, Constance; Eaton, Jeffrey W.; Robertson, Laura; Gregson, Simon] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Nyamukapa, Constance; Mutsindiri, Reggie; Chawira, Godwin; Munyati, Shungu] Biomed Res & Training Inst, Harare, Zimbabwe	Imperial College London; Biomedical Research Training Institute	Pufall, EL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London, England.	e.pufall11@imperial.ac.uk		Pufall, Erica/0000-0001-5386-4214; Eaton, Jeffrey/0000-0001-7728-728X; Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069	Canadian Institutes for Health Research; Bill and Melinda Gates foundation; Wellcome Trust [050517/z/97abc]; ESRC [ES/I033459/1] Funding Source: UKRI; Economic and Social Research Council [ES/I033459/1] Funding Source: researchfish; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ELP received a Doctoral Foreign Study Award from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). JWE thanks the Bill and Melinda Gates foundation for funding support via a grant to the HIV Modelling Consortium (http://www.gatesfoundation.org/). The Manicaland HIV/STD Prevention Project is supported by a grant from the Wellcome Trust (grant 050517/z/97abc, http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, S AFRICAN NATL HIV P; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bandason T, 2013, AIDS CARE, V25, P1520, DOI 10.1080/09540121.2013.780120; Bechtel K, 2010, CURR OPIN PEDIATR, V22, P94, DOI 10.1097/MOP.0b013e32833502ad; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Chiabi A, 2012, PAN AFR MED J, V11; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Eaton JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070447; Ferrand R, 2010, B WORLD HEALTH ORGAN, V88, P428, DOI 10.2471/BLT.09.066126; Ferrand RA, 2007, CLIN INFECT DIS, V44, P874, DOI 10.1086/511878; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Gaughan DM, 2004, PEDIATRICS, V113, pE544, DOI 10.1542/peds.113.6.e544; GELLERT GA, 1993, PEDIATRICS, V91, P39; Girardet RG, 2009, PEDIATRICS, V124, P79, DOI 10.1542/peds.2008-2947; Gomo E., 1997, Central African Journal of Medicine, V43, P350; Gomo E, 2006, HOUSEHOLD SURVEY HIV; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hammerschlag MR, 1998, SEX TRANSM INFECT, V74, P167, DOI 10.1136/sti.74.3.167; Jewkes R, 2002, LANCET, V359, P319, DOI 10.1016/S0140-6736(02)07530-X; Lindegren ML, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e46; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; Manzou R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086060; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; Meel B L, 2003, J Clin Forensic Med, V10, P65, DOI 10.1016/S1353-1131(03)00007-5; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Munyati S., 2006, CENSUS ORPHANS VULNE; Nalwoga A, 2012, TROP MED INT HEALTH, V15, P414; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nyamukapa CA, 2010, AIDS CARE, V22, P988, DOI 10.1080/09540121003615061; Okinyi M, 2009, INT J STD AIDS, V20, P852, DOI 10.1258/ijsa.2009.009204; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Rollins N, 2012, SEX TRANSM INFECT, V88, pI44, DOI 10.1136/sextrans-2012-050709; Schaaf HS, 2004, SAMJ S AFR MED J, V94, P782; Setty MKHG, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/497046; Shisana O, 2008, AIDS CARE, V20, P755, DOI 10.1080/09540120701771705; Shisana O, 2009, S AFRICAN NATL HIV P; Stover J, 2009, DEMPROJ COMPUTER PRO; Stover J, 2009, AIM COMPUTER PROGRAM; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Tsheko GN, 2005, CENSUS ORPHANS VULNE; WHO, 2006, WHO CHILD GROWTH STA; WHO, 2013, GLOB UPD HIV TREATM; Zimbabwe Ministry of Health and Child Welfare, 2010, ANT CLIN HIV SURV RE; Zimbabwe Ministry of Health and Child Welfare, 2012, ZIMB NAT HI IN PRESS, V2011; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113415	10.1371/journal.pone.0113415	http://dx.doi.org/10.1371/journal.pone.0113415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412251	Green Submitted, gold, Green Published			2022-12-27	WOS:000345253000051
J	Clausen, E; Wittman, C; Gingo, M; Fernainy, K; Fuhrman, C; Kessinger, C; Weinman, R; McMahon, D; Leader, J; Morris, A				Clausen, Emily; Wittman, Catherine; Gingo, Matthew; Fernainy, Khaled; Fuhrman, Carl; Kessinger, Cathy; Weinman, Renee; McMahon, Deborah; Leader, Joseph; Morris, Alison			Chest Computed Tomography Findings in HIV-Infected Individuals in the Era of Antiretroviral Therapy	PLOS ONE			English	Article							LUNG-CANCER; RESPIRATORY SYMPTOMS; RADIOGRAPHIC PREDICTORS; EMPHYSEMA; AIDS; CT; DIAGNOSIS; IMPACT; RISK; COPD	Background: Chest radiographic abnormalities were common in HIV-infected individuals in the pre-combination antiretroviral therapy era, but findings may differ now due to a changing spectrum of pulmonary complications. Methods: Cross-sectional study of radiographic abnormalities in an HIV-infected outpatient population during the antiretroviral therapy era. Demographics, chest computed tomography, and pulmonary function tests were obtained in HIV infected volunteers without acute respiratory illness from the University of Pittsburgh HIV/AIDS clinic. Overall prevalence of radiographic abnormalities and potential risk factors for having any abnormality, nodules, or emphysema were evaluated using univariate and multivariable analyses. Results: A majority of the 121 participants (55.4%) had a radiographic abnormality with the most common being emphysema (26.4%), nodules (17.4%), and bronchiectasis (10.7%). In multivariate models, age (odds ratio [OR] per year = 1.07, 95% confidence interval [CI] 1.04-1.14, p < 0.001), pneumonia history (OR = 3.60, 95% CI = 1.27-10.20, p = 0.016), and having ever smoked (OR = 3.66, p = 0.013, 95% CI = 1.31-10.12) were significant predictors of having any radiographic abnormality. Use of antiretroviral therapy, CD4 cell count, and HIV viral load were not associated with presence of abnormalities. Individuals with radiographic emphysema were more likely to have airway obstruction on pulmonary function tests. Only 85.8% participants with nodules had follow-up imaging resulting in 52.4% having stable nodules, 23.8% resolution of their nodules, 4.8% development of a new nodule, and 4.8% primary lung cancer. Conclusions: Radiographic abnormalities remain common in HIV-infected individuals with emphysema, nodules, and bronchiectasis being the most common. Age, smoking, and pneumonia were associated with radiographic abnormalities, but HIV-associated factors did not seem to predict risk.	[Clausen, Emily; Gingo, Matthew; Fernainy, Khaled; Kessinger, Cathy; Weinman, Renee; McMahon, Deborah; Morris, Alison] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Fuhrman, Carl; Leader, Joseph] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA 15213 USA; [Morris, Alison] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Wittman, Catherine] Kaiser Permanente, Denver, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente	Morris, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA.	morrisa@upmc.edu			National Institutes of Health (NIH) [R01HL090339, R01HL083461]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090339, R01HL083461] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Alison Morris received funding from the National Institutes of Health (NIH R01HL090339, R01HL083461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P45; Control CfD, 2013, HIV US GLANC; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Drummond MB, 2010, QUAL LIFE RES, V19, P1295, DOI 10.1007/s11136-010-9701-x; Drummond MB, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-27; Engels EA, 2006, J CLIN ONCOL, V24, P1383, DOI 10.1200/JCO.2005.03.4413; Gelman M, 1999, AM J ROENTGENOL, V172, P1033, DOI 10.2214/ajr.172.4.10587143; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gingo M, 2012, C RETR OPP INF SEATT; Gingo MR, 2012, J ALLERGY CLIN IMMUN, V129, P708, DOI 10.1016/j.jaci.2011.11.015; Gold JA, 2002, CHEST, V121, P1472, DOI 10.1378/chest.121.5.1472; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hardak E, 2010, LUNG, V188, P159, DOI 10.1007/s00408-009-9214-y; HARTMAN TE, 1994, AM J ROENTGENOL, V162, P547, DOI 10.2214/ajr.162.3.8109494; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; HOOVER DR, 1993, NEW ENGL J MED, V329, P1922, DOI 10.1056/NEJM199312233292604; Jasmer RM, 2000, CHEST, V117, P1023, DOI 10.1378/chest.117.4.1023; Jasmer RM, 2002, JAIDS, V31, P291, DOI 10.1097/00126334-200211010-00004; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Neas LM, 1996, AM J RESP CRIT CARE, V153, P656, DOI 10.1164/ajrccm.153.2.8564114; POLISH LB, 1989, CHEST, V96, P1321, DOI 10.1378/chest.96.6.1321; SIDER L, 1993, RADIOGRAPHICS, V13, P771, DOI 10.1148/radiographics.13.4.8356267; Sigel K, 2014, AIDS, V28, P1007, DOI 10.1097/QAD.0000000000000189; Sigel K, 2012, AIDS, V26, P1017, DOI 10.1097/QAD.0b013e328352d1ad; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; UNAIDS, 2012, JOINT UN PROGR HIV A; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Yuan R, 2009, THORAX, V64, P944, DOI 10.1136/thx.2008.112433	38	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112237	10.1371/journal.pone.0112237	http://dx.doi.org/10.1371/journal.pone.0112237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409510	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000345533200017
J	Johnson, AC; Tremble, SM; Chan, SL; Moseley, J; LaMarca, B; Nagle, KJ; Cipolla, MJ				Johnson, Abbie Chapman; Tremble, Sarah M.; Chan, Siu-Lung; Moseley, Janae; LaMarca, Babbette; Nagle, Keith J.; Cipolla, Marilyn J.			Magnesium Sulfate Treatment Reverses Seizure Susceptibility and Decreases Neuroinflammation in a Rat Model of Severe Preeclampsia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; UTERINE PERFUSION-PRESSURE; CEREBRAL AUTOREGULATION; ALBUMIN METABOLISM; EARLY-ONSET; PREGNANCY; RECEPTOR; ECLAMPSIA; FLOW; PERMEABILITY	Eclampsia, defined as unexplained seizure in a woman with preeclampsia, is a life-threatening complication of pregnancy with unclear etiology. Magnesium sulfate (MgSO4) is the leading eclamptic seizure prophylactic, yet its mechanism of action remains unclear. Here, we hypothesized severe preeclampsia is a state of increased seizure susceptibility due to blood-brain barrier (BBB) disruption and neuroinflammation that lowers seizure threshold. Further, MgSO4 decreases seizure susceptibility by protecting the BBB and preventing neuroinflammation. To model severe preeclampsia, placental ischemia (reduced uteroplacental perfusion pressure; RUPP) was combined with a high cholesterol diet (HC) to cause maternal endothelial dysfunction. RUPP+HC rats developed symptoms associated with severe preeclampsia, including hypertension, oxidative stress, endothelial dysfunction and fetal and placental growth restriction. Seizure threshold was determined by quantifying the amount of pentylenetetrazole (PTZ; mg/kg) required to elicit seizure in RUPP+HC +/- MgSO4 and compared to normal pregnant controls (n = 6/group; gestational day 20). RUPP+HC rats were more sensitive to PTZ with seizure threshold being similar to 65% lower vs. control (12.4 +/- 1.7 vs. 36.7 +/- 3.9 mg/kg PTZ; p < 0.05) that was reversed by MgSO4 (45.7 +/- 8.7 mg/kg PTZ; p < 0.05 vs. RUPP+HC). BBB permeability to sodium fluorescein, measured in-vivo (n = 5-7/group), was increased in RUPP+HC vs. control rats, with more tracer passing into the brain (15.9 +/- 1.0 vs. 12.2 +/- 0.3 counts/gram x 1000; p < 0.05) and was unaffected by MgSO4 (15.6 +/- 1.0 counts/gram x 1000; p < 0.05 vs. controls). In addition, RUPP+HC rats were in a state of neuroinflammation, indicated by 35 +/- 2% of microglia being active compared to 9 +/- 2% in normal pregnancy (p < 0.01; n = 3-8/group). MgSO4 treatment reversed neuroinflammation, reducing microglial activation to 6 +/- 2% (p < 0.01 vs. RUPP+HC). Overall, RUPP+HC rats were in a state of augmented seizure susceptibility potentially due to increased BBB permeability and neuroinflammation. MgSO4 treatment reversed this, increasing seizure threshold and decreasing neuroinflammation, without affecting BBB permeability. Thus, reducing neuroinflammation may be one mechanism by which MgSO4 prevents eclampsia during severe preeclampsia.	[Johnson, Abbie Chapman; Tremble, Sarah M.; Chan, Siu-Lung; Nagle, Keith J.; Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA; [Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Moseley, Janae; LaMarca, Babbette] Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA	University of Vermont; University of Vermont; University of Vermont; University of Mississippi; University of Mississippi Medical Center	Cipolla, MJ (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	Marilyn.Cipolla@uvm.edu	Chan, Siu-Lung/I-3023-2019	Chan, Siu-Lung/0000-0001-7564-3287	National Institutes of Health, National Institute of Neurologic Disorders and Stroke grant [RO1 NS045940]; National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement [RO1 NS 045940-06S1]; National Institutes of Health, National Heart Lung and Blood Institute grant [PO1 HL095488]; Totman Medical Research Trust; Preeclampsia Foundation; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R01HD067541]; American Heart Association Fellowship [14PRE18590005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067541] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045940] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurologic Disorders and Stroke grant; National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement; National Institutes of Health, National Heart Lung and Blood Institute grant; Totman Medical Research Trust; Preeclampsia Foundation; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association Fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health, National Institute of Neurologic Disorders and Stroke grant RO1 NS045940 to MJC (URL: http://www.ninds.nih.gov/), National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement RO1 NS 045940-06S1 to MJC (URL: http://www.ninds.nih.gov/), National Institutes of Health, National Heart Lung and Blood Institute grant PO1 HL095488 to MJC (URL: http://www.nhlbi.nih.gov/), Totman Medical Research Trust to MJC (URL: http://www.uvm.edu/medicine/pharmacology/?Page=totman.html&SM=totmansubmenu.html), Preeclampsia Foundation to MJC (URL: http://www.preeclampsia.org/), National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development 1R01HD067541 to BL (URL: http://www.nichd.nih.gov/) and American Heart Association Fellowship 14PRE18590005 to AJ (URL: http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amburgey OA, 2010, HYPERTENSION, V56, P1003, DOI 10.1161/HYPERTENSIONAHA.110.158931; Boulton M, 1996, NEUROPATH APPL NEURO, V22, P325, DOI 10.1111/j.1365-2990.1996.tb01111.x; Boulton M, 1999, AM J PHYSIOL-REG I, V276, pR818, DOI 10.1152/ajpregu.1999.276.3.R818; Cipolla MJ, 2012, HYPERTENSION, V60, P705, DOI 10.1161/HYPERTENSIONAHA.112.198952; Cipolla MJ, 2012, EXP NEUROL, V234, P398, DOI 10.1016/j.expneurol.2012.01.005; Cipolla MJ, 2011, J APPL PHYSIOL, V110, P329, DOI 10.1152/japplphysiol.01159.2010; Donaldson J O, 1994, Adv Neurol, V64, P25; DONALDSON JO, 1994, HYPERTENS PREGNANCY, V13, P115, DOI 10.3109/10641959409009565; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000127; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000128; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002960.pub2; Erickson MA, 2012, BRAIN BEHAV IMMUN, V26, P1085, DOI 10.1016/j.bbi.2012.07.003; Euser AG, 2008, EXP PHYSIOL, V93, P254, DOI 10.1113/expphysiol.2007.039966; Euser AG, 2007, HYPERTENSION, V49, P334, DOI 10.1161/01.HYP.0000255791.54655.29; Euser AG, 2009, STROKE, V40, P1169, DOI 10.1161/STROKEAHA.108.527788; Fawcett WJ, 1999, BRIT J ANAESTH, V83, P302, DOI 10.1093/bja/83.2.302; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; GALLERY EDM, 1979, Q J MED, V48, P593; Gao F, 2013, J SURG RES, V184, P944, DOI 10.1016/j.jss.2013.03.034; Gojnic M, 2004, Clin Exp Obstet Gynecol, V31, P209; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; HONGER PE, 1968, SCAND J CLIN LAB INV, V21, P3, DOI 10.3109/00365516809076969; HONGER PE, 1968, SCAND J CLIN LAB INV, V22, P177, DOI 10.3109/00365516809166484; Huang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089333; Janzarik WG, 2014, HYPERTENSION, V63, P161, DOI 10.1161/HYPERTENSIONAHA.113.01667; Johnson AC, 2014, REPROD SCI, V21, p284A; Kaya M, 2004, LIFE SCI, V76, P201, DOI 10.1016/j.lfs.2004.07.012; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Li J, 2012, AM J PHYSIOL-HEART C, V303, pH1, DOI 10.1152/ajpheart.00117.2012; Lin CY, 2010, BRIT J ANAESTH, V104, P44, DOI 10.1093/bja/aep336; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi Nicola, 2011, Cardiovasc Psychiatry Neurol, V2011, P482415, DOI 10.1155/2011/482415; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; MCCARTNEY CP, 1971, AM J OBSTET GYNECOL, V111, P580, DOI 10.1016/0002-9378(71)90474-1; Minshall R. D., 2006, V176, P107; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Olson DM, 2001, PEDIATRICS, V108, P163, DOI 10.1542/peds.108.1.163; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Marrone LCP, 2014, J STROKE CEREBROVASC, V23, P2075, DOI 10.1016/j.jstrokecerebrovasdis.2014.03.012; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Rochelson B, 2007, J REPROD IMMUNOL, V73, P101, DOI 10.1016/j.jri.2006.06.004; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Schreurs MPH, 2013, REPROD SCI, V20, P391, DOI 10.1177/1933719112459228; Schreurs MPH, 2013, FASEB J, V27, P1254, DOI 10.1096/fj.12-222216; Schwartz RB, 2000, RADIOLOGY, V217, P371, DOI 10.1148/radiology.217.2.r00nv44371; Sherman RW, 2002, BRIT J ANAESTH, V89, P687, DOI 10.1093/bja/aef247; Sholook MM, 2007, AM J PHYSIOL-HEART C, V293, pH2080, DOI 10.1152/ajpheart.00667.2007; SQUIRES RF, 1984, LIFE SCI, V35, P1439, DOI 10.1016/0024-3205(84)90159-0; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Thoresen M, 1997, ELECTROEN CLIN NEURO, V102, P152, DOI 10.1016/S0921-884X(96)96509-1; van Veen TR, 2013, OBSTET GYNECOL, V122, P1064, DOI 10.1097/AOG.0b013e3182a93fb5; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Warrington JP, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12134; Witlin AG, 2000, AM J OBSTET GYNECOL, V182, P607, DOI 10.1067/mob.2000.104224; Zeeman GG, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P227, DOI 10.1016/B978-0-12-374213-1.00013-6; Zeeman GG, 2004, AM J OBSTET GYNECOL, V190, P714, DOI 10.1016/j.ajog.2003.09.015; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	65	69	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113670	10.1371/journal.pone.0113670	http://dx.doi.org/10.1371/journal.pone.0113670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409522	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200142
J	Johnson, JS; Reeder, DM; McMichael, JW; Meierhofer, MB; Stern, DWF; Lumadue, SS; Sigler, LE; Winters, HD; Vodzak, ME; Kurta, A; Kath, JA; Field, KA				Johnson, Joseph S.; Reeder, DeeAnn M.; McMichael, James W., III; Meierhofer, Melissa B.; Stern, Daniel W. F.; Lumadue, Shayne S.; Sigler, Lauren E.; Winters, Harrison D.; Vodzak, Megan E.; Kurta, Allen; Kath, Joseph A.; Field, Kenneth A.			Host, Pathogen, and Environmental Characteristics Predict White-Nose Syndrome Mortality in Captive Little Brown Myotis (Myotis lucifugus)	PLOS ONE			English	Article							MAMMALIAN HIBERNATION; ENERGY AVAILABILITY; EMERGING DISEASE; METABOLIC-RATE; BATS; DESTRUCTANS; GEOMYCES; POPULATIONS; RESPONSES; AROUSALS	An estimated 5.7 million or more bats died in North America between 2006 and 2012 due to infection with the fungus Pseudogymnoascus destructans (Pd) that causes white-nose syndrome (WNS) during hibernation. The behavioral and physiological changes associated with hibernation leave bats vulnerable to WNS, but the persistence of bats within the contaminated regions of North America suggests that survival might vary predictably among individuals or in relation to environmental conditions. To investigate variables influencing WNS mortality, we conducted a captive study of 147 little brown myotis (Myotis lucifugus) inoculated with 0, 500, 5 000, 50 000, or 500 000 Pd conidia and hibernated for five months at either 4 or 10 degrees C. We found that female bats were significantly more likely to survive hibernation, as were bats hibernated at 4 degrees C, and bats with greater body condition at the start of hibernation. Although all bats inoculated with Pd exhibited shorter torpor bouts compared to controls, a characteristic of WNS, only bats inoculated with 500 conidia had significantly lower survival odds compared to controls. These data show that host and environmental characteristics are significant predictors of WNS mortality, and that exposure to up to 500 conidia is sufficient to cause a fatal infection. These results also illustrate a need to quantify dynamics of Pd exposure in free-ranging bats, as dynamics of WNS produced in captive studies inoculating bats with several hundred thousand conidia may differ from those in the wild.	[Johnson, Joseph S.; Reeder, DeeAnn M.; McMichael, James W., III; Meierhofer, Melissa B.; Stern, Daniel W. F.; Lumadue, Shayne S.; Sigler, Lauren E.; Winters, Harrison D.; Vodzak, Megan E.; Field, Kenneth A.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Kurta, Allen] Eastern Michigan Univ, Dept Biol, Ypsilanti, MI 48197 USA; [Kath, Joseph A.] Illinois Dept Nat Resources, Springfield, IL USA	Bucknell University; Eastern Michigan University	Field, KA (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	kfield@bucknell.edu	Meierhofer, Melissa/AAS-3473-2021	Meierhofer, Melissa/0000-0003-2384-1999; Field, Kenneth/0000-0001-7417-4386; Reeder, DeeAnn/0000-0001-8651-2012	United States Fish and Wildlife Service [F12AP01210]; Woodtiger Foundation	United States Fish and Wildlife Service(US Fish & Wildlife Service); Woodtiger Foundation	Funding for this project was provided by the United States Fish and Wildlife Service grant F12AP01210 (DMR and KAF) and the Woodtiger Foundation (DMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blehert DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002779; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Brock Fenton M. B., 1970, Contr. Life Sci. Div. R. Ont. Mus., V77, P1; Brownlee-Bouboulis SA, 2013, J WILDLIFE DIS, V49, P850, DOI 10.7589/2012-10-242; BUCHANAN GD, 1987, AM J ANAT, V178, P335, DOI 10.1002/aja.1001780405; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chitarra GS, 2004, APPL ENVIRON MICROB, V70, P2823, DOI 10.1128/AEM.70.5.2823-2829.2004; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Dixon MD, 2011, J MAMMAL, V92, P1343, DOI 10.1644/10-MAMM-A-426.1; Dunbar MB, 2010, J COMP PHYSIOL B, V180, P885, DOI 10.1007/s00360-010-0457-y; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; GUSTAFSON AW, 1976, BIOL REPROD, V15, P9, DOI 10.1093/biolreprod/15.1.9; Herrero-Garcia E, 2011, FUNGAL BIOL-UK, V115, P393, DOI 10.1016/j.funbio.2011.02.005; HOLM S, 1979, SCAND J STAT, V6, P65; Humphrey SR, 1976, POPULATION ECOLOGY L; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Jonasson KA, 2012, J EXP BIOL, V215, P2141, DOI 10.1242/jeb.066514; Jonasson KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021061; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Luis AD, 2006, FUNCT ECOL, V20, P471, DOI 10.1111/j.1365-2435.2006.01119.x; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Moore MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058976; Muller LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242; Norquay KJO, 2013, J MAMMAL, V94, P506, DOI 10.1644/12-MAMM-A-065.1; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reeder DeeAnn M., 2013, P413; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; SPEAKMAN JR, 1986, J ZOOL, V210, P515; Storey KR, 2010, TOP CURR GENET, V21, P227, DOI 10.1007/978-3-642-12422-8_13; THOMAS DW, 1992, PHYSIOL ZOOL, V65, P443, DOI 10.1086/physzool.65.2.30158262; THOMAS DW, 1990, J EXP BIOL, V149, P395; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Turner Gregory G., 2011, Bat Research News, V52, P13; TWENTE JW, 1985, CAN J ZOOL, V63, P2955, DOI 10.1139/z85-443; van der Plank J.E., 1963, PLANT DIS, P1; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076	52	31	31	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112502	10.1371/journal.pone.0112502	http://dx.doi.org/10.1371/journal.pone.0112502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409028	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200023
J	Lafaurie, M; De Sousa, B; Ponscarme, D; Lapidus, N; Daudon, M; Weiss, L; Rioux, C; Fourn, E; Katlama, C; Molina, JM				Lafaurie, Matthieu; De Sousa, Barbara; Ponscarme, Diane; Lapidus, Nathanael; Daudon, Michel; Weiss, Laurence; Rioux, Christophe; Fourn, Erwan; Katlama, Christine; Molina, Jean-Michel			Clinical Features and Risk Factors for Atazanavir (ATV)-Associated Urolithiasis: A Case-Control Study	PLOS ONE			English	Article							RITONAVIR-BOOSTED ATAZANAVIR; HIV-INFECTED PATIENT; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; RENAL STONES; EFFICACY; SAFETY; COMBINATION; DARUNAVIR	Objectives: Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis have not been fully investigated. Methods: We reviewed all cases of ATV-containing urolithiasis identified by infrared spectrophotometry among HIV-infected patients over a 5-year period to describe their clinical features and outcome. A case-control study was performed to identify risk factors associated with ATV-associated urolithiasis using univariate and multivariate logistic regression analyses. Results: 30 cases of ATV-associated urolithiasis were analyzed. Patients were mostly men (87%), median age: 45.5 years, median CD4 cell count: 443 cells/mu L and 97% had plasma HIV RNA level <50 cp/mL. Median time between the initiation of ATV-containing regimen and the diagnosis of urolithiasis was 3.1 years. Patients presented with flank pain in 90% and macroscopic hematuria in 82.6%, 34% had renal dysfunction and 44.8% needed ureteroscopic treatment. In univariate analysis, chronic hepatitis C, a history of urolithiasis, prior use of indinavir, ATV duration, undetectable plasma HIV RNA, use of ritonavir as a booster and serum free bilirubin level were associated with ATV-urolithiasis. Multivariate models retained serum free bilirubin level (OR: 2.31, p < 0.02) and either ATV duration (OR: = 1.42, p = <0.03) or a history of urolithiasis (OR = 4.79, p < 0.02) when adjusting on serum free bilirubin level as risk factors associated with urolithiasis. Conclusions: ATV-containing urolithiasis are associated with frank clinical symptoms and may require surgical intervention. A high serum bilirubin level, a long exposure to ATV and a history of urolithiasis are risk factors for this rare adverse event.	[Lafaurie, Matthieu; De Sousa, Barbara; Ponscarme, Diane; Molina, Jean-Michel] St Louis Hosp, Dept Infect Dis, Paris, France; [Lafaurie, Matthieu; De Sousa, Barbara; Ponscarme, Diane; Molina, Jean-Michel] Univ Paris 07, Sorbonne Paris Cite, INSERM, U941, Paris, France; [Lapidus, Nathanael] Hop St Louis, AP HP, Serv Biostat & Informat Med, Paris, France; [Lapidus, Nathanael] INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Lapidus, Nathanael] Univ Paris 06, Sorbonne Univ, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Daudon, Michel] Tenon Hosp, Lab Clin Physiol, Paris, France; [Weiss, Laurence] Georges Pompidou European Hosp, AP HP, Serv Clin Immunol, Paris, France; [Weiss, Laurence] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Rioux, Christophe] Hop Xavier Bichat, Dept Infect Dis, Paris, France; [Fourn, Erwan] Hop Bicetre, Dept Internal Med, Le Kremlin Bicetre, France; [Katlama, Christine] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Lafaurie, M (corresponding author), St Louis Hosp, Dept Infect Dis, Paris, France.	matthieu.lafaurie@sls.aphp.fr	Lapidus, N./AAT-4479-2020; WEISS, Laurence/B-1373-2012	Lapidus, N./0000-0002-4837-1068; 				Anderson PL, 2007, AIDS, V21, P1060, DOI 10.1097/QAD.0b013e3280c56ae1; Bristol-Myers Squibb, 2011, REYAT AT SULF FULL P; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Couzigou C, 2007, CLIN INFECT DIS, V45, pE105, DOI 10.1086/521930; de Lastours V, 2013, J ANTIMICROB CHEMOTH, V68, P1850, DOI 10.1093/jac/dkt125; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Hirsch MS, 2003, CLIN INFECT DIS, V37, P1119, DOI 10.1086/378063; Izzedine H, 2007, AIDS, V21, P2357, DOI 10.1097/QAD.0b013e3282f17503; Johnson DH, 2014, PHARMACOGENET GENOM, V24, P195, DOI 10.1097/FPC.0000000000000034; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Moriyama Y, 2008, UROL RES, V36, P275, DOI 10.1007/s00240-008-0147-3; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077268; Pacanowski J, 2006, AIDS, V20, P2131, DOI 10.1097/01.aids.0000247571.88256.90; Pavie J, 2011, J ANTIMICROB CHEMOTH, V66, P2372, DOI 10.1093/jac/dkr316; Rockwood N, 2011, AIDS, V25, P1671, DOI 10.1097/QAD.0b013e32834a1cd6; Smith DE, 2006, HIV CLIN TRIALS, V7, P34, DOI 10.1310/0KX0-H9VH-99EE-5D0L	16	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112836	10.1371/journal.pone.0112836	http://dx.doi.org/10.1371/journal.pone.0112836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409506	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200042
J	Nassour, H; Dubreuil, JD				Nassour, Hassan; Dubreuil, J. Daniel			Escherichia coli STb Enterotoxin Dislodges Claudin-1 from Epithelial Tight Junctions	PLOS ONE			English	Article							HEAT-STABLE ENTEROTOXIN; PROTEIN-KINASE-C; BARRIER FUNCTION; BIOCHEMICAL-CHARACTERIZATION; LABILE ENTEROTOXIN; COLORECTAL-CANCER; T84 CELLS; TOXIN; PHOSPHORYLATION; PERMEABILITY	Enterotoxigenic Escherichia coli produce various heat-labile and heat-stable enterotoxins. STb is a low molecular weight heat-resistant toxin responsible for diarrhea in farm animals, mainly young pigs. A previous study demonstrated that cells having internalized STb toxin induce epithelial barrier dysfunction through changes in tight junction (TJ) proteins. These modifications contribute probably to the diarrhea observed. To gain insight into the mechanism of increased intestinal permeability following STb exposure we treated human colon cells (T84) with purified STb toxin after which cells were harvested and proteins extracted. Using a 1% Nonidet P-40-containing solution we investigated the distribution of claudin-1, a major structural and functional TJ protein responsible for the epithelium impermeability, between membrane (NP40-insoluble) and the cytoplasmic (NP-40 soluble) location. Using immunoblot and confocal microscopy, we observed that treatment of T84 cell monolayers with STb induced redistribution of claudin-1. After 24 h, cells grown in Ca++-free medium treated with STb showed about 40% more claudin-1 in the cytoplasm compare to the control. Switching from Ca++-free to Ca++-enriched medium (1.8 mM) increased the dislodgement rate of claudin-1 as comparable quantitative delocalization was observed after only 6 h. Medium supplemented with the same concentration of Mg++ or Zn++ did not affect the dislodgement rate compared to the Ca++-free medium. Using anti-phosphoserine and anti-phosphothreonine antibodies, we observed that the loss of membrane claudin-1 was accompanied by dephosphorylation of this TJ protein. Overall, our findings showed an important redistribution of claudin-1 in cells treated with STb toxin. The loss of phosphorylated TJ membrane claudin-1 is likely to be involved in the increased permeability observed. The mechanisms by which these changes are brought about remain to be elucidated.	[Nassour, Hassan; Dubreuil, J. Daniel] Univ Montreal, Fac Vet Med, GREMIP, Montreal, PQ, Canada	Universite de Montreal	Dubreuil, JD (corresponding author), Univ Montreal, Fac Vet Med, GREMIP, Montreal, PQ, Canada.	daniel.dubreuil@umontreal.ca	Dubreuil, Jean-Daniel/A-5929-2015		Natural Sciences and Engineering Council of Canada (NSERC) [139070]	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Council of Canada (NSERC) Discovery Grant (139070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Aono S, 2008, EXP CELL RES, V314, P3326, DOI 10.1016/j.yexcr.2008.08.012; ARRIAGA YL, 1995, INFECT IMMUN, V63, P4715, DOI 10.1128/IAI.63.12.4715-4720.1995; Balkovetz DF, 2003, MICROBES INFECT, V5, P613, DOI 10.1016/S1286-4579(03)00089-3; Banan A, 2005, J PHARMACOL EXP THER, V313, P962, DOI 10.1124/jpet.104.083428; Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Chao KL, 1997, INFECT IMMUN, V65, P3209, DOI 10.1128/IAI.65.8.3209-3217.1997; D'Souza T, 2007, EXP CELL RES, V313, P3364, DOI 10.1016/j.yexcr.2007.06.026; de Oliveira SS, 2005, FEBS LETT, V579, P6179, DOI 10.1016/j.febslet.2005.09.091; de Sousa CP, 2001, INT J MED MICROBIOL, V291, P15, DOI 10.1078/1438-4221-00097; DREYFUS LA, 1993, P NATL ACAD SCI USA, V90, P3202, DOI 10.1073/pnas.90.8.3202; Dubreuil JD, 2008, FEMS MICROBIOL LETT, V278, P137, DOI 10.1111/j.1574-6968.2007.00967.x; Erume J, 2013, VET MICROBIOL, V161, P315, DOI 10.1016/j.vetmic.2012.07.048; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Fujibe M, 2004, EXP CELL RES, V295, P36, DOI 10.1016/j.yexcr.2003.12.014; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Harville BA, 1996, PEPTIDES, V17, P363, DOI 10.1016/0196-9781(96)00033-2; HARVILLE BA, 1995, INFECT IMMUN, V63, P745, DOI 10.1128/IAI.63.3.745-750.1995; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kreisberg RB, 2011, AM J TROP MED HYG, V84, P451, DOI 10.4269/ajtmh.2011.10-0445; Krug SM, 2009, BIOPHYS J, V97, P2202, DOI 10.1016/j.bpj.2009.08.003; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Labrie V, 2001, MICROBIOL-SGM, V147, P3141, DOI 10.1099/00221287-147-11-3141; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041041; Mukiza CN, 2013, INFECT IMMUN, V81, P2819, DOI 10.1128/IAI.00455-13; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nakashima R, 2013, VET IMMUNOL IMMUNOP, V152, P78, DOI 10.1016/j.vetimm.2012.09.026; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; Philpott DJ, 1996, AM J PHYSIOL-GASTR L, V270, pG634, DOI 10.1152/ajpgi.1996.270.4.G634; Philpott DJ, 1998, INFECT IMMUN, V66, P1680, DOI 10.1128/IAI.66.4.1680-1687.1998; Puthenedam M, 2007, CELL BIOL INT, V31, P836, DOI 10.1016/j.cellbi.2007.01.036; Ricardo R., 2008, J VIS EXP; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Rousset E, 1998, INFECT IMMUN, V66, P5650, DOI 10.1128/IAI.66.12.5650-5658.1998; Roxas JL, 2010, LAB INVEST, V90, P1152, DOI 10.1038/labinvest.2010.91; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Savarino SJ, 1996, J INFECT DIS, V173, P1019, DOI 10.1093/infdis/173.4.1019; Schmidt E, 2007, FEBS LETT, V581, P2974, DOI 10.1016/j.febslet.2007.05.051; Simonovic I, 2001, INFECT IMMUN, V69, P5679, DOI 10.1128/IAI.69.9.5679-5688.2001; Sjo A, 2003, BIOSCIENCE REP, V23, P87, DOI 10.1023/A:1025524323842; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; STEVENSON BR, 1988, MOL CELL BIOCHEM, V83, P129; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Suzuki H, 2012, ANN NY ACAD SCI, V1258, P65, DOI 10.1111/j.1749-6632.2012.06503.x; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Syed HC, 2012, MICROB PATHOGENESIS, V53, P147, DOI 10.1016/j.micpath.2012.06.003; Toriano R, 2001, AM J PHYSIOL-GASTR L, V281, pG816, DOI 10.1152/ajpgi.2001.281.3.G816; Turner SM, 2006, FEMS MICROBIOL LETT, V263, P10, DOI 10.1111/j.1574-6968.2006.00401.x; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; VISWESWARIAH SS, 1992, MICROB PATHOGENESIS, V12, P209, DOI 10.1016/0882-4010(92)90055-S; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	58	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113273	10.1371/journal.pone.0113273	http://dx.doi.org/10.1371/journal.pone.0113273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409315	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200090
J	Sugimoto, H; Konno, S; Nomoto, N; Nakazora, H; Murata, M; Kitazono, H; Imamura, T; Inoue, M; Sasaki, M; Fuse, A; Hagiwara, W; Kobayashi, M; Fujioka, T				Sugimoto, Hideki; Konno, Shingo; Nomoto, Nobuatsu; Nakazora, Hiroshi; Murata, Mayumi; Kitazono, Hisao; Imamura, Tomomi; Inoue, Masashi; Sasaki, Miyuki; Fuse, Akihisa; Hagiwara, Wataru; Kobayashi, Mari; Fujioka, Toshiki			The Long-Term Effects of Pitavastatin on Blood Lipids and Platelet Activation Markers in Stroke Patients: Impact of the Homocysteine Level	PLOS ONE			English	Article							ATHEROSCLEROSIS; JAPANESE; STATINS; CELLS; RISK	To examine the impact of the plasma homocysteine level on the anti-atherosclerotic effects of pitavastatin treatment, we retrospectively examined 59 patients who had a history of stroke and had been prescribed pitavastatin for the treatment of dyslipidemia at the Neurology department of Toho University Ohashi Medical Center Hospital. The patients were classified into two groups according to their homocysteine levels. Carotid artery plaque progression was determined before and after pitavastatin treatment. Plasma levels of high-sensitivity C-reactive protein, platelet molecular markers, and von Willebrand factor were measured. Pitavastatin treatment had beneficial effects on the lipid profiles of these patients and slowed atherosclerosis progression. These effects were observed in both the high and low homocysteine groups. Proactive lipid intervention using pitavastatin may inhibit the progression of atherosclerosis and contribute to secondary prevention of stroke in high-risk patients. We conclude that this statin could inhibit progression at any stage of disease and should therefore be proactively administered to these patient groups, regardless of disease severity.	[Sugimoto, Hideki; Konno, Shingo; Nomoto, Nobuatsu; Nakazora, Hiroshi; Murata, Mayumi; Kitazono, Hisao; Imamura, Tomomi; Inoue, Masashi; Sasaki, Miyuki; Fuse, Akihisa; Hagiwara, Wataru; Kobayashi, Mari; Fujioka, Toshiki] Toho Univ Ohashi, Dept Internal Med, Div Neurol, Tokyo, Japan	Toho University	Sugimoto, H (corresponding author), Toho Univ Ohashi, Dept Internal Med, Div Neurol, Tokyo, Japan.	sugi-h@oha.toho-u.ac.jp						Adachi H, 2002, STROKE, V33, P2177, DOI 10.1161/01.STR.0000026861.18199.89; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Bogdanski P, 2012, CLIN CHEM LAB MED, V50, P1107, DOI 10.1515/cclm-2011-0856; CEJKA J, 1982, CLIN CHEM, V28, P1356; Cui RZ, 2008, ATHEROSCLEROSIS, V198, P412, DOI 10.1016/j.atherosclerosis.2007.09.029; Iso H, 2004, CIRCULATION, V109, P2766, DOI 10.1161/01.CIR.0000131942.77635.2D; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Koshiyama H, 2008, J ATHEROSCLER THROMB, V15, P345, DOI 10.5551/jat.E581; Lee M, 2010, STROKE, V41, P1205, DOI 10.1161/STROKEAHA.109.573410; Li H, 2002, CIRCULATION, V105, P1037, DOI 10.1161/hc0902.104713; Lin CP, 2008, EUR J CLIN INVEST, V38, P106, DOI 10.1111/j.1365-2362.2007.01911.x; Maeda K, 2005, ATHEROSCLEROSIS, V181, P87, DOI 10.1016/j.atherosclerosis.2004.12.044; Milionis HJ, 2003, J CLIN PHARMACOL, V43, P825, DOI 10.1177/0091270003255920	13	2	2	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113766	10.1371/journal.pone.0113766	http://dx.doi.org/10.1371/journal.pone.0113766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409188	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200154
J	Kerfahi, D; Tripathi, BM; Lee, J; Edwards, DP; Adams, JM				Kerfahi, Dorsaf; Tripathi, Binu M.; Lee, Junghoon; Edwards, David P.; Adams, Jonathan M.			The Impact of Selective-Logging and Forest Clearance for Oil Palm on Fungal Communities in Borneo	PLOS ONE			English	Article							SOIL BACTERIAL COMMUNITIES; HUMID TROPICAL FORESTS; RAIN-FOREST; ECTOMYCORRHIZAL FUNGI; AGRICULTURAL LAND; SOUTHEAST-ASIA; LOGGED FORESTS; BETA-DIVERSITY; SPOROCARP DNA; BIODIVERSITY	Tropical forests are being rapidly altered by logging, and cleared for agriculture. Understanding the effects of these land use changes on soil fungi, which play vital roles in the soil ecosystem functioning and services, is a major conservation frontier. Using 454-pyrosequencing of the ITS1 region of extracted soil DNA, we compared communities of soil fungi between unlogged, once-logged, and twice-logged rainforest, and areas cleared for oil palm, in Sabah, Malaysia. Overall fungal community composition differed significantly between forest and oil palm plantation. The OTU richness and Chao 1 were higher in forest, compared to oil palm plantation. As a proportion of total reads, Basidiomycota were more abundant in forest soil, compared to oil palm plantation soil. The turnover of fungal OTUs across space, true beta-diversity, was also higher in forest than oil palm plantation. Ectomycorrhizal (EcM) fungal abundance was significantly different between land uses, with highest relative abundance (out of total fungal reads) observed in unlogged forest soil, lower abundance in logged forest, and lowest in oil palm. In their entirety, these results indicate a pervasive effect of conversion to oil palm on fungal community structure. Such wholesale changes in fungal communities might impact the long-term sustainability of oil palm agriculture. Logging also has more subtle long term effects, on relative abundance of EcM fungi, which might affect tree recruitment and nutrient cycling. However, in general the logged forest retains most of the diversity and community composition of unlogged forest.	[Kerfahi, Dorsaf; Tripathi, Binu M.; Adams, Jonathan M.] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Kerfahi, Dorsaf; Lee, Junghoon] Seoul Natl Univ, Interdisciplinary Program Bioengn, Sch Chem & Biol Engn, Seoul, South Korea; [Edwards, David P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Seoul National University (SNU); Seoul National University (SNU); University of Sheffield	Edwards, DP (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	david.edwards@sheffield.ac.uk; foundinkualalumpur@yahoo.com	Edwards, David/AAC-5091-2019; Tripathi, Binu M/J-3075-2015	Edwards, David/0000-0001-8562-3853; Tripathi, Binu M/0000-0002-7848-0206; Adams, Jonathan/0000-0001-7954-8332	National Research Foundation grant, Ministry of Education, Science and Technology, South Korea [NRF-2013-031400]	National Research Foundation grant, Ministry of Education, Science and Technology, South Korea	This project was funded by a National Research Foundation grant (NRF-2013-031400), Ministry of Education, Science and Technology, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2010, GLOBAL FOREST RESOUR; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Ba AM, 2012, MYCORRHIZA, V22, P1, DOI 10.1007/s00572-011-0415-x; Baraloto C, 2012, J APPL ECOL, V49, P861, DOI 10.1111/j.1365-2664.2012.02164.x; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Blaser J., 2011, INT TROP TIMBER ORG, V38; Brearley FQ, 2012, BIOTROPICA, V44, P637, DOI 10.1111/j.1744-7429.2012.00862.x; Bridge PD, 2009, FUNGAL ECOL, V2, P66, DOI 10.1016/j.funeco.2008.10.008; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Cleary DFR, 2007, ECOL APPL, V17, P1184, DOI 10.1890/05-0878; CORNEJO FH, 1994, OIKOS, V70, P183, DOI 10.2307/3545629; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Edwards FA, 2014, ANIM CONSERV, V17, P163, DOI 10.1111/acv.12074; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geml J, 2010, NEW PHYTOL, V187, P494, DOI 10.1111/j.1469-8137.2010.03283.x; Geml J, 2009, MOL ECOL, V18, P2213, DOI 10.1111/j.1365-294X.2009.04192.x; Ghazoul J, 2002, BIODIVERS CONSERV, V11, P521, DOI 10.1023/A:1014812701423; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Hamer KC, 2003, J APPL ECOL, V40, P150, DOI 10.1046/j.1365-2664.2003.00783.x; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Haug I, 2005, NEW PHYTOL, V165, P923, DOI 10.1111/j.1469-8137.2004.01284.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kuramae EE, 2013, FEMS MICROBIOL ECOL, V84, P519, DOI 10.1111/1574-6941.12080; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lee-Cruz L, 2013, APPL ENVIRON MICROB, V79, P7290, DOI 10.1128/AEM.02541-13; Liedloff A. C., 1999, MANTEL NONPARAMETRIC; Lupatini M, 2013, WORLD J MICROB BIOT, V29, P223, DOI 10.1007/s11274-012-1174-3; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martin F, 2011, NEW PHYTOL, V190, P818, DOI 10.1111/j.1469-8137.2011.03688.x; McGrath DA, 2001, ECOSYSTEMS, V4, P625, DOI 10.1007/s10021-001-0033-0; McGuire KL, 2014, MICROBIAL ECOL; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Moyersoen B, 2001, NEW PHYTOL, V150, P591, DOI 10.1046/j.1469-8137.2001.00125.x; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Natarajan K, 2005, CURR SCI INDIA, V88, P1893; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Oros-Sichler M, 2006, J MICROBIOL METH, V65, P63, DOI 10.1016/j.mimet.2005.06.014; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Piesse J, 2009, FOOD POLICY, V34, P119, DOI 10.1016/j.foodpol.2009.01.001; Ramage BS, 2013, CONSERV BIOL, V27, P364, DOI 10.1111/cobi.12004; Riviere T, 2007, MYCORRHIZA, V17, P415, DOI 10.1007/s00572-007-0117-6; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Whitmore TC, 1990, INTRO TROPICAL RAIN; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Woodcock P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060756; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Wu TH, 2007, SOIL BIOL BIOCHEM, V39, P1139, DOI 10.1016/j.soilbio.2006.11.024; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500	69	34	35	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111525	10.1371/journal.pone.0111525	http://dx.doi.org/10.1371/journal.pone.0111525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405609	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300012
J	Sun, Q; Tarnberg, M; Zhao, LB; Lundborg, CS; Song, YY; Grape, M; Nilsson, M; Tomson, G; Nilsson, LE				Sun, Qiang; Tarnberg, Maria; Zhao, Lingbo; Lundborg, Cecilia Stalsby; Song, Yanyan; Grape, Malin; Nilsson, Maud; Tomson, Goran; Nilsson, Lennart E.			Varying High Levels of Faecal Carriage of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in Rural Villages in Shandong, China: Implications for Global Health	PLOS ONE			English	Article							ESCHERICHIA-COLI; RISK-FACTORS; ANTIBIOTIC-RESISTANCE; NONHOSPITALIZED PATIENTS; WESTERN CHINA; PREVALENCE; COMMUNITY; EPIDEMIOLOGY; PERSISTENCE; INFECTIONS	Antibiotic resistance is considered a major threat to global health and is affected by many factors, of which antibiotic use is probably one of the more important. Other factors include hygiene, crowding and travel. The rapid resistance spread in Gram-negative bacteria, in particular extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae (ESBL-E), is a global challenge, leading to increased mortality, morbidity and health systems costs worldwide. Knowledge about resistance in commensal flora is limited, including in China. Our aim was to establish the faecal carriage rates of ESBL-E and find its association with known and suspected risk factors in rural residents of all ages in three socio-economically different counties in the Shandong Province, China. Faecal samples and risk-factor information (questionnaire) were collected in 2012. ESBL-E carriage was screened using ChromID ESBL agar. Risk factors were analysed using standard statistical methods. Data from 1000 individuals from three counties and in total 18 villages showed a high and varying level of ESBL-E carriage. Overall, 42% were ESBL-E carriers. At county level the carriage rates were 49%, 45% and 31%, respectively, and when comparing individual villages (n = 18) the rate varied from 22% to 64%. The high level of ESBL-E carriage among rural residents in China is an indication of an exploding global challenge in the years to come as resistance spreads among bacteria and travels around the world with the movement of people and freight. A high carriage rate of ESBL-E increases the risk of infection with multi-resistant bacteria, and thus the need for usage of last resort antibiotics, such as carbapenems and colistin, in the treatment of common infections.	[Sun, Qiang; Zhao, Lingbo] Shandong Univ, Ctr Hlth Management & Policy, Key Lab Hlth Econ & Policy Res, Minist Hlth, Jinan, Shandong, Peoples R China; [Tarnberg, Maria; Nilsson, Maud; Nilsson, Lennart E.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lundborg, Cecilia Stalsby; Tomson, Goran] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden; [Song, Yanyan] Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China; [Grape, Malin] Publ Hlth Agcy Sweden, Antibiot & Infect Control Unit, Solna, Sweden; [Tomson, Goran] Karolinska Inst, MMC, Dept Learning Informat Management Eth, Stockholm, Sweden	Shandong University; Linkoping University; Karolinska Institutet; Shandong University; Public Health Agency of Sweden; Karolinska Institutet	Sun, Q (corresponding author), Shandong Univ, Ctr Hlth Management & Policy, Key Lab Hlth Econ & Policy Res, Minist Hlth, Jinan, Shandong, Peoples R China.	qiangs@sdu.edu.ch		Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Tomson, Goran/0000-0001-9222-3604	National Nature Science Foundation of China [71073098]; Swedish International Development Cooperation Agency [2010-001861]; Swedish Research Council [2013-46520-109134-94]; China Medical Board [11-068]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish International Development Cooperation Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); China Medical Board	This work was supported by the National Nature Science Foundation of China (71073098); the Swedish International Development Cooperation Agency (2010-001861); The Swedish Research Council (2013-46520-109134-94); and China Medical Board (11-068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean DC, 2005, J ANTIMICROB CHEMOTH, V56, P962, DOI 10.1093/jac/dki332; Calbo E, 2006, J ANTIMICROB CHEMOTH, V57, P780, DOI 10.1093/jac/dkl035; Cars O, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1438; Coast J, 2003, DRUG DISCOV TODAY, V8, P1, DOI 10.1016/S1359-6446(02)02542-4; Colodner R, 2004, EUR J CLIN MICROBIOL, V23, P163, DOI 10.1007/s10096-003-1084-2; Dong LF, 2011, FAM PRACT, V28, P63, DOI 10.1093/fampra/cmq077; Doumith M, 2012, J ANTIMICROB CHEMOTH, V67, P878, DOI 10.1093/jac/dkr553; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Ghidan A, 2008, ACTA MICROBIOL IMM H, V55, P409, DOI 10.1556/AMicr.55.2008.4.5; Health and Family Planning Commission of Shandong Province, 2013, SHAND HLTH STAT YB; Heddini A, 2009, LANCET, V373, P30, DOI 10.1016/S0140-6736(08)61956-X; Hu YY, 2013, APPL ENVIRON MICROB, V79, P5988, DOI 10.1128/AEM.01740-13; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Li B, 2011, SCAND J INFECT DIS, V43, P170, DOI 10.3109/00365548.2010.538856; Lim SK, 2006, MICROB DRUG RESIST, V12, P136, DOI 10.1089/mdr.2006.12.136; Lo WU, 2010, J INFECTION, V60, P286, DOI 10.1016/j.jinf.2010.02.002; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Nordberg P., 2005, International Journal of Risk & Safety in Medicine, V17, P117; Rahman EMA, 2011, J INVEST MED, V59, P1284, DOI 10.2130/JIM.0b013e318238748e; Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004; Rodriguez-Bano J, 2008, J ANTIMICROB CHEMOTH, V62, P1142, DOI 10.1093/jac/dkn293; Stromdahl H, 2011, EUR J CLIN MICROBIOL, V30, P1159, DOI 10.1007/s10096-011-1202-5; Sundqvist M, 2010, J ANTIMICROB CHEMOTH, V65, P350, DOI 10.1093/jac/dkp387; Tian GB, 2012, J MED MICROBIOL, V61, P233, DOI 10.1099/jmm.0.036806-0; Tian SF, 2008, CAN J MICROBIOL, V54, P781, DOI 10.1139/w08-059; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Yezli S, 2012, INT J ANTIMICROB AG, V40, P389, DOI 10.1016/j.ijantimicag.2012.07.009; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	28	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113121	10.1371/journal.pone.0113121	http://dx.doi.org/10.1371/journal.pone.0113121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405340	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300080
J	Clark, SJ; Houle, B				Clark, Samuel J.; Houle, Brian			Validation, Replication, and Sensitivity Testing of Heckman-Type Selection Models to Adjust Estimates of HIV Prevalence	PLOS ONE			English	Article							BIAS	A recent study using Heckman-type selection models to adjust for non-response in the Zambia 2007 Demographic and Health Survey (DHS) found a large correction in HIV prevalence for males. We aim to validate this finding, replicate the adjustment approach in other DHSs, apply the adjustment approach in an external empirical context, and assess the robustness of the technique to different adjustment approaches. We used 6 DHSs, and an HIV prevalence study from rural South Africa to validate and replicate the adjustment approach. We also developed an alternative, systematic model of selection processes and applied it to all surveys. We decomposed corrections from both approaches into rate change and age-structure change components. We are able to reproduce the adjustment approach for the 2007 Zambia DHS and derive results comparable with the original findings. We are able to replicate applying the approach in several other DHSs. The approach also yields reasonable adjustments for a survey in rural South Africa. The technique is relatively robust to how the adjustment approach is specified. The Heckman selection model is a useful tool for assessing the possibility and extent of selection bias in HIV prevalence estimates from sample surveys.	[Clark, Samuel J.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Clark, Samuel J.; Houle, Brian] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Clark, Samuel J.; Houle, Brian] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Houle, Brian] Australian Natl Univ, Australian Demog & Social Res Inst, Canberra, ACT, Australia	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; University of Witwatersrand; Australian National University	Houle, B (corresponding author), Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA.	brian.houle@anu.edu.au	Clark, Samuel J/A-8419-2009	Clark, Samuel J/0000-0002-4929-6231; Houle, Brian/0000-0003-2157-3118	USAID, through the MEASURE DHS project; University of Colorado Population Center - Eunice Shriver National Institute of Child Health and Human Development [NICHD R21 HD051146]; 'Partnership for Social Science AIDS Research in South Africa's Era of ART Rollout' from the National Institute on Aging (NIA) [R24AG032112]; National Institute of Child Health and Human Development (NICHD) [K01 HD057246]; William and Flora Hewlett Foundation [2006-8377, 2009-4069]; Wellcome Trust; Anglo American Chairmans Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD057246, R24HD042828, R01HD054511, R01HD070936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R24AG032112] Funding Source: NIH RePORTER	USAID, through the MEASURE DHS project(United States Agency for International Development (USAID)); University of Colorado Population Center - Eunice Shriver National Institute of Child Health and Human Development; 'Partnership for Social Science AIDS Research in South Africa's Era of ART Rollout' from the National Institute on Aging (NIA); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); William and Flora Hewlett Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Anglo American Chairmans Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported by USAID, through the MEASURE DHS project, and received funding and administrative support from the University of Colorado Population Center, which is funded by the Eunice Shriver National Institute of Child Health and Human Development (grant NICHD R21 HD051146). The survey study at the Agincourt Health and Demographic Surveillance Site was supported by grant R24AG032112 'Partnership for Social Science AIDS Research in South Africa's Era of ART Rollout' from the National Institute on Aging (NIA). Samuel Clark was partially supported by grant K01 HD057246 from the National Institute of Child Health and Human Development (NICHD). The Agincourt site received partial support from the William and Flora Hewlett Foundation Grants 2006-8377 and 2009-4069, the Wellcome Trust and the Anglo American Chairmans Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2011, EPIDEMIOLOGY, V22, P27, DOI 10.1097/EDE.0b013e3181ffa201; Bushway S, 2007, J QUANT CRIMINOL, V23, P151, DOI 10.1007/s10940-007-9024-4; Central Statistical Office Ministry of Health Tropical Diseases Research Centre University of Zambia, 2009, ZAMB DEM HLTH SURV 2; DUBIN JA, 1989, SOCIOL METHOD RES, V18, P360, DOI 10.1177/0049124189018002006; Floyd S, 2013, AIDS, V27, P233, DOI 10.1097/QAD.0b013e32835848ab; Geneletti S, 2011, EPIDEMIOLOGY, V22, P36, DOI 10.1097/EDE.0b013e3182003276; Gomez-Olive FX, 2013, AIDS CARE, P1; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hogan DR, 2012, SEX TRANSM INFECT, V88, pI17, DOI 10.1136/sextrans-2012-050636; Janssens W, 2009, 13298 AMST I INT DEV; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Ministry of Health and Social Welfare (MOHSW) [Lesotho] and ICF Macro, 2010, LES DEM HLTH SURV 20; MoHSW, 2005, LES DEM HLTH SURV 20; Preston S., 2000, DEMOGRAPHY MEASURING; Reniers G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-163; Vella F, 1998, J HUM RESOUR, V33, P127, DOI 10.2307/146317; WINSHIP C, 1992, ANNU REV SOCIOL, V18, P327, DOI 10.1146/annurev.so.18.080192.001551	18	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112563	10.1371/journal.pone.0112563	http://dx.doi.org/10.1371/journal.pone.0112563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402333	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700054
J	Hahn, ME; McArthur, AG; Karchner, SI; Franks, DG; Jenny, MJ; Timme-Laragy, AR; Stegeman, JJ; Woodin, BR; Cipriano, MJ; Linney, E				Hahn, Mark E.; McArthur, Andrew G.; Karchner, Sibel I.; Franks, Diana G.; Jenny, Matthew J.; Timme-Laragy, Alicia R.; Stegeman, John J.; Woodin, Bruce R.; Cipriano, Michael J.; Linney, Elwood			The Transcriptional Response to Oxidative Stress during Vertebrate Development: Effects of tert-Butylhydroquinone and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin	PLOS ONE			English	Article							ELEMENT SIGNALING PATHWAY; GENE-EXPRESSION PROFILES; ZEBRAFISH DANIO-RERIO; DNA-DAMAGE; MELANOCYTE DIFFERENTIATION; ANTIOXIDANT RESPONSES; TRANSGENIC ZEBRAFISH; LIFE STAGES; NRF2; GLUTATHIONE	Oxidative stress is an important mechanism of chemical toxicity, contributing to teratogenesis and to cardiovascular and neurodegenerative diseases. Developing animals may be especially sensitive to chemicals causing oxidative stress. The developmental expression and inducibility of anti-oxidant defenses through activation of NF-E2-related factor 2 (NRF2) affect susceptibility to oxidants, but the embryonic response to oxidants is not well understood. To assess the response to chemically mediated oxidative stress and how it may vary during development, zebrafish embryos, eleutheroembryos, or larvae at 1, 2, 3, 4, 5, and 6 days post fertilization (dpf) were exposed to DMSO (0.1%), tert-butylhydroquinone (tBHQ; 10 mu M) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 2 nM) for 6 hr. Transcript abundance was assessed by real-time qRT-PCR and microarray. qRT-PCR showed strong (4- to 5-fold) induction of gstp1 by tBHQ as early as 1 dpf. tBHQ also induced gclc (2 dpf), but not sod1, nqo1, or cyp1a. TCDD induced cyp1a but none of the other genes. Microarray analysis showed that 1477 probes were significantly different among the DMSO-, tBHQ-, and TCDD-treated eleutheroembryos at 4 dpf. There was substantial overlap between genes induced in developing zebrafish and a set of marker genes induced by oxidative stress in mammals. Genes induced by tBHQ in 4-dpf zebrafish included those involved in glutathione synthesis and utilization, signal transduction, and DNA damage/stress response. The strong induction of hsp70 determined by microarray was confirmed by qRT-PCR and by use of transgenic zebrafish expressing enhanced green fluorescent protein (EGFP) under control of the hsp70 promoter. Genes strongly down-regulated by tBHQ included mitfa, providing a molecular explanation for the loss of pigmentation in tBHQ-exposed embryos. These data show that zebrafish embryos are responsive to oxidative stress as early as 1 dpf, that responsiveness varies with development in a gene-specific manner, and that the oxidative stress response is substantially conserved in vertebrate animals.	[Hahn, Mark E.; Karchner, Sibel I.; Franks, Diana G.; Jenny, Matthew J.; Timme-Laragy, Alicia R.; Stegeman, John J.; Woodin, Bruce R.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [McArthur, Andrew G.; Cipriano, Michael J.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Linney, Elwood] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole; Duke University	Hahn, ME (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mhahn@whoi.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; McArthur, Andrew/0000-0002-1142-3063; Jenny, Matthew/0000-0002-1834-2629; Stegeman, John/0000-0001-8204-5357; Timme-Laragy, Alicia/0000-0002-8835-5038; Cipriano, Michael/0000-0001-8163-8812	National Institutes of Health [R01ES016366, R01ES006272, R01ES015912, F32ES017585]; Andrew W. Mellon Foundation Endowed Fund for Innovative Research; Walter A. and Hope Noyes Smith endowed chair; Marine Biological Laboratory's Program in Global Infectious Disease - Ellison Medical Foundation; WHOI (Woods Hole Oceanographic Institution) Postdoctoral Scholar award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381, R01ES016366, F32ES017585, R01ES006272, R01ES015912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andrew W. Mellon Foundation Endowed Fund for Innovative Research; Walter A. and Hope Noyes Smith endowed chair; Marine Biological Laboratory's Program in Global Infectious Disease - Ellison Medical Foundation; WHOI (Woods Hole Oceanographic Institution) Postdoctoral Scholar award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by National Institutes of Health grants R01ES016366 (MEH), R01ES006272 (MEH), R01ES015912 (JJS), and F32ES017585 (ART-L), the Andrew W. Mellon Foundation Endowed Fund for Innovative Research, a WHOI (Woods Hole Oceanographic Institution) Postdoctoral Scholar award, and the Walter A. and Hope Noyes Smith endowed chair (MEH). AGM and MJC were supported in part by the Marine Biological Laboratory's Program in Global Infectious Disease, funded by the Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The U.S. Government is authorized to produce and distribute reprints for governmental purposes notwithstanding any copyright notation that may appear hereon.	Agyeman AS, 2012, BREAST CANCER RES TR, V132, P175, DOI 10.1007/s10549-011-1536-9; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Alexeyenko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010465; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Blechinger SR, 2002, ENVIRON HEALTH PERSP, V110, P1041, DOI 10.1289/ehp.021101041; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304; Carvan MJ, 2000, ARCH BIOCHEM BIOPHYS, V376, P320, DOI 10.1006/abbi.2000.1727; Carvan MJ, 2001, SCI TOTAL ENVIRON, V274, P183, DOI 10.1016/S0048-9697(01)00742-2; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; Dalton TP, 2004, FREE RADICAL BIO MED, V37, P1511, DOI 10.1016/j.freeradbiomed.2004.06.040; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; Dennery PA, 2004, ANTIOXID REDOX SIGN, V6, P147, DOI 10.1089/152308604771978453; Dennery Phyllis A., 2007, Birth Defects Research, V81, P155, DOI 10.1002/bdrc.20098; Di Giulio Richard T., 2008, P273, DOI 10.1201/9780203647295.ch6; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Dobbin K, 2003, J NATL CANCER I, V95, P1362, DOI 10.1093/jnci/djg049; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Fang LH, 2012, FREE RADICAL BIO MED, V53, P1411, DOI 10.1016/j.freeradbiomed.2012.08.004; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fletcher N, 2005, TOXICOL APPL PHARM, V207, P1, DOI 10.1016/j.taap.2004.12.003; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Gharavi N, 2005, DRUG METAB DISPOS, V33, P365, DOI 10.1124/dmd.104.002253; Goering W, 2008, CYTOGENET GENOME RES, V121, P88, DOI 10.1159/000125833; Goldstone HMH, 2006, DRUG METAB REV, V38, P261, DOI 10.1080/03602530600570099; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Guan CP, 2008, EXP DERMATOL, V17, P1059, DOI 10.1111/j.1600-0625.2008.00752.x; Hahn M. E., 2014, TOXICOL SCI TOXICOLO, P52; Hahn ME, 2008, MAR ENVIRON RES, V66, P138; Hahn ME, 2007, TOXICOL SCI TOXICO S, V96, P326; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Hansen Jason M., 2006, Birth Defects Research, V78, P293, DOI 10.1002/bdrc.20085; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hayes KR, 2005, CHEM RES TOXICOL, V18, P403, DOI 10.1021/tx0496690; Hernandez-Garcia D, 2010, FREE RADICAL BIO MED, V49, P130, DOI 10.1016/j.freeradbiomed.2010.03.020; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hong HK, 2001, GENESIS, V29, P163, DOI 10.1002/gene.1020; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ishibashi M, 1997, FREE RADICAL BIO MED, V22, P447, DOI 10.1016/S0891-5849(96)00338-3; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Kelly SA, 1998, ENVIRON HEALTH PERSP, V106, P375, DOI 10.2307/3434064; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kingo K, 2008, J DERMATOL SCI, V52, P39, DOI 10.1016/j.jdermsci.2008.03.013; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Konwinski RR, 2004, TOXICOL LETT, V153, P343, DOI 10.1016/j.toxlet.2004.06.006; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; Kusik BW, 2008, MAR BIOTECHNOL, V10, P750, DOI 10.1007/s10126-008-9113-x; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li J, 2005, PHYSIOL GENOMICS, V21, P43, DOI 10.1152/physiolgenomics.00214.2004; Li L, 2008, J BIOL CHEM, V283, P3248, DOI 10.1074/jbc.M708702200; Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379; Lister JA, 1999, DEVELOPMENT, V126, P3757; Loeken MR, 2006, J SOC GYNECOL INVEST, V13, P2, DOI 10.1016/j.jsgi.2005.09.007; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Manga P, 2006, AM J PATHOL, V169, P1652, DOI 10.2353/ajpath.2006.050769; Mellgren EM, 2004, DEV GENES EVOL, V214, P493, DOI 10.1007/s00427-004-0428-y; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Nakajima H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026884; Nakamichi N, 2005, J NEUROCHEM, V93, P84, DOI 10.1111/j.1471-4159.2005.02999.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; National Research Council/National Academy of Sciences, 2000, SCI FRONT DEV TOX RI; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Ornoy A, 2007, REPROD TOXICOL, V24, P31, DOI 10.1016/j.reprotox.2007.04.004; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Planchart A, 2010, CHEM RES TOXICOL, V23, P480, DOI 10.1021/tx9003165; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Pruess Manuela, 2005, In Silico Biology, V5, P179; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reichard John F., 2005, Dose-Response, V3, P306, DOI 10.2203/dose-response.003.03.003; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Rizzo AM, 2007, COMP BIOCHEM PHYS B, V146, P94, DOI 10.1016/j.cbpb.2006.09.009; Rojas E, 2000, MUTAT RES-FUND MOL M, V447, P305, DOI 10.1016/S0027-5107(99)00191-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schreiber TD, 2006, DRUG METAB DISPOS, V34, P1096, DOI 10.1124/dmd.106.009662; Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004; Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Sun YV, 2004, NUCLEIC ACIDS RES, V32, P4512, DOI 10.1093/nar/gkh782; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x; Timme-Laragy AR, 2013, FREE RADICAL BIO MED, V65, P89, DOI 10.1016/j.freeradbiomed.2013.06.011; Timme-Laragy AR, 2012, J BIOL CHEM, V287, P4609, DOI 10.1074/jbc.M111.260125; Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038; Tsujita T, 2011, GENES CELLS, V16, P46, DOI 10.1111/j.1365-2443.2010.01466.x; Usenko CY, 2008, TOXICOL APPL PHARM, V229, P44, DOI 10.1016/j.taap.2007.12.030; Voelker D, 2007, AQUAT TOXICOL, V81, P355, DOI 10.1016/j.aquatox.2006.12.013; Wang L, 2013, TOXICOL APPL PHARM, V266, P177, DOI 10.1016/j.taap.2012.11.010; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wells Peter G, 2005, Toxicol Appl Pharmacol, V207, P354, DOI 10.1016/j.taap.2005.01.061; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Wells PG, 1996, CRIT REV BIOCHEM MOL, V31, P1, DOI 10.3109/10409239609110574; Wells PG, 1997, MUTAT RES-FUND MOL M, V396, P65, DOI 10.1016/S0027-5107(97)00175-9; Williams LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079574; WOLTERING DM, 1984, AQUAT TOXICOL, V5, P1, DOI 10.1016/0166-445X(84)90028-6; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yildirim M, 2004, J EUR ACAD DERMATOL, V18, P683, DOI 10.1111/j.1468-3083.2004.01080.x; Yokoi H, 2009, DEV BIOL, V329, P1, DOI 10.1016/j.ydbio.2009.01.002; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200; Zhang XL, 2004, KIDNEY INT, V65, P798, DOI 10.1111/j.1523-1755.2004.00454.x; Zhang Y, 2011, CHEM BIOL, V18, P1355, DOI 10.1016/j.chembiol.2011.09.008; Zhu XS, 2007, ENVIRON TOXICOL CHEM, V26, P976, DOI 10.1897/06-583.1	137	38	39	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113158	10.1371/journal.pone.0113158	http://dx.doi.org/10.1371/journal.pone.0113158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402455	gold, Green Published			2022-12-27	WOS:000345158700120
J	Okland, AL; Nylund, A; Overgard, AC; Blindheim, S; Watanabe, K; Grotmol, S; Arnesen, CE; Plarre, H				Okland, Arnfinn Lodden; Nylund, Are; Overgard, Aina-Cathrine; Blindheim, Steffen; Watanabe, Kuninori; Grotmol, Sindre; Arnesen, Carl-Erik; Plarre, Heidrun			Genomic Characterization and Phylogenetic Position of Two New Species in Rhabdoviridae Infecting the Parasitic Copepod, Salmon Louse (Lepeophtheirus salmonis)	PLOS ONE			English	Article							VIRAL DISEASES; BLUE-CRAB; MOLECULAR CHARACTERIZATION; CARCINUS-MEDITERRANEUS; TAXONOMIC POSITION; HISTORIC EMERGENCE; GLYCOPROTEIN GENE; SHRIMP PATHOGENS; SPRING VIREMIA; VIRUS	Several new viruses have emerged during farming of salmonids in the North Atlantic causing large losses to the industry. Still the blood feeding copepod parasite, Lepeophtheirus salmonis, remains the major challenge for the industry. Histological examinations of this parasite have revealed the presence of several virus-like particles including some with morphologies similar to rhabdoviruses. This study is the first description of the genome and target tissues of two new species of rhabdoviruses associated with pathology in the salmon louse. Salmon lice were collected at different Atlantic salmon (Salmo salar) farming sites on the west coast of Norway and prepared for histology, transmission electron microscopy and Illumina sequencing of the complete RNA extracted from these lice. The nearly complete genomes, around 11 600 nucleotides encoding the five typical rhabdovirus genes N, P, M, G and L, of two new species were obtained. The genome sequences, the putative protein sequences, and predicted transcription strategies for the two viruses are presented. Phylogenetic analyses of the putative N and L proteins indicated closest similarity to the Sigmavirus/Dimarhabdoviruses cluster, however, the genomes of both new viruses are significantly diverged with no close affinity to any of the existing rhabdovirus genera. In situ hybridization, targeting the N protein genes, showed that the viruses were present in the same glandular tissues as the observed rhabdovirus-like particles. Both viruses were present in all developmental stages of the salmon louse, and associated with necrosis of glandular tissues in adult lice. As the two viruses were present in eggs and free-living planktonic stages of the salmon louse vertical, transmission of the viruses are suggested. The tissues of the lice host, Atlantic salmon, with the exception of skin at the attachment site for the salmon louse chalimi stages, were negative for these two viruses.	[Okland, Arnfinn Lodden; Nylund, Are; Blindheim, Steffen; Watanabe, Kuninori; Grotmol, Sindre; Plarre, Heidrun] Univ Bergen, Dept Biol, N-5020 Bergen, Norway; [Overgard, Aina-Cathrine] Inst Marine Res, SLRC, N-5817 Bergen, Norway; [Grotmol, Sindre] Univ Bergen, Dept Biol, SLRC, N-5020 Bergen, Norway; [Arnesen, Carl-Erik] Firda Sjofarmer AS, N-5966 Eivindvik, Norway	University of Bergen; Institute of Marine Research - Norway; University of Bergen	Nylund, A (corresponding author), Univ Bergen, Dept Biol, N-5020 Bergen, Norway.	are.nylund@bio.uib.no	Grotmol, Sindre/AAB-8316-2020	Overgard, Aina-Cathrine/0000-0002-7789-5581				Adair B. M., 1986, Bulletin of the European Association of Fish Pathologists, V6, P85; AHNE W, 1985, J FISH DIS, V8, P241, DOI 10.1111/j.1365-2761.1985.tb01220.x; Behringer DC, 2011, DIS AQUAT ORGAN, V94, P153, DOI 10.3354/dao02326; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; Bonami JR, 2011, J INVERTEBR PATHOL, V106, P6, DOI 10.1016/j.jip.2010.09.009; Bonami JR, 2011, J INVERTEBR PATHOL, V106, P131, DOI 10.1016/j.jip.2010.09.007; Borzym E, 2014, J FISH DIS, V37, P423, DOI 10.1111/jfd.12119; Bourhy H, 2005, J GEN VIROL, V86, P2849, DOI 10.1099/vir.0.81128-0; Chen HL, 2009, ARCH VIROL, V154, P1489, DOI 10.1007/s00705-009-0455-0; Cherian SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030315; Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026; CRYSLER JG, 1990, J GEN VIROL, V71, P2191, DOI 10.1099/0022-1317-71-9-2191; Dalvin S, 2013, J NAT HIST, V47, P889, DOI 10.1080/00222933.2012.738830; Devold M, 2000, DIS AQUAT ORGAN, V40, P9, DOI 10.3354/dao040009; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Galinier R, 2012, VIRUS RES, V166, P1, DOI 10.1016/j.virusres.2012.02.020; Ghedin E, 2013, J GEN VIROL, V94, P2609, DOI 10.1099/vir.0.055939-0; Gubala A, 2011, J GEN VIROL, V92, P2160, DOI 10.1099/vir.0.026120-0; Gubala A, 2010, VIROLOGY, V399, P98, DOI 10.1016/j.virol.2009.12.013; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Heuch PA, 2005, AQUACULTURE, V246, P79, DOI 10.1016/j.aquaculture.2004.12.027; Hoffmann B, 2002, VIRUS RES, V84, P89, DOI 10.1016/S0168-1702(01)00441-5; JAHROMI SS, 1977, J GEN VIROL, V36, P485, DOI 10.1099/0022-1317-36-3-485; Jakob E, 2011, DIS AQUAT ORGAN, V97, P155, DOI 10.3354/dao02414; Johansson T, 2001, VIRUS RES, V80, P11, DOI 10.1016/S0168-1702(01)00323-9; Johnson MC, 1999, VIRUS RES, V64, P95, DOI 10.1016/S0168-1702(99)00071-4; JOHNSON PT, 1980, J INVERTEBR PATHOL, V35, P90, DOI 10.1016/0022-2011(80)90089-0; JOHNSON PT, 1978, MAR FISH REV, V40, P13; JOHNSON PT, 1984, HELGOLANDER MEERESUN, V37, P65, DOI 10.1007/BF01989296; Karlsbakk E, 2013, AQUACULTURE, V412, P41, DOI 10.1016/j.aquaculture.2013.07.007; King A. M. Q, 2012, VIRUS TAXONOMY; Koski P., 1992, Bulletin of the European Association of Fish Pathologists, V12, P177; Krkosek M, 2012, P R SOC B; LANNAN CN, 1984, IN VITRO CELL DEV B, V20, P671, DOI 10.1007/BF02618871; Lightner DV, 2012, J INVERTEBR PATHOL, V110, P174, DOI 10.1016/j.jip.2012.03.006; Lightner DV, 2011, J INVERTEBR PATHOL, V106, P110, DOI 10.1016/j.jip.2010.09.012; Longdon B, 2010, P ROY SOC B-BIOL SCI, V277, P35, DOI 10.1098/rspb.2009.1472; Longshaw M, 2011, J INVERTEBR PATHOL, V106, P54, DOI 10.1016/j.jip.2010.09.013; LU Y, 1994, DIS AQUAT ORGAN, V19, P187, DOI 10.3354/dao019187; MARI J, 1988, J GEN VIROL, V69, P561, DOI 10.1099/0022-1317-69-3-561; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Munro J, 2007, AQUAC RES, V38, P893, DOI 10.1111/j.1365-2109.2007.01735.x; Nylund A., 1993, P367; Nylund A., 1991, Bulletin of the European Association of Fish Pathologists, V11, P213; NYLUND A, 1992, J CRUSTACEAN BIOL, V12, P423, DOI 10.2307/1549036; Oelckers K, 2014, AQUACULTURE, V420, P126, DOI 10.1016/j.aquaculture.2013.10.016; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Overstreet RM, 2009, INTEGR COMP BIOL, V49, P127, DOI 10.1093/icb/icp033; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAPPALARDO R, 1986, J INVERTEBR PATHOL, V47, P361, DOI 10.1016/0022-2011(86)90107-2; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Quan PL, 2010, VIRUS RES, V147, P17, DOI 10.1016/j.virusres.2009.09.013; Rodriguez LL, 2012, RHABDOVIRUSES MOL TA; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Skern-Mauritzen R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-32; Steigen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066840; Stentiford GD, 2009, AQUACULTURE, V291, P1, DOI 10.1016/j.aquaculture.2009.02.042; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TORDO N, 1986, NUCLEIC ACIDS RES, V14, P2671, DOI 10.1093/nar/14.6.2671; Torkarz R, 2014, VIROL J, V11, P26; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Trosse C, 2014, COMP BIOCHEM PHYS B, V170, P1, DOI 10.1016/j.cbpb.2013.12.006; Vasilakis N, 2013, VIROLOGY, V444, P80, DOI 10.1016/j.virol.2013.05.035; Vasilakis N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-69; Vega-Heredia S, 2012, TRANSBOUND EMERG DIS, V59, P95, DOI 10.1111/j.1865-1682.2011.01249.x; Vogt G, 1996, J INVERTEBR PATHOL, V68, P239, DOI 10.1006/jipa.1996.0091; Walker PJ, 2011, VIRUS RES, V162, P110, DOI 10.1016/j.virusres.2011.09.004; WALKER PJ, 1994, J GEN VIROL, V75, P1889, DOI 10.1099/0022-1317-75-8-1889; Walker PJ, VET RES, V51, P51; YUDIN AI, 1979, J INVERTEBR PATHOL, V33, P133, DOI 10.1016/0022-2011(79)90146-0; Zeng WW, 2014, ARCH VIROL, V159, P2469, DOI 10.1007/s00705-014-2061-z; Zhu RL, 2011, VIRUS RES, V155, P495, DOI 10.1016/j.virusres.2010.12.006	74	16	16	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112517	10.1371/journal.pone.0112517	http://dx.doi.org/10.1371/journal.pone.0112517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402203	Green Published, Green Accepted, gold			2022-12-27	WOS:000345158700053
J	Chang, KV; Chen, WS; Wang, TG; Hung, CY; Chien, KL				Chang, Ke-Vin; Chen, Wen-Shiang; Wang, Tyng-Guey; Hung, Chen-Yu; Chien, Kuo-Liong			Quantitative Ultrasound Facilitates the Exploration of Morphological Association of the Long Head Biceps Tendon with Supraspinatus Tendon Full Thickness Tear	PLOS ONE			English	Article							ROTATOR CUFF TEARS; ADHESIVE CAPSULITIS; SHOULDER; ULTRASONOGRAPHY; LOCATION	Backgrounds: Pathology of the long head biceps tendon (LHBT) is associated with rotator cuff tears but whether the LHBT texture changes following supraspinatus tendon full thickness tear (SSFT) can be detected at the extra-articular segment remains unknown. This cross-sectional study aimed to explore the morphological differences of the LHBT in shoulders with and without deficient rotator cuffs by using quantitative ultrasound. Materials and Methods: We selected 145 cases with SSFT and 145 age-and-gender-matched controls. The width, thickness, flattening ratio, cross-sectional area, and echogenicity ratio of the LHBT were measured and a general linear model was used to clarify the relationship between rotator cuff pathology and LHBT morphology. The receiver operating characteristic curves of each parameter were constructed for SSFT discrimination and the maximal Youden indexes were used to define the best cut-off points. Results: We found increased thickness and cross-sectional area but decreased flattening ratio in shoulders with SSFT, and no between-group differences in the width and echogenicity ratio. The LHBT appearance was modified by biceps peritendinous effusion and medial subluxation, but not by the size of SSFT. The flattening ratio was the best discriminator for SSFT with an area under curve of 0.81 (95% confidence interval, 0.76-0.86). The cut-off values to differentiate between the non-tear and tear groups were 2.00 mm of the thickness, 1.73 of the flattening ratio and 10.53 mm(2) of the crosssectional area. Conclusion: Quantitative ultrasound facilitated the detection of the LHBT morphological changes following SSFT and demonstrated its potential utility in discriminating rotator cuff deficiency.	[Chang, Ke-Vin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, BeiHu Branch, Taipei, Taiwan; [Chang, Ke-Vin; Chen, Wen-Shiang; Wang, Tyng-Guey; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chang, Ke-Vin; Chien, Kuo-Liong] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chen, Wen-Shiang; Wang, Tyng-Guey] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hung, Chen-Yu] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Chu Tung Branch, Hsinchu, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	klchien@ntu.edu.tw	Wen-shiang, Chen/B-4794-2009	Wen-shiang, Chen/0000-0003-1488-5164; WANG, TYNG-GUEY/0000-0003-3298-4916; CHIEN, KUO-LIONG/0000-0003-4979-8351	National Science Council [103-2314-B-002 -062]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council (103-2314-B-002 -062). URLs: http://www.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagarinao E, 2003, NEUROIMAGE, V19, P422, DOI 10.1016/S1053-8119(03)00081-8; Brasseur J L, 2012, J Ultrasound, V15, P29, DOI 10.1016/j.jus.2011.11.002; Chang KV, 2014, ULTRASOUND MED BIOL, V40, P313, DOI 10.1016/j.ultrasmedbio.2013.10.002; Chang KV, 2010, ARCH PHYS MED REHAB, V91, P624, DOI 10.1016/j.apmr.2009.11.024; Chen CH, 2005, J TRAUMA, V58, P1189, DOI 10.1097/01.TA.0000170052.84544.34; Chen Chien-Hao, 2012, Chang Gung Med J, V35, P263; Chen HS, 2011, ULTRASOUND MED BIOL, V37, P1392, DOI 10.1016/j.ultrasmedbio.2011.05.842; Chikui T, 2009, ULTRASOUND MED BIOL, V35, P1257, DOI 10.1016/j.ultrasmedbio.2009.03.005; Collinger JL, 2010, AM J PHYS MED REHAB, V89, P390, DOI 10.1097/PHM.0b013e3181d8a238; Hsieh LF, 2012, ARCH PHYS MED REHAB, V93, P957, DOI 10.1016/j.apmr.2012.01.021; Joseph M, 2009, J ORTHOP RES, V27, P1379, DOI 10.1002/jor.20868; Kido T, 1998, ACTA ORTHOP SCAND, V69, P575, DOI 10.3109/17453679808999258; Kim HM, 2010, J BONE JOINT SURG AM, V92A, P1088, DOI 10.2106/JBJS.I.00686; Kim HM, 2010, J BONE JOINT SURG AM, V92A, P829, DOI 10.2106/JBJS.H.01746; Namdari S, 2014, J SHOULDER ELB SURG, V23, P20, DOI 10.1016/j.jse.2013.05.015; Nielsen PK, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-2; PATTEN RM, 1994, AM J ROENTGENOL, V162, P351, DOI 10.2214/ajr.162.2.8310926; RIZK TE, 1994, ARCH PHYS MED REHAB, V75, P803; Schmidt WA, 2004, ANN RHEUM DIS, V63, P988, DOI 10.1136/ard.2003.015081; Snow BJ, 2013, ORTHOPEDICS, V36, pE1295, DOI 10.3928/01477447-20130920-23; Stevens K, 2012, SEMIN MUSCULOSKEL R, V16, P296, DOI 10.1055/s-0032-1327004; Tai TW, 2012, ULTRASOUND MED BIOL, V38, P1121, DOI 10.1016/j.ultrasmedbio.2012.02.026; Yin JJ, 2014, STAT MED, V33, P985, DOI 10.1002/sim.5992; Yu TY, 2012, J CLIN ULTRASOUND, V40, P471, DOI 10.1002/jcu.21919	24	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113803	10.1371/journal.pone.0113803	http://dx.doi.org/10.1371/journal.pone.0113803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412357	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000079
J	Sasi, NK; Tiwari, K; Soon, FF; Bonte, D; Wang, T; Melcher, K; Xu, HE; Weinreich, M				Sasi, Nanda Kumar; Tiwari, Kanchan; Soon, Fen-Fen; Bonte, Dorine; Wang, Tong; Melcher, Karsten; Xu, H. Eric; Weinreich, Michael			The Potent Cdc7-Dbf4 (DDK) Kinase Inhibitor XL413 Has Limited Activity in Many Cancer Cell Lines and Discovery of Potential New DDK Inhibitor Scaffolds	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; HUMAN CDC7 KINASE; CYCLE 7 KINASE; DNA-REPLICATION; PROTEIN-KINASE; S-PHASE; MEIOTIC RECOMBINATION; CDC7-RELATED KINASE; INITIATION; EXPRESSION	Cdc7-Dbf4 kinase or DDK (Dbf4-dependent kinase) is required to initiate DNA replication by phosphorylating and activating the replicative Mcm2-7 DNA helicase. DDK is overexpressed in many tumor cells and is an emerging chemotherapeutic target since DDK inhibition causes apoptosis of diverse cancer cell types but not of normal cells. PHA-767491 and XL413 are among a number of potent DDK inhibitors with low nanomolar IC50 values against the purified kinase. Although XL413 is highly selective for DDK, its activity has not been extensively characterized on cell lines. We measured anti-proliferative and apoptotic effects of XL413 on a panel of tumor cell lines compared to PHA-767491, whose activity is well characterized. Both compounds were effective biochemical DDK inhibitors but surprisingly, their activities in cell lines were highly divergent. Unlike PHA-767491, XL413 had significant anti-proliferative activity against only one of the ten cell lines tested. Since XL413 did not effectively inhibit DDK in multiple cell lines, this compound likely has limited bioavailability. To identify potential leads for additional DDK inhibitors, we also tested the cross-reactivity of,400 known kinase inhibitors against DDK using a DDK thermal stability shift assay (TSA). We identified 11 compounds that significantly stabilized DDK. Several inhibited DDK with comparable potency to PHA-767491, including Chk1 and PKR kinase inhibitors, but had divergent chemical scaffolds from known DDK inhibitors. Taken together, these data show that several well-known kinase inhibitors cross-react with DDK and also highlight the opportunity to design additional specific, biologically active DDK inhibitors for use as chemotherapeutic agents.	[Sasi, Nanda Kumar; Tiwari, Kanchan; Bonte, Dorine; Weinreich, Michael] Van Andel Res Inst, Lab Genome Integr & Tumorigenesis, Grand Rapids, MI 49503 USA; [Sasi, Nanda Kumar] Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; [Soon, Fen-Fen; Xu, H. Eric] VARI, Lab Struct Sci, Grand Rapids, MI USA; [Wang, Tong] Translat Drug Dev Inc TD2, Scottsdale, AZ USA; [Melcher, Karsten] VARI, Lab Struct Biol & Biochem, Grand Rapids, MI USA	Van Andel Institute; Michigan State University; Van Andel Institute; Van Andel Institute	Weinreich, M (corresponding author), Van Andel Res Inst, Lab Genome Integr & Tumorigenesis, Grand Rapids, MI 49503 USA.	michael.weinreich@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Sasi, Nanda/0000-0003-4581-2056	Van Andel Institute; National Institutes of Health [R01-DK071662]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER	Van Andel Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Van Andel Institute (KM HEX MW) and National Institutes of Health (R01-DK071662 HEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Bonte D, 2008, NEOPLASIA, V10, P920, DOI 10.1593/neo.08216; Bryan MC, 2013, BIOORG MED CHEM LETT, V23, P2056, DOI 10.1016/j.bmcl.2013.02.007; Chen HJ, 2013, WORLD J GASTROENTERO, V19, P3130, DOI 10.3748/wjg.v19.i20.3130; Cheng AN, 2013, CANCER LETT, V337, P218, DOI 10.1016/j.canlet.2013.05.008; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Choschzick M, 2010, HUM PATHOL, V41, P358, DOI 10.1016/j.humpath.2009.08.008; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Ermoli A, 2009, J MED CHEM, V52, P4380, DOI 10.1021/jm900248g; Feng DR, 2003, CANCER RES, V63, P7356; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Fluge O, 2006, THYROID, V16, P161; Fung AD, 2002, MOL CELL BIOL, V22, P4477, DOI 10.1128/MCB.22.13.4477-4490.2002; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Harkins V, 2009, GENETICS, V183, P1269, DOI 10.1534/genetics.109.110155; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Hou Y, 2012, MED ONCOL, V29, P3498, DOI 10.1007/s12032-012-0223-y; Hou Y, 2012, J CANCER RES CLIN, V138, P2027, DOI 10.1007/s00432-012-1283-2; Hughes S, 2012, NAT STRUCT MOL BIOL, V19, P1101, DOI 10.1038/nsmb.2404; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Im JS, 2008, J BIOL CHEM, V283, P25171, DOI 10.1074/jbc.M802851200; Ito S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036372; Jackson JR, 2000, CANCER RES, V60, P566; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; KASE H, 1986, J ANTIBIOT, V39, P1059, DOI 10.7164/antibiotics.39.1059; Kitamura R, 2011, J BIOL CHEM, V286, P23031, DOI 10.1074/jbc.M111.243311; Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024; Kulkarni AA, 2009, CLIN CANCER RES, V15, P2417, DOI 10.1158/1078-0432.CCR-08-1276; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Menichincheri M, 2010, J MED CHEM, V53, P7296, DOI 10.1021/jm100504d; Menichincheri M, 2009, J MED CHEM, V52, P293, DOI 10.1021/jm800977q; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Montagnoli A, 2010, CLIN CANCER RES, V16, P4503, DOI 10.1158/1078-0432.CCR-10-0185; Natoni Alessandro, 2013, Cancers (Basel), V5, P901, DOI 10.3390/cancers5030901; Natoni A, 2011, MOL CANCER THER, V10, P1624, DOI 10.1158/1535-7163.MCT-10-1119; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; TAPLEY P, 1992, ONCOGENE, V7, P371; Tsuhako AL, 2012, BIOORG MED CHEM LETT, V22, P3732, DOI 10.1016/j.bmcl.2012.04.025; Tudzarova S, 2010, EMBO J, V29, P3381, DOI 10.1038/emboj.2010.201; Vanotti E, 2008, J MED CHEM, V51, P487, DOI 10.1021/jm700956r; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Yamada M, 2013, GENE DEV, V27, P2459, DOI 10.1101/gad.224568.113; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhao CL, 2009, BIOORG MED CHEM LETT, V19, P319, DOI 10.1016/j.bmcl.2008.11.093	64	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113300	10.1371/journal.pone.0113300	http://dx.doi.org/10.1371/journal.pone.0113300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412417	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000035
J	Bauer, R; Kaiser, M; Stoll, E				Bauer, Roman; Kaiser, Marcus; Stoll, Elizabeth			A Computational Model Incorporating Neural Stem Cell Dynamics Reproduces Glioma Incidence across the Lifespan in the Human Population	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; STEM/PROGENITOR CELLS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; UNITED-STATES; PRIMARY BRAIN; MUTANT P53; IN-VIVO; AGE; CANCER	Glioma is the most common form of primary brain tumor. Demographically, the risk of occurrence increases until old age. Here we present a novel computational model to reproduce the probability of glioma incidence across the lifespan. Previous mathematical models explaining glioma incidence are framed in a rather abstract way, and do not directly relate to empirical findings. To decrease this gap between theory and experimental observations, we incorporate recent data on cellular and molecular factors underlying gliomagenesis. Since evidence implicates the adult neural stem cell as the likely cell-of-origin of glioma, we have incorporated empirically-determined estimates of neural stem cell number, cell division rate, mutation rate and oncogenic potential into our model. We demonstrate that our model yields results which match actual demographic data in the human population. In particular, this model accounts for the observed peak incidence of glioma at approximately 80 years of age, without the need to assert differential susceptibility throughout the population. Overall, our model supports the hypothesis that glioma is caused by randomly-occurring oncogenic mutations within the neural stem cell population. Based on this model, we assess the influence of the (experimentally indicated) decrease in the number of neural stem cells and increase of cell division rate during aging. Our model provides multiple testable predictions, and suggests that different temporal sequences of oncogenic mutations can lead to tumorigenesis. Finally, we conclude that four or five oncogenic mutations are sufficient for the formation of glioma.	[Bauer, Roman; Kaiser, Marcus] Newcastle Univ, Sch Comp Sci, Interdisciplinary Comp & Complex BioSyst Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kaiser, Marcus; Stoll, Elizabeth] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Stoll, E (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	elizabeth.stoll@newcastle.ac.uk	Kaiser, Marcus/A-7166-2008; Bauer, Roman/AAP-5000-2020	Kaiser, Marcus/0000-0002-4654-3110; Bauer, Roman/0000-0002-7268-9359	Human Green Brain Project through the Engineering and Physical Sciences Research Council [EP/K026992/1]; EPSRC [EP/K026992/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K026992/1] Funding Source: researchfish	Human Green Brain Project through the Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	R. B. and M. K. were supported by the Human Green Brain Project (http://www.greenbrainproject.org) through the Engineering and Physical Sciences Research Council (EP/K026992/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; Armitage P, 1961, P 4 BERK S MATH STAT, V4, P9; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bailey KJ, 2004, AGING CELL, V3, P391, DOI 10.1111/j.1474-9728.2004.00128.x; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barker FG, 2001, NEUROSURGERY, V49, P1288, DOI 10.1097/00006123-200112000-00002; Chi AS, 2012, J NEURO-ONCOL, V110, P89, DOI 10.1007/s11060-012-0938-9; Choe SC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00031; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; FISHER JC, 1958, NATURE, V181, P651, DOI 10.1038/181651b0; Frank SA, 2004, BIOESSAYS, V26, P291, DOI 10.1002/bies.20000; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Gordon RA, 2003, TOXICOL IND HEALTH, V19, P125, DOI 10.1191/0748233703th195oa; Guan XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091216; Guo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089244; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Li J, 2014, J SURG RES, V192, P509, DOI 10.1016/j.jss.2014.06.034; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Mikheev AM, 2012, AGING CELL, V11, P1027, DOI 10.1111/acel.12004; Mikheev AM, 2009, AGING CELL, V8, P499, DOI 10.1111/j.1474-9726.2009.00494.x; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ostrom QT, 2011, CURR NEUROL NEUROSCI, V11, P329, DOI 10.1007/s11910-011-0189-8; Pompei F, 2002, TOXICOL IND HEALTH, V18, P365, DOI 10.1191/0748233702th164oa; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stoll EA, 2013, AGING CELL, V12, P733, DOI 10.1111/acel.12104; Stoll EA, 2011, STEM CELLS, V29, P2005, DOI 10.1002/stem.747; Stoll EA, 2011, J BIOL CHEM, V286, P38592, DOI 10.1074/jbc.M111.252171; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Waage IS, 2013, INT J SURG PATHOL; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111219	10.1371/journal.pone.0111219	http://dx.doi.org/10.1371/journal.pone.0111219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409511	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200002
J	Eisenstein, J; O'Connor, B; Smith, NA; Xing, EP				Eisenstein, Jacob; O'Connor, Brendan; Smith, Noah A.; Xing, Eric P.			Diffusion of Lexical Change in Social Media	PLOS ONE			English	Article							LANGUAGE; DISTRIBUTIONS; EXPANSION	Computer-mediated communication is driving fundamental changes in the nature of written language. We investigate these changes by statistical analysis of a dataset comprising 107 million Twitter messages (authored by 2.7 million unique user accounts). Using a latent vector autoregressive model to aggregate across thousands of words, we identify high-level patterns in diffusion of linguistic change over the United States. Our model is robust to unpredictable changes in Twitter's sampling rate, and provides a probabilistic characterization of the relationship of macro-scale linguistic influence to a set of demographic and geographic predictors. The results of this analysis offer support for prior arguments that focus on geographical proximity and population size. However, demographic similarity - especially with regard to race - plays an even more central role, as cities with similar racial demographics are far more likely to share linguistic influence. Rather than moving towards a single unified "netspeak'' dialect, language evolution in computer-mediated communication reproduces existing fault lines in spoken American English.	[Eisenstein, Jacob] Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA; [O'Connor, Brendan] Univ Massachusetts, Sch Comp Sci, Amherst, MA 01003 USA; [Smith, Noah A.; Xing, Eric P.] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA	University System of Georgia; Georgia Institute of Technology; University of Massachusetts System; University of Massachusetts Amherst; Carnegie Mellon University	Eisenstein, J (corresponding author), Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA.	jacobe@gatech.edu			National Science Foundation [IIS-11111429, IIS-1054319]; Amazon Web Services; Gordon and Betty Moore Foundation; National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Amazon Web Services; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants IIS-1111142 and IIS-1054319, by Google's support of the Reading is Believing project at Carnegie Mellon University, a computing resources award from Amazon Web Services. This work was supported by computing resources from the Open Source Data Cloud (OSDC), which is an Open Cloud Consortium (OCC)-sponsored project. OSDC usage was supported in part by grants from Gordon and Betty Moore Foundation and the National Science Foundation, and by major contributions from OCC members like the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Androutsopoulos Jannis K., 2000, J SOCIOLING, V4, P514, DOI [DOI 10.1111/1467-9481.00128, 10.1111/1467-9481.00128]; Anis Jacques., 2007, MULTILINGUAL INTERNE, P87, DOI [10.1093/acprof:oso/9780195304794.003.0004, DOI 10.1093/ACPROF:OSO/9780195304794.003.0004]; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Bailey C.-J., 1973, VARIATION LINGUISTIC; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Baxter GJ, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046118; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Chang J., 2010, P INT WORKSH WEB SOC, V10, P18; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Crystal D, 2006, LANGUAGE AND THE INTERNET, 2ND EDITION, P1, DOI 10.2277/ 0521868599; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Duggan M, 2013, TECHNICAL REPORT; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; EISENSTEIN J., 2011, P 49 ANN M ASS COMP, V1, P1365; Fagyal Z, 2010, LINGUA, V120, P2061, DOI 10.1016/j.lingua.2010.02.001; Gelb A., 1974, APPL OPTIMAL ESTIMAT; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Godsill SJ, 2004, J AM STAT ASSOC, V99, P156, DOI 10.1198/016214504000000151; Gomez-Rodriguez M, 2012, ACM T KNOWL DISCOV D, V5, DOI 10.1145/2086737.2086741; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Gordon MJ, 2000, AM SPEECH, V75, P115, DOI 10.1215/00031283-75-2-115; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Heeringa W, 2007, TIJDSCHR NED TAAL L, V123, P70; Herring S.C., 2012, ENCY APPL LINGUISTIC; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Labov William, 2003, SOCIAL DIALECTOLOGY, P9, DOI DOI 10.1075/IMPACT.16.03LAB; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lee MG, 1999, AM SPEECH, V74, P369; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Lotan G, 2011, INT J COMMUN-US, V5, P1375; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; Milroy, 1991, LANGUAGE SOCIAL NETW; Mislove A, 2011, P 5 INT C WEBL SOC M, P554; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Morstatter F., 2013, PROC INT AAAI C WEBL, V7, P400; Nerbonne J, 2010, PHILOS T R SOC B, V365, P3821, DOI 10.1098/rstb.2010.0048; Nerbonne J, 2007, STUD GENERAT GRAMM, V96, P267; Niyogi P., 1997, Complex Systems, V11, P161; Noah A.Smith, 2010, EMNLP; Reali F, 2010, P ROY SOC B-BIOL SCI, V277, P429, DOI 10.1098/rspb.2009.1513; RICKFORD JR, 1985, AM SPEECH, V60, P99, DOI 10.2307/455300; Sadilek A., 2012, P 5 ACM INT C WEB SE, P723, DOI DOI 10.1145/2124295.2124380; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Squires L, 2010, LANG SOC, V39, P457, DOI 10.1017/S0047404510000412; Szmrecsanyi B, 2011, CORPORA, V6, P45, DOI 10.3366/cor.2011.0004; Thelwall M, 2009, J AM SOC INF SCI TEC, V60, P219, DOI 10.1002/asi.20978; Thurlow C., 2006, J COMPUT-MEDIAT COMM, V11, P667, DOI [DOI 10.1111/J.1083-6101.2006.00031.X, 10.111141083-6101.2006.00031.x]; Trapa PE, 2000, J MATH BIOL, V41, P172, DOI 10.1007/s002850070004; Trudgill Peter, 1974, LANGUAGE SOC, V3, P215, DOI [10.1017/S0047404500004358, DOI 10.1017/S0047404500004358]; WEI GCG, 1990, J AM STAT ASSOC, V85, P699, DOI 10.2307/2290005; Wieling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023613; William Labov, 2001, PRINCIPLES LINGUISTI, V2; Wolfram Walt., 1991, DIALECTS AM ENGLISH; Wu S., 2011, P 20 INT C WORLD WID, V20, P705, DOI [DOI 10.1145/1963405.1963504, 10.1145/1963405.1963504]; Zhang MH, 2013, P NATL ACAD SCI USA, V110, P9698, DOI 10.1073/pnas.1303108110; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	62	83	83	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113114	10.1371/journal.pone.0113114	http://dx.doi.org/10.1371/journal.pone.0113114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409166	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200069
J	Casals, M; Girabent-Farres, M; Carrasco, JL				Casals, Marti; Girabent-Farres, Montserrat; Carrasco, Josep L.			Methodological Quality and Reporting of Generalized Linear Mixed Models in Clinical Medicine (2000-2012): A Systematic Review	PLOS ONE			English	Article							REGRESSION; INFERENCE; OVERDISPERSION	Background: Modeling count and binary data collected in hierarchical designs have increased the use of Generalized Linear Mixed Models (GLMMs) in medicine. This article presents a systematic review of the application and quality of results and information reported from GLMMs in the field of clinical medicine. Methods: A search using the Web of Science database was performed for published original articles in medical journals from 2000 to 2012. The search strategy included the topic "generalized linear mixed models'',"hierarchical generalized linear models'', "multilevel generalized linear model'' and as a research domain we refined by science technology. Papers reporting methodological considerations without application, and those that were not involved in clinical medicine or written in English were excluded. Results: A total of 443 articles were detected, with an increase over time in the number of articles. In total, 108 articles fit the inclusion criteria. Of these, 54.6% were declared to be longitudinal studies, whereas 58.3% and 26.9% were defined as repeated measurements and multilevel design, respectively. Twenty-two articles belonged to environmental and occupational public health, 10 articles to clinical neurology, 8 to oncology, and 7 to infectious diseases and pediatrics. The distribution of the response variable was reported in 88% of the articles, predominantly Binomial (n = 64) or Poisson (n = 22). Most of the useful information about GLMMs was not reported in most cases. Variance estimates of random effects were described in only 8 articles (9.2%). The model validation, the method of covariate selection and the method of goodness of fit were only reported in 8.0%, 36.8% and 14.9% of the articles, respectively. Conclusions: During recent years, the use of GLMMs in medical literature has increased to take into account the correlation of data when modeling qualitative data or counts. According to the current recommendations, the quality of reporting has room for improvement regarding the characteristics of the analysis, estimation method, validation, and selection of the model.	[Casals, Marti] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Casals, Marti; Carrasco, Josep L.] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Casals, Marti] Univ Int Catalunya, Dept Ciencies Basiques, Barcelona, Spain; [Casals, Marti] Agencia Salut Publ Barcelona, Serv Epidemiol, Barcelona, Spain; [Girabent-Farres, Montserrat] Univ Int Catalunya, Dept Fisioterapia, Unitat Bioestadist, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Universitat Internacional de Catalunya (UIC); Public Health Agency of Barcelona; Universitat Internacional de Catalunya (UIC)	Casals, M (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.	marticasals@gmail.com	Girabent-Farrés, Montserrat/AAT-8484-2021; Carrasco, Josep L./D-3660-2011; Girabent-Farrés, Montserrat/B-8536-2008; Casals, Martí/M-8388-2019	Girabent-Farrés, Montserrat/0000-0002-9277-4729; Carrasco, Josep L./0000-0003-1184-0753; Girabent-Farrés, Montserrat/0000-0002-9277-4729; Casals, Martí/0000-0002-1775-8331				Aitkin M, 1996, STAT COMPUT, V6, P251, DOI 10.1007/BF00140869; [Anonymous], 2012, CORRELATION; Austin PC, 2003, AM HEART J, V145, P27, DOI 10.1067/mhj.2003.23; Austin PC, 2010, INT J BIOSTATISTICS, V6; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Bates D., 2004, 1 LME4 LINEAR MIXED; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bennett C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-168; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brostrom G, 2011, GEN LINEAR MODELS CL; Brown, 2006, APPL MIXED MODELS ME; Campbell MJ, 2008, STAT SQUARE 2 UNDERS; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; Davidson R, 1993, ESTIMATION INFERENCE; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Diaz-Ordaz K, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-127; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Draper N.R., 1998, APPL REGRESSION ANAL; Garson G., 2013, FUNDAMENTALS HIERARC; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gilmour A. R., 2002, ASREML USER GUIDE RE; Heck R.H., 2013, MULTILEVEL LONGITUDI, V2nd Edn; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Institute Inc S, 2008, SAS STAT 9 2 US GUID; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Lang TA, 2013, SCI EDITORS HDB; Lee Y., 2006, GEN LINEAR MODELS RA; Li BY, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-77; LINDSEY J. K., 1999, MODELS REPEATED MEAS; Lindsey JK, 2001, NONLINEAR MODELS MED; Littell RC, 2000, TUTORIAL BIOSTATISTI; Liu CY, 2010, MOL THER, V18, P1724, DOI 10.1038/mt.2010.127; MacCullagh P., 1989, GEN LINEAR MODELS; Milanzi E, 2012, STAT MED, V31, P1475, DOI 10.1002/sim.4482; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Molenberghs G, 2007, LIFETIME DATA ANAL, V13, P513, DOI 10.1007/s10985-007-9064-y; Moscatelli A, 2012, J VISION, V12, DOI 10.1167/12.11.26; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Platt RW, 1999, STAT MED, V18, P643, DOI 10.1002/(SICI)1097-0258(19990330)18:6<643::AID-SIM76>3.0.CO;2-M; Preedy VR., 2010, HDB DIS BURDENS QUAL; Rabe-Hesketh S, 2008, MULTILEVEL LONGITUDI, P433; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rowe K. J., 2007, PRACTICAL MULTILEVEL; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; SCHALL R, 1991, BIOMETRIKA, V78, P719; Skrondal A., 2003, NORSK EPIDEMIOLOGI, V13; Stryhn H, 2014, PREV VET MED, V113, P304, DOI 10.1016/j.prevetmed.2013.10.001; Thiele J, 2012, NUTR NATURAL RESOURC, V7; Tuerlinckx F, 2006, BRIT J MATH STAT PSY, V59, P225, DOI 10.1348/000711005x79857; Venables WN., 2002, MODERN APPL STAT S, V4; Wang Z, 2004, CAN J ANIM SCI, V84, P1, DOI 10.4141/A03-123; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Wolfinger RD, 1999, FITTING NONLINEAR MI, P278; ZEGER SL, 1991, J AM STAT ASSOC, V86, P79, DOI 10.2307/2289717	59	56	56	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112653	10.1371/journal.pone.0112653	http://dx.doi.org/10.1371/journal.pone.0112653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405342	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300045
J	Manohar, M; Khan, H; Sirohi, VK; Das, V; Agarwal, A; Pandey, A; Siddiqui, WA; Dwivedi, A				Manohar, Murli; Khan, Huma; Sirohi, Vijay Kumar; Das, Vinita; Agarwal, Anjoo; Pandey, Amita; Siddiqui, Waseem Ahmad; Dwivedi, Anila			Alteration in Endometrial Proteins during Early- and Mid- Secretory Phases of the Cycle in Women with Unexplained Infertility	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; DIFFERENTIALLY EXPRESSED PROTEINS; PROTEOMIC ANALYSIS; SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; IMPLANTATION FAILURE; EMBRYO IMPLANTATION; UTERINE ENDOMETRIUM; MENSTRUAL-CYCLE; IDENTIFICATION	Background: Compromised receptivity of the endometrium is a major cause of unexplained infertility, implantation failure and subclinical pregnancy loss. In order to investigate the changes in endometrial protein profile as a cause of unexplained infertility, the current study was undertaken to analyze the differentially expressed proteins of endometrium from early-secretory (LH+2) to mid-secretory phase (LH+7), in women with unexplained infertility. Methods: 2-D gel electrophoresis was performed to analyze the proteomic changes between early-(n = 8) and mid-secretory (n = 8) phase endometrium of women with unexplained infertility. The differentially expressed protein spots were identified by LC-MS analysis and validated by immunoblotting and immuno-histochemical analysis in early-(n = 4) and mid-secretory (n = 4) phase endometrium of infertile women. Validated proteins were also analyzed in early-(n = 4) and mid-secretory (n = 4) phase endometrium of fertile women. Results: Nine proteins were found to be differentially expressed between early-and mid-secretory phases of endometrium of infertile women. The expression of Ras-related protein Rap-1b, Protein disulfide isomerase A3, Apolipoprotein-A1 (Apo-A1), Cofilin-1 and RAN GTP-binding nuclear protein (Ran) were found to be significantly increased, whereas, Tubulin polymerization promoting protein family member 3, Superoxide dismutase [Cu-Zn], Sorcin, and Proteasome subunit alpha type-5 were significantly decreased in mid-secretory phase endometrium of infertile women as compared to early-secretory phase endometrium of infertile women. Validation of 4 proteins viz. Sorcin, Cofilin-1, Apo-A1 and Ran were performed in separate endometrial biopsy samples from infertile women. The up-regulated expression of Sorcin and down-regulated expression of Cofilin-1 and Apolipoprotein-A1, were observed in mid-secretory phase as compared to early-secretory phase in case of fertile women. Conclusions: De-regulation of the expression of Sorcin, Cofilin-1, Apo-A1 and Ran, during early-to mid-secretory phase may have physiological significance and it may be one of the causes for altered differentiation and/or maturation of endometrium, in women with unexplained infertility.	[Manohar, Murli; Sirohi, Vijay Kumar; Dwivedi, Anila] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Khan, Huma; Das, Vinita; Agarwal, Anjoo; Pandey, Amita] King Georges Med Univ, Dept Obstet & Gynaecol, Lucknow, Uttar Pradesh, India; [Manohar, Murli; Siddiqui, Waseem Ahmad] Jamia Hamdard, Dept Biochem, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University; Jamia Hamdard University	Dwivedi, A (corresponding author), CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	anila.dwivedi@rediffmail.com	AGARWAL, Anjoo/AAC-4411-2021; Manohar, Murli/R-8619-2018	AGARWAL, Anjoo/0000-0002-4616-177X; Siddiqui, Waseem/0000-0001-8727-866X	Ministry of Health and Family Welfare; Indian Council of Medical Research, Government of India; Council of Scientific and Industrial Research, New Delhi	Ministry of Health and Family Welfare; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Funding was provided by Ministry of Health and Family Welfare, and Indian Council of Medical Research, Government of India. One of the authors (MM) is thankful to Council of Scientific and Industrial Research, New Delhi for award of Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Altmae S, 2010, MOL HUM REPROD, V16, P178, DOI 10.1093/molehr/gap102; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Awasthi S, 2007, ACTA PHYSIOL, V189, P47, DOI 10.1111/j.1748-1716.2006.01638.x; Bao L, 2006, MOL ENDOCRINOL, V20, P3240, DOI 10.1210/me.2006-0296; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; Bringans S, 2008, RAPID COMMUN MASS SP, V22, P3450, DOI 10.1002/rcm.3752; Brosens JJ, 2010, MOL HUM REPROD, V16, P273, DOI 10.1093/molehr/gap108; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Carla B, 2005, CURRENT PHARM DESIGN, V11, P2075; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Chen JIC, 2009, J PROTEOME RES, V8, P2032, DOI 10.1021/pr801024g; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Crespo P, 2000, CELL MOL LIFE SCI, V57, P1613, DOI 10.1007/PL00000645; DeSouza L, 2005, PROTEOMICS, V5, P270, DOI 10.1002/pmic.200400920; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Dicker L, 2010, MOL CELL PROTEOMICS, V9, P2704, DOI 10.1074/mcp.M110.002774; Dominguez F, 2009, HUM REPROD, V24, P2607, DOI 10.1093/humrep/dep230; Edi-Osagie ECO, 2004, FERTIL STERIL, V82, P1379, DOI 10.1016/j.fertnstert.2004.04.046; Ferenczy A, 2008, GLOB LIB WOMENS MED, DOI [10.3843/GLOWM.10293, DOI 10.3843/GLOWM.10293]; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Frohlich T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-171; GRAHAM RA, 1990, BRIT MED J, V300, P1428, DOI 10.1136/bmj.300.6737.1428; Gundisch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060638; Hannan NJ, 2010, J PROTEOME RES, V9, P6256, DOI 10.1021/pr1004828; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Ho YS, 1998, J BIOL CHEM, V273, P7765, DOI 10.1074/jbc.273.13.7765; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Kokawa K, 1996, J CLIN ENDOCR METAB, V81, P4144, DOI 10.1210/jc.81.11.4144; LESSEY BA, 1995, FERTIL STERIL, V63, P535, DOI 10.1016/S0015-0282(16)57422-6; Li J, 2011, FERTIL STERIL, V95, P1161, DOI 10.1016/j.fertnstert.2010.09.033; Makker A, 2009, FERTIL STERIL, V91, P2298, DOI 10.1016/j.fertnstert.2008.04.018; Matsuzaki S, 2005, FERTIL STERIL, V84, P1180, DOI 10.1016/j.fertnstert.2005.04.041; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; MEYERS MB, 1987, BIOCHEM PHARMACOL, V36, P2373, DOI 10.1016/0006-2952(87)90606-X; MEYERS MB, 1995, J BIOL CHEM, V270, P26411, DOI 10.1074/jbc.270.44.26411; Morris K, 2011, REPROD SCI, V18, P1014, DOI 10.1177/1933719111401663; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Orsi NM, 2001, MOL REPROD DEV, V59, P44, DOI 10.1002/mrd.1006; Patel S, 2007, NEUROTOXICOL TERATOL, V29, P578, DOI 10.1016/j.ntt.2007.04.002; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rai P, 2010, PROTEOM CLIN APPL, V4, P48, DOI 10.1002/prca.200900094; Rashid NA, 2011, AM J REPROD IMMUNOL, V66, P23, DOI 10.1111/j.1600-0897.2011.01048.x; Ray A, 2012, REPROD BIOMED ONLINE, V24, P591, DOI 10.1016/j.rbmo.2012.02.021; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; Scotchie JG, 2009, REPROD SCI, V16, P883, DOI 10.1177/1933719109337165; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Sinha A, 2009, CLIN CHIM ACTA, V400, P14, DOI 10.1016/j.cca.2008.09.026; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sugino N, 1996, HUM REPROD, V11, P1073; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tuli L, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-13; Van Lenten BJ, 2009, CURR ATHEROSCLER REP, V11, P52, DOI 10.1007/s11883-009-0008-8; Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200; Wu YP, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-38; Xu YL, 2010, HUM REPROD, V25, P2480, DOI 10.1093/humrep/deq197; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zhuang HQ, 2013, PROTEOMICS, V13, P2398, DOI 10.1002/pmic.201300017	62	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111687	10.1371/journal.pone.0111687	http://dx.doi.org/10.1371/journal.pone.0111687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405865	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300014
J	Nash, UW				Nash, Ulrik W.			The Curious Anomaly of Skewed Judgment Distributions and Systematic Error in the Wisdom of Crowds	PLOS ONE			English	Article								Judgment distributions are often skewed and we know little about why. This paper explains the phenomenon of skewed judgment distributions by introducing the augmented quincunx (AQ) model of sequential and probabilistic cue categorization by neurons of judges. In the process of developing inferences about true values, when neurons categorize cues better than chance, and when the particular true value is extreme compared to what is typical and anchored upon, then populations of judges form skewed judgment distributions with high probability. Moreover, the collective error made by these people can be inferred from how skewed their judgment distributions are, and in what direction they tilt. This implies not just that judgment distributions are shaped by cues, but that judgment distributions are cues themselves for the wisdom of crowds. The AQ model also predicts that judgment variance correlates positively with collective error, thereby challenging what is commonly believed about how diversity and collective intelligence relate. Data from 3053 judgment surveys about US macroeconomic variables obtained from the Federal Reserve Bank of Philadelphia and the Wall Street Journal provide strong support, and implications are discussed with reference to three central ideas on collective intelligence, these being Galton's conjecture on the distribution of judgments, Muth's rational expectations hypothesis, and Page's diversity prediction theorem.	Univ Southern Denmark, Strateg Org Design, Odense, Denmark	University of Southern Denmark	Nash, UW (corresponding author), Univ Southern Denmark, Strateg Org Design, Odense, Denmark.	uwn@sam.sdu.dk		Nash, Ulrik William/0000-0002-1819-7281	University of Southern Denmark; thereby taxpayers of Denmark	University of Southern Denmark; thereby taxpayers of Denmark	This work was funded through normal wages paid by the University of Southern Denmark, and thereby taxpayers of Denmark, to the author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunswik E, 1943, PSYCHOL REV, V50, P255, DOI 10.1037/h0060889; Brunswik E., 1957, CONT APPROACHES COGN, P5; Brunswik Egon, 1952, CONCEPTUAL FRAMEWORK; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; CARLSON JA, 1975, J AM STAT ASSOC, V70, P749, DOI 10.2307/2285433; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Epley N, 2006, PSYCHOL SCI, V17, P311, DOI 10.1111/j.1467-9280.2006.01704.x; Epley N, 2001, PSYCHOL SCI, V12, P391, DOI 10.1111/1467-9280.00372; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; HAMMOND KR, 1955, PSYCHOL REV, V62, P255, DOI 10.1037/h0046845; Heady EO, 1959, J POLITICAL EC, V62, P34; Herzog SM, 2009, PSYCHOL SCI, V20, P231, DOI 10.1111/j.1467-9280.2009.02271.x; LUCAS RE, 1978, ECONOMETRICA, V46, P1429, DOI 10.2307/1913837; McMurry B, 2009, BEEF MAGAZINE   0201; MUTH JF, 1961, ECONOMETRICA, V29, P315, DOI 10.2307/1909635; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nikitin AP, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.138101; Page SE, 2008, DIFFERENCE POWER DIV; Perry-Coste FH, 1907, NATURE, V75, P509, DOI 10.1038/075509d0; Pouget A, 1999, NEURAL COMPUT, V11, P85, DOI 10.1162/089976699300016818; Rauhut H, 2011, J MATH PSYCHOL, V55, P191, DOI 10.1016/j.jmp.2010.10.002; Roitman JD, 2007, PLOS BIOL, V5, P1672, DOI 10.1371/journal.pbio.0050208; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Stark T, 2010, SPF PANELISTS FORECA; Stigler S.M., 1989, STAT SCI, V4, P73, DOI [10.1214/ss/1177012580, DOI 10.1214/SS/1177012580]; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Vul E, 2008, PSYCHOL SCI, V19, P645, DOI 10.1111/j.1467-9280.2008.02136.x; WALLACE HA, 1923, J AM SOC AGRON, P300; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112386	10.1371/journal.pone.0112386	http://dx.doi.org/10.1371/journal.pone.0112386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25406078	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300030
J	Cenit, MC; Martinez-Florensa, M; Consuegra, M; Bonet, L; Carnero-Montoro, E; Armiger, N; Caballero-Banos, M; Arias, MT; Benitez, D; Ortego-Centeno, N; de Ramon, E; Sabio, JM; Garcia-Hernandez, FJ; Tolosa, C; Suarez, A; Gonzalez-Gay, MA; Bosch, E; Martin, J; Lozano, F				Carmen Cenit, Maria; Martinez-Florensa, Mario; Consuegra, Marta; Bonet, Lizette; Carnero-Montoro, Elena; Armiger, Noelia; Caballero-Banos, Miguel; Teresa Arias, Maria; Benitez, Daniel; Ortego-Centeno, Norberto; de Ramon, Enrique; Mario Sabio, Jose; Garcia-Hernandez, Francisco J.; Tolosa, Carles; Suarez, Ana; Gonzalez-Gay, Miguel A.; Bosch, Elena; Martin, Javier; Lozano, Francisco			Analysis of Ancestral and Functionally Relevant CD5 Variants in Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article							ANTIGEN RECEPTOR COMPLEX; B-CELL SUBSET; RHEUMATOID-ARTHRITIS; SIGNAL-TRANSDUCTION; C-CBL; GENETIC SUSCEPTIBILITY; T-CELLS; ASSOCIATION; DISEASE; SELECTION	Objective: CD5 plays a crucial role in autoimmunity and is a well-established genetic risk factor of developing RA. Recently, evidence of positive selection has been provided for the CD5 Pro224-Val471 haplotype in East Asian populations. The aim of the present work was to further analyze the functional relevance of non-synonymous CD5 polymorphisms conforming the ancestral and the newly derived haplotypes (Pro224-Ala471 and Pro224-Val471, respectively) as well as to investigate the potential role of CD5 on the development of SLE and/or SLE nephritis. Methods: The CD5 SNPs rs2241002 (C/T; Pro224Leu) and rs2229177 (C/T; Ala471Val) were genotyped using TaqMan allelic discrimination assays in a total of 1,324 controls and 681 SLE patients of Spanish origin. In vitro analysis of CD3-mediated T cell proliferative and cytokine response profiles of healthy volunteers homozygous for the above mentioned CD5 haplotypes were also analyzed. Results: T-cell proliferation and cytokine release were significantly increased showing a bias towards to a Th2 profile after CD3 cross-linking of peripheral mononuclear cells from healthy individuals homozygous for the ancestral Pro224-Ala471 (CC) haplotype, compared to the more recently derived Pro224-Val471 (CT). The same allelic combination was statistically associated with Lupus nephritis. Conclusion: The ancestral Ala471 CD5 allele confers lymphocyte hyper-responsiveness to TCR/CD3 cross-linking and is associated with nephritis in SLE patients.	[Carmen Cenit, Maria; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Martinez-Florensa, Mario] ImmunNovat Dev, Barcelona, Spain; [Martinez-Florensa, Mario; Consuegra, Marta; Bonet, Lizette; Armiger, Noelia; Benitez, Daniel; Lozano, Francisco] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Carnero-Montoro, Elena; Bosch, Elena] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Dept Ciencies Expt & Salut, Barcelona, Spain; [Caballero-Banos, Miguel; Teresa Arias, Maria; Lozano, Francisco] Hosp Clin Barcelona, Dept Immunol, Barcelona, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain; [de Ramon, Enrique] Hosp Carlos Haya, Dept Internal Med, Malaga, Spain; [Mario Sabio, Jose] Hosp Virgen de las Nieves, Dept Internal Med, Granada, Spain; [Garcia-Hernandez, Francisco J.] Hosp Virgen del Rocio, Dept Internal Med, Seville, Spain; [Tolosa, Carles] Hosp Parc Tauli, Dept Internal Med, Sabadell, Spain; [Suarez, Ana] Univ Oviedo, Fac Med, Dept Funct Biol, Immunol Area, Oviedo, Spain; [Gonzalez-Gay, Miguel A.] Hosp Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain; [Lozano, Francisco] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Barcelona 7, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario San Cecilio; Hospital Carlos Haya; Hospital Universitario Virgen de las Nieves; Virgen del Rocio University Hospital; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; University of Oviedo; Hospital Universitario Marques de Valdecilla (HUMV); University of Barcelona	Lozano, F (corresponding author), Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	flozano@clinic.ub.es	Suarez, Ana/F-4492-2015; IBIS, EPIDEMIOLOGIA/O-8791-2015; González-Gay, Miguel A./B-2306-2008; Bosch, Elena/D-8681-2014; LOZANO, FRANCISCO/AAB-7888-2019; Martín, Javier/AAV-5209-2021; Centeno, Norberto Ortego/C-4793-2019; Cenit, Maria Carmen MC/E-9538-2017; Bosch, Elena/N-7603-2019; Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022	Suarez, Ana/0000-0002-4452-7539; González-Gay, Miguel A./0000-0002-7924-7406; Bosch, Elena/0000-0003-2848-103X; LOZANO, FRANCISCO/0000-0003-1119-4368; Centeno, Norberto Ortego/0000-0003-2325-0937; Cenit, Maria Carmen MC/0000-0001-8667-5313; Bosch, Elena/0000-0003-2848-103X; Martin, Javier/0000-0002-2202-0622; Consuegra-Fernandez, Marta/0000-0002-5894-2768; Caballero Banos, Miguel/0000-0002-2313-7988; Garcia-Hernandez, Francisco Jose/0000-0002-2600-0485; Carnero-Montoro, Elena/0000-0002-1947-9627	Spanish Ministerio de Economia y Competitividad [SAF2010-19717, SAF2009-11110, SAF2011-29239, BFU2008-01046]; Generalitat de Catalunya [2009SGR00252, 2009SGR1101]; Junta de Andalucia [CTS-4977]; Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional/FEDER [RD12/0009/0004]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional/FEDER(European CommissionSpanish Government)	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad [SAF2010-19717 to FL, SAF2009-11110 to JM, SAF2011-29239, and BFU2008-01046 to EB], Generalitat de Catalunya [2009SGR00252 to FL, and 2009SGR1101 to EB], Junta de Andalucia [CTS-4977], and Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional/FEDER [RD12/0009/0004 to JM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2004, J IMMUNOL, V173, P2928, DOI 10.4049/jimmunol.173.5.2928; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; Bhandoola A, 2002, EUR J IMMUNOL, V32, P1811, DOI 10.1002/1521-4141(200206)32:6<1811::AID-IMMU1811>3.0.CO;2-G; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Brito-Zeron P, 2013, REV CLIN ESP S, V213, P62; Brossard U, 2003, J IMMUNOL, V170, P4623, DOI 10.4049/jimmunol.170.9.4623; Carnero-Montoro E, 2012, MOL BIOL EVOL, V29, P811, DOI 10.1093/molbev/msr251; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; DAUPHINEE M, 1988, ARTHRITIS RHEUM, V31, P642, DOI 10.1002/art.1780310509; Demydenko D, 2010, BIOCHEM BIOPH RES CO, V392, P500, DOI 10.1016/j.bbrc.2010.01.052; Dennehy KM, 1998, EUR J IMMUNOL, V28, P1617, DOI 10.1002/(SICI)1521-4141(199805)28:05<1617::AID-IMMU1617>3.0.CO;2-7; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fehervari Z, 2004, ARTHRITIS RES THER, V6, P19, DOI 10.1186/ar1037; Friedlein G, 2007, J IMMUNOL, V178, P6821, DOI 10.4049/jimmunol.178.11.6821; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Hippen KL, 2000, J EXP MED, V191, P883, DOI 10.1084/jem.191.5.883; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; IWATANI Y, 1989, CLIN EXP IMMUNOL, V78, P196; LANKESTER AC, 1994, EUR J IMMUNOL, V24, P812, DOI 10.1002/eji.1830240406; Lau CS, 2006, LUPUS, V15, P715, DOI 10.1177/0961203306072311; Lozano F, 2000, CRIT REV IMMUNOL, V20, P347; MACKENZIE LE, 1991, SCAND J IMMUNOL, V33, P329, DOI 10.1111/j.1365-3083.1991.tb01778.x; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Morris DL, 2012, CURR OPIN RHEUMATOL, V24, P482, DOI 10.1097/BOR.0b013e3283562282; MUNOZ A, 1991, CLIN EXP IMMUNOL, V83, P304; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; PLATERZYBERK C, 1985, ARTHRITIS RHEUM, V28, P971, DOI 10.1002/art.1780280903; Ramos PS, 2010, SEMIN NEPHROL, V30, P164, DOI 10.1016/j.semnephrol.2010.01.007; Roa NS, 2013, BIOCHEM BIOPH RES CO, V432, P52, DOI 10.1016/j.bbrc.2013.01.086; Sanchez E, 2007, ARTHRITIS RHEUM, V56, P3080, DOI 10.1002/art.22871; Sanchez E, 2012, ARTHRITIS RHEUM-US, V64, P3687, DOI 10.1002/art.34650; Sanchez E, 2011, ANN RHEUM DIS, V70, P1752, DOI 10.1136/ard.2011.154104; Sestero CM, 2012, J IMMUNOL, V189, P2918, DOI 10.4049/jimmunol.1200065; SMITH HR, 1990, J RHEUMATOL, V17, P833; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P1; Stamou P, 2003, J IMMUNOL, V171, P1278, DOI 10.4049/jimmunol.171.3.1278; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Taylor KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001311; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Vera J, 2009, P NATL ACAD SCI USA, V106, P1506, DOI 10.1073/pnas.0805846106; Ward MM, 2004, ARTHRIT RHEUM-ARTHR, V51, P616, DOI 10.1002/art.20526; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	48	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113090	10.1371/journal.pone.0113090	http://dx.doi.org/10.1371/journal.pone.0113090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402503	Green Published, gold			2022-12-27	WOS:000345158700109
J	Choudhury, DR; Singh, N; Singh, AK; Kumar, S; Srinivasan, K; Tyagi, RK; Ahmad, A; Singh, NK; Singh, R				Choudhury, Debjani Roy; Singh, Nivedita; Singh, Amit Kumar; Kumar, Sundeep; Srinivasan, Kalyani; Tyagi, R. K.; Ahmad, Altaf; Singh, N. K.; Singh, Rakesh			Analysis of Genetic Diversity and Population Structure of Rice Germplasm from North-Eastern Region of India and Development of a Core Germplasm Set	PLOS ONE			English	Article							SAMPLING STRATEGIES; COLLECTION; ORIGIN; SSR; L.; CULTIVATION; SOFTWARE; SUBSET; ASSAM; WHEAT	The North-Eastern region (NER) of India, comprising of Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland and Tripura, is a hot spot for genetic diversity and the most probable origin of rice. North-east rice collections are known to possess various agronomically important traits like biotic and abiotic stress tolerance, unique grain and cooking quality. The genetic diversity and associated population structure of 6,984 rice accessions, originating from NER, were assessed using 36 genome wide unlinked single nucleotide polymorphism (SNP) markers distributed across the 12 rice chromosomes. All of the 36 SNP loci were polymorphic and bi-allelic, contained five types of base substitutions and together produced nine types of alleles. The polymorphic information content (PIC) ranged from 0.004 for Tripura to 0.375 for Manipur and major allele frequency ranged from 0.50 for Assam to 0.99 for Tripura. Heterozygosity ranged from 0.002 in Nagaland to 0.42 in Mizoram and gene diversity ranged from 0.006 in Arunachal Pradesh to 0.50 in Manipur. The genetic relatedness among the rice accessions was evaluated using an unrooted phylogenetic tree analysis, which grouped all accessions into three major clusters. For determining population structure, populations K = 1 to K = 20 were tested and population K = 3 was present in all the states, with the exception of Meghalaya and Manipur where, K = 5 and K = 4 populations were present, respectively. Principal Coordinate Analysis (PCoA) showed that accessions were distributed according to their population structure. AMOVA analysis showed that, maximum diversity was partitioned at the individual accession level (73% for Nagaland, 58% for Arunachal Pradesh and 57% for Tripura). Using POWERCORE software, a core set of 701 accessions was obtained, which accounted for approximately 10% of the total NE India collections, representing 99.9% of the allelic diversity. The rice core set developed will be a valuable resource for future genomic studies and crop improvement strategies.	[Choudhury, Debjani Roy; Singh, Nivedita; Singh, Amit Kumar; Kumar, Sundeep; Singh, Rakesh] Natl Bur Plant Genet Resources, Div Genom Resources, New Delhi 110012, India; [Srinivasan, Kalyani; Tyagi, R. K.] Natl Bur Plant Genet Resources, Div Germplasm Conservat, New Delhi 110012, India; [Ahmad, Altaf] Jamia Hamdard, Fac Sci, Dept Bot, New Delhi 110062, India; [Singh, N. K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Jamia Hamdard University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB)	Singh, R (corresponding author), Natl Bur Plant Genet Resources, Div Genom Resources, New Delhi 110012, India.	rsingh@nbpgr.ernet.in	Singh, Rakesh/AAI-6165-2020; Singh, Nouratan/N-9377-2017; SINGH, AMIT KUMAR/Q-7438-2018; AHMAD, ALTAF/AAE-9371-2020; singh, navdeep/GZA-7750-2022	Singh, Rakesh/0000-0001-7269-6420; Singh, Nouratan/0000-0002-8063-8375; SINGH, AMIT KUMAR/0000-0001-8579-6519; AHMAD, ALTAF/0000-0003-4099-7338; 	Indian Council of Agricultural Research, New Delhi, India	Indian Council of Agricultural Research, New Delhi, India(Indian Council of Agricultural Research (ICAR))	Financial support granted by Indian Council of Agricultural Research, New Delhi, India, under NPTC project, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Balfourier F, 1998, GENET SEL EVOL, V30, pS215, DOI 10.1051/gse:19980713; Bhuyan N, 2007, CURR SCI INDIA, V93, P967; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Brown A. H. D., 1989, The use of plant genetic resources., P136; Chandra S, 2002, THEOR APPL GENET, V104, P1325, DOI 10.1007/s00122-001-0854-4; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Ebana K, 2008, BREEDING SCI, V58, P281, DOI 10.1270/jsbbs.58.281; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Franco J, 2006, CROP SCI, V46, P854, DOI 10.2135/cropsci2005.07-0201; Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Hore DK, 2005, GENET RESOUR CROP EV, V52, P1129, DOI 10.1007/s10722-004-6084-2; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Jansen J, 2007, THEOR APPL GENET, V114, P421, DOI 10.1007/s00122-006-0433-9; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; Kuroda Y, 2009, GENET RESOUR CROP EV, V56, P1045, DOI 10.1007/s10722-009-9425-3; Li XL, 2011, RICE SCI, V18, P46, DOI 10.1016/S1672-6308(11)60007-3; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Odong TL, 2013, THEOR APPL GENET, V126, P289, DOI 10.1007/s00122-012-1971-y; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PEETERS JP, 1989, THEOR APPL GENET, V78, P42, DOI 10.1007/BF00299751; Pritchard JK, 2000, GENETICS, V155, P945; Rao ES, 2012, PLANT GENET RESOUR-C, V10, P38, DOI 10.1017/S1479262111000955; Reeves PA, 2012, THEOR APPL GENET, V124, P1155, DOI 10.1007/s00122-011-1776-4; Sarma R. N., 2005, Plant Genetic Resources Newsletter, P34; Sharma M, 2012, EUR J PLANT PATHOL, V133, P707, DOI 10.1007/s10658-012-9949-9; Singh NK, 2007, FUNCT INTEGR GENOMIC, V7, P17, DOI 10.1007/s10142-006-0033-4; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Skroch PW, 1998, CROP SCI, V38, P488, DOI 10.2135/cropsci1998.0011183X003800020036x; Soto-Cerda BJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-78; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Upadhyaya HD, 2011, PLANT GENET RESOUR-C, V9, P97, DOI 10.1017/S1479262110000419; Upadhyaya H. D., 2010, Electronic Journal of Plant Breeding, V1, P1294; Upadhyaya HD, 2006, GENET RESOUR CROP EV, V53, P679, DOI 10.1007/s10722-004-3228-3; VAIRAVAN S, 1973, THEOR APPL GENET, V43, P213, DOI 10.1007/BF00309136; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; van Treuren R, 2006, GENET RESOUR CROP EV, V53, P43, DOI 10.1007/s10722-004-0585-x; Varshney RK, 2010, MOL BREEDING, V26, P229, DOI 10.1007/s11032-009-9373-9; Wang JC, 2014, SCI WORLD J, DOI 10.1155/2014/503473; Wen WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032626; Yan WG, 2010, CROP SCI, V50, P2406, DOI 10.2135/cropsci2010.02.0096; Yonezawa K., 1995, P35; Zaharieva M, 2001, GENET SEL EVOL, V33, pS269, DOI 10.1186/BF03500884; Zhang PF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020827, 10.1371/journal.pone.0027565]	54	42	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113094	10.1371/journal.pone.0113094	http://dx.doi.org/10.1371/journal.pone.0113094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412256	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000024
J	Feng, CJ; Li, JW; Qin, D; Chen, LX; Zhao, F; Chen, SH; Hu, HB; Yu, CP				Feng, Cuijie; Li, Jiangwei; Qin, Dan; Chen, Lixiang; Zhao, Feng; Chen, Shaohua; Hu, Hongbo; Yu, Chang-Ping			Characterization of Exoelectrogenic Bacteria Enterobacter Strains Isolated from a Microbial Fuel Cell Exposed to Copper Shock Load	PLOS ONE			English	Article							ELECTRON-TRANSFER; GEOBACTER; IRON; SHEWANELLA; REDUCTION; OXIDATION; CATALYSTS; MEMBRANE; BIOFILMS; ENERGY	Microorganisms capable of generating electricity in microbial fuel cells (MFCs) have gained increasing interest. Here fourteen exoelectrogenic bacterial strains were isolated from the anodic biofilm in an MFC before and after copper (Cu) shock load by Hungate roll-tube technique with solid ferric (III) oxide as an electron acceptor and acetate as an electron donor. Phylogenetic analysis of the 16S rRNA gene sequences revealed that they were all closely related to Enterobacter ludwigii DSM 16688(T) within the Enterobacteriaceae family, although these isolated bacteria showed slightly different morphology before and after Cu shock load. Two representative strains R2B1 (before Cu shock load) and B4B2 (after Cu shock load) were chosen for further analysis. B4B2 is resistant to 200 mg L-1 of Cu(II) while R2B1 is not, which indicated the potential selection of the Cu shock load. Raman analysis revealed that both R2B1 and B4B2 contained c-type cytochromes. Cyclic voltammetry measurements revealed that strain R2B1 had the capacity to transfer electrons to electrodes. The experimental results demonstrated that strain R2B1 was capable of utilizing a wide range of substrates, including Luria-Bertani (LB) broth, cellulose, acetate, citrate, glucose, sucrose, glycerol and lactose to generate electricity, with the highest current density of 440 mA.m(-2) generated from LB-fed MFC. Further experiments indicated that the bacterial cell density had potential correlation with the current density.	[Feng, Cuijie; Li, Jiangwei; Qin, Dan; Chen, Lixiang; Zhao, Feng; Chen, Shaohua; Yu, Chang-Ping] Chinese Acad Sci, Inst Urban Environm, Xiamen 361021, Peoples R China; [Feng, Cuijie; Li, Jiangwei; Qin, Dan; Chen, Shaohua; Yu, Chang-Ping] Chinese Acad Sci, Ningbo Urban Environm Observat & Res Stn, Ningbo 351800, Zhejiang, Peoples R China; [Hu, Hongbo] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Yu, CP (corresponding author), Chinese Acad Sci, Inst Urban Environm, Xiamen 361021, Peoples R China.	cpyu@iue.ac.cn	Chen, Shaohua/K-1709-2013; Yu, Chang-Ping/E-9422-2010; Feng, Cuijie/P-7851-2019; Zhao, Feng/C-5293-2009	Chen, Shaohua/0000-0002-8064-0504; Feng, Cuijie/0000-0001-5047-9302; Zhao, Feng/0000-0002-1525-042X	Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences [KZCXZEW-402]; Science and Technology Planning Project of Ningbo, China [2012C5011]; Xiamen Science and Technology Planning Project [3502Z20120012]; Science and Technology Innovation and Collaboration Team Project of the Chinese Academy of Sciences; Open Fund of State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University [MMLKF13-11]	Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Planning Project of Ningbo, China; Xiamen Science and Technology Planning Project; Science and Technology Innovation and Collaboration Team Project of the Chinese Academy of Sciences; Open Fund of State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University	This work was supported by the Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (KZCXZEW-402), Science and Technology Planning Project of Ningbo, China (2012C5011), the Xiamen Science and Technology Planning Project (3502Z20120012), Science and Technology Innovation and Collaboration Team Project of the Chinese Academy of Sciences, and the Open Fund of State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University (MMLKF13-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPHENAAR PA, 1994, MICRON, V25, P129, DOI 10.1016/0968-4328(94)90037-X; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Cheng S, 2006, ENVIRON SCI TECHNOL, V40, P364, DOI 10.1021/es0512071; Coates JD, 1996, APPL ENVIRON MICROB, V62, P1531, DOI 10.1128/AEM.62.5.1531-1536.1996; Conroy O, 2010, FEMS MICROBIOL LETT, V308, P115, DOI 10.1111/j.1574-6968.2010.02006.x; Davila D, 2011, BIOSENS BIOELECTRON, V26, P2426, DOI 10.1016/j.bios.2010.10.025; Eggleston CM, 2008, INORG CHIM ACTA, V361, P769, DOI 10.1016/j.ica.2007.07.015; Feng CJ, 2013, BIORESOURCE TECHNOL, V143, P76, DOI 10.1016/j.biortech.2013.05.038; Field SJ, 2000, J BIOL CHEM, V275, P8515, DOI 10.1074/jbc.275.12.8515; Gregory KB, 2004, ENVIRON MICROBIOL, V6, P596, DOI 10.1111/j.1462-2920.2004.00593.x; Hu ZQ, 2004, WATER RES, V38, P3949, DOI 10.1016/j.watres.2004.06.025; Hungate R. E., 1973, "Modern Methods in the Study of Microbial Ecology". Bulletins from the Ecological Research Committee, Sweden, V17, P123; Kim M, 2007, J ENVIRON MONITOR, V9, P1323, DOI 10.1039/b713114c; Liang ZH, 2010, WATER RES, V44, P5432, DOI 10.1016/j.watres.2010.06.060; Logan B.E., 2008, MICROBIAL FUEL CELLS; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meitl LA, 2009, GEOCHIM COSMOCHIM AC, V73, P5292, DOI 10.1016/j.gca.2009.06.021; Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11; Nevin KP, 2008, ENVIRON MICROBIOL, V10, P2505, DOI 10.1111/j.1462-2920.2008.01675.x; Nevin KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005628; Park HS, 2001, ANAEROBE, V7, P297, DOI 10.1006/anae.2001.0399; Peng L, 2010, BIOSENS BIOELECTRON, V25, P1248, DOI 10.1016/j.bios.2009.10.002; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Rezaei F, 2009, APPL ENVIRON MICROB, V75, P3673, DOI 10.1128/AEM.02600-08; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virdis B, 2012, ENERG ENVIRON SCI, V5, P7017, DOI 10.1039/c2ee03374g; Weber KA, 2006, ENVIRON MICROBIOL, V8, P100, DOI 10.1111/j.1462-2920.2005.00873.x; Wu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073442; Zhao F, 2005, ELECTROCHEM COMMUN, V7, P1405, DOI 10.1016/j.elecom.2005.09.032; Zhuang L, 2011, BIORESOURCE TECHNOL, V102, P284, DOI 10.1016/j.biortech.2010.06.038	38	47	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113379	10.1371/journal.pone.0113379	http://dx.doi.org/10.1371/journal.pone.0113379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412475	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000045
J	Murta, D; Batista, M; Trindade, A; Silva, E; Henrique, D; Duarte, A; Lopes-da-Costa, L				Murta, Daniel; Batista, Marta; Trindade, Alexandre; Silva, Elisabete; Henrique, Domingos; Duarte, Antonio; Lopes-da-Costa, Luis			In Vivo Notch Signaling Blockade Induces Abnormal Spermatogenesis in the Mouse	PLOS ONE			English	Article							EXPRESSION FAILURE; SERTOLI-CELLS; ACTIVATION; CYCLE; PATHOGENESIS; RECEPTORS; DURATION; SYSTEM; FATE; MICE	In a previous study we identified active Notch signaling in key cellular events occurring at adult spermatogenesis. In this study, we evaluated the function of Notch signaling in spermatogenesis through the effects of in vivo Notch blockade. Adult CD1 male mice were either submitted to a long term DAPT (eE-secretase inhibitor) or vehicle treatment. Treatment duration was designed to attain one half the time (25 days) or the time (43 days) required to accomplish a complete cycle of spermatogenesis. Blockade of Notch signaling was depicted from decreased transcription of Notch effector genes. Notch signaling blockade disrupted the expression patterns of Notch components in the testis, induced male germ cell fate aberrations, and significantly increased germ cell apoptosis, mainly in the last stages of the spermatogenic cycle, and epididymis spermatozoa morphological defects. These effects were more pronounced following the 43 day than the 25 day DAPT treatment schedule. These results indicate a relevant regulatory role of Notch signaling in mammalian spermatogenesis.	[Murta, Daniel; Batista, Marta; Trindade, Alexandre; Silva, Elisabete; Duarte, Antonio; Lopes-da-Costa, Luis] Univ Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, P-1699 Lisbon, Portugal; [Trindade, Alexandre; Duarte, Antonio] Gulbenkian Inst Sci, Oeiras, Portugal; [Henrique, Domingos] Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Lopes-da-Costa, L (corresponding author), Univ Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, P-1699 Lisbon, Portugal.	lcosta@fmv.utl.pt	Duarte, Antonio/V-1178-2018; Henrique, Domingos M/E-5460-2010; Trindade, Alexandre/J-3606-2013; Silva, Maria elisabete T:S./K-3678-2017; Trindade, Alexandre/AAC-9726-2019	Duarte, Antonio/0000-0002-9255-3635; Henrique, Domingos M/0000-0001-8869-1894; Trindade, Alexandre/0000-0002-3104-9259; Silva, Maria elisabete T:S./0000-0002-2332-7642; Lopes-da-Costa, Luis/0000-0001-5165-3034; de Moura Murta, Daniel/0000-0002-5583-485X	Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/105022/2008, PEst-OE/AGR/U10276/2014]; FCT [SFRH/BD/64416/2009, SFRH/BPD/47079/2008]; Portuguese Government initiative for research jobs, Ciencia FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Government initiative for research jobs, Ciencia FCT	We thank the Portuguese Foundation for Science and Technology (FCT) for the financial support (Project PTDC/CVT/105022/2008) and (Project PEst-OE/AGR/U10276/2014). DM is a PhD student supported by grant SFRH/BD/64416/2009 from FCT. MB has a research contract under the grant PTDC/CVT/105022/2008. ES is a Postdoctoral Researcher under the Portuguese Government initiative for research jobs, Ciencia 2008-FCT. AT is a Postdoctoral Researcher supported by grant SFRH/BPD/47079/2008 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; CLERMONT Y, 1969, FERTIL STERIL, V20, P805; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; Dirami G, 2001, J ANDROL, V22, P944; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Garcia TX, 2013, DEV BIOL, V377, P188, DOI 10.1016/j.ydbio.2013.01.031; Garcia TX, 2013, CELL CYCLE, V12; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hahn KL, 2009, REPRODUCTION, V137, P79, DOI 10.1530/REP-08-0207; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Hayashi T, 2004, TUMOR BIOL, V25, P99, DOI 10.1159/000079140; Hayashi T, 2004, FERTIL STERIL, V81, P697, DOI 10.1016/j.fertnstert.2003.08.026; Hayashi T, 2001, J ANDROL, V22, P999; Hernandez F, 2011, BIOL REPROD, V84, P859, DOI 10.1095/biolreprod.110.088708; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Murta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072767; OAKBERG EF, 1957, NATURE, V180, P1137, DOI 10.1038/1801137a0; Sahin Z, 2005, FERTIL STERIL, V83, P86, DOI 10.1016/j.fertnstert.2004.09.006; Saravanamuthu SS, 2009, DEV BIOL, V332, P166, DOI 10.1016/j.ydbio.2009.05.566; Silva E, 2012, J REPROD IMMUNOL, V96, P45, DOI 10.1016/j.jri.2012.07.003; Silva E, 2010, J REPROD IMMUNOL, V84, P66, DOI 10.1016/j.jri.2009.10.004; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Zhang CP, 2011, ENDOCRINOLOGY, V152, P2437, DOI 10.1210/en.2010-1182	35	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113365	10.1371/journal.pone.0113365	http://dx.doi.org/10.1371/journal.pone.0113365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412258	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000042
J	Woltmann, S; Stouffer, PC; Burns, CMB; Woodrey, MS; Cashner, MF; Taylor, SS				Woltmann, Stefan; Stouffer, Philip C.; Burns, Christine M. Bergeon; Woodrey, Mark S.; Cashner, Mollie F.; Taylor, Sabrina S.			Population Genetics of Seaside Sparrow (Ammodramus maritimus) Subspecies along the Gulf of Mexico	PLOS ONE			English	Article							RE-IMPLEMENTATION; SOFTWARE; INFERENCE; CONSERVATION; EVOLUTIONARY; PROGRAM; DIVERSITY; GENOTYPE; PRIMERS; MARKERS	Seaside Sparrows (Ammodramus maritimus) along the Gulf of Mexico are currently recognized as four subspecies, including taxa in Florida (A. m. juncicola and A. m. peninsulae) and southern Texas (Ammodramus m. sennetti), plus a widespread taxon between them (A. m. fisheri). We examined population genetic structure of this "Gulf Coast'' clade using microsatellite and mtDNA data. Results of Bayesian analyses (STRUCTURE, GENELAND) of microsatellite data from nine locations do not entirely align with current subspecific taxonomy. Ammodramus m. sennetti from southern Texas is significantly differentiated from all other populations, but we found evidence of an admixture zone with A. m. fisheri near Corpus Christi. The two subspecies along the northern Gulf Coast of Florida are significantly differentiated from both A. m. sennetti and A. m. fisheri, but are not distinct from each other. We found a weak signal of isolation by distance within A. m. fisheri, indicating this population is not entirely panmictic throughout its range. Although continued conservation concern is warranted for all populations along the Gulf Coast, A. m. fisheri appears to be more secure than the far smaller populations in south Texas and the northern Florida Gulf Coast. In particular, the most genetically distinct populations, those in Texas south of Corpus Christi, occupy unique habitats within a very small geographic range.	[Woltmann, Stefan; Stouffer, Philip C.; Burns, Christine M. Bergeon; Taylor, Sabrina S.] Louisiana State Univ, AgCenter, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Woodrey, Mark S.] Mississippi State Univ, Coastal Res & Extens Ctr, Grand Bay Natl Estuarine Res Reserve, Moss Point, MS 39562 USA; [Cashner, Mollie F.] Austin Peay State Univ, Dept Biol, Clarksville, TN USA	Louisiana State University System; Louisiana State University; Mississippi State University; Austin Peay State University	Woltmann, S (corresponding author), Austin Peay State Univ, Dept Biol, Clarksville, TN 37040 USA.	woltmanns@apsu.edu	Woltmann, Stefan/W-2666-2019; stouffer, phil/AAF-7281-2020	Taylor, Sabrina/0000-0002-0118-9883	BP/Gulf of Mexico Research Initiative; Louisiana Department of Wildlife and Fisheries	BP/Gulf of Mexico Research Initiative; Louisiana Department of Wildlife and Fisheries	Funding was provided by grants from the BP/Gulf of Mexico Research Initiative to the Coastal Waters Consortium (SST and PCS) and by the Louisiana Department of Wildlife and Fisheries (SST, SW and PCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 1973, Auk, V90, P411; AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; BEECHER WJ, 1955, ECOLOGY, V36, P23, DOI 10.2307/1931426; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Belkhir K., 2004, GENETIX LOGICIEL SOU; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Bulgin NL, 2003, MOL ECOL, V12, P831, DOI 10.1046/j.1365-294X.2003.01774.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A. W., 1983, SEASIDE SPARROW ITS, P7; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Florida Fish and Wildlife Conservation Commission, 2011, SCOTTS SEAS SPARR BI; Florida Fish and Wildlife Conservation Commission, 2011, WAK SEAS SPARR BIOL; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Greenberg R, 2006, BIOSCIENCE, V56, P675, DOI 10.1641/0006-3568(2006)56[675:TMAGPO]2.0.CO;2; Greenberg Russell, 2006, Studies in Avian Biology, P32; Griscom L., 1944, Occasional Papers Museum of Zoology Louisiana State University, V19, P313; Griscom L., 1920, P LINN SOC NEW YORK, V32, P18; GRISCOM LUDLOW, 1948, WILSON BULL, V60, P103; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hackett SJ, 1996, MOL PHYLOGENET EVOL, V5, P368, DOI 10.1006/mpev.1996.0032; Haig SM, 2011, AUK, V128, P205, DOI 10.1525/auk.2011.128.2.205; Haig Susan M., 2010, Ornithological Monographs, V67, P24; Hardy JW, 1983, SEASIDE SPARROW ITS, P95; Hill CE, 2008, MOL ECOL RESOUR, V8, P113, DOI 10.1111/j.1471-8286.2007.01885.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hull JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-224; Hull JM, 2008, MOL PHYLOGENET EVOL, V49, P988, DOI 10.1016/j.ympev.2008.09.010; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kale H. W., 1983, SEASIDE SPARROW ITS, P41; Lehmicke AJJ, 2012, CONSERV GENET RESOUR, V4, P881, DOI 10.1007/s12686-012-9664-z; McDonald M.V., 1988, FLORIDA COOPERATIVE; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Nelson WS, 2000, MOL ECOL, V9, P809, DOI 10.1046/j.1365-294x.2000.00929.x; Oberholser HC, 1974, BIRD LIFE TEXAS; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez-eman Jorge L., 2010, Ornithological Monographs, V67, P90; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Poesel A, 2009, MOL ECOL RESOUR, V9, P795, DOI 10.1111/j.1755-0998.2008.02182.x; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Post W., 2009, BIRDS N AM; Post W., 1983, SEASIDE SPARROW ITS, Veditors, P123; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2008, CONDOR, V110, P359, DOI 10.1525/cond.2008.8475; Rambaut A., 2014, TRACER V1 6; Remsen J.V. Jr, 2010, Ornithological Monographs, V67, P62; Robbins C.S., 1983, SEASIDE SPARROW ITS, P31; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ross JD, 2014, AUK, V131, P298, DOI 10.1642/AUK-13-246.1; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sardell RJ, 2010, MOL ECOL, V19, P4352, DOI 10.1111/j.1365-294X.2010.04805.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Tomkins I. R., 1937, Auk, V1937, P185; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; WEBB WL, 1950, ECOLOGY, V31, P426, DOI 10.2307/1931496; Wilson GA, 2003, GENETICS, V163, P1177; Winker Kevin, 2010, Ornithological Monographs, V67, P6	70	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112739	10.1371/journal.pone.0112739	http://dx.doi.org/10.1371/journal.pone.0112739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412194	Green Published, gold			2022-12-27	WOS:000345253000014
J	Cheng, L; Shi, SB; Li, Q; Chen, JF; Zhang, H; Lu, YH				Cheng, Lei; Shi, Shengbao; Li, Qiang; Chen, Jianfa; Zhang, Hui; Lu, Yahai			Progressive Degradation of Crude Oil n-Alkanes Coupled to Methane Production under Mesophilic and Thermophilic Conditions	PLOS ONE			English	Article							METHANOGENIC ARCHAEAL COMMUNITY; SP NOV.; GEN. NOV.; PRODUCTION WATER; ANAEROBIC BIODEGRADATION; SMITHELLA-PROPIONICA; PETROLEUM RESERVOIR; REDUCING BACTERIUM; SP. NOV.; HYDROCARBONS	Although methanogenic degradation of hydrocarbons has become a well-known process, little is known about which crude oil tend to be degraded at different temperatures and how the microbial community is responded. In this study, we assessed the methanogenic crude oil degradation capacity of oily sludge microbes enriched from the Shengli oilfield under mesophilic and thermophilic conditions. The microbial communities were investigated by terminal restriction fragment length polymorphism (T-RFLP) analysis of 16S rRNA genes combined with cloning and sequencing. Enrichment incubation demonstrated the microbial oxidation of crude oil coupled to methane production at 35 and 55 degrees C, which generated 3.7 +/- 0.3 and 2.8 +/- 0.3 mmol of methane per gram oil, respectively. Gas chromatography-mass spectrometry (GC-MS) analysis revealed that crude oil n-alkanes were obviously degraded, and high molecular weight n-alkanes were preferentially removed over relatively shorter-chain n-alkanes. Phylogenetic analysis revealed the concurrence of acetoclastic Methanosaeta and hydrogenotrophic methanogens but different methanogenic community structures under the two temperature conditions. Candidate divisions of JS1 and WWE 1, Proteobacteria (mainly consisting of Syntrophaceae, Desulfobacteraceae and Syntrophorhabdus) and Firmicutes (mainly consisting of Desulfotomaculum) were supposed to be involved with n-alkane degradation in the mesophilic conditions. By contrast, the different bacterial phylotypes affiliated with Caldisericales, "Shengli Cluster'' and Synergistetes dominated the thermophilic consortium, which was most likely to be associated with thermophilic crude oil degradation. This study revealed that the oily sludge in Shengli oilfield harbors diverse uncultured microbes with great potential in methanogenic crude oil degradation over a wide temperature range, which extend our previous understanding of methanogenic degradation of crude oil alkanes.	[Cheng, Lei; Lu, Yahai] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Cheng, Lei; Li, Qiang; Zhang, Hui] Minist Agr, Key Lab Dev & Applicat Rural Renewable Energy, Biogas Inst, Chengdu 610041, Peoples R China; [Shi, Shengbao; Chen, Jianfa] China Univ Petr, State Key Lab Petr Resources & Prospecting, Beijing 102200, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Biogas Institute of Ministry of Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; China University of Petroleum	Lu, YH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	yhlu@cau.edu.cn	Lu, Yahai/A-5030-2013	Lu, Yahai/0000-0002-1702-9868	National Nature Science Foundation of Science [40973059, 30900049]; National High Technology Research and Development Program of China [2013aa064401]; Sichuan Projects of International Cooperation and Exchanges [2013HH0018]; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2013ZL001]	National Nature Science Foundation of Science; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Sichuan Projects of International Cooperation and Exchanges; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This work was financially supported by National Nature Science Foundation of Science (40973059, 30900049), National High Technology Research and Development Program of China (2013aa064401), Sichuan Projects of International Cooperation and Exchanges (2013HH0018) and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China (2013ZL001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CM, 2013, GEOCHIM COSMOCHIM AC, V109, P162, DOI 10.1016/j.gca.2013.01.031; ATLAS RM, 1975, APPL MICROBIOL, V30, P396, DOI 10.1128/AEM.30.3.396-403.1975; Bekins B.A., 2005, ENV GEOSCI, V12, P139, DOI DOI 10.1306/EG.11160404036; Berdugo-Clavijo C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00197; Caldwell ME, 1998, ENVIRON SCI TECHNOL, V32, P2191, DOI 10.1021/es9801083; Callaghan AV, 2012, ENVIRON MICROBIOL, V14, P101, DOI 10.1111/j.1462-2920.2011.02516.x; Callaghan AV, 2010, ENVIRON SCI TECHNOL, V44, P7287, DOI 10.1021/es1002023; Callaghan AV, 2013, FRONTIERS MICROBIOLO, V4; Callaghan AV, 2012, CURRENT OPINION BIOT; Chen CL, 2004, MICROBIOL-SGM, V150, P3429, DOI 10.1099/mic.0.27193-0; Cheng L, 2013, FEMS MICROBIOL ECOL, V85, P568, DOI 10.1111/1574-6941.12141; Cheng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066784; Cheng L, 2013, FEMS MICROBIOL ECOL, V83, P757, DOI 10.1111/1574-6941.12031; Cheng L, 2011, APPL ENVIRON MICROB, V77, P5212, DOI 10.1128/AEM.00210-11; Chin KJ, 1999, APPL ENVIRON MICROB, V65, P2341; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cravo-Laureau C, 2004, INT J SYST EVOL MICR, V54, P1639, DOI 10.1099/ijs.0.63104-0; Cravo-Laureau C, 2004, INT J SYST EVOL MICR, V54, P77, DOI 10.1099/ijs.0.02717-0; de Bok FAM, 2001, APPL ENVIRON MICROB, V67, P1800, DOI 10.1128/AEM.67.4.1800-1804.2001; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolfing J, 2008, ISME J, V2, P442, DOI 10.1038/ismej.2007.111; Drake HL, 2004, RES MICROBIOL, V155, P422, DOI 10.1016/j.resmic.2004.03.003; Embree M, 2014, ISME J, V8, P757, DOI 10.1038/ismej.2013.187; Ficker M, 1999, APPL ENVIRON MICROB, V65, P5576; Galperin Y, 2008, ENVIRON FORENSICS, V9, P117, DOI 10.1080/15275920802115324; Gieg LM, 2008, APPL ENVIRON MICROB, V74, P3022, DOI 10.1128/AEM.00119-08; Gieg LM, 2014, CURR OPIN BIOTECH, V27, P21, DOI 10.1016/j.copbio.2013.09.002; Gieg LM, 2010, ENVIRON MICROBIOL, V12, P3074, DOI 10.1111/j.1462-2920.2010.02282.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gray ND, 2011, ENVIRON MICROBIOL, V13, P2957, DOI 10.1111/j.1462-2920.2011.02570.x; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hasinger M, 2012, J BIOTECHNOL, V157, P490, DOI 10.1016/j.jbiotec.2011.09.027; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Hostettler FD, 2007, ENVIRON FORENSICS, V8, P139, DOI 10.1080/15275920601180685; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Jones DM, 2008, NATURE, V451, P176, DOI 10.1038/nature06484; Kunapuli U, 2007, ISME J, V1, P643, DOI 10.1038/ismej.2007.73; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu YT, 1999, INT J SYST BACTERIOL, V49, P545, DOI 10.1099/00207713-49-2-545; Lykidis A, 2011, ISME J, V5, P122, DOI 10.1038/ismej.2010.125; Mbadinga SM, 2012, APPL MICROBIOL BIOT, V96, P531, DOI 10.1007/s00253-011-3828-8; Meckenstock RU, 2011, CURR OPIN BIOTECH, V22, P406, DOI 10.1016/j.copbio.2011.02.009; Mori K, 2009, INT J SYST EVOL MICR, V59, P2894, DOI 10.1099/ijs.0.010033-0; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Peng JJ, 2008, APPL ENVIRON MICROB, V74, P2894, DOI 10.1128/AEM.00070-08; Peters K. E., 1993, BIOMARKER GUIDE INTE; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; Qiu YL, 2008, APPL ENVIRON MICROB, V74, P2051, DOI 10.1128/AEM.02378-07; Rabus R, 1999, ENVIRON MICROBIOL, V1, P145; RAINEY FA, 1993, INT J SYST BACTERIOL, V43, P857, DOI 10.1099/00207713-43-4-857; Rees GN, 1997, INT J SYST BACTERIOL, V47, P150, DOI 10.1099/00207713-47-1-150; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Sasaki K, 2011, J BIOSCIENC IN PRESS; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siddique T, 2006, ENVIRON SCI TECHNOL, V40, P5459, DOI 10.1021/es060993m; Siddique T, 2012, ENVIRON SCI TECHNOL, V46, P9802, DOI 10.1021/es302202c; Siddique T, 2011, ENVIRON SCI TECHNOL, V45, P5892, DOI 10.1021/es200649t; Sousa DZ, 2007, INT J SYST EVOL MICR, V57, P609, DOI 10.1099/ijs.0.64734-0; Stahl DA, 1991, DEV APPL NUCL ACID P, P205; SVETLICHNY VA, 1991, SYST APPL MICROBIOL, V14, P254, DOI 10.1016/S0723-2020(11)80377-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan B, 2014, ISME J; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Townsend GT, 2003, ENVIRON SCI TECHNOL, V37, P5213, DOI 10.1021/es0264495; Wang LY, 2011, INT BIODETER BIODEGR, V65, P444, DOI 10.1016/j.ibiod.2010.12.010; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Widdel F., 2010, HDB HYDROCARBON LIPI, P1997, DOI [10.1007/978-3-540-77587-4_146, DOI 10.1007/978-3-540-77587-4_146]; Widdel F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P1028, DOI 10.1007/0-387-30742-7_33; Zedelius J, 2011, ENV MICROBIOL REP, V3, P125, DOI 10.1111/j.1758-2229.2010.00198.x; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777; Zhou L, 2012, ECOTOXICOLOGY, V21, P1680, DOI 10.1007/s10646-012-0949-5	72	51	53	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113253	10.1371/journal.pone.0113253	http://dx.doi.org/10.1371/journal.pone.0113253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409013	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200083
J	Nah, GSS; Tay, BH; Brenner, S; Osato, M; Venkatesh, B				Nah, Giselle Sek Suan; Tay, Boon-Hui; Brenner, Sydney; Osato, Motomi; Venkatesh, Byrappa			Characterization of the Runx Gene Family in a Jawless Vertebrate, the Japanese Lamprey (Lethenteron japonicum)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PEBP2; WHOLE-GENOME DUPLICATION; TUMOR-SUPPRESSOR RUNX3; DNA-BINDING ACTIVITY; GASTRIC-CANCER; BONE-FORMATION; ANCESTRAL VERTEBRATE; CELL-PROLIFERATION; ADAPTIVE IMMUNITY; FUGU GENOME	The cyclostomes (jawless vertebrates), comprising lampreys and hagfishes, are the sister group of jawed vertebrates (gnathostomes) and are hence an important group for the study of vertebrate evolution. In mammals, three Runx genes, Runx1, Runx2 and Runx3, encode transcription factors that are essential for cell proliferation and differentiation in major developmental pathways such as haematopoiesis, skeletogenesis and neurogenesis and are frequently associated with diseases. We describe here the characterization of Runx gene family members from a cyclostome, the Japanese lamprey (Lethenteron japonicum). The Japanese lamprey contains three Runx genes, RunxA, RunxB, and RunxC. However, phylogenetic and synteny analyses suggest that they are not one-to-one orthologs of gnathostome Runx1, Runx2 and Runx3. The major protein domains and motifs found in gnathostome Runx proteins are highly conserved in the lamprey Runx proteins. Although all gnathostome Runx genes each contain two alternative promoters, P1 (distal) and P2 (proximal), only lamprey RunxB possesses the alternative promoters; lamprey RunxA and RunxC contain only P2 and P1 promoter, respectively. Furthermore, the three lamprey Runx genes give rise to fewer alternative isoforms than the three gnathostome Runx genes. The promoters of the lamprey Runx genes lack the tandem Runx-binding motifs that are highly conserved among the P1 promoters of gnathostome Runx1, Runx2 and Runx3 genes; instead these promoters contain dispersed single Runx-binding motifs. The 39UTR of lamprey RunxB contains binding sites for miR-27 and miR-130b/301ab, which are conserved in mammalian Runx1 and Runx3, respectively. Overall, the Runx genes in lamprey seem to have experienced a different evolutionary trajectory from that of gnathostome Runx genes which are highly conserved all the way from cartilaginous fishes to mammals.	[Nah, Giselle Sek Suan; Tay, Boon-Hui; Brenner, Sydney; Osato, Motomi; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Brenner, Sydney] Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa 9040495, Japan; [Osato, Motomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Osato, Motomi] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Okinawa Institute of Science & Technology Graduate University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore	Osato, M (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.	csimo@nus.edu.sg; mcbbv@imcb.a-star.edu.sg	Osato, Motomi/N-5056-2014	Osato, Motomi/0000-0003-3982-9054; Venkatesh, Byrappa/0000-0003-3620-0277	Biomedical Research Council of A*STAR, Singapore	Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	Biomedical Research Council of A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 1997, J BIOL CHEM, V272, P14497, DOI 10.1074/jbc.272.23.14497; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cattell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022474; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fujioka M, 1996, GENES CELLS, V1, P741, DOI 10.1111/j.1365-2443.1996.tb00014.x; Glusman G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-43; Golling G, 1996, MOL CELL BIOL, V16, P932; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Huang GH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000206; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Javed A, 2000, J CELL SCI, V113, P2221; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; Kalev-Zylinska ML, 2003, DEV DYNAM, V228, P323, DOI 10.1002/dvdy.10388; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kaneto S, 2011, J EXP ZOOL PART B, V316B, P409, DOI 10.1002/jez.b.21411; Kasahara M, 2014, ADV IMMUNOL, V122, P59, DOI 10.1016/B978-0-12-800267-4.00002-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Camacho C, 2014, J CELL PHYSL; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Nah GSS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093816; Nam S, 2002, MOL CELL BIOL, V22, P547, DOI 10.1128/MCB.22.2.547-554.2002; Ng CEL, 2007, GENE, V399, P162, DOI 10.1016/j.gene.2007.05.014; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2005, CRIT REV EUKAR GENE, V15, P217, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.40; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park BY, 2010, GENE EXPR PATTERNS, V10, P159, DOI 10.1016/j.gep.2010.04.004; Park ES, 2012, MOL CELL ENDOCRINOL, V362, P165, DOI 10.1016/j.mce.2012.06.005; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Robertson AJ, 2002, MECH DEVELOP, V117, P327, DOI 10.1016/S0925-4773(02)00201-0; Rossetti S, 2013, INT J MOL SCI, V14, P1566, DOI 10.3390/ijms14011566; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Sullivan JC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-228; Sun JJ, 2012, CURR BIOL, V22, P862, DOI 10.1016/j.cub.2012.03.059; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Van de Peer Y, 2010, NAT REV GENET, V11, DOI 10.1038/nrg2600-c2; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wang M, 2013, J GASTROENTEROL, V48, P1023, DOI 10.1007/s00535-012-0733-6; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Woolf E, 2007, DEV BIOL, V303, P703, DOI 10.1016/j.ydbio.2006.12.005; Xu Y, 2013, FEBS LETT, V587, P3166, DOI 10.1016/j.febslet.2013.05.069; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zhang YH, 2004, J BIOL CHEM, V279, P53116, DOI 10.1074/jbc.M405502200	75	17	18	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113445	10.1371/journal.pone.0113445	http://dx.doi.org/10.1371/journal.pone.0113445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405766	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300118
J	Borges, JP; Verdoorn, KS; Daliry, A; Powers, SK; Ortenzi, VH; Fortunato, RS; Tibirica, E; Lessa, MA				Borges, Juliana P.; Verdoorn, Karine S.; Daliry, Anissa; Powers, Scott K.; Ortenzi, Victor H.; Fortunato, Rodrigo S.; Tibirica, Eduardo; Lessa, Marcos Adriano			Delta Opioid Receptors: The Link between Exercise and Cardioprotection	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; NITRIC-OXIDE; MICROVASCULAR OBSTRUCTION; INDUCED PROTECTION; IN-VIVO; ECHOCARDIOGRAPHY; MNSOD; INVOLVEMENT	This study investigated the role of opioid receptor (OR) subtypes as a mechanism by which endurance exercise promotes cardioprotection against myocardial ischemia-reperfusion (IR) injury. Wistar rats were randomly divided into one of seven experimental groups: 1) control; 2) exercise-trained; 3) exercise-trained plus a non-selective OR antagonist; 4) control sham; 5) exercise-trained plus a kappa OR antagonist; 6) exercise-trained plus a delta OR antagonist; and 7) exercise-trained plus a mu OR antagonist. The exercised animals underwent 4 consecutive days of treadmill training (60 min/day at similar to 70% of maximal oxygen consumption). All groups except the sham group were exposed to an in vivo myocardial IR insult, and the myocardial infarct size (IS) was determined histologically. Myocardial capillary density, OR subtype expression, heat shock protein 72 (HSP72) expression, and antioxidant enzyme activity were measured in the hearts of both the exercised and control groups. Exercise training significantly reduced the myocardial IS by approximately 34%. Pharmacological blockade of the kappa or mu OR subtypes did not blunt exercise-induced cardioprotection against IR-mediated infarction, whereas treatment of animals with a non-selective OR antagonist or a delta OR antagonist abolished exercise-induced cardioprotection. Exercise training enhanced the activities of myocardial superoxide dismutase (SOD) and catalase but did not increase the left ventricular capillary density or the mRNA levels of HSP72, SOD, and catalase. In addition, exercise significantly reduced the protein expression of kappa and delta ORs in the heart by 44% and 37%, respectively. Together, these results indicate that ORs contribute to the cardioprotection conferred by endurance exercise, with the delta OR subtype playing a key role in this response.	[Borges, Juliana P.; Daliry, Anissa; Tibirica, Eduardo; Lessa, Marcos Adriano] Fiocruz MS, Inst Oswaldo Cruz, Lab Cardiovasc Invest, BR-21045900 Rio De Janeiro, RJ, Brazil; [Verdoorn, Karine S.] Univ Fed Rio de Janeiro, Macae, RJ, Brazil; [Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Ortenzi, Victor H.; Fortunato, Rodrigo S.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; State University System of Florida; University of Florida; Universidade Federal do Rio de Janeiro	Lessa, MA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Cardiovasc Invest, BR-21045900 Rio De Janeiro, RJ, Brazil.	malessa@ioc.fiocruz.br	Daliry, Anissa/F-6256-2014; Borges, Juliana P/I-3750-2014; Fortunato, Rodrigo/AAM-9931-2020; Fortunato, Rodrigo/F-2020-2014	Borges, Juliana P/0000-0002-3581-7251; Fortunato, Rodrigo/0000-0003-3497-8173	Oswaldo Cruz Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	Oswaldo Cruz Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	JPB, MAL and ET received funding from Oswaldo Cruz Institute, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aitchison KA, 2000, BASIC RES CARDIOL, V95, P1, DOI 10.1007/s003950050001; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvert JW, 2013, PHYSIOLOGY, V28, P216, DOI 10.1152/physiol.00011.2013; Calvert JW, 2011, CIRC RES, V108, P1448, DOI 10.1161/CIRCRESAHA.111.241117; Chaves EA, 2013, J STEROID BIOCHEM, V138, P267, DOI 10.1016/j.jsbmb.2013.06.006; Chaves EA, 2006, J STEROID BIOCHEM, V99, P223, DOI 10.1016/j.jsbmb.2006.01.004; Chen XH, 2009, INT J CARDIOVAS IMAG, V25, P713, DOI 10.1007/s10554-009-9474-x; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; Crapo J D, 1978, Methods Enzymol, V53, P382; Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007; dos Santos L, 2008, BRAZ J MED BIOL RES, V41, P199, DOI 10.1590/S0100-879X2008005000007; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; Estato V, 2013, MICROVASC RES, V87, P41, DOI 10.1016/j.mvr.2013.02.007; Filusch A, 2008, ECHOCARDIOGR-J CARD, V25, P974, DOI 10.1111/j.1540-8175.2008.00724.x; Frasier CR, 2011, J APPL PHYSIOL, V111, P1751, DOI 10.1152/japplphysiol.01214.2010; French JP, 2008, FASEB J, V22, P2862, DOI 10.1096/fj.07-102541; Fryer RM, 2002, CARDIOVASC RES, V55, P520, DOI 10.1016/S0008-6363(02)00316-4; Fu Q, 2009, J HUAZHONG U SCI-MED, V29, P786, DOI 10.1007/s11596-009-0623-1; Galvao TFG, 2011, CLINICS, V66, P151, DOI 10.1590/S1807-59322011000100026; Golbidi S, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/972807; Grieve SM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000956; Hamilton KL, 2004, FREE RADICAL BIO MED, V37, P1360, DOI 10.1016/j.freeradbiomed.2004.07.025; Hamilton KL, 2001, AM J PHYSIOL-HEART C, V281, pH1346, DOI 10.1152/ajpheart.2001.281.3.H1346; Hamilton KL, 2003, FREE RADICAL BIO MED, V34, P800, DOI 10.1016/S0891-5849(02)01431-4; Han BB, 2008, ECHOCARDIOGR-J CARD, V25, P312, DOI 10.1111/j.1540-8175.2007.00591.x; Husain K, 2003, PHARMACOL RES, V48, P253, DOI 10.1016/S1043-6618(03)00150-6; HUTTER MM, 1994, CIRCULATION, V89, P355, DOI 10.1161/01.CIR.89.1.355; Ji LL, 2006, ANN NY ACAD SCI, V1067, P425, DOI 10.1196/annals.1354.061; Jin JY, 2007, CARDIOVASC INTER RAD, V30, P248, DOI 10.1007/s00270-006-0004-0; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; Lee Y, 2012, MED SCI SPORT EXER, V44, P397, DOI 10.1249/MSS.0b013e318231c037; Lennon SL, 2004, AM J PHYSIOL-HEART C, V287, pH975, DOI 10.1152/ajpheart.01208.2003; Lessa MA, 2006, ANESTH ANALG, V103, P815, DOI 10.1213/01.ane.0000237284.30817.f6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; Michelsen MM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0260-x; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Park SW, 2004, INT J CARDIOL, V97, P393, DOI 10.1016/j.ijcard.2003.10.034; Peart JN, 2005, VASC PHARMACOL, V42, P211, DOI 10.1016/j.vph.2005.02.003; Powers SK, 2014, FREE RADICAL RES, V48, P43, DOI 10.3109/10715762.2013.825371; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; Powers SK, 2002, CURR OPIN CARDIOL, V17, P495, DOI 10.1097/00001573-200209000-00009; Powers SK, 1998, AM J PHYSIOL-REG I, V275, pR1468, DOI 10.1152/ajpregu.1998.275.5.R1468; Pugsley MK, 2002, PHARMACOL THERAPEUT, V93, P51, DOI 10.1016/S0163-7258(02)00165-1; Quindry JC, 2007, J APPL PHYSIOL, V103, P1056, DOI 10.1152/japplphysiol.00263.2007; Quindry John C, 2010, Am J Physiol Heart Circ Physiol, V299, pH175, DOI 10.1152/ajpheart.01211.2009; Quindry JC, 2013, CURR CARDIOL REV, V9, P220, DOI 10.2174/1573403X113099990033; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schultz JE, 2001, PHARMACOL THERAPEUT, V89, P123, DOI 10.1016/S0163-7258(00)00106-6; SCHULTZ JEJ, 1995, AM J PHYSIOL-HEART C, V268, pH2157, DOI 10.1152/ajpheart.1995.268.5.H2157; Schultz JJ, 1997, J MOL CELL CARDIOL, V29, P1355, DOI 10.1006/jmcc.1996.0369; Schultz JJ, 1997, J MOL CELL CARDIOL, V29, P2187, DOI 10.1006/jmcc.1997.0454; Surendra H, 2013, J MOL CELL CARDIOL, V60, P142, DOI 10.1016/j.yjmcc.2013.04.010; Taylor RP, 1999, AM J PHYSIOL-HEART C, V276, pH1098, DOI 10.1152/ajpheart.1999.276.3.H1098; Tsang A, 2005, AM J PHYSIOL-HEART C, V289, pH2, DOI 10.1152/ajpheart.00091.2005; Tsuchida A, 1998, CARDIOVASC DRUG THER, V12, P365, DOI 10.1023/A:1007720801004; Valtchanova-Matchouganska A, 2003, Cardiovasc J S Afr, V14, P73; VERANI MS, 1988, J AM COLL CARDIOL, V12, P1573, DOI 10.1016/S0735-1097(88)80028-7; Wang GY, 2001, AM J PHYSIOL-HEART C, V280, pH384, DOI 10.1152/ajpheart.2001.280.1.H384; White FC, 1998, J APPL PHYSIOL, V85, P1160, DOI 10.1152/jappl.1998.85.3.1160; Wittert G, 1996, BIOCHEM BIOPH RES CO, V218, P877, DOI 10.1006/bbrc.1996.0156; Wu KC, 1998, J AM COLL CARDIOL, V32, P1756, DOI 10.1016/S0735-1097(98)00429-X; Wu S, 1999, CIRC RES, V84, P1388; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699; Yang YS, 2012, QUANT IMAGING MED SU, V2, P12, DOI 10.3978/j.issn.2223-4292.2011.12.02; Zhang SZ, 2006, ANESTHESIOLOGY, V105, P550, DOI 10.1097/00000542-200609000-00019; Zhang Y, 2005, ANESTHESIOLOGY, V102, P371, DOI 10.1097/00000542-200502000-00020	70	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113541	10.1371/journal.pone.0113541	http://dx.doi.org/10.1371/journal.pone.0113541			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415192	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600056
J	Ibarra-Reynoso, LD; Pisarchyk, L; Perez-Luque, EL; Garay-Sevilla, ME; Malacara, JM				del Rocio Ibarra-Reynoso, Lorena; Pisarchyk, Liudmila; Leticia Perez-Luque, Elva; Eugenia Garay-Sevilla, Ma.; Manuel Malacara, Juan			Whole-Body and Hepatic Insulin Resistance in Obese Children	PLOS ONE			English	Article							VISCERAL ADIPOSITY INDEX; FACTOR BINDING PROTEIN-1; METABOLIC SYNDROME; HOMA-IR; CARDIOMETABOLIC RISK; MODEL ASSESSMENT; HEIGHT RATIO; MASS INDEX; LIVER; GLUCOSE	Background: Insulin resistance may be assessed as whole body or hepatic. Objective: To study factors associated with both types of insulin resistance. Methods: Cross-sectional study of 182 obese children. Somatometric measurements were registered, and the following three adiposity indexes were compared: BMI, waist-to-height ratio and visceral adiposity. Whole-body insulin resistance was evaluated using HOMA-IR, with 2.5 as the cut-off point. Hepatic insulin resistance was considered for IGFBP-1 level quartiles 1 to 3 (< 6.67 ng/ml). We determined metabolite and hormone levels and performed a liver ultrasound. Results: The majority, 73.1%, of obese children had whole-body insulin resistance and hepatic insulin resistance, while 7% did not have either type. HOMA-IR was negatively associated with IGFBP-1 and positively associated with BMI, triglycerides, leptin and mother's BMI. Girls had increased HOMA-IR. IGFBP-1 was negatively associated with waist-to-height ratio, age, leptin, HOMA-IR and IGF-I. We did not find HOMA-IR or IGFBP- 1 associated with fatty liver. Conclusion: In school-aged children, BMI is the best metric to predict whole-body insulin resistance, and waist-to-height ratio is the best predictor of hepatic insulin resistance, indicating that central obesity is important for hepatic insulin resistance. The reciprocal negative association of IGFBP- 1 and HOMA-IR may represent a strong interaction of the physiological processes of both whole-body and hepatic insulin resistance.	[del Rocio Ibarra-Reynoso, Lorena; Pisarchyk, Liudmila; Leticia Perez-Luque, Elva; Eugenia Garay-Sevilla, Ma.; Manuel Malacara, Juan] Univ Guanajuato, Dept Med Sci, Guanajuato, Mexico	Universidad de Guanajuato	Garay-Sevilla, ME (corresponding author), Univ Guanajuato, Dept Med Sci, Campus Leon,20 Enero 929, Guanajuato, Mexico.	marugaray_2000@yahoo.com	del Rocio Ibarra-Reynoso, Lorena/AAR-9678-2021	Malacara, Juan Manuel/0000-0001-9150-9088; Ibarra- Reynoso, Lorena del Rocio/0000-0002-6119-1328	CONACYT [GTO-2010-C02-145281, CB 2007 - 84277]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACYT GTO-2010-C02-145281 and in part by CONACYT grant CB 2007 - 84277. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MJ, 2013, J CLIN NURS, V22, P2002, DOI 10.1111/jocn.12034; Al-Daghri NM, 2014, PEDIATR RES, V75, P459, DOI 10.1038/pr.2013.229; Amaro A, 2010, GASTROENTEROLOGY, V139, P149, DOI 10.1053/j.gastro.2010.03.039; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Atwa M, 2014, INT J DERMATOL, V53, pE410, DOI 10.1111/ijd.12340; Barbato Mariana Tremel, 2012, An. Bras. Dermatol., V87, P97, DOI 10.1590/S0365-05962012000100012; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Bocca G, 2013, HORM RES PAEDIAT, V80, P201, DOI 10.1159/000354662; Borai A, 2014, ANN CLIN BIOCHEM, V51, P269, DOI 10.1177/0004563213495818; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Boyraz M, 2013, BIOMARK MED, V7, P737, DOI 10.2217/bmm.13.13; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Bugge A, 2012, EXP DIABETES RES, DOI 10.1155/2012/859186; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Czech MP, 2013, NAT MED, V19, P969, DOI 10.1038/nm.3293; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; EDWARDS DAW, 1955, BRIT J NUTR, V9, P133, DOI 10.1079/BJN19550021; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Galbo T, 2013, AGING-US, V5, P582, DOI 10.18632/aging.100585; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; German J, 2009, ENDOCRINOLOGY, V150, P4502, DOI 10.1210/en.2009-0445; Gokulakrishnan K, 2012, METABOLISM, V61, P43, DOI 10.1016/j.metabol.2011.05.014; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hyysalo J, 2014, DIABETES, V63, P312, DOI 10.2337/db13-0774; Kitajima Y, 2013, J GASTROEN HEPATOL, V28, P1507, DOI 10.1111/jgh.12227; Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kotronen A, 2008, J CLIN ENDOCR METAB, V93, P4867, DOI 10.1210/jc.2008-1245; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; Lecoultre V, 2013, OBESITY, V21, P782, DOI 10.1002/oby.20377; Lewitt MS, 2010, EUR J ENDOCRINOL, V163, P233, DOI 10.1530/EJE-10-0301; Lytle LA, 2011, OBESITY, V19, P324, DOI 10.1038/oby.2010.242; Madeira IR, 2008, ARQ BRAS ENDOCRINOL, V52, P1466, DOI 10.1590/S0004-27302008000900010; Makkes S, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-62; Malmstrom R, 1997, DIABETOLOGIA, V40, P454, DOI 10.1007/s001250050700; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Mittelstaedt C., 1992, GEN ULTRASOUND; Monteiro PA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-25; Motaghedi R, 2007, DIABETES TECHNOL THE, V9, P43, DOI 10.1089/dia.2006.0056; Nambiar S, 2013, J PAEDIATR CHILD H, V49, pE281, DOI 10.1111/jpc.12147; Kluczynik CEN, 2012, AN BRAS DERMATOL, V87, P531, DOI 10.1590/S0365-05962012000400002; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Pastucha D, 2013, PHYSIOL RES, V62, P277, DOI 10.33549/physiolres.932438; Pirgon O, 2013, J CLIN RES PEDIATR E, V5, P33, DOI 10.4274/Jcrpe.825; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Qureshi K, 2010, J OBES, V2010, DOI 10.1155/2010/741521; Rehman JU, 2010, EUR J ENDOCRINOL, V163, P383, DOI 10.1530/EJE-10-0297; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sayns O, 2014, J PEDIAT ENDOCRINOL, V27, P1; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Stepien M, 2014, ANGIOLOGY, V65, P22, DOI 10.1177/0003319712468291; Street ME, 2013, J BIOL REG HOMEOS AG, V27, P259; Turchiano M, 2012, ARCH PEDIAT ADOL MED, V166, P1030, DOI 10.1001/archpediatrics.2012.1263; Veena SR, 2013, PUBLIC HEALTH NUTR, V16, P1656, DOI 10.1017/S1368980012003795; Vukovic R, 2013, EUR J PEDIATR, V172, P201, DOI 10.1007/s00431-012-1867-5; Yin JH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-71; Zammit VA, 2013, BIOCHEM J, V451, P1, DOI 10.1042/BJ20121689	60	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113576	10.1371/journal.pone.0113576	http://dx.doi.org/10.1371/journal.pone.0113576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411786	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000064
J	Hansen, IA; Rodriguez, SD; Drake, LL; Price, DP; Blakely, BN; Hammond, JI; Tsujimoto, H; Monroy, EY; Maio, WA; Romero, A				Hansen, Immo A.; Rodriguez, Stacy D.; Drake, Lisa L.; Price, David P.; Blakely, Brittny N.; Hammond, John I.; Tsujimoto, Hitoshi; Monroy, Erika Y.; Maio, William A.; Romero, Alvaro			The Odorant Receptor Co-Receptor from the Bed Bug, Cimex lectularius L.	PLOS ONE			English	Article							HEMIPTERA-CIMICIDAE; CARBON-DIOXIDE; SEVERE ANEMIA; RESISTANCE; IDENTIFICATION; AGGREGATION; PHEROMONE; HEAT; ORCO	Recently, the bed bug, Cimex lectularius L. has re-emerged as a serious and growing problem in many parts of the world. Presence of resistant bed bugs and the difficulty to eliminate them has renewed interest in alternative control tactics. Similar to other haematophagous arthropods, bed bugs rely on their olfactory system to detect semiochemicals in the environment. Previous studies have morphologically characterized olfactory organs of bed bugs' antenna and have physiologically evaluated the responses of olfactory receptor neurons (ORNs) to host-derived chemicals. To date, odorant binding proteins (OBPs) and odorant receptors (ORs) associated with these olfaction processes have not been studied in bed bugs. Chemoreception in insects requires formation of heteromeric complexes of ORs and a universal OR coreceptor (Orco). Orco is the constant chain of every odorant receptor in insects and is critical for insect olfaction but does not directly bind to odorants. Orco agonists and antagonists have been suggested as high-value targets for the development of novel insect repellents. In this study, we have performed RNAseq of bed bug sensory organs and identified several odorant receptors as well as Orco. We characterized Orco expression and investigated the effect of chemicals targeting Orco on bed bug behavior and reproduction. We have identified partial cDNAs of six C. lectularius OBPs and 16 ORs. Full length bed bug Orco was cloned and sequenced. Orco is widely expressed in different parts of the bed bug including OR neurons and spermatozoa. Treatment of bed bugs with the agonist VUAA1 changed bed bug pheromone-induced aggregation behavior and inactivated spermatozoa. We have described and characterized for the first time OBPs, ORs and Orco in bed bugs. Given the importance of these molecules in chemoreception of this insect they are interesting targets for the development of novel insect behavior modifiers.	[Hansen, Immo A.; Rodriguez, Stacy D.; Drake, Lisa L.; Price, David P.; Tsujimoto, Hitoshi] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Blakely, Brittny N.; Romero, Alvaro] New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA; [Hammond, John I.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Monroy, Erika Y.; Maio, William A.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; [Hansen, Immo A.; Price, David P.] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University; University of New Mexico; New Mexico State University; New Mexico State University	Romero, A (corresponding author), New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA.	aromero2@nmsu.edu			NMSU Interdisciplinary Research Grant from the Office of the Vice President for Research [112007]; New Mexico State University; New Mexico State University Agricultural Experiment Station; National Institute of General Medical Sciences [K12GM088021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021] Funding Source: NIH RePORTER	NMSU Interdisciplinary Research Grant from the Office of the Vice President for Research; New Mexico State University; New Mexico State University Agricultural Experiment Station; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project had four funding sources. First, IAH and AR were partially supported by a NMSU Interdisciplinary Research Grant from the Office of the Vice President for Research (fund number 112007). Secondly, start-up money was given to AR by the vice president for research of New Mexico State University. Third, AR was also financially supported by the New Mexico State University Agricultural Experiment Station. Fourth, JIH was supported by grant number K12GM088021 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2009, MED VET ENTOMOL, V23, P99, DOI 10.1111/j.1365-2915.2008.00790.x; Belei D, 2012, BIOORG MED CHEM LETT, V22, P4517, DOI 10.1016/j.bmcl.2012.06.007; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Center for Disease Control and Prevention, 2016, CLIMATE CHANGE EXTRE; Clements A.N., 1999, BIOL MOSQUITOES SENS; Clements AN., 1992, BIOL MOSQUITOES DEV; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; deShazo RD, 2012, AM J MED, V125, P688, DOI 10.1016/j.amjmed.2011.11.020; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fletcher CL, 2002, CLIN EXP DERMATOL, V27, P74, DOI 10.1046/j.0307-6938.2001.00967.x; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Gordon JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03836; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guidobaldi F, 2014, J PHYSIOL-PARIS, V108, P96, DOI 10.1016/j.jphysparis.2014.04.006; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Harraca V, 2012, J EXP BIOL, V215, P623, DOI 10.1242/jeb.065748; Harraca V, 2010, CHEM SENSES, V35, P195, DOI 10.1093/chemse/bjp096; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Johnson CG, 1941, J HYG-CAMBRIDGE, V41, P345, DOI 10.1017/S0022172400012560; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Kilpinen O, 2008, BED BUG PROBLEMS DEN, P395; Kleftogiannis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075505; Koganemaru R, 2013, PESTIC BIOCHEM PHYS, V106, P177, DOI 10.1016/j.pestbp.2013.05.005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krueger L, 2000, PEST CONTROL, V68, P58; Lehane MJ., 2005, BIOL BLOODS INS 2 ED, DOI 10.1017/CBO9780511610493; Marx R., 1955, Zeitschrift fuer Parasitenkunde, V17, P41; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Olson JF, 2014, ARTHROPOD STRUCT DEV, V43, P117, DOI 10.1016/j.asd.2013.12.004; Pask GM, 2013, CHEM SENSES, V38, P221, DOI 10.1093/chemse/bjs100; Paulke-Korinek M, 2012, PARASITOL RES, V110, P2577, DOI 10.1007/s00436-011-2777-6; PINTO LJ, 2007, BED BUGS HDB COMPLET; Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Potter Michael F., 2006, American Entomologist, V52, P102; Pritchard MJ, 2009, CAN MED ASSOC J, V181, P287, DOI 10.1503/cmaj.090482; Ralph N, 2013, J ENVIRON HEALTH, V76, P38; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero Alvaro, 2011, Insects, V2, P210, DOI 10.3390/insects2020210; Romero A, 2010, J INSECT PHYSIOL, V56, P1516, DOI 10.1016/j.jinsphys.2010.04.025; SAS Institute, 2002, SAS VERS 9 3; Shiao SH, 2008, J INSECT PHYSIOL, V54, P231, DOI 10.1016/j.jinsphys.2007.09.007; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Siljander E, 2007, ENTOMOL EXP APPL, V125, P215, DOI 10.1111/j.1570-7458.2007.00617.x; Susser SR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000838; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Ter Poorten MC, 2005, PEDIATR DERMATOL, V22, P183, DOI 10.1111/j.1525-1470.2005.22301.x; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; VENKATACHALAM P. S., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P218, DOI 10.1016/0035-9203(62)90156-6; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Weeks ENI, 2011, PEST MANAG SCI, V67, P10, DOI 10.1002/ps.2024; Yang Y, 2012, INT J BIOL SCI, V8, P159, DOI 10.7150/ijbs.8.159; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355	67	17	18	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113692	10.1371/journal.pone.0113692	http://dx.doi.org/10.1371/journal.pone.0113692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411789	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000073
J	Liu, YQ; Jiang, YS; Lan, JB; Zou, Y; Gao, JP				Liu, Yiqing; Jiang, Yusong; Lan, Jianbin; Zou, Yong; Gao, Junping			Comparative Transcriptomic Analysis of the Response to Cold Acclimation in Eucalyptus dunnii	PLOS ONE			English	Article							SECONDARY METABOLISM; ENVIRONMENTAL-CONDITIONS; EXPRESSION ANALYSIS; CHILLING TOLERANCE; CAMELLIA-SINENSIS; ANALYSIS REVEALS; GENES; PLANT; PROLINE; STRESS	Eucalyptus dunnii is an important macrophanerophyte with high economic value. However, low temperature stress limits its productivity and distribution. To study the cold response mechanisms of E. dunnii, 5 cDNA libraries were constructed from mRNA extracted from leaves exposed to cold stress for varying lengths of time and were evaluated by RNA-Seq analysis. The assembly of the Illumina datasets was optimized using various assembly programs and parameters. The final optimized assembly generated 205,325 transcripts with an average length of 1,701 bp and N50 of 2,627 bp, representing 349.38 Mb of the E. dunnii transcriptome. Among these transcripts, 134,358 transcripts (65.4%) were annotated in the Nr database. According to the differential analysis results, most transcripts were up-regulated as the cold stress prolonging, suggesting that these transcripts may be involved in the response to cold stress. In addition, the cold-relevant GO categories, such as 'response to stress' and 'translational initiation', were the markedly enriched GO terms. The assembly of the E. dunnii gene index and the GO classification performed in this study will serve as useful genomic resources for the genetic improvement of E. dunnii and also provide insights into the molecular mechanisms of cold acclimation in E. dunnii.	[Liu, Yiqing; Gao, Junping] China Agr Univ, Dept Ornamental Hort, Beijing 100193, Peoples R China; [Liu, Yiqing; Jiang, Yusong; Lan, Jianbin; Zou, Yong] Chongqing Univ Art & Sci, Coll Life Sci & Forestry, Yongchuan 402160, Peoples R China	China Agricultural University; Chongqing University of Arts & Sciences	Liu, YQ (corresponding author), China Agr Univ, Dept Ornamental Hort, Beijing 100193, Peoples R China.	liung906@163.com			Natural Science Foundation of Chongqing Province, China [cstc2013jcyjA80035]; Key Program for forestry of Chongqing University of Art and Science [201302]; National Science Foundation for Young Scientists of China [31340016]	Natural Science Foundation of Chongqing Province, China; Key Program for forestry of Chongqing University of Art and Science; National Science Foundation for Young Scientists of China	1. Natural Science Foundation of Chongqing Province, China (Grant NO. cstc2013jcyjA80035), 2. Key Program for forestry of Chongqing University of Art and Science (Grant NO. 201302), 3. National Science Foundation for Young Scientists of China (Grant NO. 31340016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, PLANT MOL BIOL, V51, P363, DOI 10.1023/A:1022043000516; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Arasan SKT, 2013, INDIAN J EXP BIOL, V51, P522; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Brawner JT, 2013, EUPHYTICA, V191, P403, DOI 10.1007/s10681-013-0892-4; Cassan-Wang H, 2012, PLANT CELL PHYSIOL, V53, P2101, DOI 10.1093/pcp/pcs152; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Constabel CP, 2010, PLANT GENET GENOMICS, V8, P279, DOI 10.1007/978-1-4419-1541-2_13; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; DELAUNEY AJ, 1993, J BIOL CHEM, V268, P18673; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey S, 2010, EUR J PLANT PATHOL, V126, P217, DOI 10.1007/s10658-009-9534-z; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; El Kayal W, 2006, J EXP BOT, V57, P2455, DOI 10.1093/jxb/erl019; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; Feng BM, 2012, PLANT J, V72, P612, DOI 10.1111/j.1365-313X.2012.05104.x; Fernandes J, 2008, PLANT BIOTECHNOL J, V6, P782, DOI 10.1111/j.1467-7652.2008.00360.x; Fernandez M, 2012, TREES-STRUCT FUNCT, V26, P1483, DOI 10.1007/s00468-012-0722-7; Fernandez M, 2012, TREE GENET GENOMES, V8, P149, DOI 10.1007/s11295-011-0429-8; Fernandez M, 2010, TREES-STRUCT FUNCT, V24, P1109, DOI 10.1007/s00468-010-0483-0; Forlani G, 1997, PLANT PHYSIOL, V113, P1413, DOI 10.1104/pp.113.4.1413; Gallie DR, 1997, J BIOL CHEM, V272, P1046, DOI 10.1074/jbc.272.2.1046; Gomat HY, 2011, ANN FOREST SCI, V68, P109, DOI 10.1007/s13595-011-0012-3; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He XD, 2012, NEW FOREST, V43, P383, DOI 10.1007/s11056-011-9287-3; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hernandez D, 2014, BIOINFORMATICS, V30, P40, DOI 10.1093/bioinformatics/btt590; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Leslie AD, 2012, APPL ENERG, V89, P176, DOI 10.1016/j.apenergy.2011.07.037; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Liu SH, 2013, EXTREMOPHILES, V17, P391, DOI 10.1007/s00792-013-0528-6; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Munoz F, 2012, APPL PHYS A-MATER, V108, P1007, DOI 10.1007/s00339-012-7014-3; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Navarro M, 2011, PLANT BIOTECHNOL J, V9, P50, DOI 10.1111/j.1467-7652.2010.00530.x; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Ong WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046937; Osbourn A, 2010, TRENDS GENET, V26, P449, DOI 10.1016/j.tig.2010.07.001; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pennycooke JC, 2005, ENVIRON EXP BOT, V53, P225, DOI 10.1016/j.envexpbot.2004.04.002; Ponciano G, 2012, PHYTOCHEMISTRY, V79, P57, DOI 10.1016/j.phytochem.2012.04.007; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Ragusa M, 2012, J MOL MED, V90, P1421, DOI 10.1007/s00109-012-0918-8; Reape TJ, 2010, APOPTOSIS, V15, P249, DOI 10.1007/s10495-009-0447-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Sands PJ, 2002, FOREST ECOL MANAG, V163, P273, DOI 10.1016/S0378-1127(01)00586-2; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Torres R, 2011, BIOL CONTROL, V57, P103, DOI 10.1016/j.biocontrol.2011.01.006; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Verma P, 2013, PLANT BIOTECHNOL J, V11, P894, DOI 10.1111/pbi.12082; Verslues PE, 2010, PLANT MOL BIOL, V8, pe0140; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wang XinChao, 2003, Journal of Tea Science, V23, P94; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Yang QS, 2012, MOL CELL PROTEOMICS, V11, P1853, DOI 10.1074/mcp.M112.022079; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222; Ziemann M, 2013, ACTA PHYSIOL PLANT, V35, P1915, DOI 10.1007/s11738-013-1230-0	82	7	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113091	10.1371/journal.pone.0113091	http://dx.doi.org/10.1371/journal.pone.0113091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412179	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000023
J	Matsuo, T; Dat, LT; Komatsu, M; Yoshimaru, T; Daizumoto, K; Sone, S; Nishioka, Y; Katagiri, T				Matsuo, Taisuke; Dat, Le Tan; Komatsu, Masato; Yoshimaru, Tetsuro; Daizumoto, Kei; Sone, Saburo; Nishioka, Yasuhiko; Katagiri, Toyomasa			Early Growth Response 4 Is Involved in Cell Proliferation of Small Cell Lung Cancer through Transcriptional Activation of Its Downstream Genes	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; BONE METASTASIS; BINDING-SITE; ENCODES; MECHANISMS; EXPRESSION; DIFFERENTIATION; PROMOTER; ELEMENT; MEMBER	Small cell lung cancer (SCLC) is aggressive, with rapid growth and frequent bone metastasis; however, its detailed molecular mechanism remains poorly understood. Here, we report the critical role of early growth factor 4 (EGR4), a DNA-binding, zinc-finger transcription factor, in cell proliferation of SCLC. EGR4 overexpression in HEK293T cells conferred significant upregulation of specific splice variants of the parathyroid hormone-related protein (PTHrP) gene, resulting in enhancement of the secretion of PTHrP protein, a known mediator of osteolytic bone metastasis. More importantly, depletion of EGR4 expression by siRNA significantly suppressed growth of the SCLC cell lines, SBC-5, SBC-3 and NCI-H1048. On the other hand, introduction of EGR4 into NIH3T3 cells significantly enhanced cell growth. We identified four EGR4 target genes, SAMD5, RAB15, SYNPO and DLX5, which were the most significantly downregulated genes upon depletion of EGR4 expression in all of the SCLC cells examined, and demonstrated the direct recruitment of EGR4 to their promoters by ChIP and luciferase reporter analysis. Notably, knockdown of the expression of these genes by siRNA remarkably suppressed the growth of all the SCLC cells. Taken together, our findings suggest that EGR4 likely regulates the bone metastasis and proliferation of SCLC cells via transcriptional regulation of several target genes, and may therefore be a promising target for the development of anticancer drugs for SCLC patients.	[Matsuo, Taisuke; Dat, Le Tan; Komatsu, Masato; Yoshimaru, Tetsuro; Daizumoto, Kei; Katagiri, Toyomasa] Univ Tokushima, Div Genome Med, Inst Genome Res, Tokushima 770, Japan; [Dat, Le Tan; Sone, Saburo; Nishioka, Yasuhiko] Univ Tokushima, Inst Hlth Biosci, Dept Med Oncol, Tokushima 770, Japan	Tokushima University; Tokushima University	Katagiri, T (corresponding author), Univ Tokushima, Div Genome Med, Inst Genome Res, Tokushima 770, Japan.	tkatagi@genome.tokushima-u.ac.jp	Yoshimaru, Tetsuro/AAE-5335-2020	Yoshimaru, Tetsuro/0000-0001-8582-3011	University of Tokushima	University of Tokushima	This study was supported by future advanced research from the University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Husaini H, 2009, J THORAC ONCOL, V4, P251, DOI 10.1097/JTO.0b013e31819518fc; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; BURTIS WJ, 1990, NEW ENGL J MED, V322, P1106, DOI 10.1056/NEJM199004193221603; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; Chen YC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2781; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P4739, DOI 10.1073/pnas.89.10.4739; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Dat L, 2012, INT J ONCOL, V40, P1455, DOI 10.3892/ijo.2012.1348; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Kakiuchi S, 2003, MOL CANCER RES, V1, P485; Kato T, 2008, CLIN CANCER RES, V14, P2363, DOI 10.1158/1078-0432.CCR-07-1523; KIURA K, 1993, ANTI-CANCER DRUG DES, V8, P417; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Kuo PL, 2013, BBA-GEN SUBJECTS, V1830, P3756, DOI 10.1016/j.bbagen.2013.02.022; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Matsuo T, 2014, INT J ONCOL, V44, P427, DOI 10.3892/ijo.2013.2187; Miki T, 2004, INT J CANCER, V108, P511, DOI 10.1002/ijc.11586; MOSELEY JM, 1987, P NATL ACAD SCI USA, V84, P5048, DOI 10.1073/pnas.84.14.5048; MULLER HJ, 1991, P NATL ACAD SCI USA, V88, P10079, DOI 10.1073/pnas.88.22.10079; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakazawa K, 2012, ONCOL LETT, V4, P617, DOI 10.3892/ol.2012.792; Nishimura N, 2011, ONCOL REP, V26, P145, DOI 10.3892/or.2011.1255; Otsuka S, 2009, ONCOL RES, V17, P581, DOI 10.3727/096504009789745511; Papachristou DJ, 2012, MED RES REV, V32, P611, DOI 10.1002/med.20224; Poirier R, 2008, FRONT NEUROSCI-SWITZ, V2, P47, DOI 10.3389/neuro.01.002.2008; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; SKERKA C, 1995, J BIOL CHEM, V270, P22500, DOI 10.1074/jbc.270.38.22500; Sone S, 2007, CANCER METAST REV, V26, P685, DOI 10.1007/s10555-007-9081-z; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Watanabe T, 2014, DIS COLON RECTUM, V57, P23, DOI 10.1097/01.dcr.0000437688.33795.9d; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Wong JS, 2012, EMBO J, V31, P1028, DOI 10.1038/emboj.2011.464; Yamada T, 2009, MOL CANCER THER, V8, P119, DOI 10.1158/1535-7163.MCT-08-0874; Yano S, 1997, ONCOL RES, V9, P573; Yoshimaru T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3443; Zuk PA, 2000, J BIOL CHEM, V275, P26754	44	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113606	10.1371/journal.pone.0113606	http://dx.doi.org/10.1371/journal.pone.0113606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411851	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000065
J	Bosse, JT; Soares-Bazzolli, DM; Li, YW; Wren, BW; Tucker, AW; Maskell, DJ; Rycroft, AN; Langford, PR				Bosse, Janine T.; Soares-Bazzolli, Denise M.; Li, Yanwen; Wren, Brendan W.; Tucker, Alexander W.; Maskell, Duncan J.; Rycroft, Andrew N.; Langford, Paul R.		BRaDP1T Consortium	The Generation of Successive Unmarked Mutations and Chromosomal Insertion of Heterologous Genes in Actinobacillus pleuropneumoniae Using Natural Transformation	PLOS ONE			English	Article							SUCROSE SENSITIVITY MARKER; BIOFILM FORMATION; HAEMOPHILUS-INFLUENZAE; GENOME SEQUENCE; UREASE ACTIVITY; COMPETENCE; INFECTION; VIRULENCE; PASTEURELLACEAE; DELETION	We have developed a simple method of generating scarless, unmarked mutations in Actinobacillus pleuropneumoniae by exploiting the ability of this bacterium to undergo natural transformation, and with no need to introduce plasmids encoding recombinases or resolvases. This method involves two successive rounds of natural transformation using linear DNA: the first introduces a cassette carrying cat (which allows selection by chloramphenicol) and sacB (which allows counter-selection using sucrose) flanked by sequences to either side of the target gene; the second transformation utilises the flanking sequences ligated directly to each other in order to remove the cat-sacB cassette. In order to ensure efficient uptake of the target DNA during transformation, A. pleuropneumoniae uptake sequences are added into the constructs used in both rounds of transformation. This method can be used to generate multiple successive deletions and can also be used to introduce targeted point mutations or insertions of heterologous genes into the A. pleuropneumoniae chromosome for development of live attenuated vaccine strains. So far, we have applied this method to highly transformable isolates of serovars 8 (MIDG2331), which is the most prevalent in the UK, and 15 (HS143). By screening clinical isolates of other serovars, it should be possible to identify other amenable strains.	[Bosse, Janine T.; Soares-Bazzolli, Denise M.; Li, Yanwen; Langford, Paul R.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London, England; [Soares-Bazzolli, Denise M.] Univ Fed Vicosa, Lab Genet Mol Microorganismos, Dept Microbiol, DMB,BIOAGRO, Vicosa, MG, Brazil; [Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Tucker, Alexander W.; Maskell, Duncan J.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Rycroft, Andrew N.] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hatfield, Herts, England	Imperial College London; Universidade Federal de Vicosa; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of London; University of London Royal Veterinary College	Bosse, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Paediat Sect, St Marys Campus, London, England.	j.bosse@imperial.ac.uk	Langford, Paul/AAU-4189-2020; Chaudhuri, Roy/E-3774-2014	Langford, Paul/0000-0002-6368-4724; Chaudhuri, Roy/0000-0001-5037-2695; Tucker, Alexander William/0000-0003-0062-0843; Maglennon, Gareth/0000-0001-9783-7269; Bosse, Janine/0000-0002-8491-4779	Biotechnology and Biological Sciences Research Council [BB/G020744/1, BB/G019177/1, BB/G019274/1, BB/G018553/1]; UK Department for Environment, Food and Rural Affairs; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [PDE 201840/2011-1]; BBSRC Imperial-Brazil partnering award [BB/K021109/1]; Zoetis; BBSRC [BB/G020744/1, BB/G018553/1, BB/G019274/1, BB/K021109/1, BB/G019177/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K021109/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC Imperial-Brazil partnering award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Longer and Larger (LoLa) grant from the Biotechnology and Biological Sciences Research Council (grant numbers BB/G020744/1, BB/G019177/1, BB/G019274/1 and BB/G018553/1), the UK Department for Environment, Food and Rural Affairs, and Zoetis (formerly Pfizer Animal Health) awarded to the Bacterial Respiratory Diseases of Pigs-1 Technology (BRaDP1T) consortium, a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant number PDE 201840/2011-1) awarded to DMSB, and a BBSRC Imperial-Brazil partnering award (BB/K021109/1) awarded to PRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2008, INFECT IMMUN, V76, P5608, DOI 10.1128/IAI.00085-08; Baltes N, 2005, INFECT IMMUN, V73, P4614, DOI 10.1128/IAI.73.8.4614-4619.2005; Baltes N, 2004, VET MICROBIOL, V102, P67, DOI 10.1016/j.vetmic.2004.05.002; Baltes N, 2003, FEMS MICROBIOL LETT, V220, P41, DOI 10.1016/S0378-1097(03)00064-8; Baltes N, 2003, INFECT IMMUN, V71, P6784, DOI 10.1128/IAI.71.12.6784-6792.2003; Baltes N, 2001, INFECT IMMUN, V69, P472, DOI 10.1128/IAI.69.1.472-478.2001; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Bosse JT, 2010, J BACTERIOL, V192, P2414, DOI 10.1128/JB.01513-09; Bosse JT, 2009, APPL ENVIRON MICROB, V75, P6124, DOI 10.1128/AEM.00809-09; Bosse JT, 2009, FEMS MICROBIOL LETT, V298, P124, DOI 10.1111/j.1574-6968.2009.01706.x; Bosse JT, 2004, FEMS MICROBIOL LETT, V233, P277, DOI 10.1111/j.1574-6968.2004.tb09492.x; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bosse JT, 2001, J BACTERIOL, V183, P1242, DOI 10.1128/JB.183.4.1242-1247.2001; Buettner FFR, 2008, VET MICROBIOL, V127, P106, DOI 10.1016/j.vetmic.2007.08.005; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; Foote SJ, 2008, J BACTERIOL, V190, P1495, DOI 10.1128/JB.01845-07; Fung WWM, 2006, J CLIN MICROBIOL, V44, P4222, DOI 10.1128/JCM.01376-06; Gottschalk M, 2006, DIS SWINE, P563; INZANA TJ, 1993, INFECT IMMUN, V61, P1682, DOI 10.1128/IAI.61.5.1682-1686.1993; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jacobsen I, 2005, INFECT IMMUN, V73, P3740, DOI 10.1128/IAI.73.6.3740-3744.2005; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; JANSEN R, 1995, INFECT IMMUN, V63, P27, DOI 10.1128/IAI.63.1.27-37.1995; Jones RM, 2003, APPL ENVIRON MICROB, V69, P5627, DOI 10.1128/AEM.69.9.5627-5635.2003; Li G, 2012, J BACTERIOL, V194, P6606, DOI 10.1128/JB.01650-12; Lin LW, 2007, FEMS MICROBIOL LETT, V274, P55, DOI 10.1111/j.1574-6968.2007.00813.x; Maas A, 2006, VACCINE, V24, P7226, DOI 10.1016/j.vaccine.2006.06.047; Maas A, 2006, INFECT IMMUN, V74, P4124, DOI 10.1128/IAI.00133-06; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; Mullen LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003991; O'Neill C, 2010, VET REC, V167, P661, DOI 10.1136/vr.c5106; Oswald W, 1999, FEMS MICROBIOL LETT, V179, P153, DOI 10.1111/j.1574-6968.1999.tb08721.x; Ramjeet Mahendrasingh, 2008, Animal Health Research Reviews, V9, P25, DOI 10.1017/S1466252307001338; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Tonpitak W, 2002, INFECT IMMUN, V70, P7120, DOI 10.1128/IAI.70.12.7120-7125.2002; Tonpitak W, 2000, INFECT IMMUN, V68, P1164, DOI 10.1128/IAI.68.3.1164-1170.2000; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10; Zhan BJ, 2010, J BACTERIOL, V192, P5846, DOI 10.1128/JB.00867-10	39	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111252	10.1371/journal.pone.0111252	http://dx.doi.org/10.1371/journal.pone.0111252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409017	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200003
J	McAninch, D; Thomas, P				McAninch, Dale; Thomas, Paul			Identification of Highly Conserved Putative Developmental Enhancers Bound by SOX3 in Neural Progenitors Using ChIP-Seq	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; HUMAN GENOME; DIFFERENTIATION; EXPRESSION; BINDING; SPECIFICATION; NEUROGENESIS; MECHANISMS; SEQUENCES; PROFILES	The transcription factor SOX3 is expressed within most neural progenitor (NP) cells of the vertebrate central nervous system (CNS) and is essential for normal brain development in mice and humans. However, despite the widespread expression of Sox3, CNS defects in null mice are relatively mild due to functional redundancy with the other SOXB1 sub-group members Sox1 and Sox2. To further understand the molecular function of SOX3, we investigated the genome-wide binding profile of endogenous SOX3 in NP cells using ChIP-seq. SOX3 binding was identified at over 8,000 sites, most of which were intronic or intergeneic and were significantly associated with neurodevelopmental genes. The majority of binding sites were moderately or highly conserved (phastCons scores >0.1 and 0.5, respectively) and included the previously characterised, SOXB1-binding Nestin NP cell enhancer. Comparison of SOX3 and published ChIP-Seq data for the co-activator P300 in embryonic brain identified hundreds of highly conserved putative enhancer elements. In addition, we identified a subset of highly conserved putative enhancers for CNS development genes common to SOXB1 members in NP cells, all of which contained the SOX consensus motif (ACAAWR). Together these data implicate SOX3 in the direct regulation of hundreds of NP genes and provide molecular insight into the overlapping roles of SOXB1 proteins in CNS development.	[Thomas, Paul] Univ Adelaide, Dept Biochem, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia; Univ Adelaide, Robinson Res Inst, Adelaide, SA 5000, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide	Thomas, P (corresponding author), Univ Adelaide, Dept Biochem, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia.	paul.thomas@adelaide.edu.au	Thomas, Paul Q/K-4497-2012	McAninch, Dale/0000-0001-9735-6553	Australian Research Council [DP140103965]	Australian Research Council(Australian Research Council)	This work was fully funded by the Australian Research Council. Funding received by PT Grant #: DP140103965, URL: http://www.arc.gov.au/. No other sources of funding were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bery A, 2013, CEREB CORTEX; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Conboy CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001061; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan R, 2012, BLOOD, V119, pE139, DOI 10.1182/blood-2011-12-396754; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Holmberg J, 2008, DEVELOPMENT, V135, P1843, DOI 10.1242/dev.020180; Hughes J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003290; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KE, 2014, P NATL ACAD SCI USA, V111, P2794, DOI 10.1073/pnas.1308758111; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Oosterveen T, 2013, P NATL ACAD SCI USA, V110, P7330, DOI 10.1073/pnas.1220010110; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rizzoti K, 2005, REV ENDOCR METAB DIS, V6, P161, DOI 10.1007/s11154-005-3047-7; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rogers N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095356; Rogers N, 2013, GENE EXPR PATTERNS, V13, P240, DOI 10.1016/j.gep.2013.04.004; Shih YH, 2010, DEVELOPMENT, V137, P2671, DOI 10.1242/dev.054130; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stuebner S, 2010, DEV DYNAM, V239, P246, DOI 10.1002/dvdy.22127; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoshida M, 2014, MECH DEVELOP, V132, P59, DOI 10.1016/j.mod.2014.01.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	45	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113361	10.1371/journal.pone.0113361	http://dx.doi.org/10.1371/journal.pone.0113361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409526	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200102
J	Yin, ZW; Li, LZ				Yin, Zi-Wei; Li, Li-Zhen			Description of Bryantinus gen. n. from Sarawak, and New Distributional Records for Cerochusa cilioceps in Thailand (Coleoptera: Staphylinidae: Pselaphinae)	PLOS ONE			English	Article							BORNEO	A new genus and species of the subtribe Batrisina from western Sarawak, Bryantinus matangus gen. et sp. n., is described, illustrated, and compared with related taxa. In addition, examination of a small series of batrisine material from Thailand revealed a new country record for Cerochusa cilioceps Yin & Nomura, which was previously known only from the island of Hainan in southern China.	[Yin, Zi-Wei; Li, Li-Zhen] Shanghai Normal Univ, Coll Life & Environm Sci, Dept Biol, Shanghai, Peoples R China	Shanghai Normal University	Li, LZ (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, Dept Biol, Shanghai, Peoples R China.	pselaphinae@gmail.com			National Science Foundation of China [31172134]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (No. 31172134). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutel RG, 2005, COLEOPTERA BEETLES V, V1, P35, DOI [10.1515/9783110904550, DOI 10.1515/9783110904550]; Chandler D.S., 1990, P1175; Chandler D.S., 2001, MEMOIRS ENTOMOLOGY I, V15, P1; Chandler DS, 2000, GUIA ILLUSTRADA GENE, P49; Chandler DS, 1997, AGR HDB, V529-31; Jeannel R, 1962, BIOL AMERIQUE AUSTRA, P295; Kurbatov S, 2007, RUSSIAN ENTOMOLOGICA, V16, P275; Lobl I., 1973, Revue Suisse de Zoologie, V80, P151; LOBL I, 1975, Revue Suisse de Zoologie, V82, P563; LOBL I, 1979, REV SUISSE ZOOL, V86, P285; Lobl I., 2004, CATALOGUE PALAEARCTI, V2; Newton AF, 1995, BIOL PHYLOGENY CLASS, V1, P219; Nomura S., 2003, Serangga, V8, P55; Nomura S, 2000, TAXONOMICAL STUDIES; Nomura S, 2008, INSECT INVENTORY PRO, P253; Nomura Shuhei, 2013, Japanese Journal of Systematic Entomology, V19, P233; Nomura Shuhei, 2005, Serangga, V10, P1; Nomura Shuhei, 2008, Memoirs of the National Science Museum (Tokyo), P13; Park O., 1942, NW U STUDIES BIOL SC, V1, P1, DOI [10.5962/bhl.title.6838, DOI 10.5962/BHL.TITLE.6838]; PARK ORLANDO, 1952, CHICAGO ACAD SCI SPEC PUBL, V9, P1; Raffray A., 1894, REV ENTOMOLOGIE, V13, P197; Raffray A, 1890, REV ENTOMOLOGIE, V9, P1; Thomas, 2000, AM BEETLES, P272, DOI DOI 10.5860/CHOICE.38-5558; Yin ZW, 2012, ZOOTAXA, P62; Yin ZW, 2014, REV SUISSE ZOOL, V121, P11; Yin ZW, 2013, ZOOTAXA, V3718, P477, DOI 10.11646/zootaxa.3718.5.4	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113474	10.1371/journal.pone.0113474	http://dx.doi.org/10.1371/journal.pone.0113474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409318	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200125
J	Chen, MX; Wu, LD; Wu, F; Wittert, GA; Norman, RJ; Robker, RL; Heilbronn, LK				Chen, Miaoxin; Wu, Linda; Wu, Fang; Wittert, Gary A.; Norman, Robert J.; Robker, Rebecca L.; Heilbronn, Leonie K.			Impaired Glucose Metabolism in Response to High Fat Diet in Female Mice Conceived by In Vitro Fertilization (IVF) or Ovarian Stimulation Alone	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; BIRTH-WEIGHT; CHILDREN BORN; PREIMPLANTATION PERIOD; SECRETORY DYSFUNCTION; ASSISTED REPRODUCTION; VASCULAR DYSFUNCTION; INSULIN-RESISTANCE; EMBRYO DEVELOPMENT; ENERGY-METABOLISM	Individuals conceived by in vitro fertilization (IVF) may be at increased risk of cardio-metabolic disorders. We recently reported that IVF conceived male mice displayed impaired glucose metabolism at normal and high body weights. In this study, we examined glucose metabolism in mature female C57BL/6J mice that were conceived by natural conception (NC), by ovarian stimulation (OS) or by IVF following chow or high-fat diet (HFD) for 8 weeks. By design, litter size was comparable between groups, but interestingly the birth weight of IVF and OS females was lower than NC females (p <= 0.001). Mature IVF female mice displayed increased fasting glucose as compared to NC and OS mice, irrespective of diet. Mature IVF and OS mice were also more susceptible to the metabolic consequences of high fat diet as compared with NC females, with impaired glucose tolerance (p <= 0.01), whereas peripheral insulin resistance and increased hepatic expression of gluconeogenic genes Ppargc1 alpha, Pck1 and G6pc was observed in IVF mice only (p<0.05). This study suggests that ovarian stimulation alone and IVF program distinct metabolic effects in females, but that high fat diet may be required to unmask these effects. This study adds to the growing body of literature that assisted reproduction procedures may increase the risk of developing type 2 diabetes in an obesity prone environment.	[Chen, Miaoxin; Wu, Linda; Norman, Robert J.; Robker, Rebecca L.; Heilbronn, Leonie K.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Chen, Miaoxin] Guiyang Med Coll, Affiliated Hosp, Dept Obstet & Gynaecol, Guiyang 550004, Peoples R China; [Chen, Miaoxin; Wu, Fang; Wittert, Gary A.; Heilbronn, Leonie K.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [Wu, Fang] Guiyang Med Coll, Affiliated Hosp, Dept Emergency, Guiyang 550004, Peoples R China	Robinson Research Institute; University of Adelaide; Guizhou Medical University; University of Adelaide; Guizhou Medical University	Heilbronn, LK (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia.	leonie.heilbronn@adelaide.edu.au	wittert, gary/AAE-2398-2019; Norman, Robert J/A-1155-2007; Heilbronn, Leonie/H-1874-2013	Norman, Robert J/0000-0002-3118-3896; Robker, Rebecca/0000-0002-1538-4604; Heilbronn, Leonie/0000-0003-2106-7303; Wittert, Gary/0000-0001-6818-6065	ARC Future Fellowship [FT120100027]	ARC Future Fellowship(Australian Research Council)	This work and LH was supported by ARC Future Fellowship FT120100027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Bermejo-Alvarez P, 2011, REPRODUCTION, V141, P563, DOI 10.1530/REP-10-0482; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Ceelen M, 2007, J CLIN ENDOCR METAB, V92, P3417, DOI 10.1210/jc.2006-2896; Ceelen M, 2009, HUM REPROD, V24, P2788, DOI 10.1093/humrep/dep273; Chen M, 2012, J DIABETES RES CLIN, V1, P16, DOI [DOI 10.7243/2050-0866-1-16, 10.7243/2050-0866-1-16]; Chen MX, 2014, DIABETES, V63, P3189, DOI 10.2337/db14-0103; Chen MX, 2011, CURR DIABETES REV, V7, P426, DOI 10.2174/157339911797579151; Crescenzo R, 2003, DIABETES, V52, P1090, DOI 10.2337/diabetes.52.5.1090; D'Angelo DV, 2011, FERTIL STERIL, V96, P314, DOI 10.1016/j.fertnstert.2011.05.073; Donjacour A, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113134; Edwards LJ, 2002, AM J PHYSIOL-REG I, V283, pR669, DOI 10.1152/ajpregu.00736.2001; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Ertzeid G, 2001, HUM REPROD, V16, P221, DOI 10.1093/humrep/16.2.221; ERTZEID G, 1992, J REPROD FERTIL, V96, P649, DOI 10.1530/jrf.0.0960649; Feuer SK, 2014, ENDOCRINOLOGY, V155, P1956, DOI 10.1210/en.2013-2081; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Gardner DS, 2004, HYPERTENSION, V43, P1290, DOI 10.1161/01.HYP.0000126991.67203.7b; Gaudoin M, 2003, AM J OBSTET GYNECOL, V188, P611, DOI 10.1067/mob.2003.5; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Kelley RL, 2006, AM J PHYSIOL-ENDOC M, V291, pE761, DOI 10.1152/ajpendo.00079.2006; Klemetti R, 2010, FERTIL STERIL, V93, P1157, DOI 10.1016/j.fertnstert.2008.12.025; Kwong WY, 2007, MOL REPROD DEV, V74, P48, DOI 10.1002/mrd.20606; Kwong WY, 2000, DEVELOPMENT, V127, P4195; La Bastide-Van Gemert S, 2014, HUM REPROD, V29, P510, DOI 10.1093/humrep/det448; Le F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106070; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MITTWOCH U, 1993, HUM REPROD, V8, P1550, DOI 10.1093/oxfordjournals.humrep.a137889; Nagy A., 2003, MANIPULATING MOUSE E; Ombelet W, 2006, HUM REPROD, V21, P1025, DOI 10.1093/humrep/dei419; Ong KK, 2004, EUR J ENDOCRINOL, V151, pU131, DOI 10.1530/eje.0.151U131; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Pelinck MJ, 2010, REPROD BIOMED ONLINE, V21, P245, DOI 10.1016/j.rbmo.2010.04.024; Pelkonen S, 2010, HUM REPROD, V25, P914, DOI 10.1093/humrep/dep477; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; Rexhaj E, 2013, J CLIN INVEST, V123, P5052, DOI 10.1172/JCI68943; Sakka SD, 2010, FERTIL STERIL, V94, P1693, DOI 10.1016/j.fertnstert.2009.09.049; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Scherrer U, 2012, CIRCULATION, V125, P1890, DOI 10.1161/CIRCULATIONAHA.111.071183; Scott KA, 2010, BIOL REPROD, V83, P220, DOI 10.1095/biolreprod.109.082826; Van der Auwera I, 2001, HUM REPROD, V16, P1237, DOI 10.1093/humrep/16.6.1237; Van der Auwera I, 1999, HUM REPROD, V14, P2570, DOI 10.1093/humrep/14.10.2570; Wander PL, 2013, DIABETES CARE, V36, P289, DOI 10.2337/dc12-0198; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Wu LDL, 2012, MOL ENDOCRINOL, V26, P562, DOI 10.1210/me.2011-1362; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	62	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113155	10.1371/journal.pone.0113155	http://dx.doi.org/10.1371/journal.pone.0113155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405530	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300088
J	Kravchenko-Balasha, N; Simon, S; Levine, RD; Remacle, F; Exman, I				Kravchenko-Balasha, Nataly; Simon, Simcha; Levine, R. D.; Remacle, F.; Exman, Iaakov			Computational Surprisal Analysis Speeds-Up Genomic Characterization of Cancer Processes	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; INFORMATION; EXPRESSION	Surprisal analysis is increasingly being applied for the examination of transcription levels in cellular processes, towards revealing inner network structures and predicting response. But to achieve its full potential, surprisal analysis should be integrated into a wider range computational tool. The purposes of this paper are to combine surprisal analysis with other important computation procedures, such as easy manipulation of the analysis results - e.g. to choose desirable result subsets for further inspection -, retrieval and comparison with relevant datasets from public databases, and flexible graphical displays for heuristic thinking. The whole set of computation procedures integrated into a single practical tool is what we call Computational Surprisal Analysis. This combined kind of analysis should facilitate significantly quantitative understanding of different cellular processes for researchers, including applications in proteomics and metabolomics. Beyond that, our vision is that Computational Surprisal Analysis has the potential to reach the status of a routine method of analysis for practitioners. The resolving power of Computational Surprisal Analysis is here demonstrated by its application to a variety of cellular cancer process transcription datasets, ours and from the literature. The results provide a compact biological picture of the thermodynamic significance of the leading gene expression phenotypes in every stage of the disease. For each transcript we characterize both its inherent steady state weight, its correlation with the other transcripts and its variation due to the disease. We present a dedicated website to facilitate the analysis for researchers and practitioners.	[Kravchenko-Balasha, Nataly] CALTECH, Div Chem, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA; [Simon, Simcha; Exman, Iaakov] Azrieli, Jerusalem Coll Engn, Software Engn Dept, Jerusalem, Israel; [Levine, R. D.; Remacle, F.] Hebrew Univ Jerusalem, Inst Chem, Jerusalem, Israel; [Levine, R. D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Remacle, F.] Univ Liege, Dept Chim, Liege, Belgium	California Institute of Technology; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Liege	Exman, I (corresponding author), Azrieli, Jerusalem Coll Engn, Software Engn Dept, Jerusalem, Israel.	iaakov@jce.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479; Remacle, Francoise/0000-0001-7434-5245	EMBO postdoctoral fellowship; European Commission FP7 Future and Emerging Technologies- Open Project BAMBI [618024]	EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); European Commission FP7 Future and Emerging Technologies- Open Project BAMBI	This work was supported by an EMBO postdoctoral fellowship to N.K.B. and European Commission FP7 Future and Emerging Technologies- Open Project BAMBI 618024 (to FR and RDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057748; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Exman I, 2013, ICSOFT 2012 COMMUNIC, V411, P203, DOI DOI 10.1007/978-3-642-45404-2_; Exman I, 2012, COMPUTATIONAL SURPRI; Facciotti MT, 2013, P NATL ACAD SCI USA, V110, P19181, DOI 10.1073/pnas.1317876110; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gamma E., 1994, DESIGN PATTERNS ELEM; Gross A, 2013, BIOCHEMISTRY-US, V52, P1641, DOI 10.1021/bi3016982; Kravchenko-Balasha N, 2012, P NATL ACAD SCI USA, V109, P4702, DOI 10.1073/pnas.1200790109; Kravchenko-Balasha N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-42; Kravchenko-Balasha N, 2011, MOL BIOSYST, V7, P1501, DOI 10.1039/c0mb00284d; Kravchenko-Balasha N, 2009, J BIOL CHEM, V284, P11717, DOI 10.1074/jbc.M900217200; Laidler KJ, 1996, PURE APPL CHEM, V68, P149, DOI 10.1351/pac199668010149; LEVINE RD, 1978, ANNU REV PHYS CHEM, V29, P59, DOI 10.1146/annurev.pc.29.100178.000423; LEVINE RD, 1974, ACCOUNTS CHEM RES, V7, P393, DOI 10.1021/ar50084a001; LEVINE RD, 1980, J PHYS A-MATH GEN, V13, P91, DOI 10.1088/0305-4470/13/1/011; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Minner S, 2012, CANCER-AM CANCER SOC, V118, P1268, DOI 10.1002/cncr.26436; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Remacle F, 2010, P NATL ACAD SCI USA, V107, P10324, DOI 10.1073/pnas.1005283107; Simon S, 2012, THESIS JERUSALEM COL; Stickel JS, 2009, CANCER IMMUNOL IMMUN, V58, P1407, DOI 10.1007/s00262-008-0655-6; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Walther MM, 1998, J UROLOGY, V159, P718, DOI 10.1016/S0022-5347(01)63709-1; Weisstein EW, 2013, SINGULAR VALUE DECOM; Zadran S, 2013, P NATL ACAD SCI US	27	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e108549	10.1371/journal.pone.0108549	http://dx.doi.org/10.1371/journal.pone.0108549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405334	Green Published, gold, Green Accepted			2022-12-27	WOS:000347121300003
J	Yang, H; Ye, EL; Si, GX; Chen, LM; Cai, LQ; Ye, CF; Zhang, C; Lu, XM				Yang, Hong; Ye, Enling; Si, Guangxin; Chen, Liangmiao; Cai, Lingqiao; Ye, Chengfu; Zhang, Chi; Lu, Xuemian			Adiponectin Gene Polymorphism rs2241766 T/G Is Associated with Response to Pioglitazone Treatment in Type 2 Diabetic Patients from Southern China	PLOS ONE			English	Article							IRANIAN POPULATION RELATION; INSULIN-RESISTANCE; OBESITY	Introduction: Insulin sensitizing drugs such as pioglitazone are not uniformly treatment effective among individual type 2 diabetic patients. Here, the relationship of pioglitazone efficacy to single nucleotide polymorphisms (SNP) of the adiponectin gene, a critical gene directly regulated by the drug, was examined in a cohort of Chinese Han type 2 diabetic patients. Methods: Eighty type 2 diabetic patients were treated with pioglitazone (15 mg/day) for 12 weeks without interruption of their current therapeutic regimen. Fasting plasma glucose, fasting insulin, homeostasis model assessment for insulin resistance (HOMA-IR), and glycated hemoglobin (HbA1c%) were collected both prior to and following pioglitazone treatment. Response to pioglitazone was defined as a decrease of at least 15% in HbA1c% levels. Three regions of the adiponectin gene containing SNPs (promoter, intron 2 and exon 2, and exon 3) were amplified and sequenced to determine genotype. Results: Serum adiponectin levels were significantly increased (p<0.001) whereas fasting plasma glucose, fasting insulin, HOMA-IR, and HbA1c% values were significantly decreased relative to baseline measurements (p<0.001). Response of patients with TG and TT genotypes at rs2241766 (exon2; 52.9% vs. 12.7%, respectively p = 0.001) was statistically significant relative to all other patients. Amongst rs2241766 TG and TT patients, the mean decrease in HbA1c% levels was greater where the genotype was TG (1.15 +/- 0.80 vs. 0.52 +/- 0.64, p = 0.001). Conclusions: The adiponectin gene polymorphism rs2241766 T/G is associated with pioglitazone efficacy in type 2 diabetic patients, and status of the polymorphism may be an important clinical factor to consider prior to pioglitazone treatment.	[Yang, Hong; Ye, Enling; Chen, Liangmiao; Cai, Lingqiao; Ye, Chengfu; Lu, Xuemian] Wenzhou Med Univ, Dept Endocrinol, Hosp 3, Ruian, Zhejiang, Peoples R China; [Yang, Hong; Ye, Enling; Chen, Liangmiao; Cai, Lingqiao; Ye, Chengfu; Zhang, Chi; Lu, Xuemian] Wenzhou Med Univ, Affiliated Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Wenzhou, Peoples R China; [Si, Guangxin] Shangdong Jining 1 Peoples Hosp, Dept Endocrinol, Jining, Shangdong, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Lu, XM (corresponding author), Wenzhou Med Univ, Dept Endocrinol, Hosp 3, Ruian, Zhejiang, Peoples R China.	lu89118@medmail.com.cn	Cai, Lu/AAG-9920-2019		Wenzhou Science and Technology Plan [Y20080007]	Wenzhou Science and Technology Plan	This study was supported by a research grant from the Wenzhou Science and Technology Plan (Y20080007, to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji Vijayam, 2013, Indian J Endocrinol Metab, V17, P709, DOI 10.4103/2230-8210.113766; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bin Alwi Z, 2005, MALAYS J MED SCI, V12, P4; Bouatia-Naji N, 2006, DIABETES, V55, P545, DOI 10.2337/diabetes.55.02.06.db05-0971; Daien CI, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/386148; Derosa G, 2007, VASC HEALTH RISK MAN, V3, P665; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; Hasani-Ranjbar S, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-14; Hayes DF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-37; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Li Z, 2008, DIABETES OBES METAB, V10, P794, DOI 10.1111/j.1463-1326.2008.00905.x; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Namvaran F, 2012, MOL BIOL REP, V39, P5511, DOI 10.1007/s11033-011-1354-5; Namvaran F, 2011, EUR J PHARMACOL, V671, P1, DOI 10.1016/j.ejphar.2011.09.158; Perez A, 2009, CURR MED RES OPIN, V25, P2915, DOI 10.1185/03007990903350011; Schwarz PEH, 2006, DIABETES CARE, V29, P1645, DOI 10.2337/dc05-2123; Subbaramaiah K, 2012, CANCER PREV RES, V5, P1183, DOI 10.1158/1940-6207.CAPR-12-0201; Takahashi M, 2000, INT J OBESITY, V24, P861, DOI 10.1038/sj.ijo.0801244; Yang WS, 2007, AM J CLIN NUTR, V86, P509, DOI 10.1093/ajcn/86.2.509; Ye EL, 2014, LIFE SCI, V98, P55, DOI 10.1016/j.lfs.2013.12.232	20	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112480	10.1371/journal.pone.0112480	http://dx.doi.org/10.1371/journal.pone.0112480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405601	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300033
J	Li, JL; Li, N; Li, FC; Zou, T; Yu, SX; Wang, YC; Qin, S; Wang, GY				Li, Jialin; Li, Nan; Li, Fuchao; Zou, Tao; Yu, Shuxian; Wang, Yinchu; Qin, Song; Wang, Guangyi			Spatial Diversity of Bacterioplankton Communities in Surface Water of Northern South China Sea	PLOS ONE			English	Article							PHYTOPLANKTON GROWTH; NUTRIENT LIMITATION; MICROBIAL DIVERSITY; MARINE-SEDIMENTS; ABUNDANCE; COASTAL; ASSEMBLAGES; POPULATION; LIBRARIES; SUMMER	The South China Sea is one of the largest marginal seas, with relatively frequent passage of eddies and featuring distinct spatial variation in the western tropical Pacific Ocean. Here, we report a phylogenetic study of bacterial community structures in surface seawater of the northern South China Sea (nSCS). Samples collected from 31 sites across large environmental gradients were used to construct clone libraries and yielded 2,443 sequences grouped into 170 OTUs. Phylogenetic analysis revealed 23 bacterial classes with major components alpha-, beta- and gamma-Proteobacteria, as well as Cyanobacteria. At class and genus taxon levels, community structure of coastal waters was distinctively different from that of deep-sea waters and displayed a higher diversity index. Redundancy analyses revealed that bacterial community structures displayed a significant correlation with the water depth of individual sampling sites. Members of alpha-Proteobacteria were the principal component contributing to the differences of the clone libraries. Furthermore, the bacterial communities exhibited heterogeneity within zones of upwelling and anticyclonic eddies. Our results suggested that surface bacterial communities in nSCS had two-level patterns of spatial distribution structured by ecological types (coastal VS. oceanic zones) and mesoscale physical processes, and also provided evidence for bacterial phylogenetic phyla shaped by ecological preferences.	[Li, Jialin; Li, Nan; Yu, Shuxian; Wang, Yinchu; Qin, Song] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Biol & Bioresource Utilizat, Yantai, Peoples R China; [Li, Fuchao] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zou, Tao] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Peoples R China; [Yu, Shuxian; Wang, Yinchu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Guangyi] Tianjin Univ, Sch Environm Sci & Engn, Tianjin Univ Ctr Marine Environm Ecol, Tianjin 300072, Peoples R China; [Wang, Guangyi] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tianjin University; University of Hawaii System; University of Hawaii Manoa	Qin, S (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Biol & Bioresource Utilizat, Yantai, Peoples R China.	sqin@yic.ac.cn; gywang@tju.edu.cn		Li, Nan/0000-0003-1782-6610; li, jia lin/0000-0003-1663-2259	National Natural Science Foundation of China [41106100]; CAS/SAFEA International Partnership Program for Creative Research Teams "Representative environmental processes and resources effects in coastal zone''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams "Representative environmental processes and resources effects in coastal zone''	This research work was financially supported by grants from the National Natural Science Foundation of China 41106100 and the CAS/SAFEA International Partnership Program for Creative Research Teams "Representative environmental processes and resources effects in coastal zone''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2013, ISME J, V7, P256, DOI 10.1038/ismej.2012.108; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Bowman JP, 2005, MICROB ECOL, V49, P451, DOI 10.1007/s00248-004-0070-2; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Cai HY, 2008, MICROB ECOL, V56, P751, DOI 10.1007/s00248-008-9394-7; Chen CTA, 2001, MAR CHEM, V75, P281, DOI 10.1016/S0304-4203(01)00041-X; Chen YLL, 2004, CONT SHELF RES, V24, P527, DOI 10.1016/j.csr.2003.12.006; Copley J, 2002, NATURE, V415, P572, DOI 10.1038/415572a; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; Dang HY, 2013, APPL ENVIRON MICROB, V79, P121, DOI 10.1128/AEM.01889-12; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrier M, 2002, J APPL MICROBIOL, V92, P706, DOI 10.1046/j.1365-2672.2002.01576.x; Ghiglione JF, 2012, P NATL ACAD SCI USA, V109, P17633, DOI 10.1073/pnas.1208160109; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hu J., 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; ISHIDA Y, 1986, MAR ECOL PROG SER, V30, P197, DOI 10.3354/meps030197; Jiang HC, 2007, GEOMICROBIOL J, V24, P505, DOI 10.1080/01490450701572473; Kan J, 2008, AQUAT MICROB ECOL, V51, P55, DOI 10.3354/ame01177; Lai XT, 2007, ISME J, V1, P756, DOI 10.1038/ismej.2007.51; Lee K, 2011, ENERG ENVIRON SCI, V4, P1133, DOI 10.1039/c0ee00663g; Li L, 2014, CHINESE SCI BULL, V59, P981, DOI 10.1007/s11434-013-0106-4; Liu FF, 2013, J MARINE SYST, V123, P33, DOI 10.1016/j.jmarsys.2013.04.005; [刘恒彪 Liu Hengbiao], 2011, [光学学报, Acta Optica Sinica], V31, P133; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lydell C, 2004, MICROB ECOL, V48, P263, DOI 10.1007/s00248-003-1068-x; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Morton B, 2001, MAR POLLUT BULL, V42, P1236, DOI 10.1016/S0025-326X(01)00240-5; Ning X, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002365; Ning XR, 2005, MAR ECOL PROG SER, V293, P17, DOI 10.3354/meps293017; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pinhassi J, 2006, AQUAT MICROB ECOL, V44, P241, DOI 10.3354/ame044241; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seymour JR, 2012, ENV MICROBIOL REP, V4, P548, DOI 10.1111/j.1758-2229.2012.00362.x; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Song H, 2012, J APPL MICROBIOL, V112, P79, DOI 10.1111/j.1365-2672.2011.05187.x; Urakawa H, 2010, APPL ENVIRON MICROB, V76, P2129, DOI 10.1128/AEM.02692-09; Wang GH, 2010, ACTA OCEANOL SIN, V29, P98, DOI 10.1007/s13131-010-0054-7; Wang J, 2010, INT J SYST EVOL MICR, V60, P985, DOI 10.1099/ijs.0.013862-0; Wang SF, 2008, HYDROBIOLOGIA, V596, P79, DOI 10.1007/s10750-007-9059-4; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xu J, 2008, DEEP-SEA RES PT I, V55, P1330, DOI 10.1016/j.dsr.2008.05.007; Yin KD, 2001, MAR ECOL PROG SER, V221, P17, DOI 10.3354/meps221017; Yin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055148; Yuan XC, 2011, CONT SHELF RES, V31, P1214, DOI 10.1016/j.csr.2011.04.012; Zehr J.P., 2011, MICROBE MAG, V6, P169, DOI [10.1128/microbe.6.169.1, DOI 10.1128/MICROBE.6.169.1]; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	56	11	16	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113014	10.1371/journal.pone.0113014	http://dx.doi.org/10.1371/journal.pone.0113014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402458	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700094
J	Yu, Q; Yin, GZ; Zhang, P; Song, ZP; Chen, YG; Zhang, DD; Hu, W				Yu, Qiang; Yin, Guizhi; Zhang, Peng; Song, Zhiping; Chen, Yueguang; Zhang, Dadong; Hu, Wei			Distinct Associations between Hypertension and Obstructive Sleep Apnea in Male and Female Patients	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; RISK-FACTOR; CARDIOVASCULAR-DISEASE; HEART-FAILURE; POPULATION; MECHANISMS; GENDER; COMMITTEE; STROKE; HEALTH	Obstructive sleep apnea (OSA) is highly associated with hypertension. However, the correlation between hypertension and OSA at different levels of severity and the influence of gender on that correlation are unclear. A total of 996 patients (776 males and 190 females) with OSA were recruited. The influence of gender on the correlation between hypertension and OSA at different stratifications of severity, based on the apnea-hypopnea index (AHI), was fully evaluated together with the major health risk factors obesity, age, and diabetes. Females with OSA were significantly older on average than males with OSA. Moreover, females had milder degrees of OSA on average than the extent of severity seen in males. The proportion of females with diabetes or hypertension was higher than that of males. The proportion of males with hypertension and obesity increased significantly with OSA, and age also increased with OSA. The percentage of females with hypertension at different degrees of OSA severity was stable at about 26% in the mild, moderate, and severe OSA groups. Among females, age was increased significantly in the moderate relative to the mild OSA group. Moreover, the proportion of obese subjects was increased significantly in the severe compared with the moderate OSA group. The proportions of males and females with diabetes were not significantly different among all OSA severity groups. An ordinal multivariate logistic regression analysis confirmed that hypertension, age, and obesity were associated with OSA severity in males, whereas only age and obesity were associated with OSA severity in females. Although the proportion of subjects with hypertension was higher in females with OSA than in males with OSA, the proportion of subjects with hypertension increased as the severity of OSA increased in males but not in females.	[Yu, Qiang; Yin, Guizhi; Zhang, Peng; Song, Zhiping; Chen, Yueguang; Zhang, Dadong; Hu, Wei] Ctr Hosp Minhang Dist, Dept Cardiol, Shanghai, Peoples R China		Hu, W (corresponding author), Ctr Hosp Minhang Dist, Dept Cardiol, Shanghai, Peoples R China.	18918169120@163.com			Shanghai Medical Key Specialty Construction Projects [ZK2012A24]	Shanghai Medical Key Specialty Construction Projects	This work was supported by Shanghai Medical Key Specialty Construction Projects (Class A, series number: ZK2012A24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud F, 2014, J CLIN INVEST, V124, P1454, DOI 10.1172/JCI70420; Aurora RN, 2013, LANCET RESP MED, V1, P329, DOI 10.1016/S2213-2600(13)70039-0; Becker HF, 2003, CIRCULATION, V107, P68, DOI 10.1161/01.CIR.0000042706.47107.7A; Bosc LVG, 2010, J CELL MOL MED, V14, P3, DOI 10.1111/j.1582-4934.2009.00929.x; Bradley TD, 2003, CIRCULATION, V107, P1822, DOI 10.1161/01.CIR.0000061758.05044.64; Cano-Pumarega I, 2011, AM J RESP CRIT CARE, V184, P1299, DOI 10.1164/rccm.201101-0130OC; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Devulapally K, 2009, HEART FAIL REV, V14, P155, DOI 10.1007/s10741-008-9101-2; Drager LF, 2006, J HUM HYPERTENS, V20, P523, DOI 10.1038/sj.jhh.1002012; Endeshaw YW, 2009, J GERONTOL A-BIOL, V64, P280, DOI 10.1093/gerona/gln011; FLETCHER EC, 1992, HYPERTENSION, V19, P555, DOI 10.1161/01.HYP.19.6.555; Haas DC, 2005, CIRCULATION, V111, P614, DOI 10.1161/01.CIR.0000154540.62381.CF; Johnson EO, 2006, SLEEP, V29, P1135, DOI 10.1093/sleep/29.9.1135; Kapsimalis F, 2002, SLEEP, V25, P499, DOI 10.1093/sleep/25.5.497; Konecny T, 2014, HYPERTENSION, V63, P203, DOI 10.1161/HYPERTENSIONAHA.113.00613; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Mohsenin V, 2003, SLEEP MED, V4, P523, DOI 10.1016/S1389-9457(03)00168-0; Mohsenin V, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0482-4; Morselli LL, 2012, PFLUG ARCH EUR J PHY, V463, P139, DOI 10.1007/s00424-011-1053-z; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Paiva Teresa, 2014, Handb Clin Neurol, V119, P251, DOI 10.1016/B978-0-7020-4086-3.00018-7; Pedrosa RP, 2011, HYPERTENSION, V58, P811, DOI 10.1161/HYPERTENSIONAHA.111.179788; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Quintana-Gallego E, 2004, RESP MED, V98, P984, DOI 10.1016/j.rmed.2004.03.002; Sforza E, 2011, EUR RESPIR J, V37, P1137, DOI 10.1183/09031936.00043210; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Sin DD, 2003, CHEST, V123, P1536, DOI 10.1378/chest.123.5.1536; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Wolk R, 2003, HYPERTENSION, V42, P1067, DOI 10.1161/01.HYP.0000101686.98973.A3; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	35	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113076	10.1371/journal.pone.0113076	http://dx.doi.org/10.1371/journal.pone.0113076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402499	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700108
J	Vidergar, N; Toplak, N; Kuntner, M				Vidergar, Nina; Toplak, Natasa; Kuntner, Matjaz			Streamlining DNA Barcoding Protocols: Automated DNA Extraction and a New cox1 Primer in Arachnid Systematics	PLOS ONE			English	Article							MOLECULAR SYSTEMATICS; SPIDERS ARANEAE; PHYLOGENY; EVOLUTION; PATTERNS	Background: DNA barcoding is a popular tool in taxonomic and phylogenetic studies, but for most animal lineages protocols for obtaining the barcoding sequences-mitochondrial cytochrome C oxidase subunit I (cox1 AKA CO1)-are not standardized. Our aim was to explore an optimal strategy for arachnids, focusing on the species-richest lineage, spiders by (1) improving an automated DNA extraction protocol, (2) testing the performance of commonly used primer combinations, and (3) developing a new cox1 primer suitable for more efficient alignment and phylogenetic analyses. Methodology: We used exemplars of 15 species from all major spider clades, processed a range of spider tissues of varying size and quality, optimized genomic DNA extraction using the MagMAX Express magnetic particle processor-an automated high throughput DNA extraction system-and tested cox1 amplification protocols emphasizing the standard barcoding region using ten routinely employed primer pairs. Results: The best results were obtained with the commonly used Folmer primers (LCO1490/HCO2198) that capture the standard barcode region, and with the C1-J-2183/C1-N-2776 primer pair that amplifies its extension. However, C1-J-2183 is designed too close to HCO2198 for well-interpreted, continuous sequence data, and in practice the resulting sequences from the two primer pairs rarely overlap. We therefore designed a new forward primer C1-J-2123 60 base pairs upstream of the C1-J-2183 binding site. The success rate of this new primer (93%) matched that of C1-J-2183. Conclusions: The use of C1-J-2123 allows full, indel-free overlap of sequences obtained with the standard Folmer primers and with C1-J-2123 primer pair. Our preliminary tests suggest that in addition to spiders, C1-J-2123 will also perform in other arachnids and several other invertebrates. We provide optimal PCR protocols for these primer sets, and recommend using them for systematic efforts beyond DNA barcoding.	[Vidergar, Nina; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia; [Kuntner, Matjaz] Hubei Univ, Ctr Behav Ecol & Evolut, Coll Life Sci, Wuhan, Peoples R China; [Kuntner, Matjaz] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA; [Toplak, Natasa] Omega Doo, Ljubljana, Slovenia; [Vidergar, Nina] ICGEB, Mol Virol Lab, Trieste, Italy	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Hubei University; Smithsonian Institution; Smithsonian National Museum of Natural History; International Center for Genetic Engineering & Biotechnology (ICGEB)	Kuntner, M (corresponding author), Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia.	kuntner@gmail.com	Kuntner, Matjaz/AAE-2195-2020		Slovenian Research Agency [P1-0236, MR-2013]; EU [C1536-1 1T440013]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); EU(European Commission)	Funding: This research was supported by the Slovenian Research Agency (grants P1-0236 and MR-2013) and a Swiss Contribution to the enlarged EU grant (C1536-1 1T440013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2013, SPIDER RES 21 CENTUR, P58; Agnarsson I, 2007, MOL PHYLOGENET EVOL, V43, P833, DOI 10.1016/j.ympev.2006.09.011; Agnarsson I, 2013, J ZOOL SYST EVOL RES, V51, P100, DOI 10.1111/jzs.12007; Ahrens D, 2013, MOL PHYLOGENET EVOL, V69, P83, DOI 10.1016/j.ympev.2013.05.016; Arnedo MA, 2004, MOL PHYLOGENET EVOL, V31, P225, DOI 10.1016/S1055-7903(03)00261-6; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bidegaray-Batista L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-317; Blagoev GA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-44; Brugler MR, 2013, ZOOL J LINN SOC-LOND, V169, P312, DOI 10.1111/zoj.12060; Cheng RC, 2010, J EXP BIOL, V213, P759, DOI 10.1242/jeb.037291; Coddington JA, 2005, SPIDERS N AM IDENTIF, P18; Cohen BL, 2011, ZOOL J LINN SOC-LOND, V162, P631, DOI 10.1111/j.1096-3642.2010.00682.x; Drummond A., 2011, GENEIOUS V 5 4; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francesconi A, 2008, J CLIN MICROBIOL, V46, P1978, DOI 10.1128/JCM.02246-07; Gomez-Zurita J, 2014, SYST ENTOMOL, V39, P111, DOI 10.1111/syen.12038; Gower DJ, 2011, MOL PHYLOGENET EVOL, V59, P698, DOI 10.1016/j.ympev.2011.03.002; Hanner R., 2009, DATA STANDARDS BARCO; Havird JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084080; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin MC, 2001, MOL PHYLOGENET EVOL, V18, P386, DOI 10.1006/mpev.2000.0883; Borrero-Perez GH, 2010, MOL PHYLOGENET EVOL, V57, P899, DOI 10.1016/j.ympev.2010.08.019; Horak M, 2012, INVERTEBR SYST, V26, P357, DOI 10.1071/IS12022; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kuntner M, 2013, MOL PHYLOGENET EVOL, V69, P961, DOI 10.1016/j.ympev.2013.06.008; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002; Lloyd RE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-496; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Maddison W., 2018, MESQUITE MODULAR SYS; McDonagh LM, 2011, PARASITOLOGY, V138, P1760, DOI 10.1017/S0031182011001089; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mladineo I, 2010, PARASITOLOGY, V137, P1013, DOI 10.1017/S0031182009991703; Redmond NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024344; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807	40	18	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113030	10.1371/journal.pone.0113030	http://dx.doi.org/10.1371/journal.pone.0113030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415202	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600026
J	Lynch, HJ; Schwaller, MR				Lynch, Heather J.; Schwaller, Mathew R.			Mapping the Abundance and Distribution of Adelie Penguins Using Landsat-7: First Steps towards an Integrated Multi-Sensor Pipeline for Tracking Populations at the Continental Scale	PLOS ONE			English	Article							IMAGERY	The last several years have seen an increased interest in the use of remote sensing to identify the location of penguin colonies in Antarctica, and the estimation of the abundance of breeding pairs contained therein. High-resolution (submeter) commercial satellite imagery (e.g., Worldview-1, Quickbird) is capable of colony detection and abundance estimation for both large and small colonies, and has already been used in a continental-scale survey of Adelie penguins. Medium-resolution Landsat imagery has been used successfully to detect the presence of breeding penguins, but has not been used previously for abundance estimation nor evaluated in terms of its minimum colony size detection threshold. We report on the first comprehensive analysis of the performance of these two methods for both detection and abundance estimation, identify the sensor-specific failure modes that can lead to both false positives and false negatives, and compare the abundance estimates of each method over multiple spatial scales. We find that errors of omission using Landsat imagery are low for colonies larger than similar to 10,000 breeding pairs. Both high-resolution and Landsat imagery can be used to obtain unbiased estimates of abundance, and while Landsat-derived abundance estimates have high variance for individual breeding colonies relative to estimates derived from high-resolution imagery, this difference declines as the spatial domain of interest is increased. At the continental scale, abundance estimates using the two methods are roughly equivalent. Our comparison of these two methods represents a bridge between the more developed high-resolution imagery, which can be expensive to obtain, and the medium-resolution Landsat-7 record, which is freely available; this comparison of methodologies represents an essential step towards integration of these disparate sources of data for regional assessments of Adelie population abundance and distribution.	[Lynch, Heather J.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Schwaller, Mathew R.] NASA, Goddard Space Flight Ctr, Mesoscale Atmospher Proc Lab, Greenbelt, MD 20771 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Lynch, HJ (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	heather.lynch@stonybrook.edu			National Science Foundation/Office of Polar Programs [1255058]; National Air and Space Administration [NNX14AC32G]; Directorate For Geosciences [1255058] Funding Source: National Science Foundation	National Science Foundation/Office of Polar Programs(National Science Foundation (NSF)); National Air and Space Administration; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	HJL was supported by National Science Foundation/Office of Polar Programs - Award No. 1255058; http://www.nsf.gov. HJL and MRS were supported by the National Air and Space Administration - Award No. NNX14AC32G; http://www.nasa.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; LaRue MA, 2014, POLAR BIOL, V37, P507, DOI 10.1007/s00300-014-1451-8; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; Lynch HJ, 2013, ANTARCT SCI, V25, P19, DOI 10.1017/S0954102012000600; Lynch HJ, 2012, POLAR BIOL, V35, P963, DOI 10.1007/s00300-011-1138-3; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; Mustafa O., 2012, PILOT STUDY MONITORI; Schwaller MR, 2013, REMOTE SENS ENVIRON, V139, P353, DOI 10.1016/j.rse.2013.08.009; SCHWALLER MR, 1984, INT J REMOTE SENS, V5, P849, DOI 10.1080/01431168408948868; Southwell C, 2009, POLAR REC, V45, P375, DOI 10.1017/S0032247409008444; Woehler EJ, 1993, DISTRIBUTION ABUNDAN	11	20	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113301	10.1371/journal.pone.0113301	http://dx.doi.org/10.1371/journal.pone.0113301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412466	gold, Green Submitted, Green Published			2022-12-27	WOS:000345253000036
J	Samocha-Bonet, D; Chisholm, DJ; Gribble, FM; Coster, ACF; Carpenter, KH; Jones, GRD; Holst, JJ; Greenfield, JR				Samocha-Bonet, Dorit; Chisholm, Donald J.; Gribble, Fiona M.; Coster, Adelle C. F.; Carpenter, Kevin H.; Jones, Graham R. D.; Holst, Jens J.; Greenfield, Jerry R.			Glycemic Effects and Safety of L-Glutamine Supplementation with or without Sitagliptin in Type 2 Diabetes Patients-A Randomized Study	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1	Background and Aims: L-glutamine is an efficacious glucagon-like peptide (GLP)-1 secretagogue in vitro. When administered with a meal, glutamine increases GLP-1 and insulin excursions and reduces postprandial glycaemia in type 2 diabetes patients. The aim of the study was to assess the efficacy and safety of daily glutamine supplementation with or without the dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin in well-controlled type 2 diabetes patients. Methods: Type 2 diabetes patients treated with metformin (n = 13, 9 men) with baseline glycated hemoglobin (HbA1c) 7.1 +/- 0.3% (54 +/- 4 mmol/mol) received glutamine (15 g bd)+ sitagliptin (100 mg/d) or glutamine (15 g bd) + placebo for 4 weeks in a randomized crossover study. Results: HbA1c (P = 0.007) and fructosamine (P = 0.02) decreased modestly, without significant time-treatment interactions (both P = 0.4). Blood urea increased (P<0.001) without a significant time-treatment interaction (P = 0.8), but creatinine and estimated glomerular filtration rate (eGFR) were unchanged (P >= 0.5). Red blood cells, hemoglobin, hematocrit, and albumin modestly decreased (P <= 0.02), without significant time-treatment interactions (P >= 0.4). Body weight and plasma electrolytes remained unchanged (P >= 0.2). Conclusions: Daily oral supplementation of glutamine with or without sitagliptin for 4 weeks decreased glycaemia in well-controlled type 2 diabetes patients, but was also associated with mild plasma volume expansion.	[Samocha-Bonet, Dorit; Chisholm, Donald J.; Greenfield, Jerry R.] Garvan Inst Med Res, Diabet & Metab Div, Sydney, NSW, Australia; [Samocha-Bonet, Dorit; Chisholm, Donald J.; Jones, Graham R. D.; Greenfield, Jerry R.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Gribble, Fiona M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Gribble, Fiona M.] Univ Cambridge, Dept Clin Biochem, Cambridge, England; [Coster, Adelle C. F.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Carpenter, Kevin H.] Univ Sydney, Discipline Genet Med, Sydney, NSW 2006, Australia; [Carpenter, Kevin H.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Jones, Graham R. D.] St Vincents Hosp, Dept Chem Pathol, Sydney, NSW 2010, Australia; [Holst, Jens J.] Univ Copenhagen, Panum Inst, NNF Ctr Basic Metab Res, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Greenfield, Jerry R.] St Vincents Hosp, Dept Endocrinol, Sydney, NSW 2010, Australia; [Greenfield, Jerry R.] St Vincents Hosp, Ctr Diabet, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Cambridge; University of Cambridge; University of New South Wales Sydney; University of Sydney; University of Sydney; St Vincents Hospital Sydney; University of Copenhagen; St Vincents Hospital Sydney; St Vincents Hospital Sydney	Samocha-Bonet, D (corresponding author), Garvan Inst Med Res, Diabet & Metab Div, Sydney, NSW, Australia.	d.samochabonet@garvan.org.au	Holst, Jens/AAA-8022-2022; Coster, Adelle CF/A-7234-2013; Coster, Adelle/AAX-4829-2020	Coster, Adelle CF/0000-0002-5572-6832; Coster, Adelle/0000-0002-5572-6832; Holst, Jens Juul/0000-0001-6853-3805; Samocha-Bonet, Dorit/0000-0001-9422-7852; Gribble, Fiona/0000-0002-4232-2898	National Health and Medical Research Council (NHMRC) of Australia [535949]; Diabetes Australia Research Trust; Investigator-Initiated Studies Program of Merck and Co. (Garvan Institute of Medical Research); NHMRC; Don Chisholm Fellowship; Australian Diabetes Society (ADS); Sachdev Foundation (the Garvan Research Foundation); Investigator-Initiated Studies Program of Merck and Co.	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; Investigator-Initiated Studies Program of Merck and Co. (Garvan Institute of Medical Research); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Don Chisholm Fellowship; Australian Diabetes Society (ADS); Sachdev Foundation (the Garvan Research Foundation); Investigator-Initiated Studies Program of Merck and Co.	The research was supported by a National Health and Medical Research Council (NHMRC) of Australia Project Grant no. 535949 (JRG), Diabetes Australia Research Trust (DART and JRG), and a research grant from the Investigator-Initiated Studies Program of Merck and Co. (Garvan Institute of Medical Research). JRG was supported by a Neil Hamilton Fairley Fellowship from NHMRC and the Don Chisholm Fellowship and DS-B by the Australian Diabetes Society (ADS), the Sachdev Foundation (the Garvan Research Foundation), and the Investigator-Initiated Studies Program of Merck and Co. grant awarded to the Garvan Institute of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PJD, 2011, BMJ-BRIT MED J, P342; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Galera SC, 2010, NUTRITION, V26, P375, DOI 10.1016/j.nut.2009.05.013; Gleeson M, 2008, J NUTR, V138, p2045S, DOI 10.1093/jn/138.10.2045S; Greenfield JR, 2009, AM J CLIN NUTR, V89, P106, DOI 10.3945/ajcn.2008.26362; Heyland D, 2006, CRIT CARE MED, V34, P2031, DOI 10.1097/01.CCM.0000226837.05375.08; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; HOUSE JD, 1994, J NUTR, V124, P396, DOI 10.1093/jn/124.3.396; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; Nauck MA, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.suppl_3.S190; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Samocha-Bonet D, 2011, J NUTR, V141, P1233, DOI 10.3945/jn.111.139824; Solis-Herrera C, 2013, DIABETES CARE, V36, P2756, DOI 10.2337/dc12-2072; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007	18	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113366	10.1371/journal.pone.0113366	http://dx.doi.org/10.1371/journal.pone.0113366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412338	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000043
J	Ban, B; Bai, B; Zhang, MM; Hu, JM; Ramanjaneya, M; Tan, BK; Chen, J				Ban, Bo; Bai, Bo; Zhang, Manman; Hu, Jiamiao; Ramanjaneya, Manjunath; Tan, Bee K.; Chen, Jing			Low Serum Cartonectin/CTRP3 Concentrations in Newly Diagnosed Type 2 Diabetes Mellitus: In Vivo Regulation of Cartonectin by Glucose	PLOS ONE			English	Article							C1Q/TNF-RELATED PROTEIN-3 CTRP-3; POLYCYSTIC-OVARY-SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ADIPOKINE; ADIPONECTIN; WOMEN; CTRP3/CARTDUCIN; PROLIFERATION; ASSOCIATION	Objectives: Cartonectin is a novel adipokine of the C1q complement/TNF-related protein (CTRP) superfamily, with glucose lowering effects, anti-inflammatory and cardio-protective properties. We sought to investigate circulating cartonectin concentrations in subjects with type 2 diabetes mellitus (T2DM) as well as age and BMI matched control subjects. We also examined the effects of a 2 hour 75 g oral glucose tolerance test (OGTT) on serum cartonectin concentrations in T2DM subjects. Design: Cross-sectional study [newly diagnosed (first discovery, not on any treatments) T2DM (n = 47) and control (n = 63) subjects]. Serum cartonectin was measured by ELISA. Results: Serum cartonectin concentrations were significantly lower in patients with T2DM compared to controls (P<0.05). Furthermore, serum cartonectin was significantly negatively correlated with glucose and CRP, and significantly positively correlated with leptin, in all subjects (n = 110). When subjected to multiple regression analysis, none of these variables were predictive of serum cartonectin (P>0.05). There were no significant correlations in T2DM subjects (n = 47). In control subjects (n = 63), serum cartonectin was significantly negatively correlated with CRP, and significantly positively correlated with insulin, HOMA-IR and leptin. However, when subjected to multiple regression analysis, none of these variables were predictive of serum cartonectin (P>0.05). Finally, serum cartonectin concentrations were significantly lower in T2DM subjects after a 2 hour 75 g OGTT (P<0.01). Conclusions: Cartonectin may serve as a novel biomarker for the prediction and early diagnosis of T2DM patients. Furthermore, cartonectin and/or pharmacological agents that increase circulating cartonectin levels can represent a new therapeutic field in the treatment of T2DM patients. Further research is needed to clarify these points.	[Ban, Bo; Zhang, Manman] Jining Med Univ, Affiliated Hosp, Jining Med Coll, Dept Endocrine & Metab Dis, Jining, Shandong, Peoples R China; [Bai, Bo; Chen, Jing] Jining Med Univ, Inst Neurobiol, Jining, Shandong, Peoples R China; [Zhang, Manman] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China; [Hu, Jiamiao; Ramanjaneya, Manjunath; Tan, Bee K.; Chen, Jing] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Tan, Bee K.] Heart England NHS Fdn Trust, Dept Obstet & Gynaecol, Birmingham Heartlands Hosp, Birmingham, W Midlands, England; [Tan, Bee K.] Heart England NHS Fdn Trust, Solihull Hosp, Birmingham, W Midlands, England	Jining Medical University; Jining Medical University; Shandong University; University of Warwick; Heart of England NHS Foundation Trust; University of Birmingham; Heart of England NHS Foundation Trust	Tan, BK (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	B.K.Tan@warwick.ac.uk; Jing.Chen@warwick.ac.uk	Hu, Jiamiao/W-5312-2019; Hu, Jiamiao/GSN-1951-2022	Hu, Jiamiao/0000-0001-6489-9877	National Nature Science Foundation of China [31271243, 81070961]; Natural Science Foundation of Shandong province [ZR2009CZ006, ZR2011CM027]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong province(Natural Science Foundation of Shandong Province)	This work was supported by the National Nature Science Foundation of China (31271243 and 81070961), http://www.nsfc.gov.cn/publish/portal1/BBai, and the Natural Science Foundation of Shandong province (ZR2009CZ006 and ZR2011CM027), http://www.sdnsf.gov.cn/portal/BBan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Borch-Johnsen K, 2001, EXP CLIN ENDOCR DIAB, V109, pS86, DOI 10.1055/s-2001-18572; Buyukbese MA, 2004, MEDIAT INFLAMM, V13, P321, DOI 10.1080/09629350400008828; Choi HY, 2013, DIABETES CARE, V36, P3321, DOI 10.2337/dc13-0178; Choi KM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-14; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Clement K, 1997, INT J OBESITY, V21, P556, DOI 10.1038/sj.ijo.0800440; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Hallschmid M, 2009, DIABETES, V58, P637, DOI 10.2337/db08-1176; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Hou M, 2014, INT J MOL MED, V33, P97, DOI 10.3892/ijmm.2013.1550; Kaul K, 2013, ADV EXP MED BIOL, V771, P1; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Lewandowski KC, 2008, GYNECOL ENDOCRINOL, V24, P300, DOI 10.1080/09513590802141052; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Maeda T, 2010, CELL BIOL INT, V34, P261, DOI 10.1042/CBI20090043; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Schmid A, 2012, EXP CLIN ENDOCR DIAB, V120, P611, DOI 10.1055/s-0032-1323803; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; Tan BK, 2006, DIABETOLOGIA, V49, P2723, DOI 10.1007/s00125-006-0419-9; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Villarreal-Molina MT, 2012, BIOCHIMIE, V94, P2143, DOI 10.1016/j.biochi.2012.06.030; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolfing B, 2008, OBESITY, V16, P1481, DOI 10.1038/oby.2008.206; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Zhou Y, 2014, ARTERIOSCL THROM VAS, V34, P1002, DOI 10.1161/ATVBAHA.114.303301	34	51	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112931	10.1371/journal.pone.0112931	http://dx.doi.org/10.1371/journal.pone.0112931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409499	Green Published, gold			2022-12-27	WOS:000345533200047
J	Claverie, T; Wainwright, PC				Claverie, Thomas; Wainwright, Peter C.			A Morphospace for Reef Fishes: Elongation Is the Dominant Axis of Body Shape Evolution	PLOS ONE			English	Article							MORPHOLOGICAL DIVERSITY; TELEOST FISHES; TRADE-OFFS; DIVERSIFICATION; PERFORMANCE; FORM; DISPARITY; MECHANICS; RADIATION; EXAMPLE	Tropical reef fishes are widely regarded as being perhaps the most morphologically diverse vertebrate assemblage on earth, yet much remains to be discovered about the scope and patterns of this diversity. We created a morphospace of 2,939 species spanning 56 families of tropical Indo-Pacific reef fishes and established the primary axes of body shape variation, the phylogenetic consistency of these patterns, and whether dominant patterns of shape change can be accomplished by diverse underlying changes. Principal component analysis showed a major axis of shape variation that contrasts deepbodied species with slender, elongate forms. Furthermore, using custom methods to compare the elongation vector (axis that maximizes elongation deformation) and the main vector of shape variation (first principal component) for each family in the morphospace, we showed that two thirds of the families diversify along an axis of body elongation. Finally, a comparative analysis using a principal coordinate analysis based on the angles among first principal component vectors of each family shape showed that families accomplish changes in elongation with a wide range of underlying modifications. Some groups such as Pomacentridae and Lethrinidae undergo decreases in body depth with proportional increases in all body regions, while other families show disproportionate changes in the length of the head (e.g., Labridae), the trunk or caudal region in all combinations (e.g., Pempheridae and Pinguipedidae). In conclusion, we found that evolutionary changes in body shape along an axis of elongation dominates diversification in reef fishes. Changes in shape on this axis are thought to have immediate implications for swimming performance, defense from gape limited predators, suction feeding performance and access to some highly specialized habitats. The morphological modifications that underlie changes in elongation are highly diverse, suggesting a role for a range of developmental processes and functional consequences.	[Claverie, Thomas] CUFR Mayotte, F-97660 Dembeni, France; [Wainwright, Peter C.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Claverie, T (corresponding author), CUFR Mayotte, Route Natl 3, F-97660 Dembeni, France.	tclaverie@gmail.com	Claverie, Thomas/D-3544-2018	Claverie, Thomas/0000-0002-6258-4991	NSF [IOS 0924489, DEB 1061981]; Direct For Biological Sciences [1061981] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0924489] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the NSF grants IOS 0924489 and DEB 1061981 to PCW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Medrano R, 2013, ANIM BIOL, V63, P217, DOI 10.1163/15707563-00002407; Alfa MJ, 2009, BMC INFECT DIS, V9, DOI [10.1186/1471-2334-9-56, 10.1186/1471-2148-9-255]; [Anonymous], 2020, CATALOG FISHES; Bergmann PJ, 2012, EVOLUTION, V66, P1044, DOI 10.1111/j.1558-5646.2011.01491.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brainerd EL, 1998, COPEIA, P971, DOI 10.2307/1447344; Broughton R, 2013, PLOS CURRENTS TREE L, DOI [10.1371/currents.tol.1353ba26640df26640ccaee26675bb26165c26648c26288, DOI 10.1371/CURRENTS.TOL.1353BA26640DF26640CCAEE26675BB26165C26648C26288]; Carroll AM, 2004, J EXP BIOL, V207, P3873, DOI 10.1242/jeb.01227; Claverie T, 2013, EVOLUTION, V67, P3191, DOI 10.1111/evo.12185; Collar DC, 2006, EVOLUTION, V60, P2575; Collar DC, 2013, ZOOLOGY, V116, P246, DOI 10.1016/j.zool.2013.03.001; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Dornburg A, 2011, EVOLUTION, V65, P1912, DOI 10.1111/j.1558-5646.2011.01275.x; Ellerby DJ, 2011, EVOL BIOL, V38, P422, DOI 10.1007/s11692-011-9130-y; Frederich B, 2013, AM NAT, V181, P94, DOI 10.1086/668599; Frederich B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-82; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Gerry SP, 2012, PHYSIOL BIOCHEM ZOOL, V85, P694, DOI 10.1086/667593; Holzman R, 2012, J EXP BIOL, V215, P1, DOI 10.1242/jeb.057851; Hulsey CD, 2002, P ROY SOC B-BIOL SCI, V269, P317, DOI 10.1098/rspb.2001.1874; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kazancioglu E, 2009, P ROY SOC B-BIOL SCI, V276, P3439, DOI 10.1098/rspb.2009.0876; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Kusche H, 2014, ECOL EVOL, V4, P1127, DOI 10.1002/ece3.1015; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Legendre P., 2012, NUMERICAL ECOLOGY; Liem KF., 2001, FUNCTIONAL ANATOMY V; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Marcus Leslie F., 2000, Hystrix, V11, P27; Mehta RS, 2010, INTEGR COMP BIOL, V50, P1091, DOI 10.1093/icb/icq075; Miller TL, 2007, MOL PHYLOGENET EVOL, V44, P450, DOI 10.1016/j.ympev.2006.10.029; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Near TJ, 2013, P NATL ACAD SCI USA, P1; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Oufiero CE, 2012, J EXP BIOL, V215, P3845, DOI 10.1242/jeb.074849; Polly PD, 2001, BEYOND HETEROCHRONY, P305; Price SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0321; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Price SA, 2013, EVOLUTION, V67, P417, DOI 10.1111/j.1558-5646.2012.01773.x; R Core Team, 2020, R LANG ENV STAT COMP; Reece JS, 2013, BIOL J LINN SOC, V109, P861, DOI 10.1111/bij.12098; Rohlf F.J., 2003, TPSSMALL; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2005, TPSDIG2 DIGITIZE LAN; Sallan LC, 2012, P ROY SOC B-BIOL SCI, V279, P2025, DOI 10.1098/rspb.2011.2454; Santini F, 2013, J EVOLUTION BIOL, V26, P1003, DOI 10.1111/jeb.12112; Smith WL, 2005, LIMITS RELATIONSHIPS; Smith WL, 2007, COPEIA, P35, DOI 10.1643/0045-8511(2007)7[35:CTPNWT]2.0.CO;2; Thacker CE, 2011, SYST BIODIVERS, V9, P329, DOI 10.1080/14772000.2011.629011; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wainwright P, 2007, INTEGR COMP BIOL, V47, P96, DOI 10.1093/icb/icm032; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Ward AB, 2007, BIOL J LINN SOC, V90, P97, DOI 10.1111/j.1095-8312.2007.00714.x; Ward AB, 2014, ZOOLOGY, V117, P70, DOI 10.1016/j.zool.2013.10.006; WEBB PW, 1984, AM ZOOL, V24, P107; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Wiens JJ, 2001, EVOLUTION, V55, P2303; Yamada T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-145; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	62	99	99	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112732	10.1371/journal.pone.0112732	http://dx.doi.org/10.1371/journal.pone.0112732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409027	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200038
J	Hill, G; Headon, D; Harris, ZI; Huttner, K; Limesand, KH				Hill, Grace; Headon, Denis; Harris, Zoey I.; Huttner, Kenneth; Limesand, Kirsten H.			Pharmacological Activation of the EDA/EDAR Signaling Pathway Restores Salivary Gland Function following Radiation-Induced Damage	PLOS ONE			English	Article							ADENOVIRAL-MEDIATED TRANSFER; SUBMANDIBULAR-GLAND; AQUAPORIN-1 CDNA; FLUID SECRETION; ACINAR-CELLS; ECTODYSPLASIN; PROLIFERATION; APOPTOSIS; HYPOFUNCTION; IRRADIATION	Radiotherapy of head and neck cancers often results in collateral damage to adjacent salivary glands associated with clinically significant hyposalivation and xerostomia. Due to the reduced capacity of salivary glands to regenerate, hyposalivation is treated by substitution with artificial saliva, rather than through functional restoration of the glands. During embryogenesis, the ectodysplasin/ectodysplasin receptor (EDA/EDAR) signaling pathway is a critical element in the development and growth of salivary glands. We have assessed the effects of pharmacological activation of this pathway in a mouse model of radiation-induced salivary gland dysfunction. We report that post-irradiation administration of an EDAR-agonist monoclonal antibody (mAbEDAR1) normalizes function of radiation damaged adult salivary glands as determined by stimulated salivary flow rates. In addition, salivary gland structure and homeostasis is restored to pre-irradiation levels. These results suggest that transient activation of pathways involved in salivary gland development could facilitate regeneration and restoration of function following damage.	[Hill, Grace; Harris, Zoey I.; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA; [Headon, Denis] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Headon, Denis] Univ Edinburgh, Royal Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Huttner, Kenneth] Edimer Pharmaceut Inc, Cambridge, MA USA	University of Arizona; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Limesand, KH (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	limesank@u.arizona.edu			National Institutes of Health Research Grant [RO1DE018888]; Edimer Pharmaceuticals; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018888] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657] Funding Source: researchfish; BBSRC [BBS/E/D/20221657] Funding Source: UKRI	National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edimer Pharmaceuticals; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the National Institutes of Health Research Grant RO1DE018888 to GH and KHL. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Edimer Pharmaceuticals to GH, DH, KH, and KHL. http://edimerpharma.com/. This funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila JL, 2009, INT J RADIAT ONCOL, V73, P523, DOI 10.1016/j.ijrobp.2008.09.036; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; Beech N, 2014, AUST DENT J, V59, P20, DOI 10.1111/adj.12134; Boraks George, 2008, Braz. Dent. J., V19, P73, DOI 10.1590/S0103-64402008000100013; Bralic M, 2005, ACTA MED OKAYAMA, V59, P153; Burlage FR, 2009, RADIOTHER ONCOL, V90, P253, DOI 10.1016/j.radonc.2008.11.011; Cannon DM, 2013, HEAD NECK, V10; Carpenter GH, 2007, ACTA PHYSIOL, V189, P241, DOI 10.1111/j.1365-201X.2006.01662.x; Chang SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007591; Cotroneo E, 2008, CELL TISSUE RES, V332, P227, DOI 10.1007/s00441-008-0588-6; Cotroneo E, 2010, DIFFERENTIATION, V79, P120, DOI 10.1016/j.diff.2009.11.005; Delporte C, 1997, P NATL ACAD SCI USA, V94, P3268, DOI 10.1073/pnas.94.7.3268; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; HAND AR, 1988, J ORAL PATHOL MED, V17, P279, DOI 10.1111/j.1600-0714.1988.tb01537.x; Jaskoll T, 2003, ANAT REC PART A, V271A, P322, DOI 10.1002/ar.a.10045; Kowalczyk C, 2011, J BIOL CHEM, V286, P30769, DOI 10.1074/jbc.M111.267997; Kowalczyk-Quintas C, 2014, CYTOKINE GROWTH F R, V25, P195, DOI 10.1016/j.cytogfr.2014.01.004; Limesand KH, 2006, MOL CELL BIOL, V26, P8840, DOI 10.1128/MCB.01846-05; Limesand KH, 2010, INT J RADIAT ONCOL, V78, P579, DOI 10.1016/j.ijrobp.2010.03.035; Limesand KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004663; Lin AL, 2001, ARCH ORAL BIOL, V46, P1085, DOI 10.1016/S0003-9969(01)00063-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombaert IMA, 2011, ORAL DIS, V17, P445, DOI 10.1111/j.1601-0825.2010.01783.x; Lombaert IMA, 2008, STEM CELLS, V26, P2595, DOI 10.1634/stemcells.2007-1034; MAKKONEN TA, 1986, ORAL SURG ORAL MED O, V62, P270, DOI 10.1016/0030-4220(86)90007-1; Martin KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051363; Mitchell GC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.28; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Morgan-Bathke M, 2013, J DENT RES, V92, P911, DOI 10.1177/0022034513499350; Morgan-Bathke M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05206; Muhvic-Urek M, 2006, PHYSIOL RES, V55, P89, DOI 10.33549/physiolres.930739; National Cancer Institute, 2014, SEER STAT FACT SHEET; Sagowski C, 2003, EUR ARCH OTO-RHINO-L, V260, P513, DOI 10.1007/s00405-003-0631-x; SODICOFF M, 1974, RADIAT RES, V58, P196, DOI 10.2307/3573932; TURNER RJ, 1993, ANN NY ACAD SCI, V694, P24, DOI 10.1111/j.1749-6632.1993.tb18339.x; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Voutilainen M, 2012, P NATL ACAD SCI USA, V109, P5744, DOI 10.1073/pnas.1110627109; Wells KL, 2011, DEV BIOL, V349, P137, DOI 10.1016/j.ydbio.2010.10.012; Wells KL, 2010, DEV DYNAM, V239, P2674, DOI 10.1002/dvdy.22406	40	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112840	10.1371/journal.pone.0112840	http://dx.doi.org/10.1371/journal.pone.0112840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409170	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200044
J	Lu, HK; Gray, LR; Wightman, F; Ellenberg, P; Khoury, G; Cheng, WJ; Mota, TM; Wesselingh, S; Gorry, PR; Cameron, PU; Churchill, MJ; Lewin, SR				Lu, Hao K.; Gray, Lachlan R.; Wightman, Fiona; Ellenberg, Paula; Khoury, Gabriela; Cheng, Wan-Jung; Mota, Talia M.; Wesselingh, Steve; Gorry, Paul R.; Cameron, Paul U.; Churchill, Melissa J.; Lewin, Sharon R.			Ex Vivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; TRANSCRIPTIONAL ACTIVITY; LATENT RESERVOIR; P-TEFB; EXPRESSION; ACTIVATION; PROMOTER; REPLICATION; INCREASE	Histone deacetylase inhibitors (HDACi) can induce human immunodeficiency virus (HIV) transcription from the HIV long terminal repeat (LTR). However, ex vivo and in vivo responses to HDACi are variable and the activity of HDACi in cells other than T-cells have not been well characterised. Here, we developed a novel assay to determine the activity of HDACi on patient-derived HIV LTRs in different cell types. HIV LTRs from integrated virus were amplified using triple-nested Alu-PCR from total memory CD4(+) T-cells (CD45RO+) isolated from HIV-infected patients prior to and following suppressive antiretroviral therapy. NL4-3 or patient-derived HIV LTRs were cloned into the chromatin forming episomal vector pCEP4, and the effect of HDACi investigated in the astrocyte and epithelial cell lines SVG and HeLa, respectively. There were no significant differences in the sequence of the HIV LTRs isolated from CD4(+) T-cells prior to and after 18 months of combination antiretroviral therapy (cART). We found that in both cell lines, the HDACi panobinostat, trichostatin A, vorinostat and entinostat activated patient-derived HIV LTRs to similar levels seen with NL4-3 and all patient derived isolates had similar sensitivity to maximum HDACi stimulation. We observed a marked difference in the maximum fold induction of luciferase by HDACi in HeLa and SVG, suggesting that the effect of HDACi may be influenced by the cellular environment. Finally, we observed significant synergy in activation of the LTR with vorinostat and the viral protein Tat. Together, our results suggest that the LTR sequence of integrated virus is not a major determinant of a functional response to an HDACi.	[Lu, Hao K.; Gray, Lachlan R.; Wightman, Fiona; Ellenberg, Paula; Khoury, Gabriela; Mota, Talia M.; Gorry, Paul R.; Cameron, Paul U.; Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lu, Hao K.; Gray, Lachlan R.; Wightman, Fiona; Ellenberg, Paula; Khoury, Gabriela; Cheng, Wan-Jung; Mota, Talia M.; Wesselingh, Steve; Gorry, Paul R.; Cameron, Paul U.; Churchill, Melissa J.; Lewin, Sharon R.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Mota, Talia M.; Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Wesselingh, Steve] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Churchill, Melissa J.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Churchill, Melissa J.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst, Melbourne, Vic, Australia	Monash University; Burnet Institute; University of Melbourne; South Australian Health & Medical Research Institute (SAHMRI); Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; University of Melbourne	Lewin, SR (corresponding author), Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia.	sharon.lewin@unimelb.edu.au	Ellenberg, paula/AAW-5460-2021; Khoury, Gabriela/AAD-1524-2019; Lewin, Sharon/Z-3297-2019	Khoury, Gabriela/0000-0002-6616-3932; Lewin, Sharon Ruth/0000-0002-0330-8241; Cameron, Paul Urquhart/0000-0002-1906-6945; Lu, Hao/0000-0002-3940-3283; Mota, Talia/0000-0002-8925-0158; Ellenberg, Paula/0000-0002-7622-9106; Wightman, Fiona/0000-0003-1203-1325; Gray, Lachlan/0000-0002-9894-1049; Churchill, Melissa/0000-0001-5510-7954	Australian National Health and Medical Research Council (NHMRC) [1009533, 1051093]; National Institutes of Health, USA [NIMH100594]; Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE) [U19AI096109]; Australian Research Council Future Fellowship (FT2); NHMRC Early Career Fellowship [GNT0606967]; NHMRC Dora Lush biomedical post-graduate scholarship [579719]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE); Australian Research Council Future Fellowship (FT2)(Australian Research Council); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Dora Lush biomedical post-graduate scholarship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant 1009533 and 1051093; the National Institutes of Health, USA (NIMH100594) and the Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE; U19AI096109). S. R. L. is an NHMRC senior practitioner fellow. P. R. G is supported by an Australian Research Council Future Fellowship (FT2). L. R. G was supported by a NHMRC Early Career Fellowship (GNT0606967). G. K. is a recipient of an NHMRC Dora Lush biomedical post-graduate scholarship (579719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Barboric M, 2010, NAT STRUCT MOL BIOL, V17, P928, DOI 10.1038/nsmb0810-928; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bouchat S, 2012, AIDS, V26, P1473, DOI 10.1097/QAD.0b013e32835535f5; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10; Cillo AR, 2014, P NATL ACAD SCI US; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Einav Y, 2003, MOL CANCER THER, V2, P1121; Elliott JH, 2014, PLOS PATHOG IN PRESS; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gray LR, 2013, AIDS RES HUM RETROV, V29, P365, DOI [10.1089/aid.2012.0138, 10.1089/AID.2012.0138]; He MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067186; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hodin TL, 2013, J VIROL, V87, P13020, DOI 10.1128/JVI.01606-13; KAMINE J, 1993, J VIROL, V67, P6828, DOI 10.1128/JVI.67.11.6828-6834.1993; Kato TA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-116; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077595; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Marelli-Berg FM, 2012, IMMUNOLOGY, V136, P363, DOI 10.1111/j.1365-2567.2012.03583.x; Ramakrishnan R, 2014, AIDS RES HUM RETROVI; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P993, DOI 10.4161/hv.23800; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Shan L, 2014, J ANTIMICROB CHEMOTH, V69, P28, DOI 10.1093/jac/dkt338; Shehu-Xhilaga M, 2009, AIDS, V23, P2047, DOI 10.1097/QAD.0b013e328330342c; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wightman F, 2013, AIDS, V27, P2853, DOI 10.1097/QAD.0000000000000067; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Wightman F, 2010, J INFECT DIS, V202, P1738, DOI 10.1086/656721; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; ZEICHNER SL, 1991, J VIROL, V65, P2436, DOI 10.1128/JVI.65.5.2436-2444.1991; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113341	10.1371/journal.pone.0113341	http://dx.doi.org/10.1371/journal.pone.0113341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409334	Green Published, gold			2022-12-27	WOS:000345533200100
J	Seelig, D; Wang, AL; Jaganathan, K; Loughead, JW; Blady, SJ; Childress, AR; Romer, D; Langleben, DD				Seelig, David; Wang, An-Li; Jaganathan, Kanchana; Loughead, James W.; Blady, Shira J.; Childress, Anna Rose; Romer, Daniel; Langleben, Daniel D.			Low Message Sensation Health Promotion Videos Are Better Remembered and Activate Areas of the Brain Associated with Memory Encoding	PLOS ONE			English	Article							PUBLIC-SERVICE ANNOUNCEMENTS; LIMITED CAPACITY MODEL; CONDOM USE; VISUOSPATIAL ATTENTION; INDIVIDUAL-DIFFERENCES; CANCER COMMUNICATION; CONDITIONED FEAR; FMRI; CAMPAIGN; SMOKING	Greater sensory stimulation in advertising has been postulated to facilitate attention and persuasion. For this reason, video ads promoting health behaviors are often designed to be high in "message sensation value'' (MSV), a standardized measure of sensory intensity of the audiovisual and content features of an ad. However, our previous functional Magnetic Resonance Imaging (fMRI) study showed that low MSV ads were better remembered and produced more prefrontal and temporal and less occipital cortex activation, suggesting that high MSV may divert cognitive resources from processing ad content. The present study aimed to determine whether these findings from anti-smoking ads generalize to other public health topics, such as safe sex. Thirty-nine healthy adults viewed high- and low MSV ads promoting safer sex through condom use, during an fMRI session. Recognition memory of the ads was tested immediately and 3 weeks after the session. We found that low MSV condom ads were better remembered than the high MSV ads at both time points and replicated the fMRI patterns previously reported for the anti-smoking ads. Occipital and superior temporal activation was negatively related to the attitudes favoring condom use (see Condom Attitudes Scale, Methods and Materials section). Psychophysiological interaction (PPI) analysis of the relation between occipital and fronto-temporal (middle temporal and inferior frontal gyri) cortices revealed weaker negative interactions between occipital and fronto-temporal cortices during viewing of the low MSV that high MSV ads. These findings confirm that the low MSV video health messages are better remembered than the high MSV messages and that this effect generalizes across public health domains. The greater engagement of the prefrontal and fronto-temporal cortices by low MSV ads and the greater occipital activation by high MSV ads suggest that that the "attention-grabbing'' high MSV format could impede the learning and retention of public health messages.	[Seelig, David; Wang, An-Li; Romer, Daniel; Langleben, Daniel D.] Univ Penn, Annenberg Sch Commun, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA; [Jaganathan, Kanchana; Loughead, James W.; Blady, Shira J.; Childress, Anna Rose; Langleben, Daniel D.] Univ Penn, Dept Psychiat, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Langleben, DD (corresponding author), Univ Penn, Annenberg Sch Commun, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA.	langlebe@upenn.edu	Langleben, Daniel D/K-7407-2014; Wang, An-Li/O-9099-2016		National Institute on Drug Abuse [R03 DA035683]; National Institutes of Allergy and Infectious Diseases Penn Center for AIDS Research (CFAR) [P30 AI 045008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA035683] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Allergy and Infectious Diseases Penn Center for AIDS Research (CFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse R03 DA035683 and National Institutes of Allergy and Infectious Diseases Penn Center for AIDS Research (CFAR) P30 AI 045008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript'' to the appropriate location in the manuscript.	Akyurek EG, 2010, NEUROPSYCHOLOGIA, V48, P3335, DOI 10.1016/j.neuropsychologia.2010.07.019; Biener L, 2000, TOB CONTROL, V9, P401, DOI 10.1136/tc.9.4.401; Bolls PD, 2003, J MARK COMMUN, V9, P17; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chattopadhyay A, 2005, J ADVERTISING RES, V45, P9, DOI 10.1017/S0021849905050129; Chua HF, 2011, NAT NEUROSCI, V14, P426, DOI 10.1038/nn.2761; Chua HF, 2009, BIOL PSYCHIAT, V65, P165, DOI 10.1016/j.biopsych.2008.08.030; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; D'Silva MU, 2007, HEALTH COMMUN, V21, P65, DOI 10.1080/10410230701283405; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Emery SL, 2007, AM J PREV MED, V33, pS257, DOI 10.1016/j.amepre.2007.07.003; Erlich JC, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00016; EVERETT MW, 1995, HEALTH COMMUN, V7, P225, DOI 10.1207/s15327027hc0703_3; FESTINGER L, 1964, J ABNORM SOC PSYCH, V68, P359, DOI 10.1037/h0049073; First M, 2002, DIAGNOSTIC STAT MANU; Fishbein M, 2002, AM J PUBLIC HEALTH, V92, P238, DOI 10.2105/AJPH.92.2.238; Guhn A, 2012, NEUROPSYCHOBIOLOGY, V65, P173, DOI 10.1159/000337002; Hannula DE, 2008, J NEUROSCI, V28, P116, DOI 10.1523/JNEUROSCI.3086-07.2008; Harrington NG, 2003, COMMUN MONOGR, V70, P16, DOI 10.1080/0363775032000104568; Hartley CA, 2011, CEREB CORTEX, V21, P1954, DOI 10.1093/cercor/bhq253; Helme DW, 2007, J HEALTH COMMUN, V12, P399, DOI 10.1080/10810730701325947; Indovina I, 2004, MAGN RESON IMAGING, V22, P1477, DOI 10.1016/j.mri.2004.10.016; Indovina I, 2007, CEREB CORTEX, V17, P1701, DOI 10.1093/cercor/bhl081; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Kang YH, 2006, COMMUN MONOGR, V73, P351, DOI 10.1080/03637750601024164; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lang A, 2000, J COMMUN, V50, P46, DOI 10.1111/j.1460-2466.2000.tb02833.x; Lang A, 2006, J COMMUN, V56, pS57, DOI 10.1111/j.1460-2466.2006.00283.x; Lang A, 2006, MEDIA PSYCHOL, V8, P369, DOI 10.1207/s1532785xmep0804_3; Langleben DD, 2009, NEUROIMAGE, V46, P219, DOI 10.1016/j.neuroimage.2008.12.062; Longe O, 2009, J COGNITIVE NEUROSCI, V21, P141, DOI 10.1162/jocn.2009.21012; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McGuire W, 1989, PUBLIC COMMUNICATION, P43; MCGUIRE WJ, 1966, ANNU REV PSYCHOL, V17, P475, DOI 10.1146/annurev.ps.17.020166.002355; Miettunen J, 2008, PSYCHIAT RES, V160, P106, DOI 10.1016/j.psychres.2007.05.003; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Morgan SE, 2003, J COMMUN, V53, P512, DOI 10.1111/j.1460-2466.2003.tb02605.x; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Noar SM, 2009, J HEALTH COMMUN, V14, P15, DOI 10.1080/10810730802592239; PALMGREEN P, 1991, HEALTH COMMUN, V3, P217, DOI DOI 10.1207/S15327027HC0304_4; Petty R. E., 1986, COMMUN PERSUATION, P1; Plaud Joseph J, 2003, Span J Psychol, V6, P147; Protogerou C, 2014, AIDS BEHAV, V18, P1847, DOI 10.1007/s10461-014-0807-y; Reitman D, 1996, AIDS EDUC PREV, V8, P499; ROMER D, 1979, EUR J SOC PSYCHOL, V9, P1, DOI 10.1002/ejsp.2420090102; Rossiter J.R., 2001, J ADVERTISING RES, V41; Russell CA, 2005, J ADVERTISING RES, V45, P73, DOI 10.1017/S0021849905050038; SACCO WP, 1991, PSYCHOL ASSESSMENT J, V3, P265, DOI DOI 10.1037/1040-3590.3.2.265; Schlosser RGM, 2008, NEUROPSYCHOLOGIA, V46, P336, DOI 10.1016/j.neuropsychologia.2007.07.006; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; St Lawrence JS, 1998, AM J COMMUN PSYCHOL, V26, P7, DOI 10.1023/A:1021877906707; Stephenson MT, 2006, J COMMUN, V56, pS38, DOI 10.1111/j.1460-2466.2006.00282.x; Strasser AA, 2009, NICOTINE TOB RES, V11, P293, DOI 10.1093/ntr/ntn026; Talairach J., 1988, COPLANAR STEREOTAXIC; Thrasher JF, 2007, ADDICT BEHAV, V32, P2916, DOI 10.1016/j.addbeh.2007.05.018; Thurston IB, 2014, AM J PUBLIC HEALTH, V104, P1265, DOI 10.2105/AJPH.2013.301865; Van Stee SK, 2012, QUAL HEALTH RES, V22, P1568, DOI 10.1177/1049732312456745; Wang AL, 2013, J NEUROSCI, V33, P7420, DOI 10.1523/JNEUROSCI.3840-12.2013; Widman L, 2014, HEALTH PSYCHOL, V33, P1113, DOI 10.1037/hea0000112; WOLPE J, 1963, AM J PSYCHIAT, V119, P1062, DOI 10.1176/ajp.119.11.1062; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zimmerman RS, 2007, HEALTH EDUC BEHAV, V34, P810, DOI 10.1177/1090198107299700; Zuckerman M., 2014, SENSATION SEEKING OP	68	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113256	10.1371/journal.pone.0113256	http://dx.doi.org/10.1371/journal.pone.0113256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409187	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200084
J	Takaesu, Y; Komada, Y; Asaoka, S; Kagimura, T; Inoue, Y				Takaesu, Yoshikazu; Komada, Yoko; Asaoka, Shoichi; Kagimura, Tatsuo; Inoue, Yuichi			Factors Associated with Long-Term Use of Hypnotics among Patients with Chronic Insomnia	PLOS ONE			English	Article							SLEEP FOUNDATION SURVEY; PSYCHOLOGICAL TREATMENT; QUALITY INDEX; UNITED-STATES; OLDER-ADULTS; RISK-FACTOR; DEPRESSION; METAANALYSIS; EFFICACY; THERAPY	This study investigated factors associated with long-term use of benzodiazepines (BZDs) or benzodiazepine receptor agonists (BzRAs) as hypnotics in patients with chronic insomnia. Consecutive patients (n = 140) with chronic insomnia were enrolled in this study (68 men and 72 women; mean age, 53.8 +/- 10.8 years). All patients filled out a self-assessment questionnaire asking clinical descriptive variables at the baseline of the treatment period; patients received the usual dose of a single type of BZD or BzRA. The Pittsburgh Sleep Quality Index (PSQI) and the Zung Self-Rating Depression Scale were self-assessed at the baseline, and the former was re-evaluated at the time of cessation of medication or at the end of the 6-month treatment period. The PSQI included the following sub-items: evaluating sleep quality (C1), sleep latency (C2), sleep duration (C3), habitual sleep efficiency (C4), frequency of sleep disturbance (C5), use of sleeping medication (C6), and daytime dysfunction (C7). Among the patients, 54.6% needed to continue hypnotics for a 6-month treatment period. Logistic regression analysis revealed that, among descriptive variables, only the PSQI score appeared as a significant factor associated with long-term use {odds ratio (OR) = 2.8, 95% confidence interval (CI) = 2.0-4.0}. The receiver operating curve (ROC) analysis identified that the cut-off PSQI total score at the baseline for predicting long-term use was estimated at 13.5 points (area under the curve = 0.86, 95% CI = 0.8-0.92). Among the sub-items of PSQI, the increases in C1: (OR = 8.4, 95% CI = 2.4-30.0), C3: (OR = 3.6, 95% CI = 1.1-11.5), C4: (OR = 11.1, 95% CI = 3.6-33.9), and C6: (OR = 3.4, 95% CI = 1.9-6.2) scores were associated with long-term use. This study revealed that a high PSQI score at the baseline, particularly in the sub-items relating to sleep maintenance disturbance, is predictive of long-term hypnotic treatment. Our results imply the limitation of the effectiveness of hypnotic treatment alone for chronic insomnia.	[Takaesu, Yoshikazu; Inoue, Yuichi] Tokyo Med Univ, Dept Psychiat, Shinjuku Ku, Tokyo 1600023, Japan; [Komada, Yoko; Asaoka, Shoichi; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Shinjuku Ku, Tokyo 1600023, Japan; [Komada, Yoko; Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Shibuya Ku, Tokyo 1510053, Japan; [Kagimura, Tatsuo] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan	Tokyo Medical University; Tokyo Medical University; Institute for Biomedical Research & Innovation (IBRI)	Takaesu, Y (corresponding author), Tokyo Med Univ, Dept Psychiat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	esu-yosh@tokyo-med.ac.jp	Komada, Yoko/AAN-8342-2021	Komada, Yoko/0000-0002-0884-1555	Nippon Boehringer Ingelheim; Takeda Pharmaceutical; Mitsubishi Tanabe Pharma; Astellas Pharma; Shionogi; Sanofi-Aventis	Nippon Boehringer Ingelheim(Boehringer Ingelheim); Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Astellas Pharma(Astellas Pharmaceuticals); Shionogi; Sanofi-Aventis(Sanofi-Aventis)	Yuichi Inoue has received clinically pertinent fees, lecture fees, and research funding from Nippon Boehringer Ingelheim, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma, Astellas Pharma, Shionogi, and Sanofi-Aventis. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALLAIN H, 1991, SLEEP, V14, P408, DOI 10.1093/sleep/14.5.408; Ancoli-Israel S, 1999, SLEEP, V22, pS347; [Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; Baillargeon L, 2003, CAN MED ASSOC J, V169, P1015; Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Dundar Y, 2004, HUM PSYCHOPHARM CLIN, V19, P305, DOI 10.1002/hup.594; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kim K, 2000, SLEEP, V23, P41; Lader M, 2014, BRIT J CLIN PHARMACO, V77, P295, DOI 10.1111/j.1365-2125.2012.04418.x; Lader MH, 1999, EUR NEUROPSYCHOPHARM, V9, P399; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Morgan K, 2003, J PSYCHOSOM RES, V54, P21, DOI 10.1016/S0022-3999(02)00569-X; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Morin CM, 2004, AM J PSYCHIAT, V161, P332, DOI 10.1176/appi.ajp.161.2.332; Ohayon MM, 1996, CAN J PSYCHIAT, V41, P457, DOI 10.1177/070674379604100711; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; RICKELS K, 1983, JAMA-J AM MED ASSOC, V250, P767, DOI 10.1001/jama.250.6.767; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Roane BM, 2008, SLEEP, V31, P1351; Roehrs T, 1996, PSYCHOPHARMACOLOGY, V127, P150, DOI 10.1007/BF02805988; Rosenberg Russell P, 2006, Ann Clin Psychiatry, V18, P49, DOI 10.1080/10401230500464711; Roth T, 1999, SLEEP, V22, pS354; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Shapiro DE, 1999, STAT METHODS MED RES, V8, P113, DOI 10.1177/096228029900800203; Soeffing JP, 2008, SLEEP MED, V9, P165, DOI 10.1016/j.sleep.2007.02.009; Soldatos CR, 1999, INT CLIN PSYCHOPHARM, V14, P287; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stepanski EJ, 2003, SLEEP MED REV, V7, P215, DOI 10.1053/smrv.2001.0246; Suka M, 2003, J OCCUP HEALTH, V45, P344, DOI 10.1539/joh.45.344; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Wade AG, 2007, CURR MED RES OPIN, V23, P2597, DOI 10.1185/030079907X233098; Zammit GK, 1999, SLEEP, V22, pS379; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	35	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113753	10.1371/journal.pone.0113753	http://dx.doi.org/10.1371/journal.pone.0113753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409018	Green Published, gold			2022-12-27	WOS:000345533200153
J	Takahashi, H; Hatta, Y; Iriyama, N; Hasegawa, Y; Uchida, H; Nakagawa, M; Makishima, M; Takeuchi, J; Takei, M				Takahashi, Hiromichi; Hatta, Yoshihiro; Iriyama, Noriyoshi; Hasegawa, Yuichiro; Uchida, Hikaru; Nakagawa, Masaru; Makishima, Makoto; Takeuchi, Jin; Takei, Masami			Induced Differentiation of Human Myeloid Leukemia Cells into M2 Macrophages by Combined Treatment with Retinoic Acid and 1 alpha,25-Dihydroxyvitamin D-3	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; VITAMIN-D-RECEPTOR; TUMOR-NECROSIS-FACTOR; ALL-TRANS; LINE HL-60; RETINOBENZOIC ACIDS; GROWTH-INHIBITION; NITRIC-OXIDE; INDUCTION; EXPRESSION	Retinoids and 1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) induce differentiation of myeloid leukemia cells into granulocyte and macrophage lineages, respectively. All-trans retinoic acid (ATRA), which is effective in the treatment of acute promyelocytic leukemia, can induce differentiation of other types of myeloid leukemia cells, and combined treatment with retinoid and 1,25(OH)(2)D-3 effectively enhances the differentiation of leukemia cells into macrophage-like cells. Recent work has classified macrophages into M1 and M2 types. In this study, we investigated the effect of combined treatment with retinoid and 1,25(OH)(2)D-3 on differentiation of myeloid leukemia THP-1 and HL60 cells. 9-cis Retinoic acid (9cRA) plus 1,25(OH)(2)D-3 inhibited proliferation of THP-1 and HL60 cells and increased myeloid differentiation markers including nitroblue tetrazolium reducing activity and expression of CD14 and CD11b. ATRA and the synthetic retinoic acid receptor agonist Am80 exhibited similar effects in combination with 1,25(OH)(2)D-3 but less effectively than 9cRA, while the retinoid X receptor agonist HX630 was not effective. 9cRA plus 1,25(OH)(2)D-3 effectively increased expression of M2 macrophage marker genes, such as CD163, ARG1 and IL10, increased surface CD163 expression, and induced interleukin-10 secretion in myeloid leukemia cells, while 9cRA alone had weaker effects on these phenotypes and 1,25(OH)(2)D-3 was not effective. Taken together, our results demonstrate selective induction of M2 macrophage markers in human myeloid leukemia cells by combined treatment with 9cRA and 1,25(OH)(2)D-3. .	[Takahashi, Hiromichi; Hasegawa, Yuichiro; Uchida, Hikaru; Nakagawa, Masaru; Makishima, Makoto] Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem, Tokyo, Japan; [Takahashi, Hiromichi; Hatta, Yoshihiro; Iriyama, Noriyoshi; Nakagawa, Masaru; Takeuchi, Jin; Takei, Masami] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol, Tokyo, Japan	Nihon University; Nihon University	Makishima, M (corresponding author), Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem, Tokyo, Japan.	makishima.makoto@nihon-u.ac.jp	Iriyama, Noriyoshi/T-5879-2019		"Strategic Research Base Development'' Program for Private Universities; Nihon University School of Medicine	"Strategic Research Base Development'' Program for Private Universities; Nihon University School of Medicine	This work was supported by "Strategic Research Base Development'' Program for Private Universities subsidized by MEXT (2008-2012) and funds from Nihon University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Amano Y, 2009, J STEROID BIOCHEM, V114, P144, DOI 10.1016/j.jsbmb.2009.01.022; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; BROWN G, 1994, LEUKEMIA, V8, P806; BUNCE CM, 1995, LEUKEMIA, V9, P410; Carlberg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071042; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Connolly RM, 2013, CLIN CANCER RES, V19, P1651, DOI 10.1158/1078-0432.CCR-12-3175; DALTON WT, 1988, BLOOD, V71, P242; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Defacque H, 1997, LEUKEMIA, V11, P221, DOI 10.1038/sj.leu.2400568; Dugas N, 1996, BLOOD, V88, P3528, DOI 10.1182/blood.V88.9.3528.bloodjournal8893528; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Helming L, 2005, BLOOD, V106, P4351, DOI 10.1182/blood-2005-03-1029; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; HONMA Y, 1980, BIOCHEM BIOPH RES CO, V95, P507, DOI 10.1016/0006-291X(80)90813-X; HONMA Y, 1983, P NATL ACAD SCI-BIOL, V80, P201, DOI 10.1073/pnas.80.1.201; HONMA Y, 1983, EUR J CANCER CLIN ON, V19, P251, DOI 10.1016/0277-5379(83)90424-8; Iriyama N, 2012, ONCOL REP, V28, P1875, DOI 10.3892/or.2012.2006; Kagechika H, 2002, CURR MED CHEM, V9, P591, DOI 10.2174/0929867024606975; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Makishima M, 1999, BIOCHEM PHARMACOL, V57, P521, DOI 10.1016/S0006-2952(98)00329-3; Makishima M, 1996, BLOOD, V87, P3384, DOI 10.1182/blood.V87.8.3384.bloodjournal8783384; MANGELSDORF DJ, 1984, J CELL BIOL, V98, P391, DOI 10.1083/jcb.98.2.391; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MASCIULLI R, 1995, CELL GROWTH DIFFER, V6, P493; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020; MEHTA K, 1994, J LEUKOCYTE BIOL, V55, P336, DOI 10.1002/jlb.55.3.336; MEHTA K, 1986, CANCER RES, V46, P1388; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Nakajima H, 1996, LEUKEMIA RES, V20, P665, DOI 10.1016/0145-2126(96)00020-3; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; O'Kelly J, 2002, J CLIN INVEST, V109, P1091, DOI 10.1172/JCI200212392; Okamoto R, 2011, VITAMIN D, P1731; OLSSON IL, 1982, CANCER RES, V42, P3924; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; SAKASHITA A, 1993, BLOOD, V81, P1009; Sanchez PV, 2014, LEUKEMIA, V28, P749, DOI 10.1038/leu.2013.202; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; TAIMI M, 1993, IMMUNOLOGY, V79, P229; TAIMI M, 1991, LEUKEMIA RES, V15, P1145, DOI 10.1016/0145-2126(91)90183-T; TAVANGAR K, 1990, ANAL BIOCHEM, V186, P60, DOI 10.1016/0003-2697(90)90572-Q; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973; Tsao T, 2010, CANCER RES, V70, P4949, DOI 10.1158/0008-5472.CAN-09-1962; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; Wang XC, 2007, J CLIN IMMUNOL, V27, P193, DOI 10.1007/s10875-006-9068-5; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; XU H, 1993, SCAND J IMMUNOL, V38, P535, DOI 10.1111/j.1365-3083.1993.tb03237.x	57	23	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113722	10.1371/journal.pone.0113722	http://dx.doi.org/10.1371/journal.pone.0113722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409436	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200146
J	Turek, M; Bringmann, H				Turek, Michal; Bringmann, Henrik			Gene Expression Changes of Caenorhabditis elegans Larvae during Molting and Sleep-Like Lethargus	PLOS ONE			English	Article							WAKEFULNESS; BEHAVIOR; QUIESCENCE; CIRCUIT; NEURON; BRAIN; CUT-1	During their development, Caenorhabditis elegans larvae go through four developmental stages. At the end of each larval stage, nematodes molt. They synthesize a new cuticle and shed the old cuticle. During the molt, larvae display a sleep-like behavior that is called lethargus. We wanted to determine how gene expression changes during the C. elegans molting cycle. We performed transcriptional profiling of C. elegans by selecting larvae displaying either sleep-like behavior during the molt or wake behavior during the intermolt to identify genes that oscillate with the molting-cycle. We found that expression changed during the molt and we identified 520 genes that oscillated with the molting cycle. 138 of these genes were not previously reported to oscillate. The majority of genes that had oscillating expression levels appear to be involved in molting, indicating that the majority of transcriptional changes serve to resynthesize the cuticle. Identification of genes that control sleep-like behavior during lethargus is difficult but may be possible by looking at genes that are expressed in neurons. 22 of the oscillating genes were expressed in neurons. One of these genes, the dopamine transporter gene dat-1, was previously shown in mammals and in C. elegans to control sleep. Taken together, we provide a dataset of genes that oscillate with the molting and sleep-wake cycle, which will be useful to investigate molting and possibly also sleep-like behavior during lethargus.	[Turek, Michal; Bringmann, Henrik] Max Planck Inst Biophys Chem, Max Planck Res Grp Sleep & Wake, D-37077 Gottingen, Germany	Max Planck Society	Bringmann, H (corresponding author), Max Planck Inst Biophys Chem, Max Planck Res Grp Sleep & Wake, D-37077 Gottingen, Germany.	Henrik.Bringmann@mpibpc.mpg.de	Turek, Michał/AAT-3216-2021; Turek, Michał/H-3528-2016	Turek, Michał/0000-0002-4637-5700	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2011, J NEUROSCI METH, V201, P78, DOI 10.1016/j.jneumeth.2011.07.013; Brooks DR, 2003, J BIOL CHEM, V278, P52340, DOI 10.1074/jbc.M308858200; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cho JY, 2014, CELL, V156, P249, DOI 10.1016/j.cell.2013.11.036; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2005, J NEUROCHEM, V94, P1411, DOI 10.1111/j.1471-4159.2005.03291.x; Davis MW, 2004, DEVELOPMENT, V131, P6001, DOI 10.1242/dev.01454; Driver RJ, 2013, CURR BIOL, V23, P501, DOI 10.1016/j.cub.2013.02.009; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwanir S, 2013, SLEEP, V36, P385, DOI 10.5665/sleep.2456; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Jones S, 2008, J NEUROCHEM, V105, P46, DOI 10.1111/j.1471-4159.2007.05089.x; Kim DH, 2013, NAT GENET, V45, P1337, DOI 10.1038/ng.2763; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Muriel JM, 2003, DEV BIOL, V260, P339, DOI 10.1016/S0012-1606(03)00237-9; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Page A.P., 2007, CUTICLE, P1; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; Schwarz A, 2013, PLOS ONE, V8; Schwarz Juliane, 2012, Worm, V1, P12, DOI 10.4161/worm.19499; Schwarz J, 2011, CURR BIOL, V21, pR983, DOI 10.1016/j.cub.2011.10.046; SEBASTIANO M, 1991, DEV BIOL, V146, P519, DOI 10.1016/0012-1606(91)90253-Y; Singh K, 2014, SLEEP, V37, P1439, DOI 10.5665/sleep.3990; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Turek M, 2013, CURR BIOL, V23, P2215, DOI 10.1016/j.cub.2013.09.028; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001	41	18	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113269	10.1371/journal.pone.0113269	http://dx.doi.org/10.1371/journal.pone.0113269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409030	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200088
J	Chen, YX; Zhang, W; Wang, WM; Yu, XL; Wang, YM; Zhang, MJ; Chen, N				Chen, Yong-Xi; Zhang, Wen; Wang, Wei-Ming; Yu, Xia-Lian; Wang, Yi-Mei; Zhang, Min-Jun; Chen, Nan			Role of Moesin in Renal Fibrosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GLYCATION END-PRODUCTS; ERM PROTEINS; INTERSTITIAL FIBROSIS; ACTIN-BINDING; CELL CORTEX; EZRIN; EXPRESSION; EMT; PHOSPHORYLATION	Background: Renal fibrosis is the final common pathway of chronic kidney disease (CKD). Moesin is a member of Ezrin/Radixin/Moesin (ERM) protein family but its role in renal fibrosis is not clear. Method: Human proximal tubular cells (HK-2) were stimulated with or without TGF-beta 1. Moesin and downstream target genes were examined by real-time PCR and western blot. Phosphorylation of moesin and related signaling pathway was investigated as well. Rat model of unilateral ureteral obstruction (UUO) was established and renal moesin was examined by immunohistochemistry. Moesin in HK-2 cells were knocked down by siRNA and change of downstream genes in transfected HK-2 cells was studied. All animal experiments were reviewed and approved by the Ethics Committee for animal care of Ruijin Hospital. Result: HK-2 cells stimulated with TGF-beta 1 showed up-regulated level of alpha-SMA and down-regulated level of E-Cadherin as well as elevated mRNA and protein level of moesin. In rat model of UUO, renal moesin expression increased in accordance with severity of tubulointerestital fibrosis in the kidneys with ureteral ligation while the contralateral kidneys were normal. Further study showed that TGF-beta 1 could induce phosphorylation of moesin which depended on Erk signaling pathway and Erk inhibitor PD98059 could block moesin phosphorylation. Effects of TGF-beta 1 on moesin phosphorylation was prior to its activation to total moesin. RNA silencing studies showed that knocking down of moesin could attenuate decrease of E-Cadherin induced by TGF-beta 1. Conclusion: We find that moesin might be involved in renal fibrosis and its effects could be related to interacting with E-Cadherin.	[Chen, Yong-Xi; Zhang, Wen; Wang, Wei-Ming; Yu, Xia-Lian; Wang, Yi-Mei; Chen, Nan] Shanghai Jiao Tong Univ, Dept Nephrol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Min-Jun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Anim Expt & Res Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, N (corresponding author), Shanghai Jiao Tong Univ, Dept Nephrol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	chen-nan@medmail.com.cn			National Natural Science Foundation [81000285, 81470041]; Leading Academic Discipline Project of Shanghai Health Bureau [05III001]; Shanghai Leading Academic Discipline Project [T0201]; National Basic Research Program of China 973 [2012CB517600, 2012CB517604]; Shanghai Scientific Committee [10411965900, 08dz1900502]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Leading Academic Discipline Project of Shanghai Health Bureau; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Basic Research Program of China 973(National Basic Research Program of China); Shanghai Scientific Committee	This study was supported by grants from National Natural Science Foundation (No. 81000285, No. 81470041), a grant from the Leading Academic Discipline Project of Shanghai Health Bureau (No. 05III001), a grant from the Shanghai Leading Academic Discipline Project (No. T0201), a grant from National Basic Research Program of China 973 (No. 2012CB517600, No. 2012CB517604) and grant from Shanghai Scientific Committee (No. 10411965900, No. 08dz1900502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach LA, 2005, ANN NY ACAD SCI, V1043, P609, DOI 10.1196/annals.1338.069; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chen YX, 2010, AM J NEPHROL, V31, P24, DOI 10.1159/000253865; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Delle H, 2012, J AM SOC NEPHROL, V23, P37, DOI 10.1681/ASN.2011010046; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Hao L, 2010, TOXICON, V55, P1378, DOI 10.1016/j.toxicon.2010.02.015; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khwaja A, 2007, KIDNEY INT, V72, P1316, DOI 10.1038/sj.ki.5002489; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McRobert EA, 2003, J BIOL CHEM, V278, P25783, DOI 10.1074/jbc.M210433200; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Tokunou M, 2000, LAB INVEST, V80, P1643, DOI 10.1038/labinvest.3780174; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang AH, 2007, AM J PHYSIOL-RENAL, V293, pF723, DOI 10.1152/ajprenal.00480.2006	39	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112936	10.1371/journal.pone.0112936	http://dx.doi.org/10.1371/journal.pone.0112936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406076	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300065
J	Duan, JL; Yin, J; Wu, MM; Liao, P; Deng, D; Liu, G; Wen, QQ; Wang, YF; Qiu, W; Liu, Y; Wu, XL; Ren, WK; Tan, B; Chen, MH; Xiao, H; Wu, L; Li, TJ; Nyachoti, CM; Adeola, O; Yin, YL				Duan, Jielin; Yin, Jie; Wu, Miaomiao; Liao, Peng; Deng, Dun; Liu, Gang; Wen, Qingqi; Wang, Yongfei; Qiu, Wei; Liu, Yan; Wu, Xingli; Ren, Wenkai; Tan, Bie; Chen, Minghong; Xiao, Hao; Wu, Li; Li, Tiejun; Nyachoti, Charles M.; Adeola, Olayiwola; Yin, Yulong			Dietary Glutamate Supplementation Ameliorates Mycotoxin-Induced Abnormalities in the Intestinal Structure and Expression of Amino Acid Transporters in Young Pigs	PLOS ONE			English	Article							PORTAL-DRAINED VISCERA; L-ARGININE; N-CARBAMYLGLUTAMATE; GROWTH-PERFORMANCE; OXIDATIVE STRESS; DEOXYNIVALENOL DON; HEPATIC EXPRESSION; GENE-EXPRESSION; L-PROLINE; METABOLISM	The purpose of this study was to investigate the hypothesis that dietary supplementation with glutamic acid has beneficial effects on growth performance, antioxidant system, intestinal morphology, serum amino acid profile and the gene expression of intestinal amino acid transporters in growing swine fed mold-contaminated feed. Fifteen pigs (LandracexLarge White) with a mean body weight (BW) of 55 kg were randomly divided into control group (basal feed), mycotoxin group (contaminated feed) and glutamate group (2% glutamate+ contaminated feed). Compared with control group, mold-contaminated feed decreased average daily gain (ADG) and increased feed conversion rate (FCR). Meanwhile, fed mold-contaminated feed impaired anti-oxidative system and intestinal morphology, as well as modified the serum amino acid profile in growing pigs. However, supplementation with glutamate exhibited potential positive effects on growth performance of pigs fed mold-contaminated feed, ameliorated the imbalance antioxidant system and abnormalities of intestinal structure caused by mycotoxins. In addition, dietary glutamate supplementation to some extent restored changed serum amino acid profile caused by mold-contaminated feed. In conclusion, glutamic acid may be act as a nutritional regulating factor to ameliorate the adverse effects induced by mycotoxins.	[Duan, Jielin; Yin, Jie; Wu, Miaomiao; Liao, Peng; Deng, Dun; Liu, Gang; Liu, Yan; Wu, Xingli; Ren, Wenkai; Tan, Bie; Xiao, Hao; Wu, Li; Li, Tiejun; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr,Minist Agr, Key Lab Agroecol Proc Subtrop Reg,Hunan Prov Engn, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Changsha 410125, Hunan, Peoples R China; [Wen, Qingqi; Wang, Yongfei] Fujian Aonong Biotechnol Corp, Dept Anim Nutr, Xiamen 361007, Fujian, Peoples R China; [Qiu, Wei] Twins Grp Co Ltd, Ctr Res & Dev, Nanchang 330096, Jiangxi, Peoples R China; [Chen, Minghong] Hunan New Wellful Co LTD, Changsha 410001, Hunan, Peoples R China; [Nyachoti, Charles M.] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Adeola, Olayiwola] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Yin, Yulong] Southwest Collaborat Innovat Ctr Swine Qual & Saf, Chengdu, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; University of Manitoba; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liao, P (corresponding author), Chinese Acad Sci, Inst Subtrop Agr,Minist Agr, Key Lab Agroecol Proc Subtrop Reg,Hunan Prov Engn, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Changsha 410125, Hunan, Peoples R China.	liaopeng@isa.ac.cn; Tjli@isa.ac.cn; yinyulong@isa.ac.cn	YIN, Jie/H-3578-2019; Liao, Peng/N-7270-2017; Liu, Gang/G-5283-2017	YIN, Jie/0000-0003-1852-1042; Liao, Peng/0000-0001-5740-7272; Liu, Gang/0000-0002-9475-5134	National Natural Science Foundation of China [31110103909, 31330075, 31272463]; Hunan Provincial Natural Science Foundation of China [12JJ2014, 13JJ2034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	The present work was supported by grants from the National Natural Science Foundation of China (31110103909, 31330075, 31272463), and the Hunan Provincial Natural Science Foundation of China (No. 12JJ2014, 13JJ2034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas HK, 2013, TOXICON, V74, P68, DOI 10.1016/j.toxicon.2013.07.026; Akiba Y, 2009, AM J PHYSIOL-GASTR L, V297, pG781, DOI 10.1152/ajpgi.90605.2008; Andretta I, 2012, ANIMAL, V6, P1476, DOI 10.1017/S1751731111002278; [Anonymous], [No title captured]; Awad WA, 2005, POULTRY SCI, V84, P928, DOI 10.1093/ps/84.6.928; Beardall J, 1994, Mycotoxin Res, V10, P21, DOI 10.1007/BF03192248; Becker Christiane, 2011, Mycotoxin Res, V27, P287, DOI 10.1007/s12550-011-0106-7; Belokrylov G A, 1999, Biull Eksp Biol Med, V128, P419; Bergen WG, 2009, J NUTR, V139, P821, DOI 10.3945/jn.109.104497; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Boutry C, 2012, AMINO ACIDS, V43, P1485, DOI 10.1007/s00726-012-1221-2; Burkhardt Britta, 2009, Mycotoxin Res, V25, P149, DOI 10.1007/s12550-009-0022-2; Chen G, 2014, AMINO ACIDS, V46, P245, DOI 10.1007/s00726-013-1615-9; Chen S, 2014, AMINO ACIDS, V46, P2365, DOI 10.1007/s00726-014-1789-9; Coppock RW, 2009, TOXICOL IND HEALTH, V25, P637, DOI 10.1177/0748233709348263; Danicke S, 2012, FOOD CHEM TOXICOL, V50, P979, DOI 10.1016/j.fct.2011.12.024; Dietrich B, 2012, ANIMAL, V6, P278, DOI 10.1017/S1751731111001601; Feng YJ, 2012, ANN NY ACAD SCI, V1258, P71, DOI 10.1111/j.1749-6632.2012.06572.x; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; Fleck SC, 2012, TOXICOL LETT, V214, P27, DOI 10.1016/j.toxlet.2012.08.003; Geng MM, 2011, AMINO ACIDS, V40, P1513, DOI 10.1007/s00726-010-0761-6; Grenier B, 2013, TOXINS, V5, P396, DOI 10.3390/toxins5020396; He LQ, 2013, AMINO ACIDS, V45, P383, DOI 10.1007/s00726-013-1514-0; He QH, 2011, J PROTEOME RES, V10, P5214, DOI 10.1021/pr200688u; Hou YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060374; Janeczko MJ, 2007, J NUTR, V137, P2384, DOI 10.1093/jn/137.11.2384; Kang P, 2014, ASIAN AUSTRAL J ANIM, V27, P1150, DOI 10.5713/ajas.2013.13828; Kong XF, 2012, J NUTR BIOCHEM, V23, P1178, DOI 10.1016/j.jnutbio.2011.06.012; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Liu XD, 2012, AMINO ACIDS, V42, P2111, DOI 10.1007/s00726-011-0948-5; Liu YL, 2011, BRIT POULTRY SCI, V52, P255, DOI 10.1080/00071668.2011.559453; Makun Hussaini Anthony, 2011, Mycotoxin Res, V27, P97, DOI 10.1007/s12550-010-0080-5; Mankeviciene A, 2014, FOOD ADDIT CONTAM A, V31, P132, DOI 10.1080/19440049.2013.861614; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P1715, DOI 10.1073/pnas.87.5.1715; Meloche JL, 1995, P SOC EXP BIOL MED, V210, P260, DOI 10.3181/00379727-210-43947; Mezes M, 2010, ACTA VET HUNG, V58, P1, DOI 10.1556/AVet.58.2010.1.1; Modra H, 2013, NEUROENDOCRINOL LETT, V34, P84; Nakamura H, 2013, AM J PHYSIOL-ENDOC M, V304, pE100, DOI 10.1152/ajpendo.00331.2012; Ren WK, 2014, AMINO ACIDS, V46, P2403, DOI 10.1007/s00726-014-1793-0; Ren WK, 2014, J NUTR, V144, P988, DOI 10.3945/jn.114.192120; Ren WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088335; Ren WK, 2013, VACCINE, V31, P367, DOI 10.1016/j.vaccine.2012.10.107; Riedijk MA, 2007, PEDIATR RES, V62, P468, DOI 10.1203/PDR.0b013e31813cbeba; Ruan Z, 2014, AMINO ACIDS, V46, P2219, DOI 10.1007/s00726-014-1762-7; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Soleimany F, 2011, FOOD ADDIT CONTAM A, V28, P494, DOI 10.1080/19440049.2010.551547; Stoll B, 1999, AM J PHYSIOL-ENDOC M, V277, pE168, DOI 10.1152/ajpendo.1999.277.1.E168; Tan BE, 2012, FRONT BIOSCI-LANDMRK, V17, P2237, DOI 10.2741/4047; Tan B, 2012, AMINO ACIDS, V43, P2481, DOI 10.1007/s00726-012-1328-5; Tan B, 2011, J NUTR BIOCHEM, V22, P441, DOI 10.1016/j.jnutbio.2010.03.012; Tan B, 2010, AMINO ACIDS, V38, P1227, DOI 10.1007/s00726-009-0334-8; Tan B, 2009, AMINO ACIDS, V37, P323, DOI 10.1007/s00726-008-0155-1; Tan B, 2009, AMINO ACIDS, V37, P169, DOI 10.1007/s00726-008-0148-0; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Wu GY, 2007, LIVEST SCI, V112, P8, DOI 10.1016/j.livsci.2007.07.003; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Wu GY, 2013, AMINO ACIDS, V44, P1107, DOI 10.1007/s00726-012-1444-2; Wu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069502; Wu X, 2012, J ANIM SCI, V90, P337, DOI 10.2527/jas.53752; Wu X, 2012, ANIM REPROD SCI, V132, P187, DOI 10.1016/j.anireprosci.2012.05.002; Wu X, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-63; Wu X, 2010, AMINO ACIDS, V39, P831, DOI 10.1007/s00726-010-0538-y; Xiao H, 2013, J ANIM SCI, V91, P4772, DOI 10.2527/jas.2013-6426; Xin W, 2013, BIOL TRACE ELEM RES, V153, P191, DOI 10.1007/s12011-013-9668-x; Yang HS, 2013, J ANIM SCI, V91, P2740, DOI 10.2527/jas.2012-5795; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Yao K, 2012, AMINO ACIDS, V42, P2491, DOI 10.1007/s00726-011-1060-6; Yao Kang, 2011, Front Biosci (Schol Ed), V3, P286; Yao K, 2011, BRIT J NUTR, V105, P703, DOI 10.1017/S000711451000365X; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin J, 2013, J FOOD AGRIC ENVIRON, V11, P132; Yin YL, 2010, J FOOD AGRIC ENVIRON, V8, P447; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Yunus AW, 2012, POULTRY SCI, V91, P852, DOI 10.3382/ps.2011-01903; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2	77	44	48	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112357	10.1371/journal.pone.0112357	http://dx.doi.org/10.1371/journal.pone.0112357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405987	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300029
J	Heinonen, JPM; Palmer, SCF; Redpath, SM; Travis, JMJ				Heinonen, Johannes P. M.; Palmer, Stephen C. F.; Redpath, Steve M.; Travis, Justin M. J.			Modelling Hen Harrier Dynamics to Inform Human-Wildlife Conflict Resolution: A Spatially-Realistic, Individual-Based Approach	PLOS ONE			English	Article							CIRCUS-CYANEUS; SENSITIVITY-ANALYSIS; RED GROUSE; MANAGEMENT; BEHAVIOR; PREDATORS; RESPONSES; SELECTION; PROTOCOL; ECOLOGY	Individual-based models have gained popularity in ecology, and enable simultaneous incorporation of spatial explicitness and population dynamic processes to understand spatio-temporal patterns of populations. We introduce an individual-based model for understanding and predicting spatial hen harrier (Circus cyaneus) population dynamics in Great Britain. The model uses a landscape with habitat, prey and game management indices. The hen harrier population was initialised according to empirical census estimates for 1988/89 and simulated until 2030, and predictions for 1998, 2004 and 2010 were compared to empirical census estimates for respective years. The model produced a good qualitative match to overall trends between 1989 and 2010. Parameter explorations revealed relatively high elasticity in particular to demographic parameters such as juvenile male mortality. This highlights the need for robust parameter estimates from empirical research. There are clearly challenges for replication of real-world population trends, but this model provides a useful tool for increasing understanding of drivers of hen harrier dynamics and focusing research efforts in order to inform conflict management decisions.	[Heinonen, Johannes P. M.; Palmer, Stephen C. F.; Redpath, Steve M.; Travis, Justin M. J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen	Heinonen, JPM (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	j.heinonen@abdn.ac.uk	Palmer, Steve/GSE-1103-2022; Travis, Justin/B-8571-2014; Redpath, Stephen/B-4640-2012	Travis, Justin/0000-0002-5785-4272; Redpath, Stephen/0000-0001-5399-9477	College of Life Sciences and Medicine of the University	College of Life Sciences and Medicine of the University	Johannes Heinonen has been funded by a scholarship from the College of Life Sciences and Medicine of the University of Aberdeen during the work leading to this manuscript. The funder had no role in study design, simulation data generation and analysis, decision to publish, or preparation of the manuscript.	Aben J, 2014, J APPL ECOL, V51, P693, DOI 10.1111/1365-2664.12224; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; Anderson BJ, 2009, BIOL CONSERV, V142, P488, DOI 10.1016/j.biocon.2008.10.036; Arroyo B, 2009, BIOL CONSERV, V142, P586, DOI 10.1016/j.biocon.2008.11.013; Arroyo B, 2014, BIRD STUDY, V61, P48, DOI 10.1080/00063657.2013.874976; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Bennett VJ, 2011, ECOL MODEL, V222, P2770, DOI 10.1016/j.ecolmodel.2011.04.025; Bennett VJ, 2009, ECOL COMPLEX, V6, P113, DOI 10.1016/j.ecocom.2008.08.002; Bousquet F, 2004, ECOL MODEL, V176, P313, DOI 10.1016/j.ecolmodel.2004.01.011; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Cortes-Avizanda A, 2014, ECOLOGY, V95, P1799, DOI 10.1890/13-0574.1; de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021; Etheridge B, 1997, J APPL ECOL, V34, P1081, DOI 10.2307/2405296; Fielding A, 2011, 441 JNCC; Filatova T, 2013, ENVIRON MODELL SOFTW, V45, P1, DOI 10.1016/j.envsoft.2013.03.017; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hayhow DB, 2013, BIRD STUDY, V60, P446, DOI 10.1080/00063657.2013.839621; Jeltsch F, 1997, P ROY SOC B-BIOL SCI, V264, P495, DOI 10.1098/rspb.1997.0071; Jordan F, 2011, ECOL COMPLEX, V8, P357, DOI 10.1016/j.ecocom.2011.07.006; Le Hay G, 2001, ENVIRON MANAGE, V27, P451; Lovegrove R., 2007, SILENT FIELDS LONG D; MacDonald D, 2009, KEY TOPICS CONSERVAT; McCaffery RM, 2014, BIOL CONSERV, V170, P169, DOI 10.1016/j.biocon.2013.12.013; Merkle JA, 2011, J WILDLIFE MANAGE, V75, P1121, DOI 10.1002/jwmg.153; New LF, 2011, J APPL ECOL, V48, P1187, DOI 10.1111/j.1365-2664.2011.02013.x; Parry HR, 2013, ENVIRON MODELL SOFTW, V45, P104, DOI 10.1016/j.envsoft.2012.08.006; PICOZZI N, 1984, IBIS, V126, P356, DOI 10.1111/j.1474-919X.1984.tb00256.x; Potts GR, 1998, IBIS, V140, P76, DOI 10.1111/j.1474-919X.1998.tb04544.x; Redpath S, 1998, BIRD STUDY, V45, P51, DOI 10.1080/00063659809461077; Redpath SM, 1999, J ANIM ECOL, V68, P879, DOI 10.1046/j.1365-2656.1999.00340.x; Risely K., 2009, 537 BTO; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Sharrock J.T.R., 1976, ATLAS BREEDING BIRDS; Sim IMW, 2007, BIRD STUDY, V54, P256, DOI 10.1080/00063650709461482; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Thirgood SJ, 2000, P ROY SOC B-BIOL SCI, V267, P651, DOI 10.1098/rspb.2000.1051; Tourenq C, 2001, J APPL ECOL, V38, P170, DOI 10.1046/j.1365-2664.2001.00581.x; Travis JMJ, 2011, METHODS ECOL EVOL, V2, P477, DOI 10.1111/j.2041-210X.2011.00104.x; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Valbuena D, 2010, J ENVIRON MANAGE, V91, P2615, DOI 10.1016/j.jenvman.2010.07.041; Valbuena D, 2010, LANDSCAPE ECOL, V25, P185, DOI 10.1007/s10980-009-9380-6; White RM, 2009, LAND USE POLICY, V26, P242, DOI 10.1016/j.landusepol.2008.03.005; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, CONSERV BIOL SER, V9, P388; Woodroffe R., 2005, CONSERV BIOL; [No title captured]	52	5	5	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112492	10.1371/journal.pone.0112492	http://dx.doi.org/10.1371/journal.pone.0112492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405860	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300035
J	Iachini, T; Coello, Y; Frassinetti, F; Ruggiero, G				Iachini, Tina; Coello, Yann; Frassinetti, Francesca; Ruggiero, Gennaro			Body Space in Social Interactions: A Comparison of Reaching and Comfort Distance in Immersive Virtual Reality	PLOS ONE			English	Article							PERSONAL-SPACE; SEX	Background: Do peripersonal space for acting on objects and interpersonal space for interacting with con-specifics share common mechanisms and reflect the social valence of stimuli? To answer this question, we investigated whether these spaces refer to a similar or different physical distance. Methodology: Participants provided reachability-distance (for potential action) and comfort-distance (for social processing) judgments towards human and non-human virtual stimuli while standing still (passive) or walking toward stimuli (active). Principal Findings: Comfort-distance was larger than other conditions when participants were passive, but reachability and comfort distances were similar when participants were active. Both spaces were modulated by the social valence of stimuli (reduction with virtual females vs males, expansion with cylinder vs robot) and the gender of participants. Conclusions: These findings reveal that peripersonal reaching and interpersonal comfort spaces share a common motor nature and are sensitive, at different degrees, to social modulation. Therefore, social processing seems embodied and grounded in the body acting in space.	[Iachini, Tina; Ruggiero, Gennaro] Univ Naples 2, Lab Cognit Sci & Immers Virtual Real, Dept Psychol, Caserta, Italy; [Coello, Yann] Univ Lille, Res Unit Cognit & Affect Sci, Dept Psychol, Lille, France; [Frassinetti, Francesca] Univ Bologna, Dept Psychol, Bologna, Italy	Universita della Campania Vanvitelli; Universite de Lille - ISITE; Universite de Lille; University of Bologna	Iachini, T (corresponding author), Univ Naples 2, Lab Cognit Sci & Immers Virtual Real, Dept Psychol, Caserta, Italy.	santa.iachini@unina2.it	FRASSINETTI, FRANCESCA/ABI-1533-2020; Frassinetti, Francesca/K-1474-2016; Iachini, Tina/E-1268-2014	FRASSINETTI, FRANCESCA/0000-0001-6810-2861; Frassinetti, Francesca/0000-0001-6810-2861; Iachini, Tina/0000-0001-8405-8768; Ruggiero, Gennaro/0000-0002-3940-6740	Ministry of Research (program "Investments for the Future''); National Research Agency [ANR-11-EQPX-0023]; European funds; Second University of Naples funds	Ministry of Research (program "Investments for the Future''); National Research Agency(French National Research Agency (ANR)); European funds; Second University of Naples funds	This work was supported by a grant from the Ministry of Research (program "Investments for the Future'') and managed by the National Research Agency under the reference ANR-11-EQPX-0023, as well as by European funds through the program FEDER SCV-IrDIVE. The work was also supported by Second University of Naples funds to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello J. R., 1987, HDB ENV PSYCHOL; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bartolo A, 2009, P 14 INT C FUNCT MAP; Bell P. A., 2005, ENV PSYCHOL; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Brozzoli C, 2013, CURR BIOL, V23, P1764, DOI 10.1016/j.cub.2013.07.004; BYRNE D, 1971, J APPL SOC PSYCHOL, V1, P137; Cardellicchio P, 2011, NEUROPSYCHOLOGIA, V49, P1369, DOI 10.1016/j.neuropsychologia.2011.01.021; Cardinali L., 2011, TOOL USE CAUSAL COGN; Coello Y, 2012, COGN PROCESS, V13, pS131, DOI 10.1007/s10339-012-0470-z; Coello Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002862; Delevoye-Turrell Y., 2010, PERCEPTION ACTION CO; Delevoye-Turrell Y, 2011, SOC PSYCHOL-GERMANY, V42, P193, DOI 10.1027/1864-9335/a000063; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; FISHER JD, 1975, J PERS SOC PSYCHOL, V32, P15, DOI 10.1037/h0076837; Gabbard C, 2007, J MOTOR BEHAV, V39, P242, DOI 10.3200/JMBR.39.4.242-246; Gallese V, 2009, PSYCHOL RES-PSYCH FO, V73, P486, DOI 10.1007/s00426-009-0232-4; Gessaroli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074959; GOGEL WC, 1976, PERCEPT PSYCHOPHYS, V20, P419, DOI 10.3758/BF03208276; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Iachini T, 2011, J MENTAL IMAGERY, V35, P1; Iachini T, 2012, APPL COGNITIVE PSYCH, V26, P757, DOI 10.1002/acp.2856; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Lourenco SF, 2011, COGNITION, V119, P448, DOI 10.1016/j.cognition.2011.02.009; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PATTERSON ML, 1976, PSYCHOL REV, V83, P235, DOI 10.1037/0033-295X.83.3.235; Quesque F, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00014; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Ruggiero G, 2014, NEUROPSYCHOLOGY, V28, P147, DOI 10.1037/neu0000009; Ruotolo F, 2013, ENVIRON IMPACT ASSES, V41, P10, DOI 10.1016/j.eiar.2013.01.007; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Sommer R, 2002, HDB ENV PSYCHOL, V1937, P647; Tajadura-Jimenez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026083; Takayama L, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5495, DOI 10.1109/IROS.2009.5354145; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Uzzell D, 2006, BRIT J SOC PSYCHOL, V45, P579, DOI 10.1348/014466605X58384	45	99	101	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111511	10.1371/journal.pone.0111511	http://dx.doi.org/10.1371/journal.pone.0111511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405344	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300010
J	Moschetti, R; Celauro, E; Cruciani, F; Caizzi, R; Dimitri, P				Moschetti, Roberta; Celauro, Emanuele; Cruciani, Fulvio; Caizzi, Ruggiero; Dimitri, Patrizio			On the Evolution of Yeti, a Drosophila melanogaster Heterochromatin Gene	PLOS ONE			English	Article							CENTRIC HETEROCHROMATIN; CENTROMERIC HETEROCHROMATIN; CHROMOSOME HETEROCHROMATIN; CYTOGENETIC ANALYSIS; HYBRIDIZATION; SEQUENCE; ELEMENTS; LOCI; DNA	Constitutive heterochromatin is a ubiquitous and still unveiled component of eukaryotic genomes, within which it comprises large portions. Although constitutive heterochromatin is generally considered to be transcriptionally silent, it contains a significant variety of sequences that are expressed, among which about 300 single-copy coding genes have been identified by genetic and genomic analyses in the last decades. Here, we report the results of the evolutionary analysis of Yeti, an essential gene of Drosophila melanogaster located in the deep pericentromeric region of chromosome 2R. By FISH, we showed that Yeti maintains a heterochromatin location in both D. simulans and D. sechellia species, closely related to D. melanogaster, while in the more distant species e. g., D. pseudoobscura and D. virilis, it is found within euchromatin, in the syntenic chromosome Muller C, that corresponds to the 2R arm of D. melanogaster chromosome 2. Thus, over evolutionary time, Yeti has been resident on the same chromosomal element, but it progressively moved closer to the pericentric regions. Moreover, in silico reconstruction of the Yeti gene structure in 19 Drosophila species and in 5 non-drosophilid dipterans shows a rather stable organization during evolution. Accordingly, by PCR analysis and sequencing, we found that the single intron of Yeti does not undergo major intraspecies or interspecies size changes, unlike the introns of other essential Drosophila heterochromatin genes, such as light and Dbp80. This implicates diverse evolutionary forces in shaping the structural organization of genes found within heterochromatin. Finally, the results of d(S) - d(N) tests show that Yeti is under negative selection both in heterochromatin and euchromatin, and indicate that the change in genomic location did not affected significantly the molecular evolution of the gene. Together, the results of this work contribute to our understanding of the evolutionary dynamics of constitutive heterochromatin in the genomes of higher eukaryotes.	[Moschetti, Roberta; Caizzi, Ruggiero] Univ Bari, Dipartimento Biol, Bari, Italy; [Celauro, Emanuele; Cruciani, Fulvio; Dimitri, Patrizio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Celauro, Emanuele; Cruciani, Fulvio; Dimitri, Patrizio] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Universita degli Studi di Bari Aldo Moro; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Dimitri, P (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	patrizio.dimitri@uniroma1.it	Celauro, Emanuele/N-4228-2016	Celauro, Emanuele/0000-0002-0781-5873; Caizzi, Ruggiero/0000-0002-4360-2808; Cruciani, Fulvio/0000-0002-6900-024X; Moschetti, Roberta/0000-0003-3035-1090	Ministero dell'Universita e della Ricerca-Miur; Istituto Pasteur-Fondazione Cenci-Bolognetti; Fondazione Roma terzo settore	Ministero dell'Universita e della Ricerca-Miur(Ministry of Education, Universities and Research (MIUR)); Istituto Pasteur-Fondazione Cenci-Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Fondazione Roma terzo settore(Fondazione Roma)	This research was supported by grants from Ministero dell'Universita e della Ricerca-Miur (Prin 2008), Istituto Pasteur-Fondazione Cenci-Bolognetti and Fondazione Roma terzo settore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Berghella L, 1996, GENETICS, V144, P117; BRIZUELA BJ, 1994, GENETICS, V137, P803; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Cenci G, 2003, GENET RES, V81, P15, DOI 10.1017/S0016672302006018; Coulthard AB, 2010, GENETICS, V185, P479, DOI 10.1534/genetics.110.117259; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; DEVLIN RH, 1990, GENETICS, V125, P129; DIMITRI P, 1991, GENETICS, V127, P553; Dimitri P, 2004, METH MOL B, V260, P29, DOI 10.1385/1-59259-755-6:029; Dimitri P, 2003, GENETICA, V117, P209, DOI 10.1023/A:1022996112742; Dimitri P, 2003, MOL BIOL EVOL, V20, P503, DOI 10.1093/molbev/msg048; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Fitzpatrick KA, 2005, GENOME, V48, P571, DOI 10.1139/G05-025; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; He B, 2012, GENOME RES, V22, P2507, DOI 10.1101/gr.137406.112; Heitz E, 1928, JAHRB WISS BOT, V69, P762; HILLIKER AJ, 1976, GENETICS, V83, P765; Hoskins RA, 2002, GENOME BIOL, V3; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Iwashita S, 2003, MOL BIOL EVOL, V20, P1556, DOI 10.1093/molbev/msg168; John B, 1988, HETEROCHROMATIN MOL, P1; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Koryakov DE, 2002, GENETICS, V160, P509; MARCHANT GE, 1988, GENETICS, V120, P519; Marygold SJ, 2005, GENETICS, V169, P683, DOI 10.1534/genetics.104.034124; Messina G, 2014, J CELL SCI, V127, P2577, DOI 10.1242/jcs.150243; MORITZ KB, 1976, NATURE, V259, P55, DOI 10.1038/259055a0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pardue ML, 2007, ANNU REV CELL DEV BI, V23, P1, DOI 10.1146/annurev.cellbio.23.090506.123459; Pardue ML, 1986, DROSOPHILA PRACTICAL, P111; Peterson DG, 1998, GENOME, V41, P346, DOI 10.1139/gen-41-3-346; Rossi F, 2007, GENETICS, V175, P595, DOI 10.1534/genetics.106.065441; Schaeffer SW, 2008, GENETICS, V179, P1601, DOI 10.1534/genetics.107.086074; Schulze SR, 2006, GENETICS, V173, P1433, DOI 10.1534/genetics.106.056069; Schulze SR, 2005, GENETICS, V169, P2165, DOI 10.1534/genetics.103.023341; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Villasante A, 2007, CELL CYCLE, V6, P2872, DOI 10.4161/cc.6.23.5047; Waterhouse RM, 2011, NUCLEIC ACIDS RES, V39, pD283, DOI 10.1093/nar/gkq930; WILLIAMS SM, 1992, TRENDS GENET, V8, P335, DOI 10.1016/0168-9525(92)90277-B; Yasuhara JC, 2005, P NATL ACAD SCI USA, V102, P10958, DOI 10.1073/pnas.0503424102; ZHANG P, 1995, GENETICS, V139, P659	46	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113010	10.1371/journal.pone.0113010	http://dx.doi.org/10.1371/journal.pone.0113010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405891	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300070
J	Rudick, CN; Taylor, AK; Yaggie, RE; Schaeffer, AJ; Klumpp, DJ				Rudick, Charles N.; Taylor, Aisha K.; Yaggie, Ryan E.; Schaeffer, Anthony J.; Klumpp, David J.			Asymptomatic Bacteriuria Escherichia coli Are Live Biotherapeutics for UTI	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; RANDOMIZED CONTROLLED-TRIAL; CROSS-TALK; PREVENTION; BLADDER; PLACEBO; EVASION; INTERFERENCE; INDUCTION; WOMEN	Urinary tract infections (UTI) account for approximately 8 million clinic visits annually with symptoms that include acute pelvic pain, dysuria, and irritative voiding. Empiric UTI management with antimicrobials is complicated by increasing antimicrobial resistance among uropathogens, but live biotherapeutics products (LBPs), such as asymptomatic bacteriuria (ASB) strains of E. coli, offer the potential to circumvent antimicrobial resistance. Here we evaluated ASB E. coli as LBPs, relative to ciprofloxacin, for efficacy against infection and visceral pain in a murine UTI model. Visceral pain was quantified as tactile allodynia of the pelvic region in response to mechanical stimulation with von Frey filaments. Whereas ciprofloxacin promoted clearance of uropathogenic E. coli (UPEC), it did not reduce pelvic tactile allodynia, a measure of visceral pain. In contrast, ASB E. coli administered intravesically or intravaginally provided comparable reduction of allodynia similar to intravesical lidocaine. Moreover, ASB E. coli were similarly effective against UTI allodynia induced by Proteus mirabilis, Enterococccus faecalis and Klebsiella pneumoniae. Therefore, ASB E. coli have anti- infective activity comparable to the current standard of care yet also provide superior analgesia. These studies suggest that ASB E. coli represent novel LBPs for UTI symptoms.	[Rudick, Charles N.; Taylor, Aisha K.; Yaggie, Ryan E.; Schaeffer, Anthony J.; Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Klumpp, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	d-klumpp@northwestern.edu			National Institute of Diabetes and Digestive and Kidney Diseases;  [R01 DK042648];  [U01 DK8234201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK082342, R01DK042648] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were funded by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov/Pages/default.aspx). Funding was through awards R01 DK042648 and U01 DK8234201 to D.J.K. and A.J.S. Award U01 DK8234201 is within the Multi-Disciplinary Approaches to Chronic Pelvic Pain Research Network (MAPP, www.mappnetwork.org). This work was approved for publication by the MAPP Publications Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON P, 1991, INFECT IMMUN, V59, P2915, DOI 10.1128/IAI.59.9.2915-2921.1991; Bergsten G, 2007, CELL MICROBIOL, V9, P1766, DOI 10.1111/j.1462-5822.2007.00912.x; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bleidorn J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-30; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Czaja Christopher A, 2007, Infect Dis Obstet Gynecol, V2007, P35387, DOI 10.1155/2007/35387; Darouiche RO, 2011, UROLOGY, V78, P341, DOI 10.1016/j.urology.2011.03.062; Darouiche RO, 2005, CLIN INFECT DIS, V41, P1531, DOI 10.1086/497272; Ferry SA, 2004, SCAND J INFECT DIS, V36, P296, DOI 10.1080/00365540410019642; Fiore C, 2010, REGULATORY CONSIDERA; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Hang L, 2000, J INFECT DIS, V182, P1738, DOI 10.1086/317599; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; HOPKINS WJ, 1995, J INFECT DIS, V171, P462, DOI 10.1093/infdis/171.2.462; Hull R, 2000, J UROLOGY, V163, P872, DOI 10.1016/S0022-5347(05)67823-8; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Klemm P, 2007, INFECT IMMUN, V75, P3688, DOI 10.1128/IAI.01730-06; Klumpp DJ, 2006, INFECT IMMUN, V74, P5106, DOI 10.1128/IAI.00376-06; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; LINDBERG U, 1975, ACTA PAEDIATR SCAND, V64, P718, DOI 10.1111/j.1651-2227.1975.tb03910.x; Looft T, 2012, GUT MICROBES, V3, P463, DOI 10.4161/gmic.21288; Malykhina AP, 2012, NEUROUROL URODYNAM, V31, P352, DOI 10.1002/nau.21228; McMahon SB, 1978, J PHYSL, V275; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Naber KG, 2011, INT J ANTIMICROB AG, V38, P21, DOI 10.1016/j.ijantimicag.2011.09.003; Nelson C, 1999, VITAL HLTH STAT, V13; OLD DC, 1970, J BACTERIOL, V103, P447, DOI 10.1128/JB.103.2.447-456.1970; Parsons CL, 2006, EXPERT OPIN PHARMACO, V7, P411, DOI 10.1517/14656566.7.4.411; Pezzone MA, 2005, GASTROENTEROLOGY, V128, P1953, DOI 10.1053/j.gastro.2005.03.008; Reid G, 2006, WORLD J UROL, V24, P28, DOI 10.1007/s00345-005-0043-1; Rudick CN, 2007, AM J PHYSIOL-REG I, V293, pR1191, DOI 10.1152/ajpregu.00411.2007; Rudick CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041273; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Schaeffer AJ, 2012, CAMPBELL WALSH UROLO, P223; Stapleton A, 2003, INFECT DIS CLIN N AM, V17, P457, DOI 10.1016/S0891-5520(03)00010-2; Stewardson AJ, 2011, CURR OPIN PHARMACOL, V11, P446, DOI 10.1016/j.coph.2011.06.011; Sunden F, 2010, J UROLOGY, V184, P179, DOI 10.1016/j.juro.2010.03.024; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Wise BL, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.05.027	45	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e109321	10.1371/journal.pone.0109321	http://dx.doi.org/10.1371/journal.pone.0109321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405579	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300005
J	Park, YJ; Koh, J; Gauna, AE; Chen, SU; Cha, SH				Park, Yun-Jong; Koh, Jin; Gauna, Adrienne E.; Chen, Sixue; Cha, Seunghee			Identification of Regulatory Factors for Mesenchymal Stem Cell-Derived Salivary Epithelial Cells in a Co-Culture System	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN ADIPOSE-TISSUE; STATISTICAL-MODEL; TCF3 REPRESSION; TRANSCRIPTION; ACINAR; GENE; TRANSDIFFERENTIATION; DIFFERENTIATION; PANCREAS	Patients with Sjogren's syndrome or head and neck cancer patients who have undergone radiation therapy suffer from severe dry mouth (xerostomia) due to salivary exocrine cell death. Regeneration of the salivary glands requires a better understanding of regulatory mechanisms by which stem cells differentiate into exocrine cells. In our study, bone marrow-derived mesenchymal stem cells were co-cultured with primary salivary epithelial cells from C57BL/6 mice. Co-cultured bone marrow-derived mesenchymal stem cells clearly resembled salivary epithelial cells, as confirmed by strong expression of salivary gland epithelial cell-specific markers, such as alpha-amylase, muscarinic type 3 receptor, aquaporin-5, and cytokeratin 19. To identify regulatory factors involved in this differentiation, transdifferentiated mesenchymal stem cells were analyzed temporarily by two-dimensional-gel-electrophoresis, which detected 58 protein spots (>1.5 fold change, p < 0.05) that were further categorized into 12 temporal expression patterns. Of those proteins only induced in differentiated mesenchymal stem cells, ankryin-repeat-domain-containing-protein 56, high-mobility-group-protein 20B, and transcription factor E2a were selected as putative regulatory factors for mesenchymal stem cell transdifferentiation based on putative roles in salivary gland development. Induction of these molecules was confirmed by RT-PCR and western blotting on separate sets of co-cultured mesenchymal stem cells. In conclusion, our study is the first to identify differentially expressed proteins that are implicated in mesenchymal stem cell differentiation into salivary gland epithelial cells. Further investigation to elucidate regulatory roles of these three transcription factors in mesenchymal stem cell reprogramming will provide a critical foundation for a novel cell-based regenerative therapy for patients with xerostomia.	[Park, Yun-Jong; Gauna, Adrienne E.; Cha, Seunghee] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32611 USA; [Koh, Jin; Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Chen, Sixue] Univ Florida, UF Genet Inst, Dept Biol, Gainesville, FL USA; [Chen, Sixue] Univ Florida, Genet Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cha, SH (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32611 USA.	scha@dental.ufl.edu		Williams, Adrienne/0000-0003-0247-1175	National Institutes of Health/National Institute of Dental and Craniofacial Research [DE019644]; NIH/National Center for Advancing Translational Sciences Clinical and Translational Science Awards [UL1 TR000064, TL1 TR000066]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, TL1TR000066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990, R01DE019644] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/National Center for Advancing Translational Sciences Clinical and Translational Science Awards; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding from National Institutes of Health/National Institute of Dental and Craniofacial Research grant DE019644 (SC) and in part by the NIH/National Center for Advancing Translational Sciences Clinical and Translational Science Awards grant UL1 TR000064 and TL1 TR000066 (AEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2000, CELL GROWTH DIFFER, V11, P137; Atlasi Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003424; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; Bullard T, 2008, DEV BIOL, V320, P72, DOI 10.1016/j.ydbio.2008.04.018; Chien KR, 2008, NATURE, V453, P302, DOI 10.1038/nature07037; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; El-Badri NS, 2006, STEM CELLS DEV, V15, P473, DOI 10.1089/scd.2006.15.473; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071167; Lim JY, 2013, ORAL ONCOL, V49, P136, DOI 10.1016/j.oraloncology.2012.08.010; Lin CY, 2011, J DENT RES, V90, P341, DOI 10.1177/0022034510386374; Lin CY, 2007, J FORMOS MED ASSOC, V106, P1, DOI 10.1016/S0929-6646(09)60209-6; Lin CY, 2013, J FORMOS MED ASSOC, V112, P713, DOI 10.1016/j.jfma.2012.08.006; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Maria OM, 2011, STEM CELLS DEV, V20, P959, DOI 10.1089/scd.2010.0214; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pringle S, 2011, JOVE-J VIS EXP, DOI 10.3791/2484; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rabilloud T, 2009, MASS SPECTROM REV, V28, P816, DOI 10.1002/mas.20204; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Ravanpay AC, 2008, J NEUROSCI RES, V86, P1472, DOI 10.1002/jnr.21615; Rotter N, 2008, STEM CELLS DEV, V17, P509, DOI 10.1089/scd.2007.0180; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; SOMMER L, 1991, CELL, V67, P987, DOI 10.1016/0092-8674(91)90371-5; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Voulgarelis M, 2010, NAT REV RHEUMATOL, V6, P529, DOI 10.1038/nrrheum.2010.118; WOLFF A, 1991, ORAL SURG ORAL MED O, V71, P569, DOI 10.1016/0030-4220(91)90364-I; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Xu JJ, 2012, BLOOD, V120, P3142, DOI 10.1182/blood-2011-11-391144; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yoshida S, 2001, DEV BIOL, V240, P517, DOI 10.1006/dbio.2001.0473; Zhao Y, 2006, MOL ENDOCRINOL, V20, P2187, DOI 10.1210/me.2005-0214; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zurita M, 2008, NEUROSCI RES, V60, P275, DOI 10.1016/j.neures.2007.11.006	50	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112158	10.1371/journal.pone.0112158	http://dx.doi.org/10.1371/journal.pone.0112158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402494	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700032
J	Sparding, N; Slotved, HC; Nicolaisen, GM; Giese, SB; Elmlund, J; Steenhard, NR				Sparding, Nadja; Slotved, Hans-Christian; Nicolaisen, Gert M.; Giese, Steen B.; Elmlund, Jon; Steenhard, Nina R.			Development of an ELISA for Evaluation of Swab Recovery Efficiencies of Bovine Serum Albumin	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; BACILLUS-ANTHRACIS SPORES; FLOCKED NYLON SWABS; SENSITIVE ELISA; SURFACES; VACCINES; PROTOCOL; BSA	After a potential biological incident the sampling strategy and sample analysis are crucial for the outcome of the investigation and identification. In this study, we have developed a simple sandwich ELISA based on commercial components to quantify BSA (used as a surrogate for ricin) with a detection range of 1.32-80 ng/mL. We used the ELISA to evaluate different protein swabbing procedures (swabbing techniques and after-swabbing treatments) for two swab types: a cotton gauze swab and a flocked nylon swab. The optimal swabbing procedure for each swab type was used to obtain recovery efficiencies from different surface materials. The surface recoveries using the optimal swabbing procedure ranged from 0-60% and were significantly higher from nonporous surfaces compared to porous surfaces. In conclusion, this study presents a swabbing procedure evaluation and a simple BSA ELISA based on commercial components, which are easy to perform in a laboratory with basic facilities. The data indicate that different swabbing procedures were optimal for each of the tested swab types, and the particular swab preference depends on the surface material to be swabbed.	[Sparding, Nadja; Slotved, Hans-Christian; Nicolaisen, Gert M.; Giese, Steen B.; Elmlund, Jon; Steenhard, Nina R.] Statens Serum Inst, Ctr Biosecur & Biopreparedness, DK-2300 Copenhagen, Denmark; [Slotved, Hans-Christian] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut	Sparding, N (corresponding author), Statens Serum Inst, Ctr Biosecur & Biopreparedness, DK-2300 Copenhagen, Denmark.	nasp@ssi.dk	Slotved, Hans-Christian/H-7476-2019	Slotved, Hans-Christian/0000-0002-7294-4911				Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Dalmaso Giblerto, 2008, PDA J Pharm Sci Technol, V62, P191; Frawley DA, 2008, J FORENSIC SCI, V53, P1102, DOI 10.1111/j.1556-4029.2008.00811.x; Gage JC, 2011, ACTA CYTOL, V55, P364, DOI 10.1159/000329488; Hedin G, 2010, J HOSP INFECT, V75, P314, DOI 10.1016/j.jhin.2010.02.027; Hodges LR, 2006, APPL ENVIRON MICROB, V72, P4429, DOI 10.1128/AEM.02923-05; Hodges LR, 2010, J MICROBIOL METH, V81, P141, DOI 10.1016/j.mimet.2010.02.010; Khamehchian S, 2008, HUM VACCINES, V4, P375, DOI 10.4161/hv.4.5.6009; Lean MH, 2004, P 2 JOINT C POINT DE; Mirsky AE, 1936, P NATL ACAD SCI USA, V22, P439, DOI 10.1073/pnas.22.7.439; Probst A, 2011, APPL ENVIRON MICROB, V77, P1628, DOI 10.1128/AEM.02037-10; Rastogi VK, 2002, ASSESSMENT ENV BENIG; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Steinitz M, 2000, ANAL BIOCHEM, V282, P232, DOI 10.1006/abio.2000.4602; TERAVEST AR, 1987, J BIOL STAND, V15, P245, DOI 10.1016/0092-1157(87)90027-8; WANG J, 1994, TOHOKU J EXP MED, V172, P345, DOI 10.1620/tjem.172.345; Zhang K, 2010, HUM VACCINES, V6, P652, DOI 10.4161/hv.6.8.11935; Zhang XM, 2011, BIOSENS BIOELECTRON, V26, P3958, DOI 10.1016/j.bios.2011.02.050	18	1	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112876	10.1371/journal.pone.0112876	http://dx.doi.org/10.1371/journal.pone.0112876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402464	gold, Green Published			2022-12-27	WOS:000345158700081
J	Wang, XN; Ye, P; Cao, RH; Yang, X; Xiao, WK; Zhang, Y; Bai, YY; Wu, HM				Wang, Xiaona; Ye, Ping; Cao, Ruihua; Yang, Xu; Xiao, Wenkai; Zhang, Yun; Bai, Yongyi; Wu, Hongmei			The Association of Homocysteine with Metabolic Syndrome in a Community-Dwelling Population: Homocysteine Might Be Concomitant with Metabolic Syndrome	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; PLASMA HOMOCYSTEINE; ARTERIAL STIFFNESS; SERUM; HYPERHOMOCYSTEINEMIA; INSULIN; RISK; STRESS	Objective: Elevated plasma total homocysteine (tHcy) and metabolic syndrome (MetS) are both associated with cardiovascular disease, but the association between tHcy and MetS is not well characterized. The aim of this study was to determine the relationship between tHcy and MetS. Methods: To further estimate the time-dependent association of tHcy and MetS, we analyzed the tHcy level and MetS in 1499 subjects from a 4.8-year longitudinal study in Beijing, People's Republic of China. Results: In multiple linear regression analysis, baseline tHcy levels associated with age, BMI, SBP, DBP, LDL-C and Cr independently over 4.8-years follow-up; age, BMI, SBP, DBP and Cr were found to be associated with tHcy levels independently at the end of follow-up. Logistic regression analysis showed that there was no association between the baseline tHcy level and MetS over the 4.8-year follow-up (odds ratio (OR), 1.32; 95% confidence interval (CI), 0.79-2.19; P = 0.282); rather, there was an association only with hypertension as a MetS component (OR, 1.53; 95% CI, 1.06-2.21; P = 0.024). tHcy levels were associated with MetS at both cross-sectional baseline (OR, 1.38; 95% CI, 1.02-1.88; P = 0.038) and cross-sectional follow-up (OR, 1.60; 95% CI, 1.02-2.50; P = 0.041). The tHcy levels of MetS subjects were higher than those of non-MetS subjects at both cross-sectional baseline (19.35 +/- 7.92 mu mol/L vs. 17.45 +/- 6.70 mu mol/L, respectively; P = 0.001) and cross-sectional follow-up (18.95 +/- 7.15 mu mol/L vs. 17.11 +/- 5.98 mu mol/L, respectively; P = 0.02). Conclusion: The tHcy level was not predictive of the incidence of MetS; however, it may be a risk factor for hypertension as a MetS component. Furthermore, tHcy levels were associated with MetS at cross-sectional baseline and follow-up, which suggests that a higher level of tHcy might be concomitant with MetS.	[Wang, Xiaona; Ye, Ping; Cao, Ruihua; Yang, Xu; Xiao, Wenkai; Zhang, Yun; Bai, Yongyi; Wu, Hongmei] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Ye, P (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	yeping301@sina.com	Wang, Dapeng/HGD-4818-2022		National Nature Science Foundation of China [81270941]; Key National Basic Research Program of China [2012CB517503, 2013CB530804]; Key Science and Technology Foundation of China [2012ZX09303004-002]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Basic Research Program of China(National Basic Research Program of China); Key Science and Technology Foundation of China	This research is supported by the grant from the National Nature Science Foundation of China (81270941), the Key National Basic Research Program of China (2012CB517503, 2013CB530804) and the Key Science and Technology Foundation of China (2012ZX09303004-002) to Dr. Ping Ye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bai YY, 2011, ATHEROSCLEROSIS, V218, P493, DOI 10.1016/j.atherosclerosis.2011.06.035; Bjorck J, 2006, METABOLISM, V55, P1007, DOI 10.1016/j.metabol.2006.03.010; Bravo E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-60; Budak N, 2009, METAB SYNDR RELAT D, V7, P357, DOI 10.1089/met.2008.0037; Feng Sheng-qiang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P256; Fonseca V, 2000, METABOLISM, V49, P736, DOI 10.1053/meta.2000.6256; Garcin J. -M., 2006, Metabolic Syndrome and Related Disorders, V4, P185, DOI 10.1089/met.2006.4.185; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guven A, 2005, HEART VESSELS, V20, P290, DOI 10.1007/s00380-004-0822-4; Hajer GR, 2007, HEART, V93, P216, DOI 10.1136/hrt.2006.093971; Hao L, 2007, J NUTR, V137, P407, DOI 10.1093/jn/137.2.407; Jacques PF, 1999, AM J CLIN NUTR, V69, P482; Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lu Yan-hui, 2006, Zhonghua Yi Xue Za Zhi, V86, P386; Malinow MR, 1996, ATHEROSCLEROSIS, V126, P27, DOI 10.1016/0021-9150(96)05890-X; Meigs JB, 2001, DIABETES CARE, V24, P1403, DOI 10.2337/diacare.24.8.1403; Must A, 2003, J NUTR, V133, P2643, DOI 10.1093/jn/133.8.2643; Nabipour I, 2009, J ENDOCRINOL INVEST, V32, P406, DOI 10.1007/BF03346476; Oda E, 2012, ACTA DIABETOL, V49, P89, DOI 10.1007/s00592-011-0309-6; Rhee EJ, 2007, ENDOCR J, V54, P995, DOI 10.1507/endocrj.K07E-018; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Soonthornpun Supamai, 2007, Journal of the Medical Association of Thailand, V90, P1506; Tayama J, 2006, HYPERTENS RES, V29, P403, DOI 10.1291/hypres.29.403; UELAND PM, 1993, CLIN CHEM, V39, P1764; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yakub M, 2010, J NUTR, V140, P1261, DOI 10.3945/jn.109.120477	30	11	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113148	10.1371/journal.pone.0113148	http://dx.doi.org/10.1371/journal.pone.0113148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401978	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700117
J	Zhao, L; Gu, HH; Chang, JF; Wu, JY; Wang, DL; Chen, S; Yang, XM; Qian, BH				Zhao, Lei; Gu, Haihui; Chang, Jianfeng; Wu, Junyu; Wang, Daliang; Chen, Su; Yang, Xiaomei; Qian, Baohua			MicroRNA-383 Regulates the Apoptosis of Tumor Cells through Targeting Gadd45g	PLOS ONE			English	Article							P53-REGULATED PROTEIN GADD45; DNA-DAMAGE RESPONSE; STEM-CELLS; DROSHA-DGCR8 COMPLEX; HEMATOPOIETIC-CELLS; GENOTOXIC STRESS; KINASE-ACTIVITY; DOWN-REGULATION; SRY EXPRESSION; SELF-RENEWAL	Background: MicroRNAs (miRNAs) are a class of small non-coding single-stranded RNA molecules that inhibit gene expression at post-transcriptional level. Gadd45g (growth arrest and DNA-damage-inducible 45 gamma) is a stress-response protein, which has been implicated in several biological processes, including DNA repair, the cell cycle and cell differentiation. Results: In this work, we found that miR-383 is a negative regulator of Gadd45g. Forced expression of miR-383 decreased the expression of Gadd45g through binding to the 3' untranslated region (3'-UTR), whereas inhibition of miR-383 increased Gadd45g expression. The presence of miR-383 increased the cellular sensitivity to DNA damage in breast cancer cells, which was rescued by ectopic expression of Gadd45g without the 3'-UTR. miR-383 also regulates the expression of Gadd45g in embryonic stem (ES) cells, but not their apoptosis under genotoxic stress. miR-383 was further showed to negatively regulate ES cell differentiation via targeting Gadd45g, which subsequently modulates the pluripotency-associated genes. Taken together, our study demonstrates that miR-383 is a negative regulator of Gadd45g in both tumor cells and ES cells, however, has distinct function in regulating cell apoptosis. miR-383 may be used as antineoplastic agents in cancer chemotherapy. Conclusion: We demonstrate for the first time that miR-383 can specifically regulates the expression of Gadd45g by directly targeting to the 3-UTR region of Gadd45g mRNA, a regulatory process conserved in human tumor cells and mouse embryonic stem cells. These two compotents can be potentially used as antineoplastic agents in cancer chemotherapy.	[Zhao, Lei; Wu, Junyu; Wang, Daliang] Tsinghua Univ, Sch Med, Inst Epigenet & Canc Res, Beijing 100084, Peoples R China; [Gu, Haihui; Qian, Baohua] Second Mil Med Univ, Changhai Hosp, Dept Transfus Med, Shanghai 200433, Peoples R China; [Chang, Jianfeng; Chen, Su; Yang, Xiaomei] Tongji Univ, East Hosp, Sch Life Sci & Technol, Res Ctr Translat Med, Shanghai 200120, Peoples R China	Tsinghua University; Naval Medical University; Tongji University	Yang, XM (corresponding author), Tongji Univ, East Hosp, Sch Life Sci & Technol, Res Ctr Translat Med, 150 Jimo Rd 1239 Siping Rd, Shanghai 200120, Peoples R China.	yxm411@tongji.edu.cn; qianbh1963@163.com		Wu, Junyu/0000-0002-2515-9320	973 program of the Ministry of Science and Technology of China [2011CB965302, 2013CB967600, 2014CB964603]; National Natural Science Foundation of China [31330043, 31201051, 31271534, 91319306, 81400152]	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the 973 program of the Ministry of Science and Technology of China (Grant No.: 2011CB965302, 2013CB967600, 2014CB964603), the National Natural Science Foundation of China (Grant No.: 31330043, 31201051, 31271534, 91319306, 81400152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Calle-Mustienes ED, 2002, MECH DEVELOP, V119, P69, DOI 10.1016/S0925-4773(02)00296-4; Candal E, 2004, MECH DEVELOP, V121, P945, DOI 10.1016/j.mod.2004.03.007; Cardinal J, 2009, HEPATOLOGY, V50, P565, DOI 10.1002/hep.23021; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dormoy-Raclet V, 2007, ONCOGENE, V26, P2595, DOI 10.1038/sj.onc.1210068; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gierl MS, 2012, DEV CELL, V23, P1032, DOI 10.1016/j.devcel.2012.09.014; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Huang HS, 2010, MOL CELL NEUROSCI, V44, P282, DOI 10.1016/j.mcn.2010.03.014; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kaufmann LT, 2011, MECH DEVELOP, V128, P401, DOI 10.1016/j.mod.2011.08.002; Kaufmann LT, 2011, GENE EXPR PATTERNS, V11, P465, DOI 10.1016/j.gep.2011.07.005; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Li HY, 2008, OBESITY, V16, P356, DOI 10.1038/oby.2007.76; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lieberman HB, 2008, CURR MED CHEM, V15, P360, DOI 10.2174/092986708783497328; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Subramanyam D, 2011, CURR OPIN GENET DEV, V21, P498, DOI 10.1016/j.gde.2011.04.011; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Wan GH, 2011, TRENDS BIOCHEM SCI, V36, P478, DOI 10.1016/j.tibs.2011.06.002; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Wouters MD, 2011, MUTAT RES-FUND MOL M, V717, P54, DOI 10.1016/j.mrfmmm.2011.03.012; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang Q, 2000, J BIOL CHEM, V275, P36892, DOI 10.1074/jbc.M005319200; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang W, 1999, ONCOGENE, V18, P4899, DOI 10.1038/sj.onc.1202885	50	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e110472	10.1371/journal.pone.0110472	http://dx.doi.org/10.1371/journal.pone.0110472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415264	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600003
J	Zhao, F; Siu, MKY; Jiang, LL; Tam, KF; Ngan, HYS; Le, XF; Wong, OGW; Wong, ESY; Gomes, AR; Bella, L; Khongkow, P; Lam, EWF; Cheung, ANY				Zhao, Fung; Siu, Michelle K. Y.; Jiang, LiLi; Tam, Kar Fai; Ngan, Hextan Y. S.; Le, Xiao Feng; Wong, Oscar G. W.; Wong, Esther S. Y.; Gomes, Ana R.; Bella, Laura; Khongkow, Pasarat; Lam, Eric W-F; Cheung, Annie N. Y.			Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance	PLOS ONE			English	Article							CENTROMERE-ASSOCIATED KINESIN; BREAST-CANCER; MITOTIC CATASTROPHE; DIFFERENTIAL EXPRESSION; CELL INVASION; DNA-DAMAGE; P53; CARCINOGENESIS; INHIBITION; ACTIVATION	Aim: Deregulation of FOXM1 has been documented in various cancers. The aim of this study was to evaluate the role of FOXM1 in ovarian cancer tumorigenesis and paclitaxel resistance. Experimental Design: Expression of FOXM1 was examined in 119 clinical samples by immunohistochemistry and correlated with clinicopathological parameters. Effects of FOXM1 knockdown on ovarian cancer cell migration, invasion and mitotic catastrophe were also studied. qPCR and ChIP-qPCR were used to establish KIF2C as a novel FOXM1 target gene implicated in chemoresistance. Results: High nuclear FOXM1 expression in ovarian cancer patient samples was significantly associated with advanced stages (P = 0.035), shorter overall (P = 0.019) and disease-free (P = 0.014) survival. Multivariate analysis confirmed FOXM1 expression as an independent prognostic factor for ovarian cancer. FOXM1 knockdown significantly inhibited migration and invasion of ovarian cancer cells and enhanced paclitaxel-mediated cell death and mitotic catastrophe in a p53-independent manner. Bioinformatics analysis suggested a number of potential transcription targets of FOXM1. One of the potential targets, KIF2C, exhibited similar expression pattern to FOXM1 in chemosensitive and chemoresistant cells in response to paclitaxel treatment. FOXM1 could be detected at the promoter of KIF2C and FOXM1 silencing significantly down-regulated KIF2C. Conclusion: Our findings suggest that FOXM1 is associated with poor patient outcome and contributes to paclitaxel resistance by blocking mitotic catastrophe. KIF2C is identified as a novel FOXM1 transcriptional target that may be implicated in the acquisition of chemoresistance. FOXM1 should be further investigated as a potential prognostic marker and therapeutic target for ovarian cancer.	[Zhao, Fung; Tam, Kar Fai; Wong, Oscar G. W.; Wong, Esther S. Y.; Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hksar, Peoples R China; [Zhao, Fung; Gomes, Ana R.; Bella, Laura; Khongkow, Pasarat; Lam, Eric W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Siu, Michelle K. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, Hksar, Peoples R China; [Jiang, LiLi] Sichuang Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China; [Le, Xiao Feng] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Cheung, Annie N. Y.] Univ Hong Kong, Shenzhen Hosp, Dept Pathol, Shenzhen, Peoples R China	University of Hong Kong; Imperial College London; University of Hong Kong; Sichuan University; University of Texas System; UTMD Anderson Cancer Center; University of Hong Kong	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	eric.lam@imperial.ac.uk; anycheun@hkucc.hku.hk	Lam, Eric W-F/AAW-8566-2020; Wong, Gee Wan/C-4661-2009; Cheung, Annie Nga Yin/C-4231-2009	Lam, Eric W-F/0000-0003-1274-3576; Cheung, Annie Nga Yin/0000-0002-1584-7568; Ngan, Hextan Y S/0000-0003-3945-159X; Khongkow, Pasarat/0000-0003-3068-2412	Cancer Research UK; Breast Cancer Campaign; Royal Thai Goverment; Research Grants Council of HKSAR; Biotechnology and Biological Sciences Research Council [BBS/B/03785] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1234732] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Royal Thai Goverment; Research Grants Council of HKSAR(Hong Kong Research Grants Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Fung Zhao is a recipient of a HKU-ICL joint studentship. Ana Gomes is a post-doctoral fellow supported by Cancer Research UK. Laura Bella is supported by a studentship from Breast Cancer Campaign. Pasarat Khongkow is supported by scholarships from the Royal Thai Goverment. Eric Lam's work is supported by grants from Breast Cancer Campaign and Cancer Research UK. Annie Cheung's work is supported by funding from the Research Grants Council of HKSAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burger RA, 2008, AM J OBSTET GYNECOL, V198, P349, DOI 10.1016/j.ajog.2008.01.004; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052578; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Foster H, 2010, ANTICANCER RES, V30, P3529; Francis RE, 2009, INT J ONCOL, V35, P57, DOI 10.3892/ijo_00000313; Ganguly A, 2011, MOL CANCER THER, V10, P929, DOI 10.1158/1535-7163.MCT-10-1109; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; Katoh M, 2004, INT J ONCOL, V25, P1495; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura Y, 2007, BRIT J CANCER, V97, P543, DOI 10.1038/sj.bjc.6603905; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Wolf JK, 1999, GYNECOL ONCOL, V75, P261, DOI 10.1006/gyno.1999.5565; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yamakawa N, 2008, CANCER SCI, V99, P1455, DOI 10.1111/j.1349-7006.2008.00818.x; Zhao F, 2011, HISTOPATHOLOGY, V59, P1163, DOI 10.1111/j.1365-2559.2011.04045.x	29	18	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113478	10.1371/journal.pone.0113478	http://dx.doi.org/10.1371/journal.pone.0113478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411964	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000057
J	Galazka, MA; Roche, L; Nystrom, P; Falck-Ytter, T				Galazka, Martyna A.; Roche, Laetitia; Nystrom, Par; Falck-Ytter, Terje			Human Infants Detect Other People's Interactions Based on Complex Patterns of Kinematic Information	PLOS ONE			English	Article							BIOLOGICAL MOTION; POINT-LIGHT; RECOGNITION MEMORY; PERCEPTION; DISCRIMINATION; NOVELTY; AUTISM; FAMILIARITY; PREFERENCE; SPEECH	Do infants perceive other people's interactions by means of a mechanism that integrates biological motion information across the observed individuals? In support of this view, the present study demonstrates that infants (N = 28, Age = 14 months) discriminate between point light displays representing disrupted and non-disrupted interactions between people, even though the two interaction types are identical at the level of individual point light agents. Moreover, a second experiment (sample 2: N = 28, Age = 14 months) indicated that visual preference in this context is influenced by an audiovisual integration processes that takes into account the presence of an interaction between people. All these results were found exclusively for upright displays -when stimuli were shown upside-down (disrupting biological motion processing), performance was random. Collectively, these findings point to an important role for biological motion in social perception in human infants.	[Galazka, Martyna A.; Nystrom, Par; Falck-Ytter, Terje] Uppsala Univ, Dept Psychol, Uppsala Child & Babylab, Uppsala, Sweden; [Roche, Laetitia] INSERM, U930, Tours, France; [Roche, Laetitia] Univ Tours, Unit Imaging & Brain 930, Team Autism 1, Tours, France; [Falck-Ytter, Terje] Karolinska Inst KIND, Ctr Neurodev Disorders, Stockholm, Sweden	Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Karolinska Institutet	Galazka, MA (corresponding author), Uppsala Univ, Dept Psychol, Uppsala Child & Babylab, Uppsala, Sweden.	martyna.galazka@psyk.uu.se; laetitia.alexandra.roche@gmail.com			Bank of Sweden Tercentenary Foundation [P12-0270:1]; Swedish Research Council; FAS; FORMAS; VINNOVA [259-2012-24]; ESF COST Action BM1004 'Enhancing the Scientific Study of Early Autism' (ESSEA); European Research Council [ERC-2012-StG 312292-CACTUS]	Bank of Sweden Tercentenary Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); FAS; FORMAS(Swedish Research Council Formas); VINNOVA(Vinnova); ESF COST Action BM1004 'Enhancing the Scientific Study of Early Autism' (ESSEA); European Research Council(European Research Council (ERC)European Commission)	TFY was supported by the Bank of Sweden Tercentenary Foundation [P12-0270:1] and the Swedish Research Council in partnership with FAS, FORMAS, and VINNOVA [Cross-disciplinary research programme concerning children's and young people's mental health; grant number 259-2012-24]. The work of TFY, PN and LR was supported by the ESF COST Action BM1004 'Enhancing the Scientific Study of Early Autism' (ESSEA). The work of MG was supported by the European Research Council (ERC-2012-StG 312292-CACTUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; Bahrick LE, 2002, DEV PSYCHOBIOL, V41, P352, DOI 10.1002/dev.10049; Bahrick LE, 2004, COGN AFFECT BEHAV NE, V4, P137, DOI 10.3758/CABN.4.2.137; Bidet-Ildei C, 2014, DEV PSYCHOL, V50, P113, DOI 10.1037/a0032956; Bolte S., 2011, AUTISM SPECTRUM COND; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Centelles L, 2013, J AUTISM DEV DISORD, V43, P1140, DOI 10.1007/s10803-012-1655-0; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; CUTTING JE, 1988, PERCEPT PSYCHOPHYS, V44, P339, DOI 10.3758/BF03210415; Falck-Ytter T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068816; Falck-Ytter T, 2011, NEUROPSYCHOLOGIA, V49, P2131, DOI 10.1016/j.neuropsychologia.2011.03.040; Fawcett C, 2013, DEVELOPMENTAL SCI, V16, P841, DOI 10.1111/desc.12074; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Gilaie-Dotan S, 2013, NEUROPSYCHOLOGIA, V51, P457, DOI 10.1016/j.neuropsychologia.2012.11.027; Graf M, 2007, NEUROIMAGE, V36, pT22, DOI 10.1016/j.neuroimage.2007.03.017; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Grossmann T, 2006, DEVELOPMENTAL SCI, V9, P309, DOI 10.1111/j.1467-7687.2006.00494.x; Hirai M, 2005, COGNITIVE BRAIN RES, V22, P301, DOI 10.1016/j.cogbrainres.2004.08.008; HIRAI M, 2009, BMC PLANT BIOL, V9, DOI DOI 10.1186/1471-2202-10-39; Hortensius R, 2014, NEUROIMAGE, V93, P53, DOI 10.1016/j.neuroimage.2014.02.025; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Ikeda H, 2005, VISION RES, V45, P1935, DOI 10.1016/j.visres.2005.02.001; Jessen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036070; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kuhlmeier VA, 2010, INFANCY, V15, P83, DOI 10.1111/j.1532-7078.2009.00003.x; Lewkowicz DJ, 2004, DEVELOPMENTAL SCI, V7, P175, DOI 10.1111/j.1467-7687.2004.00336.x; Manera V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054949; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Meyer GF, 2013, NEUROPSYCHOLOGIA, V51, P1716, DOI 10.1016/j.neuropsychologia.2013.05.014; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Moore DG, 2007, COGNITION, V104, P377, DOI 10.1016/j.cognition.2006.07.007; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Pascalis O, 2003, PROGRESS INFANCY RES, V3, P95; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; QUINN PC, 1986, INFANT BEHAV DEV, V9, P57, DOI 10.1016/0163-6383(86)90038-X; Reid VM, 2006, NEUROSCI LETT, V395, P211, DOI 10.1016/j.neulet.2005.10.080; Roche L, 2013, INT J PSYCHOPHYSIOL, V88, P47, DOI 10.1016/j.ijpsycho.2013.01.009; ROSE SA, 1982, DEV PSYCHOL, V18, P704, DOI 10.1037/0012-1649.18.5.704; Saygin AP, 2008, PSYCHOL SCI, V19, P469, DOI 10.1111/j.1467-9280.2008.02111.x; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Sinke CBA, 2010, NEUROIMAGE, V49, P1717, DOI 10.1016/j.neuroimage.2009.09.065; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; TYRRELL DJ, 1991, INFANT BEHAV DEV, V14, P125, DOI 10.1016/0163-6383(91)90059-2; von Hofsten C, 2009, RES AUTISM SPECT DIS, V3, P556, DOI 10.1016/j.rasd.2008.12.003	49	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112432	10.1371/journal.pone.0112432	http://dx.doi.org/10.1371/journal.pone.0112432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409449	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200021
J	Lane, JM; Doyle, JR; Fortin, JP; Kopin, AS; Ordovas, JM				Lane, Jacqueline M.; Doyle, Jamie R.; Fortin, Jean-Philippe; Kopin, Alan S.; Ordovas, Jose M.			Development of an OP9 Derived Cell Line as a Robust Model to Rapidly Study Adipocyte Differentiation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; 3T3-L1 CELLS; PPAR-GAMMA; STEM-CELLS; ADIPOSE; ADIPOGENESIS; PU.1; RISK; MICRORNAS	One hallmark of obesity is adipocyte hypertrophy and hyperplasia. To gain novel insights into adipose biology and therapeutics, there is a pressing need for a robust, rapid, and informative cell model of adipocyte differentiation for potential RNAi and drug screens. Current models are prohibitive for drug and RNAi screens due to a slow differentiation time course and resistance to transfection. We asked if we could create a rapid, robust model of adipogenesis to potentially enable rapid functional and obesity therapeutic screens. We generated the clonal population OP9-K, which differentiates rapidly and reproducibly, and displays classic adipocyte morphology: rounded cell shape, lipid accumulation, and coalescence of lipids into a large droplet. We further validate the OP9-K cells as an adipocyte model system by microarray analysis of the differentiating transcriptome. OP9-K differentiates via known adipogenic pathways, involving the transcriptional activation and repression of common adipose markers Plin1, Gata2, C/Ebp alpha and C/Ebp beta and biological pathways, such as lipid metabolism, PPAR gamma signaling, and osteogenesis. We implemented a method to quantify lipid accumulation using automated microscopy and tested the ability of our model to detect alterations in lipid accumulation by reducing levels of the known master adipogenic regulator Ppar gamma. We further utilized our model to query the effects of a novel obesity therapeutic target, the transcription factor SPI1. We determine that reduction in levels of Spi1 leads to an increase in lipid accumulation. We demonstrate rapid, robust differentiation and efficient transfectability of the OP9-K cell model of adipogenesis. Together with our microscopy based lipid accumulation assay, adipogenesis assays can be achieved in just four days' time. The results of this study can contribute to the development of rapid screens with the potential to deepen our understanding of adipose biology and efficiently test obesity therapeutics.	[Lane, Jacqueline M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Lane, Jacqueline M.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Lane, Jacqueline M.; Ordovas, Jose M.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Doyle, Jamie R.; Fortin, Jean-Philippe; Kopin, Alan S.] Tufts Med Ctr, Mol Cardiol Res Inst, Mol Pharmacol Res Ctr, Boston, MA 02111 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Tufts University; United States Department of Agriculture (USDA); Tufts Medical Center	Lane, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	lane@chgr.mgh.harvard.edu	Ordovas, Jose/B-8727-2013	Ordovas, Jose/0000-0002-7581-5680	U.S. Department of Agriculture [58-1950-0-014]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work supported by the U.S. Department of Agriculture, under agreement No. 58-1950-0-014. Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge A, 2013, CYTOTHERAPY, V15, P89, DOI 10.1016/j.jcyt.2012.07.001; Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Bray GA., 2014, HDB OBESITY EPIDEMIO; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chen HC, 2002, J LIPID RES, V43, P986; Chen L, 2013, CELL BIOL INT, V37, P533, DOI 10.1002/cbin.10063; Chung NJ, 2010, ASSAY DRUG DEV TECHN, V8, P286, DOI 10.1089/adt.2009.0262; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Di Iorgi N, 2008, J CLIN ENDOCR METAB, V93, P2281, DOI 10.1210/jc.2007-2691; Doran AC, 2008, CIRC RES, V103, P624, DOI 10.1161/CIRCRESAHA.108.175893; Dragunow M, 2007, J BIOMOL SCREEN, V12, P999, DOI 10.1177/1087057107306502; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gade Wayne, 2010, Clin Lab Sci, V23, P39; Gasparri F, 2009, EXPERT OPIN DRUG DIS, V4, P643, DOI 10.1517/17460440902992870; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Han YY, 2013, J STEROID BIOCHEM, V133, P129, DOI 10.1016/j.jsbmb.2012.09.005; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kamstra JH, 2014, ENVIRON SCI TECHNOL, V48, P4110, DOI 10.1021/es405524b; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lin LG, 2012, AM J PHYSIOL-ENDOC M, V302, pE1550, DOI 10.1152/ajpendo.00462.2011; Ling HY, 2013, BIOCHEM CELL BIOL, V91, P195, DOI 10.1139/bcb-2012-0053; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Menssen A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-461; Morganstein DL, 2008, J LIPID RES, V49, P679, DOI 10.1194/jlr.D700029-JLR200; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Pang WJ, 2013, J CELL BIOCHEM, V114, P2500, DOI 10.1002/jcb.24595; Peng YD, 2014, CELL SIGNAL, V26, P1888, DOI 10.1016/j.cellsig.2014.05.006; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Prokesch A, 2009, CURR MED CHEM, V16, P2952, DOI 10.2174/092986709788803132; Puri V, 2007, J LIPID RES, V48, P465, DOI 10.1194/jlr.D600033-JLR200; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Shimada T, 2007, BIOCHEM BIOPH RES CO, V363, P355, DOI 10.1016/j.bbrc.2007.08.167; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Sohle J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031193; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Suwa A, 2011, ENDOCRINE, V40, P56, DOI 10.1007/s12020-011-9455-4; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tong Q, 2001, Rev Endocr Metab Disord, V2, P349, DOI 10.1023/A:1011863414321; Wang F, 2008, AM J PHYSIOL-CELL PH, V295, pC213, DOI 10.1152/ajpcell.00422.2007; Wei P, 2005, J BIOCHEM, V138, P399, DOI 10.1093/jb/mvi136; Welter JF, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/806525; WING RR, 1992, AM J CLIN NUTR, V55, P1086, DOI 10.1093/ajcn/55.6.1086; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Yaskin J, 2009, POPUL HEALTH MANAG, V12, P305, DOI 10.1089/pop.2008.0049; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005	61	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112123	10.1371/journal.pone.0112123	http://dx.doi.org/10.1371/journal.pone.0112123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409310	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200015
J	Wang, CZ; Pahk, JB; Balaban, CD; Miller, MC; Wood, AR; Vipperman, JS				Wang, Chenzhi; Pahk, Jae Bum; Balaban, Carey D.; Miller, Mark C.; Wood, Adam R.; Vipperman, Jeffrey S.			Computational Study of Human Head Response to Primary Blast Waves of Five Levels from Three Directions	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PATHOLOGY; EXPOSURE	Human exposure to blast waves without any fragment impacts can still result in primary blast-induced traumatic brain injury (bTBI). To investigate the mechanical response of human brain to primary blast waves and to identify the injury mechanisms of bTBI, a three-dimensional finite element head model consisting of the scalp, skull, cerebrospinal fluid, nasal cavity, and brain was developed from the imaging data set of a human female. The finite element head model was partially validated and was subjected to the blast waves of five blast intensities from the anterior, right lateral, and posterior directions at a stand-off distance of one meter from the detonation center. Simulation results show that the blast wave directly transmits into the head and causes a pressure wave propagating through the brain tissue. Intracranial pressure (ICP) is predicted to have the highest magnitude from a posterior blast wave in comparison with a blast wave from any of the other two directions with same blast intensity. The brain model predicts higher positive pressure at the site proximal to blast wave than that at the distal site. The intracranial pressure wave invariably travels into the posterior fossa and vertebral column, causing high pressures in these regions. The severities of cerebral contusions at different cerebral locations are estimated using an ICP based injury criterion. Von Mises stress prevails in the cortex with a much higher magnitude than in the internal parenchyma. According to an axonal injury criterion based on von Mises stress, axonal injury is not predicted to be a cause of primary brain injury from blasts.	[Wang, Chenzhi; Miller, Mark C.; Wood, Adam R.; Vipperman, Jeffrey S.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA; [Pahk, Jae Bum] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Balaban, Carey D.] Univ Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vipperman, JS (corresponding author), Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA.	jsv@pitt.edu	Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Vipperman, Jeffrey/0000-0001-5585-954X	University of Pittsburgh; National Science Foundation (NSF); NSF [1130289]; National Institute of Biomedical Imaging and BioEngineering	University of Pittsburgh(University of Pittsburgh); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); National Institute of Biomedical Imaging and BioEngineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors gratefully acknowledge the University of Pittsburgh and National Science Foundation (NSF) for the funding support. This material is based upon work supported by the NSF under Grant No. 1130289. Thanks are also expressed for the MRI data obtained from The International Consortium for Brain Mapping (ICBM 2011). The ICBM project (Principal Investigator John Mazziotta, M.D, University of California, Los Angeles) is supported by the National Institute of Biomedical Imaging and BioEngineering. ICBM is the result of efforts of co-investigators from UCLA, Montreal Neurologic Institute, University of Texas at San Antonio, and the Institute of Medicine, Juelich/Heinrich Heine University - Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cooper PW., 1996, EXPLOSIVES ENG; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Friedlander FG, 1976, WAVE EQUATION CURVED; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hoffer ME, 2013, PSYCHIAT ANN, V43, P318, DOI 10.3928/00485713-20130703-06; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Lee E., 1973, JWL EQUATION STATE C, DOI [10.2172/4479737, DOI 10.2172/4479737]; Lee EL., 1968, ADIABATIC EXPANSION; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Nahum A, 1977, 21 STAPP CAR CRASH C, DOI [10.4271/770922, DOI 10.4271/770922]; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rogers G. F. C., 1980, THERMODYNAMIC TRANSP; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wang C, 2011, P IMECE 2011; Wang C, 2012, P IMECE 2012; Ward C., 1980, SAE TECHNICAL PAPER; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	42	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113264	10.1371/journal.pone.0113264	http://dx.doi.org/10.1371/journal.pone.0113264			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409326	gold, Green Published, Green Accepted			2022-12-27	WOS:000345533200085
J	Chow, IT; Yang, JB; Gates, TJ; James, EA; Mai, DT; Greenbaum, C; Kwok, WW				Chow, I-Ting; Yang, Junbao; Gates, Theresa J.; James, Eddie A.; Mai, Duy T.; Greenbaum, Carla; Kwok, William W.			Assessment of CD4+T Cell Responses to Glutamic Acid Decarboxylase 65 Using DQ8 Tetramers Reveals a Pathogenic Role of GAD65 121-140 and GAD65 250-266 in T1D Development	PLOS ONE			English	Article							CD4(+) T-CELLS; TYPE-1 DIABETES RISK; EPITOPES; SUSCEPTIBILITY; AUTOANTIGEN; HAPLOTYPES; GENOTYPES; COMPLEX; MICE	Susceptibility to type 1 diabetes (T1D) is strongly associated with MHC class II molecules, particularly HLA-DQ8 (DQ8: DQA1* 03: 01/DQB1* 03: 02). Monitoring T1D-specific T cell responses to DQ8-restricted epitopes may be key to understanding the immunopathology of the disease. In this study, we examined DQ8-restricted T cell responses to glutamic acid decarboxylase 65 (GAD65) using DQ8 tetramers. We demonstrated that GAD65(121-140) and GAD65(250-266) elicited responses from DQ8+ subjects. Circulating CD4+ T cells specific for these epitopes were detected significantly more often in T1D patients than in healthy individuals after in vitro expansion. T cell clones specific for GAD65(121-140) and GAD65(250)-(266) carried a Th1-dominant phenotype, with some of the GAD65(121)-(140)-specific T cell clones producing IL-17. GAD65(250)-(266)-specific CD4+ T cells could also be detected by direct ex vivo staining. Analysis of unmanipulated peripheral blood mononuclear cells (PBMCs) revealed that GAD65250-266-specific T cells could be found in both healthy and diabetic individuals but the frequencies of specific T cells were higher in subjects with type 1 diabetes. Taken together, our results suggest a proinflammatory role for T cells specific for DQ8-restricted GAD65121-140 and GAD65250-266 epitopes and implicate their possible contribution to the progression of T1D.	[Chow, I-Ting; Yang, Junbao; Gates, Theresa J.; James, Eddie A.; Mai, Duy T.; Greenbaum, Carla; Kwok, William W.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Kwok, William W.] Univ Washington, Dept Med, Seattle, WA USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Kwok, WW (corresponding author), Benaroya Res Inst Virginia Mason, Seattle, WA USA.	bkwok@benaroyaresearch.org	James, Eddie/V-4929-2019	James, Eddie/0000-0002-7217-5729	National Institutes of Health [DP3 DK097653]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, DP3DK097653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by JDRF center funding for Translational Research at BRI and DP3 DK097653 grant from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Bingley PJ, 2010, J CLIN ENDOCR METAB, V95, P25, DOI 10.1210/jc.2009-1365; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Herman AE, 1999, J IMMUNOL, V163, P6275; Ide A, 2003, REV ENDOCR METAB DIS, V4, P243, DOI 10.1023/A:1025100328425; Kwok WW, 1996, J IMMUNOL, V156, P2171; Liu JL, 1999, DIABETES, V48, P469, DOI 10.2337/diabetes.48.3.469; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Narendran P, 2005, QJM-INT J MED, V98, P547, DOI 10.1093/qjmed/hci088; Novak EJ, 2001, J IMMUNOL, V166, P6665, DOI 10.4049/jimmunol.166.11.6665; Oling V, 2005, J AUTOIMMUN, V25, P235, DOI 10.1016/j.jaut.2005.09.018; Oling V, 2012, CELL IMMUNOL, V273, P133, DOI 10.1016/j.cellimm.2011.12.008; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Scriba TJ, 2005, J IMMUNOL, V175, P6334, DOI 10.4049/jimmunol.175.10.6334; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; Wen L, 1998, J CLIN INVEST, V102, P947, DOI 10.1172/JCI2723; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Yang JB, 2004, HUM IMMUNOL, V65, P692, DOI 10.1016/j.humimm.2004.04.001; Yang JB, 2013, IMMUNOLOGY, V138, P269, DOI 10.1111/imm.12034; Yoshida K, 2010, J CLIN INVEST, V120, P1578, DOI 10.1172/JCI41502	30	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112882	10.1371/journal.pone.0112882	http://dx.doi.org/10.1371/journal.pone.0112882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405480	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300060
J	Delesque-Touchard, N; Pendaries, C; Volle-Challier, C; Millet, L; Salel, V; Herve, C; Pflieger, AM; Berthou-Soulie, L; Prades, C; Sorg, T; Herbert, JM; Savi, P; Bono, F				Delesque-Touchard, Nathalie; Pendaries, Caroline; Volle-Challier, Cecile; Millet, Laurence; Salel, Veronique; Herve, Caroline; Pflieger, Anne-Marie; Berthou-Soulie, Laurence; Prades, Catherine; Sorg, Tania; Herbert, Jean-Marc; Savi, Pierre; Bono, Francoise			Regulator of G-Protein Signaling 18 Controls Both Platelet Generation and Function	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACTIVATED PLATELETS; RGS PROTEINS; MEGAKARYOCYTE DIFFERENTIATION; DRUG DISCOVERY; MEGAKARYOPOIESIS; TARGETS; LINEAGE; MICE; EXPRESSION	RGS18 is a myeloerythroid lineage-specific regulator of G-protein signaling, highly expressed in megakaryocytes (MKs) and platelets. In the present study, we describe the first generation of a RGS18 knockout mouse model (RGS18-/-). Interesting phenotypic differences between RGS18-/- and wild-type (WT) mice were identified, and show that RGS18 plays a significant role in both platelet generation and function. RGS18 deficiency produced a gain of function phenotype in platelets. In resting platelets, the level of CD62P expression was increased in RGS18-/- mice. This increase correlated with a higher level of plasmatic serotonin concentration. RGS18-/- platelets displayed a higher sensitivity to activation in vitro. RGS18 deficiency markedly increased thrombus formation in vivo. In addition, RGS18-/- mice presented a mild thrombocytopenia, accompanied with a marked deficit in MK number in the bone marrow. Analysis of MK maturation in vitro and in vivo revealed a defective megakaryopoiesis in RGS18-/- mice, with a lower bone marrow content of only the most committed MK precursors. Finally, RGS18 deficiency was correlated to a defect of platelet recovery in vivo under acute conditions of thrombocytopenia. Thus, we highlight a role for RGS18 in platelet generation and function, and provide additional insights into the physiology of RGS18.	[Delesque-Touchard, Nathalie; Pendaries, Caroline; Volle-Challier, Cecile; Millet, Laurence; Salel, Veronique; Herve, Caroline; Pflieger, Anne-Marie; Herbert, Jean-Marc; Savi, Pierre; Bono, Francoise] Sanofi, Toulouse, France; [Berthou-Soulie, Laurence; Prades, Catherine] Sanofi, SCP Biol, Vitry Sur Seine, France; [Sorg, Tania] MCI, Dept Sci Operat PhenoPro, Strasbourg, France	Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Delesque-Touchard, N (corresponding author), Sanofi, Toulouse, France.	nathalie.delesque-touchard@sanofi.com			Sanofi	Sanofi(Sanofi-Aventis)	In addition, the authors received no specific funding for this work. Sanofi provided support in the form of salaries for authors ND-T, C. Pendaries, CV-C, LM, VS, CH, A-MP, LB-S, C. Prades, J-MH, PS and FB. Sanofi had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Berthebaud M, 2005, BLOOD, V106, P2962, DOI 10.1182/blood-2005-02-0526; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Davis RE, 1997, EXP HEMATOL, V25, P638; DEJANA E, 1979, THROMB RES, V15, P191, DOI 10.1016/0049-3848(79)90064-1; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Esbenshade T, 2005, G PROTEIN COUPLED RE, P15; Gagnon AW, 2002, CELL SIGNAL, V14, P595, DOI 10.1016/S0898-6568(02)00012-8; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Gegenbauer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080251; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Gobbi G, 2003, BRIT J HAEMATOL, V121, P892, DOI 10.1046/j.1365-2141.2003.04369.x; Grillet N, 2005, MOL CELL BIOL, V25, P4221, DOI 10.1128/MCB.25.10.4221-4228.2005; Kaur K, 2011, METHODS MOL BIOL, V756, P75, DOI 10.1007/978-1-61779-160-4_4; Kim SD, 2006, PLATELETS, V17, P493, DOI 10.1080/09537100600758123; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kirito K, 2002, BLOOD, V99, P3220, DOI 10.1182/blood.V99.9.3220; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Louwette S, 2012, FASEB J, V26, P2125, DOI 10.1096/fj.11-198739; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Nagata Y, 2001, BLOOD, V97, P3051, DOI 10.1182/blood.V97.10.3051; Nieswandt B, 2000, BLOOD, V96, P2520; Okada Y, 2003, BLOOD, V101, P4748, DOI 10.1182/blood-2002-02-0380; Parks IK, 2001, J BIOL CHEM, V276, P915, DOI 10.1074/jbc.M005947200; PETERS RF, 1991, THROMB HAEMOSTASIS, V65, P268; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roth BL, 2006, CURR PHARM DESIGN, V12, P1785, DOI 10.2174/138161206776873680; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Serafimidis I, 2011, MOL CELL BIOL, V31, P4442, DOI 10.1128/MCB.05702-11; Shimizu S, 2002, BIOCHEM BIOPH RES CO, V292, P609, DOI 10.1006/bbrc.2002.6693; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Signarvic RS, 2010, BLOOD, V116, P6092, DOI 10.1182/blood-2010-05-283846; Sjogren B, 2011, ADV PHARMACOL, V62, P315, DOI 10.1016/B978-0-12-385952-5.00002-6; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Slayton WB, 2002, BLOOD, V100, P3975, DOI 10.1182/blood-2002-02-0490; Tomer A, 2004, BLOOD, V104, P2722, DOI 10.1182/blood-2004-02-0769; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Yowe D, 2001, BIOCHEM J, V359, P109, DOI 10.1042/0264-6021:3590109	40	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113215	10.1371/journal.pone.0113215	http://dx.doi.org/10.1371/journal.pone.0113215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405900	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300091
J	Elkum, N; Alkayal, F; Noronha, F; Ali, MM; Melhem, M; Al-Arouj, M; Bennakhi, A; Behbehani, K; Alsmadi, O; Abubaker, J				Elkum, Naser; Alkayal, Fadi; Noronha, Fiona; Ali, Maisa M.; Melhem, Motasem; Al-Arouj, Monira; Bennakhi, Abdullah; Behbehani, Kazem; Alsmadi, Osama; Abubaker, Jehad			Vitamin D Insufficiency in Arabs and South Asians Positively Associates with Polymorphisms in GC and CYP2R1 Genes	PLOS ONE			English	Article							D-BINDING PROTEIN; GENOME-WIDE ASSOCIATION; 25-HYDROXYVITAMIN D; HYPOVITAMINOSIS D; BONE MARKERS; LIFE-STYLE; D PATHWAY; DISEASE; WOMEN; POPULATION	Background: A number of genetic studies have reported an association between vitamin D related genes such as group-specific component gene (GC), Cytochrome P450, family 2, subfamily R, polypeptide 1 (CYP2R1) and 7-dehydrocholesterol reductase/nicotinamide-adenine dinucleotide synthetase 1 (DHCR7/NADSYN1) and serum levels of the active form of Vitamin D, 25 (OH) D among African Americans, Caucasians, and Chinese. Little is known about how genetic variations associate with, or contribute to, 25(OH) D levels in Arabs populations. Methods: Allele frequencies of 18 SNPs derived from CYP2R1, GC, and DHCR7/NADSYN1 genes in 1549 individuals (Arabs, South Asians, and Southeast Asians living in Kuwait) were determined using real time genotyping assays. Serum levels of 25(OH) D were measured using chemiluminescence immunoassay. Results: GC gene polymorphisms (rs17467825, rs3755967, rs2282679, rs7041 and rs2298850) were found to be associated with 25(OH) D serum levels in Arabs and South Asians. Two of the CYP2R1 SNPs (rs10500804 and rs12794714) and one of GC SNPs (rs1155563) were found to be significantly associated with 25(OH) D serum levels only in people of Arab origin. Across all three ethnicities none of the SNPs of DHCR7/NADSYN1 were associated with serum 25(OH) D levels and none of the 18 SNPs were significantly associated with serum 25(OH) D levels in people from South East Asia. Conclusion: Our data show for the first time significant association between the GC (rs2282679 and rs7041), CYP2R1 (rs10741657) SNPs and 25(OH) D levels. This supports their roles in vitamin D Insufficiency in Arab and South Asian populations respectively. Interestingly, two of the CYP2R1 SNPs (rs10500804 and rs12794714) and one GC SNP (rs1155563) were found to correlate with vitamin D in Arab population exclusively signifying their importance in this population.	[Elkum, Naser; Noronha, Fiona; Behbehani, Kazem] Dasman Diabet Inst, Dept Biostat & Epidemiol, Kuwait, Kuwait; [Alkayal, Fadi; Ali, Maisa M.; Melhem, Motasem; Alsmadi, Osama] Dasman Diabet Inst, Genet & Genom Unit, Kuwait, Kuwait; [Abubaker, Jehad] Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait; [Al-Arouj, Monira; Bennakhi, Abdullah] Dasman Diabet Inst, Clin Serv, Kuwait, Kuwait; [Elkum, Naser] Sidra Med & Res Ctr, Doha, Qatar	Sidra Medical & Research Center	Elkum, N (corresponding author), Dasman Diabet Inst, Dept Biostat & Epidemiol, Kuwait, Kuwait.	nelkum@sidra.org	Elkum, Naser/AAU-5555-2020	Elkum, Naser/0000-0002-0457-0444; Abubaker, Jehad/0000-0003-0681-7305; Kamkar, Maisa/0000-0001-9919-6936	Kuwait Foundation for the Advancement of Sciences	Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS))	This work was funded by Kuwait Foundation for the Advancement of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Allali F, 2009, SEMIN ARTHRITIS RHEU, V38, P444, DOI 10.1016/j.semarthrit.2008.01.009; Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P675, DOI 10.1007/s00198-011-1606-1; Borkar VV, 2010, PEDIATR DIABETES, V11, P345, DOI 10.1111/j.1399-5448.2009.00589.x; Bosse Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-98; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Elkum N, 2014, DIABETIC MED, V31, P531, DOI 10.1111/dme.12386; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Gannage-Yared MH, 2000, J BONE MINER RES, V15, P1856, DOI 10.1359/jbmr.2000.15.9.1856; Heist RS, 2008, J CLIN ONCOL, V26, P5596, DOI 10.1200/JCO.2008.18.0406; Hobbs RD, 2009, ENDOCR PRACT, V15, P35, DOI 10.4158/EP.15.1.35; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Kurylowicz A, 2006, EXP CLIN ENDOCR DIAB, V114, P329, DOI 10.1055/s-2006-924256; Larcombe L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049872; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Saliba W, 2012, OSTEOPOROSIS INT, V23, P687, DOI 10.1007/s00198-011-1597-y; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Signorello LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028623; Simonelli Christine, 2005, Minn Med, V88, P34; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zhang YL, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13636; Zhang Z, 2013, J BONE MINER RES, V28, P1784, DOI 10.1002/jbmr.1926	32	58	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113102	10.1371/journal.pone.0113102	http://dx.doi.org/10.1371/journal.pone.0113102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405862	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300077
J	Eltom, S; Belvisi, MG; Stevenson, CS; Maher, SA; Dubuis, E; Fitzgerald, KA; Birrell, MA				Eltom, Suffwan; Belvisi, Maria G.; Stevenson, Christopher S.; Maher, Sarah A.; Dubuis, Eric; Fitzgerald, Kate A.; Birrell, Mark A.			Role of the Inflammasome-Caspase1/11-IL-1/18 Axis in Cigarette Smoke Driven Airway Inflammation: An Insight into the Pathogenesis of COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; RECEPTOR; IL-18; INTERLEUKIN-18; ACTIVATION; EMPHYSEMA; POLYMORPHISMS; ASSOCIATION; INHIBITION	Background: Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory airway disease often associated with cigarette smoke (CS) exposure. The disease is increasing in global prevalence and there is no effective therapy. A major step forward would be to understand the disease pathogenesis. The ATP-P2X(7) pathway plays a dominant role in murine models of CS induced airway inflammation, and markers of activation of this axis are upregulated in patients with COPD. This strongly suggests that the axis could be important in the pathogenesis of COPD. The aim of this study was to perform a detailed characterisation of the signalling pathway components involved in the CS-driven, P2X(7) dependent airway inflammation. Methods: We used a murine model system, bioassays and a range of genetically modified mice to better understand this complex signalling pathway. Results: The inflammasome-associated proteins NALP3 and ASC, but not IPAF and AIM2, are required for CS-induced IL-1 beta/IL-18 release, but not IL-1 alpha. This was associated with a partial decrease in lung tissue caspase 1 activity and BALF neutrophilia. Mice missing caspase 1/11 or caspase 11 had markedly attenuated levels of all three cytokines and neutrophilia. Finally the mechanism by which these inflammatory proteins are involved in the CS-induced neutrophilia appeared to be via the induction of proteins involved in neutrophil transmigration e. g. E-Selectin. Conclusion: This data indicates a key role for the P2X(7)-NALP3/ASC-caspase1/11-IL-1 beta/IL-18 axis in CS induced airway inflammation, highlighting this pathway as a possible therapeutic target for the treatment of COPD.	[Eltom, Suffwan; Belvisi, Maria G.; Maher, Sarah A.; Dubuis, Eric; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England; [Stevenson, Christopher S.] Hoffmann La Roche Inc, pRED, DTA Inflammat, Nutley, NJ 07110 USA; [Fitzgerald, Kate A.] Univ Massachusetts, Div Infect Dis & Immunol, Worcester, MA 01605 USA	Imperial College London; Roche Holding; University of Massachusetts System; University of Massachusetts Worcester	Birrell, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England.	m.birrell@imperial.ac.uk	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; dubuis, eric/0000-0001-7658-4178				Asada M, 2005, CHEST, V128, P1072, DOI 10.1378/chest.128.2.1072; Bezerra FS, 2011, RESP PHYSIOL NEUROBI, V177, P120, DOI 10.1016/j.resp.2011.03.023; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Castro P, 2004, EUR J PHARMACOL, V498, P279, DOI 10.1016/j.ejphar.2004.07.047; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Ekberg-Jansson A, 2001, RESP MED, V95, P363, DOI 10.1053/rmed.2001.1050; Eltom S, 2013, CURR PROTOC PHARM; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Herfs M, 2012, AM J RESP CELL MOL, V47, P67, DOI 10.1165/rcmb.2011-0353OC; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Imaoka H, 2008, EUR RESPIR J, V31, P287, DOI 10.1183/09031936.00019207; Joos L, 2001, THORAX, V56, P863, DOI 10.1136/thorax.56.11.863; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Kang MJ, 2012, AM J RESP CRIT CARE, V185, P1205, DOI 10.1164/rccm.201108-1545OC; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kratzer A, 2013, AM J RESP CELL MOL, V48, P725, DOI 10.1165/rcmb.2012-0173OC; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Le Quement C, 2008, BRIT J PHARMACOL, V154, P1206, DOI 10.1038/bjp.2008.180; Lee JM, 2008, RESP MED, V102, P1311, DOI 10.1016/j.rmed.2008.03.026; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; MacNee W, 2005, P AM THORAC SOC, V2, P251; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Muhl H, 2004, EUR J PHARMACOL, V500, P63, DOI 10.1016/j.ejphar.2004.07.012; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Petersen AMW, 2007, LUNG, V185, P161, DOI 10.1007/s00408-007-9000-7; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rathinam VAK, 2012, CELL, V18, P1; Rovina N, 2009, RESP MED, V103, P1056, DOI 10.1016/j.rmed.2009.01.011; Sapey E, 2009, J CLIN IMMUNOL, V29, P508, DOI 10.1007/s10875-009-9286-8; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Singh B, 2010, Monaldi Arch Chest Dis, V73, P86; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; van der Deen M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-49; Wang J, 2013, INT J IMMUNOGENET, V40, P204, DOI 10.1111/iji.12014; Wang JM, 2012, COPD, V9, P375, DOI 10.3109/15412555.2012.670330; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x	49	58	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112829	10.1371/journal.pone.0112829	http://dx.doi.org/10.1371/journal.pone.0112829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405768	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300055
J	Petersen, H; Patel, M; Ingason, EF; Einarsson, EJ; Haraldsson, A; Fransson, PA				Petersen, Hannes; Patel, Mitesh; Ingason, Einar F.; Einarsson, Einar J.; Haraldsson, Asgeir; Fransson, Per-Anders			Long-Term Effects from Bacterial Meningitis in Childhood and Adolescence on Postural Control	PLOS ONE			English	Article							ADAPTATION; VIBRATION; CHILDREN; VALIDATION; MOVEMENTS; APOPTOSIS; RESPONSES; DISEASE; VERTIGO; VISION	Bacterial meningitis in childhood is associated with cognitive deficiencies, sensorimotor impairments and motor dysfunction later in life. However, the long-term effects on postural control is largely unknown, e. g., whether meningitis subjects as adults fully can utilize visual information and adaptation to enhance stability. Thirty-six subjects (20 women, mean age 19.3 years) treated in childhood or adolescence for bacterial meningitis, and 25 controls (13 women, mean age 25.1 years) performed posturography with eyes open and closed under unperturbed and perturbed standing. The meningitis subjects were screened for subjective vertigo symptoms using a questionnaire, clinically tested with headshake and head thrust test, as well as their hearing was evaluated. Meningitis subjects were significantly more unstable than controls during unperturbed (p <= 0.014) and perturbed standing, though while perturbed only with eyes open in anteroposterior direction (p = 0.034) whereas in lateral direction both with eyes open and closed (p<0.001). Meningitis subjects had poorer adaption ability to balance perturbations especially with eyes open, and they frequently reported symptoms of unsteadiness (88% of the subjects) and dizziness (81%), which was found significantly correlated to objectively decreased stability. Out of the 36 subjects only 3 had unilateral hearing impairment. Hence, survivors of childhood bacterial meningitis may suffer long-term disorders affecting postural control, and would greatly benefit if these common late effects became generally known so treatments can be developed and applied.	[Petersen, Hannes] Landspitali Univ Hosp, Dept Otorhinolaryngol, Reykjavik, Iceland; [Petersen, Hannes; Ingason, Einar F.; Einarsson, Einar J.; Haraldsson, Asgeir] Univ Iceland, Fac Med, Reykjavik, Iceland; [Haraldsson, Asgeir] Landspitali Univ Hosp, Childrens Hosp Iceland, Reykjavik, Iceland; [Patel, Mitesh; Fransson, Per-Anders] Lund Univ, Dept Clin Sci, Lund, Sweden; [Patel, Mitesh] Univ London Imperial Coll Sci Technol & Med, Neurootol Dept, Dept Clin Neurosci, London, England	Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Lund University; Imperial College London	Petersen, H (corresponding author), Landspitali Univ Hosp, Dept Otorhinolaryngol, Reykjavik, Iceland.	hpet@hi.is		Patel, Mitesh/0000-0002-3594-5448; Patel, Mitesh/0000-0001-6926-941X; Haraldsson, Asgeir/0000-0001-5364-7877; Fransson, Per-Anders/0000-0002-9789-1748				Assaiante C, 1998, NEUROSCI BIOBEHAV R, V22, P527, DOI 10.1016/S0149-7634(97)00040-7; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Black F. O., 2001, CURR OPIN OTOLARYNGO, V9, P314, DOI DOI 10.1097/00020840-200110000-00011; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; Caye-Thomasen P, 2012, ACTA OTO-LARYNGOL, V132, P720, DOI 10.3109/00016489.2012.656323; Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7; Cushing SL, 2009, OTOL NEUROTOL, V30, P488, DOI 10.1097/MAO.0b013e31819bd7c8; Eccles JC, 1986, LEARNING MOTOR SYSTE, P3; EKLUND G, 1973, UPSALA J MED SCI, V78, P65; Fellick JM, 2001, ARCH DIS CHILD, V85, P6, DOI 10.1136/adc.85.1.6; Fransson PA, 2003, IEEE T BIO-MED ENG, V50, P1310, DOI 10.1109/TBME.2003.819851; Fransson PA, 2009, ADAPTATION HUMAN POS; Fransson PA, 2007, J VESTIBUL RES-EQUIL, V17, P47; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; Grandgirard D, 2007, ACTA NEUROPATHOL, V114, P609, DOI 10.1007/s00401-007-0304-8; Hofer S, 2011, J NEUROPATH EXP NEUR, V70, P890, DOI 10.1097/NEN.0b013e3182303f31; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; JOHANSSON R, 1991, CRIT REV BIOMED ENG, V18, P413; Johansson R, 2009, J PHYSIOL-PARIS, V103, P159, DOI 10.1016/j.jphysparis.2009.08.013; KESHNER EA, 1987, EXP BRAIN RES, V69, P77; Kingma H, 2011, J VESTIBUL RES-EQUIL, V21, P117, DOI 10.3233/VES-2011-0397; Kristinsdottir EK, 2001, ACTA OTO-LARYNGOL, V121, P700, DOI 10.1080/00016480152583647; Leib SL, 1996, J INFECT DIS, V173, P166, DOI 10.1093/infdis/173.1.166; Mace SE, 2008, EMERG MED CLIN N AM, V26, P281, DOI 10.1016/j.emc.2008.02.002; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Modig F, 2012, GAIT POSTURE, V35, P410, DOI 10.1016/j.gaitpost.2011.10.364; Mongelluzzo J, 2008, JAMA-J AM MED ASSOC, V299, P2048, DOI 10.1001/jama.299.17.2048; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Neuman HB, 2001, CLIN PEDIATR, V40, P595, DOI 10.1177/000992280104001102; Ostergaard C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-1; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Patel M, 2009, CLIN NEUROPHYSIOL, V120, P601, DOI 10.1016/j.clinph.2008.11.026; Pavol MJ, 2002, EXP BRAIN RES, V145, P528, DOI 10.1007/s00221-002-1143-4; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Popov K, 1996, NEUROSCI LETT, V214, P202, DOI 10.1016/0304-3940(96)12909-8; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; RICCIO GE, 1988, HUM MOVEMENT SCI, V7, P265, DOI 10.1016/0167-9457(88)90014-0; Saez-Llorens X, 1990, Infect Dis Clin North Am, V4, P623; Snaebjarnardottir K, 2013, SCAND J INFECT DIS, V45, P819, DOI 10.3109/00365548.2013.817680; Tjernstrom F, 2005, J VESTIBUL RES-EQUIL, V15, P31; Tschan R, 2008, J NEUROL, V255, P1168, DOI 10.1007/s00415-008-0863-1; Wiener-Vacher SR, 2012, J PEDIATR-US, V161, P246, DOI 10.1016/j.jpeds.2012.02.009; Yardley L, 1999, J PSYCHOSOM RES, V46, P63, DOI 10.1016/S0022-3999(98)00056-7	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112016	10.1371/journal.pone.0112016	http://dx.doi.org/10.1371/journal.pone.0112016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405756	gold, Green Published, Green Accepted			2022-12-27	WOS:000347121300020
J	Wali, JA; Gurzov, EN; Fynch, S; Elkerbout, L; Kay, TW; Masters, SL; Thomas, HE				Wali, Jibran A.; Gurzov, Esteban N.; Fynch, Stacey; Elkerbout, Lorraine; Kay, Thomas W.; Masters, Seth L.; Thomas, Helen E.			Activation of the NLRP3 Inflammasome Complex is Not Required for Stress-Induced Death of Pancreatic Islets	PLOS ONE			English	Article							BETA-CELL APOPTOSIS; THIOREDOXIN-INTERACTING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; HIGH GLUCOSE; GLUTATHIONE-PEROXIDASE; INSULIN-SECRETION; GENE-EXPRESSION; FATTY-ACID; RAT ISLET	Loss of pancreatic beta cells is a feature of type-2 diabetes. High glucose concentrations induce endoplasmic reticulum (ER) and oxidative stress-mediated apoptosis of islet cells in vitro. ER stress, oxidative stress and high glucose concentrations may also activate the NLRP3 inflammasome leading to interleukin (IL)-1 beta production and caspase-1 dependent pyroptosis. However, whether IL-1 beta or intrinsic NLRP3 inflammasome activation contributes to beta cell death is controversial. This possibility was examined in mouse islets. Exposure of islets lacking functional NLRP3 or caspase-1 to H2O2, rotenone or thapsigargin induced similar cell death as in wild-type islets. This suggests that oxidative or ER stress do not cause inflammasome-mediated cell death. Similarly, deficiency of NLRP3 inflammasome components did not provide any protection from glucose, ribose or gluco-lipotoxicity. Finally, genetic activation of NLRP3 specifically in beta cells did not increase IL-1 beta production or cell death, even in response to glucolipotoxicity. Overall, our results show that glucose-, ER stress-or oxidative stress-induced cell death in islet cells is not dependent on intrinsic activation of the NLRP3 inflammasome.	[Wali, Jibran A.; Gurzov, Esteban N.; Fynch, Stacey; Elkerbout, Lorraine; Kay, Thomas W.; Thomas, Helen E.] St Vincents Inst, Fitzroy, Vic, Australia; [Wali, Jibran A.; Gurzov, Esteban N.; Kay, Thomas W.; Thomas, Helen E.] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Masters, Seth L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Thomas, HE (corresponding author), St Vincents Inst, Fitzroy, Vic, Australia.	hthomas@svi.edu.au	Wali, Jibran/K-9843-2019; Masters, Seth L/N-2886-2013	Wali, Jibran/0000-0002-8524-5773; Masters, Seth L/0000-0003-4763-576X; Gurzov, Esteban/0000-0003-4642-0273	National Health and Medical Research Council of Australia (NHMRC); Juvenile Diabetes Research Foundation (JDRF) [APP466658]; NHMRC [APP1032610]; NHMRC; University of Melbourne Viola Edith Reid Bequest Scholarship; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Viola Edith Reid Bequest Scholarship; Victorian Government's Operational Infrastructure Support Program	This study was supported by a National Health and Medical Research Council of Australia (NHMRC; http://www.nhmrc.gov.au/) and Juvenile Diabetes Research Foundation (JDRF; http://www.jdrf.org/) joint special program grant in type 1 diabetes (APP466658), an NHMRC project grant (APP1032610), fellowships from the NHMRC (HET and SLM) and a University of Melbourne Viola Edith Reid Bequest Scholarship (JAW). This study was supported in part by the Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/grants-and-assistance/programs/medical-research-operational-infrastructure-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMANN L, 1992, FEBS LETT, V299, P103, DOI 10.1016/0014-5793(92)80110-3; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Hou ZQ, 2008, MOL CELL ENDOCRINOL, V291, P71, DOI 10.1016/j.mce.2008.03.004; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McKenzie MD, 2006, INT IMMUNOL, V18, P837, DOI 10.1093/intimm/dxl020; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Mellado-Gil JM, 2004, J ENDOCRINOL, V183, P155, DOI 10.1677/joe.1.05542; Merry TL, 2014, ANTIOXID REDOX SIGN, V20, P2114, DOI 10.1089/ars.2013.5428; Moore PC, 2004, DIABETES, V53, P2610, DOI 10.2337/diabetes.53.10.2610; Nackiewicz D, 2014, DIABETOLOGIA, V57, P1645, DOI 10.1007/s00125-014-3249-1; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ribaux P, 2007, ENDOCRINOLOGY, V148, P5582, DOI 10.1210/en.2007-0325; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Thomas HE, 2006, IMMUNOL CELL BIOL, V84, P20, DOI 10.1111/j.1440-1711.2005.01397.x; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Welsh N, 2005, DIABETES, V54, P3238, DOI 10.2337/diabetes.54.11.3238; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	42	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113128	10.1371/journal.pone.0113128	http://dx.doi.org/10.1371/journal.pone.0113128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405767	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300083
J	Wang, R; Wen, H; Xu, YC; Chen, QL; Luo, Y; Lin, YQ; Luo, Y; Xu, AG				Wang, Ran; Wen, Hong; Xu, Yongcheng; Chen, Qiulan; Luo, Yi; Lin, Yiqin; Luo, Yu; Xu, Angao			Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles	PLOS ONE			English	Article							GASTRIC-CANCER; COLORECTAL-CANCER; PROGNOSTIC BIOMARKER; POTENTIAL BIOMARKERS; SYSTEMATIC REVIEWS; EXPRESSION PROFILE; PLASMA MICRORNAS; SERUM MIR-21; LUNG-CANCER; MIRNAS	Objective: MicroRNAs (miRNAs) have become the focus of most recent efforts in cancer research. However, there have been inconsistencies in the literature regarding the suitability of circulating miRNAs for early detection of gastrointestinal cancers. This study aims to assess the diagnostic performance of circulating miRNAs in detection of gastrointestinal cancer through a meta-analysis. Methods: Eligible studies were selected by conducting a systematic literature search of public databases. The sensitivity and specificity were used to plot the summary receiver operator characteristic (SROC) curve and calculate the area under the SROC curve (AUC). The between-study heterogeneity was evaluated by Q test and I-2 statistics. Subgroup analyses and meta-regression were further performed to explore the potential sources of heterogeneity. All analyses were performed using the STATA 12.0 software. Results: A total of 107 studies from 42 articles were included for the meta-analysis according to the inclusion criteria. The overall analysis of all gastrointestinal cancers showed that circulating miRNAs have a relatively good diagnostic performance in gastrointestinal cancers, with a sensitivity of 0.75, a specificity of 0.81 and an AUC of 0.85. In addition, subgroup analyses based on different type of miRNA assay suggested that single-miRNA assay displayed a relatively low diagnostic performance with the AUC values of 0.84 for gastric cancer (GC) and 0.79 for colorectal cancer (CRC), while multiple-miRNAs assay significantly improved the diagnosing accuracy with AUC rising to 0.92 for GC and 0.89 for CRC. Another interesting finding was that plasma-based miRNA assay reach a higher accuracy compared with serum-based one for GC, while opposite conclusion was drawn for CRC. Conclusions: In conclusion, circulating miRNAs, particularly the combination of multiple miRNAs, may present as promising biomarkers for the diagnosis of gastrointestinal cancers. Further large-scale prospective studies are necessary to validate their potential applicability in human cancer diagnosis.	[Wang, Ran; Xu, Angao] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Wang, Ran; Wen, Hong; Chen, Qiulan; Luo, Yi; Lin, Yiqin; Luo, Yu] HuiZhou Municipal Cent Hosp, Dept Ultrasound, Huizhou, Peoples R China; [Xu, Yongcheng; Xu, Angao] HuiZhou Municipal Cent Hosp, Dept Gastroenterol, Huizhou, Peoples R China	Southern Medical University - China	Xu, AG (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.	angao_xu@163.com						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brenner H, 2014, GASTROENTEROLOGY, V146, P709, DOI 10.1053/j.gastro.2013.09.001; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen QJ, 2014, ONCOL REP, V31, P1863, DOI 10.3892/or.2014.3004; Choong MK, 2012, CLIN GASTROENTEROL H, V10, P9, DOI 10.1016/j.cgh.2011.04.020; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Dbouk Hashem A, 2007, Open Clin Cancer J, V1, P1, DOI 10.2174/1874189400701010001; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Duffy MJ, 2007, EUR J INTERN MED, V18, P175, DOI 10.1016/j.ejim.2006.12.001; Feng L, 2013, CHIN J CLIN ONCOL RE, P1313; Giraldez MD, 2013, CLIN GASTROENTEROL H, V11, P681, DOI 10.1016/j.cgh.2012.12.009; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirajima S, 2013, BRIT J CANCER, V108, P1822, DOI 10.1038/bjc.2013.148; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Konishi H, 2012, BRIT J CANCER, V106, P740, DOI 10.1038/bjc.2011.588; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Li C, 2013, ANN SURG ONCOL, V20, pS397, DOI 10.1245/s10434-012-2600-3; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; [李峄清 Li Yiqing], 2012, [江苏医药, Jiangsu Medical Journal], V38, P1665; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Liu HanShao, 2012, Tumor, V32, P42; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; McFarland EG, 2008, RADIOLOGY, V248, P717, DOI 10.1148/radiol.2483080842; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Neri E, 2010, ABDOM IMAGING, V35, P596, DOI 10.1007/s00261-009-9568-x; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Peng WZ, 2014, INT J MOL SCI, V15, P4031, DOI 10.3390/ijms15034031; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Redova M, 2013, FUTURE ONCOL, V9, P387, DOI [10.2217/FON.12.192, 10.2217/fon.12.192]; Sheinerman KS, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-304; Shen J, 2013, CANCER LETT, V329, P125, DOI 10.1016/j.canlet.2012.11.001; Shiotani A, 2013, BRIT J CANCER, V109, P2323, DOI 10.1038/bjc.2013.596; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sita-Lumsden A, 2013, BRIT J CANCER, V108, P1925, DOI 10.1038/bjc.2013.192; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; Sorio C, 2006, IUBMB LIFE, V58, P193, DOI 10.1080/15216540600719598; Suzuki Haruhisa, 2006, Gastric Cancer, V9, P315, DOI 10.1007/s10120-006-0399-y; Takahashi S, 2013, GASTRIC CANCER, V16, P543, DOI 10.1007/s10120-012-0217-7; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Tarro G, 2005, J CELL PHYSIOL, V203, P1, DOI 10.1002/jcp.20195; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Valladares-Ayerbes M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-186; Wang B, 2012, J CANCER RES CLIN, V138, P1659, DOI 10.1007/s00432-012-1244-9; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398; Wang S, 2013, INT J CANC; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xu Q, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-11; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280; Zanutto S, 2014, BRIT J CANCER, V110, P1001, DOI 10.1038/bjc.2013.819; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhang GJ, 2013, MOL CLIN ONCOL, V1, P379, DOI 10.3892/mco.2013.61; Zhang TF, 2013, MOL CARCINOGEN, V52, P581, DOI 10.1002/mc.21880; Zhang TF, 2011, CLIN SCI, V121, P437, DOI 10.1042/CS20110207; Zheng YY, 2011, CANCER BIOMARK, V10, P71, DOI 10.3233/CBM-2011-0231; Zhou H, 2012, BIOMARKERS, V17, P104, DOI 10.3109/1354750X.2011.614961; Zhou H, 2010, J MOL MED, V88, P709, DOI 10.1007/s00109-010-0617-2; Zhu C, 2014, BR J CANC; [朱程君 ZHU Chengjun], 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P1173	77	41	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113401	10.1371/journal.pone.0113401	http://dx.doi.org/10.1371/journal.pone.0113401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406082	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300114
J	Wu, DM; Li, GW; Zhang, JX; Chang, SX; Hu, JN; Dai, YM				Wu, Dongmei; Li, Guanwu; Zhang, Junxiang; Chang, Shixing; Hu, Jiani; Dai, Yongming			Characterization of Breast Tumors Using Diffusion Kurtosis Imaging (DKI)	PLOS ONE			English	Article							NON-GAUSSIAN DIFFUSION; MAGNETIC-RESONANCE; WEIGHTED MRI; WATER DIFFUSION; LESION CHARACTERIZATION; DIFFERENTIAL-DIAGNOSIS; B-VALUES; COEFFICIENT; CANCER; CARCINOMA	Aim: The aim of this study was to investigate and evaluate the role of magnetic resonance (MR) diffusion kurtosis imaging (DKI) in characterizing breast lesions. Materials and Methods: One hundred and twenty-four lesions in 103 patients (mean age: 57 +/- 14 years) were evaluated by MR DKI performed with 7 b-values of 0, 250, 500, 750, 1,000, 1,500, 2,000 s/mm(2) and dynamic contrast-enhanced (DCE) MR imaging. Breast lesions were histologically characterized and DKI related parameters-mean diffusivity (MD) and mean kurtosis (MK)-were measured. The MD and MK in normal fibroglandular breast tissue, benign and malignant lesions were compared by One-way analysis of variance (ANOVA) with Tukey's multiple comparison test. Receiver operating characteristic (ROC) analysis was performed to assess the sensitivity and specificity of MD and MK in the diagnosis of breast lesions. Results: The benign lesions (n = 42) and malignant lesions (n = 82) had mean diameters of 11.4 +/- 3.4 mm and 35.8 +/- 20.1 mm, respectively. The MK for malignant lesions (0.88 +/- 0.17) was significantly higher than that for benign lesions (0.47 +/- 0.14) (P < 0.001), and, in contrast, MD for benign lesions (1.97 +/- 0.35 (10(-3) mm(2)/s)) was higher than that for malignant lesions (1.20 +/- 0.31 (10(-3) mm(2)/s)) (P < 0.001). At a cutoff MD/MK 1.58 (10(-3) mm(2)s)/0.69, sensitivity and specificity of MD/MK for the diagnosis of malignant were 79.3%/84.2% and 92.9%/92.9%, respectively. The area under the curve (AUC) is 0.86/0.92 for MD/MK. Conclusions: DKI could provide valuable information on the diffusion properties related to tumor microenvironment and increase diagnostic confidence of breast tumors.	[Wu, Dongmei] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Wu, Dongmei; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Li, Guanwu; Chang, Shixing] Shanghai Univ Tradit Chinese Med, Dept Radiol, Yue Yang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China; [Zhang, Junxiang] Bengbu Med Coll, Affiliated Hosp 1, Dept Radiol, Bengbu, Anhui, Peoples R China; [Dai, Yongming] Philips Healthcare, Shanghai, Peoples R China	East China Normal University; Wayne State University; Shanghai University of Traditional Chinese Medicine; Bengbu Medical College; Philips; Philips Healthcare	Chang, SX (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Radiol, Yue Yang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China.	shixing.chang@sohu.com		Li, Guanwu/0000-0003-0840-9022				Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Anderson SW, 2014, J MAGN RESON IMAGING, V39, P827, DOI 10.1002/jmri.24234; Pereira FPA, 2009, AM J ROENTGENOL, V193, P1030, DOI 10.2214/AJR.09.2522; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Baron P, 2010, NMR BIOMED, V23, P399, DOI 10.1002/nbm.1475; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bogner W, 2009, RADIOLOGY, V253, P341, DOI 10.1148/radiol.2532081718; Bone B, 1998, ACTA RADIOL, V39, P494; Brinck U, 1997, AM J ROENTGENOL, V168, P1331, DOI 10.2214/ajr.168.5.9129437; Costantini M, 2010, CLIN RADIOL, V65, P1005, DOI 10.1016/j.crad.2010.07.008; De Santis S, 2011, MAGN RESON IMAGING, V29, P1410, DOI 10.1016/j.mri.2011.04.006; DUCATMAN BS, 1993, MODERN PATHOL, V6, P539; El Khouli RH, 2010, RADIOLOGY, V256, P64, DOI 10.1148/radiol.10091367; Englander SA, 1997, NMR BIOMED, V10, P348, DOI 10.1002/(SICI)1099-1492(199710)10:7<348::AID-NBM487>3.0.CO;2-R; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Hochman MG, 1997, RADIOLOGY, V204, P123, DOI 10.1148/radiology.204.1.9205233; Jansen JFA, 2010, AM J NEURORADIOL, V31, P741, DOI 10.3174/ajnr.A1919; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kacl GM, 1998, EUR RADIOL, V8, P194, DOI 10.1007/s003300050362; Kinoshita T, 2002, J COMPUT ASSIST TOMO, V26, P1042, DOI 10.1097/00004728-200211000-00033; Kneeshaw PJ, 2003, BRIT J CANCER, V88, P4, DOI 10.1038/sj.bjc.6600713; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lo GG, 2009, J COMPUT ASSIST TOMO, V33, P63, DOI 10.1097/RCT.0b013e318165dc6b; Marini C, 2007, EUR RADIOL, V17, P2646, DOI 10.1007/s00330-007-0621-2; Paran Y, 2004, NMR BIOMED, V17, P170, DOI 10.1002/nbm.882; Partridge SC, 2011, MAGN RESON MED, V65, P1759, DOI 10.1002/mrm.22762; Partridge SC, 2011, MAGN RESON IMAGING, V29, P1215, DOI 10.1016/j.mri.2011.07.024; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P562, DOI 10.1002/jmri.22078; Partridge SC, 2009, AM J ROENTGENOL, V193, P1716, DOI 10.2214/AJR.08.2139; Partridge SC, 2001, J MAGN RESON IMAGING, V14, P433, DOI 10.1002/jmri.1204; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; Peters NHGM, 2010, J MAGN RESON IMAGING, V31, P1100, DOI 10.1002/jmri.22152; Petralia G, 2011, CANCER IMAGING, V11, P76, DOI 10.1102/1470-7330.2011.0014; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Rankin SC, 2000, BRIT J RADIOL, V73, P806, DOI 10.1259/bjr.73.872.11026854; Rosenkrantz AB, 2013, AM J ROENTGENOL, V201, P840, DOI 10.2214/AJR.12.10397; Rosenkrantz AB, 2012, MAGN RESON IMAGING, V30, P1534, DOI 10.1016/j.mri.2012.04.020; Rubesova E, 2006, J MAGN RESON IMAGING, V24, P319, DOI 10.1002/jmri.20643; Sigmund EE, 2011, MAGN RESON MED, V65, P1437, DOI 10.1002/mrm.22740; Sinha S, 2002, ANN NY ACAD SCI, V980, P95, DOI 10.1111/j.1749-6632.2002.tb04891.x; Sinha S, 2002, J MAGN RESON IMAGING, V15, P693, DOI 10.1002/jmri.10116; Sinha S, 2009, NMR BIOMED, V22, P3, DOI 10.1002/nbm.1270; Stomper PC, 1997, BREAST CANCER RES TR, V45, P39, DOI 10.1023/A:1005897227030; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Wenkel E, 2007, ACAD RADIOL, V14, P1077, DOI 10.1016/j.acra.2007.06.006; WESBEY GE, 1984, INVEST RADIOL, V19, P491, DOI 10.1097/00004424-198411000-00005; Woodhams R, 2005, J COMPUT ASSIST TOMO, V29, P644, DOI 10.1097/01.rct.0000171913.74086.1b; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yabuuchi H, 2010, EUR J RADIOL, V75, pE126, DOI 10.1016/j.ejrad.2009.09.013; Yabuuchi H, 2008, J MAGN RESON IMAGING, V28, P1157, DOI 10.1002/jmri.21570; Yamada I, 1999, RADIOLOGY, V210, P617, DOI 10.1148/radiology.210.3.r99fe17617; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	60	52	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113240	10.1371/journal.pone.0113240	http://dx.doi.org/10.1371/journal.pone.0113240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406010	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300092
J	Lee, JY; Lee, HS; Lee, DC; Chu, SH; Jeon, JY; Kim, NK; Lee, JW				Lee, Jee-Yon; Lee, Hye-Sun; Lee, Duk-Chul; Chu, Sang-Hui; Jeon, Justin Y.; Kim, Nam-Kyu; Lee, Ji-Won			Visceral Fat Accumulation Is Associated with Colorectal Cancer in Postmenopausal Women	PLOS ONE			English	Article							BODY-MASS INDEX; COLON-CANCER; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPONECTIN LEVELS; RECTAL-CANCER; OBESITY; RISK; METAANALYSIS; MORTALITY	Background: Obesity is a known risk factor for colorectal cancer (CRC), and emerging data suggest that this association is mediated by visceral fat rather than total body fat. However, there is a lack of studies evaluating the association between visceral fat area and the prevalence of CRC. Methods: To investigate the relationship between visceral adiposity and prevalence of CRC, data of 497 women diagnosed with CRC and 318 apparently healthy women were analysed and data of well-balanced 191 pairs of women with CRC and healthy women matched based on propensity scores were additionally analysed. Diagnosis of CRC was confirmed by colonoscopy and histology. Metabolic parameters were assessed, along with body composition, using computed tomography. Results: The median visceral fat area was significantly higher in the CRC group compared with the control group before and after matching. The prevalence of CRC increased significantly with increasing visceral fat tertiles after matching (p for trend <0.01). A multivariate analysis showed that mean visceral fat area of individuals in the 67th percentile or greater group was associated with an increased prevalence of CRC (adjusted odds ratio: 1.80; 95% confidence interval: 1.12-2.91 before matching and adjusted odds ratio: 2.96; 95% confidence interval: 1.38-6.33) compared with that of individuals in the 33th percentile or lower group. Conclusion: Thus, we conclude that visceral fat area is positively associated with the prevalence of CRC. Although we could not determine the causality, visceral adiposity may be associated with the risk of CRC. Further prospective studies are required to determine the benefits of controlling visceral obesity for reducing CRC risk.	[Lee, Jee-Yon; Lee, Duk-Chul; Lee, Ji-Won] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Lee, Hye-Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Chu, Sang-Hui] Yonsei Univ, Coll Nursing, Nursing Policy Res Inst, Biobehav Res Ctr,Dept Clin Nursing Sci, Seoul 120749, South Korea; [Jeon, Justin Y.] Yonsei Univ, Sports Med Lab, Dept Sport & Leisure Studies, Seoul 120749, South Korea; [Kim, Nam-Kyu] Yonsei Univ, Coll Med, Dept Gen Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System	Kim, NK (corresponding author), Yonsei Univ, Coll Med, Dept Gen Surg, Seoul, South Korea.	namkyuk@yuhs.ac; indi5645@yuhs.ac	; Lee, Hye Sun/J-2154-2015	LEE, JI WON/0000-0002-2666-4249; Lee, Duk Chul/0000-0001-9166-1813; Lee, Hye Sun/0000-0001-6328-6948; Jeon, Justin/0000-0001-7978-4271; CHU, Sang Hui/0000-0001-6877-5599; Kim, Nam-Kyu/0000-0003-0639-5632	Yonsei University College of Medicine [6-2013-0021]; Bio & Medical Technology Development Program, through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2013M3A9B6046413]	Yonsei University College of Medicine(General Electric); Bio & Medical Technology Development Program, through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning	This study was supported by a 2013 Faculty Research Grant from Yonsei University College of Medicine (6-2013-0021) and the Bio & Medical Technology Development Program, through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9B6046413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2012, EUR J CANCER PREV, V21, P126, DOI 10.1097/CEJ.0b013e32834c9b55; Blum WF, 2004, INSULIN LIKE GROWTH; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Erarslan E, 2009, DIGEST DIS SCI, V54, P862, DOI 10.1007/s10620-008-0440-6; FEINLEIB M, 1985, ANN INTERN MED, V103, P1019, DOI 10.7326/0003-4819-103-6-1019; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Hou LF, 2006, EUR J CANCER, V42, P84, DOI 10.1016/j.ejca.2005.09.014; Huffman DM, 2013, CANCER; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lee JW, 2007, CLIN ENDOCRINOL, V66, P572, DOI 10.1111/j.1365-2265.2007.02780.x; MANN GV, 1974, NEW ENGL J MED, V291, P178, DOI 10.1056/NEJM197407252910405; Marmot M, 2007, FOOD NUTR PHYS ACT P; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Oh TH, 2008, J GASTROEN HEPATOL, V23, P411, DOI 10.1111/j.1440-1746.2007.05125.x; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Schoen RE, 1999, JNCI-J NATL CANCER I, V91, P1147, DOI 10.1093/jnci/91.13.1147; Shimizu N, 2003, BRIT J CANCER, V88, P1038, DOI 10.1038/sj.bjc.6600845; Sugiyama M, 2009, INT J ONCOL, V34, P339, DOI 10.3892/ijo_00000156; Terry PD, 2002, GUT, V51, P191, DOI 10.1136/gut.51.2.191; Tsujinaka S, 2008, DIS COLON RECTUM, V51, P1757, DOI 10.1007/s10350-008-9395-0; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yamamoto S, 2010, DIABETES CARE, V33, P184, DOI 10.2337/dc09-1197; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011	36	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110587	10.1371/journal.pone.0110587	http://dx.doi.org/10.1371/journal.pone.0110587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402501	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700006
J	Urra, JA; Villaroel-Espindola, F; Covarrubias, AA; Rodriguez-Gil, JE; Ramirez-Reveco, A; Concha, II				Urra, Javier A.; Villaroel-Espindola, Franz; Covarrubias, Alejandra A.; Enric Rodriguez-Gil, Joan; Ramirez-Reveco, Alfredo; Concha, Ilona I.			Presence and Function of Dopamine Transporter (DAT) in Stallion Sperm: Dopamine Modulates Sperm Motility and Acrosomal Integrity	PLOS ONE			English	Article							INFERIOR MESENTERIC PLEXUS; IN-VITRO; ISOFLURANE ANESTHESIA; MAMMALIAN SPERMATOZOA; HAMSTER SPERMATOZOA; HUMAN TESTIS; CATECHOLAMINES; RECEPTORS; CAPACITATION; STIMULATION	Dopamine is a catecholamine with multiple physiological functions, playing a key role in nervous system; however its participation in reproductive processes and sperm physiology is controversial. High dopamine concentrations have been reported in different portions of the feminine and masculine reproductive tract, although the role fulfilled by this catecholamine in reproductive physiology is as yet unknown. We have previously shown that dopamine type 2 receptor is functional in boar sperm, suggesting that dopamine acts as a physiological modulator of sperm viability, capacitation and motility. In the present study, using immunodetection methods, we revealed the presence of several proteins important for the dopamine uptake and signalling in mammalian sperm, specifically monoamine transporters as dopamine (DAT), serotonin (SERT) and norepinephrine (NET) transporters in equine sperm. We also demonstrated for the first time in equine sperm a functional dopamine transporter using 4-[4-(Dimethylamino) styryl]-N-methylpyridinium iodide (ASP+), as substrate. In addition, we also showed that dopamine (1 mM) treatment in vitro, does not affect sperm viability but decreases total and progressive sperm motility. This effect is reversed by blocking the dopamine transporter with the selective inhibitor vanoxerine (GBR12909) and non-selective inhibitors of dopamine reuptake such as nomifensine and bupropion. The effect of dopamine in sperm physiology was evaluated and we demonstrated that acrosome integrity and thyrosine phosphorylation in equine sperm is significantly reduced at high concentrations of this catecholamine. In summary, our results revealed the presence of monoamine transporter DAT, NET and SERT in equine sperm, and that the dopamine uptake by DAT can regulate sperm function, specifically acrosomal integrity and sperm motility.	[Urra, Javier A.] Univ Austral Chile, Fac Ciencias Vet, Escuela Grad, Valdivia, Chile; [Urra, Javier A.; Villaroel-Espindola, Franz; Covarrubias, Alejandra A.; Concha, Ilona I.] Univ Austral Chile, Fac Ciencias, Inst Bioquim & Microbiol, Valdivia, Chile; [Urra, Javier A.; Ramirez-Reveco, Alfredo] Univ Austral Chile, Fac Ciencias Vet, Inst Ciencia Anim, Valdivia, Chile; [Enric Rodriguez-Gil, Joan] Univ Autonoma Barcelona, Fac Vet, Unitat Reprod Anim, E-08193 Barcelona, Spain	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile; Autonomous University of Barcelona	Ramirez-Reveco, A (corresponding author), Univ Austral Chile, Fac Ciencias Vet, Inst Ciencia Anim, Valdivia, Chile.	alfredoramirez@uach.cl; conchagrabinger@uach.cl	Ramírez, Alfredo/ABE-2699-2021; Villarroel-Espindola, Franz/GLU-4201-2022; Rodriguez-Gil, Joan E./F-8748-2016; Ramirez, Alfredo/AAF-8536-2020	Ramírez, Alfredo/0000-0003-4782-4261; Rodriguez-Gil, Joan E./0000-0002-1112-9884; 	FONDEF (Fondo de Fomento al Desarrollo Cientifico y Tecnologico) [D08I11076]; FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico) [1110508, 33130449]; DID-UACh Grant (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile) [D-2010-01]; Direccion de Estudios Postgrados, Universidad Austral de Chile; Escuela de Graduados, Facultad de Ciencias Veterinarias, Universidad Austral de Chile; CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica)	FONDEF (Fondo de Fomento al Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DID-UACh Grant (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile); Direccion de Estudios Postgrados, Universidad Austral de Chile; Escuela de Graduados, Facultad de Ciencias Veterinarias, Universidad Austral de Chile; CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funding: Supported by FONDEF (Fondo de Fomento al Desarrollo Cientifico y Tecnologico: Grant D08I11076 (to A.R.R.), FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico) Grant 1110508 (to I.C.), Grant 33130449 (to FVE), and DID-UACh Grant D-2010-01 (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile), Direccion de Estudios Postgrados, Universidad Austral de Chile and Escuela de Graduados, Facultad de Ciencias Veterinarias, Universidad Austral de Chile and CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) Scholarship for doctoral studies (to J.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoya-Osiguwa SA, 2007, HUM REPROD, V22, P756, DOI 10.1093/humrep/del454; Adeoya-Osiguwa SA, 2006, HUM REPROD, V21, P1555, DOI 10.1093/humrep/del016; Ayala I, 2012, RES VET SCI, V93, P103, DOI 10.1016/j.rvsc.2011.05.013; Bae SE, 2001, REPRODUCTION, V122, P275, DOI 10.1530/reprod/122.2.275; BAVISTER BD, 1979, J REPROD FERTIL, V56, P507, DOI 10.1530/jrf.0.0560507; BILLUPS KL, 1990, J UROLOGY, V143, P625, DOI 10.1016/S0022-5347(17)40043-7; BILLUPS KL, 1990, FERTIL STERIL, V53, P1076; BONISCH H, 1980, PHARMACOLOGY, V21, P93, DOI 10.1159/000137422; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAUD M, 1983, PHARMACOL RES COMMUN, V15, P923, DOI 10.1016/S0031-6989(83)80022-8; CORNETT LE, 1979, BIOL REPROD, V20, P925, DOI 10.1095/biolreprod20.4.925; CORNETT LE, 1978, P NATL ACAD SCI USA, V75, P4954, DOI 10.1073/pnas.75.10.4954; Cortes-Gutierrez EI, 2008, THERIOGENOLOGY, V69, P1022, DOI 10.1016/j.theriogenology.2008.02.002; Davidoff MS, 2005, HISTOCHEM CELL BIOL, V124, P313, DOI 10.1007/s00418-005-0024-x; Fait G, 2001, ANDROLOGIA, V33, P347, DOI 10.1046/j.1439-0272.2001.00461.x; Frungieri MB, 2000, NEUROENDOCRINOLOGY, V71, P43, DOI 10.1159/000054519; Gil AG, 2005, VET REC, V157, P589; Gil AG, 2007, LAB ANIM-UK, V41, P411, DOI 10.1258/002367707782314274; HELM G, 1982, BIOL REPROD, V26, P553, DOI 10.1095/biolreprod26.4.553; KHATCHADOURIAN C, 1987, HUM REPROD, V2, P1; Kotwica G, 2003, THERIOGENOLOGY, V60, P953, DOI 10.1016/S0093-691X(03)00086-4; LINDAHL PE, 1981, EXPERIENTIA, V37, P860, DOI 10.1007/BF01985681; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Mayerhofer A, 1999, J ANDROL, V20, P341; Mayerhofer A, 1996, BIOL REPROD, V55, P509, DOI 10.1095/biolreprod55.3.509; MEIZEL S, 1980, BIOL REPROD, V22, P211, DOI 10.1095/biolreprod22.2.211; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; OZ M, 2010, ASP J NEUROCHEM, V114, P1019; Ramirez AR, 2009, BIOL REPROD, V80, P753, DOI 10.1095/biolreprod.108.070961; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Villarroel-Espindola F, 2013, J CELL BIOCHEM, V114, P1653, DOI 10.1002/jcb.24507; Way AL, 2002, J ANDROL, V23, P352; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2	33	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112834	10.1371/journal.pone.0112834	http://dx.doi.org/10.1371/journal.pone.0112834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG2MR	25402186	Green Published, Green Submitted, gold			2022-12-27	WOS:000353109300001
J	Jing, Y; Chen, HR; Liu, MJ; Zhou, MH; Guo, YL; Gao, CJ; Wang, QS; Li, HH; Zhao, Y; Bo, J; Huang, WR; Zhu, HY; Zhang, YQ; Yu, L				Jing, Yu; Chen, Huiren; Liu, Mingjuan; Zhou, Minhang; Guo, Yuelu; Gao, Chunji; Wang, Quanshun; Li, Honghua; Zhao, Yu; Bo, Jian; Huang, Wenrong; Zhu, Haiyan; Zhang, Yongqing; Yu, Li			Susceptibility of Ph-Positive ALL to TKI Therapy Associated with BCR-ABL Rearrangement Patterns: A Retrospective Analysis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; ADULT PATIENTS; IMATINIB; CHEMOTHERAPY; COMBINATION; BREAKPOINT; MANAGEMENT	Background: Tyrosine kinase inhibitors (TKIs) have demonstrated success in the treatment of acute lymphoblastic leukemia (ALL) in patients that express BCR-ABL rearrangements (Philadelphia chromosome [Ph]). The current study aimed to assess the efficacy of TKIs and prognostic factors in the treatment of adults with Ph+-ALL. Methods: In this multicenter retrospective study, the relationship between Ph+-ALL and treatment outcomes among Chinese patients receiving TKI-containing induction/consolidation chemotherapy was examined. A total of 86 Ph+-ALL patients were included and followed for 3.85 (0.43-9.30) years. Overall survival (OS) and event-free survival (EFS) were analyzed. Results: A total of 86 Ph+-ALL patients (40 females and 46 males; median age: 34.0 years) were enrolled, including those with BCR/ABL transcripts 190 (n=52), 210 (n=25), and 230 (n=2); BCR/ABL isoform determination was not available for 7 patients. Mortality was influenced by variable BCR/ABL transcripts and TKI administration, and BCR/ABL transcripts, hematopoietic stem cell transplantation (HSCT), and TKI administration were associated with the occurrence of events. The OS rate in the TKI administration group during steady state was significantly higher compared with those patients who did not receive TKI administration (P=0.008), the EFS rate in the TKI administration group during steady state was significantly higher compared with those patients who did not receive TKIs (P=0.012), and also higher than those with TKI salvage administration (P=0.004). BCR/ABL transcripts 210 showed preferable OS and EFS compared with BCR/ABL transcripts 190 and 230 (P<0.05 for each). Conclusions: The susceptibility of Ph+-ALL to TKI associated with the patterns of BCR-ABL rearrangement is demonstrated for the first time, thus adding another risk-stratifying molecular prognostic tool for the management of patients with Ph+-ALL.	[Jing, Yu; Liu, Mingjuan; Zhou, Minhang; Guo, Yuelu; Gao, Chunji; Wang, Quanshun; Li, Honghua; Zhao, Yu; Bo, Jian; Huang, Wenrong; Zhu, Haiyan; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Jing, Yu; Liu, Mingjuan; Zhou, Minhang; Guo, Yuelu; Gao, Chunji; Wang, Quanshun; Li, Honghua; Zhao, Yu; Bo, Jian; Huang, Wenrong; Zhu, Haiyan; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, BMT Ctr, Beijing, Peoples R China; [Chen, Huiren] Gen Hosp Beijing Mil Reg, Dept Hematol, Beijing, Peoples R China; [Liu, Mingjuan; Zhang, Yongqing] 309th Hosp Chinese Peoples Liberat Army, Dept Hematol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Seventh Medical Center of Chinese PLA General Hospital	Zhang, YQ (corresponding author), 309th Hosp Chinese Peoples Liberat Army, Dept Hematol, Beijing, Peoples R China.	zhangyongqing0725@163.com; chunhuiliyu@yahoo.com	zhu, xueqiong/U-1320-2019	Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [81170518, 81270611, 81470010]; National Public Health Grant Research Foundation [201202017]; capital of the public health project [Z111107067311070];  [2013-096];  [2012FC-TSYS-201];  [CXY20140013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grant Research Foundation; capital of the public health project; ; ; 	Funding: This work was supported by grants from the National Natural Science Foundation of China (81170518, 81270611, 81470010), National Public Health Grant Research Foundation (No. 201202017) and The capital of the public health project (Z111107067311070), and local foundation from China (Qiong wei 2013-096, 2012FC-TSYS-201, and CXY20140013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burmeister T, 2008, BLOOD, V112, P918, DOI 10.1182/blood-2008-04-149286; Chalandon Y, 2008, BLOOD, V112, P11; Cimino G, 2006, HAEMATOLOGICA, V91, P377; de Labarthe A, 2007, BLOOD, V109, P1408, DOI 10.1182/blood-2006-03-011908; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Fielding AK, 2010, BLOOD, V116, P3409, DOI 10.1182/blood-2010-01-242750; Fielding AK, 2009, BLOOD, V113, P4489, DOI 10.1182/blood-2009-01-199380; Iacobucci I, 2010, HAEMATOL-HEMATOL J, V95, P1683, DOI 10.3324/haematol.2009.020792; Jones D, 2008, CANCER-AM CANCER SOC, V113, P985, DOI 10.1002/cncr.23666; Larson RA, 2006, SEMIN HEMATOL, V43, P126, DOI 10.1053/j.seminhematol.2006.01.007; Lee KH, 2005, LEUKEMIA, V19, P1509, DOI 10.1038/sj.leu.2403886; Lee S, 2005, BLOOD, V105, P3449, DOI 10.1182/blood-2004-09-3785; Mathisen MS, 2011, CURR HEMATOL MALIG R, V6, P187, DOI 10.1007/s11899-011-0093-y; McCormack PL, 2011, DRUGS, V71, P1771, DOI 10.2165/11207580-000000000-00000; Mizuta S, 2011, LEUKEMIA, V25, P41, DOI 10.1038/leu.2010.228; Moorman AV, 2007, BLOOD, V109, P3189, DOI 10.1182/blood-2006-10-051912; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; Ottmann OG, 2007, CANCER-AM CANCER SOC, V109, P2068, DOI 10.1002/cncr.22631; Pane F, 2005, LEUKEMIA, V19, P628, DOI 10.1038/sj.leu.2403683; Pfeifer H, 2010, BLOOD, V116; Ribera JM, 2013, LEUKEMIA LYMPHOMA, V54, P21, DOI 10.3109/10428194.2012.708753; SECKERWALKER LM, 1993, LEUKEMIA, V7, P147; SECKERWALKER LM, 1991, LEUKEMIA, V5, P196; Tanguy-Schmidt A, 2013, BIOL BLOOD MARROW TR, V19, P150, DOI 10.1016/j.bbmt.2012.08.021; Thomas DA, 2004, BLOOD, V103, P4396, DOI 10.1182/blood-2003-08-2958; Wassmann B, 2005, BLOOD, V106, P458, DOI 10.1182/blood-2004-05-1746; Wassmann B, 2006, BLOOD, V108, P1469, DOI 10.1182/blood-2005-11-4386; Watanabe A, 2013, PEDIATR INT, V55, pe56, DOI 10.1111/ped.12019; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177; Yanada M, 2008, BRIT J HAEMATOL, V143, P503, DOI 10.1111/j.1365-2141.2008.07377.x; Yao L, 2013, LEUKEMIA LYMPHOMA, V54, P1626, DOI 10.3109/10428194.2012.749403	31	2	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e110431	10.1371/journal.pone.0110431	http://dx.doi.org/10.1371/journal.pone.0110431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415187	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600002
J	Xia, JH; Yuan, J; Xin, LL; Zhang, YY; Kong, SY; Chen, YX; Yang, SL; Li, K				Xia, Jihan; Yuan, Jing; Xin, Leilei; Zhang, Yuanyuan; Kong, Siyuan; Chen, Yaoxing; Yang, Shulin; Li, Kui			Transcriptome Analysis on the Inflammatory Cell Infiltration of Nonalcoholic Steatohepatitis in Bama Minipigs Induced by a Long-Term High-Fat, High-Sucrose Diet	PLOS ONE			English	Article							MECHANISMS LINKING OBESITY; LIVER-DISEASE; RNA-SEQ; INSULIN-RESISTANCE; T-CELL; ASSOCIATION; INHIBITION; RECEPTOR; GROWTH; ROLES	Long-term adherence to a high-fat, high-calorie diet influences human health and causes obesity, metabolic syndrome and nonalcoholic steatohepatitis (NASH). Inflammation plays a key role in the development of NASH; however, the mechanism of inflammation induced by over-nutrition remains largely unknown. In this study, we fed Bama minipigs a high-fat, high-sucrose diet (HFHSD) for 23 months. The pigs exhibited characteristics of metabolic syndrome and developed steatohepatitis with greatly increased numbers of inflammatory cells, such as lymphocytes (2.27-fold, P<0.05), Kupffer cells (2.59-fold, P<0.05), eosinophils (1.42-fold, P<0.05) and neutrophils (2.77-fold, P<0.05). High-throughput RNA sequencing (RNA-seq) was performed to explore the systemic transcriptome of the pig liver during inflammation. Approximately 18.2 gigabases of raw sequence data were generated, and over 303 million high-quality reads were assembled into 21,126 unigenes. RNA-seq data analysis showed that 822 genes were differentially expressed in liver (P<0.05) between the HFHSD and control groups. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that the process of inflammation involved the inflammatory signal transduction-related toll-like receptor, MAPK, and PPAR signaling pathways; the cytokine-related chemokine signaling, cytokine-cytokine receptor interaction, and IL2, IL4, IL6, and IL12 signaling pathways; the leukocyte receptor signaling-related T cell, B cell, and natural killer cell signaling pathways; inflammatory cell migration and invasion- related pathways; and other pathways. Moreover, we identified several differentially expressed inflammation-related genes between the two groups, including FOS, JUN, TLR7, MYC, PIK3CD, VAV3, IL2RB and IL4R, that could be potential targets for further investigation. Our study suggested that long-term HFHSD induced obesity and liver inflammation, providing basic insight into the molecular mechanism of this condition and laying the groundwork for further studies on obesity and steatohepatitis.	[Xia, Jihan; Yuan, Jing; Xin, Leilei; Kong, Siyuan; Yang, Shulin; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Yuan, Jing] Yangtz Univ, Coll Anim Sci, Jinzhou, Hubei, Peoples R China; [Zhang, Yuanyuan; Chen, Yaoxing] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University	Yang, SL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	yangshulin@caas.cn; likui@caas.cn	Xia, Jihan/GLQ-5273-2022; zhang, yuanyuan/GYA-4428-2022	Xia, Jihan/0000-0002-0035-0727	National Natural Science Foundation of China [31372276]; State Key Development Program for Basic Research of China [2012CB517501]; National Basic Research Program [2011CBA01005]; National Key Technology Support Program [2012BAI39B04]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05]; Development Program of China [2012AA020603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Basic Research Program(National Basic Research Program of China); National Key Technology Support Program(National Key Technology R&D Program); Agricultural Science and Technology Innovation Program; Development Program of China	This work was supported by the National Natural Science Foundation of China (31372276), State Key Development Program for Basic Research of China (2012CB517501), National Basic Research Program (2011CBA01005), National Key Technology Support Program (2012BAI39B04), Agricultural Science and Technology Innovation Program (ASTIP-IAS05) and Development Program of China (2012AA020603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; BLOBE GC, 1994, CANCER METAST REV, V13, P411, DOI 10.1007/BF00666107; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chang KH, 2012, BLOOD, V120, P800, DOI 10.1182/blood-2011-06-361709; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chen JH, 2012, MED ONCOL, V29, P1972, DOI 10.1007/s12032-011-0088-5; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Haas C, 2012, METHODS MOL BIOL, V830, P169, DOI 10.1007/978-1-61779-461-2_12; Harmon RC, 2011, EXPERT REV GASTROENT, V5, P189, DOI [10.1586/egh.11.21, 10.1586/EGH.11.21]; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hulme JS, 2004, DIABETES, V53, P2479, DOI 10.2337/diabetes.53.9.2479; Ikura Y, 2006, HEPATOLOGY, V43, P506, DOI 10.1002/hep.21070; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kiyohara Chikako, 2008, Allergol Int, V57, P39, DOI 10.2332/allergolint.R-07-150; Knyazhitsky M, 2012, J BIOL CHEM, V287, P19725, DOI 10.1074/jbc.M111.309799; Kremer AN, 2014, HAEMATOLOGICA, V99, P365, DOI 10.3324/haematol.2013.086652; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Mao X, 2008, CANCER GENET CYTOGEN, V185, P86, DOI 10.1016/j.cancergencyto.2008.05.006; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Tsou RC, 2012, J OBES, V2012, DOI 10.1155/2012/926857; Valenti L, 2009, SEMIN IMMUNOPATHOL, V31, P359, DOI 10.1007/s00281-009-0152-9; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Zhang NB, 2011, MOL BIOL REP, V38, P4281, DOI 10.1007/s11033-010-0551-y	44	26	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113724	10.1371/journal.pone.0113724	http://dx.doi.org/10.1371/journal.pone.0113724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415189	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600074
J	Hung, HC; Shih, SR; Chang, TY; Fang, MY; Hsu, JTA				Hung, Hui-Chen; Shih, Shin-Ru; Chang, Teng-Yuan; Fang, Ming-Yu; Hsu, John T. -A.			The Combination Effects of LiCl and the Active Leflunomide Metabolite, A771726, on Viral-Induced Interleukin 6 Production and EV-A71 Replication	PLOS ONE			English	Article							ENTEROVIRUS 71 REPLICATION; CENTRAL-NERVOUS-SYSTEM; AURINTRICARBOXYLIC ACID; HOST FACTORS; IN-VIVO; INHIBITION; INFECTIONS; ACTIVATION; CYTOKINE; SUPPRESSION	Enterovirus 71 (EV-A71) is a neurotropic virus that can cause severe complications involving the central nervous system. No effective antiviral therapeutics are available for treating EV-A71 infection and drug discovery efforts are rarely focused to target this disease. Thus, the main goal of this study was to discover existing drugs with novel indications that may effectively inhibit EV-A71 replication and the inflammatory cytokines elevation. In this study, we showed that LiCl, a GSK3 beta inhibitor, effectively suppressed EV-A71 replication, apoptosis and inflammatory cytokines production (Interleukin 6, Interleukin-1 beta) in infected cells. Furthermore, LiCl and an immunomodular agent were shown to strongly synergize with each other in suppressing EV-A71 replication. The results highlighted potential new treatment regimens in suppressing sequelae caused by EV-A71 replication.	[Hung, Hui-Chen; Chang, Teng-Yuan; Fang, Ming-Yu; Hsu, John T. -A.] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan; [Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Shih, Shin-Ru] Chang Gung Mem Hosp, Dept Clin Pathol, Clin Virol Lab, Taoyuan, Taiwan; [Shih, Shin-Ru] Chang Gung Univ, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Hsu, John T. -A.] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Hsu, JTA (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan.	tsuanhsu@nhri.org.tw	Shih, Shin-Ru/M-9711-2016; Fang, Ming Yu/K-8577-2013; Hsu, John Tsu-An/C-1199-2010	Fang, Ming Yu/0000-0002-2530-7522; Shih, Shin-Ru/0000-0003-4874-401X	Ministry of Science and Technology (MOST) [MOST 101-2811-B-400-023, BP-101-PP-01]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	This work was supported by the Ministry of Science and Technology (MOST) Grants MOST 101-2811-B-400-023 and BP-101-PP-01 to J.T.-A.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; Cao WW, 1996, TRANSPL P, V28, P3079; Chacko B, 2012, TRANSPL INFECT DIS, V14, P111, DOI 10.1111/j.1399-3062.2011.00682.x; Chen TC, 2007, CELL MICROBIOL, V9, P2676, DOI 10.1111/j.1462-5822.2007.00988.x; Chong AS, 2006, AM J TRANSPLANT, V6, P69, DOI 10.1111/j.1600-6143.2005.01152.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Coyne CB, 2011, CELL HOST MICROBE, V9, P70, DOI 10.1016/j.chom.2011.01.001; D'Souza R, 2011, CURR PSYCHIAT REP, V13, P488, DOI 10.1007/s11920-011-0228-9; Davis JP, 1996, BIOCHEMISTRY-US, V35, P1270, DOI 10.1021/bi952168g; Dunn MCC, 2011, ANTIVIR THER, V16, P309, DOI 10.3851/IMP1763; Fortin CF, 2011, EUR J IMMUNOL, V41, P1709, DOI 10.1002/eji.201040945; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Gau SSF, 2008, PEDIATRICS, V122, pE452, DOI 10.1542/peds.2007-3799; Henao-Martinez AF, 2012, J CLIN VIROL, V54, P276, DOI 10.1016/j.jcv.2012.02.026; Hernandez F, 2012, J ALZHEIMERS DIS; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; Howley PM, 2007, FIELDS VIROLOGY, V1, P839; Huang HI, 2012, FUTURE MICROBIOL, V7, P467, DOI [10.2217/FMB.12.22, 10.2217/fmb.12.22]; Huang SW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-147; Hung HC, 2011, J INFECT DIS, V203, P1784, DOI 10.1093/infdis/jir174; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; Hung HC, 2009, ANTIVIR RES, V81, P123, DOI 10.1016/j.antiviral.2008.10.006; Ji Wen-Tsai, 2008, Recent Pat Biotechnol, V2, P218, DOI 10.2174/187220808786241042; Jung YH, 2012, PEDIAT TRANSPLANT; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Korn T, 2001, BRAIN, V124, P1791, DOI 10.1093/brain/124.9.1791; Kuo CJ, 2008, BIOORGAN MED CHEM, V16, P7388, DOI 10.1016/j.bmc.2008.06.015; Lee JC, 2008, ANAL BIOCHEM, V375, P115, DOI 10.1016/j.ab.2007.12.019; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Manna SK, 1999, J IMMUNOL, V162, P2095; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Si HF, 2008, CYTOKINE, V42, P24, DOI 10.1016/j.cyto.2008.01.017; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wang SM, 2007, CLIN MICROBIOL INFEC, V13, P677, DOI 10.1111/j.1469-0691.2007.01729.x; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wong WR, 2005, LIFE SCI, V78, P82, DOI 10.1016/j.lfs.2005.04.076; Wu WL, 2011, J CLIN IMMUNOL, V31, P1065, DOI 10.1007/s10875-011-9578-7; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652	45	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e111331	10.1371/journal.pone.0111331	http://dx.doi.org/10.1371/journal.pone.0111331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412347	Green Submitted, gold, Green Published			2022-12-27	WOS:000345253000007
J	Kang, YL; Saleem, MA; Chan, KW; Yung, BYM; Law, HKW				Kang, Yu-Lin; Saleem, Moin Ahson; Chan, Kwok Wah; Yung, Benjamin Yat-Ming; Law, Helen Ka-Wai			Trehalose, an mTOR Independent Autophagy Inducer, Alleviates Human Podocyte Injury after Puromycin Aminonucleoside Treatment	PLOS ONE			English	Article							CONGENITAL NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; DISEASE; HUNTINGTIN; PHOSPHORYLATION; DEGRADATION; EXPRESSION; APOPTOSIS; RAPAMYCIN; NEPHRIN	Glomerular diseases are commonly characterized by podocyte injury including apoptosis, actin cytoskeleton rearrangement and detachment. However, the strategies for preventing podocyte damage remain insufficient. Recently autophagy has been regarded as a vital cytoprotective mechanism for keeping podocyte homeostasis. Thus, it is reasonable to utilize this mechanism to attenuate podocyte injury. Trehalose, a natural disaccharide, is an mTOR independent autophagy inducer. It is unclear whether trehalose alleviates podocyte injury. Therefore, we investigated the efficacy of trehalose in puromycin aminonucleoside (PAN)-treated podocytes which mimic cell damage in minimal change nephrotic syndrome in vitro. Human conditional immortalized podocytes were treated with trehalose with or without PAN. Autophagy was investigated by immunofluorescence staining for LC3 puncta and Western blotting for LC3, Atg5, p-AMPK, p-mTOR and its substrates. Podocyte apoptosis and necrosis were evaluated by flow cytometry and by measuring lactate dehydrogenase activity respectively. We also performed migration assay to examine podocyte recovery. It was shown that trehalose induced podocyte autophagy in an mTOR independent manner and without reactive oxygen species involvement. Podocyte apoptosis significantly decreased after trehalose treatment, while the inhibition of trehalose-induced autophagy abolished its protective effect. Additionally, the disrupted actin cytoskeleton of podocytes was partially reversed by trehalose, accompanying with less lamellipodias and diminished motility. These results suggested that trehalose induced autophagy in human podocytes and showed cytoprotective effects in PAN-treated podocytes.	[Kang, Yu-Lin; Yung, Benjamin Yat-Ming; Law, Helen Ka-Wai] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Hlth Technol & Informat, Hunghom, Hong Kong, Peoples R China; [Kang, Yu-Lin] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China; [Saleem, Moin Ahson] Univ Bristol, Southmead Hosp, Acad Renal Unit, Bristol, Avon, England; [Chan, Kwok Wah] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Shanghai Jiao Tong University; Southmead Hospital; University of Bristol; University of Hong Kong	Law, HKW (corresponding author), Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Hlth Technol & Informat, Hunghom, Hong Kong, Peoples R China.	hthelen@polyu.edu.hk		Kang, Yulin/0000-0002-0196-7438; Yung, Benjamin Yat Ming/0000-0003-0093-3196; Saleem, Moin/0000-0002-9808-4518	HWL; Competitive Research Grants for Newly Recruited Junior Academic Staff [NRJS-A-PM13]; Departmental Research Fund, The Hong Kong Polytechnic University; Early Career Scheme from Research Grants Council of the Hong Kong Special Administrative Region, China (RGC) [589413]	HWL; Competitive Research Grants for Newly Recruited Junior Academic Staff; Departmental Research Fund, The Hong Kong Polytechnic University; Early Career Scheme from Research Grants Council of the Hong Kong Special Administrative Region, China (RGC)	This work was partially supported by grants to HWL (i) Competitive Research Grants for Newly Recruited Junior Academic Staff (NRJS-A-PM13); (ii) Departmental Research Fund, The Hong Kong Polytechnic University and (iii) Early Career Scheme from Research Grants Council of the Hong Kong Special Administrative Region, China (RGC#589413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Hartleben B, 2014, SEMIN NEPHROL, V34, P42, DOI 10.1016/j.semnephrol.2013.11.007; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Inoki K, 2014, SEMIN NEPHROL, V34, P2, DOI 10.1016/j.semnephrol.2013.11.002; Inoki K, 2012, CURR OPIN NEPHROL HY, V21, P251, DOI 10.1097/MNH.0b013e3283520f38; Kang YL, 2014, BIOCHEM BIOPH RES CO, V443, P628, DOI 10.1016/j.bbrc.2013.12.015; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Kume S, 2014, SEMIN NEPHROL, V34, P9, DOI 10.1016/j.semnephrol.2013.11.003; Lin Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/135608; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Srivastava T, 2013, J CELL COMMUN SIGNAL, V7, P49, DOI 10.1007/s12079-012-0184-0; Takabatake Y, 2014, NEPHROLOGY DIALYSIS; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Wu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063799; Yadav A, 2010, AM J PHYSIOL-CELL PH, V299, pC488, DOI 10.1152/ajpcell.00424.2009; Zhang X., 2014, AUTOPHAGY, V10; Zhuo CQ, 2013, BIOCHEM BIOPH RES CO, V437, P482, DOI 10.1016/j.bbrc.2013.06.111	42	52	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113520	10.1371/journal.pone.0113520	http://dx.doi.org/10.1371/journal.pone.0113520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412249	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000060
J	Larson, JH; Eckert, NL; Bartsch, MR				Larson, James H.; Eckert, Nathan L.; Bartsch, Michelle R.			Intrinsic Variability in Shell and Soft Tissue Growth of the Freshwater Mussel Lampsilis siliquoidea	PLOS ONE			English	Article							WEIGHT-LENGTH RELATIONSHIPS; GREAT-LAKES; BIVALVE; DIVERSITY; COMMUNITY; UNIONIDAE; SURVIVAL; MOLLUSKS; AMMONIA; SESTON	Freshwater mussels are ecologically and economically important members of many aquatic ecosystems, but are globally among the most imperiled taxa. Propagation techniques for mussels have been developed and used to boost declining and restore extirpated populations. Here we use a cohort of propagated mussels to estimate the intrinsic variability in size and growth rate of Lampsilis siliquoidea (a commonly propagated species). Understanding the magnitude and pattern of variation in data is critical to determining whether effects observed in nature or experimental treatments are likely to be important. The coefficient of variation (CV) of L. siliquoidea soft tissues (6.0%) was less than the CV of linear shell dimensions (25.1-66.9%). Size-weight relationships were best when mussel width (the maximum left-right dimension with both valves appressed) was used as a predictor, but 95% credible intervals on these predictions for soft tissues were similar to 145 mg wide (about 50% of the mean soft tissue mass). Mussels in this study were treated identically, raised from a single cohort and yet variation in soft tissue mass at a particular size class (as determined by shell dimensions) was still high. High variability in mussel size is often acknowledged, but seldom discussed in the context of mussel conservation. High variability will influence the survival of stocked juvenile cohorts, may affect the ability to experimentally detect sublethal stressors and may lead to incongruities between the effects that mussels have on structure (via hard shells) and biogeochemical cycles (via soft tissue metabolism). Given their imperiled status and longevity, there is often reluctance to destructively sample unionid mussel soft tissues even in metabolic studies (e.g., studies of nutrient cycling). High intrinsic variability suggests that using shell dimensions (particularly shell length) as a response variable in studies of sublethal stressors or metabolic processes will make confident identifications of smaller effect sizes difficult.	[Larson, James H.; Bartsch, Michelle R.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA; [Eckert, Nathan L.] US Fish & Wildlife Serv, Genoa Natl Fish Hatchery, Genoa, WI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Larson, JH (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA.	jhlarson@usgs.gov		Bartsch, Michelle/0000-0002-9571-5564				Augspurger T, 2003, ENVIRON TOXICOL CHEM, V22, P2569, DOI 10.1897/02-339; Barnhart MC, 2006, AQUACULTURE, V254, P227, DOI 10.1016/j.aquaculture.2005.08.028; Beasley CR, 2005, AMAZONIANA, V18, P173; Best N, 2007, BRUGS PACKAGE; Bogan AE, 2008, J N AM BENTHOL SOC, V27, P349, DOI 10.1899/07-069.1; Bryan NJ, 2013, J GREAT LAKES RES, V39, P449, DOI 10.1016/j.jglr.2013.06.007; Bullard AE, 2013, FRESHW SCI, V32, P976, DOI 10.1899/12-071.1; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Evans MA, 2011, ENVIRON SCI TECHNOL, V45, P3297, DOI 10.1021/es103892w; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Gaspar MB, 2001, J MAR BIOL ASSOC UK, V81, P805, DOI 10.1017/S0025315401004623; Graf DL, 2013, AM MALACOL BULL, V31, P135, DOI 10.4003/006.031.0106; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Haag WR, 2014, HYDROBIOLOGIA, V735, P45, DOI 10.1007/s10750-013-1524-7; Haag WR, 2003, FRESHWATER BIOL, V48, P2118, DOI 10.1046/j.1365-2427.2003.01155.x; Hecky RE, 2004, CAN J FISH AQUAT SCI, V61, P1285, DOI 10.1139/F04-065; Hoftyzer E, 2008, CAN J FISH AQUAT SCI, V65, P1217, DOI 10.1139/F08-024; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Meador JR, 2011, J N AM BENTHOL SOC, V30, P507, DOI 10.1899/10-105.1; Meyer E, 2010, J EXP BIOL, V213, P749, DOI 10.1242/jeb.037242; Naddafi R, 2008, LIMNOL OCEANOGR, V53, P1973, DOI 10.4319/lo.2008.53.5.1973; Ntzoufras I, 2009, BAYESIAN MODELING WI; R Core Team, 2010, R LANG ENV STAT COMP; SINGH SM, 1978, EVOLUTION, V32, P342, DOI 10.1111/j.1558-5646.1978.tb00650.x; Spooner DE, 2006, FRESHWATER BIOL, V51, P1016, DOI 10.1111/j.1365-2427.2006.01547.x; Strayer DL, 2008, FRESHW ECOL SER, V1, P1; TANABE K, 1988, LETHAIA, V21, P231; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Vaughn CC, 2008, J N AM BENTHOL SOC, V27, P409, DOI 10.1899/07-058.1; Villella RF, 2004, AM MIDL NAT, V151, P114, DOI 10.1674/0003-0031(2004)151[0114:ESARIA]2.0.CO;2; Wang N, 2007, ENVIRON TOXICOL CHEM, V26, P2048, DOI 10.1897/06-524R.1	32	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112252	10.1371/journal.pone.0112252	http://dx.doi.org/10.1371/journal.pone.0112252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411848	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000011
J	Dai, CL; Wang, K; Liu, YF; Fang, JC; Zhao, MW				Dai, Caili; Wang, Kai; Liu, Yifei; Fang, Jichao; Zhao, Mingwei			Study on the Reutilization of Clear Fracturing Flowback Fluids in Surfactant Flooding with Additives for Enhanced Oil Recovery (EOR)	PLOS ONE			English	Article							CRUDE-OIL; WETTABILITY ALTERATION; RHEOLOGICAL PROPERTIES; WORMLIKE MICELLES; HEAVY-OIL; WATER; EMULSIONS; DYNAMICS; POLYMER; EMULSIFICATION	An investigation was conducted to study the reutilization of clear fracturing flowback fluids composed of viscoelastic surfactants (VES) with additives in surfactant flooding, making the process more efficient and cost-effective. The clear fracturing flowback fluids were used as surfactant flooding system with the addition of a-olefin sulfonate (AOS) for enhanced oil recovery (EOR). The interfacial activity, emulsification activity and oil recovery capability of the recycling system were studied. The interfacial tension (IFT) between recycling system and oil can be reduced by 2 orders of magnitude to 10(-3) mN/m, which satisfies the basic demand of surfactant flooding. The oil can be emulsified and dispersed more easily due to the synergetic effect of VES and AOS. The oil-wet surface of quartz can be easily converted to water-wet through adsorption of surfactants (VES/AOS) on the surface. Thirteen core plug flooding tests were conducted to investigate the effects of AOS concentrations, slug sizes and slug types of the recycling system on the incremental oil recovery. The investigations prove that reclaiming clear fracturing flowback fluids after fracturing operation and reuse it in surfactant flooding might have less impact on environment and be more economical.	[Dai, Caili; Wang, Kai; Liu, Yifei; Fang, Jichao; Zhao, Mingwei] China Univ Petr East China, Qingdao 266580, Shandong, Peoples R China; [Wang, Kai] China Natl Offshore Oil Corp, Res Inst, Beijing 100028, Peoples R China	China University of Petroleum; China National Offshore Oil Corporation (CNOOC)	Zhao, MW (corresponding author), China Univ Petr East China, Qingdao 266580, Shandong, Peoples R China.	zhaomingwei@upc.edu.cn		Dai, Cai li/0000-0002-7477-8865	National Natural Science Foundation of China [51174221, 21303268]; Program for New Century Excellent Talents in University [20110226]; China Postdoctoral Science Foundation funded project [2013T60689]; Fundamental Research Funds for the Central Universities [14CX02041A]; Changjiang Scholars and Innovative Resaerch Team in University [IRT1294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Changjiang Scholars and Innovative Resaerch Team in University	This work was supported by the National Natural Science Foundation of China (51174221, 21303268), the Program for New Century Excellent Talents in University (20110226), China Postdoctoral Science Foundation funded project (2013T60689), the Fundamental Research Funds for the Central Universities (14CX02041A) and Changjiang Scholars and Innovative Resaerch Team in University (IRT1294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almalik MS, 1997, J PETROL SCI ENG, V17, P367, DOI 10.1016/S0920-4105(96)00035-6; Alvarado V, 2010, ENERGIES, V3, P1529, DOI 10.3390/en3091529; [Anonymous], [No title captured]; Aoudia M, 2007, 14 EUR S IMPR OIL RE; Ayatollahi SH, 2009, 1 INT PETR C EXH; Babadagli T, 2002, J COLLOID INTERF SCI, V246, P203, DOI 10.1006/jcis.2001.8015; Bai YR, 2014, ENERG FUEL, V28, P1829, DOI 10.1021/ef402313n; BHARDWAJ A, 1994, IND ENG CHEM RES, V33, P1271, DOI 10.1021/ie00029a025; Brown JE, 1996, INT S FORM DAM CONTR, P439; Bulat D., 2008, P SPE INT S EXHIBITI; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; Craig F.F., 1993, RESERVOIR ENG ASPECT; Crews JB, 2008, EUR EAGE C EXH SOC P; Dai CL, 2013, J PHYS CHEM B, V117, P9922, DOI 10.1021/jp404387d; Dantas TNC, 2003, COLLOID SURFACE A, V225, P129, DOI 10.1016/S0927-7757(03)00355-8; Dehghanpour H, 2012, ENERG FUEL, V26, P5750, DOI 10.1021/ef3009794; FARRELL JB, 1962, IND ENG CHEM, V54, P29, DOI 10.1021/ie50630a004; Fontana C., 2007, EUROPEC EAGE C EXH S; Gadiyar B., 2006, P SPE INT S EXH FORM; Goual L, 2005, LANGMUIR, V21, P8278, DOI 10.1021/la050333f; Hoff E, 2001, LANGMUIR, V17, P28, DOI 10.1021/la001175p; Hou JR, 2006, J CAN PETROL TECHNOL, V45, P27; Kokal S, 2005, SPE PROD FACIL, V20, P5, DOI 10.2118/77497-PA; Levitt DB, 2009, SPE RESERV EVAL ENG, V12, P243, DOI 10.2118/100089-PA; Li N, 2011, ENERG FUEL, V25, P4430, DOI 10.1021/ef200616b; Li Qianding, 2011, J XIAN PETROLEUM U N, V26, P60; LIN Z, 1994, J PHYS CHEM-US, V98, P5984, DOI 10.1021/j100074a027; Liu Q, 2006, COLLOID SURFACE A, V273, P219, DOI 10.1016/j.colsurfa.2005.10.016; MELROSE JC, 1974, J CAN PETROL TECHNOL, V13, P54, DOI 10.2118/74-04-05; Nehmer WL, 1988, SPE FORM DAM CONTR S, P217; Parker M, 2003, SPE EPA DOE EXPL PRO; Pei HH, 2011, ENERG FUEL, V25, P4423, DOI 10.1021/ef200605a; Qi ZY, 2013, ENERG FUEL, V27, P7354, DOI 10.1021/ef401928c; Qu ZQ, 2013, ASIAN J CHEM, V25, P6840, DOI 10.14233/ajchem.2013.14952; REHAGE H, 1988, J PHYS CHEM-US, V92, P4712, DOI 10.1021/j100327a031; RezaeiDoust A, 2009, ENERG FUEL, V23, P4479, DOI 10.1021/ef900185q; Samuel MM, 1999, SPE DRILL COMPLETION, V14, P240, DOI 10.2118/59478-PA; Seiedi O, 2009, 1 INT PETR C EXH; Seiedi O, 2008, P 10 INT S RES WETT, P26; SPENLEY NA, 1993, PHYS REV LETT, V71, P939, DOI 10.1103/PhysRevLett.71.939; Spinler EA, 2000, SURFACTANTS FUNDAMEN, P159, DOI DOI 10.1017/CBO9780511524844.006; Stewart BR, 1995, EUR FORM DAM CONTR C, P379; [王业飞 Wang Yefei], 2011, [油气地质与采收率, Petroleum Geology and Recovery Efficiency], V18, P72; Yang J, 2002, CURR OPIN COLLOID IN, V7, P276, DOI 10.1016/S1359-0294(02)00071-7; Zhang R, 2012, APPL SURF SCI, V258, P7943, DOI 10.1016/j.apsusc.2012.04.139; Zhang YP, 2006, J CAN PETROL TECHNOL, V45, P24	46	17	18	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113723	10.1371/journal.pone.0113723	http://dx.doi.org/10.1371/journal.pone.0113723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409507	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200147
J	Liao, D; Wu, YF; Pu, XX; Chen, H; Luo, SQ; Li, BB; Ding, CC; Huang, GL; He, ZW				Liao, Dan; Wu, Yongfu; Pu, Xingxiang; Chen, Hua; Luo, Shengqun; Li, BinBin; Ding, Congcong; Huang, Guo-Liang; He, Zhiwei			Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISM; CERVICAL-CANCER; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; PROGNOSIS; GENOTYPES	Background: Cyclin D1 (CCND1) plays a key role in cell cycle regulation. It is a well-established human oncogene which is frequently amplified or overexpressed in cancers. The association between CCND1 G870A polymorphism and cancer risk has been widely assessed. However, a definitive conclusion between CCND1 G870A polymorphism and risk of nasopharyngeal carcinoma (NPC) remains elusive. Methods: We firstly performed a hospital-based case-control study involving 165 NPC cases and 191 cancer-free controls in central-south China, and then conducted a meta-analysis with six case-control studies to evaluate the association between NPC risk and CCND1 G870A polymorphism. Results: The case-control study found a significant association between CCND1 G870A polymorphism and NPC risk in various comparison models (AA vs. GG: OR = 2.300, 95% CI 1.089-4.857, p = 0.029; AG vs. GG: OR = 2.832, 95% CI 1.367-5.867, p = 0.005; AA/AG vs. GG: OR = 2.597, 95% CI 1.288-5.237, p = 0.008; AA vs. AG/GG: OR = 0.984, 95% CI 0.638-1.518, p = 0.944). Further meta-analysis showed that there was no significant association between CCND1 G870A polymorphism and NPC risk in overall analysis. In the stratified analysis by race, however, significant associations were only found in Caucasians (for the allele model A vs. G: OR = 0.75, 95% CI 0.59-0.97, p = 0.03; for the co-dominant model AA vs. GG: OR = 0.52, 95% CI 0.32-0.86, p = 0.01; for the dominant model AA/AG vs. GG: OR = 0.49, 95% CI 0.32-0.74, p<0.01; for the recessive model AA vs. AG/GG: OR = 0.90, 95% CI 0.61-1.34, p = 0.60). Conclusions: A significant association between CCND1 G870A polymorphism and NPC risk was found in the central-southern Chinese population. The meta-analysis indicated that CCND1 G870A polymorphism may contribute to the development of NPC in Caucasians.	[Liao, Dan; Wu, Yongfu; Chen, Hua; Luo, Shengqun; Li, BinBin; Ding, Congcong; Huang, Guo-Liang; He, Zhiwei] Guangdong Med Coll, Sino Amer Canc Res Inst, Dongguan, Peoples R China; [Liao, Dan; Wu, Yongfu; Chen, Hua; Luo, Shengqun; Li, BinBin; Ding, Congcong; Huang, Guo-Liang; He, Zhiwei] Key Lab Med Mol Diagnost Guangdong Prov, Dongguan, Peoples R China; [Pu, Xingxiang] Hunan Tumor Hosp, Dept Med Oncol, Changsha, Hunan, Peoples R China	Guangdong Medical University	Huang, GL (corresponding author), Guangdong Med Coll, Sino Amer Canc Res Inst, Dongguan, Peoples R China.	huang.glen@gmail.com; zhiweihe688@yahoo.com	Huang, Guoliang/H-1625-2011	Huang, Guoliang/0000-0002-8902-8100	National Natural Science Foundation of China [81372137, 30973374, 81102048]; Science and Technology Innovation Fund of Guangdong Medical College [STIF201108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Fund of Guangdong Medical College	This work was supported by National Natural Science Foundation of China (No. 81372137 and No. 30973374 to ZH; No. 81102048 to G-LH, http://www.nsfc.gov.cn/), and Science and Technology Innovation Fund of Guangdong Medical College (No. STIF201108 to ZH, http://www.gdmc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae DS, 2001, GYNECOL ONCOL, V81, P341, DOI 10.1006/gyno.2001.6196; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; BATES S, 1995, SEMIN CANCER BIOL, V6, P73, DOI 10.1006/scbi.1995.0010; BETTICHER DC, 1995, ONCOGENE, V11, P1005; CALLENDER T, 1994, CANCER-AM CANCER SOC, V74, P152, DOI 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO;2-K; Catarino R, 2008, BIOCHEM BIOPH RES CO, V370, P118, DOI 10.1016/j.bbrc.2008.03.039; Catarino RJ, 2006, HEAD NECK-J SCI SPEC, V28, P603, DOI 10.1002/hed.20377; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Deng L, 2002, ACTA BIOCH BIOPH SIN, V34, P16; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Huang GL, 2013, BIOMED REP, V1, P599, DOI 10.3892/br.2013.97; Huang XP, 2006, CANCER LETT, V231, P94, DOI 10.1016/j.canlet.2005.01.040; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin ML, 2001, LUNG CANCER-J IASLC, V34, P207, DOI 10.1016/S0169-5002(01)00225-2; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Li M, 2013, SCI WORLD J, DOI 10.1155/2013/689048; Liu JM, 2012, TUMOR BIOL, V33, P1467, DOI 10.1007/s13277-012-0397-0; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lu FM, 2003, CANCER RES, V63, P7056; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Palmqvist R, 1998, EUR J CANCER, V34, P1575, DOI 10.1016/S0959-8049(98)00162-2; Sameer AS, 2013, MOL MED REP, V7, P811, DOI 10.3892/mmr.2013.1287; Sergentanis TN, 2011, MOL BIOL REP, V38, P4955, DOI 10.1007/s11033-010-0639-4; Shih LC, 2012, ANTICANCER RES, V32, P1093; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Sui Jun, 2009, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V44, P227; Wang WJ, 2013, MOL BIOL REP, V40, P87, DOI 10.1007/s11033-012-2025-x; Wu YF, 2014, TUMOR BIOL, V35, P6913, DOI 10.1007/s13277-014-1929-6; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	30	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113299	10.1371/journal.pone.0113299	http://dx.doi.org/10.1371/journal.pone.0113299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409185	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200094
J	Zhi, XY; Han, YC; Mao, SC; Wang, GP; Feng, L; Yang, BF; Fan, ZY; Du, WL; Lu, JH; Li, YB				Zhi, Xiaoyu; Han, Yingchun; Mao, Shuchun; Wang, Guoping; Feng, Lu; Yang, Beifang; Fan, Zhengyi; Du, Wenli; Lu, Jianhua; Li, Yabing			Light Spatial Distribution in the Canopy and Crop Development in Cotton	PLOS ONE			English	Article							PHOTOSYNTHETICALLY ACTIVE RADIATION; LEAF-AREA INDEX; USE EFFICIENCY; BIOMASS ACCUMULATION; PLANT-DENSITY; INTERCEPTION; YIELD; MODELS; TRANSPIRATION; ARCHITECTURE	The partitioning of light is very difficult to assess, especially in discontinuous or irregular canopies. The aim of the present study was to analyze the spatial distribution of photosynthetically active radiation (PAR) in a heterogeneous cotton canopy based on a geo-statistical sampling method. Field experiments were conducted in 2011 and 2012 in Anyang, Henan, China. Field plots were arranged in a randomized block design with the main plot factor representing the plant density. There were 3 replications and 6 densities used in every replicate. The six plant density treatments were 15,000, 33,000, 51,000, 69,000, 87,000 and 105,000 plants ha(-1). The following results were observed: 1) transmission within the canopy decreased with increasing density and significantly decreased from the top to the bottom of the canopy, but the greatest decreases were observed in the middle layers of the canopy on the vertical axis and closing to the rows along the horizontal axis; 2) the transmitted PAR (TPAR) of 6 different cotton populations decreased slowly and then increased slightly as the leaves matured, the TPAR values were approximately 52.6-84.9% (2011) and 42.7-78.8% (2012) during the early cotton developmental stage, and were 33.9-60.0% (2011) and 34.5-61.8% (2012) during the flowering stage; 3) the Leaf area index (LAI) was highly significant exponentially correlated (R-2 = 0.90 in 2011, R-2 = 0.91 in 2012) with the intercepted PAR (IPAR) within the canopy; 4) and a highly significant linear correlation (R-2 = 0.92 in 2011, R-2 = 0.96 in 2012) was observed between the accumulated IPAR and the biomass. Our findings will aid researchers to improve radiation-use efficiency by optimizing the ideotype for cotton canopy architecture based on light spatial distribution characteristics.	[Zhi, Xiaoyu; Han, Yingchun; Mao, Shuchun; Wang, Guoping; Feng, Lu; Yang, Beifang; Fan, Zhengyi; Du, Wenli; Lu, Jianhua; Li, Yabing] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, YB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	criliyabing@163.com	Yabing, Li/GLU-9964-2022		National Natural Science Foundation of China [31371561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China(31371561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados I, 1996, AGR FOREST METEOROL, V78, P121, DOI 10.1016/0168-1923(95)02245-7; Alados I, 2000, AGR FOREST METEOROL, V102, P39, DOI 10.1016/S0168-1923(00)00091-5; Castillo-Santiago MA, 2013, ENERGY SUSTAIN DEV, V17, P177, DOI 10.1016/j.esd.2012.10.007; Arbia G, 2014, SPAT STAT-NETH, V7, P21, DOI 10.1016/j.spasta.2013.10.001; Baldissera TC, 2014, ANN BOT-LONDON, V113, P145, DOI 10.1093/aob/mct251; BALDOCCHI DD, 1985, J APPL ECOL, V22, P539, DOI 10.2307/2403184; Boote KJ, 1998, SYST APPR S, V7, P99; Campbell G, 1989, PLANT CANOPIES THEIR, P1, DOI DOI 10.1017/CBO9780511752308.002; CAMPBELL GS, 1986, AGR FOREST METEOROL, V36, P317, DOI 10.1016/0168-1923(86)90010-9; Campbell GS, 1991, AGR FOREST METEOROL, V36, P107; Campillo C, 2008, HORTSCIENCE, V43, P1780, DOI 10.21273/HORTSCI.43.6.1780; CAMPILLO C, 2012, SOLAR RAD; Ceotto E, 2013, FIELD CROP RES, V149, P159, DOI 10.1016/j.fcr.2013.05.002; Chen JM, 1996, IEEE T GEOSCI REMOTE, V34, P1353, DOI 10.1109/36.544559; CHRISTENSEN S, 1993, REMOTE SENS ENVIRON, V43, P87, DOI 10.1016/0034-4257(93)90066-7; COHEN S, 1987, AGR FOREST METEOROL, V40, P123, DOI 10.1016/0168-1923(87)90002-5; Cooper J. P., 1970, Herbage Abstracts, V40, P1; Delagrange S, 2011, ENVIRON EXP BOT, V70, P1, DOI 10.1016/j.envexpbot.2010.05.008; Fila G, 2011, AGR FOREST METEOROL, V151, P575, DOI 10.1016/j.agrformet.2011.01.004; Fortin MJ, 2012, SPAT STAT-NETH, V1, P100, DOI 10.1016/j.spasta.2012.02.004; Francescangeli N, 2006, SCI HORTIC-AMSTERDAM, V110, P135, DOI 10.1016/j.scienta.2006.06.025; FROUIN R, 1995, REMOTE SENS ENVIRON, V51, P98, DOI 10.1016/0034-4257(94)00068-X; Gonias ED, 2011, ENVIRON EXP BOT, V72, P217, DOI 10.1016/j.envexpbot.2011.03.008; Gonsamo A, 2008, FOREST ECOL MANAG, V256, P749, DOI 10.1016/j.foreco.2008.05.032; Griffith DA, 2012, SPAT STAT-NETH, V1, P3, DOI 10.1016/j.spasta.2012.03.005; HALL FG, 1990, REMOTE SENS ENVIRON, V32, P47, DOI 10.1016/0034-4257(90)90097-6; HATFIELD JL, 1978, AGRON J, V70, P592, DOI 10.2134/agronj1978.00021962007000040018x; Higashide T, 2009, AGR FOREST METEOROL, V149, P756, DOI 10.1016/j.agrformet.2008.10.017; HIPPS LE, 1983, AGR METEOROL, V28, P253, DOI 10.1016/0002-1571(83)90030-4; Jamieson PD, 1998, FIELD CROP RES, V55, P23, DOI 10.1016/S0378-4290(97)00060-9; Jones CA, 1986, CERES MAIZE SIMULATI, V04; Kilicman A, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/603463; Kiniry J, 2011, AGRON J, V103, P119, DOI 10.2134/agronj2010.0280; KINIRY JR, 1989, FIELD CROP RES, V20, P51, DOI 10.1016/0378-4290(89)90023-3; Leblanc SG, 2005, AGR FOREST METEOROL, V129, P187, DOI 10.1016/j.agrformet.2004.09.006; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Maddonni G, 2001, FIELD CROP RES, V70, P1, DOI 10.1016/S0378-4290(00)00144-1; Maddonni GA, 1996, FIELD CROP RES, V48, P81, DOI 10.1016/0378-4290(96)00035-4; Mao LL, 2014, FIELD CROP RES, V155, P67, DOI 10.1016/j.fcr.2013.09.021; McCree K. J., 1981, Encyclopedia of Plant Physiology. New Series. Volume 12A. Physiological plant ecology I. Responses to the physical environment. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P41; McCREE K. J., 1966, AGR METEOROL, V3, P353, DOI 10.1016/0002-1571(66)90017-3; Melo JD, 2014, ELECTR POW SYST RES, V111, P177, DOI 10.1016/j.epsr.2014.02.019; Monsi TM, 1953, JAP J BOT, V14, P22; MORRIS JT, 1989, AGR FOREST METEOROL, V46, P349, DOI 10.1016/0168-1923(89)90036-1; MUCHOW RC, 1994, AUST J AGR RES, V45, P37, DOI 10.1071/AR9940037; Naraghi M, 2010, ACTA HORTIC, V871, P385; O'Neal ME, 2002, J ECON ENTOMOL, V95, P1190, DOI 10.1603/0022-0493-95.6.1190; Purcell LC, 2002, CROP SCI, V42, P172, DOI 10.2135/cropsci2002.0172; Ratjen AM, 2013, FIELD CROP RES, V149, P338, DOI 10.1016/j.fcr.2013.05.015; Reta-Sanchez DG, 2002, AGRON J, V94, P1317, DOI 10.2134/agronj2002.1317; Ritchie J.R., 1985, US DEPART AGR, V38, P159, DOI DOI 10.1007/978-1-4899-3665-3_27; Robinson KM, 2004, BIOMASS BIOENERG, V26, P417, DOI 10.1016/j.biombioe.2003.08.012; ROSENTHAL WD, 1977, AGRON J, V69, P461, DOI 10.2134/agronj1977.00021962006900030032x; Ross J., 1981, The radiation regime and architecture of plant stands.; Russell G., 1989, Plant canopies: their growth, form and function., P21, DOI 10.1017/CBO9780511752308.003; SAKAMOTO CM, 1967, AGRON J, V59, P73, DOI 10.2134/agronj1967.00021962005900010022x; Sarlikioti V, 2011, ANN BOT-LONDON, V108, P1065, DOI 10.1093/aob/mcr221; SASSENRATHCOLE GF, 1995, AGR FOREST METEOROL, V77, P55, DOI 10.1016/0168-1923(95)02238-S; Singer JW, 2011, FIELD CROP RES, V121, P147, DOI 10.1016/j.fcr.2010.12.007; Song QF, 2013, FUNCT PLANT BIOL, V40, P109, DOI 10.1071/FP12056; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; STOCKLE CO, 1992, ECOL MODEL, V60, P31, DOI 10.1016/0304-3800(92)90011-3; Stockle CO, 2003, EUR J AGRON, V18, P289, DOI 10.1016/S1161-0301(02)00109-0; Tharakan PJ, 2008, BIOENERG RES, V1, P229, DOI 10.1007/s12155-008-9023-9; TOURNEBIZE R, 1995, AGR FOREST METEOROL, V72, P277, DOI 10.1016/0168-1923(94)02162-D; Van der Zande D, 2011, INT J APPL EARTH OBS, V13, P792, DOI 10.1016/j.jag.2011.05.005; Vargas LA, 2002, BIOMASS BIOENERG, V22, P1, DOI 10.1016/S0961-9534(01)00058-7; Westgate ME, 1997, FIELD CROP RES, V49, P249, DOI 10.1016/S0378-4290(96)01055-6; Yang YM, 2006, PROC SPIE, V6298, DOI 10.1117/12.678677; Yaseen M, 2013, IND CROP PROD, V43, P61, DOI 10.1016/j.indcrop.2012.06.032; Zhu K, 2013, CLEAN TECHNOL ENVIR, V15, P687, DOI 10.1007/s10098-012-0563-5; Zhu XiangCheng, 2012, Scientia Agricultura Sinica, V45, P34	72	16	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113409	10.1371/journal.pone.0113409	http://dx.doi.org/10.1371/journal.pone.0113409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409026	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200113
J	Bian, J; Xie, MJ; Hudson, TJ; Eswaran, H; Brochhausen, M; Hanna, J; Hogan, WR				Bian, Jiang; Xie, Mengjun; Hudson, Teresa J.; Eswaran, Hari; Brochhausen, Mathias; Hanna, Josh; Hogan, William R.			CollaborationViz: Interactive Visual Exploration of Biomedical Research Collaboration Networks	PLOS ONE			English	Article							VISUALIZATION	Social network analysis (SNA) helps us understand patterns of interaction between social entities. A number of SNA studies have shed light on the characteristics of research collaboration networks (RCNs). Especially, in the Clinical Translational Science Award (CTSA) community, SNA provides us a set of effective tools to quantitatively assess research collaborations and the impact of CTSA. However, descriptive network statistics are difficult for non-experts to understand. In this article, we present our experiences of building meaningful network visualizations to facilitate a series of visual analysis tasks. The basis of our design is multidimensional, visual aggregation of network dynamics. The resulting visualizations can help uncover hidden structures in the networks, elicit new observations of the network dynamics, compare different investigators and investigator groups, determine critical factors to the network evolution, and help direct further analyses. We applied our visualization techniques to explore the biomedical RCNs at the University of Arkansas for Medical Sciences - a CTSA institution. And, we created CollaborationViz, an open-source visual analytical tool to help network researchers and administration apprehend the network dynamics of research collaborations through interactive visualization.	[Bian, Jiang; Eswaran, Hari; Brochhausen, Mathias] Univ Arkansas Med Sci, Div Biomed Informat, Little Rock, AR 72205 USA; [Xie, Mengjun] Univ Arkansas, Dept Comp Sci, Little Rock, AR 72204 USA; [Hudson, Teresa J.] Univ Arkansas Med Sci, Dept Psychiat & Behav Sci, Little Rock, AR 72205 USA; [Eswaran, Hari] Univ Arkansas Med Sci, Dept Obstet & Gynecol Res, Little Rock, AR 72205 USA; [Hudson, Teresa J.] Cent Arkansas Vet Healthcare Syst, HSR&D Ctr Mental Healthcare & Outcomes Res, Dept Vet Affairs, Little Rock, AR USA; [Hanna, Josh] Univ Florida, Gainesville, FL 32610 USA; [Hogan, William R.] Univ Florida, Dept Hlth Outcomes & Policy, Gainesville, FL 32610 USA; [Hogan, William R.] Univ Florida, Clin & Translat Sci Inst, Gainesville, FL 32610 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bian, J (corresponding author), Univ Arkansas Med Sci, Div Biomed Informat, Little Rock, AR 72205 USA.	jbian@uams.edu		Hogan, William/0000-0002-9881-1017; Xie, Mengjun/0000-0001-5089-9614	National Center for Advancing Translational Sciences [UL1TR000039]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work described in this manuscript is supported by award UL1TR000039 through National Center for Advancing Translational Sciences (i.e., formerly UL1RR029884 through the NIH National Center for Research Resources). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsukhni M, 2012, 2012 IEEE 13TH INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION (IRI), P247, DOI 10.1109/IRI.2012.6303017; Alvarez-Hamelin JI, 2005, ARXIV PREPRINT CS050; Auber D, 2012, TULIP 3 FRAMEWORK SC; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Batagelj V, 2004, MATH VIS, P77; Bian J, 2013, BIOINF BIOM BIBM 201, P9, DOI [10.1109/BIBM.2013.6732728, DOI 10.1109/BIBM.2013.6732728]; Bian J, 2014, J BIOMED INFORM, V52, P130, DOI 10.1016/j.jbi.2014.01.015; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; CTSA Consortium: Evaluation Key Function Committee, 2011, EV SOC NETW AN; Dwork C., 2001, P 10 INT C WORLD WID, P613, DOI DOI 10.1145/371920.372165; Dwyer T, 2009, COMPUT GRAPH FORUM, V28, P991, DOI 10.1111/j.1467-8659.2009.01449.x; EMCA International, 2013, JSON DAT INT FORM; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Freeman L. C., 2000, J SOCIAL STRUCTURE, V1, P4; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Heer J, 2005, INFOVIS 05: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION, PROCEEDINGS, P33; Kobourov S. G., 2012, ARXIV12013011; Krzywinski M, 2012, BRIEF BIOINFORM, V13, P627, DOI 10.1093/bib/bbr069; Liang J, 2010, IEEE INT CONF INF VI, P79, DOI 10.1109/IV.2010.21; Nagarajan R, 2013, J BIOMED INFORM, V46, P40, DOI 10.1016/j.jbi.2012.08.002; Nagarajan Radhakrishnan, 2011, AMIA Annu Symp Proc, V2011, P987; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Pavlopoulos GA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-104; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen Z., 2006, AS PAC S INF VIS, V60, P93; Thomas JJ, 2006, IEEE COMPUT GRAPH, V26, P10, DOI 10.1109/MCG.2006.5; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; W3C SVG Working Group, 2011, SCAL VECT GRAPH SVG	36	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111928	10.1371/journal.pone.0111928	http://dx.doi.org/10.1371/journal.pone.0111928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405477	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300018
J	Hansen, MJ; Chan, SPJ; Langenbach, SY; Dousha, LF; Jones, JE; Yatmaz, S; Seow, HJ; Vlahos, R; Anderson, GP; Bozinovski, S				Hansen, Michelle J.; Chan, Sheau Pyng J.; Langenbach, Shenna Y.; Dousha, Lovisa F.; Jones, Jessica E.; Yatmaz, Selcuk; Seow, Huei Jiunn; Vlahos, Ross; Anderson, Gary P.; Bozinovski, Steven			IL-17A and Serum Amyloid A Are Elevated in a Cigarette Smoke Cessation Model Associated with the Persistence of Pigmented Macrophages, Neutrophils and Activated NK Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY INFLAMMATION; MOUSE MODEL; LUNG INFLAMMATION; EPITHELIAL-CELLS; TOBACCO-SMOKE; COPD; MICE; EXPOSURE; EXPRESSION	While global success in cessation advocacy has seen smoking rates fall in many developed countries, persistent lung inflammation in ex-smokers is an increasingly important clinical problem whose mechanistic basis remains poorly understood. In this study, candidate effector mechanisms were assessed in mice exposed to cigarette smoke (CS) for 4 months following cessation from long term CS exposure. BALF neutrophils, CD4(+) and CD8(+) T cells and lung innate NK cells remained significantly elevated following smoking cessation. Analysis of neutrophil mobilization markers showed a transition from acute mediators (MIP-2 alpha, KC and G-CSF) to sustained drivers of neutrophil and macrophage recruitment and activation (IL-17A and Serum Amyoid A (SAA)). Follicle-like lymphoid aggregates formed with CS exposure and persisted with cessation, where they were in close anatomical proximity to pigmented macrophages, whose number actually increased 3-fold following CS cessation. This was associated with the elastolytic protease, MMP-12 (macrophage metalloelastase) which remained significantly elevated post-cessation. Both GM-CSF and CSF-1 were significantly increased in the CS cessation group relative to the control group. In conclusion, we show that smoking cessation mediates a transition to accumulation of pigmented macrophages, which may contribute to the expanded macrophage population observed in COPD. These macrophages together with IL-17A, SAA and innate NK cells are identified here as candidate persistence determinants and, we suggest, may represent specific targets for therapies directed towards the amelioration of chronic airway inflammation.	[Hansen, Michelle J.; Chan, Sheau Pyng J.; Langenbach, Shenna Y.; Dousha, Lovisa F.; Jones, Jessica E.; Yatmaz, Selcuk; Seow, Huei Jiunn; Vlahos, Ross; Anderson, Gary P.; Bozinovski, Steven] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Melbourne, Vic 3010, Australia	University of Melbourne	Hansen, MJ (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Melbourne, Vic 3010, Australia.	mjhansen@unimelb.edu.au	Vlahos, Ross/AAM-3837-2020	Vlahos, Ross/0000-0001-8443-7071; Anderson, Gary/0000-0001-6580-3398; Bozinovski, Steven/0000-0001-6533-8641; Hansen, Michelle/0000-0002-2607-461X; Seow, Huei/0000-0002-4790-4811	NHMRC (National Health and Medical Research Council) Australia [628492]	NHMRC (National Health and Medical Research Council) Australia	This work was supported by NHMRC (National Health and Medical Research Council) Australia (www.NHMRC.gov.au), project grant number 628492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Bozinovski S, 2011, AM J RESP CELL MOL, V45, P229, DOI 10.1165/rcmb.2010-0272OC; Braber S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-99; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Chang Y, 2014, AM J PHYSIOL-LUNG C, V306, pL132, DOI 10.1152/ajplung.00111.2013; Chen H, 2005, NEUROPSYCHOPHARMACOL, V30, P713, DOI 10.1038/sj.npp.1300597; Chen H, 2007, PEPTIDES, V28, P384, DOI 10.1016/j.peptides.2006.07.034; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; D'hulst AI, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-147; DAMIANO VV, 1986, J CLIN INVEST, V78, P482, DOI 10.1172/JCI112600; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Duan M-C, 2013, CLIN DEV IMMUNOL, V2013, P11; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Halappanavar S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-56; Hansen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080471; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Levy BD, 2012, CLIN CHEST MED, V33, P559, DOI 10.1016/j.ccm.2012.06.006; Morissette MC, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-49; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Rutgers SR, 2000, CHEST, V117, p262S, DOI 10.1378/chest.117.5_suppl_1.262S; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shao MXG, 2005, J IMMUNOL, V175, P4009, DOI 10.4049/jimmunol.175.6.4009; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shen N, 2011, INHAL TOXICOL, V23, P212, DOI 10.3109/08958378.2011.559603; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Stevenson CS, 2005, AM J PHYSIOL-LUNG C, V288, pL514, DOI 10.1152/ajplung.00317.2004; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Willemse BWM, 2005, EUR RESPIR J, V26, P835, DOI 10.1183/09031936.05.00108904; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC	44	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113180	10.1371/journal.pone.0113180	http://dx.doi.org/10.1371/journal.pone.0113180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405776	Green Published, gold			2022-12-27	WOS:000347121300090
J	Tanigawa, N; Fujita, T; Fujii, H				Tanigawa, Naoki; Fujita, Toshitsugu; Fujii, Hodaka			Oligoribonucleotide (ORN) Interference-PCR (ORNi-PCR): A Simple Method for Suppressing PCR Amplification of Specific DNA Sequences Using ORNs	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PYROCOCCUS-FURIOSUS; DEGENERATE PRIMERS; OLIGONUCLEOTIDES; IDENTIFICATION; SYSTEM	Polymerase chain reaction (PCR) amplification of multiple templates using common primers is used in a wide variety of molecular biological techniques. However, abundant templates sometimes obscure the amplification of minor species containing the same primer sequences. To overcome this challenge, we used oligoribonucleotides (ORNs) to inhibit amplification of undesired template sequences without affecting amplification of control sequences lacking complementarity to the ORNs. ORNs were effective at very low concentrations, with IC50 values for ORN-mediated suppression on the order of 10 nM. DNA polymerases that retain 3'-5' exonuclease activity, such as KOD and Pfu polymerases, but not those that retain 5'-3' exonuclease activity, such as Taq polymerase, could be used for ORN-mediated suppression. ORN interference-PCR (ORNi-PCR) technology should be a useful tool for both molecular biology research and clinical diagnosis.	[Tanigawa, Naoki; Fujita, Toshitsugu; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Chromatin Biochem Res Grp, Suita, Osaka 565, Japan	Osaka University	Fujii, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Chromatin Biochem Res Grp, Suita, Osaka 565, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/A-2420-2008; Tanigawa, Naoki/HCI-8558-2022; Fujii, Hodaka/N-9792-2019; Fujita, Toshitsugu/AAB-4964-2022; FUJITA, Toshitsugu/ABH-5101-2020	Fujii, Hodaka/0000-0003-1296-4256; Fujii, Hodaka/0000-0003-1296-4256; FUJITA, Toshitsugu/0000-0002-9536-9999	Research Institute for Microbial Diseases, Osaka University	Research Institute for Microbial Diseases, Osaka University	This study was supported by Research Institute for Microbial Diseases, Osaka University (TF, HF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; Carlson CM, 2003, GENETICS, V165, P243; Dominguez PL, 2005, ONCOGENE, V24, P6830, DOI 10.1038/sj.onc.1208832; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; Kornberg A., 1992, DNA REPLICATION; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; MACK DH, 1988, P NATL ACAD SCI USA, V85, P6977, DOI 10.1073/pnas.85.18.6977; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PYTELA R, 1994, METHOD ENZYMOL, V245, P420; SEYAMA T, 1992, NUCLEIC ACIDS RES, V20, P2493, DOI 10.1093/nar/20.10.2493; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; UEMORI T, 1993, NUCLEIC ACIDS RES, V21, P259, DOI 10.1093/nar/21.2.259; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Yu D, 1997, BIOTECHNIQUES, V23, P714, DOI 10.2144/97234st06; Yuen PST, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e31	16	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113345	10.1371/journal.pone.0113345	http://dx.doi.org/10.1371/journal.pone.0113345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405983	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300106
J	Thurman, SM; Lu, HJ				Thurman, Steven M.; Lu, Hongjing			Perception of Social Interactions for Spatially Scrambled Biological Motion	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ANIMACY; MODEL	It is vitally important for humans to detect living creatures in the environment and to analyze their behavior to facilitate action understanding and high-level social inference. The current study employed naturalistic point-light animations to examine the ability of human observers to spontaneously identify and discriminate socially interactive behaviors between two human agents. Specifically, we investigated the importance of global body form, intrinsic joint movements, extrinsic whole-body movements, and critically, the congruency between intrinsic and extrinsic motions. Motion congruency is hypothesized to be particularly important because of the constraint it imposes on naturalistic action due to the inherent causal relationship between limb movements and whole body motion. Using a free response paradigm in Experiment 1, we discovered that many naive observers (55%) spontaneously attributed animate and/or social traits to spatially-scrambled displays of interpersonal interaction. Total stimulus motion energy was strongly correlated with the likelihood that an observer would attribute animate/social traits, as opposed to physical/mechanical traits, to the scrambled dot stimuli. In Experiment 2, we found that participants could identify interactions between spatially-scrambled displays of human dance as long as congruency was maintained between intrinsic/extrinsic movements. Violating the motion congruency constraint resulted in chance discrimination performance for the spatially-scrambled displays. Finally, Experiment 3 showed that scrambled point-light dancing animations violating this constraint were also rated as significantly less interactive than animations with congruent intrinsic/extrinsic motion. These results demonstrate the importance of intrinsic/extrinsic motion congruency for biological motion analysis, and support a theoretical framework in which early visual filters help to detect animate agents in the environment based on several fundamental constraints. Only after satisfying these basic constraints could stimuli be evaluated for high-level social content. In this way, we posit that perceptual animacy may serve as a gateway to higher-level processes that support action understanding and social inference.	[Thurman, Steven M.; Lu, Hongjing] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Lu, Hongjing] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Thurman, SM (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	sthurman@ucla.edu		Thurman, Steven/0000-0003-3962-8447	National Science Foundation [EIA-0196217]; National Science Foundation (NSF) [BCS-1353391]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation (NSF)(National Science Foundation (NSF))	The motion capture data used in this project was obtained from mocap.cs.cmu.edu. The database was created with funding from National Science Foundation EIA-0196217. This research project was supported by a grant from the National Science Foundation (NSF BCS-1353391) awarded to HL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Bardi L, 2011, DEVELOPMENTAL SCI, V14, P353, DOI 10.1111/j.1467-7687.2010.00985.x; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Bidet-Ildei C, 2013, DEV PSYCHOL; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chang DHF, 2009, J VIS, V9; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Chang DHF, 2009, J VISION, V9, DOI [10.1167/9.1.19, 10.1167/9.5.8]; de la Rosa S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00752; Gao T, 2010, PSYCHOL SCI, V21, P1845, DOI 10.1177/0956797610388814; Gao T, 2009, COGNITIVE PSYCHOL, V59, P154, DOI 10.1016/j.cogpsych.2009.03.001; Hirai M, 2011, PSYCHOL SCI, V22, P1543, DOI 10.1177/0956797611417257; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jung EL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00795; Lu HJ, 2010, J VISION, V10, DOI 10.1167/10.12.13; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; McAleer P, 2008, BEHAV RES METHODS, V40, P830, DOI 10.3758/BRM.40.3.830; McAleer P, 2011, J AUTISM DEV DISORD, V41, P1053, DOI 10.1007/s10803-010-1130-8; Miller LE, 2013, COGNITION, V128, P140, DOI 10.1016/j.cognition.2013.03.013; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Neri P, 2009, P ROY SOC B-BIOL SCI, V276, P861, DOI 10.1098/rspb.2008.1363; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrini K, 2014, HUM BRAIN MAPP; Reid VM, 2007, EUR J DEV PSYCHOL, V4, P100, DOI 10.1080/17405620601005648; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schultz J, 2013, J VISION, V13, DOI 10.1167/13.4.15; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Simion F, 2011, PROG BRAIN RES, V189, P173, DOI 10.1016/B978-0-444-53884-0.00024-5; Tadin D, 2002, NAT NEUROSCI, V5, P1010, DOI 10.1038/nn914; Thurman SM, 2013, PSYCHOL SCI, V24, P1133, DOI 10.1177/0956797612467212; Thurman SM, 2010, J VISION, V10, DOI 10.1167/10.12.15; Thurman SM, 2008, J VISION, V8, DOI 10.1167/8.3.28; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; Vallortigara G, 2006, CURR BIOL, V16, pR279, DOI 10.1016/j.cub.2006.03.052; van Boxtel JJA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00209; Van Boxtel JJA, 2013, J VIS, V13	40	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112539	10.1371/journal.pone.0112539	http://dx.doi.org/10.1371/journal.pone.0112539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25406075	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300037
J	Torre, I; Gonzalez-Tendero, A; Garcia-Canadilla, P; Crispi, F; Garcia-Garcia, F; Bijnens, B; Iruretagoyena, I; Dopazo, J; Amat-Roldan, I; Gratacos, E				Torre, Iratxe; Gonzalez-Tendero, Anna; Garcia-Canadilla, Patricia; Crispi, Fatima; Garcia-Garcia, Francisco; Bijnens, Bart; Iruretagoyena, Igor; Dopazo, Joaquin; Amat-Roldan, Ivan; Gratacos, Eduard			Permanent Cardiac Sarcomere Changes in a Rabbit Model of Intrauterine Growth Restriction	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; TARGETED DELETION; M-BAND; TITIN; EXPRESSION; GENERATION; LENGTH; LEADS; TRANSCRIPTOMICS; CONTRACTION	Background: Intrauterine growth restriction (IUGR) induces fetal cardiac remodelling and dysfunction, which persists postnatally and may explain the link between low birth weight and increased cardiovascular mortality in adulthood. However, the cellular and molecular bases for these changes are still not well understood. We tested the hypothesis that IUGR is associated with structural and functional gene expression changes in the fetal sarcomere cytoarchitecture, which remain present in adulthood. Methods and Results: IUGR was induced in New Zealand pregnant rabbits by selective ligation of the utero-placental vessels. Fetal echocardiography demonstrated more globular hearts and signs of cardiac dysfunction in IUGR. Second harmonic generation microscopy (SHGM) showed shorter sarcomere length and shorter A-band and thick-thin filament interaction lengths, that were already present in utero and persisted at 70 postnatal days (adulthood). Sarcomeric M-band (GO: 0031430) functional term was over-represented in IUGR fetal hearts. Conclusion: The results suggest that IUGR induces cardiac dysfunction and permanent changes on the sarcomere.	[Torre, Iratxe; Gonzalez-Tendero, Anna; Garcia-Canadilla, Patricia; Crispi, Fatima; Iruretagoyena, Igor; Amat-Roldan, Ivan; Gratacos, Eduard] Univ Barcelona, IDIBAPS, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Torre, Iratxe; Gonzalez-Tendero, Anna; Garcia-Canadilla, Patricia; Crispi, Fatima; Iruretagoyena, Igor; Amat-Roldan, Ivan; Gratacos, Eduard] Univ Barcelona, IDIBAPS, Hosp St Joan de Deu, Barcelona, Spain; [Torre, Iratxe; Gonzalez-Tendero, Anna; Garcia-Canadilla, Patricia; Crispi, Fatima; Iruretagoyena, Igor; Amat-Roldan, Ivan; Gratacos, Eduard] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain; [Garcia-Canadilla, Patricia] Univ Pompeu Fabra, DTIC, Physense, Barcelona, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] CIPF, Bioinformat Dept, Valencia, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] CIPF, INB, Funct Genom Node, Valencia, Spain; [Dopazo, Joaquin] CIPF, CIBERER, Valencia, Spain; [Bijnens, Bart] Univ Pompeu Fabra, ICREA, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Pompeu Fabra University; Prince Felipe Research Center; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center; ICREA; Pompeu Fabra University	Gratacos, E (corresponding author), Univ Barcelona, IDIBAPS, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain.	gratacos@clinic.ub.es	García-García, Francisco/N-2263-2019; Dopazo, Joaquin/A-9270-2014; Bijnens, Bart/AAE-7186-2021; Garcia-Canadilla, Patricia/D-8085-2014; Bijnens, Bart H/C-2955-2008; García-García, Francisco/B-1929-2014; Gratacos, Eduard/AAR-4939-2020	García-García, Francisco/0000-0001-8354-5636; Dopazo, Joaquin/0000-0003-3318-120X; Bijnens, Bart/0000-0003-3130-6937; Garcia-Canadilla, Patricia/0000-0002-0223-1617; Bijnens, Bart H/0000-0003-3130-6937; García-García, Francisco/0000-0001-8354-5636; Gratacos, Eduard/0000-0002-7405-7224; Crispi, Fatima/0000-0002-7422-5240	Ministerio de Economia y Competitividad PN de I+D+I [SAF2009_08815, SAF2012-37196, BIO2011-27069]; Instituto de Salud Carlos III [PI11/00051, PI11/01709, PI12/00801]; Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa''; Centro para el Desarrollo Tecnico Industrial [cvREMOD 2009-2012]; Ministerio de Economia y Competitividad y Fondo de inversion local para el empleo, Spain; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "La Caixa'' (Spain); Fundacio Mutua Madrilena (Spain); Fundacio Agrupacio Mutua (Spain); AGAUR SGR [1099]; Red Tematica de Investigacion Cooperativa en cancer [RD06/0020/1019]; Carlos III Institute of Health, Spain [CD08/00176]; Programa de Ayudas Predoctorales de Formacion en Investigacion en Salud del Instituto Carlos III, Spain [FI12/00362]; IDIBAPS (Institut d'Investigacions Biomediques August Pi i Sunyer); ICREA Funding Source: Custom	Ministerio de Economia y Competitividad PN de I+D+I; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa''; Centro para el Desarrollo Tecnico Industrial; Ministerio de Economia y Competitividad y Fondo de inversion local para el empleo, Spain; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "La Caixa'' (Spain)(La Caixa Foundation); Fundacio Mutua Madrilena (Spain); Fundacio Agrupacio Mutua (Spain); AGAUR SGR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Red Tematica de Investigacion Cooperativa en cancer; Carlos III Institute of Health, Spain(Instituto de Salud Carlos III); Programa de Ayudas Predoctorales de Formacion en Investigacion en Salud del Instituto Carlos III, Spain; IDIBAPS (Institut d'Investigacions Biomediques August Pi i Sunyer); ICREA(ICREA)	This study was supported by grants from Ministerio de Economia y Competitividad PN de I+D+I 2008-2011 (ref. SAF2009_08815, SAF2012-37196, and BIO2011-27069); Instituto de Salud Carlos III (ref. PI11/00051, PI11/01709, PI12/00801) cofinanciado por el Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa''; Centro para el Desarrollo Tecnico Industrial (ref. cvREMOD 2009-2012) apoyado por el Ministerio de Economia y Competitividad y Fondo de inversion local para el empleo, Spain; The Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "La Caixa'' (Spain); Fundacio Mutua Madrilena (Spain); Fundacio Agrupacio Mutua (Spain); AGAUR 2009 SGR grant no 1099; and Red Tematica de Investigacion Cooperativa en cancer (ref. RD06/0020/1019). I. T. was supported by a post-doctoral fellowship from Carlos III Institute of Health, Spain (CD08/00176) during the time these studies were performed. P. G. C. acknowledges grant support to the Programa de Ayudas Predoctorales de Formacion en Investigacion en Salud del Instituto Carlos III, Spain (FI12/00362). A. G. T. was supported by an IDIBAPS (Institut d'Investigacions Biomediques August Pi i Sunyer) pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Alberry M, 2007, ARCH DIS CHILD-FETAL, V92, pF62, DOI 10.1136/adc.2005.082297; ANDERSON PG, 1987, AM J PATHOL, V129, P152; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulesteix T, 2004, OPT LETT, V29, P2031, DOI 10.1364/OL.29.002031; Chaturvedi RR, 2010, CIRCULATION, V121, P979, DOI 10.1161/CIRCULATIONAHA.109.850677; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Comas M, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.044; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Falcao-Pires I, 2011, BASIC RES CARDIOL, V106, P801, DOI 10.1007/s00395-011-0184-x; Fouron JC, 1999, AM J OBSTET GYNECOL, V181, P1102, DOI 10.1016/S0002-9378(99)70089-X; Fukuda N, 2001, CIRCULATION, V104, P1639, DOI 10.1161/hc3901.095898; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Garcia-Canadilla P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.056010; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gonzalez-Tendero A, 2013, AM J PHYSIOL-HEART C, V305, pH1752, DOI 10.1152/ajpheart.00514.2013; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HADDAD F, 1995, J APPL PHYSIOL, V78, P1489, DOI 10.1152/jappl.1995.78.4.1489; HECHER K, 1995, CIRCULATION, V91, P129, DOI 10.1161/01.CIR.91.1.129; Iruretagoyena JI, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.023; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Labeit S, 1997, CIRC RES, V80, P290, DOI 10.1161/01.RES.80.2.290; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NASSAR R, 1987, CIRC RES, V61, P465, DOI 10.1161/01.RES.61.3.465; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Rodriguez AG, 2011, BIOPHYS J, V101, P2455, DOI 10.1016/j.bpj.2011.09.057; Schoenauer R, 2011, BASIC RES CARDIOL, V106, P233, DOI 10.1007/s00395-010-0131-2; Schwarzer M, 2013, AM J PHYSIOL-HEART C, V304, pH529, DOI 10.1152/ajpheart.00699.2012; Sela G, 2010, ANN NY ACAD SCI, V1188, P222, DOI 10.1111/j.1749-6632.2009.05104.x; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOOTHILL PW, 1987, BRIT MED J, V294, P1051, DOI 10.1136/bmj.294.6579.1051; Tchirikov M, 2006, ULTRASOUND OBST GYN, V27, P452, DOI 10.1002/uog.2747; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Verburg BO, 2008, CIRCULATION, V117, P649, DOI 10.1161/CIRCULATIONAHA.107.709717; Wannenburg T, 2000, AM J PHYSIOL-HEART C, V279, pH779, DOI 10.1152/ajpheart.2000.279.2.H779; Warren CM, 2003, CARDIOVASC RES, V59, P86, DOI 10.1016/S0008-6363(03)00328-6; Wu Y, 2009, J MAGN RESON IMAGING, V30, P47, DOI 10.1002/jmri.21814	49	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113067	10.1371/journal.pone.0113067	http://dx.doi.org/10.1371/journal.pone.0113067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402351	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700105
J	Zhao, JJ; Gao, S; Jing, JZ; Zhu, MY; Zhou, C; Chai, Z				Zhao, Juan-Juan; Gao, Shan; Jing, Jun-Zhan; Zhu, Ming-Yue; Zhou, Chen; Chai, Zhen			Increased Na+/Ca2+ Exchanger Activity Promotes Resistance to Excitotoxicity in Cortical Neurons of the Ground Squirrel (a Hibernator)	PLOS ONE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; NMDA RECEPTOR ACTIVATION; OPERATED CA2+ ENTRY; METHYL-D-ASPARTATE; HIPPOCAMPAL-NEURONS; GLUTAMATE EXCITOTOXICITY; CALCIUM NEUROTOXICITY; INTRACELLULAR CA2+; NADPH OXIDASE; CELL-DEATH	Ground squirrel, a hibernating mammalian species, is more resistant to ischemic brain stress than rat. Gaining insight into the adaptive mechanisms of ground squirrels may help us design treatment strategies to reduce brain damage in patients suffering ischemic stroke. To understand the anti-stress mechanisms in ground squirrel neurons, we studied glutamate toxicity in primary cultured neurons of the Daurian ground squirrel (Spermophilus dauricus). At the neuronal level, for the first time, we found that ground squirrel was more resistant to glutamate excitotoxicity than rat. Mechanistically, ground squirrel neurons displayed a similar calcium influx to the rat neurons in response to glutamate or N-methyl-D-aspartate (NMDA) perfusion. However, the rate of calcium removal in ground squirrel neurons was markedly faster than in rat neurons. This allows ground squirrel neurons to maintain lower level of intracellular calcium concentration ([Ca2+](i)) upon glutamate insult. Moreover, we found that Na+/Ca2+ exchanger (NCX) activity was higher in ground squirrel neurons than in rat neurons. We also proved that overexpression of ground squirrel NCX2, rather than NCX1 or NCX3, in rat neurons promoted neuron survival against glutamate toxicity. Taken together, our results indicate that ground squirrel neurons are better at maintaining calcium homeostasis than rat neurons and this is likely achieved through the activity of ground squirrel NCX2. Our findings not only reveal an adaptive mechanism of mammalian hibernators at the cellular level, but also suggest that NCX2 of ground squirrel may have therapeutic value for suppressing brain ischemic damage.	[Zhao, Juan-Juan; Gao, Shan; Jing, Jun-Zhan; Zhu, Ming-Yue; Zhou, Chen; Chai, Zhen] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China	Peking University	Chai, Z (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	zhenchai@pku.edu.cn	Jing, Junzhan/AAE-1888-2020	Jing, Junzhan/0000-0003-4647-0932	National Basic Research Program (973 Program) of China [2012CB518200, 2006CB504100]; National Natural Science Foundation of China [30730013]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by National Basic Research Program (973 Program) of China [Grant number: 2012CB518200, 2006CB504100], URL:http://www.973.gov.cn/English/Index.aspx; National Natural Science Foundation of China [Grant number: 30730013] URL: http://www.nsfc.gov.cn/. ZC received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Bano D, 2007, ANN NY ACAD SCI, V1099, P451, DOI 10.1196/annals.1387.006; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Christian SL, 2008, J CEREBR BLOOD F MET, V28, P1307, DOI 10.1038/jcbfm.2008.20; Cross HR, 1998, CIRC RES, V83, P1215, DOI 10.1161/01.RES.83.12.1215; Czyz A, 2002, J NEUROCHEM, V83, P1321, DOI 10.1046/j.1471-4159.2002.01227.x; Dave KR, 2006, STROKE, V37, P1261, DOI 10.1161/01.STR.0000217409.60731.38; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; ESCOBAR AL, 1994, NATURE, V367, P739, DOI 10.1038/367739a0; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Furuichi T, 2005, J NEUROSCI RES, V79, P816, DOI 10.1002/jnr.20402; Gemes G, 2011, J NEUROSCI, V31, P3536, DOI 10.1523/JNEUROSCI.5053-10.2011; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Iijima T, 2006, NEUROSCI RES, V55, P234, DOI 10.1016/j.neures.2006.04.005; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Li LL, 2013, J NEUROSCI, V33, P8185, DOI 10.1523/JNEUROSCI.4578-12.2013; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Luo J, 2007, ANN NY ACAD SCI, V1099, P292, DOI 10.1196/annals.1387.016; Ma YL, 2005, AM J PHYSIOL-REG I, V289, pR1297, DOI 10.1152/ajpregu.00260.2005; Majewska A, 2000, J NEUROSCI, V20, P1722; MANEV H, 1989, MOL PHARMACOL, V36, P106; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Mielke JG, 2013, NEUROSCI LETT, V553, P13, DOI 10.1016/j.neulet.2013.07.050; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Ross AP, 2006, J CEREBR BLOOD F MET, V26, P1148, DOI 10.1038/sj.jcbfm.9600271; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sattler R, 1998, J NEUROCHEM, V71, P2349; Secondo A, 2009, J PHARMACOL EXP THER, V331, P212, DOI 10.1124/jpet.109.152132; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIPIDO KR, 1995, CARDIOVASC RES, V29, P717, DOI 10.1016/S0008-6363(96)88645-7; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Ward MW, 2000, J NEUROSCI, V20, P7208; Yu SP, 1997, EUR J NEUROSCI, V9, P1273, DOI 10.1111/j.1460-9568.1997.tb01482.x; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhao HWW, 2006, J NEUROSCI RES, V84, P291, DOI 10.1002/jnr.20893; Zhou C, 2006, NEUROSCI LETT, V403, P181, DOI 10.1016/j.neulet.2006.04.043	52	4	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113594	10.1371/journal.pone.0113594	http://dx.doi.org/10.1371/journal.pone.0113594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415196	Green Submitted, gold, Green Published			2022-12-27	WOS:000346906600062
J	Garcia-Contreras, M; Vera-Donoso, CD; Hernandez-Andreu, JM; Garcia-Verdugo, JM; Oltra, E				Garcia-Contreras, Marta; David Vera-Donoso, Cesar; Miguel Hernandez-Andreu, Jose; Manuel Garcia-Verdugo, Jose; Oltra, Elisa			Therapeutic Potential of Human Adipose-Derived Stem Cells (ADSCs) from Cancer Patients: A Pilot Study	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; DONOR AGE; REPLICATIVE SENESCENCE; TEMPORAL-CHANGES; IN-VIVO; EXOSOMES; TISSUE; CULTURE; SERUM	Mesenchymal stem cells from adipose tissue (ADSCs) are an important source of cells for regenerative medicine. The therapeutic effect of culture-expanded adipose derived stem cells has been shown; however, optimal xeno-free culture conditions remain to be determined. Cancer patients, specifically those undergoing invasive surgery, constitute a subgroup of patients who could benefit from autologous stem cell transplantation. Although regenerative potential of their ADSCs could be affected by the disease and/or treatment, we are not aware of any study that has evaluated the therapeutic potential of ADSCs isolated from cancer patients in reference to that of ADSCs derived from healthy subjects. Here we report that ADSCs isolated from subabdominal adipose tissue of patients with urological neoplasms yielded similar growth kinetics, presented equivalent mesenchymal surface markers and showed similar differentiation potential into distinct mesodermal cell lineages: adipocytes, chondroblasts and osteoblasts than ADSCs isolated from adipose tissue of age-matched non-oncogenic participants, all under xeno-free growth culture conditions. Molecular karyotyping of patient expanded ADSCs genomes showed no disease-related alterations indicating their safety. In addition, vesicles <100 nm identified as exosomes (EXOs) which may be at least partly responsible for the attributed therapeutic paracrine effects of the ADSCs were effectively isolated from ADSCs and showed equivalent miRNA content regardless they were derived from cancer patients or non-oncogenic participants indicating that the repair capabilities of xeno-free expanded ADSCs are not compromised by patient condition and therefore their xeno-free culture expanded ADSCs should be suitable for autologous stem cell transplantation in a clinical setting.	[Garcia-Contreras, Marta; Miguel Hernandez-Andreu, Jose; Oltra, Elisa] Univ Catolica Valencia San Vicente Martir, Fac Med, Valencia, Spain; [David Vera-Donoso, Cesar] Hosp Univ Politecn La Fe, Serv Urol, Valencia, Spain; [Manuel Garcia-Verdugo, Jose] Univ Valencia, CIBERNED, Inst Cavanilles Biodiversidad & Biol Evolut, Lab Comparat Neurobiol, Valencia, Spain	Universidad Catolica de Valencia San Vicente Martir; Hospital Universitari i Politecnic La Fe; CIBERNED; University of Valencia	Oltra, E (corresponding author), Univ Catolica Valencia San Vicente Martir, Fac Med, Valencia, Spain.	elisa.oltra@ucv.es	HERNÁNDEZ-ANDREU, JOSÉ MIGUEL M/H-9092-2015; García-Verdugo, José Manuel/L-8421-2017; Garcia-Contreras, Marta/AAY-2764-2021; Oltra, Elisa/I-3642-2015	HERNÁNDEZ-ANDREU, JOSÉ MIGUEL M/0000-0002-2459-9754; García-Verdugo, José Manuel/0000-0001-9872-6499; Garcia-Contreras, Marta/0000-0001-8014-7966; Oltra, Elisa/0000-0003-0598-2907; Vera-Donoso, Cesar David/0000-0002-4663-9358	Generalitat Valenciana [AP-014-10, AP-222-11]; Universidad Catolica de Valencia "San Vicente Martir" [2012-006-010, 2011-011-02, 2011-011-04, 2012-011-008]; AITEX Institute of Technology [2011-011-015]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universidad Catolica de Valencia "San Vicente Martir"; AITEX Institute of Technology	This work was supported by Generalitat Valenciana (grants AP-014-10 and AP-222-11 to JMHA), Universidad Catolica de Valencia "San Vicente Martir" (grant 2012-006-010 to JMHA) (grants 2011-011-02, 2011-011-04 and 2012-011-008 to EO), and the AITEX Institute of Technology (grant 2011-011-015 to EO). MGC received a fellowship from the Universidad Catolica de Valencia "San Vicente Martir". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Chang CL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-244; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Cho YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032778; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Crop MJ, 2010, STEM CELLS DEV, V19, P1843, DOI 10.1089/scd.2009.0368; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Estrada JC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.211; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Gimble JM, 2012, REGEN MED, V7, P225, DOI [10.2217/RME.11.119, 10.2217/rme.11.119]; He ZH, 2012, J RADIAT RES, V53, P225, DOI 10.1269/jrr.11114; Ikebe C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/951512; Jayme DW, 2000, CYTOTECHNOLOGY, V33, P27, DOI 10.1023/A:1008133717035; Julavijitphong S, 2014, CYTOTHERAPY, V16, P683, DOI 10.1016/j.jcyt.2013.07.012; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Lai Ruenn Chai, 2012, Int J Proteomics, V2012, P971907, DOI 10.1155/2012/971907; Lai RC, 2013, REGEN MED, V8, P197, DOI [10.2217/rme.13.4, 10.2217/RME.13.4]; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Lazebnik L B, 2009, Eksp Klin Gastroenterol, P4; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Lin CS, 2012, CYTOTHERAPY, V14, P1159, DOI 10.3109/14653249.2012.729817; Lin YF, 2006, MOL CELL BIOCHEM, V291, P1, DOI 10.1007/s11010-006-9188-5; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; Mazzanti B, 2008, J NEUROIMMUNOL, V199, P142, DOI 10.1016/j.jneuroim.2008.05.006; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Ohshima M, 2012, J MOL CELL CARDIOL, V53, P420, DOI 10.1016/j.yjmcc.2012.06.020; Phadwal K, 2013, CELL MOL LIFE SCI, V70, P89, DOI 10.1007/s00018-012-1032-3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rajala K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010246; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ripoll CB, 2011, STEM CELLS, V29, P67, DOI 10.1002/stem.555; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shin S, 2013, INT J MED SCI, V10, P8, DOI 10.7150/ijms.5385; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Suga H, 2009, STEM CELLS DEV, V18, P1201, DOI 10.1089/scd.2009.0003; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Venkataramana NK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/931902; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang P, 2014, CELL TRANSPLANT, V23, P1293, DOI 10.3727/096368913X667727; Wessman S J, 1999, Dev Biol Stand, V99, P3; Xing YJ, 2012, MOL CELL BIOCHEM, V360, P279, DOI 10.1007/s11010-011-1067-z; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	68	41	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113288	10.1371/journal.pone.0113288	http://dx.doi.org/10.1371/journal.pone.0113288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412325	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000034
J	Naser, WM; Shawarby, MA; Al-Tamimi, DM; Seth, A; Al-Quorain, A; Al Nemer, AM; Albagha, OME				Naser, Walid M.; Shawarby, Mohamed A.; Al-Tamimi, Dalal M.; Seth, Arun; Al-Quorain, Abdulaziz; Al Nemer, Areej M.; Albagha, Omar M. E.			Novel KRAS Gene Mutations in Sporadic Colorectal Cancer	PLOS ONE			English	Article							K-RAS MUTATIONS; ONCOGENE MUTATIONS; POINT MUTATIONS; POPULATION; SURVIVAL; STAGE; CETUXIMAB; IMPACT; CARCINOGENESIS; PREVALENCE	Introduction: In this article, we report 7 novel KRAS gene mutations discovered while retrospectively studying the prevalence and pattern of KRAS mutations in cancerous tissue obtained from 56 Saudi sporadic colorectal cancer patients from the Eastern Province. Methods: Genomic DNA was extracted from formalin-fixed, paraffin-embedded cancerous and noncancerous colorectal tissues. Successful and specific PCR products were then bi-directionally sequenced to detect exon 4 mutations while Mutector II Detection Kits were used for identifying mutations in codons 12, 13 and 61. The functional impact of the novel mutations was assessed using bioinformatics tools and molecular modeling. Results: KRAS gene mutations were detected in the cancer tissue of 24 cases (42.85%). Of these, 11 had exon 4 mutations (19.64%). They harbored 8 different mutations all of which except two altered the KRAS protein amino acid sequence and all except one were novel as revealed by COSMIC database. The detected novel mutations were found to be somatic. One mutation is predicted to be benign. The remaining mutations are predicted to cause substantial changes in the protein structure. Of these, the Q150X nonsense mutation is the second truncating mutation to be reported in colorectal cancer in the literature. Conclusions: Our discovery of novel exon 4 KRAS mutations that are, so far, unique to Saudi colorectal cancer patients may be attributed to environmental factors and/or racial/ethnic variations due to genetic differences. Alternatively, it may be related to paucity of clinical studies on mutations other than those in codons 12, 13, 61 and 146. Further KRAS testing on a large number of patients of various ethnicities, particularly beyond the most common hotspot alleles in exons 2 and 3 is needed to assess the prevalence and explore the exact prognostic and predictive significance of the discovered novel mutations as well as their possible role in colorectal carcinogenesis.	[Naser, Walid M.] Univ Dammam, King Fahd Hosp Univ, Dept Lab Med, Mol Diagnost Lab, Al Khobar, Saudi Arabia; [Shawarby, Mohamed A.; Al-Tamimi, Dalal M.; Al Nemer, Areej M.] Univ Dammam, Coll Med, Dept Pathol, Dammam, Saudi Arabia; [Seth, Arun] Sunnybrook Hlth Sci Ctr, Dept Anat Pathol, Toronto, ON M4N 3M5, Canada; [Al-Quorain, Abdulaziz] Univ Dammam, Coll Med, Dept Internal Med, Dammam, Saudi Arabia; [Albagha, Omar M. E.] Univ Edinburgh, Western Gen Hosp, Ctr Genom & Expt Med, Inst Genet & Mol Med,MRC,Rheumatol Sect, Edinburgh, Midlothian, Scotland	Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Imam Abdulrahman Bin Faisal University; University of Edinburgh	Shawarby, MA (corresponding author), Univ Dammam, Coll Med, Dept Pathol, Dammam, Saudi Arabia.	melshawarby46@hotmail.com	Naser, Walid/D-7668-2016	Naser, Walid/0000-0002-3746-4031; Al-Quorain, Abdulaziz/0000-0003-4770-3929	Deanship of Scientific Research, University of Dammam, Saudi Arabia [2011003]	Deanship of Scientific Research, University of Dammam, Saudi Arabia	This work was funded by a grant of research on "K-ras, p53, EGFR and HER2 gene aberrations in colorectal cancer'' from the Deanship of Scientific Research, University of Dammam, Saudi Arabia (grant # 2011003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zeid AA, 2002, DIS COLON RECTUM, V45, P1255, DOI 10.1007/s10350-004-6401-z; Adekunle O O, 1986, Scand J Gastroenterol Suppl, V124, P183; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al Tamimi DM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-223; AlJaberi TM, 1997, DIS COLON RECTUM, V40, P1089, DOI 10.1007/BF02050935; Amemiya Y, 2013, HUMAN GENOME MEETING; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; [Anonymous], PATHOLOGY GENETICS T, V2; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Beranek M, 1999, CLIN CHEM LAB MED, V37, P723, DOI 10.1515/CCLM.1999.111; BHARGAVA DK, 1988, DIS COLON RECTUM, V31, P692, DOI 10.1007/BF02552585; Bingham SA, 1996, CARCINOGENESIS, V17, P515, DOI 10.1093/carcin/17.3.515; BREIVIK J, 1994, BRIT J CANCER, V69, P367, DOI 10.1038/bjc.1994.67; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Cerottini JP, 1998, AM J SURG, V175, P198, DOI 10.1016/S0002-9610(97)00283-3; Chan AO, 2005, CLIN CANCER RES, V11, P8281, DOI 10.1158/1078-0432.CCR-05-1000; Chien C, 2005, CANCER, V104, P629, DOI 10.1002/cncr.21204; Cirstea IC, 2013, HUM MOL GENET, V22, P262, DOI 10.1093/hmg/dds426; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; DAJANI YF, 1980, CANCER, V46, P420, DOI 10.1002/1097-0142(19800715)46:2<420::AID-CNCR2820460236>3.0.CO;2-1; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Fadhil W, 2010, J CLIN PATHOL, V63, P134, DOI 10.1136/jcp.2009.070508; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gomez SL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-193; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; Improta G, 2013, ONCOL LETT, V5, P1741, DOI 10.3892/ol.2013.1255; ISBISTER WH, 1992, AUST NZ J SURG, V62, P468, DOI 10.1111/j.1445-2197.1992.tb07227.x; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kakeji Tomoda H, 2006, JOURNAL OF SURGICAL, V58, P125; Kampman E, 2000, CARCINOGENESIS, V21, P307, DOI 10.1093/carcin/21.2.307; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kislitsin D, 2002, DIGEST DIS SCI, V47, P1073, DOI 10.1023/A:1015090124153; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lay MJ, 1997, CLIN CHEM, V43, P2262; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Martinez-Garza SG, 1999, DIGEST DIS, V17, P225, DOI 10.1159/000016940; MOERKERK P, 1994, CANCER RES, V54, P3376; Naguib Adam, 2011, J Mol Signal, V6, P2, DOI 10.1186/1750-2187-6-2; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Ollberding NJ, 2011, INT J CANCER, V129, P1899, DOI 10.1002/ijc.25822; Palmirotta R, 2009, ANTICANCER RES, V29, P3369; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; SCOTT N, 1993, GUT, V34, P289, DOI 10.1136/gut.34.3.289; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shackelford W, 2004, ANN NY ACAD SCI, V1022, P257, DOI 10.1196/annals.1318.040; Soliman AS, 1997, INT J CANCER, V71, P26, DOI 10.1002/(SICI)1097-0215(19970328)71:1<26::AID-IJC6>3.0.CO;2-5; Span M, 1996, INT J CANCER, V69, P241, DOI 10.1002/(SICI)1097-0215(19960621)69:3<241::AID-IJC15>3.3.CO;2-D; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; STANLEY LA, 1995, TOXICOLOGY, V96, P173, DOI 10.1016/0300-483X(94)02991-3; TOPAL MD, 1988, CARCINOGENESIS, V9, P691, DOI 10.1093/carcin/9.5.691; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; UROSEVIC N, 1993, INT J CANCER, V54, P249, DOI 10.1002/ijc.2910540215; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vartanian S, 2013, J BIOL CHEM, V288, P2403, DOI 10.1074/jbc.M112.394130; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Whelan S L, 1992, IARC Sci Publ, P178; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0; Zhang J, 2007, CELL CYCLE, V6, P1970, DOI 10.4161/cc.6.16.4577	68	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113350	10.1371/journal.pone.0113350	http://dx.doi.org/10.1371/journal.pone.0113350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412182	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000041
J	Yoon, JMD; Witthoft, N; Winawer, J; Frank, MC; Everett, DL; Gibson, E				Yoon, Jennifer M. D.; Witthoft, Nathan; Winawer, Jonathan; Frank, Michael C.; Everett, Daniel L.; Gibson, Edward			Cultural Differences in Perceptual Reorganization in US and Piraha Adults	PLOS ONE			English	Article							ACTIVATION; ILLUSION	Visual illusions and other perceptual phenomena can be used as tools to uncover the otherwise hidden constructive processes that give rise to perception. Although many perceptual processes are assumed to be universal, variable susceptibility to certain illusions and perceptual effects across populations suggests a role for factors that vary culturally. One striking phenomenon is seen with two-tone images-photos reduced to two tones: black and white. Deficient recognition is observed in young children under conditions that trigger automatic recognition in adults. Here we show a similar lack of cue-triggered perceptual reorganization in the Piraha, a hunter-gatherertribe with limited exposure to modern visual media, suggesting such recognition is experience- and culture-specific.	[Yoon, Jennifer M. D.; Winawer, Jonathan] NYU, Dept Psychol, New York, NY 10003 USA; [Witthoft, Nathan; Frank, Michael C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Gibson, Edward] MIT, Cambridge, MA 02139 USA; [Everett, Daniel L.] Bentley Univ, Dept Sociol, Waltham, MA USA	New York University; Stanford University; Massachusetts Institute of Technology (MIT); Bentley University	Yoon, JMD (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	davie.yoon@nyu.edu	Winawer, Jonathan/AFQ-2476-2022	Winawer, Jonathan/0000-0001-7475-5586; Frank, Michael/0000-0002-7551-4378				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; de Fockert J, 2007, J EXP PSYCHOL HUMAN, V33, P738, DOI 10.1037/0096-1523.33.3.738; DeLoache JS, 1997, PSYCHOL SCI, V8, P308, DOI 10.1111/j.1467-9280.1997.tb00443.x; DeLoache JS, 2000, CHILD DEV, V71, P329, DOI 10.1111/1467-8624.00148; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Everett DL, 2005, CURR ANTHROPOL, V46, P621, DOI 10.1086/431525; Gregory RL, 2005, PHILOS T R SOC B, V360, P1231, DOI 10.1098/rstb.2005.1662; Gregory RL, 1970, INTELLIGENT EYE; Helmholtz H., 1971, SELECTED WRITINGS HE; Hsieh PJ, 2010, J NEUROPHYSIOL, V103, P1501, DOI 10.1152/jn.00812.2009; Jones RK, 1980, PERCEPTION PICTURES, P193; Kohler W., 1929, GESTALT PSYCHOL; Kovacs I., 2004, BINOCULAR RIVALRY, P101, DOI [10.7551/mitpress/1605.003.0008, DOI 10.7551/MITPRESS/1605.003.0008]; LEIBOWITZ H, 1969, SCIENCE, V166, P1174, DOI 10.1126/science.166.3909.1174; Ludmer R, 2011, NEURON, V69, P1002, DOI 10.1016/j.neuron.2011.02.013; MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P21, DOI 10.1037/h0083687; Pica P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028391; ROCK I, 1994, ACTA PSYCHOL, V87, P33, DOI 10.1016/0001-6918(94)90065-5; Segall MH, 1968, SOCIAL PERCEPTION DE; SPELKE ES, 1990, COGNITIVE SCI, V14, P29, DOI 10.1207/s15516709cog1401_3; Vygotskii L.S., 1978, MIND SOC DEV HIGHER; Whitaker D, 2000, NAT NEUROSCI, V3, P13, DOI 10.1038/71088; Yoon JM, 2011, P 33 ANN M COGN SCI; Yoon JMD, 2012, THESIS STANFORD U; Yoon JMD, 2007, P 6 IEEE INT C DEV L	25	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e110225	10.1371/journal.pone.0110225	http://dx.doi.org/10.1371/journal.pone.0110225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25411970	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000003
J	Hancean, MG; Perc, M; Vlasceanu, L				Hancean, Marian-Gabriel; Perc, Matjaz; Vlasceanu, Lazar			Fragmented Romanian Sociology: Growth and Structure of the Collaboration Network	PLOS ONE			English	Article							INDEX; COHESION; AUTHORSHIP	Structural patterns in collaboration networks are essential for understanding how new ideas, research practices, innovation or cooperation circulate and develop within academic communities and between and within university departments. In our research, we explore and investigate the structure of the collaboration network formed by the academics working full-time within all the 17 sociology departments across Romania. We show that the collaboration network is sparse and fragmented, and that it constitutes an environment that does not promote the circulation of new ideas and innovation within the field. Although recent years have witnessed an increase in the productivity of Romanian sociologists, there is still ample room for improvement in terms of the interaction infrastructure that ought to link individuals together so that they could maximize their potentials. We also fail to discern evidence in favor of the Matthew effect governing the growth of the network, which suggests scientific success and productivity are not rewarded. Instead, the structural properties of the collaboration network are partly those of a core-periphery network, where the spread of innovation and change can be explained by structural equivalence rather than by interpersonal influence models. We also provide support for the idea that, within the observed network, collaboration is the product of homophily rather than prestige effects. Further research on the subject based on data from other countries in the region is needed to place our results in a comparative framework, in particular to discern whether the behavior of the Romanian sociologist community is unique or rather common.	[Hancean, Marian-Gabriel; Vlasceanu, Lazar] Univ Bucharest, Dept Sociol, Bucharest, Romania; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia	University of Bucharest; University of Maribor	Hancean, MG (corresponding author), Univ Bucharest, Dept Sociol, Bucharest, Romania.	gabriel.hancean@sas.unibuc.ro	Hancean, Marian-Gabriel/B-7145-2019; Perc, Matjaz/A-5148-2009	Hancean, Marian-Gabriel/0000-0001-9358-5287; Perc, Matjaz/0000-0002-3087-541X				[Anonymous], [No title captured]; [Anonymous], THESIS CORNELL U; Araujo EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090537; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V, 2000, SOC NETWORKS, V22, P173, DOI 10.1016/S0378-8733(00)00023-X; Biscaro C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099502; Borgatti S.P., 2018, ANAL SOCIAL NETWORKS; BORGATTI SP, 1993, SOC NETWORKS, V15, P361, DOI 10.1016/0378-8733(93)90012-A; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Borgatti SP, 2012, SAGE HDB SOCIAL NETW, P40; Borgatti SP, 1992, CONNECTIONS, V15, P12; Borgatti Stephen P., 2002, NETDRAW SOFTWARE NET; Braun T, 2006, SCIENTOMETRICS, V69, P169, DOI 10.1007/s11192-006-0147-4; BURT RS, 1987, AM J SOCIOL, V92, P1287, DOI 10.1086/228667; Cardillo A, 2006, PHYSICA A, V372, P333, DOI 10.1016/j.physa.2006.08.059; Csajbok E, 2007, SCIENTOMETRICS, V73, P91, DOI 10.1007/s11192-007-1859-9; DeHaan J, 1997, SCIENTOMETRICS, V39, P197, DOI 10.1007/BF02457448; DiMaggio P. J., 1991, NEW I ORG ANAL, P1, DOI DOI 10.1007/S10551-009-0264-0; DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101; DOREIAN P, 1985, J AM SOC INFORM SCI, V36, P411, DOI 10.1002/asi.4630360611; Durkheim E, 1984, DIVISION LABOUR SOC; Frenken K, 2005, J ENG TECHNOL MANAGE, V22, P9, DOI 10.1016/j.jengtecman.2004.11.002; Friedkin NE, 1999, ADV GROUP, V16, P1; Gallos LK, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031014; Garfield E., 1964, USE CITATION DATA WR; Getoor L., 2005, ACM SIGKDD EXPLORATI, V7, P3, DOI DOI 10.1145/1117454.1117456; Glanzel W, 1999, SCIENTOMETRICS, V45, P185, DOI 10.1007/BF02458432; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Grossman, 2002, C NUMERANTIUM, V158, P202; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Harzing A. W., 2007, PUBLISH PERISH; Havlin S, 2012, EUR PHYS J-SPEC TOP, V214, P273, DOI 10.1140/epjst/e2012-01695-x; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hudson J, 1996, J ECON PERSPECT, V10, P153, DOI 10.1257/jep.10.3.153; HUMMON NP, 1989, SOC NETWORKS, V11, P39, DOI 10.1016/0378-8733(89)90017-8; Ioannidis JPA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002778; Katz E., 1957, 2 STEP FLOW COMMUNIC; Kenett DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102001; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Kronegger L, 2014, J ASS INFORM SCI TEC; Kulkarni AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020885; Laband DN, 2000, J POLIT ECON, V108, P632, DOI 10.1086/262132; Lee K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014279; Luzar B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094429; Mali F, 2012, UNDERST COMPLEX SYST, P195, DOI 10.1007/978-3-642-23068-4_6; McQuail D, 1993, COMMUNICATION MODELS; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Mizruchi MS, 1996, ANNU REV SOCIOL, V22, P271, DOI 10.1146/annurev.soc.22.1.271; Monge P. R., 2003, THEORIES COMMUNICATI, DOI 10.1093/oso/9780195160369.001.0001; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; Moody J, 2004, AM SOCIOL REV, V69, P213, DOI 10.1177/000312240406900204; Newman MEJ, 2004, LECT NOTES PHYS, V650, P337; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Perc M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01720; Perc M, 2010, J INFORMETR, V4, P475, DOI 10.1016/j.joi.2010.04.003; Perc M, 2010, J INFORMETR, V4, P358, DOI 10.1016/j.joi.2010.03.001; Schreiber M, 2008, J INFORMETR, V2, P211, DOI 10.1016/j.joi.2008.05.001; Schreiber M, 2010, J AM SOC INF SCI TEC, V61, P169, DOI 10.1002/asi.21218; SCHUBERT A, 1990, SCIENTOMETRICS, V19, P3, DOI 10.1007/BF02130461; SIMON HA, 1955, BIOMETRIKA, V42, P425; Stapenhurst T, 2009, BENCHMARKING BOOK HO; SZMATKA J, 1995, SOC PSYCHOL QUART, V58, P123, DOI 10.2307/2787150; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Wallace ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033339; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White H, 2012, SAGE HDB SOCIAL NETW, P271; Wray KB, 2002, PHILOS SCI, V69, P150, DOI 10.1086/338946; Yu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101214; Zhang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01640	73	14	14	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113271	10.1371/journal.pone.0113271	http://dx.doi.org/10.1371/journal.pone.0113271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409180	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200089
J	Hellmair, M; Kinziger, AP				Hellmair, Michael; Kinziger, Andrew P.			Increased Extinction Potential of Insular Fish Populations with Reduced Life History Variation and Low Genetic Diversity	PLOS ONE			English	Article							ENDANGERED TIDEWATER GOBY; BIODIVERSITY	Theoretical work has shown that reduced phenotypic heterogeneity leads to population instability and can increase extinction potential, yet few examples exist of natural populations that illustrate how varying levels expressed diversity may influence population persistence, particularly during periods of stochastic environmental fluctuation. In this study, we assess levels of expressed variation and genetic diversity among demographically independent populations of tidewater goby (Eucyclogobius newberryi), show that reductions in both factors typically coincide, and describe how low levels of diversity contribute to the extinction risk of these isolated populations. We illustrate that, for this annual species, continuous reproduction is a safeguard against reproductive failure by any one population segment, as natural, stochastically driven salinity increases frequently result in high mortality among juvenile individuals. Several study populations deviated from the natural pattern of year-round reproduction typical for the species, rendering those with severely truncated reproductive periods vulnerable to extinction in the event of environmental fluctuation. In contrast, demographically diverse populations are more likely to persist through such periods through the continuous presence of adults with broader physiological tolerance to abrupt salinity changes. Notably, we found a significant correlation between genetic diversity and demographic variation in the study populations, which could be the result of population stressors that restrict both of these diversity measures simultaneously, or suggestive of a causative relationship between these population characteristics. These findings demonstrate the importance of biocomplexity at the population level, and assert that the maintenance of diversity contributes to population resilience and conservation of this endangered species.	[Hellmair, Michael; Kinziger, Andrew P.] Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA; [Hellmair, Michael] FISHBIO, Chico, CA USA	California State University System; California State Polytechnic University, Humboldt	Hellmair, M (corresponding author), Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA.	michael.hellmair@humboldt.edu			United States Fish and Wildlife Service	United States Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this study was provided by the United States Fish and Wildlife Service (www.fws.gov) to Andrew P. Kinziger, administered through the Humboldt State University Sponsored Programs Foundation. The funder had no active role in study design, data collection and analysis, or preparation of the manuscript, but consents to publication.	Earl DA, 2010, CONSERV GENET, V11, P103, DOI 10.1007/s10592-009-0008-9; Fox GA, 2005, ECOLOGY, V86, P1191, DOI 10.1890/04-0594; Gamfeldt L, 2007, OIKOS, V116, P700, DOI 10.1111/j.2007.0030-1299.15382.x; GILL HS, 1993, MAR BIOL, V117, P515; GOLDBERG S R, 1977, Southwestern Naturalist, V22, P557, DOI 10.2307/3670165; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; HEALEY MC, 1971, J ZOOL, V163, P177; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kraus N.C., 2002, SHORE BEACH, V70, P21, DOI DOI 10.2112/SI59-011.1; Lafferty KD, 1999, CONSERV BIOL, V13, P1447, DOI 10.1046/j.1523-1739.1999.98016.x; Lafferty Kevin D., 1999, North American Journal of Fisheries Management, V19, P618, DOI 10.1577/1548-8675(1999)019<0618:PPAROE>2.0.CO;2; Lafferty ZD, 1996, ENVIRON BIOL FISH, V46, P254; LANDE R, 1987, VIABLE POPULATIONS C; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Matern SA, 2001, T AM FISH SOC, V130, P592, DOI 10.1577/1548-8659(2001)130<0592:UTASTT>2.0.CO;2; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCraney WT, 2010, MOL ECOL, V19, P3315, DOI 10.1111/j.1365-294X.2010.04755.x; McNeely J. A., 1990, CONSERVING WORLDS BI; Mendonca H, 2001, MAR BIOTECHNOL, V3, P91, DOI 10.1007/s101260000051; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SCHNUTE J, 1981, CAN J FISH AQUAT SCI, V38, P1128, DOI 10.1139/f81-153; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; Swenson RO, 1999, ENVIRON BIOL FISH, V55, P99, DOI 10.1023/A:1007478207892; Swenson RO, 1995, THESIS U CALIFORNIA; Swift C. C., 1989, CONTRIBUTIONS SCI, V404; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; U.S. Fish and Wildlife Service, 1994, FED REGISTER, V59, P5494; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	35	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113139	10.1371/journal.pone.0113139	http://dx.doi.org/10.1371/journal.pone.0113139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409501	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200072
J	Salinas-Rodrigues, A; Torres-Pereda, MD; Manrique-Espinoza, B; Moreno-Tamayo, K; Solis, MMTR				Salinas-Rodrigues, Aaron; Del Pilar Torres-Pereda, Ma.; Manrique-Espinoza, Betty; Moreno-Tamayo, Karla; Tellez-Rojo Solis, Martha Maria			Impact of the Non-Contributory Social Pension Program 70 y mas on Older Adults' Mental Well-Being	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DEPRESSION; HEALTH; CAUSATION	Background: In 2007, a non-contributory pension program was launched in rural areas of Mexico. The program consisted in a non-conditional cash transfer of US$40 monthly to all older adults (OA) aged 70 and over. We evaluate the effect of the program on mental well-being of its beneficiaries. Methods and Findings: Quantitative and qualitative methods were used. For the quantitative component, we used the selection criteria established by the program (age and locality size) to form the Intervention (OA aged 70-74 residing in rural localities, <2500 inhabitants) and Control groups (OA aged 70-74, in localities with 2501-2700 inhabitants). Baseline data collection was conducted in 2007 where 5,465 OA were interviewed. The follow-up survey was conducted in 2008, and it was possible to interview 5,270 OA, with a response rate of 96%. A difference-in-difference linear probability model with individual fixed effect was used to estimate the impact of the program on mental well-being indicators. In 2009 a qualitative component was designed to explore possible causal pathways of such effect. Results: After a year of exposure, the program had a significant effect on reduction of depressive symptoms (beta = -0.06, CI95% -0.12; -0.01) and an increase in empowerment indicators: OA participated in important household decisions (beta = 0.09, CI95% 0.03;0.15); and OA participated in household decisions pertaining to expenses (beta = 0.11, CI95% 0.05;0.18). Qualitative analysis found a strong trend showing a reduction of sadness, and feeling of increasing empowerment. Conclusions: These results suggest that a non-conditional transfer in older ages have an impact beyond the economic sphere, impacting even the mental well-being. This effect could be explained because the pension produces feelings of safety and welfare. It is recommendable that governments should invest efforts towards universalizing the non-contributory pension programs in order to ensure a basic income for the elderly.	[Salinas-Rodrigues, Aaron; Manrique-Espinoza, Betty; Moreno-Tamayo, Karla; Tellez-Rojo Solis, Martha Maria] Natl Inst Publ Hlth, Ctr Evaluat Res & Surveys, Cuernavaca, Morelos, Mexico; [Del Pilar Torres-Pereda, Ma.] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Manrique-Espinoza, B (corresponding author), Natl Inst Publ Hlth, Ctr Evaluat Res & Surveys, Cuernavaca, Morelos, Mexico.	bmanrique@insp.mx	Moreno-Tamayo, Karla/C-7887-2018; Salinas-Rodriguez, Aaron/L-4395-2019; Manrique Espinoza, Betty Soledad/HHS-7564-2022	Moreno-Tamayo, Karla/0000-0003-4378-8240; Salinas-Rodriguez, Aaron/0000-0001-5645-814X; Manrique Espinoza, Betty Soledad/0000-0002-3535-2124; Torres, Pilar/0000-0003-1869-2044	Mexican Ministry of Social Development; International Initiative for Impact Evaluation, Inc. (3ie), through the Global Development Network (GDN) [OW31229]	Mexican Ministry of Social Development; International Initiative for Impact Evaluation, Inc. (3ie), through the Global Development Network (GDN)	This project has been funded in part by the Mexican Ministry of Social Development and by the International Initiative for Impact Evaluation, Inc. (3ie), through the Global Development Network (GDN) in partial fulfillment of the requirements of grant OW31229 issued under Open window 3. The contents of this publication do not represent the official position of the Mexican Ministry of Social Development. The views expressed in this article are not necessarily those of 3ie or its members, or of GDN. The elaboration of this study results required additional work by the authors. The Mexican Ministry of Social Development's Website is: http://www.sedesol.gob.mx/. The International Initiative for Impact Evaluation, Inc. Website is: http://www.3ieimpact.org/en/about/3ie-affiliates/3ie-members/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abma TA, 2006, EVAL HEALTH PROF, V29, P424, DOI 10.1177/0163278706293406; Aguila E, 2011, EXPT ANAL HLTH WELL; Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; [Anonymous], IMPACTO RENTA DIGNID; Barrientos A, 2003, WORLD DEV, V31, P555, DOI 10.1016/S0305-750X(02)00211-5; Barrientos A, 2008, I PATHWAYS EQUITY AD, P169; BEBBINGTON Anthony, 2005, APRENDER EXPERIENCIA; Bernard HR, 1994, RES METHODS ANTHR QU; Bertranou F., 2002, PENSIONES CONTRIBUTI; BERTRANOU F., 2006, ENVEJECIMIENTO EMPLE; Case A, 1998, ECON J, V108, P1330, DOI 10.1111/1468-0297.00345; Case A., 2004, DOES MONEY PROTECT H, P28, DOI [10.7208/chicago/9780226903286.003.0008, DOI 10.7208/CHICAGO/9780226903286.003.0008]; Case A, 2007, SCAND J PUBLIC HEALT, V35, P157, DOI 10.1080/14034950701355445; CEPAL, 2010, ENV PERS ED IND AM L; Chapman Daniel P, 2008, Prev Chronic Dis, V5, pA22; Cho HJ, 2010, AM J GERIAT PSYCHIAT, V18, P442, DOI 10.1097/JGP.0b013e3181ca3a2d; Clandinin DJ., 1994, HDB QUALITATIVE RES, P413; de Carvalho IE, 2008, J DEV ECON, V86, P129, DOI 10.1016/j.jdeveco.2007.10.007; Diario Oficial de la Federacion, 2020, DECR QUE PUBL PROGR; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; Durston J, 2005, APRENDER EXPERIENCIA; Edmonds EV, 2005, J HUM RESOUR, V40, P186, DOI 10.3368/jhr.XL.1.186; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Gonzalez de la Roclia M., 2005, APRENDER EXPERIENCIA; Grushka C, 2004, SEGURIDAD EC VEJEZ C; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; HelpAge International, WHY SOC PENS; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Jauregui B., 2006, ENVEJECIMIENTO POBRE; Kakwani N., 2005, SOCIAL PROTECTION DI; Kassouf AL, 2012, IMPACT EVALUATION BR; Kessler G, 2005, APRENDER EXPERIENCIA; Kinsella K., 2009, US CENSUS BUREAU INT; Marquez-Serrano M, 2007, DIAGNOSTICO CONDICIO; Massey A, 1999, STUD EDUC ETHNOG, V2, P183; Mayo M, 1995, COMMUNITY PARTICIPAT; Mezuk B, 2008, OSTEOPOROSIS INT, V19, P1, DOI 10.1007/s00198-007-0449-2; Minayo C., 2002, INVESTIGACION CUALIT, P239; Moller V, 2003, DEV SO AFR, V20, P457, DOI DOI 10.1080/0376835032000124475; Namey E, 2005, QUALITATIVE RES METH; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Puga D, 2007, RED SOCIAL SALUD ADU; Rowlands Jo, 1997, PODER Y EMPODERAMIEN, P213; Rubio G, 2010, SERIE POLITICAS SOCI, V161; Schatz E, 2012, SOC SCI MED, V75, P1864, DOI 10.1016/j.socscimed.2012.07.004; Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761; Sedesol, 2013, REGL OP PROGR PENS A; Sheikh J I, 1991, Int Psychogeriatr, V3, P23, DOI 10.1017/S1041610291000480; Szasz MC., 2001, INDIAN WHITE WORLDS; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Willmore L, 2007, WORLD DEV, V35, P24, DOI 10.1016/j.worlddev.2006.09.008; World Health Organization, 2002, ACT AG POL FRAM; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	53	25	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113085	10.1371/journal.pone.0113085	http://dx.doi.org/10.1371/journal.pone.0113085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409468	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200066
J	Swift, SM; Hudgens, JW; Heselpoth, RD; Bales, PM; Nelson, DC				Swift, Steven M.; Hudgens, Jeffrey W.; Heselpoth, Ryan D.; Bales, Patrick M.; Nelson, Daniel C.			Characterization of AlgMsp, an Alginate Lyase from Microbulbifer sp 6532A	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; PSEUDOMONAS-AERUGINOSA; OLIGOALGINATE LYASE; CIRCULAR-DICHROISM; CYSTIC-FIBROSIS; IN-VITRO; PURIFICATION; DEPOLYMERIZATION; STRAIN; DELIVERY	Alginate is a polysaccharide produced by certain seaweeds and bacteria that consists of mannuronic acid and guluronic acid residues. Seaweed alginate is used in food and industrial chemical processes, while the biosynthesis of bacterial alginate is associated with pathogenic Pseudomonas aeruginosa. Alginate lyases cleave this polysaccharide into short oligo-uronates and thus have the potential to be utilized for both industrial and medicinal applications. An alginate lyase gene, algMsp, from Microbulbifer sp. 6532A, was synthesized as an E. coli codon-optimized clone. The resulting 37 kDa recombinant protein, AlgMsp, was expressed, purified and characterized. The alginate lyase displayed highest activity at pH 8 and 0.2 M NaCl. Activity of the alginate lyase was greatest at 50 degrees C; however the enzyme was not stable over time when incubated at 50 degrees C. The alginate lyase was still highly active at 25 degrees C and displayed little or no loss of activity after 24 hours at 25 degrees C. The activity of AlgMsp was not dependent on the presence of divalent cations. Comparing activity of the lyase against polymannuronic acid and polyguluronic acid substrates showed a higher turnover rate for polymannuronic acid. However, AlgMSP exhibited greater catalytic efficiency with the polyguluronic acid substrate. Prolonged AlgMsp-mediated degradation of alginate produced dimer, trimer, tetramer, and pentamer oligo-uronates.	[Swift, Steven M.; Hudgens, Jeffrey W.; Heselpoth, Ryan D.; Bales, Patrick M.; Nelson, Daniel C.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Hudgens, Jeffrey W.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Nelson, Daniel C.] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Nelson, DC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	nelsond@umd.edu	Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831; Hudgens, Jeffrey/0000-0003-2805-1048; Swift, Steven/0000-0002-3840-4401	United States Department of Defense [DM102823]	United States Department of Defense(United States Department of Defense)	This work was supported by grants from the United States Department of Defense (DM102823) to DCN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DOGGETT RG, 1966, J PEDIATR-US, V68, P215, DOI 10.1016/S0022-3476(66)80152-X; Duan GF, 2009, CAN J MICROBIOL, V55, P1113, DOI [10.1139/W09-051, 10.1139/w09-051]; Easterby JS, 2003, HYPER32 HYPER EXE VE; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; GACESA P, 1992, INT J BIOCHEM, V24, P545, DOI 10.1016/0020-711X(92)90325-U; GALAMBOS JT, 1967, ANAL BIOCHEM, V19, P119, DOI 10.1016/0003-2697(67)90141-8; Gaspar MC, 2013, EUR J CLIN MICROBIOL, V32, P1231, DOI 10.1007/s10096-013-1876-y; George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017; GILCHRIST T, 1983, BIOMATERIALS, V4, P317, DOI 10.1016/0142-9612(83)90036-4; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; HAUG A, 1962, ACTA CHEM SCAND, V16, P1908, DOI 10.3891/acta.chem.scand.16-1908; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Hutcheson SW, 2011, MAR DRUGS, V9, P645, DOI 10.3390/md9040645; Iwamoto Y, 2001, BIOSCI BIOTECH BIOCH, V65, P133, DOI 10.1271/bbb.65.133; Kim HT, 2012, APPL MICROBIOL BIOT, V93, P2233, DOI 10.1007/s00253-012-3882-x; Kobayashi T, 2009, EXTREMOPHILES, V13, P121, DOI 10.1007/s00792-008-0201-7; Li JW, 2011, MAR DRUGS, V9, P109, DOI 10.3390/md9010109; LINKER A, 1956, J BIOL CHEM, V219, P13; LINKER A, 1966, J BIOL CHEM, V241, P3845; MABEAU S, 1987, J EXP BOT, V38, P1573, DOI 10.1093/jxb/38.9.1573; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Matsubara Y, 1998, BIOSCI BIOTECH BIOCH, V62, P1055, DOI 10.1271/bbb.62.1055; McHugh DJ, 1987, PRODUCTION UTILIZATI; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miyake O, 2003, PROTEIN EXPRES PURIF, V29, P33, DOI 10.1016/S1046-5928(03)00018-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006; Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287; Sim SJ, 2012, J IND MICROBIOL BIOT, V39, P585, DOI 10.1007/s10295-011-1054-0; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Wakabayashi M, 2012, BIODEGRADATION, V23, P93, DOI 10.1007/s10532-011-9489-6; Wang Y, 2013, BIOTECHNOL LETT, V35, P703, DOI 10.1007/s10529-012-1134-x; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Xu X, 2003, BIOSCI BIOTECH BIOCH, V67, P2022, DOI 10.1271/bbb.67.2022; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075	43	55	59	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112939	10.1371/journal.pone.0112939	http://dx.doi.org/10.1371/journal.pone.0112939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409178	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200049
J	Zhang, J; Xie, LL; Li, YJ; Chatterjee, M; Ding, N				Zhang, Jin; Xie, Lingli; Li, Yongjun; Chatterjee, Monita; Ding, Nai			How Noise and Language Proficiency Influence Speech Recognition by Individual Non-Native Listeners	PLOS ONE			English	Article							NORMAL-HEARING; PERCEPTION	This study investigated how speech recognition in noise is affected by language proficiency for individual non-native speakers. The recognition of English and Chinese sentences was measured as a function of the signal-to-noise ratio (SNR) in sixty native Chinese speakers who never lived in an English-speaking environment. The recognition score for speech in quiet (which varied from 15%-92%) was found to be uncorrelated with speech recognition threshold (SRTQ/2), i.e. the SNR at which the recognition score drops to 50% of the recognition score in quiet. This result demonstrates separable contributions of language proficiency and auditory processing to speech recognition in noise.	[Zhang, Jin; Xie, Lingli] Hunan Normal Univ, Coll Math & Comp Sci, Changsha, Hunan, Peoples R China; [Li, Yongjun] Hunan Univ, Sch Software, Changsha 410082, Hunan, Peoples R China; [Chatterjee, Monita] Boys Town Natl Res Hosp, Omaha, NE 68131 USA; [Ding, Nai] NYU, Dept Psychol, New York, NY 10003 USA	Hunan Normal University; Hunan University; Boys Town National Research Hospital; New York University	Ding, N (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	nd45@nyu.edu		Chatterjee, Monita/0000-0002-8286-2557	National Natural Science Foundation of China [60901080]; National High-tech R&D Program of China (863 Program) [2009AA010314]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004662] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Part of this work was supported by National Natural Science Foundation of China (Grant No. 60901080), National High-tech R&D Program of China (863 Program, Grant No. 2009AA010314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein JGW, 2009, J ACOUST SOC AM, V125, P3358, DOI 10.1121/1.3110132; Cutler A, 2008, J ACOUST SOC AM, V124, P1264, DOI 10.1121/1.2946707; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; Fu QJ, 2011, J ACOUST SOC AM, V129, pEL267, DOI 10.1121/1.3590739; Lecumberri MLG, 2010, SPEECH COMMUN, V52, P864, DOI 10.1016/j.specom.2010.08.014; Jin SH, 2012, J ACOUST SOC AM, V132, pEL391, DOI 10.1121/1.4757730; Lecumberri MLG, 2006, J ACOUST SOC AM, V119, P2445, DOI 10.1121/1.2180210; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469	10	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113386	10.1371/journal.pone.0113386	http://dx.doi.org/10.1371/journal.pone.0113386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409435	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200106
J	Avtzis, DN; Doudoumis, V; Bourtzis, K				Avtzis, Dimitrios N.; Doudoumis, Vangelis; Bourtzis, Kostas			Wolbachia Infections and Mitochondrial Diversity of Two Chestnut Feeding Cydia Species	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HORIZONTAL TRANSFER; HYBRID INTROGRESSION; NATURAL-POPULATIONS; SELECTIVE SWEEPS; TSETSE-FLIES; HOST MTDNA; DNA; EVOLUTION; FAGIGLANDANA	Cydia splendana and C. fagiglandana are two closely related chestnut feeding lepidopteran moth species. In this study, we surveyed the bacterial endosymbiont Wolbachia in these two species. Infection rates were 31% in C. splendana and 77% in C. fagiglandana. MLST analysis showed that these two species are infected with two quite diverse Wolbachia strains. C. splendana with Sequence Type (ST) 409 from the A-supergroup and C. fagiglandana with ST 150 from the B-supergroup. One individual of C. splendana was infected with ST 150, indicating horizontal transfer between these sister species. The mitochondrial DNA of the two Cydia species showed a significantly different mtDNA diversity, which was inversely proportional to their infection rates.	[Avtzis, Dimitrios N.] Hellen Agr Org Demeter, Lab Forest Entomol, Forest Res Inst, Vassilika Thessaloniki, Greece; [Doudoumis, Vangelis; Bourtzis, Kostas] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece; [Bourtzis, Kostas] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria	University of Patras; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Avtzis, DN (corresponding author), Hellen Agr Org Demeter, Lab Forest Entomol, Forest Res Inst, Vassilika Thessaloniki, Greece.	dimitrios.avtzis@fri.gr	Avtzis, Dimitrios/F-8635-2018	Avtzis, Dimitrios/0000-0002-7772-6892				Aguin-Pombo D, 2008, ACTA HORTIC, P175, DOI 10.17660/ActaHortic.2008.784.27; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avtzis DN, 2013, J PEST SCI, V86, P185, DOI 10.1007/s10340-012-0451-0; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Ballard JWO, 2000, MOL BIOL EVOL, V17, P1126, DOI 10.1093/oxfordjournals.molbev.a026394; Ballard JWO, 2002, EVOLUTION, V56, P527; Bogenschutz H., 1991, World Crop Pests, V5, P673; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bradley JD, 1979, BRIT TORTRICOID MOTH; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; DenOtter CJ, 1996, J APPL ENTOMOL, V120, P413, DOI 10.1111/j.1439-0418.1996.tb01629.x; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; DRUMMOND AJ, 2008, GENEIOUS V4 0; Dyer KA, 2011, MOL ECOL, V20, P2805, DOI 10.1111/j.1365-294X.2011.05128.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FU YX, 1993, GENETICS, V133, P693; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Graham RI, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-204; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ilinsky Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054373; Jackel R, 2013, MOL ECOL, V22, P4241, DOI 10.1111/mec.12389; Jiggins FM, 2003, GENETICS, V164, P5; Jimenez-Pino A, 2011, SPAN J AGRIC RES, V9, P570; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Karagoz M, 2009, BIOCONTROL SCI TECHN, V19, P755, DOI 10.1080/09583150903100831; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Morrow JL, 2014, ENVIRON MICROBIOL, V16, P3622, DOI 10.1111/1462-2920.12382; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Nei M., 1987, MOL EVOLUTIONARY GEN; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Ritter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078107; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Sambrook J, 1989, MOL CLONING; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Seger J, 2010, GENETICS, V184, P529, DOI 10.1534/genetics.109.103556; Shoemaker DD, 2004, GENETICS, V168, P2049, DOI 10.1534/genetics.104.030890; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stahlhut JK, 2010, MOL ECOL, V19, P1940, DOI 10.1111/j.1365-294X.2010.04572.x; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Symula RE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-31; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xiao JH, 2012, EVOLUTION, V66, P1907, DOI 10.1111/j.1558-5646.2011.01561.x; Yun YL, 2011, CURR MICROBIOL, V62, P139, DOI 10.1007/s00284-010-9686-2; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	69	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112795	10.1371/journal.pone.0112795	http://dx.doi.org/10.1371/journal.pone.0112795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405506	gold, Green Submitted, Green Published			2022-12-27	WOS:000347121300053
J	Goldschalt, C; Doll, S; Ihle, B; Kirsch, J; Mutzbauer, TS				Goldschalt, Christin; Doll, Sara; Ihle, Brit; Kirsch, Joachim; Mutzbauer, Till Sebastian			Intraosseous Vascular Access through the Anterior Mandible - A Cadaver Model Pilot Study	PLOS ONE			English	Article							ANESTHETIC EFFICACY; INFUSION DEVICES; METHYLENE-BLUE; BONE-MARROW; VARIABILITY; PLACEMENT; ADULTS; MOLARS; TRIAL; FLUSH	Background: Several insertion sites have been described for intraosseous puncture in cases of emergencies when a conventional vascular access cannot be established. This pilot study has been designed to evaluate the feasibility of the mandibular bone for the use of an intraosseous vascular access in a cadaver model. Methodology/Principal Findings: 17 dentistry and 16 medical students participating in a voluntary course received a short introduction into the method and subsequently used the battery powered EZ-IO system with a 15 mm cannula for a puncture of the anterior mandible in 33 cadavers. The time needed to perform each procedure was evaluated. India ink was injected into the accesses and during the anatomy course cadavers were dissected to retrace the success or failure of the puncture. Dental students needed 25.5 +/- 18.9(mean +/- standard deviation)s and medical students 33 +/- 20.4 s for the procedure (p = 0.18). Floor of mouth extravasation occurred in both groups in 3 cases. Success rates were 82 and 75% (p = 0.93). Conclusions/Significance: Despite floor of mouth extravasation of injected fluid into a mandibular intraosseous access might severely complicate this procedure, the anterior mandible may be helpful as an alternative to other intraosseous and intravenous insertion sites when these are not available in medical emergencies.	[Goldschalt, Christin; Doll, Sara; Ihle, Brit; Kirsch, Joachim; Mutzbauer, Till Sebastian] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Mutzbauer, Till Sebastian] Mutzbauer&Partner, Maxillofacial Surg & Anesthesiol, Zurich, Switzerland	Ruprecht Karls University Heidelberg	Mutzbauer, TS (corresponding author), Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany.	mutzbauer@gmail.com						Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Byars DV, 2011, PREHOSP DISASTER MED, V26, P127, DOI 10.1017/S1049023X11000057; Calkins MD, 2000, J TRAUMA, V48, P1068, DOI 10.1097/00005373-200006000-00012; Erdmann L, 2013, OR SURG OR MED OR PA, V116, P686, DOI 10.1016/j.oooo.2013.07.027; Favier JC, 2007, ANN FR ANESTH, V26, P884, DOI 10.1016/j.annfar.2007.06.005; Frascone R, 2003, J BURN CARE REHABIL, V24, P306, DOI 10.1097/01.BCR.0000085875.68085.6B; Gallatin Juliane, 2003, Anesth Prog, V50, P111; Graetz C, 2013, MED ORAL PATOL ORAL, V18, pE130, DOI 10.4317/medoral.18386; Hafner JW, 2013, WEST J EMERG MED, V14, P629, DOI 10.5811/westjem.2013.4.13361; Hallas P, 2013, WEST J EMERG MED, V14, P440, DOI 10.5811/westjem.2013.1.12000; Halm B, 1998, AM J EMERG MED, V16, P420, DOI 10.1016/S0735-6757(98)90146-2; Harcke HT, 2011, J SPEC OPER MED, V11, P23; Herman MI, 1999, ANN EMERG MED, V33, P111, DOI 10.1016/S0196-0644(99)70427-0; Hori T, 2008, HEPATOB PANCREAT DIS, V7, P362; Kalpidis Christos D, 2005, Implant Dent, V14, P117; Kang SS, 2011, J ULTRAS MED, V30, P1711, DOI 10.7863/jum.2011.30.12.1711; Kovar Jay, 2010, JEMS, V35, P52, DOI 10.1016/S0197-2510(10)70207-2; Lairet J, 2013, PREHOSP EMERG CARE, V17, P280, DOI 10.3109/10903127.2012.755582; Levitan RM, 2009, ANN EMERG MED, V54, P692, DOI 10.1016/j.annemergmed.2009.06.012; McCarthy G, 2003, RESUSCITATION, V56, P183, DOI 10.1016/S0300-9572(02)00348-9; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; ONEILL JF, 1945, ANN SURG, V122, P266, DOI 10.1097/00000658-194508000-00011; Ozer S, 2012, OR SURG OR MED OR PA, V114, pS132, DOI 10.1016/j.oooo.2011.09.021; Pereira LAP, 2013, OR SURG OR MED OR PA, V116, pE85, DOI 10.1016/j.oooo.2011.10.045; Rubal BJ, 2012, LAB ANIMAL, V41, P224, DOI 10.1038/laban0812-224; Santos D, 2013, RESUSCITATION, V84, P440, DOI 10.1016/j.resuscitation.2012.11.006; Schalk R, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-65; Shavit I, 2009, RESUSCITATION, V80, P1029, DOI 10.1016/j.resuscitation.2009.05.026; Sontgerath JS, 2014, AM J EMERG MED, V32, P665, DOI 10.1016/j.ajem.2014.03.001; Tocantins LM, 1941, ANN SURG, V114, P1085, DOI 10.1097/00000658-194112000-00015; Waisman M, 1997, J TRAUMA, V42, P288, DOI 10.1097/00005373-199702000-00019; Zarei M, 2012, INT ENDOD J, V45, P921, DOI 10.1111/j.1365-2591.2012.02050.x	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112686	10.1371/journal.pone.0112686	http://dx.doi.org/10.1371/journal.pone.0112686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405476	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300046
J	Ishii, S; Tanaka, T; Akishita, M; Ouchi, Y; Tuji, T; Iijima, K				Ishii, Shinya; Tanaka, Tomoki; Akishita, Masahiro; Ouchi, Yasuyoshi; Tuji, Tetsuo; Iijima, Katsuya		Kashiwa Study Investigators	Metabolic Syndrome, Sarcopenia and Role of Sex and Age: Cross-Sectional Analysis of Kashiwa Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; VISCERAL OBESITY; AEROBIC FITNESS; BLOOD-PRESSURE; ELDERLY-MEN; OLDER MEN; ASSOCIATION	Recent epidemiological evidence suggests that effects of cardiovascular risk factors may vary depending on sex and age. In this study, we assessed the associations of metabolic syndrome (MetS) with sarcopenia and its components in older adults, and examined whether the associations vary by sex and age. We also tested if any one of the MetS components could explain the associations. We conducted a cross-sectional analysis of the baseline data from the cohort study conducted in Kashiwa city, Chiba, Japan in 2012 which included 1971 functionally-independent, community-dwelling Japanese adults aged 65 years or older (977 men, 994 women). Sarcopenia was defined based on appendicular skeletal muscle mass, grip strength and usual gait speed. MetS was defined based on the National Cholesterol Education Program's Adult Treatment Panel-III criteria. The prevalence of sarcopenia was 14.2% in men and 22.1% in women, while the prevalence of MetS was 43.6% in men and 28.9% in women. After adjustment for potential confounders, MetS was positively associated with sarcopenia in men aged 65 to 74 years (odds ratio 5.5; 95% confidence interval 1.9-15.9) but not in older men or women. Among the sarcopenia components, MetS was associated with lower muscle mass and grip strength, particularly in men aged 65 to 74 years. The associations of MetS with sarcopenia and its components were mainly driven by abdominal obesity regardless of sex or age. In conclusion, MetS is positively associated with sarcopenia in older men. The association is modified by sex and age, but abdominal obesity is the main contributor to the association across sex and age.	[Ishii, Shinya; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Tanaka, Tomoki; Tuji, Tetsuo; Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Bunkyo Ku, Tokyo 1138656, Japan; [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Minato Ku, Tokyo 1058470, Japan	University of Tokyo; University of Tokyo; Toranomon Hospital	Iijima, K (corresponding author), Univ Tokyo, Inst Gerontol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	iijima@iog.u-tokyo.ac.jp			Health and Labor Sciences Research Grant from Ministry of Health, Labor, and Welfare of Japan [H24-Choju-Ippan-002]	Health and Labor Sciences Research Grant from Ministry of Health, Labor, and Welfare of Japan	This work was supported by a Health and Labor Sciences Research Grant (H24-Choju-Ippan-002 to KI) from the Ministry of Health, Labor, and Welfare of Japan (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], CIRCULATION, V120, P1640; Auyeung TW, 2011, EUR J ENDOCRINOL, V164, P811, DOI 10.1530/EJE-10-0952; Beavers KM, 2013, J GERONTOL A-BIOL, V68, P617, DOI 10.1093/gerona/gls213; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Bucci L, 2013, BIOGERONTOLOGY, V14, P261, DOI 10.1007/s10522-013-9428-5; Carriere I, 2014, J GERONTOL A-BIOL, V69, P79, DOI 10.1093/gerona/glt101; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Everson-Rose SA, 2011, J AM GERIATR SOC, V59, P1376, DOI 10.1111/j.1532-5415.2011.03518.x; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Kawano Y, 2011, AM J HYPERTENS, V24, P1250, DOI 10.1038/ajh.2011.138; Kim TN, 2013, J CLIN ENDOCR METAB, V98, P811, DOI 10.1210/jc.2012-3292; Koh KK, 2005, J AM COLL CARDIOL, V46, P1978, DOI 10.1016/j.jacc.2005.06.082; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Landi F, 2000, ARCH INTERN MED, V160, P2641, DOI 10.1001/archinte.160.17.2641; Laudisio A, 2013, CLIN NUTR; Lee CG, 2011, J AM GERIATR SOC, V59, P1217, DOI 10.1111/j.1532-5415.2011.03472.x; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Liu PY, 2007, J CLIN ENDOCR METAB, V92, P3599, DOI 10.1210/jc.2007-0862; Lu CW, 2013, OBES RES CLIN PRACT, V7, pE301, DOI 10.1016/j.orcp.2012.02.003; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Moon SS, 2014, ENDOCR J, V61, P61, DOI 10.1507/endoc; Nagasaki H, 1996, PERCEPT MOTOR SKILL, V82, P435, DOI 10.2466/pms.1996.82.2.435; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Park S, 2013, CLIN NUTR, DOI 10.1016; Park SW, 2009, DIABETES CARE, V32, P1993, DOI 10.2337/dc09-0264; Penninx BWJH, 2009, J GERONTOL A-BIOL, V64, P96, DOI 10.1093/gerona/gln005; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P84, DOI 10.1093/gerona/glp150; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Weiss A, 2009, DIABETIC MED, V26, P253, DOI 10.1111/j.1464-5491.2009.02672.x; Wijndaele K, 2007, MED SCI SPORT EXER, V39, P233, DOI 10.1249/01.mss.0000247003.32589.a6; Yang EF, 2012, METABOLISM, V61, P317, DOI 10.1016/j.metabol.2011.07.005; Zoico E, 2004, J GERONTOL A-BIOL, V59, P935, DOI 10.1093/gerona/59.9.M935	43	55	55	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112718	10.1371/journal.pone.0112718	http://dx.doi.org/10.1371/journal.pone.0112718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405866	gold, Green Submitted, Green Published			2022-12-27	WOS:000347121300049
J	Grudzinski, JJ; Titz, B; Kozak, K; Clarke, W; Allen, E; Trembath, L; Stabin, M; Marshall, J; Cho, SY; Wong, TZ; Mortimer, J; Weichert, JP				Grudzinski, Joseph J.; Titz, Benjamin; Kozak, Kevin; Clarke, William; Allen, Ernest; Trembath, LisaAnn; Stabin, Michael; Marshall, John; Cho, Steve Y.; Wong, Terence Z.; Mortimer, Joanne; Weichert, Jamey P.			A Phase 1 Study of I-131-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety	PLOS ONE			English	Article							SOFTWARE	Introduction: I-131-CLR1404 is a small molecule that combines a tumor-targeting moiety with a therapeutic radioisotope. The primary aim of this phase 1 study was to determine the administered radioactivity expected to deliver 400 mSv to the bone marrow. The secondary aims were to determine the pharmacokinetic (PK) and safety profiles of I-131-CLR1404. Methods: Eight subjects with refractory or relapsed advanced solid tumors were treated with a single injection of 370 MBq of I-131-CLR1404. Whole body planar nuclear medicine scans were performed at 15-35 minutes, 4-6, 18-24, 48, 72, 144 hours, and 14 days post injection. Optional single photon emission computed tomography imaging was performed on two patients 6 days post injection. Clinical laboratory parameters were evaluated in blood and urine. Plasma PK was evaluated on I-127-CLR1404 mass measurements. To evaluate renal clearance of I-131-CLR1404, urine was collected for 14 days post injection. Absorbed dose estimates for target organs were determined using the RADAR method with OLINDA/EXM software. Results: Single administrations of 370 MBq of I-131-CLR1404 were well tolerated by all subjects. No severe adverse events were reported and no adverse event was dose-limiting. Plasma 127 I-CLR1404 concentrations declined in a bi-exponential manner with a mean t(1/2) value of 822 hours. Mean Cmax and AUC(0-t) values were 72.2 ng/mL and 15753 ngNhr/mL, respectively. An administered activity of approximately 740 MBq is predicted to deliver 400 mSv to marrow. Conclusions: Preliminary data suggest that I-131-CLR1404 is well tolerated and may have unique potential as an anti-cancer agent.	[Grudzinski, Joseph J.; Titz, Benjamin; Kozak, Kevin; Clarke, William; Allen, Ernest; Trembath, LisaAnn; Weichert, Jamey P.] Cellectar Biosci Inc, Madison, WI 53716 USA; [Grudzinski, Joseph J.; Titz, Benjamin] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Phys, Madison, WI USA; [Weichert, Jamey P.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Stabin, Michael] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Marshall, John] Medstar Georgetown Univ Hosp, Dept Med, Washington, DC USA; [Marshall, John] Medstar Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Cho, Steve Y.] Johns Hopkins Univ Hosp, Dept Radiol, Baltimore, MD 21287 USA; [Wong, Terence Z.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Mortimer, Joanne] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Georgetown University; Georgetown University; Johns Hopkins University; Johns Hopkins Medicine; Duke University; City of Hope	Grudzinski, JJ (corresponding author), Cellectar Biosci Inc, Madison, WI 53716 USA.	grudzinski@wisc.edu		Mortimer, Joanne/0000-0002-2935-1934	Cellectar Biosciences, Inc.	Cellectar Biosciences, Inc.	Cellectar Biosciences, Inc. funded the study and Cellectar Biosciences, Inc. personnel were responsible for study design, data collection and analysis, decision to publish, and manuscript preparation.	Barrett PHR, 1998, METABOLISM, V47, P484, DOI 10.1016/S0026-0495(98)90064-6; Deming DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060709; Jiang HL, 2010, J CHROMATOGR B, V878, P1513, DOI 10.1016/j.jchromb.2010.04.002; Pinchuk AN, 2006, J MED CHEM, V49, P2155, DOI 10.1021/jm050252g; Ries L MD, 2008, SEER CANC STAT REV 1; Siegel JA, 1999, J NUCL MED, V40, p37S; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stabin MG, 2005, J NUCL MED, V46, P1023; Stabin MG, 2003, HEALTH PHYS, V85, P294, DOI 10.1097/00004032-200309000-00006; Stabin MG, 2002, HEALTH PHYS, V83, P471, DOI 10.1097/00004032-200210000-00004; Weichert JP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007646; Zasadny KR, 1999, J NUCL MED, V40, p39P	12	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111652	10.1371/journal.pone.0111652	http://dx.doi.org/10.1371/journal.pone.0111652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402488	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700018
J	Shatz, LF; Christensen, CW				Shatz, Lisa F.; Christensen, Craig W.			Numerical Inductance Calculations Based on First Principles	PLOS ONE			English	Article								A method of calculating inductances based on first principles is presented, which has the advantage over the more popular simulators in that fundamental formulas are explicitly used so that a deeper understanding of the inductance calculation is obtained with no need for explicit discretization of the inductor. It also has the advantage over the traditional method of formulas or table lookups in that it can be used for a wider range of configurations. It relies on the use of fast computers with a sophisticated mathematical computing language such as Mathematica to perform the required integration numerically so that the researcher can focus on the physics of the inductance calculation and not on the numerical integration.	[Shatz, Lisa F.; Christensen, Craig W.] Suffolk Univ, Boston, MA 02114 USA	Suffolk University	Shatz, LF (corresponding author), Suffolk Univ, Boston, MA 02114 USA.	lshatz@suffolk.edu						Dwight HB., 1945, ELECT COILS CONDUCTO; Elliot RS, 1992, ELECTROMAGNETICS HIS, P309; Greengard L., 1988, RAPID EVALUATION POT; Irwin JD, 2011, BASIC ENG CIRCUIT AN, P491; KAMON M, 1994, IEEE T MICROW THEORY, V42, P1750, DOI 10.1109/22.310584; Kamon M, 1994, THESIS MIT CAMBRIDGE; Lorentz L., 1879, ANN PHYS, VVII, P161; Maxwell A., ANSYS MAXWELL 2D V 1, V13; Rosa EB, 1912, FORMULAS TABLES CALC, V8, P154; Rosa EB, 1912, FORMULAS TABLES CALC, V8; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; Weaver R., SOLENOID INDUCTANCE; Wheeler HA, 1928, P IRE, V16, P1398, DOI 10.1109/JRPROC.1928.221309; Wolfram S., 2009, MATH 7 0	14	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111643	10.1371/journal.pone.0111643	http://dx.doi.org/10.1371/journal.pone.0111643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402467	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700017
J	Kong, BS; Cho, YH; Lee, EJ				Kong, Byung Soo; Cho, Yoon Hee; Lee, Eun Jig			G Protein-Coupled Estrogen Receptor-1 Is Involved in the Protective Effect of Protocatechuic Aldehyde against Endothelial Dysfunction	PLOS ONE			English	Article							NEOINTIMAL HYPERPLASIA; CELL; EXPRESSION; KINASE; MODEL; INHIBITION; LYMPHOMA; ADHESION; WEIGHT; GPR30	Protocatechuic aldehyde (PCA), a phenolic aldehyde, has therapeutic potency against atherosclerosis. Although PCA is known to inhibit the migration and proliferation of vascular smooth muscle cells and intravascular thrombosis, the underlying mechanism remains unclear. In this study, we investigated the protective effect of PCA on endothelial cells and injured vessels in vivo in association with G protein-coupled estrogen receptor-1 (GPER-1). With PCA treatment, cAMP production was increased in HUVECs, while GPER-1 expression was increased in both HUVECs and a rat aortic explant. PCA and G1, a GPER-1 agonist, reduced H2O2 stimulated ROS production in HUVECs, whereas, G15, a GPER-1 antagonist, increased ROS production further. These elevations were inhibited by co-treatment with PCA or G1. TNF alpha stimulated the expression of inflammatory markers (VCAM-1, ICAM-1 and CD40), phospho-NF-kappa B, phospho-p38 and HIF-1 alpha; however, co-treatment with PCA or G1 down-regulated this expression significantly. Likewise, increased expression of inflammatory markers by treatment with G15 was inhibited by co-treatment with PCA. In re-endothelization, aortic ring sprouting and neointima formation assay, rat aortas treated with PCA or G1 showed accelerated re-endothelization of the endothelium and reduced sprouting and neointima formation. However, aortas from G15-treated rats showed decelerated re-endothelization and increased sprouting and neointima formation. The effects of G15 were restored by co-treatment with PCA or G1. Also, in the endothelia of these aortas, PCA and G1 increased CD31 and GPER-1 and decreased VCAM-1 and CD40 expression. In contrast, the opposite effect was observed in G15-treated endothelium. These results suggest that GPER-1 might mediate the protective effect of PCA on the endothelium.	[Cho, Yoon Hee] Yonsei Univ, Coll Med, Inst Endocrine Res, Seoul, South Korea; Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, YH (corresponding author), Yonsei Univ, Coll Med, Inst Endocrine Res, Seoul, South Korea.	wooriminji@yuhs.ac; ejlee423@yuhs.ac		Kong, ByungSoo/0000-0002-7916-7422; Lee, Eun Jig/0000-0002-9876-8370	Korea Health 21 Research and Development Project [A085136]; Ministry of Health & Welfare, Republic of Korea	Korea Health 21 Research and Development Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Funding: This work was supported by a grant (A085136) from the Korea Health 21 Research and Development Project, Ministry of Health & Welfare, Republic of Korea (http://www.nrf.re.kr/nrf_eng_ ms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; Chen J, 2012, ATHEROSCLEROSIS, V224, P332, DOI 10.1016/j.atherosclerosis.2012.07.020; Cho YH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/623639; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Geraldes P, 2006, CARDIOVASC RES, V71, P566, DOI 10.1016/j.cardiores.2006.05.015; Gupta P, 2012, BLOOD, V119, P3767, DOI 10.1182/blood-2011-09-381988; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hamza A, 2003, J BIOMOL STRUCT DYN, V20, P751, DOI 10.1080/07391102.2003.10506892; HOLLENBAUGH D, 1995, J EXP MED, V182, P33, DOI 10.1084/jem.182.1.33; Jeong JY, 2013, ENDOCRINOL METAB, V28, P288, DOI 10.3803/EnM.2013.28.4.288; Kawabe-Yako R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024646; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Koganti S, 2014, EUR J PHARMACOL, V723, P131, DOI 10.1016/j.ejphar.2013.10.064; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kuriyama I, 2013, MOL MED REP, V8, P535, DOI 10.3892/mmr.2013.1547; Mercier I, 2003, CARDIOVASC RES, V59, P883, DOI 10.1016/S0008-6363(03)00517-0; Milia AF, 2002, CIRC RES, V91, P346, DOI 10.1161/01.RES.0000031958.92781.9E; Moon CY, 2012, BIOCHEM BIOPH RES CO, V423, P116, DOI 10.1016/j.bbrc.2012.05.092; Nam YJ, 2013, ENDOCRINOL METAB, V28, P341, DOI 10.3803/EnM.2013.28.4.341; Nilsson BO, 2011, BRIT J PHARMACOL, V163, P1131, DOI 10.1111/j.1476-5381.2011.01235.x; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Potthoff SA, 2014, HYPERTENSION, V63, P265, DOI 10.1161/HYPERTENSIONAHA.113.02289; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; Wei G, 2013, INFLAMMATION, V36, P592, DOI 10.1007/s10753-012-9581-z; Wei MM, 2012, INFLAMMATION, V35, P1169, DOI 10.1007/s10753-011-9425-2; Zucchetti AE, 2014, HEPATOLOGY, V59, P1016, DOI 10.1002/hep.26752	33	23	24	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113242	10.1371/journal.pone.0113242	http://dx.doi.org/10.1371/journal.pone.0113242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411835	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000029
J	Mitrofanova, LB; Gorshkov, AN; Lebedev, DS; Mikhaylov, EN				Mitrofanova, Lubov B.; Gorshkov, Andrey N.; Lebedev, Dmitry S.; Mikhaylov, Evgeny N.			Evidence of Specialized Tissue in Human Interatrial Septum: Histological, Immunohistochemical and Ultrastructural Findings	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; CONDUCTION SYSTEM; HUMAN HEART; CATHETER ABLATION; PULMONARY VEINS; ATRIOVENTRICULAR NODE; PURKINJE-FIBERS; ANATOMY; ARCHITECTURE; RECONSTRUCTION	Background: There is a paucity of information on structural organization of muscular bundles in the interatrial septum (IAS). The aim was to investigate histologic and ultrastructural organization of muscular bundles in human IAS, including fossa ovalis (FO) and flap valve. Methods: Macroscopic and light microscopy evaluations of IAS were performed from postmortem studies of 40 patients. Twenty three IAS specimens underwent serial transverse sectioning, and 17 - longitudinal sectioning. The transverse sections from 10 patients were immunolabeled for HCN4, Caveolin3 and Connexin43. IAS specimens from 6 other patients underwent electron microscopy. Results: In all IAS specimens sections the FO, its rims and the flap valve had muscle fibers consisting of working cardiac myocytes. Besides the typical cardiomyocytes there were unusual cells: tortuous and horseshoe-shaped intertangled myocytes, small and large rounded myocytes with pale cytoplasm. The cells were aggregated in a definite structure in 38 (95%) cases, which was surrounded by fibro-fatty tissue. The height of the structure on transverse sections positively correlated with age (P = 0.03) and AF history (P = 0.045). Immunohistochemistry showed positive staining of the cells for HCN4 and Caveolin3. Electron microscopy identified cells with characteristics similar to electrical conduction cells. Conclusions: Specialized conduction cells in human IAS have been identified, specifically in the FO and its flap valve. The cells are aggregated in a structure, which is surrounded by fibrous and fatty tissue. Further investigations are warranted to explore electrophysiological characteristics of this structure.	[Mitrofanova, Lubov B.; Gorshkov, Andrey N.] Fed Almazov Med Res Ctr, Dept Pathol, St Petersburg, Russia; [Gorshkov, Andrey N.] Russian Acad Sci, Inst Cytol, Lab Cell Morphol, St Petersburg 194064, Russia; [Gorshkov, Andrey N.] Res Inst Influenza, Lab Struct & Funct Prote, St Petersburg, Russia; [Lebedev, Dmitry S.; Mikhaylov, Evgeny N.] Fed Almazov Med Res Ctr, Dept Arrythmol, St Petersburg, Russia; [Mikhaylov, Evgeny N.] Fed Almazov Med Res Ctr, Neuromodulat Unit, St Petersburg, Russia	Almazov National Medical Research Centre; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Almazov National Medical Research Centre; Almazov National Medical Research Centre	Mikhaylov, EN (corresponding author), Fed Almazov Med Res Ctr, Dept Arrythmol, St Petersburg, Russia.	e.mikhaylov@almazovcentre.ru	Mikhaylov, Evgeny N./K-7922-2012; Gorshkov, Andrey/J-3905-2016; Mikhaylov, Evgeny N/I-2902-2012; Lebedev, Dmitry S/I-1250-2016	Mikhaylov, Evgeny N./0000-0002-6553-9141; Gorshkov, Andrey/0000-0003-2303-1144; Mikhaylov, Evgeny N/0000-0002-6553-9141; Lebedev, Dmitry S/0000-0002-2334-1663	Russian Federation State Task program for the Almazov Centre	Russian Federation State Task program for the Almazov Centre	This work has been supported by the Russian Federation State Task program for the Almazov Centre 2012-2014#4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RH, 1999, CLIN ANAT, V12, P362, DOI 10.1002/(SICI)1098-2353(1999)12:5<362::AID-CA6>3.0.CO;2-F; Anderson RH, 2002, HEART, V88, P104, DOI 10.1136/heart.88.1.104; ANDERSON RH, 1974, EUR J CARDIOL, V2, P219; Anderson Robert H., 2004, Anatomical Record Part B:The New Anatomist, V280, P8, DOI 10.1002/ar.b.20028; Anderson RH, 2013, J CARDIOVASC TRANSL, V6, P187, DOI 10.1007/s12265-012-9433-0; Anderson RH, 2009, CLIN ANAT, V22, P99, DOI 10.1002/ca.20700; Andrey P, 2005, J NEUROSCI METH, V145, P233, DOI 10.1016/j.jneumeth.2005.01.006; Ansari A, 1999, ANAT REC, V254, P92, DOI 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3; Aschoff L., 1910, VERH DEUTSCH PATHOL, V14, P3; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Dixit S, 2008, HEART RHYTHM, V5, P174, DOI 10.1016/j.hrthm.2007.09.024; Fedorov VV, 2011, CIRC-ARRHYTHMIA ELEC, V4, P515, DOI 10.1161/CIRCEP.111.962258; Fukamizu S, 2013, J CARDIOVASC ELECTR, V24, P404, DOI 10.1111/jce.12059; Ho SY, 2001, HEART, V86, P265, DOI 10.1136/heart.86.3.265; JAMES TN, 1968, CIRCULATION, V37, P1049, DOI 10.1161/01.CIR.37.6.1049; JAMES TN, 1971, CIRCULATION, V44, P9, DOI 10.1161/01.CIR.44.1.9; James TN, 2001, PROG CARDIOVASC DIS, V43, P495, DOI 10.1053/pcad.2001.24598; LAMERS WH, 1992, CIRCULATION, V86, P1194, DOI 10.1161/01.CIR.86.4.1194; LOWE JE, 1988, BASIC RES CARDIOL, V83, P401, DOI 10.1007/BF02005826; Marrouche NF, 2004, CIRCULATION, V109, P2440, DOI 10.1161/01.CIR.0000129439.03836.96; Marrouche NF, 2002, J AM COLL CARDIOL, V40, P1133, DOI 10.1016/S0735-1097(02)02071-5; Mikhaylov E, 2011, J ELECTROCARDIOL, V44, P164, DOI 10.1016/j.jelectrocard.2010.11.002; Mikhaylov EN, 2015, J CARDIOVASC ELECTR, V26, P28, DOI 10.1111/jce.12543; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; onckeberg JG, 1910, VERH DEUTSCH PATHOL, V14, P64; OOSTHOEK PW, 1993, CIRC RES, V73, P482, DOI 10.1161/01.RES.73.3.482; Oral H, 2007, CIRCULATION, V115, P2606, DOI 10.1161/CIRCULATIONAHA.107.691386; Perez-Lugones A, 2003, J CARDIOVASC ELECTR, V14, P803, DOI 10.1046/j.1540-8167.2003.03075.x; Platonov PG, 2002, EUROPACE, V4, P183, DOI 10.1053/eupc.2002.0221; Platonov PG, 2008, HEART RHYTHM, V5, P1189, DOI 10.1016/j.hrthm.2008.04.025; Sanchez-Quintana D, 2003, REV ESP CARDIOL, V56, P1085, DOI 10.1157/13054255; Sanchez-Quintana D, 1997, J CARDIOVASC ELECTR, V8, P1396, DOI 10.1111/j.1540-8167.1997.tb01036.x; Sanders P, 2005, CIRCULATION, V112, P789, DOI 10.1161/CIRCULATIONAHA.104.517011; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Soufan AT, 2004, CIRC RES, V95, P1207, DOI 10.1161/01.RES.0000150852.04747.e1; VASSALLADAMS PR, 1983, EUR HEART J, V4, P449, DOI 10.1093/oxfordjournals.eurheartj.a061501; WIDRAN J, 1951, CIRCULATION, V4, P863, DOI 10.1161/01.CIR.4.6.863; Wong MCG, 2013, J CARDIOVASC ELECTR, V24, P413, DOI 10.1111/jce.12049; Yamamoto M, 2006, CARDIOVASC RES, V72, P271, DOI 10.1016/j.cardiores.2006.07.026; Yanni J, 2009, HEART RHYTHM, V6, P672, DOI 10.1016/j.hrthm.2009.01.021	41	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113343	10.1371/journal.pone.0113343	http://dx.doi.org/10.1371/journal.pone.0113343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412099	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000040
J	Perera, G; Khondoker, M; Broadbent, M; Breen, G; Stewart, R				Perera, Gayan; Khondoker, Mizanur; Broadbent, Matthew; Breen, Gerome; Stewart, Robert			Factors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DONEPEZIL; MORTALITY; DECLINE; SCALE	Background: Acetylcholinesterase inhibitors (AChEIs) are widely used to delay cognitive decline in Alzheimer's disease. Observational studies in routine clinical practice have shown cognitive improvement in some groups of patients receiving these agents but longitudinal trajectories before and after AChEI initiation have not previously been considered. Objectives: To compare trajectories of cognitive function before and after AChEI initiation and investigate predictors of these differences. Method: A retrospective longitudinal study was constructed using data from 2460 patients who received AChEIs and who had routine data on cognitive function (Mini-Mental State Examination; MMSE) before and after AChEI initiation. Longitudinal MMSE change was modelled using three-piece linear mixed models with the following segments: 0-12 months prior to AChEI initiation, 0-6 months and 6-36 months after initiation. Results: MMSE decline was reversed (in that the slope was improved by an average 4.2 units per year, 95% CI 3.5-4.8) during the 6-month period following AChEI initiation compared with the slope in the one year period before AChEI initiation. The slope in the period from 6-36 months following AChEI initiation returned to the pre-initiation downward trajectory. The differences in slopes in the 1 year period prior to AChEI initiation and in the 6 months after initiation were smaller among those with higher MMSE scores at the time of AChEI initiation, among those who received a vascular dementia diagnosis at any point, and among those receiving antipsychotic agents. Conclusion: In this naturalistic observational study, changes in cognitive trajectories around AChEI initiation were similar to those reported in randomised controlled trials. The magnitude of the difference in slopes between the 1 year period prior to AChEI initiation and the 6 month period after AChEI initiation was related to level of cognitive function at treatment initiation, vascular comorbidity and antipsychotic use.	[Perera, Gayan; Khondoker, Mizanur; Breen, Gerome; Stewart, Robert] Kings Coll London, Inst Psychiat, London WC2B 5RL, England; [Broadbent, Matthew] South London & Maudsley NHS Fdn Trust, London, England	University of London; King's College London; South London & Maudsley NHS Trust	Perera, G (corresponding author), Kings Coll London, Inst Psychiat, London WC2B 5RL, England.	gayan.perera@kcl.ac.uk	Khondoker, Mizanur/A-9860-2011; Khondoker, Mizanur/O-2656-2019; Breen, Gerome/Y-2706-2019; Breen, Gerome D/A-5540-2010; Stewart, Robert/B-1667-2010	Khondoker, Mizanur/0000-0002-1801-1635; Khondoker, Mizanur/0000-0002-1801-1635; Breen, Gerome/0000-0003-2053-1792; Breen, Gerome D/0000-0003-2053-1792; Stewart, Robert/0000-0002-4435-6397; Perera, Gayan/0000-0002-3414-303X	National Institute for Health Research (NIHR) Biomedical Research Centre; Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust and King's College London	National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust and King's College London	The data resource and all authors are funded by the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman S, 2011, BRIT J PSYCHIAT, V199, P119, DOI 10.1192/bjp.bp.110.086405; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Bowler JV, 1998, J NEUROL NEUROSUR PS, V65, P184, DOI 10.1136/jnnp.65.2.184; CHANG C, 2010, FILM COMMENT, V46, P6; Crane PK, 2008, J CLIN EPIDEMIOL, V61, P1018, DOI 10.1016/j.jclinepi.2007.11.011; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hayes RD, 2011, DRUG ALCOHOL DEPEN, V118, P56, DOI 10.1016/j.drugalcdep.2011.02.021; Herrmann N, 2005, CNS DRUGS, V19, P91, DOI 10.2165/00023210-200519020-00001; Inoue J, 2010, PSYCHOGERIATRICS, V10, P53, DOI 10.1111/j.1479-8301.2010.00319.x; Irizarry MC, 2008, J ALZHEIMERS DIS, V14, P301; Lopez OL, 2010, ALZHEIMERS DEMENT, V6, P431, DOI 10.1016/j.jalz.2010.04.003; Lopez-Pousa S, 2006, AGE AGEING, V35, P365, DOI 10.1093/ageing/afj083; Molinuevo JL, 2011, ARCH GERONTOL GERIAT, V52, P18, DOI 10.1016/j.archger.2009.11.004; Moretti A, 2011, CNS NEUROL DISORD-DR, V10, P370, DOI 10.2174/187152711794653832; Musicco M, 2009, J NEUROL, V256, P1288, DOI 10.1007/s00415-009-5116-4; Neary D, 1986, J NEUROL NEUROSUR PS, P49229; PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457; Proust-Lima C, 2011, AM J EPIDEMIOL, V174, P1077, DOI 10.1093/aje/kwr243; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rogers SL, 2000, EUR NEUROPSYCHOPHARM, V10, P195, DOI 10.1016/S0924-977X(00)00067-5; Santoro A, 2010, CNS DRUGS, V24, P163, DOI 10.2165/11310960-000000000-00000; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Van Der Putt R, 2006, INT J GERIATR PSYCH, V21, P755, DOI 10.1002/gps.1557; Wallin A, 2005, INT PSYCHOGERIATR, V17, P315; Wallin AK, 2004, DEMENT GERIATR COGN, V18, P197, DOI 10.1159/000079201; Wallin AK, 2007, DEMENT GERIATR COGN, V23, P150, DOI 10.1159/000098052; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489	27	52	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e109484	10.1371/journal.pone.0109484	http://dx.doi.org/10.1371/journal.pone.0109484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25411838	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000345253000002
J	Srivastava, G; Singh, K; Talat, M; Srivastava, ON; Kayastha, AM				Srivastava, Garima; Singh, Kritika; Talat, Mahe; Srivastava, Onkar Nath; Kayastha, Arvind M.			Functionalized Graphene Sheets As Immobilization Matrix for Fenugreek beta-Amylase: Enzyme Kinetics and Stability Studies	PLOS ONE			English	Article							OXIDE; STABILIZATION; COMPOSITE	beta-Amylase finds application in food and pharmaceutical industries. Functionalized graphene sheets were customised as a matrix for covalent immobilization of Fenugreek beta-amylase using glutaraldehyde as a cross-linker. The factors affecting the process were optimized using Response Surface Methodology based Box-Behnken design of experiment which resulted in 84% immobilization efficiency. Scanning and Transmission Electron Microscopy (SEM, TEM) and Fourier Tansform Infrared (FTIR) spectroscopy were employed for the purpose of characterization of attachment of enzyme on the graphene. The enzyme kinetic studies were carried out for obtaining best catalytic performance and enhanced reusability. Optimum temperature remained unchanged, whereas optimum pH showed shift towards acidic range for immobilized enzyme. Increase in thermal stability of immobilized enzyme and non-toxic nature of functionalized graphene can be exploited for production of maltose in food and pharmaceutical industries.	[Srivastava, Garima; Singh, Kritika; Kayastha, Arvind M.] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India; [Talat, Mahe; Srivastava, Onkar Nath] Banaras Hindu Univ, Dept Phys, Nanosci & Nanotechnol Unit, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Kayastha, AM (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	kayasthabhu@gmail.com		Kayastha, Arvind M./0000-0002-5090-7159	Council of Scientific and Industrial Research (CSIR), New Delhi, India; University Grants Commission-University with Potential for Excellence Grant (UGC-UPE) for innovative research from Banaras Hindu University; WOS-A (DST)	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission-University with Potential for Excellence Grant (UGC-UPE) for innovative research from Banaras Hindu University; WOS-A (DST)	This work was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India, in the form of Junior and Senior research fellowships to GS. AMK would like to thank University Grants Commission-University with Potential for Excellence Grant (UGC-UPE) for innovative research from Banaras Hindu University. MT is grateful to the WOS-A (DST) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANN YG, 1990, J FERMENT BIOENG, V70, P75, DOI 10.1016/0922-338X(90)90274-Z; Bernfeld P, 1955, METHODS ENZYMOLOGY; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryjak J, 2003, BIOCHEM ENG J, V16, P347, DOI 10.1016/S1369-703X(03)00114-1; Chang MY, 2007, BIOCHEM ENG J, V35, P93, DOI 10.1016/j.bej.2007.01.003; Dwevedi A, 2011, INT J BIOL MACROMOL, V49, P674, DOI 10.1016/j.ijbiomac.2011.06.027; Dwevedi A, 2009, BIOSENS BIOELECTRON, V25, P784, DOI 10.1016/j.bios.2009.08.029; Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011; Gu H, 2012, BIOSENS BIOELECTRON, V32, P118, DOI 10.1016/j.bios.2011.11.044; Hu NT, 2011, NANO-MICRO LETT, V3, P215, DOI 10.1007/BF03353675; Hwang ET, 2013, ENG LIFE SCI, V13, P49, DOI 10.1002/elsc.201100225; Konwarh R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225107; Li J, 2003, NANO LETT, V3, P55, DOI 10.1021/nl025778s; McAllister MJ, 2007, CHEM MATER, V19, P4396, DOI 10.1021/cm0630800; MOSBACH K, 1971, SCI AM, V224, P26, DOI 10.1038/scientificamerican0371-26; NEHETE PN, 1992, WORLD J MICROB BIOT, V8, P446, DOI 10.1007/BF01198763; Noda T, 2001, CARBOHYD POLYM, V44, P189, DOI 10.1016/S0144-8617(00)00226-5; Singh N, 2014, FOOD CHEM, V142, P430, DOI 10.1016/j.foodchem.2013.07.079; Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t; Srivastava G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088697; Stankovich S, 2006, CARBON, V44, P3342, DOI 10.1016/j.carbon.2006.06.004; Staudenmaier L., 1898, EUR J INORG CHEM, V31, P1481, DOI 10.1002/cber.18980310237; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; VIERA FB, 1988, BIOTECHNOL BIOENG, V31, P711, DOI 10.1002/bit.260310712; Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6; Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008; YOSHIDA M, 1989, AGR BIOL CHEM TOKYO, V53, P3139, DOI 10.1080/00021369.1989.10869824; Zhang JL, 2010, LANGMUIR, V26, P6083, DOI 10.1021/la904014z; Zhang XY, 2011, CARBON, V49, P986, DOI 10.1016/j.carbon.2010.11.005; Zhang YH, 2010, ACS NANO, V4, P7303, DOI 10.1021/nn1024219; Ziegler P, 1999, J CEREAL SCI, V29, P195, DOI 10.1006/jcrs.1998.0238	31	29	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113408	10.1371/journal.pone.0113408	http://dx.doi.org/10.1371/journal.pone.0113408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412079	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000049
J	Guan, WJ; Gao, YH; Xu, G; Lin, ZY; Tang, Y; Li, HM; Lin, ZM; Zheng, JP; Chen, RC; Zhong, NS				Guan, Wei-jie; Gao, Yong-hua; Xu, Gang; Lin, Zhi-ya; Tang, Yan; Li, Hui-min; Lin, Zhi-min; Zheng, Jin-ping; Chen, Rong-chang; Zhong, Nan-shan			Capsaicin Cough Sensitivity and the Association with Clinical Parameters in Bronchiectasis	PLOS ONE			English	Article							CYSTIC FIBROSIS BRONCHIECTASIS; VALIDATION; MORTALITY; TRPV1	Background: Cough hypersensitivity has been common among respiratory diseases. Objective: To determine associations of capsaicin cough sensitivity and clinical parameters in adults with clinically stable bronchiectasis. Methods: We recruited 135 consecutive adult bronchiectasis patients and 22 healthy subjects. History inquiry, sputum culture, spirometry, chest high-resolution computed tomography (HRCT), Leicester Cough Questionnaire scoring, Bronchiectasis Severity Index (BSI) assessment and capsaicin inhalation challenge were performed. Cough sensitivity was measured as the capsaicin concentration eliciting at least 2 (C-2) and 5 coughs (C-5). Results: Despite significant overlap between healthy subjects and bronchiectasis patients, both C-2 and C-5 were significantly lower in the latter group (all P<0.01). Lower levels of C-5 were associated with a longer duration of bronchiectasis symptoms, worse HRCT score, higher 24-hour sputum volume, BSI and sputum purulence score, and sputum culture positive for P. aeruginosa. Determinants associated with increased capsaicin cough sensitivity, defined as C-5 being 62.5 mu mol/L or less, encompassed female gender (OR: 3.25, 95%CI: 1.35-7.83, P<0.01), HRCT total score between 7-12 (OR: 2.57, 95%CI: 1.07-6.173, P = 0.04), BSI between 5-8 (OR: 4.05, 95%CI: 1.48-11.06, P<0.01) and 9 or greater (OR: 4.38, 95%CI: 1.48-12.93, P<0.01). Conclusion: Capsaicin cough sensitivity is heightened in a subgroup of bronchiectasis patients and associated with the disease severity. Gender and disease severity, but not sputum purulence, are independent determinants of heightened capsaicin cough sensitivity. Current testing for cough sensitivity diagnosis may be limited because of overlap with healthy subjects but might provide an objective index for assessment of cough in future clinical trials.	[Guan, Wei-jie; Lin, Zhi-ya; Tang, Yan; Li, Hui-min; Lin, Zhi-min; Zheng, Jin-ping; Chen, Rong-chang; Zhong, Nan-shan] Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Gao, Yong-hua] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou 450052, Henan, Peoples R China; [Xu, Gang] Guangzhou First Peoples Hosp, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Zhengzhou University; South China University of Technology	Zhong, NS (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	chenrc@vip.163.com; nanshan@vip.163.com	Guan, Wei-jie/K-8257-2019		Changjiang Scholars and Innovative Research Team in University [ITR0961]; National Key Technology R&D Program of the 12th National Five-year Development Plan [2012BAI05B01]; National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]	Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer	This research was supported by the Changjiang Scholars and Innovative Research Team in University ITR0961, The National Key Technology R&D Program of the 12th National Five-year Development Plan 2012BAI05B01 and National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer No. 2013BAI09B09 (to Profs. Zhong and Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar GA, 2013, RESP MED, V107, P1001, DOI 10.1016/j.rmed.2013.04.013; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; Chalmers JD, 2013, MOL IMMUNOL, V55, P27, DOI 10.1016/j.molimm.2012.09.011; Chan KKY, 2010, EUR RESPIR J, V35, P368, DOI 10.1183/09031936.00110409; Chung KF, 2011, PULM PHARMACOL THER, V24, P267, DOI 10.1016/j.pupt.2011.01.012; Couto M, 2013, J INVEST ALLERG CLIN, V23, P289; Goeminne PC, 2014, RESP MED, V108, P287, DOI 10.1016/j.rmed.2013.12.015; Goeminne PC, 2014, RESPIROLOGY, V19, P203, DOI 10.1111/resp.12219; Hilton ECY, 2013, J ALLERGY CLIN IMMUN, V132, P847, DOI 10.1016/j.jaci.2013.04.042; Ho JC, 2001, AM J RESP CRIT CARE, V163, P983, DOI 10.1164/ajrccm.163.4.9909121; KLINK ME, 1994, CHEST, V105, P151, DOI 10.1378/chest.105.1.151; Lee LY, 2011, PULM PHARMACOL THER, V24, P280, DOI 10.1016/j.pupt.2010.12.003; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Ma W, 2009, COUGH, V25, P5; Mandal P, 2014, LANCET RESP MED, V2, P455, DOI 10.1016/S2213-2600(14)70050-5; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Milross Maree A, 2002, Sleep Med, V3, P205, DOI 10.1016/S1389-9457(01)00157-5; Morice Alyn H, 2013, Cough, V9, P14, DOI 10.1186/1745-9974-9-14; Murray MP, 2009, EUR RESPIR J, V34, P125, DOI 10.1183/09031936.00160508; Olveira C, 2013, QUAL LIFE RES, V22, P597, DOI 10.1007/s11136-012-0188-5; Park HK, 2006, THORAX, V61, P1070, DOI 10.1136/thx.2005.054429; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Torrego A, 2006, THORAX, V61, P706, DOI 10.1136/thx.2005.049767; Tsang K W, 2000, Respirology, V5, P91, DOI 10.1046/j.1440-1843.2000.00233.x; Tsang KW, 2009, RESPIROLOGY, V14, P637, DOI 10.1111/j.1440-1843.2009.01569.x; Tsang KW, 2000, CHEST, V117, P420, DOI 10.1378/chest.117.2.420; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Varechova S, 2008, J PHYSIOL PHARMACOL, V59, P719; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50	33	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113057	10.1371/journal.pone.0113057	http://dx.doi.org/10.1371/journal.pone.0113057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409316	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200060
J	Tu, CC; Spencer, JV				Tu, Carolyn C.; Spencer, Juliet V.			The DRY Box and C-Terminal Domain of the Human Cytomegalovirus US27 Gene Product Play a Role in Promoting Cell Growth and Survival	PLOS ONE			English	Article							IDENTIFICATION; TRANSCRIPTION; INFECTION	Human cytomegalovirus (HCMV) is a widespread pathogen that can lay dormant in healthy individuals and establish lifelong latent infection. This successful co-existence is facilitated by a number of viral gene products that manipulate host cellular functions and immune responses. Among these immunomodulatory genes are four G-protein coupled receptors (GPCRs) encoded by HCMV, designated US27, US28, UL33, and UL78. Studies have shown the US28 gene product to be a functional chemokine receptor that signals both constitutively and in a ligand-dependent manner, resulting in a wide range of cellular effects. In previous work, we have found that US27 expression results in at least two biological effects: enhanced CXCR4 signaling and increased in cellular proliferation in HEK293 cells. Here, we examined the involvement of two protein domains, the DRY box and the C-terminal intracellular domain (CTD) of US27, in mediating both cell proliferation and survival. While both domains were required for a proliferative effect, loss of either domain only moderately impacted cell survival, suggesting that US27 may interact with cell survival pathways through protein regions other than the DRY box and CTD. Quantitative RT-PCR arrays were used to profile changes in cellular gene expression in the HEK293-US27 cell line, and down-regulation of cell cycle regulators CDKN1A/p21/CIP1 (cyclin dependent kinase inhibitor 1A) and SESN (Sestrin2 or Hi95) was observed. These results indicate that increased cell proliferation due to US27 may be linked to suppression of negative growth regulators, and that these interactions require the DRY box and CTD.	[Tu, Carolyn C.; Spencer, Juliet V.] Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA	University of San Francisco	Spencer, JV (corresponding author), Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA.	jspencer@usfca.edu			National Institutes of Health [AI074029, CA158767]; Lily Drake Cancer Fund; USF Faculty Development Funds; NATIONAL CANCER INSTITUTE [R15CA158767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI074029, R15AI111232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lily Drake Cancer Fund; USF Faculty Development Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (www.nih.gov) grants AI074029 and CA158767, the Lily Drake Cancer Fund, and USF Faculty Development Funds (www.usfca.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnolds KL, 2013, VIROLOGY, V439, P122, DOI 10.1016/j.virol.2013.02.006; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Brennan DC, 2001, J AM SOC NEPHROL, V12, P848, DOI 10.1681/ASN.V124848; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; de la Hoz RE, 2002, J CLIN VIROL, V25, pS1, DOI 10.1016/S1386-6532(02)00091-4; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Han Y, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1743; HARPER JW, 1993, CELL, V75, P805; Kesson AM, 2007, PAEDIATR RESPIR REV, V8, P231, DOI 10.1016/j.prrv.2007.07.005; Lares AP, 2013, VIRUS RES, V176, P312, DOI 10.1016/j.virusres.2013.07.002; Margulies BJ, 2007, VIRUS RES, V123, P57, DOI 10.1016/j.virusres.2006.08.003; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Mocarski ES, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P465; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10; Pleskoff O, 2005, FEBS J, V272, P4163, DOI 10.1111/j.1742-4658.2005.04829.x; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; Revello MG, 2008, J MED VIROL, V80, P1415, DOI 10.1002/jmv.21243; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Stapleton LK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-42; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Waldhoer M, 2002, J VIROL, V76, P8161, DOI 10.1128/JVI.76.16.8161-8168.2002	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113427	10.1371/journal.pone.0113427	http://dx.doi.org/10.1371/journal.pone.0113427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409008	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200118
J	Bienkowska, J; Allaire, N; Thai, A; Goyal, J; Plavina, T; Nirula, A; Weaver, M; Newman, C; Petri, M; Beckman, E; Browning, JL				Bienkowska, Jadwiga; Allaire, Norm; Thai, Alice; Goyal, Jaya; Plavina, Tatiana; Nirula, Ajay; Weaver, Megan; Newman, Charlotte; Petri, Michelle; Beckman, Evan; Browning, Jeffrey L.			Lymphotoxin-LIGHT Pathway Regulates the Interferon Signature in Rheumatoid Arthritis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DENDRITIC CELLS; I INTERFERON; PHASE-I; MONOCLONAL-ANTIBODY; IFN RESPONSE; ALPHA-BETA; ACTIVATION; EXPRESSION; MACROPHAGES	A subset of patients with autoimmune diseases including rheumatoid arthritis (RA) and lupus appear to be exposed continually to interferon (IFN) as evidenced by elevated expression of IFN induced genes in blood cells. In lupus, detection of endogenous chromatin complexes by the innate sensing machinery is the suspected driver for the IFN, but the actual mechanisms remain unknown in all of these diseases. We investigated in two randomized clinical trials the effects on RA patients of baminercept, a lymphotoxin-beta receptor-immunoglobulin fusion protein that blocks the lymphotoxin-alpha beta/LIGHT axis. Administration of baminercept led to a reduced RNA IFN signature in the blood of patients with elevated baseline signatures. Both RA and SLE patients with a high IFN signature were lymphopenic and lymphocyte counts increased following baminercept treatment of RA patients. These data demonstrate a coupling between the lymphotoxin-LIGHT system and IFN production in rheumatoid arthritis. IFN induced retention of lymphocytes within lymphoid tissues is a likely component of the lymphopenia observed in many autoimmune diseases.	[Bienkowska, Jadwiga; Allaire, Norm; Thai, Alice; Goyal, Jaya; Plavina, Tatiana] Biogen Idec Inc, Translat Med, Cambridge, MA USA; [Nirula, Ajay; Beckman, Evan; Browning, Jeffrey L.] Biogen Idec Inc, Immunobiol, Cambridge, MA USA; [Weaver, Megan; Newman, Charlotte] Biogen Idec Inc, Global Clin Operat, Cambridge, MA USA; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Biogen; Biogen; Biogen; Johns Hopkins University	Browning, JL (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.	browninj@bu.edu			Biogen Idec	Biogen Idec(Biogen)	Biogen Idec conducted, funded and provided infrastructure for these studies and had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are listed in the authors contributions section.	Allaire Normand E, 2013, BMC Res Notes, V6, P8, DOI 10.1186/1756-0500-6-8; Assassi S, 2010, ARTHRITIS RHEUM-US, V62, P589, DOI 10.1002/art.27224; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; BROWNING JL, 1995, J IMMUNOL, V154, P33; Cain DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019957; Cantaert T, 2010, RHEUMATOLOGY, V49, P156, DOI 10.1093/rheumatology/kep345; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; De Trez C, 2012, IMMUNOBIOLOGY, V217, P1250, DOI 10.1016/j.imbio.2012.06.010; deLuca LS, 2012, NAT REV IMMUNOL, V12, P339, DOI 10.1038/nri3193; Deluca LS, 2011, P NATL ACAD SCI USA, V108, P2046, DOI 10.1073/pnas.1014188108; Elewaut D, 2007, TRENDS IMMUNOL, V28, P169, DOI 10.1016/j.it.2007.02.005; Elkon KB, 2012, CURR OPIN IMMUNOL, V24, P665, DOI 10.1016/j.coi.2012.08.004; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; Gao YF, 2009, BLOOD, V114, P2623, DOI 10.1182/blood-2008-10-183301; Gommerman JL, 2014, CYTOKINE GR IN PRESS; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Hall JC, 2012, P NATL ACAD SCI USA, V109, P17609, DOI 10.1073/pnas.1209724109; Hartrich L, 2003, J NEUROIMMUNOL, V139, P84, DOI 10.1016/S0165-5728(03)00135-8; Heesters BA, 2014, MOL IMMUNOL; Higgs BW, 2014, ANN RHEUM DIS, V73, P256, DOI 10.1136/annrheumdis-2012-202794; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Huang YL, 2009, ARTHRITIS RHEUM-US, V60, P3766, DOI 10.1002/art.25019; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kirou KA, 2013, CLIN IMMUNOL, V148, P303, DOI 10.1016/j.clim.2013.02.013; Klaas M, 2012, J IMMUNOL, V189, P2414, DOI 10.4049/jimmunol.1200776; Klaas M, 2012, SEMIN IMMUNOPATHOL, V34, P353, DOI 10.1007/s00281-012-0310-3; Knight JS, 2012, CURR OPIN RHEUMATOL, V24, P441, DOI 10.1097/BOR.0b013e3283546703; Kutsch S, 2008, IMMUNOBIOLOGY, V213, P353, DOI 10.1016/j.imbio.2007.10.011; Lepelletier Y, 2010, BLOOD, V116, P3389, DOI 10.1182/blood-2010-05-282913; Lorenzi S, 2011, J IMMUNOL, V186, P5142, DOI 10.4049/jimmunol.1004163; Lu TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00047; Mavragani CP, 2007, ARTHRITIS RHEUM, V56, P3995, DOI 10.1002/art.23062; Mavragani CP, 2010, ARTHRITIS RHEUM-US, V62, P392, DOI 10.1002/art.27226; McBride JM, 2012, ARTHRITIS RHEUM-US, V64, P3666, DOI 10.1002/art.34632; Migliorini A, 2012, NAT REV NEPHROL, V8, P183, DOI 10.1038/nrneph.2011.197; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Petri M, 2013, ARTHRITIS RHEUM-US, V65, P1011, DOI 10.1002/art.37824; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Raterman HG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3819; Remouchamps C, 2011, CYTOKINE GROWTH F R, V22, P301, DOI 10.1016/j.cytogfr.2011.11.007; Reynier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024828; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Rose T, 2013, ANN RHEUM DIS, V72, P1639, DOI 10.1136/annrheumdis-2012-201586; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Steinberg MW, 2011, IMMUNOL REV, V244, P169, DOI 10.1111/j.1600-065X.2011.01064.x; Thurlings RM, 2010, ARTHRITIS RHEUM-US, V62, P3607, DOI 10.1002/art.27702; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; Upadhyay V, 2013, NAT REV IMMUNOL, V13, P270, DOI 10.1038/nri3406; Vallabhapurapu S, 2008, EUR J IMMUNOL, V38, P3508, DOI 10.1002/eji.200737830; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; Van den Broeck T, 2013, J IMMUNOL, V190, P1982, DOI 10.4049/jimmunol.1200354; Verma S, 2013, J VIROL, V87, P6201, DOI 10.1128/JVI.00113-13; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Wege AK, 2013, INNATE IMMUNITY; Yao YH, 2013, AUTOIMMUN REV, V12, P558, DOI 10.1016/j.autrev.2012.10.006; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; Yoshida S, 2012, SCAND J RHEUMATOL, V41, P170, DOI 10.3109/03009742.2011.623137	75	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112545	10.1371/journal.pone.0112545	http://dx.doi.org/10.1371/journal.pone.0112545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405351	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300038
J	Nunez, M; Sanchez-Jimenez, C; Alcalde, J; Izquierdo, JM				Nunez, Mario; Sanchez-Jimenez, Carmen; Alcalde, Jose; Izquierdo, Jose M.			Long-Term Reduction of T-Cell Intracellular Antigens Reveals a Transcriptome Associated with Extracellular Matrix and Cell Adhesion Components	PLOS ONE			English	Article							MESSENGER-RNA; PROTEIN TIA-1; BINDING; IDENTIFICATION; EXPRESSION; GENE; NORMALIZATION; REGULATOR; GENECODIS; DYNAMICS	Knockdown of T-cell intracellular antigens TIA1 and TIAR contributes to a cellular phenotype characterised by uncontrolled proliferation and tumorigenesis. Massive-scale poly(A+) RNA sequencing of TIA1 or TIAR-knocked down HeLa cells reveals transcriptome signatures comprising genes and functional categories potentially able to modulate several aspects of membrane dynamics associated with extracellular matrix and focal/cell adhesion events. The transcriptomic heterogeneity is the result of differentially expressed genes and RNA isoforms generated by alternative splicing and/or promoter usage. These results suggest a role for TIA proteins in the regulation and/or modulation of cellular homeostasis related to focal/cell adhesion, extracellular matrix and membrane and cytoskeleton dynamics.	[Nunez, Mario; Sanchez-Jimenez, Carmen; Alcalde, Jose; Izquierdo, Jose M.] Univ Autonoma Madrid CSIC UAM, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Izquierdo, JM (corresponding author), Univ Autonoma Madrid CSIC UAM, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain.	jmizquierdo@cbm.uam.es		Izquierdo, Jose M/0000-0002-7942-4046	Ministerio de Economia y Competitividad-FEDER [BFU2008-00354, BFU2011-29653]; Fundacion Ramon Areces, Spain	Ministerio de Economia y Competitividad-FEDER; Fundacion Ramon Areces, Spain	This work was supported by grants from Ministerio de Economia y Competitividad-FEDER (BFU2008-00354 and BFU2011-29653). The CBMSO receives an institutional grant from Fundacion Ramon Areces, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznarez I, 2008, GENOME RES, V18, P1247, DOI 10.1101/gr.073155.107; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Carrascoso I, 2014, BIOCHEM J, V461, P43, DOI 10.1042/BJ20140227; Carrascoso I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-90; Chen Y, 2011, BIO-PROTOCOL, V1, pe98; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Duperret EK, 2013, CELL CYCLE, V12, P3272, DOI 10.4161/cc.26385; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Gottschald OR, 2010, J MOL CELL BIOL, V2, P345, DOI 10.1093/jmcb/mjq032; Heck MV, 2014, NEUROGENETICS, V15, P135, DOI 10.1007/s10048-014-0397-x; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2011, BIOCHEM J, V435, P337, DOI 10.1042/BJ20101030; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Karalok HM, 2014, J CLIN ENDOCRINOL ME, V20; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kharraz Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011352; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li X, 2014, MOL CELL, V55, P305, DOI 10.1016/j.molcel.2014.05.027; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; McAlinden A, 2007, J BIOL CHEM, V282, P24444, DOI 10.1074/jbc.M702717200; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Miyazaki H, 2012, FEMS IMMUNOL MED MIC, V65, P481, DOI 10.1111/j.1574-695X.2012.00979.x; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oliveros JC., 2007, FIESTA BIOINFOGP INT; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Reyes R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r87; Sanchez-Jimenez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075127; Sanchez-Jimenez C, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-4; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Zadeh MAH, 2015, MOL ONCOL, V9, P167, DOI 10.1016/j.molonc.2014.07.017; Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003	52	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113141	10.1371/journal.pone.0113141	http://dx.doi.org/10.1371/journal.pone.0113141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405991	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300085
J	Oliveira, V; Akamine, EH; Carvalho, MHC; Michelini, LC; Fortes, ZB; Cunha, TS; Franco, MD				Oliveira, Vanessa; Akamine, Eliana Hiromi; Carvalho, Maria Helena C.; Michelini, Lisete Compagno; Fortes, Zuleica Bruno; Cunha, Tatiana Sousa; Franco, Maria do Carmo			Influence of Aerobic Training on the Reduced Vasoconstriction to Angiotensin II in Rats Exposed to Intrauterine Growth Restriction: Possible Role of Oxidative Stress and AT(2) Receptor of Angiotensin II	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; FRUCTOSE-RICH DIET; ENDOTHELIAL DYSFUNCTION; BLOOD-PRESSURE; NITRIC-OXIDE; UNDERNOURISHED RATS; HEART-FAILURE; CARDIOVASCULAR-DISEASE; NADPH OXIDASE; ADULT LIFE	Intrauterine growth restriction (IUGR) is associated with impaired vascular function, which contributes to the increased incidence of chronic disease. The aim of this study was to investigate whether aerobic training improves AngII-induced vasoconstriction in IUGR rats. Moreover, we assess the role of superoxide dismutase (SOD) isoforms and NADPH oxidase-derived superoxide anions in this improvement. Female Wistar rats were randomly divided into two groups on day 1 of pregnancy. A control group was fed standard chow ad libitum, and a restricted group was fed 50% of the ad libitum intake throughout gestation. At 8 weeks of age, male offspring from both groups were randomly assigned to 4 experimental groups: sedentary control (SC), trained control (TC), sedentary restricted (SRT), and trained restricted (TRT). The training protocol was performed on a treadmill and consisted of a continuous 60-min session 5 days/week for 10 weeks. Following aerobic training, concentration-response curves to AngII were obtained in endothelium-intact aortic rings. Protein expression of SOD isoforms, AngII receptors and the NADPH oxidase component p47(phox) was assessed by Western blot analysis. The dihydroethidium was used to evaluate the in situ superoxide levels under basal conditions or in the presence of apocynin, losartan or PD 123,319. Our results indicate that aerobic training can prevent IUGR-associated increases in AngII-dependent vasoconstriction and can restore basal superoxide levels in the aortic rings of TRT rats. Moreover, we observed that aerobic training normalized the increased p47(phox) protein expression and increased MnSOD and AT(2) receptor protein expression in thoracic aortas of SRT rats. In summary, aerobic training can result in an upregulation of antioxidant defense by improved of MnSOD expression and attenuation of NADPH oxidase component p47(phox). These effects are accompanied by increased expression of AT(2) receptor, which provide positive effects against Ang II-induced superoxide generation, resulting in attenuation of AngII-induced vasoconstriction.	[Oliveira, Vanessa; Franco, Maria do Carmo] Univ Fed Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [Akamine, Eliana Hiromi; Carvalho, Maria Helena C.; Fortes, Zuleica Bruno] Univ Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Michelini, Lisete Compagno] Univ Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Cunha, Tatiana Sousa] Univ Fed Sao Paulo, Sci & Technol Inst, Sao Paulo, Brazil; [Franco, Maria do Carmo] Univ Fed Sao Paulo, Sch Med, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Franco, MD (corresponding author), Univ Fed Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	maria.franco@unifesp.br	Franco, Maria CP/F-9421-2012; do Carmo P Franco, Maria/F-7771-2015; Sousa Cunha, Tatiana/GLN-2685-2022; Carvalho, Maria Helena C/C-8539-2013; Cunha, Tatiana S/G-4662-2012; Oliveira, Vanessa/AAA-4748-2021; Akamine, Eliana Hiromi/C-5231-2012	Franco, Maria CP/0000-0003-0604-7689; Sousa Cunha, Tatiana/0000-0001-9070-1414; Cunha, Tatiana S/0000-0001-9070-1414; Akamine, Eliana Hiromi/0000-0003-2715-7158	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/58044-2, 2010/51904-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by project grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2007/58044-2 and 2010/51904-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSIO HM, 1988, J APPL PHYSIOL, V64, P1333, DOI 10.1152/jappl.1988.64.4.1333; Andresen JJ, 2004, AM J PHYSIOL-HEART C, V287, pH1141, DOI 10.1152/ajpheart.01215.2003; Bacon SL, 2004, SPORTS MED, V34, P307, DOI 10.2165/00007256-200434050-00003; BARKER DJP, 1993, BRIT MED J, V306, P422, DOI 10.1136/bmj.306.6875.422; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Cambri LT, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-164; Cambri LT, 2010, APPL PHYSIOL NUTR ME, V35, P490, DOI 10.1139/H10-034; Ceravolo GS, 2007, LIFE SCI, V80, P782, DOI 10.1016/j.lfs.2006.11.006; Chakraphan D, 2005, CLIN HEMORHEOL MICRO, V32, P217; Chrissobolis S, 2010, HYPERTENSION, V55, P905, DOI 10.1161/HYPERTENSIONAHA.109.147041; Ciampone S, 2011, J RENIN-ANGIO-ALDO S, V12, P394, DOI 10.1177/1470320311408750; da Rocha RF, 2010, CELL BIOCHEM FUNCT, V28, P190, DOI 10.1002/cbf.1640; Delbin MA, 2011, INFLAMMATION, V34, P319, DOI 10.1007/s10753-010-9237-9; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Franco MD, 2002, J CARDIOVASC PHARM, V40, P501, DOI 10.1097/00005344-200210000-00002; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; Franco MDP, 2003, J CARDIOVASC PHARM, V42, P211, DOI 10.1097/00005344-200308000-00009; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Gaspari TA, 2012, HYPERTENSION, V60, P17, DOI 10.1161/HYPERTENSIONAHA.112.193375; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Kemi OJ, 2013, SCAND CARDIOVASC J, V47, P160, DOI 10.3109/14017431.2012.754935; Kimura H, 2010, CLIN EXP HYPERTENS, V32, P407, DOI 10.3109/10641961003667930; Langley-Evans SC, 1999, BIOCHEM SOC T, V27, P88, DOI 10.1042/bst0270088; Lawler JM, 2009, AM J PHYSIOL-REG I, V296, pR1496, DOI 10.1152/ajpregu.90314.2008; Li JM, 2003, J BIOL CHEM, V278, P12094, DOI 10.1074/jbc.M209793200; Li Y, 2012, CARDIOVASC DIAGN THE, V2, P56, DOI 10.3978/j.issn.2223-3652.2012.02.02; Maiorana AJ, 2011, HYPERTENSION, V57, P56, DOI 10.1161/HYPERTENSIONAHA.110.163022; McAllister RM, 2008, APPL PHYSIOL NUTR ME, V33, P173, DOI 10.1139/H07-146; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Pal S, 2013, J AM SOC HYPERTENS, V7, P494, DOI 10.1016/j.jash.2013.07.004; Roque FR, 2013, BRIT J PHARMACOL, V168, P686, DOI 10.1111/j.1476-5381.2012.02224.x; Rosety-Rodriguez M, 2012, MED SCI MONITOR, V18, pBR346, DOI 10.12659/MSM.883343; Sabuhi R, 2011, AM J PHYSIOL-RENAL, V300, pF700, DOI 10.1152/ajprenal.00616.2010; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Sohn HY, 2000, BRIT J PHARMACOL, V131, P667, DOI 10.1038/sj.bjp.0703566; Tinken TM, 2010, HYPERTENSION, V55, P312, DOI 10.1161/HYPERTENSIONAHA.109.146282; Toda N, 2007, PHARMACOL REV, V59, P54, DOI 10.1124/pr.59.1.2; Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760; Trott DW, 2009, J APPL PHYSIOL, V106, P1925, DOI 10.1152/japplphysiol.91232.2008; Wagenaar LJ, 2002, CAN J CARDIOL, V18, P1331; Warnholtz A, 1999, CIRCULATION, V99, P2027, DOI 10.1161/01.CIR.99.15.2027; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Wollert KC, 1999, CARDIOVASC RES, V43, P838, DOI 10.1016/S0008-6363(99)00145-5	49	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113035	10.1371/journal.pone.0113035	http://dx.doi.org/10.1371/journal.pone.0113035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406086	gold, Green Submitted, Green Published			2022-12-27	WOS:000347121300072
J	Paerl, HW; Xu, H; Hall, NS; Zhu, GW; Qin, BQ; Wu, YL; Rossignol, KL; Dong, LH; McCarthy, MJ; Joyner, AR				Paerl, Hans W.; Xu, Hai; Hall, Nathan S.; Zhu, Guangwei; Qin, Boqiang; Wu, Yali; Rossignol, Karen L.; Dong, Linghan; McCarthy, Mark J.; Joyner, Alan R.			Controlling Cyanobacterial Blooms in Hypertrophic Lake Taihu, China: Will Nitrogen Reductions Cause Replacement of Non-N-2 Fixing by N-2 Fixing Taxa?	PLOS ONE			English	Article							CONTROLLING EUTROPHICATION; PHYTOPLANKTON GROWTH; SHALLOW LAKES; PHOSPHORUS; INPUTS; DOMINANCE; RATIOS; LIMITATION; COMMUNITY; DYNAMICS	Excessive anthropogenic nitrogen (N) and phosphorus (P) inputs have caused an alarming increase in harmful cyanobacterial blooms, threatening sustainability of lakes and reservoirs worldwide. Hypertrophic Lake Taihu, China's third largest freshwater lake, typifies this predicament, with toxic blooms of the non-N-2 fixing cyanobacteria Microcystis spp. dominating from spring through fall. Previous studies indicate N and P reductions are needed to reduce bloom magnitude and duration. However, N reductions may encourage replacement of non-N-2 fixing with N-2 fixing cyanobacteria. This potentially counterproductive scenario was evaluated using replicate, large (1000 L), in-lake mesocosms during summer bloom periods. N+P additions led to maximum phytoplankton production. Phosphorus enrichment, which promoted N limitation, resulted in increases in N-2 fixing taxa (Anabaena spp.), but it did not lead to significant replacement of non-N-2 fixing with N-2 fixing cyanobacteria, and N-2 fixation rates remained ecologically insignificant. Furthermore, P enrichment failed to increase phytoplankton production relative to controls, indicating that N was the most limiting nutrient throughout this period. We propose that Microcystis spp. and other non-N-2 fixing genera can maintain dominance in this shallow, highly turbid, nutrient-enriched lake by outcompeting N-2 fixing taxa for existing sources of N and P stored and cycled in the lake. To bring Taihu and other hypertrophic systems below the bloom threshold, both N and P reductions will be needed until the legacy of high N and P loading and sediment nutrient storage in these systems is depleted. At that point, a more exclusive focus on P reductions may be feasible.	[Paerl, Hans W.; Hall, Nathan S.; Rossignol, Karen L.; Dong, Linghan; Joyner, Alan R.] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Xu, Hai; Zhu, Guangwei; Qin, Boqiang; Wu, Yali] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [McCarthy, Mark J.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA	University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Texas System; University of Texas Austin	Paerl, HW (corresponding author), Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA.	hpaerl@email.unc.edu	McCarthy, Mark/E-3071-2015; Qin, Boqiang/E-5900-2013	McCarthy, Mark/0000-0002-2246-5947; 	US National Science Foundation [0826819, 1230543, 1240851]; National Science Foundation of China [41003043, 41230744]; Natural Science Foundation of Jiangsu Province [BK2012895]; External Cooperation Program of Chinese Academy of Sciences; Direct For Biological Sciences [1240851] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); External Cooperation Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the US National Science Foundation (0826819, 1230543, and 1240851), the National Science Foundation of China (41003043, 41230744), Natural Science Foundation of Jiangsu Province (BK2012895), and the External Cooperation Program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2007, LIMNOL OCEANOGR-METH, V5, P111, DOI 10.4319/lom.2007.5.111; [Anonymous], 1980, FRESHWATER ALGAE CHI; APHA, 1995, STANDARD METHODS EXA, Vnineteenth; Attridge EM, 1997, NEW PHYTOL, V135, P517, DOI 10.1046/j.1469-8137.1997.00666.x; BLOMQVIST P, 1994, ARCH HYDROBIOL, V132, P141; Bryhn AC, 2009, P NATL ACAD SCI USA, V106, pE3, DOI 10.1073/pnas.0810905106; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; DODDS W K, 1989, Lake and Reservoir Management, V5, P21; EBINA J, 1983, WATER RES, V17, P1721, DOI 10.1016/0043-1354(83)90192-6; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; FOGG GE, 1974, ALGAL PHYSL BIOCH, P560; Havens KE, 2003, ENVIRON POLLUT, V122, P379, DOI 10.1016/S0269-7491(02)00304-4; Howarth R, 2012, FRONT ECOL ENVIRON, V10, P37, DOI 10.1890/100178; Jeppesen E, 2007, HYDROBIOLOGIA, V584, P239, DOI 10.1007/s10750-007-0596-7; KAPPERS FI, 1980, HYPERTROPHIC ECOSYST, P37; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Likens GE, 1972, AM SOC LIMN OC SPEC; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; McCarthy MJ, 2007, HYDROBIOLOGIA, V581, P195, DOI 10.1007/s10750-006-0496-2; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Paerl Hans W., 1996, Phycologia, V35, P160, DOI 10.2216/i0031-8884-35-6S-160.1; Paerl HW, 2009, ESTUAR COAST, V32, P593, DOI 10.1007/s12237-009-9158-8; Paerl Hans W., 1998, P3; PAERL HW, 1990, ADV MICROB ECOL, V11, P305; Papista E, 2002, HYDROBIOLOGIA, V485, P191, DOI 10.1023/A:1021329602685; Paterson MJ, 2011, LIMNOL OCEANOGR, V56, P1545, DOI 10.4319/lo.2011.56.4.1545; Pinckney JL, 2001, ORG GEOCHEM, V32, P585, DOI 10.1016/S0146-6380(00)00196-0; Qin BQ, 2007, HYDROBIOLOGIA, V581, P1, DOI 10.1007/s10750-006-0522-4; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; Scheffer M, 1997, ECOLOGY, V78, P272; Schindler D. W., 1975, INT VEREINIGUNG F R, V19, P3221; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schluter L, 2006, FRESHWATER BIOL, V51, P1474, DOI 10.1111/j.1365-2427.2006.01582.x; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Shi K, 2014, REMOTE SENS ENVIRON, V140, P365, DOI 10.1016/j.rse.2013.09.013; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Smolders AJP, 2010, BIOGEOCHEMISTRY, V98, P1, DOI 10.1007/s10533-009-9387-8; Spivak AC, 2011, FRESHWATER BIOL, V56, P279, DOI 10.1111/j.1365-2427.2010.02495.x; Trolle D, 2009, HYDROBIOLOGIA, V627, P31, DOI 10.1007/s10750-009-9713-0; VANHEUKELEM L, 1994, MAR ECOL PROG SER, V114, P303, DOI 10.3354/meps114303; Visser PM., 2005, HARMFUL CYANOBACTERI, V3; Xu H, 2013, HYDROBIOLOGIA, V700, P187, DOI 10.1007/s10750-012-1229-3; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Zhang YL, 2006, SCI CHINA SER D, V49, P114, DOI 10.1007/s11430-006-8111-y	57	76	83	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113123	10.1371/journal.pone.0113123	http://dx.doi.org/10.1371/journal.pone.0113123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405474	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300081
J	Golnabi, AH; Harris, RS; Venegas, JG; Winkler, T				Golnabi, Amir H.; Harris, R. Scott; Venegas, Jose G.; Winkler, Tilo			Deep Inspiration and the Emergence of Ventilation Defects during Bronchoconstriction: A Computational Study	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; HEALTHY-SUBJECTS; NONASTHMATIC SUBJECTS; METHACHOLINE; ASTHMA; LUNG; INFLATION; VOLUME; RESPONSIVENESS; HETEROGENEITY	Deep inspirations (DIs) have a dilatory effect on airway smooth muscle (ASM) that helps to prevent or reduce more severe bronchoconstriction in healthy individuals. However, this bronchodilation appears to fail in some asthmatic patients or under certain conditions, and the reason is unclear. Additionally, quantitative effects of the frequency and magnitude of DIs on bronchodilation are not well understood. In the present study, we used a computational model of bronchoconstriction to study the effects of DI volumes, time intervals between intermittent DIs, relative speed of ASM constriction, and ASM activation on bronchoconstriction and the emergence of ventilation defects (VDefs). Our results showed a synergistic effect between the volume of DIs and the time intervals between them on bronchoconstriction and VDefs. There was a domain of conditions with sufficiently large volumes of DIs and short time intervals between them to prevent VDefs. Among conditions without VDefs, larger volumes of DIs resulted in greater airway dilation. Similarly, the time interval between DIs, during which the activated ASM re-constricts, affected the amplitude of periodic changes in airway radii. Both the relative speed of ASM constriction and ASM activation affected what volume of DIs and what time interval between them could prevent the emergence of VDefs. In conclusion, quantitative characteristics of DIs, such as their volume and time interval between them, affect bronchoconstriction and may contribute to difficulties in asthma. Better understanding of the quantitative aspects of DIs may result in novel or improved therapeutic approaches.	[Golnabi, Amir H.; Venegas, Jose G.; Winkler, Tilo] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Golnabi, Amir H.; Harris, R. Scott; Venegas, Jose G.; Winkler, Tilo] Harvard Univ, Sch Med, Boston, MA USA; [Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Winkler, T (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	twinkler@mgh.harvard.edu	Winkler, Tilo/B-5337-2009	Winkler, Tilo/0000-0002-7276-5550; Golnabi, Amir H./0000-0002-5976-1985	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL087281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087281] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by National Heart, Lung, and Blood Institute of the National Institutes of Health under award number R01HL087281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altes TA, 2004, ACAD RADIOL, V11, P729, DOI 10.1016/j.acra.2004.04.001; Anafi RC, 2001, J APPL PHYSIOL, V91, P1185, DOI 10.1152/jappl.2001.91.3.1185; Bayat S, 2006, J APPL PHYSIOL, V100, P1964, DOI 10.1152/japplphysiol.00594.2005; BENDIXEN HH, 1964, J APPL PHYSIOL, V19, P195, DOI 10.1152/jappl.1964.19.2.195; Black LD, 2004, J APPL PHYSIOL, V96, P1808, DOI 10.1152/japplphysiol.01170.2003; Boulet Louis-Philippe, 2005, Can Respir J, V12, P371; Brown RH, 2003, EUR RESPIR J, V22, P57, DOI 10.1183/09031936.03.00090403; BROWN RH, 1994, CHEST, V106, P920, DOI 10.1378/chest.106.3.920; Brown RH, 2001, AM J RESP CRIT CARE, V163, P994, DOI 10.1164/ajrccm.163.4.2007119; Brown RH, 2001, J APPL PHYSIOL, V91, P2574, DOI 10.1152/jappl.2001.91.6.2574; Brown RH, 2006, J APPL PHYSIOL, V101, P30, DOI 10.1152/japplphysiol.01190.2005; Brusasco V, 1999, J APPL PHYSIOL, V87, P567, DOI 10.1152/jappl.1999.87.2.567; Costella S, 2012, RESPIROLOGY, V17, P1237, DOI 10.1111/j.1440-1843.2012.02250.x; Crimi E, 2002, J APPL PHYSIOL, V93, P1384, DOI 10.1152/japplphysiol.00209.2002; DUGGAN CJ, 1990, THORAX, V45, P930, DOI 10.1136/thx.45.12.930; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; GUNST SJ, 1983, J APPL PHYSIOL, V54, P906, DOI 10.1152/jappl.1983.54.4.906; GUNST SJ, 1988, J APPL PHYSIOL, V65, P2490, DOI 10.1152/jappl.1988.65.6.2490; Hulme KM, 2013, RESP PHYSIOL NEUROBI, V189, P506, DOI 10.1016/j.resp.2013.08.015; Jackson AC, 2004, J APPL PHYSIOL, V96, P137, DOI 10.1152/japplphysiol.00504.2003; Kapsali T, 2000, J APPL PHYSIOL, V89, P711, DOI 10.1152/jappl.2000.89.2.711; King GG, 2001, AM J RESP CRIT CARE, V164, P216, DOI 10.1164/ajrccm.164.2.2006101; Lavoie TL, 2012, AM J RESP CRIT CARE, V186, P225, DOI 10.1164/rccm.201202-0368OC; Moore BJ, 1997, AM J RESP CRIT CARE, V156, P1278, DOI 10.1164/ajrccm.156.4.96-11082; MORENO RH, 1986, AM REV RESPIR DIS, V133, P1171; NADEL JA, 1961, J APPL PHYSIOL, V16, P717, DOI 10.1152/jappl.1961.16.4.717; Pyrgos G, 2010, J APPL PHYSIOL, V110, P472, DOI [10.1152/japplphysiol.00603.2010, DOI 10.1152/JAPPLPHYSI0L.00603.2010]; Salerno FG, 2005, J APPL PHYSIOL, V98, P817, DOI 10.1152/japplphysiol.00763.2004; Salome CM, 2003, EUR RESPIR J, V22, P62, DOI 10.1183/09031936.03.00117502; Schweitzer C, 2002, EUR RESPIR J, V19, P1020, DOI 10.1183/09031936.02.00992001; Shen X, 1997, J APPL PHYSIOL, V83, P1202, DOI 10.1152/jappl.1997.83.4.1202; Tzeng YS, 2009, J APPL PHYSIOL, V106, P813, DOI 10.1152/japplphysiol.01133.2007; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Winkler T, 2007, J APPL PHYSIOL, V103, P655, DOI 10.1152/japplphysiol.00041.2007; Winkler Tilo, 2011, Critical Reviews in Biomedical Engineering, V39, P263, DOI 10.1615/CritRevBiomedEng.v39.i4.20	36	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112443	10.1371/journal.pone.0112443	http://dx.doi.org/10.1371/journal.pone.0112443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402457	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700044
J	Mills, P; Zara, J				Mills, Patrick; Zara, Jason			3D Simulation of an Audible Ultrasonic Electrolarynx Using Difference Waves	PLOS ONE			English	Article							FUNDAMENTAL-FREQUENCY; TOTAL LARYNGECTOMY; SPEECH; ABSORPTION; EQUATIONS; QUALITY; MEDIA	A total laryngectomy removes the vocal folds which are fundamental in forming voiced sounds that make speech possible. Although implanted prosthetics are commonly used in developed countries, simple handheld vibrating electrolarynxes are still common worldwide. These devices are easy to use but suffer from many drawbacks including dedication of a hand, mechanical sounding voice, and sound leakage. To address some of these drawbacks, we introduce a novel electrolarynx that uses vibro-acoustic interference of dual ultrasonic waves to generate an audible fundamental frequency. A 3D simulation of the principles of the device is presented in this paper.	[Mills, Patrick; Zara, Jason] George Washington Univ, Sch Engn & Appl Sci, Washington, DC 20052 USA	George Washington University	Mills, P (corresponding author), George Washington Univ, Sch Engn & Appl Sci, Washington, DC 20052 USA.	patmills@gwmail.gwu.edu						Ackermann H., 2010, HDB PHONETIC SCI, P202; Ahmadi F, 2012, PROG BIOPHYS MOL BIO, V108, P119, DOI 10.1016/j.pbiomolbio.2012.01.004; Amirat Y, 2011, INT REV ELECTR ENG-I, V6, P1249; [Anonymous], 1992, S141983 ANSI; Azhari H., 2010, BASICS BIOMEDICAL UL; Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; COLEMAN RF, 1977, J SPEECH HEAR RES, V20, P197, DOI 10.1044/jshr.2002.197; Crocker M.J., 1998, HDB ACOUSTICS; Duck F.A., 1990, MED PHYS, V18; Espy-Wilson CY, 1998, J SPEECH LANG HEAR R, V41, P1253, DOI 10.1044/jslhr.4106.1253; FORMBY C, 1982, J ACOUST SOC AM, V71, P196, DOI 10.1121/1.387347; Hasgall P. A., 2012, ITIS DATABASE THERMA; Hendee W. R., 2003, MED IMAGING PHYS; Hill AJ, 2011, J AUDIO ENG SOC, V59, P321; Hollins M., 2011, ACOUSTICS NOISE CONT; Howard Carl, 2005, J OCCUPATIONAL HLTH, V21, P253; Luo LF, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-35; Maddox PT, 2012, OTOLARYNG HEAD NECK, V147, P85, DOI 10.1177/0194599812438170; Mallis A, 2011, EUR REV MED PHARMACO, V15, P937; Mariani J., 2009, LANGUAGE SPEECH PROC; Markel J., 1976, LINEAR PREDICTION SP; Massey JW, 2011, THESIS U TEXAS AUSTI; Meltzner GS, 2003, THESIS MIT CAMBRIDGE; MUR G, 1981, IEEE T ELECTROMAGN C, V23, P377, DOI 10.1109/TEMC.1981.303970; Ooe K, 1999, C P IEEE ASME INT C; Pandey P, 2002, C P 14 INT C DIG SIG; Pierce A. D., 1989, ACOUSTICS INTRO ITS; QI YY, 1991, J SPEECH HEAR RES, V34, P1250, DOI 10.1044/jshr.3406.1250; ROSENBERG AE, 1971, J ACOUST SOC AM, V49, P583, DOI 10.1121/1.1912389; Schindler A, 2005, Acta Otorhinolaryngol Ital, V25, P240; Schneider John B., 2010, UNDERSTANDING FINITE, V28; SEHGAL CM, 1982, J ACOUST SOC AM, V72, P1711, DOI 10.1121/1.388664; Stemple JC, 2014, CLIN VOICE PATHOLOGY; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Titze IR, 1997, J ACOUST SOC AM, V101, P2234, DOI 10.1121/1.418246; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; van der Molen L, 2013, CURR OPIN OTOLARYNGO, V21, P230, DOI 10.1097/MOO.0b013e3283610060; Vikholt OB, 2012, THESIS NORGES TEKNIS; Walker J., 2007, PROGR NONLINEAR SPEE; Watson PJ, 2008, AM J SPEECH-LANG PAT, V17, P348, DOI 10.1044/1058-0360(2008/07-0048); WEISS MS, 1979, J ACOUST SOC AM, V65, P1298, DOI 10.1121/1.382697; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zuur JK, 2007, MED BIOL ENG COMPUT, V45, P737, DOI 10.1007/s11517-007-0217-7	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113339	10.1371/journal.pone.0113339	http://dx.doi.org/10.1371/journal.pone.0113339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401965	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700129
J	Niu, S; Gil-Salas, FM; Tewary, SK; Samales, AK; Johnson, J; Swaminathan, K; Wong, SM				Niu, Shengniao; Gil-Salas, Francisco M.; Tewary, Sunil Kumar; Samales, Ashwin Kuppusamy; Johnson, John; Swaminathan, Kunchithapadam; Wong, Sek-Man			Hibiscus Chlorotic Ringspot Virus Coat Protein Is Essential for Cell-to-Cell and Long-Distance Movement but Not for Viral RNA Replication	PLOS ONE			English	Article							TURNIP-CRINKLE-VIRUS; BROME-MOSAIC-VIRUS; AUG INITIATOR CODON; OPEN READING FRAMES; CAPSID PROTEIN; MOTTLE-VIRUS; SYSTEMIC MOVEMENT; POINT MUTATIONS; BETA-ANNULUS; PROTEOLYTIC DISSECTION	Hibiscus chlorotic ringspot virus (HCRSV) is a member of the genus Carmovirus in the family Tombusviridae. In order to study its coat protein (CP) functions on virus replication and movement in kenaf (Hibiscus cannabinus L.), two HCRSV mutants, designated as p2590 (A to G) in which the first start codon ATG was replaced with GTG and p2776 (C to G) in which proline 63 was replaced with alanine, were constructed. In vitro transcripts of p2590 (A to G) were able to replicate to a similar level as wild type without CP expression in kenaf protoplasts. However, its cell-to-cell movement was not detected in the inoculated kenaf cotyledons. Structurally the proline 63 in subunit C acts as a kink for beta-annulus formation during virion assembly. Progeny of transcripts derived from p2776 (C to G) was able to move from cell-to-cell in inoculated cotyledons but its long-distance movement was not detected. Virions were not observed in partially purified mutant virus samples isolated from 2776 (C to G) inoculated cotyledons. Removal of the N-terminal 77 amino acids of HCRSV CP by trypsin digestion of purified wild type HCRSV virions resulted in only T = 1 empty virus-like particles. Taken together, HCRSV CP is dispensable for viral RNA replication but essential for cell-to-cell movement, and virion is required for the virus systemic movement. The proline 63 is crucial for HCRSV virion assembly in kenaf plants and the N-terminal 77 amino acids including the b-annulus domain is required in T = 3 assembly in vitro.	[Niu, Shengniao; Gil-Salas, Francisco M.; Tewary, Sunil Kumar; Samales, Ashwin Kuppusamy; Swaminathan, Kunchithapadam; Wong, Sek-Man] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Niu, Shengniao] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Hainan, Peoples R China; [Gil-Salas, Francisco M.] Inst Andaluz Invest & Formac Agr Pesquera Aliment, Almeria, Spain; [Johnson, John] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wong, Sek-Man] Temasek Life Sci Lab, Singapore, Singapore; [Wong, Sek-Man] Natl Univ Singapore, Suzhou Res Inst, Suzhou, Jiangsu, Peoples R China	National University of Singapore; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Scripps Research Institute; National University of Singapore	Wong, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswsm@nus.edu.sg			National University of Singapore [R-154-000-552-112, R154-000-559-112]	National University of Singapore(National University of Singapore)	This work was supported by National University of Singapore research grants R-154-000-552-112 to Sek-Man Wong and R154-000-559-112 to Kunchithapadam Swaminathan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjikuttira P, 2005, J GEN VIROL, V86, P1543, DOI 10.1099/vir.0.80772-0; BRUGIDOU C, 1995, VIROLOGY, V206, P108, DOI 10.1016/S0042-6822(95)80025-5; BRUNT A, 1996, VIRUSES PLANT DESCRI; Brunt AA, 2000, PLANT PATHOL, V49, P798, DOI 10.1046/j.1365-3059.2000.00501.x; Cao MX, 2010, J VIROL, V84, P7793, DOI 10.1128/JVI.02643-09; Cheng A, 2009, ACTA CRYSTALLOGR F, V65, P589, DOI 10.1107/S1744309109015760; Cohen Y, 2000, VIROLOGY, V273, P258, DOI 10.1006/viro.2000.0441; CUILLEL M, 1981, VIROLOGY, V110, P63, DOI 10.1016/0042-6822(81)90008-8; DEGRAAFF M, 1995, VIROLOGY, V208, P583, DOI 10.1006/viro.1995.1189; Diez Juana, 1998, V81, P211; Ding XS, 1996, P NATL ACAD SCI USA, V93, P11155, DOI 10.1073/pnas.93.20.11155; Doan DNP, 2003, J STRUCT BIOL, V144, P253, DOI 10.1016/j.jsb.2003.10.001; FUENTES AL, 1993, J GEN VIROL, V74, P1903, DOI 10.1099/0022-1317-74-9-1903; Garmann RF, 2014, J MOL BIOL, V426, P1050, DOI 10.1016/j.jmb.2013.10.017; GOLDEN JS, 1982, BIOCHEMISTRY-US, V21, P3862, DOI 10.1021/bi00259a022; GORDON K, 1992, PLANT J, V2, P809, DOI 10.1046/j.1365-313X.1992.t01-17-00999.x; HACKER DL, 1992, VIROLOGY, V186, P1, DOI 10.1016/0042-6822(92)90055-T; Harrison Stephen C., 1996, P59; HEATON LA, 1991, VIROLOGY, V183, P143, DOI 10.1016/0042-6822(91)90127-W; Hill HR, 1997, J MOL BIOL, V266, P1, DOI 10.1006/jmbi.1996.0786; HOGLE JM, 1986, J MOL BIOL, V191, P625, DOI 10.1016/0022-2836(86)90450-X; Huang M, 2000, J VIROL, V74, P3149, DOI 10.1128/JVI.74.7.3149-3155.2000; Hui E, 2006, J VIROL, V80, P5968, DOI 10.1128/JVI.02485-05; Ishikawa M, 2004, P JPN ACAD B-PHYS, V80, P215, DOI 10.2183/pjab.80.215; Ivanov KI, 2012, CURR OPIN VIROL, V2, P712, DOI 10.1016/j.coviro.2012.10.001; Jones D. R., 1980, Australasian Plant Pathology, V9, P4, DOI 10.1071/APP9800004; Kakani K, 2008, J VIROL, V82, P1547, DOI 10.1128/JVI.01976-07; Ke J, 2004, VIROLOGY, V321, P349, DOI 10.1016/j.virol.2004.01.018; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lee KC, 2003, ACTA CRYSTALLOGR D, V59, P1481, DOI 10.1107/S0907444903011648; Li VZ, 1998, VIROLOGY, V244, P405, DOI 10.1006/viro.1998.9125; Li WM, 2006, J VIROL, V80, P3395, DOI 10.1128/JVI.80.7.3395-3405.2006; Liang XZ, 2002, PLANT CELL REP, V20, P982, DOI 10.1007/s00299-002-0435-2; Lokesh GL, 2002, VIROLOGY, V292, P211, DOI 10.1006/viro.2001.1242; Lommel SA, 2000, VIRUS TAXONOMY, P791; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; MACKENZIE DJ, 1986, J GEN VIROL, V67, P727, DOI 10.1099/0022-1317-67-4-727; Meng CY, 2008, J GEN VIROL, V89, P2349, DOI 10.1099/vir.0.2008/002170-0; MORGUNOVA EY, 1994, FEBS LETT, V338, P267, DOI 10.1016/0014-5793(94)80281-5; Nagano H, 1997, J VIROL, V71, P2270, DOI 10.1128/JVI.71.3.2270-2276.1997; Nagano H, 2001, J VIROL, V75, P8045, DOI 10.1128/JVI.75.17.8045-8053.2001; Nagano H, 1999, VIROLOGY, V265, P226, DOI 10.1006/viro.1999.0065; Pantaleo V, 2006, ARCH VIROL, V151, P1973, DOI 10.1007/s00705-006-0767-2; Pappachan A, 2008, VIROLOGY, V375, P190, DOI 10.1016/j.virol.2008.01.023; PETTY ITD, 1990, VIROLOGY, V179, P712, DOI 10.1016/0042-6822(90)90138-H; Powell JD, 2012, VIROLOGY, V422, P165, DOI 10.1016/j.virol.2011.10.019; Ryabov EV, 1999, P NATL ACAD SCI USA, V96, P1212, DOI 10.1073/pnas.96.4.1212; SAITO T, 1990, VIROLOGY, V176, P329, DOI 10.1016/0042-6822(90)90002-9; Sangita V, 2005, ACTA CRYSTALLOGR D, V61, P1402, DOI [10.1107/S0907444905024029, 10.1107/S090744905024029]; Sangita V, 2004, J MOL BIOL, V342, P987, DOI 10.1016/j.jmb.2004.07.003; Satheshkumar PS, 2005, J MOL BIOL, V353, P447, DOI 10.1016/j.jmb.2005.08.021; SCHOLTHOF HB, 1993, MOL PLANT MICROBE IN, V6, P309, DOI 10.1094/MPMI-6-309; Shi Y, 2009, PLANT SIGNAL BEHAV, V4, P15, DOI 10.4161/psb.4.1.7573; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Spitsin S, 1999, P NATL ACAD SCI USA, V96, P2549, DOI 10.1073/pnas.96.5.2549; Stonehouse NJ, 1996, J MOL BIOL, V256, P330, DOI 10.1006/jmbi.1996.0089; STRONG RK, 1990, J VIROL, V64, P3992, DOI 10.1128/JVI.64.8.3992-3994.1990; SUZUKI M, 1991, VIROLOGY, V183, P106, DOI 10.1016/0042-6822(91)90123-S; Takeda A, 2004, J GEN VIROL, V85, P1751, DOI 10.1099/vir.0.79976-0; Tatineni S, 2014, J VIROL, V88, P1366, DOI 10.1128/JVI.02737-13; VAEWHONGS AA, 1995, VIROLOGY, V212, P607, DOI 10.1006/viro.1995.1518; Wada Y, 2008, ACTA CRYSTALLOGR F, V64, P8, DOI 10.1107/S1744309107066481; WATERWORTH HE, 1976, PHYTOPATHOLOGY, V66, P570, DOI 10.1094/Phyto-66-570; Waterworth HE, 1980, HIBISCUS CHLOROTIC R; XIONG Z, 1993, VIROLOGY, V192, P27, DOI 10.1006/viro.1993.1004; Yuan XF, 2006, J GEN VIROL, V87, P3077, DOI 10.1099/vir.0.81928-0; Zhang XF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-200; Zhang X, 2009, J GEN VIROL, V90, P3042, DOI 10.1099/vir.0.012112-0; Zhou T, 2006, MOL PLANT MICROBE IN, V19, P1291	70	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113347	10.1371/journal.pone.0113347	http://dx.doi.org/10.1371/journal.pone.0113347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402344	Green Submitted, gold, Green Published			2022-12-27	WOS:000345158700131
J	Binsfeld, M; Beguin, Y; Belle, L; Otjacques, E; Hannon, M; Briquet, A; Heusschen, R; Drion, P; Zilberberg, J; Bogen, B; Baron, F; Caers, J				Binsfeld, Marilene; Beguin, Yves; Belle, Ludovic; Otjacques, Eleonore; Hannon, Muriel; Briquet, Alexandra; Heusschen, Roy; Drion, Pierre; Zilberberg, Jenny; Bogen, Bjarne; Baron, Frederic; Caers, Jo			Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; BONE-MARROW-TRANSPLANTATION; BETA SPECTRATYPE ANALYSIS; CD4(+) T-CELLS; HOST-DISEASE; MULTIPLE-MYELOMA; LEUKEMIA REACTION; MICE; RESPONSES; SCLERODERMA	Background: Multiple myeloma (MM) is a malignant plasma cell disorder with poor long-term survival and high recurrence rates. Despite evidence of graft-versus-myeloma (GvM) effects, the use of allogeneic hematopoietic stem cell transplantation (allo-SCT) remains controversial in MM. In the current study, we investigated the anti-myeloma effects of allo-SCT from B10.D2 mice into MHC-matched myeloma-bearing Balb/cJ mice, with concomitant development of chronic graft-versus-host disease (GvHD). Methods and results: Balb/cJ mice were injected intravenously with luciferase-transfected MOPC315.BM cells, and received an allogeneic (B10.D2 donor) or autologous (Balb/cJ donor) transplant 30 days later. We observed a GvM effect in 94% of the allogeneic transplanted mice, as the luciferase signal completely disappeared after transplantation, whereas all the autologous transplanted mice showed myeloma progression. Lower serum paraprotein levels and lower myeloma infiltration in bone marrow and spleen in the allogeneic setting confirmed the observed GvM effect. In addition, the treated mice also displayed chronic GvHD symptoms. In vivo and in vitro data suggested the involvement of effector memory CD4 and CD8 T cells associated with the GvM response. The essential role of CD8 T cells was demonstrated in vivo where CD8 T-cell depletion of the graft resulted in reduced GvM effects. Finally, TCR V beta spectratyping analysis identified V beta families within CD4 and CD8 T cells, which were associated with both GvM effects and GvHD, whereas other V beta families within CD4 T cells were associated exclusively with either GvM or GvHD responses. Conclusions: We successfully established an immunocompetent murine model of graft-versus-myeloma. This is the first murine GvM model using immunocompetent mice that develop MM which closely resembles human MM disease and that are treated after disease establishment with an allo-SCT. Importantly, using TCR V beta spectratyping, we also demonstrated the presence of GvM unique responses potentially associated with the curative capacity of this immunotherapeutic approach.	[Binsfeld, Marilene; Beguin, Yves; Belle, Ludovic; Otjacques, Eleonore; Hannon, Muriel; Briquet, Alexandra; Heusschen, Roy; Baron, Frederic; Caers, Jo] Univ Liege, Hematol Lab, GIGA Res, Liege, Belgium; [Drion, Pierre] Univ Liege, Liege, Belgium; [Zilberberg, Jenny] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Bogen, Bjarne] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; [Bogen, Bjarne] Oslo Univ Hosp, Oslo, Norway; [Bogen, Bjarne] Univ Oslo, Inst Immunol, KG Jebsen Ctr Res Influenza Vaccines, Oslo, Norway	University of Liege; University of Liege; Hackensack University Medical Center; University of Oslo; University of Oslo; University of Oslo	Caers, J (corresponding author), Univ Liege, Hematol Lab, GIGA Res, Liege, Belgium.	jo.caers@chu.ulg.ac.be	Binsfeld, Marilene/AAG-9121-2020	Caers, Jo/0000-0002-3175-1195	Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique (F.N.R.S., Belgium); Fonds speciaux de la Recherche (University of Liege); Fondation contre le Cancer; Multiple Myeloma Research Foundation; Research Council of Norway; Norwegian Cancer Society	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (F.N.R.S., Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Fondation contre le Cancer; Multiple Myeloma Research Foundation; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work has been supported by grants from the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (F.N.R.S., Belgium), and the Fonds speciaux de la Recherche (University of Liege). FB is a FNRS senior research associate, JC is a post-doctorate clinical specialist funded by the 'Fondation contre le Cancer,' and MB, LB, EO and MH are Televie-FNRS research assistants. MM's research in the Bogen lab is supported by Multiple Myeloma Research Foundation, the Research Council of Norway, and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; Baron F, 2006, MOL THER, V13, P26, DOI 10.1016/j.ymthe.2005.09.011; Baron F, 2005, J CLIN ONCOL, V23, P1993, DOI 10.1200/JCO.2005.08.136; Barrett AJ, 1997, STEM CELLS, V15, P248, DOI 10.1002/stem.150248; Binsfeld M, 2014, BBA-REV CANCER, V1846, P392, DOI 10.1016/j.bbcan.2014.08.001; Caers J, 2008, EUR J HAEMATOL, V81, P329, DOI 10.1111/j.1600-0609.2008.01127.x; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Choi EY, 2002, BLOOD, V100, P4259, DOI 10.1182/blood-2002-05-1299; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Crawley C, 2005, BLOOD, V105, P4532, DOI 10.1182/blood-2004-06-2387; Dembic Z, 2000, P NATL ACAD SCI USA, V97, P2697, DOI 10.1073/pnas.050579897; Deweerdt S, 2011, NATURE, V480, pS38, DOI 10.1038/480S38a; EISEN HN, 1968, BIOCHEMISTRY-US, V7, P4126, DOI 10.1021/bi00851a048; Fanning SL, 2013, J IMMUNOL, V190, P447, DOI 10.4049/jimmunol.1201641; Friedman TM, 2001, BIOL BLOOD MARROW TR, V7, P2, DOI 10.1053/bbmt.2001.v7.pm11215694; Gahrton G, 2011, RECENT RESULTS CANC, V183, P273, DOI 10.1007/978-3-540-85772-3_12; Giralt S, 2011, HEMATOL-AM SOC HEMAT, P191, DOI 10.1182/asheducation-2011.1.191; HAMILTON BL, 1981, J IMMUNOL, V126, P621; HAMILTON BL, 1987, J IMMUNOL, V139, P2511; Heimfeld S, 2003, LEUKEMIA, V17, P856, DOI 10.1038/sj.leu.2402893; Hofgaard PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051892; JAFFEE BD, 1983, CELL IMMUNOL, V77, P1, DOI 10.1016/0008-8749(83)90001-1; Kneppers E, 2011, BLOOD, V118, P2413, DOI 10.1182/blood-2011-04-348292; Korbling M, 2011, BLOOD, V117, P6411, DOI 10.1182/blood-2010-12-322214; KORNGOLD R, 1987, J EXP MED, V165, P1552, DOI 10.1084/jem.165.6.1552; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; LAURITZSEN GF, 1993, CELL IMMUNOL, V148, P177, DOI 10.1006/cimm.1993.1100; Lokhorst H, 2010, J CLIN ONCOL, V28, P4521, DOI 10.1200/JCO.2010.29.7929; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; McCormick LL, 1999, J IMMUNOL, V163, P5693; OKUNEWICK J, 1992, TRANSPLANT P, V24, P2998; PALATHUMPAT V, 1995, TRANSPLANTATION, V60, P355, DOI 10.1097/00007890-199508270-00010; POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0; Sakoda Y, 2007, BLOOD, V109, P1756, DOI 10.1182/blood-2006-08-042853; Tricot G, 1996, BLOOD, V87, P1196, DOI 10.1182/blood.V87.3.1196.bloodjournal8731196; TRUITT RL, 1991, BONE MARROW TRANSPL, V8, P51; van der Voort R, 2013, BIOL BLOOD MARROW TR, V19, P378, DOI 10.1016/j.bbmt.2012.12.014; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Zeis M, 2001, BONE MARROW TRANSPL, V27, P279, DOI 10.1038/sj.bmt.1702785; Zilberberg J, 2008, J IMMUNOL, V180, P5352, DOI 10.4049/jimmunol.180.8.5352	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113764	10.1371/journal.pone.0113764	http://dx.doi.org/10.1371/journal.pone.0113764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415267	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600075
J	Whitehouse, J; Waller, BM; Chanvin, M; Wallace, EK; Schel, AM; Peirce, K; Mitchell, H; Macri, A; Slocombe, K				Whitehouse, Jamie; Waller, Bridget M.; Chanvin, Mathilde; Wallace, Emma K.; Schel, Anne M.; Peirce, Kate; Mitchell, Heidi; Macri, Alaina; Slocombe, Katie			Evaluation of Public Engagement Activities to Promote Science in a Zoo Environment	PLOS ONE			English	Article							TECHNOLOGY; BEHAVIOR	Scientists are increasing their efforts to promote public engagement with their science, but the efficacy of the methods used is often not scientifically evaluated. Here, we designed, installed and evaluated the educational impact of interactive games on touchscreens at two primate research centres based in zoo environments. The games were designed to promote interest in and understanding of primates and comparative psychology, as a scaffold towards interest in science more generally and with the intention of targeting younger individuals (under 16's). We used systematic observational techniques and questionnaires to assess the impact of the games on zoo visitors. The games facilitated increased interest in psychology and science in zoo visitors, and changed the knowledge of visitors, through demonstration of learning about specific scientific findings nested within the games. The impact of such devices was greatest on younger individuals (under 16's) as they were significantly more likely to engage with the games. On the whole, therefore, this study demonstrates that interactive devices can be successful educational tools, and adds to the growing body of evidence that conducting research on public view in zoos can have a tangible impact on public engagement with science.	[Whitehouse, Jamie; Waller, Bridget M.; Chanvin, Mathilde; Macri, Alaina] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Wallace, Emma K.; Schel, Anne M.; Slocombe, Katie] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Mitchell, Heidi] Marwell Wildlife, Winchester, Hants, England; [Macri, Alaina] Royal Zool Soc Scotland, Edinburgh, Midlothian, Scotland	University of Portsmouth; University of York - UK	Waller, BM (corresponding author), Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England.	Bridget.waller@port.ac.uk	Slocombe, Katie E/B-8788-2016	Slocombe, Katie E/0000-0002-7310-1887; Whitehouse, Jamie/0000-0003-2607-5492; Waller, Bridget/0000-0001-6303-7458	British Psychological Society	British Psychological Society	British Psychological Society Research Grant (no grant number, http://www.bps.org.uk/) - "Evaluation of interactive computerized touchscreens to promote science in a zoo environment" to KS and BMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arndt MA, 1992, VISITOR STUDIES, V5, P245; Bowler MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034505; Clay AW, 2011, ZOO BIOL, V30, P487, DOI 10.1002/zoo.20353; Field A, 2000, INTRO STAT METHODS S; Fisch S. M., 2005, P 2005 C INT DES CHI, P56; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Parr LA, 2011, PHILOS T R SOC B, V366, P1764, DOI 10.1098/rstb.2010.0358; Perdue BM, 2012, VISIT STUD, V15, P16, DOI 10.1080/10645578.2012.660839; Ross SR, 2005, VISITOR STUDIES TODA, V8, P4; Ross SR, 2009, ZOO BIOL, V28, P462, DOI 10.1002/zoo.20220; Sandifer C, 1997, SCI EDUC, V81, P689, DOI 10.1002/(SICI)1098-237X(199711)81:6<689::AID-SCE6>3.0.CO;2-E; Sandifer C, 2003, J RES SCI TEACH, V40, P121, DOI 10.1002/tea.10068; STEVENSON J, 1991, INT J SCI EDUC, V13, P521, DOI 10.1080/0950069910130503; Waller B, 2013, DO YOU KNOW WHAT ITS; Waller B, 2013, ARE YOU CLEVEREST PR; Waller BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044680	17	16	16	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113395	10.1371/journal.pone.0113395	http://dx.doi.org/10.1371/journal.pone.0113395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415193	Green Submitted, gold, Green Published			2022-12-27	WOS:000346906600044
J	He, D; Miao, HL; Xu, YM; Xiong, LH; Wang, Y; Xiang, HX; Zhang, H; Zhang, ZY				He, De; Miao, Huilai; Xu, Yumin; Xiong, Longhui; Wang, Yi; Xiang, Hongxia; Zhang, Heng; Zhang, Zhiyong			MiR-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival	PLOS ONE			English	Article							GASTRIC-CANCER; ING1; GEMCITABINE; TRANSITION; EXPRESSION; GENE	Background: microRNAs (miRNAs) play a critical role in tumorigenesis, either as a tumor suppressor or as an oncogenic miRNA, depending on different tumor types. To date, scientists have obtained a substantial amount of knowledge with regard to miRNAs in pancreatic cancer. However, the expression and function of miR-371-5p in pancreatic cancer has not been clearly elucidated. The aim of this study was to investigate the roles of miR-371-5p in pancreatic cancer and its association with the survival of patients with pancreatic cancer. Methods: The expression of miR-371-5p was examined in pancreatic duct adenocarcinoma (PDAC) and their adjacent normal pancreatic tissues (ANPT) or in pancreatic cancer cell lines by qRT-PCR. The association of miR-371-5p expression with overall survival was determined. The proliferation and apoptosis of SW-1990 and Panc-1 cells, transfected with miR-371-5p mimics or inhibitor, were assessed using MTT assay and flow cytometry, respectively. The tumorigenicity was evaluated via mice xenograft experiments. miR-371-5p promoter interactions were analyzed by chromatin immunoprecipitation assays (ChIP). Protein expression was analyzed by Western blot. Results: The expression level of miR-371-5p was dramatically upregulated in clinical PDAC tissues compared with ANPT. Patients with high miR-371-5p expression had a significantly shorter survival than those with low miR-371-5p expression. The in vitro and in vivo assays showed that overexpression of miR-371-5p resulted in cell proliferation and increased tumor growth, which was associated with inhibitor of growth 1 (ING1) downregulation. Interestingly, we also found that ING1, in turn, inhibited expression of miR-371-5p in the promoter region. Conclusions: our study demonstrates a novel ING1-miR-371-5p regulatory feedback loop, which may have a critical role in PDAC. Thus miR-371-5p can prove to be a novel prognostic factor and therapeutic target for pancreatic cancer treatment.	[He, De; Xu, Yumin; Xiong, Longhui; Wang, Yi; Xiang, Hongxia] Southern Med Univ, Affiliated Baoan Hosp, Dept Gen Surg, Shenzhen, Peoples R China; [Miao, Huilai] Guangdong Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Zhanjiang, Guangdong, Peoples R China; [Zhang, Heng] Three Gorges Univ, Coll Clin Sci China, Dept Med, Yichang, Hubei, Peoples R China; [Zhang, Zhiyong] Rutgers State Univ, Robert Wood Johnson Med Sch, Univ Hosp, Dept Surg, New Brunswick, NJ 08903 USA	Southern Medical University - China; Guangdong Medical University; China Three Gorges University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, ZY (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Univ Hosp, Dept Surg, New Brunswick, NJ 08903 USA.	zhangZ2@rwjms.rutgers.edu		zhang, zhiyong/0000-0003-4061-7374; ZHANG, ZHIYONG/0000-0001-8576-1607	Innovation of Science and Technology Commission of Shenzhen Municipality [JCYJ20140414103937769]	Innovation of Science and Technology Commission of Shenzhen Municipality	This work was supported by grant from The Innovation of Science and Technology Commission of Shenzhen Municipality (No. JCYJ20140414103937769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Champagne KS, 2009, CURR DRUG TARGETS, V10, P432, DOI 10.2174/138945009788185040; Chen J, 2013, BRIT J CANCER, V108, P1143, DOI 10.1038/bjc.2013.50; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Guerillon C, 2014, CANCER LETT, V345, P1, DOI 10.1016/j.canlet.2013.11.016; Guerillon C, 2013, CELL MOL LIFE SCI, V70, P3753, DOI 10.1007/s00018-013-1270-z; Guo XB, 2011, WORLD J GASTROENTERO, V17, P1895, DOI 10.3748/wjg.v17.i14.1895; Hamada S, 2013, J CELL PHYSIOL, V228, P1255, DOI 10.1002/jcp.24280; Ingelman-Sundberg M, 2013, DRUG METAB DISPOS, V41, P1725, DOI 10.1124/dmd.113.053157; Iwagami Y, 2013, BRIT J CANCER, V109, P502, DOI 10.1038/bjc.2013.320; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Keane MG, 2014, WORLD J GASTROENTERO, V20, P2267, DOI 10.3748/wjg.v20.i9.2267; Larson RA, 2010, CHEM-BIOL INTERACT, V184, P21, DOI 10.1016/j.cbi.2009.10.002; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu RY, 2013, CANCER LETT, V335, P351, DOI 10.1016/j.canlet.2013.02.045; Mace TA, 2013, J SURG RES, V184, P855, DOI 10.1016/j.jss.2013.04.061; Marin-Muller C, 2013, CLIN CANCER RES, V19, P5901, DOI 10.1158/1078-0432.CCR-12-3776; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Sicard F, 2013, MOL THER, V21, P986, DOI 10.1038/mt.2013.35; Vimalraj S, 2014, INT J BIOL MACROMOL, V66, P194, DOI 10.1016/j.ijbiomac.2014.02.030; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58	21	60	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112930	10.1371/journal.pone.0112930	http://dx.doi.org/10.1371/journal.pone.0112930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411783	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000019
J	Qin, X; Zhang, J; Zhang, XY; Yang, Y				Qin, Xing; Zhang, Jie; Zhang, Xiaoyu; Yang, Yang			Induction, Purification and Characterization of a Novel Manganese Peroxidase from Irpex lacteus CD2 and Its Application in the Decolorization of Different Types of Dye	PLOS ONE			English	Article							WHITE-ROT FUNGUS; BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; POLYCYCLIC AROMATIC-HYDROCARBONS; DEPENDENT PEROXIDASE; LIGNIN DEGRADATION; CORN STOVER; AZO DYES; ENZYME; DETOXIFICATION; LACCASE	Manganese peroxidase (MnP) is the one of the important ligninolytic enzymes produced by lignin-degrading fungi which has the great application value in the field of environmental biotechnology. Searching for new MnP with stronger tolerance to metal ions and organic solvents is important for the maximization of potential of MnP in the biodegradation of recalcitrant xenobiotics. In this study, it was found that oxalic acid, veratryl alcohol and 2,6-Dimehoxyphenol could stimulate the synthesis of MnP in the white-rot fungus Irpex lacteus CD2. A novel manganese peroxidase named as CD2-MnP was purified and characterized from this fungus. CD2-MnP had a strong capability for tolerating different metal ions such as Ca2+, Cd2+, Co2+, Mg2+, Ni2+ and Zn2+ as well as organic solvents such as methanol, ethanol, DMSO, ethylene glycol, isopropyl alcohol, butanediol and glycerin. The different types of dyes including the azo dye (Remazol Brilliant Violet 5R, Direct Red 5B), anthraquinone dye (Remazol Brilliant Blue R), indigo dye (Indigo Carmine) and triphenylmethane dye (Methyl Green) as well as simulated textile wastewater could be efficiently decolorized by CD2-MnP. CD2-MnP also had a strong ability of decolorizing different dyes with the coexistence of metal ions and organic solvents. In summary, CD2-MnP from Irpex lacteus CD2 could effectively degrade a broad range of synthetic dyes and exhibit a great potential for environmental biotechnology.	[Qin, Xing; Zhang, Jie; Zhang, Xiaoyu; Yang, Yang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Yang, Y (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	yangyang@mail.hust.edu.cn	Zhang, xiaoyu/A-6515-2015; Zhang, xiaoyu/GXA-3206-2022		National Natural Sciences Foundation of China [31370122, 31070069, 30800007]; National High Technology Research and Development Program of China [2012AA022301D]; Fundamental Research Funds for the Central Universities [HUST 2013TS082]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Sciences Foundation of China (No. 31370122, 31070069, 30800007), National High Technology Research and Development Program of China (No. 2012AA022301D), The Fundamental Research Funds for the Central Universities (HUST 2013TS082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid AM, 2013, ADV APPL MICROBIOL, V82, P1, DOI 10.1016/B978-0-12-407679-2.00001-6; Acevedo F, 2010, CHEMOSPHERE, V80, P271, DOI 10.1016/j.chemosphere.2010.04.022; Baborova P, 2006, RES MICROBIOL, V157, P248, DOI 10.1016/j.resmic.2005.09.001; Baldrian P, 2002, FEMS MICROBIOL LETT, V206, P69, DOI 10.1111/j.1574-6968.2002.tb10988.x; Bell G, 1995, TRENDS BIOTECHNOL, V13, P468, DOI 10.1016/S0167-7799(00)89004-6; Boer CG, 2006, PROCESS BIOCHEM, V41, P1203, DOI 10.1016/j.procbio.2005.11.025; Cai YJ, 2010, BIOTECHNOL BIOPROC E, V15, P1016, DOI 10.1007/s12257-010-0130-z; Cheng XB, 2007, ENZYME MICROB TECH, V41, P258, DOI 10.1016/j.enzmictec.2007.01.020; Contreras E, 2012, BIOTECHNOL PROGR, V28, P114, DOI 10.1002/btpr.722; HATAKKA A, 1994, FEMS MICROBIOL REV, V13, P125, DOI 10.1016/0168-6445(94)90076-0; Heinfling A, 1998, APPL ENVIRON MICROB, V64, P2788; Hofrichter M, 1998, APPL ENVIRON MICROB, V64, P399; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Iqbal HMN, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-56; LI D, 1995, APPL ENVIRON MICROB, V61, P341, DOI 10.1128/AEM.61.1.341-345.1995; Lung A, 1978, J FOOD SCI, V43, P1307; Ma L, 2014, BIOCHEM ENG J, V82, P1, DOI 10.1016/j.bej.2013.10.015; Morales-Blancas EF, 2002, J FOOD SCI, V67, P146, DOI 10.1111/j.1365-2621.2002.tb11375.x; Novotny C, 2009, FOLIA MICROBIOL, V54, P375, DOI 10.1007/s12223-009-0053-2; Osma JF, 2010, APPL CATAL A-GEN, V373, P147, DOI 10.1016/j.apcata.2009.11.009; Praveen K, 2012, J MICROBIOL BIOTECHN, V22, P1540, DOI 10.4014/jmb.1112.12011; Revankar MS, 2007, BIORESOURCE TECHNOL, V98, P775, DOI 10.1016/j.biortech.2006.03.020; Salvachua D, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-115; Saravanakumar T, 2013, APPL BIOCHEM BIOTECH, V171, P1178, DOI 10.1007/s12010-013-0220-4; Scheel T, 2000, APPL MICROBIOL BIOT, V54, P686, DOI 10.1007/s002530000427; Shin KS, 2005, J MICROBIOL, V43, P503; Singh J., 2010, INT RES J BIOTECH, V4, P50; Sklenar J, 2010, ENZYME MICROB TECH, V46, P550, DOI 10.1016/j.enzmictec.2010.03.001; Steffen KT, 2002, ENZYME MICROB TECH, V30, P550, DOI 10.1016/S0141-0229(01)00525-7; Sundaramoorthy M, 2005, BIOCHEMISTRY-US, V44, P6463, DOI 10.1021/bi047318e; Susla M, 2008, FOLIA MICROBIOL, V53, P479, DOI 10.1007/s12223-008-0075-1; Sutherland GRJ, 1996, ARCH BIOCHEM BIOPHYS, V332, P128, DOI 10.1006/abbi.1996.0324; Sutherland GRJ, 1997, BIOCHEMISTRY-US, V36, P3654, DOI 10.1021/bi962195m; Urek RO, 2004, PROCESS BIOCHEM, V39, P2061, DOI 10.1016/j.procbio.2003.10.015; Van Aken B, 1999, BIODEGRADATION, V10, P83, DOI 10.1023/A:1008371209913; WARIISHI H, 1988, BIOCHEMISTRY-US, V27, P5365, DOI 10.1021/bi00414a061; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011; Xu CY, 2009, J BIOSCI BIOENG, V108, P372, DOI 10.1016/j.jbiosc.2009.04.023; Yang XW, 2010, INT BIODETER BIODEGR, V64, P119, DOI 10.1016/j.ibiod.2009.12.001; Youngs HL, 2000, EUR J BIOCHEM, V267, P1761, DOI 10.1046/j.1432-1327.2000.01173.x; Yu HB, 2010, BIORESOURCE TECHNOL, V101, P6728, DOI 10.1016/j.biortech.2010.03.119	42	40	43	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113282	10.1371/journal.pone.0113282	http://dx.doi.org/10.1371/journal.pone.0113282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412169	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000032
J	Ajagbe, OB; Kabair, Z; O'Connor, T				Ajagbe, Olurotimi Bankole; Kabair, Zubair; O'Connor, Terry			Survival Analysis of Adult Tuberculosis Disease	PLOS ONE			English	Article							ANTITUBERCULOSIS TREATMENT; HONG-KONG; SMOKING	Background: We conducted a survival analysis of all the confirmed cases of Adult Tuberculosis (TB) patients treated in Cork-City, Ireland. The aim of this study was to estimate Survival time (ST), including median time of survival and to assess the association and impact of covariates (TB risk factors) to event status and ST. The outcome of the survival analysis is reported in this paper. Methods: We used a retrospective cohort study research design to review data of 647 bacteriologically confirmed TB patients from the medical record of two teaching hospitals. Mean age 49 years (Range 18-112). We collected information on potential risk factors of all confirmed cases of TB treated between 2008-2012. For the survival analysis, the outcome of interest was 'treatment failure' or 'death' (whichever came first). A univariate descriptive statistics analysis was conducted using a non-parametric procedure, Kaplan -Meier (KM) method to estimate overall survival (OS), while the Cox proportional hazard model was used for the multivariate analysis to determine possible association of predictor variables and to obtain adjusted hazard ratio. P value was set at <0.05, log likelihood ratio test at >0.10. Data were analysed using SPSS version 15.0. Results: There was no significant difference in the survival curves of male and female patients. (Log rank statistic = 0.194, df = 1, p = 0.66) and among different age group (Log rank statistic = 1.337, df = 3, p = 0.72). The mean overall survival (OS) was 209 days (95% CI: 92-346) while the median was 51 days (95% CI: 35.7-66). The mean ST for women was 385 days (95% CI: 76.6-694) and for men was 69 days (95% CI: 48.8-88.5). Multivariate Cox regression showed that patient who had history of drug misuse had 2.2 times hazard than those who do not have drug misuse. Smokers and alcohol drinkers had hazard of 1.8 while patients born in country of high endemicity (BICHE) had hazard of 6.3 and HIV co-infection hazard was 1.2. Conclusion: There was no significant difference in survival curves of male and female and among age group. Women had a higher ST compared to men. But men had a higher hazard rate compared to women. Anti-TNF, immunosuppressive medication and diabetes were found to be associated with longer ST, while alcohol, smoking, RICHE, BICHE was associated with shorter ST.	[Ajagbe, Olurotimi Bankole; Kabair, Zubair] Natl Univ Ireland Univ Coll Cork, Dept Publ Hlth & Epidemiol, Cork, Ireland; [O'Connor, Terry] Mercy Univ Hosp, Cork, Ireland	University College Cork; University College Cork	Ajagbe, OB (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Publ Hlth & Epidemiol, Cork, Ireland.	o.ajagbe@umail.ucc.ie						[Anonymous], GUID TREATM TUB; Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Chiang YC, 2012, INT J INFECT DIS, V16, pE130, DOI 10.1016/j.ijid.2011.10.007; Health Protection Surveillance Centre, 2013, TB CAS NOT IR 2011 P; Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258; Leung CC, 2004, AM J RESP CRIT CARE, V170, P1027, DOI 10.1164/rccm.200404-512oc; Low S, 2009, INT J TUBERC LUNG D, V13, P328; Maciel EL, 2013, INT J TUBERC LUNG D, V17, P225, DOI 10.5588/ijtld.12.0426; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Oursler KK, 2010, CLIN INFECT DIS, V34, P752; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; Tachfouti N, 2011, INT J TUBERC LUNG D, V15, P838, DOI 10.5588/ijtld.10.0437; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Vasantha M, 2008, Indian J Tuberc, V55, P64; Viv B, 2004, CRITICAL CARE, V8, P389; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; World Health Organization, WHOHTMTB2007390; World Health Organization, 2021, 10 THREATS GLOB HLTH	18	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112838	10.1371/journal.pone.0112838	http://dx.doi.org/10.1371/journal.pone.0112838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409024	Green Published, gold			2022-12-27	WOS:000345533200043
J	Bauer, G; Gorb, SN; Klein, MC; Nellesen, A; von Tapavicza, M; Speck, T				Bauer, Georg; Gorb, Stanislav N.; Klein, Marie-Christin; Nellesen, Anke; von Tapavicza, Max; Speck, Thomas			Comparative Study on Plant Latex Particles and Latex Coagulation in Ficus benjamina, Campanula glomerata and Three Euphorbia species	PLOS ONE			English	Article							PARTHENIUM-ARGENTATUM GRAY; HEVEA LATEX; RUBBER PARTICLES; CARICA-PAPAYA; LATICIFERS; PROTEIN; BRASILIENSIS; MODEL	Among latex-producing plants, mainly the latex of Hevea brasiliensis has been studied in detail so far, while comprehensive comparative studies of latex coagulation mechanisms among the more than 20,000 latex-bearing plant species are lacking. In order to give new insights into the potential variety of coagulation mechanisms, the untreated natural latices of five latex-bearing plants from the families Euphorbiaceae, Moraceae and Campanulaceae were visualised using Cryo-SEM and their particle size compared using the laser diffraction method. Additionally, the laticifers of these plants species were examined in planta via Cryo-SEM. Similar latex particle sizes and shape were found in Ficus benjamina and Hevea brasiliensis. Hence, and due to other similarities, we hypothesize comparable, mainly chemical, coagulation mechanisms in these two species, whereas a physical coagulation mechanism is proposed for the latex of Euphorbia spp. The latter mechanism is based on the huge amount of densely packed particles that after evaporation of water build a large surface area, which accelerates the coagulation procedure.	[Bauer, Georg; Speck, Thomas] Univ Freiburg, Fac Biol, Plant Biomech Grp, D-79106 Freiburg, Germany; [Bauer, Georg; Speck, Thomas] Univ Freiburg, FMF Freiburg Mat Res Ctr, D-79106 Freiburg, Germany; [Gorb, Stanislav N.; Klein, Marie-Christin] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Nellesen, Anke; von Tapavicza, Max] Fraunhofer Inst Environm Safety & Energy Technol, Oberhausen, Germany	University of Freiburg; University of Freiburg; University of Kiel; Fraunhofer Gesellschaft	Speck, T (corresponding author), Univ Freiburg, Fac Biol, Plant Biomech Grp, Hugstetter Str 55, D-79106 Freiburg, Germany.	thomas.speck@biologie.uni-freiburg.de			German Federal Ministry of Education and Research within the scope of the funding program BIONA	German Federal Ministry of Education and Research within the scope of the funding program BIONA	This study is part of the project "Self-healing polymers OSIRIS'' that is funded by the German Federal Ministry of Education and Research within the scope of the funding program BIONA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2009, ANNU REV ECOL EVOL S, V40, P311, DOI 10.1146/annurev.ecolsys.110308.120307; BAUER G, 2010, P 5 INT C COMP DES N, V138, P453; Bauer G, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0847; Bauer G, 2012, ANN BOT-LONDON, V109, P807, DOI 10.1093/aob/mcr307; BUTTERY BR, 1966, J EXP BOT, V17, P283, DOI 10.1093/jxb/17.2.283; Cole TCH, 2011, ANGIOSPERM PHYLOGENY; CONDON JM, 1989, J EXP BOT, V40, P925, DOI 10.1093/jxb/40.8.925; Cornish K, 2002, J POLYM ENVIRON, V10, P13, DOI 10.1023/A:1021061805077; Cornish K, 2002, J POLYM ENVIRON, V10, P155, DOI 10.1023/A:1021196121296; DAUZAC J, 1995, PLANT PHYSIOL BIOCH, V33, P765; DUSSOURD DE, 1987, SCIENCE, V237, P898, DOI 10.1126/science.3616620; Dussourd DE, 1991, ECOLOGY, V72, P1183; Fahn A., 1979, SECRETORY TISSUES PL; GIDROL X, 1994, J BIOL CHEM, V269, P9278; Gorb S.N., 2007, MODERN RES ED TOPICS, P812; Gorb SN, 2006, MICROS TODAY, V2009, P38; Homans L.N.S., 1948, P SD RUBB TECHNOL C, P292; HUNTER JR, 1994, TREES-STRUCT FUNCT, V9, P1, DOI 10.1007/BF00197862; Kang HS, 2000, PLANT PHYSIOL BIOCH, V38, P979, DOI 10.1016/S0981-9428(00)01204-3; Kongsawadworakul P, 2003, PLANT CELL PHYSIOL, V44, P707, DOI 10.1093/pcp/pcg085; LEWINSOHN TM, 1991, CHEMOECOLOGY, V2, P64, DOI DOI 10.1007/BF01240668; MAHLBERG PG, 1993, BOT REV, V59, P1, DOI 10.1007/BF02856611; Moutim V, 1999, PLANT SCI, V142, P115, DOI 10.1016/S0168-9452(98)00226-X; RACHMILEVITZ T, 1982, ANN BOT-LONDON, V49, P13, DOI 10.1093/oxfordjournals.aob.a086223; RUDALL PJ, 1987, BOT J LINN SOC, V94, P143, DOI 10.1111/j.1095-8339.1987.tb01043.x; Silva LG, 1997, BRAZ J MED BIOL RES, V30, P615, DOI 10.1590/S0100-879X1997000500007; SOUTHORN W. A., 1969, Journal of the Rubber Research Institute, V21, P494; SOUTHORN WA, 1960, NATURE, V188, P165, DOI 10.1038/188165a0; Speck T, 2013, BIOINSPIRED MAT DESI; Ulmann M, 1951, WERTVOLLE KAUTSCHUKP; Wahler D, 2009, PLANT PHYSIOL, V151, P334, DOI 10.1104/pp.109.138743; Wititsuwannakul R, 2008, PHYTOCHEMISTRY, V69, P656, DOI 10.1016/j.phytochem.2007.09.021; Wood DF, 2000, INT J PLANT SCI, V161, P435, DOI 10.1086/314269	33	20	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113336	10.1371/journal.pone.0113336	http://dx.doi.org/10.1371/journal.pone.0113336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409036	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200098
J	Carl, J; Schwarzer, M; Klingelhoefer, D; Ohlendorf, D; Groneberg, DA				Carl, Jil; Schwarzer, Mario; Klingelhoefer, Doris; Ohlendorf, Daniela; Groneberg, David A.			Curare - A Curative Poison: A Scientometric Analysis	PLOS ONE			English	Article							BENCHMARKING PROCEDURES; INDEX	Introduction: Curare is one of the best-examined neurotoxins of the world, which has empirically been used for centuries by American Indigenes. Research on curare has been performed much later, a global scientometric analysis on curare research or its derivates does not yet exist. This bibliometric analysis is part of the global NewQis-project and should illuminate both toxic and historic issues of research on curare. Methods: The ISI Web of Science was searched for data covering 1900 to 2013 using a term which included as many original articles on curare as possible. 3,867 articles were found and analyzed for common bibliometric items such as the number of citations, language of the articles or the (modified) Hirsch-Index (h-index). Results are illustrated utilizing modern density equalizing map projections (DEMP) or beam diagrams. Results: Most publications were located in North America and Europe. The USA has the highest number of publications as well as the highest h-index. The number of publications overall rose until the late 1990s and later decreased. Furthermore, sudden increases of research activity are ascribable to historic events, like the first use of curare as muscle relaxant during surgery. Discussion: This scientometric analysis of curare research reflects several tendencies as previously seen in other bibliometric investigations, i.e. the scientific quality standard of North America and Europe. Research on curare decreased however, due to the declining attention towards this muscle relaxant. This work exemplifies also how scientometric methods can be used to illuminate historic circumstances immediately stimulating scientific research.	[Carl, Jil; Schwarzer, Mario; Klingelhoefer, Doris; Ohlendorf, Daniela; Groneberg, David A.] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Schwarzer, M (corresponding author), Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, D-60054 Frankfurt, Germany.	occup-med@uni-frankfurt.de	Klingelhoefer, Doris/AFF-8213-2022; Groneberg, David/A-5132-2018	Groneberg, David/0000-0001-8551-6556; Carl, Jil/0000-0002-9413-2375				Ball P, 2007, NATURE, V448, P737, DOI 10.1038/448737a; Bonpland A, 2004, PERSONAL NARRATIVE T; Czarnowski C, 2007, CAN FAM PHYSICIAN, V53, P1531; dAnghiera Pietro Martire., 1912, ORBE NOVO 8 DECADES, pI; FENSTER JM, 2001, ETHER DAY STRANGE TA; Fricke R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-454; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Gomsu J, 2004, HUMBOLDT NETZ, V8, P6; Groneberg DA, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-55; Groneberg-Kloft Beatrix, 2009, J Occup Med Toxicol, V4, P16, DOI 10.1186/1745-6673-4-16; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Milner D, 2009, RAINFORESTS S AM OPE; Ngudi DD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001759; Ranawaka UK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002302; Regal W, 2010, ARZTE WOCHE, V11; SCHMIDT S, 2013, J VIRAL HEPATITIS; Vogelzang B H, 2012, Indian J Psychiatry, V54, P320, DOI 10.4103/0019-5545.104807; Zell H, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-5	18	16	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112026	10.1371/journal.pone.0112026	http://dx.doi.org/10.1371/journal.pone.0112026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409503	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200007
J	Chouhan, BS; Kapyla, J; Denessiouk, K; Denesyuk, A; Heino, J; Johnson, MS				Chouhan, Bhanupratap Singh; Kapyla, Jarmo; Denessiouk, Konstantin; Denesyuk, Alexander; Heino, Jyrki; Johnson, Mark S.			Early Chordate Origin of the Vertebrate Integrin alpha I Domains	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; A-DOMAIN; CIONA-INTESTINALIS; STRUCTURAL BASIS; RKKH PEPTIDES; EVOLUTION; GENOME; RECOGNITION; INSIGHTS; BINDING	Half of the 18 human integrins alpha subunits have an inserted alpha I domain yet none have been observed in species that have diverged prior to the appearance of the urochordates (ascidians). The urochordate integrin alpha I domains are not human orthologues but paralogues, but orthologues of human alpha I domains extend throughout later-diverging vertebrates and are observed in the bony fish with duplicate isoforms. Here, we report evidence for orthologues of human integrins with alpha I domains in the agnathostomes (jawless vertebrates) and later diverging species. Sequence comparisons, phylogenetic analyses and molecular modeling show that one nearly full-length sequence from lamprey and two additional fragments include the entire integrin alpha I domain region, have the hallmarks of collagen-binding integrin alpha I domains, and we show that the corresponding recombinant proteins recognize the collagen GFOGER motifs in a metal dependent manner, unlike the alpha 1I domain of the ascidian C. intestinalis. The presence of a functional collagen receptor integrin alpha I domain supports the origin of orthologues of the human integrins with aI domains prior to the earliest diverging extant vertebrates, a domain that has been conserved and diversified throughout the vertebrate lineage.	[Chouhan, Bhanupratap Singh; Denessiouk, Konstantin; Denesyuk, Alexander; Johnson, Mark S.] Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, Turku, Finland; [Kapyla, Jarmo; Heino, Jyrki] Univ Turku, Dept Biochem, SF-20500 Turku, Finland	Abo Akademi University; Finland National Institute for Health & Welfare; University of Turku	Johnson, MS (corresponding author), Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, Turku, Finland.	johnson4@abo.fi		Kapyla, Jarmo/0000-0003-3036-713X	National Doctoral Network in Informational and Structural Biology (BSC); Academy of Finland; Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Abo Akademi Center of Excellence in Cell Stress and Aging	National Doctoral Network in Informational and Structural Biology (BSC); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Abo Akademi Center of Excellence in Cell Stress and Aging	These studies received financial support from the National Doctoral Network in Informational and Structural Biology (BSC), the Academy of Finland, Sigrid Juselius Foundation, Joe, Pentti and Tor Borg Memorial Fund, and the Abo Akademi Center of Excellence in Cell Stress and Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARNAOUT MA, 1990, BLOOD, V75, P1037; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burke RD, 1999, INT REV CYTOL, V191, P257, DOI 10.1016/S0074-7696(08)60161-8; Chin YKY, 2013, J BIOL CHEM, V288, P36796, DOI 10.1074/jbc.M113.480251; Chouhan B, 2012, WASET, V65, P546; Chouhan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025069; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DESIMONE DW, 1988, J BIOL CHEM, V263, P5333; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eble JA, 1997, INTEGRIB LIGAND INTE; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Ewan R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-31; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FLEMING JC, 1993, J IMMUNOL, V150, P480; Guyon R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-222; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1992, MOL BIOL EVOL, V9, P216; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 1999, J BIOL CHEM, V274, P3513, DOI 10.1074/jbc.274.6.3513; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; Johnson MS, 2003, MOL B INT U, P1; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; Johnson MS, 2013, EVOLUTION EXTRACELLU, P243; Johnson MS, 2014, ADV EXPT MED BIOL; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kang S.-G., UNPUB; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Lahti M, 2013, INT J BIOCHEM CELL B, V45, P1204, DOI 10.1016/j.biocel.2013.03.016; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Miyazawa S, 2001, J IMMUNOL, V166, P1710, DOI 10.4049/jimmunol.166.3.1710; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Pentikainen O, 1999, J BIOL CHEM, V274, P31493, DOI 10.1074/jbc.274.44.31493; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Suzuki T, 2004, DEV COMP IMMUNOL, V28, P993, DOI 10.1016/j.dci.2004.04.005; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Tulla M, 2007, FEBS LETT, V581, P2434, DOI 10.1016/j.febslet.2007.04.054; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022	79	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112064	10.1371/journal.pone.0112064	http://dx.doi.org/10.1371/journal.pone.0112064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409021	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200013
J	Katz, B; Reis, ST; Viana, NI; Morais, DR; Moura, CM; Dip, N; Silva, IA; Iscaife, A; Srougi, M; Leite, KRM				Katz, Betina; Reis, Sabrina T.; Viana, Nayara I.; Morais, Denis R.; Moura, Caio M.; Dip, Nelson; Silva, Iran A.; Iscaife, Alexandre; Srougi, Miguel; Leite, Katia R. M.			Comprehensive Study of Gene and microRNA Expression Related to Epithelial-Mesenchymal Transition in Prostate Cancer	PLOS ONE			English	Article							NEGATIVE FEEDBACK LOOP; E-CADHERIN; MIR-200 FAMILY; RADICAL PROSTATECTOMY; TUMOR-METASTASIS; INTRAEPITHELIAL NEOPLASIA; ANDROGEN RECEPTOR; PROGNOSTIC MARKER; REPRESSORS ZEB1; CELL MIGRATION	Prostate cancer is the most common cancer in men, and most patients have localized disease at the time of diagnosis. However, 4% already present with metastatic disease. Epithelial-mesenchymal transition is a fundamental process in carcinogenesis that has been shown to be involved in prostate cancer progression. The main event in epithelial-mesenchymal transition is the repression of E-cadherin by transcription factors, but the process is also regulated by microRNAs. The aim of this study was to analyze gene and microRNA expression involved in epithelial-mesenchymal transition in localized prostate cancer and metastatic prostate cancer cell lines and correlate with clinicopathological findings. We studied 51 fresh frozen tissue samples from patients with localized prostate cancer (PCa) treated by radical prostatectomy and three metastatic prostate cancer cell lines (LNCaP, DU145, PC3). The expression of 10 genes and 18 miRNAs were assessed by real-time PCR. The patients were divided into groups according to Gleason score, pathological stage, preoperative PSA, biochemical recurrence, and risk group for correlation with clinicopathological findings. The majority of localized PCa cases showed an epithelial phenotype, with overexpression of E-cadherin and underexpression of the mesenchymal markers. MiRNA-200 family members and miRNAs 203, 205, 183, 373, and 21 were overexpressed, while miRNAs 9, 495, 29b, and 1 were underexpressed. Low-expression levels of miRNAs 200b, 30a, and 1 were significantly associated with pathological stage. Lower expression of miR-200b was also associated with a Gleason score >= 8 and shorter biochemical recurrence-free survival. Furthermore, low-expression levels of miR-30a and high-expression levels of Vimentin and Twist1 were observed in the high-risk group. Compared with the primary tumor, the metastatic cell lines showed significantly higher expression levels of miR-183 and Twist1. In summary, miRNAs 200b, 30a, 1, and 183 and the genes Twist1 and Vimentin might play important roles in the progression of prostate cancer and may eventually become important prognostic markers.	[Katz, Betina] Univ Sao Paulo, Sch Med, Div Urol, Sao Paulo, Brazil; Univ Sao Paulo, Sch Med, Lab Med Invest LIM55, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Katz, B (corresponding author), Univ Sao Paulo, Sch Med, Div Urol, Sao Paulo, Brazil.	bkatz@usp.br	LEITE, KATIA RM/C-2055-2008; da Silva, Iran Amorim/B-2917-2013; Iscaife, Alexandre/A-5630-2015; Iscaife, Alexandre/I-8536-2012; Viana, Nayara I/P-6868-2015; Srougi, Miguel Srougi/AEV-2674-2022; Srougi, Miguel/AAT-8625-2021	LEITE, KATIA RM/0000-0002-2615-7730; da Silva, Iran Amorim/0000-0001-5441-790X; Iscaife, Alexandre/0000-0001-6388-8228; Iscaife, Alexandre/0000-0001-6388-8228; Reis, Sabrina Thalita dos/0000-0002-3564-3597; Viana, Nayara/0000-0003-4505-8508	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/50094-9]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) under protocol number 2012/50094-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Behnsawy HM, 2013, BJU INT, V111, P30, DOI 10.1111/j.1464-410X.2012.11551.x; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carlsson J, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-14; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Eide T, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-4; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; Kao CJ, 2013, ONCOGENE; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Li XL, 2014, MOL CELL BIOL, V34, P533, DOI 10.1128/MCB.01043-13; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Liu Y, 2012, MED SCI MONITOR, V18, pBR299, DOI 10.12659/MSM.883262; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mackinnon AC, 2009, ARCH PATHOL LAB MED, V133, P1033, DOI 10.1043/1543-2165-133.7.1033; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Putzke AP, 2011, AM J PATHOL, V179, P400, DOI 10.1016/j.ajpath.2011.03.028; Qu Y, 2013, INT J CANCER, V133, P544, DOI 10.1002/ijc.28056; Quinn DI, 2001, J CLIN ONCOL, V19, P3692, DOI 10.1200/JCO.2001.19.16.3692; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomita K, 2000, CANCER RES, V60, P3650; Ueno K, 2013, BRIT J CANCER, V108, P1659, DOI 10.1038/bjc.2013.125; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Wang W, 2013, EUR J SURG ONCOL; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	63	35	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113700	10.1371/journal.pone.0113700	http://dx.doi.org/10.1371/journal.pone.0113700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409297	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200145
J	Kim, S				Kim, Sooyun			Action Potential Modulation in CA1 Pyramidal Neuron Axons Facilitates OLM Interneuron Activation in Recurrent Inhibitory Microcircuits of Rat Hippocampus	PLOS ONE			English	Article							GATED K+ CHANNELS; CELLS IN-VIVO; GABAERGIC INTERNEURON; THETA OSCILLATIONS; STRATUM-ORIENS; INITIATION; CURRENTS; ASSOCIATION; DENDRITES; RELEASE	Oriens-lacunosum moleculare (O-LM) interneurons in the CA 1 region of the hippocampus play a key role in feedback inhibition and in the control of network activity. However, how these cells are efficiently activated in the network remains unclear. To address this question, I performed recordings from CA 1 pyramidal neuron axons, the presynaptic fibers that provide feedback innervation of these interneurons. Two forms of axonal action potential (AP) modulation were identified. First, repetitive stimulation resulted in activity-dependent AP broadening. Broadening showed fast onset, with marked changes in AP shape following a single AP. Second, tonic depolarization in CA 1 pyramidal neuron somata induced AP broadening in the axon, and depolarization-induced broadening summated with activity-dependent broadening. Outside-out patch recordings from CA 1 pyramidal neuron axons revealed a high density of alpha-dendrotoxin (alpha-DTX)-sensitive, inactivating K+ channels, suggesting that K+ channel inactivation mechanistically contributes to AP broadening. To examine the functional consequences of axonal AP modulation for synaptic transmission, I performed paired recordings between synaptically connected CA 1 pyramidal neurons and O-LM interneurons. CA 1 pyramidal neuron-O-LM interneuron excitatory postsynaptic currents (EPSCs) showed facilitation during both repetitive stimulation and tonic depolarization of the presynaptic neuron. Both effects were mimicked and occluded by alpha-DTX, suggesting that they were mediated by K+ channel inactivation. Therefore, axonal AP modulation can greatly facilitate the activation of O-LM interneurons. In conclusion, modulation of AP shape in CA 1 pyramidal neuron axons substantially enhances the efficacy of principal neuroninterneuron synapses, promoting the activation of O-LM interneurons in recurrent inhibitory microcircuits.	IST Austria, Klosterneuburg, Austria	Institute of Science & Technology - Austria	Kim, S (corresponding author), IST Austria, Klosterneuburg, Austria.	sooyun.kim@ist.ac.at	Kim, Sooyun/J-9071-2014; Kim, Sooyun/AAH-6262-2020	Kim, Sooyun/0000-0002-2035-3247; Kim, Sooyun/0000-0002-2035-3247	European Union (ERC advanced grant) [268548]	European Union (ERC advanced grant)	This work was supported by the European Union (ERC advanced grant 268548) to P. Jonas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Debanne D, 2013, NAT REV NEUROSCI, V14, P63, DOI 10.1038/nrn3361; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Guzman SJ, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00016; Hu H, 2014, NAT NEUROSCI, V17, P686, DOI 10.1038/nn.3678; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Katona L, 2014, NEURON, V82, P872, DOI 10.1016/j.neuron.2014.04.007; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kim S, 2012, NAT NEUROSCI, V15, P600, DOI [10.1038/nn.3060, 10.1038/nn.3173]; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; Lien CC, 2002, J PHYSIOL-LONDON, V538, P405, DOI 10.1113/jphysiol.2001.013066; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Martina M, 1998, J NEUROSCI, V18, P8111; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; McIntosh P, 1997, PFLUG ARCH EUR J PHY, V435, P43, DOI 10.1007/s004240050482; NICHOLLS J, 1978, J PHYSIOL-LONDON, V281, P157, DOI 10.1113/jphysiol.1978.sp012414; Pernia-Andrade AJ, 2014, NEURON, V81, P140, DOI 10.1016/j.neuron.2013.09.046; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Sasaki T, 2012, J NEUROSCI, V32, P2868, DOI 10.1523/JNEUROSCI.5365-11.2012; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SHIMAHARA T, 1975, J PHYSIOL-LONDON, V247, P299, DOI 10.1113/jphysiol.1975.sp010933; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P647, DOI 10.1113/jphysiol.1995.sp020997; Zhu J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001032; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	40	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113124	10.1371/journal.pone.0113124	http://dx.doi.org/10.1371/journal.pone.0113124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409299	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200070
J	Marquez, A; Solans, R; Hernandez-Rodriguez, J; Cid, MC; Castaneda, S; Ramentol, M; Rodriguez-Rodriguez, L; Narvaez, J; Blanco, R; Ortego-Centeno, N; Palm, O; Diamantopoulos, AP; Braun, N; Moosig, F; Witte, T; Beretta, L; Lunardi, C; Cimmino, MA; Vaglio, A; Salvarani, C; Gonzalez-Gay, MA; Martin, J				Marquez, Ana; Solans, Roser; Hernandez-Rodriguez, Jose; Cid, Maria C.; Castaneda, Santos; Ramentol, Marc; Rodriguez-Rodriguez, Luis; Narvaez, Javier; Blanco, Ricardo; Ortego-Centeno, Norberto; Palm, Oyvind; Diamantopoulos, Andreas P.; Braun, Niko; Moosig, Frank; Witte, Torsten; Beretta, Lorenzo; Lunardi, Claudio; Cimmino, Marco A.; Vaglio, Augusto; Salvarani, Carlo; Gonzalez-Gay, Miguel A.; Martin, Javier		Spanish GCA Consortium	A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA	PLOS ONE			English	Article							GIANT-CELL ARTERITIS; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; ADHESION MOLECULES; MAST-CELLS; IL-33; ASTHMA; METAANALYSIS; VARIANTS; DISEASE	Introduction: Increased expression of IL-33 and its receptor ST2, encoded by the IL1RL1 gene, has been detected in the inflamed arteries of giant cell arteritis (GCA) patients. The aim of the present study was to investigate for the first time the potential influence of the IL33 and IL1RL1 loci on GCA predisposition. Methods: A total of 1,363 biopsy-proven GCA patients and 3,908 healthy controls from four European cohorts (Spain, Italy, Germany and Norway) were combined in a meta-analysis. Six genetic variants: rs3939286, rs7025417 and rs7044343, within the IL33 gene, and rs2058660, rs2310173 and rs13015714, within the IL1RL1 gene, previously associated with immunerelated diseases, were genotyped using predesigned TaqMan assays. Results: A consistent association between the rs7025417 polymorphism and GCA was evident in the overall meta-analysis, under both allele (P-MH = 0.041, OR = 0.88, CI 95% 0.78-0.99) and recessive (P-MH = 3.40E-03, OR = 0.53, CI 95% 0.35-0.80) models. No statistically significant differences between allele or genotype frequencies for the other IL33 and IL1RL1 genetic variants were detected in this pooled analysis. Conclusions: Our results clearly evidenced the implication of the IL33 rs7025417 polymorphism in the genetic network underlying GCA.	[Marquez, Ana; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Marquez, Ana; Ortego-Centeno, Norberto] Hosp Clin San Cecilio, System Autoimmune Dis Unit, Granada, Spain; [Solans, Roser; Ramentol, Marc] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain; [Hernandez-Rodriguez, Jose; Cid, Maria C.] Univ Barcelona, Hosp Clin Barcelona, Ctr Recerca Biomed Cellex IDIBAPS, Vasculitis Res Unit,Dept Autoimmune & System Dis, Barcelona, Spain; [Castaneda, Santos] Hosp Princesa, IIS Princesa, Dept Rheumatol, Madrid, Spain; [Rodriguez-Rodriguez, Luis] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Narvaez, Javier] Hosp Univ Bellvitge IDIBELL, Dept Rheumatol, Barcelona, Spain; [Blanco, Ricardo; Gonzalez-Gay, Miguel A.] Hosp Univ Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain; [Palm, Oyvind] Oslo Univ Hosp, Rikshosp, Dept Rheumatol, Oslo, Norway; [Diamantopoulos, Andreas P.] Hosp Southern Norway Trust, Dept Rheumatol, Kristiansand, Norway; [Braun, Niko] Robert Bosch Krankenhaus, Dept Internal Med, Div Nephrol, Stuttgart, Germany; [Moosig, Frank] Univ Lubeck, Dept Clin Immunol & Rheumatol, Bad Bramstedt, Germany; [Witte, Torsten] Hannover Med Sch, Hannover, Germany; [Beretta, Lorenzo] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Referral Ctr Syst Autoimmune Dis, Milan, Italy; [Lunardi, Claudio] Univ Verona, Dept Med, I-37100 Verona, Italy; [Cimmino, Marco A.] Univ Genoa, Dept Internal Med, Acad Unit Clin Rheumatol, I-16126 Genoa, Italy; [Vaglio, Augusto] Univ Hosp Parma, Dept Clin Med Nephrol & Hlth Sci, Parma, Italy; [Salvarani, Carlo] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Unita Operat Reumatol, Reggio Emilia, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario San Cecilio; Hospital Universitari Vall d'Hebron; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Clinico San Carlos; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Universitario Marques de Valdecilla (HUMV); University of Oslo; National Hospital Norway; Bosch; Robert Bosch Krankenhaus; University of Lubeck; Hannover Medical School; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Verona; University of Genoa; University of Parma; University Hospital of Parma; IRCCS Arcispedale S. Maria Nuova	Marquez, A (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	anamaort@ipb.csic.es	Martín, María/HDL-9512-2022; Martin, Javier/B-8141-2008; Martín, Javier/AAV-5209-2021; González-Gay, Miguel A./B-2306-2008; Witte, Torsten/B-5783-2016; blanco, ricardo/AAA-1248-2020; Salvarani, Carlo/K-2431-2018; Beretta, Lorenzo/AAB-8605-2019; Narvaez, Javier/AAD-7434-2020; Cid, Maria C./J-4553-2016; Rodriguez-Rodriguez, Luis/H-5880-2013; Centeno, Norberto Ortego/C-4793-2019; Narvaez, Javier/AAD-7456-2020; Vaglio, Augusto/AHE-8117-2022; Hernandez-Rodriguez, Jose/L-2073-2017	Martin, Javier/0000-0002-2202-0622; González-Gay, Miguel A./0000-0002-7924-7406; blanco, ricardo/0000-0003-2344-2285; Beretta, Lorenzo/0000-0002-6529-6258; Cid, Maria C./0000-0002-4730-0938; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Centeno, Norberto Ortego/0000-0003-2325-0937; Narvaez, Javier/0000-0002-1614-8064; Vaglio, Augusto/0000-0002-3814-9172; Palm, Oyvind/0000-0001-5395-0665; Salvarani, Carlo/0000-0001-5426-5133; Marquez, Ana/0000-0001-9913-7688; Moosig, Frank/0000-0002-7341-9844; Hernandez-Rodriguez, Jose/0000-0002-2357-2015	'Instituto de Salud Carlos III' (ISCIII) [RD08/0075/0011]; Junta de Andalucia [CTS-180]; SAF [11/30073]; DFG [WI 1031/6.1]	'Instituto de Salud Carlos III' (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Junta de Andalucia(Junta de Andalucia); SAF; DFG(German Research Foundation (DFG))	This study was partially supported by RETICS Program RD08/0075/0011 (RIER) from 'Instituto de Salud Carlos III' (ISCIII) and by Junta de Andalucia, grupo CTS-180. MCC and JH-R were granted by SAF 11/30073. TW was granted by DFG WI 1031/6.1. The sponsors had no role in the design of the study, in the collection, analysis and interpretation of data or in the preparation, review or approval of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buysschaert ID, 2010, ALLERGY, V65, P616, DOI 10.1111/j.1398-9995.2009.02227.x; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Ciccia F, 2013, ANN RHEUM DIS, V72, P258, DOI 10.1136/annrheumdis-2012-201309; Cid MC, 2000, ARTHRITIS RHEUM-US, V43, P184, DOI 10.1002/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N; Carmona FD, 2014, RHEUMATOLOGY, V53, P6, DOI 10.1093/rheumatology/ket231; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gonzalez-Gay MA, 2009, ARTHRIT CARE RES, V61, P1454, DOI 10.1002/art.24459; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1065; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Latiano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062144; Li C, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4554; Li MC, 2012, J NEUROIMMUNOL, V247, P25, DOI 10.1016/j.jneuroim.2012.03.016; Ly KH, 2010, AUTOIMMUN REV, V9, P635, DOI 10.1016/j.autrev.2010.05.002; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Ramasamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044008; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Serrano A, 2013, ANN RHEUM DIS, V72, P1882, DOI 10.1136/annrheumdis-2013-203641; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tu X, 2013, AM J HUM GENET, V93, P652, DOI 10.1016/j.ajhg.2013.08.009; Weyand CM, 2013, NAT REV RHEUMATOL, V9, P731, DOI 10.1038/nrrheum.2013.161; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	30	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113476	10.1371/journal.pone.0113476	http://dx.doi.org/10.1371/journal.pone.0113476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409453	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200126
J	Pinheiro-Chagas, P; Wood, G; Knops, A; Krinzinger, H; Lonnemann, J; Starling-Alves, I; Willmes, K; Haase, VG				Pinheiro-Chagas, Pedro; Wood, Guilherme; Knops, Andre; Krinzinger, Helga; Lonnemann, Jan; Starling-Alves, Isabella; Willmes, Klaus; Haase, Vitor Geraldi			In How Many Ways is the Approximate Number System Associated with Exact Calculation?	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ACUITY; MAGNITUDE; REPRESENTATIONS; ACHIEVEMENT; PERFORMANCE; CORRELATE; CHILDREN; SKILLS; SENSE	The approximate number system (ANS) has been consistently found to be associated with math achievement. However, little is known about the interactions between the different instantiations of the ANS and in how many ways they are related to exact calculation. In a cross-sectional design, we investigated the relationship between three measures of ANS acuity (non-symbolic comparison, non-symbolic estimation and non-symbolic addition), their cross-sectional trajectories and specific contributions to exact calculation. Children with mathematical difficulties (MD) and typically achieving (TA) controls attending the first six years of formal schooling participated in the study. The MD group exhibited impairments in multiple instantiations of the ANS compared to their TA peers. The ANS acuity measured by all three tasks positively correlated with age in TA children, while no correlation was found between non-symbolic comparison and age in the MD group. The measures of ANS acuity significantly correlated with each other, reflecting at least in part a common numerosity code. Crucially, we found that non-symbolic estimation partially and non-symbolic addition fully mediated the effects of non-symbolic comparison in exact calculation.	[Pinheiro-Chagas, Pedro] INSERM, Cognit Neuroimaging Unit, U992, Gif Sur Yvette, France; [Pinheiro-Chagas, Pedro] CEA, NeuroSpin Ctr, Inst BioImaging, Gif Sur Yvette, France; [Pinheiro-Chagas, Pedro; Starling-Alves, Isabella; Haase, Vitor Geraldi] Univ Fed Minas Gerais, Dept Psychol, Dev Neuropsychol Lab, Belo Horizonte, MG, Brazil; [Wood, Guilherme] Karl Franzens Univ Graz, Dept Neuropsychol, Inst Psychol, Graz, Austria; [Knops, Andre] Humboldt Univ, Fac Life Sci, D-10099 Berlin, Germany; [Krinzinger, Helga] Univ Hosp RWTH, Dept Child & Adolescent Psychiat, Sect Child Neuropsychol, Aachen, Germany; [Lonnemann, Jan] German Inst Int Educ Res, Frankfurt, Germany; [Lonnemann, Jan] Ctr Individual Dev & Adapt Educ Children Risk IDe, Frankfurt, Germany; [Willmes, Klaus] Univ Hosp RWTH, Sect Neuropsychol, Dept Neurol, Aachen, Germany; [Haase, Vitor Geraldi] Univ Fed Minas Gerais, Programa Posgrad Neurociencias, Belo Horizonte, MG, Brazil; [Haase, Vitor Geraldi] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Saude Crianca & Adolescente, Belo Horizonte, MG, Brazil	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal de Minas Gerais; University of Graz; Humboldt University of Berlin; RWTH Aachen University; RWTH Aachen University Hospital; German Institute for International Educational Research; RWTH Aachen University; RWTH Aachen University Hospital; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Pinheiro-Chagas, P (corresponding author), INSERM, Cognit Neuroimaging Unit, U992, Gif Sur Yvette, France.	ppinheirochagas@gmail.com	Willmes, Klaus F/A-1268-2014; Knops, André/D-5457-2013	Willmes, Klaus F/0000-0002-9012-0553; Knops, André/0000-0001-6357-9951; Maia de Oliveira Wood, Guilherme/0000-0001-5055-5336; Lonnemann, Jan/0000-0002-6619-0981; Haase, Vitor Geraldi/0000-0002-1906-7702	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307006/20085, 401232/2009-3]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-02755-SHA, APQ-03289-10]; CNPq fellowships [308157/2011-7, 307975/2010-0]; FWF research project [P22577]; CNPq [246750/2012-0]; CAPES/DAAD Probral Program; Austrian Science Fund (FWF) [P 22577] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FWF research project(Austrian Science Fund (FWF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/DAAD Probral Program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was granted by the CAPES/DAAD Probral Program, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 307006/20085, 401232/2009-3) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, APQ-02755-SHA, APQ-03289-10). Vitor G. Haase is supported by CNPq fellowships (308157/2011-7 and 307975/2010-0, respectively). Guilherme Wood is supported by a FWF research project (nr. P22577). Pedro Pinheiro-Chagas has a Science Without Borders Fellowship from CNPq (nr. 246750/2012-0). CNPq: http://cnpq.br/FAPEMIG: http://www.fapemig.br/FWF: http://www.fwf.ac.at/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini A.L., 1999, MATRIZES PROGRESSIVA; Ashkenazi S, 2012, DEV COGN NEUROS-NETH, V2, pS152, DOI 10.1016/j.dcn.2011.09.006; Barth H, 2006, COGNITION, V98, P199, DOI 10.1016/j.cognition.2004.09.011; Bonny JW, 2013, J EXP CHILD PSYCHOL, V114, P375, DOI 10.1016/j.jecp.2012.09.015; Booth JL, 2006, DEV PSYCHOL, V42, P189, DOI 10.1037/0012-1649.41.6.189; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Chu FW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00195; Cordes S, 2007, PERCEPT PSYCHOPHYS, V69, P1185, DOI 10.3758/BF03193955; Costa AJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00368; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S, 2005, CONTROL OVER NON NUM; Dehaene S., 2007, ATTENTION PERFORM, P527, DOI DOI 10.1093/ACPROF:OSO/9780199231447.003.0024; Dehaene S, 2010, TRENDS COGN SCI, V14, P517, DOI 10.1016/j.tics.2010.09.009; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Desoete A, 2012, BRIT J EDUC PSYCHOL, V82, P64, DOI 10.1348/2044-8279.002002; Fazio LK, 2014, J EXP CHILD PSYCHOL, V123, P53, DOI 10.1016/j.jecp.2014.01.013; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Gilmore C, 2011, Q J EXP PSYCHOL, V64, P2099, DOI 10.1080/17470218.2011.574710; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Halberda J, 2011, WHAT IS A WEBER FRAC; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Imai K, 2013, J R STAT SOC A STAT, V176, P5, DOI 10.1111/j.1467-985X.2012.01032.x; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Izard V, 2008, COGNITION, V106, P1221, DOI 10.1016/j.cognition.2007.06.004; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Johnson MH, 2012, TRENDS COGN SCI, V16, P454, DOI 10.1016/j.tics.2012.07.001; Julio-Costa A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00531; Kingdom F.A.A., 2010, PSYCHOPHYSICS A PRAC; Knops A, 2009, ATTEN PERCEPT PSYCHO, V71, P803, DOI 10.3758/APP.71.4.803; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P546, DOI 10.1016/j.jecp.2008.12.006; Libertus ME, 2013, J EXP CHILD PSYCHOL, V116, P829, DOI 10.1016/j.jecp.2013.08.003; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lyons IM, 2011, COGNITION, V121, P256, DOI 10.1016/j.cognition.2011.07.009; Mazzocco M.M.M., 2007, WHY IS MATH SO HARD, P29; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Mejias S, 2012, CHILD NEUROPSYCHOL, V18, P550, DOI 10.1080/09297049.2011.625355; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Noel MP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00165; Oliveira-Ferreira Fernanda, 2012, Psychol. Neurosci., V5, P157, DOI 10.3922/j.psns.2012.2.05; Park J, 2014, COGNITION, V133, P188, DOI 10.1016/j.cognition.2014.06.011; Park J, 2013, PSYCHOL SCI, V24, P2013, DOI 10.1177/0956797613482944; Park J, 2013, CEREB CORTEX, V23, P2127, DOI 10.1093/cercor/bhs193; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2013, PSYCHOL SCI, V24, P1037, DOI 10.1177/0956797612464057; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; R Core Team, 2018, R LANG ENV STAT COMP; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Stein LM, 1994, TDE TESTE DO DESEMPE; Thomas MSC, 2009, J SPEECH LANG HEAR R, V52, P336, DOI 10.1044/1092-4388(2009/07-0144); Tingley D, 2014, J STAT SOFTW, V59; vanMarle K, 2014, DEVELOPMENTAL SCI, V17, P492, DOI 10.1111/desc.12143; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	65	36	41	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111155	10.1371/journal.pone.0111155	http://dx.doi.org/10.1371/journal.pone.0111155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409446	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200001
J	Wang, Q; Taylor, JE				Wang, Qi; Taylor, John E.			Quantifying Human Mobility Perturbation and Resilience in Hurricane Sandy	PLOS ONE			English	Article							IMPACT	Human mobility is influenced by environmental change and natural disasters. Researchers have used trip distance distribution, radius of gyration of movements, and individuals' visited locations to understand and capture human mobility patterns and trajectories. However, our knowledge of human movements during natural disasters is limited owing to both a lack of empirical data and the low precision of available data. Here, we studied human mobility using high-resolution movement data from individuals in New York City during and for several days after Hurricane Sandy in 2012. We found the human movements followed truncated power-law distributions during and after Hurricane Sandy, although the beta value was noticeably larger during the first 24 hours after the storm struck. Also, we examined two parameters: the center of mass and the radius of gyration of each individual's movements. We found that their values during perturbation states and steady states are highly correlated, suggesting human mobility data obtained in steady states can possibly predict the perturbation state. Our results demonstrate that human movement trajectories experienced significant perturbations during hurricanes, but also exhibited high resilience. We expect the study will stimulate future research on the perturbation and inherent resilience of human mobility under the influence of hurricanes. For example, mobility patterns in coastal urban areas could be examined as hurricanes approach, gain or dissipate in strength, and as the path of the storm changes. Understanding nuances of human mobility under the influence of such disasters will enable more effective evacuation, emergency response planning and development of strategies and policies to reduce fatality, injury, and economic loss.	[Wang, Qi; Taylor, John E.] Virginia Tech, Charles E Via Jr Dept Civil & Environm Engn, Civil Engn Network Dynam Lab, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Taylor, JE (corresponding author), Virginia Tech, Charles E Via Jr Dept Civil & Environm Engn, Civil Engn Network Dynam Lab, Blacksburg, VA 24061 USA.	jet@vt.edu			National Science Foundation [1142379]; Virginia Tech's Open Access Subvention Fund; Directorate For Engineering [1142379] Funding Source: National Science Foundation; Div Of Civil, Mechanical, & Manufact Inn [1733695] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech's Open Access Subvention Fund; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study is supported by the National Science Foundation under Grant No. 1142379. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Open access publication of this article was supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Chaintreau A, 2007, IEEE T MOBILE COMPUT, V6, P606, DOI 10.1109/TMC.2007.1060; CWS (Church World Service - Asia/Pacific), 2013, 19 CWS; Feeley M, 2004, LECT NOTES COMPUT SC, V3158, P324; Ferris E., 2013, YEAR RECURRING DISAS; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Horanont T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081153; Kaufman S., 2012, TRANSPORTATION HURRI; Kleinberg J, 2007, NATURE, V449, P287, DOI 10.1038/449287a; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; McGeeham P, 2012, NY TIMES, pA20; MORROWJONES HA, 1991, DISASTERS, V15, P126, DOI 10.1111/j.1467-7717.1991.tb00441.x; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; OCHA, 2012, 2 OCHA; Pan XS, 2007, AI SOC, V22, P113, DOI 10.1007/s00146-007-0126-1; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; UNISDR, 2013, DIS IMP 2000 2012; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	25	53	53	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112608	10.1371/journal.pone.0112608	http://dx.doi.org/10.1371/journal.pone.0112608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409009	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200028
J	Xu, XY; Shen, YB; Fu, JJ; Lu, LQ; Li, JL				Xu, Xiaoyan; Shen, Yubang; Fu, Jianjun; Lu, Liqun; Li, Jiale			De novo Assembly of the Grass Carp Ctenopharyngodon idella Transcriptome to Identify miRNA Targets Associated with Motile Aeromonad Septicemia	PLOS ONE			English	Article							RNA-SEQ DATA; IMMUNE-RESPONSE; HEAD KIDNEY; GENES; MICRORNAS; IDENTIFICATION; EXPRESSION; ACTIVATION; INNATE; QUANTIFICATION	Background: De novo transcriptome sequencing is a robust method of predicting miRNA target genes, especially for organisms without reference genomes. Differentially expressed miRNAs had been identified previously in kidney samples collected from susceptible and resistant grass carp (Ctenopharyngodon idella) affected by Aeromonas hydrophila. Target identification for these differentially expressed miRNAs poses a major challenge in this non-model organism. Results: Two cDNA libraries constructed from mRNAs of susceptible and resistant C. idella were sequenced by Illumina Hiseq 2000 technology. A total of more than 100 million reads were generated and de novo assembled into 199,593 transcripts which were further extensively annotated by comparing their sequences to different protein databases. Biochemical pathways were predicted from these transcript sequences. A BLASTx analysis against a non-redundant protein database revealed that 61,373 unigenes coded for 28,311 annotated proteins. Two cDNA libraries from susceptible and resistant samples showed that 721 unigenes were expressed at significantly different levels; 475 were significantly up-regulated and 246 were significantly down-regulated in the SG samples compared to the RG samples. The computational prediction of miRNA targets from these differentially expressed genes identified 188 unigenes as the targets of 5 conserved and 4 putative novel miRNA families. Conclusion: This study demonstrates the feasibility of identifying miRNA targets by transcriptome analysis. The transcriptome assembly data represent a substantial increase in the genomic resources available for C. idella and will provide insights into the gene expression profile analysis and the miRNA function annotations in further studies.	[Xu, Xiaoyan; Shen, Yubang; Fu, Jianjun; Li, Jiale] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China; [Li, Jiale] Shanghai Ocean Univ, E Inst Shanghai Univ, Shanghai 201306, Peoples R China; [Lu, Liqun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Coll Fisheries & Life Sci, Shanghai 201306, Peoples R China	Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China.	jlli2009@126.com	li, jia/GVT-7587-2022; Yubang, Shen/AAC-4325-2019		National Key Technology R&D Program of China [2012BAD26B02]; China's Agricultural Research System [CARS-46-04]; Agricultural Seed Development Program of Shanghai City [2012NY10]; Shanghai Ocean University Doctoral Research Foundation; Shanghai Universities First-class Disciplines Project of Fisheries; Innovation Plan of Shanghai Graduate Education	National Key Technology R&D Program of China(National Key Technology R&D Program); China's Agricultural Research System; Agricultural Seed Development Program of Shanghai City; Shanghai Ocean University Doctoral Research Foundation; Shanghai Universities First-class Disciplines Project of Fisheries; Innovation Plan of Shanghai Graduate Education	This work was supported by grants from National Key Technology R&D Program of China (2012BAD26B02), the China's Agricultural Research System (CARS-46-04), the Agricultural Seed Development Program of Shanghai City (2012NY10), Shanghai Ocean University Doctoral Research Foundation, Shanghai Universities First-class Disciplines Project of Fisheries and the Innovation Plan of Shanghai Graduate Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barozai MYK, 2012, MOL BIOL REP, V39, P8867, DOI 10.1007/s11033-012-1753-2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bhardwaj J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-647; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-108; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Enright AJ, 2004, GENOME BIOL, V5; FAO (Food and Agriculture Organization), 2014, FAO YB FISH AQ STAT; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2008, NATURE, V453, P1197, DOI 10.1038/4531197b; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heng JF, 2011, FISH SHELLFISH IMMUN, V30, P45, DOI 10.1016/j.fsi.2010.09.004; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang QY, 1983, ICHTHYOPATHOLOGY; Igbinosa IH, 2012, SCI WORLD J, DOI 10.1100/2012/625023; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu F, 2011, FISH SHELLFISH IMMUN, V31, P765, DOI 10.1016/j.fsi.2011.07.014; Liu F, 2010, COMP BIOCHEM PHYS D, V5, P116, DOI 10.1016/j.cbd.2010.02.003; Liu PT, 2012, NAT MED, V18, P267, DOI 10.1038/nm.2584; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Mennigen JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038604; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu XJ, 2011, FISH SHELLFISH IMMUN, V31, P1162, DOI 10.1016/j.fsi.2011.10.011; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Plata-Salaman CR, 1998, INT J MOL MED, V1, P387; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rahman M, 2002, APPL ENVIRON MICROB, V68, P650, DOI 10.1128/AEM.68.2.650-655.2002; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Renkui C, 1991, DEV HIST FRESHWATER; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Xu XY, 2014, FISH SHELLFISH IMMUN, V36, P374, DOI 10.1016/j.fsi.2013.12.007; Xu XY, 2013, FISH SHELLFISH IMMUN, V35, P801, DOI 10.1016/j.fsi.2013.06.009; Xu XY, 2012, FISH SHELLFISH IMMUN, V33, P251, DOI 10.1016/j.fsi.2012.05.015; Yan B, 2012, AQUACULTURE, V364, P240, DOI 10.1016/j.aquaculture.2012.08.018; Zhang PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073506; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20; Zhu YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-413	69	24	25	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112722	10.1371/journal.pone.0112722	http://dx.doi.org/10.1371/journal.pone.0112722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409340	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200035
J	Chiarelli-Neto, O; Ferreira, AS; Martins, WK; Pavani, C; Severino, D; Faiao-Flores, F; Maria-Engler, SS; Aliprandini, E; Martinez, GR; Di Mascio, P; Medeiros, MHG; Baptista, MS				Chiarelli-Neto, Orlando; Ferreira, Alan Silva; Martins, Waleska Kerllen; Pavani, Christiane; Severino, Divinomar; Faiao-Flores, Fernanda; Maria-Engler, Silvya Stuchi; Aliprandini, Eduardo; Martinez, Glaucia R.; Di Mascio, Paolo; Medeiros, Marisa H. G.; Baptista, Mauricio S.			Melanin Photosensitization and the Effect of Visible Light on Epithelial Cells	PLOS ONE			English	Article							HUMAN SKIN; SINGLET OXYGEN; DNA-DAMAGE; UVA-RADIATION; MALIGNANT-MELANOMA; COMET ASSAY; ULTRAVIOLET-RADIATION; FINGERPRINT MUTATIONS; OXIDATIVE DAMAGE; GENERATION	Protecting human skin from sun exposure is a complex issue that involves unclear aspects of the interaction between light and tissue. A persistent misconception is that visible light is safe for the skin, although several lines of evidence suggest otherwise. Here, we show that visible light can damage melanocytes through melanin photosensitization and singlet oxygen (O-1(2)) generation, thus decreasing cell viability, increasing membrane permeability, and causing both DNA photo-oxidation and necro-apoptotic cell death. UVA (355 nm) and visible (532 nm) light photosensitize O-1(2) with similar yields, and pheomelanin is more efficient than eumelanin at generating O-1(2) and resisting photobleaching. Although melanin can protect against the cellular damage induced by UVB, exposure to visible light leads to pre-mutagenic DNA lesions (i.e., Fpg- and Endo III-sensitive modifications); these DNA lesions may be mutagenic and may cause photoaging, as well as other health problems, such as skin cancer.	[Chiarelli-Neto, Orlando; Ferreira, Alan Silva; Martins, Waleska Kerllen; Pavani, Christiane; Severino, Divinomar; Di Mascio, Paolo; Medeiros, Marisa H. G.; Baptista, Mauricio S.] Univ Sao Paulo, Dept Quim, Inst Quim, Sao Paulo, Brazil; [Faiao-Flores, Fernanda; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Analises Clin, BR-09500900 Sao Paulo, Brazil; [Aliprandini, Eduardo; Martinez, Glaucia R.] Univ Fed Parana, Setor Ciencias Biol, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Parana	Baptista, MS (corresponding author), Univ Sao Paulo, Dept Quim, Inst Quim, Sao Paulo, Brazil.	baptista@iq.usp.br	Martinez, Glaucia Regina/I-3110-2016; Martins, Waleska Kerllen/L-5187-2018; Baptista, Mauricio S/AAO-5749-2021; Engler, Silvya Stuchi Maria/K-5936-2016; Baptista, Mauricio S/A-5140-2008; Maria-Engler, Silvya/ABC-2016-2020; de Medeiros, Marisa Helena Gennari/AAA-8015-2019; Faião-Flores, Fernanda/F-7111-2012; Di Mascio, Paolo/D-1264-2014; Medeiros, Marisa H. G./A-5212-2008; PAVANI, Christiane/G-5869-2012; Severino, Divinomar/F-9029-2012	Martinez, Glaucia Regina/0000-0002-2628-4406; Martins, Waleska Kerllen/0000-0003-1502-4606; Baptista, Mauricio S/0000-0001-7079-7666; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Baptista, Mauricio S/0000-0001-7079-7666; Maria-Engler, Silvya/0000-0003-4771-6041; de Medeiros, Marisa Helena Gennari/0000-0002-5438-1174; Faião-Flores, Fernanda/0000-0003-3449-9930; Di Mascio, Paolo/0000-0003-4125-8350; Medeiros, Marisa H. G./0000-0002-5438-1174; PAVANI, Christiane/0000-0001-8275-7370; Severino, Divinomar/0000-0001-9483-6287; Chiarelli-Neto, Orlando/0000-0002-8685-1185	FAPESP [12/50680-5, 13/07937-8, 2010/08796-0]; CNPq; INCT Redoxoma (FAPESP/CNPq/CAPES) [573530/2008-4]; FARMA	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT Redoxoma (FAPESP/CNPq/CAPES); FARMA	FAPESP (12/50680-5; 13/07937-8), CNPq, INCT Redoxoma (FAPESP/CNPq/CAPES; Proc. 573530/2008-4) and FARMA Service Bioextract are acknowledged for providing funds for this research. OCN acknowledges FAPESP for his PhD fellowship (2010/08796-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Beltran-Garcia MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091616; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brohem CA, 2012, PIGM CELL MELANOMA R, V25, P354, DOI 10.1111/j.1755-148X.2012.00992.x; Cadet J, 2011, J INVEST DERMATOL, V131, P1005, DOI 10.1038/jid.2011.51; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chiarelli-Neto O, 2011, FREE RADICAL BIO MED, V51, P1195, DOI 10.1016/j.freeradbiomed.2011.06.013; Collier AC, 2003, BIOCHEM PHARMACOL, V66, P281, DOI 10.1016/S0006-2952(03)00240-5; Dahle J, 2003, CANCER RES, V63, P1464; FIDLER IJ, 1975, CANCER RES, V35, P218; Fisher DE, 2010, NEW ENGL J MED, V363, P901, DOI 10.1056/NEJMp1005999; Grether-Beck S, 2014, PHOTODERMATOL PHOTO, V30, P167, DOI 10.1111/phpp.12111; Halliday GM, 2005, PHOTOCHEM PHOTOBIOL, V81, P3, DOI 10.1562/2004-07-27-IR-247.1; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Haywood RM, 2008, PHOTOCHEM PHOTOBIOL, V84, P572, DOI 10.1111/j.1751-1097.2008.00343.x; Hearing VJ, 2000, PIGM CELL RES, V13, P23, DOI 10.1034/j.1600-0749.13.s8.7.x; Heo SJ, 2009, TOXICOL IN VITRO, V23, P1123, DOI 10.1016/j.tiv.2009.05.013; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kolbe L, 2012, J INVEST DERMATOL, V132, P1756, DOI 10.1038/jid.2012.148; Kvam E, 1997, CARCINOGENESIS, V18, P2379, DOI 10.1093/carcin/18.12.2379; Liebel F, 2012, J INVEST DERMATOL, V132, P1901, DOI 10.1038/jid.2011.476; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Mahmoud BH, 2008, PHOTOCHEM PHOTOBIOL, V84, P450, DOI 10.1111/j.1751-1097.2007.00286.x; Mahmoud BH, 2010, J INVEST DERMATOL, V130, P2092, DOI 10.1038/jid.2010.95; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Oplander C, 2011, J PHOTOCH PHOTOBIO B, V103, P118, DOI 10.1016/j.jphotobiol.2011.02.018; Pierlot C, 2000, METHOD ENZYMOL, V319, P3; Pouget JP, 2000, CHEM RES TOXICOL, V13, P541, DOI 10.1021/tx000020e; RALPH P, 1975, NATURE, V257, P393, DOI 10.1038/257393a0; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; Sauvaigo S, 2002, ANAL BIOCHEM, V303, P107, DOI 10.1006/abio.2001.5559; Schieke SM, 2003, PHOTODERMATOL PHOTO, V19, P228, DOI 10.1034/j.1600-0781.2003.00054.x; SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666; Suzukawa AA, 2012, FREE RADICAL BIO MED, V52, P1945, DOI 10.1016/j.freeradbiomed.2012.02.039; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Tadokoro T, 2003, FASEB J, V17, P1177, DOI 10.1096/fj.02-0865fje; Uchoa AF, 2008, EUR BIOPHYS J BIOPHY, V37, P843, DOI 10.1007/s00249-008-0287-y; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Wood SR, 2006, P NATL ACAD SCI USA, V103, P4111, DOI 10.1073/pnas.0511248103; Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149	46	61	63	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113266	10.1371/journal.pone.0113266	http://dx.doi.org/10.1371/journal.pone.0113266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405352	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300094
J	Kurauchi, M; Niwano, Y; Shirato, M; Kanno, T; Nakamura, K; Egusa, H; Sasaki, K				Kurauchi, Michiko; Niwano, Yoshimi; Shirato, Midori; Kanno, Taro; Nakamura, Keisuke; Egusa, Hiroshi; Sasaki, Keiichi			Cytoprotective Effect of Short-Term Pretreatment with Proanthocyanidin on Human Gingival Fibroblasts Exposed to Harsh Environmental Conditions	PLOS ONE			English	Article							RAPID COLORIMETRIC ASSAY; SERUM DEPRIVATION; OXIDATIVE DAMAGE; GRAPE SEEDS; CELL-DEATH; POLYPHENOLS; TOXICITY; SURVIVAL; CYTOTOXICITY; NEUTROPHILS	Our previous study showed that exposing mouse fibroblasts to proanthocyanidin (PA) for only 1 min accelerated cell proliferation in a concentration-dependent manner. In this study, exposing human gingival fibroblasts (HGFs) to PA for 1 min similarly accelerated the proliferative response of the cells. Besides the accelerated proliferative response, PA showed a cytoprotective effect on HGFs exposed to harsh environmental conditions; short-term exposure of HGFs in the mitotic phase to pure water or physiological saline resulted in a lower recovery of viable cells. Pretreatment and concomitant treatment with PA improved the low recovery of cells exposed to pure water or physiological saline. In addition, HGFs exposed to PA for 1 min proliferated well even after being cultured in serum-free medium. In 100% confluent HGFs, being cultured in serum-free medium resulted in a high intracellular reactive oxygen species (ROS) level, but pretreatment with PA prevented the cells from increasing intracellular ROS. Thus, the results suggest that a short-term PA treatment exerts cytoprotective effects on HGFs exposed to harsh environmental conditions by improving the intracellular oxidative stress response.	[Kurauchi, Michiko; Niwano, Yoshimi; Shirato, Midori; Kanno, Taro; Nakamura, Keisuke; Egusa, Hiroshi; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 980, Japan	Tohoku University	Niwano, Y (corresponding author), Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 980, Japan.	niwano@m.tohoku.ac.jp	Egusa, Hiroshi/AFT-9694-2022; Niwnao, Yoshimi/Z-3593-2019	Egusa, Hiroshi/0000-0002-0200-8132; 	Ministry of Education, Science, Sports and Culture, Japan [25893019, 2013, 26460116, 2014]; All Japan Coffee Association	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); All Japan Coffee Association(All Japan Coffee Association)	This work was supported by The Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Research Activity start-up, 25893019, 2013, to MS; The Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 26460116, 2014, to YN; and the grant of All Japan Coffee Association, 2014, to YN and KN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASS DA, 1983, J IMMUNOL, V130, P1910; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Campos J, 2014, FOOD CHEM, V151, P175, DOI 10.1016/j.foodchem.2013.11.018; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Fine A M, 2000, Altern Med Rev, V5, P144; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Jayasena T, 2013, AGEING RES REV, V12, P867, DOI 10.1016/j.arr.2013.06.003; Kalaiselvi P, 2013, FOOD CHEM TOXICOL, V56, P110, DOI 10.1016/j.fct.2013.01.042; Kim YS, 2013, BIOL PHARM BULL, V36, P609, DOI 10.1248/bpb.b12-00990; Kim Y, 2013, FOOD CHEM, V137, P136, DOI 10.1016/j.foodchem.2012.10.006; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pandey S, 2003, APOPTOSIS, V8, P497, DOI 10.1023/A:1025542424986; PRIEUR C, 1994, PHYTOCHEMISTRY, V36, P781, DOI 10.1016/S0031-9422(00)89817-9; RAMOS CL, 1992, J BIOL CHEM, V267, P8307; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tsuruya M, 2014, APPL BIOCHEM BIOTECH, V174, P2223, DOI 10.1007/s12010-014-1124-7; Wu PF, 2013, J NUTR BIOCHEM, V24, P1070, DOI 10.1016/j.jnutbio.2012.08.005; ZHANG SZ, 1990, CELL BIOL TOXICOL, V6, P219; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012	22	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113403	10.1371/journal.pone.0113403	http://dx.doi.org/10.1371/journal.pone.0113403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405354	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300115
J	Anand, S; Ebner, J; Warren, CB; Raam, MS; Piliang, M; Billings, SD; Maytin, EV				Anand, Sanjay; Ebner, John; Warren, Christine B.; Raam, Manu S.; Piliang, Melissa; Billings, Steven D.; Maytin, Edward V.			C/EBP Transcription Factors in Human Squamous Cell Carcinoma: Selective Changes in Expression of Isoforms Correlate with the Neoplastic State	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; IN-VIVO; PHOTODYNAMIC THERAPY; INHIBITORY PROTEIN; SKIN TUMORIGENESIS; DOWN-REGULATION	The CCAAT/Enhancer Binding Proteins (C/EBPs) are a family of leucine-zipper transcription factors that regulate physiological processes such as energy metabolism, inflammation, cell cycle, and the development and differentiation of several tissues including skin. Recently, a role for C/EBPs in tumor cell proliferation and differentiation has been proposed, but the incomplete characterization in the literature of multiple translational isoforms of these proteins has made interpretation of these roles difficult. Therefore, we have carefully reexamined C/EBP isoform expression in human non-melanoma skin cancers. C/EBP alpha, C/EBP beta, and C/EBP delta were analyzed histologically in squamous cell carcinomas (SCC). The individual isoforms of C/EBP alpha and C/EBP beta were examined by immunofluorescent digital imaging, western blotting and DNA binding activity (electrophoretic mobility shift analysis). Expression of all C/EBP family proteins was decreased in SCC tumors. Suppression was greatest for C/EBP alpha, less for C/EBP beta, and least for C/EBP delta. Western analyses confirmed that C/EBP alpha p42 and p30 isoforms were decreased. For C/EBP beta, only the abundant full-length isoform (C/EBP beta-1, LAP*, 55 kD) was reduced, whereas the smaller isoforms, C/EBP beta-2 (LAP, 48 kD) and C/EBP beta-3 (LIP, 20 kD), which are predominantly nuclear, were significantly increased in well-and moderately-differentiated SCC (up to 14-fold for C/EBP beta-3). These elevations correlated with increases in PCNA, a marker of proliferation. Although C/EBP beta displayed increased post-translational modifications in SCC, phosphorylation of C/EBP beta-1 (Thr 235) was not altered. C/EBP-specific DNA binding activity in nuclear and whole-cell extracts of cultured cells and tumors was predominantly attributable to C/EBP beta. In summary, two short C/EBP beta isoforms, C/EBP beta-2 and C/EBP beta-3, represent strong candidate markers for epithelial skin malignancy, due to their preferential expression in carcinoma versus normal skin, and their strong correlation with tumor proliferation.	[Anand, Sanjay; Ebner, John; Warren, Christine B.; Piliang, Melissa; Billings, Steven D.; Maytin, Edward V.] Cleveland Clin, Dept Dermatol, Cleveland, OH 44106 USA; [Anand, Sanjay; Raam, Manu S.; Maytin, Edward V.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Piliang, Melissa; Billings, Steven D.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Maytin, Edward V.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Harvard Medical School; Massachusetts General Hospital	Maytin, EV (corresponding author), Cleveland Clin, Dept Dermatol, Cleveland, OH 44106 USA.	maytine@ccf.org			National Cancer Institute, of the National Institute of Health [PO1-CA84203]; NATIONAL CANCER INSTITUTE [P01CA084203] Funding Source: NIH RePORTER	National Cancer Institute, of the National Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Cancer Institute, of the National Institute of Health, grant number PO1-CA84203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2013, MOL CANCER THER, V12, P1638, DOI 10.1158/1535-7163.MCT-13-0047; Anand S, 2009, CLIN CANCER RES, V15, P3333, DOI 10.1158/1078-0432.CCR-08-3054; Atwood AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025205; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; Bull JJ, 2002, J INVEST DERMATOL, V118, P17, DOI 10.1046/j.0022-202x.2001.01629.x; Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Dearth LR, 2001, J CELL BIOCHEM, V82, P357, DOI 10.1002/jcb.1167; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Halmos B, 2002, CANCER RES, V62, P528; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; Korabiowska M, 2002, HISTOL HISTOPATHOL, V17, P805, DOI 10.14670/HH-17.805; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Minner F, 2009, J INVEST DERMATOL, V129, P770, DOI 10.1038/jid.2008.247; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Oya M, 2003, CLIN CANCER RES, V9, P1021; Pabst T, 2009, CLIN CANCER RES, V15, P5303, DOI 10.1158/1078-0432.CCR-08-2941; Pawar SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094967; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Raught B, 1996, CANCER RES, V56, P4382; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ridky TW, 2007, J AM ACAD DERMATOL, V57, P484, DOI 10.1016/j.jaad.2007.01.033; Sankpal NV, 2006, ONCOGENE, V25, P643, DOI 10.1038/sj.onc.1209081; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Shim M, 2005, CANCER RES, V65, P861; Sinha AK, 2006, BRIT J CANCER, V95, P485, DOI 10.1038/sj.bjc.6603273; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Takai N, 2005, MOL CANCER RES, V3, P261, DOI 10.1158/1541-7786.MCR-04-0110; Taniguchi M, 2005, FEBS LETT, V579, P5785, DOI 10.1016/j.febslet.2005.09.068; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Thompson EA, 2011, J INVEST DERMATOL, V131, P1339, DOI 10.1038/jid.2011.31; Verbeek W, 2001, LEUKEMIA, V15, P103, DOI 10.1038/sj.leu.2401995; Xu L, 2001, CANCER RES, V61, P3176; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033; Zhang WT, 2005, INT J CANCER, V116, P885, DOI 10.1002/ijc.21103; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	59	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112073	10.1371/journal.pone.0112073	http://dx.doi.org/10.1371/journal.pone.0112073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402211	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700027
J	Neilson, JD; Loefer, J; Prince, ED; Royer, F; Calmettes, B; Gaspar, P; Lopez, R; Andrushchenko, I				Neilson, John D.; Loefer, Josh; Prince, Eric D.; Royer, Francois; Calmettes, Beatriz; Gaspar, Philippe; Lopez, Remy; Andrushchenko, Irene			Seasonal Distributions and Migrations of Northwest Atlantic Swordfish: Inferences from Integration of Pop-Up Satellite Archival Tagging Studies	PLOS ONE			English	Article							HORIZONTAL MOVEMENTS; HABITAT COMPRESSION; XIPHIAS-GLADIUS; TRACKING; TUNA	Data sets from three laboratories conducting studies of movements and migrations of Atlantic swordfish (Xiphias gladius) using pop-up satellite archival tags were pooled, and processed using a common methodology. From 78 available deployments, 38 were selected for detailed examination based on deployment duration. The points of deployment ranged from southern Newfoundland to the Straits of Florida. The aggregate data comprise the most comprehensive information describing migrations of swordfish in the Atlantic. Challenges in using data from different tag manufacturers are discussed. The relative utility of geolocations obtained with light is compared with results derived from temperature information for this deep-diving species. The results show that fish tagged off North America remain in the western Atlantic throughout their deployments. This is inconsistent with the model of stock structure used in assessments conducted by the International Commission for the Conservation of Atlantic Tunas, which assumes that fish mix freely throughout the North Atlantic.	[Neilson, John D.; Andrushchenko, Irene] Fisheries & Oceans Canada, St Andrews, NB E5B 2L9, Canada; [Loefer, Josh] Marine Resources Res Inst, South Carolina Dept Nat Resources, Charleston, SC 29412 USA; [Prince, Eric D.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA; [Royer, Francois] Datasio, F-31000 Toulouse, France; [Calmettes, Beatriz; Gaspar, Philippe; Lopez, Remy] Collecte Localisat Satellites, F-31526 Ramonville St Agne, France	Fisheries & Oceans Canada; National Oceanic Atmospheric Admin (NOAA) - USA	Neilson, JD (corresponding author), Fisheries & Oceans Canada, 531 Brandy Cove Rd, St Andrews, NB E5B 2L9, Canada.	John.Neilson@dfo-mpo.gc.ca			Canadian Department of Fisheries and Oceans; United States National Marine Fisheries Service; South Carolina Department of Natural Resources	Canadian Department of Fisheries and Oceans; United States National Marine Fisheries Service; South Carolina Department of Natural Resources	The work was jointly supported by the Canadian Department of Fisheries and Oceans, the United States National Marine Fisheries Service and the South Carolina Department of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid N, 2006, SWORDFISH; Armannsson H, 2007, ICES J MAR SCI, V64, P1006, DOI 10.1093/icesjms/fsm076; Briers M, 2010, ANN I STAT MATH, V62, P61, DOI 10.1007/s10463-009-0236-2; Chaprales W, 1998, MAR TECHNOL SOC J, V32, P104; Chow S, 2007, MAR BIOL, V152, P87, DOI 10.1007/s00227-007-0662-8; Dewar H, 2011, FISH OCEANOGR, V20, P219, DOI 10.1111/j.1365-2419.2011.00581.x; Dunn J M, 1996, GENERALISED ORTHO NE; Garulli A, 2001, IEEE T ROBOTIC AUTOM, V17, P450, DOI 10.1109/70.954757; Goodyear CP, 2011, COLLECT VOL SCI PAP, V68, P1510; Guy Christophr S., 1996, P353; Hein AM, 2012, ECOL LETT, V15, P104, DOI 10.1111/j.1461-0248.2011.01714.x; MILANESE M, 1991, AUTOMATICA, V27, P997, DOI 10.1016/0005-1098(91)90134-N; Neilson J, 2013, REV FISH SCI, V21, P59, DOI 10.1080/10641262.2012.754842; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Prince ED, 2002, AM FISH S S, V30, P155; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; Royer F, 2009, POSITIONING PELAGIC; Sedberry GR, 2001, MAR BIOL, V139, P355; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Skud B.E., 1977, INT PAC HALIBUT COMM, V63, P42; Smith B.L., FISH RES; Sperling A. T., 2005, COL VOL SCI PAP ICCA, V58, P1483; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Thygesen UH, 2009, TAGGING TRACKING MAR; Vallado D.A., 2001, SPACE TECHNOLOGY LIB, V2nd ed.	28	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112736	10.1371/journal.pone.0112736	http://dx.doi.org/10.1371/journal.pone.0112736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401964	Green Published, gold			2022-12-27	WOS:000345158700066
J	Sasaki, M; Sumi, M; Eida, S; Katayama, I; Hotokezaka, Y; Nakamura, T				Sasaki, Miho; Sumi, Misa; Eida, Sato; Katayama, Ikuo; Hotokezaka, Yuka; Nakamura, Takashi			Simple and Reliable Determination of Intravoxel Incoherent Motion Parameters for the Differential Diagnosis of Head and Neck Tumors	PLOS ONE			English	Article							DIFFUSION; PERFUSION; MR; CIRRHOSIS; MODEL	Intravoxel incoherent motion (IVIM) imaging can characterize diffusion and perfusion of normal and diseased tissues, and IVIM parameters are authentically determined by using cumbersome least-squares method. We evaluated a simple technique for the determination of IVIM parameters using geometric analysis of the multiexponential signal decay curve as an alternative to the least-squares method for the diagnosis of head and neck tumors. Pure diffusion coefficients (D), microvascular volume fraction (f), perfusion-related incoherent microcirculation (D*), and perfusion parameter that is heavily weighted towards extravascular space (P) were determined geometrically (Geo D, Geo f, and Geo P) or by least-squares method (Fit D, Fit f, and Fit D*) in normal structures and 105 head and neck tumors. The IVIM parameters were compared for their levels and diagnostic abilities between the 2 techniques. The IVIM parameters were not able to determine in 14 tumors with the least-squares method alone and in 4 tumors with the geometric and least-squares methods. The geometric IVIM values were significantly different (p<0.001) from Fit values (+2 +/- 4% and -7 +/- 24% for D and f values, respectively). Geo D and Fit D differentiated between lymphomas and SCCs with similar efficacy (78% and 80% accuracy, respectively). Stepwise approaches using combinations of Geo D and Geo P, Geo D and Geo f, or Fit D and Fit D* differentiated between pleomorphic adenomas, Warthin tumors, and malignant salivary gland tumors with the same efficacy (91% accuracy = 21/23). However, a stepwise differentiation using Fit D and Fit f was less effective (83% accuracy = 19/23). Considering cumbersome procedures with the least squares method compared with the geometric method, we concluded that the geometric determination of IVIM parameters can be an alternative to least-squares method in the diagnosis of head and neck tumors.	[Sasaki, Miho; Sumi, Misa; Eida, Sato; Katayama, Ikuo; Hotokezaka, Yuka; Nakamura, Takashi] Nagasaki Univ, Sch Dent, Dept Radiol & Canc Biol, Nagasaki 852, Japan	Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Sch Dent, Dept Radiol & Canc Biol, Nagasaki 852, Japan.	taku@nagasaki-u.ac.jp			Nagasaki University	Nagasaki University	The authors received the funds of this study from the internal source of Nagasaki University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L., 2005, WHO CLASSIFICATION T; Gao Q, 2011, J MAGN RESON IMAGING, V33, P1177, DOI 10.1002/jmri.22522; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Lai V, 2013, EUR RADIOL, V23, P2793, DOI 10.1007/s00330-013-2889-8; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2008, RADIOLOGY, V249, P748, DOI 10.1148/radiol.2493081301; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lewin M, 2011, EUR RADIOL, V21, P281, DOI 10.1007/s00330-010-1914-4; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Mazaheri Y, 2012, J MAGN RESON IMAGING, V35, P660, DOI 10.1002/jmri.22888; Moteki T, 2006, J MAGN RESON IMAGING, V24, P637, DOI 10.1002/jmri.20682; Nakamura T, 2010, METHODS CANCER DIAGN, V7, P255; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Penner AH, 2013, EUR RADIOL, V23, P2773, DOI 10.1007/s00330-013-2869-z; Sasaki M, 2013, AM J ROENTGENOL, V201, P1101, DOI 10.2214/AJR.12.9729; Sumi M, 2013, AM J NEURORADIOL, V34, P410, DOI 10.3174/ajnr.A3227; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248	17	16	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112866	10.1371/journal.pone.0112866	http://dx.doi.org/10.1371/journal.pone.0112866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402436	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700080
J	Dunkler, D; Plischke, M; Leffondre, K; Heinze, G				Dunkler, Daniela; Plischke, Max; Leffondre, Karen; Heinze, Georg			Augmented Backward Elimination: A Pragmatic and Purposeful Way to Develop Statistical Models	PLOS ONE			English	Article							REGRESSION-ANALYSIS; CAUSAL DIAGRAMS; SELECTION; SIMULATION; CRITERION; EVENTS	Statistical models are simple mathematical rules derived from empirical data describing the association between an outcome and several explanatory variables. In a typical modeling situation statistical analysis often involves a large number of potential explanatory variables and frequently only partial subject-matter knowledge is available. Therefore, selecting the most suitable variables for a model in an objective and practical manner is usually a non-trivial task. We briefly revisit the purposeful variable selection procedure suggested by Hosmer and Lemeshow which combines significance and change-in-estimate criteria for variable selection and critically discuss the change-in-estimate criterion. We show that using a significance-based threshold for the change-in-estimate criterion reduces to a simple significance-based selection of variables, as if the change-in-estimate criterion is not considered at all. Various extensions to the purposeful variable selection procedure are suggested. We propose to use backward elimination augmented with a standardized change-in-estimate criterion on the quantity of interest usually reported and interpreted in a model for variable selection. Augmented backward elimination has been implemented in a SAS macro for linear, logistic and Cox proportional hazards regression. The algorithm and its implementation were evaluated by means of a simulation study. Augmented backward elimination tends to select larger models than backward elimination and approximates the unselected model up to negligible differences in point estimates of the regression coefficients. On average, regression coefficients obtained after applying augmented backward elimination were less biased relative to the coefficients of correctly specified models than after backward elimination. In summary, we propose augmented backward elimination as a reproducible variable selection algorithm that gives the analyst more flexibility in adopting model selection to a specific statistical modeling situation.	[Dunkler, Daniela; Heinze, Georg] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Clin Biometr, Vienna, Austria; [Plischke, Max] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria; [Leffondre, Karen] Univ Bordeaux Segalen, ISPED, Ctr Rech, INSERM U897, Bordeaux, France	Medical University of Vienna; Medical University of Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Heinze, G (corresponding author), Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Clin Biometr, Vienna, Austria.	georg.heinze@meduniwien.ac.at	Dunkler, Daniela/B-2733-2018; Karen, Leffondre/AAF-6490-2019	Dunkler, Daniela/0000-0003-1339-0311; Karen, Leffondre/0000-0002-1269-8069; Plischke, Max/0000-0002-7410-2611; Heinze, Georg/0000-0003-1147-8491	European Community [241544]	European Community(European Commission)	DD, KL and GH were supported by the European Community's Seventh Framework Programme, grant number 241544, URLs http://ec.europa.eu/research/fp7/index_en.cfm and http://www.syskid.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All resources needed to complete this study (SAS software, computers, office programs, IT facilities) were provided by the Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna (GH's and DD's department), using the Center's regular research budget.	Babyak MA, 2009, EVID-BASED MENT HEAL, V12, P68, DOI 10.1136/ebmh.12.3.68; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Dunkler D, 2014, ABE SAS MACRO AUGMEN; Evans D, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-156; GREENLAND S, 1980, INT J EPIDEMIOL, V9, P361, DOI 10.1093/ije/9.4.361; Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; HARRELL JFE, 2001, REGRESSION MODELING; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jager KJ, 2008, KIDNEY INT, V73, P256, DOI 10.1038/sj.ki.5002650; Lee PH, 2014, J EPIDEMIOL, V24, P161, DOI 10.2188/jea.JE20130062; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MANTEL N, 1970, TECHNOMETRICS, V12, P621, DOI 10.2307/1267207; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Pearl J, 1995, BIOMETRIKA, V82, P669, DOI 10.2307/2337329; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Plischke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093226; Remuzzi G, 2005, KIDNEY INT, V68, P57; Royston P., 2008, MULTIVARIABLE MODEL; SAS, 2010, STAT ANAL SOFTWARE V; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Tripepi G, 2008, KIDNEY INT, V74, P1512, DOI 10.1038/ki.2008.416; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P443, DOI 10.1097/EDE.0b013e31824e2d4e; VanderWeele TJ, 2011, BIOMETRICS, V67, P1406, DOI 10.1111/j.1541-0420.2011.01619.x; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vansteelandt S, 2012, STAT METHODS MED RES, V21, P7, DOI 10.1177/0962280210387717; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wolbers M, 2014, EUR HEART J, V35, P2936, DOI 10.1093/eurheartj/ehu131	34	94	96	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113677	10.1371/journal.pone.0113677	http://dx.doi.org/10.1371/journal.pone.0113677			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415265	Green Submitted, gold, Green Published			2022-12-27	WOS:000346906600069
J	Blois, S; Mallus, F; Liciardi, M; Pilo, C; Camboni, T; Macera, L; Maggi, F; Manzin, A				Blois, Sylvain; Mallus, Francesca; Liciardi, Manuele; Pilo, Cristian; Camboni, Tania; Macera, Lisa; Maggi, Fabrizio; Manzin, Aldo			High Prevalence of Co-Infection with Multiple Torque Teno Sus Virus Species in Italian Pig Herds	PLOS ONE			English	Article							WASTING SYNDROME PMWS; TT VIRUS; TORQUE-TENO-SUS-VIRUS-1 TTSUV1; MOLECULAR-DETECTION; VIREMIA; IDENTIFICATION; ANELLOVIRUSES; AMPLIFICATION; INFECTION; PRIMATES	Torque teno viruses (TTVs) are a large group of vertebrate-infecting small viruses with circular single-stranded DNA, classified in the Anelloviridae family. In swine, two genetically distinct species, Torque teno sus virus 1a (TTSuV1a) and 1b (TTSuV1b) are currently grouped into the genus Iotatorquevirus. More recently, a novel Torque teno sus virus species, named Torque teno sus virus k2b (TTSuVk2b), has been included with Torque teno sus virus k2a (TTSuVk2a) into the genus Kappatorquevirus. In the present study, TTSuV1 (TTSuV1a and TTSuV1b), TTSuVk2a and TTSuVk2b prevalence was evaluated in 721 serum samples of healthy pigs from Sardinian farms, insular Italy. This is the largest study to date on the presence of TTSuV in healthy pigs in Italy. The global prevalence of infection was 83.2% (600/721), being 62.3% (449/721), 60.6% (437/721), and 11.5% (83/721) the prevalence of TTSuV1, TTSuVk2a and TTSuVk2b, respectively. The rate of co-infection with two and/or three species was also calculated, and data show that co-infections were significantly more frequent than infections with single species, and that TTSuV1+TTSuVk2a double infection was the prevalent combination (35.4%). Quantitative results obtained using species-specific real time-qPCR evidenced the highest mean levels of viremia in the TTSuV1 subgroup, and the lowest in the TTSuVk2b subgroup. Interestingly, multiple infections with distinct TTSuV species seemed to significantly affect the DNA load and specifically, data highlighted that double infection with TTSuVk2a increased the viral titers of TTSuV1, likewise the co-infection with TTSuVk2b increased the titers of TTSuVk2a.	[Blois, Sylvain; Mallus, Francesca; Camboni, Tania; Macera, Lisa; Manzin, Aldo] Univ Cagliari, Sch Med, Dept Biomed Sci, Clin Microbiol & Virol Unit, Cagliari, Italy; [Liciardi, Manuele; Pilo, Cristian] Ist Zooprofilatt Sperimentale Sardegna, Dept Cagliari, Cagliari, Italy; [Macera, Lisa; Maggi, Fabrizio] Pisa Univ Hosp, Virol Unit, Pisa, Italy	University of Cagliari; IZS Della Sardegna; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Manzin, A (corresponding author), Univ Cagliari, Sch Med, Dept Biomed Sci, Clin Microbiol & Virol Unit, Cagliari, Italy.	aldomanzin@medicina.unica.it	Maggi, Fabrizio/AAU-5965-2021; Manzin, Aldo/F-9450-2011; Maggi, Fabrizio/L-2974-2013; Camboni, Tania/AAA-5283-2019	Maggi, Fabrizio/0000-0001-7489-5271; Manzin, Aldo/0000-0003-2961-3428; Maggi, Fabrizio/0000-0001-7489-5271; 	Regione Sardegna, Italy [F71J11000710002]	Regione Sardegna, Italy(Regione Sardegna)	Funding for the study was from a grant to AM, cod. F71J11000710002 from Regione Sardegna (http://http://www.regione.sardegna.it), Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 1999, VET MICROBIOL, V66, P115, DOI 10.1016/S0378-1135(99)00004-8; Aramouni M, 2011, VET MICROBIOL, V153, P377, DOI 10.1016/j.vetmic.2011.05.046; Biagini P., 2012, VIRUS TAXONOMY, P331; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; Bigarre L, 2005, J GEN VIROL, V86, P631, DOI 10.1099/vir.0.80573-0; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Brassard J, 2008, VET MICROBIOL, V126, P271, DOI 10.1016/j.vetmic.2007.07.014; Cornelissen-Keijsers V, 2012, J GEN VIROL, V93, P2682, DOI 10.1099/vir.0.045518-0; Cortey M, 2012, VET MICROBIOL, V156, P81, DOI 10.1016/j.vetmic.2011.10.026; Cortey M, 2011, VET MICROBIOL, V148, P125, DOI 10.1016/j.vetmic.2010.08.013; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Focosi D, 2010, J CLIN VIROL, V47, P189, DOI 10.1016/j.jcv.2009.11.027; Gallei A, 2010, VET MICROBIOL, V143, P202, DOI 10.1016/j.vetmic.2009.12.005; Griffiths P, 1999, REV MED VIROL, V9, P73, DOI 10.1002/(SICI)1099-1654(199904/06)9:2&lt;73::AID-RMV254&gt;3.0.CO;2-5; Huang YW, 2010, J VIROL METHODS, V170, P140, DOI 10.1016/j.jviromet.2010.09.018; Kekarainen T, 2007, THERIOGENOLOGY, V68, P966, DOI 10.1016/j.theriogenology.2007.07.010; Kekarainen T, 2006, J GEN VIROL, V87, P833, DOI 10.1099/vir.0.81586-0; Kekarainen T, 2012, TRANSBOUND EMERG DIS, V59, P103, DOI 10.1111/j.1865-1682.2011.01289.x; Lee SS, 2010, J VET DIAGN INVEST, V22, P261, DOI 10.1177/104063871002200217; Maggi F, 1999, J INFECT DIS, V180, P838, DOI 10.1086/314961; Maggi F, 2011, CLIN VACCINE IMMUNOL, V18, P692, DOI 10.1128/CVI.00466-10; Martelli F, 2006, J VET MED B, V53, P234, DOI 10.1111/j.1439-0450.2006.00949.x; Martinez-Guino L, 2009, THERIOGENOLOGY, V71, P1390, DOI 10.1016/j.theriogenology.2009.01.010; McKeown NE, 2004, VET MICROBIOL, V104, P113, DOI 10.1016/j.vetmic.2004.08.013; Miyata H, 1999, J VIROL, V73, P3582, DOI 10.1128/JVI.73.5.3582-3586.1999; Niel C, 2005, J GEN VIROL, V86, P1343, DOI 10.1099/vir.0.80794-0; Nieto D, 2011, VET MICROBIOL, V152, P284, DOI 10.1016/j.vetmic.2011.05.020; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2000, VIROLOGY, V277, P368, DOI 10.1006/viro.2000.0588; Okamoto H, 2002, J GEN VIROL, V83, P1291, DOI 10.1099/0022-1317-83-6-1291; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P35; Pozzuto T, 2009, VET MICROBIOL, V137, P375, DOI 10.1016/j.vetmic.2009.02.001; Segales J, 2009, VET MICROBIOL, V134, P199, DOI 10.1016/j.vetmic.2008.08.002; Sibila M, 2009, VET MICROBIOL, V139, P213, DOI 10.1016/j.vetmic.2009.05.017; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Wu ZW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-503; Zur Hausen H.eds., 2009, TT VIRUSES STILL ELU	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113720	10.1371/journal.pone.0113720	http://dx.doi.org/10.1371/journal.pone.0113720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411972	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000075
J	Forbes, SL; Perrault, KA; Stefanuto, PH; Nizio, KD; Focant, JF				Forbes, Shari L.; Perrault, Katelynn A.; Stefanuto, Pierre-Hugues; Nizio, Katie D.; Focant, Jean-Francois			Comparison of the Decomposition VOC Profile during Winter and Summer in a Moist, Mid-Latitude (Cfb) Climate	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; COLEOPTERA SILPHIDAE; ODOR ANALYSIS; CARRION; TIME; SUCCESSION; CHEMISTRY; HEADSPACE; PATTERNS; BEETLES	The investigation of volatile organic compounds (VOCs) associated with decomposition is an emerging field in forensic taphonomy due to their importance in locating human remains using biological detectors such as insects and canines. A consistent decomposition VOC profile has not yet been elucidated due to the intrinsic impact of the environment on the decomposition process in different climatic zones. The study of decomposition VOCs has typically occurred during the warmer months to enable chemical profiling of all decomposition stages. The present study investigated the decomposition VOC profile in air during both warmer and cooler months in a moist, mid-latitude (Cfb) climate as decomposition occurs year-round in this environment. Pig carcasses (Sus scrofa domesticus L.) were placed on a soil surface to decompose naturally and their VOC profile was monitored during the winter and summer months. Corresponding control sites were also monitored to determine the natural VOC profile of the surrounding soil and vegetation. VOC samples were collected onto sorbent tubes and analyzed using comprehensive two-dimensional gas chromatography - time-of-flight mass spectrometry (GCxGC-TOFMS). The summer months were characterized by higher temperatures and solar radiation, greater rainfall accumulation, and comparable humidity when compared to the winter months. The rate of decomposition was faster and the number and abundance of VOCs was proportionally higher in summer. However, a similar trend was observed in winter and summer demonstrating a rapid increase in VOC abundance during active decay with a second increase in abundance occurring later in the decomposition process. Sulfur-containing compounds, alcohols and ketones represented the most abundant classes of compounds in both seasons, although almost all 10 compound classes identified contributed to discriminating the stages of decomposition throughout both seasons. The advantages of GCxGC-TOFMS were demonstrated for detecting and identifying trace levels of VOCs, particularly ethers, which are rarely reported as decomposition VOCs.	[Forbes, Shari L.; Perrault, Katelynn A.; Nizio, Katie D.] Univ Technol Sydney, Ctr Forens Sci, Broadway, NSW, Australia; [Stefanuto, Pierre-Hugues; Focant, Jean-Francois] Univ Liege, Dept Chem, Organ & Biol Analyt Chem Grp, CART, Liege, Belgium	University of Technology Sydney; University of Liege	Forbes, SL (corresponding author), Univ Technol Sydney, Ctr Forens Sci, Broadway, NSW, Australia.	shari.forbes@uts.edu.au	Nizio, Katie/C-9234-2015; Perrault, Katelynn Amanda/J-4313-2019; Stefanuto, Pierre-Hugues/AAO-2390-2020	Nizio, Katie/0000-0002-1486-1894; Perrault, Katelynn Amanda/0000-0003-0210-2687; Stefanuto, Pierre-Hugues/0000-0002-1224-8869	Australian Research Council Future Fellowship [FT110100753]	Australian Research Council Future Fellowship(Australian Research Council)	An Australian Research Council Future Fellowship grant (FT110100753) (www.arc.gov.au) provided funding support to [SF] for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer MS, 2003, FORENSIC SCI INT, V132, P173, DOI 10.1016/S0379-0738(03)00034-3; Arnaldos MI, 2004, INT J LEGAL MED, V118, P197, DOI 10.1007/s00414-004-0446-3; Bass William M. III, 1997, P181; Horenstein MB, 2012, FORENSIC SCI INT, V217, P146, DOI 10.1016/j.forsciint.2011.10.043; Benbow ME, 2013, J MED ENTOMOL, V50, P440, DOI 10.1603/ME12194; Brasseur C, 2012, J CHROMATOGR A, V1255, P163, DOI 10.1016/j.chroma.2012.03.048; Cablk ME, 2012, FORENSIC SCI INT, V220, P118, DOI 10.1016/j.forsciint.2012.02.007; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Carter DO, 2008, APPL SOIL ECOL, V40, P129, DOI 10.1016/j.apsoil.2008.03.010; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Clark M.A., 1997, FORENSIC TAPHONOMY P, P151; Collison IB, 2005, J ANAL TOXICOL, V29, P762, DOI 10.1093/jat/29.7.762; Dabbs GR, 2013, J FORENSIC SCI, V58, pS20, DOI 10.1111/1556-4029.12025; DeGreeff LE, 2011, ANAL BIOANAL CHEM, V401, P1295, DOI 10.1007/s00216-011-5167-0; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dekeirsschieter J, 2013, J FORENSIC SCI, V58, P917, DOI 10.1111/1556-4029.12123; Dekeirsschieter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039005; Focant J-F, 2013, CHEM B KAZAKH NATL U, V4, P177, DOI [DOI 10.15328/chemb_2013_4177-186, DOI 10.15328/CHEMB_2013_4177-186]; Forbes SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095107; Gill-King H., 1997, CHEM ULTRASTRUCTURAL, P93; Hoffman EM, 2009, FORENSIC SCI INT, V186, P6, DOI 10.1016/j.forsciint.2008.12.022; Hopkins David W., 2008, P53, DOI 10.1201/9781420069921.ch3; Joy JE, 2006, FORENSIC SCI INT, V164, P183, DOI 10.1016/j.forsciint.2006.01.008; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; Kasper J, 2012, FORENSIC SCI INT, V223, P64, DOI 10.1016/j.forsciint.2012.08.001; Lauber CL, 2014, APPL ENVIRON MICROB, V80, P4920, DOI 10.1128/AEM.00957-14; LeBlanc HN, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P205, DOI 10.1007/978-1-4020-9684-6_11; Lorenzo N, 2003, ANAL BIOANAL CHEM, V376, P1212, DOI 10.1007/s00216-003-2018-7; MANN RW, 1990, J FORENSIC SCI, V35, P103; Megyesi MS, 2005, J FORENSIC SCI, V50, P618; Meyer J, 2013, J FORENSIC SCI, V58, P1175, DOI 10.1111/1556-4029.12169; O'Brien RC, 2010, FORENSIC SCI INT, V198, P85, DOI 10.1016/j.forsciint.2010.01.006; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perrault KA, 2014, CHROMATOGRAPHY, V1, P120; Podskalska H, 2009, ENTOMOL EXP APPL, V132, P59, DOI 10.1111/j.1570-7458.2009.00871.x; Castro CPE, 2013, FORENSIC SCI INT, V232, P73, DOI 10.1016/j.forsciint.2013.06.014; Sharanowski BJ, 2008, FORENSIC SCI INT, V179, P219, DOI 10.1016/j.forsciint.2008.05.019; Stadler S, 2013, ANAL CHEM, V85, P998, DOI 10.1021/ac302614y; Statheropoulos M, 2007, SCI TOTAL ENVIRON, V385, P221, DOI 10.1016/j.scitotenv.2007.07.003; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Stefanuto PH, 2014, CHEMPLUSCHEM, V79, P786, DOI 10.1002/cplu.201402003; Stejskal SM, 2013, DEATH, DECOMPOSITION, AND DETECTOR DOGS: FROM SCIENCE TO SCENE, P1; Swann L, 2010, AUST J FORENSIC SCI, V42, P199, DOI 10.1080/00450610903258102; Tipple CA, 2014, FORENSIC SCI INT, V242, P242, DOI 10.1016/j.forsciint.2014.06.033; Vass AA, 2004, J FORENSIC SCI, V49, P760; Vass AA, 2008, J FORENSIC SCI, V53, P384, DOI 10.1111/j.1556-4029.2008.00680.x; Vass AA, 2011, FORENSIC SCI INT, V204, P34, DOI 10.1016/j.forsciint.2010.04.052; Voss SC, 2009, FORENSIC SCI INT, V193, P26, DOI 10.1016/j.forsciint.2009.08.014; Young A, 2014, J FORENSIC SCI, V59, P1333, DOI 10.1111/1556-4029.12468; Zhou C, 2011, J FORENSIC LEG MED, V18, P6, DOI 10.1016/j.jflm.2010.10.003	52	46	47	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113681	10.1371/journal.pone.0113681	http://dx.doi.org/10.1371/journal.pone.0113681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412504	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000072
J	Lou, Q; Zhang, W; Liu, GC; Ma, YF				Lou, Qiang; Zhang, Wei; Liu, Guangchao; Ma, Yuanfang			The C-Type Lectin OCILRP2 Costimulates EL4 T Cell Activation via the DAP12-Raf-MAP Kinase Pathway	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PROTEIN-TYROSINE KINASE; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; MYELOID CELLS; DAP12; IMMUNORECEPTOR; PROLIFERATION; LYMPHOCYTES; RECRUITMENT	OCILRP2 is a typical Type-II transmembrane protein that is selectively expressed in activated T lymphocytes, dendritic cells, and B cells and functions as a novel co-stimulator of T cell activation. However, the signaling pathways underlying OCILRP2 in T cell activation are still not completely understood. In this study, we found that the knockdown of OCILRP2 expression with shRNA or the blockage of its activity by an anti-OCILRP2 antagonist antibody reduced CD3/CD28-costimulated EL4 T cell viability and IL-2 production, inhibit Raf1, MAPK3, and MAPK8 activation, and impair NFAT and NF-kappa B transcriptional activities. Furthermore, immunoprecipitation results indicated that OCILRP2 could interact with the DAP12 protein, an adaptor containing an intracellular ITAM motif that can transduce signals to induce MAP kinase activation for T cell activation. Our data reveal that after binding with DAP12, OCILRP2 activates the Raf-MAP kinase pathways, resulting in T cell activation.	[Lou, Qiang; Zhang, Wei; Liu, Guangchao; Ma, Yuanfang] Henan Univ, Coll Med, Henan Engn Lab Antibody Med, Key Lab Cellular & Mol Immunol, Kaifeng 475004, Peoples R China	Henan University	Ma, YF (corresponding author), Henan Univ, Coll Med, Henan Engn Lab Antibody Med, Key Lab Cellular & Mol Immunol, Kaifeng 475004, Peoples R China.	yuanfangma@126.com		Ma, yuanfang/0000-0001-5635-2660	National Natural Science Foundation of China [30972687]; Seed scientific research grant for talented scientist'	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seed scientific research grant for talented scientist'	This work was supported by grants from National Natural Science Foundation of China (No. 30972687) (http://www.nsfc.gov.cn) (YFM) and from Seed scientific research grant for talented scientist' (http://www. henu. edu. cn) (QL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; BRAMS P, 1989, IMMUNOLOGY, V66, P348; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Ishida-Kitagawa N, 2012, J BIOL CHEM, V287, P17493, DOI 10.1074/jbc.M111.324194; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Lin J, 2001, J CELL SCI, V114, P243; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mason LH, 1998, J IMMUNOL, V160, P4148; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Mulrooney TJ, 2013, J LEUKOCYTE BIOL, V94, P301, DOI 10.1189/jlb.0213093; Nunes JA, 1996, J BIOL CHEM, V271, P1591, DOI 10.1074/jbc.271.3.1591; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Ruan QG, 2012, ADV EXP MED BIOL, V946, P207, DOI 10.1007/978-1-4614-0106-3_12; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Sansbury HM, 1997, CARCINOGENESIS, V18, P1817, DOI 10.1093/carcin/18.9.1817; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Thebault P, 2009, J IMMUNOL, V183, P3099, DOI 10.4049/jimmunol.0803767; Tian WZ, 2005, CELL IMMUNOL, V235, P72, DOI 10.1016/j.cellimm.2005.07.004; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang YH, 2011, J BIOL CHEM, V286, P26603, DOI 10.1074/jbc.M111.225672; Wei P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105560; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113218	10.1371/journal.pone.0113218	http://dx.doi.org/10.1371/journal.pone.0113218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411776	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000028
J	Taboada, B; Espinoza, MA; Isa, P; Aponte, FE; Arias-Ortiz, MA; Monge-Martinez, J; Rodriguez-Vazquez, R; Diaz-Hernandez, F; Zarate-Vidal, F; Wong-Chew, RM; Firo-Reyes, V; del Rio-Almendarez, CN; Gaitan-Meza, J; Villasenor-Sierra, A; Martinez-Aguilar, G; Salas-Mier, MD; Noyola, DE; Perez-Gonzalez, LF; Lopez, S; Santos-Preciado, JI; Arias, CF				Taboada, Blanca; Espinoza, Marco A.; Isa, Pavel; Aponte, Fernando E.; Arias-Ortiz, Maria A.; Monge-Martinez, Jesus; Rodriguez-Vazquez, Ruben; Diaz-Hernandez, Fidel; Zarate-Vidal, Fernando; Maria Wong-Chew, Rosa; Firo-Reyes, Veronica; del Rio-Almendarez, Carlos N.; Gaitan-Meza, Jesus; Villasenor-Sierra, Alberto; Martinez-Aguilar, Gerardo; Salas-Mier, Ma. del Carmen; Noyola, Daniel E.; Perez-Gonzalez, Luis F.; Lopez, Susana; Santos-Preciado, Jose I.; Arias, Carlos F.			Is There Still Room for Novel Viral Pathogens in Pediatric Respiratory Tract Infections?	PLOS ONE			English	Article							YOUNG-CHILDREN; COMMON COLD; PCR ASSAY; VIRUSES; DISCOVERY; CORONAVIRUS; PNEUMONIA; ETIOLOGY; SAMPLES	Viruses are the most frequent cause of respiratory disease in children. However, despite the advanced diagnostic methods currently in use, in 20 to 50% of respiratory samples a specific pathogen cannot be detected. In this work, we used a metagenomic approach and deep sequencing to examine respiratory samples from children with lower and upper respiratory tract infections that had been previously found negative for 6 bacteria and 15 respiratory viruses by PCR. Nasal washings from 25 children (out of 250) hospitalized with a diagnosis of pneumonia and nasopharyngeal swabs from 46 outpatient children (out of 526) were studied. DNA reads for at least one virus commonly associated to respiratory infections was found in 20 of 25 hospitalized patients, while reads for pathogenic respiratory bacteria were detected in the remaining 5 children. For outpatients, all the samples were pooled into 25 DNA libraries for sequencing. In this case, in 22 of the 25 sequenced libraries at least one respiratory virus was identified, while in all other, but one, pathogenic bacteria were detected. In both patient groups reads for respiratory syncytial virus, coronavirus-OC43, and rhinovirus were identified. In addition, viruses less frequently associated to respiratory infections were also found. Saffold virus was detected in outpatient but not in hospitalized children. Anellovirus, rotavirus, and astrovirus, as well as several animal and plant viruses were detected in both groups. No novel viruses were identified. Adding up the deep sequencing results to the PCR data, 79.2% of 250 hospitalized and 76.6% of 526 ambulatory patients were positive for viruses, and all other children, but one, had pathogenic respiratory bacteria identified. These results suggest that at least in the type of populations studied and with the sampling methods used the odds of finding novel, clinically relevant viruses, in pediatric respiratory infections are low.	[Taboada, Blanca; Espinoza, Marco A.; Isa, Pavel; Aponte, Fernando E.; Lopez, Susana; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Arias-Ortiz, Maria A.; Monge-Martinez, Jesus; Rodriguez-Vazquez, Ruben; Diaz-Hernandez, Fidel; Zarate-Vidal, Fernando] Colegio Pediat Estado Veracruz, Colegio, Veracruz, Mexico; [Maria Wong-Chew, Rosa; Santos-Preciado, Jose I.] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Firo-Reyes, Veronica] Hosp Gen Mexico City, Mexico City, DF, Mexico; [del Rio-Almendarez, Carlos N.] Hosp Pediat Coyoacan, Mexico City, DF, Mexico; [Gaitan-Meza, Jesus] Nuevo Hosp Civil Guadalajara Dr Juan I Menchaca, Guadalajara, Jalisco, Mexico; [Villasenor-Sierra, Alberto] IMSS, Ctr Invest Biomed Occidente, Guadalajara, Jalisco, Mexico; [Martinez-Aguilar, Gerardo; Salas-Mier, Ma. del Carmen] IMSS, Unidad Invest Biomed, Durango, CO, Mexico; [Noyola, Daniel E.] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico; [Perez-Gonzalez, Luis F.] Hosp Cent Dr Ignacio Morones Prieto, San Luis Potosi, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Universidad Autonoma de San Luis Potosi; Hospital Central Dr. Ignacio Morones Prieto	Arias, CF (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	arias@ibt.unam.mx	Isa, Pavel/GVU-8303-2022; Noyola, Daniel/AAL-9773-2020; Taboada, Blanca/A-3974-2019; Lopez, Susana/H-6661-2017; Lopez, Susana/O-1986-2019; Arias, Carlos/O-4036-2019	Lopez, Susana/0000-0001-6336-9209; Lopez, Susana/0000-0001-6336-9209; Arias, Carlos/0000-0003-3130-4501; Noyola, Daniel/0000-0002-4840-6742; Taboada, Blanca/0000-0003-1896-5962	National Council for Science and Technology-Mexico [153639]; National Council for Science and Technology-Mexico	National Council for Science and Technology-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council for Science and Technology-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants 153639 (to JIS-P) and "Influenza 2009" (to CFA) from the National Council for Science and Technology-Mexico. www.conacyt.mx. FEA was recipient of a scholarship from the National Council for Science and Technology-Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Gruteke P, 2004, J CLIN MICROBIOL, V42, P5596, DOI 10.1128/JCM.42.12.5596-5603.2004; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Hustedt Joshua W., 2010, Yale Journal of Biology and Medicine, V83, P193; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2012, CURR OPIN PULM MED, V18, P271, DOI 10.1097/MCP.0b013e328351f8d4; Junglen S, 2013, CURR OPIN MICROBIOL, V16, P507, DOI 10.1016/j.mib.2013.06.005; Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875; Murdoch DR, 2010, INFECT DIS CLIN N AM, V24, P791, DOI 10.1016/j.idc.2010.04.006; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; van Gageldonk-Lafeber AB, 2005, CLIN INFECT DIS, V41, P490, DOI 10.1086/431982; Waman VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088981; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	32	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113570	10.1371/journal.pone.0113570	http://dx.doi.org/10.1371/journal.pone.0113570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412469	gold, Green Submitted, Green Published			2022-12-27	WOS:000345253000063
J	Dilda, V; Morris, TR; Yungher, DA; MacDougall, HG; Moore, ST				Dilda, Valentina; Morris, Tiffany R.; Yungher, Don A.; MacDougall, Hamish G.; Moore, Steven T.			Central Adaptation to Repeated Galvanic Vestibular Stimulation: Implications for Pre-Flight Astronaut Training	PLOS ONE			English	Article							EYE-MOVEMENT RESPONSE; SPACE-FLIGHT; HEAD; COORDINATION; HUMANS; SPACEFLIGHT; REFLEX; SYSTEM; ROLL	Healthy subjects (N = 10) were exposed to 10-min cumulative pseudorandom bilateral bipolar Galvanic vestibular stimulation (GVS) on a weekly basis for 12 weeks (120 min total exposure). During each trial subjects performed computerized dynamic posturography and eye movements were measured using digital video-oculography. Follow up tests were conducted 6 weeks and 6 months after the 12-week adaptation period. Postural performance was significantly impaired during GVS at first exposure, but recovered to baseline over a period of 7-8 weeks (70-80 min GVS exposure). This postural recovery was maintained 6 months after adaptation. In contrast, the roll vestibulo-ocular reflex response to GVS was not attenuated by repeated exposure. This suggests that GVS adaptation did not occur at the vestibular end-organs or involve changes in low-level (brainstem-mediated) vestibulo-ocular or vestibulo-spinal reflexes. Faced with unreliable vestibular input, the cerebellum reweighted sensory input to emphasize veridical extra-vestibular information, such as somatosensation, vision and visceral stretch receptors, to regain postural function. After a period of recovery subjects exhibited dual adaption and the ability to rapidly switch between the perturbed (GVS) and natural vestibular state for up to 6 months.	[Dilda, Valentina; Morris, Tiffany R.; Yungher, Don A.; MacDougall, Hamish G.; Moore, Steven T.] Icahn Sch Med Mt Sinai, Dept Neurol, Human Aerosp Lab, New York, NY 10029 USA; [MacDougall, Hamish G.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Icahn School of Medicine at Mount Sinai; University of Sydney	Moore, ST (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, Human Aerosp Lab, New York, NY 10029 USA.	steven.moore@mssm.edu	Moore, Steven T/W-2204-2019	Moore, Steven/0000-0003-3995-4912; MacDougall, Hamish/0000-0001-6201-1707	National Space Biomedical Research Institute [SA01603]; National Aeronautics and Space Administration [NNX12AM25G]	National Space Biomedical Research Institute; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This study was funded by grants from the National Space Biomedical Research Institute (SA01603) and the National Aeronautics and Space Administration (NNX12AM25G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloomberg JJ, 1997, J VESTIBUL RES-EQUIL, V7, P161, DOI 10.1016/S0957-4271(96)00169-3; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Cass SP, 1996, LARYNGOSCOPE, V106, P423, DOI 10.1097/00005537-199604000-00007; Cauquil AS, 2003, EXP BRAIN RES, V148, P414, DOI 10.1007/s00221-002-1326-z; Clarke AH, 2000, EXP BRAIN RES, V134, P322, DOI 10.1007/s002210000476; Clement G, 2001, EXP BRAIN RES, V138, P410, DOI 10.1007/s002210100706; Cohen Bernard, 2011, Front Neurol, V2, P90, DOI 10.3389/fneur.2011.00090; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; DAVIS JR, 1988, AVIAT SPACE ENVIR MD, V59, P1185; Day BL, 1997, J PHYSIOL-LONDON, V500, P661, DOI 10.1113/jphysiol.1997.sp022051; Dilda V, 2012, EXP BRAIN RES, V216, P275, DOI 10.1007/s00221-011-2929-z; Dilda V, 2011, AVIAT SPACE ENVIR MD, V82, P770, DOI 10.3357/ASEM.3051.2011; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GUERRAZ M, 2001, J PHYSL P, V531, P142; Harm D. L., 1999, EXTENDED DURATION OR; HASLWANTER T, 1995, IEEE T BIO-MED ENG, V42, P1053, DOI 10.1109/10.469371; Holstein Gay R, 2012, Front Neurol, V3, P4, DOI 10.3389/fneur.2012.00004; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Kim J, 2012, BRAIN RES B; Kleine JF, 1999, NEUROREPORT, V10, P1143, DOI 10.1097/00001756-199904060-00044; Kori AA, 2001, J NEUROPHYSIOL, V85, P671, DOI 10.1152/jn.2001.85.2.671; MacDougall H, 2003, THESIS U SYDNEY SYDN; MacDougall HG, 2006, EXP BRAIN RES, V172, P208, DOI 10.1007/s00221-005-0329-y; MacDougall HG, 2005, OPTOMETRY VISION SCI, V82, P706, DOI 10.1097/01.opx.0000175623.86611.03; MacDougall HG, 2005, OTOL NEUROTOL, V26, P500, DOI 10.1097/01.mao.0000169766.08421.ef; MacDougall HG, 2003, EXP BRAIN RES, V148, P166, DOI 10.1007/s00221-002-1289-0; MacDougall HG, 2002, EXP BRAIN RES, V144, P69, DOI 10.1007/s00221-002-1038-4; Magnusson M, 2011, NEUROREHABILITATION, V29, P153, DOI 10.3233/NRE-2011-0689; McCrea R, 2001, ANN NY ACAD SCI, V942, P328; Moore ST, 1996, VISION RES, V36, P445, DOI 10.1016/0042-6989(95)00130-1; MOORE ST, 1991, COMPUT METH PROG BIO, V35, P219, DOI 10.1016/0169-2607(91)90124-C; Moore ST, 2008, AVIAT SPACE ENVIR MD, V79, P888, DOI 10.3357/ASEM.2209.2008; Moore ST, 2006, EXP BRAIN RES, V174, P647, DOI 10.1007/s00221-006-0528-1; Moore ST, 2011, AVIAT SPACE ENVIR MD, V82, P535, DOI 10.3357/ASEM.2942.2011; NASHNER LM, 1993, HDB BALANCE FUNCTION, P298; Paloski W. H., 1999, EXTENDED DURATION OR, V5.4, P1; Pavlik AE, 1999, EXP BRAIN RES, V124, P273, DOI 10.1007/s002210050623; Young LR, 1996, J APPL PHYSIOL, V81, P44, DOI 10.1152/jappl.1996.81.1.44; Zink R, 1997, NEUROSCI LETT, V232, P171, DOI 10.1016/S0304-3940(97)00610-1	40	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112131	10.1371/journal.pone.0112131	http://dx.doi.org/10.1371/journal.pone.0112131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409443	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200016
J	Hedinger, D; Braun, J; Zellweger, U; Kaplan, V; Bopp, M				Hedinger, Damian; Braun, Julia; Zellweger, Ueli; Kaplan, Vladimir; Bopp, Matthias		Swiss Natl Cohort Study Grp	Moving to and Dying in a Nursing Home Depends Not Only on Health - An Analysis of Socio-Demographic Determinants of Place of Death in Switzerland	PLOS ONE			English	Article							PEOPLE DIE; LAST YEAR; CARE; LIFE; POPULATION; CHALLENGE; END	Background: In developed countries generally about 7 out of 10 deaths occur in institutions such as acute care hospitals or nursing homes. However, less is known about the influence of non-medical determinants of place of death. This study examines the influence of socio-demographic and regional factors on place of death in Switzerland. Data and Methods: We linked individual data from hospitals and nursing homes with census and mortality records of the Swiss general population. We differentiated between those who died in a hospital after a length of stay <= 2 days or >= 3 days, those who died in nursing homes, and those who died at home. In gender-specific multinomial logistic regression models we analysed N = 85,129 individuals, born before 1942 (i.e., >= 65 years old) and deceased in 2007 or 2008. Results: Almost 70% of all men and 80% of all women died in a hospital or nursing home. Regional density of nursing home beds, being single, divorced or widowed, or living in a single-person household were predictive of death in an institution, especially among women. Conversely, homeownership, high educational level and having children were associated with dying at home. Conclusion: Place of death substantially depends on socio-demographic determinants such as household characteristics and living conditions as well as on regional factors. Individuals with a lower socio-economic position, living alone or having no children are more prone to die in a nursing home. Health policy should empower these vulnerable groups to choose their place of death in accordance to needs and wishes.	[Hedinger, Damian; Braun, Julia; Zellweger, Ueli; Bopp, Matthias] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Kaplan, Vladimir] Dist Hosp Freiamt Muri, Muri, Switzerland	University of Zurich	Bopp, M (corresponding author), Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland.	matthias.bopp@uzh.ch	Puhan, Milo/ABE-6298-2020; Kuenzli, Nino/F-7195-2014	Puhan, Milo/0000-0003-4721-1879; Kuenzli, Nino/0000-0001-8360-080X; Bopp, Matthias/0000-0003-0766-3723; Zwahlen, Marcel/0000-0002-6772-6346	Swiss National Science Foundation (SNSF), project 67 "end-of-life'' [3347CO-108806, 33CS30-134273, 406740-139331]; SNSF	Swiss National Science Foundation (SNSF), project 67 "end-of-life''(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF))	The project is funded by the Swiss National Science Foundation (SNSF, grants 3347CO-108806, 33CS30-134273 and 406740-139331), project 67 "end-of-life''. Persons who received fundings from the SNSF: DH JB. Website with detail information about the financing situation: http://p3.snf.ch/Project-139331. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artazcoz L, 2007, J EPIDEMIOL COMMUN H, V61, P466, DOI 10.1136/jech.2006.058081; BAG, 2012, VERS SPEZ PALL CAR S; BfS, 2011, EINTR ALT PFLEG; BfS, 2012, INV DAT PALL CAR; Bickel H, 1998, Z GERONTOL GERIATR, V31, P193, DOI 10.1007/s003910050034; Bopp M, 2011, DIABETES CARE, V34, P2387, DOI 10.2337/dc11-0157; Bopp M, 2009, INT J EPIDEMIOL, V38, P379, DOI 10.1093/ije/dyn042; BOWLING A, 1983, J MED ETHICS, V9, P158, DOI 10.1136/jme.9.3.158; Broad JB, 2013, INT J PUBLIC HEALTH, V58, P257, DOI 10.1007/s00038-012-0394-5; Brogaard T, 2013, PALLIATIVE MED, V27, P155, DOI 10.1177/0269216312438468; Centeno C, 2007, PALLIATIVE MED, V21, P463, DOI 10.1177/0269216307081942; Clark D, 2002, BRIT MED J, V324, P905, DOI 10.1136/bmj.324.7342.905; Cohen J, 2006, HEALTH POLICY, V78, P319, DOI 10.1016/j.healthpol.2005.11.003; Evans Nici, 2002, Nurs Stand, V16, P33; Faeh D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-567; Fischer S, 2006, SWISS MED WKLY, V136, P370; Fischer S, 2004, Z GERONTOL GERIATR, V37, P467, DOI 10.1007/s00391-004-0216-3; Foreman LM, 2006, PALLIATIVE MED, V20, P447, DOI 10.1191/0269216306pm1149oa; Gomes B, 2014, COCHRANE DATABASE SY; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Houttekier D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-228; Houttekier D, 2009, J PAIN SYMPTOM MANAG, V37, P996, DOI 10.1016/j.jpainsymman.2008.05.014; Jaggi A, 2001, SOZ PRAVENTIV MED, V46, P379, DOI 10.1007/BF01321664; Jayaraman J, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-19; Kelley AS, 2011, ANN INTERN MED, V154, P235, DOI 10.7326/0003-4819-154-4-201102150-00004; Klinkenberg M, 2005, HEALTH SOC CARE COMM, V13, P420, DOI 10.1111/j.1365-2524.2005.00567.x; Medizinische Statistik der Krankenhauser, 2011, MED STAT KRANK 2011; Reich O, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-116; Rice DP, 2004, ANNU REV PUBL HEALTH, V25, P457, DOI 10.1146/annurev.publhealth.25.101802.123054; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Shugarman LR, 2009, J PAIN SYMPTOM MANAG, V38, P15, DOI 10.1016/j.jpainsymman.2009.04.004; Statistik der sozialmedizinischen Institutionen, 2011, STAT SOZ I 2011 STAN; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Thomas C, 2004, SOC SCI MED, V58, P2431, DOI 10.1016/j.socscimed.2003.09.005; TOWNSEND J, 1990, BRIT MED J, V301, P415, DOI 10.1136/bmj.301.6749.415; Weitzen S, 2003, MED CARE, V41, P323, DOI 10.1097/00005650-200302000-00013; Zellweger U, 2010, RECORD LINKAGE MED S; Zellweger U, 2011, 7 U ZUR I SOZ PRAV	38	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113236	10.1371/journal.pone.0113236	http://dx.doi.org/10.1371/journal.pone.0113236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409344	Green Published, gold			2022-12-27	WOS:000345533200080
J	Khadjesari, Z; Freemantle, N; Linke, S; Hunter, R; Murray, E				Khadjesari, Zarnie; Freemantle, Nick; Linke, Stuart; Hunter, Rachael; Murray, Elizabeth			Health on the Web: Randomised Controlled Trial of Online Screening and Brief Alcohol Intervention Delivered in a Workplace Setting	PLOS ONE			English	Article							PRIMARY-CARE; PROBLEM DRINKING; CONSUMPTION; FEEDBACK; FACILITATORS; DRINKERS; EFFICACY	Background: Alcohol misuse in England costs around 7.3 pound billion (US$12.2 billion) annually from lost productivity and absenteeism. Delivering brief alcohol interventions to employees as part of a health check may be acceptable, particularly with online delivery which can provide privacy for this stigmatised behaviour. Research to support this approach is limited and methodologically weak. The aim was to determine the effectiveness of online screening and personalised feedback on alcohol consumption, delivered in a workplace as part of a health check. Methods and Findings: This two-group online individually randomised controlled trial recruited employees from a UK-based private sector organisation (approx. 100,000 employees). 3,375 employees completed the online health check in the three week recruitment period. Of these, 1,330 (39%) scored five or more on the AUDIT-C (indicating alcohol misuse) and were randomised to receive personalised feedback on their alcohol intake, alongside feedback on other health behaviours (n = 659), or to receive feedback on all health behaviours except alcohol intake (n = 671). Participants were mostly male (75%), with a median age of 48 years and half were in managerial positions (55%). Median Body Mass Index was 26, 12% were smokers, median time undertaking moderate/ vigorous physical activity a week was 173 minutes and median fruit and vegetable consumption was three portions a day. Eighty percent (n = 1,066) of participants completed follow-up questionnaires at three months. An intention to treat analysis found no difference between experimental groups for past week drinking (primary outcome) (5.6% increase associated with the intervention (95% CI -4.7% to 16.9%; p = .30)), AUDIT (measure of alcohol-related harm) and health utility (EQ-5D). Conclusions: There was no evidence to support the use of personalised feedback within an online health check for reducing alcohol consumption among employees in this organisation. Further research is needed on how to engage a larger proportion of employees in screening.	[Khadjesari, Zarnie; Freemantle, Nick; Hunter, Rachael; Murray, Elizabeth] UCL, Royal Free Hosp, Res Dept Primary Care & Populat Hlth, London, England; [Linke, Stuart] Camden & Islington NHS Fdn Trust, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Khadjesari, Z (corresponding author), UCL, Royal Free Hosp, Res Dept Primary Care & Populat Hlth, London, England.	z.khadjesari@ucl.ac.uk	Hunter, Rachael Maree/H-7846-2019	Hunter, Rachael Maree/0000-0002-7447-8934; Khadjesari, Zarnie/0000-0002-2958-9555; Linke, Stuart/0000-0003-2515-3946; Murray, Elizabeth/0000-0002-8932-3695	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); National Institute for Health Research [SPCR-033] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a grant from the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR). Zarnie Khadjesari is funded by a 3-year National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BK, 2002, PSYCHOL ADDICT BEHAV, V16, P243, DOI 10.1037//0893-164X.16.3.243; [Anonymous], 2012, ANN SURV HOURS EARN; Babor TF., 2001, AUDIT ALCOHOL USE DI; Ballesteros J, 2004, ALCOHOL CLIN EXP RES, V28, P608, DOI 10.1097/01.ALC.0000122106.84718.67; Barnett NP, 2007, ADDICT BEHAV, V32, P2529, DOI 10.1016/j.addbeh.2007.06.017; Bennett JB, 2004, AM J HEALTH PROMOT, V19, P103, DOI 10.4278/0890-1171-19.2.103; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; British Medical Association, 2012, CLIN DIR ENH SERV DE; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carey KB, 2006, J CONSULT CLIN PSYCH, V74, P943, DOI 10.1037/0022-006X.74.5.943; Carey KB, 2009, ADDICTION, V104, P1807, DOI 10.1111/j.1360-0443.2009.02691.x; Cook R., 2002, J PRIM PREV, V23, P115, DOI [10.1023/A:1016543300433, DOI 10.1023/A:1016543300433]; Cunningham JA, 2010, ALCOHOL ALCOHOLISM, V45, P258, DOI 10.1093/alcalc/agq009; Cunningham JA, 2009, ADDICTION, V104, P2023, DOI 10.1111/j.1360-0443.2009.02726.x; Curtis L, 2013, UNIT COSTS HLTH SOCI; DiClemente CC, 2001, AM J HEALTH BEHAV, V25, P217, DOI 10.5993/AJHB.25.3.8; DONOHUE B, 2004, J ALCOHOL DRUG EDUC, V48, P13, DOI DOI 10.1056/NEJM196001072620104; Doumas DM, 2008, J SUBST ABUSE TREAT, V34, P263, DOI 10.1016/j.jsat.2007.04.006; DRUMMOND C, 2005, ALCOHOL NEEDS ASSESS; Health and Social Care Information Centre, 2013, HLTH SURV ENGL 2012; Health & Social Care Information Centre, 2014, STAT OB PHYS ACT DIE; Heirich M, 2000, J OCCUP ENVIRON MED, V42, P47, DOI 10.1097/00043764-200001000-00013; Hermansson U, 1998, Int J Occup Environ Health, V4, P71; Hutchings D, 2006, PRIM HEALTH CARE RES, V7, P221, DOI DOI 10.1191/1463423606PC2890A; Johnson M, 2011, J PUBLIC HEALTH-UK, V33, P412, DOI 10.1093/pubmed/fdq095; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Khadjesari Z, 2013, ADDICTION SCI CLI S1, pA40; Khadjesari Z, 2011, ADDICTION, V106, P267, DOI 10.1111/j.1360-0443.2010.03214.x; Khadjesari Z, 2009, ADDICT BEHAV, V34, P337, DOI 10.1016/j.addbeh.2008.11.010; Kriston L, 2008, ANN INTERN MED, V149, P879, DOI 10.7326/0003-4819-149-12-200812160-00007; Kypri K, 2005, PREV MED, V41, P761, DOI 10.1016/j.ypmed.2005.07.010; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Kypri K, 2014, JAMA-J AM MED ASSOC, V311, P1218, DOI 10.1001/jama.2014.2138; Lau-Barraco C, 2008, PSYCHOL ADDICT BEHAV, V22, P168, DOI 10.1037/0893-164X.22.2.168; Lifestyle Statistics Health and Social Care Information Centre, 2013, STAT SMOK ENGL 2013; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linke S, 2008, ALCOHOL ALCOHOLISM, V43, P669, DOI 10.1093/alcalc/agn066; Matano RA, 2007, J SUBST ABUSE TREAT, V32, P71, DOI 10.1016/j.jsat.2006.05.020; McAvoy BR, 2001, DRUG-EDUC PREV POLIC, V8, P103; McCambridge J, 2008, ADDICTION, V103, P241, DOI 10.1111/j.1360-0443.2007.02080.x; Mccambridge J, 2009, ADDICTION, V104, P1311, DOI 10.1111/j.1360-0443.2009.02684.x; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Murray E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-505; National Audit Office, 2008, RED ALC HARM HLTH SE; National Institute for Health & Clinical Excellence, 2010, NICE PUBL HLTH GUID; Office for National Statistics, 2011, GEN LIF SURV GLS; Poikolainen K, 1999, PREV MED, V28, P503, DOI 10.1006/pmed.1999.0467; Public Health England, 2013, OUR PRIOR 2013 14; Rapley T, 2006, SOC SCI MED, V63, P2418, DOI 10.1016/j.socscimed.2006.05.025; Richmond R, 2000, PREV MED, V30, P51, DOI 10.1006/pmed.1999.0587; Rooke S, 2010, ADDICTION, V105, P1381, DOI 10.1111/j.1360-0443.2010.02975.x; Wallace P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014740; Walters Scott T, 2003, Prev Sci, V4, P287, DOI 10.1023/A:1026024400450; Watson H, 2009, REDUCING ALCOHOL REL; Webb G, 2009, ADDICTION, V104, P365, DOI 10.1111/j.1360-0443.2008.02472.x; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wutzke SE, 1998, HEALTH PROMOT J AUST, V8, P1036	58	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112553	10.1371/journal.pone.0112553	http://dx.doi.org/10.1371/journal.pone.0112553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409454	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200026
J	Labonte, L; Coulombe, P; Zago, M; Bourbeau, J; Baglole, CJ				Labonte, Laura; Coulombe, Patrick; Zago, Michela; Bourbeau, Jean; Baglole, Carolyn J.			Alterations in the Expression of the NF-kappa B Family Member RelB as a Novel Marker of Cardiovascular Outcomes during Acute Exacerbations of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							CIGARETTE-SMOKE; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTORS; DEFICIENT MICE; TIME-COURSE; RESPONSES; CYCLOOXYGENASE-2; INTERLEUKIN-8; INFLAMMATION; MECHANISMS	Background: Chronic obstructive pulmonary disease (COPD) exacerbations are acute events of worsened respiratory symptoms and enhanced inflammation partly mediated by NF-kappa B activation. RelB, an NF-kappa B family member, suppresses cigarette smoke-induced inflammation but its expression in COPD is unknown. Moreover, there is no information on its association with clinical features of COPD. The objectives of this study were to assess RelB expression relative to markers of inflammation as well as its association with cardiovascular and pulmonary features of COPD patients at stable-state and exacerbation. Methods: Data from 48 COPD patients were analyzed. Blood samples were collected from stable-state and exacerbating patients. After RNA isolation, quantitative real-time polymerase chain reaction (qRT-PCR) was performed to assess RelB, Cox-2, IL-8 and IL-1 beta mRNA expression and their associations with measured clinical variables. Results: Of the 48 COPD subjects, 18 were in stable-state and 30 were in exacerbation. RelB mRNA expression was lower than that of Cox-2, IL-8, and IL-1 beta in all cases (all p<0.001, except for IL-8 at exacerbation (p = 0.22)). Cox-2, IL-8 and IL-1 beta were significantly associated with clinical features of patients in both stable-state and at exacerbation. There was no association with RelB expression and any clinical features in COPD subjects at stable-state. RelB mRNA levels were significantly associated with cardiovascular events such as systolic blood pressure during exacerbation. Conclusions: RelB mRNA expression is lower than that of the other inflammatory mediators. Expression of Cox-2, IL-8 and IL-1 beta were related to clinical features in both stable-state and at exacerbation. However, RelB expression was associated with clinical features of patients only during exacerbation, suggesting that RelB may represent a novel marker of health outcomes, in particular cardiovascular, during exacerbation in COPD.	[Labonte, Laura; Zago, Michela; Bourbeau, Jean; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Labonte, Laura; Coulombe, Patrick; Bourbeau, Jean] McGill Univ, Ctr Hlth, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Zago, Michela; Baglole, Carolyn J.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Baglole, CJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	Carolyn.baglole@McGill.ca			GlaxoSmithKline Canada Ltd [5427]; Canadian Institute of Health Research Doctoral Award; Canada Foundation for Innovation (CFI)-Leaders Opportunities Fund; Fonds de Recherche du Quebec-Sante (FRQ-S)	GlaxoSmithKline Canada Ltd; Canadian Institute of Health Research Doctoral Award(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)-Leaders Opportunities Fund; Fonds de Recherche du Quebec-Sante (FRQ-S)	This study was funded as an investigator-initiated grant (no. 5427) by GlaxoSmithKline Canada Ltd (http://www.gsk.ca/english/index.html). LL was funded by a Canadian Institute of Health Research Doctoral Award (http://www.cihr-irsc.gc.ca). Infrastructure for this project was supported by the Canada Foundation for Innovation (CFI)-Leaders Opportunities Fund (http://www.mcgill.ca/medresearch/research/funding/cfi) (CJB). CJB was supported by a salary award from the Fonds de Recherche du Quebec-Sante (FRQ-S) (http://www.frqs.gouv.qc.ca/en/index.shtml). GlaxoSmithKline Canada Ltd, had a role in study design but no role in data collection and analysis, decision to publish, or preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2012, THORAX, V67, P238, DOI 10.1136/thoraxjnl-2011-200768; Ammon C, 2000, BIOCHEM BIOPH RES CO, V268, P99, DOI 10.1006/bbrc.1999.2083; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Braam B, 2004, AM J PHYSIOL-HEART C, V287, pH1977, DOI 10.1152/ajpheart.00323.2004; Bruno CM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/915150; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; CARRASCO D, 1993, DEVELOPMENT, V118, P1221; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; Cejas PJ, 2005, MOL CELL BIOL, V25, P7900, DOI 10.1128/MCB.25.17.7900-7916.2005; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Coakley RJ, 2002, J LEUKOCYTE BIOL, V71, P603; Jancic CC, 2012, CYTOKINE, V57, P258, DOI 10.1016/j.cyto.2011.11.013; de Souza A. R., 2014, TOXICOL SCI; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; GOLD, 2011, GLOB STRAT DIAGN MAN; Grossmann M, 1999, INT J BIOCHEM CELL B, V31, P1209, DOI 10.1016/S1357-2725(99)00068-0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hocherl K, 2002, BRIT J PHARMACOL, V136, P1117, DOI 10.1038/sj.bjp.0704821; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; LO D, 1992, AM J PATHOL, V141, P1237; McAllister DA, 2012, EUR RESPIR J, V39, P1097, DOI 10.1183/09031936.00124811; McMillan DH, 2011, AM J PATHOL, V179, P125, DOI 10.1016/j.ajpath.2011.03.030; Millet P, 2013, J LEUKOCYTE BIOL, V94, P941, DOI 10.1189/jlb.0513305; Nymo SH, 2014, EUR J HEART FAIL, V16, P68, DOI 10.1093/eurjhf/hft125; Oliver KM, 2012, J BIOL CHEM, V287, P14004, DOI 10.1074/jbc.M112.347971; Patel ARC, 2013, AM J RESP CRIT CARE, V188, P1091, DOI 10.1164/rccm.201306-1170OC; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Sarir H, 2008, EUR J PHARMACOL, V585, P346, DOI 10.1016/j.ejphar.2008.03.009; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi S, 2005, SEM RESP CRIT CARE M, V26, P192, DOI 10.1055/s-2005-869538; Sincer I, 2012, HEART LUNG, V41, P238, DOI 10.1016/j.hrtlng.2011.07.011; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Tam A, 2012, MED CLIN N AM, V96, P681, DOI 10.1016/j.mcna.2012.04.012; Testelmans D, 2013, CYTOKINE, V62, P210, DOI 10.1016/j.cyto.2013.02.021; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Tully JE, 2013, J IMMUNOL, V191, P5811, DOI 10.4049/jimmunol.1301329; Tully JE, 2012, AM J RESP CELL MOL, V47, P497, DOI 10.1165/rcmb.2012-0014OC; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wedzicha Jadwiga A, 2003, Respir Care, V48, P1204; Wedzicha JA, 2014, CLIN CHEST MED, V35, P157, DOI 10.1016/j.ccm.2013.11.001; Weih F, 1997, J IMMUNOL, V158, P5211; Weih F, 1996, J IMMUNOL, V157, P3974; Xiong SL, 2014, MOL CELL BIOCHEM, V389, P197, DOI 10.1007/s11010-013-1941-y; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020	58	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112965	10.1371/journal.pone.0112965	http://dx.doi.org/10.1371/journal.pone.0112965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409035	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200053
J	von Castell, C; Oberfeld, D; Hecht, H				von Castell, Christoph; Oberfeld, Daniel; Hecht, Heiko			The Effect of Furnishing on Perceived Spatial Dimensions and Spaciousness of Interior Space	PLOS ONE			English	Article							ARCHITECTURAL SPACES; VISUAL-PERCEPTION; RESPONSE CATEGORIES; SURFACE LIGHTNESS; RATING-SCALES; DISTANCE; SIZE; NUMBER; IMPACT; ROOMS	Despite the ubiquity of interior space design, there is virtually no scientific research on the influence of furnishing on the perception of interior space. We conducted two experiments in which observers were asked to estimate the spatial dimensions (size of the room dimensions in meters and centimeters) and to judge subjective spaciousness of various rooms. Experiment 1 used true-to-scale model rooms with a square surface area. Furnishing affected both the perceived height and the spaciousness judgments. The furnished room was perceived as higher but less spacious. In Experiment 2, rooms with different square surface areas and constant physical height were presented in virtual reality. Furnishing affected neither the perceived spatial dimensions nor the perceived spaciousness. Possible reasons for this discrepancy, such as the influence of the presentation medium, are discussed. Moreover, our results suggest a compression of perceived height and depth with decreasing surface area of the room.	[von Castell, Christoph; Oberfeld, Daniel; Hecht, Heiko] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	von Castell, C (corresponding author), Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany.	castell@uni-mainz.de	Oberfeld, Daniel/A-7997-2008; Hecht, Heiko/H-3106-2011; von Castell, Christoph/AAE-2501-2021	Oberfeld, Daniel/0000-0002-6710-3309; Hecht, Heiko/0000-0001-9418-862X; von Castell, Christoph/0000-0002-0677-1055				Bennett R. R, 1998, CLIN VISUAL OPTICS; Bergmann J, 2011, EXP BRAIN RES, V210, P13, DOI 10.1007/s00221-011-2597-z; Brown A, 1993, SMALL SPACES STYLISH; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coles J, 2008, INNENARCHITEKTUR WIC; Conran T, 1999, EASY LIVING FREI EIN; Conran T, 2006, GROSSE IDEEN KLEINE; Cutting J.E., 1995, PERCEPTION SPACE MOT, P69, DOI 10.1016/B978-012240530-3/50005-5; Daum SO, 2009, ATTEN PERCEPT PSYCHO, V71, P1127, DOI 10.3758/APP.71.5.1127; Drexel T, 2007, KLEINE WOHNUNGEN GAN; EPSTEIN W, 1961, PSYCHOL BULL, V58, P491, DOI 10.1037/h0042260; Franz G, 2005, Space Syntax 5th International Symposium, Vol 2, Proceedings, P503; Franz G, 2005, AUTOMAT CONSTR, V14, P165, DOI 10.1016/j.autcon.2004.07.009; Franz G, 2006, ENV HLTH SUST DEV P; GARLING T, 1969, SCAND J PSYCHOL, V10, P250, DOI 10.1111/j.1467-9450.1969.tb00034.x; GARLING T, 1970, SCAND J PSYCHOL, V11, P133; GARLING T, 1970, SCAND J PSYCHOL, V11, P124, DOI 10.1111/j.1467-9450.1970.tb00726.x; Geuss MN, 2012, J EXP PSYCHOL HUMAN, V38, P1242, DOI 10.1037/a0027524; GIBSON James J., 1979, ECOLOGICAL APPROACH; Grechkin TY, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1823738.1823744; Heuser KC, 1989, INNENARCHITEKTUR RAU, V1; Heuser KC, 1989, INNENARCHITEKTUR RAU; Higashiyama A, 1996, PERCEPT PSYCHOPHYS, V58, P259, DOI 10.3758/BF03211879; HOLM S, 1979, SCAND J STAT, V6, P65; Holmberg L, 1967, PSYCHOL RES B, V7, P13; Holmberg L, 1966, PSYCHOL RES B, V6, P15; Holmberg L, 1966, PSYCHOL RES B, V6, P8; Hotelling H, 1950, GEN T TEST MEASURE M, P23; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Imamoglu V, 1976, METU J FAC ARCHIT, V2, P205; Imamoglu V., 1973, ARCHITECTURAL PSYCHO, P341; Imamoglu V, 1986, METU J FAC ARCHIT, V7, P127; ITTELSON WH, 1951, AM J PSYCHOL, V64, P54, DOI 10.2307/1418595; KAYE SM, 1982, HUM FACTORS, V24, P609, DOI 10.1177/001872088202400511; Kundt A., 1863, POGGENDORFFS ANN PHY, V120, P118, DOI [10.1002/andp.18631960909, DOI 10.1002/ANDP.18631960909]; KUNNAPAS TM, 1955, J EXP PSYCHOL, V49, P134; Kunz BR, 2009, ATTEN PERCEPT PSYCHO, V71, P1284, DOI 10.3758/APP.71.6.1284; LURIA SM, 1967, PERCEPT MOTOR SKILL, V24, P1007, DOI 10.2466/pms.1967.24.3.1007; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mak MY, 2005, BUILD ENVIRON, V40, P427, DOI 10.1016/j.buildenv.2004.07.016; Maydeu-Olivares A, 2009, BEHAV RES METHODS, V41, P295, DOI 10.3758/BRM.41.2.295; Metzger W., 1975, GESETZE SEHENS; Muller W, 1976, ELEMENTE BAUENS, V9; Neufert E, 2009, BAUENTWURFSLEHRE; Oberfeld D, 2011, HUM FACTORS, V53, P284, DOI 10.1177/0018720811407331; Oberfeld D, 2010, Q J EXP PSYCHOL, V63, P1999, DOI 10.1080/17470211003646161; Penny K. I., 1996, J R STAT SOC C-APPL, V45, P73, DOI 10.2307/2986224; Preston CC, 2000, ACTA PSYCHOL, V104, P1, DOI 10.1016/S0001-6918(99)00050-5; SADALLA EK, 1984, ENVIRON BEHAV, V16, P394, DOI 10.1177/0013916584163005; Shaw RB, 2004, WOHNEN DESIGN; Stamps AE, 2010, ENVIRON BEHAV, V42, P864, DOI 10.1177/0013916509337287; Stamps AE, 2007, DESIGN STUD, V28, P535, DOI 10.1016/j.destud.2007.01.001; Stamps AE, 2006, ENVIRON BEHAV, V38, P841, DOI 10.1177/0013916506288052; Stamps AE, 2013, ENVIRON BEHAV, V45, P851, DOI 10.1177/0013916512446808; Stamps AE, 2011, ENVIRON BEHAV, V43, P252, DOI 10.1177/0013916509354696; Stamps AE, 2009, ENVIRON BEHAV, V41, P526, DOI 10.1177/0013916508317931; Statistisches Bundesamt, 2010, MIKR FRAG GES KORP B; Thiel P, 1970, ENV PSYCHOL MAN HIS, P593; Toy M, 2001, MINIMAL WOHNEN KLARE; Weng LJ, 2004, EDUC PSYCHOL MEAS, V64, P956, DOI 10.1177/0013164404268674; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wiener JM, 2007, PERCEPTION, V36, P1066, DOI 10.1068/p5587; Wools RM, 1970, ARCHITECTURAL PSYCHO, P48; WorldViz, 2004, VIZ COMP SOFTW	65	18	19	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113267	10.1371/journal.pone.0113267	http://dx.doi.org/10.1371/journal.pone.0113267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409456	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200086
J	Kemse, NG; Kale, AA; Joshi, SR				Kemse, Nisha G.; Kale, Anvita A.; Joshi, Sadhana R.			A Combined Supplementation of Omega-3 Fatty Acids and Micronutrients (Folic Acid, Vitamin B-12) Reduces Oxidative Stress Markers in a Rat Model of Pregnancy Induced Hypertension	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; POLYUNSATURATED FATTY-ACIDS; NITRIC-OXIDE SYNTHASE; BLOOD-PRESSURE; PREECLAMPSIA RELATIONSHIP; GESTATIONAL HYPERTENSION; MATERNAL MICRONUTRIENTS; INFLAMMATORY MARKERS; BRAIN NEUROTROPHINS; HOMOCYSTEINE LEVELS	Objectives: Our earlier studies have highlighted that an altered one carbon metabolism (vitamin B-12, folic acid, and docosahexaenoic acid) is associated with preeclampsia. Preeclampsia is also known to be associated with oxidative stress and inflammation. The current study examines whether maternal folic acid, vitamin B-12 and omega-3 fatty acid supplementation given either individually or in combination can ameliorate the oxidative stress markers in a rat model of pregnancy induced hypertension (PIH). Materials and Methods: Pregnant Wistar rats were assigned to control and five treatment groups: PIH; PIH + vitamin B-12; PIH + folic acid; PIH + Omega-3 fatty acids and PIH + combined micronutrient supplementation (vitamin B-12 + folic acid + omega-3 fatty acids). L-Nitroarginine methylester (L-NAME; 50 mg/kg body weight/day) was used to induce hypertension during pregnancy. Blood Pressure (BP) was recorded during pregnancy and dams were dissected at d20 of gestation. Results: Animals from the PIH group demonstrated higher (p<0.01 for both) systolic and diastolic BP; lower (p<0.01) pup weight; higher dam plasma homocysteine (p<0.05) and dam and offspring malondialdehyde (MDA) (p<0.01), lower (p<0.05) placental and offspring liver DHA and higher (p<0.01) tumor necrosis factor-alpha (TNF-alpha) levels as compared to control. Individual micronutrient supplementation did not offer much benefit. In contrast, combined supplementation lowered systolic BP, homocysteine, MDA and placental TNF-alpha levels in dams and liver MDA and protein carbonyl in the offspring as compared to PIH group. Conclusion: Key constituents of one carbon cycle (folic acid, vitamin B-12 and DHA) may play a role in reducing oxidative stress and inflammation in preeclampsia.	[Kemse, Nisha G.; Kale, Anvita A.; Joshi, Sadhana R.] Bharati Vidyapeeth Deemed Univ, Interact Res Sch Hlth Affairs, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University	Joshi, SR (corresponding author), Bharati Vidyapeeth Deemed Univ, Interact Res Sch Hlth Affairs, Pune, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001	Department of Biotechnology (DBT), New Delhi, India [BT/PR6472/FNS/20/656/2012]	Department of Biotechnology (DBT), New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology (DBT), New Delhi, India DBT Sanction Order No. & Date: BT/PR6472/FNS/20/656/2012 (SRJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acilmis YG, 2011, J OBSTET GYNAECOL RE, V37, P45, DOI 10.1111/j.1447-0756.2010.01317.x; Adamcova M, 2013, J PHYSIOL PHARMACOL, V64, P211; Afshari JT, 2005, BMC PREGNANCY CHILDB, P5; ATALLAH AN, 2002, COCHRANE DB SYST REV; Atallah AN, 2010, COCHRANE DB SYST REV, V4; Bayram M, 2012, J MATERN FETAL NEONA; Bergen NE, 2012, BJOG-INT J OBSTET GY, V119, P739, DOI 10.1111/j.1471-0528.2012.03321.x; Bernardi F, 2008, J OBSTET GYNAECOL RE, V34, P948, DOI 10.1111/j.1447-0756.2008.00803.x; Bodnar LM, 2006, AM J EPIDEMIOL, V164, P470, DOI 10.1093/aje/kwj218; Brown Caneta, 2013, J Nat Sci Biol Med, V4, P330, DOI 10.4103/0976-9668.116998; Calder PC, 2002, BRIT J NUTR, V88, pS165, DOI 10.1079/BJN2002682; Catarino C, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/684384; Chaturvedi S, 2013, J HEALTH POPUL NUTR, V31, P86; Chen YC, 2013, INT J MOL SCI, V14, P5380, DOI 10.3390/ijms14035380; D'Souza V, 2013, CURR MED CHEM, V20, P4777, DOI 10.2174/09298673113209990160; De Giuseppe R, 2014, EUR J NUTR; de Moura RS, 2007, HYPERTENS PREGNANCY, V26, P89, DOI 10.1080/10641950601147960; Derks JB, 2010, PEDIATR RES, V68, P374, DOI 10.1203/PDR.0b013e3181ef7780; Dhobale M, 2012, J MATERN-FETAL NEO M, V25, P317, DOI 10.3109/14767058.2011.579209; Dhobale MV, 2011, PROSTAG LEUKOTR ESS, V85, P149, DOI 10.1016/j.plefa.2011.06.003; Ellis J, 2001, ACTA OBSTET GYN SCAN, V80, P602, DOI 10.1034/j.1600-0412.2001.800703.x; Erickson KL, 2000, J INFECT DIS, V182, pS5, DOI 10.1086/315922; Fernandez Celadilla Lina, 2005, Archives of Gynecology and Obstetrics, V271, P243, DOI 10.1007/s00404-004-0633-y; Fowles ER, 2012, ARCH GYNECOL OBSTET, V285, P891, DOI 10.1007/s00404-011-2213-2; Freeman DJ, 2004, HYPERTENSION, V44, P708, DOI 10.1161/01.HYP.0000143849.67254.ca; Gad HI, 2013, SAUDI MED J, V34, P490; Gadgil M, 2014, EUR J CLIN NUTR; Gairard A, 2004, J CARDIOVASC PHARM, V43, P731, DOI 10.1097/00005344-200405000-00017; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Gohil JT, 2011, J OBSTET GYN INDIA, V61, P638, DOI 10.1007/s13224-011-0094-8; Guven MA, 2009, HYPERTENS PREGNANCY, V28, P190, DOI 10.1080/10641950802601179; Henao DE, 2013, CURR HYPERTENS REP, V15, P600, DOI 10.1007/s11906-013-0400-1; Hernandez-Diaz S, 2002, AM J EPIDEMIOL, V156, P806, DOI 10.1093/aje/kwf129; Hopkins MH, 2010, CANCER EPIDEM BIOMAR, V19, P850, DOI 10.1158/1055-9965.EPI-09-1052; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Howlader MZH, 2009, J TROP PEDIATRICS, V55, P363, DOI 10.1093/tropej/fmp025; Isler CM, 2003, J SOC GYNECOL INVEST, V10, P151, DOI 10.1016/S1071-5576(03)00009-1; Jia D, 2014, NEUROSCIENCE, V258, P228, DOI 10.1016/j.neuroscience.2013.11.016; Jido TA, 2013, ANN AFR MED, V12, P75, DOI 10.4103/1596-3519.112395; Jones ML, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103754; Jones ML, 2014, REPRODUCTION; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kilic I, 2003, PEDIATR INT, V45, P375, DOI 10.1046/j.1442-200X.2003.01740.x; Kolling J, 2011, CARDIOVASC TOXICOL, V11, P67, DOI 10.1007/s12012-010-9094-7; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; Kulkarni A, 2011, CLIN NUTR, V30, P60, DOI 10.1016/j.clnu.2010.07.007; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Laskowska M, 2013, MED SCI MONITOR, V19, P430, DOI 10.12659/MSM.883932; Lau SY, 2013, AM J REPROD IMMUNOL, V70, P412, DOI 10.1111/aji.12138; Li ZW, 2013, HYPERTENSION, V61, P873, DOI 10.1161/HYPERTENSIONAHA.111.00230; Liu HH, 2013, SCI WORLD J, DOI 10.1155/2013/370487; Ma RQ, 2011, CHINESE MED J-PEKING, V124, P3141, DOI 10.3760/cma.j.issn.0366-6999.2011.19.033; Ma RQ, 2010, CHINESE MED J-PEKING, V123, P707, DOI 10.3760/cma.j.issn.0366-6999.2010.06.013; Maes M, 2000, BIOL PSYCHIAT, V47, P910, DOI 10.1016/S0006-3223(99)00268-1; Mahomed K, 2007, PHYSIOL RES, V56, P37, DOI 10.33549/physiolres.930859; Mayr AJ, 2005, HYPERTENS PREGNANCY, V24, P29, DOI 10.1081/PRG-200045770; McMahon JA, 2007, J NUTR, V137, P1183, DOI 10.1093/jn/137.5.1183; Mehendale S, 2008, INT J GYNECOL OBSTET, V100, P234, DOI 10.1016/j.ijgo.2007.08.011; Menon J, 2007, COMP BIOCHEM PHYS C, V145, P625, DOI 10.1016/j.cbpc.2007.02.011; Micle O, 2012, J Med Life, V5, P68; Morris CD, 2001, AM J OBSTET GYNECOL, V184, P643, DOI 10.1067/mob.2001.111101; Mujawar SA, 2011, INDIAN J CLIN BIOCHE, V26, P257, DOI 10.1007/s12291-011-0109-3; Murphy SR, 2013, AM J PHYSIOL-REG I, V304, pR130, DOI 10.1152/ajpregu.00069.2012; Namdev S, 2013, J MATERN FETAL NEONA; Nassar AH, 2012, AM J PERINAT, V29, P429, DOI 10.1055/s-0032-1304823; Neerhof MG, 2011, HYPERTENS PREGNANCY, V30, P28, DOI 10.3109/10641950903322915; Negi R, 2014, CHEM-BIOL INTERACT, V208, P77, DOI 10.1016/j.cbi.2013.11.010; Nilsson A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-99; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Oken E, 2007, ANN EPIDEMIOL, V17, P663, DOI 10.1016/j.annepidem.2007.03.003; Orhan Hilmi, 2003, Archives of Gynecology and Obstetrics, V267, P189; Ozler A, 2012, EUR REV MED PHARMACO, V16, P1707; Patil SB, 2007, CLIN EXP OBSTET GYN, V34, P239; Pimentel AML, 2013, HYPERTENS RES, V36, P783, DOI 10.1038/hr.2013.34; Poprawski G, 2012, GINEKOL POL, V83, P688; Qureshi SB, 2010, J PAK MED ASSOC, V60, P741; Rajkovic A, 1997, OBSTET GYNECOL, V90, P168, DOI 10.1016/S0029-7844(97)00223-8; Ray JG, 2002, ARCH INTERN MED, V162, P1776, DOI 10.1001/archinte.162.15.1776; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Sable PS, 2012, NEUROSCIENCE, V217, P46, DOI 10.1016/j.neuroscience.2012.05.001; Sable PS, 2013, METABOLISM, V62, P1607, DOI 10.1016/j.metabol.2013.06.002; Salvig JD, 1996, BRIT J OBSTET GYNAEC, V103, P529, DOI 10.1111/j.1471-0528.1996.tb09801.x; Sanchez SE, 2001, AM J EPIDEMIOL, V153, P474, DOI 10.1093/aje/153.5.474; Shiraishi M, 2013, NURS HLTH SCI; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Sung JL, 2013, KOREAN J PHYSIOL PHA, V17, P339, DOI 10.4196/kjpp.2013.17.4.339; Takei H, 2007, J PHARMACOL SCI, V104, P319, DOI 10.1254/jphs.FP0070224; Tang ZH, 2013, AM J REPROD IMMUNOL, V70, P104, DOI 10.1111/aji.12112; Tanir HM, 2005, EUR J OBSTET GYN R B, V118, P190, DOI 10.1016/j.ejogrb.2004.04.033; Theriault S, 2013, OBSTET GYNECOL, V122, P345, DOI 10.1097/AOG.0b013e31829b2f7c; Thompson LP, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/582748; Thurnham DI, 2004, NUTR RES REV, V17, P211, DOI 10.1079/NRR200486; Tsukimori K, 2008, AM J HYPERTENS, V21, P477, DOI 10.1038/ajh.2007.80; Tsukimori K, 2007, HYPERTENSION, V49, P1436, DOI 10.1161/HYPERTENSIONAHA.106.086751; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Villar J, 2006, AM J OBSTET GYNECOL, V194, P639, DOI 10.1016/j.ajog.2006.01.068; Walker MC, 2011, J OBSTET GYNAECOL CA, V33, P1124, DOI 10.1016/S1701-2163(16)35080-0; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Williams AL, 2006, J AFFECT DISORDERS, V93, P117, DOI 10.1016/j.jad.2006.02.023; Wintergerst ES, 2007, ANN NUTR METAB, V51, P301, DOI 10.1159/000107673; Xie C, 2011, CYTOKINE, V56, P550, DOI 10.1016/j.cyto.2011.09.021; Xun P, 2012, AM J CLIN NUTR, V95, P1023, DOI 10.3945/ajcn.111.027250; Yanez P, 2013, ARCH GYNECOL OBSTET, V288, P1011, DOI 10.1007/s00404-013-2851-7; Yang X, 2011, PLACENTA, V32, P681, DOI 10.1016/j.placenta.2011.06.020; Zhang Z, 2013, HYPERTENS PREGNANCY, V32, P270, DOI 10.3109/10641955.2013.798332; Zhou QJ, 2013, HYPERTENS PREGNANCY, V32, P422, DOI 10.3109/10641955.2013.824978; Zithanova I, 2007, CLIN BIOCHEM, V40, P567, DOI 10.1016/j.clinbiochem.2006.10.013	110	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111902	10.1371/journal.pone.0111902	http://dx.doi.org/10.1371/journal.pone.0111902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405347	gold, Green Submitted, Green Published			2022-12-27	WOS:000347121300017
J	Talley, AK; Healy, SA; Finney, OC; Murphy, SC; Kublin, J; Salas, CJ; Lundebjerg, S; Gilbert, P; Van Voorhis, WC; Whisler, J; Wang, RB; Ockenhouse, CF; Heppner, DG; Kappe, SH; Duffy, PE				Talley, Angela K.; Healy, Sara A.; Finney, Olivia C.; Murphy, Sean C.; Kublin, James; Salas, Carola J.; Lundebjerg, Susan; Gilbert, Peter; Van Voorhis, Wesley C.; Whisler, John; Wang, Ruobing; Ockenhouse, Chris F.; Heppner, D. Gray; Kappe, Stefan H.; Duffy, Patrick E.			Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naive Subjects at a New Facility for Sporozoite Challenge	PLOS ONE			English	Article							TO-BLOOD INOCULA; HUMAN VOLUNTEERS; VACCINES; IMMUNITY; UPDATE; COHORT; VIVAX; CELLS; MODEL; RATES	Background: Controlled human malaria infection (CHMI) studies which recapitulate mosquito-borne infection are a critical tool to identify protective vaccine and drug candidates for advancement to field trials. In partnership with the Walter Reed Army Institute of Research, the CHMI model was established at the Seattle Biomedical Research Institute's Malaria Clinical Trials Center (MCTC). Activities and reagents at both centers were aligned to ensure comparability and continued safety of the model. To demonstrate successful implementation, CHMI was performed in six healthy malaria-naive volunteers. Methods: All volunteers received NF54 strain Plasmodium falciparum by the bite of five infected Anopheles stephensi mosquitoes under controlled conditions and were monitored for signs and symptoms of malaria and for parasitemia by peripheral blood smear. Subjects were treated upon diagnosis with chloroquine by directly observed therapy. Immunological (T cell and antibody) and molecular diagnostic (real-time quantitative reverse transcriptase polymerase chain reaction [qRT-PCR]) assessments were also performed. Results: All six volunteers developed patent parasitemia and clinical malaria. No serious adverse events occurred during the study period or for six months post-infection. The mean prepatent period was 11.2 days (range 9-14 days), and geometric mean parasitemia upon diagnosis was 10.8 parasites/mu L (range 2-69) by microscopy. qRT-PCR detected parasites an average of 3.7 days (range 2-4 days) earlier than blood smears. All volunteers developed antibodies to the blood-stage antigen merozoite surface protein 1 (MSP-1), which persisted up to six months. Humoral and cellular responses to pre-erythrocytic antigens circumsporozoite protein (CSP) and liver-stage antigen 1 (LSA-1) were limited. Conclusion: The CHMI model was safe, well tolerated and characterized by consistent prepatent periods, pre-symptomatic diagnosis in 3/6 subjects and adverse event profiles as reported at established centers. The MCTC can now evaluate candidates in the increasingly diverse vaccine and drug pipeline using the CHMI model.	[Talley, Angela K.; Finney, Olivia C.; Lundebjerg, Susan; Whisler, John; Wang, Ruobing; Kappe, Stefan H.] Seattle Biomed Res Inst, Malaria Clin Trials Ctr, Seattle, WA 98109 USA; [Healy, Sara A.; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Bethesda, MD 20892 USA; [Murphy, Sean C.] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; [Kublin, James; Gilbert, Peter] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Salas, Carola J.] US Naval Med Res Unit 6, Lima, Peru; [Van Voorhis, Wesley C.] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA; [Ockenhouse, Chris F.; Heppner, D. Gray] Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD USA	Center for Infectious Disease Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of Washington; University of Washington Seattle; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Duffy, PE (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	patrick.duffy@nih.gov	Murphy, Sean C./AAC-7531-2019	Murphy, Sean C./0000-0002-2048-0131; Salas, Carola Janette/0000-0003-4122-9541	PATH Malaria Vaccine Initiative (MVI); United States Department of Defense; Intramural Research Program of National Institute of Allergy and Infectious Diseases, National Institutes of Health; Global Emerging Infections Surveillance and Response System of the United States Department of Defense (AFHSC/GEIS) [847705.82000.256B.B0016]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001135] Funding Source: NIH RePORTER	PATH Malaria Vaccine Initiative (MVI); United States Department of Defense(United States Department of Defense); Intramural Research Program of National Institute of Allergy and Infectious Diseases, National Institutes of Health; Global Emerging Infections Surveillance and Response System of the United States Department of Defense (AFHSC/GEIS)(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the initial MCTC infrastructure and for this clinical trial funding was provided by the PATH Malaria Vaccine Initiative (MVI) and the United States Department of Defense. MVI staff (Florence Kaltovich and Cynthia Lee) provided technical support on the chemistry, manufacturing, and control section of the IND application and the clinical operations aspects associated with this study, the latter through MVI's clinical quality assurance consultants at The Total Approach. C. F. O. is now employed by MVI/PATH and contributed to the review of the manuscript. This work was also supported by the Intramural Research Program of National Institute of Allergy and Infectious Diseases, National Institutes of Health (S. A. H., P. E. D.), and the Global Emerging Infections Surveillance and Response System of the United States Department of Defense (AFHSC/GEIS) under work unit number 847705.82000.256B.B0016 (C. J. S.). The authors have no conflicts that affect their adherence to all PLOS ONE policies on sharing data and materials.	Ballou WR, 2004, AM J TROP MED HYG, V71, P239; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; Church LWP, 1997, J INFECT DIS, V175, P915, DOI 10.1086/513990; Douglas AD, 2013, J INFECT DIS, V208, P340, DOI 10.1093/infdis/jit156; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Herrera S, 2011, AM J TROP MED HYG, V84, P4, DOI 10.4269/ajtmh.2011.09-0498; Herrera S, 2009, AM J TROP MED HYG, V81, P740, DOI 10.4269/ajtmh.2009.09-0194; Hoffman SL, 1997, ANN INTERN MED, V127, P233, DOI 10.7326/0003-4819-127-3-199708010-00010; JAMES S. P., 1931, TRANS ROY SOC TROP MED AND HYG, V24, P477, DOI 10.1016/S0035-9203(31)90068-0; JAMES SP, 1926, MALARIA COMMISSION R; Laurens Matthew B, 2012, Vaccine, V30, P5302, DOI 10.1016/j.vaccine.2012.04.088; Lyke KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013490; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Murphy SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097398; Murphy SC, 2012, J CLIN MICROBIOL, V50, P4128, DOI 10.1128/JCM.02549-12; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Nicol WD, 1927, J MENT SCI, V6, P1; Roestenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038434; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Spring M, 2014, J INFECT DIS, V209, P540, DOI 10.1093/infdis/jiu063; Todryk SM, 2009, EUR J IMMUNOL, V39, P3042, DOI 10.1002/eji.200939434; Verhage DF, 2005, NETH J MED, V63, P52; ZEVERING Y, 1992, EUR J IMMUNOL, V22, P689, DOI 10.1002/eji.1830220311	27	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e109654	10.1371/journal.pone.0109654	http://dx.doi.org/10.1371/journal.pone.0109654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405724	Green Submitted, gold, Green Published			2022-12-27	WOS:000347121300006
J	Vinicius, L; Mace, R; Migliano, A				Vinicius, Lucio; Mace, Ruth; Migliano, Andrea			Variation in Male Reproductive Longevity across Traditional Societies	PLOS ONE			English	Article							LIFE-HISTORY; EVOLUTION; MORTALITY; MENOPAUSE; PATTERNS; HUMANS; TRENDS; SPAN; MEN	Most accounts of human life history propose that women have short reproductive spans relative to their adult lifespans, while men not only remain fertile but carry on reproducing until late life. Here we argue that studies have overlooked evidence for variation in male reproductive ageing across human populations. We apply a Bayesian approach to census data from Agta hunter-gatherers and Gambian farmers to show that long post-reproductive lifespans characterise not only women but also males in some traditional human populations. We calculate three indices of reproductive ageing in men (oldest age at reproduction, male late-life reproduction, and post-reproductive representation) and identify a continuum of male reproductive longevity across eight traditional societies ranging from IKung, Hadza and Agta hunter-gatherers exhibiting low levels of polygyny, early age at last reproduction and long post-reproductive lifespans, to male Gambian agriculturalists and Turkana pastoralists showing higher levels of polygyny, late-life reproduction and shorter postreproductive lifespans. We conclude that the uniquely human detachment between rates of somatic senescence and reproductive decline, and the existence of post-reproductive lifespans, are features of both male and female life histories, and therefore not exclusive consequences of menopause.	[Vinicius, Lucio; Mace, Ruth; Migliano, Andrea] UCL, Dept Anthropol, London, England	University of London; University College London	Vinicius, L (corresponding author), UCL, Dept Anthropol, London, England.	l.vinicius@ucl.ac.uk		Mace, Ruth/0000-0002-6137-7739; Migliano, Andrea/0000-0003-4364-2735	Leverhulme Trust [RP2011-R-045]; ERC [AdG 249347]	Leverhulme Trust(Leverhulme Trust); ERC(European Research Council (ERC)European Commission)	AM is funded by the Leverhulme Trust ('Hunter-gatherers' Resilience', RP2011-R-045) and RM is funded by the ERC (The Evolution of Cultural Norms in Real World Settings', AdG 249347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2013, P NATL ACAD SCI USA, V110, P13440, DOI 10.1073/pnas.1311857110; Blurton-Jones NG, 2013, HADZA DEMOGRAPHY SOC; Bribiescas RG, 2006, EVOL ANTHROPOL, V15, P132, DOI 10.1002/evan.20087; Bribiescas RG, 2012, CURR ANTHROPOL, V53, pS424, DOI 10.1086/667538; Colchero F, 2012, METHODS ECOL EVOL, V3, P466, DOI 10.1111/j.2041-210X.2012.00186.x; Colchero F, 2012, J ANIM ECOL, V81, P139, DOI 10.1111/j.1365-2656.2011.01898.x; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; Early JD, 1998, POPULATION DYNAMICS; Early JD, 2000, XILIXANA YANOMAMI AM; Finch CE, 1990, LONGEVITY SENESCENCE; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Hawkes K, 2009, AM J HUM BIOL, V21, P578, DOI 10.1002/ajhb.20890; Headland TN, 2011, SIL LANGUAGE CULTURE, V2; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Howell N., 1979, DEMOGRAPHY DOBE KUNG; Kaplan H, 2010, ANN NY ACAD SCI, V1204, P30, DOI [10.1111/J.1749-6632.2010.05528.x, 10.1111/j.1749-6632.2010.05528.x]; Levitis DA, 2013, EVOL ANTHROPOL, V22, P66, DOI 10.1002/evan.21332; Little MA, 1999, TURKANA HERDERS DRY; Marlowe FW, 2003, EVOL HUM BEHAV, V24, P217, DOI 10.1016/S1090-5138(03)00014-X; Marlowe FW, 2000, HUM NATURE-INT BIOS, V11, P27, DOI 10.1007/s12110-000-1001-7; MCGREGOR IA, 1991, DIS MORTALITY SUBSAH, P306; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Morton RA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003092; NEEL JV, 1975, AM J PHYS ANTHROPOL, V42, P25, DOI 10.1002/ajpa.1330420105; PARTRIDGE L, 1993, GENETICA, V91, P89, DOI 10.1007/BF01435990; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; Rayco-Solon P, 2004, TROP MED INT HEALTH, V9, P1151, DOI 10.1111/j.1365-3156.2004.01325.x; Tuljapurkar SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000785; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Weiss K. M., 1973, MEMOIRS SOC AM ARCHA, V27; WHITE DR, 1988, CURR ANTHROPOL, V29, P529, DOI 10.1086/203674; Winking J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3078	32	17	17	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112236	10.1371/journal.pone.0112236	http://dx.doi.org/10.1371/journal.pone.0112236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405763	Green Published, gold			2022-12-27	WOS:000347121300027
J	Wang, YJ; McAllister, F; Bailey, JM; Scott, SG; Hendley, AM; Leach, SD; Ghosh, B				Wang, Yue J.; McAllister, Florencia; Bailey, Jennifer M.; Scott, Sherri-Gae; Hendley, Audrey M.; Leach, Steven D.; Ghosh, Bidyut			Dicer Is Required for Maintenance of Adult Pancreatic Acinar Cell Identity and Plays a Role in Kras-Driven Pancreatic Neoplasia	PLOS ONE			English	Article							MICRORNA EXPRESSION; DIFFERENTIATION; REGENERATION; METAPLASIA; CONTRIBUTE; INDUCTION; ONCOGENES	The role of miRNA processing in the maintenance of adult pancreatic acinar cell identity and during the initiation and progression of pancreatic neoplasia has not been studied in detail. In this work, we deleted Dicer specifically in adult pancreatic acinar cells, with or without simultaneous activation of oncogenic Kras. We found that Dicer is essential for the maintenance of acinar cell identity. Acinar cells lacking Dicer showed increased plasticity, as evidenced by loss of polarity, initiation of epithelial-to-mesenchymal transition (EMT) and acinar-to-ductal metaplasia (ADM). In the context of oncogenic Kras activation, the initiation of ADM and pancreatic intraepithelial neoplasia (PanIN) were both highly sensitive to Dicer gene dosage. Homozygous Dicer deletion accelerated the formation of ADM but not PanIN. In contrast, heterozygous Dicer deletion accelerated PanIN initiation, revealing complex roles for Dicer in the regulation of both normal and neoplastic pancreatic epithelial identity.	[Wang, Yue J.; Bailey, Jennifer M.; Hendley, Audrey M.; Leach, Steven D.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [McAllister, Florencia] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bailey, Jennifer M.; Leach, Steven D.; Ghosh, Bidyut] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Scott, Sherri-Gae] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Leach, SD (corresponding author), Mem Sloan Kettering Canc Ctr, David M Rubenstein Ctr Pancreat Canc Res, 1275 York Ave, New York, NY 10021 USA.	leachs@mskcc.org	Wang, Julia/M-4516-2016	Wang, Julia/0000-0003-2641-6904; Bailey-Lundberg, Jennifer/0000-0002-4750-106X; Hendley, Audrey/0000-0003-0289-2092	NIH [P01 CA134292]; Paul K. Neumann Professorship in Pancreatic Cancer at Johns Hopkins University; NIGMS [T32GMO66691]; Pancreatic Cancer Action Network-AACR Fellowship in Memory of Samuel Stroum [12-40-25-MCAL]; Conquer Cancer Foundation Young Investigator Award; Pancreatic Cancer Action Network-AACR Pathway; NCI [5F32 CA157044]; NATIONAL CANCER INSTITUTE [P01CA134292, F32CA157044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul K. Neumann Professorship in Pancreatic Cancer at Johns Hopkins University; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pancreatic Cancer Action Network-AACR Fellowship in Memory of Samuel Stroum; Conquer Cancer Foundation Young Investigator Award; Pancreatic Cancer Action Network-AACR Pathway; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SDL was supported by NIH P01 CA134292 and the Paul K. Neumann Professorship in Pancreatic Cancer at Johns Hopkins University. FM was supported by NIGMS T32GMO66691, a 2012 Pancreatic Cancer Action Network-AACR Fellowship in Memory of Samuel Stroum, Grant Number 12-40-25-MCAL and a Conquer Cancer Foundation Young Investigator Award 2012. JMB was supported by the 2011 Pancreatic Cancer Action Network-AACR Pathway to Leadership Award and NCI 5F32 CA157044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bombardelli L, 2010, GASTROENTEROLOGY, V138, P2531, DOI 10.1053/j.gastro.2010.02.043; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Esni F, 2005, METH MOLEC MED, V103, P259; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Morris JPt, 2014, PLOS ONE, V9; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Prevot PP, 2013, GASTROENTEROLOGY, V145, P668, DOI 10.1053/j.gastro.2013.05.016; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Shi G, 2013, ONCOGENE, V32, P1950, DOI 10.1038/onc.2012.210; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Yoshikawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071969; Zhang B, 2013, ONCOGENE; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	38	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113127	10.1371/journal.pone.0113127	http://dx.doi.org/10.1371/journal.pone.0113127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405615	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300082
J	Deeny, S; Chicoine, C; Hargrove, L; Parrish, T; Jayaraman, A				Deeny, Sean; Chicoine, Caitlin; Hargrove, Levi; Parrish, Todd; Jayaraman, Arun			A Simple ERP Method for Quantitative Analysis of Cognitive Workload in Myoelectric Prosthesis Control and Human-Machine Interaction	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; MENTAL WORKLOAD; PERFORMANCE; REINNERVATION; ELECTROENCEPHALOGRAPHY; REHABILITATION; CLASSIFICATION; RECOGNITION; THERAPY; TASKS	Common goals in the development of human-machine interface (HMI) technology are to reduce cognitive workload and increase function. However, objective and quantitative outcome measures assessing cognitive workload have not been standardized for HMI research. The present study examines the efficacy of a simple event-related potential (ERP) measure of cortical effort during myoelectric control of a virtual limb for use as an outcome tool. Participants trained and tested on two methods of control, direct control (DC) and pattern recognition control (PRC), while electroencephalographic (EEG) activity was recorded. Eighteen healthy participants with intact limbs were tested using DC and PRC under three conditions: passive viewing, easy, and hard. Novel auditory probes were presented at random intervals during testing, and significant task-difficulty effects were observed in the P200, P300, and a late positive potential (LPP), supporting the efficacy of ERPs as a cognitive workload measure in HMI tasks. LPP amplitude distinguished DC from PRC in the hard condition with higher amplitude in PRC, consistent with lower cognitive workload in PRC relative to DC for complex movements. Participants completed trials faster in the easy condition using DC relative to PRC, but completed trials more slowly using DC relative to PRC in the hard condition. The results provide promising support for ERPs as an outcome measure for cognitive workload in HMI research such as prosthetics, exoskeletons, and other assistive devices, and can be used to evaluate and guide new technologies for more intuitive HMI control.	[Deeny, Sean; Chicoine, Caitlin; Hargrove, Levi; Jayaraman, Arun] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Deeny, Sean; Parrish, Todd; Jayaraman, Arun] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine	Jayaraman, A (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.	a-jayaraman@northwestern.edu		Parrish, Todd/0000-0002-1184-1572	National Institute on Disability and Rehabilitation Research (NIDRR) [H133F120017]; American Orthotic and Prosthetic Association (AOPA) [EBP-043012]	National Institute on Disability and Rehabilitation Research (NIDRR); American Orthotic and Prosthetic Association (AOPA)	This research was supported by the National Institute on Disability and Rehabilitation Research (NIDRR) (H133F120017), and the American Orthotic and Prosthetic Association (AOPA) (EBP-043012). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe HA, 2013, IEEE ENG MED BIO, P5590, DOI 10.1109/EMBC.2013.6610817; Allison BZ, 2008, BIOL PSYCHOL, V77, P277, DOI 10.1016/j.biopsycho.2007.10.014; BAUER LO, 1987, HUM FACTORS, V29, P213, DOI 10.1177/001872088702900208; Behrend C, 2011, J HAND SURG-AM, V36A, P1711, DOI 10.1016/j.jhsa.2011.07.024; Belter JT, 2013, J REHABIL RES DEV, V50, P599, DOI 10.1682/JRRD.2011.10.0188; Casson AJ, 2010, IEEE ENG MED BIOL, V29, P44, DOI 10.1109/MEMB.2010.936545; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Dawson MR, 2011, EXPERT REV MED DEVIC, V8, P581, DOI [10.1586/erd.11.23, 10.1586/ERD.11.23]; Diaz I, 2014, COMPUT METH PROG BIO, V116, P97, DOI 10.1016/j.cmpb.2013.10.010; Do AH, 2012, IEEE ENG MED BIO, P6414, DOI 10.1109/EMBC.2012.6347462; Do AH, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-49; Fabiani M, 1996, PSYCHOPHYSIOLOGY, V33, P462, DOI 10.1111/j.1469-8986.1996.tb01072.x; Fabiani M., 2000, HDB PSYCHOPHYSIOLOGY; Gentili RJ, 2009, IEEE ENG MED BIO, P5930, DOI 10.1109/IEMBS.2009.5334743; Goldberg JH, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P493, DOI 10.1016/B978-044451020-4/50027-X; Gollee H, 2010, IEEE T BIO-MED ENG, V57, P1847, DOI 10.1109/TBME.2010.2043432; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Handy TC, 2005, EVENT RELATED POTENT; Hill W, 2009, J PROSTHET ORTHOT S, V21, P69, DOI DOI 10.1097/JPO.0B013E3181AE970B; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kilicarslan A, 2013, IEEE ENG MED BIO, P5606, DOI 10.1109/EMBC.2013.6610821; King CE, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-77; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kothe CA, 2011, IEEE ENG MED BIO, P6547, DOI 10.1109/IEMBS.2011.6091615; KRAMER AF, 1987, HUM FACTORS, V29, P145, DOI 10.1177/001872088702900203; KRAMER AF, 1995, BIOL PSYCHOL, V40, P83, DOI 10.1016/0301-0511(95)05108-2; KRAMER AF, 1985, J EXP PSYCHOL HUMAN, V11, P393, DOI 10.1037/0096-1523.11.4.393; Kruse AA, 2007, AVIAT SPACE ENVIR MD, V78, pB191; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lan Tian, 2007, Comput Intell Neurosci, P74895, DOI 10.1155/2007/74895; Lindner HYN, 2010, PROSTHET ORTHOT INT, V34, P109, DOI 10.3109/03093641003776976; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; Marasco PD, 2009, BRAIN, V132, P1441, DOI 10.1093/brain/awp082; Mathan S, 2010, IEEE ENG MED BIO, P6595, DOI 10.1109/IEMBS.2010.5627126; Mazur LM, 2013, PRACT RADIAT ONCOL, V3, pE171, DOI 10.1016/j.prro.2013.01.001; Metcalf C, 2007, MUSCULOSKELET CARE, V5, P160, DOI 10.1002/msc.108; Miller MW, 2011, INT J PSYCHOPHYSIOL, V80, P75, DOI 10.1016/j.ijpsycho.2011.02.003; PAPANICOLAOU AC, 1984, INT J NEUROSCI, V24, P107, DOI 10.3109/00207458409089800; PARASURAMAN R, 1980, SCIENCE, V210, P80, DOI 10.1126/science.7414324; Parker P, 2006, J ELECTROMYOGR KINES, V16, P541, DOI 10.1016/j.jelekin.2006.08.006; Pascual J, 2012, IEEE ENG MED BIO, P3269, DOI 10.1109/EMBC.2012.6346663; Paulmann S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00345; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pons JL, 2010, IEEE ENG MED BIOL, V29, P57, DOI 10.1109/MEMB.2010.936548; Resnik L, 2012, ARCH PHYS MED REHAB, V93, P710, DOI 10.1016/j.apmr.2011.11.010; Rietschel JC, 2012, BIOL PSYCHOL, V90, P127, DOI 10.1016/j.biopsycho.2012.02.022; Sale P, 2012, EUR J PHYS REHAB MED, V48, P111; Schultz AE, 2009, BRAIN RES, V1251, P121, DOI 10.1016/j.brainres.2008.11.039; Seneviratne U, 2013, EPILEPSY RES, V105, P1, DOI 10.1016/j.eplepsyres.2013.02.004; Simon AM, 2011, J REHABIL RES DEV, V48, P619, DOI 10.1682/JRRD.2010.08.0149; Simorov A, 2012, SURG ENDOSC, V26, P2117, DOI 10.1007/s00464-012-2182-y; SIREVAAG EJ, 1993, ERGONOMICS, V36, P1121, DOI 10.1080/00140139308967983; Sobuh MMD, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-72; Soussou W, 2012, IEEE ENG MED BIO, P1623, DOI 10.1109/EMBC.2012.6346256; Tokuda S, 2011, C P IEEE ENG MED BIO, V45, P23; Ullsperger P, 2001, INT J PSYCHOPHYSIOL, V40, P201, DOI 10.1016/S0167-8760(00)00188-4; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Wilson GF, 2003, HUM FACTORS, V45, P635, DOI 10.1518/hfes.45.4.635.27088; Witteveen HJB, 2012, J REHABIL RES DEV, V49, P1517, DOI 10.1682/JRRD.2011.12.0243; Young AJ, 2013, IEEE T BIO-MED ENG, V60, P1250, DOI 10.1109/TBME.2012.2232293	63	37	37	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112091	10.1371/journal.pone.0112091	http://dx.doi.org/10.1371/journal.pone.0112091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402345	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700028
J	Geronikolou, S; Zimeras, S; Davos, CH; Michalopoulos, I; Tsitomeneas, S				Geronikolou, Styliani; Zimeras, Stelios; Davos, Constantinos H.; Michalopoulos, Ioannis; Tsitomeneas, Stephanos			Diverse Radiofrequency Sensitivity and Radiofrequency Effects of Mobile or Cordless Phone near Fields Exposure in Drosophila melanogaster	PLOS ONE			English	Article							MEASUREMENT ERROR; JUVENILE-HORMONE; RADIATION; STROKE; CELL; REPRODUCTION; ASSOCIATION	Introduction: The impact of electromagnetic fields on health is of increasing scientific interest. The aim of this study was to examine how the Drosophila melanogaster animal model is affected when exposed to portable or mobile phone fields. Methods/Results: Two experiments have been designed and performed in the same laboratory conditions. Insect cultures were exposed to the near field of a 2G mobile phone (the GSM 2G networks support and complement in parallel the 3G wide band or in other words the transmission of information via voice signals is served by the 2G technology in both mobile phones generations) and a 1880 MHz cordless phone both digitally modulated by human voice. Comparison with advanced statistics of the egg laying of the second generation exposed and non-exposed cultures showed limited statistical significance for the cordless phone exposed culture and statistical significance for the 900 MHz exposed insects. We calculated by physics, simulated and illustrated in three dimensional figures the calculated near fields of radiation inside the experimenting vials and their difference. Comparison of the power of the two fields showed that the difference between them becomes null when the experimental cylinder radius and the height of the antenna increase. Conclusions/Significance: Our results suggest a possible radiofrequency sensitivity difference in insects which may be due to the distance from the antenna or to unexplored intimate factors. Comparing the near fields of the two frequencies bands, we see similar not identical geometry in length and height from the antenna and that lower frequencies tend to drive to increased radiofrequency effects.	[Geronikolou, Styliani; Davos, Constantinos H.; Michalopoulos, Ioannis] Biomed Res Fdn, Acad Athens, Athens 11527, Greece; [Tsitomeneas, Stephanos] TEI Piraeus, Dept Elect, Athens 12244, Greece; [Zimeras, Stelios] Univ Aegean, Div Stat & Actuarial Financial Math, Dept Math, Karlovassi 82300, Samos, Greece	Academy of Athens; University of West Attica; University of Aegean	Geronikolou, S (corresponding author), Biomed Res Fdn, Acad Athens, 4 Soranou Efessiou Str, Athens 11527, Greece.	sgeronik@bioacademy.gr	, 0000-0001-8991-8712/S-4398-2016; Davos, Constantinos/AAR-3259-2021; Davos, Constantinos H./AAR-9392-2020	, 0000-0001-8991-8712/0000-0001-8991-8712; Davos, Constantinos/0000-0002-0321-7569; 				Atli E, 2006, INT J RADIAT BIOL, V82, P435, DOI 10.1080/09553000600798849; DAPPLES CC, 1970, Z ZELLFORSCH MIK ANA, V103, P34, DOI 10.1007/BF00335399; Davies L, 2007, PROTEINS, V67, P720, DOI 10.1002/prot.21357; Demarin V, 2011, ACTA CLIN CROAT, V50, P67; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; DUTTA SK, 1989, BIOELECTROMAGNETICS, V10, P197, DOI 10.1002/bem.2250100208; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Geronikolou S, 1996, REGRESSION ANAL SOLA; Geronikolou S, 2005, MORTALITY GREECE REL; Geronikolou S, 1996, 3 SOLT S BEIJ; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; HANDLER AM, 1977, J EXP ZOOL, V202, P389, DOI 10.1002/jez.1402020309; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; HATCH M, 1993, ENVIRON HEALTH PERSP, V101, P49, DOI 10.2307/3431659; Heid IM, 2004, J EXPO ANAL ENV EPID, V14, P365, DOI 10.1038/sj.jea.7500332; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Huang CJ, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00314; Kubli E, 2003, CELL MOL LIFE SCI, V60, P1689, DOI 10.1007/s00018-003-3052; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; LINLIU S, 1982, BIOELECTROMAGNETICS, V3, P309, DOI 10.1002/bem.2250030303; Luechese FA, 2013, REV BRAS CIR CARDIOV, V28, P103, DOI 10.5935/1678-9741.20130015; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Mu QY, 2014, MCN-AM J MATERN-CHIL, V39, P35, DOI 10.1097/NMC.0b013e3182a76b88; Otsuka K, 2001, BIOMED PHARMACOTHER, V55, p63S; Ovbiagele B, 2011, NEUROTHERAPEUTICS, V8, P319, DOI 10.1007/s13311-011-0053-1; Panagopoulos DJ, 2007, ELECTROMAGN BIOL MED, V26, P33, DOI 10.1080/15368370701205644; Panagopoulos DJ, 2000, BIOCHEM BIOPH RES CO, V272, P634, DOI 10.1006/bbrc.2000.2746; Panagopoulos DJ., 2018, MOBILE TELEPHONES, P107; PAY TL, 1978, RADIAT RES, V76, P271, DOI 10.2307/3574778; Potter CJ, 2000, TRENDS GENET, V16, P33, DOI 10.1016/S0168-9525(99)01878-8; RAMIREZ E, 1983, BIOELECTROMAGNETICS, V4, P315, DOI 10.1002/bem.2250040404; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Satterfield G, 2012, J NEUROSCI NURS, V44, P244, DOI 10.1097/JNN.0b013e3182666248; SHIRRAS AD, 1989, P NATL ACAD SCI USA, V86, P4559, DOI 10.1073/pnas.86.12.4559; Stoupel E., 2002, Journal of Basic and Clinical Physiology and Pharmacology, V13, P23; Stoupel E, 1996, J Basic Clin Physiol Pharmacol, V7, P303; Stoupel E., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P37; Stoupel Elijah, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P225; Stoupel Elijah, 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P135; Stoupel E, 2007, MEDICINA-LITHUANIA, V43, P824, DOI 10.3390/medicina43100106; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; Tsitomeneas S, 2010, SAFETY MEASURES PROD, P177; Tsitomeneas S, 1993, RISK ISSUES USERS PO, P62; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Weisbrot D, 2003, J CELL BIOCHEM, V89, P48, DOI 10.1002/jcb.10480; Wilson ME, 2013, PFLUG ARCH EUR J PHY, V465, P595, DOI 10.1007/s00424-013-1260-x; Wilson TG, 2003, INSECT BIOCHEM MOLEC, V33, P1167, DOI 10.1016/j.ibmb.2003.06.007	49	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112139	10.1371/journal.pone.0112139	http://dx.doi.org/10.1371/journal.pone.0112139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402465	Green Published, gold			2022-12-27	WOS:000345158700030
J	Kinoshita, T; Yano, T; Sugiura, M; Nagasaki, Y				Kinoshita, Takafumi; Yano, Takayoshi; Sugiura, Makoto; Nagasaki, Yuji			Effects of Controlled-Release Fertilizer on Leaf Area Index and Fruit Yield in High-Density Soilless Tomato Culture Using Low Node-Order Pinching	PLOS ONE			English	Article							QUANTITATIVE NUTRIENT MANAGEMENT; LIGHT-INTERCEPTION; ROCKWOOL HYDROPONICS; GROWTH; TEMPERATURE; PLANTS; SET	To further development of a simplified fertigation system using controlled-release fertilizers (CRF), we investigated the effects of differing levels of fertilizers and plant density on leaf area index (LAI), fruit yields, and nutrient use in soilless tomato cultures with low node-order pinching and high plant density during spring-summer (SS), summer-fall (SF), and fall-winter (FW) seasons. Plants were treated with 1 of 3 levels of CRF in a closed system, or with liquid fertilizer (LF) with constant electrical conductivity (EC) in a drip-draining system. Two plant densities were examined for each fertilizer treatment. In CRF treatments, LAI at pinching increased linearly with increasing nutrient supply for all cropping seasons. In SS, both light interception by plant canopy at pinching and total marketable fruit yield increased linearly with increasing LAI up to 6 m(2).m(-2); the maximization point was not reached for any of the treatments. In FW, both light interception and yield were maximized at an LAI of approximately 4. These results suggest that maximizing the LAI in SS and FW to the saturation point for light interception is important for increasing yield. In SF, however, the yield maximized at an LAI of approximately 3, although the light interception linearly increased with increasing LAI, up to 4.5. According to our results, the optimal LAI at pinching may be 6 in SS, 3 in SF, and 4 in FW. In comparing LAI values with similar fruit yield, we found that nutrient supply was 32-46% lower with the CRF method than with LF. In conclusion, CRF application in a closed system enables growers to achieve a desirable LAI to maximize fruit yield with a regulated amount of nutrient supply per unit area. Further, the CRF method greatly reduced nutrient use without decreasing fruit yield at similar LAIs, as compared to the LF method.	[Kinoshita, Takafumi] Natl Agr & Food Res Org NARO, NARO Tohoku Agr Res Ctr, Morioka, Iwate, Japan; [Yano, Takayoshi; Sugiura, Makoto; Nagasaki, Yuji] Natl Agr & Food Res Org NARO, NARO Western Reg Agr Res Ctr, Zentsuji, Kagawa, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Kinoshita, T (corresponding author), Natl Agr & Food Res Org NARO, NARO Tohoku Agr Res Ctr, Morioka, Iwate, Japan.	takino@affrc.go.jp						Bertin N, 2005, ANN BOT-LONDON, V95, P439, DOI 10.1093/aob/mci042; BROUGHAM R. W., 1958, Australian Journal of Agricultural Research, V9, P39, DOI 10.1071/AR9580039; COCKSHULL KE, 1992, J HORTIC SCI, V67, P11, DOI 10.1080/00221589.1992.11516215; Constabel AJ, 1996, CAN J FOREST RES, V26, P1008, DOI 10.1139/x26-111; Heuvelink E, 2004, ACTA HORTIC, V691, P43; Heuvelink E, 2005, CROP PRODUCTION SCI, V13, P53; Higashide T, 2009, J AM SOC HORTIC SCI, V134, P460, DOI 10.21273/JASHS.134.4.460; Higashide T, 2009, AGR FOREST METEOROL, V149, P756, DOI 10.1016/j.agrformet.2008.10.017; Hikosaka K, 2001, FUNCT ECOL, V15, P642, DOI 10.1046/j.0269-8463.2001.00557.x; Hosoi N., 2003, Bulletin of the National Institute of Vegetable and Tea Science, P245; Isoda A, 1990, TECH B FAC HORTIC CH, V43, P39; Iwakiri S., 1974, J AGRIC METEOROL, V30, P17, DOI [10.2480/agrmet.30.17, DOI 10.2480/AGRMET.30.17]; Kinoshita T, 2014, ACTA HORTIC, V1034, P517; Kinoshita T, 2012, HORTSCIENCE, V47, P1529, DOI 10.21273/HORTSCI.47.10.1529; Kinoshita T, 2011, HORTSCIENCE, V46, P1170, DOI 10.21273/HORTSCI.46.8.1170; KURATA K, 1988, Journal of Agricultural Meteorology, V44, P15; Matsuda Ryo, 2011, Journal of Agricultural Meteorology, V67, P117, DOI 10.2480/agrmet.67.3.6; Matsuda Ryo, 2010, Journal of Agricultural Meteorology, V66, P217, DOI 10.2480/agrmet.66.4.4; Monteith JL., 1969, PHYSL ASPECTS CROP Y, P89, DOI DOI 10.2135/1969.PHYSIOLOGICALASPECTS.C9; Nakano Y, 2006, J JPN SOC HORTIC SCI, V75, P421, DOI 10.2503/jjshs.75.421; Nakano Y, 2010, J JPN SOC HORTIC SCI, V79, P47, DOI 10.2503/jjshs1.79.47; Pardossi A, 2002, SCI HORTIC-AMSTERDAM, V92, P89, DOI 10.1016/S0304-4238(01)00292-8; Peet MM, 1996, J AM SOC HORTIC SCI, V121, P514, DOI 10.21273/JASHS.121.3.514; Peet MM, 1998, PLANT CELL ENVIRON, V21, P225, DOI 10.1046/j.1365-3040.1998.00281.x; Saeki T, 1960, J PLANT RES, V73, P55; Sasaki H, 2005, JARQ-JPN AGR RES Q, V39, P135, DOI 10.6090/jarq.39.135; Sato S., 2006, HortResearch, P85; Shiraiwa T., 2011, JPN J CROP SCI, V80, P360; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; Terabayashi S, 2004, J JPN SOC HORTIC SCI, V73, P324, DOI 10.2503/jjshs.73.324; Watanabe S, 2003, J JPN SOC HORTIC SCI, V72, P497, DOI 10.2503/jjshs.72.497; Watanabe S., 2006, P VEGE TEA SCI, V3, P91; Yoshikawa H., 2010, MISC PUB NARO W REG, V7, P21	33	9	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113074	10.1371/journal.pone.0113074	http://dx.doi.org/10.1371/journal.pone.0113074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402478	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700107
J	Vladusich, T; McDonnell, MD				Vladusich, Tony; McDonnell, Mark D.			A Unified Account of Perceptual Layering and Surface Appearance in Terms of Gamut Relativity	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; LIGHTNESS PERCEPTION; SURROUND ARTICULATION; BRIGHTNESS CONTRAST; PERCEIVED LIGHTNESS; GANGLION-CELLS; ILLUMINATION; LUMINANCE; RESPONSES	When we look at the world-or a graphical depiction of the world-we perceive surface materials (e. g. a ceramic black and white checkerboard) independently of variations in illumination (e. g. shading or shadow) and atmospheric media (e. g. clouds or smoke). Such percepts are partly based on the way physical surfaces and media reflect and transmit light and partly on the way the human visual system processes the complex patterns of light reaching the eye. One way to understand how these percepts arise is to assume that the visual system parses patterns of light into layered perceptual representations of surfaces, illumination and atmospheric media, one seen through another. Despite a great deal of previous experimental and modelling work on layered representation, however, a unified computational model of key perceptual demonstrations is still lacking. Here we present the first general computational model of perceptual layering and surface appearance-based on a boarder theoretical framework called gamut relativity-that is consistent with these demonstrations. The model (a) qualitatively explains striking effects of perceptual transparency, figure-ground separation and lightness, (b) quantitatively accounts for the role of stimulus-and task-driven constraints on perceptual matching performance, and (c) unifies two prominent theoretical frameworks for understanding surface appearance. The model thereby provides novel insights into the remarkable capacity of the human visual system to represent and identify surface materials, illumination and atmospheric media, which can be exploited in computer graphics applications.	[Vladusich, Tony; McDonnell, Mark D.] Univ S Australia, Inst Telecommun Res, Mawson Lakes 5095, Australia; [Vladusich, Tony] Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA	University of South Australia; Boston University	Vladusich, T (corresponding author), Univ S Australia, Inst Telecommun Res, Mawson Lakes 5095, Australia.	therealrealvlad@gmail.com	McDonnell, Mark/A-8374-2008	McDonnell, Mark/0000-0002-7009-3869	Australian Research Fellowship from the Australian Research Council [DP1093425]	Australian Research Fellowship from the Australian Research Council(Australian Research Council)	Mark D. McDonnell's contribution was supported by an Australian Research Fellowship from the Australian Research Council (http://www.arc.gov.au/), project number DP1093425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson E. H., 1995, Proceedings IEEE Workshop on Representation of Visual Scenes (In Conjunction with ICCV'95) (Cat. No.95TB8126), P3, DOI 10.1109/WVRS.1995.476846; Adelson E. H., 2000, NEW COGNITIVE NEUROS, V339, P339, DOI DOI 10.1068/P230869; ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; Allred SR, 2013, J VISION, V13, DOI 10.1167/13.7.18; Anderson BL, 2008, J VISION, V8, DOI 10.1167/8.7.18; Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; Anderson BL, 2003, PSYCHOL REV, V110, P785, DOI 10.1037/0033-295X.110.4.785; Anderson BL, 1999, NEURON, V24, P919, DOI 10.1016/S0896-6273(00)81039-9; AREND LE, 1993, PERCEPT PSYCHOPHYS, V54, P446, DOI 10.3758/BF03211767; AREND LE, 1987, J OPT SOC AM A, V4, P2281, DOI 10.1364/JOSAA.4.002281; AREND LE, 1993, PERCEPT PSYCHOPHYS, V54, P457, DOI 10.3758/BF03211768; AREND LE, 1990, J OPT SOC AM A, V7, P1929, DOI 10.1364/JOSAA.7.001929; BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; BARLOW RB, 1978, EXP BRAIN RES, V31, P163; BARLOW RB, 1976, VISION RES, V16, P1291, DOI 10.1016/0042-6989(76)90056-0; Barrow H.G., 1978, COMPUTER VISION SYST, P3; Blakeslee B, 2012, VISION RES, V60, P40, DOI 10.1016/j.visres.2012.03.006; Blakeslee B, 2008, J VISION, V8, DOI 10.1167/8.11.3; Bressan P, 2001, PERCEPTION, V30, P1031, DOI 10.1068/p3109; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Chandraker M, 2011, IEEE T PATTERN ANAL, V33, P2122, DOI 10.1109/TPAMI.2011.124; Corney D, 2007, PLOS COMPUT BIOL, V3, P1790, DOI 10.1371/journal.pcbi.0030180; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Donner C, 2005, ACM T GRAPHIC, V24, P1032, DOI 10.1145/1073204.1073308; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Ekroll V, 2002, P NATL ACAD SCI USA, V99, P13352, DOI 10.1073/pnas.192216699; Faul F, 2002, J OPT SOC AM A, V19, P1084, DOI 10.1364/JOSAA.19.001084; Faul F, 2012, J VISION, V12, DOI 10.1167/12.12.7; Faul F, 2011, J VISION, V11, DOI 10.1167/11.7.7; Fleming RW, 2014, VISION RES, V94, P62, DOI 10.1016/j.visres.2013.11.004; Fleming RW, 2012, CURR BIOL, V22, pR865, DOI 10.1016/j.cub.2012.08.030; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Geisler WS, 2007, J NEUROSCI, V27, P5063, DOI 10.1523/JNEUROSCI.0835-07.2007; Ghosh A, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1409060.1409092; Gilchrist A, 1999, PSYCHOL REV, V106, P795, DOI 10.1037/0033-295X.106.4.795; GILCHRIST A, 1983, PERCEPT PSYCHOPHYS, V33, P425, DOI 10.3758/BF03202893; Gilchrist A., 2006, SEEING BLACK WHITE; Gilchrist AL, 2005, CURR BIOL, V15, pR330, DOI 10.1016/j.cub.2005.04.028; GILCHRIST AL, 1983, J EXP PSYCHOL HUMAN, V9, P936, DOI 10.1037/0096-1523.9.6.936; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; Gilchrist AL, 2007, CURR BIOL, V17, pR267, DOI 10.1016/j.cub.2007.01.040; Grady L, 2006, IEEE T PATTERN ANAL, V28, P469, DOI 10.1109/TPAMI.2006.57; Hillis JM, 2007, CURR BIOL, V17, P1714, DOI 10.1016/j.cub.2007.09.012; HUBEL DH, 1960, J PHYSIOL-LONDON, V154, P572, DOI 10.1113/jphysiol.1960.sp006596; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; KAYAMA Y, 1979, J NEUROPHYSIOL, V42, P1495, DOI 10.1152/jn.1979.42.6.1495; Kim J, 2012, NAT NEUROSCI, V15, P1590, DOI 10.1038/nn.3221; Kim J, 2011, J VISION, V11, DOI 10.1167/11.9.4; Kim J, 2010, J VISION, V10, DOI 10.1167/10.9.3; Kingdom FAA, 2008, VISION RES, V48, P2090, DOI 10.1016/j.visres.2008.03.020; Kingdom FAA, 2011, VISION RES, V51, P652, DOI 10.1016/j.visres.2010.09.012; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Knau H, 2000, J OPT SOC AM A, V17, P1382, DOI 10.1364/JOSAA.17.001382; Logvinenko AD, 2006, PERCEPT PSYCHOPHYS, V68, P76, DOI 10.3758/BF03193657; Logvinenko AD, 2004, J VISION, V4, P1102, DOI 10.1167/4.12.9; Logvinenko AD, 1999, PERCEPTION, V28, P803, DOI 10.1068/p2801; Logvinenko AD, 2011, ATTEN PERCEPT PSYCHO, V73, P1886, DOI 10.3758/s13414-011-0154-2; Logvinenko AD, 2008, PERCEPT PSYCHOPHYS, V70, P828, DOI 10.3758/PP.70.5.828; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Mausfeld R., 2003, COLOUR PERCEPTION MI, P381, DOI 10.1093/acprof:oso/9780198505006.001.0001; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; Odermatt B, 2012, NEURON, V73, P758, DOI 10.1016/j.neuron.2011.12.023; PAPAIOANNOU J, 1972, EXP NEUROL, V34, P558, DOI 10.1016/0014-4886(72)90050-7; Peng XM, 2005, J NEUROPHYSIOL, V93, P1620, DOI 10.1152/jn.00793.2004; Poirier FJAM, 2009, ATTEN PERCEPT PSYCHO, V71, P1353, DOI 10.3758/APP.71.6.1353; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Rudd ME, 2013, J VISION, V13, DOI 10.1167/13.14.18; SCHIRILLO J, 1990, PERCEPT PSYCHOPHYS, V48, P82, DOI 10.3758/BF03205014; Schirillo JA, 1999, J OPT SOC AM A, V16, P793, DOI 10.1364/JOSAA.16.000793; Schirillo JA, 1999, J OPT SOC AM A, V16, P804, DOI 10.1364/JOSAA.16.000804; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Singh M, 2002, PSYCHOL REV, V109, P492, DOI 10.1037//0033-295X.109.3.492; Sinha P., 1993, [1993] Proceedings Fourth International Conference on Computer Vision, P156, DOI 10.1109/ICCV.1993.378224; Tappen MF, 2005, IEEE T PATTERN ANAL, V27, P1459, DOI 10.1109/TPAMI.2005.185; Todorovic D, 2006, SPATIAL VISION, V19, P219, DOI 10.1163/156856806776923407; Vladusich T, 2006, J NEUROPHYSIOL, V95, P2638, DOI 10.1152/jn.01016.2005; Vladusich T, 2014, COLOR RES APPL, V39, P463, DOI 10.1002/col.21823; Vladusich T, 2013, J OPT SOC AM A, V30, P1568, DOI 10.1364/JOSAA.30.001568; Vladusich T, 2013, J OPT SOC AM A, V30, P418, DOI 10.1364/JOSAA.30.000418; Vladusich T, 2013, J VISION, V13, DOI 10.1167/13.1.14; Vladusich T, 2012, VISION RES, V69, P49, DOI 10.1016/j.visres.2012.07.022; Vladusich T, 2007, PLOS COMPUT BIOL, V3, P1849, DOI 10.1371/journal.pcbi.0030179; Xing DJ, 2014, P NATL ACAD SCI USA, V111, P1210, DOI 10.1073/pnas.1314690111; Xing DJ, 2010, J NEUROSCI, V30, P13504, DOI 10.1523/JNEUROSCI.2473-10.2010; Yeh CI, 2009, J NEUROSCI, V29, P11753, DOI 10.1523/JNEUROSCI.1991-09.2009; Zurawel G, 2014, J NEUROSCI, V34, P14388, DOI 10.1523/JNEUROSCI.0848-14.2014	90	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113159	10.1371/journal.pone.0113159	http://dx.doi.org/10.1371/journal.pone.0113159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402466	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000345158700121
J	Allonso, D; Meneses, MDF; Fernandes, CA; Ferreira, DF; Mohana-Borges, R				Allonso, Diego; Meneses, Marcelo D. F.; Fernandes, Carlos A.; Ferreira, Davis F.; Mohana-Borges, Ronaldo			Assessing Positivity and Circulating Levels of NS1 in Samples from a 2012 Dengue Outbreak in Rio de Janeiro, Brazil	PLOS ONE			English	Article							LINKED IMMUNOSORBENT ASSAYS; PROTEIN NS1; PLASMA-LEVELS; SOLUBLE ST2; VIRUS; ANTIGEN; DIAGNOSIS; CORRELATE; DISEASE	Dengue virus (DENV) represents a major threat to public health worldwide. Early DENV diagnosis should not only detect the infection but also identify patients with a higher likelihood to develop severe cases. Previous studies have suggested the potential for NS1 to serve as a viral marker for dengue severity. However, further studies using different sera panels are required to confirm this hypothesis. In this context, we developed a lab-based ELISA to detect and quantitate NS1 protein from the four DENV serotypes and from primary and secondary cases. This approach was used to calculate the circulating NS1 concentration in positive samples. We also tested the NS1 positivity of DENV-positive samples according to the Platelia Dengue NS1 Ag assay. A total of 128 samples were positive for DENV infection and were classified according to the WHO guidelines. The overall NS1 positivity was 68% according to the Platelia assay, whereas all samples were NS1-positive when analyzed with our lab-based ELISA. Fifty-four samples were positive by PCR, revealing a co-circulation of DENV1 and DENV4, and the NS1 positivity for DENV4 samples was lower than that for DENV1. The circulating NS1 concentration ranged from 7 to 284 ng/mL. Our results support previous data indicating the low efficiency of the Platelia assay to detect DENV4 infection. Moreover, this work is the first to analyze NS1 antigenemia using retrospective samples from a Brazilian outbreak.	[Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Meneses, Marcelo D. F.; Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil; [Fernandes, Carlos A.] Lab Cent Noel Nutels LACEN, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.	mohana@biof.ufrj.br	Allonso, Diego/Y-3446-2018; Borges, Ronaldo S Mohana/C-5575-2013; Ferreira, Davis/D-9356-2014	Allonso, Diego/0000-0002-1410-480X; 	Brazilian Funding Agency: Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-INBEB); Brazilian Funding Agency: Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Brazilian Funding Agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian Funding Agency: Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Brazilian Funding Agency: Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-INBEB); Brazilian Funding Agency: Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Brazilian Funding Agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Funding Agency: Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Brazilian Funding Agencies: Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-INBEB), Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Allonso D, 2013, AM J TROP MED HYG, V88, P506, DOI 10.4269/ajtmh.2012.12-0619; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029; [Anonymous], 2008, EVALUATION 2 NEW COM, V2, pe280; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Becerra A, 2008, CYTOKINE, V41, P114, DOI 10.1016/j.cyto.2007.11.001; Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023; Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280; Guerrero CD, 2013, CYTOKINE, V61, P766, DOI 10.1016/j.cyto.2012.12.024; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hober D, 1996, MICROBIOL IMMUNOL, V40, P569, DOI 10.1111/j.1348-0421.1996.tb01110.x; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Lima MDQ, 2011, CLIN VACCINE IMMUNOL, V18, P1031, DOI 10.1128/CVI.00024-11; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x; Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657; Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11; WHO, 2009, WHO TECH REP SER, V958, P1; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000	27	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113634	10.1371/journal.pone.0113634	http://dx.doi.org/10.1371/journal.pone.0113634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412084	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000067
J	Wang, DD; Wang, LL; Zhou, J; Pan, JH; Qian, W; Fu, JF; Zhang, GL; Zhu, YM; Liu, CS; Wang, CL; Jin, ZK; He, ZQ; Wu, JM; Shi, B				Wang, Dandan; Wang, Leilei; Zhou, Jun; Pan, Jihong; Qian, Wei; Fu, Jiafang; Zhang, Genglin; Zhu, Youming; Liu, Chunshan; Wang, Chunliang; Jin, Zongkun; He, Ziqing; Wu, Jianmei; Shi, Bin			Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR; HOMOZYGOUS DELETIONS; CANCER GENOME; LUNG-CANCER; GENE; GLIOBLASTOMA; CANDIDATE; MELANOMA; DISEASE	Background: PTPRD, encoding protein tyrosine phosphatases receptor type D, is located at chromosome 9p23-24.1, a loci frequently lost in many types of tumors. Recently, PTPRD has been proposed to function as a tumor suppressor gene. The current study aimed to investigate PTPRD expression and its prognostic significance in primary gastric adenocarcinoma. Methods and Results: Quantitative real time reverse transcription PCR (qRT-PCR) and western blotting were used to examine PTPRD expression in paired gastric tumourous and paracancerous tissues. Compared with the matched normal gastric mucosa tissues, both the mRNA (P=0.0138) and protein (P=0.0093) expression of PTPRD in fresh surgical specimens were significantly reduced. Clinicopathological and prognostic roles of PTPRD in gastric adenocarcinoma were investigated using immunohistochemistry with 513 paraffin-embedded gastric adenocarcinoma tissue blocks. Statistical analysis revealed that reduced PTPRD expression was significantly associated with T stage (P=0.004), TNM stage (P<0.001) and tumor size (P=0.003). Furthermore, Kaplan-Meier survival analysis revealed that low expression of PTPRD significantly correlated with poor survival of gastric cancer patients (P<0.001). Cox regression analysis confirmed PTPRD expression as independent predictor of the overall survival of gastric cancer patients. The MTT assay determined the effects of PTPRD on cell proliferation of MGC803 and GES1 cell lines. Restoring PTPRD expression in MGC803 cells significantly inhibited their growth rate. Silencing PTPRD expression by siRNA treatment in GES1 significantly enhanced cell proliferation compared with mock siRNA treatment. Methylation analysis of PTPRD promoter CpG island in 3 primary GC samples showed one case with partial methylation. Conclusions: These results indicated that PTPRD is a candidate tumour suppressor in gastric cancer. Thus, PTPRD may play an important role in gastric tumorigenesis and serve as a valuable prognostic marker of gastric adenocarcinoma.	[Wang, Dandan; Pan, Jihong; Fu, Jiafang; Zhang, Genglin; Zhu, Youming; Liu, Chunshan; Wang, Chunliang; Jin, Zongkun; He, Ziqing; Wu, Jianmei; Shi, Bin] Shandong Acad Med Sci, Key Lab Modern Med & Technol Shandong Prov, Key Lab Rare & Uncommon Dis Shandong Prov, Key Lab Biotech Drugs,Minist Hlth,Key Lab Virol S, Jinan, Peoples R China; [Wang, Leilei] Shandong Acad Sci, Inst Biol, Jinan, Peoples R China; [Zhou, Jun] Shandong Univ, Prov Hosp, Dept Oncol, Jinan, Peoples R China; [Qian, Wei] Jinan Mil Command, Gen Hosp, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Qilu University of Technology; Shandong University	Wu, JM (corresponding author), Shandong Acad Med Sci, Key Lab Modern Med & Technol Shandong Prov, Key Lab Rare & Uncommon Dis Shandong Prov, Key Lab Biotech Drugs,Minist Hlth,Key Lab Virol S, Jinan, Peoples R China.	jianmei662004@163.com; sdyky-shibin@163.com			Shandong Science&Development Program [2012GSF12115]; National Natural Science Foundation of China [81273776]	Shandong Science&Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shandong Science&Development Program (No. 2012GSF12115) and National Natural Science Foundation of China (81273776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Calhoun ES, 2006, CANCER RES, V66, P7920, DOI 10.1158/0008-5472.CAN-06-0721; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nakamura M, 2003, CANCER RES, V63, P737; Nobili S, 2011, WORLD J GASTROENTERO, V17, P290, DOI 10.3748/wjg.v17.i3.290; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Purdie KJ, 2007, GENE CHROMOSOME CANC, V46, P661, DOI 10.1002/gcc.20447; Purdie KJ, 2009, J INVEST DERMATOL, V129, P1562, DOI 10.1038/jid.2008.408; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2009, PIGM CELL MELANOMA R, V22, P489, DOI 10.1111/j.1755-148X.2009.00587.x; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Urushibara N, 1998, INT J ONCOL, V12, P603; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	28	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113754	10.1371/journal.pone.0113754	http://dx.doi.org/10.1371/journal.pone.0113754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412184	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000077
J	Burdisso, P; Milia, F; Schapire, AL; Bologna, NG; Palatnik, JF; Rasia, RM				Burdisso, Paula; Milia, Fernando; Schapire, Arnaldo L.; Bologna, Nicolas G.; Palatnik, Javier F.; Rasia, Rodolfo M.			Structural Determinants of Arabidopsis thaliana Hyponastic Leaves 1 Function In Vivo	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; BINDING-PROTEIN; MICRORNA BIOGENESIS; NMR-SPECTROSCOPY; MINOR-GROOVE; PRI-MIRNA; HYL1; DOMAINS; RECOGNITION; DICER	MicroRNAs have turned out to be important regulators of gene expression. These molecules originate from longer transcripts that are processed by ribonuclease III (RNAse III) enzymes. Dicer proteins are essential RNAse III enzymes that are involved in the generation of microRNAs (miRNAs) and other small RNAs. The correct function of Dicer relies on the participation of accessory dsRNA binding proteins, the exact function of which is not well-understood so far. In plants, the double stranded RNA binding protein Hyponastic Leaves 1 (HYL1) helps Dicer Like protein (DCL1) to achieve an efficient and precise excision of the miRNAs from their primary precursors. Here we dissected the regions of HYL1 that are essential for its function in Arabidopsis thaliana plant model. We generated mutant forms of the protein that retain their structure but affect its RNA-binding properties. The mutant versions of HYL1 were studied both in vitro and in vivo, and we were able to identify essential aminoacids/residues for its activity. Remarkably, mutation and even ablation of one of the purportedly main RNA binding determinants does not give rise to any major disturbances in the function of the protein. We studied the function of the mutant forms in vivo, establishing a direct correlation between affinity for the pri-miRNA precursors and protein activity.	[Burdisso, Paula; Milia, Fernando; Schapire, Arnaldo L.; Bologna, Nicolas G.; Palatnik, Javier F.; Rasia, Rodolfo M.] Inst Biol Mol & Celular Rosario, Rosario, Argentina; [Burdisso, Paula; Rasia, Rodolfo M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Area Biofis, RA-2000 Rosario, Argentina; [Schapire, Arnaldo L.] CSIC IRTA UAB UB, Ctr Res Agr Genom, Barcelona, Spain; [Bologna, Nicolas G.] ETH, Swiss Fed Inst Technol, Zurich, Switzerland	National University of Rosario; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rasia, RM (corresponding author), Inst Biol Mol & Celular Rosario, Rosario, Argentina.	rasia@ibr-conicet.gov.ar	Bologna, Nicolas/GPP-6279-2022; Bologna, Nicolas/B-2546-2018	Bologna, Nicolas/0000-0002-2161-7910; Burdisso, Paula/0000-0002-8845-1345; Palatnik, Javier/0000-0001-7996-5224; Rasia, Rodolfo/0000-0003-3940-067X	ANPCyT [PICT 2007-720, 2008-318]; CONICET	ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Grants PICT 2007-720 and 2008-318 from ANPCyT to RMR. PB and ALS are recipients of a fellowship from CONICET. JFP and RMR are members of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Burdisso P, 2012, BIOCHEMISTRY-US, V51, P10159, DOI 10.1021/bi301247r; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Krovat BC, 1996, J BIOL CHEM, V271, P28112, DOI 10.1074/jbc.271.45.28112; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Lee JY, 2004, J BIOL CHEM, V279, P30265, DOI 10.1074/jbc.M312083200; Liu CG, 2012, PLANT PHYSIOL, V159, P748, DOI 10.1104/pp.112.193508; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2007, RNA, V13, P2324, DOI 10.1261/rna.723707; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Rasia RM, 2010, BIOCHEMISTRY-US, V49, P8237, DOI 10.1021/bi100672x; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Tagami Y, 2009, RNA, V15, P450, DOI 10.1261/rna.1297109; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Wostenberg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051829; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006	45	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113243	10.1371/journal.pone.0113243	http://dx.doi.org/10.1371/journal.pone.0113243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409478	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200081
J	Kaneko, T; Ito, H; Sakamoto, H; Onuma, M; Inoue-Murayama, M				Kaneko, Takehito; Ito, Hideyuki; Sakamoto, Hidefusa; Onuma, Manabu; Inoue-Murayama, Miho			Sperm Preservation by Freeze-Drying for the Conservation of Wild Animals	PLOS ONE			English	Article							DRIED MOUSE SPERMATOZOA; LONG-TERM PRESERVATION; INTRACYTOPLASMIC INJECTION; EMBRYOS; OOCYTES; CRYOPROTECTION; ABILITY; MICE	Sperm preservation is a useful technique for the maintenance of biological resources in experimental and domestic animals, and in wild animals. A new preservation method has been developed that enables sperm to be stored for a long time in a refrigerator at 4 degrees C. Sperm are freeze-dried in a solution containing 10 mM Tris and 1 mM EDTA. Using this method, liquid nitrogen is not required for the storage and transportation of sperm. We demonstrate that chimpanzee, giraffe, jaguar, weasel and the long-haired rat sperm remain viable after freeze-drying. In all species, pronuclei were formed after the injection of freeze-dried sperm into the mouse oocytes. Although preliminary, these results may be useful for the future establishment of "freeze-drying zoo'' to conserve wild animals.	[Kaneko, Takehito] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan; [Ito, Hideyuki; Sakamoto, Hidefusa] Kyoto City Zoo, Kyoto, Japan; [Ito, Hideyuki; Sakamoto, Hidefusa; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Onuma, Manabu; Inoue-Murayama, Miho] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Ibaraki, Japan	Kyoto University; Kyoto University; National Institute for Environmental Studies - Japan	Kaneko, T (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan.	tkaneko@anim.med.kyoto-u.ac.jp		Ito, Hideyuki/0000-0002-3502-0074	JSPS [30332878, 25290082]; Wildlife Research Center of Kyoto University	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Wildlife Research Center of Kyoto University	This work was supported in part by a Grant-in-Aid for Scientific Research from JSPS (No. 30332878 and 25290082) and the Cooperation Research Program from Wildlife Research Center of Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Choi YH, 2011, REPRODUCTION, V142, P529, DOI 10.1530/REP-11-0145; Comizzoli P, 2000, REPROD NUTR DEV, V40, P493, DOI 10.1051/rnd:2000113; Dickey RP, 2006, FERTIL STERIL, V86, P732, DOI 10.1016/j.fertnstert.2006.01.035; Kaneko T, 2007, THERIOGENOLOGY, V68, P1017, DOI 10.1016/j.theriogenology.2007.07.017; Kaneko T, 2005, COMPARATIVE MED, V55, P140; Kaneko T, 2003, BIOL REPROD, V68, P136, DOI 10.1095/biolreprod.102.008706; Kaneko T, 2014, LATEST IMPROVEMENTS, P357, DOI [DOI 10.1007/978-1-60327-292-6_21, 10.1007/978-1-60327-292-6_21]; Kaneko T, 2006, CRYOBIOLOGY, V53, P279, DOI 10.1016/j.cryobiol.2006.06.004; Kaneko T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035043; Kaneko T, 2012, CRYOBIOLOGY, V64, P211, DOI 10.1016/j.cryobiol.2012.01.010; Kaneko T, 2009, CRYOBIOLOGY, V58, P293, DOI 10.1016/j.cryobiol.2009.02.004; Keskintepe L, 2002, BIOL REPROD, V67, P409, DOI 10.1095/biolreprod67.2.409; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kishikawa H, 1999, J REPROD FERTIL, V116, P217, DOI 10.1530/jrf.0.1160217; KOSOWER NS, 1992, J ANDROL, V13, P342; Kwon IK, 2004, BIOL REPROD, V71, P1430, DOI 10.1095/biolreprod.104.031260; Lee JD, 1996, HUM REPROD, V11, P1942; Leibo SP, 2002, THERIOGENOLOGY, V57, P303, DOI 10.1016/S0093-691X(01)00673-2; Li MW, 2009, ZYGOTE, V17, P239, DOI 10.1017/S0967199409005292; Liu JL, 2004, BIOL REPROD, V70, P1776, DOI 10.1095/biolreprod.103.025957; Muneto T., 2011, Journal of Mammalian Ova Research, V28, P32, DOI 10.1274/jmor.28.32; Sanchez-Partida LG, 2008, FERTIL STERIL, V89, P742, DOI 10.1016/j.fertnstert.2007.02.066; Ward MA, 2003, BIOL REPROD, V69, P2100, DOI 10.1095/biolreprod.103.020529; Watanabe H, 2010, J ASSIST REPROD GEN, V27, P581, DOI 10.1007/s10815-010-9445-0; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471	27	25	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113381	10.1371/journal.pone.0113381	http://dx.doi.org/10.1371/journal.pone.0113381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409172	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200104
J	Tondervik, A; Sletta, H; Klinkenberg, G; Emanuel, C; Powell, LC; Pritchard, MF; Khan, S; Craine, KM; Onsoyen, E; Rye, PD; Wright, C; Thomas, DW; Hill, KE				Tondervik, Anne; Sletta, Havard; Klinkenberg, Geir; Emanuel, Charlotte; Powell, Lydia C.; Pritchard, Manon F.; Khan, Saira; Craine, Kieron M.; Onsoyen, Edvar; Rye, Phil D.; Wright, Chris; Thomas, David W.; Hill, Katja E.			Alginate Oligosaccharides Inhibit Fungal Cell Growth and Potentiate the Activity of Antifungals against Candida and Aspergillus spp	PLOS ONE			English	Article							AMPHOTERICIN-B; DRUG-RESISTANCE; ESSENTIAL OIL; COMBINATION; ALBICANS; DISEASE; ECHINOCANDINS; TERBINAFINE; SYNERGY; AGENTS	The oligosaccharide OligoG, an alginate derived from seaweed, has been shown to have anti-bacterial and anti-biofilm properties and potentiates the activity of selected antibiotics against multi-drug resistant bacteria. The ability of OligoG to perturb fungal growth and potentiate conventional antifungal agents was evaluated using a range of pathogenic fungal strains. Candida (n = 11) and Aspergillus (n = 3) spp. were tested using germ tube assays, LIVE/DEAD staining, scanning electron microscopy (SEM), atomic force microscopy (AFM) and high-throughput minimum inhibition concentration assays (MICs). In general, the strains tested showed a significant dose-dependent reduction in cell growth at >= 6% OligoG as measured by optical density (OD600;p<0.05). OligoG (>0.5%) also showed a significant inhibitory effect on hyphal growth in germ tube assays, although strain-dependent variations in efficacy were observed (P<0.05). SEM and AFM both showed that OligoG (>= 2%) markedly disrupted fungal biofilm formation, both alone, and in combination with fluconazole. Cell surface roughness was also significantly increased by the combination treatment (P<0.001). High-throughput robotic MIC screening demonstrated the potentiating effects of OligoG (2, 6, 10%) with nystatin, amphotericin B, fluconazole, miconazole, voriconazole or terbinafine with the test strains. Potentiating effects were observed for the Aspergillus strains with all six antifungal agents, with an up to 16-fold (nystatin) reduction in MIC. Similarly, all the Candida spp. showed potentiation with nystatin (up to 16-fold) and fluconazole (up to 8-fold). These findings demonstrate the antifungal properties of OligoG and suggest a potential role in the management of fungal infections and possible reduction of antifungal toxicity.	[Tondervik, Anne; Sletta, Havard; Klinkenberg, Geir] SINTEF Mat & Chem, Dept Bioproc Technol, N-7465 Trondheim, Norway; [Emanuel, Charlotte; Powell, Lydia C.; Pritchard, Manon F.; Khan, Saira; Craine, Kieron M.; Thomas, David W.; Hill, Katja E.] Cardiff Univ, Sch Dent, Adv Therapies Grp, Cardiff CF14 4XY, S Glam, Wales; [Onsoyen, Edvar; Rye, Phil D.] AlgiPharma AS, N-1337 Sandvika, Norway; [Wright, Chris] Swansea Univ, Coll Engn, Ctr NanoHlth, Syst & Proc Engn Ctr, Swansea SA2 8PP, W Glam, Wales	SINTEF; Cardiff University; Swansea University	Sletta, H (corresponding author), SINTEF Mat & Chem, Dept Bioproc Technol, N-7465 Trondheim, Norway.	Havard.Sletta@sintef.no		/0000-0002-8590-0117; Khan, Saira/0000-0002-3284-3198; Rye, Philip/0000-0001-7762-3300; Thomas, David/0000-0001-7319-5820; Pritchard, Manon/0000-0002-5135-4744; Wright, Chris/0000-0003-2375-8159; Powell, Lydia/0000-0002-8641-0160	AlgiPharma AS	AlgiPharma AS	This work was supported by AlgiPharma AS. The funding organization was directly involved in the study design, decision to publish and preparation of the manuscript.	Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896; Ali I, 2011, J MED MICROBIOL, V60, P1326, DOI 10.1099/jmm.0.031906-0; Alves IA, 2012, MYCOPATHOLOGIA, V174, P215, DOI 10.1007/s11046-012-9538-7; Aperis G, 2006, EXPERT OPIN INV DRUG, V15, P1319, DOI 10.1517/13543784.15.11.1319; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x; Bes DF, 2012, ARCH ARGENT PEDIATR, V110, P46, DOI [10.5546/aap.2012.46, 10.1590/S0325-00752012000100010]; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Emri T, 2013, APPL MICROBIOL BIOT, V97, P3267, DOI 10.1007/s00253-013-4761-9; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Fukuda T, 2008, J ANTIBIOT, V61, P550, DOI 10.1038/ja.2008.73; Giordani R, 2006, PHYTOTHER RES, V20, P58, DOI 10.1002/ptr.1803; Giordani R, 2004, PHYTOTHER RES, V18, P990, DOI 10.1002/ptr.1594; Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539; Harris MR, 2010, INT J ANTIMICROB AG, V35, P347, DOI 10.1016/j.ijantimicag.2009.11.021; Institute CaLS, 2005, M100S15 I CALS; Kalkanci A, 2010, CENT EUR J MED, V5, P194, DOI 10.2478/s11536-010-0010-0; Kamysz W, 2006, POL J MICROBIOL, V55, P303; Khan S, 2012, ANTIMICROB AGENTS CH, V56, P5134, DOI 10.1128/AAC.00525-12; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Lagorce A, 2002, EUR J BIOCHEM, V269, P1697, DOI 10.1046/j.1432-1327.2002.02814.x; Lass-Florl C, 2009, MYCOSES, V52, P197, DOI 10.1111/j.1439-0507.2009.01691.x; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Odds FC, 2009, FEMS YEAST RES, V9, P1091, DOI 10.1111/j.1567-1364.2009.00577.x; Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0; Powell LC, 2014, AM J RESP CELL MOL, V50, P483, DOI 10.1165/rcmb.2013-0287OC; Powell LC, 2013, BIOFOULING, V29, P413, DOI 10.1080/08927014.2013.777954; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Ryder NS, 1998, ANTIMICROB AGENTS CH, V42, P1057, DOI 10.1128/AAC.42.5.1057; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Simon J, 2013, MYCOSES, V56, P601, DOI 10.1111/myc.12085; Veiga-Santos P, 2012, INT J ANTIMICROB AG, V40, P61, DOI 10.1016/j.ijantimicag.2012.03.009; Veras HNH, 2011, CURR TOP NUTRACEUT R, V9, P25; Walsh TJ, 2013, HEMATOL-AM SOC HEMAT, P423, DOI 10.1182/asheducation-2013.1.423; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yalcin B, 2010, MIKROBIYOL BUL, V44, P65; Zarember KA, 2009, ANTIMICROB AGENTS CH, V53, P2654, DOI 10.1128/AAC.01547-08; Zeidler U, 2013, J ANTIMICROB CHEMOTH, V68, P1285, DOI 10.1093/jac/dks538	40	53	61	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112518	10.1371/journal.pone.0112518	http://dx.doi.org/10.1371/journal.pone.0112518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409186	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000345533200024
J	Velez-Zuazo, X; Quinones, J; Pacheco, AS; Klinge, L; Paredes, E; Quispe, S; Kelez, S				Velez-Zuazo, Ximena; Quinones, Javier; Pacheco, Aldo S.; Klinge, Luciana; Paredes, Evelyn; Quispe, Sixto; Kelez, Shaleyla			Fast Growing, Healthy and Resident Green Turtles (Chelonia mydas) at Two Neritic Sites in the Central and Northern Coast of Peru: Implications for Conservation	PLOS ONE			English	Article							BAJA-CALIFORNIA; FEEDING ECOLOGY; SOMATIC GROWTH; SEA-TURTLES; SURVIVAL PROBABILITY; BAHIA MAGDALENA; MARINE TURTLES; OCEAN; MIGRATIONS; PATTERNS	In order to enhance protection and conservation strategies for endangered green turtles (Chelonia mydas), the identification of neritic habitats where this species aggregates is mandatory. Herein, we present new information about the population parameters and residence time of two neritic aggregations from 2010 to 2013; one in an upwelling dominated site (Paracas similar to 14 degrees S) and the other in an ecotone zone from upwelling to warm equatorial conditions (El Nuro similar to 4 degrees S) in the Southeast Pacific. We predicted proportionally more adult individuals would occur in the ecotone site; whereas in the site dominated by an upwelling juvenile individuals would predominate. At El Nuro, the population was composed by (15.3%) of juveniles, (74.9%) sub-adults, and (9.8%) adults, with an adult sex ratio of 1.16 males per female. Times of residence in the area ranged between a minimum of 121 and a maximum of 1015 days (mean 331.1 days). At Paracas the population was composed by (72%) of juveniles and (28%) sub-adults, no adults were recorded, thus supporting the development habitat hypothesis stating that throughout the neritic distribution there are sites exclusively occupied by juveniles. Residence time ranged between a minimum of 65 days and a maximum of 680 days (mean 236.1). High growth rates and body condition index values were estimated suggesting healthy individuals at both study sites. The population traits recorded at both sites suggested that conditions found in Peruvian neritic waters may contribute to the recovery of South Pacific green turtles. However, both aggregations are still at jeopardy due to pollution, bycatch and illegal catch and thus require immediate enforcing of conservation measurements.	[Velez-Zuazo, Ximena] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR USA; [Velez-Zuazo, Ximena; Pacheco, Aldo S.; Klinge, Luciana; Kelez, Shaleyla] ecOceanica, Lima, Peru; [Quinones, Javier; Quispe, Sixto] Inst Mar Peru, Lab Costero Pisco, Ica, Peru; [Pacheco, Aldo S.] Univ Antofagasta, CENSOR Lab, Inst Ciencias Nat Alexander von Humboldt, Antofagasta, Chile; [Paredes, Evelyn] Inst Mar Peru, Unidad Invest Depredadores Super, Callao, Peru	University of Puerto Rico; University of Puerto Rico Rio Piedras; Instituto del Mar del Peru; Universidad de Antofagasta; Instituto del Mar del Peru	Quinones, J (corresponding author), Inst Mar Peru, Lab Costero Pisco, Ica, Peru.	javierantonioquinones@gmail.com; shaleyla.kelez@ecoceanica.org	Pacheco, Aldo S/L-9939-2017; Kelez, Shaleyla/AAE-8259-2020; Quinones, Javier/O-7755-2018	Pacheco, Aldo S/0000-0002-2767-6436; Kelez, Shaleyla/0000-0003-3296-8721; Paredes-Coral, Evelyn/0000-0002-9940-3066; Quinones, Javier/0000-0002-6193-8022	PADI Fundation; Idea Wild; Pro Natura Japan; Rufford Small Grants Foundation; Patagonia Footwear through 1% for the Planet; OAK Foundation through Duke Minigrants; Umanotera Foundation through Krilca Gifts; Instituto del Mar del Peru	PADI Fundation; Idea Wild; Pro Natura Japan; Rufford Small Grants Foundation; Patagonia Footwear through 1% for the Planet; OAK Foundation through Duke Minigrants; Umanotera Foundation through Krilca Gifts; Instituto del Mar del Peru	Green turtle research at El Nuro was supported with funds from PADI Fundation, Idea Wild, Pro Natura Japan, Rufford Small Grants Foundation, Patagonia Footwear through 1% for the Planet, OAK Foundation through Duke Minigrants and Umanotera Foundation through Krilca Gifts. The Instituto del Mar del Peru provided funds for sea turtle research at Paracas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro Shigueto Joanna, 2008, Endangered Species Research, V5, P129, DOI 10.3354/esr00142; Alfaro-Shigueto J., 2010, Marine Turtle Newsletter, P19; Alfaro-Shigueto J, 2011, J APPL ECOL, V48, P1432, DOI 10.1111/j.1365-2664.2011.02040.x; Amorocho Diego F., 2007, Endangered Species Research, V3, P43, DOI 10.3354/esr003043; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aranda A. C., 1989, Boletin de Lima, V11, P77; Arthur Karen E., 2009, Marine Turtle Newsletter, P6; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; Bjorndal KA, 2003, MAR ECOL PROG SER, V252, P273, DOI 10.3354/meps252273; BJORNDAL KA, 1988, COPEIA, P555, DOI 10.2307/1445373; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bjorndal KA, 1997, BIOL SEA TURTLES, P137; CARR A, 1980, COPEIA, P366, DOI 10.2307/1444022; CARR A, 1987, Conservation Biology, V1, P103, DOI 10.1111/j.1523-1739.1987.tb00020.x; Carrion J, 2010, J MAR BIOL ASS UK, V90, P1005; Castro J, 2012, LAT AM J AQUAT RES, V40, P970, DOI 10.3856/vol40-issue4-fulltext-13; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; Christianen MJA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2890; de Paz N, 2002, 1 JORN CIENT BAS EC, P125; Echevin V, 2008, PROG OCEANOGR, V79, P167, DOI 10.1016/j.pocean.2008.10.026; Eguchi T, 2012, HERPETOLOGICA, V68, P76, DOI 10.1655/HERPETOLOGICA-D-11-00050.1; Eguchi T, 2010, MAR BIOL, V157, P1869, DOI 10.1007/s00227-010-1458-9; Ehrhart Llewellyn M., 1999, P61; Forsberg Kerstin S., 2012, Marine Turtle Newsletter, P9; Gil-Kodaka P., 2002, JORNADA CIENT FICA B, P154; Hamann Mark, 2006, Endangered Species Research, V2, P81, DOI 10.3354/esr002081; Hays-Brown C, 1982, BIOL CONSERVATION SE, P235; Kelez Shaleyla, 2003, Ecol. apl., V2, P141; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Koch V, 2007, MAR BIOL, V153, P35, DOI 10.1007/s00227-007-0782-1; Krueger BH, 2011, MAR ECOL PROG SER, V432, P269, DOI 10.3354/meps09125; Kubis S, 2009, MAR ECOL PROG SER, V389, P257, DOI 10.3354/meps08206; Lopez-Castro Melania C., 2010, Endangered Species Research, V11, P35, DOI 10.3354/esr00264; Lopez-Mendilaharsu M, 2005, AQUAT CONSERV, V15, P259, DOI 10.1002/aqc.676; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Marquez R, 1990, FAO SPECIES CATALOGU, V125, P1; McMichael E, 2008, J NAT HIST, V42, P2793, DOI 10.1080/00222930802357335; Meylan PA, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/357.1; Mianzan Hermes W., 1999, P513; MORTIMER JA, 1981, BIOTROPICA, V13, P49, DOI 10.2307/2387870; Munoz Perez JP, 2009, THESIS U SAN FRANCIS; Musick John A., 1997, P137; NMFS, 1998, REC PLAN E PAC GREEN; Paredes R, 1969, THESIS U NACL FEDERI; Patricio AR, 2011, MAR ECOL PROG SER, V440, P217, DOI 10.3354/meps09337; Patricio R, 2014, ENDANGER SPECIES RES, V23, P51, DOI 10.3354/esr00554; Quinones J, 2008, INFORME INSTITUTO MA, V35, P221; Quinones J, 2010, DEV HYDROBIOL, V212, P69, DOI 10.1007/s10750-010-0225-8; Riascos JM, 2013, J MAR BIOL ASSOC UK, V93, P919, DOI 10.1017/S002531541200094X; Rosales Carlos A., 2010, Rev. peru biol., V17, P293; Santillan LA, 2008, THESIS U NACL AGRARI; Seminoff JA, 2003, J MAR BIOL ASSOC UK, V83, P1355, DOI 10.1017/S0025315403008816; Seminoff JA, 2002, J HERPETOL, V36, P447, DOI 10.2307/1566189; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Senko J, 2010, J EXP MAR BIOL ECOL, V391, P92, DOI 10.1016/j.jembe.2010.06.017; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sterling EJ, 2013, CHELONIAN CONSERV BI, V12, P2, DOI 10.2744/CCB-1014.1; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Taquet C, 2006, MAR ECOL PROG SER, V306, P295, DOI 10.3354/meps306295; Wabnitz CCC, 2010, MAR ECOL PROG SER, V420, P27, DOI 10.3354/meps08846; Wallace BP, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00388.1; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Wester J, 2010, THESIS LEIDEN U NEDE	63	26	27	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113068	10.1371/journal.pone.0113068	http://dx.doi.org/10.1371/journal.pone.0113068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409240	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200064
J	Jin, H; Mimura, N; Kashio, M; Koseki, H; Aoe, T				Jin, Hisayo; Mimura, Naoya; Kashio, Makiko; Koseki, Haruhiko; Aoe, Tomohiko			Late-Onset of Spinal Neurodegeneration in Knock-In Mice Expressing a Mutant BiP	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; KDEL RECEPTOR; ER STRESS; REELIN; MOUSE; DISEASE; GLYCOPROTEIN; DYSFUNCTION	Most human neurodegenerative diseases are sporadic, and appear later in life. While the underlying mechanisms of the progression of those diseases are still unclear, investigations into the familial forms of comparable diseases suggest that endoplasmic reticulum (ER) stress is involved in the pathogenesis. Binding immunoglobulin protein (BiP) is an ER chaperone that is central to ER function. We produced knock-in mice expressing a mutant BiP that lacked the retrieval sequence in order to evaluate the effect of a functional defect in an ER chaperone in multi-cellular organisms. Here we report that heterozygous mutant BiP mice revealed motor disabilities in aging. We found a degeneration of some motoneurons in the spinal cord accompanied by accumulations of ubiquitinated proteins. The defect in retrieval of BiP by the KDEL receptor leads to impaired activities in quality control and autophagy, suggesting that functional defects in the ER chaperones may contribute to the late onset of neurodegenerative diseases.	[Jin, Hisayo; Kashio, Makiko; Aoe, Tomohiko] Chiba Univ, Dept Anesthesiol, Grad Sch Med, Chiba, Japan; [Mimura, Naoya] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Koseki, Haruhiko] RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Aoe, Tomohiko] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Anesthesiol, Chiba, Japan	Chiba University; Chiba University; RIKEN; Tokyo Women's Medical University	Aoe, T (corresponding author), Chiba Univ, Dept Anesthesiol, Grad Sch Med, Chiba, Japan.	taoe@faculty.chiba-u.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854	Ministry of Education, Culture, Sports, Science and Technology of Japan [20059008]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aids for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.A. (20059008, http://www.mext.go.jp/english/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; BEH CT, 1995, P NATL ACAD SCI USA, V92, P9820, DOI 10.1073/pnas.92.21.9820; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dobashi T, 2010, J CELL MOL MED, V14, P2816, DOI 10.1111/j.1582-4934.2009.00932.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fatemi SH, 2005, MOL PSYCHIATR, V10, P251, DOI 10.1038/sj.mp.4001613; Gorbatyuk MS., 2013, J GENET SYNDR GENE T, V4; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Mimura N, 2007, CELL DEATH DIFFER, V14, P1475, DOI 10.1038/sj.cdd.4402151; Mimura N, 2008, MOL CELL BIOL, V28, P293, DOI 10.1128/MCB.00473-07; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Wang P, 2011, NEUROSCIENCE, V190, P43, DOI 10.1016/j.neuroscience.2011.06.008; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	30	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112837	10.1371/journal.pone.0112837	http://dx.doi.org/10.1371/journal.pone.0112837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405877	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300056
J	Laur, J; Hacke, UG				Laur, Joan; Hacke, Uwe G.			The Role of Water Channel Proteins in Facilitating Recovery of Leaf Hydraulic Conductance from Water Stress in Populus trichocarpa	PLOS ONE			English	Article							DROUGHT STRESS; PLASMA-MEMBRANE; AQUAPORIN EXPRESSION; GENE-EXPRESSION; XYLEM EMBOLISM; VULNERABILITY; PLANT; TRANSPORT; RICE; DEHYDRATION	Gas exchange is constrained by the whole-plant hydraulic conductance (K-plant). Leaves account for an important fraction of Kplant and may therefore represent a major determinant of plant productivity. Leaf hydraulic conductance (K-leaf) decreases with increasing water stress, which is due to xylem embolism in leaf veins and/or the properties of the extra-xylary pathway. Water flow through living tissues is facilitated and regulated by water channel proteins called aquaporins (AQPs). Here we assessed changes in the hydraulic conductance of Populus trichocarpa leaves during a dehydration-rewatering episode. While leaves were highly sensitive to drought, K-leaf recovered only 2 hours after plants were rewatered. Recovery of K-leaf was absent when excised leaves were bench-dried and subsequently xylem-perfused with a solution containing AQP inhibitors. We examined the expression patterns of 12 highly expressed AQP genes during a dehydration-rehydration episode to identify isoforms that may be involved in leaf hydraulic adjustments. Among the AQPs tested, several genes encoding tonoplast intrinsic proteins (TIPs) showed large increases in expression in rehydrated leaves, suggesting that TIPs contribute to reversing drought-induced reductions in K-leaf. TIPs were localized in xylem parenchyma, consistent with a role in facilitating water exchange between xylem vessels and adjacent living cells. Dye uptake experiments suggested that reversible embolism formation in minor leaf veins contributed to the observed changes in K-leaf.	[Laur, Joan; Hacke, Uwe G.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Laur, J (corresponding author), Univ Alberta, Dept Renewable Resources, 442 Earth Sci Bldg, Edmonton, AB, Canada.	laur@ualberta.ca	Hacke, Uwe/M-7719-2015; laur, joan/M-5727-2017	Hacke, Uwe/0000-0001-5983-3582; laur, joan/0000-0001-6759-6484	Natural Sciences and Engineering Research Council (NSERC) Discovery grant; Canada Foundation for Innovation; Canada Research Chair program	Natural Sciences and Engineering Research Council (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair program(Canada Research Chairs)	U. G. H. acknowledges funding from a Natural Sciences and Engineering Research Council (NSERC) Discovery grant, the Canada Foundation for Innovation and the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Almeida-Rodriguez AM, 2010, PHYSIOL PLANTARUM, V140, P321, DOI 10.1111/j.1399-3054.2010.01405.x; Almeida-Rodriguez AM, 2012, AM J BOT, V99, P1249, DOI 10.3732/ajb.1200088; Almeida-Rodriguez AM, 2011, PLANT CELL ENVIRON, V34, P1318, DOI 10.1111/j.1365-3040.2011.02331.x; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Barrieu F, 1998, PLANT PHYSIOL, V117, P1153, DOI 10.1104/pp.117.4.1153; Brodribb TJ, 2005, PLANT PHYSIOL, V137, P1139, DOI 10.1104/pp.104.058156; Brodribb TJ, 2004, NEW PHYTOL, V162, P663, DOI 10.1111/j.1469-8137.2004.01060.x; Brodribb TJ, 2003, PLANT CELL ENVIRON, V26, P443, DOI 10.1046/j.1365-3040.2003.00975.x; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Chitarra W, 2014, PLANTA, V239, P887, DOI 10.1007/s00425-013-2017-7; Christman MA, 2012, NEW PHYTOL, V193, P713, DOI 10.1111/j.1469-8137.2011.03984.x; Cohen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055506; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Gong HQ, 2006, PLANT MOL BIOL REP, V24, P93, DOI 10.1007/BF02914049; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Guyot G, 2012, PLANT CELL ENVIRON, V35, P857, DOI 10.1111/j.1365-3040.2011.02458.x; Hacke UG, 2000, OECOLOGIA, V124, P495, DOI 10.1007/PL00008875; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Jang HY, 2013, J PLANT PHYSIOL, V170, P1028, DOI 10.1016/j.jplph.2013.03.001; Johnson DM, 2011, TREE PHYSIOL, V31, P659, DOI 10.1093/treephys/tpr050; Johnson DM, 2012, PLANT CELL ENVIRON, V35, P760, DOI 10.1111/j.1365-3040.2011.02449.x; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; Kirch HH, 2000, PLANT PHYSIOL, V123, P111, DOI 10.1104/pp.123.1.111; LARSON P R, 1971, Canadian Journal of Forest Research, V1, P1, DOI 10.1139/x71-001; Laur J, 2014, NEW PHYTOL, V203, P388, DOI 10.1111/nph.12806; Laur J, 2013, J EXP BOT, V64, P2283, DOI 10.1093/jxb/ert096; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martorell S, 2014, PLANT CELL ENVIRON, V37, P617, DOI 10.1111/pce.12182; Martre P, 2002, PLANT PHYSIOL, V130, P2101, DOI 10.1104/pp.009019; Mayr S, 2014, PLANT PHYSIOL, V164, P1731, DOI 10.1104/pp.114.236646; Nardini A, 2003, TREES-STRUCT FUNCT, V17, P529, DOI 10.1007/s00468-003-0265-z; Nardini A, 2014, FUNCT ECOL, V28, P810, DOI 10.1111/1365-2435.12246; Nardini A, 2011, PLANT SCI, V180, P604, DOI 10.1016/j.plantsci.2010.12.011; North GB, 2004, PLANT CELL ENVIRON, V27, P219, DOI 10.1111/j.1365-3040.2003.01137.x; Pavy N, 2008, NEW PHYTOL, V180, P766, DOI 10.1111/j.1469-8137.2008.02615.x; PEZESHKI SR, 1982, CAN J FOREST RES, V12, P761, DOI 10.1139/x82-115; Postaire O, 2010, PLANT PHYSIOL, V152, P1418, DOI 10.1104/pp.109.145326; Pou A, 2013, PLANT CELL ENVIRON, V36, P828, DOI 10.1111/pce.12019; Prado K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00255; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; SACK L, 2012, JOVE-J VIS EXP, P1, DOI DOI 10.3791/4179; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Sakurai J, 2008, PLANT CELL PHYSIOL, V49, P30, DOI 10.1093/pcp/pcm162; SCHULTE PJ, 1987, PLANT CELL ENVIRON, V10, P313, DOI 10.1111/j.1365-3040.1987.tb01611.x; Scoffoni C, 2014, PLANT PHYSIOL, V164, P1772, DOI 10.1104/pp.113.221424; Scoffoni C, 2012, J EXP BOT, V63, P643, DOI 10.1093/jxb/err270; Secchi F, 2007, ANN APPL BIOL, V150, P163, DOI 10.1111/j.1744-7348.2007.00118.x; Secchi F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00507; Secchi F, 2010, PLANT CELL ENVIRON, V33, P1285, DOI 10.1111/j.1365-3040.2010.02147.x; Shatil-Cohen A, 2011, PLANT J, V67, P72, DOI 10.1111/j.1365-313X.2011.04576.x; Sparks JP, 1999, TREE PHYSIOL, V19, P453; Sperry JS, 2002, PLANT CELL ENVIRON, V25, P251, DOI 10.1046/j.0016-8025.2001.00799.x; Stiller V, 2003, PLANT PHYSIOL, V132, P1698, DOI 10.1104/pp.102.019851; Stiller V, 2005, AM J BOT, V92, P1970, DOI 10.3732/ajb.92.12.1970; Trifilo P, 2003, J EXP BOT, V54, P2323, DOI 10.1093/jxb/erg259; TYREE MT, 1988, PLANT PHYSIOL, V88, P574, DOI 10.1104/pp.88.3.574; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yamada S, 2000, PLANT CELL PHYSIOL, V41, P719, DOI 10.1093/pcp/41.6.719	64	33	35	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111751	10.1371/journal.pone.0111751	http://dx.doi.org/10.1371/journal.pone.0111751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406088	gold, Green Submitted, Green Published			2022-12-27	WOS:000347121300016
J	Mohideen, AMSH; Hyde, A; Squires, J; Wang, J; Dicks, E; Younghusband, B; Parfrey, P; Green, R; Savas, S				Mohideen, Asan M. S. Haja; Hyde, Angela; Squires, Jessica; Wang, Jing; Dicks, Elizabeth; Younghusband, Ban; Parfrey, Patrick; Green, Roger; Savas, Sevtap			Examining the Polymorphisms in the Hypoxia Pathway Genes in Relation to Outcome in Colorectal Cancer	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; LYSYL OXIDASE; IMPACT	Introduction: Colorectal cancer is a common malignancy. Identification of genetic prognostic markers may help prognostic estimations in colorectal cancer. Genes that regulate response to hypoxia and other genes that are regulated under the hypoxic conditions have been shown to play roles in cancer progression. In this study, we hypothesized that genetic variations in the hypoxia pathway genes were associated with the risk of outcome in colorectal cancer patients. Methods: This study was performed in two phases. In the first phase, 49 SNPs from six hypoxia pathway genes (HIF1A, HIF1B, HIF2A, LOX, MIF and CXCL12) in 272 colorectal cancer patients were analyzed. In the second phase, 77 SNPs from seven hypoxia pathway genes (HIF1A, HIF1B, HIF2A, HIF2B, HIF3A, LOX and CXCL12) were analyzed in an additional cohort of 535 patients. Kaplan Meier, Cox univariate and multivariable regression analyses were performed to analyze the relationship between the SNPs and overall survival (OS), disease free survival (DFS) or disease specific survival (DSS). Since this was a hypothesis-generating study, no correction for multiple testing was applied. Results: In phase I, one SNP (HIF2A rs11125070) was found to be associated with DFS in multivariable analysis; yet association of a proxy polymorphism (HIF2A rs4953342) was not detected in the phase II patient cohort. In phase II, associations of two SNPs (HIF2A rs4953352 and HIF2B rs12593988) were significant in both OS and DFS multivariable analyses. However, association of HIF2A rs4953352 was not replicated in the phase I cohort using a proxy SNP (HIF2A rs6706003). Conclusion: Overall, our study did not find a convincing evidence of association of the investigated polymorphisms with the disease outcomes in colorectal cancer.	[Mohideen, Asan M. S. Haja; Hyde, Angela; Squires, Jessica; Younghusband, Ban; Green, Roger; Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Wang, Jing] Mem Univ Newfoundland, Fac Med, Div Community Hlth & Humanities, St John, NF, Canada; [Dicks, Elizabeth; Parfrey, Patrick] Mem Univ Newfoundland, Fac Med, Clin Epidemiol Unit, St John, NF, Canada; [Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Oncol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Savas, S (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.	savas@mun.ca			Research and Development Corporation of Newfoundland (RDC; Ignite fund) [5404.1201.101]; Research and Development Corporation of Newfoundland (RDC; leverage fund) [5404.1201.102]; Canadian Institute of Health Research (CIHR) operating fund [FRN: 110045]; Medical Research Foundation (MRF)-Cox Award; CIHR fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University; National Cancer Institute of Canada [18223, 18226]; Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; Walter and Jessie Boyd & Charles Scriver MD/PhD Studentship Award (Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation)	Research and Development Corporation of Newfoundland (RDC; Ignite fund); Research and Development Corporation of Newfoundland (RDC; leverage fund); Canadian Institute of Health Research (CIHR) operating fund(Canadian Institutes of Health Research (CIHR)); Medical Research Foundation (MRF)-Cox Award; CIHR fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; Walter and Jessie Boyd & Charles Scriver MD/PhD Studentship Award (Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation)	This study was supported by the Research and Development Corporation of Newfoundland (RDC; Ignite fund to SS: contract number: 5404.1201.101 and leverage fund to SS, RG, PP: contract number: 5404.1201.102), the Canadian Institute of Health Research (CIHR) operating fund (to SS, RG, PP; FRN: 110045), the Medical Research Foundation (MRF)-Cox Award 2010 (to SS and RG), CIHR fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University, the National Cancer Institute of Canada (grants 18223 and 18226) and the Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics. Angela Hyde was supported by the Walter and Jessie Boyd & Charles Scriver MD/PhD Studentship Award (Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Beerlage C, 2013, INFECT IMMUN, V81, P2562, DOI 10.1128/IAI.00302-13; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chang SC, 2009, ANN SURG ONCOL, V16, P2323, DOI 10.1245/s10434-009-0501-x; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gerger A, 2011, CLIN CANCER RES, V17, P5783, DOI 10.1158/1078-0432.CCR-11-1115; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Hidalgo-Pascual M, 2007, ONCOL REP, V18, P1583; Negandhi AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061469; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Santiago B, 2011, CYTOKINE, V53, P184, DOI 10.1016/j.cyto.2010.06.006; Savas S, 2010, HUM MUTAT, V31, P901, DOI 10.1002/humu.21285; Szkandera J, 2010, ANTICANCER RES, V30, P2393; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Woods MO, 2010, GUT, V59, P1369, DOI 10.1136/gut.2010.208462; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135	20	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113513	10.1371/journal.pone.0113513	http://dx.doi.org/10.1371/journal.pone.0113513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405996	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000347121300120
J	Valcz, G; Patai, AV; Kalmar, A; Peterfia, B; Furi, I; Wichmann, B; Muzes, G; Sipos, F; Krenacs, T; Mihaly, E; Spisak, S; Molnar, B; Tulassay, Z				Valcz, Gabor; Patai, Arpad V.; Kalmar, Alexandra; Peterfia, Balint; Furi, Istvan; Wichmann, Barnabas; Muzes, Gyoergyi; Sipos, Ferenc; Krenacs, Tibor; Mihaly, Emese; Spisak, Sandor; Molnar, Bela; Tulassay, Zsolt			Myofibroblast-Derived SFRP1 as Potential Inhibitor of Colorectal Carcinoma Field Effect	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; WNT SIGNALING PATHWAY; BETA-CATENIN; COLON-CANCER; PROMOTER METHYLATION; WNT/BETA-CATENIN; GENES; EXPRESSION; CELLS; BINDS	Epigenetic changes of stromal-epithelial interactions are of key importance in the regulation of colorectal carcinoma (CRC) cells and morphologically normal, but genetically and epigenetically altered epithelium in normal adjacent tumor (NAT) areas. Here we demonstrated retained protein expression of well-known Wnt inhibitor, secreted frizzled-related protein 1 (SFRP1) in stromal myofibroblasts and decreasing epithelial expression from NAT tissues towards the tumor. SFRP1 was unmethylated in laser microdissected myofibroblasts and partially hypermethylated in epithelial cells in these areas. In contrast, we found epigenetically silenced myofibroblast-derived SFRP1 in CRC stroma. Our results suggest that the myofibroblast-derived SFRP1 protein might be a paracrine inhibitor of epithelial proliferation in NAT areas and loss of this signal may support tumor proliferation in CRC.	[Valcz, Gabor; Wichmann, Barnabas; Molnar, Bela; Tulassay, Zsolt] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Patai, Arpad V.; Kalmar, Alexandra; Peterfia, Balint; Furi, Istvan; Muzes, Gyoergyi; Sipos, Ferenc; Mihaly, Emese; Molnar, Bela; Tulassay, Zsolt] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Spisak, Sandor] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Patai, AV (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	arpad.patai@gmail.com	Sipos, Ferenc/GYV-6182-2022		National Office for Research and Technology, Hungary [TECH08-AI/2-2008_0114]	National Office for Research and Technology, Hungary(National Office for Research and Technology)	This study was supported in part by the National Office for Research and Technology, Hungary, Grant number: TECH08-AI/2-2008_0114. Funder's website:www.magzrt.hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no other funding to this study.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bernstein C, 2008, CANCER LETT, V260, P1, DOI 10.1016/j.canlet.2007.11.027; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Di Domenico M, 2011, CANCER BIOL THER, V12, P447, DOI 10.4161/cbt.12.5.15963; Galamb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048547; Ge L, 2010, MED HYPOTHESES, V75, P26, DOI 10.1016/j.mehy.2010.01.019; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Patai AV, 2012, DIGEST DIS, V30, P310, DOI 10.1159/000337004; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Rubin JS, 2006, FRONT BIOSCI, V11, P2093, DOI 10.2741/1952; Saini S, 2009, CANCER RES, V69, P6815, DOI 10.1158/0008-5472.CAN-09-1254; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Shtilbans V, 2013, CANCER MICROENVIRON, V6, P193, DOI 10.1007/s12307-013-0131-5; Spisak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046215; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tanaka J, 2008, HEPATO-GASTROENTEROL, V55, P1265; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Trujillo KA, 2011, INT J CANCER, V129, P1310, DOI 10.1002/ijc.25788; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	45	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e106143	10.1371/journal.pone.0106143	http://dx.doi.org/10.1371/journal.pone.0106143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405986	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300001
J	Vinit, S; Keomani, E; Deramaudt, TB; Spruance, VM; Bezdudnaya, T; Lane, MA; Bonay, M; Petitjean, M				Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Spruance, Victoria M.; Bezdudnaya, Tatiana; Lane, Michael A.; Bonay, Marcel; Petitjean, Michel			Interdisciplinary Approaches of Transcranial Magnetic Stimulation Applied to a Respiratory Neuronal Circuitry Model	PLOS ONE			English	Article							MOTOR EVOKED-POTENTIALS; COIL ORIENTATION; SPINAL-CORD; CORTICAL REPRESENTATION; PHRENIC MOTONEURONS; BRAIN-STIMULATION; HUMAN DIAPHRAGM; RAT; CORTEX; NERVE	Respiratory related diseases associated with the neuronal control of breathing represent life-threatening issues and to date, no effective therapeutics are available to enhance the impaired function. The aim of this study was to determine whether a preclinical respiratory model could be used for further studies to develop a non-invasive therapeutic tool applied to rat diaphragmatic neuronal circuitry. Transcranial magnetic stimulation (TMS) was performed on adult male Sprague-Dawley rats using a human figure-of-eight coil. The largest diaphragmatic motor evoked potentials (MEPdia) were recorded when the center of the coil was positioned 6 mm caudal from Bregma, involving a stimulation of respiratory supraspinal pathways. Magnetic shielding of the coil with mu metal reduced magnetic field intensities and improved focality with increased motor threshold and lower amplitude recruitment curve. Moreover, transynaptic neuroanatomical tracing with pseudorabies virus (applied to the diaphragm) suggest that connections exist between the motor cortex, the periaqueductal grey cell regions, several brainstem neurons and spinal phrenic motoneurons (distributed in the C3-4 spinal cord). These results reveal the anatomical substrate through which supraspinal stimulation can convey descending action potential volleys to the spinal motoneurons (directly or indirectly). We conclude that MEPdia following a single pulse of TMS can be successfully recorded in the rat and may be used in the assessment of respiratory supraspinal plasticity. Supraspinal non-invasive stimulations aimed to neuromodulate respiratory circuitry will enable new avenues of research into neuroplasticity and the development of therapies for respiratory dysfunction associated with neural injury and disease (e.g. spinal cord injury, amyotrophic lateral sclerosis).	[Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Bonay, Marcel; Petitjean, Michel] Univ Versailles St Quentin En Yvelines, Unite End Icap, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France; [Deramaudt, Therese B.; Bonay, Marcel] CSM, LIA BAHN, Monaco, Monaco; [Spruance, Victoria M.; Bezdudnaya, Tatiana; Lane, Michael A.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Bonay, Marcel; Petitjean, Michel] Hop Ambroise Pare, AP HP, Serv Physiol Explorat Fonct, Grp Hosp Paris Ile de France Ouest, Boulogne, France	UDICE-French Research Universities; Universite Paris Saclay; Drexel University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Petitjean, M (corresponding author), Univ Versailles St Quentin En Yvelines, Unite End Icap, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France.	michel.petitjean134@gmail.com	Lane, Michael/B-3395-2014; Bonay, Marcel/ABG-2039-2020	Lane, Michael/0000-0003-1375-6483; Bonay, Marcel/0000-0003-1446-7456; vinit, stephane/0000-0001-7013-1741	European Union Seventh framework Programme (FP7) (European project RBUCE-UP) [246556]; internal funds	European Union Seventh framework Programme (FP7) (European project RBUCE-UP); internal funds	This work was supported by funding from the European Union Seventh framework Programme (FP7/2007-2013) under grant agreement No. 246556 (European project RBUCE-UP), HandiMedEx allocated by the French Public Investment Board, the Chancellerie des Universites de Paris (Legs Poix), the << Centre d'Assistance Respiratoire a Domicile d'Ile de France (CARDIF) >>, the << Fonds de Dotation de Recherche en Sante Respiratoire >> and LVL Medical. Financial support for neuroanatomical studies was provided through internal funds awarded to Michael Lane at Drexel University - College of Medicine, Department of Neurobiology & Anatomy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov VG, 2007, J PHYSIOL PHARMACOL, V58, P17; Azabou E, 2013, RESP PHYSIOL NEUROBI, V189, P183, DOI 10.1016/j.resp.2013.07.024; Bader SR, 2011, J NEUROSCI METH, V194, P342, DOI 10.1016/j.jneumeth.2010.11.002; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; CROS D, 1990, MUSCLE NERVE, V13, P1076, DOI 10.1002/mus.880131110; Davey NJ, 1996, RESP PHYSIOL, V106, P127, DOI 10.1016/S0034-5687(96)00069-2; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; Dubach P, 2004, CLIN NEUROPHYSIOL, V115, P862, DOI 10.1016/j.clinph.2003.11.033; FISHBACK AS, 1995, NEUROSURGERY, V37, P969, DOI 10.1227/00006123-199511000-00017; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109, DOI 10.1113/jphysiol.1987.sp016445; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Hunanyan AS, 2012, J NEUROPHYSIOL, V107, P3027, DOI 10.1152/jn.00015.2012; Huxtable AG, 2011, RESP PHYSIOL NEUROBI, V178, P482, DOI 10.1016/j.resp.2011.06.017; Kamida T, 1998, MUSCLE NERVE, V21, P722, DOI 10.1002/(SICI)1097-4598(199806)21:6<722::AID-MUS3>3.0.CO;2-9; Khedr EM, 2001, EUR J APPL PHYSIOL, V85, P560, DOI 10.1007/s004210100504; Kolb B.E., 1990, CEREBRAL CORTEX RAT; Lane MA, 2008, TRENDS NEUROSCI, V31, P538, DOI 10.1016/j.tins.2008.07.002; Lane MA, 2008, J COMP NEUROL, V511, P692, DOI 10.1002/cne.21864; Lane MA, 2009, RESP PHYSIOL NEUROBI, V169, P123, DOI 10.1016/j.resp.2009.08.007; Laviolette L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062258; Linden RD, 1999, J NEUROSURG, V91, P205, DOI 10.3171/spi.1999.91.2.0205; LIPSKI J, 1986, EXP BRAIN RES, V61, P280; LISSENS MA, 1994, J NEUROL SCI, V124, P204, DOI 10.1016/0022-510X(94)90327-1; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Maccabee PJ, 1998, J PHYSIOL-LONDON, V513, P571, DOI 10.1111/j.1469-7793.1998.571bb.x; MACEFIELD G, 1991, J PHYSIOL-LONDON, V439, P545, DOI 10.1113/jphysiol.1991.sp018681; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Muller PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091065; Nakatoh S, 1998, MUSCLE NERVE, V21, P1172, DOI 10.1002/(SICI)1097-4598(199809)21:9<1172::AID-MUS8>3.0.CO;2-4; Ni Z, 2011, J NEUROPHYSIOL, V105, P749, DOI 10.1152/jn.00640.2010; Niehaus L, 2000, CLIN NEUROPHYSIOL, V111, P75, DOI 10.1016/S1388-2457(99)00198-4; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PLANCHE D, 1972, J PHYSIOL-PARIS, V64, P31; Raux M, 2010, J APPL PHYSIOL, V108, P39, DOI 10.1152/japplphysiol.91454.2008; Rotenberg A, 2010, CLIN NEUROPHYSIOL, V121, P104, DOI 10.1016/j.clinph.2009.09.008; Sharshar T, 2003, AM J RESP CRIT CARE, V168, P760, DOI 10.1164/rccm.200203-241OC; Sharshar T, 2003, J APPL PHYSIOL, V95, P26, DOI 10.1152/japplphysiol.00918.2002; Subramanian HH, 2013, J COMP NEUROL, V521, P3083, DOI 10.1002/cne.23334; Vinit S, 2011, RESP PHYSIOL NEUROBI, V176, P130, DOI 10.1016/j.resp.2011.02.008; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Zifko U, 1996, MUSCLE NERVE, V19, P614, DOI 10.1002/(SICI)1097-4598(199605)19:5<614::AID-MUS9>3.0.CO;2-E	43	17	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113251	10.1371/journal.pone.0113251	http://dx.doi.org/10.1371/journal.pone.0113251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406091	Green Published, gold			2022-12-27	WOS:000347121300093
J	Bruch, J; Xu, H; De Andrade, A; Hoglinger, G				Bruch, Julius; Xu, Hong; De Andrade, Anderson; Hoeglinger, Guenter			Mitochondrial Complex 1 Inhibition Increases 4-Repeat Isoform Tau by SRSF2 Upregulation	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; I INHIBITOR; PHOSPHORYLATION; TAUOPATHIES; ANNONACIN; NEURONS; DEGENERATION; DYSFUNCTION; DISEASE; BRAIN	Progressive Supranuclear Palsy (PSP) is a neurodegenerative disorder characterised by intracellular aggregation of the microtubule-associated protein tau. The tau protein exists in 6 predominant isoforms. Depending on alternative splicing of exon 10, three of these isoforms have four microtubule-binding repeat domains (4R), whilst the others only have three (3R). In PSP there is an excess of the 4R tau isoforms, which are thought to contribute significantly to the pathological process. The cause of this 4R increase is so far unknown. Several lines of evidence link mitochondrial complex I inhibition to the pathogenesis of PSP. We demonstrate here for the first time that annonacin and MPP+, two prototypical mitochondrial complex I inhibitors, increase the 4R isoforms of tau in human neurons. We show that the splicing factor SRSF2 is necessary to increase 4R tau with complex I inhibition. We also found SRSF2, as well as another tau splicing factor, TRA2B, to be increased in brains of PSP patients. Thereby, we provide new evidence that mitochondrial complex I inhibition may contribute as an upstream event to the pathogenesis of PSP and suggest that splicing factors may represent an attractive therapeutic target to intervene in the disease process.	[Bruch, Julius; Xu, Hong; De Andrade, Anderson; Hoeglinger, Guenter] German Ctr Neurodegenerat Dis DZNE, Dept Translat Neurodegenerat, Munich, Germany; [Bruch, Julius; Xu, Hong; Hoeglinger, Guenter] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich	Hoglinger, G (corresponding author), German Ctr Neurodegenerat Dis DZNE, Dept Translat Neurodegenerat, Munich, Germany.	hoeglinger@lrz.tum.de	Höglinger, Günter U/F-2388-2015; Xu, Hong/AAP-6568-2020	Höglinger, Günter U/0000-0001-7587-6187; 	Bavarian Research Foundation (Bayerische Forschungsstiftung); DAAD ( German Academic Exchange Service); DFG (Deutsche Forschungsgemeinschaft) [HO2402/6-2]	Bavarian Research Foundation (Bayerische Forschungsstiftung); DAAD ( German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	J.B. was funded by the Bavarian Research Foundation (Bayerische Forschungsstiftung), H. X. by the DAAD ( German Academic Exchange Service), G. U. H. by the DFG (Deutsche Forschungsgemeinschaft, HO2402/6-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers DS, 2001, EXP NEUROL, V168, P196, DOI 10.1006/exnr.2000.7607; Avale ME, 2013, HUM MOL GENET, V22, P2603, DOI 10.1093/hmg/ddt108; Buee L, 1999, BRAIN PATHOL, V9, P681; Chambers CB, 1999, ANN NEUROL, V46, P325, DOI 10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V; Chen SF, 2010, J ALZHEIMERS DIS, V22, P1313, DOI 10.3233/JAD-2010-101155; Edmond V, 2011, CELL CYCLE, V10, P1968, DOI 10.4161/cc.10.12.15825; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; Glinka Y, 1997, J NEURAL TRANSM-SUPP, P55; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Lannuzel A, 2003, NEUROSCIENCE, V121, P287, DOI 10.1016/S0306-4522(03)00441-X; Lannuzel A, 2007, BRAIN, V130, P816, DOI 10.1093/brain/awl347; Lenaz Giorgio, 2006, Ital J Biochem, V55, P232; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Pilch B, 2001, CANCER RES, V61, P6876; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; SILVER IA, 1994, J NEUROSCI, V14, P5068; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stamelou M, 2010, BRAIN, V133, P1578, DOI 10.1093/brain/awq115; Stamelou M, 2009, J CEREBR BLOOD F MET, V29, P861, DOI 10.1038/jcbfm.2009.2; Swerdlow RH, 2000, J NEUROCHEM, V75, P1681, DOI 10.1046/j.1471-4159.2000.0751681.x; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Yamada ES, 2014, EXP NEUROL, V253, P113, DOI 10.1016/j.expneurol.2013.12.017; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou JH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S10	28	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113070	10.1371/journal.pone.0113070	http://dx.doi.org/10.1371/journal.pone.0113070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402454	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700106
J	Cai, FF; Chen, P; Chen, L; Biskup, E; Liu, Y; Chen, PC; Chang, JF; Jiang, WJ; Jing, YY; Chen, YW; Jin, H; Chen, S				Cai, Fengfeng; Chen, Ping; Chen, Li; Biskup, Ewelina; Liu, Yan; Chen, Pei-Chao; Chang, Jian-Feng; Jiang, Wenjie; Jing, Yuanya; Chen, Youwei; Jin, Hui; Chen, Su			Human RAD6 Promotes G1-S Transition and Cell Proliferation through Upregulation of Cyclin D1 Expression	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; HISTONE H2B; DNA-REPAIR; PROTEIN-DEGRADATION; H3 METHYLATION; YEAST RAD6; SUMO; UBIQUITYLATION; CROSSTALK; END	Protein ubiquitinylation regulates protein stability and activity. RAD6, an E2 ubiquitin-conjugating enzyme, which that has been substantially biochemically characterized, functions in a number of biologically relevant pathways, including cell cycle progression. In this study, we show that RAD6 promotes the G1-S transition and cell proliferation by regulating the expression of cyclin D1 (CCND1) in human cells. Furthermore, our data indicate that RAD6 influences the transcription of CCND1 by increasing monoubiquitinylation of histone H2B and trimethylation of H3K4 in the CCND1 promoter region. Our study presents, for the first time, an evidence for the function of RAD6 in cell cycle progression and cell proliferation in human cells, raising the possibility that RAD6 could be a new target for molecular diagnosis and prognosis in cancer therapeutics.	[Cai, Fengfeng; Chen, Ping; Chen, Li; Chang, Jian-Feng; Jiang, Wenjie; Jing, Yuanya; Chen, Youwei; Chen, Su] Tongji Univ, Sch Life Sci & Technol, Dept Breast Surg, Yangpu Hosp,Res Ctr Translat Med,East Hosp, Shanghai 200092, Peoples R China; [Biskup, Ewelina] Univ Basel Hosp, Dept Oncol, CH-4031 Basel, Switzerland; [Liu, Yan] Hebei United Univ, Coll Life Sci, Tangshan, Hebei Province, Peoples R China; [Liu, Yan] Tangshan Peoples Hosp, Inst Canc, Tangshan, Hebei Province, Peoples R China; [Chen, Pei-Chao] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China; [Jin, Hui] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China	Tongji University; University of Basel; North China University of Science & Technology; Wenzhou University; Shanghai Jiao Tong University	Jin, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China.	joycejinhui@shsmu.edu.cn; chensu@tongji.edu.cn		biskup, ewelina/0000-0002-9871-927X; Chen, Peichao/0000-0001-9587-7080	National Natural Science Foundation of China [31201051, 31301148]; Shanghai Municipal Natural Science Foundation [12ZR1433100, 12ZR1433000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported by National Natural Science Foundation of China (Youth Program, #31201051, #31301148) and Shanghai Municipal Natural Science Foundation (General Program, #12ZR1433100, #12ZR1433000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chen S, 2012, MOL CELL BIOL, V32, P576, DOI 10.1128/MCB.05966-11; Chen S, 2011, J BIOL CHEM, V286, P9020, DOI 10.1074/jbc.M110.190314; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kessler BM, 2013, CURR OPIN CHEM BIOL, V17, P59, DOI 10.1016/j.cbpa.2012.12.024; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shekhar MPV, 2002, CANCER RES, V62, P2115; Shimura T, 2013, CELL CYCLE, V12, P2738, DOI 10.4161/cc.25746; Soares LM, 2013, MOL CELL, V49, P1019, DOI 10.1016/j.molcel.2013.03.012; Stein GS, 2006, J CELL PHYSIOL, V209, P706, DOI 10.1002/jcp.20843; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; WATKINS JF, 1993, GENE DEV, V7, P250, DOI 10.1101/gad.7.2.250; Zimmermann C, 2011, P NATL ACAD SCI USA, V108, P18748, DOI 10.1073/pnas.1115885108	25	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113727	10.1371/journal.pone.0113727	http://dx.doi.org/10.1371/journal.pone.0113727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409181	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200149
J	Comstedt, P; Hanner, M; Schuler, W; Meinke, A; Lundberg, U				Comstedt, Par; Hanner, Markus; Schueler, Wolfgang; Meinke, Andreas; Lundberg, Urban			Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; BURGDORFERI SENSU-LATO; DISEASE ANTIGEN OSPA; MONOCLONAL-ANTIBODIES; MEMBRANE-PROTEIN; DISULFIDE BONDS; A OSPA; IDENTIFICATION; IMMUNITY; SPIROCHETE	There is currently no Lyme borreliosis vaccine available for humans, although it has been shown that the disease can be prevented by immunization with an OspA-based vaccine (LYMErix). Outer surface protein A (OspA) is one of the dominant antigens expressed by the spirochetes when present in a tick. The Borrelia species causing Lyme borreliosis in Europe express different OspA serotypes on their surface, B. burgdorferi (serotype 1), B. afzelii (serotype 2), B. garinii (serotypes, 3, 5 and 6) and B. bavariensis (serotype 4), while only B. burgdorferi is present in the US. In order to target all these pathogenic Borrelia species, we have designed a multivalent OspA-based vaccine. The vaccine includes three proteins, each containing the C-terminal half of two OspA serotypes linked to form a heterodimer. In order to stabilize the C-terminal fragment and thus preserve important structural epitopes at physiological temperature, disulfide bonds were introduced. The immunogenicity was increased by introduction of a lipidation signal which ensures the addition of an N-terminal lipid moiety. Three immunizations with 3.0 mu g adjuvanted vaccine protected mice from a challenge with spirochetes expressing either OspA serotype 1, 2 or 5. Mice were protected against both challenge with infected ticks and in vitro grown spirochetes. Immunological analyses (ELISA, surface binding and growth inhibition) indicated that the vaccine can provide protection against the majority of Borrelia species pathogenic for humans. This article presents the approach which allows for the generation of a hexavalent vaccine that can potentially protect against a broad range of globally distributed Borrelia species causing Lyme borreliosis.	[Comstedt, Par; Hanner, Markus; Schueler, Wolfgang; Meinke, Andreas; Lundberg, Urban] Valneva Austria GmbH, Vienna, Austria		Comstedt, P (corresponding author), Valneva Austria GmbH, Vienna, Austria.	par.comstedt@valneva.com			Austrian Research Promotion Agency, BorreliaVac [821824]	Austrian Research Promotion Agency, BorreliaVac	This study was funded by the Austrian Research Promotion Agency (www.ffg.at/en), BorreliaVac; grant 821824. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1983, INFECT IMMUN, V41, P795, DOI 10.1128/IAI.41.2.795-804.1983; Battisti JM, 2008, INFECT IMMUN, V76, P5228, DOI 10.1128/IAI.00410-08; BERGSTROM S, 1989, MOL MICROBIOL, V3, P479, DOI 10.1111/j.1365-2958.1989.tb00194.x; BOCKENSTEDT LK, 1993, J IMMUNOL, V151, P900; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Centers for Disease Control and Prevention, 2013, MAN PEOPL GET LYM DI; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Ding W, 2000, J MOL BIOL, V302, P1153, DOI 10.1006/jmbi.2000.4119; Diza E, 2004, EMERG INFECT DIS, V10, P1692, DOI 10.3201/eid1009.030439; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; FIKRIG E, 1995, J EXP MED, V181, P215, DOI 10.1084/jem.181.1.215; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Foldvari G, 2005, EMERG INFECT DIS, V11, P1794; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gern L, 1997, VACCINE, V15, P1551, DOI 10.1016/S0264-410X(97)00066-2; Gipson CL, 2005, INFECT IMMUN, V73, P1644, DOI 10.1128/IAI.73.3.1644-1647.2005; Golde WT, 1997, INFECT IMMUN, V65, P882, DOI 10.1128/IAI.65.3.882-889.1997; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Huang XL, 1998, J MOL BIOL, V281, P61, DOI 10.1006/jmbi.1998.1930; Hubalek Zdenek, 2009, V37, P31, DOI 10.1159/000213069; JOHNSON BJB, 1995, VACCINE, V13, P1086, DOI 10.1016/0264-410X(95)00035-Y; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koide S, 2005, J MOL BIOL, V350, P290, DOI 10.1016/j.jmb.2005.04.066; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; Liang FT, 1999, J IMMUNOL, V163, P5566; Lindgren E, 2006, CITESEER; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Makabe K, 2008, J MOL BIOL, V378, P459, DOI 10.1016/j.jmb.2008.02.051; Maraspin V, 2006, EMERG INFECT DIS, V12, P1177, DOI 10.3201/eid1207.060077; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Nadelman RB, 1998, LANCET, V352, P557, DOI 10.1016/S0140-6736(98)01146-5; Noppa L, 2001, INFECT IMMUN, V69, P3323, DOI 10.1128/IAI.69.5.3323-3334.2001; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Poljak A, 2012, VACCINE, V30, P4398, DOI 10.1016/j.vaccine.2011.10.073; Rathinavelu S, 2003, INFECT IMMUN, V71, P822, DOI 10.1128/IAI.71.2.822-829.2003; Rizzoli A, 2011, EURO SURVEILL, V16; Ruzic-Sabljic E, 2002, WIEN KLIN WOCHENSCHR, V114, P544; SCHAIBLE UE, 1990, P NATL ACAD SCI USA, V87, P3768, DOI 10.1073/pnas.87.10.3768; SCHUBACH WH, 1991, INFECT IMMUN, V59, P1911, DOI 10.1128/IAI.59.6.1911-1915.1991; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwendinger MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079022; SEARS JE, 1991, J IMMUNOL, V147, P1995; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Steere AC, 2011, CLIN INFECT DIS, V52, pS259, DOI 10.1093/cid/ciq117; Strle F, 1997, CLIN INFECT DIS, V25, P273, DOI 10.1086/514551; Vinayagam A, 2004, NUCLEIC ACIDS RES, V32, pD200, DOI 10.1093/nar/gkh026; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Wressnigg N, 2013, LANCET INFECT DIS, V13, P680, DOI 10.1016/S1473-3099(13)70110-5	55	29	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113294	10.1371/journal.pone.0113294	http://dx.doi.org/10.1371/journal.pone.0113294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409015	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200093
J	Liechti, FD; Studle, N; Theurillat, R; Grandgirard, D; Thormann, W; Leib, SL				Liechti, Fabian D.; Stuedle, Nicolas; Theurillat, Regula; Grandgirard, Denis; Thormann, Wolfgang; Leib, Stephen L.			The Mood-Stabilizer Lithium Prevents Hippocampal Apoptosis and Improves Spatial Memory in Experimental Meningitis	PLOS ONE			English	Article							DENTATE GYRUS; BACTERIAL-MENINGITIS; NEUROTROPHIC FACTOR; BRAIN-INJURY; MATRIX METALLOPROTEINASES; PNEUMOCOCCAL MENINGITIS; CEREBROSPINAL-FLUID; MOUSE MODEL; NEUROGENESIS; NEURONS	Pneumococcal meningitis is associated with high morbidity and mortality rates. Brain damage caused by this disease is characterized by apoptosis in the hippocampal dentate gyrus, a morphological correlate of learning deficits in experimental paradigms. The mood stabilizer lithium has previously been found to attenuate brain damage in ischemic and inflammatory diseases of the brain. An infant rat model of pneumococcal meningitis was used to investigate the neuroprotective and neuroregenerative potential of lithium. To assess an effect on the acute disease, LiCl was administered starting five days prior to intracisternal infection with live Streptococcus pneumoniae. Clinical parameters were recorded, cerebrospinal fluid ( CSF) was sampled, and the animals were sacrificed 42 hours after infection to harvest the brain and serum. Cryosections of the brains were stained for Nissl substance to quantify brain injury. Hippocampal gene expression of Bcl-2, Bax, p53, and BDNF was analyzed. Lithium concentrations were measured in serum and CSF. The effect of chronic lithium treatment on spatial memory function and cell survival in the dentate gyrus was evaluated in a Morris water maze and by quantification of BrdU incorporation after LiCl treatment during 3 weeks following infection. In the hippocampus, LiCl significantly reduced apoptosis and gene expression of Bax and p53 while it increased expression of Bcl-2. IL-10, MCP-1, and TNF were significantly increased in animals treated with LiCl compared to NaCl. Chronic LiCl treatment improved spatial memory in infected animals. The mood stabilizer lithium may thus be a therapeutic alternative to attenuate neurofunctional deficits as a result of pneumococcal meningitis.	[Liechti, Fabian D.; Stuedle, Nicolas; Grandgirard, Denis; Leib, Stephen L.] Univ Bern, Inst Infect Dis, Neuroinfect Lab, Bern, Switzerland; [Liechti, Fabian D.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Theurillat, Regula; Thormann, Wolfgang] Univ Bern, Inst Infect Dis, Clin Pharmacol Lab, Bern, Switzerland; [Leib, Stephen L.] Swiss Fed Off Civil Protect, Spiez Lab, Div Biol, Spiez, Switzerland	University of Bern; University of Bern; University of Bern	Leib, SL (corresponding author), Univ Bern, Inst Infect Dis, Neuroinfect Lab, Bern, Switzerland.	stephen.leib@ifik.unibe.ch	Leib, Stephen/M-3786-2019; Grandgirard, Denis/AAB-8786-2020; Leib, Stephen L/A-7866-2011	Leib, Stephen/0000-0002-1106-6123; Grandgirard, Denis/0000-0002-4151-5196; Leib, Stephen L/0000-0002-1106-6123; Liechti, Fabian D./0000-0003-1006-6903	Gottfried und Julia Bangerter-Rhyner Stiftung; Swiss National Science Foundation [138094]	Gottfried und Julia Bangerter-Rhyner Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by financial contributions from the Gottfried und Julia Bangerter-Rhyner Stiftung (www.bangerter-stiftung.ch) and the Swiss National Science Foundation (Grant 138094, www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, BIOL PHARM BULL, V34, P272, DOI 10.1248/bpb.34.272; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Bifrare YD, 2003, HIPPOCAMPUS, V13, P481, DOI 10.1002/hipo.10142; Blaser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017840; Brandt CT, 2008, J INFECT DIS, V197, P235, DOI 10.1086/524874; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Caldero J, 2010, NEUROSCIENCE, V165, P1353, DOI 10.1016/j.neuroscience.2009.11.034; Castro AA, 2012, BEHAV BRAIN RES, V229, P208, DOI 10.1016/j.bbr.2012.01.016; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chandran A, 2010, PEDIAT INFECT DIS J; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Epp JR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00057; Ferrucci M, 2010, NEUROBIOL DIS, V37, P370, DOI 10.1016/j.nbd.2009.10.017; Forlenza OV, 2014, ACS CHEM NEUROSCI; Fukumoto T, 2001, PSYCHOPHARMACOLOGY, V158, P100, DOI 10.1007/s002130100871; Gehre F, 2008, J INTERN MED; Gerber J, 2003, J NEUROSCI RES, V73, P441, DOI 10.1002/jnr.10682; Gerber J, 2009, NEUROLOGY, V73, P1026, DOI 10.1212/WNL.0b013e3181b9c892; Giambelluca MS, 2014, FASEB J; Gianinazzi C, 2003, ACTA NEUROPATHOL, V105, P499, DOI 10.1007/s00401-003-0672-7; Grandgirard D, 2007, DEV NEUROSCI-BASEL, V29, P134, DOI 10.1159/000096218; Grandgirard D, 2007, ACTA NEUROPATHOL, V114, P609, DOI 10.1007/s00401-007-0304-8; Grandjean EM, 2009, CNS DRUGS, V23, P331, DOI 10.2165/00023210-200923040-00005; Guron G, 2000, J HYPERTENS, V18, P123, DOI 10.1097/00004872-200018020-00001; Hanson ND, 2011, J PHARMACOL EXP THER, V337, P180, DOI 10.1124/jpet.110.175372; Hillert M, 2012, NEUROSCI LETT, V521, P62, DOI 10.1016/j.neulet.2012.05.060; Huo KM, 2012, MOL CELL NEUROSCI, V51, P32, DOI 10.1016/j.mcn.2012.07.002; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Jornada LK, 2010, J PSYCHIATR RES, V44, P506, DOI 10.1016/j.jpsychires.2009.11.002; Kang K, 2014, NEUROL RES, V36, P79, DOI 10.1179/1743132813Y.0000000265; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KERSTEN L, 1982, ARCH INT PHARMACOD T, V260, P4; Kim JS, 2004, J NEUROCHEM, V89, P324, DOI 10.1046/j.1471-4159.2004.02329.x; Kjaersgaard G, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.202; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Leib SL, 2003, PEDIATR RES, V54, P353, DOI 10.1203/01.PDR.0000079185.67878.72; Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000; Leib SL, 2001, BRAIN, V124, P1734, DOI 10.1093/brain/124.9.1734; Liechti FD, 2014, INFECT IMMUN, V82, P1710, DOI 10.1128/IAI.00073-14; Linder MW, 1998, CLIN CHEM, V44, P1073; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malhi GS, 2012, AUST NZ J PSYCHIAT, V46, P192, DOI 10.1177/0004867412437346; Manji HK, 1999, BIOL PSYCHIAT, V46, P929, DOI 10.1016/S0006-3223(99)00165-1; Mitchell L, 2004, J INFECT DIS, V190, P2039, DOI 10.1086/425520; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Morichi S, 2013, INT J NEUROSCI, V123, P17, DOI 10.3109/00207454.2012.721829; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Nassar A, 2014, ACS CHEM NEUROSCI; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Nonaka S, 1998, NEUROREPORT, V9, P2081, DOI 10.1097/00001756-199806220-00031; Pascali JP, 2010, ANAL BIOANAL CHEM, V396, P2543, DOI 10.1007/s00216-010-3537-7; Quiroz JA, 2010, NEUROPSYCHOBIOLOGY, V62, P50, DOI 10.1159/000314310; Ratajczak MZ, 2010, LEUKEMIA, V24, P1667, DOI 10.1038/leu.2010.162; Severus WE, 2009, J AFFECT DISORDERS, V115, P466, DOI 10.1016/j.jad.2008.10.009; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Son H, 2003, J NEUROCHEM, V85, P872, DOI 10.1046/j.1471-4159.2003.01725.x; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; vanFurth AM, 1996, INFECT IMMUN, V64, P4883, DOI 10.1128/IAI.64.12.4883-4890.1996; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wada A, 2005, J PHARMACOL SCI, V99, P307, DOI 10.1254/jphs.CRJ05009X; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Wittwer M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-176; WRAAE O, 1978, BRIT J PHARMACOL, V64, P273, DOI 10.1111/j.1476-5381.1978.tb17300.x; Yoneyama M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087953; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008; Zysset-Burri DC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-393	76	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113607	10.1371/journal.pone.0113607	http://dx.doi.org/10.1371/journal.pone.0113607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409333	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200140
J	Phelan, JA; Abrams, WR; Norman, RG; Li, YH; Laverty, M; Corby, PM; Nembhard, J; Neri, D; Barber, CA; Aberg, JA; Fisch, GS; Poles, MA; Malamud, D				Phelan, Joan A.; Abrams, William R.; Norman, Robert G.; Li, Yihong; Laverty, Maura; Corby, Patricia M.; Nembhard, Jason; Neri, Dinah; Barber, Cheryl A.; Aberg, Judith A.; Fisch, Gene S.; Poles, Michael A.; Malamud, Daniel			Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; TYPE-1 INFECTION; EPITHELIAL-CELLS; LYMPHOID-TISSUE; INDIVIDUALS; CARIES; SALIVA; TRACT; HAART	Introduction: The impaired host defense system in HIV infection impacts the oral and gastrointestinal microbiota and associated opportunistic infections. Antiretroviral treatment is predicted to partially restore host defenses and decrease the oral manifestation of HIV/AIDS. Well-designed longitudinal studies are needed to better understand the interactions of soluble host defense proteins with bacteria and virus in HIV/AIDS. "Crosstalk'' was designed as a longitudinal study of host responses along the gastrointestinal (GI) tract and interactions between defense molecules and bacteria in HIV infection and subsequent therapy. Purpose: The clinical core formed the infrastructure for the study of the interactions between the proteome, microbiome and innate immune system. The core recruited and retained study subjects, scheduled visits, obtained demographic and medical data, assessed oral health status, collected samples, and guided analysis of the hypotheses. This manuscript presents a well-designed clinical core that may serve as a model for studies that combine clinical and laboratory data. Methods: Crosstalk was a case-control longitudinal clinical study an initial planned enrollment of 170 subjects. HIV+ antiretroviral naive subjects were followed for 9 visits over 96 weeks and HIV uninfected subjects for 3 visits over 24 weeks. Clinical prevalence of oral mucosal lesions, dental caries and periodontal disease were assessed. Results: During the study, 116 subjects (47 HIV+, 69 HIV-) were enrolled. Cohorts of HIV+ and HIV- were demographically similar except for a larger proportion of women in the HIV-group. The most prevalent oral mucosal lesions were oral candidiasis and hairy leukoplakia in the HIV+ group. Discussion: The clinical core was essential to enable the links between clinical and laboratory data. The study aims to determine specific differences between oral and GI tissues that account for unique patterns of opportunistic infections and to delineate the differences in their susceptibility to infection by HIV and their responses post-HAART.	[Phelan, Joan A.] NYU, Coll Dent, Dept Oral & Maxillofacial Pathol Radiol & Med, New York, NY USA; [Abrams, William R.; Li, Yihong; Barber, Cheryl A.; Malamud, Daniel] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10012 USA; [Norman, Robert G.; Fisch, Gene S.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA; [Laverty, Maura; Aberg, Judith A.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Laverty, Maura; Aberg, Judith A.] Icahn Sch Med Mt Sinai, Dept Immunol & Infect Dis, New York, NY 10029 USA; [Corby, Patricia M.; Nembhard, Jason; Neri, Dinah] NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY USA; [Poles, Michael A.] NYU, Langone Med Ctr, Dept Med, Div Gastroenterol, New York, NY USA; [Malamud, Daniel] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; New York University; NYU Langone Medical Center; New York University	Abrams, WR (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10012 USA.	william.abrams@nyu.edu	Abrams, William R/A-5782-2008	Poles, Michael/0000-0002-7993-6156; Malamud, Daniel/0000-0002-9094-4122; Li, Yihong/0000-0002-5476-1943	National Institute of Dental and Craniofacial Research [U19DE018385]; NYU HHC Clinical and Translational Science Institute [NIH/NCRR1UL1RR029893-01]; NYU Center for AIDS Research (CFAR) National Institute of Allergy and Infectious Diseases [5P30AI027742]; NYU AIDS Clinical Trials Unit [5U01AI069532]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027742, U01AI069532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE018385] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NYU HHC Clinical and Translational Science Institute; NYU Center for AIDS Research (CFAR) National Institute of Allergy and Infectious Diseases; NYU AIDS Clinical Trials Unit; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The National Institute of Dental and Craniofacial Research (U19DE018385); the NYU HHC Clinical and Translational Science Institute (NIH/NCRR1UL1RR029893-01) supported this work; the support of the NYU Center for AIDS Research (CFAR) National Institute of Allergy and Infectious Diseases (5P30AI027742); and the NYU AIDS Clinical Trials Unit (5U01AI069532) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NEW YORK CIT HIV AID; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cameron Jennifer E, 2008, Curr HIV/AIDS Rep, V5, P126, DOI 10.1007/s11904-008-0020-6; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Dietrich EA, 2012, AIDS RES HUM RETROV, V28, P1574, DOI [10.1089/aid.2011.0069, 10.1089/AID.2011.0069]; Feller L, 2011, SADJ, V66, P82; FLEISS JL, 1987, COMMUNITY DENT ORAL, V15, P221, DOI 10.1111/j.1600-0528.1987.tb00525.x; GREENSPAN D, 1988, GASTROENTEROL CLIN N, V17, P535; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hamza Omar J M, 2006, BMC Oral Health, V6, P12; KATZ RV, 1980, J PUBLIC HEALTH DENT, V40, P7, DOI 10.1111/j.1752-7325.1980.tb01844.x; Langman LJ, 2007, ANN NY ACAD SCI, V1098, P145, DOI 10.1196/annals.1384.001; Liu G, 2012, J DENT RES, V91, P834, DOI 10.1177/0022034512454298; Malamud D, 2011, Adv Dent Res, V23, P34, DOI 10.1177/0022034511399282; Malamud D, 2010, AIDS, V24, P5, DOI 10.1097/QAD.0b013e328333525f; Marcus M, 2005, COMMUNITY DENT ORAL, V33, P99, DOI 10.1111/j.1600-0528.2004.00171.x; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Mehandru S, 2007, J VIROL, V81, P599, DOI 10.1128/JVI.01739-06; Mravak-Stipetic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069736; Navazesh M, 2009, ORAL DIS, V15, P52, DOI 10.1111/j.1601-0825.2008.01456.x; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Phelan JA, 2004, J DENT RES, V83, P869, DOI 10.1177/154405910408301109; PHELAN JA, 1987, ORAL SURG ORAL MED O, V64, P50, DOI 10.1016/0030-4220(87)90116-2; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; Ramirez-Amador V, 2011, Adv Dent Res, V23, P165, DOI 10.1177/0022034511400080; Rodriguez-Inigo E, 2005, J MED VIROL, V77, P17, DOI [10.1002/jmv.20409, 10.1002/JMV.20409]; Saxena D, 2012, CURR HIV-AIDS REP, V9, P44, DOI 10.1007/s11904-011-0103-7; SCHIODT M, 1987, ORAL SURG ORAL MED O, V64, P716, DOI 10.1016/0030-4220(87)90174-5; SCHIODT M, 1987, INT J ORAL MAX SURG, V16, P1, DOI 10.1016/S0901-5027(87)80025-5; Shiboski CH, 2009, J ORAL PATHOL MED, V38, P481, DOI 10.1111/j.1600-0714.2009.00749.x; Tami-Maury I, 2011, J PUBLIC HEALTH DENT, V71, P257, DOI 10.1111/j.1752-7325.2011.00256.x; van der Burg SH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-108; Veazey R S, 1998, AIDS, V12 Suppl A, pS35; Veazey RS, 2004, J EXP MED, V200, P697, DOI 10.1084/jem.20041464; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Zakrzewska J M, 2003, Oral Health Prev Dent, V1, P73; Zhang NW, 2013, ANAL CHIM ACTA, V774, P61, DOI 10.1016/j.aca.2013.02.038	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112901	10.1371/journal.pone.0112901	http://dx.doi.org/10.1371/journal.pone.0112901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409430	gold, Green Published			2022-12-27	WOS:000345533200046
J	Salazar, N; Castiblanco-Valencia, MM; da Silva, LB; de Castro, IA; Monaris, D; Masuda, HP; Barbosa, AS; Areas, APM				Salazar, Natalia; Castiblanco-Valencia, Monica Marcela; da Silva, Ludmila Bezerra; de Castro, Iris Arantes; Monaris, Denize; Masuda, Hana Paula; Barbosa, Angela Silva; Mattos Areas, Ana Paula			Staphylococcus aureus Manganese Transport Protein C (MntC) Is an Extracellular Matrix- and Plasminogen-Binding Protein	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; CHOLERA-TOXIN-B; STREPTOCOCCUS-PNEUMONIAE; CELL-SURFACE; FUSION PROTEIN; LIGB; IDENTIFICATION; FIBRONECTIN; COMPLEMENT; ACTIVATION	Infections caused by Staphylococcus aureus - particularly nosocomial infections - represent a great concern. Usually, the early stage of pathogenesis consists on asymptomatic nasopharynx colonization, which could result in dissemination to other mucosal niches or invasion of sterile sites, such as blood. This pathogenic route depends on scavenging of nutrients as well as binding to and disrupting extracellular matrix (ECM). Manganese transport protein C (MntC), a conserved manganese-binding protein, takes part in this infectious scenario as an ion-scavenging factor and surprisingly as an ECM and coagulation cascade binding protein, as revealed in this work. This study showed a marked ability of MntC to bind to several ECM and coagulation cascade components, including laminin, collagen type IV, cellular and plasma fibronectin, plasminogen and fibrinogen by ELISA. The MntC binding to plasminogen appears to be related to the presence of surfaceexposed lysines, since previous incubation with an analogue of lysine residue, epsilon-aminocaproic acid, or increasing ionic strength affected the interaction between MntC and plasminogen. MntC-bound plasminogen was converted to active plasmin in the presence of urokinase plasminogen activator (uPA). The newly released plasmin, in turn, acted in the cleavage of the alpha and beta chains of fibrinogen. In conclusion, we describe a novel function for MntC that may help staphylococcal mucosal colonization and establishment of invasive disease, through the interaction with ECM and coagulation cascade host proteins. These data suggest that this potential virulence factor could be an adequate candidate to compose an anti-staphylococcal human vaccine formulation.	[Salazar, Natalia; Masuda, Hana Paula; Mattos Areas, Ana Paula] Univ Fed ABCSanto Andre, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Castiblanco-Valencia, Monica Marcela; de Castro, Iris Arantes] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [da Silva, Ludmila Bezerra; Monaris, Denize; Barbosa, Angela Silva] Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Barbosa, AS (corresponding author), Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil.	angela.barbosa@butantan.gov.br	Salazar, Natalia/GQP-2961-2022; Mattos Areas, Ana Paula/B-3557-2013; Masuda, Hana P/T-8818-2018; Mattos Areas, Ana Paula/AFL-7865-2022; Mattos Arêas, Ana Paula/L-1569-2015; Barbosa, Angela S/I-3518-2013; Mattos Areas, Ana Paula/AAG-7805-2022	Mattos Areas, Ana Paula/0000-0002-1946-9285; Masuda, Hana P/0000-0003-0530-9077; Barbosa, Angela S/0000-0002-6458-9489; Mattos Areas, Ana Paula/0000-0002-1946-9285	Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP) [2011/07297-3, 2010/50043-0]; Institutional UFABC support	Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Institutional UFABC support	Funding from Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP) (2011/07297-3 and 2010/50043-0) (http:// www. bv. fapesp. br/ pt/) to ASB and Institutional UFABC support to the Research group of pathogens (2009) (www. ufabc. edu. br) to APMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Areas APM, 2004, BIOCHEM BIOPH RES CO, V321, P192, DOI 10.1016/j.bbrc.2004.06.118; Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Cameron CE, 2003, INFECT IMMUN, V71, P2525, DOI 10.1128/IAI.71.5.2525-2533.2003; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Diep BA, 2014, J INFECT DIS, V209, P1533, DOI 10.1093/infdis/jit662; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Ernst Harold C, 1896, J Boston Soc Med Sci, V1, P3; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Furuya H, 2009, MICROBIOL-SGM, V155, P2707, DOI 10.1099/mic.0.028068-0; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Gribenko A, 2013, J MOL BIOL, V425, P3429, DOI 10.1016/j.jmb.2013.06.033; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Gupta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055157; Halkier T., 1991, MECH BLOOD COAGULATI; Handke LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077874; Johannessen M, 2012, FRONTIERS CELLULAR I, V4, P2; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; KUUSELA P, 1992, INFECT IMMUN, V60, P196, DOI 10.1128/IAI.60.1.196-201.1992; KUUSELA P, 1990, EUR J BIOCHEM, V193, P759, DOI 10.1111/j.1432-1033.1990.tb19397.x; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Mina MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01040-13; Molkanen T, 2002, FEBS LETT, V517, P72, DOI 10.1016/S0014-5793(02)02580-2; Morse J L, 1896, J Exp Med, V1, P613, DOI 10.1084/jem.1.4.613; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; Otto A, 2014, INT J MED MICROBIOL, V304, P110, DOI 10.1016/j.ijmm.2013.11.007; Pimenta FC, 2006, INFECT IMMUN, V74, P4939, DOI 10.1128/IAI.00134-06; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Ruffing U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052487; Scully IL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00109; Shiri T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-483; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wolff DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081818; Zautner AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009452	53	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112730	10.1371/journal.pone.0112730	http://dx.doi.org/10.1371/journal.pone.0112730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409527	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200037
J	Seeley, CJ; Beninger, RJ; Smith, CT				Seeley, Corrine J.; Beninger, Richard J.; Smith, Carlyle T.			Post Learning Sleep Improves Cognitive-Emotional Decision-Making: Evidence for a 'Deck B Sleep Effect' in the Iowa Gambling Task	PLOS ONE			English	Article							EXPLICIT KNOWLEDGE; DECLARATIVE MEMORY; PERFORMANCE; SPINDLES; CONSOLIDATION; CONSEQUENCES; DAMAGE; ROLES; LEVEL; THETA	The Iowa Gambling Task (IGT) is widely used to assess real life decision-making impairment in a wide variety of clinical populations. Our study evaluated how IGT learning occurs across two sessions, and whether a period of intervening sleep between sessions can enhance learning. Furthermore, we investigate whether pre-sleep learning is necessary for this improvement. A 200-trial version of the IGT was administered at two sessions separated by wake, sleep or sleep and wake (time-of-day control). Participants were categorized as learners and non-learners based on initial performance in session one. In session one, participants initially preferred the high-frequency reward decks B and D, however, a subset of learners decreased choice from negative expected value 'bad' deck B and increased choices towards with a positive expected value 'good' decks (decks C and D). The learners who had a period of sleep (sleep and sleep/wake control conditions) between sessions showed significantly larger reduction in choices from deck B and increase in choices from good decks compared to learners that had intervening wake. Our results are the first to show that post-learning sleep can improve performance on a complex decision-making task such as the IGT. These results provide new insights into IGT learning and have important implications for understanding the neural mechanisms of "sleeping on'' a decision.	[Seeley, Corrine J.; Beninger, Richard J.] Queens Univ, Ctr Neurosci, Kingston, ON, Canada; [Beninger, Richard J.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Smith, Carlyle T.] Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada	Queens University - Canada; Queens University - Canada; Trent University	Seeley, CJ (corresponding author), Queens Univ, Ctr Neurosci, Kingston, ON, Canada.	corrineseeley@gmail.com	Beninger, Richard/AAR-1584-2021		Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by grants from the Natural Sciences and Engineering Research Council of Canada to RJB and CTS and Canadian Institute of Health Research to CTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2012, SLEEP BIOL RHYTHMS, V10, P72, DOI 10.1111/j.1479-8425.2011.00509.x; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Chiu YC, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-13; Crone EA, 2004, PSYCHOPHYSIOLOGY, V41, P531, DOI 10.1111/j.1469-8986.2004.00197.x; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Djonlagic I, 2009, LEARN MEMORY, V16, P751, DOI 10.1101/lm.1634509; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Fernie G, 2006, BRAIN COGNITION, V60, P94, DOI 10.1016/j.bandc.2005.09.011; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Fogel SM, 2010, BRAIN RES, V1319, P112, DOI 10.1016/j.brainres.2010.01.026; Fogel SM, 2009, BRAIN RES BULL, V79, P445, DOI 10.1016/j.brainresbull.2009.03.002; Guillaume S, 2009, NEUROPSYCHOLOGIA, V47, P2120, DOI 10.1016/j.neuropsychologia.2009.04.003; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Killgore WDS, 2012, CHRONOBIOL INT, V29, P43, DOI 10.3109/07420528.2011.635230; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Lin CH, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-16; Lin CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-72; Linnet J, 2011, ADDICTION, V106, P383, DOI 10.1111/j.1360-0443.2010.03126.x; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Overman WH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00935; Pace-Schott EF, 2012, J SLEEP RES, V21, P30, DOI 10.1111/j.1365-2869.2011.00921.x; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Perogamvros L, 2012, NEUROSCI BIOBEHAV R, V36, P1934, DOI 10.1016/j.neubiorev.2012.05.010; Peters KR, 2007, J COGNITIVE NEUROSCI, V19, P817, DOI 10.1162/jocn.2007.19.5.817; Preston SD, 2007, BEHAV NEUROSCI, V121, P257, DOI 10.1037/0735-7044.121.2.257; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Seeley CJ, 2014, J BEHAV DECIS MAKING, V27, P170, DOI 10.1002/bdm.1795; Singh V, 2009, MIND SOC, V8, P43, DOI [10.1007/s11299-008-0050-1, DOI 10.1007/S11299-008-0050-1]; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SMITH C, 1991, BEHAV NEUROSCI, V105, P282, DOI 10.1037/0735-7044.105.2.282; Smith Carlyle, 2011, Handb Clin Neurol, V98, P259, DOI 10.1016/B978-0-444-52006-7.00017-4; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Wasserman JI, 2012, PSYCHOPHARMACOLOGY, V222, P173, DOI 10.1007/s00213-011-2634-4; Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Yordanova J, 2008, LEARN MEMORY, V15, P508, DOI 10.1101/lm.897908	45	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112056	10.1371/journal.pone.0112056	http://dx.doi.org/10.1371/journal.pone.0112056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409323	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200010
J	Tschinkel, WR				Tschinkel, Walter R.			Nest Relocation and Excavation in the Florida Harvester Ant, Pogonomyrmex badius	PLOS ONE			English	Article							EMIGRATION; HYMENOPTERA; COLONY; RECRUITMENT; FORMICIDAE; POLYDOMY; ECOLOGY	The Florida harvester ant (Pogonomyrmex badius) excavates deep nests in the sandy soils of the Gulf and Atlantic coastal plains. Nest relocations of over 400 colonies in a north Florida coastal plains pine forest were tracked and mapped from 2010 to 2013. Individual colonies varied from one move in two years to four times a year, averaging about one per year. Almost all moves occurred between May and November peaking in July when more than 1% of the colonies moved per day. Move directions were random, and averaged 4 m, with few moves exceeding 10 m. Distance moved was not related to colony size. Over multiple moves, paths were random walks around the original nest location. Relocation is probably intrinsic to the life history of this species, and the causes of relocation remain obscure-the architecture of old and new nests was very similar, and neither the forest canopy nor the density or size of neighbors was correlated with relocation. Monitoring entire relocations (n = 20) showed that they were usually completed in 4 to 6 days. Moves were diurnal, peaking in the mornings and afternoons dipping during mid-day, and ceasing before sundown. Workers excavated the new nest continuously during the daytime throughout the move and beyond. A minority of workers carried seeds, charcoal and brood, with seeds being by far the most common burden. The proportion of burdened workers increased throughout the move. Measured from year to year, small colonies gained size and large ones lost it. Colonies moving more than once in two years lost more size than those moving less often, suggesting that moving may bear a fitness cost. Colony relocation is a dramatic and consistent feature of the life history of the Florida harvester ant, inviting inquiry into its proximal and ultimate causes.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation Grant [IOS 1021632]	National Science Foundation Grant(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant No. IOS 1021632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AN, 1991, ANT - PLANT INTERACTIONS, P539; Apple JL, 2014, INSECT SOC, V61, P347, DOI 10.1007/s00040-014-0359-1; AUTUORI M., 1941, ARQ INST BIOL [SAO PAULO], V12, P197; Avargues-Weber A, 2009, INSECT SOC, V56, P177, DOI 10.1007/s00040-009-0009-1; Brown MJF, 1999, INSECT SOC, V46, P66, DOI 10.1007/s000400050114; Buczkowski G, 2008, ECOL ENTOMOL, V33, P780, DOI 10.1111/j.1365-2311.2008.01034.x; CARLSON DM, 1973, ECOLOGY, V54, P452, DOI 10.2307/1934357; Dahbi A, 2008, NEST MOVING POLYDOMO; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Diniz JLM, 1998, NATURWISSENSCHAFTEN, V85, P270, DOI 10.1007/s001140050497; FOWLER HG, 1981, BIOTROPICA, V13, P316, DOI 10.2307/2387811; Gibb H, 2003, INSECT SOC, V50, P323, DOI 10.1007/s00040-003-0689-x; GOLLEY FB, 1964, ECOLOGY, V45, P217, DOI 10.2307/1933834; GORDON DM, 1992, ANN ENTOMOL SOC AM, V85, P44, DOI 10.1093/aesa/85.1.44; Halfen AF, 2010, 19 WORLD C SOIL SCI; HARRISON JS, 1981, ECOLOGY, V62, P1467, DOI 10.2307/1941503; Hart AG, 2001, ANIM BEHAV, V62, P227, DOI 10.1006/anbe.2001.1743; Heller NE, 2006, ECOL ENTOMOL, V31, P499, DOI 10.1111/j.1365-2311.2006.00806.x; HERBERS JM, 1985, INSECT SOC, V32, P224, DOI 10.1007/BF02224913; Johnson RA, 2000, SOCIOBIOLOGY, V36, P89; Kwapich CL, 2013, BEHAV ECOL SOCIOBIOL, V67, P2011, DOI 10.1007/s00265-013-1611-9; Laskis KO, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0201; LONGHURST C, 1979, INSECT SOC, V26, P204, DOI 10.1007/BF02223798; LOPEZ F, 1994, TRENDS ECOL EVOL, V9, P150, DOI 10.1016/0169-5347(94)90185-6; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; McGlynn TP, 2007, ECOL ENTOMOL, V32, P621, DOI 10.1111/j.1365-2311.2007.00909.x; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; McGlynn TP, 2010, J TROP ECOL, V26, P559, DOI 10.1017/S0266467410000313; McGlynn TP, 2006, BIOTROPICA, V38, P419, DOI 10.1111/j.1744-7429.2006.00153.x; McGlynn TP, 2004, OIKOS, V106, P611, DOI 10.1111/j.0030-1299.2004.13135.x; Mikheyev AS, 2004, INSECT SOC, V51, P30, DOI 10.1007/s00040-003-0703-3; Nickele MA, 2012, REV BRAS ENTOMOL, V56, P385, DOI [10.1590/S0085-56262012005000045, 10.1590/S0085-56262012000300020]; PORTER SD, 1980, BIOTROPICA, V12, P232, DOI 10.2307/2387983; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; Pratt SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1369, DOI 10.1007/s00265-008-0565-9; Rink WJ, 2013, J ARCHAEOL SCI, V40, P2217, DOI 10.1016/j.jas.2012.11.006; ROCKWOOD LL, 1973, J ANIM ECOL, V42, P803, DOI 10.2307/3140; Seeley T.D., 2010, HONEYBEE DEMOCRACY; SMALLWOOD J, 1982, INSECT SOC, V29, P138, DOI 10.1007/BF02228747; Smith CR, 2007, ECOL ENTOMOL, V32, P105, DOI 10.1111/j.1365-2311.2006.00845.x; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2013, ONLINE PLOSONE, V8; TSUJI K, 1988, INSECT SOC, V35, P321, DOI 10.1007/BF02225809; VANPELT A, 1976, ANN ENTOMOL SOC AM, V69, P493, DOI 10.1093/aesa/69.3.493	45	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112981	10.1371/journal.pone.0112981	http://dx.doi.org/10.1371/journal.pone.0112981			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409332	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200055
J	Vereshchaka, AL; Olesen, J; Lunina, AA				Vereshchaka, Alexander L.; Olesen, Jorgen; Lunina, Anastasia A.			Global Diversity and Phylogeny of Pelagic Shrimps of the Former Genera Sergestes and Sergia (Crustacea, Dendrobranchiata, Sergestidae), with Definition of Eight New Genera	PLOS ONE			English	Article							NEAR-BOTTOM LAYER; VERTICAL-DISTRIBUTION; SYMPATRIC SPECIATION; OCEAN; BIOLUMINESCENCE; DECAPODA	We revise the global diversity of the former genera Sergia and Sergestes which include 71 valid species. The revision is based on examination of more than 37,000 specimens from collections in the Natural History Museum of Denmark and the Museum of Natural History, Paris. We used 72 morphological characters (61 binary, 11 multistate) and Sicyonella antennata as an outgroup for cladistic analysis. There is no support for the genera Sergia and Sergestes as they have been defined until now. We define and diagnose eight genera of the former genus Sergia (Sergia and new genera Gardinerosergia, Phorcosergia, Prehensilosergia, Robustosergia, Scintillosergia, Challengerosergia, and Lucensosergia) and seven genera of the former genus Sergestes (Sergestes, Deosergestes, Eusergestes, Allosergestes, Parasergestes, Neosergestes, and a new genus Cornutosergestes). An identification key is presented for all genera of the family Sergestidae. The phylogeny of Sergestidae is mainly based on three categories of characters related to: (1) general decapod morphology, (2) male copulatory organs, and (3) photophores. Only simultaneous use of all three character types resulted in a resolved tree with minimal Bootstrap support 75 for each clade. Most genera are interzonal mesopelagic migrants, some are benthopelagic (Scintillosergia, Lucensosergia), bathypelagic (Sergia), or epipelagic (Cornutosergestes). Within each of meso- and benthopelagic genera there is one species with panoceanic distribution, while most species ranges are restricted to a single ocean. The genera demonstrate two different strategies expressed both in morphology and behavior: protective (Eusergestes, Sergestes, Cornutosergestes, Prehensilosergia, Scintillosergia, Lucensosergia, Challengerosergia, Gardinerosergia, Robustosergia, Phorcosergia, Sergia) and offensive (Neosergestes, Parasergestes, Allosergestes, Deosergestes).	[Vereshchaka, Alexander L.; Lunina, Anastasia A.] Russian Acad Sci, Inst Oceanol, Moscow, Russia; [Olesen, Jorgen] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	Russian Academy of Sciences; University of Copenhagen	Vereshchaka, AL (corresponding author), Russian Acad Sci, Inst Oceanol, Moscow, Russia.	alv@ocean.ru	Olesen, Jørgen/A-3353-2013; Lunina, Anastasia/L-3699-2014; Vereshchaka, Alexander L/E-6205-2014	Olesen, Jørgen/0000-0001-9582-7083; Lunina, Anastasia/0000-0002-1105-8027; Vereshchaka, Alexander L/0000-0002-6756-2468; Olesen, Jes/0000-0002-6712-2702	Danish Carlsberg Foundation; Russian Academy of Sciences [23, 28]	Danish Carlsberg Foundation(Carlsberg Foundation); Russian Academy of Sciences(Russian Academy of Sciences)	Financial support for the project was provided by the Danish Carlsberg Foundation and Russian Academy of Sciences (Programmes 23 and 28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard K, 1946, ANN MAG NAT HIST SER, V11, P362; Bate C. Spence., 1881, Annals of Natural History, V(5), P169; Burkenroad M, 1940, ANN MAG NAT HIST SER, V11, P34; BURKENROAD MARTIN D., 1937, ZOOLOGICA [NEW YORK], V22, P315; Burkenroad Martin D., 1945, TRANS CONNECTICUT ACAD ARTS AND SCI, V36, P553; Crosnier A., 1973, Faune Tropicale, V19, P1; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Faxon W., 1893, B MUS COMP ZOOL HARV, V24, P149; Fukuoka K, 2005, ZOOTAXA, P1; GOLOBOFF P, 2000, TNT TREE ANAL USING; Gordon I., 1939, Annals & Magazine of Natural History Series 11, V4, P498; HANSEN H. J., 1920, B MUS HIST NAT PARIS, V26, P477; Hansen H.J., 1919, SIBOGA EXPEDITIE, V38, P1; Hansen HJ, 1903, P ZOOL SOC LOND, V1903, P52; Hansen HJ, 1927, SERGESTIDES SCHIZOPO, P1; Hansen HJ, 1908, I DAN INGOLF EXPED, V3, P1; Hansen HJ, 1896, P ZOOL SOC LOND, V1896, P936; Hansen HJ, 1922, RESULT CAMP SCI PRIN, V164, P1; Hashizume Kazuyoshi, 1995, Bulletin of the National Science Museum Series A (Zoology), V21, P71; HERRING PJ, 1976, J MAR BIOL ASSOC UK, V56, P1029, DOI 10.1017/S0025315400021056; Herring PJ, 2002, BIOL DEEP OCEAN; Illig, 1927, WISSENSCHAFTLICHE ER, V23, P277; Illig G, 1914, SERGESTIDEN DT SUDPO, V15, P347; Iwasaki N, 2001, MARINE BIODIVERSITY, V31, P91; JUDKINS D C, 1978, Smithsonian Contributions to Zoology, P1; Judkins DC, 2008, P BIOL SOC WASH, V121, P72, DOI 10.2988/06-26.1; Kemp Stanley., 1913, Transactions of the Linnean Society 2nd Ser Zoology London, V16; Kroyer H, 1855, BIDRAG KUNDSKAB KRAE, V22-34, P1; Lindsay SM, 1999, BIOL BULL-US, V197, P348, DOI 10.2307/1542789; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Mcleay L, 1998, J MAR BIOL ASSOC UK, V78, P497, DOI 10.1017/S0025315400041588; Milne D. S., 1968, Crustaceana, V14, P21, DOI 10.1163/156854068X01132; Milne Edwards H., 1830, ANN SCI NATUR, V19, P333; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; OMORI M, 1974, ADV MAR BIOL, V12, P233; OMORI M, 1982, MAR BIOL, V72, P193, DOI 10.1007/BF00396920; OMORI M, 1981, Journal of Plankton Research, V3, P107, DOI 10.1093/plankt/3.1.107; Ortmann A, 1893, HUMBOLDT STIFT, V2, P1; Perez Farfante I., 1997, Memoires du Museum National d'Histoire Naturelle, V175, P1; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Smith S.I., 1882, B MUS COMP ZOOL HARV, V10, P1; Stimpson W, 1860, P ACAD NAT SCI PHILA, V12, P22; Stupnikova AN, 2013, J MARINE SYST, V128, P175, DOI 10.1016/j.jmarsys.2013.04.016; Sund O., 1920, REPORT SCI RESULTS M, V3, P1; Vereshchaka A, 2000, 19 GAL; Vereshchaka A, 2009, 22 GAL; Vereshchaka A. L., 1994, Steenstrupia, V20, P73; Vereshchaka A. L., 2000, THE DEEP SEA BENTHOP; VERESHCHAKA AL, 1990, OKEANOLOGIYA+, V30, P126; VERESHCHAKA AL, 1995, DEEP-SEA RES PT I, V42, P1639, DOI 10.1016/0967-0637(95)00065-E; Vereshchaka AL, 1999, DEEP-SEA RES PT I, V46, P1615, DOI 10.1016/S0967-0637(99)00018-7; Wood-Mason J., 1891, ANN MAGAZINE NATURAL, V7, P186, DOI DOI 10.1080/00222939109460596; YALDWYN J. C., 1957, ZOOL PUBL VICTORIA UNIV COLL, V22, P1	53	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112057	10.1371/journal.pone.0112057	http://dx.doi.org/10.1371/journal.pone.0112057			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409458	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200011
J	Yamada, S; Koyama, T; Noguchi, H; Ueda, Y; Kitsuyama, R; Shimizu, H; Tanimoto, A; Wang, KY; Nawata, A; Nakayama, T; Sasaguri, Y; Satoh, T				Yamada, Sohsuke; Koyama, Tomoyuki; Noguchi, Hirotsugu; Ueda, Yuki; Kitsuyama, Ryo; Shimizu, Hiroya; Tanimoto, Akihide; Wang, Ke-Yong; Nawata, Aya; Nakayama, Toshiyuki; Sasaguri, Yasuyuki; Satoh, Takumi			Marine Hydroquinone Zonarol Prevents Inflammation and Apoptosis in Dextran Sulfate Sodium-Induced Mice Ulcerative Colitis	PLOS ONE			English	Article							BOWEL-DISEASE; ELECTROPHILIC COMPOUND; DICTYOPTERIS-UNDULATA; EPITHELIAL APOPTOSIS; MAINTENANCE THERAPY; CARNOSIC ACID; NITRIC-OXIDE; ACTIVATION; INFLIXIMAB; PROTECTS	Background and Aim: We previously identified an anti-inflammatory compound, zonarol, a hydroquinone isolated from the brown algae Dictyopteris undulata as a marine natural product. To ascertain the in vivo functions of zonarol, we examined the pharmacological effects of zonarol administration on dextran sulfate sodium (DSS)-induced inflammation in a mouse model of ulcerative colitis (UC). Our goal is to establish a safe and effective cure for inflammatory bowel disease (IBD) using zonarol. Methods and Results: We subjected Slc:ICR mice to the administration of 2% DSS in drinking water for 14 days. At the same time, 5-aminosalicylic acid (5-ASA) at a dose of 50 mg/kg (positive control) and zonarol at doses of 10 and 20 mg/kg, were given orally once a day. DSS-treated animals developed symptoms similar to those of human UC, such as severe bloody diarrhea, which were evaluated by the disease activity index (DAI). Treatment with 20 mg/kg of zonarol, as well as 5-ASA, significantly suppressed the DAI score, and also led to a reduced colonic ulcer length and/or mucosal inflammatory infiltration by various immune cells, especially macrophages. Zonarol treatment significantly reduced the expression of pro-inflammatory signaling molecules, and prevented the apoptosis of intestinal epithelial cells. Finally, zonarol protected against in vitro lipopolysaccharide (LPS)-induced activation in the RAW264.7 mouse macrophage cell line. Conclusions: This is the first report that a marine bioproduct protects against experimental UC via the inhibition of both inflammation and apoptosis, very similar to the standard-of-care sulfasalazine, a well-known prodrug that releases 5-ASA. We believe that the oral administration of zonarol might offer a better treatment for human IBDs than 5-ASA, or may be useful as an alternative/additive therapeutic strategy against UC, without any evidence of side effects.	[Yamada, Sohsuke; Noguchi, Hirotsugu; Wang, Ke-Yong; Nawata, Aya; Nakayama, Toshiyuki; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan; [Koyama, Tomoyuki; Ueda, Yuki] Grad Sch Marine Sci & Technol, Lab Nutraceut & Funct Foods Sci, Tokyo 1088477, Japan; [Kitsuyama, Ryo; Shimizu, Hiroya; Satoh, Takumi] Iwate Univ, Dept Welf Engn, Fac Engn, Morioka, Iwate 0208551, Japan; [Tanimoto, Akihide] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Pathol, Kagoshima 8908544, Japan; [Wang, Ke-Yong] Univ Occupat & Environm Hlth, Shared Use Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Sasaguri, Yasuyuki] Fukuoka Wajiro Hosp, Pathol Lab, Fukuoka 8110213, Japan; [Satoh, Takumi] Tokyo Univ Technol, Sch Biosci & Biotechnol, Dept Antiaging Food Res, Hachioji, Tokyo 1920982, Japan	University of Occupational & Environmental Health - Japan; Iwate University; Kagoshima University; University of Occupational & Environmental Health - Japan; Tokyo University of Technology	Yamada, S (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan.	sousuke@med.uoeh-u.ac.jp		wang, ke-yong/0000-0001-8295-1229	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [21510223, 22500282, 24790394, 25350963, 25350985]; A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) from the JST (Japan Science and Technology Agency), Tokyo, Japan [AS251Z01987Q]	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) from the JST (Japan Science and Technology Agency), Tokyo, Japan	This work was supported in part by Grants-in-Aid for Scientific Research (21510223, 22500282, 24790394, 25350963 and 25350985) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan (to S.Y. T.K. and T.S.) and by A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) (AS251Z01987Q) from the JST (Japan Science and Technology Agency), Tokyo, Japan (to T.K. and T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CIMINO G, 1975, EXPERIENTIA, V31, P1250, DOI 10.1007/BF01945759; Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e; FENICAL W, 1973, J ORG CHEM, V38, P2383, DOI 10.1021/jo00953a022; Geerling BJ, 2000, EUR J CLIN NUTR, V54, P514, DOI 10.1038/sj.ejcn.1601049; Ishibashi F, 2013, BIOSCI BIOTECH BIOCH, V77, P1120, DOI 10.1271/bbb.130018; Katsanos KH, 2012, J CROHNS COLITIS, V6, P735, DOI 10.1016/j.crohns.2012.03.005; Koyama T, 2010, J JPN SOC MED USE FU, V6, P109; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; Kwon KH, 2005, BIOCHEM BIOPH RES CO, V337, P647, DOI 10.1016/j.bbrc.2005.09.107; Larrosa M, 2009, MOL NUTR FOOD RES, V53, P1044, DOI 10.1002/mnfr.200800446; Lee JH, 2015, J AQUAT FOOD PROD T, V24, P227, DOI 10.1080/10498850.2013.770809; Linares V, 2011, EXPERT OPIN DRUG SAF, V10, P253, DOI 10.1517/14740338.2011.529898; MAYER AMS, 1993, HYDROBIOLOGIA, V261, P521; Montrose DC, 2011, CARCINOGENESIS, V32, P343, DOI 10.1093/carcin/bgq248; MORI K, 1986, B SOC CHIM BELG, V95, P771; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Noguchi H, 2014, AM J PATHOL, V184, P644, DOI 10.1016/j.ajpath.2013.11.030; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Olsen T, 2007, SCAND J GASTROENTERO, V42, P1312, DOI 10.1080/00365520701409035; Opheim R, 2012, SCAND J GASTROENTERO, V47, P1436, DOI 10.3109/00365521.2012.725092; Oz HS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00132; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Reinisch W, 2012, INFLAMM BOWEL DIS, V18, P201, DOI 10.1002/ibd.21697; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Schreiber O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071843; Sha T, 2013, INT IMMUNOPHARMACOL, V15, P23, DOI 10.1016/j.intimp.2012.10.022; Skyberg JA, 2011, J LEUKOCYTE BIOL, V90, P1043, DOI 10.1189/jlb.0311168; Szigethy E, 2011, PEDIATR CLIN N AM, V58, P903, DOI 10.1016/j.pcl.2011.06.007; Takenouchi T, 2005, BBA-GEN SUBJECTS, V1726, P177, DOI 10.1016/j.bbagen.2005.08.001; TANIGUCHI K, 1993, NIPPON SUISAN GAKK, V59, P339; Tasaki T, 2013, AM J PATHOL, V182, P597, DOI 10.1016/j.ajpath.2012.10.008; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Yamada S, 2011, ARTERIOSCL THROM VAS, V31, P1555, DOI 10.1161/ATVBAHA.111.227140; Yanagitai M, 2012, BIOCHEM BIOPH RES CO, V418, P22, DOI 10.1016/j.bbrc.2011.12.087; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	39	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113509	10.1371/journal.pone.0113509	http://dx.doi.org/10.1371/journal.pone.0113509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409433	Green Published, gold			2022-12-27	WOS:000345533200131
J	Agha, Z; Iqbal, Z; Azam, M; Ayub, H; Vissers, LELM; Gilissen, C; Ali, SHB; Riaz, M; Veltman, JA; Pfundt, R; van Bokhoven, H; Qamar, R				Agha, Zehra; Iqbal, Zafar; Azam, Maleeha; Ayub, Humaira; Vissers, Lisenka E. L. M.; Gilissen, Christian; Ali, Syeda Hafiza Benish; Riaz, Moeen; Veltman, Joris A.; Pfundt, Rolph; van Bokhoven, Hans; Qamar, Raheel			Exome Sequencing Identifies Three Novel Candidate Genes Implicated in Intellectual Disability	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; MUTATIONS; DISORDERS; DELETION; REVEALS; CILIA	Intellectual disability (ID) is a major health problem mostly with an unknown etiology. Recently exome sequencing of individuals with ID identified novel genes implicated in the disease. Therefore the purpose of the present study was to identify the genetic cause of ID in one syndromic and two non-syndromic Pakistani families. Whole exome of three ID probands was sequenced. Missense variations in two plausible novel genes implicated in autosomal recessive ID were identified: lysine (K)-specific methyltransferase 2B (KMT2B), zinc finger protein 589 (ZNF589), as well as hedgehog acyltransferase (HHAT) with a de novo mutation with autosomal dominant mode of inheritance. The KMT2B recessive variant is the first report of recessive Kleefstra syndrome-like phenotype. Identification of plausible causative mutations for two recessive and a dominant type of ID, in genes not previously implicated in disease, underscores the large genetic heterogeneity of ID. These results also support the viewpoint that large number of ID genes converge on limited number of common networks i.e. ZNF589 belongs to KRAB-domain zinc-finger proteins previously implicated in ID, HHAT is predicted to affect sonic hedgehog, which is involved in several disorders with ID, KMT2B associated with syndromic ID fits the epigenetic module underlying the Kleefstra syndromic spectrum. The association of these novel genes in three different Pakistani ID families highlights the importance of screening these genes in more families with similar phenotypes from different populations to confirm the involvement of these genes in pathogenesis of ID.	[Agha, Zehra; Azam, Maleeha; Ayub, Humaira; Ali, Syeda Hafiza Benish; Riaz, Moeen; Qamar, Raheel] COMSATS Inst Informat Technol, Fac Sci, Dept Biosci, Islamabad, Pakistan; [Agha, Zehra; Iqbal, Zafar; Vissers, Lisenka E. L. M.; Gilissen, Christian; Veltman, Joris A.; Pfundt, Rolph; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Agha, Zehra] Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad, Pakistan; [van Bokhoven, Hans] Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Dept Biochem, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Radboud University Nijmegen; International Islamic University, Pakistan; Radboud University Nijmegen	van Bokhoven, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	h.vanbokhoven@radboudumc.nl; raheelqamar@hotmail.com	Gilissen, Christian/E-5246-2012; Iqbal, Zafar/J-8700-2015; Veltman, Joris A/F-5128-2010; Azam, Maleeha/AAD-9924-2022; Pfundt, Rolph/L-4576-2015; Bokhoven, J.H.L.M. van van/H-8015-2014; Vissers, Lisenka ELM/A-2598-2015; Azam, Maleeha/L-1721-2017	Gilissen, Christian/0000-0003-1693-9699; Iqbal, Zafar/0000-0002-6387-8019; Veltman, Joris A/0000-0002-3218-8250; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Vissers, Lisenka ELM/0000-0001-6470-5497; agha, zehra/0000-0003-3413-0578; Iqbal, Zafar/0000-0002-1334-6372; Azam, Maleeha/0000-0003-0170-3325	COMSATS Institute of Information Technology; European Union [241995, 223143]	COMSATS Institute of Information Technology; European Union(European Commission)	This work was supported by the COMSATS Institute of Information Technology to RQ. This study was also supported by the European Union's Seventh Framework Program [grant agreement number 241995 project GENCODYS and grant agreement number 223143, project TECHGENE]. None of the funding agencies had any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agha Z, 2013, GENE, V519, P177, DOI 10.1016/j.gene.2013.01.047; Barbaro V, 2012, AM J MED GENET A, V158A, P1957, DOI 10.1002/ajmg.a.35414; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Das I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005983; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dennis JF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002927; Ding G, 2009, NUCLEIC ACIDS RES, V37, pD267, DOI 10.1093/nar/gkn782; Fickie MR, 2011, AM J MED GENET A, V155A, P2105, DOI 10.1002/ajmg.a.34156; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Iqbal Z, 2014, HUM HERED, V77, P150, DOI 10.1159/000360539; Kanda H, 2013, MOL CELL BIOL, V33, P1702, DOI 10.1128/MCB.01585-12; Kerimoglu C, 2013, J NEUROSCI, V33, P3452, DOI 10.1523/JNEUROSCI.3356-12.2013; Kim DH, 2009, MOL ENDOCRINOL, V23, P1556, DOI 10.1210/me.2009-0099; Kleefstra T, 1993, KLEEFSTRA SYNDROME; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Liu C, 1999, EXP HEMATOL, V27, P313, DOI 10.1016/S0301-472X(98)00035-6; Lugtenberg D, 2006, AM J HUM GENET, V78, P265, DOI 10.1086/500306; Makrythanasis P, 2013, CLIN GENET, V84, P539, DOI 10.1111/cge.12081; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; Stein Z, 1987, Ups J Med Sci Suppl, V44, P89; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; van Bokhoven H, 2010, NEUROBIOL DIS, V39, P3, DOI 10.1016/j.nbd.2010.03.010; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Vissers LELM, 2012, METHODS MOL BIOL, V838, P29, DOI 10.1007/978-1-61779-507-7_2	35	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112687	10.1371/journal.pone.0112687	http://dx.doi.org/10.1371/journal.pone.0112687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405613	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300047
J	Huerta, E; Kampichler, C; Ochoa-Gaona, S; De Jong, B; Hernandez-Daumas, S; Geissen, V				Huerta, Esperanza; Kampichler, Christian; Ochoa-Gaona, Susana; De Jong, Ben; Hernandez-Daumas, Salvador; Geissen, Violette			A Multi-Criteria Index for Ecological Evaluation of Tropical Agriculture in Southeastern Mexico	PLOS ONE			English	Article							SUSTAINABILITY INDICATORS; CROPPING SYSTEMS; FARMING SYSTEMS; SOIL PROPERTIES; MANAGEMENT; AGROECOSYSTEMS; BIODIVERSITY; PLANTATIONS; CHALLENGES; IMPACTS	The aim of this study was to generate an easy to use index to evaluate the ecological state of agricultural land from a sustainability perspective. We selected environmental indicators, such as the use of organic soil amendments (green manure) versus chemical fertilizers, plant biodiversity (including crop associations), variables which characterize soil conservation of conventional agricultural systems, pesticide use, method and frequency of tillage. We monitored the ecological state of 52 agricultural plots to test the performance of the index. The variables were hierarchically aggregated with simple mathematical algorithms, if-then rules, and rule-based fuzzy models, yielding the final multi-criteria index with values from 0 (worst) to 1 (best conditions). We validated the model through independent evaluation by experts, and we obtained a linear regression with an r(2) = 0.61 (p = 2.4e-06, d.f. = 49) between index output and the experts' evaluation.	[Huerta, Esperanza; Hernandez-Daumas, Salvador] El Colegio Frontera Sur, Unidad Campeche, Dept Agroecol, Campeche, Mexico; [Kampichler, Christian] Univ Juarez Autonoma Tabasco, Div Ciencias Biol, Villahermosa, Tabasco, Mexico; [Kampichler, Christian] Sovon Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [Ochoa-Gaona, Susana; De Jong, Ben] El Colegio Frontera Sur, Unidad Campeche, Dept Sustainabil Sci, Campeche, Mexico; [Geissen, Violette] Univ Bonn, INRES, Bonn, Germany; [Geissen, Violette] Wageningen Univ & Res Ctr Alterra, Wageningen, Gelderland, Netherlands	El Colegio de la Frontera Sur (ECOSUR); Universidad Juarez Autonoma de Tabasco; El Colegio de la Frontera Sur (ECOSUR); University of Bonn; Wageningen University & Research	Huerta, E (corresponding author), El Colegio Frontera Sur, Unidad Campeche, Dept Agroecol, Campeche, Mexico.	ehuerta@ecosur.mx	de Jong, Ben HJ/GYV-3632-2022		Conacyt-SEMARNAT Project "Uso sustentable de los recursos naturales en la frontera sur de Mexico'' (Sustainable use of natural resources on the southern border of Mexico) [SEMARNAT-2002-C01-1109]	Conacyt-SEMARNAT Project "Uso sustentable de los recursos naturales en la frontera sur de Mexico'' (Sustainable use of natural resources on the southern border of Mexico)	Financial support was obtained from the Conacyt-SEMARNAT Project "Uso sustentable de los recursos naturales en la frontera sur de Mexico'' (Sustainable use of natural resources on the southern border of Mexico) (code SEMARNAT-2002-C01-1109). El Colegio de la Frontera Sur provided infrastructural resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbede TM, 2008, SOIL TILL RES, V99, P49, DOI 10.1016/j.still.2007.12.003; Allen CR, 2011, J ENVIRON MANAGE, V92, P1339, DOI 10.1016/j.jenvman.2010.11.019; Garcia-Perez JA, 2014, APPL SOIL ECOL, V83, P230, DOI 10.1016/j.apsoil.2013.09.006; Aryal DR, 2012, J PLANT NUTR SOIL SC, V175, P553, DOI 10.1002/jpln.201100117; Astier M, 2011, INT J AGR SUSTAIN, V9, P409, DOI 10.1080/14735903.2011.583481; Belalcazar S., 2000, Better Crops International, V14, P12; BELLON MR, 1995, HUM ORGAN, V54, P263, DOI 10.17730/humo.54.3.98460132152k434l; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Bockstaller C, 2003, AGR SYST, V76, P639, DOI 10.1016/S0308-521X(02)00053-7; Bockstaller C, 1997, EUR J AGRON, V7, P261, DOI 10.1016/S1161-0301(97)00041-5; Bockstaller C, 2008, AGRIENVIRONMENTAL IN, P725; Bockstaller C, 2009, AGRON SUSTAIN DEV, V29, P223, DOI 10.1051/agro:2008058; Borjesson P, 1999, BIOMASS BIOENERG, V16, P137, DOI 10.1016/S0961-9534(98)00080-4; Brussaard L, 2010, CURR OPIN ENV SUST, V2, P34, DOI 10.1016/j.cosust.2010.03.007; Cabell JF, 2012, ECOL SOC, V17, DOI 10.5751/ES-04666-170118; Carter H, 1989, CALIF AGR, V43, P1618; Correia FV, 2010, B ENVIRON CONTAM TOX, V85, P264, DOI 10.1007/s00128-010-0089-7; Darnhofer I, 2010, AGRON SUSTAIN DEV, V30, P545, DOI 10.1051/agro/2009053; Dick J, 2008, SOIL USE MANAGE, V24, P292, DOI 10.1111/j.1475-2743.2008.00163.x; Dobbs T. L., 1991, Journal for Farming Systems Research-Extension, V2, P109; EDWARDS CA, 1993, AGR ECOSYST ENVIRON, V46, P99, DOI 10.1016/0167-8809(93)90017-J; EDWARDS CA, 1989, AGR ECOSYST ENVIRON, V27, P25, DOI 10.1016/0167-8809(89)90069-8; Geissen V, 2009, GEODERMA, V151, P87, DOI 10.1016/j.geoderma.2009.03.011; Geissen V, 2006, APPL SOIL ECOL, V841, P1; Grande D., 2010, Research Journal of Biological Sciences, V5, P75; Gurr GM, 2003, BASIC APPL ECOL, V4, P107, DOI 10.1078/1439-1791-00122; HAUPTLI H, 1990, SUSTAINABLE AGRICULTURAL SYSTEMS, P141; HOUGHTON RA, 1994, BIOSCIENCE, V44, P305, DOI 10.2307/1312380; Huerta E, 2009, PESQUI AGROPECU BRAS, V44, P1056, DOI 10.1590/S0100-204X2009000800039; INEGI, 2000, CUAD EST MUN TEN GOB; INEGI, 2008, CUAD EST MUN TEN; Isaac-Marquez R, 2008, ANALISIS CAMBIO USO; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kampichler C, 2004, ECOL INDIC, V4, P99, DOI 10.1016/j.ecolind.2004.01.001; Kampichler C, 2010, ECOL INDIC, V10, P320, DOI 10.1016/j.ecolind.2009.06.010; Knorr Cetina K.D., 1984, ALTERATIONS FOOD PRO, P223; Koocheki A, 2009, AGRON SUSTAIN DEV, V29, P401, DOI 10.1051/agro/2008061; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li BL, 1996, ECOL MODEL, V90, P109, DOI 10.1016/0304-3800(96)90072-1; Lockeretz W., 1988, American Journal of Alternative Agriculture, V3, P174, DOI 10.1017/S0889189300002460; Madden P, 1990, SUSTAINABLE AGR TEMP, P315; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; Manjarrez-Munoz B, 2008, ORDENAMIENTO TERRITO; Melgar C, 2008, J PLANT NUTR SOIL SC, V171, P597, DOI 10.1002/jpln.200700171; Mendoza G.A., 2003, ECOLOGICAL INDICATOR, V3, P227, DOI DOI 10.1016/J.ECOLIND.2003.08.001; Meul M, 2009, ECOL INDIC, V9, P284, DOI 10.1016/j.ecolind.2008.05.007; MITCHELL G, 1995, INT J SUST DEV WORLD, V2, P104, DOI 10.1080/13504509509469893; Morales H., 2000, Agriculture and Human Values, V17, P49, DOI 10.1023/A:1007680726231; Moreno-Unda AA, 2011, ENV EFFECTS NATL TRE; Nambiar KKM, 2001, AGR ECOSYST ENVIRON, V87, P209, DOI 10.1016/S0167-8809(01)00279-1; Nyende R, 2004, EXP AGR, V40, P77, DOI 10.1017/S0014479703001443; Ortiz SM, 1994, EVALUACION CARTOGRAF; Ouedraogo E, 2001, AGR ECOSYST ENVIRON, V84, P259, DOI 10.1016/S0167-8809(00)00246-2; Pervanchon F, 2002, AGR SYST, V72, P149, DOI 10.1016/S0308-521X(01)00073-7; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Rigby D, 2001, ECOL ECON, V39, P463, DOI 10.1016/S0921-8009(01)00245-2; Riley J, 2001, AGR ECOSYST ENVIRON, V87, P119, DOI 10.1016/S0167-8809(01)00271-7; Rommelse R, 2001, ICRAF NATURAL RESOUR; Salski A, 1996, ECOL MODEL, V85, P1, DOI 10.1016/0304-3800(96)90053-8; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Shaahan MM, 1999, SCI HORTIC-AMSTERDAM, V82, P339, DOI 10.1016/S0304-4238(99)00060-6; STINNER B.R., 1987, AM J ALTERNATIVE AGR, V2, P146, DOI [10.1017/S0889189300009243, DOI 10.1017/S0889189300009243]; Tellarini V, 2000, AGR ECOSYST ENVIRON, V77, P111, DOI 10.1016/S0167-8809(99)00097-3; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; van der Werf HMG, 2002, AGR ECOSYST ENVIRON, V93, P131, DOI 10.1016/S0167-8809(01)00354-1	65	5	6	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112493	10.1371/journal.pone.0112493	http://dx.doi.org/10.1371/journal.pone.0112493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405980	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300036
J	Christopher, MM; Hawkins, MG; Burton, AG				Christopher, Mary M.; Hawkins, Michelle G.; Burton, Andrew G.			Poikilocytosis in Rabbits: Prevalence, Type, and Association with Disease	PLOS ONE			English	Article							LIVER-DISEASE; ECHINOCYTOSIS; ERYTHROCYTES; CHOLESTEROL; ANEMIA; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; ACANTHOCYTOSIS; INFLAMMATION; ASYMMETRY	Rabbits (Oryctolagus cuniculus) are a popular companion animal, food animal, and animal model of human disease. Abnormal red cell shapes (poikilocytes) have been observed in rabbits, but their significance is unknown. The objective of this study was to investigate the prevalence and type of poikilocytosis in pet rabbits and its association with physiologic factors, clinical disease, and laboratory abnormalities. We retrospectively analyzed blood smears from 482 rabbits presented to the University of California-Davis Veterinary Medical Teaching Hospital from 1990 to 2010. Number and type of poikilocytes per 2000 red blood cells (RBCs) were counted and expressed as a percentage. Acanthocytes (>3% of RBCs) were found in 150/482 (31%) rabbits and echinocytes (>3% of RBCs) were found in 127/482 (27%) of rabbits, both healthy and diseased. Thirty-three of 482 (7%) rabbits had >30% acanthocytes and echinocytes combined. Mild to moderate (>0.5% of RBCs) fragmented red cells (schistocytes, microcytes, keratocytes, spherocytes) were found in 25/403 (6%) diseased and 0/79 (0%) healthy rabbits (P = 0.0240). Fragmentation and acanthocytosis were more severe in rabbits with inflammatory disease and malignant neoplasia compared with healthy rabbits (P < 0.01). The % fragmented cells correlated with % polychromasia, RDW, and heterophil, monocyte, globulins, and fibrinogen concentrations (P < 0.05). Echinocytosis was significantly associated with renal failure, azotemia, and acid-base/electrolyte abnormalities (P < 0.05). Serum cholesterol concentration correlated significantly with % acanthocytes (P < 0.0001), % echinocytes (P = 0.0069), and % fragmented cells (P = 0.0109), but correlations were weak (Spearman rho < 0.02). These findings provide important insights into underlying pathophysiologic mechanisms that appear to affect the prevalence and type of naturally-occurring poikilocytosis in rabbits. Our findings support the need to carefully document poikilocytes in research investigations and in clinical diagnosis and to determine their diagnostic and prognostic value.	[Christopher, Mary M.] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA; [Hawkins, Michelle G.] Univ Calif Davis, Dept Med & Epidemiol, Davis, CA 95616 USA; [Burton, Andrew G.] Univ Calif Davis, William R Pritchard Vet Med Teaching Hosp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Christopher, MM (corresponding author), Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA.	mmchristopher@ucdavis.edu						Agroyannis B, 2001, ARTIF ORGANS, V25, P486, DOI 10.1046/j.1525-1594.2001.025006486.x; Christopher MM, 2008, ISR J VET MED, V63, P4; Christopher Mary M., 1994, Vet Clin Pathol, V23, P7, DOI 10.1111/j.1939-165X.1994.tb01007.x; COOPER RA, 1980, J LIPID RES, V21, P1082; Duranthon V, 2012, TRANSGENIC RES, V21, P699, DOI 10.1007/s11248-012-9599-x; Harvey J.W., 2012, VET HEMATOLOGY DIAGN, P328, DOI 10.1016/C2009-0-39565-3; KANAKARAJ P, 1989, ATHEROSCLEROSIS, V76, P209, DOI 10.1016/0021-9150(89)90105-6; Karbiner MS, 2013, LIFE SCI, V93, P503, DOI 10.1016/j.lfs.2013.08.003; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; KLAINER AS, 1972, INFECT IMMUN, V5, P808, DOI 10.1128/IAI.5.5.808-813.1972; Kuwai T, 2006, J ATHEROSCLER THROMB, V13, P286, DOI 10.5551/jat.13.286; LANGE Y, 1984, J MEMBRANE BIOL, V77, P153; Lichtman M, 2006, WILLIAMS HEMATOLOGY, Vseventh; Lopez-Revuelta A, 2007, FREE RADICAL BIO MED, V42, P1106, DOI 10.1016/j.freeradbiomed.2007.01.010; Marks PW, 2013, SEMIN HEMATOL, V50, P216, DOI 10.1053/j.seminhematol.2013.06.003; Moore DM, 1986, SCHALMS VET HEMATOLO, P1100; MORSE EE, 1990, ANN CLIN LAB SCI, V20, P169; OWEN JS, 1985, J CLIN INVEST, V76, P2275, DOI 10.1172/JCI112237; Palek J, 1994, WILLIAMS HEMATOLOGY, P557; PESSINA GP, 1981, INT J BIOCHEM, V13, P805, DOI 10.1016/0020-711X(81)90099-9; PINTER GG, 1961, AM J PHYSIOL, V200, P292, DOI 10.1152/ajplegacy.1961.200.2.292; REBAR AH, 1981, VET PATHOL, V18, P415, DOI 10.1177/030098588101800401; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Sakthivel R, 2007, CLIN CHIM ACTA, V382, P1, DOI 10.1016/j.cca.2007.02.044; Sanderson JH, 1981, ATLAS LAB ANIMAL HEM; Schermer S., 1967, BLOOD MORPHOLOGY LAB; Straat M, 2012, TRANSFUS MED HEMOTH, V39, P353, DOI 10.1159/000342229; Susheela AK, 1985, STUDIES ENV SCI, V27, P231; Warry E, 2013, VET CLIN PATH, V42, P465, DOI 10.1111/vcp.12097; Weiss D J, 1984, Vet Clin Pathol, V13, P27, DOI 10.1111/j.1939-165X.1984.tb00836.x; WEISS DJ, 1992, AM J VET RES, V53, P1769; Weiss Douglas J., 1993, Vet Clin Pathol, V22, P117, DOI 10.1111/j.1939-165X.1993.tb00663.x; Weiss Douglas J., 1990, Vet Clin Pathol, V19, P114, DOI 10.1111/j.1939-165X.1990.tb00556.x; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628; Zini G, 2012, INT J LAB HEMATOL, V34, P107, DOI 10.1111/j.1751-553X.2011.01380.x	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112455	10.1371/journal.pone.0112455	http://dx.doi.org/10.1371/journal.pone.0112455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402479	Green Published, gold			2022-12-27	WOS:000345158700045
J	Huber, R; Parsa, V; Scollie, S				Huber, Rainer; Parsa, Vijay; Scollie, Susan			Predicting the Perceived Sound Quality of Frequency-Compressed Speech	PLOS ONE			English	Article							AUDIO QUALITY; HEARING; MODEL; PERCEPTION; ACCLIMATIZATION; MUSIC	The performance of objective speech and audio quality measures for the prediction of the perceived quality of frequency-compressed speech in hearing aids is investigated in this paper. A number of existing quality measures have been applied to speech signals processed by a hearing aid, which compresses speech spectra along frequency in order to make information contained in higher frequencies audible for listeners with severe high-frequency hearing loss. Quality measures were compared with subjective ratings obtained from normal hearing and hearing impaired children and adults in an earlier study. High correlations were achieved with quality measures computed by quality models that are based on the auditory model of Dau et al., namely, the measure PSM, computed by the quality model PEMO-Q; the measure qc, computed by the quality model proposed by Hansen and Kollmeier; and the linear subcomponent of the HASQI. For the prediction of quality ratings by hearing impaired listeners, extensions of some models incorporating hearing loss were implemented and shown to achieve improved prediction accuracy. Results indicate that these objective quality measures can potentially serve as tools for assisting in initial setting of frequency compression parameters.	[Huber, Rainer] Ctr Competence HorTech gGmbH, Oldenburg, Germany; [Huber, Rainer] Cluster Excellence Hearing4All, Oldenburg, Germany; [Huber, Rainer] Ctr Competence HorTech gGmbH, Hannover, Germany; [Parsa, Vijay; Scollie, Susan] Univ Western Ontario, Natl Ctr Audiol, London, ON, Canada	Western University (University of Western Ontario)	Huber, R (corresponding author), Ctr Competence HorTech gGmbH, Oldenburg, Germany.	Rainer.Huber@HoerTech.de			Deutsche Forschungsgemeinschaft (Research Unit "Individualized Hearing Acoustics") [For-1732]; NSERC	Deutsche Forschungsgemeinschaft (Research Unit "Individualized Hearing Acoustics")(German Research Foundation (DFG)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the following: Deutsche Forschungsgemeinschaft (Research Unit "Individualized Hearing Acoustics"; For-1732) (to Dr. Huber), http://www.dfg.de/en/research_funding/programmes/coordinated_programmes/research_units/index.html; NSERC Discovery grant (to Dr. Vijay Parsa), http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp; and NSERC Collaborative Health Research grant (to Dr. Scollie), http://www.nserc-crsng.gc.ca/Professors-Professeurs/grants-subs/CHRP-PRCS_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, WID EXT REC P 862 AS; [Anonymous], 2001, PERC EV SPEECH QUAL; Beerends JG, 2008, P 124 AES CONV AMST; Beerends JG, 1994, WORKSH SPEECH QUAL A; Chen G, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P2174; Dau T, 1996, J ACOUST SOC AM, V99, P3623, DOI 10.1121/1.414960; Dau T, 1996, J ACOUST SOC AM, V99, P3615, DOI 10.1121/1.414959; Dau T, 1997, J ACOUST SOC AM, V102, P2906, DOI 10.1121/1.420345; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Derleth RP, 2000, J ACOUST SOC AM, V108, P285, DOI 10.1121/1.429464; Derleth RP, 2001, HEARING RES, V159, P132, DOI 10.1016/S0378-5955(01)00322-7; Dillon H., 2012, HEARING AIDS; Fassel R, 1994, THESIS U GOTTINGEN G; Glista D, 2012, J SPEECH LANG HEAR R, V55, P1765, DOI 10.1044/1092-4388(2012/11-0163); Glista D, 2009, INT J AUDIOL, V48, P632, DOI 10.1080/14992020902971349; Goetze S, 2010, P ICASSP; HAGERMAN B, 1985, SCAND AUDIOL, V14, P109, DOI 10.3109/01050398509045931; Hansen J, 1998, P ICSLP 98 SYDN AUST; Hansen M, 2000, J AUDIO ENG SOC, V48, P395; Huber R, 2010, 2 WORKSH SPEECH NOIS; Huber R, 2003, THESIS U OLDENBURG G; Huber R, 2006, IEEE T AUDIO SPEECH, V14, P1902, DOI 10.1109/TASL.2006.883259; ITAKURA F, 1975, IEEE T ACOUST SPEECH, VAS23, P67, DOI 10.1109/TASSP.1975.1162641; Itakura F, 1997, SPEECH ANAL; ITU-R Recommendation BS. 1387, 1998, METH OBJ MEAS PERC A; ITU-T, 2002, E MOD COMP MOD US TR; Kates JM, 2014, J AUDIO ENG SOC, V62, P99, DOI 10.17743/jaes.2014.0006; Kates JM, 2010, J AUDIO ENG SOC, V58, P363; Klatt D, 1998, P IEEE ICASSP, V1982, P1278; Kochkin S., 2002, HEAR REV, V9, P14; Krebber J, 2007, REPORT EXPT PERFORMA; Kuk P, 2006, HEARING REV, V13, P42; McDermott HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022358; Moore BCJ, 2004, EAR HEARING, V25, P98, DOI 10.1097/01.AUD.0000120359.49711.D7; Moore BCJ, 1997, AUDIT NEUROSCI, V3, P289; Moore BCJ, 2004, HEARING RES, V188, P70, DOI 10.1016/S0378-5955(03)00347-2; Moore BCJ, 2004, J AUDIO ENG SOC, V52, P1228; Moore BCJ, 2004, J AUDIO ENG SOC, V52, P900; Moore BCJ, 1997, CONTRIBUTIONS PSYCHO; Munkner S, 1993, CONTRIB PSYCHOL, P121; NIELSEN LB, 1993, OBJECTIVE SCALING SO; Ovegard A, 1997, SCAND AUDIOL, V26, P43, DOI 10.3109/01050399709074974; Parsa V, 2013, TRENDS AMPLIF, V17, P54, DOI 10.1177/1084713813480856; Quackenbush S. R., 1998, OBJECTIVE MEASURES S; Recommendation ITU-R, 2003, METH SUBJ ASS INT QU; Rix AW, 2006, IEEE T AUDIO SPEECH, V14, P1890, DOI 10.1109/TASL.2006.883260; Rohdenburg T, 2005, P INT WORKSH AC ECH; Sander A, 1994, THESIS U OLDENBURG G; Schmalfuss G, 2004, THESIS TU MUNICH GER; Scollie Susan, 2005, Trends Amplif, V9, P159, DOI 10.1177/108471380500900403; Simpson A, 2005, INT J AUDIOL, V44, P281, DOI 10.1080/14992020500060636; Souza PE, 2013, J SPEECH LANG HEAR R, V56, P1349, DOI 10.1044/1092-4388(2013/12-0151); Stelmachowicz PG, 2007, EAR HEARING, V28, P483, DOI 10.1097/AUD.0b013e31806dc265; Tan CT, 2004, J AUDIO ENG SOC, V52, P699; Verhey JL, 1998, PSYCHOACOUSTICS SPEC; Wolfe J, 2010, J AM ACAD AUDIOL, V21, P618, DOI 10.3766/jaaa.21.10.2; Wong Lena L N, 2003, Trends Amplif, V7, P117, DOI 10.1177/108471380300700402	57	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110260	10.1371/journal.pone.0110260	http://dx.doi.org/10.1371/journal.pone.0110260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402456	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700002
J	Wang, YX; Yang, M				Wang, Yixing; Yang, Ming			Loss-of-Function Mutants and Overexpression Lines of the Arabidopsis Cyclin CYCA1;2/TARDY ASYNCHRONOUS MEIOSIS Exhibit Different Defects in Prophase-I Meiocytes but Produce the Same Meiotic Products	PLOS ONE			English	Article							HISTONE-H3 SERINE-10 PHOSPHORYLATION; CELL-DIVISION; PROGRESSION; SYNAPSIS; RECOMBINATION; REGULATOR; ROUGHEX; PROTEIN; DAMAGE; SMG7	In Arabidopsis, loss-of-function mutations in the A-type cyclin CYCA1;2/TARDY ASYNCHRONOUS MEIOSIS (TAM) gene lead to the production of abnormal meiotic products including triads and dyads. Here we report that overexpression of TAM by the ASK1:TAM transgene also led to the production of triads and dyads in meiosis, as well as shriveled seeds, in a dominant fashion. However, the partial loss-of-function mutant tam-1, an ASK1:TAM line, and the wild type differed in dynamic changes in chromosome thread thickness from zygotene to diplotene. We also found that the pericentromeric heterochromatin regions in male meiocytes in tam-1 and tam-2 (a null allele) frequently formed a tight cluster at the pachytene and diplotene stages, in contrast to the infrequent occurrences of such clusters in the wild type and the ASK1:TAM line. Immunolocalization studies of the chromosome axial component ASY1 revealed that ASY1 was highly expressed at the appropriate male meiotic stages but not localized to the chromosomes in tam-2. The level of ASY1, however, was greatly reduced in another ASK1:TAM line with much overexpressed TAM. Our results indicate that the reduction and increase in the activity of TAM differentially affect chromosomal morphology and the action of ASY1 in prophase I. Based on these results, we propose that either the different meiotic defects or a common defect such as missing ASY1 on the chromosomal axes triggers a hitherto uncharacterized cell cycle checkpoint in the male meiocytes in the tam mutants and ASK1:TAM lines, leading to the production of the same abnormal meiotic products.	[Wang, Yixing; Yang, Ming] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yang, M (corresponding author), Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA.	ming.yang@okstate.edu			Environmental Institute, Oklahoma State University; Oklahoma Center for the Advancement of Science and Technology [PS13-006]	Environmental Institute, Oklahoma State University; Oklahoma Center for the Advancement of Science and Technology	This work was partially supported by a grant from the Environmental Institute, Oklahoma State University, and a grant (PS13-006) from the Oklahoma Center for the Advancement of Science and Technology to M.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SJ, 2002, J CELL SCI, V115, P3645, DOI 10.1242/jcs.00048; Avedisov SN, 2000, MOL CELL BIOL, V20, P8220, DOI 10.1128/MCB.20.21.8220-8229.2000; Bolcun-Filas E, 2014, SCIENCE, V343, P533, DOI 10.1126/science.1247671; Bulankova P, 2010, PLANT CELL, V22, P3791, DOI 10.1105/tpc.110.078378; Caryl AP, 2003, J EXP BOT, V54, P25, DOI 10.1093/jxb/erg041; Chaubet-Gigot N, 2000, PLANT MOL BIOL, V43, P659, DOI 10.1023/A:1006303100592; Chuang CN, 2012, NUCLEIC ACIDS RES, V40, P11416, DOI 10.1093/nar/gks920; Cromer L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002865; d'Erfurth I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000989; Foley E, 1999, CURR BIOL, V9, P1392, DOI 10.1016/S0960-9822(00)80084-6; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Garber PM, 2005, TRENDS BIOCHEM SCI, V30, P63, DOI 10.1016/j.tibs.2004.12.004; GONCZY P, 1994, CELL, V77, P1015, DOI 10.1016/0092-8674(94)90441-3; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Iwata E, 2011, PLANT CELL, V23, P4382, DOI 10.1105/tpc.111.092049; Jha AK, 2014, PLANT MOL BIOL, V85, P81, DOI 10.1007/s11103-013-0170-9; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Magnard JL, 2001, PLANT PHYSIOL, V127, P1157, DOI 10.1104/pp.010473; Nickerson HD, 2007, DEV BIOL, V306, P725, DOI 10.1016/j.ydbio.2007.04.009; Riehs N, 2008, J CELL SCI, V121, P2208, DOI 10.1242/jcs.027862; Ross KJ, 1997, CHROMOSOME RES, V5, P551, DOI 10.1023/A:1018497804129; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Subramanian VV, 2014, COLD SPRING HARB PER, V6; Vasileva A, 2013, J CELL SCI, V126, P3927, DOI 10.1242/jcs.126763; Wang YX, 2010, GENESIS, V48, P254, DOI [10.1002/dvg.20610, 10.1002/dvg.20629]; Wang YX, 2004, PLANT PHYSIOL, V136, P4127, DOI 10.1104/pp.104.051201; Wang YX, 2004, SEX PLANT REPROD, V16, P273, DOI 10.1007/s00497-004-0206-z; Wijnker E, 2013, PLANT REPROD, V26, P143, DOI 10.1007/s00497-013-0223-x; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Yang M, 1999, P NATL ACAD SCI USA, V96, P11416, DOI 10.1073/pnas.96.20.11416; Yang M, 2001, PLANT PHYSIOL, V126, P622, DOI 10.1104/pp.126.2.622; Zamariola L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00279	33	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113348	10.1371/journal.pone.0113348	http://dx.doi.org/10.1371/journal.pone.0113348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402453	Green Submitted, gold, Green Published			2022-12-27	WOS:000345158700132
J	Bennett, L; Kittas, A; Liu, S; Papageorgiou, LG; Tsoka, S				Bennett, Laura; Kittas, Aristotelis; Liu, Songsong; Papageorgiou, Lazaros G.; Tsoka, Sophia			Community Structure Detection for Overlapping Modules through Mathematical Programming in Protein Interaction Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; FUNCTIONAL MODULES; MODULARITY; APOPTOSIS; GENOME; IDENTIFICATION; ESSENTIALITY; CENTRALITY; DATABASE; CHAINS	Community structure detection has proven to be important in revealing the underlying properties of complex networks. The standard problem, where a partition of disjoint communities is sought, has been continually adapted to offer more realistic models of interactions in these systems. Here, a two-step procedure is outlined for exploring the concept of overlapping communities. First, a hard partition is detected by employing existing methodologies. We then propose a novel mixed integer non linear programming (MINLP) model, known as OverMod, which transforms disjoint communities to overlapping. The procedure is evaluated through its application to protein-protein interaction (PPI) networks of the rat, E. coli, yeast and human organisms. Connector nodes of hard partitions exhibit topological and functional properties indicative of their suitability as candidates for multiple module membership. OverMod identifies two types of connector nodes, inter and intra-connector, each with their own particular characteristics pertaining to their topological and functional role in the organisation of the network. Inter-connector proteins are shown to be highly conserved proteins participating in pathways that control essential cellular processes, such as proliferation, differentiation and apoptosis and their differences with intra-connectors is highlighted. Many of these proteins are shown to possess multiple roles of distinct nature through their participation in different network modules, setting them apart from proteins that are simply 'hubs', i.e. proteins with many interaction partners but with a more specific biochemical role.	[Bennett, Laura; Liu, Songsong; Papageorgiou, Lazaros G.] UCL, Dept Chem Engn, Ctr Proc Syst Engn, London WC1E 7JE, England; [Kittas, Aristotelis; Tsoka, Sophia] Kings Coll London, Dept Informat, London WC2R 2LS, England	University of London; University College London; University of London; King's College London	Tsoka, S (corresponding author), Kings Coll London, Dept Informat, London WC2R 2LS, England.	sophia.tsoka@kcl.ac.uk	Liu, Songsong/B-4580-2012; Papageorgiou, Lazaros/L-2122-2013	Liu, Songsong/0000-0001-8412-274X; Tsoka, Sophia/0000-0001-8403-1282; Papageorgiou, Lazaros/0000-0003-4652-6086	EU [HEALTH-F2-2011-261366]; Leverhulme Trust [RPG-2012-686]; UK Engineering & Physical Sciences Research Council	EU(European Commission); Leverhulme Trust(Leverhulme Trust); UK Engineering & Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The funding of the EU (to ST; HEALTH-F2-2011-261366), the Leverhulme Trust (to ST and LGP; RPG-2012-686) and the UK Engineering & Physical Sciences Research Council (to LGP; EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2008, EUR PHYS J B, V66, P409, DOI 10.1140/epjb/e2008-00425-1; Aloise D, 2013, CONTEMP MATH, V588, P113, DOI 10.1090/conm/588/11705; Aloise D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046112; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asur S, 2007, BIOINFORMATICS, V23, pI29, DOI 10.1093/bioinformatics/btm212; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Becker E, 2012, BIOINFORMATICS, V28, P84, DOI 10.1093/bioinformatics/btr621; Bennett L, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911500238; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cafieri S, 2014, DISCRETE APPL MATH, V163, P65, DOI 10.1016/j.dam.2012.03.030; Cafieri S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056105; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dartnell L, 2005, FEBS LETT, V579, P3037, DOI 10.1016/j.febslet.2005.03.101; Dhillon IS, 2007, IEEE T PATTERN ANAL, V29, P1944, DOI 10.1109/TP'AMI.2007.1115; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dwinell MR, 2009, NUCLEIC ACIDS RES, V37, pD744, DOI 10.1093/nar/gkn842; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jierui Xie, 2012, Advances in Knowledge Discovery and Data Mining. Proceedings 16th Pacific-Asia Conference (PAKDD 2012), P25, DOI 10.1007/978-3-642-30220-6_3; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lewis ACF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-100; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Medus A, 2005, PHYSICA A, V358, P593, DOI 10.1016/j.physa.2005.04.022; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pei DS, 2012, ONCOTARGET, V3, P228; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenthal R, 2008, GAMS USERS GUIDE; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen HW, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07042; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih YK, 2012, BIOINFORMATICS, V28, pI473, DOI 10.1093/bioinformatics/bts370; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Ucar D, 2006, LECT NOTES ARTIF INT, V4213, P371; Voevodski K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-297; Wakita K, 2007, 16 INT WORLD WIDE WE, P1275, DOI [10.1145/1242572.1242805, DOI 10.1145/1242572.1242805]; Wang XS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S4; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Xu G, 2007, EUR PHYS J B, V60, P231, DOI 10.1140/epjb/e2007-00331-0; Xu G, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-36; Yoshihama M, 2006, PLOS GENET, V2, P237, DOI 10.1371/journal.pgen.0020025; Zhang RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048141, 10.1371/journal.pone.0050348]; Zinman GE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-134	81	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112821	10.1371/journal.pone.0112821	http://dx.doi.org/10.1371/journal.pone.0112821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412367	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000016
J	Leyn, SA; Suvorova, IA; Kholina, TD; Sherstneva, SS; Novichkov, PS; Gelfand, MS; Rodionov, DA				Leyn, Semen A.; Suvorova, Inna A.; Kholina, Tatiana D.; Sherstneva, Sofia S.; Novichkov, Pavel S.; Gelfand, Mikhail S.; Rodionov, Dmitry A.			Comparative Genomics of Transcriptional Regulation of Methionine Metabolism in Proteobacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; S-ADENOSYLHOMOCYSTEINE; SALMONELLA-TYPHIMURIUM; CORYNEBACTERIUM-GLUTAMICUM; BIOSYNTHETIC-PATHWAY; SALVAGE PATHWAY; NAD METABOLISM; METR PROTEIN; BINDING-SITE; RNA MOTIFS	Methionine metabolism and uptake genes in Proteobacteria are controlled by a variety of RNA and DNA regulatory systems. We have applied comparative genomics to reconstruct regulons for three known transcription factors, MetJ, MetR, and SahR, and three known riboswitch motifs, SAH, SAM-SAH, and SAM_alpha, in similar to 200 genomes from 22 taxonomic groups of Proteobacteria. We also identified two novel regulons: a SahR-like transcription factor SamR controlling various methionine biosynthesis genes in the Xanthomonadales group, and a potential RNA regulatory element with terminator-antiterminator mechanism controlling the metX or metZ genes in beta-proteobacteria. For each analyzed regulator we identified the core, taxon-specific and genome-specific regulon members. By analyzing the distribution of these regulators in bacterial genomes and by comparing their regulon contents we elucidated possible evolutionary scenarios for the regulation of the methionine metabolism genes in Proteobacteria.	[Leyn, Semen A.; Suvorova, Inna A.; Gelfand, Mikhail S.; Rodionov, Dmitry A.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Kholina, Tatiana D.; Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Sherstneva, Sofia S.] Comprehens Sch 463, Moscow, Russia; [Novichkov, Pavel S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Rodionov, Dmitry A.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Sanford Burnham Prebys Medical Discovery Institute	Rodionov, DA (corresponding author), Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia.	rodionov@burnham.org	Leyn, Semen A/J-1069-2019; Rodionov, Dmitry A/V-2688-2018; Gelfand, Mikhail S/F-3425-2012	Leyn, Semen A/0000-0002-9886-9120; Gelfand, Mikhail/0000-0003-4181-0846	Russian Science Foundation [14-14-00289, 14-24-00155]; Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER); U.S. Department of Energy (DOE)	Russian Science Foundation(Russian Science Foundation (RSF)); Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER); U.S. Department of Energy (DOE)(United States Department of Energy (DOE))	This research was supported by the Russian Science Foundation via grants 14-14-00289 (to S.A.L and D.A.R.) and 14-24-00155 (to I.A.S. and M.S.G.). This research was also partially supported by the Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), and U.S. Department of Energy (DOE), and is a contribution of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2001, ARCH MICROBIOL, V176, P151, DOI 10.1007/s002030100293; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Augustus AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-558; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batey RT, 2011, WIRES RNA, V2, P299, DOI 10.1002/wrna.63; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; Bourhy P, 1997, J BACTERIOL, V179, P4396, DOI 10.1128/jb.179.13.4396-4398.1997; Brune I, 2011, J BIOTECHNOL, V151, P22, DOI 10.1016/j.jbiotec.2010.11.005; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; CAI XY, 1989, P NATL ACAD SCI USA, V86, P4407, DOI 10.1073/pnas.86.12.4407; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; COWAN JM, 1993, J BACTERIOL, V175, P5862, DOI 10.1128/JB.175.18.5862-5866.1993; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; FOGLINO M, 1995, MICROBIOL-UK, V141, P431, DOI 10.1099/13500872-141-2-431; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Gophna U, 2005, GENE, V355, P48, DOI 10.1016/j.gene.2005.05.028; Green RC, 1994, ESCHERICHIA COLI SAL, P542; Grundy FJ, 2003, FRONT BIOSCI-LANDMRK, V8, pD20, DOI 10.2741/908; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; Kovaleva GY, 2007, FEMS MICROBIOL LETT, V276, P207, DOI 10.1111/j.1574-6968.2007.00934.x; Lee HS, 2003, APPL MICROBIOL BIOT, V62, P459, DOI 10.1007/s00253-003-1306-7; Liu MJ, 2012, J BACTERIOL, V194, P3522, DOI 10.1128/JB.06816-11; MARES R, 1992, J BACTERIOL, V174, P390, DOI 10.1128/jb.174.2.390-397.1992; Marincs F, 2006, BIOCHEM J, V396, P227, DOI 10.1042/BJ20060021; MARTEL A, 1987, BIOCHEM BIOPH RES CO, V147, P565, DOI 10.1016/0006-291X(87)90968-5; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Novichkov PS, 2014, ENVIRON MICROBIOL, V16, P1, DOI 10.1111/1462-2920.12273; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Park SD, 1998, MOL CELLS, V8, P286; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Price IR, 2014, BIOCH BIOPHYS ACTA; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Rey DA, 2005, MOL MICROBIOL, V56, P871, DOI 10.1111/j.1365-2958.2005.04586.x; Rodionov DA, 2004, NUCLEIC ACIDS RES, V32, P3340, DOI 10.1093/nar/gkh659; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2032, DOI 10.1093/nar/gkn046; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; ROWBURY RJ, 1964, J GEN MICROBIOL, V36, P341, DOI 10.1099/00221287-36-3-341; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Smith AM, 2010, MOL MICROBIOL, V78, P1393, DOI 10.1111/j.1365-2958.2010.07410.x; Sperandio B, 2005, J BACTERIOL, V187, P3762, DOI 10.1128/JB.187.11.3762-3778.2005; Sperandio B, 2007, J BACTERIOL, V189, P7032, DOI 10.1128/JB.00703-07; Sun EI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-597; Tuite NL, 2005, J BACTERIOL, V187, P4362, DOI 10.1128/JB.187.13.4362-4371.2005; UELAND PM, 1982, PHARMACOL REV, V34, P223; URBANOWSKI ML, 1989, J BACTERIOL, V171, P3277, DOI 10.1128/jb.171.6.3277-3281.1989; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Wang JX, 2008, BIOCHEM CELL BIOL, V86, P157, DOI 10.1139/O08-008; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	14	14	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113714	10.1371/journal.pone.0113714	http://dx.doi.org/10.1371/journal.pone.0113714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411846	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000074
J	Li, B; Ma, YF; Huang, JL; Xiao, XF; Li, L; Liu, C; Shi, YQ; Wang, D; Wang, XH				Li, Bo; Ma, Yefei; Huang, Jianlei; Xiao, Xifeng; Li, Li; Liu, Chuang; Shi, Yongqian; Wang, Dong; Wang, Xiaohong			Probing the Effect of Human Normal Sperm Morphology Rate on Cycle Outcomes and Assisted Reproductive Methods Selection	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; BIRTH-WEIGHT; CHROMOSOMAL-ABNORMALITIES; SEMEN PARAMETERS; STRICT CRITERIA; INFERTILE MEN; PATERNAL AGE; SEX-RATIO; PREGNANCY; EMBRYOS	Sperm morphology is the best predictor of fertilization potential, and the critical predictive information for supporting assisted reproductive methods selection. Given its important predictive value and the declining reality of semen quality in recent years, the threshold of normal sperm morphology rate (NSMR) is being constantly corrected and controversial, from the 4th edition (14%) to the 5th version (4%). We retrospectively analyzed 4756 cases of infertility patients treated with conventional-IVF(c-IVF) or ICSI, which were divided into three groups according to NSMR: >= 14%, 4%-14% and <4%. Here, we demonstrate that, with decrease in NSMR(>= 14%, 4%-14%, <4%), in the c-IVF group, the rate of fertilization, normal fertilization, high-quality embryo, multi-pregnancy and birth weight of twins gradually decreased significantly (P<0.05), while the miscarriage rate was significantly increased (p<0.01) and implantation rate, clinical pregnancy rate, ectopic pregnancy rate, preterm birth rate, live birth rate, sex ratio, and birth weight(Singleton) showed no significant change. In the ICSI group, with decrease in NSMR (>= 14%, 4%-14%, <4%), high-quality embryo rate, multi-pregnancy rate and birth weight of twins were gradually decreased significantly (p<0.05), while other parameters had no significant difference. Considering the clinical assisted methods selection, in the NFMR >= 14% group, normal fertilization rate of c-IVF was significantly higher than the ICSI group (P<0.05), in the 4%-14% group, birth weight (twins) of c-IVF were significantly higher than the ICSI group, in the <4% group, miscarriage of c-IVF was significantly higher than the ICSI group. Therefore, we conclude that NSMR is positively related to embryo reproductive potential, and when NSMR<4% (5th edition), ICSI should be considered first, while the NSMR >= 4%, c-IVF assisted reproduction might be preferred.	[Li, Bo; Ma, Yefei; Huang, Jianlei; Xiao, Xifeng; Li, Li; Liu, Chuang; Shi, Yongqian; Wang, Dong; Wang, Xiaohong] Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710038, Peoples R China	Air Force Military Medical University	Li, B (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710038, Peoples R China.	lbtn2000@126.com; xhwang_1968@126.com	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Li, Bo/0000-0001-7818-0070	National Natural Science Foundation of China [81300531]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Grant No. 81300531), http://www.nsfc.gov.cn/. B.L. received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori M, 2008, REPROD BIOMED ONLINE, V16, P835, DOI 10.1016/S1472-6483(10)60150-2; Belloc S, 2008, REPROD BIOMED ONLINE, V17, P392, DOI 10.1016/S1472-6483(10)60223-4; Berger DS, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-37; Berkovitz A, 2005, HUM REPROD, V20, P185, DOI 10.1093/humrep/deh545; Bloise E, 2012, ENDOCRINOLOGY, V153, P3457, DOI 10.1210/en.2011-1921; Brahem S, 2011, J ASSIST REPROD GEN, V28, P41, DOI 10.1007/s10815-010-9482-8; Brugh VM, 2004, MED CLIN N AM, V88, P367, DOI 10.1016/S0025-7125(03)00150-0; Calogero A E, 2003, Reprod Biomed Online, V6, P310; Dul EC, 2012, HUM REPROD, V27, P2850, DOI 10.1093/humrep/des222; Eaton JL, 2012, HUM REPROD, V27, P375, DOI 10.1093/humrep/der381; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; Gardner DK, 2011, HUM REPROD, V26, P1981, DOI 10.1093/humrep/der143; GOSHEN R, 1994, FERTIL STERIL, V62, P903; GROW DR, 1994, FERTIL STERIL, V62, P559; Gutierrez-Adan A, 2001, REPROD FERT DEVELOP, V13, P361, DOI 10.1071/RD00039; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Haeussner E, 2013, PLACENTA, V34, P574, DOI 10.1016/j.placenta.2013.04.011; Horsthemke B, 2005, HUM REPROD UPDATE, V11, P473, DOI 10.1093/humupd/dmi022; Hotaling JM, 2011, FERTIL STERIL, V95, P1141, DOI 10.1016/j.fertnstert.2010.09.029; Kahraman S, 2006, REPROD BIOMED ONLINE, V12, P752, DOI 10.1016/S1472-6483(10)61087-5; Keegan BR, 2007, FERTIL STERIL, V88, P1583, DOI 10.1016/j.fertnstert.2007.01.057; KRUGER TF, 1988, FERTIL STERIL, V49, P112; Kruger TF, 1999, HUM REPROD UPDATE, V5, P172, DOI 10.1093/humupd/5.2.172; Lewis-Jones I, 2003, FERTIL STERIL, V79, P212, DOI 10.1016/S0015-0282(02)04411-4; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071215; Loebel DAF, 2004, NATURE, V428, P809, DOI 10.1038/428809a; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Mokanszki A, 2012, REPROD BIOMED ONLINE, V25, P620, DOI 10.1016/j.rbmo.2012.08.003; Natali I, 2013, FERTIL STERIL, V99, P1227, DOI 10.1016/j.fertnstert.2012.11.047; Ombelet W, 1997, HUM REPROD, V12, P987; Perrin A, 2011, REPROD BIOMED ONLINE, V22, P148, DOI 10.1016/j.rbmo.2010.10.006; Rubessa M, 2011, THERIOGENOLOGY, V76, P1347, DOI 10.1016/j.theriogenology.2011.06.004; Shih W, 2008, HUM REPROD, V23, P1644, DOI 10.1093/humrep/den150; Terriou P, 2001, FERTIL STERIL, V75, P525, DOI 10.1016/S0015-0282(00)01741-6; Utsuno H, 2013, FERTIL STERIL, V99, P1573, DOI 10.1016/j.fertnstert.2013.01.100; Vawda AI, 1996, HUM REPROD, V11, P1445; Wong EC, 2011, FERTIL STERIL, V95, P2524, DOI 10.1016/j.fertnstert.2011.05.047; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011; Zhong YP, 2012, INT J MED SCI, V9, P121, DOI 10.7150/ijms.3467	40	21	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113392	10.1371/journal.pone.0113392	http://dx.doi.org/10.1371/journal.pone.0113392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411962	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000048
J	Magnezi, R; Glasser, S				Magnezi, Racheli; Glasser, Saralee			Psychometric Properties of the Hebrew Translation of the Patient Activation Measure (PAM-13)	PLOS ONE			English	Article							PRIMARY-CARE; SHORT-FORM; DEPRESSION; OUTCOMES; PHQ-9	Objective: "Patient activation'' reflects involvement in managing ones health. This cross-sectional study assessed the psychometric properties of the Hebrew translation (PAM-H) of the PAM-13. Methods: A nationally representative sample of 203 Hebrew-speaking Israeli adults answered the PAM-H, PHQ-9 depression scale, SF-12, and Self-efficacy Scale via telephone. Results: Mean PAM-H scores were 70.7 +/- 15.4. Rasch analysis indicated that the PAM-H is a good measure of activation. There were no differences in PAM-H scores based on gender, age or education. Subjects with chronic disease scored lower than those without. Scores correlated with the Self-efficacy Scale (0.47), Total SF-12 (0.39) and PHQ-9 (-0.35, P<0.0001), indicating concurrent validity. Discriminant validity was reflected by a significant difference in the mean PAM-H score of those who scored below 10 (72.1 +/- 14.8) on the PHQ-9 (not depressed) compared to those scoring >= 10 (i.e. probable depression) (59.2 +/- 15.8; t 3.75; P = 0.001). Conclusion: The PAM-H psychometric properties indicate its usefulness with the Hebrew-speaking Israeli population.	[Magnezi, Racheli] Bar Ilan Univ, Dept Management, Ramat Gan, Israel; [Glasser, Saralee] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel	Bar Ilan University; Chaim Sheba Medical Center	Magnezi, R (corresponding author), Bar Ilan Univ, Dept Management, Ramat Gan, Israel.	magnezir@biu.ac.il			Israel National Institute for Health Policy Research Grant [206981]	Israel National Institute for Health Policy Research Grant	This research was fully funded by the Israel National Institute for Health Policy Research Grant #206981. www.israelhpr.org.il/e/. The funders or any individuals employed or contracted by them had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alegria M, 2009, J GEN INTERN MED, V24, P534, DOI 10.1007/s11606-009-1074-x; Amir M, 2002, MED CARE, V40, P918, DOI 10.1097/00005650-200210000-00009; Geulayov G, 2009, ISR J PSYCHIAT, V46, P45; Green CA, 2010, ADM POLICY MENT HLTH, V37, P327, DOI 10.1007/s10488-009-0239-6; Greene J, 2005, MUCH DO HLTH LITERAC; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2009, AM J MANAG CARE, V15, P353; Insignia Health LLC, PAT ACT MEAS PAM 12; Insignia Health LLC, PAT ACT MEAS PAM 13; Israel Ministry of Health, 2011, HLTH SERV ISR; Jerusalem M., 1992, SELF EFFICACY THOUGH, P195, DOI DOI 10.4324/9781315800820; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee HS, 2014, SUBST USE MISUSE, V49, P1332, DOI 10.3109/10826084.2014.901386; Linacre J. M., 2014, DIMENSIONALITY CONTR; Magnezi R, 2014, PATIENT EDUC COUNS, V94, P432, DOI 10.1016/j.pec.2013.10.015; Magnezi R, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2630; Mahoney ER, 2011, INSIGNIA PSYCHOMETRI; Maindal HT, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-209; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Marshall R, 2013, J GEN INTERN MED, V28, P668, DOI 10.1007/s11606-012-2307-y; Mohebi Siamak, 2014, J Educ Health Promot, V3, P21, DOI 10.4103/2277-9531.127608; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Rademakers J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-577; Remmers C, 2009, J AMBUL CARE MANAG, V32, P320, DOI 10.1097/JAC.0b013e3181ba6e77; Schwarzer R., 1993, MEASUREMENT PERCEIVE; Simon Y, 2007, THESIS TEL AVIV YAFF; Skolasky RL, 2011, HEALTH SERV RES, V46, P457, DOI 10.1111/j.1475-6773.2010.01210.x; Skolasky RL, 2009, QUAL LIFE RES, V18, P1357, DOI 10.1007/s11136-009-9549-0; Skolasky Richard L, 2008, Spine (Phila Pa 1976), V33, pE784, DOI 10.1097/BRS.0b013e31818027f1; Stempleman L, 2010, DISABIL REHABIL, V32, P1158; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wong ST, 2011, MED CARE, V49, P469, DOI 10.1097/MLR.0b013e31820bf970; World Health Organization, PROC TRANSL AD INSTR; Zeidner M, 1994, HEBREW VERSION SELF; Zill JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1027	38	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113391	10.1371/journal.pone.0113391	http://dx.doi.org/10.1371/journal.pone.0113391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25411841	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000047
J	Ojima-Kato, T; Yamamoto, N; Suzuki, M; Fukunaga, T; Tamura, H				Ojima-Kato, Teruyo; Yamamoto, Naomi; Suzuki, Mayumi; Fukunaga, Tomohiro; Tamura, Hiroto			Discrimination of Escherichia coli O157, O26 and O111 from Other Serovars by MALDI-TOF MS Based on the S10-GERMS Method	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; S10-SPC-ALPHA OPERON; STRAIN LEVEL; PROTEINS; CLASSIFICATION; GENOMES; IDENTIFICATION; PSEUDOMONAS; BIOMARKERS	Enterohemorrhagic Escherichia coli (EHEC), causes a potentially life-threatening infection in humans worldwide. Serovar O157:H7, and to a lesser extent serovars O26 and O111, are the most commonly reported EHEC serovars responsible for a large number of outbreaks. We have established a rapid discrimination method for E. coli serovars O157, O26 and O111 from other E. coli serovars, based on the pattern matching of mass spectrometry (MS) differences and the presence/absence of biomarker proteins detected in matrix-assisted laser desorption/ionization time-of-flight MS (MALDI-TOF MS). Three biomarkers, ribosomal proteins S15 and L25, and acid stress chaperone HdeB, with MS m/z peaks at 10138.6/10166.6, 10676.4/10694.4 and 9066.2, respectively, were identified as effective biomarkers for O157 discrimination. To distinguish serovars O26 and O111 from the others, DNA-binding protein H-NS, with an MS peak at m/z 15409.4/15425.4 was identified. Sequence analysis of the O157 biomarkers revealed that amino acid changes: Q80R in S15, M50I in L25 and one mutation within the start codon ATG to ATA in the encoded HdeB protein, contributed to the specific peak pattern in O157. We demonstrated semi-automated pattern matching using these biomarkers and successfully discriminated total 57 O157 strains, 20 O26 strains and 6 O111 strains with 100% reliability by conventional MALDI-TOF MS analysis, regardless of the sample conditions. Our simple strategy, based on the S10-spc-alpha operon gene-encoded ribosomal protein mass spectrum (S10-GERMS) method, therefore allows for the rapid and reliable detection of this pathogen and may prove to be an invaluable tool both clinically and in the food industry.	[Ojima-Kato, Teruyo] Aichi Sci & Technol Fdn, Hub Knowledge Aichi, Toyota, Aichi, Japan; [Yamamoto, Naomi; Suzuki, Mayumi; Tamura, Hiroto] Meijo Univ, Sch Agr, Tenpaku ku, Nagoya, Aichi, Japan; [Fukunaga, Tomohiro] Japan Food Res Labs, Naka Ku, Nagoya, Aichi, Japan	Meijo University	Ojima-Kato, T (corresponding author), Aichi Sci & Technol Fdn, Hub Knowledge Aichi, Toyota, Aichi, Japan.	teruyo.ojima@gmail.com; hiroto@meijo-u.ac.jp			Aichi Science and Technology Foundation (Japan)	Aichi Science and Technology Foundation (Japan)	This work was financially supported by Aichi Science and Technology Foundation (Japan, http://www.astf.or.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barloy-Hubler F, 2001, NUCLEIC ACIDS RES, V29, P2747, DOI 10.1093/nar/29.13.2747; Benagli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048441; Carter MQ, 2012, APPL ENVIRON MICROB, V78, P1004, DOI 10.1128/AEM.07033-11; Clark CG, 2013, J MICROBIOL METH, V94, P180, DOI 10.1016/j.mimet.2013.06.020; Coenye T, 2005, FEMS MICROBIOL LETT, V242, P117, DOI 10.1016/j.femsle.2004.10.050; Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; Hotta Y, 2011, J AGR FOOD CHEM, V59, P5222, DOI 10.1021/jf2004095; Hotta Y, 2010, J PROTEOME RES, V9, P6722, DOI 10.1021/pr100868d; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Khot PD, 2013, J CLIN MICROBIOL, V51, P3711, DOI 10.1128/JCM.01526-13; Momo RA, 2013, ANAL BIOANAL CHEM, V405, P8251, DOI 10.1007/s00216-013-7245-y; Sato H, 2012, SYST APPL MICROBIOL, V35, P447, DOI 10.1016/j.syapm.2012.08.008; Tamura H, 2013, J AM SOC MASS SPECTR, V24, P1185, DOI 10.1007/s13361-013-0627-8; Teramoto K, 2007, ANAL CHEM, V79, P8712, DOI 10.1021/ac701905r; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; Wieme AD, 2014, APPL ENVIRON MICROB, V80, P1528, DOI 10.1128/AEM.03708-13; Ziegler D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037189	21	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113458	10.1371/journal.pone.0113458	http://dx.doi.org/10.1371/journal.pone.0113458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411793	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000055
J	Black, KH; Travouillon, KJ; Den Boer, W; Kear, BP; Cooke, BN; Archer, M				Black, Karen H.; Travouillon, Kenny J.; Den Boer, Wendy; Kear, Benjamin P.; Cooke, Bernard N.; Archer, Michael			A New Species of the Basal "Kangaroo'' Balbaroo and a Re-Evaluation of Stem Macropodiform Interrelationships	PLOS ONE			English	Article							WORLD HERITAGE AREA; NORTHWESTERN QUEENSLAND; BANDICOOTS MARSUPIALIA; PHYLOGENETIC INFERENCE; OLIGOMIOCENE DEPOSITS; MISSING ENTRIES; LATE OLIGOCENE; MIOCENE; RIVERSLEIGH; PERAMELEMORPHIA	Exceptionally well-preserved skulls and postcranial elements of a new species of the plesiomorphic stem macropodiform Balbaroo have been recovered from middle Miocene freshwater limestone deposits in the Riversleigh World Heritage Area of northwestern Queensland, Australia. This constitutes the richest intraspecific sample for any currently known basal "kangaroo'', and, along with additional material referred to Balbaroo fangaroo, provides new insights into structural variability within the most prolific archaic macropodiform clade - Balbaridae. Qualitative and metric evaluations of taxonomic boundaries demonstrate that the previously distinct species Nambaroo bullockensis is a junior synonym of B. camfieldensis. Furthermore, coupled Maximum Parsimony and Bayesian phylogenetic analyses reveal that our new Balbaroo remains represent the most derived member of the Balbaroo lineage, and are closely related to the middle Miocene B. camfieldensis, which like most named balbarid species is identifiable only from isolated jaws. The postcranial elements of Balbaroo concur with earlier finds of the stratigraphically oldest balbarid skeleton, Nambaroo gillespieae, and suggest that quadrupedal progression was a primary gait mode as opposed to bipedal saltation. All Balbaroo spp. have low-crowned bilophodont molars, which are typical for browsing herbivores inhabiting the densely forested environments envisaged for middle Miocene northeastern Australia.	[Black, Karen H.; Travouillon, Kenny J.; Archer, Michael] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Travouillon, Kenny J.] Univ Queensland, Sch Earth Sci, St Lucia, Qld, Australia; [Den Boer, Wendy; Kear, Benjamin P.] Uppsala Univ, Dept Earth Sci, Palaeobiol Programme, Uppsala, Sweden; [Cooke, Bernard N.] Queensland Museum, South Brisbane, Qld, Australia	University of New South Wales Sydney; University of Queensland; Uppsala University; Queensland Museum	Black, KH (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	k.black@unsw.edu.au	Travouillon, Kenny/ABD-1040-2021	Black, Karen/0000-0003-0645-5172; Archer, Michael/0000-0002-0304-4039; Travouillon, Kenny/0000-0003-1734-4742	Australian Research Council [DE130100467, DP043262, DP1094569, LP0453664, LP0989969, LP100200486]; Xstrata Community Partnership Program North Queensland; Queensland Parks and Wildlife Service, Environment Australia; Queensland and Australian Museums; University of New South Wales; P. Creaser and the CREATE Fund at UNSW; Outback at Isa; Mount Isa City Council; Waanyi people of northwestern Queensland; University of Queensland; Swedish Research Council	Australian Research Council(Australian Research Council); Xstrata Community Partnership Program North Queensland; Queensland Parks and Wildlife Service, Environment Australia; Queensland and Australian Museums; University of New South Wales; P. Creaser and the CREATE Fund at UNSW; Outback at Isa; Mount Isa City Council; Waanyi people of northwestern Queensland; University of Queensland(University of Queensland); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Support for Riversleigh research has been provided by the Australian Research Council grants to MA, Suzanne J. Hand and KHB (DE130100467, DP043262, DP1094569, LP0453664, LP0989969, LP100200486), Xstrata Community Partnership Program North Queensland, Queensland Parks and Wildlife Service, Environment Australia, the Queensland and Australian Museums, University of New South Wales, P. Creaser and the CREATE Fund at UNSW, Outback at Isa, Mount Isa City Council and the Waanyi people of northwestern Queensland. R. Day provided funding to the University of Queensland to create a postdoctoral position for KJT. BPK acknowledges funding from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2001, SYST BIOL, V50, P170; Aplin K.P., 1987, P369; APLIN KP, 1990, THESIS U NEW S WALES; Archer M, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P77; ARCHER M, 1978, Memoirs of the Queensland Museum, V18, P157; Archer M., 1982, P477; ARCHER M, 1989, Australian Zoologist, V25, P29; ARCHER M, 1976, ZOOL J LINN SOC-LOND, V59, P217, DOI 10.1111/j.1096-3642.1976.tb01016.x; Archer M., 2006, ALCHERINGA AUSTRALAS, V30, P1, DOI DOI 10.1080/03115510609506851; Archer Michael, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P131; Arena DA, 2005, GEOLOGICAL HIST DEV; Arena DA, 2014, SEDIMENT GEOL, V304, P28, DOI 10.1016/j.sedgeo.2014.01.005; BARTHOLOMAI A, 1971, Memoirs of the Queensland Museum, V16, P1; Billups K, 2010, SPEC PUBL INT ASS SE, V42, P1; Black K, 2006, ALCHERINGA, V30, P351, DOI 10.1080/03115510608619322; Black Karen, 1997, Memoirs of the Queensland Museum, V41, P181; Black Karen, 1997, Memoirs of the Queensland Museum, V41, P187; Black KH, 2014, GONDWANA RES, V25, P1186, DOI 10.1016/j.gr.2013.12.008; Black KH, 2014, J SYST PALAEONTOL, V12, P237, DOI 10.1080/14772019.2013.768304; Black KH, 2013, ACTA PALAEONTOL POL, V58, P679, DOI 10.4202/app.2012.0001; Black KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048213; Black KH, 2010, J VERTEBR PALEONTOL, V30, P993, DOI 10.1080/02724634.2010.483567; Black KH, 2010, AM MUS NOVIT, P1, DOI 10.1206/666.1; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Cooke B. N., 1997, Memoirs of the Queensland Museum, V41, P295; Cooke B. N., 1997, Memoirs of the Queensland Museum, V41, P269; Cooke Bernard, 2006, P647; COOKE BN, 1992, ALCHERINGA, V16, P201, DOI 10.1080/03115519208619119; Cooke BN, 2000, J PALEONTOL, V74, P317, DOI 10.1666/0022-3360(2000)074<0317:CROANS>2.0.CO;2; Cooke BN, 1999, AUST MAMMAL, V21, P34; Cooke BN, 1999, AUST MAMMAL, V21, P27; Cooke BN, 1997, THESIS U NEW S WALES, P456; Creaser Phil, 1997, Memoirs of the Queensland Museum, V41, P303; Felsenstein J., 2004, INFERRING PHYLOGENIE; FLANNERY T, 1986, J PALEONTOL, V60, P418, DOI 10.1017/S0022336000021958; FLANNERY TF, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P1; Flannery TF, 1983, J AUSTR GEOLOGY GEOP, V7, P287; Flower W. H., 1867, PHILOS T ROY SOC LON, V157, P631, DOI DOI 10.1098/RSTL.1867.0020; FREEDMAN L, 1967, REC AUSTMUS, V27, P197; Gillespie AK, 2014, ALCHERINGA, V38, P513, DOI 10.1080/03115518.2014.908268; Gurovich Y, 2014, J SYST PALAEONTOL, V12, P265, DOI 10.1080/14772019.2013.776646; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; JOHNSON P M, 1982, Australian Zoologist, V21, P27; Jones FW, 1924, MAMMALS S AUSTR 2, P133; Kear BP, 2007, AUST J ZOOL, V55, P331, DOI 10.1071/ZO08002; Kear BP, 2007, J PALEONTOL, V81, P1147, DOI 10.1666/04-218.1; Kear BP, 2011, ZOOL J LINN SOC-LOND, V161, P663, DOI 10.1111/j.1096-3642.2010.00648.x; Kear BP, 2001, ASS AUSTRALASIAN PAL, V25, P83; Kirsch JAW, 1997, AUST J ZOOL, V45, P211, DOI 10.1071/ZO96030; Kolaczkowski B, 2006, MOL BIOL EVOL, V23, P1819, DOI 10.1093/molbev/msl059; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; LUCKETT WP, 1993, MAMMAL PHYLOGENY, P182; Martin GM, 2005, J MAMMAL, V86, P793, DOI 10.1644/1545-1542(2005)086[0793:IVILHM]2.0.CO;2; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Megirian D, 2004, AUST J EARTH SCI, V51, P701, DOI 10.1111/j.1400-0952.2004.01085.x; Megirian Dirk, 1992, Beagle, V9, P219; Megirian D, 2010, PALEOBIOLOGY, V36, P658, DOI 10.1666/09047.1; Meredith RW, 2008, AUST J ZOOL, V56, P395, DOI 10.1071/ZO08044; MUIRHEAD J, 1995, J PALEONTOL, V69, P127, DOI 10.1017/S0022336000026986; Muirhead J, 2000, J PALEONTOL, V74, P512, DOI 10.1666/0022-3360(2000)074<0512:YMPANS>2.0.CO;2; MURRAY P, 1990, Beagle, V7, P53; Murray P., 2000, MEMOIRS QUEEN VICTOR, V105, P1; MURRAY P F, 1986, Beagle, V3, P195; Murray Peter, 1992, Beagle, V9, P195; Murray Peter, 2000, MAGNT Research Report, V6, P1; Nixon KC, 2003, J VERTEBR PALEONTOL, V23, P275; Price GJ, 2008, ZOOL J LINN SOC-LOND, V153, P369, DOI 10.1111/j.1096-3642.2008.00387.x; Prideaux GJ, 2010, ZOOL J LINN SOC-LOND, V159, P954, DOI 10.1111/j.1096-3642.2009.00607.x; Ride W. D. L., 1997, Proceedings of the Linnean Society of New South Wales, V117, P243; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schwartz LRS, 2004, J VERTEBR PALEONTOL, V24, P668, DOI 10.1671/0272-4634(2004)024[0668:ANSONM]2.0.CO;2; Simpson G. G., 1960, QUANTITATIVE ZOOLOGY; Sorensen MD, 2007, TREEROT VERSION 3; Stirton R. A., 1967, Bulletin Bureau of Mineral Resources Geology and Geophysics Australia, V85, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TEDFORD RH, 1987, POSSUMS OPOSSUMS STU, P401; Travouillon KJ, 2014, J VERTEBR PALEONTOL, V34, P375, DOI 10.1080/02724634.2013.799071; Travouillon KJ, 2013, PALAEONTOL ELECTRON, V16; Travouillon KJ, 2013, J VERTEBR PALEONTOL, V33, P153, DOI 10.1080/02724634.2012.713416; Travouillon KJ, 2010, J VERTEBR PALEONTOL, V30, P1528, DOI 10.1080/02724634.2010.501463; Travouillon KJ, 2009, PALAEOGEOGR PALAEOCL, V276, P24, DOI 10.1016/j.palaeo.2009.02.025; Travouillon KJ, 2011, PALEOBIOLOGY, V37, P696, DOI 10.1666/09050.1; Travouillon KJ, 2006, ALCHERINGA SPEC ISSU, V1, DOI [10.1080/03115510609506871, DOI 10.1080/03115510609506871]; Travouillon KJ, 2012, GEOLOGY, V40, pe273, DOI [10.1130/G32600C.1, DOI 10.1130/G32600C.1]; WELLS RT, 1995, B AM MUS NAT HIST, P1; Westerman M, 2012, MOL PHYLOGENET EVOL, V62, P97, DOI 10.1016/j.ympev.2011.09.009; Wilkinson M, 2003, J VERTEBR PALEONTOL, V23, P311, DOI 10.1671/0272-4634(2003)023[0311:MEAMTI]2.0.CO;2; Wilkinson M, 1995, SYST BIOL, V44, P501, DOI 10.1093/sysbio/44.4.501; Woodburne Michael O., 1993, Journal of Vertebrate Paleontology, V13, P483; Wroe S, 1998, J PALEONTOL, V72, P738, DOI 10.1017/S0022336000040439; Xu X, 2014, J SYST PALAEONTOL, V12, P323, DOI 10.1080/14772019.2013.764357; [No title captured], DOI DOI 10.1111/j.1096-0031.2008.00229.x; [No title captured]; [No title captured]	95	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112705	10.1371/journal.pone.0112705	http://dx.doi.org/10.1371/journal.pone.0112705			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409233	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200034
J	Correia, C; Oliveira, G; Vicente, AM				Correia, Catarina; Oliveira, Guiomar; Vicente, Astrid M.			Protein Interaction Networks Reveal Novel Autism Risk Genes within GWAS Statistical Noise	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATION; DE-NOVO MUTATIONS; OXIDATIVE STRESS; REFERENCE DATABASE; LOCI; VARIANTS; PHENOTYPE; LINKAGE; ALLELES	Genome-wide association studies (GWAS) for Autism Spectrum Disorder (ASD) thus far met limited success in the identification of common risk variants, consistent with the notion that variants with small individual effects cannot be detected individually in single SNP analysis. To further capture disease risk gene information from ASD association studies, we applied a network-based strategy to the Autism Genome Project (AGP) and the Autism Genetics Resource Exchange GWAS datasets, combining family-based association data with Human Protein-Protein interaction (PPI) data. Our analysis showed that autism-associated proteins at higher than conventional levels of significance (P < 0.1) directly interact more than random expectation and are involved in a limited number of interconnected biological processes, indicating that they are functionally related. The functionally coherent networks generated by this approach contain ASD-relevant disease biology, as demonstrated by an improved positive predictive value and sensitivity in retrieving known ASD candidate genes relative to the top associated genes from either GWAS, as well as a higher gene overlap between the two ASD datasets. Analysis of the intersection between the networks obtained from the two ASD GWAS and six unrelated disease datasets identified fourteen genes exclusively present in the ASD networks. These are mostly novel genes involved in abnormal nervous system phenotypes in animal models, and in fundamental biological processes previously implicated in ASD, such as axon guidance, cell adhesion or cytoskeleton organization. Overall, our results highlighted novel susceptibility genes previously hidden within GWAS statistical "noise'' that warrant further analysis for causal variants.	[Correia, Catarina; Vicente, Astrid M.] Inst Nacl Saude Doutor Ricardo Jorge, Dept Promocao Saude & Doencas Nao Transmissiveis, P-1649016 Lisbon, Portugal; [Correia, Catarina; Vicente, Astrid M.] Univ Lisbon, Fac Sci, Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Correia, Catarina; Vicente, Astrid M.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Oliveira, Guiomar] Ctr Hosp & Univ Coimbra, Hosp Pediat, Ctr Desenvolvimento, Unidade Neurodesenvolvimento & Autismo, P-3000602 Coimbra, Portugal; [Oliveira, Guiomar] Ctr Invest & Formacao Clin HP CHUC, P-3000602 Coimbra, Portugal; [Oliveira, Guiomar] Univ Coimbra, Fac Med, P-3000548 Coimbra, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra	Vicente, AM (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge, Dept Promocao Saude & Doencas Nao Transmissiveis, P-1649016 Lisbon, Portugal.	astrid.vicente@insa.min-saude.pt	Oliveira, Guiomar/AAF-3911-2021; Vicente, Astrid/F-8692-2014	Oliveira, Guiomar/0000-0002-7049-1277; Vicente, Astrid/0000-0001-7134-8037; Correia, Catarina/0000-0001-5481-2010	Autism Speaks (USA); Health Research Board (HRB, Ireland) [AUT/2006/1, AUT/2006/2, PD/2006/48]; Medical Research Council (MRC, UK); Genome Canada/Ontario Genomics Institute; Hilibrand Foundation (USA); US National Institutes of Health (NIH) [HD055751, HD055782, HD055784, MH52708, MH55284, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261]; NS049261), the Canadian Institutes for Health Research (CIHR); Assistance Publique - Hopitaux de Paris (France), Autism Speaks UK; Canada Foundation for Innovation/Ontario Innovation Trust; Deutsche Forschungsgemeinschaft (Germany) [Po 255/17-4]; EC Sixth FP AUTISM MOLGEN; Fundacao Calouste Gulbenkian (Portugal); Fondation de France; Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France); Fundacao para a Ciencia e Tecnologia (Portugal); Hospital for Sick Children Foundation and University of Toronto (Canada); INSERM (France); Institut Pasteur (France); Ministry of Health (convention 181 of 19 October 2001); John P. Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK) [075491/Z/04]; National Institute of Mental Health [1U24MH081810]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/64281/2009]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055782, P50HD055751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052708, R01MH055284, U54MH066673, R01MH080647, R01MH081754, U10MH066766, R01MH061009, R10MH055284, U24MH081810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042165, R01NS049261, P01NS026630] Funding Source: NIH RePORTER	Autism Speaks (USA); Health Research Board (HRB, Ireland); Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Genome Canada/Ontario Genomics Institute(Genome Canada); Hilibrand Foundation (USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NS049261), the Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Assistance Publique - Hopitaux de Paris (France), Autism Speaks UK; Canada Foundation for Innovation/Ontario Innovation Trust(Canada Foundation for Innovation); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); EC Sixth FP AUTISM MOLGEN; Fundacao Calouste Gulbenkian (Portugal); Fondation de France(Fondation de France); Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Hospital for Sick Children Foundation and University of Toronto (Canada); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur (France); Ministry of Health (convention 181 of 19 October 2001); John P. Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada)(Ministry of Research and Innovation, Ontario); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK)(Wellcome Trust); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The AGP study was funded by Autism Speaks (USA), the Health Research Board (HRB, Ireland; AUT/2006/1, AUT/2006/2, PD/2006/48), The Medical Research Council (MRC, UK), Genome Canada/Ontario Genomics Institute and the Hilibrand Foundation (USA). Additional support for individual groups was provided by the US National Institutes of Health (NIH Grants: HD055751, HD055782, HD055784, MH52708, MH55284, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261), the Canadian Institutes for Health Research (CIHR), Assistance Publique - Hopitaux de Paris (France), Autism Speaks UK, Canada Foundation for Innovation/Ontario Innovation Trust, Deutsche Forschungsgemeinschaft (Grant: Po 255/17-4) (Germany), EC Sixth FP AUTISM MOLGEN, Fundacao Calouste Gulbenkian (Portugal), Fondation de France, Fondation FondaMental (France), Fondation Orange (France), Fondation pour la Recherche Medicale (France), Fundacao para a Ciencia e Tecnologia (Portugal), the Hospital for Sick Children Foundation and University of Toronto (Canada), INSERM (France), Institut Pasteur (France), the Italian Ministry of Health (convention 181 of 19 October 2001), the John P. Hussman Foundation (USA), McLaughlin Centre (Canada), Ontario Ministry of Research and Innovation (Canada), the Seaver Foundation (USA), the Swedish Science Council, The Centre for Applied Genomics (Canada), the Utah Autism Foundation (USA) and the Wellcome Trust core award 075491/Z/04 (UK). The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). Catarina Correia is supported by grant SFRH/BPD/64281/2009 from the Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024220; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Ben-David E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002556; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Buxbaum JD, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-1; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chow ML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-449; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Crespi B, 2011, Autism Res, V4, P302, DOI 10.1002/aur.208; Curran S, 2011, AM J MED GENET B, V156B, P633, DOI 10.1002/ajmg.b.31201; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Devlin B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/j.brainres.2010.11.026; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Ghanizadeh A, 2012, CURR MED CHEM, V19, P4000, DOI 10.2174/092986712802002572; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; He WW, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-38; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hollander E, 2009, PSYCHIAT RES, V170, P43, DOI 10.1016/j.psychres.2008.07.014; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hussman JP, 2011, MOL AUTISM, V2, DOI [10.1186/2040-2392-2-1, 10.1186/2040-2392-2-18]; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; O'Roak BJ, 2012, NAT GENET, V44, P471, DOI 10.1038/ng0412-471; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Pan W, 2008, HUM GENET, V124, P225, DOI 10.1007/s00439-008-0545-1; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scheuerle A, 2011, AM J MED GENET B, V156B, P413, DOI 10.1002/ajmg.b.31176; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Weng MP, 2010, BIOINFORMATICS, V26, P2212, DOI 10.1093/bioinformatics/btq359; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yaspan BL, 2011, HUM GENET, V129, P563, DOI 10.1007/s00439-011-0956-2	66	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112399	10.1371/journal.pone.0112399	http://dx.doi.org/10.1371/journal.pone.0112399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409314	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200020
J	Galley, JD; Bailey, M; Dush, CK; Schoppe-Sullivan, S; Christian, LM				Galley, Jeffrey D.; Bailey, Michael; Dush, Claire Kamp; Schoppe-Sullivan, Sarah; Christian, Lisa M.			Maternal Obesity Is Associated with Alterations in the Gut Microbiome in Toddlers	PLOS ONE			English	Article							BODY-MASS INDEX; BACTERIAL; WEIGHT; COMMUNITIES; ACQUISITION; PREVALENCE; GREENGENES; SEQUENCES; CHILDREN; TRENDS	Children born to obese mothers are at increased risk for obesity, but the mechanisms behind this association are not fully delineated. A novel possible pathway linking maternal and child weight is the transmission of obesogenic microbes from mother to child. The current study examined whether maternal obesity was associated with differences in the composition of the gut microbiome in children in early life. Fecal samples from children 18-27 months of age (n = 77) were analyzed by pyro-tag 16S sequencing. Significant effects of maternal obesity on the composition of the gut microbiome of offspring were observed among dyads of higher socioeconomic status (SES). In the higher SES group (n = 47), children of obese (BMI >= 30) versus non-obese mothers clustered on a principle coordinate analysis (PCoA) and exhibited greater homogeneity in the composition of their gut microbiomes as well as greater alpha diversity as indicated by the Shannon Diversity Index, and measures of richness and evenness. Also in the higher SES group, children born to obese versus non-obese mothers had differences in abundances of Faecalibacterium spp., Eubacterium spp., Oscillibacter spp., and Blautia spp. Prior studies have linked some of these bacterial groups to differences in weight and diet. This study provides novel evidence that maternal obesity is associated with differences in the gut microbiome in children in early life, particularly among those of higher SES. Among obese adults, the relative contribution of genetic versus behavioral factors may differ based on SES. Consequently, the extent to which maternal obesity confers measureable changes to the gut microbiome of offspring may differ based on the etiology of maternal obesity. Continued research is needed to examine this question as well as the relevance of the observed differences in gut microbiome composition for weight trajectory over the life course.	[Galley, Jeffrey D.; Bailey, Michael] Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA; [Bailey, Michael; Christian, Lisa M.] Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA; [Dush, Claire Kamp; Schoppe-Sullivan, Sarah] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Psychiat, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bailey, M (corresponding author), Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA.	Michael.Bailey@osumc.edu	Christian, Lisa/E-2892-2011; Dush, Claire Kamp/B-4572-2012; Schoppe-Sullivan, Sarah/F-7137-2013	Christian, Lisa/0000-0001-5571-050X; Dush, Claire Kamp/0000-0003-4307-6825; Bailey, Michael/0000-0002-2222-3980	Food Innovation Center at The Ohio State University; NINR [R01NR01366]; NICHD [R21HD067670]; NCCAM [R01AT006552]; NIDCR [T32 DE014320]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD067670] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014320] Funding Source: NIH RePORTER	Food Innovation Center at The Ohio State University; NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by an Innovative Initiative Award to MTB and LMC from the Food Innovation Center at The Ohio State University. This study was also supported by awards from NINR (R01NR01366) and NICHD (R21HD067670) to LMC, NCCAM (R01AT006552) to MTB and NIDCR (T32 DE014320). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The sponsors did not participate in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzman SL, 2010, INT J OBESITY, V34, P1116, DOI 10.1038/ijo.2010.43; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; COATES ME, 1968, BRIT J NUTR, V22, P493, DOI 10.1079/BJN19680057; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Development RCT, R LANG ENV STAT COMP; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith M.S., 2006, GENES BEHAV SOCIAL E, P236; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Holland E, 2013, MATERN CHILD HLTH J, V17, P1872, DOI 10.1007/s10995-012-1210-9; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Keski-Nisula L, 2013, ACTA PAEDIATR, V102, P480, DOI 10.1111/apa.12186; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koupil I, 2008, INT J OBESITY, V32, P73, DOI 10.1038/sj.ijo.0803681; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Linabery AM, 2013, PEDIATR OBES, V8, P159, DOI 10.1111/j.2047-6310.2012.00100.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oksanen J., **DATA OBJECT**; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Park DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059470; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; Thompson AL, 2013, NUTR REV, V71, pS55, DOI 10.1111/nure.12054; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	51	109	118	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113026	10.1371/journal.pone.0113026	http://dx.doi.org/10.1371/journal.pone.0113026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409177	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200059
J	Gao, Q; Yu, M				Gao, Qiong; Yu, Mei			Discerning Fragmentation Dynamics of Tropical Forest and Wetland during Reforestation, Urban Sprawl, and Policy Shifts	PLOS ONE			English	Article							PUERTO-RICO; LAND-USE; HABITAT FRAGMENTATION; CARBON EMISSIONS; DEFORESTATION; CONSEQUENCES; TRANSITION; HETEROGENEITY; BIODIVERSITY; ECOLOGY	Despite the overall trend of worldwide deforestation over recent decades, reforestation has also been found and is expected in developing countries undergoing fast urbanization and agriculture abandonment. The consequences of reforestation on landscape patterns are seldom addressed in the literature, despite their importance in evaluating biodiversity and ecosystem functions. By analyzing long-term land cover changes in Puerto Rico, a rapidly reforested (6 to 42% during 1940-2000) and urbanized tropical island, we detected significantly different patterns of fragmentation and underlying mechanisms among forests, urban areas, and wetlands. Forest fragmentation is often associated with deforestation. However, we also found significant fragmentation during reforestation. Urban sprawl and suburb development have a dominant impact on forest fragmentation. Reforestation mostly occurs along forest edges, while significant deforestation occurs in forest interiors. The deforestation process has a much stronger impact on forest fragmentation than the reforestation process due to their different spatial configurations. In contrast, despite the strong interference of coastal urbanization, wetland aggregation has occurred due to the effective implementation of laws/ regulations for wetland protection. The peak forest fragmentation shifted toward rural areas, indicating progressively more fragmentation in forest interiors. This shift is synchronous with the accelerated urban sprawl as indicated by the accelerated shift of the peak fragmentation index of urban cover toward rural areas, i.e., 1.37% yr(-1) in 1977-1991 versus 2.17% yr(-1) in 1991-2000. Based on the expected global urbanization and the regional forest transition from deforested to reforested, the fragmented forests and aggregated wetlands in this study highlight possible forest fragmentation processes during reforestation in an assessment of biodiversity and functions and suggest effective laws/regulations in land planning to reduce future fragmentation.	[Yu, Mei] Univ Puerto Rico, Dept Environm Sci, San Juan, PR 00936 USA; Univ Puerto Rico, Inst Trop Ecosyst Studies, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras	Yu, M (corresponding author), Univ Puerto Rico, Dept Environm Sci, San Juan, PR 00936 USA.	meiyu@ites.upr.edu			NASA ROSES Land Cover and Land Use Change Program [NNX12AE98G]; Puerto Rico NASA IDEAS-ER fund	NASA ROSES Land Cover and Land Use Change Program; Puerto Rico NASA IDEAS-ER fund	This work was supported by The NASA ROSES Land Cover and Land Use Change Program Grant #NNX12AE98G, and The Puerto Rico NASA IDEAS-ER fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brush R, 2008, ANTHR NEWS, P13; Butler BJ, 2004, FOREST ECOL MANAG, V189, P363, DOI 10.1016/j.foreco.2003.09.013; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Doody J. Pat, 2004, Journal of Coastal Conservation, V10, P129, DOI 10.1007/BF02818949; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fernandez-Prieto D, 2009, J ENVIRON MANAGE, V90, P2119, DOI 10.1016/j.jenvman.2008.01.015; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gao Q, 2004, ECOL MODEL, V172, P1, DOI 10.1016/S0304-3800(03)00250-3; Gao QO, 1997, LANDSCAPE ECOL, V12, P321, DOI 10.1023/A:1007985624887; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hansen MC, 2008, P NATL ACAD SCI; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Helmer EH, 2002, CARIBB J SCI, V38, P165; Irwin EG, 2007, P NATL ACAD SCI USA, V104, P20672, DOI 10.1073/pnas.0705527105; Jibson R. W., 1989, LANDSLIDE PROCESSES, DOI [10.1130/SPE236-p29, DOI 10.1130/SPE236-P29]; Kennaway T, 2007, GISCI REMOTE SENS, V44, P356, DOI 10.2747/1548-1603.44.4.356; Laurance WF, 1998, CONSERV BIOL, V12, P460, DOI 10.1046/j.1523-1739.1998.97175.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Lugo AE, 2004, FOREST ECOL MANAG, V190, P145, DOI 10.1016/j.foreco.2003.09.012; LUGO AE, 1988, ACTA CIENTIFICA, V2, P48; Martinuzzi S, 2009, FOREST ECOL MANAG, V257, P75, DOI 10.1016/j.foreco.2008.08.037; Martinuzzi S, 2007, LANDSCAPE URBAN PLAN, V79, P288, DOI 10.1016/j.landurbplan.2006.02.014; Mather AS, 1998, AREA, V30, P117, DOI 10.1111/j.1475-4762.1998.tb00055.x; McGarigal K., 2012, TECH REP; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Pares-Ramos IK, 2008, ECOL SOC, V13; R Core Team, 2021, R LANGUAGE ENV STAT; Redo DJ, 2012, P NATL ACAD SCI USA, V109, P8839, DOI 10.1073/pnas.1201664109; Rudel TK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0405; Rudel TK, 2000, PROF GEOGR, V52, P386, DOI 10.1111/0033-0124.00233; Rudel TK, 1998, RURAL SOCIOL, V63, P533, DOI 10.1111/j.1549-0831.1998.tb00691.x; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Stedman S.M., 2013, STATUS TRENDS WETLAN; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; United Nations Human Settlements Programme, 2011, CIT CLIM CHANG POL D; Uuemaa E, 2013, ECOL INDIC, V28, P100, DOI 10.1016/j.ecolind.2012.07.018	50	20	21	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113140	10.1371/journal.pone.0113140	http://dx.doi.org/10.1371/journal.pone.0113140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409016	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200073
J	Lysoe, E; Harris, LJ; Walkowiak, S; Subramaniam, R; Divon, HH; Riiser, ES; Llorens, C; Gabaldon, T; Kistler, HC; Jonkers, W; Kolseth, AK; Nielsen, KF; Thrane, U; Frandsen, RJN				Lysoe, Erik; Harris, Linda J.; Walkowiak, Sean; Subramaniam, Rajagopal; Divon, Hege H.; Riiser, Even S.; Llorens, Carlos; Gabaldon, Toni; Kistler, H. Corby; Jonkers, Wilfried; Kolseth, Anna-Karin; Nielsen, Kristian F.; Thrane, Ulf; Frandsen, Rasmus J. N.			The Genome of the Generalist Plant Pathogen Fusarium avenaceum Is Enriched with Genes Involved in Redox, Signaling and Secondary Metabolism	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; MATING-TYPE; MYCOTOXIN PRODUCTION; FUNCTIONAL-CHARACTERIZATION; BIOSYNTHETIC-PATHWAY; CYCLIC TETRAPEPTIDE; GIBBERELLA-AVENACEA; DRY ROT; FUNGUS; ZEARALENONE	Fusarium avenaceum is a fungus commonly isolated from soil and associated with a wide range of host plants. We present here three genome sequences of F. avenaceum, one isolated from barley in Finland and two from spring and winter wheat in Canada. The sizes of the three genomes range from 41.6-43.1 MB, with 13217-13445 predicted protein-coding genes. Whole-genome analysis showed that the three genomes are highly syntenic, and share>95% gene orthologs. Comparative analysis to other sequenced Fusaria shows that F. avenaceum has a very large potential for producing secondary metabolites, with between 75 and 80 key enzymes belonging to the polyketide, non-ribosomal peptide, terpene, alkaloid and indole-diterpene synthase classes. In addition to known metabolites from F. avenaceum, fuscofusarin and JM-47 were detected for the first time in this species. Many protein families are expanded in F. avenaceum, such as transcription factors, and proteins involved in redox reactions and signal transduction, suggesting evolutionary adaptation to a diverse and cosmopolitan ecology. We found that 20% of all predicted proteins were considered to be secreted, supporting a life in the extracellular space during interaction with plant hosts.	[Lysoe, Erik; Riiser, Even S.] Bioforsk Norwegian Inst Agr & Environm Res, Dept Plant Hlth & Plant Protect, As, Norway; [Harris, Linda J.; Walkowiak, Sean; Subramaniam, Rajagopal] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Walkowiak, Sean; Subramaniam, Rajagopal] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Divon, Hege H.] Norwegian Vet Inst, Sect Mycol, Oslo, Norway; [Llorens, Carlos] Biotechvana, Valencia, Spain; [Gabaldon, Toni] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain; [Gabaldon, Toni] Univ Pompeu Fabra, Barcelona, Spain; [Gabaldon, Toni] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Kistler, H. Corby; Jonkers, Wilfried] USDA ARS, Cereal Dis Lab, St Paul, MN USA; [Kolseth, Anna-Karin] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Nielsen, Kristian F.; Thrane, Ulf; Frandsen, Rasmus J. N.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Bioforsk; Agriculture & Agri Food Canada; Carleton University; Norwegian Veterinary Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; United States Department of Agriculture (USDA); Swedish University of Agricultural Sciences; Technical University of Denmark	Lysoe, E (corresponding author), Bioforsk Norwegian Inst Agr & Environm Res, Dept Plant Hlth & Plant Protect, As, Norway.	erik.lysoe@bioforsk.no	Nielsen, Kristian Fog/C-7233-2011; Thrane, Ulf/G-2978-2016; Kistler, Harold/AAC-1645-2019; Lysøe, Erik/AAJ-8894-2020; Gabaldón, Toni/A-7336-2008	Nielsen, Kristian Fog/0000-0002-5848-0911; Thrane, Ulf/0000-0002-6040-4141; Kistler, Harold/0000-0001-5312-6297; Gabaldón, Toni/0000-0003-0019-1735; Frandsen, Rasmus John Normand/0000-0002-3799-6062; Lysoe, Erik/0000-0001-5204-2577; Harris, Linda/0000-0002-9098-305X	Nordisk komite for jordbruks- og matforskning (NKJ) [NKJ 135]; Agriculture and Agri-Food Canada's Genomics Research & Development Initiative; ICREA Funding Source: Custom	Nordisk komite for jordbruks- og matforskning (NKJ); Agriculture and Agri-Food Canada's Genomics Research & Development Initiative(Agriculture & Agri Food Canada); ICREA(ICREA)	Nordisk komite for jordbruks- og matforskning (NKJ), Project number: "NKJ 135 - Impact of climate change on the interaction of Fusarium species in oats and barley'', and Agriculture and Agri-Food Canada's Genomics Research & Development Initiative funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Reedy RM, 2012, FUNGAL GENET BIOL, V49, P2, DOI 10.1016/j.fgb.2011.11.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Batta Y. A., 2012, Journal of Entomological and Acarological Research, V44, P51, DOI 10.4081/jear.2012.e11; Bomke C, 2008, APPL ENVIRON MICROB, V74, P5325, DOI 10.1128/AEM.00694-08; Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020; BOOTH C, 1984, T BRIT MYCOL SOC, V82, P178, DOI 10.1016/S0007-1536(84)80231-4; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; CHELKOWSKI J, 1983, PHYTOPATHOL Z, V106, P354; CHELKOWSKI J, 1983, NAHRUNG, V27, P525, DOI 10.1002/food.19830270602; CHELKOWSKI J, 1984, NAHRUNG, V28, P493, DOI 10.1002/food.19840280505; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Condon BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003233; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK RJ, 1967, PHYTOPATHOLOGY, V57, P732; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Crous Pedro W., 1995, Mycoscience, V36, P105, DOI 10.1007/BF02268579; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Desjardins AE, 2003, ANNU REV PHYTOPATHOL, V41, P177, DOI 10.1146/annurev.phyto.41.011703.115501; Dill-Macky R, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P184; Farman ML, 2002, MOL PLANT MICROBE IN, V15, P6, DOI 10.1094/MPMI.2002.15.1.6; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fourie G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-605; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Futami R., 2011, BIOTECHVANA BIOINFOR; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Hamilton AJ, 1999, MED MYCOL, V37, P375, DOI 10.1046/j.1365-280X.1999.00208.x; Hansen FT, 2012, INT J FOOD MICROBIOL, V155, P128, DOI 10.1016/j.ijfoodmicro.2012.01.018; HARRIS SD, 1994, GENETICS, V136, P517; de Dios CH, 2010, CURR PROTEIN PEPT SC, V11, P693; HERSHENHORN J, 1992, PLANT SCI, V86, P155, DOI 10.1016/0168-9452(92)90161-E; Holtz MD, 2011, CAN J PLANT PATHOL, V33, P61, DOI 10.1080/07060661.2011.536651; HUSSEIN HM, 1991, MYCOPATHOLOGIA, V113, P35, DOI 10.1007/BF00436385; ISHII K, 1974, APPL MICROBIOL, V27, P625, DOI 10.1191/0309133303pp399xx; Jiang Z, 2002, PHYTOCHEMISTRY, V60, P33, DOI 10.1016/S0031-9422(02)00061-4; Jin JM, 2010, MOL MICROBIOL, V76, P456, DOI 10.1111/j.1365-2958.2010.07109.x; Jose B, 2004, BIOORG MED CHEM LETT, V14, P5343, DOI 10.1016/j.bmcl.2004.08.016; Karanyi Z, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat037; Kawaide H, 2006, BIOSCI BIOTECH BIOCH, V70, P583, DOI 10.1271/bbb.70.583; Kerenyi Z, 2004, APPL ENVIRON MICROB, V70, P4419, DOI 10.1128/AEM.70.8.4419-4423.2004; Kildgaard S, 2014, MAR DRUGS, V12, P3681, DOI 10.3390/md12063681; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Klitgaard A, 2014, ANAL BIOANAL CHEM, V406, P1933, DOI 10.1007/s00216-013-7582-x; Kohl J, 2007, PHYTOPATHOLOGY, V97, P971, DOI 10.1094/PHYTO-97-8-0971; Kokkonen M, 2010, INT J FOOD MICROBIOL, V143, P17, DOI 10.1016/j.ijfoodmicro.2010.07.015; Kosti I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-133; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulik T, 2011, INT J MOL SCI, V12, P5626, DOI 10.3390/ijms12095626; Kurtz S, 2004, GENOME BIOL, P5; Laatch H., 2012, ANTIBASE 2012 NATURA; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leach MC, 2013, LEARN PUBL, V26, P180, DOI 10.1087/20130305; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; LEE SL, 1976, ARCH BIOCHEM BIOPHYS, V177, P84, DOI 10.1016/0003-9861(76)90418-5; Lysoe E, 2006, APPL ENVIRON MICROB, V72, P3924, DOI 10.1128/AEM.00963-05; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P995, DOI 10.1094/MPMI-02-11-0038; Ma LJ, 2013, ANNU REV MICROBIOL, V67, P399, DOI 10.1146/annurev-micro-092412-155650; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Makkonen J, 2013, J INVERTEBR PATHOL, V113, P184, DOI 10.1016/j.jip.2013.03.008; Malonek S, 2005, APPL ENVIRON MICROB, V71, P1462, DOI 10.1128/AEM.71.3.1462-1472.2005; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; MARASAS WFO, 1984, TOXIGENIC FUSARIUM S; Marcet-Houben M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-646; Marcet-Houben M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004357; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin SH, 2011, FUNGAL GENET BIOL, V48, P731, DOI 10.1016/j.fgb.2011.03.005; Marx F, 2004, APPL MICROBIOL BIOT, V65, P133, DOI 10.1007/s00253-004-1600-z; MERCIER J, 1991, CAN PLANT DIS SURV, V71, P161; Morrison E, 2002, J AGR FOOD CHEM, V50, P3070, DOI 10.1021/jf011532h; Nalim FA, 2009, PHYTOPATHOLOGY, V99, P462, DOI 10.1094/PHYTO-99-4-0462; Niehaus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103336; Nielsen KF, 2011, J NAT PROD, V74, P2338, DOI 10.1021/np200254t; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; PANACCIONE DG, 1992, P NATL ACAD SCI USA, V89, P6590, DOI 10.1073/pnas.89.14.6590; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Peters RD, 2007, HORTSCIENCE, V42, P737, DOI 10.21273/HORTSCI.42.3.737; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plancot B, 2013, PLANT PHYSIOL, V163, P1584, DOI 10.1104/pp.113.222356; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rim SO, 2013, J MICROBIOL BIOTECHN, V23, P623, DOI 10.4014/jmb.1212.12029; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Sato T, 1998, INT CON PLANT PAT, V2, P48; Satyaprasad K, 1997, POTATO RES, V40, P357, DOI 10.1007/BF02357994; Seshime Y, 2005, BIOCHEM BIOPH RES CO, V331, P253, DOI 10.1016/j.bbrc.2005.03.160; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Song ZS, 2004, CHEMBIOCHEM, V5, P1196, DOI 10.1002/cbic.200400138; Sorensen JL, 2013, TOXINS, V5, P1655, DOI 10.3390/toxins5091655; Sorensen JL, 2009, J AGR FOOD CHEM, V57, P1632, DOI 10.1021/jf802926u; Sorensen LQ, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-15; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; TAKEUCHI M, 1989, J ANTIBIOT, V42, P198, DOI 10.7164/antibiotics.42.198; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; Thrane U, 1988, Mycotoxin Res, V4, P2, DOI 10.1007/BF03192082; Uhlig S, 2007, INT J FOOD MICROBIOL, V119, P17, DOI 10.1016/j.ijfoodmicro.2007.07.021; Urban M, 2013, FUSARIUM: GENOMICS, MOLECULAR AND CELLULAR BIOLOGY, P43; Varvas Triin, 2013, Acta Mycologica, V48, P41, DOI 10.5586/am.2013.006; von Dohren H, 2004, ADV BIOCHEM ENG BIOT, V88, P217, DOI 10.1007/b99262; Watanabe M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-322; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Young CA, 2009, APPL ENVIRON MICROB, V75, P2200, DOI 10.1128/AEM.00953-08; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	110	57	58	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112703	10.1371/journal.pone.0112703	http://dx.doi.org/10.1371/journal.pone.0112703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409087	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200033
J	Tudorache, C; Burgerhout, E; Brittijn, S; van den Thillart, G				Tudorache, Christian; Burgerhout, Erik; Brittijn, Sebastiaan; van den Thillart, Guido			The Effect of Drag and Attachment Site of External Tags on Swimming Eels: Experimental Quantification and Evaluation Tool	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; ANGUILLA-ANGUILLA; SILVER EELS; PERFORMANCE; MIGRATION; COST; TRANSMITTERS; ENERGETICS; TROUT; HYDRODYNAMICS	Telemetry studies on aquatic animals often use external tags to monitor migration patterns and help to inform conservation effort. However, external tags are known to impair swimming energetics dramatically in a variety of species, including the endangered European eel. Due to their high swimming efficiency, anguilliform swimmers are very susceptibility for added drag. Using an integration of swimming physiology, behaviour and kinematics, we investigated the effect of additional drag and site of externally attached tags on swimming mode and costs. The results show a significant effect of a) attachment site and b) drag on multiple energetic parameters, such as Cost Of Transport (COT), critical swimming speed (U-crit) and optimal swimming speed (U-opt), possibly due to changes in swimming kinematics. Attachment at 0.125 bl from the tip of the snout is a better choice than at the Centre Of Mass (0.35 bl), as it is the case in current telemetry studies. Quantification of added drag effect on COT and Ucrit show a (limited) correlation, suggesting that the Ucrit test can be used for evaluating external tags for telemetry studies until a certain threshold value. Uopt is not affected by added drag, validating previous findings of telemetry studies. The integrative methodology and the evaluation tool presented here can be used for the design of new studies using external telemetry tags, and the (re-) evaluation of relevant studies on anguilliform swimmers.	[Tudorache, Christian; Burgerhout, Erik] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Burgerhout, Erik; Brittijn, Sebastiaan; van den Thillart, Guido] NewCatch BV, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Tudorache, C (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.	c.tudorache@biology.leidenuniv.nl	Burgerhout, Erik/AAI-4527-2020	Tudorache, Christian/0000-0002-6208-9608	Dutch Technology Foundation STW-VENI grant [11731]	Dutch Technology Foundation STW-VENI grant	CT was supported by a Dutch Technology Foundation STW-VENI grant [11731]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Erik Burgerhout, Sebastiaan Brittijn and Guido van den Thillart are employed by NewCatch B. V. NewCatch B.V. provided support in the form of salaries for authors EB, SB and GvdT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section''.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; Beguer-Pon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046830; Behrens JW, 2007, MAR BIOL, V150, P1365, DOI 10.1007/s00227-006-0456-4; Bell W. H, 1970, Rep. Fish. Res. Bd Can., VNo. 195, P1; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Burgerhout E, 2011, NATURWISSENSCHAFTEN, V98, P631, DOI 10.1007/s00114-011-0805-0; CULIK BM, 1993, MAR ECOL PROG SER, V98, P209, DOI 10.3354/meps098209; Durif C, 2005, J FISH BIOL, V66, P1025, DOI 10.1111/j.0022-1112.2005.00662.x; Farrell AP, 2007, PHILOS T R SOC B, V362, P2017, DOI 10.1098/rstb.2007.2111; French AP, 1970, MIT INTRO PHYS SERIE; Grusha DS, 2005, FISH B-NOAA, V103, P63; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Haro A, 2004, CAN J FISH AQUAT SCI, V61, P1590, DOI 10.1139/F04-093; HAYNES JM, 1978, T AM FISH SOC, V107, P275, DOI 10.1577/1548-8659(1978)107<275:SMOWSA>2.0.CO;2; Hazekamp AAH, 2010, EUR J WILDLIFE RES, V56, P131, DOI 10.1007/s10344-009-0293-0; Jacoby D, 2014, IUCN 2014 IUCN RED L; Jellyman D, 2002, MAR ECOL PROG SER, V233, P207, DOI 10.3354/meps233207; Jennings JG, 1980, TRACKING PELAGIC DOL, P753; JONES DR, 1974, J FISH RES BOARD CAN, V31, P1641, DOI 10.1139/f74-206; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Lindsey CC, 1978, FISH PHYSIOL, VVII, DOI DOI 10.1016/S1546-5098(08)60163-6; Maes GE, 2006, MOL ECOL, V15, P2095, DOI 10.1111/j.1365-294X.2006.02925.x; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; McCleave J.D., 1985, Contributions in Marine Science, V27, P316; Methling C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020797; Okland F., 2013, ANIM BIOTELEM, V1, P3, DOI [10.1186/2050-3385-1-3, DOI 10.1186/2050-3385-1-3]; Palstra AP, 2007, J EXP MAR BIOL ECOL, V352, P244, DOI 10.1016/j.jembe.2007.08.003; Palstra A, 2008, COMP BIOCHEM PHYS A, V151, P37, DOI 10.1016/j.cbpa.2008.05.011; Pavlov VV, 2007, DEEP-SEA RES PT II, V54, P404, DOI 10.1016/j.dsr2.2006.11.010; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Read DA, 2003, J FLUID STRUCT, V17, P163, DOI 10.1016/S0889-9746(02)00115-9; Righton D, 2012, J FISH BIOL, V81, P365, DOI 10.1111/j.1095-8649.2012.03373.x; Schabetsberger R, 2013, MAR ECOL PROG SER, V475, P177, DOI 10.3354/meps10254; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Sloman KA, 2000, FISH PHYSIOL BIOCHEM, V23, P49, DOI 10.1023/A:1007855100185; Steinhausen MF, 2006, J FISH BIOL, V69, P951, DOI 10.1111/j.1095-8649.2006.01143.x; Tesch WW, 1977, BIOL MANAGEMENT ANGU; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; Triantafyllou MS, 2002, INTEGR COMP BIOL, V42, P1026, DOI 10.1093/icb/42.5.1026; Tudorache C, 2007, J FISH BIOL, V71, P1630, DOI 10.1111/j.1095-8649.2007.01620.x; Tudorache C, 2009, ENVIRON BIOL FISH, V84, P121, DOI 10.1007/s10641-008-9395-x; Tytell ED, 2004, J EXP BIOL, V207, P1825, DOI 10.1242/jeb.00968; Tytell ED, 2007, EXP FLUIDS, V43, P701, DOI 10.1007/s00348-007-0343-x; van den Thillart G, 2004, J FISH BIOL, V65, P312, DOI 10.1111/j.0022-1112.2004.00447.x; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; van Ginneken VJT, 2000, NATURE, V403, P156, DOI 10.1038/35003110; VANDENTHILLART G, 2009, ESTIMATED REPROD SUC, V30, P3; Vogel S., 2003, COMP BIOMECHANICS LI; Watson KP, 1998, J EXP BIOL, V201, P2497; WEBB PW, 1971, J EXP BIOL, V55, P489; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067	54	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112280	10.1371/journal.pone.0112280	http://dx.doi.org/10.1371/journal.pone.0112280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409179	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200019
J	Yang, Y; Wang, GQ; Wang, LJ; Yu, JS; Xu, ZX				Yang, Yan; Wang, Guoqiang; Wang, Lijing; Yu, Jingshan; Xu, Zongxue			Evaluation of Gridded Precipitation Data for Driving SWAT Model in Area Upstream of Three Gorges Reservoir	PLOS ONE			English	Article							GAUGE OBSERVATIONS; DAILY RAINFALL; ERA-INTERIM; UNCERTAINTY; SOIL; TOOL; REANALYSES; SATELLITE; IMPACTS; RUNOFF	Gridded precipitation data are becoming an important source for driving hydrologic models to achieve stable and valid simulation results in different regions. Thus, evaluating different sources of precipitation data is important for improving the applicability of gridded data. In this study, we used three gridded rainfall datasets: 1) National Centers for Environmental Prediction - Climate Forecast System Reanalysis (NCEP-CFSR); 2) Asian Precipitation - Highly-Resolved Observational Data Integration Towards Evaluation (APHRODITE); and 3) China trend - surface reanalysis (trend surface) data. These are compared with monitoring precipitation data for driving the Soil and Water Assessment Tool in two basins upstream of Three Gorges Reservoir (TGR) in China. The results of one test basin with significant topographic influence indicates that all the gridded data have poor abilities in reproducing hydrologic processes with the topographic influence on precipitation quantity and distribution. However, in a relatively flat test basin, the APHRODITE and trend surface data can give stable and desirable results. The results of this study suggest that precipitation data for future applications should be considered comprehensively in the TGR area, including the influence of data density and topography.	[Yang, Yan; Wang, Guoqiang; Yu, Jingshan; Xu, Zongxue] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Yang, Yan] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Wang, Lijing] Chinese Res Inst Environm Sci, State Environm Protect Key Lab Drinking Water Sou, Beijing 100012, Peoples R China	Beijing Normal University; Gifu University; Chinese Research Academy of Environmental Sciences	Wang, GQ (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	wanggq@bnu.edu.cn		YANG, YAN/0000-0002-4128-8077; Wang, Guoqiang/0000-0002-3976-1056	Chinese National Special Science and Technology Program of Water Pollution Control and Treatment [2012ZX07503-002, 2009ZX07528-003]; Program for New Century Excellent Talents in University [NCET-12-0058]; Fundamental Research Funds for the Central Universities [2012LZD10]	Chinese National Special Science and Technology Program of Water Pollution Control and Treatment; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the Chinese National Special Science and Technology Program of Water Pollution Control and Treatment (No. 2012ZX07503-002 & No. 2009ZX07528-003), Program for New Century Excellent Talents in University (Grant No. NCET-12-0058), and Fundamental Research Funds for the Central Universities (Grant No. 2012LZD10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour KC, 2007, J HYDROL, V333, P413, DOI 10.1016/j.jhydrol.2006.09.014; Andermann C, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003513; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Arnold JG, 2005, HYDROL PROCESS, V19, P563, DOI 10.1002/hyp.5611; Bao XH, 2013, J CLIMATE, V26, P206, DOI 10.1175/JCLI-D-12-00056.1; Betts AK, 2003, J HYDROMETEOROL, V4, P1194, DOI 10.1175/1525-7541(2003)004<1194:EOTESW>2.0.CO;2; Bosilovich MG, 2008, J APPL METEOROL CLIM, V47, P2279, DOI 10.1175/2008JAMC1921.1; Chappell A, 2013, J HYDROL, V493, P105, DOI 10.1016/j.jhydrol.2013.04.024; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Douglas-Mankin KR, 2010, T ASABE, V53, P1423; Duethmann D, 2012, HYDROL EARTH SYST SC, V9, P10719, DOI DOI 10.5194/HESSD-9-10719-2012; Fontaine TA, 2002, J HYDROL, V262, P209, DOI 10.1016/S0022-1694(02)00029-X; Fuka DR, 2014, HYDROL PROCESS, V28, P5613, DOI 10.1002/hyp.10073; Hong Y, 2005, INT J CLIMATOL, V25, P1369, DOI 10.1002/joc.1187; Huang CC, 2014, J HYDROL, V508, P410, DOI 10.1016/j.jhydrol.2013.11.022; IMAN RL, 1988, RISK ANAL, V8, P71, DOI 10.1111/j.1539-6924.1988.tb01155.x; Li T, 2014, ADV ATMOS S IN PRESS, V73; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Ono K, 2013, HYDROL RES LETT, V7, P66, DOI 10.3178/hrl.7.66; Panday PK, 2014, HYDROL PROCESS, V28, P5337, DOI 10.1002/hyp.10005; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Sanchez-Moreno JF, 2014, INT J CLIMATOL, V34, P1081, DOI 10.1002/joc.3747; Shen ZY, 2012, HYDROL EARTH SYST SC, V16, P121, DOI 10.5194/hess-16-121-2012; Shen ZY, 2009, AGR WATER MANAGE, V96, P1435, DOI 10.1016/j.agwat.2009.04.017; Shi ZH, 2012, J HYDROL, V438, P156, DOI 10.1016/j.jhydrol.2012.03.016; Silva VBS, 2011, J HYDROMETEOROL, V12, P101, DOI 10.1175/2010JHM1303.1; Tong K, 2014, INT J CLIMATOL, V34, P265, DOI 10.1002/joc.3682; Uhlenbrook S, 2004, J HYDROL, V291, P278, DOI 10.1016/j.jhydrol.2003.12.038; van Griensven A, 2006, J HYDROL, V324, P10, DOI 10.1016/j.jhydrol.2005.09.008; Vu MT, 2012, HYDROL EARTH SYST SC, V16, P2801, DOI 10.5194/hess-16-2801-2012; Wang AH, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016553; Wang GQ, 2014, HYDROL PROCESS, V28, P1032, DOI 10.1002/hyp.9645; Weisse AK, 2001, J APPL METEOROL, V40, P720, DOI 10.1175/1520-0450(2001)040<0720:TEOSCO>2.0.CO;2; Widmann M, 2003, J CLIMATE, V16, P799, DOI 10.1175/1520-0442(2003)016<0799:SPDOTN>2.0.CO;2; Xie PP, 2007, J HYDROMETEOROL, V8, P607, DOI 10.1175/JHM583.1; Yang H, 2014, SCIENTIFICWORLDJOURN; Yang J, 2008, J HYDROL, V358, P1, DOI 10.1016/j.jhydrol.2008.05.012; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1	40	55	55	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112725	10.1371/journal.pone.0112725	http://dx.doi.org/10.1371/journal.pone.0112725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409467	gold, Green Published			2022-12-27	WOS:000345533200036
J	Ahn, S; Kim, WY; Lim, KS; Ryoo, SM; Sohn, CH; Seo, DW; Kwak, MK; Yoon, JC				Ahn, Shin; Kim, Won Young; Lim, Kyung Soo; Ryoo, Seung Mok; Sohn, Chang Hwan; Seo, Dong Woo; Kwak, Myoung Kwan; Yoon, Jae Chol			Advanced Radiology Utilization in a Tertiary Care Emergency Department from 2001 to 2010	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PULMONARY-EMBOLISM; CT; TRENDS; PATIENT; INJURY; MRI	Objective To evaluate the utilization trends of advanced radiology, i.e. computed tomography (CT) and magnetic resonance imaging (MRI), examination in an emergency department (ED) of an academic medical center from 2001 to 2010. Patients and Methods: We assessed the overall CT and MRI utilization, and the ED patient encounters. Each examination was evaluated according to the patient's age and anatomically relevant regions. Results: During the study period, 737,760 patient visited the ED, and 156,287 CT and 35,018 MRI examinations were performed. The number of annual ED patients increased from 63,770 in 2001 to 94,609 in 2010 (P = 0.018). The rate of CT utilization increased from 105.5 per 1000 patient visits in 2001 to 289.2 in 2010 (P<0.001), and the rate of MRI utilization increased from 8.1 per 1000 patient visits in 2001 to 74.6 in 2010 (P<0.001). In all of the patient age groups, the overall CT and MRI utilization increased. The greater the patient age, the more likely the use of advanced radiology [CT: 87.1 per 1000 patients in age <20 vs. 293.9 per 1000 in age>60 (P<0.001); MRI: 5.1 per 1000 patients in age <20 vs. 108.7 per 1000 in age>60 (P<0.001)]. Abdomen-pelvis (40.2%) and the head (35.7%) comprised the majority of CT scans, while the head (86.4%) comprised the majority of MRI examinations. The rates of advanced radiology use increased across all anatomical regions, with the highest increase being in chest CT (5.9 per 1000 to 49.2) and head MRI (7.2 per 1000 to 61.9). Conclusion: We report a three-fold and nine-fold increase in the use of CT and MRI, respectively, during the study period. Additional studies will be required to understand the causes of this change and to determine the effect of advanced radiology utilization on the patient outcome.	[Ahn, Shin; Kim, Won Young; Lim, Kyung Soo; Ryoo, Seung Mok; Sohn, Chang Hwan; Seo, Dong Woo] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Emergency Med, Seoul, South Korea; [Kwak, Myoung Kwan] Seoul Med Ctr, Dept Emergency Med, Seoul, South Korea; [Yoon, Jae Chol] Chonbuk Natl Univ Hosp, Dept Emergency Med, Jeonju, South Korea	University of Ulsan; Asan Medical Center; Seoul Medical Center; Jeonbuk National University; Jeonbuk National University Hospital	Kim, WY (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Dept Emergency Med, Seoul, South Korea.	wonpia73@naver.com		Ryoo, Seung Mok/0000-0002-2436-3311				Boland GWL, 2009, EUR RADIOL, V19, P9, DOI 10.1007/s00330-008-1159-7; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Broder J, 2006, EMERG RADIOL, V13, P25, DOI 10.1007/s10140-006-0493-9; Chung SP, 2006, EMERG MED J, V23, P675, DOI 10.1136/emj.2006.035402; Davis DP, 2006, J EMERG MED, V31, P269, DOI 10.1016/j.jemermed.2005.10.003; DeMonaco NA, 2008, AM J MED, V121, P611, DOI 10.1016/j.amjmed.2008.02.035; Gottlieb RH, 2002, RADIOLOGY, V225, P441, DOI 10.1148/radiol.2252020101; Kirsch TD, 2011, J EMERG MED, V41, P302, DOI 10.1016/j.jemermed.2010.06.030; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Lee DH, 2013, EMERG MED J; Lee J, 2010, ANN EMERG MED, V56, P591, DOI 10.1016/j.annemergmed.2010.05.027; Mitchell AM, 2007, J THROMB HAEMOST, V5, P50, DOI 10.1111/j.1538-7836.2006.02251.x; Oh HY, 2012, KOREAN J RADIOL, V13, P536, DOI 10.3348/kjr.2012.13.5.536; Raja AS, 2014, AM J ROENTGENOL, V203, P355, DOI 10.2214/AJR.13.11892; Rankey D, 2008, ACAD RADIOL, V15, P438, DOI 10.1016/j.acra.2008.01.003; Sosna J, 1997, AM J EMERG MED, V15, P244, DOI 10.1016/S0735-6757(97)90005-X; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; You JS, 2010, EMERG MED J, V27, P131, DOI 10.1136/emj.2008.066399	20	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112650	10.1371/journal.pone.0112650	http://dx.doi.org/10.1371/journal.pone.0112650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406081	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300044
J	Farley, JE; Kelly, AM; Reiser, K; Brown, M; Kub, J; Davis, JG; Walshe, L; Van der Walt, M				Farley, Jason E.; Kelly, Ana M.; Reiser, Katrina; Brown, Maria; Kub, Joan; Davis, Jeane G.; Walshe, Louise; Van der Walt, Martie			Development and Evaluation of a Pilot Nurse Case Management Model to Address Multidrug-Resistant Tuberculosis (MDR-TB) and HIV in South Africa	PLOS ONE			English	Article							XDR-TB; GUIDELINES; INFECTION; EPIDEMIC; CARE	Setting: Multidrug-resistant tuberculosis (MDR-TB) unit in KwaZulu-Natal, South Africa. Objective: To develop and evaluate a nurse case management model and intervention using the tenets of the Chronic Care Model to manage treatment for MDR-TB patients with a high prevalence of human immunodeficiency virus (HIV) co-infection. Design: A quasi-experimental pilot programme utilizing a nurse case manager to manage care for 40 hospitalized MDR-TB patients, 70% HIV co-infected, during the intensive phase of MDR-TB treatment. Patients were followed for six months to compare proximal outcomes identified in the model between the pre- and post-intervention period. Results: The greatest percent differences between baseline and six-month MDR-TB proximal outcomes were seen in the following three areas: baseline symptom evaluation on treatment initiation (95% improvement), baseline and monthly laboratory evaluations completed per guidelines (75% improvement), and adverse drug reactions acted upon by medical and/or nursing intervention (75% improvement). Conclusion: Improvements were identified in guideline-based treatment and monitoring of adverse drug reactions following implementation of the nurse case management intervention. Further study is required to determine if the intervention introduced in this model will ultimately result in improvements in final MDR-TB treatment outcomes.	[Farley, Jason E.; Reiser, Katrina; Brown, Maria; Kub, Joan; Davis, Jeane G.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA; [Kelly, Ana M.] Michigan State Univ, Coll Nursing, E Lansing, MI 48824 USA; [Kub, Joan; Walshe, Louise] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Van der Walt, Martie] MRC, TB Epidemiol & Intervent Res Unit, Pretoria, South Africa	Johns Hopkins University; Michigan State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Farley, JE (corresponding author), Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA.	jfarley@son.jhmi.edu	van der Walt, Martie/CAH-0101-2022	van der Walt, Martie/0000-0001-9987-3167; Farley, Jason/0000-0002-6896-0134	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [1R01AI104488-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104488] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) 1R01AI104488-01: A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-infection Outcomes. Funding was received by JEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; Andersen M D, 1999, J Assoc Nurses AIDS Care, V10, P55, DOI 10.1016/S1055-3290(06)60299-9; [Anonymous], 2008, GUID PROGR MAN DRUG; Berra K, 2011, J CARDIOVASC NURS, V26, P145, DOI 10.1097/JCN.0b013e3181ec1337; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Del Sindaco D, 2007, J CARDIOVASC MED, V8, P324, DOI 10.2459/JCM.0b013e32801164cb; Department of Health, 2013, MAN DRUG RES TUB POL; Department of Health Republic of South Africa, 2012, 20122016 STIS TB; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Farley JE, 2012, INT J TUBERC LUNG D, V16, P82, DOI 10.5588/ijtld.10.0791; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Gabbay RA, 2006, DIABETES RES CLIN PR, V71, P28, DOI 10.1016/j.diabres.2005.05.002; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Green L.W., 2005, HLTH PROGRAM PLANNIN, V4th; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Jones D, 2014, INT J BEHAV MED; Lin RL, 2006, J FORMOS MED ASSOC, V105, P636, DOI 10.1016/S0929-6646(09)60162-5; Nyamathi AM, 2006, INT J TUBERC LUNG D, V10, P775; Pasricha A, 2013, J GEN INTERN MED, V28, P127, DOI 10.1007/s11606-012-2145-y; Perumal R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-243; Phillips JL, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/279431; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Reimanis C L, 2001, Lippincotts Case Manag, V6, P230, DOI 10.1097/00129234-200111000-00002; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Satti H, 2012, PLOS ONE, V7; Scano F, 2008, INT J TUBERC LUNG D, V12, P1370; Schumann A, 2007, J HEALTH PSYCHOL, V12, P833, DOI 10.1177/1359105307080618; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Tudor C., 2013, International Journal of Tuberculosis and Lung Disease, V17, pS22; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2012, WHO POL COLL TB HIV	35	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111702	10.1371/journal.pone.0111702	http://dx.doi.org/10.1371/journal.pone.0111702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405988	gold, Green Submitted, Green Published			2022-12-27	WOS:000347121300015
J	Ivory, SJ; McGlue, MM; Ellis, GS; Lezine, AM; Cohen, AS; Vincens, A				Ivory, Sarah J.; McGlue, Michael M.; Ellis, Geoffrey S.; Lezine, Anne-Marie; Cohen, Andrew S.; Vincens, Annie			Vegetation Controls on Weathering Intensity during the Last Deglacial Transition in Southeast Africa	PLOS ONE			English	Article							LATE QUATERNARY; LAKE MALAWI; EAST-AFRICA; RAINFALL SEASONALITY; CLIMATIC CHANGES; GLACIAL MAXIMUM; CARBON-DIOXIDE; TANGANYIKA; POLLEN; TROPICS	Tropical climate is rapidly changing, but the effects of these changes on the geosphere are unknown, despite a likelihood of climatically-induced changes on weathering and erosion. The lack of long, continuous paleo-records prevents an examination of terrestrial responses to climate change with sufficient detail to answer questions about how systems behaved in the past and may alter in the future. We use high-resolution records of pollen, clay mineralogy, and particle size from a drill core from Lake Malawi, southeast Africa, to examine atmosphere-biosphere-geosphere interactions during the last deglaciation (similar to 18-9 ka), a period of dramatic temperature and hydrologic changes. The results demonstrate that climatic controls on Lake Malawi vegetation are critically important to weathering processes and erosion patterns during the deglaciation. At 18 ka, afromontane forests dominated but were progressively replaced by tropical seasonal forest, as summer rainfall increased. Despite indication of decreased rainfall, drought-intolerant forest persisted through the Younger Dryas (YD) resulting from a shorter dry season. Following the YD, an intensified summer monsoon and increased rainfall seasonality were coeval with forest decline and expansion of drought-tolerant miombo woodland. Clay minerals closely track the vegetation record, with high ratios of kaolinite to smectite (K/S) indicating heavy leaching when forest predominates, despite variable rainfall. In the early Holocene, when rainfall and temperature increased (effective moisture remained low), open woodlands expansion resulted in decreased K/S, suggesting a reduction in chemical weathering intensity. Terrigenous sediment mass accumulation rates also increased, suggesting critical linkages among open vegetation and erosion during intervals of enhanced summer rainfall. This study shows a strong, direct influence of vegetation composition on weathering intensity in the tropics. As climate change will likely impact this interplay between the biosphere and geosphere, tropical landscape change could lead to deleterious effects on soil and water quality in regions with little infrastructure for mitigation.	[Ivory, Sarah J.] Brown Univ, Providence, RI 02912 USA; [McGlue, Michael M.] Univ Kentucky, Lexington, KY USA; [Ellis, Geoffrey S.] US Geol Survey, Denver, CO 80225 USA; [Lezine, Anne-Marie] CNRS, LOCEAN, Paris, France; [Cohen, Andrew S.] Univ Arizona, Tucson, AZ USA; [Vincens, Annie] CNRS, CEREGE, Aix En Provence, France	Brown University; University of Kentucky; United States Department of the Interior; United States Geological Survey; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Arizona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ivory, SJ (corresponding author), Brown Univ, Providence, RI 02912 USA.	sarah_ivory@brown.edu	Ellis, Geoffrey S/G-8970-2011	Ivory, Sarah/0000-0003-4709-4406; LEZINE, Anne-Marie/0000-0002-3555-5124; Ellis, Geoffrey/0000-0003-4519-3320	NSF Graduate Research Fellowship [2009078688]	NSF Graduate Research Fellowship(National Science Foundation (NSF))	Lake Malawi Drilling Project-Earth System History Program (NSF-EAR-0602404) funded field operations, logistics, and some laboratory analysis. NSF Graduate Research Fellowship (2009078688) provided student salary and tuition and some travel support for laboratory analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizai A, 2012, QUATERNARY RES, V77, P368, DOI 10.1016/j.yqres.2012.01.008; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Andrews JT, 2008, J QUATERNARY SCI, V23, P3, DOI 10.1002/jqs.1142; [Anonymous], 1992, PROC OCEAN DRILL SCI; Barker PA, 2007, EARTH PLANET SC LETT, V261, P93, DOI 10.1016/j.epsl.2007.06.010; Barry SL, 2002, ADV GLOB CHANGE RES, V12, P369; Beaulieu E, 2012, NAT CLIM CHANGE, V2, P346, DOI [10.1038/NCLIMATE1419, 10.1038/nclimate1419]; Beaulieu E, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003078; Beuning KRM, 1997, PALAEOGEOGR PALAEOCL, V136, P259, DOI 10.1016/S0031-0182(97)00034-5; Birkeland P.W., 1984, GEOL MAG, DOI DOI 10.1017/S0016756800031617; Bonnefille R, 1995, QUATERNARY SCI REV, V14, P917, DOI 10.1016/0277-3791(95)00071-2; Bonneville S, 2009, GEOLOGY, V37, P615, DOI 10.1130/G25699A.1; Branchu P, 2005, J AFR EARTH SCI, V43, P433, DOI 10.1016/j.jafrearsci.2005.09.004; Brantley SL, 2011, GEOBIOLOGY, V9, P140, DOI 10.1111/j.1472-4669.2010.00264.x; Brown ET, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031240; Burnett AP, 2011, PALAEOGEOGR PALAEOCL, V303, P155, DOI 10.1016/j.palaeo.2010.02.011; Carter S, 1966, FLORA TROPICAL E AFR; Castaneda IS, 2007, GEOLOGY, V35, P823, DOI 10.1130/G23916A.1; Cecil CB, 2003, SOC SEDIMENTARY GEOL, V77; Chamley H, 1989, CLAY SEDIMENTOLOGY, V623; Cohen AS, 2013, PALAEOGEOGR PALAEOCL, V392, P79, DOI 10.1016/j.palaeo.2013.09.007; DeBusk G.H., 1994, THESIS DUKE U; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Dosseto A, 2010, GEOLOGY, V38, P395, DOI 10.1130/G30708.1; Duhnforth M, 2012, J GEOPHYS RES-EARTH, P117; DUNNE T, 1979, J HYDROL, V42, P281, DOI 10.1016/0022-1694(79)90052-0; Eberl D.D., 2003, 200378 US GEOL SURV; EBINGER CJ, 1989, GEOL SOC AM BULL, V101, P885, DOI 10.1130/0016-7606(1989)101<0885:TDOTWB>2.3.CO;2; Egli M, 2008, GEOMORPHOLOGY, V102, P307, DOI 10.1016/j.geomorph.2008.04.001; Einsele G, 1998, PALAEOGEOGR PALAEOCL, V140, P7, DOI 10.1016/S0031-0182(98)00041-8; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; FAO, 1988, 60 FAO; Felton AA, 2007, PALAEOGEOGR PALAEOCL, V252, P405, DOI 10.1016/j.palaeo.2007.04.003; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Godderis Y, 2013, BIOGEOSCIENCES, V10, P135, DOI 10.5194/bg-10-135-2013; Godderis Y, 2008, GEODERMA, V145, P439, DOI 10.1016/j.geoderma.2008.01.020; Godderis Y, 2009, REV MINERAL GEOCHEM, V70, P411, DOI 10.2138/rmg.2009.70.9; Hay WW, 1998, CHEM GEOL, V145, P287, DOI 10.1016/S0009-2541(97)00149-6; Hely C, 2006, GLOBAL ECOL BIOGEOGR, V15, P258, DOI 10.1111/j.1466-822x.2006.00235.x; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Iversen J, 1989, J BIOGEOGR; Ivory SJ, 2012, QUATERNARY RES, V77, P77, DOI 10.1016/j.yqres.2011.11.005; Johnson TC, 2002, SCIENCE, V296, P113, DOI 10.1126/science.1070057; Johnson TC, 2008, LIMNOL OCEANOGR, V53, P1622, DOI 10.4319/lo.2008.53.4.1622; Kalindekafe L.N., 1996, LIMNOLOGY CLIMATOLOG, P443; Keiro Heins, 2007, GSA SPECIAL PAPER, V420, P345; Konecky BL, 2011, EARTH PLANET SC LETT, V312, P318, DOI 10.1016/j.epsl.2011.10.020; Landeweert R, 2001, TRENDS ECOL EVOL, V16, P248, DOI 10.1016/S0169-5347(01)02122-X; Langbein W. B., 1958, AM GEOPHYS UNION T, V39, P1076, DOI DOI 10.1029/TR039I006P01076; Lezine AM, 2005, PALAEOGEOGR PALAEOCL, V219, P225, DOI 10.1016/j.palaeo.2004.12.027; Lyons WB, 2005, J GEOPHYS RES-EARTH, P110; Malawi Government, 1983, NAT ATL MAL; McGlue MM, 2008, J PALEOLIMNOL, V40, P635, DOI 10.1007/s10933-007-9187-x; Moquet JS, 2011, CHEM GEOL, V287, P1, DOI 10.1016/j.chemgeo.2011.01.005; Moulton KL, 2000, AM J SCI, V300, P539, DOI 10.2475/ajs.300.7.539; PASTOURET L, 1978, OCEANOL ACTA, V1, P217; Powers LA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022014; Refsnider KA, 2010, EARTH PLANET SC LETT, V297, P505, DOI 10.1016/j.epsl.2010.07.002; Rodriguez-Iturbe I., 2004, SOIL MOISTURE PLANT; Roelandt C, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003420; Roering JJ, 2010, EARTH PLANET SC LETT, V298, P183, DOI 10.1016/j.epsl.2010.07.040; ROSENDAHL BR, 1987, ANNU REV EARTH PL SC, V15, P445, DOI 10.1146/annurev.ea.15.050187.002305; Ryner M, 2007, PALAEOGEOGR PALAEOCL, V248, P440, DOI 10.1016/j.palaeo.2006.12.014; Schluater T., 2006, GEOLOGICAL ATLAS AFR; SCHOLZ CA, 1995, AAPG BULL, V79, P1679; Scholz CA, 1989, PROJECT PROBE GEOPHY, V2; Scholz CA, 2007, P NATL ACAD SCI USA, V104, P16416, DOI 10.1073/pnas.0703874104; Scott DL, 1991, SPEC PUBL INT ASS SE, V13, P129; Semah A.M., 2004, MODERN QUATERNARY RE, V18, P63; Soreghan MJ, 1999, J SEDIMENT RES, V69, P832, DOI 10.2110/jsr.69.832; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; Stocker T. F., 2013, CLIMATE CHANGE 2013; Stone JR, 2011, PALAEOGEOGR PALAEOCL, V303, P51, DOI 10.1016/j.palaeo.2010.01.012; StreetPerrott FA, 1997, SCIENCE, V278, P1422, DOI 10.1126/science.278.5342.1422; Thiry M, 2000, EARTH-SCI REV, V49, P201, DOI 10.1016/S0012-8252(99)00054-9; Vanacker V, 2007, GEOLOGY, V35, P303, DOI 10.1130/G23109A.1; VINCENS A, 1993, REV PALAEOBOT PALYNO, V78, P381, DOI 10.1016/0034-6667(93)90072-3; VINCENS A, 1991, PALAEOGEOGR PALAEOCL, V86, P207, DOI 10.1016/0031-0182(91)90081-2; Vincens A, 2007, J BIOGEOGR, V34, P1274, DOI 10.1111/j.1365-2699.2007.01698.x; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; Weaver C.E., 1989, CLAYS MUDS SHALES, V44; White F., 1983, 20 UNESCO; Wohlfarth B, 1996, QUATERNARY SCI REV, V15, P267, DOI 10.1016/0277-3791(96)00001-7; Woltering M, 2011, PALAEOGEOGR PALAEOCL, V303, P93, DOI 10.1016/j.palaeo.2010.02.013; Wu HB, 2007, CLIM DYNAM, V29, P211, DOI 10.1007/s00382-007-0231-3	86	11	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112855	10.1371/journal.pone.0112855	http://dx.doi.org/10.1371/journal.pone.0112855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406090	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300058
J	Kuehl, CJ; Dragoi, AM; Agaisse, H				Kuehl, Carole J.; Dragoi, Ana-Maria; Agaisse, Herve			The Shigella flexneri Type 3 Secretion System Is Required for Tyrosine Kinase-Dependent Protrusion Resolution, and Vacuole Escape during Bacterial Dissemination	PLOS ONE			English	Article							III SECRETION; INTERCELLULAR DISSEMINATION; EPITHELIAL-CELLS; IPA INVASINS; HOST-CELLS; APPARATUS; ACTIN; ENTRY; PROTEIN; GENES	Shigella flexneri is a human pathogen that triggers its own entry into intestinal cells and escapes primary vacuoles to gain access to the cytosolic compartment. As cytosolic and motile bacteria encounter the cell cortex, they spread from cell to cell through formation of membrane protrusions that resolve into secondary vacuoles in adjacent cells. Here, we examined the roles of the Type 3 Secretion System (T3SS) in S. flexneri dissemination in HT-29 intestinal cells infected with the serotype 2a strain 2457T. We generated a 2457T strain defective in the expression of MxiG, a central component of the T3SS needle apparatus. As expected, the Delta mxiG strain was severely affected in its ability to invade HT-29 cells, and expression of mxiG under the control of an arabinose inducible expression system (Delta mxiG/pmxiG) restored full infectivity. In this experimental system, removal of the inducer after the invasion steps (Delta mxiG/pmxiG (Ara withdrawal)) led to normal actin-based motility in the cytosol of HT-29 cells. However, the time spent in protrusions until vacuole formation was significantly increased. Moreover, the number of formed protrusions that failed to resolve into vacuoles was also increased. Accordingly, the DmxiG/pmxiG (Ara withdrawal) strain failed to trigger tyrosine phosphorylation in membrane protrusions, a signaling event that is required for the resolution of protrusions into vacuoles. Finally, the Delta mxiG/pmxiG (Ara withdrawal) strain failed to escape from the formed secondary vacuoles, as previously reported in non-intestinal cells. Thus, the T3SS system displays multiple roles in S. flexneri dissemination in intestinal cells, including the tyrosine kinase signaling-dependent resolution of membrane protrusions into secondary vacuoles, and the escape from the formed secondary vacuoles.	[Kuehl, Carole J.; Dragoi, Ana-Maria; Agaisse, Herve] Yale Univ, Boyer Ctr Mol Med, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Agaisse, H (corresponding author), Yale Univ, Boyer Ctr Mol Med, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	herve.agaisse@yale.edu			NIH [R01AI073904]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH Grant R01AI073904. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAOUI A, 1995, MOL MICROBIOL, V17, P461, DOI 10.1111/j.1365-2958.1995.mmi_17030461.x; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Campbell-Valois FX, 2014, CELL HOST MICROBE, V15, P177, DOI 10.1016/j.chom.2014.01.005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeMali KA, 2006, J BIOL CHEM, V281, P39534, DOI 10.1074/jbc.M605939200; Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894; Dragoi AM, 2014, INFECT IMMUN, V82, P4447, DOI 10.1128/IAI.02078-14; Dragoi AM, 2013, INFECT IMMUN, V81, P598, DOI 10.1128/IAI.00853-12; Gouin E, 1999, J CELL SCI, V112, P1697; Hachani A, 2008, MICROBES INFECT, V10, P260, DOI 10.1016/j.micinf.2007.11.011; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; Leung Y, 2008, CELL HOST MICROBE, V3, P39, DOI 10.1016/j.chom.2007.10.011; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; Mavris M, 2002, J BACTERIOL, V184, P6751, DOI 10.1128/JB.184.24.6751-6759.2002; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Menard R, 1996, P NATL ACAD SCI USA, V93, P1254, DOI 10.1073/pnas.93.3.1254; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; Page AL, 1999, CELL MICROBIOL, V1, P183, DOI 10.1046/j.1462-5822.1999.00019.x; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Sansonetti PJ, 1998, FOLIA MICROBIOL, V43, P239, DOI 10.1007/BF02818608; Schuch R, 1999, MOL MICROBIOL, V34, P675, DOI 10.1046/j.1365-2958.1999.01627.x; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; Wing HJ, 2004, J BACTERIOL, V186, P699, DOI 10.1128/JB.186.3.699-705.2004	28	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112738	10.1371/journal.pone.0112738	http://dx.doi.org/10.1371/journal.pone.0112738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405985	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300050
J	Ellison, TJ; Kedes, DH				Ellison, Thomas J.; Kedes, Dean H.			Variable Episomal Silencing of a Recombinant Herpesvirus Renders Its Encoded GFP an Unreliable Marker of Infection in Primary Cells	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; LYTIC GENE-EXPRESSION; KAPOSIS-SARCOMA; HISTONE DEACETYLASE; FLUORESCENT PROTEIN; DNA-SEQUENCES; LATENCY; KSHV; PERSISTENCE; DIFFERENTIATION	The availability of reliable recombinant reporter virus systems has been a great boon to the study of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8). Unexpectedly, we found that expression of the ostensibly constitutive green fluorescent protein (GFP) marker was progressively lost during unselected passage in primary rat mesenchymal precursor cells (MM), despite efficient maintenance of latent viral gene expression and episomal partitioning. This repression of EF1-alpha promoter-driven GFP expression appeared to be passage-dependent, however, since functionally immortalized MM cells derived from long serial passage retained stable expression of GFP following rKSHV. 219 infection. Chromatin analysis of cultures that we had infected in parallel demonstrated an increase in repressive H3K27 tri-methylation across the viral episome with the exception of the LANA control region in MM cells infected at early rather than late passage post-isolation. The silencing of GFP expression in the MM cells was reversible in a dose-dependent fashion by the histone deacetylase inhibitor valproic acid, further implicating cellular silencing on incoming viral genomes, and underscoring potential differences in viral gene regulation between primary and functionally immortalized cells. Furthermore, using multispectral imaging flow cytometry, we also determined that the extent of GFP expression per cell among those that were positive did not correlate with the number of LANA dots per nucleus nor the extent of overall LANA expression per cell. This suggests a more complex mode of local gene regulation, rather than one that simply reflects the relative intracellular viral copy number. In sum, we have demonstrated the significant potential for false-negative data when using a constitutive marker gene as a sole means of evaluating herpesviral infection, especially in primary cells.	[Ellison, Thomas J.; Kedes, Dean H.] Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22904 USA; [Kedes, Dean H.] Univ Virginia, Dept Internal Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA	University of Virginia; University of Virginia	Kedes, DH (corresponding author), Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22904 USA.	kedes@virginia.edu		Ellison, Thomas/0000-0001-9231-918X	National Institute of Dental and Craniofacial Research [R01DE022291]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022291] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research R01DE022291 to DHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang LA, 2006, J VIROL, V80, P10073, DOI 10.1128/JVI.01156-06; Ashlock BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087324; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Ballestas ME, 2001, J VIROL, V75, P3250, DOI 10.1128/JVI.75.7.3250-3258.2001; Borah S, 2012, RNA, V18, P1573, DOI 10.1261/rna.033126.112; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; Dollery SJ, 2014, J VIROL, V88, P1748, DOI 10.1128/JVI.03063-13; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Jeffery HC, 2013, J VIROL METHODS, V193, P251, DOI 10.1016/j.jviromet.2013.06.001; Johnson AS, 2005, J VIROL, V79, P13769, DOI 10.1128/JVI.79.21.13769-13777.2005; Jones T, 2012, J CLIN INVEST, V122, P1076, DOI 10.1172/JCI58530; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Myoung J, 2011, J VIROL, V85, P9767, DOI 10.1128/JVI.05136-11; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Myoung JJ, 2011, VIROLOGY, V413, P1, DOI 10.1016/j.virol.2010.12.036; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Nichols LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014535; Seifi A, 2011, VIROLOGY, V410, P17, DOI 10.1016/j.virol.2010.10.023; Shin HJ, 2014, J VIROL, V88, P1281, DOI 10.1128/JVI.02665-13; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Toth Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003813; Toth Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001013; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111502	10.1371/journal.pone.0111502	http://dx.doi.org/10.1371/journal.pone.0111502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402328	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700015
J	Chang, CC; Ting, CT; Chang, CH; Fang, S; Chang, HY				Chang, Chia-chen; Ting, Chau-Ti; Chang, Ching-Ho; Fang, Shu; Chang, Hwei-yu			The Persistence of Facultative Parthenogenesis in Drosophila albomicans	PLOS ONE			English	Article							SEXUAL REPRODUCTION; CHROMOSOME EVOLUTION; BDELLOID ROTIFERS; MERCATORUM; ANANASSAE; INSECTS; TRANSITION; PALLIDOSA; WOLBACHIA; MECHANISM	Parthenogenesis has evolved independently in more than 10 Drosophila species. Most cases are tychoparthenogenesis, which is occasional or accidental parthenogenesis in normally bisexual species with a low hatching rate of eggs produced by virgin females; this form is presumed to be an early stage of parthenogenesis. To address how parthenogenesis and sexual reproduction coexist in Drosophila populations, we investigated several reproductive traits, including the fertility, parthenogenetic capability, diploidization mechanisms, and mating propensity of parthenogenetic D. albomicans. The fertility of mated parthenogenetic females was significantly higher than that of virgin females. The mated females could still produce parthenogenetic offspring but predominantly produced offspring by sexual reproduction. Both mated parthenogenetic females and their parthenogenetic-sexual descendants were capable of parthenogenesis. The alleles responsible for parthenogenesis can be propagated through both parthenogenesis and sexual reproduction. As diploidy is restored predominantly by gamete duplication, heterozygosity would be very low in parthenogenetic individuals. Hence, genetic variation in parthenogenetic genomes would result from sexual reproduction. The mating propensity of females after more than 20 years of isolation from males was decreased. If mutations reducing mating propensities could occur under male-limited conditions in natural populations, decreased mating propensity might accelerate tychoparthenogenesis through a positive feedback mechanism. This process provides an opportunity for the evolution of obligate parthenogenesis. Therefore, the persistence of facultative parthenogenesis may be an adaptive reproductive strategy in Drosophila when a few founders colonize a new niche or when small populations are distributed at the edge of a species' range, consistent with models of geographical parthenogenesis.	[Chang, Chia-chen; Chang, Hwei-yu] Natl Taiwan Univ, Dept Entomol, Taipei 10617, Taiwan; [Ting, Chau-Ti; Chang, Ching-Ho] Natl Taiwan Univ, Dept Life Sci, Taipei 10617, Taiwan; [Chang, Ching-Ho] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Genome & Syst Biol Degree Program, Taipei 10617, Taiwan; [Ting, Chau-Ti] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10617, Taiwan; [Fang, Shu; Chang, Hwei-yu] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Fang, S (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan.	zofang@sinica.edu.tw; hwei@ntu.edu.tw	Chang, Ching-Ho/AAG-4560-2021	Chang, Ching-Ho/0000-0001-9361-1190; Chang, Chia-chen/0000-0001-9853-8949; Ting, Chau-Ti/0000-0003-1802-8864	National Science Council (Taiwan, ROC) [NSC99-2815-C002-025B]; National Science Council (Taiwan, ROC); Academia Sinica	National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	Funding: This work was initiated as an undergraduate summer project supported by National Science Council (Taiwan, ROC, NSC99-2815-C002-025B) to CC, and was supported by grants from National Science Council (Taiwan, ROC) to HC and CTT, and from Academia Sinica to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Markow TA, 2013, G3-GENES GENOM GENET, V3, P757, DOI 10.1534/g3.112.005421; [Anonymous], 1877, DIFFERENT FORMS FLOW; ASADA N, 1988, ZOOL SCI, V5, P915; Bell G, 1982, MASTERPIECE NATURE E; CARSON HL, 1967, GENETICS, V55, P157; CARSON HL, 1982, SCIENCE, V218, P68, DOI 10.1126/science.218.4567.68; CARSON HL, 1973, P NATL ACAD SCI USA, V70, P1772, DOI 10.1073/pnas.70.6.1772; CARSON HL, 1961, AM NAT, V95, P81, DOI 10.1086/282161; CARSON HL, 1969, GENETICS, V63, P619; Carson HL, 1962, U TEXAS PUBL, V6205; Carson HL, 1957, GENET DROSOPH, V5721, P115; Chang CC, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0035-1; Chang TP, 2008, ZOOL STUD, V47, P574; CUELLAR O, 1977, SCIENCE, V197, P837, DOI 10.1126/science.887925; Eisman R, 2007, FLY, V1, P317, DOI 10.4161/fly.5408; Ferree PM, 2006, CURR BIOL, V16, P801, DOI 10.1016/j.cub.2006.03.066; FUTCH DG, 1973, GENETICS, V74, pS86; Futch DG, 1972, DROS INFORM SERV, V48, P78; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Kramer MG, 2001, EVOLUTION, V55, P748, DOI [10.1554/0014-3820(2001)055[0748:LHCTAT]2.0.CO;2, 10.1111/j.0014-3820.2001.tb00811.x]; Matsuda M, 2004, GENET RES, V83, P83, DOI 10.1017/S0016672303006657; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; MITTWOCH U, 1978, J MED GENET, V15, P165, DOI 10.1136/jmg.15.3.165; MURDY WH, 1959, AM NAT, V93, P355, DOI 10.1086/282095; Normark BB, 2014, EVOLUTION OF INSECT MATING SYSTEMS, P1; Ohsako T., 1995, Drosophila Information Service, V76, P150; Pearcy M, 2006, HEREDITY, V96, P377, DOI 10.1038/sj.hdy.6800813; Phillips E. F., 1903, P AM PHILOS SOC, V42, P275; Ram KR, 2007, PLOS GENET, V3, P2428, DOI 10.1371/journal.pgen.0030238; Riparbelli MG, 2003, DEV BIOL, V260, P298, DOI 10.1016/S0012-1606(03)00243-4; Sawamura K, 2006, GENET RES, V88, P1, DOI 10.1017/S0016672306008299; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Schwander T, 2010, P ROY SOC B-BIOL SCI, V277, P1435, DOI 10.1098/rspb.2009.2113; Schwander T, 2009, EVOLUTION, V63, P84, DOI 10.1111/j.1558-5646.2008.00524.x; SMITH JM, 1978, EVOLUTION SEX; STALKER HD, 1954, GENETICS, V39, P4; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; SUOMALAINEN E, 1950, ADV GENET, V3, P193, DOI 10.1016/S0065-2660(08)60086-3; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Templeton A.R., 1982, P75; Templeton A.R., 1983, Genetics and Biology of Drosophila, V3c, P343; Tram U, 2000, CURR BIOL, V10, P1413, DOI 10.1016/S0960-9822(00)00795-8; Vorburger C, 2014, SEX DEV, V8, P50, DOI 10.1159/000356508; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Werren John H., 1993, P42; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Zhou Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-109	50	7	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113275	10.1371/journal.pone.0113275	http://dx.doi.org/10.1371/journal.pone.0113275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415200	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600038
J	Miyazaki, Y; Vieira-de-Abreu, A; Harris, ES; Shah, AM; Weyrich, AS; Castro-Faria-Neto, HC; Zimmerman, GA				Miyazaki, Yasunari; Vieira-de-Abreu, Adriana; Harris, Estelle S.; Shah, Amrapali M.; Weyrich, Andrew S.; Castro-Faria-Neto, Hugo C.; Zimmerman, Guy A.			Integrin alpha(D)beta(2) (CD11d/CD18) Is Expressed by Human Circulating and Tissue Myeloid Leukocytes and Mediates Inflammatory Signaling	PLOS ONE			English	Article							PRIMARY HUMAN MONOCYTES; GENE-EXPRESSION; BETA(2) INTEGRINS; DENDRITIC CELLS; SPINAL-CORD; ALPHA-D; ADHESION; DEFICIENCY; NEUTROPHILS; MOUSE	Integrin alpha(D)beta(2) is the most recently identified member of the leukocyte, or b2, subfamily of integrin heterodimers. Its distribution and functions on human leukocytes have not been clearly defined and are controversial. We examined these issues and found that alpha(D)beta(2) is prominently expressed by leukocytes in whole blood from healthy human subjects, including most polymorphonuclear leukocytes and monocytes. We also found that alpha(D)beta(2) is displayed by leukocytes in the alveoli of uninjured and inflamed human lungs and by human monocyte- derived macrophages and dendritic cells, indicating broad myeloid expression. Using freshly- isolated human monocytes, we found that alpha(D)beta(2) delivers outside- in signals to pathways that regulate cell spreading and gene expression. Screening expression analysis followed by validation of candidate transcripts demonstrated that engagement of alpha(D)beta(2) induces mRNAs encoding inflammatory chemokines and cytokines and secretion of their protein products. Thus, alpha(D)beta(2) is a major member of the integrin repertoire of both circulating and tissue myeloid leukocytes in humans. Its broad expression and capacity for outside- in signaling indicate that it is likely to have important functions in clinical syndromes of infection, inflammation, and tissue injury.	[Miyazaki, Yasunari] Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo 1138519, Japan; [Vieira-de-Abreu, Adriana; Harris, Estelle S.; Shah, Amrapali M.; Weyrich, Andrew S.; Zimmerman, Guy A.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; [Weyrich, Andrew S.] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84112 USA; [Vieira-de-Abreu, Adriana; Castro-Faria-Neto, Hugo C.; Zimmerman, Guy A.] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Immunofarmacol, BR-20001 Rio De Janeiro, Brazil	Tokyo Medical & Dental University (TMDU); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Fundacao Oswaldo Cruz	Miyazaki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	guy.zimmerman@u2m2.utah.edu	Miyazaki, Yasunari/B-7847-2015	Miyazaki, Yasunari/0000-0002-9073-9815	National Institutes of Health [R37HL044525]; Conselho Nacional de Pesquisa e Desenvolvimento Technologico (CNPq) of the Ministry of Science, Technology, and Innovation of Brazil; Ciencia Sem Fronteiras (Science Without Borders) Special Visiting Professorship from CNPq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL044525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Pesquisa e Desenvolvimento Technologico (CNPq) of the Ministry of Science, Technology, and Innovation of Brazil; Ciencia Sem Fronteiras (Science Without Borders) Special Visiting Professorship from CNPq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: Work in this report was supported by award R37HL044525 from the National Institutes of Health. Dr. Vieira-de-Abreu was supported by a fellowship award from the Conselho Nacional de Pesquisa e Desenvolvimento Technologico (CNPq) of the Ministry of Science, Technology, and Innovation of Brazil. Dr. Zimmerman is the recipient of a Ciencia Sem Fronteiras (Science Without Borders) Special Visiting Professorship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; BERMAN ME, 1995, J IMMUNOL, V154, P299; Campbell L, 2010, J EXP MED, V207, P1825, DOI 10.1084/jem.20100500; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Costantini C, 2011, HAEMATOL-HEMATOL J, V96, P1543, DOI 10.3324/haematol.2011.044578; DANILENKO DM, 1995, J IMMUNOL, V155, P35; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; ElGabalawy H, 1996, ARTHRITIS RHEUM-US, V39, P1913, DOI 10.1002/art.1780391119; ELSTAD MR, 1989, J BIOL CHEM, V264, P8467; Etzioni A, 1999, BLOOD, V94, P3281, DOI 10.1182/blood.V94.10.3281.422k37_3281_3288; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grayson MH, 1998, J EXP MED, V188, P2187, DOI 10.1084/jem.188.11.2187; Gris P, 2009, J NEUROIMMUNOL, V209, P104, DOI 10.1016/j.jneuroim.2009.02.002; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Harris ES, 2010, ACUTE RESP DISTRESS, P369; Harris ES, 2013, CURR OPIN HEMATOL, V20, P16, DOI 10.1097/MOH.0b013e32835a0091; Harris ES, 2012, AM J HEMATOL, V87, P311, DOI 10.1002/ajh.22253; HASKILL S, 1988, J IMMUNOL, V140, P1690; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kessel JM, 1998, J IMMUNOL, V160, P5579; Lefort CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00157; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Lindemann SW, 2004, P NATL ACAD SCI USA, V101, P7076, DOI 10.1073/pnas.0401901101; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; Mahoney TS, 2001, P NATL ACAD SCI USA, V98, P10284, DOI 10.1073/pnas.181201398; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mao A, 2005, J IMMUNOL, V175, P5146, DOI 10.4049/jimmunol.175.8.5146; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; McIntyre TM, 2003, CURR OPIN HEMATOL, V10, P150, DOI 10.1097/00062752-200303000-00009; McKillop WM, 2009, J LEUKOCYTE BIOL, V86, P850, DOI 10.1189/jlb.0309150; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miyazaki Y, 2008, J IMMUNOL, V180, P590, DOI 10.4049/jimmunol.180.1.590; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Noti JD, 2005, J BIOL CHEM, V280, P3449, DOI 10.1074/jbc.M412627200; Noti JD, 2000, J BIOL CHEM, V275, P8959, DOI 10.1074/jbc.275.12.8959; Noti JD, 2002, INT J MOL MED, V10, P721; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Palucka KA, 1998, J IMMUNOL, V160, P4587; PETRUZZELLI L, 1995, J IMMUNOL, V155, P854; Pioli PA, 2007, J IMMUNOL, V179, P6284, DOI 10.4049/jimmunol.179.9.6284; Rezzonico R, 2000, BLOOD, V95, P3868; Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932; Rodrigues RS, 2009, PULMONARY ENDOTHELIU, P143; ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111; Saville LR, 2004, J NEUROIMMUNOL, V156, P42, DOI 10.1016/j.jneuroim.2004.07.002; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shanley TP, 1998, J IMMUNOL, V160, P1014; Shelley CS, 1998, GENOMICS, V49, P334, DOI 10.1006/geno.1998.5232; SPORN SA, 1990, J IMMUNOL, V144, P4434; Steeber DA, 1997, J IMMUNOL, V159, P952; Steppich B, 2000, AM J PHYSIOL-CELL PH, V279, pC578, DOI 10.1152/ajpcell.2000.279.3.C578; Thomas AP, 2011, J NUTR, V141, P1172, DOI 10.3945/jn.110.127068; TREZZINI C, 1990, IMMUNOLOGY, V71, P29; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; van de Vijver E, 2012, BLOOD CELL MOL DIS, V48, P53, DOI 10.1016/j.bcmd.2011.10.004; Van der Vieren M, 1999, J IMMUNOL, V163, P1984; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Vieira-de-Abreu A, 2012, SEMIN IMMUNOPATHOL, V34, P5, DOI 10.1007/s00281-011-0286-4; Walzog B, 1999, FASEB J, V13, P1855, DOI 10.1096/fasebj.13.13.1855; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Weyrich AS, 2005, CIRCULATION, V111, P633, DOI 10.1161/01.CIR.0000154607.90506.45; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Wong DA, 1996, GENE, V171, P291, DOI 10.1016/0378-1119(95)00869-1; Wu HZ, 2004, J IMMUNOL, V173, P297, DOI 10.4049/jimmunol.173.1.297; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yakubenko VP, 2008, EXP CELL RES, V314, P2569, DOI 10.1016/j.yexcr.2008.05.016; Yakubenko VP, 2006, BLOOD, V107, P1643, DOI 10.1182/blood-2005-06-2509; Yost CC, 2004, J EXP MED, V200, P671, DOI 10.1084/jem.20040224; Yost CC, 2009, BLOOD, V113, P6419, DOI 10.1182/blood-2008-07-171629; YUROCHKO AD, 1992, P NATL ACAD SCI USA, V89, P9034, DOI 10.1073/pnas.89.19.9034; Zimmerman GA, 2009, BLOOD, V113, P4485, DOI 10.1182/blood-2009-01-198853	81	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112770	10.1371/journal.pone.0112770	http://dx.doi.org/10.1371/journal.pone.0112770			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415295	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600015
J	Chowdhury, SR; Sengupta, S; Biswas, S; Sinha, TK; Sen, R; Basak, RK; Adhikari, B; Bhattacharyya, A				Chowdhury, Sougata Roy; Sengupta, Suman; Biswas, Subir; Sinha, Tridib Kumar; Sen, Ramkrishna; Basak, Ratan Kumar; Adhikari, Basudam; Bhattacharyya, Arindam			Bacterial Fucose-Rich Polysaccharide Stabilizes MAPK-Mediated Nrf2/Keap1 Signaling by Directly Scavenging Reactive Oxygen Species during Hydrogen Peroxide-Induced Apoptosis of Human Lung Fibroblast Cells	PLOS ONE			English	Article							BACILLUS-MEGATERIUM RB-05; INDUCED OXIDATIVE STRESS; CYTOCHROME-C RELEASE; EXTRACELLULAR POLYSACCHARIDE; H2O2-INDUCED APOPTOSIS; LIQUID-CHROMATOGRAPHY; BAICALEIN INHIBITION; ANTIOXIDANT ACTIVITY; CASPASE ACTIVATION; GENE-EXPRESSION	Continuous free radical assault upsets cellular homeostasis and dysregulates associated signaling pathways to promote stress-induced cell death. In spite of the continuous development and implementation of effective therapeutic strategies, limitations in treatments for stress-induced toxicities remain. The purpose of the present study was to determine the potential therapeutic efficacy of bacterial fucose polysaccharides against hydrogen peroxide (H2O2)-induced stress in human lung fibroblast (WI38) cells and to understand the associated molecular mechanisms. In two different fermentation processes, Bacillus megaterium RB-05 biosynthesized two non-identical fucose polysaccharides; of these, the polysaccharide having a high-fucose content (similar to 42%) conferred the maximum free radical scavenging efficiency in vitro. Structural characterizations of the purified polysaccharides were performed using HPLC, GC-MS, and H-1/C-13/2D-COSY NMR. H2O2 (300 mu M) insult to WI38 cells showed anti-proliferative effects by inducing intracellular reactive oxygen species (ROS) and by disrupting mitochondrial membrane permeability, followed by apoptosis. The polysaccharide (250 mu g/mL) attenuated the cell death process by directly scavenging intracellular ROS rather than activating endogenous antioxidant enzymes. This process encompasses inhibition of caspase-9/3/7, a decrease in the ratio of Bax/Bcl2, relocalization of translocated Bax and cytochrome c, upregulation of anti-apoptotic members of the Bcl2 family and a decrease in the phosphorylation of MAPKs (mitogen activated protein kinases). Furthermore, cellular homeostasis was re-established via stabilization of MAPK-mediated Nrf2/Keap1 signaling and transcription of downstream cytoprotective genes. This molecular study uniquely introduces a fucose-rich bacterial polysaccharide as a potential inhibitor of H2O2-induced stress and toxicities.	[Chowdhury, Sougata Roy; Sinha, Tridib Kumar; Basak, Ratan Kumar; Adhikari, Basudam] Indian Inst Technol Kharagpur, Ctr Mat Sci, Kharagpur, W Bengal, India; [Chowdhury, Sougata Roy; Sengupta, Suman; Biswas, Subir; Bhattacharyya, Arindam] Univ Calcutta, Dept Zool, Immunol Lab, Kolkata 700019, W Bengal, India; [Sen, Ramkrishna] Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Calcutta; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Sen, R (corresponding author), Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India.	rksen@yahoo.com; arindam19@yahoo.com	Sinha, Tridib Kumar/AAN-6813-2020; BISWAS, SUBIR/AAZ-6856-2021; ROY CHOWDHURY, SOUGATA/AAE-3605-2022; Sen, Ramkrishna/C-8772-2014	Sinha, Tridib Kumar/0000-0002-6040-1311; BISWAS, SUBIR/0000-0003-2428-6288; Sen, Ramkrishna/0000-0002-6207-3307; Roy Chowdhury, Sougata/0000-0002-2705-3343	institutional fund of Indian Institute of Technology Kharagpur, Kharagpur, India	institutional fund of Indian Institute of Technology Kharagpur, Kharagpur, India	All the financial support of this paper is from the institutional fund of Indian Institute of Technology Kharagpur, Kharagpur, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243; AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; Alaimo A, 2011, NEUROCHEM INT, V59, P297, DOI 10.1016/j.neuint.2011.06.001; ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; BJORNDAL H, 1970, ANGEW CHEM INT EDIT, V9, P610, DOI 10.1002/anie.197006101; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Bowler RP, 2001, AM J RESP CRIT CARE, V164, P290, DOI 10.1164/ajrccm.164.2.2011054; Braca A, 2002, J ETHNOPHARMACOL, V79, P379, DOI 10.1016/S0378-8741(01)00413-5; Carvalho H, 2004, J CELL BIOCHEM, V92, P502, DOI 10.1002/jcb.20070; Chen YC, 2006, TOXICOL APPL PHARM, V216, P263, DOI 10.1016/j.taap.2006.05.008; Chowdhury SR, 2011, J APPL MICROBIOL, V111, P1381, DOI 10.1111/j.1365-2672.2011.05162.x; Chowdhury SR, 2012, MATER LETT, V66, P216, DOI 10.1016/j.matlet.2011.08.040; Chowdhury SR, 2011, CARBOHYD POLYM, V86, P1327, DOI 10.1016/j.carbpol.2011.06.050; Chowdhury SR, 2011, BIORESOURCE TECHNOL, V102, P6629, DOI 10.1016/j.biortech.2011.03.099; Clutton S, 1997, BRIT MED BULL, V53, P662; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Delivani P, 2006, CELL DEATH DIFFER, V13, P2007, DOI 10.1038/sj.cdd.4402049; Duan JY, 2011, GLYCOBIOLOGY, V21, P401, DOI 10.1093/glycob/cwq171; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fernandes E, 1999, TOXICOL LETT, V109, P42; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hammel KE, 2002, ENZYME MICROB TECH, V30, P445, DOI 10.1016/S0141-0229(02)00011-X; Hazra B, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-20; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Inngjerdingen KT, 2006, BIOMACROMOLECULES, V7, P48, DOI 10.1021/bm050330h; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; KIRK TK, 1991, HOLZFORSCHUNG, V45, P239, DOI 10.1515/hfsg.1991.45.4.239; Kitts DD, 2000, MOL CELL BIOCHEM, V203, P1, DOI 10.1023/A:1007078414639; Kumar S, 2009, LIFE SCI, V84, P328, DOI 10.1016/j.lfs.2008.12.016; KUNCHANDY E, 1990, INT J PHARM, V58, P237, DOI 10.1016/0378-5173(90)90201-E; Lee HJ, 2005, EUR J CELL BIOL, V84, P897, DOI 10.1016/j.ejcb.2005.07.003; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lin HY, 2007, BBA-MOL CELL RES, V1773, P1073, DOI 10.1016/j.bbamcr.2007.04.008; Liu BM, 2012, FREE RADICAL BIO MED, V53, P183, DOI 10.1016/j.freeradbiomed.2012.04.015; Liu CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001321; Liu J, 2009, CARBOHYD POLYM, V78, P275, DOI 10.1016/j.carbpol.2009.03.046; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Miller JG, 2001, CARBOHYD RES, V332, P389, DOI 10.1016/S0008-6215(01)00110-0; Nagamine T, 2009, NUTR CANCER, V61, P340, DOI 10.1080/01635580802567133; Nakajima Y, 2009, FREE RADICAL BIO MED, V47, P1154, DOI 10.1016/j.freeradbiomed.2009.07.029; Nergard CS, 2006, BIOMACROMOLECULES, V7, P71, DOI 10.1021/bm050355g; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Peterszegi G, 2003, BIOMED PHARMACOTHER, V57, P240, DOI 10.1016/S0753-3322(03)00028-3; Peterszegi G, 2003, BIOMED PHARMACOTHER, V57, P130, DOI 10.1016/S0753-3322(03)00019-2; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Rinaudo M., 1982, CARBOHYD POLYM, V2; Shi XJ, 2010, TOXICOL SCI, V115, P391, DOI 10.1093/toxsci/kfq066; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stepkowski TM, 2011, FREE RADICAL BIO MED, V50, P1186, DOI 10.1016/j.freeradbiomed.2011.01.033; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Valentao P, 2002, BIOL PHARM BULL, V25, P1324, DOI 10.1248/bpb.25.1324; Yamasaki-Miyamoto Y, 2009, J AGR FOOD CHEM, V57, P8677, DOI 10.1021/jf9010406; Yazdanparast R, 2007, J MED FOOD, V10, P667, DOI 10.1089/jmf.2006.090; Yazdanparast R, 2008, CHEM-BIOL INTERACT, V172, P176, DOI 10.1016/j.cbi.2008.01.006; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	68	31	31	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113663	10.1371/journal.pone.0113663	http://dx.doi.org/10.1371/journal.pone.0113663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412177	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000068
J	Genevini, P; Papiani, G; Ruggiano, A; Cantoni, L; Navone, F; Borgese, N				Genevini, Paola; Papiani, Giulia; Ruggiano, Annamaria; Cantoni, Lavinia; Navone, Francesca; Borgese, Nica			Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model	PLOS ONE			English	Article							MEMBRANE CONTACT SITES; MOTOR-NEURON DISEASES; ENDOPLASMIC-RETICULUM; WILD-TYPE; NEURODEGENERATIVE DISEASES; DROSOPHILA MODEL; GOLGI-APPARATUS; P56S MUTATION; SPINAL-CORD; FFAT MOTIF	VAPB is a ubiquitously expressed, ER-resident adaptor protein involved in interorganellar lipid exchange, membrane contact site formation, and membrane trafficking. Its mutant form, P56S-VAPB, which has been linked to a dominantly inherited form of Amyotrophic Lateral Sclerosis (ALS8), generates intracellular inclusions consisting in restructured ER domains whose role in ALS pathogenesis has not been elucidated. P56S-VAPB is less stable than the wild-type protein and, at variance with most pathological aggregates, its inclusions are cleared by the proteasome. Based on studies with cultured cells overexpressing the mutant protein, it has been suggested that VAPB inclusions may exert a pathogenic effect either by sequestering the wild-type protein and other interactors (loss-of-function by a dominant negative effect) or by a more general proteotoxic action (gain-of-function). To investigate P56S-VAPB degradation and the effect of the inclusions on proteostasis and on ER-to-plasma membrane protein transport in a more physiological setting, we used stable HeLa and NSC34 Tet-Off cell lines inducibly expressing moderate levels of P56S-VAPB. Under basal conditions, P56S-VAPB degradation was mediated exclusively by the proteasome in both cell lines, however, it could be targeted also by starvation-stimulated autophagy. To assess possible proteasome impairment, the HeLa cell line was transiently transfected with the ERAD (ER Associated Degradation) substrate CD3 delta, while autophagic flow was investigated in cells either starved or treated with an autophagy-stimulating drug. Secretory pathway functionality was evaluated by analyzing the transport of transfected Vesicular Stomatitis Virus Glycoprotein (VSVG). P56S-VAPB expression had no effect either on the degradation of CD3 delta or on the levels of autophagic markers, or on the rate of transport of VSVG to the cell surface. We conclude that P56S-VAPB inclusions expressed at moderate levels do not interfere with protein degradation pathways or protein transport, suggesting that the dominant inheritance of the mutant gene may be due mainly to haploinsufficiency.	[Genevini, Paola; Papiani, Giulia; Ruggiano, Annamaria; Navone, Francesca; Borgese, Nica] Univ Milan, CNR, Inst Neurosci, Milan, Italy; [Genevini, Paola; Papiani, Giulia; Ruggiano, Annamaria; Navone, Francesca; Borgese, Nica] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, Milan, Italy; [Cantoni, Lavinia] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Borgese, Nica] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Magna Graecia University of Catanzaro	Navone, F (corresponding author), Univ Milan, CNR, Inst Neurosci, Milan, Italy.	f.navone@in.cnr.it; n.borgese@in.cnr.it	Ruggiano, Annamaria/ABF-4337-2021; Borgese, Nica/GWZ-8895-2022	Ruggiano, Annamaria/0000-0003-4514-7922; Borgese, Nica/0000-0002-7537-3974	CARIPLO Foundation [2007-5098]; PNR-CNR Aging Program; Universita Statale di Milano	CARIPLO Foundation(Fondazione Cariplo); PNR-CNR Aging Program; Universita Statale di Milano	This work was supported by the CARIPLO Foundation (http://www.fondazionecariplo.it/it/index.html) project 2007-5098 (NB), PNR-CNR Aging Program 2012-2014, and Universita Statale di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliaga L, 2013, HUM MOL GENET, V22, P4293, DOI 10.1093/hmg/ddt279; Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Anagnostou G, 2010, NEUROBIOL AGING, V31, P969, DOI 10.1016/j.neurobiolaging.2008.07.005; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Babetto E, 2005, MOL BRAIN RES, V140, P63, DOI 10.1016/j.molbrainres.2005.07.010; Bergmann JE, 1989, METHOD CELL BIOL, V32, P85; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Chattopadhyay D, 2014, BIOCHEM BIOPH RES CO, V448, P108, DOI 10.1016/j.bbrc.2014.04.102; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; De Vos KJ, 2012, HUM MOL GENET, V21, P1299, DOI 10.1093/hmg/ddr559; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Forrest S, 2013, HUM MOL GENET, V22, P2689, DOI 10.1093/hmg/ddt118; Funke AD, 2010, CLIN GENET, V77, P302, DOI 10.1111/j.1399-0004.2009.01319.x; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Han SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003738; Kabashi E, 2013, HUM MOL GENET, V22, P2350, DOI 10.1093/hmg/ddt080; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuijpers M, 2013, EMBO J, V32, P2056, DOI 10.1038/emboj.2013.131; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Moumen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026066; Moustaqim-Barrette A, 2014, HUM MOL GENET, V23, P1975, DOI 10.1093/hmg/ddt594; Nishimura AL, 2004, J MED GENET, V41, P315, DOI 10.1136/jmg.2003.013029; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Ohnishi T, 2014, GENES CELLS, V19, P97, DOI 10.1111/gtc.12109; Papiani G, 2012, J CELL SCI, V125, P3601, DOI 10.1242/jcs.102137; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Qiu LH, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-1; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; SEELIG HP, 1994, J AUTOIMMUN, V7, P67, DOI 10.1006/jaut.1994.1006; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Tudor EL, 2010, NEUROSCIENCE, V167, P774, DOI 10.1016/j.neuroscience.2010.02.035; van Blitterswijk M, 2012, NEUROBIOL AGING, V33; van Dis V, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-38; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yang Z, 2012, J NEUROSCI, V32, P17241, DOI 10.1523/JNEUROSCI.2834-12.2012	61	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113416	10.1371/journal.pone.0113416	http://dx.doi.org/10.1371/journal.pone.0113416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409455	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200116
J	Grarup, PA; Janner, JH; Ulrik, CS				Grarup, Pernille A.; Janner, Julie H.; Ulrik, Charlotte Suppli			Passive Smoking Is Associated with Poor Asthma Control during Pregnancy: A Prospective Study of 500 Pregnancies	PLOS ONE			English	Article							CIGARETTE-SMOKING; MANAGEMENT; OUTCOMES; WOMEN	Background and Aim: Asthma and tobacco exposure is common among pregnant women. We investigated the effect of passive and active smoking on asthma control during pregnancy. Methods: Prospective observational design. Patients had their asthma control, based on symptoms, use of medication, spirometry, and exhaled nitric oxide [FENO], assessed every four weeks during 2(nd) and 3(rd) trimester of pregnancy; data on tobacco exposure were also collected prospectively. The primary outcome was episodes of uncontrolled and partly controlled asthma during pregnancy (defined according to GINA-guidelines). Results: A total of 500 pregnant women with asthma (mean age 30.8 years, range 17 to 44) were consecutively included, of whom 32 (6.4%), 115 (23.0%) and 353 (70.6%), respectively, were current smokers, ex-smokers and never smokers [NS]. Sixty five NS (18.4%) reported passive tobacco exposure. NS with passive tobacco exposure had significantly lower FEV1% predicted (p<0.02) and FENO (p = 0.01) compared to NS without passive tobacco exposure. The relative risk [RR] of an episode of uncontrolled asthma during pregnancy was 4.5 (95% CI 2.7-7.5: p<0.001) in current and ex-smokers compared with never smokers, and 2.9 (95% CI 1.4-5.9; p = 0.004) in NS-women with passive tobacco exposure compared with NS-women not reporting passive tobacco exposure. Treatment with inhaled corticosteroids, most likely as a marker of more severe asthma, was also associated with a higher risk (RR 8.1, 95% CI 5.1-13.0; p<0.001) of an episode of uncontrolled asthma. Conclusion: Passive tobacco exposure in never smokers is associated with an increased risk of episodes of uncontrolled asthma during pregnancy, which is likely to have adverse effects on pregnancy outcome.	[Grarup, Pernille A.; Janner, Julie H.; Ulrik, Charlotte Suppli] Univ Copenhagen, Hvidovre Hosp, Dept Pulm Med, DK-2650 Hvidovre, Denmark; [Ulrik, Charlotte Suppli] Univ Copenhagen, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Ulrik, CS (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Pulm Med, DK-2650 Hvidovre, Denmark.	csulrik@dadlnet.dk						Ali Z, 2013, J ASTHMA ALLERGY, V6, P53, DOI 10.2147/JAA.S43183; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9; Chalmers GW, 2002, THORAX, V57, P226, DOI 10.1136/thorax.57.3.226; Einarson A, 2009, EUR J CLIN PHARMACOL, V65, P325, DOI 10.1007/s00228-008-0609-0; Juel CTB, 2012, J ASTHMA ALLERGY, V5, P21, DOI 10.2147/JAA.S32232; Kallen B, 2000, EUR J EPIDEMIOL, V16, P167, DOI 10.1023/A:1007678404911; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murphy VE, 2010, THORAX, V65, P739, DOI 10.1136/thx.2009.124941; Newman RB, 2010, CHEST, V137, P601, DOI 10.1378/chest.09-0942; Ortega H, 2014, EUR RESP J; Powell H, 2011, LANCET, V378, P983, DOI 10.1016/S0140-6736(11)60971-9; Rocklin RE, 2011, REPROD TOXICOL, V32, P189, DOI 10.1016/j.reprotox.2011.05.023; Saba M, 2014, J ASTHMA, P1; Schatz M, 2009, NEW ENGL J MED, V360, P1862, DOI 10.1056/NEJMcp0809942; Thomson NC, 2004, EUR RESPIR J, V24, P822, DOI 10.1183/09031936.04.00039004; WALSH RA, 1994, HUM BIOL, V66, P1059; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537	18	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112435	10.1371/journal.pone.0112435	http://dx.doi.org/10.1371/journal.pone.0112435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409513	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200022
J	Gurcha, SS; Usha, V; Cox, JAG; Fuetterer, K; Abrahams, KA; Bhatt, A; Alderwick, LJ; Reynolds, RC; Loman, NJ; Nataraj, V; Alemparte, C; Barros, D; Lloyd, AJ; Ballell, L; Hobrath, JV; Besra, GS				Gurcha, Sudagar S.; Usha, Veeraraghavan; Cox, Jonathan A. G.; Fuetterer, Klaus; Abrahams, Katherine A.; Bhatt, Apoorva; Alderwick, Luke J.; Reynolds, Robert C.; Loman, Nicholas J.; Nataraj, VijayaShankar; Alemparte, Carlos; Barros, David; Lloyd, Adrian J.; Ballell, Lluis; Hobrath, Judith V.; Besra, Gurdyal S.			Biochemical and Structural Characterization of Mycobacterial Aspartyl-tRNA Synthetase AspS, a Promising TB Drug Target	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; ESCHERICHIA-COLI; INHIBITORS; DISCOVERY; IDENTIFICATION; MECHANISM; ASSAY; GENOME; TMC207; SQ109	The human pathogen Mycobacterium tuberculosis is the causative agent of pulmonary tuberculosis (TB), a disease with high worldwide mortality rates. Current treatment programs are under significant threat from multi-drug and extensively-drug resistant strains of M. tuberculosis, and it is essential to identify new inhibitors and their targets. We generated spontaneous resistant mutants in Mycobacterium bovis BCG in the presence of 10x the minimum inhibitory concentration (MIC) of compound 1, a previously identified potent inhibitor of mycobacterial growth in culture. Whole genome sequencing of two resistant mutants revealed in one case a single nucleotide polymorphism in the gene aspS at (535)GAC>(535)AAC (D179N), while in the second mutant a single nucleotide polymorphism was identified upstream of the aspS promoter region. We probed whole cell target engagement by overexpressing either M. bovis BCG aspS or Mycobacterium smegmatis aspS, which resulted in a ten-fold and greater than ten-fold increase, respectively, of the MIC against compound 1. To analyse the impact of inhibitor 1 on M. tuberculosis AspS (Mt-AspS) activity we over-expressed, purified and characterised the kinetics of this enzyme using a robust tRNA-independent assay adapted to a high-throughput screening format. Finally, to aid hit-to-lead optimization, the crystal structure of apo M. smegmatis AspS was determined to a resolution of 2.4 angstrom.	[Gurcha, Sudagar S.; Usha, Veeraraghavan; Cox, Jonathan A. G.; Fuetterer, Klaus; Abrahams, Katherine A.; Bhatt, Apoorva; Alderwick, Luke J.; Loman, Nicholas J.; Nataraj, VijayaShankar; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Reynolds, Robert C.] Univ Alabama Birmingham, Dept Chem, Coll Arts & Sci, Birmingham, AL 35294 USA; [Alemparte, Carlos; Barros, David; Ballell, Lluis] GlaxoSmithKline, Dis Developing World, Madrid 28760, Spain; [Lloyd, Adrian J.] Univ Warwick, Dept Life Sci, Coventry CV4 7AL, W Midlands, England; [Hobrath, Judith V.] So Res Inst, Dept Organ Chem, Birmingham, AL 35205 USA	University of Birmingham; University of Alabama System; University of Alabama Birmingham; GlaxoSmithKline; University of Warwick	Besra, GS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	g.besra@bham.ac.uk	Loman, Nicholas/Z-1573-2019	Loman, Nicholas/0000-0002-9843-8988; Abrahams, Katherine/0000-0002-0769-3423; Alderwick, Luke/0000-0002-1257-6053; Ballell, Lluis/0000-0002-3029-1860; Besra, Gurdyal/0000-0002-5605-0395; Lloyd, Adrian/0000-0002-4638-4586; Cox, Jonathan/0000-0001-5208-4056; Futterer, Klaus/0000-0001-7445-5372; Alemparte, Carlos/0000-0001-5521-8304	Royal Society Wolfson Research Merit Award; Medical Research Council [MR/K012118/1]; European Union [261378]; Wellcome Trust [081569/Z/06/Z]; MRC [MR/K012118/1, MR/J014370/1, MR/L015080/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1112080] Funding Source: researchfish; Medical Research Council [MR/J014370/1, MR/L015080/1] Funding Source: researchfish	Royal Society Wolfson Research Merit Award(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GSB acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick and a Royal Society Wolfson Research Merit Award (https://royalsociety.org/), the Medical Research Council (http://www.mrc.ac.uk; MR/K012118/1), European Union 7th Framework Programme (FP7-2007-2013; http://cordis.europa.eu/fp7/home_en.html) under grant agreement no 261378; and The Wellcome Trust (081569/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Agarwal V, 2012, MEDCHEMCOMM, V3, P887, DOI 10.1039/c2md20032e; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dietrich G, 2000, FEMS MICROBIOL LETT, V186, P177, DOI 10.1016/S0378-1097(00)00138-5; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ezgimen MD, 2009, BIOORGAN MED CHEM, V17, P3278, DOI 10.1016/j.bmc.2009.03.050; Goldman RC, 2013, TUBERCULOSIS, V93, P569, DOI 10.1016/j.tube.2013.09.003; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Guo M, 2012, CURR OPIN STRUC BIOL, V22, P119, DOI 10.1016/j.sbi.2011.11.008; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Jain AK, 2012, BIOORGAN MED CHEM, V20, P3378, DOI 10.1016/j.bmc.2012.03.069; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2003, APPL MICROBIOL BIOT, V61, P278, DOI 10.1007/s00253-003-1243-5; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lloyd AJ, 2013, ACS CHEM BIOL, V8, P2157, DOI 10.1021/cb400248f; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Mahenthiralingam E, 1998, METH MOL B, V101, P65, DOI 10.1385/0-89603-471-2:65; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Matteelli A, 2010, FUTURE MICROBIOL, V5, P849, DOI [10.2217/fmb.10.50, 10.2217/FMB.10.50]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Mitchell JE, 2003, NUCLEIC ACIDS RES, V31, P4689, DOI 10.1093/nar/gkg694; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palomino JC, 2013, FUTURE MICROBIOL, V8, P1071, DOI 10.2217/fmb.13.85; Paravisi S, 2009, FEBS J, V276, P1398, DOI 10.1111/j.1742-4658.2009.06880.x; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; ROY S, 1983, ANAL BIOCHEM, V133, P292, DOI 10.1016/0003-2697(83)90086-6; Sacksteder KA, 2012, FUTURE MICROBIOL, V7, P823, DOI [10.2217/FMB.12.56, 10.2217/fmb.12.56]; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Vondenhoff GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079234; Vondenhoff GH, 2012, CHEMBIOCHEM, V13, P1959, DOI 10.1002/cbic.201200174; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Walter F, 2002, EMBO J, V21, P760, DOI 10.1093/emboj/21.4.760; Wang F, 2013, P NATL ACAD SCI USA, V110, pE2510, DOI 10.1073/pnas.1309171110; Yew WW, 2011, AM J RESP CRIT CARE, V184, P180, DOI 10.1164/rccm.201102-0325UP	62	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113568	10.1371/journal.pone.0113568	http://dx.doi.org/10.1371/journal.pone.0113568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409504	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200137
J	Morrissey, RC; Jenkins, MA; Saunders, MR				Morrissey, Robert C.; Jenkins, Michael A.; Saunders, Michael R.			Accumulation and Connectivity of Coarse Woody Debris in Partial Harvest and Unmanaged Relict Forests	PLOS ONE			English	Article							PICEA-ABIES FOREST; OLD-GROWTH FORESTS; DECAYING FUNGI; DEAD WOOD; SPATIAL-DISTRIBUTION; MANAGED FORESTS; SPRUCE FORESTS; CENTRAL-EUROPE; MESIC FORESTS; PATTERNS	When a tree dies, it continues to play an important ecological role within forests. Coarse woody debris (CWD), including standing deadwood (SDW) and downed deadwood (DDW), is an important functional component of forest ecosystems, particularly for many dispersal-limited saproxylic taxa and for metapopulation dynamics across landscapes. Processes, such as natural disturbance or management, modify forest composition and structure, thereby influencing CWD abundance and distribution. Many studies have compared older forests to forests managed with even-aged silvicultural systems and observed a prolonged period of low CWD occurrence after harvesting. With fine-scale spatial data, our study compares the long-term impacts of light partial harvesting on the CWD structure of eastern deciduous hardwood forests. We mapped and inventoried DDW and SDW using variable radius plots based on a 10 m x 10 m grid throughout an unmanaged, structurally-complex relict forest and two nearby forests that were partially harvested over 46 years ago. The relict stand had significantly larger individual pieces and higher accumulations of DDW and SDW than both of the partially harvested stands. Connectivity of CWD was much higher in the relict stand, which had fewer, larger patches. Larger pieces and higher proportion of decay-resistant species (e. g. Quercus spp.) in the relict forest resulted in slower decomposition, greater accumulation and increased connectivity of CWD. Partial harvests, such that occur with selection forestry, are generally considered less disruptive of ecosystem services, but this study highlights the long-term impacts of even light partial harvests on CWD stocks and distribution. When planning harvesting events, forest managers should also consider alternative methods to ensure the sustainability of deadwood resources and function.	[Morrissey, Robert C.] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Ecol, Prague, Czech Republic; [Morrissey, Robert C.; Jenkins, Michael A.; Saunders, Michael R.] Purdue Univ, Dept Forestry & Nat Resources, Hardwood Tree Improvement & Regenerat Ctr, W Lafayette, IN 47907 USA	Czech University of Life Sciences Prague; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Morrissey, RC (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Ecol, Prague, Czech Republic.	robcmorrissey@gmail.com	Saunders, Michael/A-7035-2010; Jenkins, Michael/F-7396-2016	Saunders, Michael/0000-0001-5621-4321; Jenkins, Michael/0000-0002-1612-6383; Morrissey, Robert/0000-0002-0665-5935	Hardwood Tree Improvement and Regeneration Center; Department of Forestry and Natural Resources at Purdue University	Hardwood Tree Improvement and Regeneration Center; Department of Forestry and Natural Resources at Purdue University	This work was funded by the Hardwood Tree Improvement and Regeneration Center, and the Department of Forestry and Natural Resources at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakala T, 2007, CAN J FOREST RES, V37, P50, DOI 10.1139/X06-201; Aakala T, 2012, CAN J FOREST RES, V42, P899, DOI [10.1139/X2012-044, 10.1139/x2012-044]; Angers VA, 2005, FOREST ECOL MANAG, V217, P275, DOI 10.1016/j.foreco.2005.06.008; [Anonymous], 2014, R LANG ENV STAT COMP; BADER P, 1995, BIOL CONSERV, V72, P355, DOI 10.1016/0006-3207(94)00029-P; Butts SR, 2000, J WILDLIFE MANAGE, V64, P95, DOI 10.2307/3802978; Edman M, 2001, J VEG SCI, V12, P609, DOI 10.2307/3236900; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Fraver S, 2007, CAN J FOREST RES, V37, P627, DOI 10.1139/X06-269; Gove JH, 2001, J FOREST, V99, P4; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Harmon ME, 2009, ECOL STUD-ANAL SYNTH, V207, P159, DOI 10.1007/978-3-540-92706-8_8; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Jonsson MT, 2008, J ECOL, V96, P1065, DOI 10.1111/j.1365-2745.2008.01411.x; Komonen A, 2005, SCAND J FOREST RES, V20, P393, DOI 10.1080/02827580500281983; Laaka-Lindberg S, 2006, J HATTORI BOT LAB, P311; Linden DW, 2012, FOREST ECOL MANAG, V284, P174, DOI 10.1016/j.foreco.2012.08.002; MAC ARTHUR ROBERT H., 1967; MACMILLAN PC, 1988, CAN J FOREST RES, V18, P1353, DOI 10.1139/x88-212; Manning AD, 2013, BIOL CONSERV, V157, P204, DOI 10.1016/j.biocon.2012.06.028; McComb William C., 2003, P374, DOI 10.1017/CBO9780511615757.012; Mesavage C., 1946, Tables for estimating board-foot volume of timber.; Morrissey R.C., 2013, THESIS PURDUE U; PARKER GR, 1983, B TORREY BOT CLUB, V110, P482, DOI 10.2307/2996282; Riffell S, 2011, FOREST ECOL MANAG, V261, P878, DOI 10.1016/j.foreco.2010.12.021; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Schiegg K, 2000, ECOSCIENCE, V7, P290, DOI 10.1080/11956860.2000.11682598; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; SIPPOLA AL, 2001, ECOL B, V49, P243; SZWAGRZYK J, 1993, J VEG SCI, V4, P469, DOI 10.2307/3236074; Turcotte RM, 2012, NORTH J APPL FOR, V29, P53, DOI 10.5849/njaf.10-053; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vandekerkhove K, 2009, FOREST ECOL MANAG, V258, P425, DOI 10.1016/j.foreco.2009.01.055; Ylisirnio AL, 2009, SCAND J FOREST RES, V24, P527, DOI 10.1080/02827580903362489	36	13	14	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113323	10.1371/journal.pone.0113323	http://dx.doi.org/10.1371/journal.pone.0113323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409459	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200096
J	Palve, V; Mallick, S; Ghaisas, G; Kannan, S; Teni, T				Palve, Vinayak; Mallick, Sanchita; Ghaisas, Gauri; Kannan, Sadhana; Teni, Tanuja			Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; BCL2 FAMILY; EXPRESSION; APOPTOSIS; LINES; SURVIVAL; HEAD; BAK	Background: Altered expression of Mcl-1, an anti-apoptotic member of the Bcl-2 family, has been linked to the progression and outcome of a variety of malignancies. We have previously reported the overexpression of Mcl-1 protein in human oral cancers. The present study aimed to evaluate the clinicopathological significance of the expression of three known Mcl-1 isoforms in oral tumors and the effect of targeting Mcl-1L isoform on chemosensitivity of oral cancer cells. Methods: The expression of Mcl-1 isoforms-Mcl-1L, Mcl-1S & Mcl-1ES was analyzed in 130 paired oral tumors and 9 oral cell lines using quantitative real-time PCR & protein by western blotting. The Mcl-1 mRNA levels were correlated with clinicopathological parameters and outcome of oral cancer patients. The effect of Mcl-1L shRNA or Obatoclax (a small molecule Mcl-1 inhibitor), in combination with Cisplatin on chemosensitivity of oral cancer cells was also assessed. Results: Anti-apoptotic Mcl-1L was predominantly expressed, over low or undetectable pro-apoptotic Mcl-1S and Mcl-1ES isoforms. The Mcl-1L transcripts were significantly overexpressed in all cancer cell lines and in 64% oral tumors versus adjacent normals (P<0.02). In oral cancer patients, high Mcl-1L expression was significantly associated with node positivity (P = 0.021), advanced tumor size (P = 0.013) and poor overall survival (P = 0.002). Multivariate analysis indicated Mcl-1L to be an independent prognostic factor for oral cancers (P = 0.037). Mcl-1L shRNA knockdown or its inhibition by Obatoclax in combination with Cisplatin synergistically reduced viability and growth of oral cancer cells than either treatment alone. Conclusion: Our studies suggest that overexpression of Mcl-1L is associated with poor prognosis and chemoresistance in oral cancers. Mcl-1L is an independent prognostic factor and a potential therapeutic target in oral cancers.	[Palve, Vinayak; Mallick, Sanchita; Ghaisas, Gauri; Teni, Tanuja] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Teni Lab, Kharghar 410210, Navi Mumbai, India; [Kannan, Sadhana] Tata Mem Hosp, Epidemiol & Clin Trial Unit, Adv Ctr Treatment Res & Educ Canc, Kharghar 410210, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Teni, T (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Teni Lab, Kharghar 410210, Navi Mumbai, India.	tteni@actrec.gov.in		Palve, Vinayak/0000-0002-8221-5018				Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Coelho KR, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/701932; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Hamada T, 2014, 2014 ANN M AAOMS; Kempkensteffen C, 2009, TUMOR BIOL, V30, P73, DOI 10.1159/000215826; Kim JH, 2009, FEBS LETT, V583, P2758, DOI 10.1016/j.febslet.2009.08.006; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Liu X, 2014, J ANAL ONCOLOGY, V3, P18; Luo L, 2012, MED ONCOL, V29, P1681, DOI 10.1007/s12032-011-0085-8; Mallick S, 2009, J PATHOL, V217, P398, DOI 10.1002/path.2459; Mallick S, 2010, ORAL ONCOL, V46, P688, DOI 10.1016/j.oraloncology.2010.04.003; Martin CL, 2008, ORAL ONCOL, V44, P369, DOI 10.1016/j.oraloncology.2007.05.003; Nagata M, 2009, J PHARMACOL SCI, V110, P344, DOI 10.1254/jphs.08339FP; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; O'Driscoll L, 2004, ANTICANCER RES, V24, P473; Palve VC, 2012, RADIAT ONCOL, V7, P1; Park HR, 2011, CANCER-AM CANCER SOC, V117, P1864, DOI 10.1002/cncr.25760; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; Peter B, 2013, J LEUKOCYTE BIOL; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulze-Bergkamen H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-232; Shigemasa K, 2002, JPN J CANCER RES, V93, P542, DOI 10.1111/j.1349-7006.2002.tb01289.x; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Simonin K, 2009, MOL CANCER THER, V8, P3162, DOI 10.1158/1535-7163.MCT-09-0493; Su LP, 2010, ORAL SURG ORAL MED O, V110, P484, DOI 10.1016/j.tripleo.2010.04.009; TATAKE RJ, 1990, J CANCER RES CLIN, V116, P179, DOI 10.1007/BF01612674; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Wang LK, 2009, J SURG ONCOL, V100, P396, DOI 10.1002/jso.21344; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang C, 2007, AM J PHYSIOL-RENAL, V292, pF1710, DOI 10.1152/ajprenal.00505.2006; Yazbeck VY, 2014, ORAL ONCOL, V50, P120, DOI 10.1016/j.oraloncology.2013.10.013; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559; Zhang Tian C., 2012, Membrane Technology and Environmental Applications, P1; Zhang T, 2012, MED ONCOL, V29, P1985, DOI 10.1007/s12032-011-0005-y	45	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111927	10.1371/journal.pone.0111927	http://dx.doi.org/10.1371/journal.pone.0111927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409302	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200005
J	Slubowski, CJ; Paulissen, SM; Huang, LS				Slubowski, Christian J.; Paulissen, Scott M.; Huang, Linda S.			The GCKIII Kinase Sps1 and the 14-3-3 Isoforms, Bmh1 and Bmh2, Cooperate to Ensure Proper Sporulation in Saccharomyces cerevisiae	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN-KINASE; PROTEOMIC ANALYSIS; STRUCTURAL BASIS; SKELETAL-MUSCLE; HIGH-THROUGHPUT; DNA-DAMAGE; YEAST; 14-3-3-PROTEINS; IDENTIFICATION	Sporulation in the budding yeast Saccharomyces cerevisiae is a developmental program initiated in response to nutritional deprivation. Sps1, a serine/threonine kinase, is required for sporulation, but relatively little is known about the molecular mechanisms through which it regulates this process. Here we show that SPS1 encodes a bona-fide member of the GCKIII subfamily of STE20 kinases, both through phylogenetic analysis of the kinase domain and examination of its C-terminal regulatory domain. Within the regulatory domain, we find Sps1 contains an invariant ExxxPG region conserved from plant to human GCKIIIs that we call the EPG motif; we show this EPG motif is important for SPS1 function. We also find that Sps1 is phosphorylated near its N-terminus on Threonine 12, and that this phosphorylation is required for the efficient production of spores. In Sps1, Threonine 12 lies within a 14-3-3 consensus binding sequence, and we show that the S. cerevisiae 14-3-3 proteins Bmh1 and Bmh2 bind Sps1 in a Threonine 12-dependent fashion. This interaction is significant, as BMH1 and BMH2 are required during sporulation and genetically interact with SPS1 in sporulating cells. Finally, we observe that Sps1, Bmh1 and Bmh2 are present in both the nucleus and cytoplasm during sporulation. We identify a nuclear localization sequence in Sps1 at amino acids 411-415, and show that this sequence is necessary and sufficient for nuclear localization. Taken together, these data identify regions within Sps1 critical for its function and indicate that SPS1 and 14-3-3s act together to promote proper sporulation in S. cerevisiae.	[Slubowski, Christian J.; Paulissen, Scott M.; Huang, Linda S.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Huang, LS (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	Linda.Huang@umb.edu	Huang, Linda/C-9903-2014	Huang, Linda/0000-0002-9033-4391; Paulissen, Scott/0000-0002-9258-2380	Goranson Research Award; University of Massachusetts Boston Dissertation Support Grant; National Science Foundation [MCB-0544160]	Goranson Research Award; University of Massachusetts Boston Dissertation Support Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by a Goranson Research Award to CJS, an University of Massachusetts Boston Dissertation Support Grant to CJS and by the National Science Foundation (MCB-0544160) to LSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Alexander JS, 2007, J MOL NEUROSCI, V32, P169, DOI 10.1007/s12031-007-0018-3; Ametzazurra A, 2009, HUM REPROD, V24, P954, DOI 10.1093/humrep/den450; [Anonymous], 1991, Methods Enzymol, V194, P1; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Caydasi AK, 2014, MOL BIOL CELL, V25, P2143, DOI 10.1091/mbc.E14-04-0890; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Chohan G, 2010, J NEUROL NEUROSUR PS, V81, P1243, DOI 10.1136/jnnp.2009.197962; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Demmel L, 2008, MOL BIOL CELL, V19, P1046, DOI 10.1091/mbc.E07-02-0134; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engels K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001367; Enyenihi AH, 2003, GENETICS, V163, P47; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; FRIESEN H, 1994, GENE DEV, V8, P2162, DOI 10.1101/gad.8.18.2162; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; GARRELS JI, 1994, ELECTROPHORESIS, V15, P1466, DOI 10.1002/elps.11501501210; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Grandin N, 2008, CELL CYCLE, V7, P2749, DOI 10.4161/cc.7.17.6592; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall BG, 2007, PLOS COMPUT BIOL, V3, P473, DOI 10.1371/journal.pcbi.0030051; Huang LS, 2005, P NATL ACAD SCI USA, V102, P12431, DOI 10.1073/pnas.0502324102; Irwin N, 2006, P NATL ACAD SCI USA, V103, P18320, DOI 10.1073/pnas.0605135103; Iwamoto MA, 2005, EUKARYOT CELL, V4, P536, DOI 10.1128/EC.4.3.536-544.2005; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kilani RT, 2007, J RHEUMATOL, V34, P1650; Krishnamoorthy T, 2006, GENE DEV, V20, P2580, DOI 10.1101/gad.1457006; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kyriakakis P, 2008, FLY, V2, P229, DOI 10.4161/fly.6669; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee P, 2011, MOL MICROBIOL, V79, P633, DOI 10.1111/j.1365-2958.2010.07471.x; Lee WS, 2004, FEBS LETT, V572, P41, DOI 10.1016/j.febslet.2004.07.007; Li DJ, 2009, CANCER LETT, V279, P65, DOI 10.1016/j.canlet.2009.01.028; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo J, 2010, MED ONCOL, V27, P791, DOI 10.1007/s12032-009-9287-8; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Matsuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031152; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Nerstedt A, 2012, DIABETOLOGIA, V55, P1797, DOI 10.1007/s00125-012-2511-7; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Parodi EM, 2012, EUKARYOT CELL, V11, P1191, DOI 10.1128/EC.00076-12; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Puig O, 1998, YEAST, V14, P1139; Roberts RL, 1997, CELL, V89, P1055, DOI 10.1016/S0092-8674(00)80293-7; Rolli E, 2011, MOL BIOL CELL, V22, P1585, DOI 10.1091/mbc.E10-03-0268; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Suda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007184; Suel KE, 2009, J BIOL CHEM, V284, P15416, DOI 10.1074/jbc.M809384200; Sugden PH, 2013, BIOCHEM J, V454, P13, DOI 10.1042/BJ20130219; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Trembley MA, 2014, BIOSCIENCE REP, V34, P119, DOI 10.1042/BSR20130096; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; VANHEUSDEN GPH, 1992, FEBS LETT, V302, P145, DOI 10.1016/0014-5793(92)80426-H; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wang C, 2009, GENETICS, V183, P1373, DOI 10.1534/genetics.109.107797; Wang DY, 2010, INVEST OPHTH VIS SCI, V51, P4084, DOI 10.1167/iovs.09-4864; Watanabe K, 2009, ACTA PHYSIOL HUNG, V96, P277, DOI 10.1556/APhysiol.96.2009.3.3; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Wu HY, 2011, INT J BIOCHEM CELL B, V43, P742, DOI 10.1016/j.biocel.2011.01.015; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zahradka J, 2012, BBA-GEN SUBJECTS, V1820, P849, DOI 10.1016/j.bbagen.2012.03.013; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhou JB, 2009, MOL CELL BIOL, V29, P4167, DOI 10.1128/MCB.01067-08; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	86	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113528	10.1371/journal.pone.0113528	http://dx.doi.org/10.1371/journal.pone.0113528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409301	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200135
J	Tang, Y; Liu, CY; Liu, ZJ; Hu, XP; Yu, YQ; Zhou, YF				Tang, Yong; Liu, Caiyuan; Liu, Zhongjian; Hu, Xiaopeng; Yu, Yong-Qiang; Zhou, Yifeng			Processing Deficits of Motion of Contrast-Modulated Gratings in Anisometropic Amblyopia	PLOS ONE			English	Article							2ND-ORDER MOTION; GLOBAL MOTION; STRABISMIC AMBLYOPIA; CONTOUR INTEGRATION; ASYMMETRIC TRANSFER; VISUAL DEFICITS; ADULT AMBLYOPIA; DEFINED LETTERS; LOCAL MOTION; 1ST-ORDER	Several studies have indicated substantial processing deficits for static second-order stimuli in amblyopia. However, less is known about the perception of second-order moving gratings. To investigate this issue, we measured the contrast sensitivity for second-order (contrast-modulated) moving gratings in seven anisometropic amblyopes and ten normal controls. The measurements were performed with non-equated carriers and a series of equated carriers. For comparison, the sensitivity for first-order motion and static second-order stimuli was also measured. Most of the amblyopic eyes (AEs) showed reduced sensitivity for second-order moving gratings relative to their non-amblyopic eyes (NAEs) and the dominant eyes (CEs) of normal control subjects, even when the detectability of the noise carriers was carefully controlled, suggesting substantial processing deficits of motion of contrast-modulated gratings in anisometropic amblyopia. In contrast, the nonamblyopic eyes of the anisometropic amblyopes were relatively spared. As a group, NAEs showed statistically comparable performance to CEs. We also found that contrast sensitivity for static second-order stimuli was strongly impaired in AEs and part of the NAEs of anisometropic amblyopes, consistent with previous studies. In addition, some amblyopes showed impaired performance in perception of static second-order stimuli but not in that of second-order moving gratings. These results may suggest a dissociation between the processing of static and moving second-order gratings in anisometropic amblyopia.	[Tang, Yong; Zhou, Yifeng] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China; [Tang, Yong; Zhou, Yifeng] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Tang, Yong; Liu, Caiyuan; Liu, Zhongjian; Zhou, Yifeng] Univ Sci & Technol China, Res & Treatment Ctr Amblyopia & Strabismus, Hefei 230026, Anhui, Peoples R China; [Hu, Xiaopeng; Yu, Yong-Qiang] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China; [Zhou, Yifeng] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yu, YQ (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China.	yuyongqiang@hotmail.com			National Natural Science Foundation of China [NSFC 31300913, NSFC 81261120562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China grants (NSFC 31300913) to YT and (NSFC 81261120562) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2008, VISION RES, V48, P1965, DOI 10.1016/j.visres.2008.06.012; Aaen-Stockdale C, 2007, INVEST OPHTH VIS SCI, V48, P5532, DOI 10.1167/iovs.07-0447; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Allard R, 2008, J VIS, V8, P11; Baker CL, 2001, PROG BRAIN RES, V134, P171; Barnes GR, 2001, J PHYSIOL-LONDON, V533, P281, DOI 10.1111/j.1469-7793.2001.0281b.x; Bertone A, 2008, NEUROREPORT, V19, P225, DOI 10.1097/WNR.0b013e3282f48401; Bonhomme GR, 2006, J AAPOS, V10, P540, DOI 10.1016/j.jaapos.2006.07.008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMPOS E, 1995, SURV OPHTHALMOL, V40, P23, DOI 10.1016/S0039-6257(95)80044-1; Chen R, 2009, PROG BIOCHEM BIOPHYS, V36, P1442, DOI 10.3724/SP.J.1206.2009.00224; CHINO YM, 1983, J NEUROPHYSIOL, V50, P265, DOI 10.1152/jn.1983.50.1.265; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; Chung STL, 2008, VISION RES, V48, P2739, DOI 10.1016/j.visres.2008.09.009; Chung STL, 2006, VISION RES, V46, P3853, DOI 10.1016/j.visres.2006.06.014; Colombo E, 2001, DISPLAYS, V22, P87, DOI 10.1016/S0141-9382(01)00055-5; Constantinescu T, 2005, INVEST OPHTH VIS SCI, V46, P3008, DOI 10.1167/iovs.05-0242; CREWTHER DP, 1990, EXP BRAIN RES, V79, P615; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; Dosher BA, 2006, VISION RES, V46, P1996, DOI 10.1016/j.visres.2005.11.025; EGGERS HM, 1978, SCIENCE, V201, P264, DOI 10.1126/science.663654; Ellemberg D, 2005, VISION RES, V45, P2877, DOI 10.1016/j.visres.2004.11.019; Ellemberg D, 2002, VISION RES, V42, P169, DOI 10.1016/S0042-6989(01)00278-4; Hess RF, 2010, RESTOR NEUROL NEUROS, V28, P793, DOI 10.3233/RNN-2010-0550; Hess RE, 2006, J OPT SOC AM A, V23, P986, DOI 10.1364/JOSAA.23.000986; Hess RF, 1998, VISION RES, V38, P889, DOI 10.1016/S0042-6989(97)00233-2; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; Hess RF, 1997, VISION RES, V37, P1303, DOI 10.1016/S0042-6989(96)00277-5; Hess RF, 2010, HUM BRAIN MAPP, V31, P1233, DOI 10.1002/hbm.20931; Ho CS, 2009, VISION RES, V49, P2891, DOI 10.1016/j.visres.2009.07.012; Hou F, 2011, INVEST OPHTH VIS SCI, V52, P6501, DOI 10.1167/iovs.11-7541; HOWELL ER, 1983, INVEST OPHTH VIS SCI, V24, P782; Huang CB, 2008, P NATL ACAD SCI USA, V105, P4068, DOI 10.1073/pnas.0800824105; Hutchinson CV, 2006, VISION RES, V46, P324, DOI 10.1016/j.visres.2005.03.002; Kiorpes L, 1998, J NEUROSCI, V18, P6411; Kiorpes L, 1999, CURR OPIN NEUROBIOL, V9, P480, DOI 10.1016/S0959-4388(99)80072-5; Kiorpes L, 2006, STRABISMUS, V14, P3, DOI 10.1080/09273970500536193; Knox PJ, 2012, INVEST OPHTH VIS SCI, V53, P817, DOI 10.1167/iovs.11-8219; Kozma P, 2003, VISUAL NEUROSCI, V20, P577, DOI 10.1017/S0952523803205113; Landy M., 2004, VISUAL NEUROSCIENCES, P1106; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Ledgeway T, 2005, VISION RES, V45, P2081, DOI 10.1016/j.visres.2005.02.005; Ledgeway T, 1997, VISION RES, V37, P215, DOI 10.1016/S0042-6989(96)00122-8; Levi DM, 1997, INVEST OPHTH VIS SCI, V38, P1493; Levi DM, 1996, P NATL ACAD SCI USA, V93, P6830, DOI 10.1073/pnas.93.13.6830; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li G, 2011, NEUR M 2011 WASH DC; Li RW, 2008, J NEUROSCI, V28, P14223, DOI 10.1523/JNEUROSCI.4271-08.2008; Li RW, 2005, INVEST OPHTH VIS SCI, V46, P3161, DOI 10.1167/iovs.05-0286; Li RW, 2004, J VISION, V4, P476, DOI 10.1167/4.6.7; Li XF, 2007, INVEST OPHTH VIS SCI, V48, P1575, DOI 10.1167/iovs.06-1021; Li XR, 2003, J NEUROSCI METH, V130, P9, DOI 10.1016/S0165-0270(03)00174-2; Lin LM, 1996, VISION RES, V36, P1907, DOI 10.1016/0042-6989(95)00260-X; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; Mansouri B, 2005, VISION RES, V45, P2449, DOI 10.1016/j.visres.2005.02.018; Mansouri B, 2006, VISION RES, V46, P4104, DOI 10.1016/j.visres.2006.07.017; Mareschal I, 1998, NAT NEUROSCI, V1, P150, DOI 10.1038/401; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Movshon J. A., 1985, PATTERN RECOGNITION; MOVSHON JA, 1987, J NEUROSCI, V7, P1340; Mussap AJ, 2000, VISION RES, V40, P3297, DOI 10.1016/S0042-6989(00)00154-1; Nishida S, 1997, VISION RES, V37, P2685, DOI 10.1016/S0042-6989(97)00092-8; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2010, J VISION, V10, DOI 10.1167/10.14.11; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Polat U, 2009, VISION RES, V49, P2599, DOI 10.1016/j.visres.2009.07.008; Popple AV, 2000, P NATL ACAD SCI USA, V97, P11667, DOI 10.1073/pnas.97.21.11667; Qiu Z, 2007, J VIS, V7, P1, DOI DOI 10.1167/7.11.7; Schofield AJ, 2007, J VISION, V7, DOI 10.1167/7.8.1; Schroder JH, 2002, VISION RES, V42, P29, DOI 10.1016/S0042-6989(01)00263-2; Selenow A., 1991, AMBLYOPIA BASIC CLIN; Sharma V, 2000, NAT NEUROSCI, V3, P496, DOI 10.1038/74872; Simmers AJ, 2006, VISION RES, V46, P2571, DOI 10.1016/j.visres.2006.01.009; Simmers AJ, 2011, VISION RES, V51, P2008, DOI 10.1016/j.visres.2011.07.012; Simmers AJ, 2005, VISION RES, V45, P449, DOI 10.1016/j.visres.2004.08.026; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; SOLOMON JA, 1995, VISION RES, V35, P59, DOI 10.1016/0042-6989(94)E0077-X; SUTTER A, 1995, VISION RES, V35, P2825, DOI 10.1016/0042-6989(95)00045-2; Tang Y, 2009, J VISION, V9, DOI 10.1167/9.7.18; Tang Y, 2012, VISUAL NEUROSCI, V29, P315, DOI 10.1017/S095252381200034X; Thompson B, 2012, NEUROIMAGE, V60, P1307, DOI 10.1016/j.neuroimage.2012.01.078; Thompson B, 2008, VISION RES, V48, P1307, DOI 10.1016/j.visres.2008.02.020; Tinsley CJ, 2003, J NEUROPHYSIOL, V90, P930, DOI 10.1152/jn.00708.2002; VOLKERS ACW, 1987, BRIT J OPHTHALMOL, V71, P58, DOI 10.1136/bjo.71.1.58; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; Wong EH, 2001, VISION RES, V41, P2951, DOI 10.1016/S0042-6989(01)00189-4; Wu C, 2006, AM J OPHTHALMOL, V141, P175, DOI 10.1016/j.ajo.2005.07.060; Xu P, 2006, VISION RES, V46, P3748, DOI 10.1016/j.visres.2006.06.013; Zanker JM, 1999, VISION RES, V39, P1293, DOI 10.1016/S0042-6989(98)00234-X; Zhou YF, 2006, VISION RES, V46, P739, DOI 10.1016/j.visres.2005.07.031; ZHOU YX, 1993, SCIENCE, V261, P98, DOI 10.1126/science.8316862; ZHOU YX, 1994, J NEUROPHYSIOL, V72, P2134, DOI 10.1152/jn.1994.72.5.2134	96	1	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113400	10.1371/journal.pone.0113400	http://dx.doi.org/10.1371/journal.pone.0113400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409477	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200111
J	Walker, BJ; Abeel, T; Shea, T; Priest, M; Abouelliel, A; Sakthikumar, S; Cuomo, CA; Zeng, QD; Wortman, J; Young, SK; Earl, AM				Walker, Bruce J.; Abeel, Thomas; Shea, Terrance; Priest, Margaret; Abouelliel, Amr; Sakthikumar, Sharadha; Cuomo, Christina A.; Zeng, Qiandong; Wortman, Jennifer; Young, Sarah K.; Earl, Ashlee M.			Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRAFT ASSEMBLIES; READ ALIGNMENT; PROTEIN-A; SEQUENCE; EPIDEMIOLOGY	Advances in modern sequencing technologies allow us to generate sufficient data to analyze hundreds of bacterial genomes from a single machine in a single day. This potential for sequencing massive numbers of genomes calls for fully automated methods to produce high-quality assemblies and variant calls. We introduce Pilon, a fully automated, all-in-one tool for correcting draft assemblies and calling sequence variants of multiple sizes, including very large insertions and deletions. Pilon works with many types of sequence data, but is particularly strong when supplied with paired end data from two Illumina libraries with small e.g., 180 bp and large e.g., 3-5 Kb inserts. Pilon significantly improves draft genome assemblies by correcting bases, fixing mis-assemblies and filling gaps. For both haploid and diploid genomes, Pilon produces more contiguous genomes with fewer errors, enabling identification of more biologically relevant genes. Furthermore, Pilon identifies small variants with high accuracy as compared to state-of-the-art tools and is unique in its ability to accurately identify large sequence variants including duplications and resolve large insertions. Pilon is being used to improve the assemblies of thousands of new genomes and to identify variants from thousands of clinically relevant bacterial strains. Pilon is freely available as open source software.	[Walker, Bruce J.; Abeel, Thomas; Shea, Terrance; Priest, Margaret; Abouelliel, Amr; Sakthikumar, Sharadha; Cuomo, Christina A.; Zeng, Qiandong; Wortman, Jennifer; Young, Sarah K.; Earl, Ashlee M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Abeel, Thomas] Univ Ghent, VIB Dept Plant Syst Biol, B-9000 Ghent, Belgium	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Flanders Institute for Biotechnology (VIB); Ghent University	Walker, BJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	bruce@broadinstitute.org; aearl@broadinstitute.org	Cuomo, Christina/L-2222-2019; Zeng, Qiandong/AAF-3305-2019	Cuomo, Christina/0000-0002-5778-960X; Earl, Ashlee/0000-0001-7857-9145; Abeel, Thomas/0000-0002-7205-7431	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900018C]; Federal funds from the National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services [U54HG003067]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818] Funding Source: NIH RePORTER	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; Federal funds from the National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272200900018C. This project has been also been funded in part with Federal funds from the National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, under grant U54HG003067. TA is a postdoctoral fellow of the Research Foundation-Flanders. The funders played no role collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Abeel T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr995; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Das S, 1995, TUBERCLE LUNG DIS, V76, P550, DOI 10.1016/0962-8479(95)90533-2; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; El-Metwally S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003345; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grad YH, 2014, LANCET INFECT DIS, V14, P220, DOI 10.1016/S1473-3099(13)70693-5; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Kohli S, 2012, NUCLEIC ACIDS RES, V40, P7113, DOI 10.1093/nar/gks465; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo RS, 2005, EMBO J, V24, P34, DOI 10.1038/sj.emboj.7600490; Marschall T, 2012, BIOINFORMATICS, V28, P2875, DOI 10.1093/bioinformatics/bts566; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muzzey D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r97; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Ronen R, 2012, BIOINFORMATICS, V28, pI188, DOI 10.1093/bioinformatics/bts219; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Vicedomini R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S6; Vordermeier HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040890; Weiner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026038; Williams LJS, 2012, GENOME RES, V22, P2241, DOI 10.1101/gr.138925.112	45	3674	3714	22	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112963	10.1371/journal.pone.0112963	http://dx.doi.org/10.1371/journal.pone.0112963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409509	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200052
J	Zampini, V; Johnson, SL; Franz, C; Knipper, M; Holley, MC; Magistretti, J; Russo, G; Marcotti, W; Masetto, S				Zampini, Valeria; Johnson, Stuart L.; Franz, Christoph; Knipper, Marlies; Holley, Matthew C.; Magistretti, Jacopo; Russo, Giancarlo; Marcotti, Walter; Masetto, Sergio			Fine Tuning of Ca(V)1.3 Ca2+ Channel Properties in Adult Inner Hair Cells Positioned in the Most Sensitive Region of the Gerbil Cochlea	PLOS ONE			English	Article							CALCIUM-CHANNELS; TRANSMITTER RELEASE; FUNCTIONAL-PROPERTIES; PRESYNAPTIC ACTIVITY; PHASE-LOCKING; GUINEA-PIG; CURRENTS; DEPENDENCE; EXOCYTOSIS; POTENTIALS	Hearing relies on faithful signal transmission by cochlear inner hair cells (IHCs) onto auditory fibres over a wide frequency and intensity range. Exocytosis at IHC ribbon synapses is triggered by Ca2+ inflow through Ca(V)1.3 (L-type) Ca2+ channels. We investigated the macroscopic (whole-cell) and elementary (cell-attached) properties of Ca2+ currents in IHCs positioned at the middle turn (frequency similar to 2 kHz) of the adult gerbil cochlea, which is their most sensitive hearing region. Using near physiological recordings conditions (body temperature and a Na+ based extracellular solution), we found that the macroscopic Ca2+ current activates and deactivates very rapidly (time constant below 1 ms) and inactivates slowly and only partially. Single-channel recordings showed an elementary conductance of 15 pS, a sub-ms latency to first opening, and a very low steady-state open probability (P-o: 0.024 in response to 500-ms depolarizing steps at similar to-18 mV). The value of P-o was significantly larger (0.06) in the first 40 ms of membrane depolarization, which corresponds to the time when most Ca2+ channel openings occurred clustered in bursts (mean burst duration: 19 ms). Both the P-o and the mean burst duration were smaller than those previously reported in high-frequency basal IHCs. Finally, we found that middle turn IHCs are likely to express about 4 times more Ca2+ channels per ribbon than basal cells. We propose that middle-turn IHCs finely-tune Ca(V)1.3 Ca2+ channel gating in order to provide reliable information upon timing and intensity of lower-frequency sounds.	[Zampini, Valeria; Johnson, Stuart L.; Holley, Matthew C.; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Franz, Christoph; Knipper, Marlies] Univ Tubingen, Tubingen Hearing Res Ctr, Dept Otolaryngol, Lab Mol Physiol Hearing, Tubingen, Germany; [Magistretti, Jacopo] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Zampini, Valeria; Russo, Giancarlo; Masetto, Sergio] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy	University of Sheffield; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Pavia; University of Pavia	Masetto, S (corresponding author), Univ Pavia, Dept Brain & Behav Sci, Via Palestro 3, I-27100 Pavia, Italy.	smasetto@unipv.it		Holley, Matthew/0000-0001-9547-1953	Ministero dell'Istruzione, dell'Universita e della Ricerca; Wellcome Trust [091895]; European Union [MRTN-CT-2006-035367]; Royal Society	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Wellcome Trust(Wellcome Trust); European Union(European Commission); Royal Society(Royal Society of London)	This work was supported by grants (PRIN) from the Ministero dell'Istruzione, dell'Universita e della Ricerca to SM; the Wellcome Trust (091895) to WM, and by the European Union Research Programm 6th FP MRTN-CT-2006-035367 to MK. VZ was supported by The Royal Society Short Incoming Visit grant to WM. SLJ is Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J.B., 1986, Lecture Notes in Biomathematics, V64, P44; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt A, 2003, J NEUROSCI, V23, P10832; BYERLY L, 1985, J GEN PHYSIOL, V85, P491, DOI 10.1085/jgp.85.4.491; Carabelli V, 2001, J PHYSIOL-LONDON, V532, P73, DOI 10.1111/j.1469-7793.2001.0073g.x; CENA V, 1989, J MEMBRANE BIOL, V112, P255, DOI 10.1007/BF01870956; Cho S, 2011, J NEUROSCI, V31, P5682, DOI 10.1523/JNEUROSCI.5453-10.2011; COLQUHOUN D, 1987, PROC R SOC SER B-BIO, V230, P15, DOI 10.1098/rspb.1987.0008; DALLOS P, 1985, J NEUROSCI, V5, P1591; EHRET G, 1975, J COMP PHYSIOL, V103, P329, DOI 10.1007/BF00612025; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Goutman JD, 2012, J NEUROSCI, V32, P17025, DOI 10.1523/JNEUROSCI.0457-12.2012; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Johnson SL, 2012, J NEUROSCI, V32, P10479, DOI 10.1523/JNEUROSCI.0803-12.2012; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kim MH, 2013, J PHYSIOL-LONDON, V591, P3167, DOI 10.1113/jphysiol.2012.249482; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Li GL, 2014, NEURON, V83, P1404, DOI 10.1016/j.neuron.2014.08.027; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Mahapatra S, 2012, J PHYSIOL-LONDON, V590, P5053, DOI 10.1113/jphysiol.2012.236729; MARKWARDT F, 1988, J PHYSIOL-LONDON, V399, P559; McAlpine D, 2005, J PHYSIOL-LONDON, V566, P21, DOI 10.1113/jphysiol.2005.083113; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; MOORE DR, 1991, AUDIOLOGY, V30, P125; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Pickles JO, 1996, INTRO PHYSL HEARING; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Puschner B, 1997, HEARING RES, V114, P102, DOI 10.1016/S0378-5955(97)00163-9; Rodriguez-Contreras A, 2003, BIOPHYS J, V84, P3457, DOI 10.1016/S0006-3495(03)70066-6; Rodriguez-Contreras A, 2001, J PHYSIOL-LONDON, V534, P669, DOI 10.1111/j.1469-7793.2001.00669.x; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Rossing T., 2007, SPRINGER HDB ACOUSTI; RYAN A, 1976, J ACOUST SOC AM, V59, P1222, DOI 10.1121/1.380961; Safa P, 2001, J BIOL CHEM, V276, P38727, DOI 10.1074/jbc.M103724200; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Scholze A, 2001, MOL ENDOCRINOL, V15, P1211, DOI 10.1210/me.15.7.1211; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; SMITH PA, 1993, J GEN PHYSIOL, V101, P767, DOI 10.1085/jgp.101.5.767; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; THIBAULT O, 1993, P NATL ACAD SCI USA, V90, P11792, DOI 10.1073/pnas.90.24.11792; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Weiler S, 2014, J NEUROSCI, V34, P6843, DOI 10.1523/JNEUROSCI.4990-13.2014; Wong AB, 2014, EMBO J, V33, P247, DOI 10.1002/embj.201387110; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zampini V, 2006, J NEUROPHYSIOL, V96, P602, DOI 10.1152/jn.01315.2005; Zampini V, 2013, J PHYSIOL-LONDON, V591, P3811, DOI 10.1113/jphysiol.2013.251272; Zampini V, 2010, J PHYSIOL-LONDON, V588, P187, DOI 10.1113/jphysiol.2009.181917; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	63	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113750	10.1371/journal.pone.0113750	http://dx.doi.org/10.1371/journal.pone.0113750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409445	Green Published, Green Accepted, gold			2022-12-27	WOS:000345533200151
J	Zhou, SM; Lyons, RA; Bodger, OG; John, A; Brunt, H; Jones, K; Gravenor, MB; Brophy, S				Zhou, Shang-Ming; Lyons, Ronan A.; Bodger, Owen G.; John, Ann; Brunt, Huw; Jones, Kerina; Gravenor, Mike B.; Brophy, Sinead			Local Modelling Techniques for Assessing Micro-Level Impacts of Risk Factors in Complex Data: Understanding Health and Socioeconomic Inequalities in Childhood Educational Attainments	PLOS ONE			English	Article							LEVEL; MORTALITY; INTERVENTION	Although inequalities in health and socioeconomic status have an important influence on childhood educational performance, the interactions between these multiple factors relating to variation in educational outcomes at micro-level is unknown, and how to evaluate the many possible interactions of these factors is not well established. This paper aims to examine multi-dimensional deprivation factors and their impact on childhood educational outcomes at micro-level, focusing on geographic areas having widely different disparity patterns, in which each area is characterised by six deprivation domains (Income, Health, Geographical Access to Services, Housing, Physical Environment, and Community Safety). Traditional health statistical studies tend to use one global model to describe the whole population for macro-analysis. In this paper, we combine linked educational and deprivation data across small areas (median population of 1500), then use a local modelling technique, the Takagi-Sugeno fuzzy system, to predict area educational outcomes at ages 7 and 11. We define two new metrics, "Micro-impact of Domain'' and "Contribution of Domain'', to quantify the variations of local impacts of multidimensional factors on educational outcomes across small areas. The two metrics highlight differing priorities. Our study reveals complex multi-way interactions between the deprivation domains, which could not be provided by traditional health statistical methods based on single global model. We demonstrate that although Income has an expected central role, all domains contribute, and in some areas Health, Environment, Access to Services, Housing and Community Safety each could be the dominant factor. Thus the relative importance of health and socioeconomic factors varies considerably for different areas, depending on the levels of each of the other factors, and therefore each component of deprivation must be considered as part of a wider system. Childhood educational achievement could benefit from policies and intervention strategies that are tailored to the local geographic areas' profiles.	[Zhou, Shang-Ming; Lyons, Ronan A.; Bodger, Owen G.; John, Ann; Jones, Kerina; Gravenor, Mike B.; Brophy, Sinead] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales; [Brunt, Huw] Temple Peace & Hlth, Publ Hlth Wales, Cardiff, S Glam, Wales	Swansea University	Zhou, SM (corresponding author), Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales.	s.zhou@swansea.ac.uk	; Zhou, Shang-Ming/A-8443-2008	Bodger, Owen/0000-0002-4022-9964; John, Ann/0000-0002-5657-6995; Brophy, Sinead/0000-0001-7417-2858; Jones, Kerina/0000-0001-8164-3718; Lyons, Ronan/0000-0001-5225-000X; Brunt, Huw/0000-0002-3976-672X; Zhou, Shang-Ming/0000-0002-0719-9353	Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); UKCRC Public Health Research Centre of Excellence; Economic and Social Research Council [MR/KO232331/1, MR/K006525/1]; Medical Research Council [MR/KO232331/1, MR/K006525/1]; Welsh Government [MR/KO232331/1]; Wellcome Trust, under the UK Clinical Research Collaboration [MR/KO232331/1]; Farr Institute of Health Informatics Research; Arthritis Research UK [MR/K006525/1]; British Heart Foundation [MR/KO232331/1, MR/K006525/1]; Cancer Research UK [MR/KO232331/1, MR/K006525/1]; Engineering and Physical Sciences Research Council [MR/K006525/1]; National Institute of Health Research [MR/K006525/1]; National Institute for Social Care and Health Research (Welsh Government) [MR/K006525/1]; Chief Scientist Office (Scottish Government Health Directorates) [MR/K006525/1]; ESRC [ES/L007444/1] Funding Source: UKRI; MRC [MR/K023233/1, MR/K006525/1] Funding Source: UKRI; Economic and Social Research Council [ES/L007444/1] Funding Source: researchfish; Medical Research Council [MR/K023233/1] Funding Source: researchfish	Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); UKCRC Public Health Research Centre of Excellence; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Government; Wellcome Trust, under the UK Clinical Research Collaboration(Wellcome Trust); Farr Institute of Health Informatics Research; Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Government); Chief Scientist Office (Scottish Government Health Directorates); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence. Joint funding (MR/KO232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. This research was also supported by the Farr Institute of Health Informatics Research. The Farr Institute is funded by a consortium of ten UK research organizations (MR/K006525/1): Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Government), and the Chief Scientist Office (Scottish Government Health Directorates). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbema EA, 2004, HEALTH PROMOT INT, V19, P141, DOI 10.1093/heapro/dah202; Acheson D, INDEPENDENT INQUIRY; Administrative Data Liaison Service, NAT PUP DAT NPD; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; Blanc PD, 2006, EUR RESPIR J, V27, P85, DOI 10.1183/09031936.06.00061205; BROWNELL M, 2006, IRPP CHOICES, V0012; Chadli M., 2012, MULTIPLE MODELS APPR; Currie J, 2007, WORKSH LONG RUN IMP; Department for Children Schools and Families (DCSF), 2008, SAF BULL; Dibben C, 2013, EUR J PUBLIC HEALTH, V23, P39, DOI 10.1093/eurpub/cks019; Ford D.V., DATA ANONYMISATION P; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Juang CF, 2012, IEEE T IND ELECTRON, V59, P3309, DOI 10.1109/TIE.2011.2159949; Kelaher M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-53; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Malacova E, 2008, AM J EPIDEMIOL, V168, P21, DOI 10.1093/aje/kwn085; Ngo AD, 2014, INT J ENV RES PUB HE, V11, P830, DOI 10.3390/ijerph110100830; Ngo AD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-681; Picciotto S, 2006, J EPIDEMIOL COMMUN H, V60, P37, DOI 10.1136/jech.2005.037846; Popham F, 2013, J EPIDEMIOL COMMUN H, V67, P412, DOI 10.1136/jech-2012-201525; Precup RE, 2011, COMPUT IND, V62, P213, DOI 10.1016/j.compind.2010.10.001; Schwartz J, 2004, PEDIATRICS, V113, P1037; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Steenland K, 2004, AM J EPIDEMIOL, V159, P1047, DOI 10.1093/aje/kwh129; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Thomson H, 2001, BRIT MED J, V323, P187, DOI 10.1136/bmj.323.7306.187; UK Office for National Statistics, SUP OUTP AR; Victorian Auditor-general, 2007, GIV VICT CHILDR BEST; Webber R, 2005, 99 CASA UCL; Welsh Assembly Government, AN CORR WELSH IND MU; Welsh Assembly Government, WELSH IND MULT DEPR; Welsh Statistical Directorate, 2008, TECHNICAL REPORT; Whitworth A., 2009, RAISING ED ATTAINMEN; World Health Organisation, 1998, HEALTH21 HLTH ALL 21; Wynn BO, 2005, CHALLENGES PROGRAM E; Zhou SM, 2008, FUZZY SET SYST, V159, P3091, DOI 10.1016/j.fss.2008.05.016; Zhou SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051468; Zhou SM, 2009, IEEE T KNOWL DATA EN, V21, P1191, DOI 10.1109/TKDE.2008.208; Zhou SM, 2006, FUZZY SET SYST, V157, P1057, DOI 10.1016/j.fss.2005.08.004	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113592	10.1371/journal.pone.0113592	http://dx.doi.org/10.1371/journal.pone.0113592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409038	Green Published, gold, Green Accepted			2022-12-27	WOS:000345533200138
J	Munari, CC; de Oliveira, PF; Leandro, LF; Pimenta, LM; Ferreira, NH; da Costa, JD; Bastos, JK; Tavares, DC				Munari, Carla Carolina; de Oliveira, Pollyanna Francielli; Leandro, Luis Fernando; Pimenta, Leandra Mara; Ferreira, Natalia Helen; da Costa, Juliana de Carvalho; Bastos, Jairo Kenupp; Tavares, Denise Crispim			In Vivo Assessment of Genotoxic, Antigenotoxic and Anticarcinogenic Activities of Solanum lycocarpum Fruits Glycoalkaloidic Extract	PLOS ONE			English	Article							ST-HILL FRUITS; COMET ASSAY; RESPONSES; NIGRUM; ANTIMUTAGENICITY; CONSUMPTION; TOXICITY; CONDUCT; PLANTS; CELLS	The fruits of Solanum lycocarpum, known as wolf-fruit, are used in folk medicine, and because of that we have evaluated both the genotoxic potential of its glycoalkaloidic extract (SL) and its influence on the genotoxicity induced by methyl methanesulfonate. Furthermore, the potential blocking effect of SL intake in the initial stage of colon carcinogenesis in Wistar rats was investigated in a short-term (4-week) bioassay using aberrant crypt foci (ACF) as biomarker. The genotoxic potential was evaluated using the Swiss mice peripheral blood micronucleus test. The animals were treated with different doses of SL (15, 30 and 60 mg/kg b.w.) for 14 days, and the peripheral blood samples were collected at 48 h, 7 days and 14 days after starting the treatment. For antigenotoxicity assessment, MMS was administered on the 14 th day, and after 24 h the harvesting of bone marrow and liver cells was performed, for the micronucleus and comet assays, respectively. In the ACF assay, male Wistar rats were given four subcutaneous injections of the carcinogen 1,2-dimethylhydrazine (DMH, 40 mg/kg b.w.), twice a week, during two weeks to induce ACF. The treatment with SL (15, 30 and 60 mg/kg b.w.) was given for four weeks during and after carcinogen treatment to investigate the potential beneficial effects of SL on DMH-induced ACF. The results demonstrated that SL was not genotoxic in the mouse micronucleus test. In animals treated with SL and MMS, the frequencies of micronucleus and extensions of DNA damage were significantly reduced in comparison with the animals receiving only MMS. Regarding the ACF assay, SL significantly reduced the frequency of ACF induced by DMH.	[Munari, Carla Carolina] Univ Estadual Paulista, Fac Med Botucatu, Dept Patol, Dist Rubiao Jr, SP, Brazil; [de Oliveira, Pollyanna Francielli; Leandro, Luis Fernando; Pimenta, Leandra Mara; Ferreira, Natalia Helen; Tavares, Denise Crispim] Univ Franca, Franca, SP, Brazil; [da Costa, Juliana de Carvalho; Bastos, Jairo Kenupp] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade Estadual Paulista; Universidad de Franca; Universidade de Sao Paulo	Munari, CC (corresponding author), Univ Estadual Paulista, Fac Med Botucatu, Dept Patol, Dist Rubiao Jr, SP, Brazil.	camunari@yahoo.com.br	da Costa, Juliana/AAL-4204-2021; Tavares, Denise C/C-3396-2012; Munari, Carla Carolina/I-2481-2012	Tavares, Denise C/0000-0003-4646-5914; Munari, Carla/0000-0001-6922-369X; Ferreira, Natalia/0000-0002-0052-6139; Oliveira, Pollyanna/0000-0002-1646-0277; de Carvalho da Costa, Juliana/0000-0002-2336-7361	Sao Paulo Research Foundation (FAPESP; Brazil) [2011/05732-4]; FAPESP [2009/15871-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Sao Paulo Research Foundation (FAPESP; Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the Sao Paulo Research Foundation (FAPESP; Brazil; grant # 2011/05732-4). C.C. Munari thanks FAPESP for a Doctor's scholarship (grant # 2009/15871-1). The authors are grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwikar S, 2012, INT J AYURVEDA RES, V3, P167; Bahgat A, 2008, FUND CLIN PHARMACOL, V22, P693, DOI 10.1111/j.1472-8206.2008.00627.x; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; Chacon Daniele Roswell, 2002, Cytologia (Tokyo), V67, P417, DOI 10.1508/cytologia.67.417; Choudhary G, 1998, CHEMOSPHERE, V37, P801, DOI 10.1016/S0045-6535(98)00088-5; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Ding X, 2012, J ETHNOPHARMACOL, V139, P599, DOI 10.1016/j.jep.2011.11.058; Farina F, 2010, APPL PHYSIOL NUTR ME, V35, P40, DOI 10.1139/H09-131; Ferguson LR, 2005, MUTAT RES-FUND MOL M, V591, P3, DOI 10.1016/j.mrfmmm.2005.05.017; Gupta RK, 2011, ASIAN PAC J TROP MED, V4, P964, DOI 10.1016/S1995-7645(11)60227-7; Hanausek M, 2001, P NATL ACAD SCI USA, V98, P11551, DOI 10.1073/pnas.191363198; Javed T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-26; Tiossi RFJ, 2012, J ANAL METHODS CHEM, V2012, DOI 10.1155/2012/947836; Khazir J, 2013, J ASIAN NAT PROD RES, V15, P764, DOI 10.1080/10286020.2013.798314; Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2; Li X, 2011, LIFE SCI, V88, P314, DOI 10.1016/j.lfs.2010.12.006; MACGREGOR JT, 1980, ENVIRON MUTAGEN, V2, P509, DOI 10.1002/em.2860020408; MACGREGOR JT, 1987, MUTAT RES, V189, P103, DOI 10.1016/0165-1218(87)90016-4; Maruo VM, 2003, NEUROTOXICOL TERATOL, V25, P627, DOI 10.1016/S0892-0362(03)00038-2; Maruo VM, 2003, PHYTOMEDICINE, V10, P48, DOI 10.1078/094471103321648656; Munari CC, 2012, FOOD CHEM TOXICOL, V50, P3696, DOI 10.1016/j.fct.2012.07.028; Munari CC, 2013, J NAT MED, V68, P231; Nirmal SA, 2012, J ETHNOPHARMACOL, V142, P91, DOI 10.1016/j.jep.2012.04.019; Patel PK, 2012, J YOUNG PHARM, V4, P164, DOI 10.4103/0975-1483.100022; Peters VM, 2001, CONTRACEPTION, V63, P53, DOI 10.1016/S0010-7824(00)00188-8; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Sa RDDE, 2000, J ETHNOPHARMACOL, V73, P283, DOI 10.1016/S0378-8741(00)00250-6; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Soares-Mota MR, 2010, EXP TOXICOL PATHOL, V62, P549, DOI 10.1016/j.etp.2009.07.006; SULTANA S, 1995, J ETHNOPHARMACOL, V45, P189, DOI 10.1016/0378-8741(94)01214-K; Tavares DC, 2011, PLANTA MED, V77, P1489, DOI 10.1055/s-0030-1270886; TOMASI A, 1987, TOXICOL PATHOL, V15, P178, DOI 10.1177/019262338701500208; vandeWater B, 1996, ARCH BIOCHEM BIOPHYS, V327, P71, DOI 10.1006/abbi.1996.0094; WATERS MD, 1990, MUTAT RES, V238, P57, DOI 10.1016/0165-1110(90)90039-E; Weissenberg M, 2001, PHYTOCHEMISTRY, V58, P501, DOI 10.1016/S0031-9422(01)00185-6; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yen GC, 2001, FOOD CHEM TOXICOL, V39, P1045, DOI 10.1016/S0278-6915(01)00053-9	38	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111999	10.1371/journal.pone.0111999	http://dx.doi.org/10.1371/journal.pone.0111999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405606	Green Submitted, gold, Green Published			2022-12-27	WOS:000347121300019
J	Trotta, E				Trotta, Edoardo			On the Normalization of the Minimum Free Energy of RNAs by Sequence Length	PLOS ONE			English	Article							FOLDING FREE-ENERGIES; PREDICTION; FEATURES; DATABASE; MIRNAS; GENES	The minimum free energy (MFE) of ribonucleic acids (RNAs) increases at an apparent linear rate with sequence length. Simple indices, obtained by dividing the MFE by the number of nucleotides, have been used for a direct comparison of the folding stability of RNAs of various sizes. Although this normalization procedure has been used in several studies, the relationship between normalized MFE and length has not yet been investigated in detail. Here, we demonstrate that the variation of MFE with sequence length is not linear and is significantly biased by the mathematical formula used for the normalization procedure. For this reason, the normalized MFEs strongly decrease as hyperbolic functions of length and produce unreliable results when applied for the comparison of sequences with different sizes. We also propose a simple modification of the normalization formula that corrects the bias enabling the use of the normalized MFE for RNAs longer than 40 nt. Using the new corrected normalized index, we analyzed the folding free energies of different human RNA families showing that most of them present an average MFE density more negative than expected for a typical genomic sequence. Furthermore, we found that a well-defined and restricted range of MFE density characterizes each RNA family, suggesting the use of our corrected normalized index to improve RNA prediction algorithms. Finally, in coding and functional human RNAs the MFE density appears scarcely correlated with sequence length, consistent with a negligible role of thermodynamic stability demands in determining RNA size.	CNR, Inst Translat Pharmacol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Trotta, E (corresponding author), CNR, Inst Translat Pharmacol, Rome, Italy.	edoardo.trotta@ift.cnr.it	Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238				Alkan C, 2006, LECT NOTES COMPUT SC, V3909, P130, DOI 10.1007/11732990_12; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Catania F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-129; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Felden B, 2007, CURR OPIN MICROBIOL, V10, P286, DOI 10.1016/j.mib.2007.05.001; FREYHULT E, 2005, BMC BIOINFORMATICS, V6; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Knuth D, 1997, SEMINUMERICAL ALGORI, V3; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Loong SNK, 2007, RNA, V13, P170, DOI 10.1261/rna.223807; LE SY, 1989, J THEOR BIOL, V138, P495, DOI 10.1016/S0022-5193(89)80047-5; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Li XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088339; Lopes IDN, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-124; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Ni M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-329; Pervouchine DD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng049; Puzey JR, 2009, GENE, V448, P46, DOI 10.1016/j.gene.2009.08.005; Seffens W, 1999, NUCLEIC ACIDS RES, V27, P1578, DOI 10.1093/nar/27.7.1578; Spirollari J, 2009, BIOINFORM BIOL INSIG, V3, P51; Thakur V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-108; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; WOLFF T, 1993, GENE DEV, V7, P1377, DOI 10.1101/gad.7.7b.1377; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhao DY, 2010, ARTIF INTELL MED, V49, P127, DOI 10.1016/j.artmed.2010.03.004; Zhu Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-718; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113380	10.1371/journal.pone.0113380	http://dx.doi.org/10.1371/journal.pone.0113380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405875	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300112
J	Zhao, C; Wang, XB; Cong, YL; Deng, Y; Xu, YJ; Chen, AH; Yin, YR				Zhao, Cong; Wang, Xianbao; Cong, Yuling; Deng, Yi; Xu, Yijun; Chen, Aihua; Yin, Yanru			Effects of Bile Acids and the Bile Acid Receptor FXR Agonist on the Respiratory Rhythm in the In Vitro Brainstem Medulla Slice of Neonatal Sprague-Dawley Rats	PLOS ONE			English	Article							SPINAL-CORD PREPARATION; NUCLEAR RECEPTOR; IDENTIFICATION; GENERATION	Intrahepatic cholestasis of pregnancy is always accompanied by adverse fetal outcomes such as malfunctions of respiration. Farnesoid X receptor (FXR) plays a critical role in the homeostasis of bile acids. Thus, we are determined to explore the effects of farnesoid X receptor (FXR) and five bile acids on respiratory rhythm generation and modulation of neonatal rats. Spontaneous periodic respiratory-related rhythmical discharge activity (RRDA) was recorded from hypoglossal nerves during the perfusion of modified Krebs solution. Group 1-6 was each given GW4064 and five bile acids of chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA), cholic acid (CA) as well as ursodeoxycholic acid (UDCA) at different concentrations to identify their specific functions on respiratory rhythm modulations. Group 7 was applied to receive FXR blocker Z-guggulsterone and Z-guggulsterone with the above bile acids separately to explore the role of FXR in the respiratory rhythm modulation. Group 8 was given dimethyl sulfoxide (DMSO) as controls. Apart from UDCA, CDCA, DCA LCA and CA all exerted effects on RRDA recorded from hypoglossal nerves in a concentration-dependent manner. Respiratory cycle (RC), Inspiratory time (TI), Expiratory Time (TE) and Integral Amplitude (IA) were influenced and such effects could be reversed by Z-guggulsterone. FXR may contribute to the effects on the modulation of respiratory rhythm exerted by bile acids.	[Zhao, Cong; Wang, Xianbao; Deng, Yi; Chen, Aihua] Southern Med Univ, Zhujiang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Cong, Yuling] Cent Hosp Shengli Oil Field, Dongying, Peoples R China; [Xu, Yijun; Yin, Yanru] Southern Med Univ, Dept Physiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Chen, AH (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	zj_chenaihua@126.com; yyr1707@163.com	王, 贤保/F-8798-2012		Project of National Science Foundation of China [31071010]	Project of National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Project of National Science Foundation of China (31071010, http://www.nsfc.gov.cn/). The funders played a role in study design, decision to publish, and preparation of the manuscript	Cabrerizo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087697; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Chiang JYL, 2003, AM J PHYSIOL-GASTR L, V284, pG349, DOI 10.1152/ajpgi.00417.2002; Herraez E, 2014, J MOL MED, V92, P359, DOI 10.1007/s00109-013-1106-1; Hilaire G, 1997, NEUROSCI LETT, V224, P13, DOI 10.1016/S0304-3940(97)13458-9; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Johnson SM, 2001, J NEUROPHYSIOL, V86, P59; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Perng DW, 2008, RESPIROLOGY, V13, P983, DOI 10.1111/j.1440-1843.2008.01402.x; RIOSECO AJ, 1994, AM J OBSTET GYNECOL, V170, P890, DOI 10.1016/S0002-9378(94)70304-3; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Wang Fei, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1181; Wu Z H, 1990, Sheng Li Xue Bao, V42, P68; WU Z-H, 1988, Acta Physiologica Sinica, V40, P250; Wu ZH, 1997, ACTA PHYSL SIN, V49, P389; Yu L, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/308274; Zecca E, 2008, PEDIATRICS, V121, pE146, DOI 10.1542/peds.2007-1220; ZHANG FT, 1991, RESP PHYSIOL, V85, P73, DOI 10.1016/0034-5687(91)90007-6	28	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112212	10.1371/journal.pone.0112212	http://dx.doi.org/10.1371/journal.pone.0112212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405617	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300026
J	Kim, WY; Kwak, MK; Ko, BS; Yoon, JC; Sohn, CH; Lim, KS; Andersen, LW; Donnino, MW				Kim, Won Young; Kwak, Myoung Kwan; Ko, Byuk Sung; Yoon, Jae Chol; Sohn, Chang Hwan; Lim, Kyoung Soo; Andersen, Lars W.; Donnino, Michael W.			Factors Associated with the Occurrence of Cardiac Arrest after Emergency Tracheal Intubation in the Emergency Department	PLOS ONE			English	Article							RAPID-SEQUENCE INTUBATION; INTENSIVE-CARE-UNIT; AIRWAY MANAGEMENT; ENDOTRACHEAL INTUBATION; CLINICAL-PRACTICE; MULTIPLE-CENTER; CRITICALLY-ILL; RISK-FACTORS; COMPLICATIONS; HYPOTENSION	Objectives: Emergency tracheal intubation has achieved high success and low complication rates in the emergency department (ED). The objective of this study was to evaluate the incidence of post-intubation CA and determine the clinical factors associated with this complication. Methods: A matched case-control study with a case to control ratio of 1: 3 was conducted at an urban tertiary care center between January 2007 and December 2011. Critically ill adult patients requiring emergency airway management in the ED were included. The primary endpoint was post-intubation CA, defined as CA within 10 minutes after tracheal intubation. Clinical variables were compared between patients with post-intubation CA and patients without CA who were individually matched based on age, sex, and pre-existing comorbidities. Results: Of 2,403 patients who underwent emergency tracheal intubation, 41 patients (1.7%) had a post-intubation CA within 10 minutes of the procedure. The most common initial rhythm was pulseless electrical activity (78.1%). Patients experiencing CA had higher in-hospital mortality than patients without CA (61.0% vs. 30.1%; p<0.001). Systolic hypotension prior to intubation, defined as a systolic blood pressure <= 90 mmHg, was independently associated with post-intubation CA (OR, 3.67 [95% CI, 1.58-8.55], p = 0.01). Conclusion: Early post-intubation CA occurred with an approximate 2% frequency in the ED. Systolic hypotension before intubation is associated with this complication, which has potentially significant implications for clinicians at the time of intubation.	[Kim, Won Young; Ko, Byuk Sung; Sohn, Chang Hwan; Lim, Kyoung Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea; [Kim, Won Young; Kwak, Myoung Kwan] Seoul Med Ctr, Dept Emergency Med, Seoul, South Korea; [Yoon, Jae Chol] Chonbuk Natl Univ Hosp, Dept Emergency Med, Jeonju, South Korea; [Andersen, Lars W.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Andersen, Lars W.] Aarhus Univ Hosp, Dept Anesthesiol, DK-8000 Aarhus, Denmark	University of Ulsan; Asan Medical Center; Seoul Medical Center; Jeonbuk National University; Jeonbuk National University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Aarhus University	Kim, WY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea.	wonpia@yahoo.co.kr		Andersen, Lars Wiuff/0000-0001-5752-8082				American College of Emergency Physicians, 1997, ANN EMERG MED, V29, P573; Ballow SL, 2012, J TRAUMA ACUTE CARE, V73, P1401, DOI 10.1097/TA.0b013e318270dcf5; Bowles TM, 2011, BRIT J ANAESTH, V107, P687, DOI 10.1093/bja/aer251; Chopra H, 2000, Indian J Otolaryngol Head Neck Surg, V52, P364, DOI 10.1007/BF02991479; Dewhirst Elisabeth, 2013, J Intensive Care Med, V28, P375, DOI 10.1177/0885066612448732; FRANKLIN C, 1994, AM J EMERG MED, V12, P425, DOI 10.1016/0735-6757(94)90053-1; Griesdale DEG, 2008, INTENS CARE MED, V34, P1835, DOI 10.1007/s00134-008-1205-6; Heffner AC, 2013, RESUSCITATION, V84, P1500, DOI 10.1016/j.resuscitation.2013.07.022; Heffner AC, 2012, J CRIT CARE, V27, P587, DOI 10.1016/j.jcrc.2012.04.022; Heffner AC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.011; Hulme J, 2006, EMERG MED J, V23, P162; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jaber S, 2010, INTENS CARE MED, V36, P248, DOI 10.1007/s00134-009-1717-8; Kovacs G, 2004, CAN J ANAESTH, V51, P174, DOI 10.1007/BF03018780; Mason MA, 2013, ADV EMERG NURS J, V35, P16, DOI 10.1097/TME.0b013e31827fb706; Mort TC, 2004, J CLIN ANESTH, V16, P508, DOI 10.1016/j.jclinane.2004.01.007; Mort TC, 1998, ANESTH ANALG, V86, P1171, DOI 10.1097/00000539-199806000-00006; Mort Thomas C, 2007, J Intensive Care Med, V22, P157, DOI 10.1177/0885066607299525; Mort Thomas C, 2007, J Intensive Care Med, V22, P208, DOI 10.1177/0885066607301359; Newland MC, 2002, ANESTHESIOLOGY, V97, P108, DOI 10.1097/00000542-200207000-00016; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; Schwab TM, 1998, AM J EMERG MED, V16, P609, DOI 10.1016/S0735-6757(98)90229-7; SCHWARTZ DE, 1995, ANESTHESIOLOGY, V82, P367, DOI 10.1097/00000542-199502000-00007; Tourtier Jean-Pierre, 2012, J Intensive Care Med, V27, P66, DOI 10.1177/0885066611410375; Walls RM, 2011, J EMERG MED, V41, P347, DOI 10.1016/j.jemermed.2010.02.024; Wang HE, 2008, RESUSCITATION, V79, P234, DOI 10.1016/j.resuscitation.2008.06.025; Wilcox SR, 2012, CRIT CARE MED, V40, P1808, DOI 10.1097/CCM.0b013e31824e0e67	27	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112779	10.1371/journal.pone.0112779	http://dx.doi.org/10.1371/journal.pone.0112779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402500	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700071
J	Massacesi, L; Tramacere, I; Amoroso, S; Battaglia, MA; Benedetti, MD; Filippini, G; La Mantia, L; Repice, A; Solari, A; Tedeschi, G; Milanese, C				Massacesi, Luca; Tramacere, Irene; Amoroso, Salvatore; Battaglia, Mario A.; Benedetti, Maria Donata; Filippini, Graziella; La Mantia, Loredana; Repice, Anna; Solari, Alessandra; Tedeschi, Gioacchino; Milanese, Clara			Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial	PLOS ONE			English	Article							DOUBLE-BLIND; EFFICACY; NONINFERIORITY; EXTENSION	For almost three decades in many countries azathioprine has been used to treat relapsing-remitting multiple sclerosis. However its efficacy was usually considered marginal and following approval of beta interferons for this indication it was no longer recommended as first line treatment, even if presently no conclusive direct beta interferon-azathioprine comparison exists. To compare azathioprine efficacy versus the currently available beta interferons in relapsing-remitting multiple sclerosis, a multicenter, randomized, controlled, single-blinded, non-inferiority trial was conducted in 30 Italian multiple sclerosis centers. Eligible patients (relapsing-remitting course; >= 2 relapses in the last 2 years) were randomly assigned to azathioprine or beta interferons. The primary outcome was annualized relapse rate ratio (RR) over 2 years. Key secondary outcome was number of new brain MRI lesions. Patients (n = 150) were randomized in 2 groups (77 azathioprine, 73 beta interferons). At 2 years, clinical evaluation was completed in 127 patients (62 azathioprine, 65 beta interferons). Annualized relapse rate was 0.26 (95% Confidence Interval, CI, 0.19-0.37) in the azathioprine and 0.39 (95% CI 0.30-0.51) in the interferon group. Non-inferiority analysis showed that azathioprine was at least as effective as beta interferons (relapse RRAZA/IFN 0.67, one-sided 95% CI 0.96; p<0.01). MRI outcomes were analyzed in 97 patients (50 azathioprine and 47 beta interferons). Annualized new T2 lesion rate was 0.76 (95% CI 0.61-0.95) in the azathioprine and 0.69 (95% CI 0.54-0.88) in the interferon group. Treatment discontinuations due to adverse events were higher (20.3% vs. 7.8%, p = 0.03) in the azathioprine than in the interferon group, and concentrated within the first months of treatment, whereas in the interferon group discontinuations occurred mainly during the second year. The results of this study indicate that efficacy of azathioprine is not inferior to that of beta interferons for patients with relapsing-remitting multiple sclerosis. Considering also the convenience of the oral administration, and the low cost for health service providers, azathioprine may represent an alternative to interferon treatment, while the different side effect profiles of both medications have to be taken into account.	[Massacesi, Luca] Univ Florence, Dipartimento Neurosci Psicol Farmaco & Salute Bam, Florence, Italy; [Massacesi, Luca; Repice, Anna] Azienda Osped Univ Careggi, Florence, Italy; [Tramacere, Irene; Filippini, Graziella; Solari, Alessandra; Milanese, Clara] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy; [Amoroso, Salvatore] Univ Politecn Marche, Dipartimento Neurosci, Sez Farmacol, Ancona, Italy; [Battaglia, Mario A.] FISM, AISM, Genoa, Italy; [Benedetti, Maria Donata] Univ Integrata Verona, Azienda Osped, Dipartimento Univ Neurol, Verona, Italy; [La Mantia, Loredana] IRCCS Santa Maria Nascente Fdn Don Gnocchi, Multiple Sclerosis Ctr, Unita Neurol, Milan, Italy; [Tedeschi, Gioacchino] Univ Naples Federico II, Clin Neurol, Naples, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Istituto Neurologico Besta; Marche Polytechnic University; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Naples Federico II	Massacesi, L (corresponding author), Univ Florence, Dipartimento Neurosci Psicol Farmaco & Salute Bam, Florence, Italy.	massacesi@unifi.it	Solari, Alessandra/AAO-1741-2021; Massacesi, Luca/ABA-9431-2020; Repice, Anna/AAX-6008-2020; tramacere, irene/B-2876-2013	Solari, Alessandra/0000-0001-9930-7579; Massacesi, Luca/0000-0001-5083-372X; tramacere, irene/0000-0001-5550-3412; Benedetti, Maria Donata/0000-0002-8340-2915	AIFA (Agenzia Italiana del Farmaco)	AIFA (Agenzia Italiana del Farmaco)	The present study was funded by AIFA (Agenzia Italiana del Farmaco, www.agenziafarmaco.gov.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand J., 1999, THESIS ERASMUS U ROT; Casetta I, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003982.pub2; Cavazzuti M, 1997, EUR NEUROL, V38, P284, DOI 10.1159/000113395; Clegg A, 2000, Health Technol Assess, V4, pi; Committee for Medicinal Products for Human Use (CHMP), 2005, EMEACPMPEWP215899 CH; CTC, 2003, CANC THER EV PROGR C; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; ELLISON GW, 1989, NEUROLOGY, V39, P1018, DOI 10.1212/WNL.39.8.1018; Etemadifar M, 2007, J NEUROL, V254, P1723, DOI 10.1007/s00415-007-0637-1; Filippini G, 2003, LANCET, V361, P545, DOI 10.1016/S0140-6736(03)12512-3; Filippini G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008933.pub2; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; GOODKIN DE, 1991, NEUROLOGY, V41, P20, DOI 10.1212/WNL.41.1.20; HUGHES RAC, 1988, LANCET, V2, P179; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Massacesi L, 2005, ARCH NEUROL-CHICAGO, V62, P1843, DOI 10.1001/archneur.62.12.1843; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Milanese C, 2001, J NEUROL NEUROSUR PS, V70, P413, DOI 10.1136/jnnp.70.3.413; MILANESE C, 1993, J NEUROL, V240, P295, DOI 10.1007/BF00838165; Palace J, 1997, LANCET, V350, P261, DOI 10.1016/S0140-6736(97)24030-4; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Rubin DB, 2004, MULTIPLE IMPUTATION; Sackett David L, 2004, ACP J Club, V140, pA11; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Solari A, 1999, J NEUROL NEUROSUR PS, V67, P158, DOI 10.1136/jnnp.67.2.158; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; YUDKIN PL, 1991, LANCET, V338, P1051, DOI 10.1016/0140-6736(91)91909-E	32	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113371	10.1371/journal.pone.0113371	http://dx.doi.org/10.1371/journal.pone.0113371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402490	Green Published, gold			2022-12-27	WOS:000345158700135
J	Zhan, HX; Li, GR; Zhang, XJ; Li, X; Guo, HJ; Gong, WP; Jia, JQ; Qiao, LY; Ren, YK; Yang, ZJ; Chang, ZJ				Zhan, Haixian; Li, Guangrong; Zhang, Xiaojun; Li, Xin; Guo, Huijuan; Gong, Wenping; Jia, Juqing; Qiao, Linyi; Ren, Yongkang; Yang, Zujun; Chang, Zhijian			Chromosomal Location and Comparative Genomics Analysis of Powdery Mildew Resistance Gene Pm51 in a Putative Wheat-Thinopyrum ponticum Introgression Line	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; ADULT-PLANT RESISTANCE; CONFERRING RESISTANCE; COMMON WHEAT; STEM-RUST; LEAF RUST; MARKERS; IDENTIFICATION; INTERMEDIUM; TRANSLOCATION	Powdery mildew (PM) is a very destructive disease of wheat (Triticum aestivum L.). Wheat-Thinopyrum ponticum introgression line CH7086 was shown to possess powdery mildew resistance possibly originating from Th. ponticum. Genomic in situ hybridization and molecular characterization of the alien introgression failed to identify alien chromatin. To study the genetics of resistance, CH7086 was crossed with susceptible genotypes. Segregation in F-2 populations and F-2:3 lines tested with Chinese Bgt race E09 under controlled conditions indicated that CH7086 carries a single dominant gene for powdery mildew resistance. Fourteen SSR and EST-PCR markers linked with the locus were identified. The genetic distances between the locus and the two flanking markers were 1.5 and 3.2 cM, respectively. Based on the locations of the markers by nullisomic-tetrasomic and deletion lines of 'Chinese Spring', the resistance gene was located in deletion bin 2BL-0.89-1.00. Conserved orthologous marker analysis indicated that the genomic region flanking the resistance gene has a high level of collinearity to that of rice chromosome 4 and Brachypodium chromosome 5. Both resistance specificities and tests of allelism suggested the resistance gene in CH7086 was different from previously reported powdery mildew resistance genes on 2BL, and the gene was provisionally designated PmCH86. Molecular analysis of PmCH86 compared with other genes for resistance to Bgt in the 2BL-0.89-1.00 region suggested that PmCH86 may be a new PM resistance gene, and it was therefore designated as Pm51. The closely linked flanking markers could be useful in exploiting this putative wheat-Thinopyrum translocation line for rapid transfer of Pm51 to wheat breeding programs.	[Zhan, Haixian; Li, Guangrong; Gong, Wenping; Yang, Zujun] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Sichuan, Peoples R China; [Zhan, Haixian; Zhang, Xiaojun; Li, Xin; Guo, Huijuan; Qiao, Linyi; Ren, Yongkang; Chang, Zhijian] Shanxi Acad Agr Sci, Crop Sci Inst, Taiyuan, Shanxi, Peoples R China; [Chang, Zhijian] Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Taiyuan, Shanxi, Peoples R China; [Jia, Juqing] Shanxi Agr Univ, Coll Agron, Taigu, Shanxi, Peoples R China	University of Electronic Science & Technology of China; Shanxi Agricultural University; Ministry of Agriculture & Rural Affairs; Shanxi Agricultural University	Yang, ZJ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Sichuan, Peoples R China.	yangzujun@uestc.edu.cn; wrczj@126.com	zhang, jin/GXV-9154-2022	Li, Guangrong/0000-0002-8425-0212; Yang, Zujun/0000-0003-4617-1422	National Natural Science Foundation of China [31171542, 31171839, 31101143]; Shanxi Provincial Program of International S T Cooperation [2013081007, 2012081006-2]; Shanxi Provincial Program of Science and Technology [20130311001-5]; State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Chinese Academy of Science Foundation [2012-PCCE-KF-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Provincial Program of International S T Cooperation; Shanxi Provincial Program of Science and Technology; State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Chinese Academy of Science Foundation	This study was funded by The National Natural Science Foundation of China (No. 31171542, 31171839, 31101143); Shanxi Provincial Program of International S & T Cooperation (2013081007; 2012081006-2); Shanxi Provincial Program of Science and Technology (20130311001-5); The Opening Project of the State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Chinese Academy of Science Foundation (2012-PCCE-KF-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ANN WHEAT NEWSL; Caceres ME, 2012, CYTOGENET GENOME RES, V136, P75, DOI 10.1159/000334275; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Cheng P, 2010, THEOR APPL GENET, V121, P195, DOI 10.1007/s00122-010-1302-0; Conley EJ, 2004, GENETICS, V168, P625, DOI 10.1534/genetics.104.034801; Faris JD, 2008, CHROMOSOME RES, V16, P1097, DOI 10.1007/s10577-008-1261-3; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Gao HD, 2012, THEOR APPL GENET, V125, P967, DOI 10.1007/s00122-012-1886-7; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Han FP, 2009, PLANT CELL, V21, P1929, DOI 10.1105/tpc.109.066662; He F, 2013, PLANT BREEDING, V132, P553, DOI 10.1111/pbr.12104; He RL, 2009, THEOR APPL GENET, V118, P1173, DOI 10.1007/s00122-009-0971-z; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; Ji Han-Hui, 2007, Yichuan, V29, P1256, DOI 10.1360/yc-007-1256; Ji JH, 2008, EUPHYTICA, V163, P159, DOI 10.1007/s10681-007-9578-0; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Kuraparthy V, 2007, CROP SCI, V47, P1995, DOI 10.2135/cropsci2007.01.0038; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Lee TG, 2010, GENETICA, V138, P1277, DOI 10.1007/s10709-010-9528-y; Li HJ, 2009, J GENET GENOMICS, V36, P557, DOI 10.1016/S1673-8527(08)60147-2; Li ZS, 1985, WHEAT WIDE HYBRIDIZA, P59; Liu C, 2008, EUPHYTICA, V159, P249, DOI 10.1007/s10681-007-9484-5; Mohler V, 2005, EUPHYTICA, V142, P161, DOI 10.1007/s10681-005-1251-x; Qin B, 2011, THEOR APPL GENET, V123, P207, DOI 10.1007/s00122-011-1577-9; Rouse MN, 2012, THEOR APPL GENET, V125, P877, DOI 10.1007/s00122-012-1879-6; SEARS ER, 1968, CROP SCI, V8, P371, DOI 10.2135/cropsci1968.0011183X000800030032x; Singh A, 2011, PLANT BREEDING, V130, P31, DOI 10.1111/j.1439-0523.2010.01820.x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Wang ZL, 2005, PLANT DIS, V89, P457, DOI 10.1094/PD-89-0457; Yin GuiHong, 2009, Acta Agronomica Sinica, V35, P1425, DOI 10.3724/SP.J.1006.2009.01425; Zhan Hai-xian, 2008, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V28, P1960; Zhang P, 2009, THEOR APPL GENET, V120, P25, DOI 10.1007/s00122-009-1156-5; Zhao ZH, 2013, THEOR APPL GENET, V126, P3081, DOI 10.1007/s00122-013-2194-6; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0; Zhu ZD, 2005, GENOME, V48, P585, DOI 10.1139/G05-016	36	50	57	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113455	10.1371/journal.pone.0113455	http://dx.doi.org/10.1371/journal.pone.0113455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415194	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600050
J	Chuang, LP; Chen, NH; Lin, SW; Chang, YL; Liao, HR; Lin, YS; Chao, IJ; Lin, YL; Pang, JHS				Chuang, Li-Pang; Chen, Ning-Hung; Lin, Shih-Wei; Chang, Ying-Ling; Liao, Hsiang-Ruei; Lin, Yu-Sheng; Chao, I-Ju; Lin, Yuling; Pang, Jong-Hwei S.			Increased C-C Chemokine Receptor 2 Gene Expression in Monocytes of Severe Obstructive Sleep Apnea Patients and under Intermittent Hypoxia	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; ACUTE CORONARY SYNDROMES; CHEMOATTRACTANT PROTEIN-1; ESTABLISHED ATHEROSCLEROSIS; MACROPHAGE INFILTRATION; ADHESION MOLECULES; CCR2 EXPRESSION; HEART-FAILURE; P38 MAPK; MICE	Background: Obstructive sleep apnea (OSA) is known to be a risk factor of coronary artery disease. The chemotaxis and adhesion of monocytes to the endothelium in the early atherosclerosis is important. This study aimed to investigate the effect of intermittent hypoxia, the hallmark of OSA, on the chemotaxis and adhesion of monocytes. Methods: Peripheral blood was sampled from 54 adults enrolled for suspected OSA. RNA was prepared from the isolated monocytes for the analysis of C-C chemokine receptor 2 (CCR2). The effect of intermittent hypoxia on the regulation and function of CCR2 was investigated on THP-1 monocytic cells and monocytes. The mRNA and protein expression levels were investigated by RT/real-time PCR and western blot analysis, respectively. Transwell filter migration assay and cell adhesion assay were performed to study the chemotaxis and adhesion of monocytes. Results: Monocytic CCR2 gene expression was found to be increased in severe OSA patients and higher levels were detected after sleep. Intermittent hypoxia increased the CCR2 expression in THP-1 monocytic cells even in the presence of TNF-alpha and CRP. Intermittent hypoxia also promoted the MCP-1-mediated chemotaxis and adhesion of monocytes to endothelial cells. Furthermore, inhibitor for p42/44 MAPK or p38 MAPK suppressed the activation of monocytic CCR2 expression by intermittent hypoxia. Conclusions: This is the first study to demonstrate the increase of CCR2 gene expression in monocytes of severe OSA patients. Monocytic CCR2 gene expression can be induced under intermittent hypoxia which contributes to the chemotaxis and adhesion of monocytes.	[Chuang, Li-Pang; Chao, I-Ju; Lin, Yuling; Pang, Jong-Hwei S.] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chuang, Li-Pang; Chen, Ning-Hung; Lin, Shih-Wei] Chang Gung Mem Hosp, Sleep Ctr, Dept Pulm & Crit Care Med, Taoyuan, Taiwan; [Chang, Ying-Ling] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan; [Liao, Hsiang-Ruei] Chang Gung Univ, Coll Med, Grad Inst Nat Prod, Taoyuan, Taiwan; [Lin, Yu-Sheng] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taipei 10591, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Pang, JHS (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	jonghwei@mail.cgu.edu.tw	Chuang, Li-Pang/L-8929-2019; Lin, Shih-Wei/I-9294-2019	Chuang, Li-Pang/0000-0001-5466-8995; Lin, Shih-Wei/0000-0002-7915-0014; PANG, JONG-HWEI/0000-0003-3432-0208	Chang Gung Memorial Hospital, Taiwan [CMRPG3A1311, CMRPD190341, CMRPD190342]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was supported by Grant CMRPG3A1311, CMRPD190341 and CMRPD190342 from Chang Gung Memorial Hospital, Taiwan. The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2000, CARDIOLOGY, V94, P188, DOI 10.1159/000047315; Amasyali B, 2009, INT J CARDIOL, V136, P356, DOI 10.1016/j.ijcard.2008.04.080; American Thoracic Society, 1994, AM J RESP CRIT CARE, V150, P1738; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Chuang LP, 2013, LIFE SCI, V93, P220, DOI 10.1016/j.lfs.2013.06.009; Chuang SY, 2011, BIOCHEM BIOPH RES CO, V411, P402, DOI 10.1016/j.bbrc.2011.06.163; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Dyugovskaya L, 2008, AM J RESP CRIT CARE, V177, P544, DOI 10.1164/rccm.200705-675OC; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Green SR, 2006, J IMMUNOL, V176, P7412, DOI 10.4049/jimmunol.176.12.7412; Han KH, 1998, ARTERIOSCL THROM VAS, V18, P1983, DOI 10.1161/01.ATV.18.12.1983; Hansson GK, 2009, J THROMB HAEMOST, V7, P328, DOI 10.1111/j.1538-7836.2009.03416.x; Hiraoka M, 2004, LIFE SCI, V75, P1333, DOI 10.1016/j.lfs.2004.02.028; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; Javaheri S, 1998, CIRCULATION, V97, P2154, DOI 10.1161/01.CIR.97.21.2154; Kaditis AG, 2010, PEDIATR PULM, V45, P693, DOI 10.1002/ppul.21251; Ko J, 2007, EXP MOL MED, V39, P129, DOI 10.1038/emm.2007.15; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lam SY, 2012, HISTOCHEM CELL BIOL, V137, P303, DOI 10.1007/s00418-011-0900-5; Lattimore JDL, 2005, ATHEROSCLEROSIS, V179, P255, DOI 10.1016/j.atherosclerosis.2004.11.010; Lavie L, 2005, ATHEROSCLEROSIS, V183, P183, DOI 10.1016/j.atherosclerosis.2005.06.024; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Lavie Lena, 2008, Archives of Physiology and Biochemistry, V114, P244, DOI [10.1080/13813450802306701, 10.1080/13813450802306701 ]; Loftus IM, 2000, STROKE, V31, P40, DOI 10.1161/01.STR.31.1.40; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Minoguchi K, 2004, CHEST, V126, P1473, DOI 10.1378/chest.126.5.1473; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Morgan BJ, 2007, ADV EXP MED BIOL, V618, P69; Murphy N, 2003, ARTERIOSCL THROM VAS, V23, P1615, DOI 10.1161/01.ATV.0000084636.01328.C7; Nacher M, 2009, SLEEP MED, V10, P892, DOI 10.1016/j.sleep.2008.09.014; Nakashima H, 2006, EUR HEART J, V27, P2317, DOI 10.1093/eurheartj/ehl219; Nanduri J, 2008, RESP PHYSIOL NEUROBI, V164, P277, DOI 10.1016/j.resp.2008.07.006; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Ni WH, 2004, ARTERIOSCL THROM VAS, V24, P534, DOI 10.1161/01.ATV.0000118275.60121.2b; Okumoto S, 2009, THER APHER DIAL, V13, P205, DOI 10.1111/j.1744-9987.2009.00658.x; Olzinski AR, 2010, ARTERIOSCL THROM VAS, V30, P253, DOI 10.1161/ATVBAHA.109.198812; Ono SJ, 2003, J ALLERGY CLIN IMMUN, V111, P1185, DOI 10.1067/mai.2003.1594; Parker JD, 1999, AM J RESP CRIT CARE, V160, P1888, DOI 10.1164/ajrccm.160.6.9807074; Pasterkamp G, 2000, ATHEROSCLEROSIS, V150, P245, DOI 10.1016/S0021-9150(99)00371-8; Ryan Silke, 2008, Archives of Physiology and Biochemistry, V114, P261, DOI [10.1080/13813450802307337, 10.1080/13813450802307337 ]; Tamaki S, 2009, INTERNAL MED, V48, P1255, DOI 10.2169/internalmedicine.48.2366; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tkacova R, 1998, CIRCULATION, V98, P2269, DOI 10.1161/01.CIR.98.21.2269; Yamashita A, 2000, Masui, V49, P987; Yamashita C, 2010, LIFE SCI, V86, P322, DOI 10.1016/j.lfs.2009.12.013; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	49	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113304	10.1371/journal.pone.0113304	http://dx.doi.org/10.1371/journal.pone.0113304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411969	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000039
J	Fujiwara, Y; Kobayashi, T; Chayahara, N; Imamura, Y; Toyoda, M; Kiyota, N; Mukohara, T; Nishiumi, S; Azuma, T; Yoshida, M; Minami, H				Fujiwara, Yutaka; Kobayashi, Takashi; Chayahara, Naoko; Imamura, Yoshinori; Toyoda, Masanori; Kiyota, Naomi; Mukohara, Toru; Nishiumi, Shin; Azuma, Takeshi; Yoshida, Masaru; Minami, Hironobu			Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra- Day Variation in Patients with Advanced Pancreatic Cancer	PLOS ONE			English	Article							SPECTROMETRY-BASED METABOLOMICS; QUALITY-OF-LIFE; PROINFLAMMATORY CYTOKINES; GASTROINTESTINAL CANCER; LEPTIN; CAFFEINE; PARAXANTHINE; GHRELIN; HUMANS; PLASMA	Purpose: Cancer cachexia is a multifactorial syndrome characterized by progressive loss of weight and muscle atrophy. Using metabolomics, we investigated serum markers and their intra-day variation in advanced pancreatic cancer patients with cachexia. Methods: Patients were enrolled in two groups: those with or without cachexia. Blood samples collected at 6: 30 AM, 11: 30 AM, 4: 30 PM, and 9: 30 PM were analyzed using metabolomics, and serum levels of IL-6, TNF-alpha, and leptin were measured and compared between the two groups. Intra-day variation was then evaluated. Results: Twenty-one patients were enrolled in total. In the cachexia group (n = 9), median body weight loss rate over 6 months was greater, performance status was poorer, and anorexia was more severe than in the non-cachexia group (n = 12). Each metabolites level showed substantial intra-day variation, and some of them displayed significant differences between the two groups. Levels of paraxanthine remained markedly lower in the cohort with cachexia at all measurement points. Besides, median IL-6 and TNF-alpha levels appeared higher and leptin concentration appeared lower in the cachexia group, albeit without statistical significance. Conclusion: Some metabolites and some serological marker levels were affected by cancer cachexia. Although paraxanthine levels were consistently lower in patients with cachexia, we identified that many metabolites indicated large intra- and inter-day variation and that it might be necessary to pay attention to intra-day variation in metabolomics research.	[Fujiwara, Yutaka; Chayahara, Naoko; Imamura, Yoshinori; Toyoda, Masanori; Kiyota, Naomi; Mukohara, Toru; Minami, Hironobu] Kobe Univ, Grad Sch Med, Div Med Oncol Hematol, Kobe, Hyogo 657, Japan; [Kobayashi, Takashi; Nishiumi, Shin; Azuma, Takeshi; Yoshida, Masaru] Kobe Univ, Grad Sch Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Mukohara, Toru; Minami, Hironobu] Kobe Univ Hosp, Ctr Canc, Kobe, Hyogo, Japan; [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Div Metabol Res, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University; Kobe University	Fujiwara, Y (corresponding author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Invest Canc Therapeut, 1-1 Tsukiji 5 chome, Tokyo, Japan.	yutakafu@ncc.go.jp	Kiyota, Naomi/K-3226-2016; KOBAYASHI, Takashi/AAM-7549-2021; Nishiumi, Shin/ABD-5775-2020; Imamura, Yoshinori/ABD-4175-2021; Fujiwara, Yutaka/ABB-4863-2020	Kiyota, Naomi/0000-0001-8021-6116; KOBAYASHI, Takashi/0000-0002-9202-7643; Nishiumi, Shin/0000-0003-2126-3013; Fujiwara, Yutaka/0000-0001-6981-0800; Imamura, Yoshinori/0000-0002-5202-531X	Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant for Research on Applying Health Technology from the Ministry of Health, Labour, and Welfare of Japan. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson KJ, 2004, AM J CLIN NUTR, V79, P40; Argiles JM, 2012, NUTR METAB CARDIOVAS; Argiles JM, 2013, EXPERT OPIN BIOL TH, V13, P67, DOI 10.1517/14712598.2013.727390; Bachmann J, 2008, J GASTROINTEST SURG, V12, P1193, DOI 10.1007/s11605-008-0505-z; Davidson W, 2004, CLIN NUTR, V23, P239, DOI 10.1016/j.clnu.2003.07.001; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dulger H, 2004, INT J CLIN PRACT, V58, P545, DOI 10.1111/j.1368-5031.2004.00149.x; Fearon KCH, 2002, INT J CARDIOL, V85, P73, DOI 10.1016/S0167-5273(02)00235-8; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gupta SC, 2011, EXP BIOL MED, V236, P658, DOI 10.1258/ebm.2011.011028; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; HETZLER RK, 1990, J APPL PHYSIOL, V68, P44, DOI 10.1152/jappl.1990.68.1.44; Inui A, 1999, TRENDS NEUROSCI, V22, P62, DOI 10.1016/S0166-2236(98)01292-2; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Ma ZM, 1996, CLIN CHEM, V42, P942; Maccio A, 2012, GYNECOL ONCOL, V124, P417, DOI 10.1016/j.ygyno.2011.12.435; Mantovani G, 2001, J MOL MED-JMM, V79, P406, DOI 10.1007/s001090100234; Nagaya N, 2006, INTERNAL MED, V45, P127, DOI 10.2169/internalmedicine.45.1402; Nishiumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040459; Nishiumi S, 2010, METABOLOMICS, V6, P518, DOI 10.1007/s11306-010-0224-9; Perera V, 2010, BIOMED CHROMATOGR, V24, P1136, DOI 10.1002/bmc.1419; Suzuki H, 2013, J GASTROENTEROL, V48, P574, DOI 10.1007/s00535-013-0787-0; Tajima S, 1998, IGAKU YAKUGAKU, V40, P775; Takemura M, 1996, IGAKU TO YAKUGAKU, V36, P1071; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tsoli M, 2013, TRENDS ENDOCRIN MET, V24, P174, DOI 10.1016/j.tem.2012.10.006; Tsugawa H, 2011, J BIOSCI BIOENG, V112, P292, DOI 10.1016/j.jbiosc.2011.05.001; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Wallace AM, 1998, CLIN CANCER RES, V4, P2977; Yoshida M, 2012, J GASTROENTEROL, V47, P9, DOI 10.1007/s00535-011-0493-8	30	32	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113259	10.1371/journal.pone.0113259	http://dx.doi.org/10.1371/journal.pone.0113259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411961	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000030
J	Pal, S; Dauner, AL; Mitra, I; Forshey, BM; Garcia, P; Morrison, AC; Halsey, ES; Kochel, TJ; Wu, SJL				Pal, Subhamoy; Dauner, Allison L.; Mitra, Indrani; Forshey, Brett M.; Garcia, Paquita; Morrison, Amy C.; Halsey, Eric S.; Kochel, Tadeusz J.; Wu, Shuenn-Jue L.			Evaluation of Dengue NS1 Antigen Rapid Tests and ELISA Kits Using Clinical Samples	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; POLYMERASE CHAIN-REACTION; PROTEIN NS1; VIRUS-INFECTION; CAPTURE ELISA; DIAGNOSTIC-ACCURACY; DISEASE SEVERITY; PERFORMANCE; PCR; SENSITIVITY	Background: Early diagnosis of dengue virus (DENV) infection can improve clinical outcomes by ensuring close follow-up, initiating appropriate supportive therapies and raising awareness to the potential of hemorrhage or shock. Non-structural glycoprotein-1 (NS1) has proven to be a useful biomarker for early diagnosis of dengue. A number of rapid diagnostic tests (RDTs) and enzyme-linked immunosorbent assays (ELISAs) targeting NS1 antigen (Ag) are now commercially available. Here we evaluated these tests using a well-characterized panel of clinical samples to determine their effectiveness for early diagnosis. Methodology/Principal Findings: Retrospective samples from South America were used to evaluate the following tests: (i) "Dengue NS1 Ag STRIP'' and (ii) "Platelia Dengue NS1 Ag ELISA'' (Bio-Rad, France), (iii) "Dengue NS1 Detect Rapid Test (1st Generation)'' and (iv) "DENV Detect NS1 ELISA'' (InBios International, United States), (v) "Panbio Dengue Early Rapid (1st generation)'' (vi) "Panbio Dengue Early ELISA (2nd generation)'' and (vii) "SD Bioline Dengue NS1 Ag Rapid Test'' (Alere, United States). Overall, the sensitivity of the RDTs ranged from 71.9%-79.1% while the sensitivity of the ELISAs varied between 85.6-95.9%, using virus isolation as the reference method. Most tests had lower sensitivity for DENV-4 relative to the other three serotypes, were less sensitive in detecting secondary infections, and appeared to be most sensitive on Day 3-4 post symptom onset. The specificity of all evaluated tests ranged from 95%-100%. Conclusions: ELISAs had greater overall sensitivity than RDTs. In conjunction with other parameters, the performance data can help determine which dengue diagnostics should be used during the first few days of illness, when the patients are most likely to present to a clinic seeking care.	[Pal, Subhamoy; Dauner, Allison L.; Mitra, Indrani; Kochel, Tadeusz J.; Wu, Shuenn-Jue L.] Naval Med Res Ctr, Silver Spring, MD 20910 USA; [Forshey, Brett M.; Morrison, Amy C.; Halsey, Eric S.] US Naval Med Res Unit, Lima, Peru; [Garcia, Paquita] Peruvian Minist Hlth, Inst Nacl Salud, Lima, Peru; [Morrison, Amy C.] Univ Calif Davis, Davis, CA 95616 USA	Naval Medical Research Center (NMRC); Instituto Nacional de Salud - Peru; University of California System; University of California Davis	Pal, S (corresponding author), Naval Med Res Ctr, Silver Spring, MD 20910 USA.	pal.subhamoy@med.navy.mil	Pal, Subhamoy/A-9526-2015; Morrison, Amy/AAU-6511-2020; Pal, Subhamoy/H-3166-2019; Halsey, Eric/AAC-8110-2022	Pal, Subhamoy/0000-0003-0133-8444; Pal, Subhamoy/0000-0003-0133-8444; Halsey, Eric/0000-0001-6291-8923; Morrison, Amy/0000-0001-6224-5984; Dauner, Allison/0000-0001-7346-7355	Military Infectious Diseases Research Program [L0262_12_NM];  [6000.RAD1.L.A1221]	Military Infectious Diseases Research Program; 	This work was funded by the Military Infectious Diseases Research Program, proposal number L0262_12_NM. SP is the Principal Investigator. The work was supported by Work Unit Number 6000.RAD1.L.A1221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; ANSARI MZ, 1993, J CLIN LAB ANAL, V7, P230, DOI 10.1002/jcla.1860070408; Arya SC, 2007, J CLIN VIROL, V40, P89, DOI 10.1016/j.jcv.2007.06.008; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Berlioz-Arthaud Alain, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P55; Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244; Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360; Harris E, 1998, J CLIN MICROBIOL, V36, P2634, DOI 10.1128/JCM.36.9.2634-2639.1998; Hsieh CJ, 2009, J CLIN VIROL, V44, P102, DOI 10.1016/j.jcv.2008.10.003; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Kalayanarooj S., 1999, Dengue Bulletin, V23, P10; Kao Chuan-Liang, 2005, Journal of Microbiology Immunology and Infection, V38, P5; Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006; Kumarasamy V, 2007, SMJ Singapore Medical Journal, V48, P669; Kumarasamy V, 2007, J VIROL METHODS, V140, P75, DOI 10.1016/j.jviromet.2006.11.001; Lan NT, 1998, DENGUE B, V22, P99; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lin L, 2008, J BIOPHARM STAT, V18, P126, DOI 10.1080/10543400701668290; McBride WJH, 2009, DIAGN MICR INFEC DIS, V64, P31, DOI 10.1016/j.diagmicrobio.2009.01.002; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Sadon N, 2008, J VIROL METHODS, V153, P1, DOI 10.1016/j.jviromet.2008.06.023; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004; Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028; Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461; Thai KTD, 2010, J INFECTION, V60, P229, DOI 10.1016/j.jinf.2010.01.003; Trent DW, 1989, APPL VIROLOGY RES VI; Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477; *WHO, STRENGTH IMPL GLOB S; World Health Organization, 2009, DENGUE GUIDELINES DI; Wu SJ, 2008, AM J TROP MED HYG, V79, P505, DOI 10.4269/ajtmh.2008.79.505; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000; Zainah S, 2009, J VIROL METHODS, V155, P157, DOI 10.1016/j.jviromet.2008.10.016	48	97	104	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113411	10.1371/journal.pone.0113411	http://dx.doi.org/10.1371/journal.pone.0113411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412170	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000050
J	Poquet, Y; Bodin, L; Tchamitchian, M; Fusellier, M; Giroud, B; Lafay, F; Bulete, A; Tchamitchian, S; Cousin, M; Pelissier, M; Brunet, JL; Belzunces, LP				Poquet, Yannick; Bodin, Laurent; Tchamitchian, Marc; Fusellier, Marion; Giroud, Barbara; Lafay, Florent; Bulete, Audrey; Tchamitchian, Sylvie; Cousin, Marianne; Pelissier, Michel; Brunet, Jean-Luc; Belzunces, Luc P.			A Pragmatic Approach to Assess the Exposure of the Honey Bee (Apis mellifera) When Subjected to Pesticide Spray	PLOS ONE			English	Article							TOXICITY	Plant protection spray treatments may expose non-target organisms to pesticides. In the pesticide registration procedure, the honey bee represents one of the non-target model species for which the risk posed by pesticides must be assessed on the basis of the hazard quotient (HQ). The HQ is defined as the ratio between environmental exposure and toxicity. For the honey bee, the HQ calculation is not consistent because it corresponds to the ratio between the pesticide field rate (in mass of pesticide/ha) and LD50 (in mass of pesticide/bee). Thus, in contrast to all other species, the HQ can only be interpreted empirically because it corresponds to a number of bees/ha. This type of HQ calculation is due to the difficulty in transforming pesticide field rates into doses to which bees are exposed. In this study, we used a pragmatic approach to determine the apparent exposure surface area of honey bees submitted to pesticide treatments by spraying with a Potter-type tower. The doses received by the bees were quantified by very efficient chemical analyses, which enabled us to determine an apparent surface area of 1.05 cm(2)/bee. The apparent surface area was used to calculate the exposure levels of bees submitted to pesticide sprays and then to revisit the HQ ratios with a calculation mode similar to that used for all other living species. X-tomography was used to assess the physical surface area of a bee, which was 3.27 cm(2)/bee, and showed that the apparent exposure surface was not overestimated. The control experiments showed that the toxicity induced by doses calculated with the exposure surface area was similar to that induced by treatments according to the European testing procedure. This new approach to measure risk is more accurate and could become a tool to aid the decision-making process in the risk assessment of pesticides.	[Poquet, Yannick; Tchamitchian, Sylvie; Cousin, Marianne; Pelissier, Michel; Brunet, Jean-Luc; Belzunces, Luc P.] INRA, Lab Toxicol Environm, UR A&E 406, F-84914 Avignon 9, France; [Bodin, Laurent] French Agcy Food Environm & Occupat Hlth Safety, ANSES, F-94701 Maisons Alfort, France; [Tchamitchian, Marc] INRA, UR Ecodev, F-84914 Avignon 9, France; [Fusellier, Marion] Natl Vet Sch Oniris, CRIP, Dept Diagnost Imaging, Nantes, France; [Giroud, Barbara; Lafay, Florent; Bulete, Audrey] Univ Lyon 1, ENS Lyon, Inst Sci Analyt, CNRS UMR5280, F-69100 Villeurbanne, France	INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Belzunces, LP (corresponding author), INRA, Lab Toxicol Environm, UR A&E 406, F-84914 Avignon 9, France.	luc.belzunces@avignon.inra.fr	Tchamitchian, Marc/B-2019-2009; BRUNET, Jean-Luc/ABE-9178-2021; , Belzunces/P-7061-2019; Fusellier, Marion S/P-1541-2014	BRUNET, Jean-Luc/0000-0002-3827-1135; , Belzunces/0000-0003-1798-9962; Fusellier, Marion S/0000-0001-5336-9352; LAFAY, Florent/0000-0002-5119-9801; Tchamitchian, Marc/0000-0002-9251-2403	French National Institute for the Agricultural Research (INRA); European Union FEAGA Beekeeping program [11-43 R]; MACIF Foundation; Terre d'Abeilles	French National Institute for the Agricultural Research (INRA); European Union FEAGA Beekeeping program; MACIF Foundation; Terre d'Abeilles	This work was supported in part by the French National Institute for the Agricultural Research (INRA) and by grants from the European Union FEAGA Beekeeping program managed by the INRA-France AgriMer Agreement 11-43 R. YP's doctoral grant was funded by MACIF Foundation (http://www.fondation-macif.org) and Terre d'Abeilles (www.sauvonslesabeilles.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins E.L., 1981, DIV AGR SCI U CALIF, P1; Barlow S, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1150; BARNES DG, 1995, REGUL TOXICOL PHARM, V21, P296, DOI 10.1006/rtph.1995.1043; Brunet JL, 2005, PEST MANAG SCI, V61, P742, DOI 10.1002/ps.1046; Canton JH, 1991, 678801002 RIVM, P1; COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206; Commission des Essais Biologiques (CEB), 2010, 230 CEB AFPP; COOPER PD, 1985, J EXP BIOL, V114, P1; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.589; European Chemicals Agency (ECHA), 2013, GUID HUM HLTH RISK B, VIII, P1; European Chemicals Bureau, 2003, TECHN GUID DOC RIS 2, P1; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; Fischer D, 2011, SOC ENV TOXICOL ANS, P1; Grodzicki P, 2005, J INSECT PHYSIOL, V51, P315, DOI 10.1016/j.jinsphys.2005.01.001; Hatch GE, 2001, TOXICOL IND HEALTH, V17, P285, DOI 10.1191/0748233701th123oa; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; JOHANSEN CA, 1983, ENVIRON ENTOMOL, V12, P1513, DOI 10.1093/ee/12.5.1513; Koch H, 1997, APIDOLOGIE, V28, P439, DOI 10.1051/apido:19970610; OECD, 1998, OECD GUIDEL TEST CHE, P1; OEPP/EPPO, 2003, B OEPP EPPO, V33, P141; OEPP/EPPO, 2001, B OEPP EPPO, V170, P95; Schmolz E, 2002, THERMOCHIM ACTA, V382, P221, DOI 10.1016/S0040-6031(01)00740-7; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Societe Francaise de Phytiatrie et de Phytopharmacie (SFPP), 1982, COMM ESSAIS BIOL, V19; STEVENS PJG, 1988, PESTIC SCI, V24, P31, DOI 10.1002/ps.2780240105; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; TORCHIO P F, 1973, Journal of the Kansas Entomological Society, V46, P446; United Nations Environment Programme (UNEP), 2003, GLOB REP, P1; United States Environmental Protection Agency (US EPA), 2011, PLAN EJ 2014, P1; University of Hertfordshire, 2013, PEST PROP DATABASE P, P2006; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; Wiest L, 2011, J CHROMATOGR A, V1218, P5743, DOI 10.1016/j.chroma.2011.06.079; Wise JC, 2010, CROP PROT, V29, P378, DOI 10.1016/j.cropro.2009.11.014	34	31	31	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113728	10.1371/journal.pone.0113728	http://dx.doi.org/10.1371/journal.pone.0113728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412103	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000076
J	Guarino, E; Cojoc, G; Garcia-Ulloa, A; Tolic, IM; Kearsey, SE				Guarino, Estrella; Cojoc, Gheorghe; Garcia-Ulloa, Alfonso; Tolic, Iva M.; Kearsey, Stephen E.			Real-Time Imaging of DNA Damage in Yeast Cells Using Ultra-Short Near-Infrared Pulsed Laser Irradiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; NUCLEAR ANTIGEN PCNA; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; MAMMALIAN-CELLS; GENOME INTEGRITY; REPLICATION FORK; RPA-SSDNA; IN-VIVO; REPAIR	Analysis of accumulation of repair and checkpoint proteins at repair sites in yeast nuclei has conventionally used chemical agents, ionizing radiation or induction of endonucleases to inflict localized damage. In addition to these methods, similar studies in mammalian cells have used laser irradiation, which has the advantage that damage is inflicted at a specific nuclear region and at a precise time, and this allows accurate kinetic analysis of protein accumulation at DNA damage sites. We show here that it is feasible to use short pulses of near-infrared laser irradiation to inflict DNA damage in subnuclear regions of yeast nuclei by multiphoton absorption. In conjunction with use of fluorescently-tagged proteins, this allows quantitative analysis of protein accumulation at damage sites within seconds of damage induction. PCNA accumulated at damage sites rapidly, such that maximum accumulation was seen approximately 50 s after damage, then levels declined linearly over 200-1000 s after irradiation. RPA accumulated with slower kinetics such that hardly any accumulation was detected within 60 s of irradiation, and levels subsequently increased linearly over the next 900 s, after which levels were approximately constant (up to ca. 2700 s) at the damage site. This approach complements existing methodologies to allow analysis of key damage sensors and chromatin modification changes occurring within seconds of damage inception.	[Guarino, Estrella; Kearsey, Stephen E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Cojoc, Gheorghe; Garcia-Ulloa, Alfonso; Tolic, Iva M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Tolic, Iva M.] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia	University of Oxford; Max Planck Society; Rudjer Boskovic Institute	Kearsey, SE (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	stephen.kearsey@zoo.ox.ac.uk	Tolić, Iva/F-1704-2014	Tolić, Iva/0000-0003-1305-7922	John Fell Oxford University Press Research Fund; European Molecular Biology Organization; Oxford Cancer Research Centre Development Fund; Max Planck Society; Department of Zoology, University of Oxford; Biotechnology and Biological Sciences Research Council [BB/K016598/1] Funding Source: researchfish; Medical Research Council [MR/L016591/1] Funding Source: researchfish; BBSRC [BB/K016598/1] Funding Source: UKRI; MRC [MR/L016591/1] Funding Source: UKRI	John Fell Oxford University Press Research Fund; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Oxford Cancer Research Centre Development Fund; Max Planck Society(Max Planck Society); Department of Zoology, University of Oxford; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the John Fell Oxford University Press Research Fund, the European Molecular Biology Organization, the Oxford Cancer Research Centre Development Fund and the Max Planck Society. Funding for open access charge: Department of Zoology, University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1995, EXP CELL RES, V221, P326, DOI 10.1006/excr.1995.1382; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; BELENGUER P, 1995, YEAST, V11, P225, DOI 10.1002/yea.320110305; Carneiro T, 2010, NATURE, V467, P228, DOI 10.1038/nature09353; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Ferrando-May Elisa, 2013, Frontiers in Genetics, V4, P135, DOI 10.3389/fgene.2013.00135; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; Harper JV, 2008, PHOTOCHEM PHOTOBIOL, V84, P1506, DOI 10.1111/j.1751-1097.2008.00378.x; JANNER F, 1979, MUTAT RES, V63, P11, DOI 10.1016/0027-5107(79)90100-3; Khoury-Haddad H, 2014, P NATL ACAD SCI USA, V111, pE728, DOI 10.1073/pnas.1317585111; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; LEHMANN AR, 1991, MUTAT RES, V250, P205, DOI 10.1016/0027-5107(91)90177-P; Li R, 1996, CURR BIOL, V6, P189, DOI 10.1016/S0960-9822(02)00452-9; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maghelli N, 2011, METHODS MOL BIOL, V777, P261, DOI 10.1007/978-1-61779-252-6_19; Maghelli N, 2010, METHOD CELL BIOL, V97, P173, DOI 10.1016/S0091-679X(10)97010-6; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Meldrum RA, 2003, EMBO REP, V4, P1144, DOI 10.1038/sj.embor.7400028; Miura M, 1996, MUTAT RES-DNA REPAIR, V364, P51, DOI 10.1016/0921-8777(96)00021-3; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Moss J, 2010, GENE DEV, V24, P2705, DOI 10.1101/gad.1970810; Perucca P, 2006, J CELL SCI, V119, P1517, DOI 10.1242/jcs.02868; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Prudden J, 2003, EMBO J, V22, P1419, DOI 10.1093/emboj/cdg119; Raabe I, 2009, J MICROSC-OXFORD, V234, P1, DOI 10.1111/j.1365-2818.2009.03142.x; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Roukos V, 2011, J CELL SCI, V124, P422, DOI 10.1242/jcs.074229; Rumpf C, 2010, CELL CYCLE, V9, P3997, DOI 10.4161/cc.9.19.13233; Sacconi L, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854675; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Xiaoqing C, 2013, NUCL ACIDS RES; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113325	10.1371/journal.pone.0113325	http://dx.doi.org/10.1371/journal.pone.0113325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409521	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200097
J	Aregawi, M; Lynch, M; Bekele, W; Kebede, H; Jima, D; Taffese, HS; Yenehun, MA; Lilay, A; Williams, R; Thomson, M; Nafo-Traore, F; Admasu, K; Gebreyesus, TA; Coosemans, M				Aregawi, Maru; Lynch, Michael; Bekele, Worku; Kebede, Henok; Jima, Daddi; Taffese, Hiwot Solomon; Yenehun, Meseret Aseffa; Lilay, Abraham; Williams, Ryan; Thomson, Madeleine; Nafo-Traore, Fatoumata; Admasu, Kesetebirhan; Gebreyesus, Tedros Adhanom; Coosemans, Marc			Time Series Analysis of Trends in Malaria Cases and Deaths at Hospitals and the Effect of Antimalarial Interventions, 2001-2011, Ethiopia	PLOS ONE			English	Article							SCALE-UP	Background: The Government of Ethiopia and its partners have deployed artemisinin-based combination therapies (ACT) since 2004 and long-lasting insecticidal nets (LLINs) since 2005. Malaria interventions and trends in malaria cases and deaths were assessed at hospitals in malaria transmission areas during 2001-2011. Methods: Regional LLINs distribution records were used to estimate the proportion of the population-at-risk protected by LLINs. Hospital records were reviewed to estimate ACT availability. Time-series analysis was applied to data from 41 hospitals in malaria risk areas to assess trends of malaria cases and deaths during pre-intervention (2001-2005) and post-interventions (2006-2011) periods. Findings: The proportion of the population-at-risk potentially protected by LLINs increased to 51% in 2011. The proportion of facilities with ACTs in stock exceeded 87% during 2006-2011. Among all ages, confirmed malaria cases in 2011 declined by 66% (95% confidence interval [CI], 44-79%) and SPR by 37% (CI, 20%-51%) compared to the level predicted by preintervention trends. In children under 5 years of age, malaria admissions and deaths fell by 81% (CI, 47%-94%) and 73% (CI, 48%-86%) respectively. Optimal breakpoint of the trendlines occurred between January and June 2006, consistent with the timing of malaria interventions. Over the same period, non-malaria cases and deaths either increased or remained unchanged, the number of malaria diagnostic tests performed reflected the decline in malaria cases, and rainfall remained at levels supportive of malaria transmission. Conclusions: Malaria cases and deaths in Ethiopian hospitals decreased substantially during 2006-2011 in conjunction with scale-up of malaria interventions. The decrease could not be accounted for by changes in hospital visits, malaria diagnostic testing or rainfall. However, given the history of variable malaria transmission in Ethiopia, more data would be required to	[Aregawi, Maru; Lynch, Michael; Williams, Ryan] WHO, Global Malaria Program, CH-1211 Geneva, Switzerland; [Bekele, Worku; Kebede, Henok; Nafo-Traore, Fatoumata] WHO, Country Off, Addis Ababa, Ethiopia; [Jima, Daddi; Taffese, Hiwot Solomon; Yenehun, Meseret Aseffa; Lilay, Abraham; Admasu, Kesetebirhan; Gebreyesus, Tedros Adhanom] Fed Minist Hlth, Addis Ababa, Ethiopia; [Thomson, Madeleine] Columbia Univ, Earth Inst, Int Res Inst Climate & Soc IRI, New York, NY USA; [Coosemans, Marc] Inst Trop Med, B-2000 Antwerp, Belgium	World Health Organization; World Health Organization; Federal Ministry of Health - Ethiopia (FMOH); Columbia University; Institute of Tropical Medicine (ITM)	Aregawi, M (corresponding author), WHO, Global Malaria Program, CH-1211 Geneva, Switzerland.	aregawim@who.int			International Research Institute for Climate and Society, Columbia University, New York, USA; analysing spatial and temporal climate data for Ethiopia; National Meteorological Agency of Ethiopia	International Research Institute for Climate and Society, Columbia University, New York, USA; analysing spatial and temporal climate data for Ethiopia; National Meteorological Agency of Ethiopia	We thank Ministry of Health of the Federal Government of Ethiopia and the health staff who were involved in data collection and supervision. We also thank the Global Fund for availing resources for this study. We are grateful to the support provided by the International Research Institute for Climate and Society, Columbia University, New York, USA, in compiling and analysing spatial and temporal climate data for Ethiopia and to the National Meteorological Agency of Ethiopia for availing meteorological data mainly Enhanced National Climate Services (ENACTS) rainfall data aggregated for five major regions of the country. We thank Mehran Hosseini and John Aponte for their critical review and suggestion on the statistical methods. We thank Richard Cibulskis, Robert Newman, Umberto D'Alessandro and Christopher Dye for their critical review.	[Anonymous], 2007, RMRSGTR189 USDA FOR; [Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Checchi F, 2006, EMERGING INFECT DIS, V12; Connor S., 2011, WMO B, V60; FONTAINE RE, 1961, AM J TROP MED HYG, V10, P795, DOI 10.4269/ajtmh.1961.10.795; Hodrick RJ, 1997, J MONEY CREDIT BANK, V29, P1, DOI 10.2307/2953682; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Ministry of Health of the Federal Democratic Republic of Ethiopia, 2004, MAL DIAGN TREATM GUI; Negash K, 2006, E AFR MED J, V82, P186; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Teklehaimanot HD, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-39; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Thomson M, 2003, LANCET, V362, P580, DOI 10.1016/S0140-6736(03)14135-9; UN (Unites Nations), 2013, WORLD POP PROSP; United Nations, 2011, WORLD POP PROSP; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization-Geneva Switzerland, 2012, GLOB MAL DIS SRUV MA; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	24	57	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e106359	10.1371/journal.pone.0106359	http://dx.doi.org/10.1371/journal.pone.0106359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406083	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300002
J	Kendrick, BJ; DiTullio, GR; Cyronak, TJ; Fulton, JM; Van Mooy, BAS; Bidle, KD				Kendrick, B. Jacob; DiTullio, Giacomo R.; Cyronak, Tyler J.; Fulton, James M.; Van Mooy, Benjamin A. S.; Bidle, Kay D.			Temperature-Induced Viral Resistance in Emiliania huxleyi (Prymnesiophyceae)	PLOS ONE			English	Article							C-TYPE LECTINS; DIMETHYL SULFIDE; MARINE VIRUSES; ALGAL VIRUS; CELL-DEATH; DIMETHYLSULFONIOPROPIONATE; DMSP; COCCOLITHOPHORE; INFECTION; PHYTOPLANKTON	Annual Emiliania huxleyi blooms (along with other coccolithophorid species) play important roles in the global carbon and sulfur cycles. E. huxleyi blooms are routinely terminated by large, host-specific dsDNA viruses, (Emiliania huxleyi Viruses; EhVs), making these host-virus interactions a driving force behind their potential impact on global biogeochemical cycles. Given projected increases in sea surface temperature due to climate change, it is imperative to understand the effects of temperature on E. huxleyi's susceptibility to viral infection and its production of climatically active dimethylated sulfur species (DSS). Here we demonstrate that a 3 degrees C increase in temperature induces EhV-resistant phenotypes in three E. huxleyi strains and that successful virus infection impacts DSS pool sizes. We also examined cellular polar lipids, given their documented roles in regulating host-virus interactions in this system, and propose that alterations to membrane-bound surface receptors are responsible for the observed temperature-induced resistance. Our findings have potential implications for global biogeochemical cycles in a warming climate and for deciphering the particular mechanism(s) by which some E. huxleyi strains exhibit viral resistance.	[Kendrick, B. Jacob; DiTullio, Giacomo R.; Cyronak, Tyler J.] Coll Charleston, Grice Marine Lab, Charleston, SC 29401 USA; [Fulton, James M.; Van Mooy, Benjamin A. S.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Bidle, Kay D.] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08903 USA	College of Charleston; Woods Hole Oceanographic Institution; Rutgers State University New Brunswick	Kendrick, BJ (corresponding author), Coll Charleston, Grice Marine Lab, Charleston, SC 29401 USA.	jacobkendrick@gmail.com		Fulton, James/0000-0001-7213-8015; Cyronak, Tyler/0000-0003-3556-7616	National Science Foundation [OCE-1061883, OCE-1061876]; Gordon and Betty Moore Foundation; Division Of Ocean Sciences [1061883] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by funding from the National Science Foundation (OCE-1061883 to KDB, BVM, and OCE-1061876 to GRD) and in part by grants from The Gordon and Betty Moore Foundation (to BVM and KDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYERS GP, 1991, NATURE, V349, P404, DOI 10.1038/349404a0; Bell MV, 1996, PHYTOCHEMISTRY, V41, P465, DOI 10.1016/0031-9422(95)00663-X; BERGE GRIM, 1962, SARSIA, V6, P27; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2011, CURR OPIN MICROBIOL, V14, P449, DOI 10.1016/j.mib.2011.07.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bratbak G, 1995, MAR ECOL PROG SER, V128, P133, DOI 10.3354/meps128133; Bratbak G, 1996, J MARINE SYST, V9, P75, DOI 10.1016/0924-7963(96)00018-8; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; DITULLIO GR, 1995, DEEP-SEA RES PT I, V42, P873, DOI 10.1016/0967-0637(95)00051-7; Edenhofer O., 2014, CONTRIBUTION WORKING; Eichenberger W, 1997, PHYTOCHEMISTRY, V45, P1561, DOI 10.1016/S0031-9422(97)00201-X; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Evans C, 2007, LIMNOL OCEANOGR, V52, P1036, DOI 10.4319/lo.2007.52.3.1036; Evans C, 2006, LIMNOL OCEANOGR, V51, P2468, DOI 10.4319/lo.2006.51.5.2468; Evans C, 2006, J PHYCOL, V42, P1040, DOI 10.1111/j.1529-8817.2006.00256.x; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Frada MJ, 2012, ENVIRON MICROBIOL, V14, P1558, DOI 10.1111/j.1462-2920.2012.02745.x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fulton JM, 2014, ENVIRON MICROBIOL, V16, P1137, DOI 10.1111/1462-2920.12358; Goss R, 2009, ADV PHOTOSYNTH RESP, V30, P117; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hill RW, 1998, AQUAT MICROB ECOL, V14, P1, DOI 10.3354/ame014001; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Jacquet S, 2002, AQUAT MICROB ECOL, V27, P111, DOI 10.3354/ame027111; Kegel JU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080684; Keller MD, 1989, ACS SYM SER, P167, DOI 10.1021/bk-1989-0393.ch011; KIENE RP, 1990, NATURE, V345, P702, DOI 10.1038/345702a0; Lehahn Y, 2014, CURR BIOL, V24, P2041, DOI 10.1016/j.cub.2014.07.046; Mackinder LCM, 2009, J GEN VIROL, V90, P2306, DOI 10.1099/vir.0.011635-0; Malin G, 1998, LIMNOL OCEANOGR, V43, P1389, DOI 10.4319/lo.1998.43.6.1389; MANSKY LM, 1991, PHYTOPATHOLOGY, V81, P535, DOI 10.1094/Phyto-81-535; Nagasaki K, 1998, AQUAT MICROB ECOL, V15, P211, DOI 10.3354/ame015211; Neilan JG, 1999, J GEN VIROL, V80, P2693, DOI 10.1099/0022-1317-80-10-2693; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Pagarete A, 2009, ENVIRON MICROBIOL, V11, P2840, DOI 10.1111/j.1462-2920.2009.02006.x; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Popendorf KJ, 2013, LIPIDS, V48, P185, DOI 10.1007/s11745-012-3748-0; Riekhof WR, 2005, ARCH BIOCHEM BIOPHYS, V441, P96, DOI 10.1016/j.abb.2005.07.001; Riseman SF, 2004, CAN J FISH AQUAT SCI, V61, P721, DOI 10.1139/F04-052; Rose SL, 2014, ENVIRON MICROBIOL, V16, P1150, DOI 10.1111/1462-2920.12357; Sanabria Natasha M, 2010, Self Nonself, V1, P40; SATO N, 1992, BOT MAG TOKYO, V105, P185, DOI 10.1007/BF02489414; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Silva NF, 2002, PLANT MOL BIOL, V50, P667, DOI 10.1023/A:1019951120788; Spiese CE, 2009, LIMNOL OCEANOGR, V54, P560, DOI 10.4319/lo.2009.54.2.0560; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Suzuki T, 2006, BIOL PHARM BULL, V29, P1538, DOI 10.1248/bpb.29.1538; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; SYLLER J, 1991, J PHYTOPATHOL, V133, P216, DOI 10.1111/j.1439-0434.1991.tb00156.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Tyrrell T, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P75; Van Mooy BAS, 2010, GEOCHIM COSMOCHIM AC, V74, P6499, DOI 10.1016/j.gca.2010.08.026; van Rijssel M, 2002, J SEA RES, V48, P17, DOI 10.1016/S1385-1101(02)00134-X; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Wilson WH, 2002, DEEP-SEA RES PT II, V49, P2951, DOI 10.1016/S0967-0645(02)00065-6; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109	66	20	20	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112134	10.1371/journal.pone.0112134	http://dx.doi.org/10.1371/journal.pone.0112134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405345	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300024
J	Staes, N; Stevens, JMG; Helsen, P; Hillyer, M; Korody, M; Eens, M				Staes, Nicky; Stevens, Jeroen M. G.; Helsen, Philippe; Hillyer, Mia; Korody, Marisa; Eens, Marcel			Oxytocin and Vasopressin Receptor Gene Variation as a Proximate Base for Inter- and Intraspecific Behavioral Differences in Bonobos and Chimpanzees	PLOS ONE			English	Article							PAN-TROGLODYTES; WILD CHIMPANZEES; SOCIAL-BEHAVIOR; RELATIONSHIP QUALITY; DICTATOR GAME; OXTR GENE; ASSOCIATION; MICROSATELLITE; DOMINANCE; PANISCUS	Recent literature has revealed the importance of variation in neuropeptide receptor gene sequences in the regulation of behavioral phenotypic variation. Here we focus on polymorphisms in the oxytocin receptor gene (OXTR) and vasopressin receptor gene 1a (Avpr1a) in chimpanzees and bonobos. In humans, a single nucleotide polymorphism (SNP) in the third intron of OXTR (rs53576 SNP (A/G)) is linked with social behavior, with the risk allele (A) carriers showing reduced levels of empathy and prosociality. Bonobos and chimpanzees differ in these same traits, therefore we hypothesized that these differences might be reflected in variation at the rs53576 position. We sequenced a 320 bp region surrounding rs53576 but found no indications of this SNP in the genus Pan. However, we identified previously unreported SNP variation in the chimpanzee OXTR sequence that differs from both humans and bonobos. Humans and bonobos have previously been shown to have a more similar 59 promoter region of Avpr1a when compared to chimpanzees, who are polymorphic for the deletion of,360 bp in this region (+/- DupB) which includes a microsatellite (RS3). RS3 has been linked with variation in levels of social bonding, potentially explaining part of the interspecies behavioral differences found in bonobos, chimpanzees and humans. To date, results for bonobos have been based on small sample sizes. Our results confirmed that there is no DupB deletion in bonobos with a sample size comprising approximately 90% of the captive founder population, whereas in chimpanzees the deletion of DupB had the highest frequency. Because of the higher frequency of DupB alleles in our bonobo population, we suggest that the presence of this microsatellite may partly reflect documented differences in levels of sociability found in bonobos and chimpanzees.	[Staes, Nicky; Stevens, Jeroen M. G.; Helsen, Philippe; Eens, Marcel] Univ Antwerp, Dept Biol, Ethol Res Grp, B-2610 Antwerp, Belgium; [Staes, Nicky; Stevens, Jeroen M. G.; Helsen, Philippe; Hillyer, Mia] Royal Zool Soc Antwerp, Ctr Res & Conservat, B-2018 Antwerp, Belgium; [Korody, Marisa] San Diego Zoo Inst Conservat Res, Escondido, CA 92027 USA; [Hillyer, Mia] Western Australian Museum, Mol Systemat Unit, Perth, WA 6106, Australia	University of Antwerp; Zoological Society of San Diego; Western Australian Museum	Staes, N (corresponding author), Univ Antwerp, Dept Biol, Ethol Res Grp, B-2610 Antwerp, Belgium.	Nicky.Staes@kmda.org	Helsen, Philippe/K-8660-2018; Eens, Marcel/AAC-8466-2020; Staes, Nicky/AAD-4317-2019	Staes, Nicky/0000-0002-5444-4470	Flemish government	Flemish government(European Commission)	Funds for this study come from the Flemish government, who provides structural support of the CRC of the RSZA, FWO Flanders and the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anestis SF, 2014, INT J PRIMATOL, V35, P305, DOI 10.1007/s10764-013-9747-z; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Carlsen F., 2012, EUROPEAN STUDBOOK CH; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; Donaldson ZR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003729; Donaldson ZR, 2008, BMC EVOLUTIONARY BIO, V8, P180; Doran M.D., 2002, BEHAV DIVERSITY CHIM; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Gilby IC, 2010, J HUM EVOL, V59, P44, DOI 10.1016/j.jhevol.2010.02.006; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hammock EAD, 2005, GENES BRAIN BEHAV, V4, P289, DOI 10.1111/j.1601-183X.2005.00119.x; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Hohmann G, 1999, BEHAVIOUR, V136, P1219, DOI 10.1163/156853999501739; Hong KW, 2009, J NEURAL TRANSM, V116, P535, DOI 10.1007/s00702-009-0219-8; Hopkins WD, 2012, GENES BRAIN BEHAV, V11, P552, DOI 10.1111/j.1601-183X.2012.00799.x; Hopkins WD, 2014, SCI REP-UK, V4, DOI 10.1038/srep03774; Idani G., 1990, African Study Monographs, V11, P153; Insel TR, 2000, CURR OPIN NEUROBIOL, V10, P784, DOI 10.1016/S0959-4388(00)00146-X; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Kano T., 1992, LAST APE PYGMY CHIMP; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Koski SE, 2012, INT J PRIMATOL, V33, P905, DOI 10.1007/s10764-012-9623-2; KURODA S, 1980, Primates, V21, P181, DOI 10.1007/BF02374032; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Langergraber KE, 2013, BEHAV ECOL SOCIOBIOL, V67, P861, DOI 10.1007/s00265-013-1509-6; Lehmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P525, DOI 10.1007/s00265-004-0891-5; Lehmann J, 2008, INT J PRIMATOL, V29, P65, DOI 10.1007/s10764-007-9230-9; Lehmann J, 2009, ANIM BEHAV, V77, P377, DOI 10.1016/j.anbehav.2008.09.038; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; Machanda ZP, 2013, INT J PRIMATOL, V34, P917, DOI 10.1007/s10764-013-9707-7; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matsumoto-Oda A, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P168, DOI 10.1017/CBO9780511606397.017; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Newton-Fisher NE, 2006, INT J PRIMATOL, V27, P1589, DOI 10.1007/s10764-006-9087-3; Newton-Fisher NE, 2014, BIOL REV, V89, P356, DOI 10.1111/brv.12058; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; Ophir AG, 2008, HORM BEHAV, V54, P694, DOI 10.1016/j.yhbeh.2008.07.009; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Paoli T, 2006, AM J PRIMATOL, V68, P333, DOI 10.1002/ajp.20228; Parish AR, 1996, HUM NATURE-INT BIOS, V7, P61, DOI 10.1007/BF02733490; Parish AR, 2000, ANN NY ACAD SCI, V907, P97; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Reinartz GE, 1997, THESIS U WISCONSIN M THESIS U WISCONSIN M; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Robinson GE, 2004, SCIENCE, V304, P397, DOI 10.1126/science.1095766; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rosso L, 2008, BIOL LETTERS, V4, P375, DOI 10.1098/rsbl.2008.0122; Sala M, 2013, J NEUROENDOCRINOL, V25, P107, DOI 10.1111/j.1365-2826.2012.02385.x; Seo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076960; Stanford CB, 1998, CURR ANTHROPOL, V39, P399, DOI 10.1086/204757; Stevens JMG, 2006, PRIMATES, V47, P210, DOI 10.1007/s10329-005-0177-1; Stumpf R, 2007, PRIMATES PERSPECTIVE, P321; SUGIYAMA Y, 1988, INT J PRIMATOL, V9, P393, DOI 10.1007/BF02736216; Surbeck M, 2012, ANIM BEHAV, V83, P659, DOI 10.1016/j.anbehav.2011.12.010; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; Tansey KE, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-3; Thomas MA, 2004, TRENDS ECOL EVOL, V19, P439, DOI 10.1016/j.tree.2004.06.010; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Vervaecke H, 2000, INT J PRIMATOL, V21, P47, DOI 10.1023/A:1005471512788; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Walum H, 2012, BIOL PSYCHIAT, V71, P419, DOI 10.1016/j.biopsych.2011.09.002; Wang JP, 2013, NEUROIMAGE, V81, P199, DOI 10.1016/j.neuroimage.2013.05.029; White Frances J., 1996, P29, DOI 10.1017/CBO9780511752414.005; Williams JM, 2002, ANIM BEHAV, V63, P347, DOI 10.1006/anbe.2001.1916; Wingender E, 1997, NUCLEIC ACIDS RES, V25, P265, DOI 10.1093/nar/25.1.265; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3096; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young WS, 2003, NEUROENDOCRINOLOGY, V78, P185, DOI 10.1159/000073702	93	35	36	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113364	10.1371/journal.pone.0113364	http://dx.doi.org/10.1371/journal.pone.0113364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405348	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300108
J	te Beest, D; de Bruin, E; Imholz, S; Wallinga, J; Teunis, P; Koopmans, M; van Boven, M				te Beest, Dennis; de Bruin, Erwin; Imholz, Sandra; Wallinga, Jacco; Teunis, Peter; Koopmans, Marion; van Boven, Michiel			Discrimination of Influenza Infection (A/2009 H1N1) from Prior Exposure by Antibody Protein Microarray Analysis	PLOS ONE			English	Article							VIRUS; RESPONSES	Reliable discrimination of recent influenza A infection from previous exposure using hemagglutination inhibition (HI) or virus neutralization tests is currently not feasible. This is due to low sensitivity of the tests and the interference of antibody responses generated by previous infections. Here we investigate the diagnostic characteristics of a newly developed antibody (HA1) protein microarray using data from cross-sectional serological studies carried out before and after the pandemic of 2009. The data are analysed by mixture models, providing a probabilistic classification of sera (susceptible, prior-exposed, recently infected). Estimated sensitivity and specificity for identifying A/2009 infections are low using HI (66% and 51%), and high when using A/2009 microarray data alone or together with A/1918 microarray data (96% and 95%). As a heuristic, a high A/2009 to A/1918 antibody ratio (>1.05) is indicative of recent infection, while a low ratio is indicative of a pre-existing response, even if the A/2009 titer is high. We conclude that highly sensitive and specific classification of individual sera is possible using the protein microarray, thereby enabling precise estimation of age-specific infection attack rates in the population even if sample sizes are small.	[te Beest, Dennis; de Bruin, Erwin; Wallinga, Jacco; Teunis, Peter; Koopmans, Marion; van Boven, Michiel] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Imholz, Sandra] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands; [Teunis, Peter] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Emory University; Rollins School Public Health; Erasmus University Rotterdam; Erasmus MC	van Boven, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	michiel.van.boven@rivm.nl	Wallinga, Jacco/C-4382-2018	Wallinga, Jacco/0000-0003-1725-5627; te Beest, Dennis E./0000-0001-5265-9008	National Institute for Public Health; Environment project [S/210096]	National Institute for Public Health; Environment project	This work was supported by the National Institute for Public Health and the Environment project S/210096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas DC, 2013, J MED VIROL, V85, P899, DOI 10.1002/jmv.23535; Boni M. F., 2013, J INFECT DIS; Gilks WR, 1996, MARKOV CHAIN MONTE C; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; Huijskens EGW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054890; Kerkhove MD, 2013, INFLUENZA OTHER RESP; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; MCDONALD S, UNPUB; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; Teunis PFM, 2009, VET PARASITOL, V159, P345, DOI 10.1016/j.vetpar.2008.10.071; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	16	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113021	10.1371/journal.pone.0113021	http://dx.doi.org/10.1371/journal.pone.0113021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405997	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300071
J	Kusuda, T; Nakashima, Y; Murata, K; Kanno, S; Nishio, H; Saito, M; Tanaka, T; Yamamura, K; Sakai, Y; Takada, H; Miyamoto, T; Mizuno, Y; Ouchi, K; Waki, K; Hara, T				Kusuda, Takeshi; Nakashima, Yasutaka; Murata, Kenji; Kanno, Shunsuke; Nishio, Hisanori; Saito, Mitsumasa; Tanaka, Tamami; Yamamura, Kenichiro; Sakai, Yasunari; Takada, Hidetoshi; Miyamoto, Tomofumi; Mizuno, Yumi; Ouchi, Kazunobu; Waki, Kenji; Hara, Toshiro			Kawasaki Disease-Specific Molecules in the Sera Are Linked to Microbe-Associated Molecular Patterns in the Biofilms	PLOS ONE			English	Article							PATHOGENESIS; ACTIVATION	Background: Kawasaki disease (KD) is a systemic vasculitis of unknown etiology. The innate immune system is involved in its pathophysiology at the acute phase. We have recently established a novel murine model of KD coronary arteritis by oral administration of a synthetic microbe-associated molecular pattern (MAMP). On the hypothesis that specific MAMPs exist in KD sera, we have searched them to identify KD-specific molecules and to assess the pathogenesis. Methods: We performed liquid chromatography-mass spectrometry (LC-MS) analysis of fractionated serum samples from 117 patients with KD and 106 controls. Microbiological and LC-MS evaluation of biofilm samples were also performed. Results: KD samples elicited proinflammatory cytokine responses from human coronary artery endothelial cells (HCAECs). By LC-MS analysis of KD serum samples collected at 3 different periods, we detected a variety of KD-specific molecules in the lipophilic fractions that showed distinct m/z and MS/MS fragmentation patterns in each cluster. Serum KD-specific molecules showed m/z and MS/MS fragmentation patterns almost identical to those of MAMPs obtained from the biofilms formed in vitro (common MAMPs from Bacillus cereus, Yersinia pseudotuberculosis and Staphylococcus aureus) at the 1st study period, and from the biofilms formed in vivo (common MAMPs from Bacillus cereus, Bacillus subtilis/Bacillus cereus/Yersinia pseudotuberculosis and Staphylococcus aureus) at the 2nd and 3rd periods. The biofilm extracts from Bacillus cereus, Bacillus subtilis, Yersinia pseudotuberculosis and Staphylococcus aureus also induced proinflammatory cytokines by HCAECs. By the experiments with IgG affinity chromatography, some of these serum KD-specific molecules bound to IgG. Conclusions: We herein conclude that serum KD-specific molecules were mostly derived from biofilms and possessed molecular structures common to MAMPs from Bacillus cereus, Bacillus subtilis, Yersinia pseudotuberculosis and Staphylococcus aureus. Discovery of these KD-specific molecules might offer novel insight into the diagnosis and management of KD as well as its pathogenesis.	[Kusuda, Takeshi; Nakashima, Yasutaka; Murata, Kenji; Kanno, Shunsuke; Nishio, Hisanori; Tanaka, Tamami; Yamamura, Kenichiro; Sakai, Yasunari; Takada, Hidetoshi; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 812, Japan; [Saito, Mitsumasa] Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Fukuoka 812, Japan; [Miyamoto, Tomofumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Mizuno, Yumi] Fukuoka Childrens Hosp, Dept Pediat Infect Dis, Fukuoka, Japan; [Mizuno, Yumi] Med Ctr Infect Dis, Fukuoka, Japan; [Ouchi, Kazunobu] Kawasaki Med Sch Hosp, Dept Pediat, Okayama, Japan; [Waki, Kenji] Kurashiki Cent Hosp, Dept Pediat, Okayama, Japan	Kyushu University; Kyushu University; Kyushu University; Kawasaki Medical School; Kurashiki Central Hospital	Hara, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 812, Japan.	harat@pediatr.med.kyushu-u.ac.jp	Murata, Kenji/AAO-8899-2021; Sakai, Yasunari/S-7965-2018	Murata, Kenji/0000-0002-2698-7160; Sakai, Yasunari/0000-0002-5747-8692	Japan Society for the Promotion of Science [22249043, 22591183]; Health and Labour Science Research Grants from the Japanese Ministry of Health, Labour and Welfare; Japan Therapeutic Study Group for Kawasaki Disease (JSGK); Grants-in-Aid for Scientific Research [24591551] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Science Research Grants from the Japanese Ministry of Health, Labour and Welfare; Japan Therapeutic Study Group for Kawasaki Disease (JSGK); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants (Grant A for Toshiro Hara [No. 22249043], Grant C for Hisanori Nishio [No. 22591183]) from the Japan Society for the Promotion of Science, the Health and Labour Science Research Grants (for Toshiro Hara) from the Japanese Ministry of Health, Labour and Welfare, and grants (for Takeshi Kusuda and Kenji Murata) from the Japan Therapeutic Study Group for Kawasaki Disease (JSGK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; [Anonymous], 2012, BAC SUBT FIN RISK AS; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Burns JC, 2007, NEW ENGL J MED, V356, P659, DOI 10.1056/NEJMp068268; Carrillo PG, 1996, WORLD J MICROB BIOT, V12, P82, DOI 10.1007/BF00327807; Christie WW, 2011, RHAMNOLIPIDS SOPHORO; Cyberlipid Center, 2011, LIP EXTR; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foell D, 2003, LANCET, V361, P1270, DOI 10.1016/S0140-6736(03)12986-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Ikeda K, 2010, CLIN EXP IMMUNOL, V160, P246, DOI 10.1111/j.1365-2249.2009.04073.x; Im J H, 2001, BMC Biotechnol, V1, P5, DOI 10.1186/1472-6750-1-5; Ito S, 2007, COLLOID SURFACE B, V58, P165, DOI 10.1016/j.colsurfb.2007.03.003; KEREN G, 1979, ISRAEL J MED SCI, V15, P592; LEUNG DYM, 1989, LANCET, V2, P1298; Moran A. P., 2003, Reviews in Environmental Science and Bio/Technology, V2, P121, DOI 10.1023/B:RESB.0000040462.36578.54; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; Onghena M, 2011, ANAL BIOANAL CHEM, V400, P1263, DOI 10.1007/s00216-011-4741-9; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Popper SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r261; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Secor PR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-143; Tahara M, 2006, ACTA PAEDIATR, V95, P1661, DOI 10.1080/08035250600750080; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; Vincent P, 2007, PEDIATR INFECT DIS J, V26, P629, DOI 10.1097/INF.0b013e3180616d3c; Yamashiro Y, 1996, PEDIATR RES, V39, P622, DOI 10.1203/00006450-199604000-00010; Yeung RSM, 2005, CURR OPIN RHEUMATOL, V17, P617, DOI 10.1097/01.bor.0000174184.15901.ee	32	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113054	10.1371/journal.pone.0113054	http://dx.doi.org/10.1371/journal.pone.0113054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411968	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000021
J	Zanluca, C; Mazzarotto, GACA; Bordignon, J; dos Santos, CND				Zanluca, Camila; Mazzarotto, Giovanny Augusto Camacho Antevere; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes			Development, Characterization and Application of Monoclonal Antibodies against Brazilian Dengue Virus Isolates	PLOS ONE			English	Article							RAPID IMMUNOCHROMATOGRAPHIC TEST; ANTIGEN CAPTURE IMMUNOASSAY; LINKED-IMMUNOSORBENT-ASSAY; ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; DIAGNOSIS; ELISA; NEUTRALIZATION; FEVER; IGM	Dengue is the most prevalent human arboviral disease. The morbidity related to dengue infection supports the need for an early, quick and effective diagnostic test. Brazil is a hotspot for dengue, but no serological diagnostic test has been produced using Brazilian dengue virus isolates. This study aims to improve the development of immunodiagnostic methods for dengue virus (DENV) detection through the production and characterization of 22 monoclonal antibodies (mAbs) against Brazilian isolates of DENV-1, -2 and -3. The mAbs include IgG2b kappa, IgG2a kappa and IgG1 kappa isotypes, and most were raised against the envelope or the pre-membrane proteins of DENV. When the antibodies were tested against the four DENV serotypes, different reactivity patterns were identified: group-specific, subcomplex specific (DENV-1, -3 and -4 and DENV-2 and -3) and dengue serotype-specific (DENV-2 or -3). Additionally, some mAbs cross-reacted with yellow fever virus (YFV), West Nile virus (WNV) and Saint Louis encephalitis virus (SLEV). None of the mAbs recognized the alphavirus Venezuelan equine encephalitis virus (VEEV). Furthermore, mAbs D3 424/8G, D1 606/A12/B9 and D1 695/12C/2H were used to develop a capture enzyme-linked immunosorbent assay (ELISA) for anti-dengue IgM detection in sera from patients with acute dengue. To our knowledge, these are the first monoclonal antibodies raised against Brazilian DENV isolates, and they may be of special interest in the development of diagnostic assays, as well as for basic research.	[Zanluca, Camila; Mazzarotto, Giovanny Augusto Camacho Antevere; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes] Inst Carlos Chagas, ICC Fiocruz PR, Mol Virol Lab, Curitiba, Parana, Brazil; [Zanluca, Camila] Univ Fed Parana UFPR, Programa Posgrad Biol Celular & Mol, Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Parana	Bordignon, J (corresponding author), Inst Carlos Chagas, ICC Fiocruz PR, Mol Virol Lab, Curitiba, Parana, Brazil.	julianobordignon@fiocruz.br; clsantos@tecpar.br	Bordignon, Juliano/Z-6268-2019; dos Santos, Claudia Duarte/P-4868-2019; Zanluca, Camila/O-6943-2017; dos Santos, Claudia Nunes Duarte/E-1857-2018	Bordignon, Juliano/0000-0002-1965-6152; dos Santos, Claudia Duarte/0000-0001-8707-6638; dos Santos, Claudia Nunes Duarte/0000-0001-8707-6638; Zanluca, Camila/0000-0001-7350-9105	CNPq; CNPq/Prosul; Fiocruz; Fundacao Araucaria; Fundo Parana; CNPq/CAPES PROCAD/Casadinho	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Prosul(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fiocruz; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Fundo Parana; CNPq/CAPES PROCAD/Casadinho	The authors thank CNPq, CNPq/Prosul, Fiocruz, Fundacao Araucaria and Fundo Parana and CNPq/CAPES PROCAD/Casadinho for financial support. CNDS is a CNPq fellowship recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brasil. Ministerio de Saude. Secretaria de Vigilancia em Saude, 2010, RES PREL AV DET OC O; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; CALISHER CH, 1988, ACTA VIROL, V32, P469; CARDIFF RD, 1973, INFECT IMMUN, V7, P809, DOI 10.1128/IAI.7.5.809-816.1973; Chan AHY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033451; Chiang CF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-115; Chong C F, 1994, Clin Diagn Virol, V1, P335, DOI 10.1016/0928-0197(94)90063-9; DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469; DITTMAR D, 1980, J CLIN MICROBIOL, V12, P74, DOI 10.1128/JCM.12.1.74-78.1980; Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Kang XP, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-56; Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12; KOBAYASHI Y, 1985, MICROBIOL IMMUNOL, V29, P1069, DOI 10.1111/j.1348-0421.1985.tb00897.x; KUNO G, 1985, J VIROL METHODS, V12, P93, DOI 10.1016/0166-0934(85)90011-4; Kuroda JK, 1986, J GEN VIROL, V67, P2663; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam SK, 1998, CLIN DIAGN VIROL, V10, P75, DOI 10.1016/S0928-0197(98)00002-6; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lelli D, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-81; Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024; Mazzarotto GCA, 2009, J VIROL METHODS, V162, P96, DOI 10.1016/j.jviromet.2009.07.022; MITCHELL CJ, 1985, AM J TROP MED HYG, V34, P945, DOI 10.4269/ajtmh.1985.34.945; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852; Nelson PN, 2000, J CLIN PATHOL-MOL PA, V53, P111; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Palmer CJ, 1999, J CLIN MICROBIOL, V37, P1600, DOI 10.1128/JCM.37.5.1600-1601.1999; Perrin P., 1996, P433; Pierson TC., 2013, FIELDS VIROLOGY, V6th ed., P747; Post PR, 2001, MEM I OSWALDO CRUZ, V96, P849, DOI 10.1590/S0074-02762001000600019; Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Romero-Vivas CME, 1998, MED VET ENTOMOL, V12, P284, DOI 10.1046/j.1365-2915.1998.00117.x; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; SINGH KRP, 1969, B WORLD HEALTH ORGAN, V40, P982; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13; Takasaki T, 2002, J VIROL METHODS, V102, P61, DOI 10.1016/S0166-0934(01)00449-9; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; Trainor NB, 2007, VIROLOGY, V360, P398, DOI 10.1016/j.virol.2006.10.033; Vaughn DW, 1998, J CLIN MICROBIOL, V36, P234, DOI 10.1128/JCM.36.1.234-238.1998; Vazquez S, 2003, J VIROL METHODS, V110, P179, DOI 10.1016/S0166-0934(03)00128-9; Wan SW, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-37; Wisdom G Brian, 2005, Methods Mol Biol, V295, P127; Wu SJL, 1997, CLIN DIAGN LAB IMMUN, V4, P452, DOI 10.1128/CDLI.4.4.452-457.1997; Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06	59	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e110620	10.1371/journal.pone.0110620	http://dx.doi.org/10.1371/journal.pone.0110620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412181	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000005
J	Cai, YY; Yu, SQ; Postnikova, EN; Mazur, S; Bernbaum, JG; Burk, R; Zhang, TF; Radoshitzky, SR; Muller, MA; Jordan, I; Bollinger, L; Hensley, LE; Jahrling, PB; Kuhn, JH				Cai, Yingyun; Yu, Shulqing; Postnikova, Elena N.; Mazur, Steven; Bernbaum, John G.; Burk, Robin; Zhang, Tengfei; Radoshitzky, Sheli R.; Mueller, Marcel A.; Jordan, Ingo; Bollinger, Laura; Hensley, Lisa E.; Jahrling, Peter B.; Kuhn, Jens H.			CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection	PLOS ONE			English	Article							TO-HUMAN TRANSMISSION; DROMEDARY CAMELS; VIRUS; RECEPTOR; EMERGENCE; USAGE	Middle East respiratory syndrome coronavirus (MERS-CoV) is a recently isolated betacoronavirus identified as the etiologic agent of a frequently fatal disease in Western Asia, Middle East respiratory syndrome. Attempts to identify the natural reservoirs of MERS-CoV have focused in part on dromedaries. Bats are also suspected to be reservoirs based on frequent detection of other betacoronaviruses in these mammals. For this study, ten distinct cell lines derived from bats of divergent species were exposed to MERS-CoV. Plaque assays, immunofluorescence assays, and transmission electron microscopy confirmed that six bat cell lines can be productively infected. We found that the susceptibility or resistance of these bat cell lines directly correlates with the presence or absence of cell surface-expressed CD26/DPP4, the functional human receptor for MERS-CoV. Human anti-CD26/DPP4 antibodies inhibited infection of susceptible bat cells in a dose-dependent manner. Overexpression of human CD26/DPP4 receptor conferred MERS-CoV susceptibility to resistant bat cell lines. Finally, sequential passage of MERS-CoV in permissive bat cells established persistent infection with concomitant downregulation of CD26/DPP4 surface expression. Together, these results imply that bats indeed could be among the MERS-CoV host spectrum, and that cellular restriction of MERS-CoV is determined by CD26/DPP4 expression rather than by downstream restriction factors.	[Cai, Yingyun; Yu, Shulqing; Postnikova, Elena N.; Mazur, Steven; Bernbaum, John G.; Burk, Robin; Zhang, Tengfei; Bollinger, Laura; Hensley, Lisa E.; Jahrling, Peter B.; Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA; [Radoshitzky, Sheli R.] US Army Med Res Inst, Frederick, MD USA; [Mueller, Marcel A.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Jordan, Ingo] ProBioGen AG, Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bonn	Kuhn, JH (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA.	kuhnjens@mail.nih.gov	Radoshitzky, Sheli/L-8410-2019; Radoshitzky, Sheli S/F-2766-2019; Müller, Marcel A./O-2425-2019; Kuhn, Jens H./B-7615-2011	Radoshitzky, Sheli/0000-0001-8976-8056; Müller, Marcel A./0000-0003-2242-5117; Kuhn, Jens H./0000-0002-7800-6045; Burk, Robin/0000-0003-4651-6486; Hensley, Lisa/0000-0003-1188-4342; Jordan, Ingo/0000-0003-2711-7252; Cai, Yingyun/0000-0002-1101-0920	US Department of Health and Human Services [HHSN272200700016I]; Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology (HBIGS), Heidelberg, Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIDAI009006] Funding Source: NIH RePORTER	US Department of Health and Human Services; Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology (HBIGS), Heidelberg, Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YC, SY, ENP, SM, RB, TZ, LB, and JHK performed this work for the US Department of Health and Human Services under contract number HHSN272200700016I (Battelle Memorial Institute). RB was supported by the Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology (HBIGS), Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaili AN, 2014, MBIO, V5, DOI [10.1128/mBio.00884-14, 10.1128/mBio.01482-14]; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Baric RS, 1999, J VIROL, V73, P638, DOI 10.1128/JVI.73.1.638-649.1999; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Briese T, 2014, MBIO, V5, DOI 10.1128/mBio.01146-14; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Corman VM, 2014, J VIROL, V88, P11297, DOI 10.1128/JVI.01498-14; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; de Oliveira RC, 2014, VIRUSES-BASEL, V6, P1929, DOI 10.3390/v6051929; de Wit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069127; DOBOS P, 1976, J CLIN MICROBIOL, V3, P373; Goyens J, 2013, J THEOR BIOL, V317, P55, DOI 10.1016/j.jtbi.2012.09.039; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jordan I, 2009, VIRUS RES, V145, P54, DOI 10.1016/j.virusres.2009.06.007; Klein SL, 2007, CURR TOP MICROBIOL, V315, P217; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Mizutani T, 2005, BBA-MOL BASIS DIS, V1741, P4, DOI 10.1016/j.bbadis.2005.04.004; Nishiura H, 2009, EPIDEMICS-NETH, V1, P118, DOI 10.1016/j.epidem.2009.04.002; Nowotny N, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.16.20781; Ohnuma K, 2013, J VIROL, V87, P13892, DOI 10.1128/JVI.02448-13; Palacios G, 2005, CHINESE MED J-PEKING, V118, P451; Perera RA, 2013, EURO SURVEILL, V18; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Raj VS, 2014, EMERG INFECT DIS, V20, P1339, DOI 10.3201/eid2008.140663; Reusken CB, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.50.20662; Traub E, 1936, J EXP MED, V63, P847, DOI 10.1084/jem.63.6.847; van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14; Wang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080430; Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009; World Health Organization, 2014, MIDDL E RESP SYNDR C; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	39	26	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112060	10.1371/journal.pone.0112060	http://dx.doi.org/10.1371/journal.pone.0112060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409519	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200012
J	Ford, BE; Sun, B; Carpino, J; Chapler, ES; Ching, J; Choi, Y; Jhun, K; Kim, JD; Lallos, GG; Morgenstern, R; Singh, S; Theja, S; Dennehy, JJ				Ford, Brian E.; Sun, Bruce; Carpino, James; Chapler, Elizabeth S.; Ching, Jane; Choi, Yoon; Jhun, Kevin; Kim, Jung D.; Lallos, Gregory G.; Morgenstern, Rachelle; Singh, Shalini; Theja, Sai; Dennehy, John J.			Frequency and Fitness Consequences of Bacteriophage Phi 6 Host Range Mutations	PLOS ONE			English	Article							STRANDED-RNA SEGMENT; SOURCE-SINK DYNAMICS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; CELL RECOGNITION; HOT-SPOTS; I-TASSER; VIRUS; EVOLUTION; DEHYDROGENASE	Viruses readily mutate and gain the ability to infect novel hosts, but few data are available regarding the number of possible host range-expanding mutations allowing infection of any given novel host, and the fitness consequences of these mutations on original and novel hosts. To gain insight into the process of host range expansion, we isolated and sequenced 69 independent mutants of the dsRNA bacteriophage 6 able to infect the novel host, Pseudomonas pseudoalcaligenes. In total, we found at least 17 unique suites of mutations among these 69 mutants. We assayed fitness for 13 of 17 mutant genotypes on P. pseudoalcaligenes and the standard laboratory host, P. phaseolicola. Mutants exhibited significantly lower fitnesses on P. pseudoalcaligenes compared to P. phaseolicola. Furthermore, 12 of the 13 assayed mutants showed reduced fitness on P. phaseolicola compared to wildtype 6, confirming the prevalence of antagonistic pleiotropy during host range expansion. Further experiments revealed that the mechanistic basis of these fitness differences was likely variation in host attachment ability. In addition, using computational protein modeling, we show that host-range expanding mutations occurred in hotspots on the surface of the phage's host attachment protein opposite a putative hydrophobic anchoring domain.	[Ford, Brian E.; Sun, Bruce; Carpino, James; Chapler, Elizabeth S.; Ching, Jane; Choi, Yoon; Jhun, Kevin; Kim, Jung D.; Lallos, Gregory G.; Morgenstern, Rachelle; Singh, Shalini; Theja, Sai; Dennehy, John J.] CUNY Queens Coll, Dept Biol, New York, NY USA; [Ford, Brian E.] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; City University of New York (CUNY) System	Dennehy, JJ (corresponding author), New York Stem Cell Fdn, New York, NY 10023 USA.	john.dennehy@qc.cuny.edu	Ford, Brian E/G-5875-2010; Dennehy, John/A-9704-2008	Ford, Brian E/0000-0003-0543-4978; Dennehy, John/0000-0002-9678-4529	Professional Staff Congress of the City University of New York Award [62886-00-40]; National Science Foundation Division of Environmental Biology Award [0804039]; National Science Foundation Faculty Early Career Award [1148879]	Professional Staff Congress of the City University of New York Award; National Science Foundation Division of Environmental Biology Award(National Science Foundation (NSF)); National Science Foundation Faculty Early Career Award	This work was supported by the National Science Foundation Faculty Early Career Award #1148879 (JJD), Professional Staff Congress of the City University of New York Award #62886-00-40 (JJD), and National Science Foundation Division of Environmental Biology Award #0804039 (JJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HK, 2010, J R SOC INTERFACE, V7, P1455, DOI 10.1098/rsif.2010.0123; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Ayora-Talavera G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007836; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Baranowski E, 2003, ADV VIRUS RES, V62, P19, DOI 10.1016/S0065-3527(03)62002-6; Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Bono LM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0616; Chao L, 2002, J VIROL, V76, P3276, DOI 10.1128/JVI.76.7.3276-3281.2002; Chattopadhyay S, 2007, J MOL EVOL, V64, P204, DOI 10.1007/s00239-006-0063-5; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Christensen KLY, 2009, CLIN INFECT DIS, V49, P1025, DOI 10.1086/605562; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Cox J, 2010, J VIROL, V84, P4860, DOI 10.1128/JVI.00047-10; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; CUPPELS DA, 1981, CURR MICROBIOL, V5, P247, DOI 10.1007/BF01571156; DAWKINS B, 1991, AM STAT, V45, P76, DOI 10.2307/2685247; Dennehy JJ, 2006, AM NAT, V167, P429, DOI 10.1086/499381; Dennehy JJ, 2014, ANN REV MICROBIOL; Dennehy John J, 2012, Int J Evol Biol, V2012, P396165, DOI 10.1155/2012/396165; Dennehy JJ, 2009, TRENDS MICROBIOL, V17, P450, DOI 10.1016/j.tim.2009.07.006; Duffy S, 2006, GENETICS, V172, P751, DOI 10.1534/genetics.105.051136; Ellegren H, 2003, CURR OPIN GENET DEV, V13, P562, DOI 10.1016/j.gde.2003.10.008; Ferris MT, 2007, GENETICS, V176, P1013, DOI 10.1534/genetics.106.064634; Fisher RA, 1930, GENETICAL THEORY NAT; Gandon S, 2012, PHILOS T R SOC B, V368; GHOSH M, 1995, STRUCTURE, V3, P177, DOI 10.1016/S0969-2126(01)00148-4; GOTTLIEB P, 1988, VIROLOGY, V163, P183, DOI 10.1016/0042-6822(88)90245-0; Hall AR, 2011, AM NAT, V177, P44, DOI 10.1086/657441; Hoper D, 2012, J VIROL, V86, P1394, DOI 10.1128/JVI.00797-11; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jonah G, 2003, J VIROL, V77, P6709, DOI 10.1128/JVI.77.12.6709-6719.2003; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keitel T, 2000, J MOL BIOL, V297, P961, DOI 10.1006/jmbi.2000.3603; KENNEY JM, 1992, VIROLOGY, V190, P635, DOI 10.1016/0042-6822(92)90901-Z; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lide D.R., 1991, HDB CHEM PHYS; Luria SE, 1943, GENETICS, V28, P491; MCGRAW T, 1986, J VIROL, V58, P142, DOI 10.1128/JVI.58.1.142-151.1986; MINDICH L, 1988, J VIROL, V62, P1180, DOI 10.1128/JVI.62.4.1180-1185.1988; MINDICH L, 1985, J BACTERIOL, V162, P992, DOI 10.1128/JB.162.3.992-999.1985; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Ng TI, 2001, ANTIMICROB AGENTS CH, V45, P1629, DOI 10.1128/AAC.45.6.1629-1636.2001; Oubrie A, 2002, J BIOL CHEM, V277, P3727, DOI 10.1074/jbc.M109403200; Petsko G., 2004, PROTEIN STRUCTURE FU; ROSE MR, 1982, HEREDITY, V48, P63, DOI 10.1038/hdy.1982.7; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; Sasadeusz JJ, 1997, J VIROL, V71, P3872, DOI 10.1128/JVI.71.5.3872-3878.1997; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; STITT BL, 1983, VIROLOGY, V127, P446, DOI 10.1016/0042-6822(83)90157-5; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapparel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021163; VIDAVER AK, 1973, J VIROL, V11, P799, DOI 10.1128/JVI.11.5.799-805.1973; Williams PD, 2010, TRENDS PARASITOL, V26, P83, DOI 10.1016/j.pt.2009.11.009; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; Yamada S, 2005, VIRUS GENES, V31, P107, DOI 10.1007/s11262-005-2206-y; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yuang TTT, 2000, J VIROL, V74, P4929, DOI 10.1128/JVI.74.10.4929-4932.2000; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113078	10.1371/journal.pone.0113078	http://dx.doi.org/10.1371/journal.pone.0113078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409341	Green Published, gold			2022-12-27	WOS:000345533200065
J	Horsch, M; Beckers, J; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Rathkolb, B; Wolf, E; Aigner, B; Kemter, E				Horsch, Marion; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Rathkolb, Birgit; Wolf, Eckhard; Aigner, Bernhard; Kemter, Elisabeth			Uromodulin Retention in Thick Ascending Limb of Henle's Loop Affects SCD1 in Neighboring Proximal Tubule: Renal Transcriptome Studies in Mouse Models of Uromodulin-Associated Kidney Disease	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; GENE-EXPRESSION; UMOD GENE; MICE; MUTATION; HYPERTENSION; NEPHROPATHY; INJURY; DEFECT	Uromodulin-associated kidney disease (UAKD) is a hereditary progressive renal disease which can lead to renal failure and requires renal replacement therapy. UAKD belongs to the endoplasmic reticulum storage diseases due to maturation defect of mutant uromodulin and its retention in the enlarged endoplasmic reticulum in the cells of the thick ascending limb of Henle's loop (TALH). Dysfunction of TALH represents the key pathogenic mechanism of UAKD causing the clinical symptoms of this disease. However, the molecular alterations underlying UAKD are not well understood. In this study, transcriptome profiling of whole kidneys of two mouse models of UAKD, Umod(A227T) and Umod(C93F), was performed. Genes differentially abundant in UAKD affected kidneys of both Umod mutant lines at different disease stages were identified and verified by RT-qPCR. Additionally, differential protein abundances of SCD1 and ANGPTL7 were validated by immunohistochemistry and Western blot analysis. ANGPTL7 expression was down-regulated in TALH cells of Umod mutant mice which is the site of the mutant uromodulin maturation defect. SCD1 was expressed selectively in the S3 segment of proximal tubule cells, and SCD1 abundance was increased in UAKD affected kidneys. This finding demonstrates that a cross talk between two functionally distinct tubular segments of the kidney, the TALH segment and the S3 segment of proximal tubule, exists.	[Horsch, Marion; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Rathkolb, Birgit] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Rathkolb, Birgit; Wolf, Eckhard; Aigner, Bernhard; Kemter, Elisabeth] LMU Munchen, Gene Ctr, Munich, Germany; [Rathkolb, Birgit; Wolf, Eckhard; Aigner, Bernhard; Kemter, Elisabeth] LMU Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; University of Munich	Kemter, E (corresponding author), LMU Munchen, Gene Ctr, Munich, Germany.	kemter@lmb.uni-muenchen.de	Gailus-Durner, Valerie/M-7337-2014; de Angelis, Martin Hrabe/F-5531-2012; Beckers, Johannes/K-7237-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Beckers, Johannes/0000-0001-7874-3822; Aigner, Bernhard/0000-0003-1644-2711; Wolf, Eckhard/0000-0002-0430-9510; Kemter, Elisabeth/0000-0001-7785-7502	German Research Foundation (DFG) [KE1673/1-1]; German Federal Ministry of Education and Research (Infrafrontier grant) [01KX1012]; German Center for Diabetes Research (DZD e.V.)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (Infrafrontier grant); German Center for Diabetes Research (DZD e.V.)	This work has been funded by the German Research Foundation (DFG) (grant number KE1673/1-1), by the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012) and by the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; Darisipudi MN, 2012, J AM SOC NEPHROL, V23, P1783, DOI 10.1681/ASN.2012040338; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Achkar TM, 2012, AM J KIDNEY DIS, V59, P452, DOI 10.1053/j.ajkd.2011.10.054; El-Achkar TM, 2011, AM J PHYSIOL-RENAL, V300, pF999, DOI 10.1152/ajprenal.00621.2010; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Kemter E, 2014, J BIOL CHEM, V289, P10715, DOI 10.1074/jbc.M113.537035; Kemter E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078337; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2010, AM J PHYSIOL-RENAL, V298, pF1405, DOI 10.1152/ajprenal.00522.2009; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Kuchtey J, 2008, INVEST OPHTH VIS SCI, V49, P3438, DOI 10.1167/iovs.07-1347; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Puig O, 2010, PHYSIOL GENOMICS, V42A, P24, DOI 10.1152/physiolgenomics.00010.2010; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang YH, 2006, AM J PHYSIOL-RENAL, V290, pF1065, DOI 10.1152/ajprenal.00131.2005	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113125	10.1371/journal.pone.0113125	http://dx.doi.org/10.1371/journal.pone.0113125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409434	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200071
J	Huang, CY; Chuang, CY; Shu, WY; Chang, CW; Chen, CR; Fan, TC; Hsu, IC				Huang, Chao-Ying; Chuang, Chun-Yu; Shu, Wun-Yi; Chang, Cheng-Wei; Chen, Chaang-Ray; Fan, Tai-Ching; Hsu, Ian C.			Distinct Epidermal Keratinocytes Respond to Extremely Low-Frequency Electromagnetic Fields Differently	PLOS ONE			English	Article							ATM PROTEIN-KINASE; HZ MAGNETIC-FIELD; DNA-DAMAGE; INTERMITTENT EXPOSURE; CHROMOSOMAL DAMAGE; CELL-PROLIFERATION; STRAND BREAKS; ACTIVATION; APOPTOSIS; FIBROBLASTS	Following an increase in the use of electric appliances that can generate 50 or 60 Hz electromagnetic fields, concerns have intensified regarding the biological effects of extremely low-frequency electromagnetic fields (ELF-EMFs) on human health. Previous epidemiological studies have suggested the carcinogenic potential of environmental exposure to ELF-EMFs, specifically at 50 or 60 Hz. However, the biological mechanism facilitating the effects of ELF-EMFs remains unclear. Cellular studies have yielded inconsistent results regarding the biological effects of ELF-EMFs. The inconsistent results might have been due to diverse cell types. In our previous study, we indicated that 1.5 mT, 60 Hz ELF-EMFs will cause G1 arrest through the activation of the ATM-Chk2-p21 pathway in human keratinocyte HaCaT cells. The aim of the current study was to investigate whether ELF-EMFs cause similar effects in a distinct epidermal keratinocyte, primary normal human epidermal keratinocytes (NHEK), by using the same ELF-EMF exposure system and experimental design. We observed that ELF-EMFs exerted no effects on cell growth, cell proliferation, cell cycle distribution, and the activation of ATM signaling pathway in NHEK cells. We demonstrated that the 2 epidermal keratinocytes responded to ELF-EMFs differently. To further validate this finding, we simultaneously exposed the NHEK and HaCaT cells to ELF-EMFs in the same incubator for 168 h and observed the cell growths. The simultaneous exposure of the two cell types results showed that the NHEK and HaCaT cells exhibited distinct responses to ELF-EMFs. Thus, we confirmed that the biological effects of ELF-EMFs in epidermal keratinocytes are cell type specific. Our findings may partially explain the inconsistent results of previous studies when comparing results across various experimental models.	[Huang, Chao-Ying; Chuang, Chun-Yu; Chang, Cheng-Wei; Chen, Chaang-Ray; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Fan, Tai-Ching] Natl Synchrotron Radiat Res Ctr, Magnet Grp, Instrumentat Dev Div, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Synchrotron Radiation Research Center	Hsu, IC (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw		Chen, Chaang-Ray/0000-0003-2106-8699	National Science Council, Taiwan [NSC 101-2112-M-007-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council, Taiwan, for supporting this research financially under Contract (Grant number: NSC 101-2112-M-007-003-MY3, http://web1.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2005, SCIENCE, V308, P510, DOI 10.1126/science.1112069; Trillo MA, 2012, INT J ONCOL, V40, P1405, DOI 10.3892/ijo.2012.1347; Martinez MA, 2012, CELL PHYSIOL BIOCHEM, V29, P675, DOI 10.1159/000178457; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burdak-Rothkamm S, 2009, MUTAT RES-GEN TOX EN, V672, P82, DOI 10.1016/j.mrgentox.2008.10.016; Chang CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073311; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; Gluck B, 2001, Cell Mol Biol (Noisy-le-grand), V47 Online Pub, pOL115; Huang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104732; Huang CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029241; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Isoir M, 2006, J DERMATOL SCI, V41, P55, DOI 10.1016/j.jdermsci.2005.11.008; Ivancsits S, 2005, MUTAT RES-GEN TOX EN, V583, P184, DOI 10.1016/j.mrgentox.2005.03.011; Ivancsits S, 2003, INT ARCH OCC ENV HEA, V76, P431, DOI 10.1007/s00420-003-0446-5; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Lewis DA, 2003, EXP CELL RES, V284, P316, DOI 10.1016/S0014-4827(02)00043-5; Lewis DA, 2003, J INVEST DERMATOL, V120, P483, DOI 10.1046/j.1523-1747.2003.12060.x; Lewis DA, 2006, J INVEST DERMATOL, V126, P1885, DOI 10.1038/sj.jid.5700333; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcantonio P, 2010, BIOELECTROMAGNETICS, V31, P425, DOI 10.1002/bem.20581; Okada S, 2014, J ORAL PATHOL MED; Pastore S, 2011, J DERMATOL SCI, V63, P104, DOI 10.1016/j.jdermsci.2011.04.011; Petit-Frere C, 2000, CARCINOGENESIS, V21, P1087, DOI 10.1093/carcin/21.6.1087; Ramos-Jerz MD, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/391247; Scarfi MR, 2005, RADIAT RES, V164, P270, DOI 10.1667/RR3427.1; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Stronati L, 2004, BIOELECTROMAGNETICS, V25, P41, DOI 10.1002/bem.10141; Van Den Heuvel R, 2001, TOXICOL IN VITRO, V15, P351, DOI 10.1016/S0887-2333(01)00035-2; Vianale G, 2008, BRIT J DERMATOL, V158, P1189, DOI 10.1111/j.1365-2133.2008.08540.x; Vijayalaxmi, 2005, BIOELECTROMAGNETICS, V26, P412, DOI 10.1002/bem.20111; Winker R, 2005, MUTAT RES-GEN TOX EN, V585, P43, DOI 10.1016/j.mrgentox.2005.04.013; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Yoshizawa H, 2002, BIOELECTROMAGNETICS, V23, P355, DOI 10.1002/bem.10006; Zhang L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-78; Zhou J, 2011, BONE, V49, P753, DOI 10.1016/j.bone.2011.06.026	46	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113424	10.1371/journal.pone.0113424	http://dx.doi.org/10.1371/journal.pone.0113424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409520	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200117
J	Leite, NA; Alves-Pereira, A; Correa, AS; Zucchi, MI; Omoto, C				Leite, Natalia A.; Alves-Pereira, Alessandro; Correa, Alberto S.; Zucchi, Maria I.; Omoto, Celso			Demographics and Genetic Variability of the New World Bollworm (Helicoverpa zea) and the Old World Bollworm (Helicoverpa armigera) in Brazil	PLOS ONE			English	Article							LEPIDOPTERA-NOCTUIDAE HELIOTHINAE; MITOCHONDRIAL-DNA; COTTON BOLLWORM; HUBNER LEPIDOPTERA; POPULATION-GROWTH; RESISTANCE; SOFTWARE; IDENTIFICATION; AMPLIFICATION; POLYMORPHISM	Helicoverpa armigera is one of the primary agricultural pests in the Old World, whereas H. zea is predominant in the New World. However, H. armigera was first documented in Brazil in 2013. Therefore, the geographical distribution, range of hosts, invasion source, and dispersal routes for H. armigera are poorly understood or unknown in Brazil. In this study, we used a phylogeographic analysis of natural H. armigera and H. zea populations to (1) assess the occurrence of both species on different hosts; (2) infer the demographic parameters and genetic structure; (3) determine the potential invasion and dispersal routes for H. armigera within the Brazilian territory; and (4) infer the geographical origin of H. armigera. We analyzed partial sequence data from the cytochrome c oxidase subunit I (COI) gene. We determined that H. armigera individuals were most prevalent on dicotyledonous hosts and that H. zea were most prevalent on maize crops, based on the samples collected between May 2012 and April 2013. The populations of both species showed signs of demographic expansion, and no genetic structure. The high genetic diversity and wide distribution of H. armigera in mid-2012 are consistent with an invasion period prior to the first reports of this species in the literature and/or multiple invasion events within the Brazilian territory. It was not possible to infer the invasion and dispersal routes of H. armigera with this dataset. However, joint analyses using sequences from the Old World indicated the presence of Chinese, Indian, and European lineages within the Brazilian populations of H. armigera. These results suggest that sustainable management plans for the control of H. armigera will be challenging considering the high genetic diversity, polyphagous feeding habits, and great potential mobility of this pest on numerous hosts, which favor the adaptation of this insect to diverse environments and control strategies.	[Leite, Natalia A.; Correa, Alberto S.; Omoto, Celso] Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Alves-Pereira, Alessandro] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Zucchi, Maria I.] Agencia Paulista Tecnol Agronegocios, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Omoto, C (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	celso.omoto@usp.br	Correa, Alberto S/C-4683-2014; Zucchi, Maria Imaculada/D-2637-2012; Omoto, Celso/D-9794-2012; Alves-Pereira, Alessandro/I-6595-2012; Zucchi, Maria Imaculada/AAC-8157-2019	Correa, Alberto S/0000-0002-3788-7480; Zucchi, Maria Imaculada/0000-0002-4863-1843; Omoto, Celso/0000-0002-6432-830X; Alves-Pereira, Alessandro/0000-0002-3012-6355; Zucchi, Maria Imaculada/0000-0002-4863-1843	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [308150/2009-0]; Comite Brasileiro de Acao a Resistencia a Inseticidas (IRAC-BR)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Comite Brasileiro de Acao a Resistencia a Inseticidas (IRAC-BR)	This work was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant 308150/2009-0) and Comite Brasileiro de Acao a Resistencia a Inseticidas (IRAC-BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaleke J, 2010, PEST MANAG SCI, V66, P137, DOI 10.1002/ps.1843; Agropec Consultoria, 2013, PRAG QUAR CONS DAD P; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albernaz KC, 2012, B ENTOMOL RES, V102, P333, DOI 10.1017/S0007485311000678; Asokan R, 2012, ORIENT INSECTS, V46, P130, DOI 10.1080/00305316.2012.699264; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; Degrande PE, 2013, CULTIVAR GRANDES CUL, V15, P32; Domingues FA, 2012, J ECON ENTOMOL, V105, P2136, DOI 10.1603/EC12123; Endersby NM, 2007, ENTOMOL EXP APPL, V122, P253, DOI 10.1111/j.1570-7458.2006.00515.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han QF, 2002, ENVIRON ENTOMOL, V31, P462, DOI 10.1603/0046-225X-31.3.462; LASTER ML, 1995, J ECON ENTOMOL, V88, P1288, DOI 10.1093/jee/88.5.1288; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; Li QQ, 2011, MOL BIOL REP, V38, P5107, DOI 10.1007/s11033-010-0658-1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOPEZ JV, 1994, J MOL EVOL, V39, P174; MALLET J, 1993, ANN ENTOMOL SOC AM, V86, P189, DOI 10.1093/aesa/86.2.189; (MAPA) Ministerio da Agricultura Pecuaria e Abastecimento, 2014, COMB PRAG HEL ARM; Martin T, 2000, PEST MANAG SCI, V56, P549, DOI 10.1002/(SICI)1526-4998(200006)56:6<549::AID-PS160>3.0.CO;2-Y; Martin T, 2005, AGR ECOSYST ENVIRON, V107, P409, DOI 10.1016/j.agee.2004.11.006; Matten T, 2002, NCBI HDB; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; Nair R, 2013, CURR SCI INDIA, V104, P215; Nibouche S, 1998, HEREDITY, V80, P438, DOI 10.1046/j.1365-2540.1998.00273.x; Nylander J.A.A, 2004, MRMODELTEST V2; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Pogue MG, 2013, SYST ENTOMOL, V38, P523, DOI 10.1111/syen.12010; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Technelysium Pty Ltd, 1998, CHROM LIT VERS 2 01; TEMPLETON AR, 1992, GENETICS, V132, P619; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; Zhang XP, 2009, J IND MICROBIOL BIOT, V36, P815, DOI 10.1007/s10295-009-0556-5; Zhou XF, 2000, HEREDITY, V85, P251, DOI 10.1046/j.1365-2540.2000.00738.x	51	61	63	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113286	10.1371/journal.pone.0113286	http://dx.doi.org/10.1371/journal.pone.0113286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409452	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200091
J	Moutaoufik, MT; El Fatimy, R; Nassour, H; Gareau, C; Lang, J; Tanguay, RM; Mazroui, R; Khandjian, EW				Moutaoufik, Mohamed Taha; El Fatimy, Rachid; Nassour, Hassan; Gareau, Cristina; Lang, Jerome; Tanguay, Robert M.; Mazroui, Rachid; Khandjian, Edouard W.			UVC-Induced Stress Granules in Mammalian Cells	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; INDUCED DNA-DAMAGE; MESSENGER-RNA; TRANSLATIONAL CONTROL; CYTOPLASMIC GRANULES; HISTONE H2AX; PHOSPHORYLATION; RECRUITMENT; REPAIR; ACTIVATION	Stress granules (SGs) are well characterized cytoplasmic RNA bodies that form under various stress conditions. We have observed that exposure of mammalian cells in culture to low doses of UVC induces the formation of discrete cytoplasmic RNA granules that were detected by immunofluorescence staining using antibodies to RNA-binding proteins. UVC-induced cytoplasmic granules are not Processing Bodies (P-bodies) and are bone fide SGs as they contain TIA-1, TIA-1/R, Caprin1, FMRP, G3BP1, PABP1, well known markers, and mRNA. Concomitant with the accumulation of the granules in the cytoplasm, cells enter a quiescent state, as they are arrested in G1 phase of the cell cycle in order to repair DNA damages induced by UVC irradiation. This blockage persists as long as the granules are present. A tight correlation between their decay and re-entry into S-phase was observed. However the kinetics of their formation, their low number per cell, their absence of fusion into larger granules, their persistence over 48 hours and their slow decay, all differ from classical SGs induced by arsenite or heat treatment. The induction of these SGs does not correlate with major translation inhibition nor with phosphorylation of the a subunit of eukaryotic translation initiation factor 2 (eIF2 alpha). We propose that a restricted subset of mRNAs coding for proteins implicated in cell cycling are removed from the translational apparatus and are sequestered in a repressed form in SGs.	[Moutaoufik, Mohamed Taha; El Fatimy, Rachid; Lang, Jerome; Khandjian, Edouard W.] Univ Laval, Dept Psychiat & Neurosci, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Nassour, Hassan; Gareau, Cristina; Mazroui, Rachid] Univ Laval, Dept Biol Mol Biochim Med & Pathol, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Tanguay, Robert M.] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Lab Genet Cellulaire & Dev, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Khandjian, EW (corresponding author), Univ Laval, Dept Psychiat & Neurosci, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada.	Edward.khandjian@crulrg.ulaval.ca	Fatimy, Rachid El/K-2822-2019	EL FATIMY, Rachid/0000-0002-7652-5562; Moutaoufik, Mohamed Taha/0000-0002-2013-1601	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	This work has been supported by grants from the Canadian Institutes of Health Research (CIHR), and the Natural Sciences and Engineering Research Council of Canada (NSERC) to EWK. MTM holds a studentship from PROTEO, Quebec. RM is a recipient of a CIHR New Investigator Scholarship award and holds an NSERC discovery fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Behrmann J, 2007, DETERMINING ROLE RNA; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Dury AY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003890; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Gaillard H, 2008, MOL BIOL CELL, V19, P4980, DOI 10.1091/mbc.E08-02-0193; Gareau C, 2013, BIOL OPEN, V2, P68, DOI 10.1242/bio.20123012; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Isabelle M, 2012, J CELL SCI, V125, P4555, DOI 10.1242/jcs.106963; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Kruger T, 2013, MOL BIOL CELL, V24, P2098, DOI 10.1091/mbc.E13-01-0068; Kuo LJ, 2008, IN VIVO, V22, P305; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Matthews JD, 2012, J GEN VIROL, V93, P267, DOI 10.1099/vir.0.036780-0; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stoecklin G, 2013, ADV EXP MED BIOL, V768, P197, DOI 10.1007/978-1-4614-5107-5_12; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; TSAI RL, 1973, NATURE-NEW BIOL, V243, P168, DOI 10.1038/newbio243168a0; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013	45	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112742	10.1371/journal.pone.0112742	http://dx.doi.org/10.1371/journal.pone.0112742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409157	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200039
J	Pan, J; Park, TJ; Cutz, E; Yeger, H				Pan, Jie; Park, Thomas J.; Cutz, Ernest; Yeger, Herman			Immunohistochemical Characterization of the Chemosensory Pulmonary Neuroepithelial Bodies in the Naked Mole-Rat Reveals a Unique Adaptive Phenotype	PLOS ONE			English	Article							NEUROENDOCRINE CELLS; HYPOXIA TOLERANCE; SMOOTH-MUSCLE; INNERVATION; INSIGHTS; RODENT; LUNGS; MODEL	The pulmonary neuroepithelial bodies (NEBs) constitute polymodal airway chemosensors for monitoring and signaling ambient gas concentrations (pO(2), pCO(2)/H+) via complex innervation to the brain stem controlling breathing. NEBs produce the bioactive amine, serotonin (5-HT), and a variety of peptides with multiple effects on lung physiology and other organ systems. NEBs in mammals appear prominent and numerous during fetal and neonatal periods, and decline in the postnatal period suggesting an important role during perinatal adaptation. The naked mole-rat (NMR), Heterocephalus glaber, has adapted to the extreme environmental conditions of living in subterranean burrows in large colonies (up to 300 colony mates). The crowded, unventilated burrows are environments of severe hypoxia and hypercapnia. However, NMRs adjust readily to above ground conditions. The chemosensory NEBs of this species were characterized and compared to those of the conventional Wistar rat (WR) to identify similarities and differences that could explain the NMR's adaptability to environments. A multilabel immunohistochemical analysis combined with confocal microscopy revealed that the expression patterns of amine, peptide, neuroendocrine, innervation markers and chemosensor component proteins in NEBs of NMR were similar to that of WR. However, we found the following differences: 1) NEBs in both neonatal and adult NMR lungs were significantly larger and more numerous as compared to WR; 2) NEBs in NMR had a more variable compact cell organization and exhibited significant differences in the expression of adhesion proteins; 3) NMR NEBs showed a significantly greater ratio of 5-HT positive cells with an abundance of 5-HT; 4) NEBs in NMR expressed the proliferating cell nuclear antigen (PCNA) and the neurogenic gene (MASH1) indicating active proliferation and a state of persistent differentiation. Taken together our findings suggest that NEBs in lungs of NMR are in a hyperactive, functional and developmental state, reminiscent of a persistent fetal state that extends postnatally.	[Pan, Jie; Cutz, Ernest; Yeger, Herman] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [Pan, Jie; Cutz, Ernest; Yeger, Herman] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Cutz, Ernest; Yeger, Herman] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto	Yeger, H (corresponding author), Hosp Sick Children, Dept Paediat Lab Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hermie@sickkids.ca			Canadian Institutes of Health Research (CIHR) [MOP-15270]; National Science Foundation (NSF) [0744979]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF)(National Science Foundation (NSF))	The work presented here was supported by an operating grant from Canadian Institutes of Health Research (CIHR; cihr.ca) to EC and HY (MOP-15270) and National Science Foundation (NSF; www.nsf.gov) Grant number 0744979 to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azpurua Jorge, 2013, Frontiers in Genetics, V3, P319, DOI 10.3389/fgene.2012.00319; Brouns I, 2006, AUTON NEUROSCI-BASIC, V126, P307, DOI 10.1016/j.autneu.2006.02.006; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Cutz E, 2013, SEMIN CELL DEV BIOL, V24, P40, DOI 10.1016/j.semcdb.2012.09.003; Cutz E, 2009, ADV EXP MED BIOL, V648, P427, DOI 10.1007/978-90-481-2259-2_49; Edrey YH, 2013, NEUROBIOL AGING, V34, P2352, DOI 10.1016/j.neurobiolaging.2013.03.032; Gladyshev VN, 2011, AGING-US, V3, P1124, DOI 10.18632/aging.100417; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; LaVinka PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045060; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911; Maina JN, 2001, J ZOOL, V253, P371, DOI 10.1017/S0952836901000346; McGovern S, 2010, LAB INVEST, V90, P180, DOI 10.1038/labinvest.2009.135; Miki M, 2012, LUNG CANCER, V75, P58, DOI 10.1016/j.lungcan.2011.05.019; Nathaniel TI, 2009, J INTEGR NEUROSCI, V8, P123, DOI 10.1142/S0219635209002149; Pan J, 2006, AM J RESP CELL MOL, V35, P320, DOI 10.1165/rcmb.2005-0468OC; Pan J, 2012, ADV EXP MED BIOL, V758, P149, DOI 10.1007/978-94-007-4584-1_21; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Peterson BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031568; Peterson BL, 2012, NEUROSCI LETT, V506, P342, DOI 10.1016/j.neulet.2011.11.042; Rodriguez KA, 2011, CURR PHARM DESIGN, V17, P2290; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Wong AP, 2009, CYTOTHERAPY, V11, P676, DOI 10.3109/14653240903313974; Yeger H, 2009, AIRWAY CHEMORECEPTOR, V306, P287	32	6	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112623	10.1371/journal.pone.0112623	http://dx.doi.org/10.1371/journal.pone.0112623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409164	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200029
J	Datta, S; Roy, S; Chatterjee, S; Saha, A; Sen, B; Pal, T; Som, T; Basu, S				Datta, Saswati; Roy, Subhasree; Chatterjee, Somdatta; Saha, Anindya; Sen, Barsha; Pal, Titir; Som, Tapas; Basu, Sulagna			A Five-Year Experience of Carbapenem Resistance in Enterobacteriaceae Causing Neonatal Septicaemia: Predominance of NDM-1	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; GRAM-NEGATIVE BACILLI; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; MULTIPLEX PCR; SEPSIS; GENES; SUSCEPTIBILITY; DETERMINANTS	Treatment of neonatal sepsis has become a challenge with the emergence of carbapenemase-producing bacteria. This study documents the trend of carbapenem susceptibility in Enterobacteriaceae that caused septicaemia in neonates over a five year period (2007-2011) and the molecular characterisation of Enterobacteriaceae resistant to carbapenems and cephalosporins. Hundred and five Enterobacteriaceae including Escherichia coli (n = 27), Klebsiella pneumoniae (n = 68) and Enterobacter spp. (n = 10) were isolated from blood of septicaemic neonates followed by antibiotic susceptibility tests, determination of MIC values, phenotypic and genotypic detection of beta-lactamases. Carbapenem was the most active antimicrobial tested after tigecycline. CTX-M type was the most prevalent ESBL throughout the period (82%). New Delhi Metallo-beta-lactamase-1 (NDM-1), which is a recent addition to the carbapenemase list, was the only carbapenemase identified in our setting. Fourteen percent of the isolates possessed bla(NDM)-(1). Carbapenem non-susceptibility was first observed in 2007 and it was due to loss of Omp F/Ompk36 in combination with the presence of ESBLs/AmpCs. NDM-1 first emerged in E. coli during 2008; later in 2010, the resistance was detected in K. pneumoniae and E. cloacae isolates. NDM-1producing isolates were resistant to other broad-spectrum antibiotics and possessed ESBLs, AmpCs, 16S-rRNA methylases, AAC(69)-Ib-cr, bleomycin resistant gene and class 1 integron. Pulsed field gel electrophoresis of the NDM-1-producing isolates indicated that the isolates were clonally diverse. The study also showed that there was a significantly higher incidence of sepsis caused by NDM-1-harbouring isolates in the male sex, in neonates with low birth weight and neonates born at an extramural centre. However, sepsis with NDM-1-harbouring isolates did not result in a higher mortality rate. The study is the first to review the carbapenem resistance patterns in neonatal sepsis over an extended period of time. The study highlights the persistence of ESBLs (CTX-Ms) and the emergence of NDM-1 in Enterobacteriaceae in the unit.	[Datta, Saswati; Roy, Subhasree; Chatterjee, Somdatta; Basu, Sulagna] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, W Bengal, India; [Saha, Anindya; Sen, Barsha; Som, Tapas] SSKM Hosp, Inst Postgrad Med Educ & Res, Dept Neonatol, Kolkata, W Bengal, India; [Pal, Titir] AbsolutData Res & Analyt, Gurgaon, Haryana, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Basu, S (corresponding author), Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, W Bengal, India.	supabasu@yahoo.co.in	Som, Tapas/GQP-1694-2022; Basu, Sulagna/AAL-5503-2021	Som, Tapas/0000-0002-8356-9125; Basu, Sulagna/0000-0002-7811-7140	Department of Science and Technology (DST), West Bengal; "Indian Council of Medical Research''	Department of Science and Technology (DST), West Bengal(Department of Science & Technology (India)); "Indian Council of Medical Research''(Indian Council of Medical Research (ICMR))	The study was partially supported by a fund from Department of Science and Technology (DST), West Bengal. Saswati Datta is now being supported by a fellowship from "Indian Council of Medical Research'' but earlier she had been supported by a fellowship from Department of Science and Technology (DST), West Bengal. Somdatta Chatterjee has been supported by a fellowship from Department of Biotechnology, India. All other funds required for the study were provided by internal funding (Indian Council of Medical Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co- author Titir Pal is employed by AbsolutData Research and Analytics. AbsolutData Research and Analytics provided support in the form of salary for author TP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions'' section.	BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bercot B, 2011, DIAGN MICR INFEC DIS, V71, P442, DOI 10.1016/j.diagmicrobio.2011.08.016; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Chang YY, 2015, J MICROBIOL IMMUNOL, V48, P219, DOI 10.1016/j.jmii.2014.05.010; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; Coudron PE, 2005, J CLIN MICROBIOL, V43, P4163, DOI 10.1128/JCM.43.8.4163-4167.2005; Das P, 2011, J MED MICROBIOL, V60, P1651, DOI 10.1099/jmm.0.033803-0; Datta S, 2014, J MED MICROBIOL, V63, P480, DOI 10.1099/jmm.0.067223-0; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Jacoby GA, 2004, ANTIMICROB AGENTS CH, V48, P3203, DOI 10.1128/AAC.48.8.3203-3206.2004; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Parveen RM, 2012, INDIAN J MICROBIOL, V52, P35, DOI 10.1007/s12088-011-0140-3; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Patel J. B., 2009, Clinical Microbiology Newsletter, V31, P55, DOI 10.1016/j.clinmicnews.2009.03.005; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P447, DOI 10.1128/AAC.49.1.447-450.2005; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; POLIN RA, 1989, NEW ETHICALS 2, V25, P109; POLIN RA, 1989, NEW ETHICALS 1, V25, P133; Romero L, 2005, CLIN MICROBIOL INFEC, V11, P625, DOI 10.1111/j.1469-0691.2005.01194.x; Roy S, 2010, EUR J CLIN MICROBIOL, V29, P1495, DOI 10.1007/s10096-010-1030-z; Roy S, 2013, INDIAN J MED RES, V137, P791; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Roy S, 2011, J ANTIMICROB CHEMOTH, V66, P2773, DOI 10.1093/jac/dkr376; Roy S, 2011, J ANTIMICROB CHEMOTH, V66, P1411, DOI 10.1093/jac/dkr068; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Shakil S, 2010, J MED MICROBIOL, V59, P948, DOI 10.1099/jmm.0.020214-0; Shibata N, 2003, J CLIN MICROBIOL, V41, P5407, DOI 10.1128/JCM.41.12.5407-5413.2003; Stuart JC, 2010, INT J ANTIMICROB AG, V36, P205, DOI 10.1016/j.ijantimicag.2010.05.014; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tsai MH, 2014, CLIN MICROBIOL INFEC, V20, pO928, DOI 10.1111/1469-0691.12661; Viswanathan R, 2012, ARCH DIS CHILD-FETAL, V97, pF182, DOI 10.1136/archdischild-2011-300097; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	41	53	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112101	10.1371/journal.pone.0112101	http://dx.doi.org/10.1371/journal.pone.0112101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406074	Green Published, gold			2022-12-27	WOS:000347121300023
J	Huang, XL; Gao, Y; Qin, JJ; Lu, S				Huang, Xinli; Gao, Yun; Qin, Jianjie; Lu, Sen			The Role of miR-34a in the Hepatoprotective Effect of Hydrogen Sulfide on Ischemia/Reperfusion Injury in Young and Old Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SIGNALING MOLECULE; LIVER; MICRORNAS; NRF2; PATHWAY; DEATH	Hydrogen sulfide (H2S) can protect the liver against ischemia-reperfusion (I/R) injury. However, it is unknown whether H2S plays a role in the protection of hepatic I/R injury in both young and old patients. This study compared the protective effects of H2S in a rat model (young and old animals) of I/R injury and the mechanism underlying its effects. Young and old rats were assessed following an injection of NaHS. NaHS alone reduced hepatic I/R injury in the young rats by activating the nuclear erythroid-related factor 2 (Nrf2) signaling pathway, but it had little effect on the old rats. NaHS pretreatment decreased miR-34a expression in the hepatocytes of the young rats with hepatic I/R. Overexpresion of miR-34a decreased Nrf-2 and its downstream target expression, impairing the hepatoprotective effect of H2S on the young rats. More importantly, downregulation of miR-34a expression increased Nrf-2 and the expression of its downstream targets, enhancing the effect of H2S on hepatic I/R injury in the old rats. This study reveals the different effects of H2S on hepatic I/R injury in young and old rats and sheds light on the involvement of H2S in miR-34a modulation of the Nrf-2 pathway.	[Huang, Xinli; Gao, Yun; Qin, Jianjie; Lu, Sen] Nanjing Med Univ, Affiliated Hosp 1, Ctr Liver Transplantat, Key Lab Living Donor Liver Transplantat,Minist Hl, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Lu, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Ctr Liver Transplantat, Key Lab Living Donor Liver Transplantat,Minist Hl, Nanjing, Jiangsu, Peoples R China.	senlusen@163.com			Priority Academic Program of Jiangsu Higher Education Institutions	Priority Academic Program of Jiangsu Higher Education Institutions	This work was supported by grant from the Priority Academic Program of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrevoet F, 2003, ACTA CHIR BELG, V103, P485; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Cheng XH, 2013, FREE RADICAL BIO MED, V64, P4, DOI 10.1016/j.freeradbiomed.2013.07.025; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Guo W, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/878052; Henderson PW, 2010, J GASTROEN HEPATOL, V25, P1642, DOI 10.1111/j.1440-1746.2010.06380.x; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jaeschke H, 2012, TRANSPLANT REV-ORLAN, V26, P103, DOI 10.1016/j.trre.2011.10.006; Ke BB, 2013, J HEPATOL, V59, P1200, DOI 10.1016/j.jhep.2013.07.016; Kimura H, 2013, NEUROCHEM INT, V63, P492, DOI 10.1016/j.neuint.2013.09.003; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Lu YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093013; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Papadopoulos D, 2013, ARCH TRAUMA RES, V2, P63, DOI 10.5812/atr.12501; Park SY, 2013, TOXICOL APPL PHARM, V268, P68, DOI 10.1016/j.taap.2013.01.017; Peake BF, 2013, AM J PHYSIOL-HEART C, V304, pH1215, DOI 10.1152/ajpheart.00796.2012; Sahin K, 2014, NUTR CANC; Schiesser M, 2009, J SURG RES, V152, P61, DOI 10.1016/j.jss.2008.01.007; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Tanaka Y, 2007, MOL PHARMACOL, V71, P817, DOI 10.1124/mol.106.029033; Tulsawani R, 2013, INDIAN J PHARMACOL, V45, P258, DOI 10.4103/0253-7613.111943; van der Bilt JDW, 2008, ANN SURG ONCOL, V15, P1392, DOI 10.1245/s10434-007-9758-0; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Zeng T, 2013, BBA-GEN SUBJECTS, V1830, P4848, DOI 10.1016/j.bbagen.2013.06.028; Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074422	31	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113305	10.1371/journal.pone.0113305	http://dx.doi.org/10.1371/journal.pone.0113305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405338	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300101
J	Lowrie, R; Lloyd, SM; McConnachie, A; Morrison, J				Lowrie, Richard; Lloyd, Suzanne M.; McConnachie, Alex; Morrison, Jill			A Cluster Randomised Controlled Trial of a Pharmacist-Led Collaborative Intervention to Improve Statin Prescribing and Attainment of Cholesterol Targets in Primary Care	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; GENERAL-PRACTICE; STROKE PREVENTION; BLOOD-PRESSURE; HIGH-RISK; MANAGEMENT; GUIDELINES; EDUCATION; PRESCRIPTION; MEDICATION	Background: Small trials with short term follow up suggest pharmacists' interventions targeted at healthcare professionals can improve prescribing. In comparison with clinical guidance, contemporary statin prescribing is sub-optimal and achievement of cholesterol targets falls short of accepted standards, for patients with atherosclerotic vascular disease who are at highest absolute risk and who stand to obtain greatest benefit. We hypothesised that a pharmacist-led complex intervention delivered to doctors and nurses in primary care, would improve statin prescribing and achievement of cholesterol targets for incident and prevalent patients with vascular disease, beyond one year. Methods: We allocated general practices to a 12-month Statin Outreach Support (SOS) intervention or usual care. SOS was delivered by one of 11 pharmacists who had received additional training. SOS comprised academic detailing and practical support to identify patients with vascular disease who were not prescribed a statin at optimal dose or did not have cholesterol at target, followed by individualised recommendations for changes to management. The primary outcome was the proportion of patients achieving cholesterol targets. Secondary outcomes were: the proportion of patients prescribed simvastatin 40 mg with target cholesterol achieved; cholesterol levels; prescribing of simvastatin 40 mg; prescribing of any statin and the proportion of patients with cholesterol tested. Outcomes were assessed after an average of 1.7 years (range 1.4-2.2 years), and practice level simvastatin 40 mg prescribing was assessed after 10 years. Findings: We randomised 31 practices (72 General Practitioners (GPs), 40 nurses). Prior to randomisation a subset of eligible patients were identified to characterise practices; 40% had cholesterol levels below the target threshold. Improvements in data collection procedures allowed identification of all eligible patients (n = 7586) at follow up. Patients in practices allocated to SOS were significantly more likely to have cholesterol at target (69.5% vs 63.5%; OR 1.11, CI 1.00-1.23; p = 0.043) as a result of improved simvastatin prescribing. Subgroup analysis showed the primary outcome was achieved by prevalent but not incident patients. Statistically significant improvements occurred in all secondary outcomes for prevalent patients and all but one secondary outcome (the proportion of patients with cholesterol tested) for incident patients. SOS practices prescribed more simvastatin 40 mg than usual care practices, up to 10 years later. Interpretation: Through a combination of educational and organisational support, a general practice based pharmacist led collaborative intervention can improve statin prescribing and achievement of cholesterol targets in a high-risk primary care based population.	[Lowrie, Richard] NHS Greater Glasgow & Clyde, Pharm & Prescribing Support Unit, Glasgow, Lanark, Scotland; [Lloyd, Suzanne M.; McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Morrison, Jill] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Lowrie, R (corresponding author), NHS Greater Glasgow & Clyde, Pharm & Prescribing Support Unit, Glasgow, Lanark, Scotland.	Richard.Lowrie@ggc.scot.nhs.uk		Lowrie, Richard/0000-0002-6440-9089	NHS Greater Glasgow and Clyde	NHS Greater Glasgow and Clyde	The study was funded and sponsored by NHS Greater Glasgow and Clyde. The study sponsor had no role in the study design, delivery, analyses or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PHYS COMPLIANCE PUBL; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Avorn J, 2011, NEW ENGL J MED, V364, P1185, DOI 10.1056/NEJMp1011713; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Beney J., 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000336; Bloom BS, 2005, INT J TECHNOL ASSESS, V21, P380, DOI 10.1017/S026646230505049X; Brufsky JW, 1998, MED CARE, V36, P321, DOI 10.1097/00005650-199803000-00009; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Carter BL, 2010, CIRC-CARDIOVASC QUAL, V3, P418, DOI 10.1161/CIRCOUTCOMES.109.908038; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Charrois TL, 2012, PHARMACOTHERAPY, V32, P222, DOI 10.1002/j.1875-9114.2012.01022.x; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Department of Health, 2004, QOF GUID; DESANTIS G, 1994, MED J AUSTRALIA, V160, P502; DIWAN VK, 1995, J CLIN EPIDEMIOL, V48, P705, DOI 10.1016/0895-4356(94)00221-B; Donner-Banzhoff N, 2008, BMJ-BRIT MED J, V336, P288, DOI 10.1136/bmj.39387.573947.80; Fairhurst K, 1998, BMJ-BRIT MED J, V317, P1130; FEDER G, 1995, BRIT MED J, V311, P1473, DOI 10.1136/bmj.311.7018.1473; Figueiras A, 2001, J EVAL CLIN PRACT, V7, P223, DOI 10.1046/j.1365-2753.2001.00234.x; Fleetcroft R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-131; Foy R, 2001, FAM PRACT, V18, P353, DOI 10.1093/fampra/18.4.353; Fretheim A, 2006, PLOS MED, V3, P783, DOI 10.1371/journal.pmed.0030134; GARDNER SF, 1995, PHARMACOTHERAPY, V15, P292; Gerada C, 2012, PATIENTS DOCTORS NHS; Goldberg H I, 1998, Jt Comm J Qual Improv, V24, P130; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Haynes B, 1998, BMJ-BRIT MED J, V317, P273, DOI 10.1136/bmj.317.7153.273; Holland R, 2008, BRIT J CLIN PHARMACO, V65, P303, DOI 10.1111/j.1365-2125.2007.03071.x; Hulscher MEJL, 1998, INT J QUAL HEALTH C, V10, P105, DOI 10.1093/intqhc/10.2.105; Ilett KF, 2000, BRIT J CLIN PHARMACO, V49, P168, DOI 10.1046/j.1365-2125.2000.00123.x; Jaffray M, 2007, FAM PRACT, V24, P189, DOI 10.1093/fampra/cml075; Joseph LN, 1999, STROKE, V30, P16, DOI 10.1161/01.STR.30.1.16; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kucukarslan SN, 2011, AM J HEALTH-SYST PH, V68, P335, DOI 10.2146/ajhp100405; Kumar Amit, 2009, Crit Pathw Cardiol, V8, P104, DOI 10.1097/HPC.0b013e3181b8395d; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Liew D, 2012, PRIMARY CARE CARDIOV, V5, P127; Lowrie R, 2012, EUR HEART J, V33, P314, DOI 10.1093/eurheartj/ehr433; Lowrie R, 2010, CONTEMP CLIN TRIALS, V31, P303, DOI 10.1016/j.cct.2010.03.010; Mason J, 2001, JAMA-J AM MED ASSOC, V286, P2988, DOI 10.1001/jama.286.23.2988; McAlister FA, 2014, CAN MED ASSOC J, V186, P577, DOI 10.1503/cmaj.140053; Medical Research Council, 2011, DEV EV COMPL INT NEW; Mouradian MS, 2002, STROKE, V33, P1656, DOI 10.1161/01.STR.0000017877.62543.14; MULLEN PD, 1985, PREV MED, V14, P753, DOI 10.1016/0091-7435(85)90070-2; National Institute for Health and Care Excellence, 2008, CARD RISK ASS MOD BL; National Institute for Health and Clinical Excellence, 2008, STAT PREV CARD EV, V94; National prescribing Centre and NHS Executive, 1998, GP PRESCR SUPP RES D; New JP, 2004, DIABETIC MED, V21, P599, DOI 10.1111/j.1464-5491.2004.01213.x; NEWTONSYMS FAO, 1992, BRIT J CLIN PHARMACO, V33, P69, DOI 10.1111/j.1365-2125.1992.tb04002.x; Nilsson G, 2001, EUR J CLIN PHARMACOL, V56, P843, DOI 10.1007/s002280000242; Nkansah N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000336.pub2; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Pande S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010398; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; Pittman DG, 2012, AM J CARDIOL, V110, P1459, DOI 10.1016/j.amjcard.2012.07.008; Rognstad S, 2013, BRIT J GEN PRACT, V63, pE554, DOI 10.3399/bjgp13X670688; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Santschi V, 2011, ARCH INTERN MED, V171, P1441, DOI 10.1001/archinternmed.2011.399; SCHAFFNER W, 1983, JAMA-J AM MED ASSOC, V250, P1728, DOI 10.1001/jama.250.13.1728; SOUMERAI SB, 1987, MED CARE, V25, P210, DOI 10.1097/00005650-198703000-00005; STEELE MA, 1989, DICP ANN PHARMAC, V23, P497, DOI 10.1177/106002808902300612; Thomson MA, 2005, COCHRANE DATABASE SY, V3; Thomson O'Brien MA, 2002, COCHRANE LIB, V1, P1; Tomlinson J, 2008, SHAPE PRIMARY CARE N; Tsuyuki RT, 2002, ARCH INTERN MED, V162, P1149, DOI 10.1001/archinte.162.10.1149; van de Steeg-van Gompel CH, 2012, EUR J PREV CARDIOL, V19, P169; Villeneuve J, 2010, CAN MED ASSOC J, V182, P447, DOI 10.1503/cmaj.090533; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466; Welschen I, 2004, BRIT MED J, V329, P431, DOI 10.1136/bmj.38182.591238.EB; Witt K, 2004, FAM PRACT, V21, P248, DOI 10.1093/fampra/cmh306; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Zwar N, 1999, FAM PRACT, V16, P495, DOI 10.1093/fampra/16.5.495	77	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113370	10.1371/journal.pone.0113370	http://dx.doi.org/10.1371/journal.pone.0113370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405478	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000347121300109
J	Worker, A; Blain, C; Jarosz, J; Chaudhuri, KR; Barker, GJ; Williams, SCR; Brown, RG; Leigh, PN; Dell'Acqua, F; Simmons, A				Worker, Amanda; Blain, Camilla; Jarosz, Jozef; Chaudhuri, K. Ray; Barker, Gareth J.; Williams, Steve C. R.; Brown, Richard G.; Leigh, P. Nigel; Dell'Acqua, Flavio; Simmons, Andrew			Diffusion Tensor Imaging of Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy: A Tract-Based Spatial Statistics Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CORTICOBASAL DEGENERATION; DIAGNOSTIC-CRITERIA; CLINICAL-DIAGNOSIS; BRAIN PATHOLOGY; PATTERNS; VARIANT; DAMAGE; PSP	Although often clinically indistinguishable in the early stages, Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) have distinct neuropathological changes. The aim of the current study was to identify white matter tract neurodegeneration characteristic of each of the three syndromes. Tract-based spatial statistics (TBSS) was used to perform a whole-brain automated analysis of diffusion tensor imaging (DTI) data to compare differences in fractional anisotropy (FA) and mean diffusivity (MD) between the three clinical groups and healthy control subjects. Further analyses were conducted to assess the relationship between these putative indices of white matter microstructure and clinical measures of disease severity and symptoms. In PSP, relative to controls, changes in DTI indices consistent with white matter tract degeneration were identified in the corpus callosum, corona radiata, corticospinal tract, superior longitudinal fasciculus, anterior thalamic radiation, superior cerebellar peduncle, medial lemniscus, retrolenticular and anterior limb of the internal capsule, cerebral peduncle and external capsule bilaterally, as well as the left posterior limb of the internal capsule and the right posterior thalamic radiation. MSA patients also displayed differences in the body of the corpus callosum corticospinal tract, cerebellar peduncle, medial lemniscus, anterior and superior corona radiata, posterior limb of the internal capsule external capsule and cerebral peduncle bilaterally, as well as the left anterior limb of the internal capsule and the left anterior thalamic radiation. No significant white matter abnormalities were observed in the PD group. Across groups, MD correlated positively with disease severity in all major white matter tracts. These results show widespread changes in white matter tracts in both PSP and MSA patients, even at a mid-point in the disease process, which are not found in patients with PD.	[Worker, Amanda; Blain, Camilla; Chaudhuri, K. Ray; Barker, Gareth J.; Williams, Steve C. R.; Brown, Richard G.; Dell'Acqua, Flavio; Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Worker, Amanda; Chaudhuri, K. Ray; Williams, Steve C. R.; Brown, Richard G.; Dell'Acqua, Flavio; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London WC2R 2LS, England; [Worker, Amanda; Chaudhuri, K. Ray; Williams, Steve C. R.; Brown, Richard G.; Dell'Acqua, Flavio; Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Worker, Amanda; Chaudhuri, K. Ray; Brown, Richard G.; Dell'Acqua, Flavio; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Unit Dementia, London WC2R 2LS, England; [Blain, Camilla; Jarosz, Jozef; Chaudhuri, K. Ray] Kings Coll Hosp London, London, England; [Leigh, P. Nigel] Univ Sussex, Trafford Ctr Biomed Res, Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Brighton; University of Sussex	Simmons, A (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	andy.simmons@kcl.ac.uk	Dell'Acqua, Flavio/I-1407-2012; Williams, Steve C/D-6979-2011; Simmons, Andrew/B-8848-2008; Leigh, Peter/AAD-5638-2019; Brown, Richard G/A-9599-2010; Barker, Gareth J/C-9616-2009	Williams, Steve C/0000-0003-4299-1941; Simmons, Andrew/0000-0003-2306-5811; Brown, Richard G/0000-0001-9021-0172; Barker, Gareth J/0000-0002-5214-7421; Dell'Acqua, Flavio/0000-0001-5313-5476; Ray Chaudhuri, K/0000-0003-2815-0505; opoku, anita/0000-0001-7243-8157	NIHR Biomedical Research Centre for Mental Health; NIHR Biomedical Research Unit for Dementia at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit for Dementia at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	Support for this study was provided by the NIHR Biomedical Research Centre for Mental Health and NIHR Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2014, J NEUROL, V261, P913, DOI 10.1007/s00415-014-7301-3; Agosta F, 2012, NEUROBIOL AGING, V33, P2817, DOI 10.1016/j.neurobiolaging.2012.02.002; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Boxer AL, 2006, ARCH NEUROL-CHICAGO, V63, P81, DOI 10.1001/archneur.63.1.81; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brenneis C, 2004, J NEUROL NEUROSUR PS, V75, P246; Caso F, 2014, NEUROLOGY, V82; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Ishizawa K, 2004, J NEUROPATH EXP NEUR, V63, P43, DOI 10.1093/jnen/63.1.43; Ishizawa K, 2001, J NEUROPATH EXP NEUR, V60, P647, DOI 10.1093/jnen/60.6.647; Ito S, 2008, NEURORADIOLOGY, V50, P981, DOI 10.1007/s00234-008-0447-x; Josephs KA, 2013, MOVEMENT DISORD, V28, P1117, DOI 10.1002/mds.25437; Klegeris A, 1997, J NEUROSCI RES, V49, P229, DOI 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W; Knake S, 2010, MOVEMENT DISORD, V25, P1232, DOI 10.1002/mds.23054; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Mattis S, 1988, DEMENTIA RATING SCAL; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Paviour DC, 2007, MOVEMENT DISORD, V22, P68, DOI 10.1002/mds.21204; Payan CAM, 2002, MOVEMENT DISORD, V17, pS256; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Price S, 2004, NEUROIMAGE, V23, P663, DOI 10.1016/j.neuroimage.2004.06.013; Prodoehl J, 2013, MOVEMENT DISORD, V28, P1816, DOI 10.1002/mds.25491; Rizzo G, 2008, BRAIN, V131, P2690, DOI 10.1093/brain/awn195; Schocke MFH, 2002, NEUROLOGY, V58, P575, DOI 10.1212/WNL.58.4.575; Schwab R.S., 1969, 3 S PARK DIS, P152; Seppi K, 2006, MOVEMENT DISORD, V21, P847, DOI 10.1002/mds.20843; Simmons A, 1999, MAGNET RESON MED, V41, P1274, DOI 10.1002/(SICI)1522-2594(199906)41:6<1274::AID-MRM27>3.0.CO;2-1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Tsuboi Y, 2003, NEUROLOGY, V60, P1766, DOI 10.1212/01.WNL.0000068011.21396.F4; Tsukamoto K, 2012, NEURORADIOLOGY, V54, P947, DOI 10.1007/s00234-012-1009-9; Whitwell JL, 2011, ARCH NEUROL-CHICAGO, V68, P753, DOI 10.1001/archneurol.2011.107	47	55	56	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112638	10.1371/journal.pone.0112638	http://dx.doi.org/10.1371/journal.pone.0112638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405990	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000347121300043
J	Yamada, A; Cox, MA; Gaffney, KA; Moreland, A; Boland, CR; Goel, A				Yamada, Atsushi; Cox, Mary A.; Gaffney, Kristin A.; Moreland, Amber; Boland, C. Richard; Goel, Ajay			Technical Factors Involved in the Measurement of Circulating MicroRNA Biomarkers for the Detection of Colorectal Neoplasia	PLOS ONE			English	Article							DIAGNOSTIC-MARKER; LUNG-CANCER; PLASMA; CHALLENGES; SIGNATURES; EXPRESSION; MIR-21; SERUM	Background: Circulating miRNAs are emerging as promising blood-based biomarkers for colorectal and other human cancers; however, technical factors that confound the development of these assays remain poorly understood and present a clinical challenge. The aim of this study was to systematically evaluate the effects of factors that may interfere with the accurate measurement of circulating miRNAs for clinical purposes. Methods: Blood samples from 53 subjects, including routinely drawn serum samples, matched plasma from 30 subjects, and matched serum samples drawn before and after bowel preparation for colonoscopy from 29 subjects were collected. Additionally, 38 serum specimens stored in the clinical laboratory for seven days were used to test the stability of miRNAs. Hemolysis controls with serial dilutions of hemoglobin were prepared. RNA was extracted from serum, plasma or hemolyzed controls with spiked-in cel-miR-39, and levels of miR-21, miR-29a, miR-125b and miR-16 were examined by real-time RT-PCR. Hemolysis was measured by spectrophotometry. Results: The expression levels of miR-16 and the degree of hemolysis were significantly higher in plasma than in serum (P<0.0001). Measured miR-21, miR-29a, miR-125b and miR-16 expression increased with hemoglobin levels in hemolyzed controls. The degree of hemolysis in serum samples correlated significantly with the levels of miR-21 (P<0.0001), miR-29a (P = 0.0002), miR-125b (P<0.0001) and miR-16 (P<0.0001). All four miRNAs showed significantly lower levels in sera that had been stored at 4 degrees C for seven days (P<0.0001). Levels of miR-21 (P<0.0001), miR-29a (P<0.0001) and miR-16 (P = 0.0003), and the degree of hemolysis (P = 0.0002) were significantly higher in sera drawn after vs. before bowel preparation. Conclusions: The measured levels of miRNAs in serum and plasma from same patients varied in the presence of hemolysis, and since hemolysis and other factors affected miRNA expression, it is important to consider these confounders while developing miRNA-based diagnostic assays.	[Yamada, Atsushi; Cox, Mary A.; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab, Dallas, TX 75246 USA; [Yamada, Atsushi; Cox, Mary A.; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA; [Gaffney, Kristin A.; Moreland, Amber] Baylor Univ, Med Ctr, Dept Internal Med, Dallas, TX USA	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Boland, CR (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab, Dallas, TX 75246 USA.	rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu		Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [R01 CA72851, CA 181572]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA072851, R01CA181572] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA 181572 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; CRIPPS CM, 1968, J CLIN PATHOL, V21, P110, DOI 10.1136/jcp.21.1.110; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Fortunato O, 2014, MOLECULES, V19, P3038, DOI 10.3390/molecules19033038; Giraldez MD, 2013, CLIN GASTROENTEROL H, V11, P681, DOI 10.1016/j.cgh.2012.12.009; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Kanaan Z, 2012, ANN SURG, V256, P544, DOI 10.1097/SLA.0b013e318265bd6f; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561	27	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112481	10.1371/journal.pone.0112481	http://dx.doi.org/10.1371/journal.pone.0112481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405754	Green Submitted, gold, Green Published			2022-12-27	WOS:000347121300034
J	Zhang, F; Wang, XT; Qiu, XC; Wang, JJ; Fang, H; Wang, ZH; Sun, Y; Xia, ZF				Zhang, Fang; Wang, Xingtong; Qiu, Xiaochen; Wang, Junjie; Fang, He; Wang, Zhihong; Sun, Yu; Xia, Zhaofan			The Protective Effect of Esculentoside A on Experimental Acute Liver Injury in Mice	PLOS ONE			English	Article							ACUTE LUNG INJURY; NF-KAPPA-B; CARBON-TETRACHLORIDE; OXIDATIVE STRESS; APOPTOSIS; MODEL; LIPOPOLYSACCHARIDE; HEPATOTOXICITY; INTERLEUKIN-1; ACTIVATION	Inflammatory response and oxidative stress are considered to play an important role in the development of acute liver injury induced by carbon tetrachloride (CCl4) and galactosamine (GalN)/lipopolysaccharides (LPS). Esculentoside A (EsA), isolated from the Chinese herb phytolacca esculenta, has the effect of modulating immune response, cell proliferation and apoptosis as well as anti-inflammatory effects. The present study is to evaluate the protective effect of EsA on CCl4 and GalN/LPS-induced acute liver injury. In vitro, CCK-8 assays showed that EsA had no cytotoxicity, while it significantly reduced levels of TNF-alpha and cell death rate challenged by CCl4. Moreover, EsA treatment up-regulated PPAR-c expression of LO2 cells and reduced levels of reactive oxygen species (ROS) challenged by CCl4. In vivo, EsA prevented mice from CCl4-induced liver histopathological damage. In addition, levels of AST and ALT were significantly decreased by EsA treatment. Furthermore, the mice treated with EsA had a lower level of TNF-alpha, Interleukin (IL)-1 beta and IL-6 in mRNA expression. EsA prevented MDA release and increased GSH-Px activity in liver tissues. Immunohistochemical staining showed that over-expression of F4/80 and CD11b were markedly inhibited by EsA. The western bolt results showed that EsA significantly inhibited CCl4-induced phosphonated IkBalpha (P-I kappa B) and ERK. Furthermore, EsA treatment also alleviated GalN/LPS-induced acute liver injury on liver enzyme and histopathological damage. Unfortunately, our results exhibited that EsA had no effects on CCl4-induced hepatocyte apoptosis which were showed by TUNEL staining and Bax, Caspase-3 and cleaved Caspase-3 expression. Our results proved that EsA treatment attenuated CCl4 and GalN/LPS-induced acute liver injury in mice and its protective effects might be involved in inhibiting inflammatory response and oxidative stress, but not apoptosis with its underlying mechanism associated with PPAR-gamma, NF-kappa B and ERK signal pathways.	[Zhang, Fang; Wang, Xingtong; Wang, Junjie; Fang, He; Wang, Zhihong; Sun, Yu; Xia, Zhaofan] Second Mil Med Univ, Changhai Hosp, Dept Burn Surg, Shanghai, Peoples R China; [Zhang, Fang] 73901 Troop PLA, Shanghai, Peoples R China; [Qiu, Xiaochen] 309th Hosp PLA, Dept Gen Surg, Beijing, Peoples R China	Naval Medical University	Xia, ZF (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Burn Surg, Shanghai, Peoples R China.	xiazhaofan@163.com		Xia, Zhaofan/0000-0002-0806-1508	National Natural Science Foundation of China [81120108015]; National "973'' key project of China [2012CB518100]; 1255 Foundation of Changhai Hospital [CH125510200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "973'' key project of China(National Basic Research Program of China); 1255 Foundation of Changhai Hospital	This work was financially supported by the key project of the National Natural Science Foundation of China (No. 81120108015), the National "973'' key project of China (No. 2012CB518100) and the 1255 Foundation of Changhai Hospital (No. CH125510200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhondave PD, 2014, J ETHNOPHARMACOL, V151, P183, DOI 10.1016/j.jep.2013.10.025; Cui YM, 2014, MOLECULES, V19, P291, DOI 10.3390/molecules19010291; Domitrovic R, 2011, TOXICOLOGY, V280, P33, DOI 10.1016/j.tox.2010.11.005; El-Naggar SA, 2014, PHARM BIOL; Fan Q, 2013, EUR REV MED PHARMACO, V17, P3296; Hagiwara S, 2008, CRIT CARE MED, V36, P2407, DOI 10.1097/CCM.0b013e318180b3ba; He DK, 2014, INHAL TOXICOL, V26, P185, DOI 10.3109/08958378.2013.872213; Hu ZL, 2010, INT IMMUNOPHARMACOL, V10, P65, DOI 10.1016/j.intimp.2009.09.022; Hydes T, 2014, BMJ CASE REP; Ju DW, 1998, PHARMACOLOGY, V56, P187, DOI 10.1159/000028197; Jun F, 1992, Mediators Inflamm, V1, P375, DOI 10.1155/S0962935192000565; Kaneko M, 2013, J TOXICOL SCI, V38, P115, DOI 10.2131/jts.38.115; Li WQ, 2013, INT IMMUNOPHARMACOL, V16, P248, DOI 10.1016/j.intimp.2013.02.022; Liu CM, 2013, J AGR FOOD CHEM, V61, P1146, DOI 10.1021/jf304562b; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Ma HL, 2013, ARCH MED SCI, V9, P354, DOI 10.5114/aoms.2012.31439; Ma JQ, 2014, FOOD CHEM TOXICOL, V64, P41, DOI 10.1016/j.fct.2013.11.017; Man X, 2014, TUMOUR BIOL; Montanari RM, 2012, MOLECULES, V17, P9728, DOI 10.3390/molecules17089728; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Patel RP, 2014, WORLD J HEPATOL, V6, P1, DOI 10.4254/wjh.v6.i1.1; Sato A, 2014, PLOS ONE, V25; Seki A, 2013, HEPATOLOGY, V58, P1133, DOI 10.1002/hep.26470; Sun F, 2001, BBA-MOL BASIS DIS, V1535, P186, DOI 10.1016/S0925-4439(00)00098-3; Sun HY, 2011, J HEPATOL, V54, P471, DOI 10.1016/j.jhep.2010.08.011; Tao LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026055; Wang Y, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/153902; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wu F, 2007, BIOORG MED CHEM LETT, V17, P6430, DOI 10.1016/j.bmcl.2007.10.006; Wu Hai-Jian, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3633; Xiao ZY, 2006, INT J RADIAT ONCOL, V65, P882, DOI 10.1016/j.ijrobp.2006.01.031; Xiao ZW, 2002, ACTA PHARMACOL SIN, V23, P638; Xiao ZY, 2004, ACTA PHARMACOL SIN, V25, P817; Yin GJ, 2011, FISH PHYSIOL BIOCHEM, V37, P209, DOI 10.1007/s10695-010-9436-1; Yu H, 2014, INT IMMUNOPHARMACOL; Zhong WT, 2013, J SURG RES, V185, P364, DOI 10.1016/j.jss.2013.05.018; Zhou RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023079	37	46	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113107	10.1371/journal.pone.0113107	http://dx.doi.org/10.1371/journal.pone.0113107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405982	Green Submitted, gold, Green Published			2022-12-27	WOS:000347121300078
J	Antero-Jacquemin, J; Desgorces, FD; Dor, F; Sedeaud, A; Haida, A; LeVan, P; Toussaint, JF				Antero-Jacquemin, Juliana; Desgorces, Francois Deni; Dor, Frederic; Sedeaud, Adrien; Haida, Amal; LeVan, Philippe; Toussaint, Jean-Francois			Row for Your Life: A Century of Mortality Follow-Up of French Olympic Rowers	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; LONGEVITY; SPORTS; RISK; POPULATION; EXPECTANCY; MEDICINE; SURVIVAL; EXERCISE	Background/Aim: Strenuous endurance training required to participate in the highest sports level has been associated with deleterious effects on elite athletes' health and cardiac abnormalities. We aimed to describe overall mortality and main causes of deaths of male French rowers participating in at least one Olympic Game (OG) from 1912 to 2012 in comparison with the French general population. Methods: Identity information and vital status of French Olympic rowers were validated by National sources from 1912 to 2013 (study's endpoint) among 203 rowers; 52 out of 255 (20.3%) were excluded because their vital statuses could not be confirmed. Main causes of deaths were obtained from the National registry from 1968 up to 2012. Overall and disease-specific mortalities were calculated through standardised mortality ratios (SMRs) with its 95% confidence intervals (CIs). The overall mortality was calculated for the whole rowers' cohort (PT) and for two periods apart: (P1) including rowers from 1912 to 1936 OG, a cohort in which all rowers have deceased and (P2) considering rowers from 1948 to 2012 OG. Results: Among the 203 rowers analysed, 46 died before the study's endpoint, mainly from neoplasms (33%), cardiovascular diseases (21%) and external causes (18%). PT demonstrates a significant 42% lower overall mortality (SMR: 0.58, 95% CI: 0.43-0.78, p<0.001), P1 a 37% reduction (SMR: 0.63, 95% CI: 0.43-0.89, p = 0.009) and P2 a 60% reduction (SMR: 0.40, 95% CI: 0.23-0.65, p<0.001) compared with their compatriots. Mortality due to cardiovascular diseases is significantly reduced (SMR: 0.41, 95% CI: 0.16-0.84, p = 0.01) among rowers. Conclusions: French Olympic rowers benefit of lower overall mortality compared with the French general population. Among rowers' main causes of death, cardiovascular diseases are reduced in relation to their compatriots. Analytical studies with larger samples are needed to understand the reasons for such reductions.	[Antero-Jacquemin, Juliana; Desgorces, Francois Deni; Dor, Frederic; Sedeaud, Adrien; Haida, Amal; Toussaint, Jean-Francois] INSEP, Inst Rech Biomed & Epidemiol Sport IRMES, Paris, France; [Antero-Jacquemin, Juliana; Desgorces, Francois Deni; Toussaint, Jean-Francois] Univ Paris 05, Sorbonne Paris Cite, EA 7329, Paris, France; [LeVan, Philippe] CNOSF, Med Commiss, Paris, France; [LeVan, Philippe] INSEP, Dept Med, Paris, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, Ctr Invest Med Sport, F-75181 Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis; Sanofi France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Antero-Jacquemin, J (corresponding author), INSEP, Inst Rech Biomed & Epidemiol Sport IRMES, Paris, France.	juliana.antero@insep.fr		Sedeaud, Adrien/0000-0002-8492-3579; Antero, Juliana/0000-0001-6894-6693	Ministry of Sports, Youth, Popular Education and Community life of France [12-R-10]	Ministry of Sports, Youth, Popular Education and Community life of France	This work was supported by a grant from the Ministry of Sports, Youth, Popular Education and Community life of France [Project no12-R-10]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard P-M, 1987, MESURES STAT EPIDEMI; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Brosh S, 1988, Br J Sports Med, V22, P169; Clarke PM, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8308; Cooper DM, 2007, J APPL PHYSIOL, V103, P700, DOI 10.1152/japplphysiol.00225.2007; Deligiannis A, 2006, EUR J CARDIOV PREV R, V13, P687, DOI 10.1097/01.hjr.0000224482.95597.7a; Drezner JA, 2008, CURR OPIN CARDIOL, V23, P494, DOI 10.1097/HCO.0b013e32830b3624; Dumanoir GR, 2007, INT J SPORTS MED, V28, P488, DOI 10.1055/s-2006-955897; Ector J, 2007, EUR HEART J, V28, P345, DOI 10.1093/eurheartj/ehl468; Fiskerstrand A, 2004, SCAND J MED SCI SPOR, V14, P303, DOI 10.1046/j.1600-0838.2003.370.x; Gajewski AK, 2008, EUR J EPIDEMIOL, V23, P335, DOI 10.1007/s10654-008-9237-3; Garatachea N, 2014, MAYO CLIN PROC, V89, P1195, DOI 10.1016/j.mayocp.2014.06.004; Hartley PHS, 1939, BRIT MED J, V1939, P657; Kujala UM, 2000, BRIT J SPORT MED, V34, P445, DOI 10.1136/bjsm.34.6.445; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; LAST JM, 1995, DICT EPIDEMIOLOGY; Lehman EJ, 2012, NEUROLOGY; LIDDELL FDK, 1984, J EPIDEMIOL COMMUN H, V38, P85, DOI 10.1136/jech.38.1.85; Marijon E, 2013, EUR HEART J, V34, P3145, DOI 10.1093/eurheartj/eht347; Marijon E, 2013, JAMA-J AM MED ASSOC, V310, P641, DOI 10.1001/jama.2013.8711; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Marquet LA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-510; Mohlenkamp S, 2008, EUR HEART J, V29, P1903, DOI 10.1093/eurheartj/ehn163; Mont L, 2009, EUROPACE, V11, P11, DOI 10.1093/europace/eun289; Moorstein B, 1968, JAMA-J AM MED ASSOC, V205, P106, DOI [DOI 10.1001/JAMA.1968.03140280060019, 10.1001/jama.1968.03140280060019]; Pelliccia A, 2010, J AM COLL CARDIOL, V55, P1619, DOI 10.1016/j.jacc.2009.10.068; Petibois C, 2004, J CLIN ENDOCR METAB, V89, P3377, DOI 10.1210/jc.2003-031311; Pohar M, 2006, COMPUT METH PROG BIO, V81, P272, DOI 10.1016/j.cmpb.2006.01.004; Predel HG, 2014, EUR HEART J, V35, P3091, DOI 10.1093/eurheartj/eht502; PROUT C, 1972, J AMER MED ASSOC, V220, P1709, DOI 10.1001/jama.220.13.1709; Ruiz JR, 2014, INT J SPORT PHYSIOL, V9, P1046, DOI 10.1123/ijspp.2013-0492; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Sallis RE, 2009, BRIT J SPORT MED, V43, P3, DOI 10.1136/bjsm.2008.054825; SARNA S, 1993, MED SCI SPORT EXER, V25, P237; Schnohr P, 2013, AM J EPIDEMIOL, V177, P683, DOI 10.1093/aje/kws301; Shephard RJ, 1998, J SPORT SCI, V16, P603, DOI 10.1080/026404198366416; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Witkowski S, 2008, BRIT J SPORT MED, V42, P952, DOI 10.1136/bjsm.2008.054353; Yoshiga CC, 2002, EUR J APPL PHYSIOL, V87, P228, DOI 10.1007/s00421-002-0627-z	40	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113362	10.1371/journal.pone.0113362	http://dx.doi.org/10.1371/journal.pone.0113362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402483	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700134
J	Hayden, CJ; Beman, JM				Hayden, Curtis J.; Beman, J. Michael			High Abundances of Potentially Active Ammonia-Oxidizing Bacteria and Archaea in Oligotrophic, High-Altitude Lakes of the Sierra Nevada, California, USA	PLOS ONE			English	Article							PHOSPHORUS LIMITATION; FRESH-WATER; NITRIFYING ARCHAEA; NITROGEN DEPOSITION; DIVERSITY; ECOLOGY; MARINE; NITRIFICATION; CRENARCHAEOTA; POPULATIONS	Nitrification plays a central role in the nitrogen cycle by determining the oxidation state of nitrogen and its subsequent bioavailability and cycling. However, relatively little is known about the underlying ecology of the microbial communities that carry out nitrification in freshwater ecosystems-and particularly within high-altitude oligotrophic lakes, where nitrogen is frequently a limiting nutrient. We quantified ammonia-oxidizing archaea (AOA) and bacteria (AOB) in 9 high-altitude lakes (2289-3160 m) in the Sierra Nevada, California, USA, in relation to spatial and biogeochemical data. Based on their ammonia monooxygenase (amoA) genes, AOB and AOA were frequently detected. AOB were present in 88% of samples and were more abundant than AOA in all samples. Both groups showed.100 fold variation in abundance between different lakes, and were also variable through time within individual lakes. Nutrient concentrations (ammonium, nitrite, nitrate, and phosphate) were generally low but also varied across and within lakes, suggestive of active internal nutrient cycling; AOB abundance was significantly correlated with phosphate (r(2) = 0.32, p < 0.1), whereas AOA abundance was inversely correlated with lake elevation (r(2) = 0.43, p < 0.05). We also measured low rates of ammonia oxidation-indicating that AOB, AOA, or both, may be biogeochemically active in these oligotrophic ecosystems. Our data indicate that dynamic populations of AOB and AOA are found in oligotrophic, high-altitude, freshwater lakes.	[Hayden, Curtis J.; Beman, J. Michael] Univ Calif Merced, Life & Environm Sci & Sierra Nevada Res Inst, Merced, CA 95343 USA	University of California System; University of California Merced	Beman, JM (corresponding author), Univ Calif Merced, Life & Environm Sci & Sierra Nevada Res Inst, Merced, CA 95343 USA.	jmbeman@gmail.com			University of California; UC Merced Sierra Nevada Research Institute	University of California(University of California System); UC Merced Sierra Nevada Research Institute	This work was supported University of California start-up funds (to JMB) and the UC Merced Sierra Nevada Research Institute (to JMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguet JC, 2008, ENVIRON MICROBIOL, V10, P1080, DOI 10.1111/j.1462-2920.2007.01498.x; Auguet JC, 2013, FEMS MICROBIOL ECOL, V84, P154, DOI 10.1111/1574-6941.12047; Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; Baron JS, 2013, BIOGEOCHEMISTRY, V114, P71, DOI 10.1007/s10533-012-9788-y; Baron JS, 2006, ECOL APPL, V16, P433, DOI 10.1890/1051-0761(2006)016[0433:HNDTDA]2.0.CO;2; Beman JM, 2012, LIMNOL OCEANOGR, V57, P711, DOI 10.4319/lo.2012.57.3.0711; Beman JM, 2010, ENVIRON MICROBIOL, V12, P1282, DOI 10.1111/j.1462-2920.2010.02172.x; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Bytnerowicz A, 2002, ENVIRON POLLUT, V118, P187, DOI 10.1016/S0269-7491(01)00312-8; Callieri C, 2009, APPL ENVIRON MICROB, V75, P7298, DOI 10.1128/AEM.01231-09; Cebron A, 2004, APPL ENVIRON MICROB, V70, P6726, DOI 10.1128/AEM.70.11.6726-6737.2004; Church MJ, 2010, ENVIRON MICROBIOL, V12, P679, DOI 10.1111/j.1462-2920.2009.02108.x; Clarisse L, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013291; Clow DW, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008316; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Eilers JM, 1987, CHARACTERISTICS LAKE, VII; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Finlay JC, 2007, ECOL APPL, V17, P2323, DOI 10.1890/07-0245.1; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; French E, 2012, APPL ENVIRON MICROB, V78, P5773, DOI 10.1128/AEM.00432-12; Goldman C. R., 1983, LIMNOLOGY; HALL GH, 1984, MICROB ECOL, V10, P37, DOI 10.1007/BF02011593; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Hu AY, 2010, FRESHWATER BIOL, V55, P2375, DOI 10.1111/j.1365-2427.2010.02454.x; Hugoni M, 2013, RES MICROBIOL, V164, P360, DOI 10.1016/j.resmic.2013.01.004; Junier P, 2008, APPL ENVIRON MICROB, V74, P5231, DOI 10.1128/AEM.00288-08; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lomas MW, 2006, LIMNOL OCEANOGR, V51, P2453, DOI 10.4319/lo.2006.51.5.2453; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Meixner T, 2004, J HYDROL, V285, P272, DOI 10.1016/j.jhydrol.2003.09.005; Merbt SN, 2012, FEMS MICROBIOL LETT, V327, P41, DOI 10.1111/j.1574-6968.2011.02457.x; Murphy DD, 2000, LAKE TAHOE WATERSHED, V1; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; RUDD JWM, 1988, SCIENCE, V240, P1515, DOI 10.1126/science.240.4858.1515; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Sickman JO, 2001, WATER RESOUR RES, V37, P1445, DOI 10.1029/2000WR900371; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Small GE, 2013, LIMNOL OCEANOGR, V58, P276, DOI 10.4319/lo.2013.58.1.0276; Sommaruga R, 2001, J PHOTOCH PHOTOBIO B, V62, P35, DOI 10.1016/S1011-1344(01)00154-3; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Vrede T, 2009, FRESHWATER BIOL, V54, P331, DOI 10.1111/j.1365-2427.2008.02118.x; Ward BB, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P199, DOI 10.1016/B978-0-12-372522-6.00005-0; Whitby CB, 2001, ANTON LEEUW INT J G, V79, P179, DOI 10.1023/A:1010202211368; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273	55	27	29	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111560	10.1371/journal.pone.0111560	http://dx.doi.org/10.1371/journal.pone.0111560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402442	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700016
J	Dall'Olmo, L; Fassan, M; Dassie, E; Scarpa, M; Realdon, S; Cavallin, F; Cagol, M; Battaglia, G; Pizzi, M; Guzzardo, V; Franceschinis, E; Pasut, G; Rugge, M; Zaninotto, G; Realdon, N; Castoro, C				Dall'Olmo, Luigi; Fassan, Matteo; Dassie, Elisa; Scarpa, Marco; Realdon, Stefano; Cavallin, Francesco; Cagol, Matteo; Battaglia, Giorgio; Pizzi, Marco; Guzzardo, Vincenza; Franceschinis, Erica; Pasut, Gianfranco; Rugge, Massimo; Zaninotto, Giovanni; Realdon, Nicola; Castoro, Carlo			Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; RAT MODEL; ACID; ADENOCARCINOMA; OMEPRAZOLE; PROLIFERATION; DIFFERENTIATION; CANCER	Chronic gastro-duodenal reflux in the esophagus is a major risk for intestinal metaplasia and Barrett's adenocarcinoma. A role for chronic use of proton pump inhibitor (PPI) in the increased incidence of esophageal adenocarcinoma in Western countries has been previously suggested. The aim of this work was to study the effect of chronic administration of omeprazole (a proton pump inhibitor) per os in a model of reflux induced esophageal carcinogenesis. One week after esophago-gastro-jejunostomy, 115 Sprague-Dawley rats were randomized to receive 10 mg/Kg per day of omeprazole or placebo, 5 days per week. The esophago-gastric specimens were collected 2862 weeks after randomization and analyzed in a blinded fashion. Mortality and esophageal metaplasia rates did not differ between the two groups (p = 0.99 for mortality, p = 0.36 for intestinal metaplasia and p = 0.66 for multi-layered epithelium). Gastric pancreatic acinar cell metaplasia (PACM) was more frequently observed in PPI-treated rats (p = 0.003). Severe ulcer lesions significantly prevailed in the placebo group (p = 0.03). Locally invasive esophageal epithelial neoplasia were observed in 23/39 PPI-treated versus 14/42 placebo-animals (p = 0.03). In conclusion, chronic omeprazole treatment improved the healing of esophageal ulcerative lesions. Locally invasive neoplastic lesions and PACM prevailed among PPI-treated animals. However, neither an effect on the overall mortality nor on the incidence of pre-neoplastic lesions was observed in this work.	[Dall'Olmo, Luigi; Scarpa, Marco; Cavallin, Francesco; Cagol, Matteo; Rugge, Massimo; Castoro, Carlo] IRCCS, IOV, Surg Oncol Unit, Padua, Italy; [Fassan, Matteo] Univ & Hosp Trust Verona, ARC NET Res Ctr, Verona, Italy; [Fassan, Matteo; Pizzi, Marco; Guzzardo, Vincenza] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, Padua, Italy; [Dassie, Elisa; Realdon, Stefano; Battaglia, Giorgio] IRCCS, IOV, Endoscopy Unit, Padua, Italy; [Dassie, Elisa; Realdon, Stefano] VIMM, Padua, Italy; [Franceschinis, Erica; Pasut, Gianfranco; Realdon, Nicola] Univ Padua, Pharmaceut Chem & Pharmacol Dept, Padua, Italy; [Rugge, Massimo] Univ Padua, Dept Med DIMED, Padua, Italy; [Zaninotto, Giovanni] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	IRCCS Istituto Oncologico Veneto (IOV); University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Veneto Institute Molecular Medicine; University of Padua; University of Padua; Imperial College London	Dall'Olmo, L (corresponding author), IRCCS, IOV, Surg Oncol Unit, Padua, Italy.	dallolmo.luigi@gmail.com	Scarpa, Marco/K-9970-2016; Castoro, Carlo/AAO-6927-2020; Rugge, Massimo/K-7525-2016; Pasut, Gianfranco/I-5944-2012; Pizzi, Marco/H-6273-2016; Realdon, Stefano/K-8664-2016; Castoro, Carlo/GNM-8249-2022; Fassan, Matteo/F-5152-2012	Scarpa, Marco/0000-0002-0217-6523; Pasut, Gianfranco/0000-0002-8754-0899; FRANCESCHINIS, ERICA/0000-0002-3915-5144; Pizzi, Marco/0000-0003-4006-7317; Realdon, Stefano/0000-0001-6843-7637; dall'olmo, luigi/0000-0003-1564-2594; Castoro, Carlo/0000-0001-9601-9336; Fassan, Matteo/0000-0001-6515-5482	Istituto Oncologico Veneto (IOV-IRCCS) Padua, Italy; School of General Surgery - Padua University, Italy	Istituto Oncologico Veneto (IOV-IRCCS) Padua, Italy; School of General Surgery - Padua University, Italy	Funding: This project was funded by the grant "Ricerca corrente 2011" of the Istituto Oncologico Veneto (IOV-IRCCS) Padua, Italy, and supported by the School of General Surgery - Padua University, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buskens CJ, 2006, J SURG RES, V135, P337, DOI 10.1016/j.jss.2006.04.023; Chandrasoma PT, 2006, GERD REFLUX ESOPHAGE; Clemons NJ, 2007, GASTROENTEROLOGY, V133, P1198, DOI 10.1053/j.gastro.2007.06.061; Dedja A, 2005, MICROSURG, V25, P227, DOI 10.1002/micr.20101; ERICKSON RA, 1991, DIGEST DIS SCI, V36, P897, DOI 10.1007/BF01297138; Feagins LA, 2007, AM J GASTROENTEROL, V102, P10, DOI 10.1111/j.1572-0241.2006.01005.x; Fein M, 1998, J Gastrointest Surg, V2, P260, DOI 10.1016/S1091-255X(98)80021-8; Fitzgerald RC, 1996, J CLIN INVEST, V98, P2120, DOI 10.1172/JCI119018; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Green Daniel A, 2011, Therap Adv Gastroenterol, V4, P89, DOI 10.1177/1756283X10392444; Hagiwara T, 2007, DIGEST DIS SCI, V52, P1219, DOI 10.1007/s10620-006-9253-7; Haigh CR, 2003, GASTROENTEROLOGY, V124, P615, DOI 10.1053/gast.2003.50091; Hao J, 2009, INT J CANCER, V124, P1270, DOI 10.1002/ijc.24077; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Ingravallo G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-108; Jolly AJ, 2004, MUTAGENESIS, V19, P319, DOI 10.1093/mutage/geh035; Katzung B.G., 2012, PHARMACOL TOXICOL; Lloyd MH, 1998, P INT C 22 25 NOV 19, P48; Miwa H, 2009, NEUROGASTROENT MOTIL, V21, P296, DOI 10.1111/j.1365-2982.2008.01221.x; Miyashita T, 2013, SURG TODAY, V43, P831, DOI 10.1007/s00595-012-0395-2; Moore KH, 2001, DIS ESOPHAGUS, V14, P17, DOI 10.1111/j.1442-2050.2001.00145.x; Ouatu-Lascar R, 1999, GASTROENTEROLOGY, V117, P327, DOI 10.1053/gast.1999.0029900327; Rugge M, 2014, WORLD J SURG; Rugge M, 2012, ANN SURG, V256, P788, DOI 10.1097/SLA.0b013e3182737a7e; Shaheen NJ, 2009, LANCET, V373, P850, DOI 10.1016/S0140-6736(09)60487-6; Su YH, 2004, LAB INVEST, V84, P753, DOI 10.1038/labinvest.3700079; Viste Asgaut, 2004, Gastric Cancer, V7, P31, DOI 10.1007/s10120-003-0264-1; Waldum HL, 2000, ALIMENT PHARM THERAP, V14, P1537, DOI 10.1046/j.1365-2036.2000.00859.x; Wang JS, 2010, AM J GASTROENTEROL, V105, P1039, DOI 10.1038/ajg.2009.629; Wetscher GJ, 1999, DIGEST DIS SCI, V44, P1132, DOI 10.1023/A:1026615905170; Yenisehirli A, 2008, PHARMACOL RES, V58, P65, DOI 10.1016/j.phrs.2008.06.012	31	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112862	10.1371/journal.pone.0112862	http://dx.doi.org/10.1371/journal.pone.0112862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415190	gold, Green Submitted, Green Published			2022-12-27	WOS:000346906600020
J	Xu, WL; Wang, YG; Tong, HY; Qian, WB; Jin, J				Xu, Weilai; Wang, Yungui; Tong, Hongyan; Qian, Wenbin; Jin, Jie			Downregulation of hTERT: An Important As2O3 Induced Mechanism of Apoptosis in Myelodysplastic Syndrome	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NF-KAPPA-B; ARSENIC TRIOXIDE AS2O3; CELL-LINES; CARCINOMA-CELLS; UP-REGULATION; REDOX STATE; IN-VITRO; INHIBITION; EXPRESSION	Two myelodysplastic syndrome (MDS) celllines, MUTZ-1 and SKM-1 cells, were used to study the effect of arsenic trioxide (As2O3) on hematological malignant cells. As2O3 induced this two cell lines apoptosis via activation of caspase-3/8 and cleavage of poly (ADP-ribose) polymerase (PARP), a DNA repair enzyme. As2O3 reduced NF-kappa B activity, which was important for inducing MUTZ-1 and SKM-1 cells apoptosis. As2O3 also inhibited the activities of hTERT in MUTZ-1 and SKM-1 cells. Moreover, the NF-kappa B inhibitor, pyrrolidine dithiocarbamate (PDTC), had no effect on caspase-8 activation, although PDTC did inhibit MUTZ-1 and SKM-1 cells proliferation. Incubation of MUTZ-1 cells with a caspase-8 inhibitor failed to block As2O3-induced inhibition of NF-kappa B activity. Our findings suggest that As2O3 may induce apoptosis in MUTZ-1 and SKM-1 cells by two independent pathways: first, by activation of caspase-3/8 and PARP; and second, by inhibition of NF-kappa B activity, which results in downregulation of hTERT expression. We conclude that hTERT and NF-kappa B are important molecular targets in As2O3-induced apoptosis.	[Xu, Weilai; Wang, Yungui; Tong, Hongyan; Qian, Wenbin; Jin, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Jin, J (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China.	jiej0503@163.com			Ministry of Education of China [20120101110010]; National Natural Science Foundation of China [81370645]; Zhejiang Leading Team of ST Innovation [2011R50015]	Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Leading Team of ST Innovation	Funding: This work was supported by grants from Doctoral Fund of Ministry of Education of China (No 20120101110010), National Natural Science Foundation of China grants (No 81370645), Zhejiang Leading Team of S&T Innovation (No 2011R50015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2003, CANCER RES, V63, P18; Chen GQ, 1997, BLOOD, V89, P3345; Chen GQ, 1996, BLOOD, V88, P1052; Chou WC, 2005, BLOOD, V106, P304, DOI 10.1182/blood-2005-01-0241; Delhommeau FO, 2002, ONCOGENE, V21, P8262, DOI 10.1038/sj.onc.1206054; Dubrana K, 2001, CURR OPIN CELL BIOL, V13, P281, DOI 10.1016/S0955-0674(00)00210-6; Feinman Rena, 2004, Clin Adv Hematol Oncol, V2, P162; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Gorbunova V, 2003, CELL CYCLE, V2, P534, DOI 10.4161/cc.2.6.515; Hermine O, 2004, HEMATOL J, V5, P130, DOI 10.1038/sj.thj.6200374; Jing YW, 2004, ACTA BIOCH BIOPH SIN, V36, P235, DOI 10.1093/abbs/36.3.235; Kajiguchi T, 2003, LEUKEMIA, V17, P2189, DOI 10.1038/sj.leu.2403120; Kerbauy DMB, 2005, BLOOD, V106, P3917, DOI 10.1182/blood-2005-04-1424; Mathas S, 2003, BLOOD, V102, P1028, DOI 10.1182/blood-2002-04-1154; NAKAGAWA T, 1993, BRIT J HAEMATOL, V85, P469; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Poole JC, 2001, GENE, V269, P1, DOI 10.1016/S0378-1119(01)00440-1; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Qiao L, 2005, CANCER BIOL THER, V4, P1195, DOI 10.4161/cbt.4.11.2078; Raza A, 2004, LEUKEMIA RES, V28, P791, DOI 10.1016/j.leukres.2003.11.018; Rojewski MT, 2002, BRIT J HAEMATOL, V116, P555, DOI 10.1046/j.0007-1048.2001.03298.x; Rousselot P, 2004, LEUKEMIA, V18, P1518, DOI 10.1038/sj.leu.2403424; Sanz C, 2002, HAEMATOLOGICA, V87, P1005; Sekeres Mikkael A, 2005, Curr Hematol Rep, V4, P59; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Sinha-Datta U, 2004, BLOOD, V104, P2523, DOI 10.1182/blood-2003-12-4251; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Steube KG, 1997, LEUKEMIA LYMPHOMA, V25, P345, DOI 10.3109/10428199709114174; Stewart SA, 2005, CURR MOL MED, V5, P253, DOI 10.2174/1566524053586653; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Woo SH, 2004, INT J CANCER, V112, P596, DOI 10.1002/ijc.20433; Zhou CX, 2007, GYNECOL ONCOL, V105, P218, DOI 10.1016/j.ygyno.2006.11.027	32	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113199	10.1371/journal.pone.0113199	http://dx.doi.org/10.1371/journal.pone.0113199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415199	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600032
J	Aguilera, V; Briceno, L; Contreras, H; Lamperti, L; Sepulveda, E; Diaz-Perez, F; Leon, M; Veas, C; Maura, R; Toledo, JR; Fernandez, P; Covarrubias, A; Zuniga, FA; Radojkovic, C; Escudero, C; Aguayo, C				Aguilera, Valeria; Briceno, Luis; Contreras, Hector; Lamperti, Liliana; Sepulveda, Esperanza; Diaz-Perez, Francisca; Leon, Marcelo; Veas, Carlos; Maura, Rafael; Roberto Toledo, Jorge; Fernandez, Paulina; Covarrubias, Ambart; Andres Zuniga, Felipe; Radojkovic, Claudia; Escudero, Carlos; Aguayo, Claudio			Endothelium Trans Differentiated from Wharton's Jelly Mesenchymal Cells Promote Tissue Regeneration: Potential Role of Soluble Pro-Angiogenic Factors	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; IN-VITRO; HUMAN PLACENTA; STROMAL CELLS; RODENT MODEL; ADIPOSE; NEOVASCULARIZATION; TRANSPLANTATION; THERAPY	Background: Mesenchymal stem cells have a high capacity for trans-differentiation toward many adult cell types, including endothelial cells. Feto-placental tissue, such as Wharton's jelly is a potential source of mesenchymal stem cells with low immunogenic capacity; make them an excellent source of progenitor cells with a potential use for tissue repair. We evaluated whether administration of endothelial cells derived from mesenchymal stem cells isolated from Wharton's jelly (hWMSCs) can accelerate tissue repair in vivo. Methods: Mesenchymal stem cells were isolated from human Wharton's jelly by digestion with collagenase type I. Endothelial trans-differentiation was induced for 14 (hWMSC-End14d) and 30 (hWMSC-End30d) days. Cell phenotyping was performed using mesenchymal (CD90, CD73, CD105) and endothelial (Tie-2, KDR, eNOS, ICAM-1) markers. Endothelial trans-differentiation was demonstrated by the expression of endothelial markers and their ability to synthesize nitric oxide (NO). Results: hWMSCs can be differentiated into adipocytes, osteocytes, chondrocytes and endothelial cells. Moreover, these cells show high expression of CD73, CD90 and CD105 but low expression of endothelial markers prior to differentiation. hWMSCs-End express high levels of endothelial markers at 14 and 30 days of culture, and also they can synthesize NO. Injection of hWMSC-End30d in a mouse model of skin injury significantly accelerated wound healing compared with animals injected with undifferentiated hWMSC or injected with vehicle alone. These effects were also observed in animals that received conditioned media from hWMSC-End30d cultures. Conclusion: These results demonstrate that mesenchymal stem cells isolated from Wharton's jelly can be cultured in vitro and trans-differentiated into endothelial cells. Differentiated hWMSC-End may promote neovascularization and tissue repair in vivo through the secretion of soluble pro-angiogenic factors.	[Aguilera, Valeria; Briceno, Luis; Lamperti, Liliana; Sepulveda, Esperanza; Diaz-Perez, Francisca; Leon, Marcelo; Veas, Carlos; Fernandez, Paulina; Andres Zuniga, Felipe; Radojkovic, Claudia; Aguayo, Claudio] Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile; [Contreras, Hector] Univ Catolica Santisima Concepcion, Fac Med, Concepcion, Chile; [Maura, Rafael; Roberto Toledo, Jorge] Univ Concepcion, Fac Biol Sci, Dept Physiopathol, Concepcion, Chile; [Fernandez, Paulina; Covarrubias, Ambart] Univ San Sebastian, Escuela Tecnol Med, Fac Ciencias Salud, Concepcion, Chile; [Escudero, Carlos] Univ Bio Bio, Dept Basic Sci, Grp Invest Tumor Angiogenesis GIANT, Vasc Physiol Lab, Chillan, Chile; [Escudero, Carlos; Aguayo, Claudio] Univ Bio Bio, Dept Basic Sci, Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Chillan, Chile	Universidad de Concepcion; Universidad Catolica de la Santisima Concepcion; Universidad de Concepcion; Universidad San Sebastian; Universidad del Bio-Bio; Universidad del Bio-Bio	Aguayo, C (corresponding author), Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile.	caguayo@udec.cl	Escudero, Carlos/AAJ-1963-2020; Aguayo, Claudio/AAX-7364-2020; Zuniga, Felipe/Q-8035-2019; Zuniga, Felipe A/L-7885-2013	Covarrubias, Ambart/0000-0001-6460-9980; Zuniga, Felipe A./0000-0003-0286-565X; Toledo, Jorge R./0000-0002-9879-7710; Aguayo, Claudio/0000-0003-4565-9602; Contreras Moraga, Hector Antonio/0000-0002-1818-9433	INNOVA CORFO [12IDL2-13351]; INNOVA BIOBIO [1245-EM.TES(12.21)]; Direccion de Investigacion, Universidad de Concepcion, Chile [DIUC 211.072.034-1.0]; Convenio de desempeno, Universidad de Concepcion [UCO1201]; Fondecyt [1100684]; DIUBB [122109 GI/EF]	INNOVA CORFO; INNOVA BIOBIO; Direccion de Investigacion, Universidad de Concepcion, Chile; Convenio de desempeno, Universidad de Concepcion; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DIUBB	This study was supported by INNOVA CORFO (12IDL2-13351) and INNOVA BIOBIO (1245-EM.TES(12.21), Direccion de Investigacion, Universidad de Concepcion (DIUC 211.072.034-1.0), Chile and Convenio de desempeno, Universidad de Concepcion, UCO1201.CE is supported by Fondecyt 1100684, DIUBB 122109 GI/EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2010, J CELL PHYSIOL, V223, P640, DOI 10.1002/jcp.22062; Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11; Battula VL, 2007, DIFFERENTIATION, V75, P279, DOI 10.1111/j.1432-0436.2006.00139.x; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003; Choi M, 2013, INT J BIOCHEM CELL B, V45, P560, DOI 10.1016/j.biocel.2012.12.001; Conconi MT, 2006, INT J MOL MED, V18, P1089; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; Diaz-Perez F, 2012, J CARDIOVASC PHARM, V60, P439, DOI [10.1097/FJC.0b013e318269ae2f., 10.1097/FJC.0b013e318269ae2f]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fernandez P, 2012, J CARDIOVASC PHARM, V59, P397, DOI 10.1097/FJC.0b013e3182471d14; Fu XB, 2009, CELL TISSUE RES, V335, P317, DOI 10.1007/s00441-008-0724-3; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gang EJ, 2006, CYTOTHERAPY, V8, P215, DOI 10.1080/14653240600735933; Guzman-Gutierrez E, 2010, PLACENTA, V31, P928, DOI 10.1016/j.placenta.2010.07.016; Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kim SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041105; Kim SW, 2012, INT J CARDIOL; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; La Rocca G, 2009, HISTOCHEM CELL BIOL, V131, P267, DOI 10.1007/s00418-008-0519-3; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Li HH, 2006, CELL TISSUE RES, V326, P725, DOI 10.1007/s00441-006-0270-9; Li ZC, 2009, BIOL PHARM BULL, V32, P1343, DOI 10.1248/bpb.32.1343; Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x; Liu Y., 2012, CLIN EXP MED; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Meyer T, 2008, EUR SURG, V40, P239, DOI 10.1007/s10353-008-0417-x; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Mitrano TI, 2010, J PERIODONTOL, V81, P917, DOI 10.1902/jop.2010.090566; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Orbay H, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/461718; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Petsa A, 2009, IN VITRO CELL DEV-AN, V45, P573, DOI 10.1007/s11626-009-9227-0; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rachakatla RS, 2007, CANCER GENE THER, V14, P828, DOI 10.1038/sj.cgt.7701077; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Salvolini E, 2010, ARCH DERMATOL RES, V302, P367, DOI 10.1007/s00403-009-1018-7; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Tang JM, 2009, EUR J CARDIO-THORAC, V36, P644, DOI 10.1016/j.ejcts.2009.04.052; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang SH, 2009, ARTERIOSCL THROM VAS, V29, P816, DOI 10.1161/ATVBAHA.109.184739; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yoon HH, 2010, PROCESS BIOCHEM, V45, P1857, DOI 10.1016/j.procbio.2010.06.009; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124	55	31	32	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e111025	10.1371/journal.pone.0111025	http://dx.doi.org/10.1371/journal.pone.0111025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412260	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000006
J	Lv, WY; Guo, XD; Wang, GY; Xu, YX; Kang, JH				Lv, Weiying; Guo, Xudong; Wang, Guiying; Xu, Yanxin; Kang, Jiuhong			Histone Deacetylase 1 and 3 Regulate the Mesodermal Lineage Commitment of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							T-BOX GENES; NEURONAL DIFFERENTIATION; DNA METHYLATION; EMBRYOGENESIS; EXPRESSION; INHIBITORS; MORPHOGENESIS; ACETYLATION; DEGRADATION; RECRUITMENT	The important role of histone acetylation alteration has become increasingly recognized in mesodermal lineage differentiation and development. However, the contribution of individual histone deacetylases (HDACs) to mesoderm specification remains poorly understood. In this report, we found that trichostatin A (TSA), an inhibitor of histone deacetylase (HDACi), could induce early differentiation of embryonic stem cells (ESCs) and promote mesodermal lineage differentiation. Further analysis showed that the expression levels of HDAC1 and 3 are decreased gradually during ESCs differentiation. Ectopic expression of HDAC1 or 3 significantly inhibited differentiation into the mesodermal lineage. By contrast, loss of either HDAC1 or 3 enhanced the mesodermal differentiation of ESCs. Additionally, we demonstrated that the activity of HDAC1 and 3 is indeed required for the regulation of mesoderm gene expression. Furthermore, HDAC1 and 3 were found to interact physically with the T-box transcription factor T/Bry, which is critical for mesodermal lineage commitment. These findings indicate a key mechanism for the specific role of HDAC1 and 3 in mammalian mesoderm specification.	[Lv, Weiying; Guo, Xudong; Wang, Guiying; Xu, Yanxin; Kang, Jiuhong] Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, Shanghai 200092, Peoples R China	Tongji University	Kang, JH (corresponding author), Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, Shanghai 200092, Peoples R China.	jhkang@tongji.edu.cn		Xu, Yanxin/0000-0003-3651-6909	Ministry of Science and Technology [2011CB965100, 2010CB944900, 2011CBA01100, 2012CB966603, 2013CB967600, 2013CB967401]; National Natural Science Foundation of China [91219305, 31210103905, 31371510, 31101061, 31171432, 81170499, 31201107, 31301208, 81201599]; Science and Technology Commission of Shanghai Municipality [12ZR1450900]; Ministry of Education - Shanghai Rising-Star Program [IRT1168, 14QA1403900]; Specialized Research Fund for the Doctoral Program of Higher Education [20110072110039]; "Chen Guang" project from the Shanghai Municipal Education Commission; Shanghai Education Development Foundation [12CG19]; Fundamental Research Funds for the Central Universities [2000219099]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education - Shanghai Rising-Star Program; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); "Chen Guang" project from the Shanghai Municipal Education Commission; Shanghai Education Development Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants obtained from the Ministry of Science and Technology (grant numbers 2011CB965100, 2010CB944900, 2011CBA01100, 2012CB966603, 2013CB967600, 2013CB967401), National Natural Science Foundation of China (grant numbers 91219305, 31210103905, 31371510, 31101061, 31171432, 81170499, 31201107, 31301208, 81201599), Science and Technology Commission of Shanghai Municipality (grant number 12ZR1450900), IRT1168 from Ministry of Education, sponsored by Shanghai Rising-Star Program (14QA1403900), Specialized Research Fund for the Doctoral Program of Higher Education (20110072110039), support of the "Chen Guang" project from the Shanghai Municipal Education Commission and Shanghai Education Development Foundation (12CG19) and the Fundamental Research Funds for the Central Universities (2000219099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, MAMM GENOME, V11, P238, DOI 10.1007/s003350010044; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Balasubramaniyan V, 2006, NEUROSCIENCE, V143, P939, DOI 10.1016/j.neuroscience.2006.08.082; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Karamboulas C, 2006, J CELL SCI, V119, P4305, DOI 10.1242/jcs.03185; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Latham T, 2008, CELL TISSUE RES, V331, P31, DOI 10.1007/s00441-007-0537-9; Li T, 2007, J MOL BIOL, V370, P976, DOI 10.1016/j.jmb.2007.05.033; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Siebzehnrubl FA, 2007, EXP BRAIN RES, V176, P672, DOI 10.1007/s00221-006-0831-x; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang G, CELL TRANSPLANT, V21, P985; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7	42	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113262	10.1371/journal.pone.0113262	http://dx.doi.org/10.1371/journal.pone.0113262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412078	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000031
J	Ekvall, MK; Urrutia-Cordero, P; Hansson, LA				Ekvall, Mattias K.; Urrutia-Cordero, Pablo; Hansson, Lars-Anders			Linking Cascading Effects of Fish Predation and Zooplankton Grazing to Reduced Cyanobacterial Biomass and Toxin Levels Following Biomanipulation	PLOS ONE			English	Article							FRESH-WATER; LAKE RESTORATION; FOOD; EUTROPHICATION; MICROCYSTINS; COMMUNITY; DEGRADATION; LIMITATION; REDUCTION; SELECTION	Eutrophication has been one of the largest environmental problems in aquatic ecosystems during the past decades, leading to dense, and often toxic, cyanobacterial blooms. In a way to counteract these problems many lakes have been subject to restoration through biomanipulation. Here we combine 13 years of monitoring data with experimental assessment of grazing efficiency of a naturally occurring zooplankton community and a, from a human perspective, desired community of large Daphnia to assess the effects of an altered trophic cascade associated with biomanipulation. Lake monitoring data show that the relative proportion of Daphnia spp. grazers in June has increased following years of biomanipulation and that this increase coincides with a drop in cyanobacterial biomass and lowered microcystin concentrations compared to before the biomanipulation. In June, the proportion of Daphnia spp. (on a biomass basis) went from around 3% in 2005 (the first year of biomanipulation) up to around 58% in 2012. During months when the proportion of Daphnia spp. remained unchanged (July and August) no effect on lower trophic levels was observed. Our field grazing experiment revealed that Daphnia were more efficient in controlling the standing biomass of cyanobacteria, as grazing by the natural zooplankton community never even compensated for the algal growth during the experiment and sometimes even promoted cyanobacterial growth. Furthermore, although the total cyanobacterial toxin levels remained unaffected by both grazer communities in the experimental study, the Daphnia dominated community promoted the transfer of toxins to the extracellular, dissolved phase, likely through feeding on cyanobacteria. Our results show that biomanipulation by fish removal is a useful tool for lake management, leading to a top-down mediated trophic cascade, through alterations in the grazer community, to reduced cyanobacterial biomass and lowered cyanobacterial toxin levels. This improved water quality enhances both the ecological and societal value of lakes as units for ecosystem services.	[Ekvall, Mattias K.; Urrutia-Cordero, Pablo; Hansson, Lars-Anders] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Urrutia-Cordero, Pablo] Lund Univ, Ctr Environm & Climate Res, SE-22362 Lund, Sweden	Lund University; Lund University	Ekvall, MK (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, SE-22362 Lund, Sweden.	mattias.ekvall@biol.lu.se	Hansson, Lars-Anders/HCI-2735-2022	Urrutia Cordero, Pablo/0000-0001-9560-8374; Hansson, Lars-Anders/0000-0002-3035-1317	European Union Interreg IV A project "Algae be gone!''; ERA-Net BiodivERsA; FORMAS	European Union Interreg IV A project "Algae be gone!''; ERA-Net BiodivERsA; FORMAS(Swedish Research Council Formas)	This work was funded by the European Union Interreg IV A project "Algae be gone!'' and by the ERA-Net BiodivERsA, with the national funders FORMAS, part of the 2012 BiodivERsA call for research proposals (LIMNOTIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNDORF J, 1984, INT REV GES HYDROBIO, V69, P407, DOI 10.1002/iroh.19840690308; Bergman E, 1999, HYDROBIOLOGIA, V404, P77, DOI 10.1023/A:1003776613724; Bergman E, 1999, HYDROBIOLOGIA, V404, P145, DOI 10.1023/A:1003788900521; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chislock MF, 2013, WATER RES, V47, P1961, DOI 10.1016/j.watres.2012.12.038; Christoffersen K, 2002, AQUAT MICROB ECOL, V27, P125, DOI 10.3354/ame027125; Codd GA, 1995, WATER SCI TECHNOL, V32, P149, DOI 10.1016/0273-1223(95)00692-3; CODD GA, 1989, WATER SCI TECHNOL, V21, P1; DAWIDOWICZ P, 1990, HYDROBIOLOGIA, V200, P43, DOI 10.1007/BF02530327; DEBERNARDI R, 1990, HYDROBIOLOGIA, V200, P29, DOI 10.1007/BF02530326; DEMOTT WR, 1986, OECOLOGIA, V69, P334, DOI 10.1007/BF00377053; DeMott WR, 2001, LIMNOL OCEANOGR, V46, P2054, DOI 10.4319/lo.2001.46.8.2054; Dumont H.J., 1975, Oecologia, V19, P75, DOI 10.1007/BF00377592; Ekvall MK, 2013, FRESHWATER BIOL, V58, P2414, DOI 10.1111/fwb.12220; Faassen EJ, 2012, TOXICON, V60, P378, DOI 10.1016/j.toxicon.2012.04.335; Falconer IR, 2005, ACTA HYDROCH HYDROB, V33, P64, DOI 10.1002/aheh.200300551; Gagala I, 2012, POL J ENVIRON STUD, V21, P1125; GLIWICZ ZM, 1990, HYDROBIOLOGIA, V200, P83, DOI 10.1007/BF02530331; Ha JY, 2013, LIMNOLOGY, V14, P19, DOI 10.1007/s10201-012-0381-9; Hansson LA, 1998, ECOSYSTEMS, V1, P558, DOI 10.1007/s100219900051; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Jang MH, 2007, LIMNOL OCEANOGR, V52, P1454, DOI 10.4319/lo.2007.52.4.1454; Lebret K, 2012, LIMNOL OCEANOGR, V57, P727, DOI 10.4319/lo.2012.57.3.0727; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; MEIJER ML, 1994, HYDROBIOLOGIA, V275, P457, DOI 10.1007/BF00026734; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Reitzel K, 2013, HYDROBIOLOGIA, V703, P189, DOI 10.1007/s10750-012-1358-8; Rohrlack T, 2007, PHYCOLOGIA, V46, P277, DOI 10.2216/06-14.1; Romare P, 1999, HYDROBIOLOGIA, V404, P89, DOI 10.1023/A:1003731128746; Sarnelle O, 2010, J PLANKTON RES, V32, P471, DOI 10.1093/plankt/fbp151; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SHAPIRO J, 1984, FRESHWATER BIOL, V14, P371; Shapiro J., 1975, WATER QUALITY MANAGE, P85; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SONDERGAARD M, 1990, HYDROBIOLOGIA, V200, P229, DOI 10.1007/BF02530342; THEISS J, 1990, HYDROBIOLOGIA, V200, P59, DOI 10.1007/BF02530329; Uusi-Kamppa Jaana, 2000, Journal of Environmental Quality, V29, P151, DOI 10.2134/jeq2000.00472425002900010019x; WEBSTER KE, 1978, LIMNOL OCEANOGR, V23, P1238, DOI 10.4319/lo.1978.23.6.1238; Wilson AE, 2007, LIMNOL OCEANOGR, V52, P1467, DOI 10.4319/lo.2007.52.4.1467	47	44	44	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112956	10.1371/journal.pone.0112956	http://dx.doi.org/10.1371/journal.pone.0112956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409309	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200050
J	Amorim, D; David-Pereira, A; Marques, P; Puga, S; Rebelo, P; Costa, P; Pertovaara, A; Almeida, A; Pinto-Ribeiro, F				Amorim, Diana; David-Pereira, Ana; Marques, Patricia; Puga, Sonia; Rebelo, Patricia; Costa, Patricio; Pertovaara, Antti; Almeida, Armando; Pinto-Ribeiro, Filipa			A Role of Supraspinal Galanin in Behavioural Hyperalgesia in the Rat	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; ROSTRAL VENTROMEDIAL MEDULLA; LOCUS-CERULEUS NEURONS; SPINAL-CORD; DESCENDING MODULATION; MESSENGER-RNA; ANTINOCICEPTIVE ROLE; PERIAQUEDUCTAL GRAY; THERMAL NOCICEPTION; NEUROPATHIC PAIN	Introduction: In chronic pain disorders, galanin (GAL) is able to either facilitate or inhibit nociception in the spinal cord but the contribution of supraspinal galanin to pain signalling is mostly unknown. The dorsomedial nucleus of the hypothalamus (DMH) is rich in galanin receptors (GALR) and is involved in behavioural hyperalgesia. In this study, we evaluated the contribution of supraspinal GAL to behavioural hyperalgesia in experimental monoarthritis. Methods:In Wistar-Han males with a four week kaolin/carrageenan-induced monoarthritis (ARTH), paw-withdrawal latency (PWL) was assessed before and after DMH administration of exogenous GAL, a non-specific GALR antagonist (M40), a specific GALR1 agonist (M617) and a specific GALR2 antagonist (M871). Additionally, the analysis of c-Fos expression after GAL injection in the DMH was used to investigate the potential involvement of brainstem pain control centres. Finally, electrophysiological recordings were performed to evaluate whether pronociceptive On- or antinociceptive Off-like cells in the rostral ventromedial medulla (RVM) relay the effect of GAL. Results: Exogenous GAL in the DMH decreased PWL in ARTH and SHAM animals, an effect that was mimicked by a GALR1 agonist (M617). In SHAM animals, an unselective GALR antagonist (M40) increased PWL, while a GALR2 antagonist (M871) decreased PWL. M40 or M871 failed to influence PWL in ARTH animals. Exogenous GAL increased c-Fos expression in the RVM and dorsal raphe nucleus (DRN), with effects being more prominent in SHAM than ARTH animals. Exogenous GAL failed to influence activity of RVM On- or Off-like cells of SHAM and ARTH animals. Conclusions: Overall, exogenous GAL in the DMH had a pronociceptive effect that is mediated by GALR1 in healthy and arthritic animals and is associated with alterations of c-Fos expression in RVM and DRN that are serotonergic brainstem nuclei known to be involved in the regulation of pain.	[Amorim, Diana; David-Pereira, Ana; Marques, Patricia; Puga, Sonia; Rebelo, Patricia; Costa, Patricio; Almeida, Armando; Pinto-Ribeiro, Filipa] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci ECS, Braga, Portugal; [Amorim, Diana; David-Pereira, Ana; Marques, Patricia; Puga, Sonia; Rebelo, Patricia; Costa, Patricio; Almeida, Armando; Pinto-Ribeiro, Filipa] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Pertovaara, Antti] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland	Universidade do Minho; University of Helsinki	Pinto-Ribeiro, F (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci ECS, Braga, Portugal.	filiparibeiro@ecsaude.uminho.pt	Pinto-Ribeiro, Filipa/AAB-4822-2019; Pinto-Ribeiro, Filipa/AAM-6559-2021; Pertovaara, Antti Yrjö/AAM-9213-2021; Pinto-Ribeiro, Filipa/M-2696-2013; Almeida, Armando/H-5122-2011; Costa, Patrício/A-3072-2013	Pinto-Ribeiro, Filipa/0000-0001-7574-6489; Pertovaara, Antti Yrjö/0000-0002-8590-7220; Pinto-Ribeiro, Filipa/0000-0001-7574-6489; Almeida, Armando/0000-0002-6233-4693; Costa, Patrício/0000-0002-1201-9177; Puga, Sonia/0000-0003-2995-5356; Rebelo, Patricia/0000-0001-5209-668X; Amorim, Diana/0000-0001-6402-0834; David-Pereira, Ana/0000-0002-5454-966X	Portuguese Science Foundation (FCT) Project [PTDC/SAU-NEU/108557/2008]; FEDER-COMPETE; Academy of Finland; Sigrid Juselius Foundation, Helsinki, Finland; FCT [SFRH/BD/71219/2010, SFRH/BD/90374/2012]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/108557/2008] Funding Source: FCT	Portuguese Science Foundation (FCT) Project; FEDER-COMPETE(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation, Helsinki, Finland(Sigrid Juselius Foundation); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This study was supported by grants from the Portuguese Science Foundation (FCT) Project no PTDC/SAU-NEU/108557/2008, FEDER-COMPETE, by the Academy of Finland and the Sigrid Juselius Foundation, Helsinki, Finland. DA was supported by FCT grant SFRH/BD/71219/2010 and ADP was supported by FCT grant SFRH/BD/90374/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A., 2006, DRUG DISCOV TODAY DI, V3, P305, DOI [10.1016/j.ddmec.2006.09.001, DOI 10.1016/J.DDMEC.2006.09.001]; Amorim D, 2014, BEHAV BRAIN RES, V265, P12, DOI 10.1016/j.bbr.2014.02.003; Ansah OB, 2007, ANESTH ANALG, V105, P245, DOI 10.1213/01.ane.0000265850.08385.a6; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Barton NJ, 2007, J NEUROSCI METH, V163, P67, DOI 10.1016/j.jneumeth.2007.02.012; Blackshear A, 2007, PEPTIDES, V28, P1120, DOI 10.1016/j.peptides.2007.01.015; Blakeman KH, 2003, NEUROSCIENCE, V117, P221, DOI 10.1016/S0306-4522(02)00779-0; Brumovsky P, 2006, BRAIN RES, V1085, P111, DOI 10.1016/j.brainres.2006.02.088; CERVERO F, 1991, EXP BRAIN RES, V83, P675; CHNG JLC, 1985, NEUROSCIENCE, V16, P343, DOI 10.1016/0306-4522(85)90007-7; de Luca MCZ, 2003, PHARMACOL BIOCHEM BE, V75, P459, DOI 10.1016/S0091-3057(03)00145-X; FIELDS HL, 1985, PHILOS T ROY SOC B, V308, P361, DOI 10.1098/rstb.1985.0037; FIELDS HL, 1983, J NEUROSCI, V3, P2545; Fu LB, 2011, NEUROSCI LETT, V491, P174, DOI 10.1016/j.neulet.2011.01.030; Galban CJ, 2007, OSTEOARTHR CARTILAGE, V15, P550, DOI 10.1016/j.joca.2006.10.007; Gu XL, 2007, BEHAV BRAIN RES, V179, P331, DOI 10.1016/j.bbr.2007.02.033; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; HEINRICHER MM, 1989, SOMATOSENS MOT RES, V6, P427, DOI 10.3109/08990228909144685; Herrero JF, 1996, NEUROSCI LETT, V209, P21, DOI 10.1016/0304-3940(96)12588-X; Hickey L, 2014, J NEUROSCI, V34, P4148, DOI 10.1523/JNEUROSCI.4835-13.2014; Hua XY, 2004, J PHARMACOL EXP THER, V308, P574, DOI 10.1124/jpet.103.058289; Hulse RP, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-41; Jacobowitz DM, 2004, PEPTIDES, V25, P433, DOI 10.1016/j.peptides.2004.02.015; Jimenez-Andrade JM, 2004, PAIN, V110, P10, DOI 10.1016/j.pain.2004.02.032; Jin WY, 2010, BRAIN RES, V1320, P16, DOI 10.1016/j.brainres.2009.12.060; Johnson PL, 2008, J PSYCHOPHARMACOL, V22, P642, DOI 10.1177/0269881107082900; JONES SL, 1991, PROG BRAIN RES, V88, P381; Kong Q, 2013, NEUROSCI LETT, P4; Kovelowski CJ, 2000, PAIN, V87, P265, DOI 10.1016/S0304-3959(00)00290-6; Kuteeva E, 2008, NEUROPSYCHOPHARMACOL, V33, P2573, DOI 10.1038/sj.npp.1301660; Larm JA, 2003, EUR J NEUROSCI, V17, P481, DOI 10.1046/j.1460-9568.2003.02471.x; Li J, 2012, NEUROSCI LETT, V526, P45, DOI 10.1016/j.neulet.2012.07.041; Liu HX, 2002, TRENDS PHARMACOL SCI, V23, P468, DOI 10.1016/S0165-6147(02)02074-6; Liu HX, 2001, P NATL ACAD SCI USA, V98, P9960, DOI 10.1073/pnas.161293598; Lu XY, 2005, NEUROPEPTIDES, V39, P143, DOI 10.1016/j.npep.2004.12.012; Martenson ME, 2009, PAIN, V142, P236, DOI 10.1016/j.pain.2009.01.011; Mennicken F, 2002, J CHEM NEUROANAT, V24, P257, DOI 10.1016/S0891-0618(02)00068-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Mitchell V, 1999, J CHEM NEUROANAT, V16, P265, DOI 10.1016/S0891-0618(99)00011-3; Mitchell V, 1997, NEUROENDOCRINOLOGY, V66, P160, DOI 10.1159/000127234; Morgado C, 2007, DIABETES-METAB RES, V23, P644, DOI 10.1002/dmrr.751; Murphy LB, 2012, ARTHRIT CARE RES, V64, P968, DOI 10.1002/acr.21685; MYERS RD, 1966, PHYSIOL BEHAV, V1, P171, DOI 10.1016/0031-9384(66)90064-3; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; Pertovaara A, 2006, HAND CLINIC, V81, P179, DOI 10.1016/S0072-9752(06)80017-5; Pinto-Ribeiro F, 2008, BRAIN RES, V1197, P63, DOI 10.1016/j.brainres.2007.12.038; Pinto-Ribeiro F, 2013, BRAIN RES BULL, V99, P100, DOI 10.1016/j.brainresbull.2013.10.001; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; POTREBIC SB, 1994, J NEUROSCI, V14, P1655, DOI 10.1523/JNEUROSCI.14-03-01655.1994; Prado WA, 2000, PAIN, V88, P169, DOI 10.1016/S0304-3959(00)00326-2; QIAO JT, 1988, PAIN, V34, P65, DOI 10.1016/0304-3959(88)90183-2; Radhakrishnan R, 2003, PAIN, V104, P567, DOI 10.1016/S0304-3959(03)00114-3; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Reeve AJ, 2000, NEUROSCI LETT, V295, P25, DOI 10.1016/S0304-3940(00)01576-7; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; Ren K, 1996, J NEUROPHYSIOL, V76, P3025, DOI 10.1152/jn.1996.76.5.3025; Rivat C, 2008, PAIN, V137, P125, DOI 10.1016/j.pain.2007.08.021; Sanoja R, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.04.006; SEVCIK J, 1993, EUR J PHARMACOL, V230, P223, DOI 10.1016/0014-2999(93)90806-S; Song Z, 2013, NEUROSCIENCE, V247, P134, DOI 10.1016/j.neuroscience.2013.05.027; Sun YG, 2007, J NEUROSCI RES, V85, P2400, DOI 10.1002/jnr.21396; Sun YG, 2004, J NEUROSCI RES, V77, P718, DOI 10.1002/jnr.20206; Sun YG, 2003, PAIN, V106, P143, DOI 10.1016/S0304-3959(03)00316-6; Terayama R, 2000, NEUROREPORT, V11, P1915, DOI 10.1097/00001756-200006260-00022; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Verdu B, 2008, DRUGS, V68, P2611, DOI 10.2165/0003495-200868180-00007; Voisin DL, 2005, J PHYSIOL-LONDON, V566, P929, DOI 10.1113/jphysiol.2005.086520; Wagner KM, 2013, NEUROSCIENCE, V238, P29, DOI 10.1016/j.neuroscience.2013.02.009; Wang D, 2000, NEUROSCIENCE, V96, P767, DOI 10.1016/S0306-4522(00)00005-1; WANG QP, 1994, BRAIN RES BULL, V34, P575; Wang S, 1998, BIOCHEMISTRY-US, V37, P6711, DOI 10.1021/bi9728405; Wang SX, 2012, PAIN, V153, P2448, DOI 10.1016/j.pain.2012.08.016; Waters SM, 2000, NEUROSCIENCE, V95, P265; Webling Kristin E B, 2012, Front Endocrinol (Lausanne), V3, P146, DOI 10.3389/fendo.2012.00146; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; Xu SL, 2012, NEUROSCI LETT, V520, P43, DOI 10.1016/j.neulet.2012.05.027; Yue HY, 2011, J NEUROPHYSIOL, V105, P2337, DOI 10.1152/jn.00991.2010	81	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113077	10.1371/journal.pone.0113077	http://dx.doi.org/10.1371/journal.pone.0113077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405608	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300075
J	Balliu, B; Wurtz, RP; Horsthemke, B; Wieczorek, D; Bohringer, S				Balliu, Brunilda; Wuertz, Rolf P.; Horsthemke, Bernhard; Wieczorek, Dagmar; Boehringer, Stefan			Classification and Visualization Based on Derived Image Features: Application to Genetic Syndromes	PLOS ONE			English	Article								Data transformations prior to analysis may be beneficial in classification tasks. In this article we investigate a set of such transformations on 2D graph-data derived from facial images and their effect on classification accuracy in a high-dimensional setting. These transformations are low-variance in the sense that each involves only a fixed small number of input features. We show that classification accuracy can be improved when penalized regression techniques are employed, as compared to a principal component analysis (PCA) pre-processing step. In our data example classification accuracy improves from 47% to 62% when switching from PCA to penalized regression. A second goal is to visualize the resulting classifiers. We develop importance plots highlighting the influence of coordinates in the original 2D space. Features used for classification are mapped to coordinates in the original images and combined into an importance measure for each pixel. These plots assist in assessing plausibility of classifiers, interpretation of classifiers, and determination of the relative importance of different features.	[Balliu, Brunilda; Boehringer, Stefan] Leiden Univ, Med Ctr, Leiden, Netherlands; [Wuertz, Rolf P.] Ruhr Univ Bochum, Inst Neuroinformat, Bochum, Germany; [Horsthemke, Bernhard; Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, Essen, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ruhr University Bochum; University of Duisburg Essen	Bohringer, S (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.	S.Boehringer@lumc.nl	Würtz, Rolf P./A-7644-2012; Wieczorek, Dagmar/AAU-6008-2021	Würtz, Rolf P./0000-0002-7160-4157; Wieczorek, Dagmar/0000-0003-2812-6492	DFG [BO 1955/2-3, WU 314/6-2]; German Ministry of Research and Education [BMBF 01GM0802]	DFG(German Research Foundation (DFG)); German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF))	This work was supported by DFG grants BO 1955/2-3 and WU 314/6-2, and by two grants (CRANIRARE and FACE) from the German Ministry of Research and Education to D.W. (BMBF 01GM0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehringer S, 2006, EUR J HUM GENET, V14, P1082, DOI 10.1038/sj.ejhg.5201673; Boehringer S, 2011, AM J MED GENET A, V155A, P2161, DOI 10.1002/ajmg.a.34157; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Guunther M, 2012, STAT GABOR GRAPH BAS; Hammond P, 2005, AM J HUM GENET, V77, P999, DOI 10.1086/498396; Hammond P, 2012, EUR J HUM GENET, V20, P33, DOI 10.1038/ejhg.2011.135; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hennessy RJ, 2007, BIOL PSYCHIAT, V61, P1187, DOI 10.1016/j.biopsych.2006.08.045; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; R Core Development Team, 2013, R LANG ENV STAT COMP; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vollmar T, 2008, EUR J MED GENET, V51, P44, DOI 10.1016/j.ejmg.2007.10.002; Winter RM, 1996, NAT GENET, V12, P124, DOI 10.1038/ng0296-124	16	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e109033	10.1371/journal.pone.0109033	http://dx.doi.org/10.1371/journal.pone.0109033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405460	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300004
J	Barroso, GF; Goncalves, MA; Garcia, FD				Barroso, Gilberto F.; Goncalves, Monica A.; Garcia, Fabio da C.			The Morphometry of Lake Palmas, a Deep Natural Lake in Brazil	PLOS ONE			English	Article							DYNAMICS; WATER	Lake Palmas (A = 10.3 km(2)) is located in the Lower Doce River Valley (LDRV), on the southeastern coast of Brazil. The Lake District of the LDRV includes 90 lakes, whose basic geomorphology is associated with the alluvial valleys of the Barreiras Formation (Cenozoic, Neogene) and with the Holocene coastal plain. This study aimed to investigate the relationship of morphometry and thermal pattern of a LDRV deep lake, Lake Palmas. A bathymetric survey carried out in 2011 and the analysis of hydrographic and wind data with a geographic information system allowed the calculation of several metrics of lake morphometry. The vertical profiling of physical and chemical variables in the water column during the wet/warm and dry/mild cold seasons of 2011 to 2013 has furnished a better understanding of the influence of the lake morphometry on its structure and function. The overdeepened basin has a subrectangular elongated shape and is aligned in a NW-SE direction in an alluvial valley with a maximum depth (Z(max)) of 50.7 m, a volume of 2.2 x 10(8) m(3) (0.22 km(3)) and a mean depth (Z(mv)) of 21.4 m. These metrics suggest Lake Palmas as the deepest natural lake in Brazil. Water column profiling has indicated strong physical and chemical stratification during the wet/warm season, with a hypoxic/anoxic layer occupying one- half of the lake volume. The warm monomictic pattern of Lake Palmas, which is in an accordance to deep tropical lakes, is determined by water column mixing during the dry and mild cold season, especially under the influence of a high effective fetch associated with the incidence of cold fronts. Lake Palmas has a very long theoretical retention time, with a mean of 19.4 years. The changes observed in the hydrological flows of the tributary rivers may disturb the ecological resilience of Lake Palmas.	[Barroso, Gilberto F.; Garcia, Fabio da C.] Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil; [Goncalves, Monica A.] Espirito Santo State Water Resources Agcy, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo	Barroso, GF (corresponding author), Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil.	gilberto.barroso@ufes.br	Barroso, Gilberto F/E-5253-2019; ANIKUZHIYIL, ANISH/Y-8609-2018	Barroso, Gilberto F/0000-0002-4886-4890; ANIKUZHIYIL, ANISH/0000-0001-9686-1283	Espirito Santo State Agency for Environment and Water Resources (IEMA); Linhares Aquaculture Association (AquaLin); Espirito Santo State and Federal research supporting agency FAPES; Espirito Santo State and Federal research supporting agency CNPq; Fabio da Cunha Garcia's researcher fellowship grant; Espirito Santo State Agency for Agriculture, Aquaculture (SEAG)	Espirito Santo State Agency for Environment and Water Resources (IEMA); Linhares Aquaculture Association (AquaLin); Espirito Santo State and Federal research supporting agency FAPES; Espirito Santo State and Federal research supporting agency CNPq; Fabio da Cunha Garcia's researcher fellowship grant; Espirito Santo State Agency for Agriculture, Aquaculture (SEAG)	The authors acknowledge Espirito Santo State Agencies for Environment and Water Resources (IEMA) and Agriculture, Aquaculture (SEAG) as well as Linhares Aquaculture Association (AquaLin) for field work logistics. They also would like to acknowledge Espirito Santo State and Federal research supporting agencies FAPES and CNPq, respectively, for Dr. Fabio da Cunha Garcia's researcher fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti Walter, 2002, Journal of Limnology, V61, P159; Ambrosetti Walter, 2002, Journal of Limnology, V61, P147; Ambrosetti Walter, 2003, Journal of Limnology, V62, P1; [Anonymous], ACTA LIMNOLOGICA BRA; [Anonymous], PRINCIPLES LAKES SED; Aprile FM, 2005, BIOTUPE PHYS BIODIVE; Barroso GF, 2012, P 1 NAT SEM SUST MAN; Barroso GF, 2013, P 15 BRAZ S APPL PHY, P158; Bezerra-Neto Jose Fernandes, 2010, Acta Scientiarum Biological Sciences, V32, P49, DOI 10.4025/actascibiolsci.v32i1.4990; BEZERRANETO JF, 2008, ACTA LIMNOL BRAS, V20, P161; BLAIS JM, 1995, LIMNOL OCEANOGR, V40, P582, DOI 10.4319/lo.1995.40.3.0582; Bozelli R.L., 1992, ACTA LIMNOL BRAS, V4, P13; Bricalli LL, 2013, REV BRAS GEOMORFOL, V14, P301; Brighenti Ludmila Silva, 2011, Acta Scientiarum Biological Sciences, V33, P281, DOI 10.4025/actascibiolsci.v33i3.5545; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Cole GA, 1994, TXB LIMNOLOGY, P4; Dadon JR, 1995, ECOSISTEMAS AGUAS CO, V1, P47; Barros CFD, 2013, ACTA BOT BRAS, V27, P327, DOI 10.1590/S0102-33062013000200009; DUARTE CM, 1986, LIMNOL OCEANOGR, V31, P1072, DOI 10.4319/lo.1986.31.5.1072; Fee EJA, 1980, LIMNOLOGY OCEANOGRAP, V24, P401; HAKANSON L, 1978, WATER RESOUR RES, V14, P545, DOI 10.1029/WR014i004p00545; Hakanson L, 2004, LAKES FORM FUNCTION; HATUSHIKA R.S., 2007, REV BRAS GEOFIS, V25, P433, DOI DOI 10.1590/S0102-261X2007000400007; Hennemann MC, 2011, ENVIRON MONIT ASSESS, V181, P347, DOI 10.1007/s10661-010-1833-5; HENRY R., 1997, LIMNOLOGICAL STUDIES; Herdendorf CE, 1984, TECHNICAL B OHIO STA; Hollister J, 2010, LAKE RESERV MANAGE, V26, P194, DOI 10.1080/07438141.2010.504321; Hollister JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025764; Hutchinson G. E., 1957, TREATISE LIMNOLOGY; IMBERGER J, 1982, ANNU REV FLUID MECH, V14, P153, DOI 10.1146/annurev.fl.14.010182.001101; Isaaks E.H., 1989, ISA; KEREKES J, 1977, INT REV GES HYDROBIO, V62, P291, DOI 10.1002/iroh.1977.3510620207; Kjerfve B, 1996, ESTUAR COAST SHELF S, V42, P701, DOI 10.1006/ecss.1996.0045; KLING GW, 1988, LIMNOL OCEANOGR, V33, P27, DOI 10.4319/lo.1988.33.1.0027; Kosten S, 2009, ECOL APPL, V19, P1791, DOI 10.1890/08-0906.1; Kvarnas H, 2001, AMBIO, V30, P467, DOI 10.1639/0044-7447(2001)030[0467:MAHOTF]2.0.CO;2; Liu WZ, 2010, HYDROBIOLOGIA, V644, P289, DOI 10.1007/s10750-010-0151-9; Llames M.E., 2010, LAKE ECOSYSTEM ECOLO, P332; Marchioro E, 2012, REV ACTA GEOGR, P49, DOI 10.5654/actageo2012.0002.0003; Martin L., 1996, ACAD BRAS CIENCIAS, V68, P389; Melack J. M., 1990, ACTA LIMNOL BRAS, V3, P1; Niencheski L.F.H., 2004, J COASTAL RES, V39, P1040; Noges T, 2009, HYDROBIOLOGIA, V633, P33, DOI 10.1007/s10750-009-9874-x; Panosso R, 2000, LAKE BATATA IMPACTS; PBMC, 2013, CONTR WORK GROUP 2 1; RASMUSSEN JB, 1989, LIMNOL OCEANOGR, V34, P1336, DOI 10.4319/lo.1989.34.7.1336; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Ryanzhin SV, 1999, LIMNOLOGY REMOTE SEN, P53; SCHWARZBOLD A, 1984, AMAZONIANA, V9, P87; Soares MCS, 2012, LIMNOLOGICA, V42, P197, DOI 10.1016/j.limno.2011.11.002; Souza MBG, 2008, HYDROBIOLOGIA, V607, P211, DOI 10.1007/s10750-008-9392-2; Staehr PA, 2012, AQUAT SCI, V74, P155, DOI 10.1007/s00027-011-0207-6; Straskraba M, 1999, THEORETICAL RESERVOIR ECOLOGY AND ITS APPLICATIONS, P385; Straskraba M, 1998, COAST ESTUAR STUD, V288, P601, DOI [10.1029/CE054p0623, DOI 10.1029/CE054P0623]; Tundisi JG, 2010, BRAZ J BIOL, V70, P815, DOI 10.1590/S1519-69842010000400012; von Sperling E, 1999, MORPHOLOGY LAKES RES; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X	57	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111469	10.1371/journal.pone.0111469	http://dx.doi.org/10.1371/journal.pone.0111469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406062	Green Submitted, gold, Green Published			2022-12-27	WOS:000347121300009
J	Hashimdeen, SH; Miodownik, M; Edirisinghe, MJ				Hashimdeen, Shaikh Hafeez; Miodownik, Mark; Edirisinghe, Mohan J.			The Design and Construction of an Electrohydrodynamic Cartesian Robot for the Preparation of Tissue Engineering Constructs	PLOS ONE			English	Article							FABRICATION; CARTILAGE; SCAFFOLDS	In this work we bring together replicating rapid prototyping technology with electrohydrodynamic phenomena to develop a device with the ability to build structures in three-dimensions while simultaneously affording the user a degree of designing versatility and ease that is not seen in conventional computer numerically controlled machines. An attempt at reproducing an actual human ear using polycaprolactone was pursued to validate the hardware. Five different polycaprolactone solution concentrations between 7-15 wt% were used and printing was performed at applied voltages that ranged from 1 to 6 kV and at flow rates from 5 mu l/min to 60 mu l/min. The corresponding geometrical and aesthetic features of the printed constructs were studied to determine the effectiveness of the device. The 15 wt% concentration at 60ml/min under an applied electric field of 6 kV was identified as the best operating parameters to work with.	[Hashimdeen, Shaikh Hafeez; Miodownik, Mark; Edirisinghe, Mohan J.] UCL, Dept Mech Engn, London, England	University of London; University College London	Edirisinghe, MJ (corresponding author), UCL, Dept Mech Engn, London, England.	m.edirisinghe@ucl.ac.uk		Hashimdeen, Shaikh Hafeez/0000-0001-8593-6702	EPSRC [EP/I00159X/1, EP/I00159X/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I00159X/2, EP/I00159X/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Berman B, 2012, BUS HORIZONS, V55, P155, DOI 10.1016/j.bushor.2011.11.003; Brent B, 1999, PLAST RECONSTR SURG, V104, P319, DOI 10.1097/00006534-199908000-00001; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325; Hashimdeen SH, 2013, MAT SCI ENG C-MATER, V33, P3309, DOI 10.1016/j.msec.2013.04.020; HAYATI I, 1987, J COLLOID INTERF SCI, V117, P205, DOI 10.1016/0021-9797(87)90185-8; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347; Levy GN, 2003, CIRP ANN-MANUF TECHN, V52, P589, DOI 10.1016/S0007-8506(07)60206-6; Lewis JA, 2004, MATER TODAY, V7, P32, DOI 10.1016/S1369-7021(04)00344-X; Mannoor MS, 2013, NANO LETT, V13, P2634, DOI 10.1021/nl4007744; Park JU, 2008, NANO LETT, V8, P4210, DOI 10.1021/nl801832v; Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j; Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506; Sherman LM, 2009, PLAST TECHNOL, V55, P35; TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205; Wang DZ, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942531; Wang K, 2010, ANAL CHIM ACTA, V679, P81, DOI 10.1016/j.aca.2010.09.005; Wang K, 2010, APPL PHYS A-MATER, V99, P763, DOI 10.1007/s00339-010-5701-5; Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001; ZELENY J, 1917, PHYS REV, V10, P1; Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i	22	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112166	10.1371/journal.pone.0112166	http://dx.doi.org/10.1371/journal.pone.0112166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405473	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300025
J	Kahilainen, KK; Patterson, WP; Sonninen, E; Harrod, C; Kiljunen, M				Kahilainen, Kimmo Kalevi; Patterson, William Paul; Sonninen, Eloni; Harrod, Chris; Kiljunen, Mikko			Adaptive Radiation along a Thermal Gradient: Preliminary Results of Habitat Use and Respiration Rate Divergence among Whitefish Morphs	PLOS ONE			English	Article							COREGONUS-LAVARETUS L.; SALVELINUS-ALPINUS L.; TROUT SALMO-TRUTTA; FRESH-WATER FISH; EUROPEAN WHITEFISH; SYMPATRIC WHITEFISH; ECOLOGICAL SPECIATION; DELTA-C-13 VALUES; LAKE WHITEFISH; ARCTIC CHARR	Adaptive radiation is considered an important mechanism for the development of new species, but very little is known about the role of thermal adaptation during this process. Such adaptation should be especially important in poikilothermic animals that are often subjected to pronounced seasonal temperature variation that directly affects metabolic function. We conducted a preliminary study of individual lifetime thermal habitat use and respiration rates of four whitefish (Coregonus lavaretus (L.)) morphs (two pelagic, one littoral and one profundal) using stable carbon and oxygen isotope values of otolith carbonate. These morphs, two of which utilized pelagic habitats, one littoral and one profundal recently diverged via adaptive radiation to exploit different major niches in a deep and thermally stratified subarctic lake. We found evidence that the morphs used different thermal niches. The profundal morph had the most distinct thermal niche and consistently occupied the coldest thermal habitat of the lake, whereas differences were less pronounced among the shallow water pelagic and littoral morphs. Our results indicated ontogenetic shifts in thermal niches: juveniles of all whitefish morphs inhabited warmer ambient temperatures than adults. According to sampling of the otolith nucleus, hatching temperatures were higher for benthic compared to pelagic morphs. Estimated respiration rate was the lowest for benthivorous profundal morph, contrasting with the higher values estimated for the other morphs that inhabited shallower and warmer water. These preliminary results suggest that physiological adaptation to different thermal habitats shown by the sympatric morphs may play a significant role in maintaining or strengthening niche segregation and divergence in life-history traits, potentially contributing to reproductive isolation and incipient speciation.	[Kahilainen, Kimmo Kalevi] Univ Helsinki, Kilpisjarvi Biol Stn, Kilpisjarvi, Finland; [Kahilainen, Kimmo Kalevi] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Patterson, William Paul] Univ Saskatchewan, Dept Geol Sci, Isotope Lab, Saskatoon, SK S7N 0W0, Canada; [Sonninen, Eloni] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Harrod, Chris] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Harrod, Chris] Univ Antofagasta, Inst Ciencias Nat Alexander Von Humboldt, Antofagasta, Chile; [Kiljunen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Helsinki; University of Helsinki; University of Saskatchewan; University of Helsinki; University of London; Queen Mary University London; Universidad de Antofagasta; University of Jyvaskyla	Kahilainen, KK (corresponding author), Univ Helsinki, Kilpisjarvi Biol Stn, Kilpisjarvi, Finland.	kimmo.kahilainen@helsinki.fi	, Bill/GSD-6628-2022; Harrod, Chris/A-8830-2008; Patterson, William P/J-6473-2012	Harrod, Chris/0000-0002-5353-1556; Kahilainen, Kimmo/0000-0002-1539-014X; Patterson, William/0000-0003-3387-708X	Ministry of Agriculture and Forestry, Academy of Finland [140903, 1268566, 134139]; Emil Aaltonen Foundation	Ministry of Agriculture and Forestry, Academy of Finland(Academy of Finland); Emil Aaltonen Foundation	Funding of this study was obtained from Ministry of Agriculture and Forestry, Academy of Finland (projects # 140903, # 1268566, and # 134139) and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 2004, ANN ZOOL FENN, V41, P301; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Bolnick DI, 2008, AM NAT, V172, P1, DOI 10.1086/587805; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Caro LM, 2013, J EVOLUTION BIOL, V26, P357, DOI 10.1111/jeb.12055; Couton M., 2012, THESIS U TROMSO TROM; Coyne J.A., 2004, SPECIATION; Culumber ZW, 2012, J EVOLUTION BIOL, V25, P1800, DOI 10.1111/j.1420-9101.2012.02562.x; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Dufour E, 2007, CAN J FISH AQUAT SCI, V64, P1736, DOI 10.1139/F07-132; Evans ML, 2012, MOL ECOL, V21, P4038, DOI 10.1111/j.1365-294X.2012.05682.x; Forsstrom L, 2007, INT REV HYDROBIOL, V92, P301, DOI 10.1002/iroh.200610928; Gao YW, 2003, FISH RES, V60, P393, DOI 10.1016/S0165-7836(02)00134-0; Godiksen J, 2010, HYDROBIOLOGIA, V650, P67, DOI 10.1007/s10750-009-0056-7; Grant P. R., 2008, WHY SPECIES MULTIPLY; Greenberg R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040933; Hanson P. C., 1997, WISCUT97001 U WISC S; Harrod C, 2010, J ANIM ECOL, V79, P1057, DOI 10.1111/j.1365-2656.2010.01702.x; Hayden B, 2013, ECOL FRESHW FISH, V22, P192, DOI 10.1111/eff.12014; HOKANSON KEF, 1977, J FISH RES BOARD CAN, V34, P1524, DOI 10.1139/f77-217; Hudson AG, 2007, ADV LIMNOL, V60, P111; Jensen H, 2008, CAN J FISH AQUAT SCI, V65, P1831, DOI 10.1139/F08-096; Jonsson CE, 2009, J HYDROL, V376, P143, DOI 10.1016/j.jhydrol.2009.07.021; Joukhadar Z, 2002, ERGEB LIMNOL, V57, P453; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kahilainen K, 2005, ECOL FRESHW FISH, V14, P50, DOI 10.1111/j.1600-0633.2004.00075.x; Kahilainen K, 2004, J FISH BIOL, V64, P418, DOI 10.1111/j.0022-1112.2004.00307.x; Kahilainen K, 2002, ERGEB LIMNOL, V57, P277; Kahilainen K, 2003, ECOL FRESHW FISH, V12, P275, DOI 10.1046/j.1600-0633.2003.00029.x; Kahilainen K, 2003, J FISH BIOL, V63, P659, DOI 10.1046/j.1095-8649.2003.00179.x; Kahilainen K, 2002, ECOL FRESHW FISH, V11, P158, DOI 10.1034/j.1600-0633.2002.t01-2-00001.x; Kahilainen KK, 2009, ECOL FRESHW FISH, V18, P481, DOI 10.1111/j.1600-0633.2009.00363.x; Kahilainen KK, 2007, BIOL J LINN SOC, V92, P561, DOI 10.1111/j.1095-8312.2007.00856.x; Kahilainen KK, 2011, MOL ECOL, V20, P3838, DOI 10.1111/j.1365-294X.2011.05209.x; Kahilainen KK, 2011, EVOL ECOL, V25, P573, DOI 10.1007/s10682-010-9411-4; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; LINDSTROM T, 1988, Finnish Fisheries Research, V9, P89; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Muir AP, 2014, MOL ECOL, V23, P561, DOI 10.1111/mec.12624; NAESJE TF, 1986, ENVIRON BIOL FISH, V15, P309; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Ohlberger J, 2008, FUNCT ECOL, V22, P501, DOI 10.1111/j.1365-2435.2008.01391.x; Ohlberger J, 2013, AM NAT, V182, P359, DOI 10.1086/671169; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Ostbye K, 2005, MOL ECOL, V14, P4371, DOI 10.1111/j.1365-294X.2005.02737.x; Patterson W.P., 1993, AM GEOPHYS UNION MON, V78, P191, DOI [10.1029/GM078p0191, DOI 10.1029/GM078P0191]; Patterson WP, 1998, PALAEOGEOGR PALAEOCL, V138, P271, DOI 10.1016/S0031-0182(97)00137-5; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Praebel K, 2013, ECOL EVOL, V3, P4970, DOI 10.1002/ece3.867; Price T, 2008, SPECIATION BIRDS; Ravinet M, 2013, J EVOLUTION BIOL, V26, P186, DOI 10.1111/jeb.12049; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; SALONEN K, 1976, LIMNOL OCEANOGR, V21, P724, DOI 10.4319/lo.1976.21.5.0724; SCHLUTER D, 1993, TRENDS ECOL EVOL, V8, P197, DOI 10.1016/0169-5347(93)90098-A; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sherwood GD, 2003, MAR ECOL PROG SER, V258, P283, DOI 10.3354/meps258283; Siikavuopio SI, 2010, HYDROBIOLOGIA, V650, P255, DOI 10.1007/s10750-010-0192-0; Siwertsson A, 2010, EVOL ECOL RES, V12, P929; Solomon CT, 2006, CAN J FISH AQUAT SCI, V63, P79, DOI 10.1139/F05-200; Storm-Suke A, 2007, RAPID COMMUN MASS SP, V21, P4109, DOI 10.1002/rcm.3320; SVARDSON G, 1979, Institute of Freshwater Research Drottningholm Report, P1; Svensson EI, 2012, ORG DIVERS EVOL, V12, P229, DOI 10.1007/s13127-012-0082-6; Trudel M, 2001, CAN J FISH AQUAT SCI, V58, P394, DOI 10.1139/cjfas-58-2-394; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Wanzenbock J, 2012, ADV LIMNOL, V63, P89; WEBB PW, 1984, SCI AM, V251, P72, DOI 10.1038/scientificamerican0784-72; Weidman CR, 2000, FISH RES, V46, P327, DOI 10.1016/S0165-7836(00)00157-0; Wurster CM, 2005, CAN J FISH AQUAT SCI, V62, P700, DOI 10.1139/F04-241; Wurster CM, 2003, PALEOBIOLOGY, V29, P492, DOI 10.1666/0094-8373(2003)029<0492:MROLHF>2.0.CO;2; Wurster CM, 1999, COMPUT GEOSCI, V25, P1159, DOI 10.1016/S0098-3004(99)00052-7	74	37	36	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112085	10.1371/journal.pone.0112085	http://dx.doi.org/10.1371/journal.pone.0112085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405979	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300022
J	Perignon, M; Fiorentino, M; Kuong, K; Burja, K; Parker, M; Sisokhom, S; Chamnan, C; Berger, J; Wieringa, FT				Perignon, Marlene; Fiorentino, Marion; Kuong, Khov; Burja, Kurt; Parker, Megan; Sisokhom, Sek; Chamnan, Chhoun; Berger, Jacques; Wieringa, Frank T.			Stunting, Poor Iron Status and Parasite Infection Are Significant Risk Factors for Lower Cognitive Performance in Cambodian School-Aged Children	PLOS ONE			English	Article							SERUM TRANSFERRIN RECEPTOR; RETINOL-BINDING-PROTEIN; VITAMIN-A-DEFICIENCY; MICRONUTRIENT DEFICIENCIES; DEVELOPING-COUNTRIES; METAANALYSIS; GROWTH; INDICATORS; IMPACT; ZINC	Background: Nutrition is one of many factors affecting the cognitive development of children. In Cambodia, 55% of children <5 y were anemic and 40% stunted in 2010. Currently, no data exists on the nutritional status of Cambodian school-aged children, or on how malnutrition potentially affects their cognitive development. Objective: To assess the anthropometric and micronutrient status (iron, vitamin A, zinc, iodine) of Cambodian schoolchildren and their associations with cognitive performance. Methods: School children aged 6-16 y (n = 2443) from 20 primary schools in Cambodia were recruited. Anthropometry, hemoglobin, serum ferritin, transferrin receptors, retinol-binding protein and zinc concentrations, inflammation status, urinary iodine concentration and parasite infection were measured. Socio-economic data were collected in a sub-group of children (n = 616). Cognitive performance was assessed using Raven's Colored Progressive Matrices (RCPM) and block design and picture completion, two standardized tests from the Wechsler Intelligence Scale for Children (WISC-III). Results: The prevalence of anemia, iron, zinc, iodine and vitamin A deficiency were 15.7%; 51.2%, 92.8%, 17.3% and 0.7% respectively. The prevalence of stunting was 40.0%, including 10.9% of severe stunting. Stunted children scored significantly lower than non-stunted children on all tests. In RCPM test, boys with iron-deficiency anemia had lower scores than boys with normal iron status (-1.46, p<0.05). In picture completion test, children with normal iron status tended to score higher than iron-deficient children with anemia (-0.81; p = 0.067) or without anemia (-0.49; p = 0.064). Parasite infection was associated with an increase in risk of scoring below the median value in block design test (OR = 1.62; p<0.05), and with lower scores in other tests, for girls only (both p<0.05). Conclusion: Poor cognitive performance of Cambodian school-children was multifactorial and significantly associated with long-term (stunting) and current nutritional status indicators (iron status), as well as parasite infection. A life-cycle approach with programs to improve nutrition in early life and at school-age could contribute to optimal cognitive performance.	[Perignon, Marlene; Fiorentino, Marion; Berger, Jacques; Wieringa, Frank T.] Inst Rech Dev, Montpellier, France; [Kuong, Khov; Chamnan, Chhoun] Minist Agr Forestry & Fisheries, Dept Fisheries Postharvest Technol & Qual Control, Phnom Penh, Cambodia; [Burja, Kurt] United Nations World Food Programme, Phnom Penh, Cambodia; [Parker, Megan] PATH, Seattle, WA USA; [Sisokhom, Sek] Royal Univ Phnom Penh, Dept Psychol, Phnom Penh, Cambodia	Institut de Recherche pour le Developpement (IRD)	Perignon, M (corresponding author), Inst Rech Dev, Montpellier, France.	perignonmarlene@gmail.com	Wieringa, Frank Tammo/K-7565-2017; Khov, Kuong/E-5114-2015	Wieringa, Frank Tammo/0000-0002-6010-355X; Khov, Kuong/0000-0002-0464-9179; PERIGNON, Marlene/0000-0003-2862-9030; fiorentino, marion/0000-0002-1615-4579	United Nations World Food Programme (WFP) - DSM consortium; United States Department of Agriculture/Foreign Agricultural Service (USDA/FAS); Institut de Recherche pour le Developpement (IRD)	United Nations World Food Programme (WFP) - DSM consortium; United States Department of Agriculture/Foreign Agricultural Service (USDA/FAS)(United States Department of Agriculture (USDA)); Institut de Recherche pour le Developpement (IRD)	This work has been funded by the United Nations World Food Programme (WFP) - DSM consortium, the United States Department of Agriculture/Foreign Agricultural Service (USDA/FAS), and the Institut de Recherche pour le Developpement (IRD). The WFP had a role in study design. The IRD had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The USDA/FAS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash LR., 1994, BENCH AIDS DIAGNOSIS; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; Cogill B, 2003, ANTHROPOMETRIC INDIC; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Crookston BT, 2011, MATERN CHILD NUTR, V7, P397, DOI 10.1111/j.1740-8709.2010.00255.x; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Dunn JT., 1993, METHODS MEASURING IO; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Falkingham M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-4; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Grantham-McGregor S, 2002, LANCET, V359, P542, DOI 10.1016/S0140-6736(02)07719-X; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hall A, 2007, LANCET INFECT DIS, V7, P297, DOI 10.1016/S1473-3099(07)70084-1; Hermoso M, 2011, ANN NUTR METAB, V59, P154, DOI 10.1159/000334490; Hughes D, 2003, NUTR REV, V61, P413, DOI 10.1301/nr.2003.dec.413-422; Isaacs E, 2008, EUR J NUTR, V47, P4, DOI 10.1007/s00394-008-3002-y; Kaplan R.M., 2009, PSYCHOL TESTING PRIN, V7th edition; Khor GL, 2012, ASIA PAC J CLIN NUTR, V21, P476; Knowles J, 2013, BRIT J NUTR, V110, P2285, DOI 10.1017/S000711451300158X; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; National Institute of Public Health National Institute of Statistics (Cambodia) ORC Macro, 2006, CAMB DEM HLTH SURV 2; National Institute of Statistics, 2011, CAMB DEM HLTH SURV 2; Sandjaja, 2013, BRIT J NUTR, V110, pS57, DOI 10.1017/S0007114513002079; SKIKNE BS, 1990, BLOOD, V75, P1870; Sokolovic N, 2014, EUR J CLIN NUTR, V68, P14, DOI 10.1038/ejcn.2013.208; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Thurlow RA, 2006, EUR J CLIN NUTR, V60, P623, DOI 10.1038/sj.ejcn.1602361; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; UNICEF/MI, 2004, VIT MIN DEF GLOB PRO; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 1995, WHO TECHN REP SER; World Health Organization United Nations Children's Fund and International Council for the Control of Iodine Deficiency Disorders., 2007, ASS IOD DEF DIS MON, P32; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X	42	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112605	10.1371/journal.pone.0112605	http://dx.doi.org/10.1371/journal.pone.0112605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405764	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300041
J	Hsu, YW; Wang, HJ; Hsieh, MH; Hsieh, HL; Jauh, GY				Hsu, Ya-Wen; Wang, Huei-Jing; Hsieh, Ming-Hsiun; Hsieh, Hsu-Liang; Jauh, Guang-Yuh			Arabidopsis mTERF15 Is Required for Mitochondrial nad2 Intron 3 Splicing and Functional Complex I Activity	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; HIGHER-PLANT MITOCHONDRIA; RNA-BINDING DOMAIN; GENE-EXPRESSION; MONOCLONAL-ANTIBODIES; MTDNA TRANSCRIPTION; CHLOROPLASTS; THALIANA; TERMINATION; FAMILY	Mitochondria play a pivotal role in most eukaryotic cells, as they are responsible for the generation of energy and diverse metabolic intermediates for many cellular events. During endosymbiosis, approximately 99% of the genes encoded by the mitochondrial genome were transferred into the host nucleus, and mitochondria import more than 1000 nuclear-encoded proteins from the cytosol to maintain structural integrity and fundamental functions, including DNA replication, mRNA transcription and RNA metabolism of dozens of mitochondrial genes. In metazoans, a family of nuclear-encoded proteins called the mitochondrial transcription termination factors (mTERFs) regulates mitochondrial transcription, including transcriptional termination and initiation, via their DNA-binding activities, and the dysfunction of individual mTERF members causes severe developmental defects. Arabidopsis thaliana and Oryza sativa contain 35 and 48 mTERFs, respectively, but the biological functions of only a few of these proteins have been explored. Here, we investigated the biological role and molecular mechanism of Arabidopsis mTERF15 in plant organelle metabolism using molecular genetics, cytological and biochemical approaches. The null homozygous T-DNA mutant of mTERF15, mterf15, was found to result in substantial retardation of both vegetative and reproductive development, which was fully complemented by the wild-type genomic sequence. Surprisingly, mitochondria-localized mTERF15 lacks obvious DNA-binding activity but processes mitochondrial nad2 intron 3 splicing through its RNA-binding ability. Impairment of this splicing event not only disrupted mitochondrial structure but also abolished the activity of mitochondrial respiratory chain complex I. These effects are in agreement with the severe phenotype of the mterf15 homozygous mutant. Our study suggests that Arabidopsis mTERF15 functions as a splicing factor for nad2 intron 3 splicing in mitochondria, which is essential for normal plant growth and development.	[Hsu, Ya-Wen; Hsieh, Hsu-Liang] Natl Taiwan Univ, Inst Plant Biol, Taipei 116, Taiwan; [Hsu, Ya-Wen; Wang, Huei-Jing; Hsieh, Ming-Hsiun; Jauh, Guang-Yuh] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Jauh, Guang-Yuh] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 402, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Chung Hsing University	Jauh, GY (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	jauh@gate.sinica.edu.tw		Hsieh, Hsu-Liang/0000-0003-3201-3677; Jauh, Guang-Yuh/0000-0003-3459-1331	Academia Sinica (Taiwan); National Science and Technology Program for Agricultural Biotechnology (NSTP/AB, Taiwan) [098S0030055-AA]; Ministry of Science and Technology [99-2321-B-001-036-MY3, 102-2321-B-001-040-MY3]	Academia Sinica (Taiwan)(Academia Sinica - Taiwan); National Science and Technology Program for Agricultural Biotechnology (NSTP/AB, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by research grants from Academia Sinica (Taiwan; http://ipmb.sinica.edu.tw/index.html/), the National Science and Technology Program for Agricultural Biotechnology (NSTP/AB, 098S0030055-AA, Taiwan) and the Ministry of Science and Technology (99-2321-B-001-036-MY3 and 102-2321-B-001-040-MY3; http://www.most.gov.tw/) to G.-Y. Jauh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2001, BIOCHEM SOC T, V29, P427, DOI 10.1042/BST0290427; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Asakura Y, 2008, RNA, V14, P2319, DOI 10.1261/rna.1223708; Asakura Y, 2007, PLANT CELL, V19, P3864, DOI 10.1105/tpc.107.055160; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Bechtold N, 1998, METH MOL B, V82, P259; Binder S, 2003, PHILOS T R SOC B, V358, P181, DOI 10.1098/rstb.2002.1179; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Chaudhury AM, 2001, SEMIN CELL DEV BIOL, V12, P381, DOI 10.1006/scdb.2001.0267; Cupp JD, 2012, PHYSIOL PLANTARUM, V49, P91; de Longevialle AF, 2008, PLANT J, V56, P157, DOI 10.1111/j.1365-313X.2008.03581.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; des Francs-Small CC, 2012, PLANT J, V69, P996, DOI 10.1111/j.1365-313X.2011.04849.x; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Gkikas I, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00155; GRAY MW, 1989, ANNU REV CELL BIOL, V5, P25, DOI 10.1146/annurev.cb.05.110189.000325; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hammani K, 2014, NUCLEIC ACIDS RES, V42, P5033, DOI 10.1093/nar/gku112; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kim M, 2012, PLANT CELL, V24, P3349, DOI 10.1105/tpc.112.101006; Kleine T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00233; Koprivova A, 2010, J BIOL CHEM, V285, P32192, DOI 10.1074/jbc.M110.147603; Kroeger TS, 2009, P NATL ACAD SCI USA, V106, P4537, DOI 10.1073/pnas.0812503106; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Kuhn K, 2011, PLANT J, V67, P1067, DOI 10.1111/j.1365-313X.2011.04658.x; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Liu Y, 2010, PLANT J, V63, P749, DOI 10.1111/j.1365-313X.2010.04280.x; LUETHY MH, 1993, PLANT PHYSIOL, V101, P931, DOI 10.1104/pp.101.3.931; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Meskauskiene R, 2009, PLANT J, V60, P399, DOI 10.1111/j.1365-313X.2009.03965.x; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pellegrini M, 2009, BBA-BIOENERGETICS, V1787, P294, DOI 10.1016/j.bbabio.2009.01.018; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Robles P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042924; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Thangasamy S, 2012, PLANT J, V71, P288, DOI 10.1111/j.1365-313X.2012.04989.x; Udy DB, 2012, PLANT PHYSIOL, V160, P1420, DOI 10.1104/pp.112.204198; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Watkins KP, 2011, PLANT CELL, V23, P1082, DOI 10.1105/tpc.111.084335; Welchen E, 2014, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00551; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yakubovskaya E, 2012, STRUCTURE, V20, P1940, DOI 10.1016/j.str.2012.08.027; Yakubovskaya E, 2010, CELL, V141, P982, DOI 10.1016/j.cell.2010.05.018; Zmudjak M, 2013, NEW PHYTOL, V199, P379, DOI 10.1111/nph.12282	58	71	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112360	10.1371/journal.pone.0112360	http://dx.doi.org/10.1371/journal.pone.0112360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402171	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700041
J	Zhang, ZC; Guo, J; Su, G; Li, J; Wu, H; Xie, XD				Zhang, Zhenchang; Guo, Jia; Su, Gang; Li, Jiong; Wu, Hua; Xie, Xiaodong			Evaluation of the Quality of Guidelines for Myasthenia Gravis with the AGREE II Instrument	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; NEUROMUSCULAR-TRANSMISSION DISORDERS; TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; AMERICAN-ACADEMY; INTRAVENOUS IMMUNOGLOBULIN; METHODOLOGICAL QUALITY; STANDARDS SUBCOMMITTEE; ACUTE GASTROENTERITIS; MANAGEMENT; NEUROLOGY	Background: Clinical practice guidelines (CPGs) are systematically developed statements to assist practitioners in making decisions about appropriate healthcare in specific clinical circumstances. The methodological quality of CPGs for myasthenia gravis (MG) are unclear. Objective: To critically evaluate the methodological quality of CPGs for MG using AGREE II instrument. Method: A systematical search strategy on PubMed, EMBASE, DynaMed, the National Guideline Clearinghouse (NGC) and the Chinese Biomedical Literature database (CBM) was performed on September 20th 2013. All guidelines related to MG were evaluated with AGREE II. The software used for analysis was SPSS 17.0. Results: A total of 15 CPGs for MG met the inclusion criteria (12 CPGs in English, 3 CPGs in Chinese). The overall agreement among reviews was moderate or high (ICC > 0.70). The mean scores (mean +/- SD) for al six domains were presented as follows: scope and purpose (60.93% +/- 16.62%), stakeholder involvement (40.93% +/- 20.04%), rigor of development (37.22% +/- 30.46%), clarity of presentation (64.26% +/- 16.36%), applicability (28.19% +/- 20.56%) and editorial independence (27.78% +/- 28.28%). Compared with non-evidence-based CPGs, evidence-based CPGs had statistically significant higher quality scores for all AGREE II domains (P < 0.05). All domain scores appear slightly higher for CPGs published after AGREE II instrument development and validation (P < 0.05). The quality scores of CPGs developed by NGC/AAN were higher than the quality scores of CPGs developed by other organizations for all domains. The difference was statistically significant for all domains with the exception of clarity of presentation (P = 0.07). Conclusions: The qualities of CPGs on MG were generally acceptable with several flaws. The AGREE II instrument should be adopted by guideline developers, particularly in China.	[Zhang, Zhenchang; Su, Gang; Li, Jiong; Xie, Xiaodong] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Zhang, Zhenchang; Guo, Jia; Wu, Hua] Lanzhou Univ, Hosp 2, Dept Neurol, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Xie, XD (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.	xdxie@lzu.edu.cn						AAEM Quality Assurance Comm, 2001, MUSCLE NERVE, V24, P1236; Adekanye O, 2009, ANAESTHESIA, V64, P923, DOI 10.1111/j.1365-2044.2009.06028_1.x; Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Basic-Kes V, 2012, ACTA CLIN CROAT, V51, P673; Benatar M, 2007, NEUROLOGY, V68, P2144, DOI 10.1212/01.wnl.0000263481.14289.90; Benatar M, 2012, MUSCLE NERVE, V45, P909, DOI 10.1002/mus.23330; BEZERRA JA, 1992, PEDIATRICS, V90, P1; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Burda BU, 2011, J CLIN EPIDEMIOL, V64, P968, DOI 10.1016/j.jclinepi.2010.12.005; Burgers JS, 2004, J CLIN ONCOL, V22, P2000, DOI 10.1200/JCO.2004.06.157; Chen YL, 2012, CHINESE MED J-PEKING, V125, P3660, DOI 10.3760/cma.j.issn.0366-6999.2012.20.011; Cortese I, 2011, NEUROLOGY, V76, P294, DOI 10.1212/WNL.0b013e318207b1f6; Donofrio PD, 2009, MUSCLE NERVE, V40, P890, DOI 10.1002/mus.21433; Elovaara I, 2008, EUR J NEUROL, V15, P893, DOI 10.1111/j.1468-1331.2008.02246.x; Feasby T, 2007, TRANSFUS MED REV, V21, pS57, DOI 10.1016/j.tmrv.2007.01.002; Field MJ, 1990, CLIN PRACTICE GUIDEL; Grob D, 2008, MUSCLE NERVE, V37, P141, DOI 10.1002/mus.20950; Grol R, 2003, BRIT J CANCER, V89, pS4, DOI 10.1038/sj.bjc.6601077; Gronseth GS, 2000, NEUROLOGY, V55, P7, DOI 10.1212/WNL.55.1.7; Hoekstra JH, 2001, J PEDIATR GASTR NUTR, V33, pS31, DOI 10.1097/00005176-200110002-00006; Huang TW, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-191; Immunology nerve immunology branch in China, 2012, CHIN J NEUROIMMUNOLO, V6, P401; Knai C, 2012, HEALTH POLICY, V107, P157, DOI 10.1016/j.healthpol.2012.06.004; Lo Vecchio A, 2011, J PEDIATR GASTR NUTR, V52, P183, DOI 10.1097/MPG.0b013e3181e233ac; Marinos CD, 1999, MUSCLE NERVE, V22, P1479; Myasthenia Gravis Foundation of America, 2013, WHAT IS MYASTH GRAV; Owe JF, 2006, J NEUROL NEUROSUR PS, V77, P203, DOI 10.1136/jnnp.2005.072355; Patwa HS, 2012, NEUROLOGY, V78, P1009, DOI 10.1212/WNL.0b013e31824de293; REIS EC, 1994, PEDIATRICS, V93, P708; Richman DP, 2003, NEUROLOGY, V61, P1652, DOI 10.1212/01.WNL.0000098887.24618.A0; Simone B, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-143; Skeie GO, 2006, EUR J NEUROL, V13, P691, DOI 10.1111/j.1468-1331.2006.01476.x; Skeie GO, 2010, EUR J NEUROL, V17, P893, DOI 10.1111/j.1468-1331.2010.03019.x; Szajewska H, 2000, J PEDIATR GASTR NUTR, V30, P522, DOI 10.1097/00005176-200005000-00011; The neurology branch of Chinese medical association neural immune group China's nerve immunology branch of immunology, 2011, CHIN J NEUROIMMUNOLO, V5, P368; Willison HJ, 2000, EUR J NEUROL, V7, P625, DOI 10.1046/j.1468-1331.2000.00158.x; Xie LM, 2012, J CHINESE INTEGRATIV, V10, P160; Zhang ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053566	38	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111796	10.1371/journal.pone.0111796	http://dx.doi.org/10.1371/journal.pone.0111796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402504	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700019
J	Chen, L; Peng, F; Wang, T; Chen, DS; Yang, JY				Chen, Lin; Peng, Feng; Wang, Tao; Chen, Desong; Yang, Jianyun			Traumatic Pseudoaneurysm of Axillary Artery Combined with Brachial Plexus Injury	PLOS ONE			English	Article							FALSE ANEURYSM; SHOULDER; DISLOCATION	Traumatic pseudoaneurysm of the axillary artery combined with brachial plexus injury is extremely rare. The factors that influence the symptoms and functional recovery related to this condition are unclear. Nine patients who had sustained this trauma were surgically treated at our unit between June 1999 and November 2010. The cause of trauma, symptoms, signs and examinations of neurological and vascular deficits, and the surgical findings of the involved nerves and vessels were recorded in detail. The functional recovery of vessels and nerves, as well as the extent of pain, were evaluated, respectively. The average length of patient follow-up was 4.5 years (range, 24 months to 11.3 years). After vessel repair, whether by endovascular or operative treatment, the distending, constant, and pulsating pain was relieved in all patients. Furthermore, examination of the radial artery pulse on the repaired side appeared normal at last follow-up. All patients showed satisfactory sensory recovery, with motor recovery rated as good in five patients and fair in four patients. The symptom characteristics varied with the location of the damage to the axillary artery. Ultrasound examination and computed tomography angiography are useful to evaluate vascular injury and provide valuable information for operative planning. Surgical exploration is an effective therapy with results related to the nerve injury condition of the brachial plexus.	[Chen, Lin; Peng, Feng; Wang, Tao; Chen, Desong; Yang, Jianyun] Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai 200433, Peoples R China; [Chen, Lin; Peng, Feng; Wang, Tao; Chen, Desong; Yang, Jianyun] Minist Hlth, Key Lab Hand Reconstruct, Shanghai, Peoples R China; [Chen, Lin; Peng, Feng; Wang, Tao; Chen, Desong; Yang, Jianyun] Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China	Fudan University	Peng, F (corresponding author), Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai 200433, Peoples R China.	peng_f@163.com						Adovasio R, 1996, J TRAUMA, V41, P754, DOI 10.1097/00005373-199610000-00028; Birch R, 1998, SURG DISORDERS PERIP, P235; GALLEN J, 1984, J TRAUMA, V24, P350, DOI 10.1097/00005373-198404000-00013; GRAHAM JM, 1982, ANN SURG, V195, P232, DOI 10.1097/00000658-198202000-00020; GROH GI, 1990, J BONE JOINT SURG AM, V72A, P1407, DOI 10.2106/00004623-199072090-00022; Helm AT, 2002, J SHOULDER ELB SURG, V11, P278, DOI 10.1067/mse.2002.122231; Jackson MR, 1997, J TRAUMA, V43, P159, DOI 10.1097/00005373-199707000-00041; Julia J, 1998, J CARDIOVASC SURG, V39, P167; Kapoor BS, 2009, CURR PROBL DIAGN RAD, V38, P170, DOI 10.1067/j.cpradiol.2008.11.001; Kumar RM, 2009, CARDIOVASC INTER RAD, V32, P598, DOI 10.1007/s00270-009-9543-5; Martinez R, 1999, J CARDIOVASC SURG, V40, P413; Miller-Thomas MM, 2005, RADIOGRAPHICS, V25, pS133, DOI 10.1148/rg.25si055511; NASH E, 1984, J TRAUMA, V24, P546, DOI 10.1097/00005373-198406000-00016; Roganovic Z, 2007, J NEUROSURG, V107, P765, DOI 10.3171/JNS-07/10/0765; Stenning M, 2005, J BONE JOINT SURG BR, V87B, P1102, DOI 10.1302/0301-620X.87B8.15976	15	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113099	10.1371/journal.pone.0113099	http://dx.doi.org/10.1371/journal.pone.0113099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412426	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000026
J	Hooper, CM; Hawes, SM; Kees, UR; Gottardo, NG; Dallas, PB				Hooper, Cornelia M.; Hawes, Susan M.; Kees, Ursula R.; Gottardo, Nicholas G.; Dallas, Peter B.			Gene Expression Analyses of the Spatio-Temporal Relationships of Human Medulloblastoma Subgroups during Early Human Neurogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ALPHA-SYNUCLEIN; NEURAL PROGENITORS; INITIATING CELLS; PRECURSOR CELLS; MAMMALIAN BRAIN; MOUSE MODEL; DIFFERENTIATION; TUMORS; IDENTIFICATION	Medulloblastoma is the most common form of malignant paediatric brain tumour and is the leading cause of childhood cancer related mortality. The four molecular subgroups of medulloblastoma that have been identified - WNT, SHH, Group 3 and Group 4 - have molecular and topographical characteristics suggestive of different cells of origin. Definitive identification of the cell(s) of origin of the medulloblastoma subgroups, particularly the poorer prognosis Group 3 and Group 4 medulloblastoma, is critical to understand the pathogenesis of the disease, and ultimately for the development of more effective treatment options. To address this issue, the gene expression profiles of normal human neural tissues and cell types representing a broad neuro-developmental continuum, were compared to those of two independent cohorts of primary human medulloblastoma specimens. Clustering, co-expression network, and gene expression analyses revealed that WNT and SHH medulloblastoma may be derived from distinct neural stem cell populations during early embryonic development, while the transcriptional profiles of Group 3 and Group 4 medulloblastoma resemble cerebellar granule neuron precursors at weeks 10-15 and 20-30 of embryogenesis, respectively. Our data indicate that Group 3 medulloblastoma may arise through abnormal neuronal differentiation, whereas deregulation of synaptic pruning-associated apoptosis may be driving Group 4 tumorigenesis. Overall, these data provide significant new insight into the spatio-temporal relationships and molecular pathogenesis of the human medulloblastoma subgroups, and provide an important framework for the development of more refined model systems, and ultimately improved therapeutic strategies.	[Hooper, Cornelia M.; Gottardo, Nicholas G.; Dallas, Peter B.] Univ Western Australia, Telethon Kids Inst, Brain Tumour Res Program, Subiaco, WA, Australia; [Hooper, Cornelia M.] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Ctr Excellence Computat Syst Biol, Perth, WA 6009, Australia; [Hawes, Susan M.] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Kees, Ursula R.] Univ Western Australia, Telethon Kids Inst, Div Childrens Leukaemia & Canc Res, Subiaco, WA, Australia; [Gottardo, Nicholas G.] Princess Margaret Hosp Children, Dept Paediat Oncol & Haematol, Subiaco, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; Monash University; Telethon Kids Institute; University of Western Australia	Dallas, PB (corresponding author), Univ Western Australia, Telethon Kids Inst, Brain Tumour Res Program, Subiaco, WA, Australia.	peter.dallas@telethonkids.org.au	Hooper, Cornelia M M/H-5060-2014	Hooper, Cornelia M M/0000-0002-3471-8286; Gottardo, Nicholas/0000-0002-1082-6776	Australian National Health and Research Council (NHMRC) [403893]; Government of Western Australia; Stan and Jean Perron award; Jock and Marjorie Hetherington Award for Neuroscience Tesearch; Children's Leukaemia and Cancer Research Foundation/Three boys Legacy	Australian National Health and Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Government of Western Australia; Stan and Jean Perron award; Jock and Marjorie Hetherington Award for Neuroscience Tesearch; Children's Leukaemia and Cancer Research Foundation/Three boys Legacy	This work was supported by the Australian National Health and Research Council (NHMRC, Project grant 403893, URK and PBD); the Government of Western Australia through funding for the WA Centre of Excellence for Computational Systems Biology (DIR WA CoE) (CMH), the Stan and Jean Perron award (CMH), and the Jock and Marjorie Hetherington Award for Neuroscience Tesearch (CMH). The authors thank The Children's Leukaemia and Cancer Research Foundation/Three boys Legacy for financial support for the purchase of critical equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RY, 2012, CANCER RES, V72, P5988, DOI 10.1158/0008-5472.CAN-12-0614; Basak O, 2009, CELL MOL LIFE SCI, V66, P1057, DOI 10.1007/s00018-008-8544-x; Ben-Zvi A, 2006, J NEUROCHEM, V96, P585, DOI 10.1111/j.1471-4159.2005.03580.x; Bertram CM, 2010, STEM CELLS DEV, V19, P569, DOI 10.1089/scd.2009.0183; Bibb LC, 2001, HUM MOL GENET, V10, P1571, DOI 10.1093/hmg/10.15.1571; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Colombo E, 2006, STEM CELLS, V24, P825, DOI 10.1634/stemcells.2005-0313; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gielen GH, 2012, APPL IMMUNOHISTOCHEM; Gottardo NG, 2014, ACTA NEUROPATHOL, V127, P189, DOI 10.1007/s00401-013-1213-7; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hoffmann K, 2005, MOL BIOTECHNOL, V29, P31, DOI 10.1385/MB:29:1:31; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jossin Y, 2004, MOL NEUROBIOL, V30, P225, DOI 10.1385/MN:30:3:225; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kast RE, 2013, J NEUROONCOLOGY; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kimura J, 2011, INT J CANCER, V128, P1524, DOI 10.1002/ijc.25475; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Kowara R, 2007, BIOCHEM BIOPH RES CO, V363, P190, DOI 10.1016/j.bbrc.2007.08.163; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kulkarni AV, 2013, J NEUROSURG-PEDIATR, V12, P235, DOI 10.3171/2013.6.PEDS12535; Kumar K, 2013, CELL MOL NEUROBIOL, V33, P731, DOI 10.1007/s10571-013-9942-7; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Monti B, 2007, J NEUROCHEM, V103, P518, DOI 10.1111/j.1471-4159.2007.04778.x; Mori F, 2003, J NEUROPATH EXP NEUR, V62, P812, DOI 10.1093/jnen/62.8.812; Muranishi Y, 2010, BIOCHEM BIOPH RES CO, V392, P317, DOI 10.1016/j.bbrc.2010.01.007; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Nuber S, 2010, NEUROGENETICS, V11, P107, DOI 10.1007/s10048-009-0212-2; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P2212, DOI 10.1093/nar/30.10.2212; Santagata S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007932; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Teo WY, 2013, PEDIATR BLOOD CANCER, V60, P1408, DOI 10.1002/pbc.24511; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Unland R, 2014, J NEURO-ONCOL, V116, P237, DOI 10.1007/s11060-013-1313-1; Wefers AK, 2014, ACTA NEUROPATHOL, V127, P931, DOI 10.1007/s00401-014-1271-5; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	62	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112909	10.1371/journal.pone.0112909	http://dx.doi.org/10.1371/journal.pone.0112909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412507	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000018
J	Wang, RJ; Wu, P; Shi, DB; Zheng, HT; Huang, LY; Gu, WL; Xu, Y; Cai, SJ; Cai, GX				Wang, Renjie; Wu, Peng; Shi, Debing; Zheng, Hongtu; Huang, Liyong; Gu, Weilie; Xu, Ye; Cai, Sanjun; Cai, Guoxiang			Risk Factors of Synchronous Inguinal Lymph Nodes Metastasis for Lower Rectal Cancer Involving the Anal Canal	PLOS ONE			English	Article							EPIDERMOID CARCINOMA; ADENOCARCINOMA; MORBIDITY; LYMPHADENECTOMY; ANORECTUM	Purpose: The aim of the study is to identify the risk factors of synchronous ILN metastasis for lower rectal cancer involving the anal canal. Methods: Patients with lower rectal cancer who underwent radical resection at the Fudan University Shanghai Cancer Center were retrospectively analyzed. The synchronous ILN metastasis was defined as the metastasis occurring within 6 months after the diagnosis of rectal cancer. Patients' gender, age, tumor diameter, dentate line invasion, differentiation level, histological type, depth of invasion, perirectal LN metastasis, lymphovascular invasion or perineural invasion were analyzed in the study. The correlation between synchronous ILN involvement and clinicopathological features were analyzed with Chi-square test/fisher's exact test. Variables with p<0.05 in univariate analysis were then analyzed in a multivariate logistic model. Odds ratio (OR) along with 95% confidence intervals (95% CI) were calculated. Results: A total of 325 patients (182 men and 143 women) with lower rectal cancer met the criteria and were enrolled in the study. Among them, 20 patients (6.2%) had synchronous ILN metastasis. Both univariate and multivariate analysis showed the invasion of the dentate line had a strong correlation with synchronous ILN metastasis with the odds ratio (OR) of 23.558 [95% confidence interval (CI) 6.380-86.982] (p<0.001). The presence of lymphovascular invasion also showed a significant correlation synchronous ILN metastasis with odds ratio (OR) of 5.260 [95% confidence interval (CI) 1.818-15.212] (p = 0.002). Conclusions: The invasion of dentate line and lymphovascular invasion are two independent risk factors of inguinal lymph node metastasis for lower rectal cancer involving the anal canal.	[Wang, Renjie; Wu, Peng; Shi, Debing; Zheng, Hongtu; Huang, Liyong; Gu, Weilie; Xu, Ye; Cai, Sanjun; Cai, Guoxiang] Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Wang, Renjie; Wu, Peng; Shi, Debing; Zheng, Hongtu; Huang, Liyong; Gu, Weilie; Xu, Ye; Cai, Sanjun; Cai, Guoxiang] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Cai, GX (corresponding author), Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	gxcai@fudan.edu.cn			National Natural Science Foundation of China [81001055]; Shanghai Pujiang Program [13PJD008]; National High Technology Research and Development Program (863 Program) [2012AA02A506]; Shanghai Shenkang Program [SHDC12014206, SHDC12012120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Shenkang Program	This study was supported by grants from the National Natural Science Foundation of China (No. 81001055), Shanghai Pujiang Program (No. 13PJD008), National High Technology Research and Development Program (863 Program, No. 2012AA02A506) and Shanghai Shenkang Program (No. SHDC12014206 and No. SHDC12012120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebenek M, 2009, ANN SURG ONCOL, V16, P887, DOI 10.1245/s10434-009-0324-9; BOMAN BM, 1984, CANCER-AM CANCER SOC, V54, P114, DOI 10.1002/1097-0142(19840701)54:1<114::AID-CNCR2820540124>3.0.CO;2-P; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; FROST DB, 1984, CANCER, V53, P1285, DOI 10.1002/1097-0142(19840315)53:6<1285::AID-CNCR2820530611>3.0.CO;2-N; Fuchshuber PR, 1997, J AM COLL SURGEONS, V185, P494, DOI 10.1016/S1072-7515(01)00967-X; Glimelius B, 2010, ANN ONCOL, V21, pv82, DOI 10.1093/annonc/mdq170; GRAHAM RA, 1990, DIS COLON RECTUM, V33, P212, DOI 10.1007/BF02134182; Grinnell RS, 1942, ANN SURG, V116, P200, DOI 10.1097/00000658-194208000-00005; Hamano T, 2010, COLORECTAL DIS, V12, pE200, DOI 10.1111/j.1463-1318.2009.02134.x; Luna-Perez P, 1999, J SURG ONCOL, V70, P177, DOI 10.1002/(SICI)1096-9098(199903)70:3<177::AID-JSO6>3.0.CO;2-0; Mistrangelo M, 2010, INT J RADIAT ONCOL, V77, P73, DOI 10.1016/j.ijrobp.2009.04.020; Mori Takeo, 2003, Nihon Rinsho, V61 Suppl 7, P255; Paley PJ, 1997, GYNECOL ONCOL, V64, P237, DOI 10.1006/gyno.1996.4557; PAPILLON J, 1987, DIS COLON RECTUM, V30, P324, DOI 10.1007/BF02555448; PINTOR MP, 1989, BRIT J SURG, V76, P806, DOI 10.1002/bjs.1800760814; STEARNS MW, 1970, SURG GYNECOL OBSTETR, V131, P953; Taylor N, 2001, INT J RADIAT ONCOL, V51, P741, DOI 10.1016/S0360-3016(01)01687-X; Tocchi A, 1999, DIS COLON RECTUM, V42, P1464, DOI 10.1007/BF02235048; Tonouchi H, 2004, SURG TODAY, V34, P413, DOI 10.1007/s00595-003-2738-5; URIST MM, 1983, CANCER, V51, P2152, DOI 10.1002/1097-0142(19830601)51:11<2152::AID-CNCR2820511134>3.0.CO;2-7	20	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111770	10.1371/journal.pone.0111770	http://dx.doi.org/10.1371/journal.pone.0111770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409168	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200004
J	Deng, SB; Wang, J; Xiao, J; Wu, L; Jing, XD; Yan, YL; Du, JL; Liu, YJ; She, Q				Deng, Song-Bai; Wang, Jing; Xiao, Jun; Wu, Ling; Jing, Xiao-Dong; Yan, Yu-Ling; Du, Jian-Lin; Liu, Ya-Jie; She, Qiang			Adjunctive Manual Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CLINICAL FOLLOW-UP; INITIAL THROMBOSUCTION; PRIMARY ANGIOPLASTY; EXPORT CATHETER; STEMI PATIENTS; THROMBECTOMY; REPERFUSION; IMPACT; ABCIXIMAB	Objective: The aim of this study was to synthesize evidence by examining the effects of manual thrombus aspiration on clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI). Methods and Results: A total of 26 randomized controlled trials (RCTs), enrolling 11,780 patients, with 5,869 patients randomized to manual thrombus aspiration and 5,911 patients randomized to conventional percutaneous coronary intervention (PCI), were included in the meta-analysis. Separate clinical outcome analyses were based on different follow-up periods. There were no statistically reductions in the incidences of mortality (risk ratio [RR], 0.86 [95% confidence interval [CI]: 0.73 to 1.02]), reinfarction (RR, 0.62 [CI, 0.31 to 1.32]) or target vessel revascularization (RR, 0.89 [CI, 0.75 to 1.05]) in the manual thrombus aspiration arm at 12 to 24 months of follow-up. The composite major adverse cardiac events (MACEs) outcomes were significantly lower in the manual thrombus aspiration arm over the long-term follow-up (RR, 0.76 [CI, 0.63 to 0.91]). A lower incidence of reinfarction was observed in the hospital to 30 days (RR, 0.59 [CI, 0.37 to 0.92]). Conclusion: The present meta-analysis suggested that there was no evidence that using manual thrombus aspiration in patients with STEMI could provide distinct benefits in long-term clinical outcomes.	[Deng, Song-Bai; Wang, Jing; Wu, Ling; Jing, Xiao-Dong; Yan, Yu-Ling; Du, Jian-Lin; Liu, Ya-Jie; She, Qiang] Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China; [Xiao, Jun] Med Emergency Ctr Chongqing, Dept Cardiol, Chongqing, Peoples R China	Chongqing Medical University	She, Q (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China.	qshe98@hotmail.com			University of Glasgow; Institute of Health; Wellbeing's Department of General Practice and Primary Care 'Master of Primary Care' course and Doctorate of Philosophy degree programme	University of Glasgow; Institute of Health; Wellbeing's Department of General Practice and Primary Care 'Master of Primary Care' course and Doctorate of Philosophy degree programme	This study was supported by the University of Glasgow, Institute of Health and Wellbeing's Department of General Practice and Primary Care 'Master of Primary Care' course and Doctorate of Philosophy degree programme. We would like to thank Brian Rae for NHS research management support and advice and the SOS (previously known as 'Clinical Facilitation') team: Victoria Hunt, Janet Black, Lynn Walker, Jan Currie, Marjorie McGhie, Sheila Tennant, Fiona Allen, Dinesh Soni, Alia Gilani, Noreen Downes, Chris Johnson. We are grateful to Zarina Khan and other researchers for data cleaning and collection and to participating practices and to Ruth and Kenny for compiling 10 year follow up prescribing data. We thank the editor and reviewers for helpful comments and suggestions that materially improved this manuscript.	Bavry AA, 2008, EUR HEART J, V29, P2989, DOI 10.1093/eurheartj/ehn421; Bulum J, 2012, CORONARY ARTERY DIS, V23, P487, DOI 10.1097/MCA.0b013e3283587866; Burzotta F, 2005, J AM COLL CARDIOL, V46, P371, DOI 10.1016/j.jacc.2005.04.057; Chao CL, 2008, INT J CLIN PRACT, V62, P555, DOI 10.1111/j.1742-1241.2007.01542.x; Chevalier Bernard, 2008, EuroIntervention, V4, P222, DOI 10.4244/EIJV4I2A40; Ciszewski M, 2011, CATHETER CARDIO INTE, V78, P523, DOI 10.1002/ccd.22933; Costopoulos C, 2013, INT J CARDIOL, V163, P229, DOI 10.1016/j.ijcard.2011.11.014; De Carlo M, 2012, JACC-CARDIOVASC INTE, V5, P1223, DOI 10.1016/j.jcin.2012.08.013; De Luca G, 2008, EUR HEART J, V29, P3002, DOI 10.1093/eurheartj/ehn389; De Luca L, 2006, HEART, V92, P951, DOI 10.1136/hrt.2005.074716; Dudek Dariusz, 2004, Kardiol Pol, V61, P523; Dudek D, 2010, AM HEART J, V160, P966, DOI 10.1016/j.ahj.2010.07.024; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ikari Y, 2008, JACC-CARDIOVASC INTE, V1, P424, DOI 10.1016/j.jcin.2008.06.004; Jolly SS, 2014, AM HEART J, V167, P315, DOI 10.1016/j.ahj.2013.12.002; Kaltoft A, 2006, CIRCULATION, V114, P40, DOI 10.1161/CIRCULATIONAHA.105.595660; Kikkert WJ, 2013, CATHETER CARDIO INTE, V81, P922, DOI 10.1002/ccd.24592; Kilic S, 2014, THROMB HAEMOSTASIS, V111, P165, DOI 10.1160/TH13-05-0433; Kozuma K, 2007, CIRCULATION, V116, P378; Kozuma K, 2009, CIRCULATION, V120, pS985; Kumbhani DJ, 2014, CATHETER CARDIO INTE, V84, P973, DOI 10.1002/ccd.25532; Kumbhani DJ, 2013, J AM COLL CARDIOL, V62, P1409, DOI 10.1016/j.jacc.2013.04.025; Kunii H, 2004, J AM COLL CARDIOL, V43, p245A; Lagerqvist B, 2014, NEW ENGL J MED, V371, P1111, DOI 10.1056/NEJMoa1405707; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liistro F, 2009, CIRC-CARDIOVASC INTE, V2, P376, DOI 10.1161/CIRCINTERVENTIONS.109.852665; Lipiecki J, 2008, AM HEART J, V157, P581; Liu CP, 2012, INT J CARDIOL, V156, P174, DOI 10.1016/j.ijcard.2010.10.129; Noel B, 2005, CIRCULATION, V112, pU579; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Onuma Y, 2013, EUR HEART J, V34, P1050, DOI 10.1093/eurheartj/ehs456; Sardella G, 2010, AM J CARDIOL, V106, P624, DOI 10.1016/j.amjcard.2010.04.014; Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017; Silva-Orrego P, 2006, J AM COLL CARDIOL, V48, P1552, DOI 10.1016/j.jacc.2006.03.068; Sim DS, 2013, INT J CARDIOL, V168, P4328, DOI 10.1016/j.ijcard.2013.05.088; Stone GW, 2013, CIRC-CARDIOVASC INTE, V6, P527, DOI 10.1161/CIRCINTERVENTIONS.113.000644; Stone GW, 2012, JAMA-J AM MED ASSOC, V307, P1817, DOI 10.1001/jama.2012.421; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; Tanabe K, 2011, CIRCULATION, V124; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Woo SI, 2014, EUROINTERVENTION, V9, P57, DOI [10.4244/EIJV919A179, 10.4244/EIJV9I9A179]	44	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113481	10.1371/journal.pone.0113481	http://dx.doi.org/10.1371/journal.pone.0113481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405874	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300119
J	Diederich, A; Schomburg, A; van Vugt, M				Diederich, Adele; Schomburg, Annette; van Vugt, Marieke			Fronto-Central Theta Oscillations Are Related to Oscillations in Saccadic Response Times (SRT): An EEG and Behavioral Data Analysis	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; VISUAL-CORTEX; PHASE RESET; SYNCHRONIZATION; PERFORMANCE; ATTENTION	The phase reset hypothesis states that the phase of an ongoing neural oscillation, reflecting periodic fluctuations in neural activity between states of high and low excitability, can be shifted by the occurrence of a sensory stimulus so that the phase value become highly constant across trials (Schroeder et al., 2008). From EEG/MEG studies it has been hypothesized that coupled oscillatory activity in primary sensory cortices regulates multi sensory processing (Senkowski et al. 2008). We follow up on a study in which evidence of phase reset was found using a purely behavioral paradigm by including also EEG measures. In this paradigm, presentation of an auditory accessory stimulus was followed by a visual target with a stimulus-onset asynchrony (SOA) across a range from 0 to 404 ms in steps of 4 ms. This fine-grained stimulus presentation allowed us to do a spectral analysis on the mean SRT as a function of the SOA, which revealed distinct peak spectral components within a frequency range of 6 to 11 Hz with a modus of 7 Hz. The EEG analysis showed that the auditory stimulus caused a phase reset in 7-Hz brain oscillations in a widespread set of channels. Moreover, there was a significant difference in the average phase at which the visual target stimulus appeared between slow and fast SRT trials. This effect was evident in three different analyses, and occurred primarily in frontal and central electrodes.	[Diederich, Adele; Schomburg, Annette] Jacobs Univ Bremen, Sch Humanities & Social Sci, D-28759 Bremen, Germany; [van Vugt, Marieke] Univ Groningen, Dept Artificial Intelligence & Cognit Engn, Groningen, Netherlands	Jacobs University; University of Groningen	Diederich, A (corresponding author), Jacobs Univ Bremen, Sch Humanities & Social Sci, D-28759 Bremen, Germany.	a.diederich@jacobs-university.de	van Vugt, Marieke/A-8159-2011	van Vugt, Marieke/0000-0003-3200-0059	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [DI506/12-1]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) grant DI506/12-1 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Clochon P, 1996, ELECTROEN CLIN NEURO, V98, P126, DOI 10.1016/0013-4694(95)00192-1; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Diederich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044910; Drewes J, 2011, J NEUROSCI, V31, P4698, DOI 10.1523/JNEUROSCI.4795-10.2011; Fiebelkorn IC, 2013, CURR BIOL, V23, P2553, DOI 10.1016/j.cub.2013.10.063; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; Freeman WJ, 2002, J NEUROPHYSIOL, V87, P937, DOI 10.1152/jn.00254.2001; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Fries P, 2002, J NEUROSCI, V22, P3739; Hanslmayr S, 2013, CURR BIOL, V23, P2273, DOI 10.1016/j.cub.2013.09.020; Kaiser J, 2002, CEREB CORTEX, V12, P212, DOI 10.1093/cercor/12.2.212; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Mercier MR, 2013, NEUROIMAGE, V79, P19, DOI 10.1016/j.neuroimage.2013.04.060; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Romei V, 2012, CURR BIOL, V22, P807, DOI 10.1016/j.cub.2012.03.025; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Thorne J, 2014, HEARING RES, P1144; Thorne JD, 2011, J NEUROSCI, V31, P3853, DOI 10.1523/JNEUROSCI.6176-10.2011; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van Atteveldt N, 2014, NEURON, V81, P1240, DOI 10.1016/j.neuron.2014.02.044; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; VARELA FJ, 1981, NEUROPSYCHOLOGIA, V19, P675	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112974	10.1371/journal.pone.0112974	http://dx.doi.org/10.1371/journal.pone.0112974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405521	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300067
J	Garcia, A; Leonardi, D; Vasconi, MD; Hinrichsen, LI; Lamas, MC				Garcia, Agustina; Leonardi, Dario; Vasconi, Maria D.; Hinrichsen, Lucila I.; Lamas, Maria C.			Characterization of Albendazole-Randomly Methylated-beta-Cyclodextrin Inclusion Complex and In Vivo Evaluation of Its Antihelmitic Activity in a Murine Model of Trichinellosis	PLOS ONE			English	Article							TRICHINELLA-SPIRALIS; KETOPROFEN; NAPROXEN; BINARY	Albendazole is a benzimidazole carbamate extensively used in oral chemotherapy against intestinal parasites, due to its broad spectrum activity, good tolerance and low cost. However, the drug has the disadvantage of poor bioavailability due to its very low solubility in water; as a consequence, a very active area of research focuses on the development of new pharmaceutical formulations to increase its solubility, dissolution rate, and bioavailability. The primary objective of this study was to prepare randomly methylated beta-cyclodextrins inclusion complexes to increase albendazole dissolution rate, in order to enhance its antiparasitic activity. This formulation therapeutic efficacy was contrasted with that of the pure drug by treating Trichinella spiralis infected mice during the intestinal phase of the parasite cycle, on days five and six post-infection. This protocol significantly decreased muscle larval burden measured in the parenteral stage on day 30 post-infection, when compared with the untreated control. Thus, it could be demonstrated that the inclusion complexes improve the in vivo therapeutic activity of albendazole.	[Garcia, Agustina; Leonardi, Dario; Lamas, Maria C.] Univ Nacl Rosario, Dept Farm, RA-2000 Rosario, Santa Fe, Argentina; [Garcia, Agustina; Leonardi, Dario; Lamas, Maria C.] Univ Nacl Rosario, IQUIR CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Vasconi, Maria D.] Univ Nacl Rosario, Area Parasitol, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Vasconi, Maria D.; Hinrichsen, Lucila I.] Univ Nacl Rosario, Inst Genet Expt, RA-2000 Rosario, Santa Fe, Argentina; [Hinrichsen, Lucila I.] Univ Nacl Rosario, CIC UNR, Fac Ciencias Med, RA-2000 Rosario, Santa Fe, Argentina	National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; National University of Rosario; National University of Rosario	Lamas, MC (corresponding author), Univ Nacl Rosario, Dept Farm, RA-2000 Rosario, Santa Fe, Argentina.	mlamas@fbioyf.unr.edu.ar		/0000-0001-6738-1918; Leonardi, Dario/0000-0003-2292-3570	Proyectos de investigacion plurianuales; Consejo Nacional de Investigaciones Cientificas y Tecnicas [112-201001-00194]	Proyectos de investigacion plurianuales; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was supported by the following: Proyectos de investigacion plurianuales. Funder: Consejo Nacional de Investigaciones Cientificas y Tecnicas, N<SUP>o</SUP> 112-201001-00194, MCL and DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzouqi AH, 2009, J PHARMACEUT BIOMED, V49, P227, DOI 10.1016/j.jpba.2008.10.032; Bassani VL, 1996, J INCLUS PHENOM MOL, V25, P149, DOI 10.1007/BF01041557; Bettinetti G, 2002, EUR J PHARM SCI, V15, P21, DOI 10.1016/S0928-0987(01)00199-3; Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012; Carrier RL, 2007, J CONTROL RELEASE, V123, P78, DOI 10.1016/j.jconrel.2007.07.018; Castillo JA, 1999, DRUG DEV IND PHARM, V25, P1241, DOI 10.1081/DDC-100102294; Cirri M, 2009, J PHARMACEUT BIOMED, V50, P683, DOI 10.1016/j.jpba.2008.11.003; Duchene D, 1999, ADV DRUG DELIVER REV, V36, P29, DOI 10.1016/S0169-409X(98)00053-2; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; Evrard B, 2004, J CONTROL RELEASE, V96, P403, DOI 10.1016/j.jconrel.2004.02.010; Garcia A, 2013, PARASITOL INT, V62, P568, DOI 10.1016/j.parint.2013.08.009; Gokturk S, 2012, SCI WORLD J, DOI 10.1100/2012/718791; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Jug M, 2010, J PHARMACEUT BIOMED, V52, P9, DOI 10.1016/j.jpba.2009.11.013; KHAN KA, 1976, J PHARM PHARMACOL, V28, P633, DOI 10.1111/j.2042-7158.1976.tb02816.x; Kociecka W, 2000, VET PARASITOL, V93, P365, DOI 10.1016/S0304-4017(00)00352-6; Kurkov SV, 2013, INT J PHARMACEUT, V453, P167, DOI 10.1016/j.ijpharm.2012.06.055; LopezGarcia ML, 1997, INT J PARASITOL, V27, P781, DOI 10.1016/S0020-7519(97)00052-0; Mura P, 1999, INT J PHARM, V179, P117, DOI 10.1016/S0378-5173(98)00390-1; Mura P, 2005, J PHARMACEUT BIOMED, V37, P987, DOI 10.1016/j.jpba.2004.06.016; Neghina R, 2011, PARASITOL INT, V60, P230, DOI 10.1016/j.parint.2011.01.007; Palomares-Alonso F, 2010, ACTA TROP, V113, P56, DOI 10.1016/j.actatropica.2009.09.006; Pathak SM, 2010, EUR J PHARM SCI, V41, P440, DOI 10.1016/j.ejps.2010.07.013; Piccirilli GN, 2013, DRUG DEV IND PHARM, P1; Pinho E, 2014, CARBOHYD POLYM, V101, P121, DOI 10.1016/j.carbpol.2013.08.078; Sajeesh S, 2010, J CONTROL RELEASE, V147, P377, DOI 10.1016/j.jconrel.2010.08.007; Salustio PJ, 2009, EUR J PHARM BIOPHARM, V71, P377, DOI 10.1016/j.ejpb.2008.09.027; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Teunis PFM, 2012, EPIDEMIOL INFECT, V140, P210, DOI 10.1017/S0950268811000380; United States Pharmacopeial Convention, 2012, US PHARM; Yang B, 2009, BIOORGAN MED CHEM, V17, P6311, DOI 10.1016/j.bmc.2009.07.060; Zoppi A, 2013, AAPS PHARMSCITECH, V14, P727, DOI 10.1208/s12249-013-9958-9	32	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113296	10.1371/journal.pone.0113296	http://dx.doi.org/10.1371/journal.pone.0113296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406084	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300100
J	Liu, X; Wang, ZZ; Zhao, P; Fan, ZM; Sun, AQ; Zhan, F; Fan, YB; Deng, XY				Liu, Xiao; Wang, Zhenze; Zhao, Ping; Fan, Zhanming; Sun, Anqiang; Zhan, Fan; Fan, Yubo; Deng, Xiaoyan			Nitric Oxide Transport in Normal Human Thoracic Aorta: Effects of Hemodynamics and Nitric Oxide Scavengers	PLOS ONE			English	Article							SHEAR-STRESS; ENDOTHELIAL DYSFUNCTION; FLOW; ATHEROSCLEROSIS; BLOOD; BIOAVAILABILITY; DIFFUSION; SYNTHASE; MODEL; CALCIUM	Despite the crucial role of nitric oxide (NO) in the homeostasis of the vasculature, little quantitative information exists concerning NO transport and distribution in medium and large-sized arteries where atherosclerosis and aneurysm occur and hemodynamics is complex. We hypothesized that local hemodynamics in arteries may govern NO transport and affect the distribution of NO in the arteries, hence playing an important role in the localization of vascular diseases. To substantiate this hypothesis, we presented a lumen/wall model of the human aorta based on its MRI images to simulate the production, transport and consumption of NO in the arterial lumen and within the aortic wall. The results demonstrated that the distribution of NO in the aorta was quite uneven with remarkably reduced NO bioavailability in regions of disturbed flow, and local hemodynamics could affect NO distribution mainly via flow dependent NO production rate of endothelium. In addition, erythrocytes in the blood could moderately modulate NO concentration in the aorta, especially at the endothelial surface. However, the reaction of NO within the wall could only slightly affect NO concentration on the luminal surface, but strongly reduce NO concentration within the aortic wall. A strong positive correlation was revealed between wall shear stress and NO concentration, which was affected by local hemodynamics and NO reaction rate. In conclusion, the distribution of NO in the aorta may be determined by local hemodynamics and modulated differently by NO scavengers in the lumen and within the wall.	[Liu, Xiao; Wang, Zhenze; Zhao, Ping; Sun, Anqiang; Zhan, Fan; Fan, Yubo; Deng, Xiaoyan] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing 100191, Peoples R China; [Fan, Zhanming] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China	Beihang University; Capital Medical University	Fan, YB (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing 100191, Peoples R China.	yubofan@buaa.edu.cn; dengxy1953@buaa.edu.cn			National Natural Science Research Foundation of China [31200703, 11332003, 61190123, 11202016, 11421202]; Specialized Research Fund for the Doctoral Program of Higher Education [20121102120038]; National Key Technology RD Program [2012BAI18B02]; 111 Project [B13003]; Beijing Natural Science Foundation [7132086]	National Natural Science Research Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Technology RD Program(National Key Technology R&D Program); 111 Project(Ministry of Education, China - 111 Project); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by Grants-in-Aid from the National Natural Science Research Foundation of China (No. 31200703, 11332003, 61190123, 11202016, 11421202, http://www.nsfc.gov.cn), Specialized Research Fund for the Doctoral Program of Higher Education (20121102120038, http://www.cutech.edu.cn), the National Key Technology R&D Program (2012BAI18B02, http://www.most.gov.cn/), the 111 Project (B13003, http://www.moe.edu.cn/) and Beijing Natural Science Foundation (7132086, http://www.bjnsf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aji W, 1997, CIRCULATION, V95, P430; Andrews AM, 2010, NITRIC OXIDE-BIOL CH, V23, P335, DOI 10.1016/j.niox.2010.08.003; Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Chen KJ, 2008, ANTIOXID REDOX SIGN, V10, P1185, DOI 10.1089/ars.2007.1959; Chen KJ, 2006, FREE RADICAL BIO MED, V41, P668, DOI 10.1016/j.freeradbiomed.2006.05.009; Chen XW, 2011, MED BIOL ENG COMPUT, V49, P633, DOI 10.1007/s11517-011-0758-7; Chen XW, 2006, J APPL PHYSIOL, V100, P482, DOI 10.1152/japplphysiol.00633.2005; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; CHO YI, 1991, BIORHEOLOGY, V28, P241; Choi HW, 2007, ANN BIOMED ENG, V35, P505, DOI 10.1007/s10439-006-9247-9; Cicha I, 2008, CLIN HEMORHEOL MICRO, V39, P113, DOI 10.3233/CH-2008-1074; Cooke JP, 2004, P NATL ACAD SCI USA, V101, P18262, DOI 10.1073/pnas.0409068101; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; de Nigris F, 2004, P NATL ACAD SCI USA, V101, P18262, DOI 10.1073/pnas.0409060101; El Aidi H, 2009, NAT CLIN PRACT CARD, V6, P219, DOI 10.1038/ncpcardio1444; Fadel AA, 2009, ANN BIOMED ENG, V37, P943, DOI 10.1007/s10439-009-9658-5; Gallo D, 2012, ANN BIOMED ENG, V40, P729, DOI 10.1007/s10439-011-0431-1; Grisham MB, 1999, AM J PHYSIOL-GASTR L, V276, pG315, DOI 10.1152/ajpgi.1999.276.2.G315; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hsiai TK, 2007, FREE RADICAL BIO MED, V42, P519, DOI 10.1016/j.freeradbiomed.2006.11.017; Jiang S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3225; Jin RC, 2010, J BLOOD MED, V1, P147; Kauser K, 2000, AM J PHYSIOL-HEART C, V278, pH1679, DOI 10.1152/ajpheart.2000.278.5.H1679; KUCHAN MJ, 1994, AM J PHYSIOL, V266, pC628, DOI 10.1152/ajpcell.1994.266.3.C628; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Lantz J, 2011, INT J APPL MECH, V3, P759, DOI 10.1142/S1758825111001226; Lasheras JC, 2007, ANNU REV FLUID MECH, V39, P293, DOI 10.1146/annurev.fluid.39.050905.110128; Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757; Liu X, 2012, J R SOC INTERFACE, V9, P2468, DOI 10.1098/rsif.2012.0224; Liu X, 2010, ANN BIOMED ENG, V38, P917, DOI 10.1007/s10439-009-9878-8; Liu X, 2009, AM J PHYSIOL-HEART C, V297, pH163, DOI 10.1152/ajpheart.00266.2009; Liu XP, 2008, BIOPHYS J, V94, P1880, DOI 10.1529/biophysj.107.120626; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morbiducci U, 2011, BIOMECH MODEL MECHAN, V10, P339, DOI 10.1007/s10237-010-0238-2; Napoli C, 2006, NITRIC OXIDE-BIOL CH, V15, P265, DOI 10.1016/j.niox.2006.03.011; Neishi Y, 2005, P NATL ACAD SCI USA, V102, P11456, DOI 10.1073/pnas.0501392102; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Plank MJ, 2006, PROG BIOPHYS MOL BIO, V91, P287, DOI 10.1016/j.pbiomolbio.2005.07.005; Plata AM, 2010, ANN BIOMED ENG, V38, P2805, DOI 10.1007/s10439-010-0039-x; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tsoukias N, 2008, MICROCIRCULATION, V15, P813, DOI 10.1080/10739680802010070; Vandrangi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035260; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163; Wang H, 2013, BRIT J HAEMATOL, V162, P120, DOI 10.1111/bjh.12342	52	17	18	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112395	10.1371/journal.pone.0112395	http://dx.doi.org/10.1371/journal.pone.0112395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405341	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300031
J	Stanisavljevic, D; Trajkovic, G; Marinkovic, J; Bukumiric, Z; Cirkovic, A; Milic, N				Stanisavljevic, Dejana; Trajkovic, Goran; Marinkovic, Jelena; Bukumiric, Zoran; Cirkovic, Andja; Milic, Natasa			Assessing Attitudes towards Statistics among Medical Students: Psychometric Properties of the Serbian Version of the Survey of Attitudes Towards Statistics (SATS)	PLOS ONE			English	Article							COLLEGE-STUDENTS; ACHIEVEMENT; PERFORMANCE; VALIDATION; EMOTIONS; SAMPLE; SCALE	Background: Medical statistics has become important and relevant for future doctors, enabling them to practice evidence based medicine. Recent studies report that students' attitudes towards statistics play an important role in their statistics achievements. The aim of the study was to test the psychometric properties of the Serbian version of the Survey of Attitudes Towards Statistics (SATS) in order to acquire a valid instrument to measure attitudes inside the Serbian educational context. Methods: The validation study was performed on a cohort of 417 medical students who were enrolled in an obligatory introductory statistics course. The SATS adaptation was based on an internationally accepted methodology for translation and cultural adaptation. Psychometric properties of the Serbian version of the SATS were analyzed through the examination of factorial structure and internal consistency. Results: Most medical students held positive attitudes towards statistics. The average total SATS score was above neutral (4.3 +/- 0.8), and varied from 1.9 to 6.2. Confirmatory factor analysis validated the six-factor structure of the questionnaire (Affect, Cognitive Competence, Value, Difficulty, Interest and Effort). Values for fit indices TLI (0.940) and CFI (0.961) were above the cut-off of >= 0.90. The RMSEA value of 0.064 (0.051-0.078) was below the suggested value of <= 0.08. Cronbach's alpha of the entire scale was 0.90, indicating scale reliability. In a multivariate regression model, self-rating of ability in mathematics and current grade point average were significantly associated with the total SATS score after adjusting for age and gender. Conclusion: Present study provided the evidence for the appropriate metric properties of the Serbian version of SATS. Confirmatory factor analysis validated the six-factor structure of the scale. The SATS might be reliable and a valid instrument for identifying medical students' attitudes towards statistics in the Serbian educational context.	[Stanisavljevic, Dejana; Trajkovic, Goran; Marinkovic, Jelena; Bukumiric, Zoran; Cirkovic, Andja; Milic, Natasa] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade 11001, Serbia	University of Belgrade	Stanisavljevic, D (corresponding author), Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade 11001, Serbia.	dstanisavljevic@med.bg.ac.rs		Cirkovic, Andja/0000-0002-7542-5690	Ministry of Education, Science and Technological Development of the Republic of Serbia [175020]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This study was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (project No. 175020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artino AR, 2010, MED EDUC, V44, P1203, DOI 10.1111/j.1365-2923.2010.03712.x; Artino AR, 2012, MED TEACH, V34, P240, DOI 10.3109/0142159X.2012.643265; Baloglu M, 2003, PERS INDIV DIFFER, V34, P855, DOI 10.1016/S0191-8869(02)00076-4; Carmona J, 2005, PSYCHOL REP, V97, P53, DOI 10.2466/pr0.97.1.53-62; Cashin SE, 2005, EDUC PSYCHOL MEAS, V65, P509, DOI 10.1177/0013164404272488; Chiesi F, 2010, STAT ED RES J, V9, P6, DOI [DOI 10.52041/SERJ.V9I1.385, DOI 10.1177/0734282911404985]; Chiesi F, 2009, LEARN INDIVID DIFFER, V19, P309, DOI 10.1016/j.lindif.2008.10.008; Freeman JV, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-28; Gal I., 1997, ASSESSMENT CHALLENGE, V12, P37; Hannigan A, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-70; Harlow LL, 2002, STRUCT EQU MODELING, V9, P413, DOI 10.1207/S15328007SEM0903_6; Hilton SC, 2004, STRUCT EQU MODELING, V11, P92, DOI 10.1207/S15328007SEM1101_7; HUNPONUWUSU OO, 1977, MED EDUC, V11, P351, DOI 10.1111/j.1365-2923.1977.tb00627.x; Khavenson T, 2012, PROCD SOC BEHV, V46, P2126, DOI 10.1016/j.sbspro.2012.05.440; Morris RW, 2002, STAT MED, V21, P969, DOI 10.1002/sim.1126; Onwuegbuzie A. J., 2000, ASSESS EVAL HIGH EDU, V25, P321, DOI [DOI 10.1080/713611437, 10.1080/713611437]; Onwuegbuzie A.J., 2003, TEACH HIGH EDUC, V8, P195, DOI [DOI 10.1080/1356251032000052447, 10.1080/1356251032000052447]; Onwuegbuzie AJ, 2003, EDUC PSYCHOL MEAS, V63, P1020, DOI 10.1177/0013164402250989; SCHAU C, 1995, EDUC PSYCHOL MEAS, V55, P868, DOI 10.1177/0013164495055005022; Schau C, 2003, ASA P AM STAT ASS JO, P3673; Schutz PA, 1998, LEARN INDIVID DIFFER, V10, P291, DOI 10.1016/S1041-6080(99)80124-1; Tang M, 2005, J INSTR PSYCHOL, V32, P205; Tremblay PF, 2000, CAN J BEHAV SCI, V32, P40, DOI 10.1037/h0087099; Windish DM, 2007, JAMA-J AM MED ASSOC, V298, P1010, DOI 10.1001/jama.298.9.1010; WISE SL, 1985, EDUC PSYCHOL MEAS, V45, P401, DOI 10.1177/001316448504500226; Zhang YH, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-117	26	18	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112567	10.1371/journal.pone.0112567	http://dx.doi.org/10.1371/journal.pone.0112567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405489	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300039
J	Tsuda, N; Kumadaki, S; Higashi, C; Ozawa, M; Shinozaki, M; Kato, Y; Hoshida, K; Kikuchi, S; Nakano, Y; Ogawa, Y; Furusako, S				Tsuda, Naoto; Kumadaki, Shin; Higashi, Chika; Ozawa, Makoto; Shinozaki, Mikihiko; Kato, Yutaka; Hoshida, Koutarou; Kikuchi, Satomi; Nakano, Yoshihisa; Ogawa, Yoshihiro; Furusako, Shoji			Intestine-Targeted DGAT1 Inhibition Improves Obesity and Insulin Resistance without Skin Aberrations in Mice	PLOS ONE			English	Article							ACYLTRANSFERASE 1 INHIBITION; DIACYLGLYCEROL ACYLTRANSFERASE; TRIGLYCERIDE SYNTHESIS; LIPID-METABOLISM; SKELETAL-MUSCLE; INTRAMUSCULAR TRIGLYCERIDE; SENSITIVITY; STEATOSIS; SECRETION; POTENT	Objective: Diacylglycerol O-acyltransferase 1 (DGAT1) catalyzes the final committed step in triglyceride biosynthesis. DGAT1 null mice are known to be resistant to diet-induced obesity, and more insulin sensitive relative to the wild-type; however, the mice exhibit abnormalities in the skin. This work determined whether the intestine-targeted DGAT1 inhibitor could improve obesity and insulin resistance without skin aberrations in mice. Design and Methods: We synthesized 2 DGAT1 inhibitors: Compound A, described in the patent application from the Japan Tobacco, and Compound B (A-922500), reported by Abbott Laboratories. Both compounds were evaluated for inhibitory activities against DGAT1 enzymes and effects on the skin in mice in vivo. Compound B was further investigated for effects on obesity and insulin resistance in diet-induced-obese (DIO) mice. Results: The 2 compounds comparably inhibited the DGAT1 enzyme activity and the cellular triglyceride synthesis in vitro, while they showed different distribution patterns in mice in vivo. Compound A, which distributed systemically, caused skin aberrations, while Compound B, which preferentially distributed to the intestine, improved obesity and insulin resistance without skin aberrations in DIO mice. Conclusions: Our results suggest that the intestine is the key tissue in which DGAT1 plays a role in promoting obesity and insulin resistance.	[Tsuda, Naoto; Kumadaki, Shin; Higashi, Chika; Ozawa, Makoto; Shinozaki, Mikihiko; Kato, Yutaka; Hoshida, Koutarou; Kikuchi, Satomi; Nakano, Yoshihisa; Furusako, Shoji] Mochida Pharmaceut Co Ltd, Discovery Res, Shizuoka, Japan; [Tsuda, Naoto; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan	Mochida Pharmaceutical Co Ltd; Tokyo Medical & Dental University (TMDU)	Tsuda, N (corresponding author), Mochida Pharmaceut Co Ltd, Discovery Res, Shizuoka, Japan.	naoto.tsuda@mochida.co.jp		Ogawa, Yoshihiro/0000-0002-0834-2836	Mochida Pharmaceutical	Mochida Pharmaceutical	Mochida Pharmaceutical provided all funds for this work. NT, SK, CH, MO, MS, YK, KH, SK, YN, and SF are current employees of Mochida Pharmaceutical and may own stock or hold stock options in Mochida Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, J LIPID RES, V53, P2364, DOI 10.1194/jlr.M029041; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Denison H, 2014, DIABETES OBES METAB, V16, P334, DOI 10.1111/dom.12221; Ebeling P, 1998, DIABETOLOGIA, V41, P111, DOI 10.1007/s001250050875; Fox B.M., 2004, Fused bicyclic nitrogen-containing heterocycles, Patent No. [WO2004047755, 2004047755]; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; King AJ, 2009, J PHARMACOL EXP THER, V330, P526, DOI 10.1124/jpet.109.154047; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Manco M, 2000, METABOLISM, V49, P220, DOI 10.1016/S0026-0495(00)91377-5; Muise ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088908; Musso G, 2005, HEPATOLOGY, V42, P1175, DOI 10.1002/hep.20896; Okawa M, 2009, BIOCHEM BIOPH RES CO, V390, P377, DOI 10.1016/j.bbrc.2009.08.167; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Serrano-Wu MH, 2012, ACS MED CHEM LETT, V3, P411, DOI 10.1021/ml3000512; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Yamamoto T, 2011, EUR J PHARMACOL, V650, P663, DOI 10.1016/j.ejphar.2010.10.040; Yamamoto T, 2010, EUR J PHARMACOL, V640, P243, DOI 10.1016/j.ejphar.2010.04.050; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	28	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112027	10.1371/journal.pone.0112027	http://dx.doi.org/10.1371/journal.pone.0112027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405858	Green Submitted, gold, Green Published			2022-12-27	WOS:000347121300021
J	Alexandrescu, R; Siegert, RJ; Turner-Stokes, L				Alexandrescu, Roxana; Siegert, Richard John; Turner-Stokes, Lynne			Functional Outcomes and Efficiency of Rehabilitation in a National Cohort of Patients with Guillain - Barre Syndrome and Other Inflammatory Polyneuropathies	PLOS ONE			English	Article							CARE NEEDS-ASSESSMENT; QUALITY-OF-LIFE; DISABILITY; DEPENDENCY; FIM; MANAGEMENT; SCALE; SCORE; UK	Objectives: To describe functional outcomes, care needs and cost-efficiency of hospital rehabilitation for a UK cohort of inpatients with complex rehabilitation needs arising from inflammatory polyneuropathies. Subjects and Setting: 186 patients consecutively admitted to specialist neurorehabilitation centres in England with Guillain-Barre 'Syndrome (n = 118 (63.4%)) or other inflammatory polyneuropathies, including chronic inflammatory demyelinating polyneuropathy (n = 15 (8.1%) or critical illness neuropathy (n = 32 (17.2%)). Methods: Cohort analysis of data from the UK Rehabilitation Outcomes Collaborative national clinical dataset. Outcome measures include the UK Functional Assessment Measure, Northwick Park Dependency Score (NPDS) and Care Needs Assessment (NPCNA). Patients were analysed in three groups of dependency based on their admission NPDS score: 'low' (NPDS, 10), 'medium' (NPDS 10-24) and 'high' (NPDS $25). Cost-efficiency was measured as the time taken to offset the cost of rehabilitation by savings in NPCNA-estimated costs of on-going care in the community. Results: The mean rehabilitation length of stay was 72.2 (sd = 66.6) days. Significant differences were seen between the diagnostic groups on admission, but all showed significant improvements between admission and discharge, in both motor and cognitive function (p < 0.0001). Patients who were highly dependent on admission had the longest lengths of stay (mean 97.0 (SD 79.0) days), but also showed the greatest reduction in on-going care costs (1049 pound per week (SD 994)) pound, so that overall they were the most cost-efficient to treat. Conclusions: Patients with polyneuropathies have both physical and cognitive disabilities that are amenable to change with rehabilitation, resulting in significant reduction in on-going care-costs, especially for highly dependent patients.	[Alexandrescu, Roxana; Turner-Stokes, Lynne] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London, England; [Siegert, Richard John] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Siegert, Richard John] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Auckland, New Zealand; [Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, London, England	University of London; King's College London; Auckland University of Technology; Auckland University of Technology; Imperial College London	Alexandrescu, R (corresponding author), Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London, England.	roxana.alexandrescu@kcl.ac.uk	Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462; Siegert, Richard/0000-0002-3074-0929	National Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical Trust; National Institute for Health Research [RP-PG-0407-10185] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (RP-PG-0407-10185). Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottemiller KL, 2006, REHABIL NURS, V31, P22, DOI 10.1002/j.2048-7940.2006.tb00006.x; British Society of Rehabilitation Medicine, 2010, SPEC NEUR REH SERV P; Carroll A, 2003, INT J REHABIL RES, V26, P297, DOI 10.1097/01.mrr.0000102064.48781.30; Demir SO, 2008, DISABIL REHABIL, V30, P593, DOI 10.1080/09638280701352626; Forsberg A, 2005, CLIN REHABIL, V19, P900, DOI 10.1191/0269215505cr918oa; Hall K.M., 1993, J HEAD TRAUMA REHAB, DOI [10.1097/00001199-199308020-00008, DOI 10.1097/00001199-199308020-00008]; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Khan F, 2010, J NEUROL, V257, P2024, DOI 10.1007/s00415-010-5653-x; Khan F, 2009, MULT SCLER J, V15, P869, DOI 10.1177/1352458509105230; Khan F, 2010, COCHRANE DB SYST REV, V10; Khan F, 2011, J REHABIL MED, V43, P638, DOI 10.2340/16501977-0826; Law J, 2009, DISABIL REHABIL, V31, P825, DOI 10.1080/09638280802355049; Meythaler JM, 1997, AM J PHYS MED REHAB, V76, P411, DOI 10.1097/00002060-199709000-00012; MOLENAAR DSM, 1995, J NEUROL NEUROSUR PS, V59, P165, DOI 10.1136/jnnp.59.2.165; Nicholas R, 2000, DISABIL REHABIL, V22, P451, DOI 10.1080/09638280050045929; Novak P, 2011, INT J REHABIL RES, V34, P336, DOI 10.1097/MRR.0b013e32834d32c7; Porter M.E., 2006, REDEFINING HLTH CARE; Prasad R, 2001, INT J REHABIL RES, V24, P59, DOI 10.1097/00004356-200103000-00008; Siegert RJ, 2010, J REHABIL MED, V42, P936, DOI 10.2340/16501977-0602; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600; Turner-Stokes L, 2013, DISABIL REHABIL, V35, P1885, DOI 10.3109/09638288.2013.766271; Turner-Stokes L, 2012, CLIN REHABIL, V26, P256, DOI 10.1177/0269215511417469; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Vajsar J, 2003, J PEDIATR-US, V142, P305, DOI 10.1067/mpd.2003.115; Westblad ME, 2009, DISABIL REHABIL, V31, P720, DOI 10.1080/09638280802306497; Williams H, 2007, J ADV NURS, V59, P612, DOI 10.1111/j.1365-2648.2007.04344.x	29	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110532	10.1371/journal.pone.0110532	http://dx.doi.org/10.1371/journal.pone.0110532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25402491	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700005
J	Bettaieb, A; Chahed, S; Tabet, G; Yang, J; Morisseau, C; Griffey, S; Hammock, BD; Haj, FG				Bettaieb, Ahmed; Chahed, Samah; Tabet, George; Yang, Jun; Morisseau, Christophe; Griffey, Stephen; Hammock, Bruce D.; Haj, Fawaz G.			Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice	PLOS ONE			English	Article							KAPPA-B ACTIVATION; CERULEIN-INDUCED PANCREATITIS; HORMONE-INDUCED PANCREATITIS; EPOXYEICOSATRIENOIC ACIDS; INFLAMMATORY RESPONSE; GLUCOSE-HOMEOSTASIS; PROTEIN-KINASE; ACINAR-CELLS; MOUSE MODEL; MAP KINASE	Background: Acute pancreatitis (AP) is a frequent gastrointestinal disorder that causes significant morbidity, and its incidence has been progressively increasing. AP starts as a local inflammation in the pancreas that often leads to systemic inflammatory response and complications. Soluble epoxide hydrolase (sEH) is a cytosolic enzyme whose inhibition in murine models has beneficial effects in inflammatory diseases, but its significance in AP remains unexplored. Methodology/Principal Findings: To investigate whether sEH may have a causal role in AP we utilized Ephx2 knockout (KO) mice to determine the effects of sEH deficiency on cerulein-and arginine-induced AP. sEH expression increased at the protein and messenger RNA levels, as well as enzymatic activity in the early phase of cerulein-and arginine-induced AP in mice. In addition, amylase and lipase levels were lower in cerulein-treated Ephx2 KO mice compared with controls. Moreover, pancreatic mRNA and serum concentrations of the inflammatory cytokines IL-1B and IL-6 were lower in cerulein-treated Ephx2 KO mice compared with controls. Further, Ephx2 KO mice exhibited decreased cerulein-and arginine-induced NF-kappa B inflammatory response, MAPKs activation and decreased cell death. Conclusions-These findings demonstrate a novel role for sEH in the progression of cerulein-and arginine-induced AP.	[Bettaieb, Ahmed; Chahed, Samah; Tabet, George; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Yang, Jun; Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Yang, Jun; Morisseau, Christophe; Hammock, Bruce D.; Haj, Fawaz G.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Griffey, Stephen] Univ Calif Davis, Comparat Pathol Lab, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Div Endocrinol Diabet & Metab, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	fghaj@ucdavis.edu	Yang, Jun/B-2262-2010	Yang, Jun/0000-0001-8126-1728	JDRF [1-2009-337]; NIH [R56DK084317, R01DK090492, RO1DK095359, K99DK100736, ES02710]; NIEHS [P42 ES04699]; NHLBI [HL059699];  [U24DK097154]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL059699, R01HL059699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095359, K99DK100736, U24DK092993, R56DK084317, R01DK090492, U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002710, R01ES002710, P42ES004699] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by research grants from the JDRF (1-2009-337) and NIH (R56DK084317, R01DK090492 and RO1DK095359) to F. G. H.; K99DK100736 to A. B. and by NIH ES02710 and Superfund Basic Research Program Grant P42 ES04699 from NIEHS, and HL059699 Grant from NHLBI and U24DK097154 (to B. D. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae GS, 2011, BIOCHEM BIOPH RES CO, V410, P382, DOI 10.1016/j.bbrc.2011.05.136; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Bettaieb A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-13; Bettaieb A, 2013, J BIOL CHEM, V288, P14189, DOI 10.1074/jbc.M113.458414; BIALEK R, 1991, SCAND J GASTROENTERO, V26, P190, DOI 10.3109/00365529109025030; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen LD, 2013, PROSTAG OTH LIPID M, V104, P42, DOI 10.1016/j.prostaglandins.2012.12.001; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Dahmer MK, 2005, J NEUROSCI RES, V80, P576, DOI 10.1002/jnr.20471; Dawra R, 2007, AM J PHYSIOL-GASTR L, V292, pG1009, DOI 10.1152/ajpgi.00167.2006; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Hofken T, 2000, BIOCHEM BIOPH RES CO, V276, P680, DOI 10.1006/bbrc.2000.3530; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Jha RK, 2009, MED SCI MONITOR, V15, pRA147; Ji B, 2003, PHYSIOL GENOMICS, V14, P59, DOI 10.1152/physiolgenomics.00174.2002; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; LESER HG, 1991, GASTROENTEROLOGY, V101, P782, DOI 10.1016/0016-5085(91)90539-W; Lim JW, 2008, INT J BIOCHEM CELL B, V40, P2065, DOI 10.1016/j.biocel.2008.02.015; Lugea A, 2011, GASTROENTEROLOGY, V140, P987, DOI 10.1053/j.gastro.2010.11.038; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Minutoli L, 2004, LIFE SCI, V75, P2853, DOI 10.1016/j.lfs.2004.03.040; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Naruse S, 2003, INTERNAL MED, V42, P288, DOI 10.2169/internalmedicine.42.288; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Norman J, 1998, AM J SURG, V175, P76, DOI 10.1016/S0002-9610(97)00240-7; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Sarmiento N, 2008, BBA-MOL BASIS DIS, V1782, P271, DOI 10.1016/j.bbadis.2008.01.005; SATO S, 1989, AM J PHYSIOL, V257, pG202, DOI 10.1152/ajpgi.1989.257.2.G202; Schafer C, 2000, J GASTROENTEROL, V35, P1; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Sirish P, 2013, P NATL ACAD SCI USA, V110, P5618, DOI 10.1073/pnas.1221972110; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Tapia JA, 1999, J BIOL CHEM, V274, P31261, DOI 10.1074/jbc.274.44.31261; Vaquero E, 2001, AM J PHYSIOL-GASTR L, V280, pG1197, DOI 10.1152/ajpgi.2001.280.6.G1197; Wagner ACC, 1999, DIGESTION, V60, P41, DOI 10.1159/000007587; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; WILLEMER S, 1992, EUR SURG RES, V24, P29, DOI 10.1159/000129237; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang J, 2014, AM J RESP CELL MOL B; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhang WY, 2013, MOL CARCINOGEN, V52, P726, DOI 10.1002/mc.21918; Zhang XP, 2007, J PANCREAS, V8, P400	54	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113019	10.1371/journal.pone.0113019	http://dx.doi.org/10.1371/journal.pone.0113019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402489	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700096
J	Graham, SM; Raboud, J; Jaoko, W; Mandaliya, K; McClelland, RS; Bayoumi, AM				Graham, Susan M.; Raboud, Janet; Jaoko, Walter; Mandaliya, Kishor; McClelland, R. Scott; Bayoumi, Ahmed M.			Changes in Sexual Risk Behavior in the Mombasa Cohort: 1993-2007	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMMERCIAL SEX; HIV RISK; HEALTH-EDUCATION; WORKERS; PROSTITUTES; KENYA; WOMEN; TRANSMISSION; ACQUISITION	The Mombasa Cohort is an open cohort study following HIV-seronegative women reporting transactional sex. Established in 1993, the cohort provides regular HIV counseling and testing at monthly visits. Over time, HIV acquisition risk has declined steadily in this cohort. To evaluate whether this decline may reflect changes in sexual risk behavior, we investigated trends in condom use and partner numbers among women who participated in the Mombasa Cohort between 1993 and 2007. Multinomial logistic regression and generalized estimating equations were used to evaluate the association of calendar time and follow-up time with key risk behaviors, after adjustment for potential confounding factors. At enrollment visits by 1,844 women, the adjusted probability of never using condoms decreased over time, from 34.2% to 18.9%. Over 23,911 follow-up visits, the adjusted probabilities of reporting >2 partners decreased from 9.9% to 4.9% and inconsistent condom use decreased from 7.9% to 5.3% after >= 12 cohort visits. Important predictors of risk behavior were work venue, charging low fees for sex, and substance abuse. Women with a later sexual debut had less risky behavior. Although sexual risk has declined among women participating in the Mombasa Cohort, HIV acquisition continues to occur and interventions to promote and reinforce safer sex are clearly needed.	[Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Graham, Susan M.; Jaoko, Walter; McClelland, R. Scott] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Raboud, Janet] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Raboud, Janet] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Mandaliya, Kishor] PathCare, Mombasa, Kenya; [McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Bayoumi, Ahmed M.] St Michaels Hosp, Keenan Res Ctr, Ctr Res Inner City Hlth, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] St Michaels Hosp, Div Gen Internal Med, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Washington; University of Washington Seattle; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Graham, SM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	grahamsm@u.washington.edu	Jaoko, Walter/AAN-5048-2020		NIH [K23 AI-069990, P01 HD64915, R01 AI71794, P30 AI027757]; Ontario HIV Treatment Network; Ontario Ministry of Health and Long-Term Care; NIH, NIAID; NIH, NCI; NIH, NIMH; NIH, NIDA; NIH, NICHD; NIH, NHLBI; NIH, NIA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD064915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K23AI069990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario HIV Treatment Network; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SMG was supported by NIH grant K23 AI-069990 (www.nih.gov), JR was supported by an Ontario HIV Treatment Network Career Scientist Award (http://www.ohtn.on.ca), and AMB holds a Chair in Applied Health Services Research from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and the Ontario Ministry of Health and Long-Term Care (http://www.health.gov.on.ca/en). Ongoing support for the Mombasa Cohort includes NIH grants P01 HD64915 and R01 AI71794. Additional infrastructure support for the Mombasa Field Site was provided by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baeten JM, 2000, J ACQ IMMUN DEF SYND, V24, P458, DOI 10.1097/00126334-200008150-00011; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Browne FA, 2010, CURR OPIN PSYCHIATR, V23, P205, DOI 10.1097/YCO.0b013e32833864eb; CHIKWEM JO, 1988, PUBLIC HEALTH, V102, P439, DOI 10.1016/S0033-3506(88)80081-7; Cho H, 2011, J ADOLESCENT HEALTH, V48, P523, DOI 10.1016/j.jadohealth.2010.08.007; Coulaud J P, 1987, Med Trop (Mars), V47, P279; Cox DR., 1989, ANAL BINARY DATA; DAY S, 1988, AIDS, V2, P421, DOI 10.1097/00002030-198812000-00002; DCOSTA LJ, 1985, SEX TRANSM DIS, V12, P64, DOI 10.1097/00007435-198504000-00002; Fisher JC, 2010, SEX TRANSM DIS, V37, P571, DOI 10.1097/OLQ.0b013e3181dbafad; Gelmon L, 2009, KENYA HIV PREVENTION; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; JOHNSON AM, 1988, AIDS, V2, pS49, DOI 10.1097/00002030-198800001-00008; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Lavreys L, 2004, J INFECT DIS, V189, P303, DOI 10.1086/380974; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; MARTIN HL, 1994, AIDS RES HUM RETROV, V10, pS235; McClelland L, 2011, AIDS EDUC PREV, V23, P299, DOI 10.1521/aeap.2011.23.4.299; McClelland RS, 2008, J INFECT DIS, V197, P1361, DOI 10.1086/587490; McClelland RS, 2006, AIDS, V20, P1969, DOI 10.1097/01.aids.0000247119.12327.e6; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Pickering H, 1997, AIDS CARE, V9, P199, DOI 10.1080/09540129750125217; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; ROUMELIOTOU A, 1988, LANCET, V2, P1249; SAWA T, 1978, ECONOMETRICA, V46, P1273, DOI 10.2307/1913828; STATA, 2001, STAT STAT SOFTW REL; *UNAIDS WHO, 2009, 2009 AIDS EP UPD; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Walden VM, 1999, HEALTH EDUC RES, V14, P545, DOI 10.1093/her/14.4.545; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Yadav G, 2005, JAIDS-J ACQ IMM DEF, V38, P329; Yeboah-Afari A, 1988, AIDSWATCH, V4, P4	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113543	10.1371/journal.pone.0113543	http://dx.doi.org/10.1371/journal.pone.0113543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MM	25415287	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600057
J	Gupta, B; Johnson, NW				Gupta, Bhawna; Johnson, Newell W.			Systematic Review and Meta-Analysis of Association of Smokeless Tobacco and of Betel Quid without Tobacco with Incidence of Oral Cancer in South Asia and the Pacific	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; CAVITY CANCER; CHEWING TOBACCO; RISK-FACTORS; GLOBAL EPIDEMIOLOGY; CIGARETTE-SMOKING; ALCOHOL-DRINKING; INDIA; OROPHARYNGEAL; CONSUMPTION	Aim: This systematic review and meta-analysis aimed to critically appraised data from comparable studies leading to quantitative assessment of any independent association between use of oral smokeless tobacco in any form, of betel quid without tobacco and of areca nut with incidence of oral cancer in South Asia and the Pacific. Methods: Studies (case control and/or cohort) were identified by searching Pub Med, CINAHL and Cochrane databases through June 2013 using the keywords oral cancer: chewing tobacco; smokeless tobacco; betel quid; betel quid without tobacco; areca nut; Asia, the Pacific and the reference lists of retrieved articles. A random effects model was used to compute adjusted summary ORRE for the main effect of these habits along with their corresponding 95% confidence intervals. To quantify the impact of between-study heterogeneity on adjusted main-effect summary ORRE, Higgins' H and I-2 statistics along with their 95% uncertainty intervals were used. Funnel plots and Egger's test were used to evaluate publication bias. Results: Meta-analysis of fifteen case-control studies (4,553 cases; 8,632 controls) and four cohort studies (15,342) which met our inclusion criteria showed that chewing tobacco is significantly and independently associated with an increased risk of squamous-cell carcinoma of the oral cavity (adjusted main-effect summary for case-control studies ORRE = 7.46; 95% CI = 5.86-9.50, P<0.001), (adjusted main-effect summary for cohort studies RR = 5.48; 95% CI = 2.56-11.71, P<0.001). Furthermore, meta-analysis of fifteen case control studies (4,648 cases; 7,847 controls) has shown betel quid without tobacco to have an independent positive association with oral cancer, with OR = 2.82 (95% CI = 2.35-3.40, P<0.001). This is presumably due to the carcinogenicity of areca nut. There was no significant publication bias. Conclusion: There is convincing evidence that smokeless (aka chewing) tobacco, often used as a component of betel quid, and betel quid without tobacco, are both strong and independent risk factors for oral cancer in these populations. However, studies with better separation of the types of tobacco and the ways in which it is used, and studies with sufficient power to quantify dose-response relationships are still needed.	[Gupta, Bhawna] Griffith Univ, Griffith Hlth Inst, Sch Dent & Oral Hlth, Populat & Social Hlth Res Programme, Gold Coast, Qld, Australia; [Johnson, Newell W.] Griffith Univ, Griffith Hlth Inst, Canc Res Ctr, Populat & Social Hlth Res Programme, Gold Coast, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; Menzies Health Institute Queensland	Gupta, B (corresponding author), Griffith Univ, Griffith Hlth Inst, Sch Dent & Oral Hlth, Populat & Social Hlth Res Programme, Gold Coast, Qld, Australia.	bhawna.gupta@griffithuni.edu.au	Johnson, Newell W/D-8152-2019; Gupta, bhawna/AAD-3108-2019	Johnson, Newell W/0000-0001-5866-262X; Gupta, bhawna/0000-0003-1467-0139				Armitage P., 2001, STAT METHODS MED RES; ATKINSON L, 1964, CANCER-AM CANCER SOC, V17, P1289, DOI 10.1002/1097-0142(196410)17:10<1289::AID-CNCR2820171011>3.0.CO;2-E; Balaram P, 2002, INT J CANCER, V98, P440, DOI 10.1002/ijc.10200; Berman Nancy G, 2002, BMC Med Res Methodol, V2, P10, DOI 10.1186/1471-2288-2-10; BHONSLE RB, 1992, CONTROL OF TOBACCO-RELATED CANCERS AND OTHER DISEASES, P25; Bile K M, 2010, East Mediterr Health J, V16 Suppl, pS24; Brady M, 2002, AUST NZ J PUBL HEAL, V26, P120, DOI 10.1111/j.1467-842X.2002.tb00903.x; CAWTE J, 1985, AUST NZ J PSYCHIAT, V19, P83, DOI 10.3109/00048678509158818; Chen PCH, 2002, J ORAL PATHOL MED, V31, P317, DOI 10.1034/j.1600-0714.2002.00129.x; Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247; Davidson J, 1923, BRIT MED J, V1923, P733; DAVIES G N, 1963, J Dent Res, V2, P209; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dikshit RP, 2000, INT J EPIDEMIOL, V29, P609, DOI 10.1093/ije/29.4.609; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellis AG, 1921, ARCH INTERN MED, V28, P252, DOI 10.1001/archinte.1921.00100150015002; Ferlay J, 2012, GLOBOCAN V1 0 ICNI; FLEISS JL, 1991, J CLIN EPIDEMIOL, V44, P127, DOI 10.1016/0895-4356(91)90261-7; GATS 2016-17 World Health Organization Regional Office for South -East Asia, 2009, REG OFF S E AS GLOB; Ghosh S, 1996, EUR J SURG ONCOL, V22, P359, DOI 10.1016/S0748-7983(96)90242-5; GOUD ML, 1990, EUR J EPIDEMIOL, V6, P219, DOI 10.1007/BF00145797; GROSS AJ, 1995, ENVIRON INT, V21, P381, DOI 10.1016/0160-4120(95)00040-R; Guha N., 2013, INT J CANC; Gupta B, 2013, INT DENT J, V63, P12, DOI 10.1111/j.1875-595x.2012.00131.x; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Hay TE, 2003, DRUGS LABOR COLONIAL, P59; Herzog TA, 2014, DRUG ALCOHOL DEPEN, V138, P154, DOI 10.1016/j.drugalcdep.2014.02.022; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIRAYAMA T, 1966, B WORLD HEALTH ORGAN, V34, P41; Horsley T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000026.pub2; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1; Jayalekshmi PA, 2009, BRIT J CANCER, V100, P848, DOI 10.1038/sj.bjc.6604907; Jayalekshmi PA, 2011, CANCER SCI, V102, P460, DOI 10.1111/j.1349-7006.2010.01785.x; JAYANT K, 1977, BRIT J CANCER, V35, P232, DOI 10.1038/bjc.1977.31; Johnson NW, 2011, PERIODONTOL 2000, V57, P19, DOI 10.1111/j.1600-0757.2011.00401.x; Johnson NW, 2011, HEAD NECK CANC MULTI, P1, DOI [10.1007/978-1-4419-9464-6_1, DOI 10.1007/978-1-4419-9464-6_1]; JUSSAWALLA DJ, 1971, CANCER-AM CANCER SOC, V28, P244, DOI 10.1002/1097-0142(197107)28:1<244::AID-CNCR2820280150>3.0.CO;2-H; Kakde S, 2012, PUBLIC HEALTH, V126, P635, DOI 10.1016/j.puhe.2012.05.002; Khalili J., 2008, Experimental Oncology, V30, P259; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lin WJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/525976; Lin YS, 2005, ORL-J OTO-RHIN-LARYN, V67, P230, DOI 10.1159/000089214; Loyha K, 2012, ASIAN PAC J CANCER P, V13, P5087, DOI 10.7314/APJCP.2012.13.10.5087; Lu CT, 1996, J ORAL PATHOL MED, V25, P245, DOI 10.1111/j.1600-0714.1996.tb01379.x; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Mack TM, 2001, LANCET, V357, P1638, DOI 10.1016/S0140-6736(00)04860-1; Madani Abdoul Hossain, 2012, Indian J Public Health, V56, P57, DOI 10.4103/0019-557X.96977; MARSDEN A T, 1960, Med J Malaya, V14, P162; MARSHALL M, 1990, BRIT J ADDICT, V85, P1457; Merchant A, 2000, INT J CANCER, V86, P128, DOI 10.1002/(SICI)1097-0215(20000401)86:1&lt;128::AID-IJC20&gt;3.0.CO;2-M; Michael B, COMPREHENSIVE METAAN; Moore SR, 2000, ORAL DIS, V6, P191; Muwonge R, 2008, ORAL ONCOL, V44, P446, DOI 10.1016/j.oraloncology.2007.06.002; Nair U, 2004, MUTAGENESIS, V19, P251, DOI 10.1093/mutage/geh036; NANDAKUMAR A, 1990, BRIT J CANCER, V62, P847, DOI 10.1038/bjc.1990.392; Orr IM, 1933, LANCET, V2, P575; Pednekar MS, 2011, CANCER CAUSE CONTROL, V22, P859, DOI 10.1007/s10552-011-9756-1; Pietrusewsky M, 1997, AM J PHYS ANTHROPOL, V104, P315; SANGHVI LD, 1955, BMJ-BRIT MED J, V1, P1111, DOI 10.1136/bmj.1.4922.1111; SANKARANARAYANAN R, 1989, BRIT J CANCER, V60, P638, DOI 10.1038/bjc.1989.330; SANKARANARAYANAN R, 1989, INT J CANCER, V44, P617, DOI 10.1002/ijc.2910440410; SANKARANARAYANAN R, 1990, J EPIDEMIOL COMMUN H, V44, P286, DOI 10.1136/jech.44.4.286; SANKARANARAYANAN R, 1990, ORAL SURG ORAL MED O, V69, P325, DOI 10.1016/0030-4220(90)90294-3; SHANTA V, 1963, BRIT J CANCER, V17, P8, DOI 10.1038/bjc.1963.2; SHANTA V, 1964, ACTA UNION INT CONTR, V20, P586; SHANTA V, 1959, BRIT J CANCER, V13, P381, DOI 10.1038/bjc.1959.43; Shiu MN, 2004, EUR J CANCER PREV, V13, P39, DOI 10.1097/00008469-200402000-00007; SINGH AD, 1966, AMER J ROENTGENOL RA, V96, P6, DOI 10.2214/ajr.96.1.6; Stanfill SB, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037465; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sturmer T, 2001, EPIDEMIOLOGY, V12, P101; Sutton A J, 1998, Health Technol Assess, V2, P1; Thomas SJ, 2008, INT J CANCER, V123, P1871, DOI 10.1002/ijc.23739; Thomas SJ, 2007, INT J CANCER, V120, P1318, DOI 10.1002/ijc.22304; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wahi PN, 1965, B WORLD HEALTH ORGAN, V38, P495; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wasnik Khetchandra S., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P827; Wen CP, 2010, CANCER CAUSE CONTROL, V21, P1427, DOI 10.1007/s10552-010-9570-1; Winstock A, 2002, ADDICT BIOL, V7, P133, DOI 10.1080/13556210120091509; World Health Organization, 2012, REV AR BET NUT TOB U; World Health Organization, 2007, INT CLASS DIS MAL NE; Yen LL, 1995, CHIN J PUBLIC HLTH, V14, P358, DOI DOI 10.6288/CJPH1995-14-04-07; Yen TT, 2008, EUR ARCH OTO-RHINO-L, V265, P1403, DOI 10.1007/s00405-008-0659-z; Znaor A, 2003, INT J CANCER, V105, P681, DOI 10.1002/ijc.11114	91	106	106	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113385	10.1371/journal.pone.0113385	http://dx.doi.org/10.1371/journal.pone.0113385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25411778	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000046
J	Poole, D; Chieregato, A; Langer, M; Viaggi, B; Cingolani, E; Malacarne, P; Mengoli, F; Nardi, G; Nascimben, E; Riccioni, L; Turriziani, I; Volpi, A; Coniglio, C; Gordini, G				Poole, Daniele; Chieregato, Arturo; Langer, Martin; Viaggi, Bruno; Cingolani, Emiliano; Malacarne, Paolo; Mengoli, Francesca; Nardi, Giuseppe; Nascimben, Ennio; Riccioni, Luigi; Turriziani, Ilaria; Volpi, Annalisa; Coniglio, Carlo; Gordini, Giovanni		Trauma Update Working Grp	Systematic Review of the Literature and Evidence-Based Recommendations for Antibiotic Prophylaxis in Trauma: Results from an Italian Consensus of Experts	PLOS ONE			English	Article							PENETRATING ABDOMINAL-TRAUMA; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS MRSA; BASILAR SKULL FRACTURES; EARLY-ONSET PNEUMONIA; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-AEROGENES; COMATOSE PATIENTS; GUIDELINES; GRADE	Background: Antibiotic prophylaxis is frequently administered in severe trauma. However, the risk of selecting resistant bacteria, a major issue especially in critical care environments, has not been sufficiently investigated. The aim of the present study was to provide guidelines for antibiotic prophylaxis for four different trauma-related clinical conditions, taking into account the risks of antibiotic-resistant bacteria selection, thus innovating previous guidelines in the field. Methods: The MEDLINE database was searched for studies comparing antibiotic prophylaxis to controls (placebo or no antibiotic administration) in four clinical traumatic conditions that were selected on the basis of the traumatic event frequency and/or infection severity. The selected studies focused on the prevention of early ventilator associated pneumonia (VAP) in comatose patients with traumatic brain injury, of meningitis in severe basilar skull fractures, of wound infections in long-bone open fractures. Since no placebo-controlled study was available for deep surgical site-infections prevention in abdominal trauma with enteric contamination, we compared 24-hour and 5-day antibiotic prophylaxis policies. A separate specific research focused on the question of antibiotic-resistant bacteria selection caused by antibiotic prophylaxis, an issue not adequately investigated by the selected studies. Randomised trials, reviews, meta-analyses, observational studies were included. Data extraction was carried out by one author according to a predefined protocol, using an electronic form. The strength of evidence was stratified and recommendations were given according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Results: Uncertain evidence deserving further studies was found for two-dose antibiotic prophylaxis for early VAP prevention in comatose patients. In the other cases the risk of resistant-bacteria selection caused by antibiotic administration for 48 hours or more, outweighed potential benefits. Conclusions: When accounting for antibiotic-resistant bacteria selection we found no evidence in favour of antibiotic prophylaxis lasting two or more days in the studied clinical conditions.	[Poole, Daniele] Osped San Martino Genova, UO Anestesia & Rianimaz, Belluno, Italy; [Chieregato, Arturo; Viaggi, Bruno] AOU Careggi, SOD Anestesia & Area Intens CTO, Florence, Italy; [Langer, Martin] Fdn IRCCS Ist Nazl Tumori, Dipartimento Anestesia & Rianimaz, Milan, Italy; [Langer, Martin] Univ Milan, Milan, Italy; [Cingolani, Emiliano; Nardi, Giuseppe; Riccioni, Luigi] AO San Camillo Forlanini, UOC Shock & Trauma, Rome, Italy; [Malacarne, Paolo] Azienda Osped Univ Pisana, UO Anestesia & Rianimaz PS, Pisa, Italy; [Mengoli, Francesca; Turriziani, Ilaria; Coniglio, Carlo; Gordini, Giovanni] Osped Maggiore Bologna, UO Rianimaz 118, Bologna, Italy; [Nascimben, Ennio] Neurorianimaz Osped S Maria Ca Foncello, Treviso, Italy; [Volpi, Annalisa] Azienda Osped Univ Parma, I-43100 Parma, Italy	ULSS 1 Dolomiti; Ospedale di Belluno; University of Genoa; IRCCS AOU San Martino IST; University of Florence; Azienda Ospedaliero Universitaria Careggi; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Azienda Ospedaliera San Camillo-Forlanini; University of Pisa; Azienda Ospedaliero Universitaria Pisana; AUSL di Bologna; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; University of Parma; University Hospital of Parma	Poole, D (corresponding author), Osped San Martino Genova, UO Anestesia & Rianimaz, Belluno, Italy.	daniele.poole@alice.it	Coniglio, Carlo/AAB-7128-2022; Gordini, Giovanni/AAB-8170-2022; Poole, Daniele/X-7210-2019; Viaggi, Bruno/X-5074-2018; Volpi, Annalisa/AHH-5394-2022	Coniglio, Carlo/0000-0002-8207-0525; Gordini, Giovanni/0000-0003-4518-0204; Poole, Daniele/0000-0001-5279-9844; Viaggi, Bruno/0000-0001-5710-2479; Volpi, Annalisa/0000-0001-5337-9155				Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BERGMAN BR, 1982, ACTA ORTHOP SCAND, V53, P57, DOI 10.3109/17453678208992179; Bonten MJM, 1998, ARCH INTERN MED, V158, P1127, DOI 10.1001/archinte.158.10.1127; Bozorgzadeh A, 1999, AM J SURG, V177, P125, DOI 10.1016/S0002-9610(98)00317-1; Brand M, 2013, COCHRANE DB SYST REV, V11; Brand M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007370.pub2; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Braun R, 1987, J Orthop Trauma, V1, P12, DOI 10.1097/00005131-198701010-00002; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Cornwell EE, 1999, J GASTROINTEST SURG, V3, P648, DOI 10.1016/S1091-255X(99)80088-2; Dagi T F, 1983, Am J Emerg Med, V1, P295, DOI 10.1016/0735-6757(83)90109-2; de Kraker MEA, 2011, J ANTIMICROB CHEMOTH, V66, P398, DOI 10.1093/jac/dkq412; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; DEMETRIADES D, 1992, INJURY, V23, P377, DOI 10.1016/0020-1383(92)90011-G; Dickey R L, 1989, J Orthop Trauma, V3, P6, DOI 10.1097/00005131-198903010-00002; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; FABIAN TC, 1992, SURGERY, V112, P788; FEINSTEIN AR, 1995, J CLIN EPIDEMIOL, V48, P71, DOI 10.1016/0895-4356(94)00110-C; Filius PMG, 2005, ANTIMICROB AGENTS CH, V49, P2879, DOI 10.1128/AAC.49.7.2879-2886.2005; FRAZEE RC, 1988, POSTGRAD MED, V83, P267, DOI 10.1080/00325481.1988.11700238; Gosselin R A, 2004, Cochrane Database Syst Rev, pCD003764, DOI 10.1002/14651858.CD003764.pub2; Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; Hauser Carl J, 2006, Surg Infect (Larchmt), V7, P379; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOFF JT, 1976, J NEUROSURG, V44, P649; Hoff WS, 2011, J TRAUMA, V70, P751, DOI 10.1097/TA.0b013e31820930e5; Hospenthal DR, 2011, J TRAUMA, V71, pS210, DOI 10.1097/TA.0b013e318227ac4b; Hurwitz B, 1999, BRIT MED J, V318, P661, DOI 10.1136/bmj.318.7184.661; IGNELZI RJ, 1975, J NEUROSURG, V43, P721, DOI 10.3171/jns.1975.43.6.0721; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; KERNODLE DS, 1988, ANTIMICROB AGENTS CH, V32, P202, DOI 10.1128/AAC.32.2.202; Kirton OC, 2000, J TRAUMA, V49, P822, DOI 10.1097/00005373-200011000-00006; Klastersky J, 1976, Surg Neurol, V6, P111; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Luchette FA, 2000, E PRACT MAN GUID WOR; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; PATZAKIS MJ, 1983, CLIN ORTHOP RELAT R, P31; PATZAKIS MJ, 1974, J BONE JOINT SURG AM, VA 56, P532, DOI 10.2106/00004623-197456030-00010; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PRICE D, 1970, J CLIN PATHOL, V23, P378, DOI 10.1136/jcp.23.4.378-c; PRICE DJE, 1972, J NEUROL NEUROSUR PS, V35, P903, DOI 10.1136/jnnp.35.6.903; PRICE DJE, 1970, LANCET, V2, P1213; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; Ratilal BO, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004884, 10.1002/14651858.CD004884.pub3]; Rojczyk M, 1983, Hefte Unfallheilkd, V162, P33; Schentag JJ, 1998, CLIN INFECT DIS, V26, P1204, DOI 10.1086/520287; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Tacconelli E, 2008, J ANTIMICROB CHEMOTH, V61, P26, DOI 10.1093/jac/dkm416; Tacconelli Evelina, 2009, Antimicrob Agents Chemother, V53, P4264, DOI 10.1128/AAC.00431-09; Tacconelli E, 2009, CURR OPIN INFECT DIS, V22, P352, DOI 10.1097/QCO.0b013e32832d52e0; Valles J, 2013, CHEST, V143, P1219, DOI 10.1378/chest.12-1361; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Zrebeet H A, 1986, Del Med J, V58, P741	70	16	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113676	10.1371/journal.pone.0113676	http://dx.doi.org/10.1371/journal.pone.0113676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412442	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000071
J	Hammel, JU; Nickel, M				Hammel, Joerg U.; Nickel, Michael			A New Flow-Regulating Cell Type in the Demosponge Tethya wilhelma - Functional Cellular Anatomy of a Leuconoid Canal System	PLOS ONE			English	Article							FRESH-WATER SPONGE; FLUVIATILIS L PORIFERA; ELECTRON-MICROSCOPE HISTOLOGY; X-RAY MICROTOMOGRAPHY; MARINE SPONGES; BODY STRUCTURE; PETROSIA-FICIFORMIS; CHOANOCYTE CHAMBERS; AQUIFEROUS SYSTEMS; SPECIES PORIFERA	Demosponges possess a leucon-type canal system which is characterized by a highly complex network of canal segments and choanocyte chambers. As sponges are sessile filter feeders, their aquiferous system plays an essential role in various fundamental physiological processes. Due to the morphological and architectural complexity of the canal system and the strong interdependence between flow conditions and anatomy, our understanding of fluid dynamics throughout leuconoid systems is patchy. This paper provides comprehensive morphometric data on the general architecture of the canal system, flow measurements and detailed cellular anatomical information to help fill in the gaps. We focus on the functional cellular anatomy of the aquiferous system and discuss all relevant cell types in the context of hydrodynamic and evolutionary constraints. Our analysis is based on the canal system of the tropical demosponge Tethya wilhelma, which we studied using scanning electron microscopy. We found a hitherto undescribed cell type, the reticuloapopylocyte, which is involved in flow regulation in the choanocyte chambers. It has a highly fenestrated, grid-like morphology and covers the apopylar opening. The minute opening of the reticuloapopylocyte occurs in an opened, intermediate and closed state. These states permit a gradual regulation of the total apopylar opening area. In this paper the three states are included in a theoretical study into flow conditions which aims to draw a link between functional cellular anatomy, the hydrodynamic situation and the regular body contractions seen in T. wilhelma. This provides a basis for new hypotheses regarding the function of bypass elements and the role of hydrostatic pressure in body contractions. Our study provides insights into the local and global flow conditions in the sponge canal system and thus enhances current understanding of related physiological processes.	[Hammel, Joerg U.; Nickel, Michael] Univ Jena, Phyletischem Museum, Inst Spezielle Zool & Evolut Biol, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Hammel, JU (corresponding author), Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Max Planck Str 1, D-21502 Geesthacht, Germany.	joerg.hammel@uni-jena.de	Hammel, Jörg/D-6555-2011	Hammel, Jörg/0000-0002-6744-6811	Deutsche Forschungs Gemeinschaft [HA 6405/1-1]	Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	Funding for this research came from Deutsche Forschungs Gemeinschaft (www.dfg.de) research grant HA 6405/1-1 to JUH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNDT W, 1933, HDB BIOL ARBEITSMETH, V1, P443; BAVESTRELLO G, 1988, ZOOMORPHOLOGY, V108, P161, DOI 10.1007/BF00363932; Boury-Esnault N, 2006, CAN J ZOOL, V84, P205, DOI 10.1139/Z06-003; BOURYESNAULT N, 1984, J MORPHOL, V180, P3, DOI 10.1002/jmor.1051800103; BURLANDO B, 1990, B ZOOL, V57, P233, DOI 10.1080/11250009009355701; De Vos C, 1990, APOPYLAR CELL SPONGE, P153; Elliott GRD, 2007, J EXP BIOL, V210, P3736, DOI 10.1242/jeb.003392; EMSON RH, 1966, COMP BIOCHEM PHYSIOL, V18, P805, DOI 10.1016/0010-406X(66)90215-5; Fossa SA, 1996, KORALLENRIFF AQUARIU, V5, P35; Hammel JU, 2012, ACTA ZOOL-STOCKHOLM, V93, P160, DOI 10.1111/j.1463-6395.2010.00492.x; Hammel JU, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-19; HARRISON FW, 1972, HYDROBIOLOGIA, V40, P513, DOI 10.1007/BF00019986; Humphries S, 2009, P NATL ACAD SCI USA, V106, P7882, DOI 10.1073/pnas.0809063106; Jensen KH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00151; JONES WC, 1962, BIOL REV, V37, P1, DOI 10.1111/j.1469-185X.1962.tb01602.x; JORGENSEN CB, 1983, MAR ECOL PROG SER, V11, P89, DOI 10.3354/meps011089; Kinne O, 1977, MARINE ECOLOGY, VIII, P627; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; LANGENBRUCH PF, 1985, ZOOMORPHOLOGY, V105, P383, DOI 10.1007/BF00312282; LANGENBRUCH PF, 1988, ZOOMORPHOLOGY, V108, P13, DOI 10.1007/BF00312210; LANGENBRUCH PF, 1990, J MORPHOL, V204, P1, DOI 10.1002/jmor.1052040102; Langenbruch PF, 1990, STRUCTURE CHOANOCYTE, P245; LARSEN PS, 1994, J THEOR BIOL, V168, P53, DOI 10.1006/jtbi.1994.1087; Leys SP, 2006, BIOL BULL-US, V211, P157, DOI 10.2307/4134590; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Leys SP, 2006, CAN J ZOOL, V84, P288, DOI 10.1139/Z05-171; Ludeman DA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-3; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nickel M, 2004, J EXP BIOL, V207, P4515, DOI 10.1242/jeb.01289; Nickel M, 2006, ZOOMORPHOLOGY, V125, P225, DOI 10.1007/s00435-006-0022-0; Nickel M, 2006, ZOOMORPHOLOGY, V125, P209, DOI 10.1007/s00435-006-0021-1; Nickel M, 2011, J EXP BIOL, V214, P1692, DOI 10.1242/jeb.049148; Nickel M, 2010, INVERTEBR BIOL, V129, P1, DOI 10.1111/j.1744-7410.2010.00193.x; Pettitt ME, 2002, EUR J PROTISTOL, V38, P313, DOI 10.1078/0932-4739-00854; Rasband W., 2006, IMAGEJ; REISWIG HM, 1975, J MORPHOL, V145, P493, DOI 10.1002/jmor.1051450407; REISWIG HM, 1977, ZOOMORPHOLOGIE, V88, P81, DOI 10.1007/BF01880648; Riisgard HU, 2010, MAR ECOL PROG SER, V418, P255, DOI 10.3354/meps08755; Riisgard HU, 2001, LIMNOL OCEANOGR, V46, P882, DOI 10.4319/lo.2001.46.4.0882; SALLER U, 1990, ZOOMORPHOLOGY, V109, P295, DOI 10.1007/BF00803569; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schippers KJ, 2012, ADV MAR BIOL, V62, P273, DOI 10.1016/B978-0-12-394283-8.00006-0; SHIMETA J, 1991, OCEANOGR MAR BIOL, V29, P191; Simpson T., 1984, CELL BIOL SPONGES; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; VACELET J, 1989, J MORPHOL, V201, P119, DOI 10.1002/jmor.1052010203; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Vogel S., 1995, B MATH BIOL, V57, P949, DOI [10.2307/1352661, DOI 10.2307/1352661]; Waters SL, 2011, PROG BIOPHYS MOL BIO, V104, P49, DOI 10.1016/j.pbiomolbio.2010.10.001; WEISSENFELS N, 1982, MICROSC ACTA, V85, P345; WEISSENFELS N, 1980, ZOOMORPHOLOGIE, V95, P27, DOI 10.1007/BF01342232; WEISSENFELS N, 1982, ZOOMORPHOLOGY, V100, P75, DOI 10.1007/BF00310355; WEISSENFELS N, 1981, ZOOMORPHOLOGY, V98, P35, DOI 10.1007/BF00310319	55	14	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113153	10.1371/journal.pone.0113153	http://dx.doi.org/10.1371/journal.pone.0113153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409176	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200074
J	Sombolos, K; Tsakiris, D; Boletis, J; Vlahakos, D; Siamopoulos, KC; Vargemezis, V; Nikolaidis, P; Iatrou, C; Dafnis, E; Xynos, K; Argyropoulos, C				Sombolos, Konstantinos; Tsakiris, Demitrios; Boletis, John; Vlahakos, Demetrios; Siamopoulos, Kostas C.; Vargemezis, Vassilios; Nikolaidis, Pavlos; Iatrou, Christos; Dafnis, Eugene; Xynos, Konstantinos; Argyropoulos, Christos			Multicenter Epidemiological Study to Assess the Population of CKD Patients in Greece: Results from the PRESTAR Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; OF-NO-RETURN; PRIMARY-CARE; RENAL-DISEASE; NEPHROLOGY VISITS; SERUM CREATININE; SECONDARY CARE; ESTIMATED GFR; IMPACT	Background: Chronic Kidney Disease (CKD) is a relatively common condition not only associated with increased morbidity and mortality but also fuelling End Stage Renal Disease (ESRD). Among developed nations, Greece has one of the highest ESRD incidence rates, yet there is limited understanding of the epidemiology of earlier stages of CKD. Methods: Cross-sectional survey of pre-dialysis CKD outpatients in nephrology clinics in the National Health Care system between October 2009 and October 2010. Demographics, cause of CKD, blood pressure, level of renal function, duration of CKD and nephrology care, and specialty of referral physician were collected and analyzed. Different methods for estimating renal function (Cockroft-Gault [CG], CKD-Epi and MDRD) and staging CKD were assessed for agreement. Results: A total of 1,501 patients in 9 centers were enrolled. Diabetic nephropathy was the most common nephrologist assigned cause of CKD (29.7%). In total, 36.5% of patients had self-referred to the nephrologist; patients with diabetes or serum creatinine above 220 mu mol/l (eGFR<40 ml/min/1.73 m(2)) were more likely to have been referred by a physician. Agreement between MDRD and CKD-Epi, but not between CG, the other estimating equations, was excellent. There was substantial heterogeneity with respect to renal diagnoses, referral patterns and blood pressure among participating centers. Conclusions: In this first epidemiologic assessment of CKD in Greece, we documented delayed referral and high rates of self-referral among patients with CKD. eGFR reporting, currently offered by a limited number of laboratories, may facilitate detection of CKD at an earlier, more treatable stage.	[Sombolos, Konstantinos] Papanikolaou Hosp, Nephrol Clin, Thessaloniki, Greece; [Tsakiris, Demitrios] Papageorgiou Hosp, Nephrol Clin, Thessaloniki, Greece; [Boletis, John] Laiko Hosp, Nephrol Clin, Athens, Greece; [Vlahakos, Demetrios] ATTIKON Univ Hosp, Nephrol Clin, Athens, Greece; [Siamopoulos, Kostas C.] Ioannina Univ Hosp, Nephrol Clin, Ioannina, Greece; [Vargemezis, Vassilios] Alexandroupoli Univ Hosp, Nephrol Clin, Alexandroupolis, Greece; [Nikolaidis, Pavlos] AHEPA Hosp, Nephrol Clin, Thessaloniki, Greece; [Iatrou, Christos] Nikea Hosp, Ctr Nephrol, Athens, Greece; [Dafnis, Eugene] Crete Univ Hosp, PEPAGNI, Nephrol Clin, Iraklion, Greece; [Xynos, Konstantinos] AbbVie Pharmaceut, Chicago, IL USA; [Argyropoulos, Christos] AbbVie Pharmaceut SA, Athens, Greece	George Papanikolaou General Hospital of Thessaloniki; Papageorgiou Hospital; Laiko General Hospital; University Hospital Attikon; University Hospital Ioannina; Aristotle University of Thessaloniki; Ahepa University Hospital; University of Crete; AbbVie; AbbVie	Argyropoulos, C (corresponding author), AbbVie Pharmaceut SA, Athens, Greece.	argchris@hotmail.com	Argyropoulos, Christos/I-2803-2019	Argyropoulos, Christos/0000-0002-9679-7805	Greek Affiliate of Abbott Laboratories	Greek Affiliate of Abbott Laboratories	The PRESTAR (PRospective Epidemiology STudy Aiming to Register CKD Patients Stage 3, 4, and 5 not on Hemodialysis Followed by Nephrologists) study was designed and funded by the Greek Affiliate of Abbott Laboratories. AbbVie reviewed the manuscript for potential issues pertaining to Intellectual Property rights protection and for scientific content. Abbott and AbbVie Laboratories Sales and Marketing personnel did not influence the content development of this manuscript in any way, including through discussions with the external authors (SK, DT, JB, DV, KS, VV, PV, CI, ED). The funder provided support in the form of salaries for authors CA & KX, designed the study and provided funding for data collection and analysis and participated in the decision to publish and the preparation of the manuscript. The specific roles of these authors are articulated in the ''author contributions'' section.	Aakre KM, 2011, CLIN CHIM ACTA, V412, P1138, DOI 10.1016/j.cca.2011.03.004; Abdel-Kader K, 2011, AM J KIDNEY DIS, V58, P894, DOI 10.1053/j.ajkd.2011.08.028; Abdel-Kader K, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-12; Agrawal V, 2009, CLIN J AM SOC NEPHRO, V4, P323, DOI 10.2215/CJN.03510708; Akbari A, 2004, ARCH INTERN MED, V164, P1788, DOI 10.1001/archinte.164.16.1788; Akbari A, 2012, CAN MED ASSOC J, V184, pE269, DOI 10.1503/cmaj.110678; Bayliss EA, 2011, CLIN J AM SOC NEPHRO, V6, P704, DOI 10.2215/CJN.06610810; Black C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14210; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boulware LE, 2006, AM J KIDNEY DIS, V48, P192, DOI 10.1053/j.ajkd.2006.04.073; Campbell GA, 2011, ADV CHRONIC KIDNEY D, V18, P420, DOI 10.1053/j.ackd.2011.10.006; Campbell KH, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-47; Chen SC, 2010, AM J MED SCI, V339, P123, DOI 10.1097/MAJ.0b013e3181c0678a; Chen SC, 2008, NEPHROLOGY, V13, P730, DOI 10.1111/j.1440-1797.2008.01023.x; Cheung CK, 2009, CLIN J AM SOC NEPHRO, V4, P258, DOI 10.2215/CJN.05151008; Coritsidis GN, 2011, POSTGRAD MED, V123, P177, DOI 10.3810/pgm.2011.09.2473; de Jager DJ, 2011, NEPHROL DIAL TRANSPL, V26, P652, DOI 10.1093/ndt/gfq438; Diamantidis CJ, 2011, CLIN J AM SOC NEPHRO, V6, P334, DOI 10.2215/CJN.06240710; Finkelstein FO, 2008, KIDNEY INT, V74, P1178, DOI 10.1038/ki.2008.376; Giardina TD, 2011, JAMA-J AM MED ASSOC, V306, P2502, DOI 10.1001/jama.2011.1797; Goransson LG, 2001, J INTERN MED, V250, P154, DOI 10.1046/j.1365-2796.2001.00869.x; Hasegawa T, 2009, CLIN J AM SOC NEPHRO, V4, P595, DOI 10.2215/CJN.03540708; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P1151, DOI 10.1001/jama.2010.303; Herget-Rosenthal S, 2010, INT J CLIN PRACT, V64, P1784, DOI 10.1111/j.1742-1241.2010.02535.x; Jain A, 2011, CURR OPIN NEPHROL HY, V20, P218, DOI 10.1097/MNH.0b013e3283446193; Jain AK, 2012, KIDNEY INT, V81, P1248, DOI 10.1038/ki.2012.18; Jain AK, 2009, KIDNEY INT, V76, P318, DOI 10.1038/ki.2009.158; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Jurkovitz CT, 2012, AM J KIDNEY DIS, V59, pS24, DOI 10.1053/j.ajkd.2011.11.019; Kagoma YK, 2011, AM J KIDNEY DIS, V57, P592, DOI 10.1053/j.ajkd.2010.08.029; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Komatsu H, 2005, J NEPHROL, V18, P690; Lenz O, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-30; Lenz Oliver, 2005, BMC Nephrol, V6, P11, DOI 10.1186/1471-2369-6-11; Levin A, 2000, NEPHROL DIAL TRANSPL, V15, P8, DOI 10.1093/oxfordjournals.ndt.a027977; Locatelli F, 2002, NEPHROL DIAL TRANSPL, V17, P2, DOI 10.1093/ndt/17.suppl_11.2; MASCHIO G, 1991, J AM SOC NEPHROL, V2, P832; Mendelssohn DC, 1999, CAN MED ASSOC J, V161, P413; Meran S, 2011, QJM-INT J MED, V104, P27, DOI 10.1093/qjmed/hcq151; Mondry Adrian, 2004, BMC Nephrol, V5, P16, DOI 10.1186/1471-2369-5-16; Navaneethan SD, 2010, CLIN NEPHROL, V73, P260; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; O'Callaghan CA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000308; Orlando Lori A, 2007, N C Med J, V68, P9; Phillips LA, 2009, QJM-INT J MED, V102, P415, DOI 10.1093/qjmed/hcp030; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P556, DOI 10.1093/ndt/gfm839; Ruppert D, 2009, ELECTRON J STAT, V3, P1193, DOI 10.1214/09-EJS525; Shin SJ, 2007, NEPHRON CLIN PRACT, V107, pC139, DOI 10.1159/000110034; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stevens LA, 2010, CURR OPIN NEPHROL HY, V19, P298, DOI 10.1097/MNH.0b013e32833893e2; Stolk Mordecai, 2011, Med Health R I, V94, P63; Swedko P, 2003, ARCH INTERN MED, V163, P356, DOI 10.1001/archinte.163.3.356; Tamba K, 2009, CLIN EXP NEPHROL, V13, P447, DOI 10.1007/s10157-009-0176-4; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Wyatt C, 2007, AM J KIDNEY DIS, V49, P634, DOI 10.1053/j.ajkd.2007.02.258; Yang M, 2011, ADV CHRONIC KIDNEY D, V18, P400, DOI 10.1053/j.ackd.2011.10.001	57	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112767	10.1371/journal.pone.0112767	http://dx.doi.org/10.1371/journal.pone.0112767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406080	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300051
J	Wang, N; Yang, XH; Jiao, SJ; Zhang, J; Ye, BP; Gao, SX				Wang, Na; Yang, Xiaohong; Jiao, Shaojun; Zhang, Jun; Ye, Boping; Gao, Shixiang			Sulfonamide-Resistant Bacteria and Their Resistance Genes in Soils Fertilized with Manures from Jiangsu Province, Southeastern China	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; SUL3; PREVALENCE; ANIMALS	Antibiotic-resistant bacteria and genes are recognized as new environmental pollutants that warrant special concern. There were few reports on veterinary antibiotic-resistant bacteria and genes in China. This work systematically analyzed the prevalence and distribution of sulfonamide resistance genes in soils from the environments around poultry and livestock farms in Jiangsu Province, Southeastern China. The results showed that the animal manure application made the spread and abundance of antibiotic resistance genes (ARGs) increasingly in the soil. The frequency of sulfonamide resistance genes was sul1 > sul2 > sul3 in pig-manured soil DNA and sul2 > sul1 > sul3 in chicken-manured soil DNA. Further analysis suggested that the frequency distribution of the sul genes in the genomic DNA and plasmids of the SR isolates from manured soil was sul2 > sul1 > sul3 overall (p<0.05). The combination of sul1 and sul2 was the most frequent, and the co-existence of sul1 and sul3 was not found either in the genomic DNA or plasmids. The sample type, animal type and sampling time can influence the prevalence and distribution pattern of sulfonamide resistance genes. The present study also indicated that Bacillus, Pseudomonas and Shigella were the most prevalent sul-positive genera in the soil, suggesting a potential human health risk. The above results could be important in the evaluation of antibiotic-resistant bacteria and genes from manure as sources of agricultural soil pollution; the results also demonstrate the necessity and urgency of the regulation and supervision of veterinary antibiotics in China.	[Wang, Na; Gao, Shixiang] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Na; Jiao, Shaojun] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China; [Yang, Xiaohong; Zhang, Jun; Ye, Boping] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China	Nanjing University; China Pharmaceutical University	Ye, BP (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China.	yebp@cpu.edu.cn; ecsxg@nju.edu.cn	GAO, Shixiang/K-8702-2012	GAO, Shixiang/0000-0001-9066-6970	MEP [201109038, 201309031]	MEP	The funding source of this study are the Commonwealth and Environmental Protection project granted by the MEP "The health risk assessment and management technology of veterinary medicine'' (201109038), "Study of determination method, pollution level and pollution control strategy of antibiotic-resistant gene in China'' (201309031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Diene SM, 2013, EXPERT REV ANTI-INFE, V11, P277, DOI [10.1586/ERI.13.1, 10.1586/eri.13.1]; Ghosh S, 2007, ISME J, V1, P191, DOI 10.1038/ismej.2007.31; Hammerum AM, 2006, INT J FOOD MICROBIOL, V106, P235, DOI 10.1016/j.ijfoodmicro.2005.06.023; Heuer H, 2004, MICROBIOL-SGM, V150, P3591, DOI 10.1099/mic.0.27304-0; Heuer H, 2007, ENVIRON MICROBIOL, V9, P657, DOI 10.1111/j.1462-2920.2006.01185.x; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hoa P. T. P., 2010, INTERDISCIPLINARY ST, V3, P15; Hoa PTP, 2008, SCI TOTAL ENVIRON, V405, P377, DOI 10.1016/j.scitotenv.2008.06.023; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; Jechalke S, 2013, APPL ENVIRON MICROB, V79, P1704, DOI 10.1128/AEM.03172-12; Kim KR, 2011, WATER AIR SOIL POLL, V214, P163, DOI 10.1007/s11270-010-0412-2; Kools SAE, 2008, REGUL TOXICOL PHARM, V50, P59, DOI 10.1016/j.yrtph.2007.06.003; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Perreten V, 2003, ANTIMICROB AGENTS CH, V47, P1169, DOI 10.1128/AAC.47.3.1169-1172.2003; Phan TPH, 2011, SCI TOTAL ENVIRON, V409, P2894, DOI 10.1016/j.scitotenv.2011.04.030; Popowska M, 2012, ANTIMICROB AGENTS CH, V56, P1434, DOI 10.1128/AAC.05766-11; Sengelov G, 2003, ENVIRON INT, V28, P587, DOI 10.1016/S0160-4120(02)00084-3; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146; Suzuki S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00102; Ungemach F, 1999, ACTA VET SCAND S, V93, P97; Ungemach F, 1999, ACTA VET SCAND S, V93, P111; Ungemach F, 1999, ACTA VET SCAND S, V93, P89; Valderas MW, 2007, MICROB DRUG RESIST, V13, P11, DOI 10.1089/mdr.2006.9992; Xia SL, 2011, J CLIN MICROBIOL, V49, P232, DOI 10.1128/JCM.01508-10; Yun MK, 2012, SCIENCE, V335, P1110, DOI 10.1126/science.1214641; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	29	68	74	4	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112626	10.1371/journal.pone.0112626	http://dx.doi.org/10.1371/journal.pone.0112626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405870	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300042
J	Cao, HL; Zhou, Q; Lan, RF; Roe, OD; Chen, X; Chen, YJ; Wang, DJ				Cao, Hailong; Zhou, Qing; Lan, Rongfang; Roe, Oluf Dimitri; Chen, Xin; Chen, Yijiang; Wang, Dongjin			A Functional Polymorphism C-509T in TGF beta-1 Promoter Contributes to Susceptibility and Prognosis of Lone Atrial Fibrillation in Chinese Population	PLOS ONE			English	Article							GROWTH-FACTOR BETA-1; TRANSFORMING GROWTH-FACTOR-BETA-1; GENETIC POLYMORPHISMS; EUROPEAN-SOCIETY; MAZE PROCEDURE; TASK-FORCE; FIBROSIS; EXPRESSION; ASSOCIATION; MANAGEMENT	Transforming growth factor-b1 (TGF-beta 1) is an important mediator of atrial fibrosis and atrial fibrillation (AF). But the involved genetic mechanism is unknown. Herein, the TGF-beta 1 C-509T polymorphism (rs1800469) was genotyped in a case-control study of 840 patients and 845 controls in Chinese population to explore the association between the polymorphism and susceptibility and prognosis of lone AF. As a result, the CT and/or TT genotypes had an increased lone AF risk [adjusted odds ratio (OR) = 1.50 for CT, OR = 3.72 for TT, and OR = 2.15 for CT/TT], compared with the TGF-beta 1CC genotype. Moreover, patients carrying CT/TT genotypes showed a higher possibility of AF recurrence after catheter ablation, compared with patients carrying CC genotype. In a genotype-phenotype correlation analysis using 24 normal left atrial appendage samples, increasing gradients of atrial TGF-beta 1 expression levels positively correlated with atrial collagen volume fraction were identified in samples with CC, CT and TT genotypes. The in vitro luciferase assays also showed a higher luciferase activity of the -509T allele than that of the -509C allele. In conclusion, the TGF-beta 1 C-509T polymorphism is involved in the etiology of lone AF and thus may be a marker for genetic susceptibility to lone AF and predicting prognosis after catheter ablation in Chinese populations. Therefore, we provide new information about treatment strategies and our understanding of TGF-beta 1 in AF.	[Cao, Hailong; Zhou, Qing; Wang, Dongjin] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac & Cardiovasc Surg, Nanjing 210008, Jiangsu, Peoples R China; [Lan, Rongfang; Chen, Xin] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China; [Roe, Oluf Dimitri; Chen, Yijiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway	Nanjing University; Nanjing University; Nanjing Medical University; Norwegian University of Science & Technology (NTNU)	Wang, DJ (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac & Cardiovasc Surg, Nanjing 210008, Jiangsu, Peoples R China.	gldjw@163.com		Roe, Oluf Dimitri/0000-0002-4870-5822	National Natural Science Foundation of China [81200133]; Jiangsu Top Expert Program in Six Professions [WSN-032]; Jiangsu health department [Z201411]; Medical Science and technology development Foundation, Nanjing Department of Health [YKK12056]; Fundamental Research Funds for the Central Universities [021414330063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Top Expert Program in Six Professions; Jiangsu health department; Medical Science and technology development Foundation, Nanjing Department of Health; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by the National Natural Science Foundation of China [81200133], Jiangsu Top Expert Program in Six Professions [WSN-032], Medical science project supported by Jiangsu health department [Z201411], Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health [YKK12056], the Fundamental Research Funds for the Central Universities [021414330063]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bunch TJ, 2006, CIRCULATION, V113, P2485, DOI 10.1161/CIRCULATIONAHA.105.570796; Burstein B, 2008, J CARDIOVASC PHARM, V52, P4, DOI 10.1097/FJC.0b013e3181668057; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; den Uijl DW, 2011, HEART, V97, P1847, DOI 10.1136/hrt.2010.215335; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Goudis CA, 2012, EUROPACE, V14, P623, DOI 10.1093/europace/eur398; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hussein AA, 2011, CIRCULATION, V123, P2077, DOI 10.1161/CIRCULATIONAHA.110.007252; Kikuchi K, 2007, ANN NY ACAD SCI, V1110, P15, DOI 10.1196/annals.1423.003; Li Y, 2013, CARDIOLOGY, V124, P233, DOI 10.1159/000347126; Luedecking EK, 2000, HUM GENET, V106, P565, DOI 10.1007/s004390050026; Mattey DL, 2005, ANN RHEUM DIS, V64, P1190, DOI 10.1136/ard.2004.031674; Nakatani Y, 2013, J AM COLL CARDIOL, V61, P582, DOI 10.1016/j.jacc.2012.11.014; Nguyen TN, 2013, INT J CARDIOL, V167, P2412, DOI 10.1016/j.ijcard.2013.01.184; Park SJ, 2013, INT J CARDIOL, V164, P232, DOI 10.1016/j.ijcard.2013.01.066; Rahmutula D, 2013, CARDIOVASC RES, V99, P769, DOI 10.1093/cvr/cvt074; Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273; Tsai CT, 2011, CARDIOVASC RES, V89, P805, DOI 10.1093/cvr/cvq322; Tzou WS, 2010, CIRC-ARRHYTHMIA ELEC, V3, P237, DOI 10.1161/CIRCEP.109.923771; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wang W, 2012, TEX HEART I J, V39, P17; Wang YZ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-23; Wokhlu A, 2010, J CARDIOVASC ELECTR, V21, P1071, DOI 10.1111/j.1540-8167.2010.01786.x; Xiao H, 2010, CLIN CARDIOL, V33, P149, DOI 10.1002/clc.20713; Zhang YJ, 2009, CANCER LETT, V275, P102, DOI 10.1016/j.canlet.2008.10.017; Zheng WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083033	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112912	10.1371/journal.pone.0112912	http://dx.doi.org/10.1371/journal.pone.0112912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402477	Green Submitted, gold, Green Published			2022-12-27	WOS:000345158700082
J	Fried, TR; O'Leary, J; Towle, V; Goldstein, MK; Trentelange, M; Martin, DK				Fried, Terri R.; O'Leary, John; Towle, Virginia; Goldstein, Mary K.; Trentelange, Mark; Martin, Deanna K.			The Effects of Comorbidity on the Benefits and Harms of Treatment for Chronic Disease: A Systematic Review	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; BLOOD-PRESSURE CONTROL; POPULATION-BASED-COHORT; CHRONIC KIDNEY-DISEASE; GLYCEMIC CONTROL; DIABETIC-PATIENTS; CARDIOVASCULAR OUTCOMES; RENAL-INSUFFICIENCY; CLINICAL-PRACTICE; OLDER PATIENTS	Background: There are concerns about the potential for unintentional harms when clinical practice guidelines are applied to patients with multimorbidity. The objective was to summarize the evidence regarding the effect(s) of comorbidity on the outcomes of medication for an index chronic condition. Methods: A systematic review was conducted of studies published in MEDLINE and Cochrane Trials before May 2012. The search strategy was constructed to identify articles indexed with "comorbidity'' or a related term or by a given condition and one or more additional specified comorbid conditions. The search yielded 3252 articles, of which 37 passed the title/abstract screening process, and 22 were included after full-text review. An additional 23 articles were identified by screening the reference lists for included articles. Information was extracted on study design; population; therapy; comparison groups; outcome(s); main findings. Findings: Indexing of articles was inconsistent, with no term for "multimorbidity,'' and rare use of "comorbidity''. Only one article examined the effects of comorbidity per se, finding no benefit of tight control of DM among persons with high comorbidity, defined using a comorbidity index. The remainder examined pairs of conditions, the majority of which were post-hoc analyses of randomized controlled trials and which found no difference in outcomes according to whether a comorbid condition was present. Several demonstrated no difference or an increased risk of adverse outcome among persons with DM and tight control of HTN as compared to usual control. Several demonstrated lack of benefit of statins among persons with end-stage renal disease. Conclusions: There is limited evidence regarding the effects of multiple comorbidities on treatment outcomes. The majority of studies demonstrated no effect of a single comorbid condition on outcomes. Additional studies examining a broad range of comorbidity are required, along with clear and consistent indexing to allow for improved synthesis of the evidence.	[Fried, Terri R.; O'Leary, John; Martin, Deanna K.] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; [Fried, Terri R.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [O'Leary, John; Towle, Virginia; Trentelange, Mark; Martin, Deanna K.] Yale Univ, Sch Med, Program Aging, New Haven, CT USA; [Goldstein, Mary K.] VA Palo Alto Hlth Care Syst, Palo Alto Geriatr Res Educ & Clin Ctr GRECC, Palo Alto, CA 94304 USA; [Goldstein, Mary K.] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Fried, TR (corresponding author), VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA.	terri.fried@yale.edu			Donaghue Foundation [DF11-303]; NIH/NIA [P30 AG021342]; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER	Donaghue Foundation; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by grant DF11-303 from the Donaghue Foundation (www.donaghue.org) and by grant P30 AG021342 from the NIH/NIA (www.nih.nia.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini JV, 2004, J AM GERIATR SOC, V52, P1719, DOI 10.1111/j.1532-5415.2004.52467.x; American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity, 2012, J Am Geriatr Soc, V60, P1957, DOI 10.1111/j.1532-5415.2012.04187.x; Arauz-Pacheco Carlos, 2003, Diabetes Care, V26 Suppl 1, pS80; Bahit MC, 2003, AM HEART J, V145, P109, DOI 10.1067/mhj.2003.43; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bavry AA, 2010, HYPERTENSION, V55, P48, DOI 10.1161/HYPERTENSIONAHA.109.142240; Beer C, 2011, BRIT J CLIN PHARMACO, V71, P592, DOI 10.1111/j.1365-2125.2010.03875.x; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Berthet K, 2004, BLOOD PRESSURE, V13, P7, DOI 10.1080/08037050410029605; Bobbio M, 2003, J CARD FAIL, V9, P192, DOI 10.1054/jcaf.2003.31; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Cohen-Solal A, 2009, EUR J HEART FAIL, V11, P872, DOI 10.1093/eurjhf/hfp104; Collins R, 2003, LANCET, V361, P2005; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; D'Agostino Ralph B Jr, 2000, Curr Control Trials Cardiovasc Med, V1, P76, DOI 10.1186/CVM-1-2-076; de Boer RA, 2010, AM J CARDIOL, V106, P78, DOI 10.1016/j.amjcard.2010.02.018; Deedwania PC, 2005, AM HEART J, V149, P159, DOI 10.1016/j.ahj.2004.05.056; Domanski M, 2003, J AM COLL CARDIOL, V42, P914, DOI 10.1016/S0735-1097(03)00856-8; Du X, 2009, EUR HEART J, V30, P1128, DOI 10.1093/eurheartj/ehp055; Erdmann E, 2001, EUR J HEART FAIL, V3, P469, DOI 10.1016/S1388-9842(01)00174-X; Estacio RO, 2000, DIABETES CARE, V23, pB54; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haas L, 2013, DIABETES CARE, V36, pS100, DOI [10.2337/dc13-S100, 10.2337/dc13-S004]; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hayashino Y, 2007, DIABETOLOGIA, V50, P1170, DOI 10.1007/s00125-007-0650-z; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kalantar-Zadeh K, 2007, DIABETES CARE, V30, P1049, DOI 10.2337/dc06-2127; Komajda M, 2010, EUR HEART J, V31, P824, DOI 10.1093/eurheartj/ehp604; Lambers Heerspink HJ, 2010, EUR HEART J, V31, P2888, DOI 10.1093/eurheartj/ehq139; MacDonald MR, 2008, EUR HEART J, V29, P1377, DOI 10.1093/eurheartj/ehn153; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; Nakamura H, 2009, ATHEROSCLEROSIS, V206, P512, DOI 10.1016/j.atherosclerosis.2009.03.031; Nodari S, 2003, EUR J HEART FAIL, V5, P803, DOI 10.1016/S1388-9842(03)00151-X; Okada T, 2007, INTERNAL MED, V46, P807, DOI 10.2169/internalmedicine.46.6355; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ryden L, 2000, EUR HEART J, V21, P1967, DOI 10.1053/euhj.2000.2311; Shinohara Y, 2008, CEREBROVASC DIS, V26, P63, DOI 10.1159/000135654; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Shurraw S, 2010, AM J KIDNEY DIS, V55, P875, DOI 10.1053/j.ajkd.2009.12.038; Sin DD, 2002, AM J MED, V113, P650, DOI 10.1016/S0002-9343(02)01346-3; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Subramanian U, 2009, AM J CARDIOVASC DRUG, V9, P231, DOI 10.2165/1006180-000000000-00000; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Torp-Pedersen C, 2007, HEART, V93, P968, DOI 10.1136/hrt.2006.092379; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wernicke JF, 2009, J DIABETES COMPLICAT, V23, P349, DOI 10.1016/j.jdiacomp.2008.07.004; Williams ME, 2006, KIDNEY INT, V70, P1503, DOI 10.1038/sj.ki.5001789	65	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112593	10.1371/journal.pone.0112593	http://dx.doi.org/10.1371/journal.pone.0112593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402463	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700056
J	Jin, PY; Peng, JJ; Zou, HD; Wang, WW; Fu, J; Shen, BJ; Bai, XL; Xu, X; Zhang, X				Jin, Peiyao; Peng, Jinjuan; Zou, Haidong; Wang, Weiwei; Fu, Jiong; Shen, Binjie; Bai, Xuelin; Xu, Xun; Zhang, Xi			The 5-Year Onset and Regression of Diabetic Retinopathy in Chinese Type 2 Diabetes Patients	PLOS ONE			English	Article							INTRAVITREAL BEVACIZUMAB AVASTIN; PANRETINAL PHOTOCOAGULATION; MACULAR EDEMA; PROGRESSION; RISK; PATHOGENESIS; POPULATION; PREVALENCE; GLUCOSE; SYSTEM	Purpose: To determine the rate and risk factors of diabetic retinopathy (DR) onset and regression in Chinese type 2 diabetes mellitus patients. Methods: This is a 5-year community-based prospective study. The demographic information, systemic examination results and ophthalmological test results of each participant were collected. The study outcomes were DR incidence, defined as the onset of DR in at least one eye, and DR regression, defined as full regression from existing DR to no retinopathy without invasive treatments. The associations between each potential risk factor and the outcomes were studied. Results: In total, 778 participants were enrolled. There were 322 patients without DR at baseline, of which 151 participants developed DR during follow-up (DR incidence rate = 46.89%). Baseline hyperglycemia and high blood pressure were two independent risk factors associated with DR incidence. Among the 456 participants with existing DR at entry, 110 fully recovered after 5 years (DR regression rate = 24.12%). Low baseline glucose and low serum triglyceride were two independent factors associated with DR regression. Conclusions: DR incidence occurred more frequently in patients with hyperglycemia and high blood pressure. DR regression occurred mostly in patients with lower glucose and lower serum triglyceride levels among Chinese type 2 diabetes patients.	[Jin, Peiyao; Peng, Jinjuan; Zou, Haidong; Xu, Xun; Zhang, Xi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China; [Zou, Haidong] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai 200040, Peoples R China; [Wang, Weiwei; Fu, Jiong; Shen, Binjie; Bai, Xuelin] Beixinjing Community Hlth Serv Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China.	zouhaidong@hotmail.com	Dagdelen, Selcuk/A-9432-2017	Dagdelen, Selcuk/0000-0002-0513-1750; Zou, Haidong/0000-0002-6831-7560	Chinese National Natural Science Foundation [81371069]; Shanghai Pujiang Program [PJ (2012) 0001652]; Shanghai New Hundred Talents Program from the Shanghai Medical and Family Planning Committee [13B141]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai New Hundred Talents Program from the Shanghai Medical and Family Planning Committee	This work was funded by the Chinese National Natural Science Foundation (Project number 81371069), the Shanghai Pujiang Program (Project number PJ (2012) 0001652), and the Shanghai New Hundred Talents Program from the Shanghai Medical and Family Planning Committee (Project number 13B141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2010, OPHTHALMOLOGY, V117, P946, DOI 10.1016/j.ophtha.2009.10.002; Arevalo JF, 2009, EYE, V23, P117, DOI 10.1038/sj.eye.6702980; Bao Y, 2010, BMJ, V340; Cikamatana L, 2007, EYE, V21, P465, DOI 10.1038/sj.eye.6702771; Consultation W, 1999, DEF DIAGN CLASS DIAB; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; GERRITZEN FM, 1973, DIABETES, V22, P122, DOI 10.2337/diab.22.2.122; Gibbins RL, 1998, DIABETOLOGIA, V41, P59, DOI 10.1007/s001250050867; GORDON B, 1991, AM J OPHTHALMOL, V112, P385, DOI 10.1016/S0002-9394(14)76244-0; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Han Jae Ryong, 2004, Korean J Ophthalmol, V18, P41; Hellstedt T, 1996, BRIT J OPHTHALMOL, V80, P135, DOI 10.1136/bjo.80.2.135; Higashi S, 1998, DIABETES, V47, P653, DOI 10.2337/diabetes.47.4.653; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kameda Y, 2010, BRIT J OPHTHALMOL, V94, P725, DOI 10.1136/bjo.2009.158501; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P244, DOI 10.1001/archopht.1989.01070010250031; Leske MC, 2003, OPHTHALMOLOGY, V110, P941, DOI 10.1016/S0161-6420(03)00086-1; Lopez F, 2007, EUROPEAN OPHTHALMIC, P68; Manaviat MR, 2008, EUR J OPHTHALMOL, V18, P572, DOI 10.1177/112067210801800412; Mirshahi A, 2008, EUR J OPHTHALMOL, V18, P263, DOI 10.1177/112067210801800215; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Peng JJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-250; Perol J, 2012, DIABETES METAB, V38, P225, DOI 10.1016/j.diabet.2012.01.001; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; ROY S, 1990, P NATL ACAD SCI USA, V87, P404, DOI 10.1073/pnas.87.1.404; Ruggenenti P, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/106384; Scanlon PH, 2013, MIDDLE EAST AFR J OP, V20, P293, DOI 10.4103/0974-9233.120007; Schoenlau Frank, 2001, International Ophthalmology, V24, P161, DOI 10.1023/A:1021160924583; Sjolie AK, 2011, DIABETIC MED, V28, P345, DOI 10.1111/j.1464-5491.2010.03210.x; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Steigerwalt R, 2009, J OCUL PHARMACOL TH, V25, P537, DOI 10.1089/jop.2009.0023; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tam VHK, 2009, J DIABETES COMPLICAT, V23, P185, DOI 10.1016/j.jdiacomp.2008.03.001; Tapp RJ, 2006, DIABETES RES CLIN PR, V73, P298, DOI 10.1016/j.diabres.2006.02.009; THEODOSSIADIS GP, 1990, OPHTHALMOLOGICA, V201, P71, DOI 10.1159/000310130; Varma R, 2010, AM J OPHTHALMOL, V149, P752, DOI 10.1016/j.ajo.2009.11.014; Wang N, 2008, OPHTHALMOLOGICA, V222, P32, DOI 10.1159/000109276; WHITE MC, 1981, BRIT J OPHTHALMOL, V65, P307, DOI 10.1136/bjo.65.5.307; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yang CS, 2013, J OCUL PHARMACOL TH, V29, P550, DOI 10.1089/jop.2012.0202; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zavrelova H, 2011, DIABETES CARE, V34, P867, DOI 10.2337/dc10-1741; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524	48	34	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113359	10.1371/journal.pone.0113359	http://dx.doi.org/10.1371/journal.pone.0113359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402474	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700133
J	Liang, CK; Chu, CL; Chou, MY; Lin, YT; Lu, T; Hsu, CJ; Chen, LK				Liang, Chih-Kuang; Chu, Chin-Liang; Chou, Ming-Yueh; Lin, Yu-Te; Lu, Ti; Hsu, Chien-Jen; Chen, Liang-Kung			Interrelationship of Postoperative Delirium and Cognitive Impairment and Their Impact on the Functional Status in Older Patients Undergoing Orthopaedic Surgery: A Prospective Cohort Study	PLOS ONE			English	Article							ELDERLY-PATIENTS; HIP FRACTURE; RISK-FACTORS; OUTCOMES; VALIDATION; DEMENTIA; SYMPTOMS; RECOVERY; DECLINE	Background: The impact of postoperative delirium on post-discharge functional status of older patients remains unclear, and little is known regarding the interrelationship between cognitive impairment and post-operative delirium. Therefore, the main purpose was to evaluate the post-discharge functional status of patients who experience delirium after undergoing orthopaedic surgery and the interrelationship of postoperative delirium with underlying cognitive impairment. Method: This prospective cohort study, conducted at a tertiary care medical center from April 2011 to March 2012, enrolled all subjects aged over 60 years who were admitted for orthopaedic surgery. The baseline characteristics (age, gender, BMI, and living arrangement), surgery-related factors (ASA class, admission type, type of surgery, and length of hospital stay), results of geriatric assessment (postoperative delirium, cognition, depressive mood, comorbidity, pain, malnutrition, polypharmacy, ADL, and instrumental [I] ADL) and 1-12-month postoperative ADL and IADL functional status were collected for analysis. Results: Overall, 9.1% of 232 patients (mean age: 74.767.8 years) experienced postoperative delirium, which was significantly associated with IADL decline at only 6 and 12 months postoperatively (RR: 6.22, 95% CI: 1.08-35.70 and RR: 12.54, 95% CI: 1.88-83.71, respectively). Delirium superimposed on cognitive impairment was a significant predictor for poor functional status at 6 and 12 months postoperatively (RR: 12.80, 95% CI: 1.65-99.40 for ADL at the 6 th month, and RR: 7.96, 95% CI: 1.35-46.99 at the 12 th month; RR: 13.68, 95% CI: 1.94-96.55 for IADL at the 6 th month, and RR: 30.61, 95% CI: 2.94318.54 at the 12 th month, respectively). Conclusion: Postoperative delirium is predictive of IADL decline in older patients undergoing orthopaedic surgery, and delirium superimposed on cognitive impairment is an independent risk factor for deterioration of ADL and IADL functional status. Early identification of cognitive function and to prevent delirium are needed to improve functional status following orthopaedic surgery.	[Liang, Chih-Kuang; Chu, Chin-Liang; Chou, Ming-Yueh; Lin, Yu-Te] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan; [Liang, Chih-Kuang; Lin, Yu-Te] Kaohsiung Vet Gen Hosp, Dept Med, Div Neurol, Kaohsiung, Taiwan; [Liang, Chih-Kuang; Chu, Chin-Liang; Chou, Ming-Yueh; Lin, Yu-Te; Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Chu, Chin-Liang; Lu, Ti] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Chou, Ming-Yueh] Kaohsiung Vet Gen Hosp, Dept Family Med, Kaohsiung, Taiwan; [Hsu, Chien-Jen] Kaohsiung Vet Gen Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital	Lin, YT (corresponding author), Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan.	ytlin@vghks.gov.tw; lkchen2@vghtpe.gov.tw	Liang, Chih-Kuang/AAJ-5235-2020	Liang, Chih-Kuang/0000-0003-1604-1600; Chen, Liang-Kung/0000-0002-2387-8508	Veteran Affairs Commission of Taiwan	Veteran Affairs Commission of Taiwan	This work was supported by grants from the Veteran Affairs Commission of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu CL, 2011, J CLIN GERONTOL GERI, V2, P100, DOI 10.1016/j.jcgg.2011.11.005; Collin C, 1988, Int Disabil Stud, V10, P61; Edelstein DM, 2004, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000128649.59959.0c; Elie M, 2000, CAN MED ASSOC J, V163, P977; Fick DM, 2013, J HOSP MED, V8, P500, DOI 10.1002/jhm.2077; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; FRANCIS J, 1990, J GEN INTERN MED, V5, P65, DOI 10.1007/BF02602312; Givens JL, 2008, J AM GERIATR SOC, V56, P1075, DOI 10.1111/j.1532-5415.2008.01711.x; Gottesman RF, 2010, ANN NEUROL, V67, P338, DOI 10.1002/ana.21899; GUSTAFSON Y, 1988, J AM GERIATR SOC, V36, P525, DOI 10.1111/j.1532-5415.1988.tb04023.x; Holmes J, 2000, PSYCHOL MED, V30, P921, DOI 10.1017/S0033291799002548; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; KOPONEN H, 1989, ACTA PSYCHIAT SCAND, V79, P579, DOI 10.1111/j.1600-0447.1989.tb10306.x; Koster S, 2009, ANN THORAC SURG, V87, P1469, DOI 10.1016/j.athoracsur.2009.02.080; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334; Liao C. Y., 1995, CHANGHUA MED J, V1, P11; Lundstrom M, 2003, J AM GERIATR SOC, V51, P1002, DOI 10.1046/j.1365-2389.2003.51315.x; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x; Norkiene I, 2007, SCAND CARDIOVASC J, V41, P180, DOI 10.1080/14017430701302490; Nyunt MSZ, 2009, AGING MENT HEALTH, V13, P376, DOI 10.1080/13607860902861027; POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x; Quinlan N, 2011, J AM GERIATR SOC, V59, pS301, DOI 10.1111/j.1532-5415.2011.03679.x; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Rudolph JL, 2008, ANAESTHESIA, V63, P941, DOI 10.1111/j.1365-2044.2008.05523.x; Rudolph JL, 2007, AM J MED, V120, P807, DOI 10.1016/j.amjmed.2007.02.026; Rudolph JL, 2011, ANESTH ANALG, V112, P1202, DOI 10.1213/ANE.0b013e3182147f6d; Sanders RD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4331; SCHOR JD, 1992, JAMA-J AM MED ASSOC, V267, P827, DOI 10.1001/jama.267.6.827; Steiner JF, 1997, J AM GERIATR SOC, V45, P1510, DOI 10.1111/j.1532-5415.1997.tb03204.x; Vida S, 2006, INT PSYCHOGERIATR, V18, P681, DOI 10.1017/S1041610206003310; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wu CH, 2012, J CLIN GERONTOL GERI, V3, P14, DOI 10.1016/j.jcgg.2011.05.002	42	36	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110339	10.1371/journal.pone.0110339	http://dx.doi.org/10.1371/journal.pone.0110339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25402484	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700004
J	Botcheva, K; McCorkle, SR				Botcheva, Krassimira; McCorkle, Sean R.			Cell Context Dependent p53 Genome-Wide Binding Patterns and Enrichment at Repeats	PLOS ONE			English	Article							CHIP-SEQ EXPERIMENTS; DNA-BINDING; MICROSATELLITE INSTABILITY; P53-BINDING SITES; COLORECTAL-CANCER; RESPONSE ELEMENT; MOTIF DISCOVERY; GENES; HYPOMETHYLATION; METHYLATION	The p53 ability to elicit stress specific and cell type specific responses is well recognized, but how that specificity is established remains to be defined. Whether upon activation p53 binds to its genomic targets in a cell type and stress type dependent manner is still an open question. Here we show that the p53 binding to the human genome is selective and cell context-dependent. We mapped the genomic binding sites for the endogenous wild type p53 protein in the human cancer cell line HCT116 and compared them to those we previously determined in the normal cell line IMR90. We report distinct p53 genome-wide binding landscapes in two different cell lines, analyzed under the same treatment and experimental conditions, using the same ChIP-seq approach. This is evidence for cell context dependent p53 genomic binding. The observed differences affect the p53 binding sites distribution with respect to major genomic and epigenomic elements (promoter regions, CpG islands and repeats). We correlated the high-confidence p53 ChIP-seq peaks positions with the annotated human repeats (UCSC Human Genome Browser) and observed both common and cell line specific trends. In HCT116, the p53 binding was specifically enriched at LINE repeats, compared to IMR90 cells. The p53 genome-wide binding patterns in HCT116 and IMR90 likely reflect the different epigenetic landscapes in these two cell lines, resulting from cancer-associated changes (accumulated in HCT116) superimposed on tissue specific differences (HCT116 has epithelial, while IMR90 has mesenchymal origin). Our data support the model for p53 binding to the human genome in a highly selective manner, mobilizing distinct sets of genes, contributing to distinct pathways.	[Botcheva, Krassimira; McCorkle, Sean R.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Botcheva, K (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	kalexiev@lbl.gov		McCorkle, Sean/0000-0003-1126-4071	U.S. Department of Energy, Low Dose Radiation Research Program (CWA) [DE AC02 98CH10886]	U.S. Department of Energy, Low Dose Radiation Research Program (CWA)	The work described in the manuscript was performed at Brookhaven National Laboratory supported by a grant DE AC02 98CH10886 from the U.S. Department of Energy, Low Dose Radiation Research Program (CWA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; BOYER JC, 1995, CANCER RES, V55, P6063; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Freed-Pastor WA, 2011, CELL CYCLE, V10, P4207, DOI 10.4161/cc.10.24.18723; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Harris CR, 2009, ONCOGENE, V28, P3857, DOI 10.1038/onc.2009.246; Hearnes JM, 2005, MOL CELL BIOL, V25, P10148, DOI 10.1128/MCB.25.22.10148-10158.2005; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Horvath MM, 2007, PLOS GENET, V3, P1284, DOI 10.1371/journal.pgen.0030127; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaneshiro K, 2007, GENOMICS, V89, P178, DOI 10.1016/j.ygeno.2006.09.001; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Krieg AJ, 2006, MOL CELL BIOL, V26, P7030, DOI 10.1128/MCB.00322-06; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Levine AJ, 2012, ONCOTARGET, V3, P1503; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Millau JF, 2010, BIOESSAYS, V32, P392, DOI 10.1002/bies.200900160; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Vega VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005241; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017	48	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113492	10.1371/journal.pone.0113492	http://dx.doi.org/10.1371/journal.pone.0113492			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415302	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600051
J	Ghosh, R; Vegesna, S; Safi, R; Bao, H; Zhang, B; Marenda, DR; Liebl, FLW				Ghosh, Rupa; Vegesna, Srikar; Safi, Ramia; Bao, Hong; Zhang, Bing; Marenda, Daniel R.; Liebl, Faith L. W.			Kismet Positively Regulates Glutamate Receptor Localization and Synaptic Transmission at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							AXONAL-TRANSPORT DEFECTS; HUMAN CHARGE SYNDROME; IN-VIVO; EPIGENETIC MECHANISMS; BEHAVIORAL PHENOTYPES; ALZHEIMERS-DISEASE; GENE-EXPRESSION; ACTIVE ZONES; PROTEIN; CHD7	The Drosophila neuromuscular junction (NMJ) is a glutamatergic synapse that is structurally and functionally similar to mammalian glutamatergic synapses. These synapses can, as a result of changes in activity, alter the strength of their connections via processes that require chromatin remodeling and changes in gene expression. The chromodomain helicase DNA binding (CHD) protein, Kismet (Kis), is expressed in both motor neuron nuclei and postsynaptic muscle nuclei of the Drosophila larvae. Here, we show that Kis is important for motor neuron synaptic morphology, the localization and clustering of postsynaptic glutamate receptors, larval motor behavior, and synaptic transmission. Our data suggest that Kis is part of the machinery that modulates the development and function of the NMJ. Kis is the homolog to human CHD7, which is mutated in CHARGE syndrome. Thus, our data suggest novel avenues of investigation for synaptic defects associated with CHARGE syndrome.	[Ghosh, Rupa; Vegesna, Srikar; Marenda, Daniel R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Bao, Hong; Zhang, Bing] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Marenda, Daniel R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Safi, Ramia; Liebl, Faith L. W.] So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA	Drexel University; University of Missouri System; University of Missouri Columbia; Drexel University; Southern Illinois University System; Southern Illinois University Edwardsville	Marenda, DR (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	daniel.marenda@drexel.edu; fliebl@siue.edu			National Institutes of Health [RO1NS060878, 1R15NS063315-01]; National Science Foundation [IOS1256114, IOS0822236]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060878, R15NS063315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (nih.gov) RO1NS060878 to BZ; National Institutes of Health (nih. gov) 1R15NS063315-01 to FLWL; National Science Foundation (nsf.gov) IOS1256114 to DRM; and National Science Foundation (nsf. gov) IOS0822236 to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2007, J COMP NEUROL, V504, P519, DOI 10.1002/cne.21460; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blake KD, 2008, AM J MED GENET A, V146A, P585, DOI 10.1002/ajmg.a.32179; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Daubresse G, 1999, DEVELOPMENT, V126, P1175; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dickins EM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00162; DICKINSON WJ, 1980, SCIENCE, V207, P995, DOI 10.1126/science.7352303; Dorighi KM, 2013, DEVELOPMENT, V140, P4182, DOI 10.1242/dev.095786; Dubruille R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000787; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gjorgjieva J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00024; Goellner B, 2012, DEV NEUROBIOL, V72, P111, DOI 10.1002/dneu.20892; Gomez-Palacio-Schjetnan Andrea, 2013, Curr Top Behav Neurosci, V15, P117, DOI 10.1007/7854_2012_231; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Graze RM, 2009, GENETICS, V183, P547, DOI 10.1534/genetics.109.105957; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hartshorne TS, 2005, AM J MED GENET A, V133A, P228, DOI 10.1002/ajmg.a.30541; Heckscher ES, 2012, J NEUROSCI, V32, P12460, DOI 10.1523/JNEUROSCI.0222-12.2012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd EA, 2011, HEARING RES, V282, P184, DOI 10.1016/j.heares.2011.08.005; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Johnson AA, 2013, J NEUROSCI, V33, P7535, DOI 10.1523/JNEUROSCI.3739-12.2013; Kida S, 2014, BRAIN RES B; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; Lipsky RH, 2013, INT J DEV NEUROSCI, V31, P353, DOI 10.1016/j.ijdevneu.2012.10.110; Ljaschenko D, 2013, CELL REP, V3, P1407, DOI 10.1016/j.celrep.2013.04.003; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Melicharek D, 2008, GENETICS, V180, P2095, DOI 10.1534/genetics.108.093302; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; Mhatre SD, 2014, DIS MODEL MECH, V7, P373, DOI 10.1242/dmm.012104; Middei S, 2013, HIPPOCAMPUS, V23, P488, DOI 10.1002/hipo.22108; Mudher A, 2004, MOL PSYCHIATR, V9, P522, DOI 10.1038/sj.mp.4001483; Murawska M, 2011, TRANSCR-AUSTIN, V2, P244, DOI 10.4161/trns.2.6.17840; Park EJ, 2011, BIOCHEM BIOPH RES CO, V416, P416, DOI 10.1016/j.bbrc.2011.11.069; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Ran I, 2012, J NEUROSCI, V32, P6335, DOI 10.1523/JNEUROSCI.5463-11.2012; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Roch F, 1998, MOL GEN GENET, V257, P103, DOI 10.1007/PL00008620; Sandstrom DJ, 2004, J PHYSIOL-LONDON, V558, P489, DOI 10.1113/jphysiol.2004.065748; Sanlaville D, 2007, EUR J HUM GENET, V15, P389, DOI 10.1038/sj.ejhg.5201778; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Shi WW, 2013, J NEUROSCI, V33, P12352, DOI 10.1523/JNEUROSCI.0386-13.2013; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Stewart BA, 2004, J NEUROBIOL, V61, P392, DOI 10.1002/neu.20096; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; Therrien M, 2000, GENETICS, V156, P1231; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vanlandingham PA, 2014, TRAFFIC, V15, P433, DOI 10.1111/tra.12153; Viquez NM, 2009, J NEUROSCI, V29, P11484, DOI 10.1523/JNEUROSCI.5584-08.2009; Vogler G, 2008, DEV BIOL, V319, P78, DOI 10.1016/j.ydbio.2008.04.008; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Winther AME, 2013, J CELL SCI, V126, P1021, DOI 10.1242/jcs.118968; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yan YP, 2007, J NEUROSCI METH, V162, P198, DOI 10.1016/j.jneumeth.2007.01.013; Yokoyama H, 2009, J CELL BIOL, V187, P813, DOI 10.1083/jcb.200906020; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323	84	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113494	10.1371/journal.pone.0113494	http://dx.doi.org/10.1371/journal.pone.0113494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412171	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000059
J	Liemburg, EJ; Castelein, S; van Es, F; Scholte-Stalenhoef, AN; van de Willige, G; Smid, H; Visser, E; Knegtering, H; Bruggeman, R				Liemburg, Edith J.; Castelein, Stynke; van Es, Frank; Scholte-Stalenhoef, Anne Neeltje; van de Willige, Gerard; Smid, Henderikus; Visser, Ellen; Knegtering, Henderikus; Bruggeman, Richard			The Psychosis Recent Onset GRoningen Survey (PROGR-S): Defining Dimensions and Improving Outcomes in Early Psychosis	PLOS ONE			English	Article							1ST-EPISODE PSYCHOSIS; UNTREATED PSYCHOSIS; PHYSICAL HEALTH; HIGH-RISK; SCHIZOPHRENIA; CANNABIS; METAANALYSIS; RELIABILITY; PREDICTORS; DISORDERS	Psychotic disorders are among the most complex medical conditions. Longitudinal cohort studies may offer further insight into determinants of functional outcome after a psychotic episode. This paper describes the Psychosis Recent Onset in GRoningen Survey (PROGR-S) that currently contains data on 1076 early-episode patients with psychosis, including symptoms, personality, cognition, life events and other outcome determinants. Our goal in this report is to give an overview of PROGR-S, as a point of reference for future publications on the effect of cognition, personality and psychosocial functioning on outcomes. PROGR-S contains an extensive, diagnostic battery including anamnesis, biography, socio-demographic characteristics, clinical status, drug use, neuropsychological assessment, personality questionnaires, and physical status tests. Extensive follow-up data is available on psychopathology, physical condition, medication use, and care consumption. Sample characteristics were determined and related to existing literature. PROGR-S (period 1997-2009, n = 718) included the majority of the expected referrals in the catchment area. The average age was 27 (SD = 8.6) and two-thirds were male. The average IQ was lower than that in the healthy control group. The majority had been diagnosed with a psychotic spectrum disorder. A substantial number of the patients had depressive symptoms (479/718, 78%) and current cannabis or alcohol use (465/718, 75%). The level of community functioning was moderate, i.e. most patients were not in a relationship and were unemployed. The PROGR-S database contains a valuable cohort to study a range of aspects related to symptomatic and functional outcomes of recent onset psychosis, which may play a role in the treatment of this complex and disabling disorder. Results reported here show interesting starting points for future research. Thus, we aim to investigate long-term outcomes on the basis of cognition, personality, negative symptoms and physical health. Ultimately, we hope that this paper will contribute improving the health of patients with psychotic disorders.	[Liemburg, Edith J.; Castelein, Stynke; van Es, Frank; Scholte-Stalenhoef, Anne Neeltje; van de Willige, Gerard; Smid, Henderikus; Visser, Ellen; Knegtering, Henderikus; Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Groningen, Netherlands; [Liemburg, Edith J.; Knegtering, Henderikus] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NeuroImaging Ctr, Groningen, Netherlands; [Castelein, Stynke; Knegtering, Henderikus] Lentis Mental Healthcare Ctr, Lentis Res, Groningen, Netherlands	University of Groningen; University of Groningen	Liemburg, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Groningen, Netherlands.	e.j.liemburg@umcg.nl		Castelein, Stynke/0000-0002-8419-568X; Bruggeman, Richard/0000-0002-3238-8471				Achim AM, 2005, J COGNITIVE NEUROSCI, V17, P652, DOI 10.1162/0898929053467578; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; Alvarez-Jimenez M, 2012, SCHIZOPHR RES, V139, P116, DOI 10.1016/j.schres.2012.05.007; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Bajs M, 2011, COLLEGIUM ANTROPOL, V35, P39; Boonstra N, 2012, SCHIZOPHR RES, V142, P12, DOI 10.1016/j.schres.2012.08.017; Bora E, 2013, SCHIZOPHR RES, V144, P31, DOI 10.1016/j.schres.2012.12.013; Bowie CR, 2005, PSYCHIAT CLIN N AM, V28, P613, DOI 10.1016/j.psc.2005.05.004; Bromet EJ, 2011, AM J PSYCHIAT, V168, P1186, DOI 10.1176/appi.ajp.2011.11010048; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Costa Jr PT, 1990, REVISED NEO PERSONAL; Cotton SM, 2013, SCHIZOPHR RES, V147, P169, DOI 10.1016/j.schres.2013.02.036; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Delis D. C., 2000, CVLT 2 CALIFORNIA VE; Dell'Osso B, 2013, PSYCHOPATHOLOGY, V46, P14, DOI 10.1159/000338608; Devylder JE, 2012, PSYCHOL MED, V43, P1, DOI DOI 10.1017/S0033291712001262; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Giel R., 1996, SCAN 2 1 SCHEDULES C; Gold JM, 2009, NEUROPSYCHOL REV, V19, P294, DOI 10.1007/s11065-009-9098-x; Golden C.J., 1978, STROOP COLOR WORD TE; Gumley AI, 2014, ACTA PSYCHIAT SCAND, V129, P257, DOI 10.1111/acps.12172; Gunter TD, 2012, BEHAV SCI LAW, V30, P615, DOI 10.1002/bsl.2037; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; Harrington E, 2013, EARLY INTERV PSYCHIA, V7, P311, DOI 10.1111/eip.12028; Heald A, 2010, EUR PSYCHIAT, V25, pS41, DOI 10.1016/S0924-9338(10)71706-5; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hermann D, 2007, BIOL PSYCHIAT, V61, P1281, DOI 10.1016/j.biopsych.2006.08.027; Hill M, 2012, SCHIZOPHR RES, V141, P215, DOI 10.1016/j.schres.2012.08.013; Hoekstra H., 1996, NEO PERSOONLIJKHEIDS; Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe Richard S E, 2012, Handb Exp Pharmacol, P11, DOI 10.1007/978-3-642-25758-2_2; Lako IM, 2012, EUR PSYCHIAT, V27, P240, DOI 10.1016/j.eurpsy.2010.10.007; Lasalvia A, 2012, EPIDEMIOL PSYCH SCI, V21, P281, DOI 10.1017/S2045796012000315; Leucht S, 2009, MOL PSYCHIATR, V14, P429, DOI 10.1038/sj.mp.4002136; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Levine SZ, 2011, SCHIZOPHR RES, V126, P184, DOI 10.1016/j.schres.2010.10.026; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lysaker PH, 2007, PSYCHOPATHOLOGY, V40, P338, DOI 10.1159/000105532; Marshall M, 2011, COCHRANE DB SYST REV, V15; MCEVOY J, 1995, BIOL PSYCHIAT, V37, P550, DOI 10.1016/0006-3223(94)00365-A; McGorry PD, 2010, CAN J PSYCHIAT, V55, P486, DOI 10.1177/070674371005500803; Meijer JH, 2012, PSYCHOL MED, V42, P705, DOI 10.1017/S0033291711001656; Menezes NM, 2006, PSYCHOL MED, V36, P1349, DOI 10.1017/S0033291706007951; Montejo AL, 2010, EUR PSYCHIAT, V25, pS3, DOI 10.1016/S0924-9338(10)71699-0; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nuechterlein KH, 2011, SCHIZOPHRENIA BULL, V37, pS33, DOI 10.1093/schbul/sbr084; Ochoa S, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/916198; Pagel T, 2013, BIPOLAR DISORD, V15, P229, DOI 10.1111/bdi.12057; Palmer BW, 2009, NEUROPSYCHOL REV, V19, P365, DOI 10.1007/s11065-009-9109-y; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; PHELAN M, 1995, BRIT J PSYCHIAT, V167, P589, DOI 10.1192/bjp.167.5.589; Reichenberg A, 2009, SCHIZOPHRENIA BULL, V35, P1022, DOI 10.1093/schbul/sbn044; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Rund BR, 2006, ACTA PSYCHIAT SCAND, V113, P350, DOI 10.1111/j.1600-0447.2005.00626.x; Saracco-Alvarez R, 2009, PSYCHIAT RES, V165, P234, DOI 10.1016/j.psychres.2007.11.004; Schennach Rebecca, 2012, Clin Psychopharmacol Neurosci, V10, P78, DOI 10.9758/cpn.2012.10.2.78; Schorch S., 2010, DEUTEROCANONICAL ADD, P30; Schreurs P. J. G., 1988, OMGAAN MET PROBLEMEN; Smid HGOM, 2006, J CLIN EXP NEUROPSYC, V28, P859, DOI 10.1080/13803390591001025; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x; Spreen O, 1998, COMPENDIUM NEUROPSYC; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Van Alphen C, 2012, MULTIDISCIPLINIARE R; van der Gaag M, 2012, SCHIZOPHRENIA BULL, V38, P1180, DOI 10.1093/schbul/sbs105; van der Meer FJ, 2012, CURR PHARM DESIGN, V18, P5036; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; van Winkel R, 2011, NEUROPSYCHOPHARMACOL, V36, P2529, DOI 10.1038/npp.2011.141; Vancampfort D, 2010, PSYCHIAT RES, V177, P271, DOI 10.1016/j.psychres.2010.03.011; Verhage F., 1984, INTELLIGENTIE LEEFTI; Waterreus A, 2012, AUST NZ J PSYCHIAT, V46, P762, DOI 10.1177/0004867412450471; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wiersma D., 1990, GSDS 2 GRONINGEN SOC; Wiersma D, 1999, HDB PSYCHIAT EPIDEMI; Williams JBW, 2008, BRIT J PSYCHIAT, V192, P52, DOI 10.1192/bjp.bp.106.032532; Zaytseva Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/819587; Zimbron J, 2013, ACTA PSYCHIAT SCAND, V127, P210, DOI 10.1111/acps.12000; Zipursky RB, 2014, SCHIZOPHR RES, V152, P408, DOI 10.1016/j.schres.2013.08.001	83	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113521	10.1371/journal.pone.0113521	http://dx.doi.org/10.1371/journal.pone.0113521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25412332	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000061
J	Medina, NG; Estebanez, B				Medina, Nagore G.; Estebanez, Belen			Does Spore Ultrastructure Mirror Different Dispersal Strategies in Mosses? A Study of Seven Iberian Orthotrichum Species	PLOS ONE			English	Article							SP-NOV; BRYOPSIDA	Most mosses have xerochastic dispersal (i.e., they open their capsules when conditions are dry), which is thought to favor long-distance dispersal. However, there are several species that use a hygrochastic strategy: spores are dispersed when conditions are wet. The significance of this strategy in the Mediterranean region is unknown. In this study, we explored whether ultrastructural features related to differences in spore resistance may explain these different strategies of spore dispersal. To this end, we examined the ultrastructural features of the spores of seven closely related species in the moss genus Orthotrichum. These species all grow as epiphytes in sub-Mediterranean forests, and the group includes both xerochastic and hygrochastic members. First, we found that the spore wall layers exhibit several features previously undescribed in mosses. Second, we discovered that there are only subtle differences in spore ultrastructure with regards to spore wall thickness, the degree of plastid development, or the storage substances used. We suggest that the hygrochastic dispersal in mosses from Mediterranean environments might be related to a safe-site strategy, rather than to drought avoidance, and we underscore the necessity of conducting spore ultrastructural studies on a greater number of bryophyte species.	[Medina, Nagore G.; Estebanez, Belen] Univ Autonoma Madrid, Fac Ciencias, Dept Biol Bot, E-28049 Madrid, Spain	Autonomous University of Madrid	Medina, NG (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Biol Bot, Campus Cantoblanco,C Darwin 2, E-28049 Madrid, Spain.	nagore.garcia@uam.es; belen.estebanez@uam.es	Medina, Nagore G./M-1117-2018	Medina, Nagore G./0000-0003-4702-1610; Estebanez Perez, Belen/0000-0002-5567-0234	UAM Madrid [CCG10-UAM/AMB-5630]	UAM Madrid	The experimental part has been partially self-funded, it also received support from the regional project ref. CCG10-UAM/AMB-5630 (UAM & Madrid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfayate C, 2013, BRYOLOGIST, V116, P97, DOI 10.1639/0007-2745-116.2.097; Ballesteros D, 2011, WORKING WITH FERNS: ISSUES AND APPLICATIONS, P165, DOI 10.1007/978-1-4419-7162-3_12; Brown R.C., 1990, MICROSPORES EVOLUTIO, P55; Caparros R, 2011, J BRYOL, V33, P210, DOI 10.1179/1743282011Y.0000000008; CARRION JS, 1990, NOVA HEDWIGIA, V51, P411; Casas C., 2020, HDB MOSSES IBERIAN P; Clarke GCS., 1979, BRYOPHYTE SYSTEMATIC, P231; Cortini Pedrotti C., 2001, FLORA MUSCHI ITALIA; Estebanez B, 2006, GRANA, V45, P61, DOI 10.1080/00173130600555722; Estebanez B, 1997, GRANA, V36, P347, DOI 10.1080/00173139709362628; Fahn A, 1972, SEED BIOL IMPORTANCE, P151; Garilleti R, 2012, ATLAS ENDANGERED BRY; Hedenas L, 2012, J BRYOL, V34, P79, DOI 10.1179/1743282011Y.0000000049; Hegazy AK, 2007, ACTA OECOL, V31, P332, DOI 10.1016/j.actao.2007.01.006; LARA F, 1993, NOVA HEDWIGIA, V56, P263; Lara F, 1996, NOVA HEDWIGIA, V63, P517; Lloyd R.M., 1970, BIOTROPICA, V2, P129, DOI DOI 10.2307/2989770; Lobel S, 2009, OECOLOGIA, V161, P569, DOI 10.1007/s00442-009-1402-1; MCCLYMONT J, 1964, AM J BOT, V51, P195, DOI 10.2307/2440105; Medina NG, 2009, J BRYOL, V31, P124, DOI 10.1179/174328209X415086; Meyer S.L., 1941, BRYOLOGIST, V44, P69, DOI [10.1639/0007-2745(1941)44[69:PSOMIS]2.0.CO;2, DOI 10.1639/0007-2745(1941)44[69:PSOMIS]2.0.CO;2, DOI 10.2307/3239358]; MILLER JH, 1968, BOT REV, V34, P361, DOI 10.1007/BF02859133; Mogensen GS, 1983, NEW MANUAL BRYOLOGY, V1, P324; Mueller MD, 1988, ADV BRYOLOGY J CRAME, V3, P135; MURBECK S, 1919, BEITRAGE BIOL WUSTEN; Nakanishi K, 2001, J HATTORI BOT LAB, P301; OLESEN P, 1978, BRYOLOGIST, V81, P493, DOI 10.2307/3242337; Pais M. S., 1967, REV BIOL-LISBON, V5, P239; Parolin P, 2006, FLORA, V201, P511, DOI 10.1016/j.flora.2005.11.003; Patterson PM, 1953, BRYOLOGIST, V56, P157, DOI [DOI 10.1639/0007-2745(1953)56[157:TABOTP]2.0.CO;2, 10.2307/3240111]; Pufal G, 2010, ANN BOT-LONDON, V106, P405, DOI 10.1093/aob/mcq136; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STEBBINS G. L., 1971, Annual review of ecology and systematics. Volume 2., P237; Sundberg S, 2000, NEW PHYTOL, V148, P105, DOI 10.1046/j.1469-8137.2000.00746.x; Van Rheede van Oudtshoorn K., 1999, DISPERSAL BIOL DESER, DOI 10.1007/978-3-662-03561-0; Van Rooyen MW, J ARID ENV, V19, P133; van Zanten B. O., 1988, NOVA HEDWIGIA S, V90, P41; van Zanten B. O., 1976, J HATTORI BOT LAB, V41, P133; van Zanten BO, 1981, ADV BRYOLOGY, V1, P479; VITT DH, 1981, BRYOLOGIST, V84, P166, DOI 10.2307/3242820; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Zohary M, 1937, BOT ZENTRALBLATT A S, V61A, P1	43	13	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112867	10.1371/journal.pone.0112867	http://dx.doi.org/10.1371/journal.pone.0112867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412450	gold, Green Submitted, Green Published			2022-12-27	WOS:000345253000017
J	Naito, A; Tanabe, N; Jujo, T; Shigeta, A; Sugiura, T; Sakao, S; Ishida, K; Tatsumi, K				Naito, Akira; Tanabe, Nobuhiro; Jujo, Takayuki; Shigeta, Ayako; Sugiura, Toshihiko; Sakao, Seiichiro; Ishida, Keiichi; Tatsumi, Koichiro			Pentraxin3 in Chronic Thromboembolic Pulmonary Hypertension: A New Biomarker for Screening from Remitted Pulmonary Thromboembolism	PLOS ONE			English	Article							ACID-BINDING PROTEIN; LONG PENTRAXIN; DISEASE-ACTIVITY; 3 PTX3; MARKER; CLASSIFICATION; RECOGNITION; INDICATOR; DIAGNOSIS	Background: Pentraxin3 (PTX3) is a protein, which has multifaceted effects on innate immunity, angiogenesis, and vascular remodeling then could be a disease marker of acute myocardial infarction, heart failure, vasculitis. In addition, PTX3 has been recognized as a biomarker for pulmonary arterial hypertension, however whether it is the case in chronic thromboembolic pulmonary hypertension (CTEPH) remains unclear. Therefore, we investigated whether PTX3 would be a useful biomarker for detecting CTEPH with respect to differentiation from stable pulmonary thromboembolism (PTE), in comparison to other biomarkers. Methods: Plasma PTX3 and brain natriuretic peptide (BNP) levels were measured in 70 patients with CTEPH at their first diagnostic right heart catheterization (CTEPH group) and in 20 patients with clinically stable PTE more than three months after the acute episode (control group). The levels of plasma C-reactive protein (CRP) and heart-type fatty acid-binding protein (H-FABP) were also analyzed to compare the diagnostic ability of these biomarkers. Results: The mean level of PTX3 (ng/mL) was significantly higher in the CTEPH group than in the control group (5.51 +/- 4.53 versus 2.01 +/- 0.96, respectively), and PTX3 levels had mild negative correlation with cardiac output. BNP levels were also higher in the CTEPH group and better correlated with pulmonary hemodynamics than PTX3. However, a receiver operating characteristic (ROC) curve showed PTX3 levels were better for detecting CTEPH, and could detect CTEPH patients with less severe pulmonary hemodynamics and low plasma BNP levels. There was no significant increase in CRP and H-FABP levels in the CTEPH patients. Conclusions: Plasma PTX3 level was the most sensitive biomarker of CTEPH. Although plasma PTX3 levels did not correlate with the severity of the pulmonary hemodynamics compared to BNP, high levels in clinically stable patients following PTE should prompt a further work-up for CTEPH, which may lead to an early diagnosis.	[Naito, Akira; Tanabe, Nobuhiro; Jujo, Takayuki; Shigeta, Ayako; Sugiura, Toshihiko; Sakao, Seiichiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, Chiba 2608670, Japan; [Tanabe, Nobuhiro; Jujo, Takayuki; Shigeta, Ayako] Chiba Univ, Grad Sch Med, Dept Adv Med Pulm Hypertens, Chuo Ku, Chiba 2608670, Japan; [Ishida, Keiichi] Chiba Univ, Grad Sch Med, Dept Cardiovasc Surg, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University	Naito, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	akira-n.390@chiba-u.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Ministry of Education, Culture, Sports, Science and Technology of Japan [25461148]; Ministry of Health, Labour and Welfare, Japan [H26-076]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	The present study was supported, in part, by a research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (https://kaken.nii.ac.jp/d/p/25461148.ja.html) [No. 25461148 awarded to Dr. NT] and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/) [H26-076 awarded to Drs. NT SS KT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastrup-Birk S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073119; Boomsma F, 2001, CARDIOVASC RES, V51, P442, DOI 10.1016/S0008-6363(01)00195-X; Cieslik P, 2012, AUTOIMMUNITY, V45, P119, DOI 10.3109/08916934.2011.611549; Dagna L, 2011, ANN INTERN MED, V155, P425, DOI 10.7326/0003-4819-155-7-201110040-00005; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dentali F, 2009, INTERN EMERG MED, V4, P123, DOI 10.1007/s11739-009-0231-x; Duran S, 2013, CLIN BIOCHEM, V46, P983, DOI 10.1016/j.clinbiochem.2013.04.026; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Galie Nazzareno, 2006, Proc Am Thorac Soc, V3, P571, DOI 10.1513/pats.200605-113LR; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Kao SJ, 2013, CLIN CHEM LAB MED, V51, P907, DOI 10.1515/cclm-2012-0459; Kim NH, 2013, J AM COLL CARDIOL, V62, pD92, DOI 10.1016/j.jacc.2013.10.024; Kim Nick H S, 2006, Proc Am Thorac Soc, V3, P584, DOI 10.1513/pats.200605-106LR; Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312; Lankeit M, 2008, EUR RESPIR J, V31, P1024, DOI 10.1183/09031936.00100407; Leary PJ, 2014, PULM CIRC, V4, P250, DOI 10.1086/675988; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Napoleone E, 2002, ARTERIOSCL THROM VAS, V22, P782, DOI 10.1161/01.ATV.0000012282.39306.64; Nebuloni Manuela, 2011, Cardiovasc Pathol, V20, pe27, DOI 10.1016/j.carpath.2010.02.005; Niizeki T, 2007, CIRC J, V71, P1452, DOI 10.1253/circj.71.1452; Nishimura R, 2013, CIRC J, V77, P2110, DOI 10.1253/circj.CJ-12-1391; Ortega-Hernandez OD, 2009, SEMIN ARTHRITIS RHEU, V39, P38, DOI 10.1016/j.semarthrit.2008.03.006; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Quarck R, 2009, J AM COLL CARDIOL, V53, P1211, DOI 10.1016/j.jacc.2008.12.038; Reesink HJ, 2007, ANN THORAC SURG, V84, P537, DOI 10.1016/j.athoracsur.2007.04.006; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Tamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045834; Thistlethwaite PA, 2002, J THORAC CARDIOV SUR, V124, P1203, DOI 10.1067/mtc.2002.127313; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110; Zabini D, 2014, EUR RESP J	35	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113086	10.1371/journal.pone.0113086	http://dx.doi.org/10.1371/journal.pone.0113086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412085	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000022
J	Remacle, AG; Shiryaev, SA; Strongin, AY				Remacle, Albert G.; Shiryaev, Sergey A.; Strongin, Alex Y.			Distinct Interactions with Cellular E-Cadherin of the Two Virulent Metalloproteinases Encoded by a Bacteroides fragilis Pathogenicity Island	PLOS ONE			English	Article							TOXIN GENE; ENTEROTOXIN; CLEAVAGE; CLONING; COLON	Bacteroides fragilis causes the majority of Gram-negative anaerobic infections in the humans. The presence of a short, 6-kb, pathogenicity island in the genome is linked to enterotoxigenic B. fragilis (ETBF). The role of the enterotoxin in B. fragilis virulence, however, remains to be determined, as the majority of clinical isolates lack ETBF genes and healthy individuals carry enterotoxin-positive B. fragilis. The island encodes secretory metalloproteinase II (MPII) and one of three homologous enterotoxigenic fragilysin isoenzymes (FRA; also termed B. fragilis toxin or BFT). The secretory metalloproteinases expressed from the genes on the B. fragilis pathogenicity island may have pathological importance within the gut, not linked to diarrhea. MPII and FRA are counter-transcribed in the bacterial genome, implying that regardless of their structural similarity and overlapping cleavage preferences these proteases perform distinct and highly specialized functions in the course of B. fragilis infection. The earlier data by us and others have demonstrated that FRA cleaves cellular E-cadherin, an important adherens junction protein, and weakens cell-to-cell contacts. Using E-cadherin-positive and E-cadherin-deficient cancer cells, and the immunostaining, direct cell binding and pull-down approaches, we, however, demonstrated that MPII via its catalytic domain efficiently binds, rather than cleaves, E-cadherin. According to our results, E-cadherin is an adherens junction cellular receptor, rather than a proteolytic target, of the B. fragilis secretory MPII enzyme. As a result of the combined FRA and MPII proteolysis, cell-to-cell contacts and adherens junctions are likely to weaken further.	[Remacle, Albert G.; Shiryaev, Sergey A.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [R01CA83017, R01CA157328, R01DE022757]; NATIONAL CANCER INSTITUTE [R01CA157328, R01CA083017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by R01CA83017, R01CA157328 and R01DE022757 grants (to AYS) from the National Institutes of Health (http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Dejea C, 2013, FUTURE MICROBIOL, V8, P445, DOI [10.2217/fmb.13.17, 10.2217/FMB.13.17]; Franco AA, 1997, INFECT IMMUN, V65, P1007, DOI 10.1128/IAI.65.3.1007-1013.1997; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Kharlampieva DD, 2013, BIOCHIMIE, V95, P2123, DOI 10.1016/j.biochi.2013.08.005; Kling JJ, 1997, FEMS MICROBIOL LETT, V146, P279, DOI 10.1016/S0378-1097(96)00488-0; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; MONCRIEF JS, 1995, INFECT IMMUN, V63, P175, DOI 10.1128/IAI.63.1.175-181.1995; OBISO RJ, 1995, INFECT IMMUN, V63, P3820, DOI 10.1128/IAI.63.10.3820-3826.1995; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Sanchez E, 2012, APPL ENVIRON MICROB, V78, P6507, DOI 10.1128/AEM.00563-12; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Shiryaev SA, 2014, FEBS J, V281, P2487, DOI 10.1111/febs.12804; Shiryaev SA, 2013, J BIOL CHEM, V288, P34956, DOI 10.1074/jbc.M113.516153; WEIKEL CS, 1992, INFECT IMMUN, V60, P321, DOI 10.1128/IAI.60.2.321-327.1992; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2007, J CELL SCI, V120, P1944, DOI 10.1242/jcs.03455; Wu SG, 2006, INFECT IMMUN, V74, P5382, DOI 10.1128/IAI.00060-06; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	23	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113896	10.1371/journal.pone.0113896	http://dx.doi.org/10.1371/journal.pone.0113896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411788	Green Submitted, gold, Green Published			2022-12-27	WOS:000345253000082
J	Goncalves, B; Sanchez, D				Goncalves, Bruno; Sanchez, David			Crowdsourcing Dialect Characterization through Twitter	PLOS ONE			English	Article								We perform a large-scale analysis of language diatopic variation using geotagged microblogging datasets. By collecting all Twitter messages written in Spanish over more than two years, we build a corpus from which a carefully selected list of concepts allows us to characterize Spanish varieties on a global scale. A cluster analysis proves the existence of well defined macroregions sharing common lexical properties. Remarkably enough, we find that Spanish language is split into two superdialects, namely, an urban speech used across major American and Spanish citites and a diverse form that encompasses rural areas and small towns. The latter can be further clustered into smaller varieties with a stronger regional character.	[Goncalves, Bruno] Aix Marseille Univ, CNRS, CPT, UMR 7332, F-13288 Marseille, France; [Goncalves, Bruno] Univ Toulon & Var, CNRS, CPT, UMR 7332, F-83957 La Garde, France; [Sanchez, David] UIB CSIC, Inst Fis Interdisciplinar & Sistemas Complejos, E-07122 Palma De Mallorca, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Goncalves, B (corresponding author), Aix Marseille Univ, CNRS, CPT, UMR 7332, F-13288 Marseille, France.	bgoncalves@gmail.com	Gonçalves, Bruno/A-8541-2009; SANCHEZ, DAVID/A-9135-2009	Gonçalves, Bruno/0000-0001-5644-3749; SANCHEZ, DAVID/0000-0002-2549-7071	United States Department of Energy [DE-AC05-00OR22725]	United States Department of Energy(United States Department of Energy (DOE))	This product was made utilizing the LandScan 2007 High Resolution global Population Data Set copyrighted by UT-Battelle, LLC, operator of Oak Ridge National Laboratory under Contract No. DE-AC05-00OR22725 with the United States Department of Energy. The United States Government has certain rights in this Data Set. Neither UT-BATTELLE, LLC NOR THE UNITED STATES DEPARTMENT OF ENERGY, NOR ANY OF THEIR EMPLOYEES, MAKES ANY WARRANTY, EXPRESS OR IMPLIED, OR ASSUMES ANY LEGAL LIABILITY OR RESPONSIBILITY FOR THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE DATA SET.	[Anonymous], P 6 INT AAAI C WEBL; Bauer L, 2004, HDB LANGUAGE VARIATI, V97, P114; Boberg, 2005, ATLAS N AM ENGLISH P; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Chambers J., 1980, DIALECTOLOGY; Cotton EG, 1988, SPANISH AM; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Hong L., 2011, AAAI, P518; Lopez Morales H, 2005, HOMENAJE JJM GIRALDO, P333; Mislove A, P 5 INT AAAI C WEBLO; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; Moreno Fern?ndez F., 2007, ATLAS LENGUA ESPANOL; Noah A.Smith, 2010, EMNLP; Penny Ralph, 2000, VARIATION CHANGE SPA; Pham DT, 2005, P I MECH ENG C-J MEC, V219, P103, DOI 10.1243/095440605X8298; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Russ B, 2012, ADS ANN M; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Smith A, 2010, OVERVIEW PEOPLE WHO; Stewart Miranda, 1999, SPANISH LANGUAGE TOD; Trudgill Peter, 2002, INT ENGLISH GUIDE VA; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Ueda H, 1993, VARILEX VARIACION LE	24	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112074	10.1371/journal.pone.0112074	http://dx.doi.org/10.1371/journal.pone.0112074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409174	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200014
J	Jonas, JB; Nangia, V; Rietschel, M; Paul, T; Behere, P; Panda-Jonas, S				Jonas, Jost B.; Nangia, Vinay; Rietschel, Marcella; Paul, Torsten; Behere, Prakash; Panda-Jonas, Songhomitra			Prevalence of Depression, Suicidal Ideation, Alcohol Intake and Nicotine Consumption in Rural Central India. The Central India Eye and Medical Study	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; SYSTEMATIC ANALYSIS; SMOKING-CESSATION; GLOBAL BURDEN; RISK-FACTORS; 21 REGIONS; TOBACCO; HEALTH; EPIDEMIOLOGY; POPULATION	Background: To investigate the prevalence of depression, suicidal ideations, alcohol and nicotine consumption in adults in an agrarian society mostly unchanged by the effects of urbanization. Methods: The Central India Eye and Medical Study is a population-based study in rural Central India close to the tribal belt and included 4711 subjects (aged 30+ years). Depression was assessed by the Center for Epidemiologic Studies Depression Scale (CESD), suicidal ideation by six standardized questions, nicotine use by the Fagerstroem Nicotine Tolerance Questionnaire (FTNQ), and alcohol consumption by the Alcohol Use Disorders Identification Test (AUDIT). Results: Mild to moderate depression (CESD sum score: 15-21) was detected in 1862 (39.6%) individuals (33.5% of men, 44.8 of women), and major depression (CESD sum score >21) in 613 (13.0%) individuals (8.1 of men, 17.3% of women). Suicide attempt was reported by 199 (4.2%) participants and suicidal thoughts during the last 6 months by 238 (5.1%) individuals. There were 887 (18.9%) smokers and smokeless tobacco was consumed by 1968 (41.8%) subjects. Alcohol consumption was reported by 1081 (23.0%) participants; 283 (6.0%) subjects had an AUDIT score >= 8 (hazardous drinking), and 108 (4.63%) subjects a score >= 13 (women) or >= 15 (men) (alcohol dependence). Conclusions: In rural Central India, prevalence of major depression was comparable to figures reported from other developing countries. Prevalence of smoking and hazardous alcohol consumption was higher than as reported from urban regions. Measures should be taken to address the relatively high prevalence of suicide attempts and thoughts on suicide in rural Central India.	[Jonas, Jost B.; Nangia, Vinay; Behere, Prakash; Panda-Jonas, Songhomitra] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Rietschel, Marcella; Paul, Torsten] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Behere, Prakash] Datta Meghe Inst Med Sci, Dept Psychiat, Wardha, Maharashtra, India	Suraj Eye Institute; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Datta Meghe Institute of Medical Sciences - Deemed to be University; Jawaharlal Nehru Medical College Wardha	Jonas, JB (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	jost.jonas@medma.uni-heidelberg.de; nagpursuraj@gmail.com	Behere, P. B./AAL-5280-2020	Behere, P. B./0000-0001-5064-3328	Om Drishti Trust Nagpur; Heidelberg Engineering Co. Heidelberg, Germany; Rotary Sight Saver Netherlands; Orbis India; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust Nagpur; Heidelberg Engineering Co. Heidelberg, Germany; Rotary Sight Saver Netherlands; Orbis India; Carl Zeiss Meditec Co., Jena, Germany	Support was provided by an unrestricted grant from Om Drishti Trust Nagpur; Heidelberg Engineering Co. Heidelberg, Germany; Rotary Sight Saver Netherlands; Orbis India; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron R, 2004, LANCET, V363, P1117, DOI 10.1016/S0140-6736(04)15896-0; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Ganguli H C, 2000, Indian J Psychiatry, V42, P14; Ghosh S, 2012, J HEALTH POPUL NUTR, V30, P73; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Glassman AH, 2001, LANCET, V357, P1929, DOI 10.1016/S0140-6736(00)05064-9; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Jonas JB, 2010, EPIDEMIOLOGY, V21, P754, DOI 10.1097/EDE.0b013e3181e66201; Lester D, 1999, ARCH SUICIDE RES, V5, P91, DOI 10.1080/13811119908258320; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Math SB, 2007, INDIAN J MED RES, V126, P183; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nandi DN, 2000, BRIT J PSYCHIAT, V176, P351, DOI 10.1192/bjp.176.4.351; Nandi P S, 1997, Indian J Psychiatry, V39, P122; Neufeld KJ, 2005, DRUG ALCOHOL DEPEN, V77, P283, DOI 10.1016/j.drugalcdep.2004.08.022; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Patton GC, 2014, LANCET, V383, P1404, DOI [10.1016/s0140-6736(13)62116-9, 10.1016/S0140-6736(13)62116-9]; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Poongothai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007185; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Reddy KS, 2006, LANCET, V367, P589, DOI 10.1016/S0140-6736(06)68225-1; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; Tiwari SC, 2000, INT PSYCHOGERIATR, V12, P35, DOI 10.1017/S1041610200006189; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; World Health Organization, 2008, GLOB BURD DIS 2004 U	36	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113550	10.1371/journal.pone.0113550	http://dx.doi.org/10.1371/journal.pone.0113550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409441	Green Published, gold			2022-12-27	WOS:000345533200136
J	Lata, C; Mishra, AK; Muthamilarasan, M; Bonthala, VS; Khan, Y; Prasad, M				Lata, Charu; Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Bonthala, Venkata Suresh; Khan, Yusuf; Prasad, Manoj			Genome-Wide Investigation and Expression Profiling of AP2/ERF Transcription Factor Superfamily in Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							SCALE GENOTYPING APPLICATIONS; ERF GENE FAMILY; ABIOTIC STRESS; MOLECULAR EVOLUTION; ARABIDOPSIS; SEQUENCE; DOMAIN; IDENTIFICATION; TOLERANCE; SOFTWARE	The APETALA2/ethylene-responsive element binding factor (AP2/ERF) family is one of the largest transcription factor (TF) families in plants that includes four major sub-families, namely AP2, DREB (dehydration responsive element binding), ERF (ethylene responsive factors) and RAV (Related to ABI3/VP). AP2/ERFs are known to play significant roles in various plant processes including growth and development and biotic and abiotic stress responses. Considering this, a comprehensive genome-wide study was conducted in foxtail millet (Setaria italica L.). A total of 171 AP2/ERF genes were identified by systematic sequence analysis and were physically mapped onto nine chromosomes. Phylogenetic analysis grouped AP2/ERF genes into six classes (I to VI). Duplication analysis revealed that 12 (similar to 7%) SiAP2/ERF genes were tandem repeated and 22 (similar to 13%) were segmentally duplicated. Comparative physical mapping between foxtail millet AP2/ERF genes and its orthologs of sorghum (18 genes), maize (14 genes), rice (9 genes) and Brachypodium (6 genes) showed the evolutionary insights of AP2/ERF gene family and also the decrease in orthology with increase in phylogenetic distance. The evolutionary significance in terms of gene-duplication and divergence was analyzed by estimating synonymous and non-synonymous substitution rates. Expression profiling of candidate AP2/ERF genes against drought, salt and phytohormones revealed insights into their precise and/or overlapping expression patterns which could be responsible for their functional divergence in foxtail millet. The study showed that the genes SiAP2/ERF-069, SiAP2/ERF-103 and SiAP2/ERF-120 may be considered as potential candidate genes for further functional validation as well for utilization in crop improvement programs for stress resistance since these genes were up-regulated under drought and salinity stresses in ABA dependent manner. Altogether the present study provides new insights into evolution, divergence and systematic functional analysis of AP2/ERF gene family at genome level in foxtail millet which may be utilized for improving stress adaptation and tolerance in millets, cereals and bioenergy grasses.	[Lata, Charu] Natl Res Ctr Plant Biotechnol, New Delhi, India; [Lata, Charu] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Bonthala, Venkata Suresh; Khan, Yusuf; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	manoj_prasad@nipgr.ac.in	khan, yusuf/E-6726-2015; MISHRA, AWDHESH/U-1920-2019; Muthamilarasan, Mehanathan/H-9340-2017; khan, yusuf/AAQ-9470-2021; Bonthala, Venkata Suresh/G-9852-2013; Lata, Charu/AAG-1723-2019; Prasad, Manoj/AAE-8540-2019	khan, yusuf/0000-0001-6986-4657; Muthamilarasan, Mehanathan/0000-0001-7589-6372; Bonthala, Venkata Suresh/0000-0001-6550-1648; Prasad, Manoj/0000-0003-0691-0163	National Institute of Plant Genome Research, New Delhi, India; Department of Science & Technology, Government of India through INSPIRE Faculty Award [IFA-11LSPA-01]; Department of Science Technology; Council of Scientific and Industrial Research; University Grants Commission, New Delhi	National Institute of Plant Genome Research, New Delhi, India; Department of Science & Technology, Government of India through INSPIRE Faculty Award(Department of Science & Technology (India)); Department of Science Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	This work was financially supported by core grant of National Institute of Plant Genome Research, New Delhi, India, and Department of Science & Technology, Government of India through INSPIRE Faculty Award [IFA-11LSPA-01]. CL is the recipient of INSPIRE Faculty Award from Department of Science & Technology, while AKM and MM are the recipients of Research Fellowships from Council of Scientific and Industrial Research and University Grants Commission, New Delhi, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonthala VS, 2014, MOL BIOL REP, V41, P6343, DOI 10.1007/s11033-014-3574-y; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Cochrane G, 2013, NUCLEIC ACIDS RES, V41, pD30, DOI 10.1093/nar/gks1175; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Gil-Humanes J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-66; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan Y, 2014, PLANT CELL TISS ORG, V118, P279, DOI 10.1007/s11240-014-0480-x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2014, J PLANT BIOCHEM BIOT, V23, P119, DOI 10.1007/s13562-013-0193-y; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2013, J PLANT BIOCHEM BIOT, V22, P257, DOI 10.1007/s13562-013-0216-8; Lata C, 2011, ABIOTIC STRESS RESPONSE IN PLANTS - PHYSIOLOGICAL, BIOCHEMICAL AND GENETIC PERSPECTIVES, P269; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez CG, 2003, CROP SCI, V43, P577, DOI 10.2135/cropsci2003.0577; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Muthamilarasan M, 2014, DNA RES, V21, P41, DOI 10.1093/dnares/dst039; Muthamilarasan M, 2013, CURR SCI INDIA, V105, P155; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Riechmann JL, 1998, BIOL CHEM, V379, P633; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Saleh A., 2003, GENETIKA+, V35, P37, DOI DOI 10.2298/GENSR0301037S; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Shigyo M, 2004, DEV GENES EVOL, V214, P105, DOI 10.1007/s00427-004-0385-5; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Song XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-573; Sun ZM, 2014, FUNCT INTEGR GENOMIC, V14, P453, DOI 10.1007/s10142-014-0372-5; Suresh BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071418; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; Yadav CB, 2015, PLANT MOL BIOL REP, V33, P43, DOI 10.1007/s11105-014-0736-y; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2011, PLANT MOL BIOL REP, V29, P209, DOI 10.1007/s11105-010-0227-8; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7; Zhuang J, 2009, SCI HORTIC-AMSTERDAM, V123, P73, DOI 10.1016/j.scienta.2009.08.002	73	110	122	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113092	10.1371/journal.pone.0113092	http://dx.doi.org/10.1371/journal.pone.0113092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409524	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200067
J	Majrooh, MA; Hasnain, S; Akram, J; Siddiqui, A; Memon, ZA				Majrooh, Muhammad Ashraf; Hasnain, Seema; Akram, Javaid; Siddiqui, Arif; Memon, Zahid Ali			Coverage and Quality of Antenatal Care Provided at Primary Health Care Facilities in the 'Punjab' Province of 'Pakistan'	PLOS ONE			English	Article							PATIENT SATISFACTION; DETERMINANTS; INDIA	Background: Antenatal care is a very important component of maternal health services. It provides the opportunity to learn about risks associated with pregnancy and guides to plan the place of deliveries thereby preventing maternal and infant morbidity and mortality. In 'Pakistan' antenatal services to rural population are being provided through a network of primary health care facilities designated as Basic Health Units and Rural Health Centers. Pakistan is a developing country, consisting of four provinces and federally administered areas. Each province is administratively subdivided in to 'Divisions' and 'Districts'. By population 'Punjab' is the largest province of Pakistan having 36 districts. This study was conducted to assess the coverage and quality antenatal care in the primary health care facilities in 'Punjab' province of 'Pakistan'. Methods: Quantitative and Qualitative methods were used to collect data. Using multistage sampling technique nine out of thirty six districts were selected and 19 primary health care facilities of public sector (seventeen Basic Health Units and two Rural Health Centers were randomly selected from each district. Focus group discussions and in-depth interviews were conducted with clients, providers and health managers. Results: The overall enrollment for antenatal checkup was 55.9% and drop out was 32.9% in subsequent visits. The quality of services regarding assessment, treatment and counseling was extremely poor. The reasons for low coverage and quality were the distant location of facilities, deficiency of facility resources, indifferent attitude and non availability of the staff. Moreover, lack of client awareness about importance of antenatal care and self empowerment for decision making to seek care were also responsible for low coverage. Conclusion: The coverage and quality of the antenatal care services in 'Punjab' are extremely compromised. Only half of the expected pregnancies are enrolled and out of those 1/3 drop out in follow-up visits.	[Majrooh, Muhammad Ashraf; Hasnain, Seema; Akram, Javaid; Siddiqui, Arif] Allama Iqbal Med Coll, Lahore, Pakistan; [Memon, Zahid Ali] Populat Surv Int Greenstar, Karachi, Pakistan		Majrooh, MA (corresponding author), Allama Iqbal Med Coll, Lahore, Pakistan.	majrooh58@yahoo.com	Memon, Zahid Ali/GRE-8118-2022	Memon, Zahid Ali/0000-0002-5321-8885	Maternal and Newborn Health Programme - Research and Advocacy Fund (RAF)	Maternal and Newborn Health Programme - Research and Advocacy Fund (RAF)	This manuscript is an output from a research funded by Maternal and Newborn Health Programme - Research and Advocacy Fund (RAF) and conducted by Research Society Allama Iqbal Medical College Lahore, Pakistan. The views expressed and the information contained is not necessarily endorsed by funding agencies DFID/AusAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Ali AAA, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-67; Andaleeb SS, 2001, SOC SCI MED, V52, P1359, DOI 10.1016/S0277-9536(00)00235-5; [Anonymous], MULT IND CLUST SURV; [Anonymous], 2007, PAK STAT YB; [Anonymous], DISTR HLTH INF SYST; [Anonymous], DISTR BAS MULT IND C, P12; Barua A, 2003, REPROD HEALTH MATTER, V11, P140, DOI 10.1016/S0968-8080(03)02162-1; Ghobashi Mohammed, 2008, Sultan Qaboos Univ Med J, V8, P325; Gupta R S, 2006, J Commun Dis, V38, P79; Hudak PL, 2000, SPINE, V25, P3167, DOI 10.1097/00007632-200012150-00012; Jafari F, 2010, HEALTH CARE WOMEN IN, V31, P571, DOI 10.1080/07399331003646323; Luyben AG, 2005, MIDWIFERY, V21, P212, DOI 10.1016/j.midw.2004.11.001; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; Musarrat Jabeen, 2005, Journal of Postgraduate Medical Institute, V19, P377; National Institute of Population Studies (NIPS) and Macro International, 2006, PAKISTAN DEMOGRAPHIC; Nisar N, 2003, JPMA, V53, P1; Nisar Nighat, 2007, J Ayub Med Coll Abbottabad, V19, P11; Raisa BG, 2009, J PROFESSIONAL NURSI, V25, P240; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; United Nations Decade of Education for Sustainable Develop- ment, 2005, IMPR MAT HLTH, P1; World Health Organization, 2008, MAT MORT 2005 EST DE, P48; Zeidan Z. A., 2011, KHARTOUM MED J, V4, P590; Ziaul Hasan, 2007, Journal of Postgraduate Medical Institute, V21, P29	25	45	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113390	10.1371/journal.pone.0113390	http://dx.doi.org/10.1371/journal.pone.0113390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409502	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200107
J	Slater, J; Strait, DL; Skoe, E; O'Connell, S; Thompson, E; Kraus, N				Slater, Jessica; Strait, Dana L.; Skoe, Erika; O'Connell, Samantha; Thompson, Elaine; Kraus, Nina			Longitudinal Effects of Group Music Instruction on Literacy Skills in Low-Income Children	PLOS ONE			English	Article							READING-SKILLS; PHONOLOGICAL AWARENESS; BIOLOGICAL IMPACT; POOR READERS; SPEECH; BRAIN; ABILITY; LANGUAGE; RHYTHM; SOUND	Children from low-socioeconomic backgrounds tend to fall progressively further behind their higher-income peers over the course of their academic careers. Music training has been associated with enhanced language and learning skills, suggesting that music programs could play a role in helping low-income children to stay on track academically. Using a controlled, longitudinal design, the impact of group music instruction on English reading ability was assessed in 42 low-ncome Spanish-English bilingual children aged 6-9 years in Los Angeles. After one year, children who received music training retained their age-normed level of reading performance while a matched control group's performance deteriorated, consistent with expected declines in this population. While the extent of change is modest, outcomes nonetheless provide evidence that music programs may have value in helping to counteract the negative effects of low-socioeconomic status on child literacy development.	[Slater, Jessica; Strait, Dana L.; Skoe, Erika; O'Connell, Samantha; Thompson, Elaine; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Slater, Jessica; Skoe, Erika; Thompson, Elaine; Kraus, Nina] Northwestern Univ, Dept Commun Sci, Evanston, IL USA; [Strait, Dana L.; Kraus, Nina] Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Kraus, N (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	nkraus@northwestern.edu	Slater, Jessica/AAS-4515-2020; OConnell, Samantha/HDN-0054-2022	Slater, Jessica/0000-0001-7281-5231; OConnell, Samantha/0000-0002-0302-2198	Knowles Hearing Center; National Association of Music Merchants Foundation (NAMM); Grammy Foundation	Knowles Hearing Center; National Association of Music Merchants Foundation (NAMM); Grammy Foundation	This work was supported by the Knowles Hearing Center (http://comm.soc.northwestern.edu/ knowles-hearing-center/), the National Association of Music Merchants Foundation (NAMM http://www.namm.org/) and the Grammy Foundation (http://www.grammy.org/grammy- foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, EDUC PSYCHOL-UK, DOI [DOI 10.1080/0144341930130103, 10.1080/0144341930130103]; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Baker Jr RA, 2011, RELATIONSHIP MUSIC V; Banai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075876; BARWICK J, 1989, BRIT J EDUC PSYCHOL, V59, P253, DOI 10.1111/j.2044-8279.1989.tb03097.x; Besson Mireille, 2011, Front Psychol, V2, P94, DOI 10.3389/fpsyg.2011.00094; Bhide A, 2013, MIND BRAIN EDUC, V7, P113, DOI 10.1111/mbe.12016; Blachman BA, 1999, READ WRIT, V11, P239, DOI 10.1023/A:1008050403932; Bugaj K, 2011, B COUN RES MUSIC ED, P89; Butzlaff R, 2000, J AESTHET EDUC, V34, P167, DOI 10.2307/3333642; Catterall J, 1997, INVOLVEMENT ARTS SUC; Catterall J., 1999, INVOLVEMENT ARTS HUM, P1; Catts HW, 2002, J LEARN DISABIL-US, V35, P509; Chobert J, 2014, CEREB CORTEX, V24, P956, DOI 10.1093/cercor/bhs377; Corrigall KA, 2011, MUSIC PERCEPT, V29, P147, DOI 10.1525/MP.2011.29.2.147; Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; Costa-Giomi E, 2012, MUSIC HLTH WELLBEING, P339; CUTLER A, 1992, J MEM LANG, V31, P218, DOI 10.1016/0749-596X(92)90012-M; de Jong PF, 2004, ANN DYSLEXIA, V54, P65, DOI 10.1007/s11881-004-0004-1; Dege F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00124; Douglas S., 1994, J RES READ, V17, p99?107, DOI [DOI 10.1111/J.1467-9817.1994.TB00057.X, 10.1111/j.1467-9817.1994.tb00057.x]; Flaugnacco E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00392; Forgeard M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003566; Foxton JM, 2003, NAT NEUROSCI, V6, P343, DOI 10.1038/nn1035; Francois C, 2013, CEREB CORTEX, V23, P2038, DOI 10.1093/cercor/bhs180; Fryer Jr R.G., 2006, AM LAW ECON REV, V8, P249, DOI DOI 10.1093/ALER/AHL003; Goldstein B., 2004, DEV LIT SPAN SPEAK D; Gromko JE, 2005, J RES MUSIC EDUC, V53, P199, DOI 10.2307/3598679; Guthrie JT, 2001, J EDUC RES, V94, P145, DOI 10.1080/00220670109599912; Hallam S, 2010, INT J MUSIC EDUC, V28, P269, DOI 10.1177/0255761410370658; Hansen D, 2002, MUSIC EDUC J, V88, P52; Hansen Dee., 2002, MUSIC EDUC J, V8, P17, DOI [10.2307/3399821, DOI 10.2307/3399821]; Haskins R., 2005, CLOSING ACHIEVEMENT; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Holliman AJ, 2010, J EDUC PSYCHOL, V102, P356, DOI 10.1037/a0018049; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Hudson M, 2007, SOCIAL COHESION DIVE; HURWITZ I, 1975, J LEARN DISABIL, V8, P167, DOI 10.1177/002221947500800310; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Kelly SJ, 2009, 2007 2008 12 GRADE C; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Kovelman I, 2008, BILING-LANG COGN, V11, P203, DOI 10.1017/S1366728908003386; Kraus N, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00351; Kraus N, 2014, J NEUROSCI, V34, P11913, DOI 10.1523/JNEUROSCI.1881-14.2014; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Marinak BA, 2013, J EDUC RES, V106, P39, DOI 10.1080/00220671.2012.658455; Mather N, 2004, TOSWRF TEST SILENT W; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Moreno S, 2006, PSYCHOPHYSIOLOGY, V43, P287, DOI 10.1111/j.1469-8986.2006.00401.x; Moreno S, 2011, MUSIC PERCEPT, V29, P165, DOI 10.1525/MP.2011.29.2.165; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Moritz C, 2013, READ WRIT, V26, P739, DOI 10.1007/s11145-012-9389-0; Neuman SB, 2001, READ RES QUART, V36, P8, DOI 10.1598/RRQ.36.1.1; Overy K, 2003, ANN NY ACAD SCI, V999, P497, DOI 10.1196/annals.1284.060; Overy K., 2000, PSYCHOL MUSIC, V28, P218, DOI DOI 10.1177/0305735600282010; Parbery-Clark A, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00030; Patel AD, 2014, HEARING RES, V308, P98, DOI 10.1016/j.heares.2013.08.011; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Patel Aniruddh D, 2010, MUSIC LANGUAGE BRAIN; PAYNE AC, 1994, EARLY CHILD RES Q, V9, P427, DOI 10.1016/0885-2006(94)90018-3; Penhune VB, 2011, CORTEX, V47, P1126, DOI 10.1016/j.cortex.2011.05.010; Peretz I, 2012, LANGUAGE MUSIC COGNI, P254; PITT MA, 1990, J EXP PSYCHOL HUMAN, V16, P564, DOI 10.1037/0096-1523.16.3.564; Putkinen V, 2013, EUR J NEUROSCI, V37, P654, DOI 10.1111/ejn.12049; Quirk Matthew P, 2004, Read Res Instr, V43, P1; Rabkin N, 2011, NATL ENDOWMENT ARTS; Rauscher FH, 2011, MUSIC PERCEPT, V29, P215, DOI 10.1525/MP.2011.29.2.215; Ritter M, 2013, COMMUN DISORD Q, V34, P106, DOI 10.1177/1525740112456422; Roncaglia-Denissen MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056000; Rothermich K, 2012, NEUROPSYCHOLOGIA, V50, P232, DOI 10.1016/j.neuropsychologia.2011.10.025; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Schlaug G, 2005, ANN NY ACAD SCI, V1060, P219, DOI 10.1196/annals.1360.015; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Seppanen M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00043; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Skoe E, 2013, FRONT PSYCHOL, V4; Skoe E, 2013, J NEUROSCI, V33, P17221, DOI 10.1523/JNEUROSCI.2102-13.2013; Skoe E, 2012, J NEUROSCI, V32, P11507, DOI 10.1523/JNEUROSCI.1949-12.2012; Slater J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077250; Standley JM, 1997, MUSIC THERAPY PERSPE, V15, P79, DOI DOI 10.1093/MTP/15.2.79; Standley JM, 2008, UPDATE APPL RES MUS, V27, P17, DOI DOI 10.1177/8755123308322270; STANOVICH KE, 1986, READ RES QUART, V21, P360, DOI 10.1598/RRQ.21.4.1; Stevens C, 2009, DEVELOPMENTAL SCI, V12, P634, DOI 10.1111/j.1467-7687.2009.00807.x; Strait DL, 2014, HEARING RES, V308, P109, DOI 10.1016/j.heares.2013.08.004; Strait DL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-44; Strait DL, 2013, CEREBRAL CORTEX; Taub GE, 2013, CONT ISSUES ED RES C, V5, P343; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Tervaniemi M, 2009, EUR J NEUROSCI, V30, P1636, DOI 10.1111/j.1460-9568.2009.06955.x; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Tierney A, 2013, APPL BRAIN PLASTICIT; Tierney A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00855; Tierney A, 2013, J NEUROSCI, V33, P14981, DOI 10.1523/JNEUROSCI.0612-13.2013; Tierney AT, 2013, BRAIN LANG, V124, P225, DOI 10.1016/j.bandl.2012.12.014; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; White-Schwoch T, 2013, J NEUROSCI, V33, P17667, DOI 10.1523/JNEUROSCI.2560-13.2013; Woerner C, 1999, WECHSLER ABBREVIATED; Wolf M, 2000, J LEARN DISABIL-US, V33, P387, DOI 10.1177/002221940003300409; Wood C, 1998, BRIT J DEV PSYCHOL, V16, P397, DOI 10.1111/j.2044-835X.1998.tb00760.x; Wood C, 2006, J RES READ, V29, P270, DOI 10.1111/j.1467-9817.2006.00308.x; Woodruff Carr K, 2014, P NATL ACAD SCI USA; Zendel BR, 2012, PSYCHOL AGING, V27, P410, DOI 10.1037/a0024816; Zendel BR, 2009, J COGNITIVE NEUROSCI, V21, P1488, DOI 10.1162/jocn.2009.21140	104	44	49	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113383	10.1371/journal.pone.0113383	http://dx.doi.org/10.1371/journal.pone.0113383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409300	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200105
J	Wong, W; Price, NSC				Wong, William; Price, Nicholas Seow Chiang			Testing Neuronal Accounts of Anisotropic Motion Perception with Computational Modelling	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; AREA MT; ORIENTATION SELECTIVITY; POPULATION CODES; UNEQUAL REPRESENTATION; REFERENCE REPULSION; NEURAL POPULATIONS; STRIATE CORTEX; MACAQUE MT; DIRECTION	There is an over-representation of neurons in early visual cortical areas that respond most strongly to cardinal (horizontal and vertical) orientations and directions of visual stimuli, and cardinal-and oblique-preferring neurons are reported to have different tuning curves. Collectively, these neuronal anisotropies can explain two commonly-reported phenomena of motion perception -the oblique effect and reference repulsion -but it remains unclear whether neuronal anisotropies can simultaneously account for both perceptual effects. We show in psychophysical experiments that reference repulsion and the oblique effect do not depend on the duration of a moving stimulus, and that brief adaptation to a single direction simultaneously causes a reference repulsion in the orientation domain, and the inverse of the oblique effect in the direction domain. We attempted to link these results to underlying neuronal anisotropies by implementing a large family of neuronal decoding models with parametrically varied levels of anisotropy in neuronal direction-tuning preferences, tuning bandwidths and spiking rates. Surprisingly, no model instantiation was able to satisfactorily explain our perceptual data. We argue that the oblique effect arises from the anisotropic distribution of preferred directions evident in V1 and MT, but that reference repulsion occurs separately, perhaps reflecting a process of categorisation occurring in higher-order cortical areas.	[Wong, William; Price, Nicholas Seow Chiang] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia	Monash University	Price, NSC (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.	Nicholas.Price@monash.edu		Price, Nicholas/0000-0001-9404-7704	Australian National Health and Medical Research Council Project [APP1008287]; Human Frontier Science Program Career Development Award; Ramaciotti Equipment Grant	Australian National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program Career Development Award; Ramaciotti Equipment Grant	This work was supported by an Australian National Health and Medical Research Council Project grant APP1008287, a Human Frontier Science Program Career Development Award, and a Ramaciotti Equipment Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028675; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BARLOW HB, 1976, VISION RES, V16, P1043, DOI 10.1016/0042-6989(76)90241-8; Benjamini Y, 2001, ANN STAT, V29, P1165; Berens P, 2011, P NATL ACAD SCI USA, V108, P4423, DOI 10.1073/pnas.1015904108; Blake R, 1997, J EXP PSYCHOL HUMAN, V23, P353, DOI 10.1037/0096-1523.23.2.353; Blum J, 2014, J VISION, P14; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; Clifford CWG, 2009, J NEUROPHYSIOL, V102, P2974, DOI 10.1152/jn.00411.2009; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; COLETTA NJ, 1993, VISION RES, V33, P2747, DOI 10.1016/0042-6989(93)90233-M; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Curran W, 2006, VISION RES, V46, P4270, DOI 10.1016/j.visres.2006.08.026; Dakin SC, 2010, J VISION, P10; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; FINLAY BL, 1976, BRAIN RES, V105, P350, DOI 10.1016/0006-8993(76)90433-9; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Ganguli D, 2014, NEURAL COMPUT, V26, P2103, DOI 10.1162/NECO_a_00638; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Gros BL, 1998, J OPT SOC AM A, V15, P2003, DOI 10.1364/JOSAA.15.002003; Grunewald A, 2004, J VISION, V4, P548; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Iyer PB, 2011, J VISION, V11, DOI 10.1167/11.3.16; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kleiner M, 2007, PERCEPTION, V36, P14; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; LEVINSON E, 1980, VISION RES, V20, P103, DOI 10.1016/0042-6989(80)90151-0; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Loffler G, 2001, VISION RES, V41, P3677, DOI 10.1016/S0042-6989(01)00209-7; Mannion DJ, 2010, J NEUROPHYSIOL, V103, P3465, DOI 10.1152/jn.00190.2010; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MORGAN MJ, 1980, VISION RES, V20, P431, DOI 10.1016/0042-6989(80)90033-4; Nichols MJ, 2002, J NEUROSCI, V22, P9530; Phinney RE, 1997, VISION RES, V37, P865, DOI 10.1016/S0042-6989(96)00244-1; Price NSC, 2005, J NEUROPHYSIOL, V94, P3451, DOI 10.1152/jn.00564.2005; Price NSC, 2005, J NEUROPHYSIOL, V94, P235, DOI 10.1152/jn.00041.2005; Price NSC, 2012, J VISION, P12; Rauber HJ, 1998, PERCEPTION, V27, P393, DOI 10.1068/p270393; RAYMOND JE, 1993, VISION RES, V33, P767, DOI 10.1016/0042-6989(93)90196-4; Rokem A, 2009, BRAIN RES, V1299, P3, DOI 10.1016/j.brainres.2009.07.005; ROSE D, 1974, EXP BRAIN RES, V20, P1; Scheffe H., 1999, ANAL VARIANCE; Serences JT, 2009, NEUROIMAGE, V44, P223, DOI 10.1016/j.neuroimage.2008.07.043; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shen G, 2014, J VISION, V14; Swisher JD, 2010, J NEUROSCI, V30, P325, DOI 10.1523/JNEUROSCI.4811-09.2010; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; WADE NJ, 1994, PERCEPTION, V23, P1111, DOI 10.1068/p231111; Wiese M, 2008, PERCEPTION, V37, P1380, DOI 10.1068/p5863; WILSON JR, 1976, J NEUROPHYSIOL, V39, P512, DOI 10.1152/jn.1976.39.3.512; Xu XM, 2006, P NATL ACAD SCI USA, V103, P17490, DOI 10.1073/pnas.0608502103	64	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113061	10.1371/journal.pone.0113061	http://dx.doi.org/10.1371/journal.pone.0113061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409518	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200062
J	Espinosa-Hernandez, W; Velez-Uriza, D; Valdes, J; Velez-Del Valle, C; Salas-Benito, J; Martinez-Contreras, R; Garcia-Espitia, M; Salas-Benito, M; Vega-Almeida, T; De Nova-Ocampo, M				Espinosa-Hernandez, Wendy; Velez-Uriza, Dora; Valdes, Jesus; Velez-Del Valle, Cristina; Salas-Benito, Juan; Martinez-Contreras, Rebeca; Garcia-Espitia, Matilde; Salas-Benito, Mariana; Vega-Almeida, Tania; De Nova-Ocampo, Monica			PTB Binds to the 3 ' Untranslated Region of the Human Astrovirus Type 8: A Possible Role in Viral Replication	PLOS ONE			English	Article							TERMINAL NSP1A PROTEIN; DENGUE VIRUS; RNA SEQUENCE; STRAND RNA; TRANSLATION; CELL; RELOCALIZATION; IDENTIFICATION; POLYMERASE; REGULATOR	The 3' untranslated region (3'UTR) of human astroviruses (HAstV) consists of two hairpin structures (helix I and II) joined by a linker harboring a conserved PTB/hnRNP1 binding site. The identification and characterization of cellular proteins that interact with the 3'UTR of HAstV-8 virus will help to uncover cellular requirements for viral functions. To this end, mobility shift assays and UV cross-linking were performed with uninfected and HAstV-8-infected cell extracts and HAstV-8 3'UTR probes. Two RNA-protein complexes (CI and CII) were recruited into the 3'UTR. Complex CII formation was compromised with cold homologous RNA, and seven proteins of 35, 40, 45, 50, 52, 57/60 and 75 kDa were cross-linked to the 3'UTR. Supermobility shift assays indicated that PTB/hnRNP1 is part of this complex, and 3'UTR-crosslinked PTB/hnRNP1 was immunoprecipitated from HAstV-8 infected cell-membrane extracts. Also, immunofluorescence analyses revealed that PTB/ hnRNP1 is distributed in the nucleus and cytoplasm of uninfected cells, but it is mainly localized perinuclearly in the cytoplasm of HAstV-8 infected cells. Furthermore, the minimal 3'UTR sequences recognized by recombinant PTB are those conforming helix I, and an intact PTB/hnRNP1-binding site. Finally, small interfering RNA-mediated PTB/hnRNP1 silencing reduced synthesis viral genome and virus yield in CaCo2 cells, suggesting that PTB/hnRNP1 is required for HAstV replication. In conclusion, PTB/hnRNP1 binds to the 3'UTR HAstV-8 and is required or participates in viral replication.	[Espinosa-Hernandez, Wendy; Velez-Uriza, Dora; Salas-Benito, Juan; Garcia-Espitia, Matilde; Salas-Benito, Mariana; De Nova-Ocampo, Monica] Inst Politecn Nacl, ENMH, Programa Inst Biomed Mol, Secc Estudios Posgrad & Invest, Mexico City, DF, Mexico; [Valdes, Jesus] IPN, Ctr Invest & Estudios Avanzados, Dept Bioquim, Mexico City 07738, DF, Mexico; [Velez-Del Valle, Cristina] IPN, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City 07738, DF, Mexico; [Martinez-Contreras, Rebeca] BUAP, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Vega-Almeida, Tania] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico	Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico	De Nova-Ocampo, M (corresponding author), Inst Politecn Nacl, ENMH, Programa Inst Biomed Mol, Secc Estudios Posgrad & Invest, Mexico City, DF, Mexico.	mdenova@ipn.mx	Martínez-Contreras, Rebeca/S-9605-2019	Velez-delValle, Cristina/0000-0002-2377-942X; De Nova Ocampo, Monica/0000-0002-0750-7977; , Wendy/0000-0003-0254-7782; Salas-Benito, Juan Santiago/0000-0002-4096-0079	Secretaria de Investigacion y Posgrado-Instituto Politecnico Nacional [20080174, 20090206, 20100054, 20110182, 20120179, 20130689]; Consejo Nacional de Ciencia y Tecnologia [99682 (MDO), 49355M, 127557M]; Instituto de Ciencia Tecnologia [71/2012]; Consejo Nacional de Ciencia y Tecnologia; Comision de Operacion y Fomento de Actividades Academicas-Instituto Politecnico Nacional/Estimulo al Desempeno de los Investigadores fellowships	Secretaria de Investigacion y Posgrado-Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Ciencia Tecnologia; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision de Operacion y Fomento de Actividades Academicas-Instituto Politecnico Nacional/Estimulo al Desempeno de los Investigadores fellowships	This work was partially supported by Secretaria de Investigacion y Posgrado-Instituto Politecnico Nacional grants 20080174, 20090206, 20100054, 20110182, 20120179, and 20130689; Consejo Nacional de Ciencia y Tecnologia grants 99682 (MDO), 49355M, and 127557M; and Instituto de Ciencia Tecnologia grant 71/2012 (JV). WEH and DVU were Programa Institucional de Formacion de Investigadores-Instituto Politecnico Nacional scholars. DVU was supported by a scholarship from Consejo Nacional de Ciencia y Tecnologia. MDO and JSB received Comision de Operacion y Fomento de Actividades Academicas-Instituto Politecnico Nacional/Estimulo al Desempeno de los Investigadores fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; Belliot G, 1997, ARCH VIROL, V142, P1323, DOI 10.1007/s007050050163; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Cancio-Lonches C, 2011, J VIROL, V85, P8056, DOI 10.1128/JVI.01878-10; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Coulson JM, 2000, CANCER RES, V60, P1840; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Banos-Lara MD, 2010, VIROLOGY, V401, P322, DOI 10.1016/j.virol.2010.02.028; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Fuentes C, 2011, J VIROL, V85, P4470, DOI 10.1128/JVI.01515-10; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Guix S, 2004, J VIROL, V78, P13627, DOI 10.1128/JVI.78.24.13627-13636.2004; Guix S, 2005, VIROLOGY, V333, P124, DOI 10.1016/j.virol.2004.12.023; Gutierrez-Escolano AL, 2003, BIOCHEM BIOPH RES CO, V311, P759, DOI 10.1016/j.bbrc.2003.10.066; Gutierrez-Escolano AL, 2000, J VIROL, V74, P8558, DOI 10.1128/JVI.74.18.8558-8562.2000; HELLEN CUT, 1994, J VIROL, V68, P941, DOI 10.1128/JVI.68.2.941-950.1994; Herold J, 2001, MOL CELL, V7, P581, DOI 10.1016/S1097-2765(01)00205-2; Isken O, 2004, RNA, V10, P1637, DOI 10.1261/rna.7290904; Jang SY, 2010, ARCH VIROL, V155, P1383, DOI 10.1007/s00705-010-0718-9; JIANG BM, 1993, P NATL ACAD SCI USA, V90, P10539, DOI 10.1073/pnas.90.22.10539; Karakasiliotis I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009562; Lai MMC, 1998, VIROLOGY, V244, P1, DOI 10.1006/viro.1998.9098; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Lou Z, 2014, PLOS ONE, V9; McBride AE, 1996, P NATL ACAD SCI USA, V93, P2296, DOI 10.1073/pnas.93.6.2296; Mendez E, 2003, J VIROL, V77, P11378, DOI 10.1128/JVI.77.21.11378-11384.2003; Mendez E, 2012, ASTROVIRUS RES, P19, DOI DOI 10.1007/978-1-4614-4735-1_2; Mendez E., 2007, FIELDS VIROLOGY, P982; Monceyron C, 1997, ARCH VIROL, V142, P699, DOI 10.1007/s007050050112; MONROE SS, 1993, J VIROL, V67, P3611, DOI 10.1128/JVI.67.6.3611-3614.1993; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Shi ST, 2005, CURR TOP MICROBIOL, V287, P95, DOI 10.1007/3-540-26765-4_4; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Velazquez-Moctezuma R, 2012, J VIROL METHODS, V179, P295, DOI 10.1016/j.jviromet.2011.11.005; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Waggoner S, 1998, J VIROL, V72, P6699, DOI 10.1128/JVI.72.8.6699-6709.1998; WILLCOCKS MM, 1992, ARCH VIROL, V124, P279, DOI 10.1007/BF01309809; Zoll J, 2009, VIRUS RES, V139, P209, DOI 10.1016/j.virusres.2008.07.014; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113113	10.1371/journal.pone.0113113	http://dx.doi.org/10.1371/journal.pone.0113113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406089	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300079
J	Futami, J; Fujiyama, H; Kinoshita, R; Nonomura, H; Honjo, T; Tada, H; Matsushita, H; Abe, Y; Kakimi, K				Futami, Junichiro; Fujiyama, Haruna; Kinoshita, Rie; Nonomura, Hidenori; Honjo, Tomoko; Tada, Hiroko; Matsushita, Hirokazu; Abe, Yoshito; Kakimi, Kazuhiro			Denatured Mammalian Protein Mixtures Exhibit Unusually High Solubility in Nucleic Acid-Free Pure Water	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; SALT-FREE WATER; FUNCTIONAL PROTEIN; SAMPLE PREPARATION; ENTROPIC BRISTLES; DENDRITIC CELLS; AGGREGATION; DISORDER; REAGENT; RNA	Preventing protein aggregation is a major goal of biotechnology. Since protein aggregates are mainly comprised of unfolded proteins, protecting against denaturation is likely to assist solubility in an aqueous medium. Contrary to this concept, we found denatured total cellular protein mixture from mammalian cell kept high solubility in pure water when the mixture was nucleic acids free. The lysates were prepared from total cellular protein pellet extracted by using guanidinium thiocyanate-phenol-chloroform mixture of TRIzol, denatured and reduced total protein mixtures remained soluble after extensive dialysis against pure water. The total cell protein lysates contained fully disordered proteins that readily formed large aggregates upon contact with nucleic acids or salts. These findings suggested that the highly flexible mixtures of disordered proteins, which have fully ionized side chains, are protected against aggregation. Interestingly, this unusual solubility is characteristic of protein mixtures from higher eukaryotes, whereas most prokaryotic protein mixtures were aggregated under identical conditions. This unusual solubility of unfolded protein mixtures could have implications for the study of intrinsically disordered proteins in a variety of cells.	[Futami, Junichiro; Fujiyama, Haruna; Kinoshita, Rie; Nonomura, Hidenori; Honjo, Tomoko; Tada, Hiroko] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biotechnol, Okayama 7008530, Japan; [Matsushita, Hirokazu; Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Tokyo 113, Japan; [Abe, Yoshito] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Fukuoka 812, Japan	Okayama University; University of Tokyo; Kyushu University	Futami, J (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biotechnol, Okayama 7008530, Japan.	futamij@okayama-u.ac.jp	Abe, Yoshito/AAH-6141-2021; Abe, Yoshito/D-8370-2012; Futami, Junichiro/B-2578-2011	Abe, Yoshito/0000-0002-0016-8490; Abe, Yoshito/0000-0002-0016-8490; Futami, Junichiro/0000-0002-0020-2855	Japan Society for the Promotion of Science (JSPS) for Junichiro Futami (JSPS KAKENHI) [23360370, 24656506]	Japan Society for the Promotion of Science (JSPS) for Junichiro Futami (JSPS KAKENHI)	This work was supported by the grants from the Japan Society for the Promotion of Science (JSPS: http://www.jsps.go.jp/english/index.html) for Junichiro Futami (JSPS KAKENHI Grant Numbers 23360370 and 24656506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2013, PROTEIN SCI, V22, P467, DOI 10.1002/pro.2228; ATKINSON A, 1973, BIOCHIM BIOPHYS ACTA, V308, P41, DOI 10.1016/0005-2787(73)90120-2; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Csizmok V, 2006, MOL CELL PROTEOMICS, V5, P265, DOI 10.1074/mcp.M500181-MCP200; De Simone A, 2012, P NATL ACAD SCI USA, V109, P6951, DOI 10.1073/pnas.1118048109; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Fukuchi S, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-29; Futami J, 2000, J BIOCHEM, V127, P435, DOI 10.1093/oxfordjournals.jbchem.a022625; Futami J, 2007, EXPERT OPIN DRUG DIS, V2, P261, DOI 10.1517/17460441.2.2.261; Galea CA, 2006, J PROTEOME RES, V5, P2839, DOI 10.1021/pr060328c; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Grana-Montes R, 2014, BIOMACROMOLECULES, V15, P1194, DOI 10.1021/bm401776z; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Ham BM, 2008, J PROTEOME RES, V7, P2215, DOI 10.1021/pr700575m; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; Hummon AB, 2007, BIOTECHNIQUES, V42, P467, DOI 10.2144/000112401; Kim TD, 2000, BIOCHEMISTRY-US, V39, P14839, DOI 10.1021/bi001441y; Kirkland PA, 2006, ANAL BIOCHEM, V351, P254, DOI 10.1016/j.ab.2006.01.017; Kuwada E, 2011, ANTICANCER RES, V31, P881; Li MF, 2006, BIOPHYS J, V91, P4201, DOI 10.1529/biophysj.106.093187; Li MF, 2006, PROTEIN SCI, V15, P1835, DOI 10.1110/ps.062306906; Liu JX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007805; May M, 2010, CANCER IMMUNOL IMMUN, V59, P687, DOI 10.1007/s00262-009-0784-6; Mishima T, 2010, BIOCHEM BIOPH RES CO, V391, P615, DOI 10.1016/j.bbrc.2009.11.108; Murata H, 2006, BIOCHEMISTRY-US, V45, P6124, DOI 10.1021/bi052642a; Obita T, 2003, CELL MOL LIFE SCI, V60, P176, DOI 10.1007/s000180300012; Pace CN, 2004, PHILOS T ROY SOC B, V359, P1225, DOI 10.1098/rstb.2004.1500; Romero P, 1998, Pac Symp Biocomput, P437; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Song Jianxing, 2013, F1000Res, V2, P94, DOI 10.12688/f1000research.2-94.v1; Song JX, 2009, FEBS LETT, V583, P953, DOI 10.1016/j.febslet.2009.02.022; Szasz C, 2011, BIOCHEMISTRY-US, V50, P5834, DOI [10.1021/bi200365J, 10.1021/bi200365j]; Thumann P, 2003, J IMMUNOL METHODS, V277, P1, DOI 10.1016/S0022-1759(03)00102-9; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wolfraim LA, 2013, INT IMMUNOPHARMACOL, V15, P488, DOI 10.1016/j.intimp.2013.01.009; YAMADA H, 1994, J BIOCHEM-TOKYO, V116, P852, DOI 10.1093/oxfordjournals.jbchem.a124606; Yamaguchi S, 2013, BIOTECHNOL J, V8, P17, DOI 10.1002/biot.201200025; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053	41	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113295	10.1371/journal.pone.0113295	http://dx.doi.org/10.1371/journal.pone.0113295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405999	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300099
J	Pan, JF; Liu, NH; Sun, H; Xu, F				Pan, Jian-feng; Liu, Ning-hua; Sun, Hui; Xu, Feng			Preparation and Characterization of Electrospun PLCL/Poloxamer Nanofibers and Dextran/Gelatin Hydrogels for Skin Tissue Engineering	PLOS ONE			English	Article							DRUG-DELIVERY; BLOCK-COPOLYMERS; SCAFFOLDS; FABRICATION; GELATIN; MATS	In this study, two different biomaterials were fabricated and their potential use as a bilayer scaffold for skin tissue engineering applications was assessed. The upper layer biomaterial was a Poly(epsilon-caprolactone-co-lactide)/Poloxamer (PLCL/Poloxamer) nanofiber membrane fabricated using electrospinning technology. The PLCL/Poloxamer nanofibers (PLCL/Poloxamer, 9/1) exhibited strong mechanical properties (stress/strain values of 9.37 +/- 0.38 MPa/187.43 +/- 10.66%) and good biocompatibility to support adipose-derived stem cells proliferation. The lower layer biomaterial was a hydrogel composed of 10% dextran and 20% gelatin without the addition of a chemical crosslinking agent. The 5/5 dextran/gelatin hydrogel displayed high swelling property, good compressive strength, capacity to present more than 3 weeks and was able to support cells proliferation. A bilayer scaffold was fabricated using these two materials by underlaying the nanofibers and casting hydrogel to mimic the structure and biological function of native skin tissue. The upper layer membrane provided mechanical support in the scaffold and the lower layer hydrogel provided adequate space to allow cells to proliferate and generate extracellular matrix. The biocompatibility of bilayer scaffold was preliminarily investigated to assess the potential cytotoxicity. The results show that cell viability had not been affected when cocultured with bilayer scaffold. As a consequence, the bilayer scaffold composed of PLCL/Poloxamer nanofibers and dextran/gelatin hydrogels is biocompatible and possesses its potentially high application prospect in the field of skin tissue engineering.	[Pan, Jian-feng; Liu, Ning-hua; Sun, Hui] Shanghai Jiao Tong Univ, Dept Orthopaed, Peoples Hosp 6, Shanghai 200030, Peoples R China; [Xu, Feng] Kunshan Tradit Chinese Med Hosp, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University	Sun, H (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed, Peoples Hosp 6, Shanghai 200030, Peoples R China.	sunshine20002000@126.com						Adams DC, 2005, DERMATOL SURG, V31, P1055; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9; Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002; Ding FY, 2013, J MATER CHEM B, V1, P1729, DOI 10.1039/c3tb00517h; Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031; Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007; Hajiali H, 2011, INT J NANOMED, V6, P2133, DOI 10.2147/IJN.S24312; Hassanzadeh P, 2013, J MATER CHEM B, V1, P4217, DOI [10.1039/c3tb20782j, 10.1039/C3TB20782J]; Heimbach DM, 2003, J BURN CARE REHABIL, V24, P42, DOI 10.1097/00004630-200301000-00009; Ignatova M, 2009, MACROMOL BIOSCI, V9, P102, DOI 10.1002/mabi.200800189; Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218; Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906; Jeong SI, 2008, J BIOMAT SCI-POLYM E, V19, P339, DOI 10.1163/156856208783721029; Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017; Jung Y, 2008, J BIOMAT SCI-POLYM E, V19, P1073, DOI 10.1163/156856208784909336; Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244; Kim Y, 2013, J MATER CHEM B, V1, P3185, DOI 10.1039/c3tb20485e; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013; Kuwazuru O, 2008, MED ENG PHYS, V30, P516, DOI 10.1016/j.medengphy.2007.06.001; Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497; Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020; Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167; Lin GY, 2013, J MATER CHEM B, V1, P1249, DOI 10.1039/c2tb00468b; Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mo XM, 2010, J BIOMED MATER RES A, V94A, P326, DOI 10.1002/jbm.a.32788; Mo XM, 2000, J BIOMAT SCI-POLYM E, V11, P341, DOI 10.1163/156856200743742; Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011; Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9; Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318; Rieger KA, 2013, J MATER CHEM B, V1, P4531, DOI 10.1039/c3tb20795a; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Spitzenberger TJ, 2007, J CEREBR BLOOD F MET, V27, P1033, DOI 10.1038/sj.jcbfm.9600414; Sun XM, 2014, J MATER CHEM B, V2, P3636, DOI 10.1039/c3tb21814g; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.tea.2010.0568, 10.1089/ten.TEA.2010.0568]; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k	39	100	104	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112885	10.1371/journal.pone.0112885	http://dx.doi.org/10.1371/journal.pone.0112885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405611	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300061
J	Petrella, C; Giuli, C; Agostini, S; Bacquie, V; Zinni, M; Theodorou, V; Broccardo, M; Casolini, P; Improta, G				Petrella, Carla; Giuli, Chiara; Agostini, Simona; Bacquie, Valerie; Zinni, Manuela; Theodorou, Vassilia; Broccardo, Maria; Casolini, Paola; Improta, Giovanna			Maternal Exposure to Low Levels of Corticosterone during Lactation Protects against Experimental Inflammatory Colitis-Induced Damage in Adult Rat Offspring	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; COLONIC BARRIER DYSFUNCTION; STRESS-RELATED ALTERATIONS; ENVIRONMENTAL ENRICHMENT; CHILDHOOD ABUSE; MOTOR FUNCTION; RECEPTOR; GLUCOCORTICOIDS; INTESTINE; DISEASE	Opposing emotional events (negative/trauma or positive/maternal care) during the postnatal period may differentially influence vulnerability to the effects of stress later in life. The development and course of intestinal disorders such as inflammatory bowel disease are negatively affected by persistent stress, but to date the role of positive life events on these pathologies has been entirely unknown. In the present study, the effect of early life beneficial experiences in the development of intestinal dysfunctions, where inflammation and stress stimuli play a primary role, was investigated. As a "positive'' experimental model we used adult male rat progeny nursed by mothers whose drinking water was supplemented with moderate doses of corticosterone (CORT) (0.2 mg/ml) during the lactation period. Such animals have been generally shown to cope better with different environmental situations during life. The susceptibility to inflammatory experimental colitis induced by intracolonic infusion of TNBS (2,4,6-trinitrobenzenesulphonic acid) was investigated in CORT-nursed rats in comparison with control rats. This mild increase in maternal corticosterone during lactation induced, in CORT-nursed rats, a long lasting protective effect on TNBS-colitis, characterized by improvements in some indices of the disease (increased colonic myeloperoxidase activity, loss of body weight and food intake) and by the involvement of endogenous peripheral pathways known to participate in intestinal disorder development (lower plasma corticosterone levels and colonic mast cell degranulation, alterations in the colonic expression of both corticotrophin releasing factor/CRF and its receptor/CRH-1R). All these findings contribute to suggesting that the reduced vulnerability to TNBS-colitis in CORT-nursed rats is due to recovery from the colonic mucosal barrier dysfunction. Such long lasting changes induced by mild hormonal manipulation during lactation, making the adult also better adapted to colonic inflammatory stress, constitute a useful experimental model to investigate the etiopathogenetic mechanisms and therapeutic treatments of some gastrointestinal diseases.	[Petrella, Carla; Giuli, Chiara; Zinni, Manuela; Broccardo, Maria; Casolini, Paola; Improta, Giovanna] Univ Roma La Sapienza, Dept Physiol & Pharmacol V Erspamer, I-00185 Rome, Italy; [Agostini, Simona; Bacquie, Valerie; Theodorou, Vassilia] INRA, EI Purpan, UMR 1331, TOXALIM Neurogastroenterol & Nutr Team, F-31931 Toulouse, France	Sapienza University Rome; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Petrella, C (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol V Erspamer, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	carla.petrella@uniroma1.it	Petrella, Carla/AAX-1265-2020	Petrella, Carla/0000-0003-0651-1816; ZINNI, MANUELA/0000-0001-8896-5090				ANGELUCCI L, 1983, ENDOCRINOL EXP, V17, P191; Barreau F, 2006, BRAIN BEHAV IMMUN, V20, P254, DOI 10.1016/j.bbi.2005.07.003; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; BIFULCO A, 1991, BRIT J PSYCHIAT, V159, P115, DOI 10.1192/bjp.159.1.115; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BROWN GR, 1991, AM J PSYCHIAT, V148, P55; Casolini P, 1997, NEUROSCIENCE, V79, P1005, DOI 10.1016/S0306-4522(96)00668-9; Casolini P, 2007, J NEUROSCI, V27, P7041, DOI 10.1523/JNEUROSCI.1074-07.2007; Catalani A, 2000, NEUROSCIENCE, V100, P319, DOI 10.1016/S0306-4522(00)00277-3; Catalani A, 2011, NEUROSCI BIOBEHAV R, V35, P1502, DOI 10.1016/j.neubiorev.2010.10.017; Chang J, 2007, PEPTIDES, V28, P1453, DOI 10.1016/j.peptides.2007.05.008; Chen M, 2011, WORLD J GASTROENTERO, V17, P2933, DOI 10.3748/wjg.v17.i24.2933; Costalos C, 2003, EARLY HUM DEV, V74, P83, DOI 10.1016/S0378-3782(03)00087-2; Dermitzaki E, 2007, ENDOCRINOLOGY, V148, P1524, DOI 10.1210/en.2006-0967; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Ergang P, 2008, DIGEST DIS SCI, V53, P2160, DOI 10.1007/s10620-007-0125-6; FABIA R, 1992, DIGESTION, V53, P35, DOI 10.1159/000200969; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Francis DD, 2002, J NEUROSCI, V22, P7840; Greenwood-van Meerveld B, 2005, NEUROGASTROENT MOTIL, V17, P415, DOI 10.1111/j.1365-2982.2005.00648.x; Hart A, 2002, ALIMENT PHARM THER, V16, P2017, DOI 10.1046/j.1365-2036.2002.01359.x; HENNING SJ, 1975, J BIOL CHEM, V250, P2073; Hutchinson KM, 2012, NEUROBIOL LEARN MEM, V97, P250, DOI 10.1016/j.nlm.2012.01.003; Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055; Kiank C, 2010, BRAIN BEHAV IMMUN, V24, P41, DOI 10.1016/j.bbi.2009.08.006; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Maillot C, 2000, GASTROENTEROLOGY, V119, P1569, DOI 10.1053/gast.2000.20251; MAKINO S, 1995, ENDOCRINOLOGY, V136, P4517, DOI 10.1210/en.136.10.4517; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Milde AM, 2004, PHYSIOL BEHAV, V81, P71, DOI 10.1016/j.physbeh.2004.01.002; Million M, 2003, BRAIN RES, V985, P32, DOI 10.1016/S0006-8993(03)03027-0; MORTEAU O, 1994, DIGEST DIS SCI, V39, P1239, DOI 10.1007/BF02093789; Moussaoui N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088382; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Pacha J, 2003, PEDIATR RES, V53, P808, DOI 10.1203/01.PDR.0000058923.08017.6F; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Ringel Y, 2001, SURG CLIN N AM, V81, P231, DOI 10.1016/S0039-6109(05)70283-8; Ringel Y, 2001, ANN REV MED; RUTTER M, 1979, CHILD DEV, V50, P283, DOI 10.2307/1129404; Rutter M, 1979, Ann Acad Med Singap, V8, P324; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; SMITH J, 1995, J AM ACAD CHILD PSY, V34, P168, DOI 10.1097/00004583-199502000-00012; Soderholm JD, 2002, AM J PHYSIOL-GASTR L, V283, pG1257, DOI 10.1152/ajpgi.00314.2002; Soderholm JD, 2002, GASTROENTEROLOGY, V123, P1099, DOI 10.1053/gast.2002.36019; Tache Y, 2004, NEUROGASTROENT MOTIL, V16, P137, DOI 10.1111/j.1743-3150.2004.00490.x; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Teitelbaum AA, 2008, AM J PHYSIOL-GASTR L, V295, pG452, DOI 10.1152/ajpgi.90210.2008; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; vanTol EAF, 1996, GUT, V39, P385, DOI 10.1136/gut.39.3.385; WALLACE JL, 1992, GASTROENTEROLOGY, V102, P18, DOI 10.1016/0016-5085(92)91779-4; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Yorty JL, 2004, AM J PHYSIOL-REG I, V287, pR1316, DOI 10.1152/ajpregu.00685.2003; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149; Zheng G, 2013, NEUROGASTROENT MOTIL, V25, pE127, DOI 10.1111/nmo.12066	60	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113389	10.1371/journal.pone.0113389	http://dx.doi.org/10.1371/journal.pone.0113389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405993	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300113
J	Santos, F; Penaflor, MFGV; Pare, PW; Sanches, PA; Kamiya, AC; Tonelli, M; Nardi, C; Bento, JMS				Santos, Franciele; Penaflor, Maria Fernanda G. V.; Pare, Paul W.; Sanches, Patricia A.; Kamiya, Aline C.; Tonelli, Mateus; Nardi, Cristiane; Bento, Jose Mauricio S.			A Novel Interaction between Plant-Beneficial Rhizobacteria and Roots: Colonization Induces Corn Resistance against the Root Herbivore Diabrotica speciosa	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; SYSTEMIC RESISTANCE; CUCUMBER; CHRYSOMELIDAE; COLEOPTERA; INDUCTION; ACID	A number of soil-borne microorganisms, such as mycorrhizal fungi and rhizobacteria, establish mutualistic interactions with plants, which can indirectly affect other organisms. Knowledge of the plant-mediated effects of mutualistic microorganisms is limited to aboveground insects, whereas there is little understanding of what role beneficial soil bacteria may play in plant defense against root herbivory. Here, we establish that colonization by the beneficial rhizobacterium Azospirillum brasilense affects the host selection and performance of the insect Diabrotica speciosa. Root larvae preferentially orient toward the roots of non-inoculated plants versus inoculated roots and gain less weight when feeding on inoculated plants. As inoculation by A. brasilense induces higher emissions of (E)-beta-caryophyllene compared with non-inoculated plants, it is plausible that the non-preference of D. speciosa for inoculated plants is related to this sesquiterpene, which is well known to mediate belowground insect-plant interactions. To the best of our knowledge, this is the first study showing that a beneficial rhizobacterium inoculant indirectly alters belowground plant-insect interactions. The role of A. brasilense as part of an integrative pest management (IPM) program for the protection of corn against the South American corn rootworm, D. speciosa, is considered.	[Santos, Franciele; Penaflor, Maria Fernanda G. V.; Sanches, Patricia A.; Kamiya, Aline C.; Tonelli, Mateus; Bento, Jose Mauricio S.] Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Pare, Paul W.] Texas Tech Univ, Dept Chem, Lubbock, TX 79409 USA; [Pare, Paul W.] Texas Tech Univ, Dept Biol, Lubbock, TX 79409 USA; [Tonelli, Mateus; Nardi, Cristiane] Mid West State Univ, Dept Agron, Guarapuava, PR, Brazil	Universidade de Sao Paulo; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Bento, JMS (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	jmsbento@usp.br	Bento, José Maurício Simões/A-9759-2008; Peñaflor, Maria Fernanda G.V./F-7591-2013; Pare, Paul W/E-3055-2013; Sanches, Patricia/J-3035-2017	Bento, José Maurício Simões/0000-0001-8655-5178; Peñaflor, Maria Fernanda G.V./0000-0001-8240-8840; Pare, Paul W/0000-0003-1644-723X; Tonelli, Mateus/0000-0002-2324-8901; Nardi, Cristiane/0000-0003-4264-5379; Sanches, Patricia/0000-0002-9379-9303; Santos, Franciele/0000-0001-8099-4882	Instituto Nacional de Ciencia e Tecnologia (INCT) Semioquimicos na Agricultura; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57701-2, 2012/12252-1, 2013/11993-0]; Fulbright Scholar Program (U.S. Scholar)	Instituto Nacional de Ciencia e Tecnologia (INCT) Semioquimicos na Agricultura; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fulbright Scholar Program (U.S. Scholar)	This work was supported in part by the Instituto Nacional de Ciencia e Tecnologia (INCT) Semioquimicos na Agricultura, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP 2008/57701-2). MFGVP and PAS are funded by the Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP 2012/12252-1 and 2013/11993-0). PWP was funded by the Fulbright Scholar Program (U.S. Scholar 2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda L, 2013, APPL SOIL ECOL, V63, P15, DOI 10.1016/j.apsoil.2012.09.001; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; D'Alessandro M, 2014, PLANT CELL ENVIRON, V37, P813, DOI 10.1111/pce.12220; Dean JM, 2009, PLANT SOIL, V323, P187, DOI 10.1007/s11104-009-9924-1; Fontana A, 2009, J CHEM ECOL, V35, P833, DOI 10.1007/s10886-009-9654-0; Gange AC, 2003, ECOL LETT, V6, P1051, DOI 10.1046/j.1461-0248.2003.00540.x; GarciadeSalomone I, 1996, BIOL FERT SOILS, V21, P193, DOI 10.1007/BF00335934; Heath KD, 2011, ACTA OECOL, V37, P87, DOI 10.1016/j.actao.2010.12.002; Herschkovitz Y, 2005, ENVIRON MICROBIOL, V7, P1847, DOI 10.1111/j.1462-2920.2005.00926.x; HUANG BR, 1993, INT J PLANT SCI, V154, P425, DOI 10.1086/297125; Valenzuela-Soto JH, 2010, PLANTA, V231, P397, DOI 10.1007/s00425-009-1061-9; Hungria M, 2011, INOCULACAO COM AZOSP; Hungria M, 2010, PLANT SOIL, V331, P413, DOI 10.1007/s11104-009-0262-0; Kovats E, 1965, ADV CHROMATOGR, V1, P229; Kupferschmied P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00287; Milanez Jose M., 2000, Anais da Sociedade Entomologica do Brasil, V29, P23, DOI 10.1590/S0301-80592000000100003; Pineda A, 2012, PLANT BIOLOGY, V14, P83, DOI 10.1111/j.1438-8677.2011.00549.x; Pineda A, 2013, PLANT CELL ENVIRON, V36, P393, DOI 10.1111/j.1365-3040.2012.02581.x; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Ramamoorthy V, 2001, CROP PROT, V20, P1, DOI 10.1016/S0261-2194(00)00056-9; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Robert CAM, 2012, FUNCT ECOL, V26, P1429, DOI 10.1111/j.1365-2435.2012.02030.x; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Sabulal B, 2006, PHYTOCHEMISTRY, V67, P2469, DOI 10.1016/j.phytochem.2006.08.003; ULUBELEN A, 1994, PHYTOCHEMISTRY, V36, P971, DOI 10.1016/S0031-9422(00)90474-6; Van Oosten VR, 2008, MOL PLANT MICROBE IN, V21, P919, DOI 10.1094/MPMI-21-7-0919; Ventura Mauricio U., 2001, Neotropical Entomology, V30, P361, DOI 10.1590/S1519-566X2001000300003; Walker V, 2011, NEW PHYTOL, V189, P494, DOI 10.1111/j.1469-8137.2010.03484.x; Walsh GC, 2003, ENVIRON ENTOMOL, V32, P276, DOI 10.1603/0046-225X-32.2.276; Zehnder G, 1997, J ECON ENTOMOL, V90, P391, DOI 10.1093/jee/90.2.391; Zehnder G, 1997, ENTOMOL EXP APPL, V83, P81, DOI 10.1023/A:1002907604294	31	24	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113280	10.1371/journal.pone.0113280	http://dx.doi.org/10.1371/journal.pone.0113280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405495	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300095
J	Coloccini, RS; Dilernia, D; Ghiglione, Y; Turk, G; Laufer, N; Rubio, A; Socias, ME; Figueroa, MI; Sued, O; Cahn, P; Salomon, H; Mangano, A; Pando, MA				Soledad Coloccini, Romina; Dilernia, Dario; Ghiglione, Yanina; Turk, Gabriela; Laufer, Natalia; Rubio, Andrea; Eugenia Socias, Maria; Ines Figueroa, Maria; Sued, Omar; Cahn, Pedro; Salomon, Horacio; Mangano, Andrea; Angeles Pando, Maria			Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HLA CLASS-I; ANTIGEN CLASS-I; TYPE-1 INFECTION; NATURAL-HISTORY; RNA LEVELS; CCR5; ALLELES; VIREMIA; AIDS	Background: Variants in HIV-coreceptor C-C chemokine receptor type 5 (CCR5) and Human leukocyte antigen (HLA) genes are the most important host genetic factors associated with HIV infection and disease progression. Our aim was to analyze the association of these genetic factors in the presence of clinical symptoms during Primary HIV Infection (PHI) and disease progression within the first year. Methods: Seventy subjects diagnosed during PHI were studied (55 symptomatic and 15 asymptomatic). Viral load (VL) and CD4 T-cell count were evaluated. HIV progression was defined by presence of B or C events and/or CD4 T-cell counts, 350 cell/mm(3). CCR5 haplotypes were characterized by polymerase chain reaction and SDM-PCR-RFLP. HLA-I characterization was performed by Sequencing. Results: Symptoms during PHI were significantly associated with lower frequency of CCR5-CF1 (1.8% vs. 26.7%, p = 0.006). Rapid progression was significantly associated with higher frequency of CCR5-CF2 (16.7% vs. 0%, p = 0.024) and HLA-A*11 (16.7% vs. 1.2%, p = 0.003) and lower frequency of HLA-C*3 (2.8% vs. 17.5%, p = 0.035). Higher baseline VL was significantly associated with presence of HLA-A*11, HLA-A*24, and absence of HLA-A*31 and HLA-B*57. Higher 6-month VL was significantly associated with presence of CCR5-HHE, HLA-A*24, HLA-B*53, and absence of HLA-A*31 and CCR5-CF1. Lower baseline CD4 T-cell count was significantly associated with presence of HLA-A*24/*33, HLA-B*53, CCR5-CF2 and absence of HLA-A*01/*23 and CCR5-HHA. Lower 6-month CD4 T-cell count was associated with presence of HLA-A*24 and HLA-B*53, and absence of HLA-A*01 and HLA-B*07/*39. Moreover, lower 12-month CD4 T-cell count was significantly associated with presence of HLA-A*33, HLA-B*14, HLA-C*08, CCR5-CF2, and absence of HLA-B*07 and HLA-C*07. Conclusion: Several host factors were significantly associated with disease progression in PHI subjects. Most results agree with previous studies performed in other groups. However, some genetic factor associations are being described for the first time, highlighting the importance of genetic studies at a local level.	[Soledad Coloccini, Romina; Dilernia, Dario; Ghiglione, Yanina; Turk, Gabriela; Laufer, Natalia; Rubio, Andrea; Salomon, Horacio; Angeles Pando, Maria] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Laufer, Natalia; Eugenia Socias, Maria; Ines Figueroa, Maria; Sued, Omar; Cahn, Pedro] Hosp Juan A Fernandez, Buenos Aires, DF, Argentina; [Eugenia Socias, Maria; Ines Figueroa, Maria; Sued, Omar; Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Mangano, Andrea] Hosp Pediat Prof Dr Juan P Garrahan, CONICET, Lab Biol Celular & Retrovirus, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Pediatria Doctor Juan Garrahan	Pando, MA (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina.	mpando@fmed.uba.ar	Laufer, Natalia/AAB-7472-2022; Sued, Omar/H-3325-2019	Laufer, Natalia/0000-0002-5690-9454; Sued, Omar/0000-0001-5818-770X	Agencia Nacional de Promocion Cientifica y Tecnologica [2008-0559]; Fundacion Florencio Fiorini; UBACYT; CONICET (PIP)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Florencio Fiorini; UBACYT; CONICET (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was funded by grants from: Agencia Nacional de Promocion Cientifica y Tecnologica (grant number 2008-0559), "Fundacion Florencio Fiorini" (period: 2009-2010), UBACYT (period: 2010-2012) and CONICET (PIP 2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2013, BOLETIN; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buchacz K, 2004, JAIDS-J ACQ IMM DEF, V36, P853, DOI 10.1097/00126334-200407010-00013; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; de Sorrentino AH, 2000, J INFECT DIS, V182, P1523, DOI 10.1086/315854; Douek Daniel, 2007, Top HIV Med, V15, P114; Dun PPJ, 2001, SEQUENCING BASED TYP, P1; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Hightow-Weidman LB, 2009, AIDS BEHAV, V13, P1075, DOI 10.1007/s10461-008-9519-5; Huang X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-201; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hurley CK, 2007, HUM IMMUNOL, V68, P30, DOI 10.1016/j.humimm.2006.09.004; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li LN, 2005, IMMUNOGENETICS, V57, P315, DOI 10.1007/s00251-005-0801-7; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Magierowska M, 1999, BLOOD, V93, P936, DOI 10.1182/blood.V93.3.936.403k08_936_941; Mangano A, 2000, J ACQ IMMUN DEF SYND, V23, P52; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Marmor M, 2006, J URBAN HEALTH, V83, P5, DOI 10.1007/s11524-005-9003-8; McGovern RA, 2010, JOVE-J VIS EXP, V46, P2531; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mummidi S, 1997, J BIOL CHEM, V272, P30662, DOI 10.1074/jbc.272.49.30662; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Naruto T, 2012, J VIROL, V86, P10870, DOI 10.1128/JVI.00689-12; Nguyen L, 2004, JAIDS-J ACQ IMM DEF, V37, P1318, DOI 10.1097/01.qai.0000127059.98621.55; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Prentice HA, 2014, VIROLOGY, V449, P254, DOI 10.1016/j.virol.2013.11.024; Richey LE, 2013, AM J MED SCI, V345, P136, DOI 10.1097/MAJ.0b013e31825d4b88; Rocco CA, 2003, AIDS RES HUM RETROV, V19, P943, DOI 10.1089/088922203322588288; Salamon R, 2002, J ACQ IMMUN DEF SYND, V29, P149, DOI 10.1097/00042560-200202010-00007; Smith Miranda Z, 2005, Sex Health, V2, P53, DOI 10.1071/SH04057; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Socias ME, 2011, J INT AIDS SOC, P14; Tang J, 1999, GENES IMMUN, V1, P20, DOI 10.1038/sj.gene.6363640; Tang JM, 2002, J VIROL, V76, P662, DOI 10.1128/JVI.76.2.662-672.2002; Telenti A, 2006, NAT REV MICROBIOL, V4, P865, DOI 10.1038/nrmicro1532; Telenti A, 2006, FUTURE VIROL, V1, P55, DOI 10.2217/17460794.1.1.55; Tincati C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/935425	57	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113146	10.1371/journal.pone.0113146	http://dx.doi.org/10.1371/journal.pone.0113146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406087	Green Published, gold			2022-12-27	WOS:000347121300086
J	Xu, EK; Fan, GQ; Niu, SY; Zhao, ZL; Deng, MJ; Dong, YP				Xu, Enkai; Fan, Guoqiang; Niu, Suyan; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng			Transcriptome-Wide Profiling and Expression Analysis of Diploid and Autotetraploid Paulownia tomentosa x Paulownia fortunei under Drought Stress	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; GENE-EXPRESSION; PROTEIN-KINASES; PROLINE BIOSYNTHESIS; SUPEROXIDE-DISMUTASE; SIGNAL-TRANSDUCTION; LIPID-PEROXIDATION; STOMATAL CLOSURE; LEAF SENESCENCE; PLANT-GROWTH	Paulownia is a fast-growing deciduous hardwood species native to China, which has high ecological and economic value. In an earlier study, we reported ploidy-dependent differences in Paulownia drought tolerance by the microscopic observations of the leaves. Autotetraploid Paulownia has a higher resistance to drought stress than their diploid relatives. In order to obtain genetic information on molecular mechanisms responses of Paulownia plants to drought, Illumina/Solexa Genome sequencing platform was used to de novo assemble the transcriptomes of leaves from diploid and autotetraploid Paulownia tomentosa x Paulownia fortunei seedlings (PTF2 and PTF4 respectively) grown under control conditions and under drought stress and obtained 98,671 nonredundant unigenes. A comparative transcriptome analysis revealed that hundreds of unigenes were predicted to be involved mainly in ROS-scavenging system, amino acid and carbohydrate metabolism, plant hormone biosynthesis and signal transduction, while these unigenes exhibited differential transcript alteration of the two accessions. This study provides a comprehensive map of how P. tomentosa x P. fortunei responds to drought stress at physiological and molecular levels, which may help in understanding the mechanisms involve in water-deficit response and will be useful for further study of drought tolerance in woody plants.	[Xu, Enkai; Fan, Guoqiang; Niu, Suyan; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng] Henan Agr Univ, Inst Paulownia, Jinshui Area, Zhengzhou, Henan, Peoples R China; [Xu, Enkai; Fan, Guoqiang; Niu, Suyan; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng] Henan Agr Univ, Coll Forestry, Jinshui Area, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Jinshui Area, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com			National Natural Science Foundation of China [30271082, 30571496, U1204309]; Outstanding Talents Project of Henan Province [122101110700]; Transformation Project of the National Agricultural Scientific and Technological Achievement of China [2012GB2D000271]; Science and Technology Innovation Team Project of Zhengzhou City [121PCXTD515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Talents Project of Henan Province; Transformation Project of the National Agricultural Scientific and Technological Achievement of China; Science and Technology Innovation Team Project of Zhengzhou City	This work was supported by GQF, National Natural Science Foundation of China (Grant no. 30271082, 30571496, U1204309, http://www.nsfc.gov.cn/), GQF, Outstanding Talents Project of Henan Province (Grant no. 122101110700), GQF, Transformation Project of the National Agricultural Scientific and Technological Achievement of China (Grant no. 2012GB2D000271), and GQF, Science and Technology Innovation Team Project of Zhengzhou City (Grant no. 121PCXTD515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; [Anonymous], 1997, ACTA GENET SIN; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baloglu MC, 2012, PLANT MOL BIOL REP, V30, P1246, DOI 10.1007/s11105-012-0445-3; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benjamini Y, 2001, ANN STAT, V29, P1165; Bertauche N, 1996, EUR J BIOCHEM, V241, P193, DOI 10.1111/j.1432-1033.1996.0193t.x; Bohnert HJ, 2001, PLANT PHYSIOL BIOCH, V39, P295, DOI 10.1016/S0981-9428(00)01237-7; Bojovic BM., 2005, ARCH BIOL SCI, V57, P283, DOI [10.2298/ABS0504283B, DOI 10.2298/ABS0504283B]; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JH, 2013, PLANT MOL BIOL REP, V31, P946, DOI 10.1007/s11105-013-0563-6; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cho EK, 2006, PLANT CELL REP, V25, P349, DOI 10.1007/s00299-005-0093-2; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CSONKA LN, 1988, GENE, V64, P199, DOI 10.1016/0378-1119(88)90335-6; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; DWIVEDI NK, 1989, CYTOLOGIA, V54, P13, DOI 10.1508/cytologia.54.13; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Fan GuoQiang, 2010, Journal of Northeast Forestry University, V38, P22; Fock I, 2000, PLANT SCI, V160, P165, DOI 10.1016/S0168-9452(00)00375-7; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GUY C, 1992, PLANTA, V188, P265, DOI 10.1007/BF00216823; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Hall T, 2008, TREES LIFE J, V3, P3; Hamdy A, 2003, IRRIG DRAIN, V52, P3, DOI 10.1002/ird.73; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu XJ, 2010, BIOL PLANTARUM, V54, P213, DOI 10.1007/s10535-010-0039-6; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Ipekci Z, 2003, PLANT CELL REP, V22, P16, DOI 10.1007/s00299-003-0650-5; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Muoma J, 2011, BIOTECHNOLOGY, V10, P469; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nadarajah Kalaivani, 2010, Asian Journal of Plant Sciences, V9, P1; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Oliver MJ, 2010, METHODS MOL BIOL, V639, P3, DOI 10.1007/978-1-60761-702-0_1; Peng SM, 2012, TREE PHYSIOL, V32, P1541, DOI 10.1093/treephys/tps110; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Riddle NC, 2010, THEOR APPL GENET, V120, P341, DOI 10.1007/s00122-009-1113-3; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2004, TRANSCRIPTOME ANAL A, P271; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SnedecorGW WG C, 1980, STAT METHODS, P507; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; Sugano S, 2003, PLANT J, V36, P830, DOI 10.1046/j.1365-313X.2003.01924.x; SUN Y, 1988, CLIN CHEM, V34, P497; Tang S, 2013, PLANT MOL BIOL, V83, P539, DOI 10.1007/s11103-013-0107-3; Tardieu F, 2010, CURR OPIN PLANT BIOL, V13, P206, DOI 10.1016/j.pbi.2009.12.012; Thompson AJ, 2007, PLANT CELL ENVIRON, V30, P67, DOI 10.1111/j.1365-3040.2006.01606.x; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Vandenbussche F, 2010, DEVELOPMENT, V137, P597, DOI 10.1242/dev.040790; Verma DPS, 1999, BIOTECHNOL INTELL UN, P153; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wang W, 2000, BIOTECHNOLOGY PLANT, P285; Wang Y, 2005, PLANT J, V43, P413, DOI 10.1111/j.1365-313X.2005.02463.x; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103.026914; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Wittenmyer L, 2005, J PLANT NUTR SOIL SC, V168, P531, DOI 10.1002/jpln.200520507; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Woo HR, 2004, PLANT CELL PHYSIOL, V45, P923, DOI 10.1093/pcp/pch110; Yan DH, 2012, PLANT SCI, V195, P24, DOI 10.1016/j.plantsci.2012.06.005; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhang JZ, 2003, CURR OPIN PLANT BIOL, V6, P430, DOI 10.1016/S1369-5266(03)00081-5; Zhang X.S., 2013, J HENAN AGR U, V46, P646; Zhang XY, 2010, J PLANT PHYSIOL, V167, P88, DOI 10.1016/j.jplph.2009.07.006; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu Z.-H., 1986, PAULOWNIA CHINA CULT; Zhu ZhiTi, 1997, Journal of Beijing Forestry University, English edition, V6, P1	113	18	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113313	10.1371/journal.pone.0113313	http://dx.doi.org/10.1371/journal.pone.0113313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405758	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300104
J	Ahmed, B; Nanji, K; Mujeeb, R; Patel, MJ				Ahmed, Bilal; Nanji, Kashmira; Mujeeb, Rakshinda; Patel, Muhammad Junaid			Effects of Polypharmacy on Adverse Drug Reactions among Geriatric Outpatients at a Tertiary Care Hospital in Karachi: A Prospective Cohort Study	PLOS ONE			English	Article							ELDERLY-PATIENTS; EVENTS	Background: Adverse drug reactions (ADRs) present a challenging and expensive public health problem. Polypharmacy is defined according to the WHO criteria as the, "concurrent use of five or more different prescription medication''. Elderly are more prone to adverse reactions due to comorbid conditions, longer lists of medications and sensitivity to drug effects. The aim of the study is to estimate the incidence and strength of association of ADRs due to polypharmacy among the geriatric cohort attending outpatient clinics at a tertiary care center. Methods: A hospital based prospective cohort study was conducted at ambulatory care clinics of Aga Khan University Hospital April 2012 to March 2013. One thousand geriatrics patients (age >= 65 years) visiting ambulatory clinics were identified. They were divided on the basis of exposure (polypharmacy vs. no polypharmacy). We followed them from the time of their enrollment (day zero) to six weeks, checking up on them once a week. Incidence was calculated and Cox Proportional Hazard Model estimates were used. Results: The final analysis was performed on 1000 elderly patients. The occurrence of polypharmacy was 70% and the incidence of ADRs was 10.5% among the study cohort. The majority (30%) of patients were unable to read or write. The use of herbal medicine was reported by 3.2% of the patients and homeopathic by 3%. Our Cox adjusted model shows that polypharmacy was 2.3 times more associated with ADRs, con-current complementary and alternative medicine (CAM) was 7.4 times and those who cannot read and write were 1.5 times more associated with ADRs. Conclusion: The incidence of ADRs due to poly pharmacy is alarmingly high. The factors associated with ADRs are modifiable. Policies are needed to design and strengthen the prescription pattern.	[Ahmed, Bilal; Mujeeb, Rakshinda; Patel, Muhammad Junaid] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Nanji, Kashmira] Aga Khan Univ, Dept Family Med, Karachi, Pakistan	Aga Khan University; Aga Khan University	Patel, MJ (corresponding author), Aga Khan Univ, Dept Med, Karachi, Pakistan.	junaiddrpatel@gmail.com			University Research Council, Aga Khan University URC [102013MED]	University Research Council, Aga Khan University URC	This work was supported by the University Research Council, Aga Khan University URC ID 102013MED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Chumney Elinor C., 2006, Pharmacy Pract (Granada), V4, P103, DOI 10.4321/s1885-642x2006000300001; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Ernst E, 2000, BMJ-BRIT MED J, V321, P1133, DOI 10.1136/bmj.321.7269.1133; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Haider SI, 2007, INT J CLIN PHARM TH, V45, P643; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Herman Patricia M, 2005, BMC Complement Altern Med, V5, P11, DOI 10.1186/1472-6882-5-11; Hilmer SN, 2008, AUST PRESCR, V31, P2, DOI 10.18773/austprescr.2008.001; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Lam DPY, 2010, J AM GERIATR SOC, V58, P203, DOI 10.1111/j.1532-5415.2009.02656.x; Najjar MF, 2010, HEALTHMED, V4; Nguyen Julia K, 2006, Am J Geriatr Pharmacother, V4, P36, DOI 10.1016/j.amjopharm.2006.03.002; Nobili A, 2011, EUR J CLIN PHARMACOL, V67, P507, DOI 10.1007/s00228-010-0977-0; Population Division Department of Economic and Social Affairs United Nations, 2013, WORLD POP AG 2013; Sabzwari SR, 2013, J PAK MED ASSOC, V63, P624; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; Trumic Edisa, 2012, Mater Sociomed, V24, P68, DOI 10.5455/msm.2012.24.68-72; Viktil KK, 2007, BRIT J CLIN PHARMACO, V63, P187, DOI 10.1111/j.1365-2125.2006.02744.x; WORLD HEALTH ORGANIZATION, 2009, DENGUE: GUIDELINES FOR DIAGNOSIS, TREATMENT, PREVENTION AND CONTROL, P3	23	58	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112133	10.1371/journal.pone.0112133	http://dx.doi.org/10.1371/journal.pone.0112133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402452	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700029
J	Suzuki, G; Weil, BR; Leiker, MM; Ribbeck, AE; Young, RF; Cimato, TR; Canty, JM				Suzuki, Gen; Weil, Brian R.; Leiker, Merced M.; Ribbeck, Amanda E.; Young, Rebeccah F.; Cimato, Thomas R.; Canty, John M., Jr.			Global Intracoronary Infusion of Allogeneic Cardiosphere-Derived Cells Improves Ventricular Function and Stimulates Endogenous Myocyte Regeneration throughout the Heart in Swine with Hibernating Myocardium	PLOS ONE			English	Article							CARDIAC STEM-CELLS; MARROW PROGENITOR CELLS; ISCHEMIC CARDIOMYOPATHY; PORCINE MODEL; THERAPY; PIGS; HYPERTROPHY; EFFICACY; VALIDATION; INFARCTION	Background: Cardiosphere-derived cells (CDCs) improve ventricular function and reduce fibrotic volume when administered via an infarct-related artery using the "stop-flow'' technique. Unfortunately, myocyte loss and dysfunction occur globally in many patients with ischemic and non-ischemic cardiomyopathy, necessitating an approach to distribute CDCs throughout the entire heart. We therefore determined whether global intracoronary infusion of CDCs under continuous flow improves contractile function and stimulates new myocyte formation. Methods and Results: Swine with hibernating myocardium from a chronic LAD occlusion were studied 3-months after instrumentation (n = 25). CDCs isolated from myocardial biopsies were infused into each major coronary artery (similar to 33x10(6) icCDCs). Global icCDC infusion was safe and while similar to 3% of injected CDCs were retained, they did not affect ventricular function or myocyte proliferation in normal animals. In contrast, four-weeks after icCDCs were administered to animals with hibernating myocardium, %LADWT increased from 23 +/- 6 to 51 +/- 5% (p<0.01). In diseased hearts, myocyte proliferation (phospho-histone-H3) increased in hibernating and remote regions with a concomitant increase in myocyte nuclear density. These effects were accompanied by reductions in myocyte diameter consistent with new myocyte formation. Only rare myocytes arose from sex-mismatched donor CDCs. Conclusions: Global icCDC infusion under continuous flow is feasible and improves contractile function, regresses myocyte cellular hypertrophy and increases myocyte proliferation in diseased but not normal hearts. New myocytes arising via differentiation of injected cells are rare, implicating stimulation of endogenous myocyte regeneration as the primary mechanism of repair.	[Canty, John M., Jr.] Vet Affairs Western New York Hlth Care Syst, Div Cardiovasc Med, Buffalo, NY 14215 USA; [Suzuki, Gen; Weil, Brian R.; Leiker, Merced M.; Ribbeck, Amanda E.; Young, Rebeccah F.; Cimato, Thomas R.; Canty, John M., Jr.] SUNY Buffalo, Dept Med, Div Cardiovasc Med, Buffalo, NY 14260 USA; [Canty, John M., Jr.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Canty, John M., Jr.] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Suzuki, Gen; Weil, Brian R.; Leiker, Merced M.; Ribbeck, Amanda E.; Young, Rebeccah F.; Cimato, Thomas R.; Canty, John M., Jr.] SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Canty, JM (corresponding author), Vet Affairs Western New York Hlth Care Syst, Div Cardiovasc Med, Buffalo, NY 14215 USA.	canty@buffalo.edu	Canty, John M/C-5349-2009	Cimato, Thomas/0000-0001-9230-4463	NIH [HL55324, HL61610, F32 HL114335]; American Heart Association [SDG3990004]; New York State Department of Health NYSTEM [CO24351]; Albert and Elizabeth Rekate Fund in Cardiovascular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL114335, R01HL055324, R01HL061610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); New York State Department of Health NYSTEM; Albert and Elizabeth Rekate Fund in Cardiovascular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH HL55324, HL61610, F32 HL114335, American Heart Association SDG3990004, New York State Department of Health NYSTEM CO24351, and the Albert and Elizabeth Rekate Fund in Cardiovascular Medicine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2012, HEART FAIL CLIN, V8, P79, DOI 10.1016/j.hfc.2011.08.010; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Bruel A, 2005, BASIC RES CARDIOL, V100, P311, DOI 10.1007/s00395-005-0524-9; Canty JM, 2004, CIRC RES, V94, P1142, DOI 10.1161/01.RES.0000125628.57672.CF; Cheng K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001260; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Fallavollita JA, 1997, CIRCULATION, V95, P1900; Fallavollita JA, 2001, J AM COLL CARDIOL, V37, P1989, DOI 10.1016/S0735-1097(01)01250-5; Fallavollita JA, 2014, J AM COLL CARDIOL, V63, P141, DOI 10.1016/j.jacc.2013.07.096; Gago-Lopez N, 2014, STEM CELL REP, V2, P576, DOI 10.1016/j.stemcr.2014.03.003; GLENNY RW, 1993, J APPL PHYSIOL, V74, P2585, DOI 10.1152/jappl.1993.74.5.2585; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Lim HJ, 1999, CIRCULATION, V100, P2380, DOI 10.1161/01.CIR.100.23.2380; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Malm BJ, 2002, CARDIOVASC RES, V56, P422, DOI 10.1016/S0008-6363(02)00599-0; Marban E, 2010, CIRCULATION, V121, P1981, DOI 10.1161/CIRCULATIONAHA.110.952580; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Simpson DL, 2012, CIRCULATION, V126, pS46, DOI 10.1161/CIRCULATIONAHA.111.084699; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; SPINALE FG, 1991, CIRC RES, V69, P1058, DOI 10.1161/01.RES.69.4.1058; Suzuki G, 2005, CIRC RES, V96, P767, DOI 10.1161/01.RES.0000162099.01268.d1; Suzuki G, 2011, CIRC RES, V109, P1044, DOI 10.1161/CIRCRESAHA.111.245969; Suzuki G, 2009, CIRC RES, V104, P255, DOI 10.1161/CIRCRESAHA.108.188730; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Xie YC, 2014, STEM CELLS, V32, P2397, DOI 10.1002/stem.1736; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894	42	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113009	10.1371/journal.pone.0113009	http://dx.doi.org/10.1371/journal.pone.0113009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402428	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700093
J	Tepel, M; Borst, C; Bistrup, C; Marcussen, N; Pagonas, N; Seibert, FS; Arndt, R; Zidek, W; Westhoff, TH				Tepel, Martin; Borst, Christoffer; Bistrup, Claus; Marcussen, Niels; Pagonas, Nikolaos; Seibert, Felix S.; Arndt, Robert; Zidek, Walter; Westhoff, Timm H.			Urinary Calprotectin and Posttransplant Renal Allograft Injury	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; ACUTE KIDNEY INJURY; GLOMERULAR-FILTRATION-RATE; TRANSPLANTATION; SURVIVAL; EQUATION; CELLS	Objective: Current methods do not predict the acute renal allograft injury immediately after kidney transplantation. We evaluated the diagnostic performance of urinary calprotectin for predicting immediate posttransplant allograft injury. Methods: In a multicenter, prospective-cohort study of 144 incipient renal transplant recipients, we postoperatively measured urinary calprotectin using an enzyme-linked immunosorbent assay and estimated glomerular filtration rate (eGFR) after 4 weeks, 6 months, and 12 months. Results: We observed a significant inverse association of urinary calprotectin concentrations and eGFR 4 weeks after transplantation (Spearman r = -0.33; P<0.001). Compared to the lowest quartile, patients in the highest quartile of urinary calprotectin had an increased risk for an eGFR less than 30 mL/min/1.73 m(2) four weeks after transplantation (relative risk, 4.3; P<0.001; sensitivity, 0.92; 95% CI, 0.77 to 0.98; specificity, 0.48; 95% CI, 0.31 to 0.66). Higher urinary calprotectin concentrations predicted impaired kidney function 4 weeks after transplantation, as well as 6 months and 12 months after transplantation. When data were analyzed using the urinary calprotectin/creatinine-ratio similar results were obtained. Urinary calprotectin was superior to current use of absolute change of plasma creatinine to predict allograft function 12 months after transplantation. Urinary calprotectin predicted an increased risk both in transplants from living and deceased donors. Multivariate linear regression showed that higher urinary calprotectin concentrations and older donor age predicted lower eGFR four weeks, 6 months, and 12 months after transplantation. Conclusions: Urinary calprotectin is an early, noninvasive predictor of immediate renal allograft injury after kidney transplantation.	[Tepel, Martin; Borst, Christoffer; Bistrup, Claus] Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark; [Tepel, Martin; Borst, Christoffer; Bistrup, Claus] Univ Southern Denmark, Inst Mol Med Cardiovasc & Renal Res, Inst Clin Res, Odense, Denmark; [Marcussen, Niels] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Marcussen, Niels] Univ Southern Denmark, Odense, Denmark; [Pagonas, Nikolaos; Seibert, Felix S.; Arndt, Robert; Zidek, Walter; Westhoff, Timm H.] Charite, Dept Nephrol, Berlin, Germany; [Pagonas, Nikolaos; Seibert, Felix S.; Westhoff, Timm H.] Ruhr Univ Bochum, Univ Klin Marienhosp Herne, Med Klin 1, Bochum, Germany	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum	Westhoff, TH (corresponding author), Charite, Dept Nephrol, Campus Benjamin Franklin, Berlin, Germany.	timm.westhoff@marienhospital-herne.de	Pagonas, Nikolaos/V-2241-2019; Bistrup, Claus/F-3960-2019; Tepel, Martin/GRS-9581-2022	Bistrup, Claus/0000-0002-9280-916X; Tepel, Martin/0000-0002-0086-0997; Westhoff, Timm H./0000-0001-5797-834X	Deutsche Forschungsgemeinschaft (German Research Foundation, Research Unit FOR 1368); European Union (Interreg 4A) [62-1.2-10]	Deutsche Forschungsgemeinschaft (German Research Foundation, Research Unit FOR 1368); European Union (Interreg 4A)	This work was supported by Deutsche Forschungsgemeinschaft (German Research Foundation, Research Unit FOR 1368) and the European Union (Interreg 4A, grant number 62-1.2-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2010, J AM SOC NEPHROL, V21, P1270, DOI 10.1681/ASN.2010030233; Daly PJA, 2005, BJU INT, V96, P498, DOI 10.1111/j.1464-410X.2005.05673.x; De Vusser K, 2013, J AM SOC NEPHROL, V24, P1913, DOI 10.1681/ASN.2012111081; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Heller F, 2011, CLIN J AM SOC NEPHRO, V6, P2347, DOI 10.2215/CJN.02490311; Knoll GA, 2009, NAT CLIN PRACT NEPHR, V5, P72, DOI 10.1038/ncpneph1005; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li L, 2010, SEMIN NEPHROL, V30, P268, DOI 10.1016/j.semnephrol.2010.03.005; Raimundo M, 2013, TRANSPL P, V45, P1070, DOI 10.1016/j.transproceed.2013.02.013; Resende L, 2009, TRANSPL P, V41, P846, DOI 10.1016/j.transproceed.2009.01.066; Seibert FS, 2013, ACTA PHYSIOL, V207, P700, DOI 10.1111/apha.12064; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Szeto CC, 2010, CLIN J AM SOC NEPHRO, V5, P2329, DOI 10.2215/CJN.01910310; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743; White CA, 2010, CLIN CHEM, V56, P474, DOI 10.1373/clinchem.2009.135111; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	21	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113006	10.1371/journal.pone.0113006	http://dx.doi.org/10.1371/journal.pone.0113006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402277	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700092
J	Wang, HW; Wang, FQ; Wang, W; Yao, XL; Wei, DZ; Cheng, HR; Deng, ZX				Wang, Hengwei; Wang, Fengqing; Wang, Wei; Yao, Xueling; Wei, Dongzhi; Cheng, Hairong; Deng, Zixin			Improving the Expression of Recombinant Proteins in E. coli BL21 (DE3) under Acetate Stress: An Alkaline pH Shift Approach	PLOS ONE			English	Article							INDEPENDENT METHIONINE SYNTHASE; HIGH-CELL-DENSITY; ESCHERICHIA-COLI; ACETIC-ACID; INTRACELLULAR PH; GROWTH; ACCUMULATION; INHIBITION; HOMOSERINE; TOLERANCE	Excess acetate has long been an issue for the production of recombinant proteins in E. coli cells. Recently, improvements in acetate tolerance have been achieved through the use of genetic strategies and medium supplementation with certain amino acids and pyrimidines. The aim of our study was to evaluate an alternative to improve the acetate tolerance of E. coli BL21 (DE3), a popular strain used to express recombinant proteins. In this work we reported the cultivation of BL21 (DE3) in complex media containing acetate at high concentrations. In the presence of 300 mM acetate, compared with pH 6.5, pH 7.5 improved cell growth by approximately 71%, reduced intracellular acetate by approximately 50%, and restored the expression of glutathione S-transferase (GST), green fluorescent protein (GFP) and cytochrome P450 monooxygenase (CYP). Further experiments showed that alkaline pHs up to 8.5 had little inhibition in the expression of GST, GFP and CYP. In addition, the detrimental effect of acetate on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) by the cell membrane, an index of cellular metabolic capacity, was substantially alleviated by a shift to alkaline pH values of 7.5-8.0. Thus, we suggest an approach of cultivating E. coli BL21 (DE3) at pH 8.0 +/- 0.5 to minimize the effects caused by acetate stress. The proposed strategy of an alkaline pH shift is a simple approach to solving similar bioprocessing problems in the production of biofuels and biochemicals from sugars.	[Wang, Hengwei] Zhejiang Ocean Univ, IAI, Zhoushan, Peoples R China; [Wang, Hengwei; Cheng, Hairong; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Wang, Fengqing; Wang, Wei; Yao, Xueling; Wei, Dongzhi] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, New World Inst Biotechnol, Shanghai 200237, Peoples R China	Zhejiang Ocean University; Shanghai Jiao Tong University; East China University of Science & Technology	Cheng, HR (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	chrqrq@sjtu.edu.cn	Wei, Dongzhi/AAJ-3404-2021; Wang, Hengwei/AAZ-5205-2021		National Basic Research Program of China [2013CB733903]; Scientific Research Foundation (SRF), Zhejiang Ocean University	National Basic Research Program of China(National Basic Research Program of China); Scientific Research Foundation (SRF), Zhejiang Ocean University	This project is supported by the National Basic Research Program of China (No. 2013CB733903) and Scientific Research Foundation (SRF), Zhejiang Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2001, BIOTECHNOL BIOENG, V73, P223, DOI 10.1002/bit.1054; AXE DD, 1995, BIOTECHNOL BIOENG, V47, P8, DOI 10.1002/bit.260470103; Born TL, 1999, BIOCHEMISTRY-US, V38, P14416, DOI 10.1021/bi991710o; Chong HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077422; De Mey M, 2007, J IND MICROBIOL BIOT, V34, P689, DOI 10.1007/s10295-007-0244-2; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; HAN K, 1993, BIOTECHNOL BIOENG, V41, P316, DOI 10.1002/bit.260410305; Handke P, 2011, METAB ENG, V13, P28, DOI 10.1016/j.ymben.2010.10.007; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Huffer S, 2012, TRENDS BIOTECHNOL, V30, P538, DOI 10.1016/j.tibtech.2012.07.002; JENSEN EB, 1990, BIOTECHNOL BIOENG, V36, P1, DOI 10.1002/bit.260360102; KO YF, 1995, APPL BIOCHEM BIOTECH, V50, P145, DOI 10.1007/BF02783451; Kruse A, 2003, IND ENG CHEM RES, V42, P267, DOI 10.1021/ie0202773; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lara AR, 2008, BIOTECHNOL BIOENG, V99, P893, DOI 10.1002/bit.21664; Liu TG, 2010, ANNU REV GENET, V44, P53, DOI 10.1146/annurev-genet-102209-163440; Ma XY, 2006, PROTEIN EXPRES PURIF, V47, P36, DOI 10.1016/j.pep.2005.09.012; Mordukhova EA, 2013, APPL ENVIRON MICROB, V79, P7905, DOI 10.1128/AEM.01952-13; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; Nakano K, 1997, APPL MICROBIOL BIOT, V48, P597, DOI 10.1007/s002530051101; Roe AJ, 1998, J BACTERIOL, V180, P767, DOI 10.1128/JB.180.4.767-772.1998; Roe AJ, 2002, MICROBIOL-SGM, V148, P2215, DOI 10.1099/00221287-148-7-2215; RUSSELL JB, 1991, APPL ENVIRON MICROB, V57, P3383, DOI 10.1128/AEM.57.11.3383-3384.1991; RUSSELL JB, 1991, APPL ENVIRON MICROB, V57, P255, DOI 10.1128/AEM.57.1.255-259.1991; RUSSELL JB, 1992, J APPL BACTERIOL, V73, P363, DOI 10.1111/j.1365-2672.1992.tb04990.x; Sandoval NR, 2011, METAB ENG, V13, P214, DOI 10.1016/j.ymben.2010.12.001; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; SLONCZEWSKI JL, 1982, J BACTERIOL, V152, P384; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Wang HW, 2012, ANAL BIOCHEM, V421, P324, DOI 10.1016/j.ab.2011.10.043; Wang HW, 2011, J MICROBIOL METH, V84, P140, DOI 10.1016/j.mimet.2010.11.005; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Wang HW, 2009, APPL MICROBIOL BIOT, V82, P249, DOI 10.1007/s00253-008-1756-z; Warnecke T, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-25; Wong MS, 2008, METAB ENG, V10, P97, DOI 10.1016/j.ymben.2007.10.003; Ziegler K, 2007, BIOCHEMISTRY-US, V46, P2674, DOI 10.1021/bi0620252	42	9	11	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112777	10.1371/journal.pone.0112777	http://dx.doi.org/10.1371/journal.pone.0112777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402470	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700070
J	Popescu, VD; Rozylowicz, L; Niculae, IM; Cucu, AL; Hartel, T				Popescu, Viorel D.; Rozylowicz, Laurentiu; Niculae, Iulian M.; Cucu, Adina L.; Hartel, Tibor			Species, Habitats, Society: An Evaluation of Research Supporting EU's Natura 2000 Network	PLOS ONE			English	Article							ECOSYSTEM SERVICES; PROTECTED AREAS; CONSERVATION POLICY; BIODIVERSITY CONSERVATION; LANDSCAPE; SCIENCE; RESPONSIBILITIES; IMPLEMENTATION; MANAGEMENT; ECOLOGY	The Natura 2000 network is regarded as one of the conservation success stories in the global effort to protect biodiversity. However, significant challenges remain in Natura 2000 implementation, owing to its rapid expansion, and lack of a coherent vision for its future. Scientific research is critical for identifying conservation priorities, setting management goals, and reconciling biodiversity protection and society in the complex political European landscape. Thus, there is an urgent need for a comprehensive evaluation of published Natura 2000 research to highlight prevalent research themes, disciplinary approaches, and spatial entities. We conducted a systematic review of 572 scientific articles and conference proceedings focused on Natura 2000 research, published between 1996 and 2014. We grouped these articles into 'ecological' and 'social and policy' categories. Using a novel application of network analysis of article keywords, we found that Natura 2000 research forms a cohesive small-world network, owing to the emphasis on ecological research (79% of studies, with a strong focus on spatial conservation planning), and the underrepresentation of studies addressing 'social and policy' issues (typically focused on environmental impact assessment, multi-level governance, agri-environment policy, and ecosystem services valuation). 'Ecological' and 'social and policy' research shared only general concepts (e. g., Natura 2000, Habitats Directive) suggesting a disconnection between these disciplines. The UK and the Mediterranean basin countries dominated Natura 2000 research, and there was a weak correlation between number of studies and proportion of national territory protected. Approximately 40% of 'social and policy' research and 26% of 'ecological' studies highlighted negative implications of Natura 2000, while 21% of studies found positive social and biodiversity effects. We emphasize the need for designing inter- and transdisciplinary research in order to promote a social-ecological understanding of Natura 2000, and advance EU conservation policies.	[Popescu, Viorel D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Popescu, Viorel D.; Rozylowicz, Laurentiu; Niculae, Iulian M.; Cucu, Adina L.] Univ Bucharest, Ctr Environm Res CCMESI, Bucharest, Romania; [Hartel, Tibor] Sapientia Hungarian Univ Transylvania, Dept Environm Studies, Cluj Napoca, Romania	Simon Fraser University; University of Bucharest; Sapientia Hungarian University of Transylvania	Popescu, VD (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	vioreldpopescu@gmail.com	Niculae, Mihaita Iulian/I-6591-2016; Tibor, Hartel/B-3440-2012; Popescu, Viorel/O-3792-2014; Popescu, Viorel/AAP-4699-2021; Rozylowicz, Laurentiu/B-4540-2009	Rozylowicz, Laurentiu/0000-0001-7174-032X; Niculae, Mihaita Iulian/0000-0001-7340-6835	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PN-II-RU-TE-2011-3-0183]; David H Smith Fellowship in Conservation Research; Alexander von Humboldt Fellowship	Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); David H Smith Fellowship in Conservation Research; Alexander von Humboldt Fellowship(Alexander von Humboldt Foundation)	LR was supported by a grant of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro), project number PN-II-RU-TE-2011-3-0183. VDP was supported by a David H Smith Fellowship in Conservation Research (smithfellows.org). TH was supported by an Alexander von Humboldt Fellowship (http://www.humboldt-foundation.de/web/humboldt-fellowship-postdoc.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ, 2014, ECOL ECON, V103, P29, DOI 10.1016/j.ecolecon.2014.04.012; Agrawal A, 2006, CONSERV BIOL, V20, P681, DOI 10.1111/j.1523-1739.2006.00468.x; Apostolopoulou E, 2012, J ENVIRON MANAGE, V113, P308, DOI 10.1016/j.jenvman.2012.09.006; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bertzky M, 2010, IMPACTS CLIMATE CHAN; Beunen R, 2013, LAND USE POLICY, V31, P280, DOI 10.1016/j.landusepol.2012.07.009; Bryan S, 2012, J RURAL STUD, V28, P80, DOI 10.1016/j.jrurstud.2011.09.002; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Choi J, 2011, INFORM MANAGE-AMSTER, V48, P371, DOI 10.1016/j.im.2011.09.004; Cogalniceanu D, 2010, BIODIVERS CONSERV, V19, P1471, DOI 10.1007/s10531-010-9777-1; Cowx IG, 2009, AQUAT CONSERV, V19, P96, DOI 10.1002/aqc.968; Cvitanovic C, 2013, J ENVIRON MANAGE, V114, P84, DOI 10.1016/j.jenvman.2012.10.051; de Snoo GR, 2013, CONSERV LETT, V6, P66, DOI 10.1111/j.1755-263X.2012.00296.x; Dragos CM, 2013, SCI TOTAL ENVIRON, V449, P184, DOI 10.1016/j.scitotenv.2013.01.057; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; European Commission, 2013, NAT 2000 NAT BIOD NE, P8; Evans D, 2012, NATURE CONSERVATION, V1, P11, DOI DOI 10.3897/NATURECONSERVATION.1.1808; Ferranti F, 2010, J ENVIRON POL PLAN, V12, P293, DOI 10.1080/1523908X.2010.505417; Fischer J, 2014, BASIC APPL ECOL, V15, P187, DOI 10.1016/j.baae.2013.12.002; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Fox HE, 2006, CONSERV BIOL, V20, P1817, DOI 10.1111/j.1523-1739.2006.00598.x; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Gruber B, 2012, NAT CONSERV-BULGARIA, P45, DOI 10.3897/natureconservation.3.3732; Halada L, 2011, BIODIVERS CONSERV, V20, P2365, DOI 10.1007/s10531-011-9989-z; Hartel T, 2014, ECOL SOC, V19, DOI 10.5751/ES-06333-190242; Hartel T, 2013, BIOL CONSERV, V166, P267, DOI 10.1016/j.biocon.2013.06.020; Hochkirch A, 2013, CONSERV LETT, V6, P462, DOI 10.1111/conl.12006; Holmes J, 2008, ENVIRON SCI POLICY, V11, P702, DOI 10.1016/j.envsci.2008.08.004; Hooghe L, 2003, AM POLIT SCI REV, V97, P233; Ioja C, 2011, AGRICULTURAL AND ENVIRONMENTAL INFORMATICS, GOVERNANCE AND MANAGEMENT: EMERGING RESEARCH APPLICATIONS, P339, DOI 10.4018/978-1-60960-621-3.ch018; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; Kutnar L, 2011, SUMAR LIST, V135, P215; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Louette G, 2011, J NAT CONSERV, V19, P224, DOI 10.1016/j.jnc.2011.02.001; Mascia MB, 2003, CONSERV BIOL, V17, P649, DOI 10.1046/j.1523-1739.2003.01738.x; Mikulcak F, 2013, ENVIRON CONSERV, V40, P129, DOI 10.1017/S0376892912000392; Molnar Z, 2014, RANGELAND ECOL MANAG, V67, P107, DOI 10.2111/REM-D-13-00082.1; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Nieto-Romero M, 2014, ENVIRON SCI POLICY, V37, P121, DOI 10.1016/j.envsci.2013.09.003; Opermanis O, 2014, ENVIRON MANAGE, V53, P702, DOI 10.1007/s00267-013-0212-8; Oteros Rozas E, 2013, ECOLOGY SOC, V18; Palomo I, 2014, BIOSCIENCE, V64, P181, DOI 10.1093/biosci/bit033; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Pooley SP, 2014, CONSERV BIOL, V28, P22, DOI 10.1111/cobi.12183; Primack R. B., 2014, ESSENTIALS CONSERVAT, V6th; Primack RB, 2009, BIOL CONSERV, V142, P1559, DOI 10.1016/j.biocon.2009.04.027; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Pullin AS, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-21; Pullin AS, 2009, CONSERV BIOL, V23, P818, DOI 10.1111/j.1523-1739.2009.01283.x; Rae H, 2013, NATURAL ENGLAND REPO; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Rubio-Salcedo M, 2013, J NAT CONSERV, V21, P1, DOI 10.1016/j.jnc.2012.06.001; Ryder TB, 2008, P ROY SOC B-BIOL SCI, V275, P1367, DOI 10.1098/rspb.2008.0205; Sandbrook C, 2013, CONSERV BIOL, V27, P1487, DOI 10.1111/cobi.12141; Schmeller D, 2008, BIODIVERS CONSERV, V17, P3607, DOI 10.1007/s10531-008-9439-8; Schmeller DS, 2008, CONSERV BIOL, V22, P593, DOI 10.1111/j.1523-1739.2008.00961.x; Sherren K, 2010, LANDSCAPE ECOL, V25, P1219, DOI 10.1007/s10980-010-9494-x; Smith M., 2010, NODEXL FREE OPEN NET; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Sumares D, 2011, J INTEGR ENVIRON SCI, V8, P53, DOI 10.1080/1943815X.2011.556649; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Young JC, 2013, CONSERV LETT, V6, P333, DOI 10.1111/conl.12012; Young JC, 2013, BIOL CONSERV, V158, P359, DOI 10.1016/j.biocon.2012.08.018; Zografou K, 2009, J INSECT CONSERV, V13, P505, DOI 10.1007/s10841-008-9198-6	68	70	74	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113648	10.1371/journal.pone.0113648	http://dx.doi.org/10.1371/journal.pone.0113648			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415188	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600068
J	Asher, AJ; Holt, DC; Andrews, RM; Power, ML				Asher, Amy J.; Holt, Deborah C.; Andrews, Ross M.; Power, Michelle L.			Distribution of Giardia duodenalis Assemblages A and B among Children Living in a Remote Indigenous Community of the Northern Territory, Australia	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; MOLECULAR EPIDEMIOLOGY; ABORIGINAL COMMUNITIES; HUMAN FECES; IDENTIFICATION; PREVALENCE; GENOTYPES; HOOKWORM; SPACER; GENE	Giardiasis is a communicable gastrointestinal disease caused by Giardia duodenalis and two genetic assemblages, A and B, cause human infection. In remote Indigenous communities of Australia, giardiasis is highly prevalent among children but disease transmission is poorly understood. This study investigated the prevalence of Giardia and genetic subtypes contributing to human disease in a remote Indigenous community, in the Northern Territory of Australia. Eighty-seven faecal samples were collected from 74 children (<15 years) over an 18 month period, and the distribution of positive cases relative to participant age and gender were examined. Screening by microscopy and 18S rRNA PCR amplification showed 66.7% (58/87) of faecal samples were positive for Giardia. Both males and females were equally affected and high detection rates were obtained for participants aged 0-<5 years and 5-<10 years (66.0 and 60.0% respectively). For 58.6% of the positive samples, Giardia was only detected by 18S rRNA PCR. Approximately 75% of cases were assemblage B, and subassemblage analyses using terminal restriction fragment length polymorphism of the glutamate dehydrogenase gene demonstrated that a variety of genetic variants were present. The high proportion of positive cases that were not detectable by microscopy, and dominance of assemblage B cases highlights the need for further research in this community, to assess the contribution of Giardia to chronic gastrointestinal disease among children, and to understand conditions conductive to assemblage B transmission.	[Asher, Amy J.; Power, Michelle L.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Holt, Deborah C.; Andrews, Ross M.] Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, NT, Australia	Macquarie University; Charles Darwin University; Menzies School of Health Research	Asher, AJ (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	amy.asher@mq.edu.au		Holt, Deborah/0000-0003-4951-1891; Power, Michelle/0000-0003-3160-4301	Macquarie University Research Excellence Scholarship; Department of Biological Sciences, Macquarie University; Australian National Health and Medical Research Council [605804]	Macquarie University Research Excellence Scholarship; Department of Biological Sciences, Macquarie University(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a Macquarie University Research Excellence Scholarship, provided by the Department of Biological Sciences, Macquarie University, and was received by AA (http://bio.mq.edu.au/). The collection of the faecal samples was supported by the Australian National Health and Medical Research Council project grant 605804, and was received by RA, DH (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asher AJ, 2012, PARASITOLOGY, V139, P1005, DOI 10.1017/S0031182012000388; Asher AJ, 2012, PARASITOL RES, V110, P853, DOI 10.1007/s00436-011-2565-3; Australian Institute of Health and Welfare, 2021, AUSTR BURD DIS STUD; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Ghosh S, 2000, MOL CELL PROBE, V14, P181, DOI 10.1006/mcpr.2000.0302; Holt DC, 2010, INT J PARASITOL, V40, P1119, DOI 10.1016/j.ijpara.2010.04.002; Hopkins RM, 1999, PARASITOLOGY, V118, P531, DOI 10.1017/S003118209900428X; Hopkins RM, 1997, J PARASITOL, V83, P44, DOI 10.2307/3284315; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; JONES HI, 1980, MED J AUSTRALIA, V2, P375, DOI 10.5694/j.1326-5377.1980.tb131877.x; Kearns T, 2009, TROP MED INT HEALTH, V14, P196; McDonald E, 2010, J PAEDIATR CHILD H, V46, P491, DOI 10.1111/j.1440-1754.2010.01846.x; McDonald E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-153; MELONI BP, 1993, MED J AUSTRALIA, V158, P157, DOI 10.5694/j.1326-5377.1993.tb121692.x; Nesselquist EL, 2010, INT J PARASITOL, V40, P1063, DOI DOI 10.1016/J.IJPARA.2010.02.015; Read C, 2002, INT J PARASITOL, V32, P229, DOI 10.1016/S0020-7519(01)00340-X; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Reynoldson JA, 1998, ACTA TROP, V71, P27, DOI 10.1016/S0001-706X(98)00048-5; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7; Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5; Thompson RCA, 2001, LANCET, V357, P770, DOI 10.1016/S0140-6736(00)04162-3; Thompson RCA, 2008, ANN NESTLE, V66, P23, DOI DOI 10.1159/000151270; Traub RJ, 2005, INT J PARASITOL, V35, P1295, DOI 10.1016/j.ijpara.2005.06.008; Waldron LS, 2009, APPL ENVIRON MICROB, V75, P108, DOI 10.1128/AEM.01341-08; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Yang RC, 2010, INT J PARASITOL, V40, P293, DOI 10.1016/j.ijpara.2009.08.003	31	9	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112058	10.1371/journal.pone.0112058	http://dx.doi.org/10.1371/journal.pone.0112058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412502	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000009
J	Leung, KK; Wong, HTH; Naftalin, CM; Lee, SS				Leung, Ka-Kit; Wong, Horas T. H.; Naftalin, Claire M.; Lee, Shui Shan			A New Perspective on Sexual Mixing among Men Who Have Sex with Men by Body Image	PLOS ONE			English	Article							GAY MALE ATTRACTION; PHYSICAL ATTRACTIVENESS; RISK BEHAVIORS; MASCULINITY; NETWORK	Background: "Casual sex'' is seldom as non-selective and random as it may sound. During each sexual encounter, people consciously and unconsciously seek their casual sex partners according to different attributes. Influential to a sexual network, research focusing on quantifying the effects of physical appearance on sexual network has been sparse. Methods: We evaluated the application of Log odds score (LOD) to assess the mixing patterns of 326 men who have sex with men (MSM) in Hong Kong in their networking of casual sex partners by Body Image Type (BIT). This involved an analysis of 1,196 respondents-casual sex partner pairs. Seven BITs were used in the study: Bear, Chubby, Slender, Lean toned, Muscular, Average and Other. Results: A hierarchical pattern was observed in the preference of MSM for casual sex partners by the latter's BIT. Overall, Muscular men were most preferred, followed by Lean toned while the least preferred was Slender, as illustrated by LOD going down along the hierarchy in the same direction. Marked avoidance was found between men who self-identified as Chubby and men of Other body type (within-group-LOD: 1.25-2.89; between-group-LOD: <-1). None of the respondents reported to have networked a man who self-identified as Average for casual sex. Conclusions: We have demonstrated the possibility of adopting a mathematical prototype to investigate the influence of BIT in a sexual network of MSM. Construction of matrix based on culture-specific BIT and cross-cultural comparisons would generate new knowledge on the mixing behaviors of MSM.	[Leung, Ka-Kit; Wong, Horas T. H.; Naftalin, Claire M.; Lee, Shui Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Lee, SS (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; Wong, Horas/AAP-5311-2020	Lee, Shui Shan/0000-0003-1448-765X; 	AIDS Trust Fund of Hong Kong Special Administrative Region Government [MSS-172R]	AIDS Trust Fund of Hong Kong Special Administrative Region Government	The study was supported by the AIDS Trust Fund of Hong Kong Special Administrative Region Government (Grant code MSS-172R). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackard DM, 2000, INT J EAT DISORDER, V28, P422, DOI 10.1002/1098-108X(200012)28:4<422::AID-EAT10>3.3.CO;2-T; Brown SP, 2013, GEOPHYSICS, V78, pV157, DOI 10.1190/GEO2012-0209.1; Connell R., 2005, MASCULINITIES; Connell RW, 2007, VERY STRAIGHT GAY MA; DEENEN AA, 1994, ARCH SEX BEHAV, V23, P421, DOI 10.1007/BF01541407; Halkitis Perry N., 2001, J MENS STUDIES, V9.3, P413, DOI DOI 10.3149/JMS.0903.413; Hartmann H, 2013, GENOME RES, V23, P181, DOI 10.1101/gr.139881.112; Hsieh MH, 2011, PSYCHOL MARKET, V28, P388, DOI 10.1002/mar.20394; Kong Travis., 2012, CHINESE MALE HOMOSEX; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Lanzieri N, 2011, J HOMOSEXUAL, V58, P275, DOI 10.1080/00918369.2011.540184; Lee SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031072; LEIGH BC, 1989, J SEX RES, V26, P199, DOI 10.1080/00224498909551506; Lorenzo GL, 2010, PSYCHOL SCI, V21, P1777, DOI 10.1177/0956797610388048; Manley E, 2007, J HOMOSEXUAL, V53, P89, DOI 10.1080/00918360802103365; MILLER HL, 1970, PSYCHOL REP, V27, P701, DOI 10.2466/pr0.1970.27.3.701; MILLER LC, 1983, J PERS SOC PSYCHOL, V44, P1234, DOI 10.1037/0022-3514.44.6.1234; Monaghan L. F., 2005, BODY SOC, V11, P81, DOI [DOI 10.1177/1357034X05052463, 10.1177/1357034X05052463]; Moskowitz DA, 2013, ARCH SEX BEHAV, V42, P775, DOI 10.1007/s10508-013-0095-z; Niekamp AM, 2013, SOC NETWORKS, V35, P223, DOI 10.1016/j.socnet.2013.02.006; Peacock B., 2001, CULTURE HLTH SEXUALI, V3, P183, DOI DOI 10.1080/136910501750153003; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Ruan YH, 2011, AIDS CARE, V23, P1014, DOI 10.1080/09540121.2010.542127; Sanchez FJ, 2009, PSYCHOL MEN MASCULIN, V10, P73, DOI 10.1037/a0013513; Thomas LynC., 2009, CONSUMER CREDIT MODE; Tiggemann M., 2007, PSYCHOL MEN MASCULIN, V8, P15, DOI [10.1037/1524-9220.8.1.15, DOI 10.1037/1524-9220.8.1.15]; van der Meij L, 2010, HORM BEHAV, V58, P501, DOI 10.1016/j.yhbeh.2010.04.009; Varangis E, 2012, BODY IMAGE, V9, P270, DOI 10.1016/j.bodyim.2012.01.003; Wiederman MW, 2008, BODY SIZE PHYS ATTRA; Willoughby BLB, 2008, PSYCHOL MEN MASCULIN, V9, P235, DOI 10.1037/1524-9220.9.4.235; Yang CFJ, 2005, AM J PSYCHIAT, V162, P263, DOI 10.1176/appi.ajp.162.2.263; Yelland Christine, 2003, Eat Behav, V4, P107; Yera ER, 2011, J MED CHEM, V54, P6771, DOI 10.1021/jm200666a	33	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113791	10.1371/journal.pone.0113791	http://dx.doi.org/10.1371/journal.pone.0113791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25412266	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000078
J	Lovato, N; Lack, L; Wright, H				Lovato, Nicole; Lack, Leon; Wright, Helen			The Napping Behaviour of Australian University Students	PLOS ONE			English	Article							COLLEGE-STUDENTS; DAYTIME SLEEPINESS; PUBLIC UNIVERSITY; NAP; PERFORMANCE; PATTERNS	The purpose of this study was to evaluate the self-reported sleep and napping behaviour of Australian university students and the relationship between napping and daytime functioning. A sample of 280 university first-year psychology students (median age =19.00 years) completed a 6-item napping behaviour questionnaire, a 12-item Daytime Feelings and Functioning Scale, the Pittsburg Sleep Quality Index and the Epworth Sleepiness Scale. Results indicated that 53.6% of students reported napping with 34% napping at least 1-2 times per week, and 17% napping three or more occasions per week. Long naps, those over 30 minutes, were taken by 77% of the napping students. Sixty-one percent of students reported they took long naps during the post-lunch dip period, from 2-4pm. Students who nap at least once per week reported significantly more problems organizing their thoughts, gaining motivation, concentrating, and finishing tasks than students who did not nap. Students who napped also felt significantly more sleepy and depressed when compared to students who did not nap. The results also indicated that nap frequency increased with daytime sleepiness. The majority of students (51%) reported sleeping 6-7 hours per night or less. Overall, the results from this study suggest that among this population of Australian first-year university students habitual napping is common and may be used in an attempt to compensate for the detrimental effects of excessive sleepiness.	[Lovato, Nicole; Lack, Leon; Wright, Helen] Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia	Flinders University South Australia	Lovato, N (corresponding author), Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia.	nicole.lovato@flinders.edu.au	Lovato, Nicole/U-5681-2019	Lovato, Nicole/0000-0001-8990-6658				Bahammam Ahmed S, 2005, Neurosciences (Riyadh), V10, P159; Brooks A, 2006, SLEEP, V29, P831, DOI 10.1093/sleep/29.6.831; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Debarnot U, 2011, COGN AFFECT BEHAV NE, V11, P541, DOI 10.3758/s13415-011-0052-z; Forquer LM, 2008, J AM COLL HEALTH, V56, P563, DOI 10.3200/JACH.56.5.563-565; Fukunishi I, 1997, PSYCHIAT CLIN NEUROS, V51, P1, DOI 10.1111/j.1440-1819.1997.tb02357.x; Gradisar M, 2006, SLEEP, V29, pA339; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kerkhof GA, 2010, PROG BRAIN RES, V185, P155, DOI 10.1016/B978-0-444-53702-7.00009-9; King DL, 2014, INT J MENT HEALTH AD, V12, P21, DOI 10.1007/s11469-013-9461-2; Kubiszewski V, 2014, INT J ADOLESC YOUTH, V19, P395, DOI 10.1080/02673843.2012.751039; LACK L C, 1986, Journal of American College Health, V35, P105; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Melamed S, 2002, SLEEP, V25, P315, DOI 10.1093/sleep/25.3.315; Oginska H, 2006, CHRONOBIOL INT, V23, P1317, DOI 10.1080/07420520601089349; Orzech KM, 2011, J AM COLL HEALTH, V59, P612, DOI 10.1080/07448481.2010.520051; Takahashi M, 2000, SLEEP, V23, P813; Tietzel AJ, 2003, SLEEP, V26, pA431; Tsai LL, 2004, J PSYCHOSOM RES, V56, P231, DOI 10.1016/S0022-3999(03)00507-5; Tucker MA, 2008, SLEEP, V31, P197, DOI 10.1093/sleep/31.2.197	21	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113666	10.1371/journal.pone.0113666	http://dx.doi.org/10.1371/journal.pone.0113666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9ND	25412257	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000069
J	Turner, J; Quek, LE; Titmarsh, D; Kromer, JO; Kao, LP; Nielsen, L; Wolvetang, E; Cooper-White, J				Turner, Jennifer; Quek, Lake-Ee; Titmarsh, Drew; Kroemer, Jens O.; Kao, Li-Pin; Nielsen, Lars; Wolvetang, Ernst; Cooper-White, Justin			Metabolic Profiling and Flux Analysis of MEL-2 Human Embryonic Stem Cells during Exponential Growth at Physiological and Atmospheric Oxygen Concentrations	PLOS ONE			English	Article							PROLIFERATION; CANCER; DIFFERENTIATION; EXPANSION; GLUCOSE; LINES; PCR; PLURIPOTENCY; PROPAGATION; OXIDATION	As human embryonic stem cells (hESCs) steadily progress towards regenerative medicine applications there is an increasing emphasis on the development of bioreactor platforms that enable expansion of these cells to clinically relevant numbers. Surprisingly little is known about the metabolic requirements of hESCs, precluding the rational design and optimisation of such platforms. In this study, we undertook an in-depth characterisation of MEL-2 hESC metabolic behaviour during the exponential growth phase, combining metabolic profiling and flux analysis tools at physiological (hypoxic) and atmospheric (normoxic) oxygen concentrations. To overcome variability in growth profiles and the problem of closing mass balances in a complex environment, we developed protocols to accurately measure uptake and production rates of metabolites, cell density, growth rate and biomass composition, and designed a metabolic flux analysis model for estimating internal rates. hESCs are commonly considered to be highly glycolytic with inactive or immature mitochondria, however, whilst the results of this study confirmed that glycolysis is indeed highly active, we show that at least in MEL-2 hESC, it is supported by the use of oxidative phosphorylation within the mitochondria utilising carbon sources, such as glutamine to maximise ATP production. Under both conditions, glycolysis was disconnected from the mitochondria with all of the glucose being converted to lactate. No difference in the growth rates of cells cultured under physiological or atmospheric oxygen concentrations was observed nor did this cause differences in fluxes through the majority of the internal metabolic pathways associated with biogenesis. These results suggest that hESCs display the conventional Warburg effect, with high aerobic activity despite high lactate production, challenging the idea of an anaerobic metabolism with low mitochondrial activity. The results of this study provide new insight that can be used in rational bioreactor design and in the development of novel culture media for hESC maintenance and expansion.	[Turner, Jennifer; Titmarsh, Drew; Cooper-White, Justin] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, St Lucia, Qld, Australia; [Turner, Jennifer; Titmarsh, Drew; Kao, Li-Pin; Wolvetang, Ernst] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Stem Cell Engn Grp, St Lucia, Qld, Australia; [Quek, Lake-Ee; Kroemer, Jens O.; Nielsen, Lars] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Ctr Syst & Synthet Biotechnol, St Lucia, Qld, Australia; [Kroemer, Jens O.; Nielsen, Lars] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Metabol Australia, St Lucia, Qld, Australia; [Cooper-White, Justin] Univ Queensland, Sch Chem Engn, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland	Wolvetang, E (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Stem Cell Engn Grp, St Lucia, Qld, Australia.	e.wolvetang@uq.edu.au; j.cooperwhite@uq.edu.au	Titmarsh, Drew M/F-9546-2011; kao, Betty/M-5480-2017; Nielsen, Lars K/A-5519-2011; Wolvetang, Ernst jurgen/D-6644-2017; Krömer, Jens O./C-5958-2009	Titmarsh, Drew M/0000-0001-8379-6136; Nielsen, Lars K/0000-0001-8191-3511; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Krömer, Jens O./0000-0001-5006-0819; Cooper-White, Justin/0000-0002-1920-8229	Australian Research Council Special Research Initiative Stem Cells Australia [SR110001002]; Australian Stem Cell Centre's Core hESC Laboratories (Stem Core)	Australian Research Council Special Research Initiative Stem Cells Australia(Australian Research Council); Australian Stem Cell Centre's Core hESC Laboratories (Stem Core)	The authors would like to acknowledge the financial support of the Australian Research Council Special Research Initiative Stem Cells Australia (SR110001002), and the support of the Australian Stem Cell Centre's Core hESC Laboratories (Stem Core) for providing cell culture and support services. The authors would also like to acknowledge the Queensland Brain Institute Flow Cytometry Facility for assistance sorting cells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; ARGILES JM, 1990, MED HYPOTHESES, V32, P151, DOI 10.1016/0306-9877(90)90039-H; Bonarius HPJ, 1996, BIOTECHNOL BIOENG, V50, P299, DOI 10.1002/(SICI)1097-0290(19960505)50:3<299::AID-BIT9>3.0.CO;2-B; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen X, 2010, STEM CELLS DEV, V19; Costa M, 2008, STEM CELL BIOL, V1; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Fernandes TG, 2010, BIOTECHNOL LETT, V32, P171, DOI 10.1007/s10529-009-0108-0; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Fong WJ, 2005, BIOPROC BIOSYST ENG, V27, P381, DOI 10.1007/s00449-005-0421-5; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hernandez D, 2011, STEM CELLS DEV, V20, P1089, DOI 10.1089/scd.2009.0507; Instruments WP, 2003, OXYMICRO US MAN FIBR; Jezek P, 2010, INT J BIOCHEM CELL B, V42, P604, DOI 10.1016/j.biocel.2009.11.008; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Kromer JO, 2005, ANAL BIOCHEM, V340, P171, DOI 10.1016/j.ab.2005.01.027; Kurosawa H, 2006, J BIOSCI BIOENG, V101, P26, DOI 10.1263/jbb.101.26; Li B, 2012, BBA-BIOENERGETICS, V1817, P1628, DOI 10.1016/j.bbabio.2012.05.011; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Miller L., 2010, ANAL GELS W BLOTS IM; Oh SKW, 2006, CLIN EXP PHARMACOL P, V33, P489, DOI 10.1111/j.1440-1681.2006.04397.x; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Perry RH, 1999, PERRYS CHEM ENG HDB; Prasad SM, 2009, CELL PROLIFERAT, V42, P63, DOI 10.1111/j.1365-2184.2008.00571.x; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; Quek LE, 2008, GENOME INFORM SER, V21, P89; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang FN, 2006, CLONING STEM CELLS, V8, P108, DOI 10.1089/clo.2006.8.108; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Zeng AP, 1998, BIOTECHNOL PROGR, V14, P434, DOI 10.1021/bp9800337; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318	48	33	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112757	10.1371/journal.pone.0112757	http://dx.doi.org/10.1371/journal.pone.0112757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412279	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000015
J	Vargas-Asensio, G; Pinto-Tomas, A; Rivera, B; Hernandez, M; Hernandez, C; Soto-Montero, S; Murillo, C; Sherman, DH; Tamayo-Castillo, G				Vargas-Asensio, Gabriel; Pinto-Tomas, Adrian; Rivera, Beatriz; Hernandez, Myriam; Hernandez, Carlos; Soto-Montero, Silvia; Murillo, Catalina; Sherman, David H.; Tamayo-Castillo, Giselle			Uncovering the Cultivable Microbial Diversity of Costa Rican Beetles and Its Ability to Break Down Plant Cell Wall Components	PLOS ONE			English	Article							PACHNODA-EPHIPPIATA COLEOPTERA; HUMUS-FEEDING LARVA; SP NOV.; GUT; BACTERIA; HINDGUT; COMMUNITY; MIDGUT; LIGNIN; CATERPILLARS	Coleopterans are the most diverse insect order described to date. These organisms have acquired an array of survival mechanisms through their evolution, including highly efficient digestive systems. Therefore, the coleopteran intestinal microbiota constitutes an important source of novel plant cell wall-degrading enzymes with potential biotechnological applications. We isolated and described the cultivable fungi, actinomycetes and aerobic eubacteria associated with the gut of larvae and adults from six different beetle families colonizing decomposing logs in protected Costa Rican ecosystems. We obtained 611 isolates and performed phylogenetic analyses using the ITS region (fungi) and 16S rDNA (bacteria). The majority of fungal isolates belonged to the order Hypocreales (26% of 169 total), while the majority of actinomycetes belonged to the genus Streptomyces (86% of 241 total). Finally, we isolated 201 bacteria spanning 19 different families belonging into four phyla: Firmicutes, alpha, beta and gamma-proteobacteria. Subsequently, we focused on microbes isolated from Passalid beetles to test their ability to degrade plant cell wall polymers. Highest scores in these assays were achieved by a fungal isolate (Anthostomella sp.), two Streptomyces and one Bacillus bacterial isolates. Our study demonstrates that Costa Rican beetles harbor several types of cultivable microbes, some of which may be involved in symbiotic relationships that enable the insect to digest complex polymers such as lignocellulose.	[Vargas-Asensio, Gabriel; Pinto-Tomas, Adrian; Rivera, Beatriz; Hernandez, Myriam; Hernandez, Carlos; Soto-Montero, Silvia; Murillo, Catalina; Tamayo-Castillo, Giselle] Inst Nacl Biodiversidad INBio, Santo Domingo De Heredia, Costa Rica; [Vargas-Asensio, Gabriel; Pinto-Tomas, Adrian] Univ Costa Rica, Dept Bioquim, San Pedro, Costa Rica; [Pinto-Tomas, Adrian] Univ Costa Rica, Ctr Invest Estruct Microscop CIEMIC, San Pedro, Costa Rica; [Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Tamayo-Castillo, Giselle] Univ Costa Rica, Escuela Quim, San Pedro, Costa Rica; [Tamayo-Castillo, Giselle] Univ Costa Rica, Ctr Invest Prod Nat CIPRONA, San Pedro, Costa Rica	Universidad Costa Rica; Universidad Costa Rica; University of Michigan System; University of Michigan; Universidad Costa Rica; Universidad Costa Rica	Pinto-Tomas, A (corresponding author), Inst Nacl Biodiversidad INBio, Santo Domingo De Heredia, Costa Rica.	adrian.pinto@ucr.ac.cr; gtamayo@inbio.ac.cr	Tamayo, Giselle/J-3609-2015	Tamayo, Giselle/0000-0002-4912-8895	International Cooperative Biodiversity Groups Initiative at the Fogarty International Center [U01 TW007404]; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER	International Cooperative Biodiversity Groups Initiative at the Fogarty International Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the International Cooperative Biodiversity Groups Initiative (U01 TW007404, http://www.icbg.org) at the Fogarty International Center (to D.H.S. and G.T.C) and the Hans W. Vahlteich Professorship (D.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; [Anonymous], 2010, HDB MICROBIOLOGICAL, DOI DOI 10.1201/EBK1439804063; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Brune A., 2009, ENCY INSECTS, P978; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; Cazemier AE, 1997, COMP BIOCHEM PHYS A, V118, P101, DOI 10.1016/S0300-9629(96)00443-4; Collins PJ, 1997, APPL ENVIRON MICROB, V63, P2543, DOI 10.1128/AEM.63.7.2543-2548.1997; Crawford D, 1976, APPL ENVIRON MICROB, V35, P1041; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dunn AK, 2005, APPL ENVIRON MICROB, V71, P8784, DOI 10.1128/AEM.71.12.8784-8794.2005; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Freinkman E, 2009, TETRAHEDRON LETT, V50, P6834, DOI 10.1016/j.tetlet.2009.09.120; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Geib SM, 2009, MICROB ECOL, V58, P199, DOI 10.1007/s00248-009-9501-4; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; GRAY IE, 1946, AM MIDL NAT, V35, P728, DOI 10.2307/2421554; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kar S, 2008, J IND MICROBIOL BIOT, V35, P245, DOI 10.1007/s10295-007-0292-7; Kim H, 2012, INT J SYST EVOL MICR, V62, P2363, DOI 10.1099/ijs.0.034678-0; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Lemke T, 2003, APPL ENVIRON MICROB, V69, P6650, DOI 10.1128/AEM.69.11.6650-6658.2003; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Matsui T, 2012, J BASIC MICROB, V52, P731, DOI 10.1002/jobm.201100500; Morales-Jimenez J, 2009, MICROB ECOL, V58, P879, DOI 10.1007/s00248-009-9548-2; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Nardi JB, 2006, ARTHROPOD STRUCT DEV, V35, P57, DOI 10.1016/j.asd.2005.06.003; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Pinto-Tomas A, 2007, REV BIOL TROP, V55, P401; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; POMETTO AL, 1986, APPL ENVIRON MICROB, V52, P246, DOI 10.1128/AEM.52.2.246-250.1986; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rahman Z, 2009, BIOSCI BIOTECH BIOCH, V73, P1083, DOI 10.1271/bbb.80852; Reyes-Castillo P., 1984, Bulletin de la Societe Entomologique de France, V88, P619; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Schafer A, 1996, J APPL BACTERIOL, V80, P471, DOI 10.1111/j.1365-2672.1996.tb03245.x; Shi WB, 2010, INSECT SCI, V17, P199, DOI 10.1111/j.1744-7917.2010.01340.x; Solis A, 1999, ESCARABAJOS COSTA RI, P1; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Suh SO, 2005, MYCOL RES, V109, P261, DOI 10.1017/S0953756205002388; Sukharnikov LO, 2011, TRENDS BIOTECHNOL, V29, P473, DOI 10.1016/j.tibtech.2011.04.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thorne BL, 1997, ANNU REV ECOL SYST, V28, P27, DOI 10.1146/annurev.ecolsys.28.1.27; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Voglmayr H, 2011, FUNGAL BIOL-UK, V115, P1077, DOI 10.1016/j.funbio.2010.11.006; VYAS BRM, 1995, APPL ENVIRON MICROB, V61, P3919, DOI 10.1128/AEM.61.11.3919-3927.1995; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Whipps CM, 2007, INT J SYST EVOL MICR, V57, P2525, DOI 10.1099/ijs.0.64841-0; 姜怡, 2006, [微生物学通报, Microbiology], V33, P181	61	18	18	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113303	10.1371/journal.pone.0113303	http://dx.doi.org/10.1371/journal.pone.0113303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411842	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000038
J	Vitales, D; Garcia-Fernandez, A; Pellicer, J; Valles, J; Santos-Guerra, A; Cowan, RS; Fay, MF; Hidalgo, O; Garnatje, T				Vitales, Daniel; Garcia-Fernandez, Alfredo; Pellicer, Jaume; Valles, Joan; Santos-Guerra, Arnoldo; Cowan, Robyn S.; Fay, Michael F.; Hidalgo, Oriane; Garnatje, Teresa			Key Processes for Cheirolophus (Asteraceae) Diversification on Oceanic Islands Inferred from AFLP Data	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISMS; LONG-DISTANCE DISPERSAL; GENETIC-VARIATION; SEED DISPERSAL; ADAPTIVE RADIATION; CANARY-ISLANDS; MULTIPLE COLONIZATIONS; CARDUEAE-CENTAUREINAE; SPECIES DELIMITATION; MOLECULAR EVIDENCE	The radiation of the genus Cheirolophus (Asteraceae) in Macaronesia constitutes a spectacular case of rapid diversification on oceanic islands. Twenty species - nine of them included in the IUCN Red List of Threatened Species - have been described to date inhabiting the Madeiran and Canarian archipelagos. A previous phylogenetic study revealed that the diversification of Cheirolophus in Macaronesia started less than 2 Ma. As a result of such an explosive speciation process, limited phylogenetic resolution was reported, mainly due to the low variability of the employed molecular markers. In the present study, we used highly polymorphic AFLP markers to i) evaluate species' boundaries, ii) infer their evolutionary relationships and iii) investigate the patterns of genetic diversity in relation to the potential processes likely involved in the radiation of Cheirolophus. One hundred and seventy-two individuals representing all Macaronesian Cheirolophus species were analysed using 249 AFLP loci. Our results suggest that geographic isolation played an important role in this radiation process. This was likely driven by the combination of poor gene flow capacity and a good ability for sporadic long-distance colonisations. In addition, we also found some traces of introgression and incipient ecological adaptation, which could have further enhanced the extraordinary diversification of Cheirolophus in Macaronesia. Last, we hypothesize that current threat categories assigned to Macaronesian Cheirolophus species do not reflect their respective evolutionary relevance, so future evaluations of their conservation status should take into account the results presented here.	[Vitales, Daniel; Valles, Joan; Hidalgo, Oriane] Univ Barcelona, Fac Farm, Unitat Associada CSIC, Lab Bot, E-08028 Barcelona, Catalonia, Spain; [Garcia-Fernandez, Alfredo; Garnatje, Teresa] Inst Bot Barcelona IBB CSIC ICUB, Barcelona, Catalonia, Spain; [Garcia-Fernandez, Alfredo] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain; [Pellicer, Jaume; Cowan, Robyn S.; Fay, Michael F.; Hidalgo, Oriane] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Santos-Guerra, Arnoldo] ICIA, Unidad Bot, Puerto La Cruz, Canary Islands, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Botanic de Barcelona (ICUB); Universidad Rey Juan Carlos; Royal Botanic Gardens, Kew	Vitales, D (corresponding author), Univ Barcelona, Fac Farm, Unitat Associada CSIC, Lab Bot, E-08028 Barcelona, Catalonia, Spain.	dvitales@ub.edu	Pellicer, Jaume/L-3048-2015; Garcia, Alfredo/I-2772-2015; Fay, Michael/AAU-5861-2021; Vitales, Daniel/AAA-6563-2020; Pellicer, Jaume/AAA-3065-2022; Fay, Michael F/G-4741-2010; Hidalgo, Oriane/F-5985-2013; Garnatje, Teresa/L-3028-2014; García-Fernández, Alfredo/AAE-2520-2022; MARTINEZ, ANTONIO PELLICER/C-4832-2015	Pellicer, Jaume/0000-0001-7632-9775; Garcia, Alfredo/0000-0002-5185-559X; Pellicer, Jaume/0000-0001-7632-9775; Fay, Michael F/0000-0003-3491-9093; Hidalgo, Oriane/0000-0002-1547-8627; Garnatje, Teresa/0000-0001-6295-6217; García-Fernández, Alfredo/0000-0002-7672-9872; Vitales, Daniel/0000-0002-3109-5028	Spanish Ministry of Science [CGL2010-22234-C02-01, 02/BOS]; Generalitat de Catalunya [2009/SGR/00439]; Spanish Ministry of Education; Secretary for Universities and Research of the Ministry of Economy and Knowledge (Government of Catalonia); Marie Curie Actions (European Union 7th R&D Framework Programme); postdoctoral contract [CGL2010-22234-C02-01]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education(Spanish Government); Secretary for Universities and Research of the Ministry of Economy and Knowledge (Government of Catalonia); Marie Curie Actions (European Union 7th R&D Framework Programme); postdoctoral contract	This work was subsidized by the Spanish Ministry of Science (projects CGL2010-22234-C02-01 and 02/BOS) http://www.idi.mineco.gob.es/ and the Generalitat de Catalunya (Ajuts a grups de recerca consolidats, 2009/SGR/00439) http://www.gencat.cat/. DV benefited from a FPU grant from the Spanish Ministry of Education http://www.mecd.gob.es. JP benefited from a Beatriu de Pinos postdoctoral fellowship with the support of the Secretary for Universities and Research of the Ministry of Economy and Knowledge (Government of Catalonia) http://www.gencat.cat/ and the co-fund of Marie Curie Actions (European Union 7th R&D Framework Programme) http://ec.europa.eu/. AG-F benefited from a postdoctoral contract (Project CGL2010-22234-C02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; Ancochea E, 1999, J VOLCANOL GEOTH RES, V88, P177, DOI 10.1016/S0377-0273(98)00106-1; [Anonymous], 1997, TFPGA TOOLS POPULATI; Arponen A, 2012, BIODIVERS CONSERV, V21, P875, DOI 10.1007/s10531-012-0242-1; Bacon CD, 2011, TAXON, V60, P733, DOI 10.1002/tax.603009; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; BANARES A, 2010, ATLAS LIBRO ROJO FLO; Bellemain E, 2008, TRENDS ECOL EVOL, V23, P461, DOI 10.1016/j.tree.2008.05.001; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Bramwell D., 1976, Monographiae Biologicae, V30, P207; Bramwell D, 2001, WILD FLOWERS CANARY, V2nd; Bremer K., 1994, ASTERACEAE CLADISTIC; Bromham L, 2004, SYST BIOL, V53, P758, DOI 10.1080/10635150490522278; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bussell JD, 2005, PERSPECT PLANT ECOL, V7, P3, DOI 10.1016/j.ppees.2004.07.001; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; CARRACEDO JC, 1994, J VOLCANOL GEOTH RES, V60, P225, DOI 10.1016/0377-0273(94)90053-1; Caujape-Castells J., 2011, The biology of island floras, P284; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Coart E, 2005, CONSERV GENET, V6, P259, DOI 10.1007/s10592-004-7833-7; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Crawford D.J., 2011, BIOL ISLAND FLORAS, P11, DOI DOI 10.1017/CBO9780511844270.003; Crawford DJ, 2009, SYSTEMATICS EVOLUTIO, P139; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; Diaz-Perez A, 2008, SYST BIOL, V57, P732, DOI 10.1080/10635150802302450; Dostal J, 1976, FLORA EUROPAEA, P249; Doyle J., 1987, PHYTOCHEM B, V19, P1; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Ellis AG, 2006, EVOLUTION, V60, P39; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Palacios JM, 2008, J BIOGEOGR, V35, P379, DOI 10.1111/j.1365-2699.2008.01890.x; Fiz-Palacios O, 2010, ANN BOT-LONDON, V106, P871, DOI 10.1093/aob/mcq184; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Francisco-Ortega J, 2001, AM J BOT, V88, P161, DOI 10.2307/2657136; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Garcia-Maroto F, 2009, MOL PHYLOGENET EVOL, V52, P563, DOI 10.1016/j.ympev.2009.04.009; Garnatje T, 2007, PLANT SYST EVOL, V264, P117, DOI 10.1007/s00606-006-0489-7; Garnatje T, 2012, GENOME, V55, P529, DOI [10.1139/G2012-041, 10.1139/g2012-041]; Garnatje T, 1998, PLANT SYST EVOL, V213, P57, DOI 10.1007/BF00988908; Garnatje T, 2013, PLANT BIOLOGY, P1; Gaudeul M, 2012, AM J BOT, V99, P68, DOI 10.3732/ajb.1100321; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Grehan J, 2001, BIOL J LINN SOC, V74, P267, DOI 10.1006/bijl.2001.0576; Gruenstaeudl M, 2012, CLADISTICS, V1, P1; Guillou H, 2004, EARTH PLANET SC LETT, V222, P599, DOI 10.1016/j.epsl.2004.03.012; Guo YP, 2005, NEW PHYTOL, V166, P273, DOI 10.1111/j.1469-8137.2005.01315.x; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; HAMRICK JL, 1979, ANNU REV ECOL SYST, V10, P173, DOI 10.1146/annurev.es.10.110179.001133; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Heads M, 2010, J BIOGEOGR, V37, P1239, DOI 10.1111/j.1365-2699.2010.02292.x; Heleno R, 2011, INTEGR ZOOL, V6, P110, DOI 10.1111/j.1749-4877.2011.00236.x; Heleno RH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2112; Herrmann D, 2010, GENOME, V53, P302, DOI [10.1139/G10-006, 10.1139/g10-006]; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Humphries CJ, 1979, PLANTS ISLANDS, P171; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IUCN, 2012, IUCN RED LIST THREAT; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Jorgensen TH, 2001, PERSPECT PLANT ECOL, V4, P29, DOI 10.1078/1433-8319-00013; Jorgensen TH, 2002, BIOL J LINN SOC, V76, P521, DOI 10.1046/j.1095-8312.2002.00088.x; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; JUAN C, 1995, P ROY SOC B-BIOL SCI, V261, P173, DOI 10.1098/rspb.1995.0133; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kim SC, 2012, J PLANT RES, V125, P125, DOI 10.1007/s10265-011-0424-z; Kim SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002139; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Knope ML, 2012, J BIOGEOGR, V39, P1206, DOI 10.1111/j.1365-2699.2012.02687.x; Koopman WJM, 2001, AM J BOT, V88, P1881, DOI 10.2307/3558364; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; Ley AC, 2013, MOL ECOL, V22, P1984, DOI 10.1111/mec.12214; Linder HP, 2008, PHILOS T R SOC B, V363, P3097, DOI 10.1098/rstb.2008.0075; Lopez-Sepulveda P, 2013, TAXON, V62, P550, DOI 10.12705/623.14; Luo RY, 2007, STAT APPL GENET MOL, V6; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Meudt HM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-111; Guerrero AM, 2009, WILSON J ORNITHOL, V121, P752, DOI 10.1676/09-035.1; Montelongo Parada V, 1982, BOT MACARONESICA, V10, P67; Mort ME, 2010, TAXON, V59, P581, DOI 10.1002/tax.592022; Mzighani SI, 2010, GENE, V450, P39, DOI 10.1016/j.gene.2009.10.002; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nievergelt CM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030051; Nogales M, 1998, J ECOL, V86, P866, DOI 10.1046/j.1365-2745.1998.8650866.x; Nogales M, 2012, NEW PHYTOL, V194, P313, DOI 10.1111/j.1469-8137.2011.04051.x; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Oksanen J., 2008, VEGAN PACKAGE VERSIO; Padilla DP, 2012, J ECOL, V100, P416, DOI 10.1111/j.1365-2745.2011.01924.x; Papadopulos AST, 2013, J EVOLUTION BIOL, V26, P733, DOI 10.1111/jeb.12071; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Development Core Team, 2012, R LANG ENV STAT COMP; Rambaut A, 2013, TRACER VERSION 1 6; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Renner SS, 2010, J BIOGEOGR, V37, P1227, DOI 10.1111/j.1365-2699.2010.02319.x; Richardson JE, 2003, EVOLUTION, V57, P816; Richardson JE, 2001, TAXON, V50, P405, DOI 10.2307/1223889; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Silvertown J, 2005, J ECOL, V93, P653, DOI 10.1111/j.1365-2745.2005.01038.x; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Susanna A, 1999, PLANT SYST EVOL, V214, P147, DOI 10.1007/BF00985736; Sventenius ER, 1960, ANU ESTUD ATL, V6, P219; Trusty JL, 2005, MOL ECOL, V14, P1177, DOI 10.1111/j.1365-294X.2005.02487.x; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; VALIDO A, 1994, OIKOS, V70, P403, DOI 10.2307/3545778; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vitales D, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-118; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vriesendorp B, 2005, TAXON, V54, P593, DOI 10.2307/25065417; WARWICK SI, 1985, EVOLUTION, V39, P1236, DOI 10.1111/j.1558-5646.1985.tb05689.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x	140	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113207	10.1371/journal.pone.0113207	http://dx.doi.org/10.1371/journal.pone.0113207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412495	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000027
J	Wang, M; Cao, JX; Pan, JH; Liu, YS; Xu, BL; Li, D; Zhang, XY; Li, JL; Liu, JL; Wang, HB; Wang, ZX				Wang, Min; Cao, Jun-Xia; Pan, Jian-Hong; Liu, Yi-Shan; Xu, Bei-Lei; Li, Duo; Zhang, Xiao-Yan; Li, Jun-Li; Liu, Jin-Long; Wang, Hai-Bo; Wang, Zheng-Xu			Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CLINICAL-TRIALS; CHEMOTHERAPY; COMBINATION; EFFECTOR; CHINA	Aim: The aim of this study was to systemically evaluate the therapeutic efficacy of cytokine-induced killer (CIK) cells for the treatment of non-small cell lung cancer. Materials and Methods: A computerized search of randomized controlled trials for CIK cell-based therapy was performed. The overall survival, clinical response rate, immunological assessment and side effects were evaluated. Results: Overall, 17 randomized controlled trials of non-small cell lung cancer (NSCLC) with a total of 1172 patients were included in the present analysis. Our study showed that the CIK cell therapy significantly improved the objective response rate and overall survival compared to the non-CIK cell-treated group. After CIK combined therapy, we observed substantially increased percentages of CD3(+), CD4(+), CD4(+) CD8(+), CD3(+) CD56(+) and NK cells, whereas significant decreases were noted in the percentage of CD8(+) and regulatory T cell (Treg) subgroups. A significant increase in Ag-NORs was observed in the CIK-treated patient group (p = 0.00001), whereas carcinoembryonic antigen (CEA) was more likely to be reduced to a normal level after CIK treatment (p = 0.0008). Of the possible major side effects, only the incidence of fever in the CIK group was significantly higher compared to the group that received chemotherapy alone. Conclusion: The CIK cell combined therapy demonstrated significant superiority in the overall survival, clinical response rate, and T lymphocytes responses and did not present any evidence of major adverse events in patients with NSCLC.	[Wang, Min; Cao, Jun-Xia; Liu, Yi-Shan; Xu, Bei-Lei; Li, Duo; Zhang, Xiao-Yan; Li, Jun-Li; Liu, Jin-Long; Wang, Hai-Bo; Wang, Zheng-Xu] Gen Hosp Beijing Mil Command, Biotherapy Ctr, Beijing, Peoples R China; [Pan, Jian-Hong] Peking Univ, Hlth Sci Ctr, Clin Res Inst, Dept Biostat, Beijing 100871, Peoples R China	Seventh Medical Center of Chinese PLA General Hospital; Peking University	Wang, ZX (corresponding author), Gen Hosp Beijing Mil Command, Biotherapy Ctr, Beijing, Peoples R China.	zhxwang18@hotmail.com			National Natural Science Foundation of China [31171427, 30971651]; Beijing Municipal Science & Technology Project; Clinical characteristics and Application Research of Capital [Z121107001012136]; Postdoctoral Foundation of China [20060400775]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Project(Beijing Municipal Science & Technology Commission); Clinical characteristics and Application Research of Capital; Postdoctoral Foundation of China(China Postdoctoral Science Foundation)	This research work was supported by the National Natural Science Foundation of China (No. 31171427 and 30971651 to Zheng-Xu Wang), Beijing Municipal Science & Technology Project; Clinical characteristics and Application Research of Capital (No. Z121107001012136 to Zheng-Xu Wang) and the Postdoctoral Foundation of China (No. 20060400775 to Jun-Xia Cao). Zheng-Xu Wang designed the research; Jun-Xia Cao is one of the people who performed the research and wrote the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CHIN GER J CLIN ONCO, V11, P67, DOI DOI 10.1016/j.foodchem.2012.11.067; Arango BA, 2009, CLIN LUNG CANCER, V10, P91, DOI 10.3816/CLC.2009.n.011; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Chen WQ, 2013, CHINESE J CANCER RES, V25, P10, DOI 10.3978/j.issn.1000-9604.2012.12.04; Choi Donghoon, 2012, Immune Netw, V12, P139, DOI 10.4110/in.2012.12.4.139; Dongyun, 2011, CHIN J CANC PREV TRE, V18, P1032; Gallimore A, 2008, IMMUNOLOGY, V123, P157, DOI 10.1111/j.1365-2567.2007.02748.x; Hontscha C, 2011, J CANCER RES CLIN, V137, P305, DOI 10.1007/s00432-010-0887-7; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jakel CE, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/473245; Jiang JW, 2013, J CANCER RES CLIN, V139, P25, DOI 10.1007/s00432-012-1294-z; Li H, 2009, CYTOTHERAPY, V11, P1076, DOI 10.3109/14653240903121252; Li RM, 2012, CANCER IMMUNOL IMMUN, V61, P2125, DOI 10.1007/s00262-012-1260-2; Li XD, 2012, CLIN TRANSL ONCOL, V14, P102, DOI 10.1007/s12094-012-0768-4; Ma Y, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-11; Ma Y, 2012, CYTOTHERAPY, V14, P483, DOI 10.3109/14653249.2011.649185; McCoy MJ, 2013, CANCER IMMUNOL IMMUN, V62, P529, DOI 10.1007/s00262-012-1360-z; Mo C, 2005, CHINESE J CANC BIOTH, V17, P419, DOI [10.3872/j.issn.1007-385X.2010.04.011, DOI 10.3872/J.ISSN.1007-385X.2010.04.011]; Mucida D, 2010, ADV IMMUNOL, V107, P139, DOI [10.1016/S0065-2776(10)07007-0, 10.1016/B978-0-12-381300-8.00005-8]; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng DaWei, 2012, Chinese Journal of Immunology, V28, P648; Rutella S, 2012, CYTOTHERAPY, V14, P841, DOI 10.3109/14653249.2012.681038; Sangiolo D, 2011, J CANCER, V2, P363, DOI 10.7150/jca.2.363; Schmidt-Wolf IGH, 1999, BRIT J CANCER, V81, P1009, DOI 10.1038/sj.bjc.6690800; Sheng C. H., 2011, J PRACT ONCOL, V26, P503; Shepherd FA, 2011, J THORAC ONCOL, V6, P1763, DOI 10.1097/JTO.0b013e31822e28fc; Shi SB, 2012, TUMORI, V98, P314, DOI 10.1700/1125.12398; Wang YY, 2013, EXP THER MED, V5, P453, DOI 10.3892/etm.2012.818; Wang ZX, 2014, WORLD J GASTROENTERO, V20, P1095, DOI 10.3748/wjg.v20.i4.1095; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wu CP, 2008, ANTICANCER RES, V28, P3997; Xu Y, 2011, PRAC J CANC, V25, P163; Yang LL, 2013, CANCER IMMUNOL IMMUN, V62, P65, DOI 10.1007/s00262-012-1311-8; You Z, 2012, ANTITUMOR PHAR, V2, P193, DOI [10.3969/j.issn.2095-1264.2012.03.010, DOI 10.3969/J.ISSN.2095-1264.2012.03.010]; Yu JP, 2008, CANCER BIOTHER RADIO, V23, P342, DOI 10.1089/cbr.2007.0454; Yuan J., 2011, J CLIN PULM MED, V16, P1910; Zheng FC, 2012, J CHINESE ONCOLOGY, V18, P815; Zhong RB, 2011, CANCER IMMUNOL IMMUN, V60, P1497, DOI 10.1007/s00262-011-1060-0; [钟润波 ZHONG Runbo], 2008, [中国癌症杂志, China Oncology], V18, P760	40	28	31	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e112662	10.1371/journal.pone.0112662	http://dx.doi.org/10.1371/journal.pone.0112662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412106	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000013
J	Chanyi, RM; Koval, SF				Chanyi, Ryan M.; Koval, Susan F.			Role of Type IV Pili in Predation Bdellovibrio bacteriovorus	PLOS ONE			English	Article							BIOFILM FORMATION; GLIDING MOTILITY; LIFE-CYCLE; PROTEINS; MUTANTS; SYSTEM; PREY	Bdellovibrio bacteriovorus, as an obligate predator of Gram-negative bacteria, requires contact with the surface of a prey cell in order to initiate the life cycle. After attachment, the predator penetrates the prey cell outer membrane and enters the periplasmic space. Attack phase cells of B. bacteriovorus have polar Type IV pili that are required for predation. In other bacteria, these pili have the ability to extend and retract via the PilT protein. B. bacteriovorus has two pilT genes, pilT1 and pilT2, that have been implicated in the invasion process. Markerless in-frame deletion mutants were constructed in a preyindependent mutant to assess the role of PilT1 and PilT2 in the life cycle. When predation was assessed using liquid cocultures, all mutants produced bdelloplasts of Escherichia coli. These results demonstrated that PilT1 and PilT2 are not required for invasion of prey cells. Predation of the mutants on biofilms of E. coli was also assessed. Wild type B. bacteriovorus 109JA and the pilT1 mutant decreased the mass of the biofilm to 35.4% and 27.9% respectively. The pilT1pilT2 mutant was able to prey on the biofilm, albeit less efficiently with 50.2% of the biofilm remaining. The pilT2 mutant was unable to disrupt the biofilm, leaving 92.5% of the original biofilm after predation. The lack of PilT2 function may impede the ability of B. bacteriovorus to move in the extracellular polymeric matrix and find a prey cell. The role of Type IV pili in the life cycle of B. bacteriovorus is thus for initial recognition of and attachment to a prey cell in liquid cocultures, and possibly for movement within the matrix of a biofilm.	[Chanyi, Ryan M.; Koval, Susan F.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada	Western University (University of Western Ontario)	Koval, SF (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.	skoval@uwo.ca		Chanyi, Ryan/0000-0002-0189-0303	Natural Sciences and Engineering Research Council of Canada [155492]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided to SFK by the Natural Sciences and Engineering Research Council of Canada (155492), www.nserc-crsng.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asikyan ML, 2008, J BACTERIOL, V190, P7022, DOI 10.1128/JB.00938-08; Aukema KG, 2005, J BACTERIOL, V187, P611, DOI 10.1128/JB.187.2.611-618.2005; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Chanyi RM, 2013, CAN J MICROBIOL, V59, P273, DOI 10.1139/cjm-2013-0041; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; COTTER TW, 1992, J BACTERIOL, V174, P6011, DOI 10.1128/JB.174.19.6011-6017.1992; Dwidar M, 2012, BIOFOULING, V28, P671, DOI 10.1080/08927014.2012.701286; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri DE, 2013, APPL ENVIRON MICROB, V79, P5264, DOI 10.1128/AEM.01193-13; Koval SF, 2013, INT J SYST EVOL MICR, V63, P146, DOI 10.1099/ijs.0.039701-0; Lambert C, 2011, J BACTERIOL, V193, P3139, DOI 10.1128/JB.00224-11; Lambert C, 2009, ADV MICROB PHYSIOL, V54, P313, DOI 10.1016/S0065-2911(08)00005-2; Mahmoud KK, 2010, MICROBIOL-SGM, V156, P1040, DOI 10.1099/mic.0.036137-0; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Medina AA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-33; Monnappa AK, 2014, SCI REP-UK, V4, DOI 10.1038/srep03811; Pasternak Z, 2014, ISME J, V8, P625, DOI 10.1038/ismej.2013.164; REID G, 1984, CURR MICROBIOL, V11, P67, DOI 10.1007/BF01567706; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Steyert SR, 2007, APPL ENVIRON MICROB, V73, P4717, DOI 10.1128/AEM.00640-07; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x	23	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113404	10.1371/journal.pone.0113404	http://dx.doi.org/10.1371/journal.pone.0113404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409535	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200112
J	Marion, JW; Lee, C; Lee, CS; Wang, QH; Lemeshow, S; Buckley, TJ; Saif, LJ; Lee, J				Marion, Jason W.; Lee, Cheonghoon; Lee, Chang Soo; Wang, Qiuhong; Lemeshow, Stanley; Buckley, Timothy J.; Saif, Linda J.; Lee, Jiyoung			Integrating Bacterial and Viral Water Quality Assessment to Predict Swimming-Associated Illness at a Freshwater Beach: A Cohort Study	PLOS ONE			English	Article							RECREATIONAL MARINE WATERS; POLYMERASE-CHAIN-REACTION; FECAL INDICATOR BACTERIA; REAL-TIME PCR; ESCHERICHIA-COLI; COASTAL WATERS; QUANTITATIVE PCR; NONPOINT SOURCES; ENTERIC VIRUSES; GENETIC-MARKERS	Background & Objective: Recreational waters impacted by fecal contamination have been linked to gastrointestinal illness in swimmer populations. To date, few epidemiologic studies examine the risk for swimming-related illnesses based upon simultaneous exposure to more than one microbial surrogate (e. g. culturable E. coli densities, genetic markers). We addressed this research gap by investigating the association between swimming-related illness frequency and water quality determined from multiple bacterial and viral genetic markers. Methods: Viral and bacterial genetic marker densities were determined from beach water samples collected over 23 weekend days and were quantified using quantitative polymerase chain reaction (qPCR). These genetic marker data were paired with previously determined human exposure data gathered as part of a cohort study carried out among beach users at East Fork Lake in Ohio, USA in 2009. Using previously unavailable genetic marker data in logistic regression models, single-and multi-marker/multi-water quality indicator approaches for predicting swimming-related illness were evaluated for associations with swimming-associated gastrointestinal illness. Results: Data pertaining to genetic marker exposure and 8- or 9-day health outcomes were available for a total of 600 healthy susceptible swimmers, and with this population we observed a significant positive association between human adenovirus (HAdV) exposure and diarrhea (odds ratio = 1.6; 95% confidence interval: 1.1-2.3) as well as gastrointestinal illness (OR = 1.5; 95% CI: 1.0-2.2) upon adjusting for culturable E. coli densities in multivariable models. No significant associations between bacterial genetic markers and swimming-associated illness were observed. Conclusions: This study provides evidence that a combined measure of recreational water quality that simultaneously considers both bacterial and viral densities, particularly HAdV, may improve prediction of disease risk than a measure of a single agent in a beach environment likely influenced by nonpoint source human fecal contamination.	[Marion, Jason W.; Lee, Cheonghoon; Lee, Chang Soo; Buckley, Timothy J.; Lee, Jiyoung] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Wang, Qiuhong; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA; [Lemeshow, Stanley] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Lee, Jiyoung] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lee, J (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA.	lee.3598@osu.edu	Buckley, Timothy/AAS-7516-2021; Saif, Linda/E-4005-2011; Lee, Chang Soo/AAA-9586-2022	Lee, Chang Soo/0000-0001-7327-4852; Marion, Jason/0000-0001-5177-889X	Public Health Preparedness for Infectious Diseases program; Ohio State University Targeted Investment in Excellence program - Offices of Academic Affairs, the President, and Research; Ohio Water Development Authority	Public Health Preparedness for Infectious Diseases program; Ohio State University Targeted Investment in Excellence program - Offices of Academic Affairs, the President, and Research; Ohio Water Development Authority	This study was funded by the Public Health Preparedness for Infectious Diseases program (http://phpid.osu.edu) and The Ohio State University Targeted Investment in Excellence program sponsored by the Offices of Academic Affairs, the President, and Research. The human health and exposure data collection effort was funded by the Ohio Water Development Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelzaher AM, 2013, J ENV PUBLIC HLTH, V2013, DOI DOI 10.1155/2013/138521; Abdelzaher AM, 2011, J WATER HEALTH, V9, P443, DOI 10.2166/wh.2011.146; Albinana-Gimenez N, 2009, WATER RES, V43, P2011, DOI 10.1016/j.watres.2009.01.025; Arnold BF, 2013, EPIDEMIOLOGY, V24, P845, DOI 10.1097/01.ede.0000434431.06765.4a; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P1587, DOI 10.1128/AEM.66.4.1587-1594.2000; Boehm AB, 2009, J WATER HEALTH, V7, P9, DOI 10.2166/wh.2009.122; Chern EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/j.1472-765X.2010.03001.x; Chern EC, 2009, WATER QUAL EXPOS HEA, V1, P203, DOI 10.1007/s12403-009-0019-2; Colford JM, 2012, WATER RES, V46, P2176, DOI 10.1016/j.watres.2012.01.033; Colford JM, 2007, EPIDEMIOLOGY, V18, P27, DOI 10.1097/01.ede.0000249425.32990.b9; Dorevitch S, 2012, ENVIRON HEALTH PERSP, V120, P192, DOI 10.1289/ehp.1103934; Dufour A, 1984, EPA6001842004 OFF RE; FEWTRELL L, 1992, LANCET, V339, P1587, DOI 10.1016/0140-6736(92)91843-W; Fewtrell L., 2001, WATER QUALITY GUIDEL; Fleisher JM, 2010, INT J EPIDEMIOL, V39, P1291, DOI 10.1093/ije/dyq084; Fleisher JM, 1996, AM J PUBLIC HEALTH, V86, P1228, DOI 10.2105/AJPH.86.9.1228; FLEISHER JM, 1993, INT J EPIDEMIOL, V22, P698, DOI 10.1093/ije/22.4.698; Fongaro G, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-166; Ge ZF, 2012, ENVIRON SCI TECHNOL, V46, P2204, DOI 10.1021/es203847n; Gerba CP, 2002, APPL ENVIRON MICROB, V68, P5167, DOI 10.1128/AEM.68.10.5167-5169.2002; Gruber SJ, 2005, STORMWATER, V6, P40; Haramoto E, 2005, APPL ENVIRON MICROB, V71, P2403, DOI 10.1128/AEM.71.5.2403-2411.2005; Haugland RA, 2005, WATER RES, V39, P559, DOI 10.1016/j.watres.2004.11.011; Heaney CD, 2012, EPIDEMIOLOGY, V23, P95, DOI 10.1097/EDE.0b013e31823b504c; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hlavsa Michele C., 2011, Morbidity and Mortality Weekly Report, V60, P1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jiang S, 2001, APPL ENVIRON MICROB, V67, P179, DOI 10.1128/AEM.67.1.179-184.2001; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kundu A, 2013, WATER RES, V47, P6309, DOI 10.1016/j.watres.2013.08.002; Lee CS, 2014, SCI TOTAL ENVIRON, V472, P757, DOI 10.1016/j.scitotenv.2013.11.088; Lee CS, 2010, J MICROBIOL METH, V82, P311, DOI 10.1016/j.mimet.2010.07.012; Lee C, 2012, APPL ENVIRON MICROB, V78, P5511, DOI 10.1128/AEM.08009-11; Lee JY, 2004, LUMINESCENCE, V19, P31, DOI 10.1002/bio.753; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lodder WJ, 2005, APPL ENVIRON MICROB, V71, P1453, DOI 10.1128/AEM.71.3.1453-1461.2005; Ludwig W, 2000, SYST APPL MICROBIOL, V23, P556, DOI 10.1016/S0723-2020(00)80030-2; Marion JW, 2010, WATER RES, V44, P4796, DOI 10.1016/j.watres.2010.07.065; McQuaig S, 2012, APPL ENVIRON MICROB, V78, P6423, DOI 10.1128/AEM.00024-12; Monpoeho S, 2000, BIOTECHNIQUES, V29, P88, DOI 10.2144/00291st03; Newton RJ, 2011, APPL ENVIRON MICROB, V77, P6972, DOI 10.1128/AEM.05480-11; Noble RT, 2001, HYDROBIOLOGIA, V460, P175, DOI 10.1023/A:1013121416891; Okabe S, 2007, APPL MICROBIOL BIOT, V74, P890, DOI 10.1007/s00253-006-0714-x; PAYMENT P, 1982, WATER RES, V16, P939, DOI 10.1016/0043-1354(82)90026-4; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peed LA, 2011, ENVIRON SCI TECHNOL, V45, P5652, DOI 10.1021/es2003167; Pike E, 1994, 34122 WRC DOE, P9; Sinclair RG, 2009, J APPL MICROBIOL, V107, P1769, DOI 10.1111/j.1365-2672.2009.04367.x; Sinigalliano CD, 2010, WATER RES, V44, P3763, DOI 10.1016/j.watres.2010.04.026; Soller JA, 2010, WATER RES, V44, P4736, DOI 10.1016/j.watres.2010.07.064; Soller JA, 2010, WATER RES, V44, P4674, DOI 10.1016/j.watres.2010.06.049; U.S. Army Corps of Engineers Louisville District, 2013, DAT YEARL LAK REP; U.S. Environmental Protection Agency, 2010, EPA821R10004; United States Environmental Protection Agency (US EPA), 2014, HLTH RISK EXP ASS OZ; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wade TJ, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-66; Wade TJ, 2006, ENVIRON HEALTH PERSP, V114, P24, DOI 10.1289/ehp.8273; Wade TJ, 2003, ENVIRON HEALTH PERSP, V111, P1102, DOI 10.1289/ehp.6241; Wyn-Jones AP, 2011, WATER RES, V45, P1025, DOI 10.1016/j.watres.2010.10.015; Yau VM, 2014, WATER RES, V59, P23, DOI 10.1016/j.watres.2014.03.050	61	10	10	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112029	10.1371/journal.pone.0112029	http://dx.doi.org/10.1371/journal.pone.0112029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409012	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200008
J	Mayer, AE; Parks, GD				Mayer, Anne E.; Parks, Griffith D.			An AGM Model for Changes in Complement during Pregnancy: Neutralization of Influenza Virus by Serum Is Diminished in Late Third Trimester	PLOS ONE			English	Article							MONKEY CERCOPITHECUS-AETHIOPS; ANIMAL-MODELS; VERVET MONKEY; RESPIRATORY ILLNESS; INFECTED-CELLS; IN-VIVO; ACTIVATION; PROTEINS; PATHWAY; HOSPITALIZATIONS	Pregnant women in the third trimester are at increased risk of severe influenza disease relative to the general population, though mechanisms behind this are not completely understood. The immune response to influenza infection employs both complement (C') and antibody (Ab). The relative contributions of these components to the anti-viral response are difficult to dissect because most humans have pre-existing influenza-specific Abs. We developed the African green monkey (AGM) as a tractable nonhuman primate model to study changes in systemic innate immunity to influenza during pregnancy. Because the AGMs were influenza-naive, we were able to examine the role of C' in influenza virus neutralization using serum from non-pregnant animals before and after influenza infection. We determined that serum from naive AGMs neutralized influenza via C', while post-infection neutralization did not require C', suggesting an Ab-mediated mechanism. The latter mimicked neutralization using human serum. Further, we found that ex vivo neutralization of influenza with both naive and influenza-immune AGM serum occurred by virus particle aggregation and lysis, with immune serum lysing virus at a much higher rate than naive serum. We hypothesized that the anti-influenza C' response would diminish late in AGM pregnancy, corresponding with the time when pregnant women suffer increased influenza severity. We found that influenza neutralization capacity is significantly diminished in serum collected late in the third trimester. Strikingly, we found that circulating levels of C3, C3a, and C4 are diminished late in gestation relative to nonpregnant animals, and while neutralization capacity and serum C3a return to normal shortly after parturition, C3 and C4 levels do not. This AGM model system will enable further studies of the role of physiologic and hormonal changes in downregulating C'-mediated anti-viral immunity during pregnancy, and it will permit the identification of therapeutic targets to improve outcomes of influenza virus infection in pregnant women.	[Mayer, Anne E.; Parks, Griffith D.] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27101 USA	Wake Forest University	Mayer, AE (corresponding author), Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27101 USA.	anmayer@wakehealth.edu			National Institutes of Health [AI083253, AI101675]; NCI CCSG [P30CA012197, RR019963/OD010965, T32 OD010957]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083253, R03AI101675] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010965, T32OD010957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health www.nih.gov AI083253 (GDP), AI101675 (GDP), NCI CCSG P30CA012197 (flow cytometry and imaging core), RR019963/OD010965 (animal resources), T32 OD010957 (AEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, THROMB RES, V127, pS72, DOI 10.1016/S0049-3848(11)70020-2; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; [Anonymous], 1966, BIOL LAB MOUSE; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; BAINES MG, 1974, OBSTET GYNECOL, V43, P806; Baskin C, 2013, CURR TOP MICROBIOL, V363, P69, DOI 10.1007/82_2012_248; BENSTER B, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P518; BERENDT RF, 1974, INFECT IMMUN, V9, P101, DOI 10.1128/IAI.9.1.101-105.1974; Billington WD, 2003, J REPROD IMMUNOL, V60, P1, DOI 10.1016/S0165-0378(03)00083-4; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006; Bossi F, 2004, J IMMUNOL, V173, P6921, DOI 10.4049/jimmunol.173.11.6921; Bowes WK, 2002, OBSTET NORMAL PROBLE; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Carroll RL, 2007, AM J PRIMATOL, V69, P901, DOI 10.1002/ajp.20396; Cerneca F, 1997, EUR J OBSTET GYN R B, V73, P31, DOI 10.1016/S0301-2115(97)02734-6; Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262; Conroy AL, 2011, TRENDS PARASITOL, V27, P294, DOI 10.1016/j.pt.2011.02.005; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Denny KJ, 2013, J REPROD IMMUNOL, V97, P211, DOI 10.1016/j.jri.2012.11.006; Denny KJ, 2013, AM J REPROD IMMUNOL, V69, P3, DOI 10.1111/aji.12000; Devaux P, 2004, J GEN VIROL, V85, P1665, DOI 10.1099/vir.0.79880-0; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Doyle TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079040; ELEY RM, 1989, AM J PRIMATOL, V17, P1, DOI 10.1002/ajp.1350170102; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; ELSE JG, 1986, AM J PRIMATOL, V11, P333, DOI 10.1002/ajp.1350110404; Francis J, 2006, MOL HUM REPROD, V12, P435, DOI 10.1093/molehr/gal048; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; GALLERY ED, 1981, AUST NZ J MED, V11, P243; Ghannam A, 2014, MOL IMMUNOL, V58, P98, DOI 10.1016/j.molimm.2013.11.010; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Gonzalez SF, 2008, VACCINE, V26, pI86, DOI 10.1016/j.vaccine.2008.11.057; HESS DL, 1979, J MED PRIMATOL, V8, P273; HIRSCH RL, 1986, ARCH VIROL, V87, P181, DOI 10.1007/BF01315298; Holmberg V, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-61; HYTTEN F, 1985, CLIN HAEMATOL, V14, P601; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Johnson JB, 2008, VIROLOGY, V376, P112, DOI 10.1016/j.virol.2008.03.022; Jones R., 2013, HUMAN REPROD BIOL, V4th ed; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; KORITNIK DR, 1984, METABOLISM, V33, P840, DOI 10.1016/0026-0495(84)90112-4; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; KOVAR IZ, 1988, J CLIN PATHOL, V41, P650, DOI 10.1136/jcp.41.6.650; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Kundu MC, 2013, SYST BIOL REPROD MED, V59, P74, DOI 10.3109/19396368.2012.752547; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; LEWISJONES DI, 1985, ACTA PAEDIATR SCAND, V74, P655, DOI 10.1111/j.1651-2227.1985.tb10007.x; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; NYLAND TG, 1984, J CLIN ULTRASOUND, V12, P387, DOI 10.1002/jcu.1870120703; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Oluyomi-Obi T, 2010, J OBSTET GYNAECOL CA, V32, P443, DOI 10.1016/S1701-2163(16)34497-8; Ostensen M, 2002, TRANSPL IMMUNOL, V9, P155, DOI 10.1016/S0966-3274(02)00017-5; Pacheco LD, 2011, AM J PERINAT, V28, P565, DOI 10.1055/s-0031-1274510; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Parks GD, 2002, J GEN VIROL, V83, P1167, DOI 10.1099/0022-1317-83-5-1167; PATERSON RG, 1995, VIROLOGY, V208, P121, DOI 10.1006/viro.1995.1135; Pazos MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040502; Richani K, 2005, J MATERN-FETAL NEO M, V17, P239, DOI 10.1080/14767050500072722; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Ross TM, 2014, HUM VACCIN IMMUNOTHE, V10; Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852; Simpson KC, 2001, AHWONNS PERINATAL NU; Stephens SM, 2013, COMPARATIVE MED, V63, P432; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; WELSH RM, 1977, J IMMUNOL, V118, P348; Wilder RL, 1998, ANN NY ACAD SCI, V840, P45, DOI 10.1111/j.1749-6632.1998.tb09547.x; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498	84	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112749	10.1371/journal.pone.0112749	http://dx.doi.org/10.1371/journal.pone.0112749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409303	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200040
J	Sandstrom, G; Rodjer, S; Kaijser, B; Borjesson, M				Sandstrom, Goran; Rodjer, Stig; Kaijser, Bertil; Borjesson, Mats			Helicobacter pylori Antibodies and Iron Deficiency in Female Adolescents	PLOS ONE			English	Article							GASTRIC-CANCER; INFECTION; ANEMIA; METAANALYSIS; ERADICATION; PREVALENCE; CHILDREN	Objective: Iron deficiency (ID) is a common clinical problem worldwide, affecting primarily females. Helicobacter pylori (HP) infection has been shown to be associated with ID. The objective of this study was to define the prevalence of HP antibodies in female adolescents, and to find out if there was a correlation between HP infection and ID. The secondary aim was to study if regularly performed sporting activity, have any association to HP infection, in itself. Design: A controlled clinical trial. Setting: A senior high school in Gothenburg, Sweden. Subjects: All female athletes at a senior high school for top-level athletes were offered to take part, and 56 athletes took part in the study. The control group consisted of a random sample of age-matched non-athlete students of which 71 entered the study. Main outcome measures: Iron deficiency (ID) and iron deficiency anaemia (IDA) were defined by the use of levels of haemoglobin, serum iron, total iron-binding capacity, transferrin saturation, and serum ferritin, as previously described. HP IgG-antibodies were detected by ELISA. Results: 18 of 127 (14%) adolescent females had antibodies against HP. Only 3% had IDA, while 50% had ID. In total, 66% of the HP positive females had ID compared to 48% of the negative females (p = 0.203). No correlation between sporting activity and HP infection was found. Regarding ethnicity, 11/28 of subjects from medium-high risk areas were HP-positive, compared to 7/99 coming from low-risk areas (p<0.001). Conclusion: The main finding of this study is that the prevalence of HP IgG antibodies was 14% in adolescent females. We could not find any difference regarding frequency of ID and IDA, between HP positive and negative individuals. Ethnicity is of great importance for the risk of HP infection, while sporting activity itself seems to have no association to HP-infection.	[Sandstrom, Goran; Rodjer, Stig] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Univ Hospital Ostra, Dept Mol & Clin Med,Inst Med, Gothenburg, Sweden; [Kaijser, Bertil] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Univ Hosp, Dept Med Microbiol, Gothenburg, Sweden; [Borjesson, Mats] Swedish Sch Sports & Hlth Sci, Stockholm, Sweden; [Borjesson, Mats] Karolinska Univ Hosp, Stockholm, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Swedish School of Sport & Health Sciences; Karolinska Institutet; Karolinska University Hospital	Sandstrom, G (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Univ Hospital Ostra, Dept Mol & Clin Med,Inst Med, Gothenburg, Sweden.	goran.sandstrom@gu.se	Sandström, Göran/A-6822-2013	Sandström, Göran/0000-0001-7352-4356; Borjesson, Mats/0000-0002-8786-0438	Swedish National Center for Research in Sports; Goteborg Medical Society	Swedish National Center for Research in Sports; Goteborg Medical Society	This study was supported by grants from The Swedish National Center for Research in Sports, www.gih.se/CIF and The Goteborg Medical Society, www.goteborgslakaresallskap.se/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHEL JS, 1990, REV INFECT DIS, V12, pS107; Choe YH, 2001, J PEDIATR-US, V139, P100, DOI 10.1067/mpd.2001.114700; Feldman RA, 2001, ALIMENT PHARM THERAP, V15, P2, DOI 10.1046/j.1365-2036.2001.00109.x; Granquist A, 2002, ACTA PAEDIATR, V91, P636, DOI 10.1080/080352502760069025; HALLBERG L, 1993, BRIT J HAEMATOL, V85, P787, DOI 10.1111/j.1365-2141.1993.tb03225.x; HALLBERG L, 1993, PEDIATR RES, V34, P680, DOI 10.1203/00006450-199311000-00023; Hershko C, 2009, ACTA HAEMATOL-BASEL, V122, P97, DOI 10.1159/000243793; Huang XL, 2010, POSTGRAD MED J, V86, P272, DOI 10.1136/pgmj.2009.089987; Khalifa MM, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-2; Landahl G, 2005, INT J SPORT NUTR EXE, V15, P689, DOI 10.1123/ijsnem.15.6.689; LEE A, 1992, VET PATHOL, V29, P487, DOI 10.1177/030098589202900601; MARSHALL BJ, 1984, LANCET, V1, P1311; Monzon H, 2013, WORLD J GASTROENTERO, V19, P4166, DOI 10.3748/wjg.v19.i26.4166; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Papagiannakis P, 2013, EUR J INTERN MED, V24, P685, DOI 10.1016/j.ejim.2013.02.011; Peter S, 2007, DIGESTION, V75, P25, DOI 10.1159/000101564; Qu XH, 2010, WORLD J GASTROENTERO, V16, P886, DOI 10.3748/wjg.v16.i7.886; Sandstrom G, 2012, CLIN J SPORT MED, V22, P495, DOI 10.1097/JSM.0b013e3182639522; Thjodleifsson B, 2007, SCAND J INFECT DIS, V39, P683, DOI 10.1080/00365540701225736; Tindberg Y, 2001, GASTROENTEROLOGY, V121, P310, DOI 10.1053/gast.2001.26282; Weyermann M, 2009, AM J GASTROENTEROL, V104, P182, DOI 10.1038/ajg.2008.61; World Health Organization TUNCsF United Nations University, 2004, IR DEF AN ASS PREV C	22	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113059	10.1371/journal.pone.0113059	http://dx.doi.org/10.1371/journal.pone.0113059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409451	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200061
J	Theiss, AP; Chafin, D; Bauer, DR; Grogan, TM; Baird, GS				Theiss, Abbey P.; Chafin, David; Bauer, Daniel R.; Grogan, Thomas M.; Baird, Geoffrey S.			Immunohistochemistry of Colorectal Cancer Biomarker Phosphorylation Requires Controlled Tissue Fixation	PLOS ONE			English	Article							COLD ISCHEMIC TIME; PHOSPHOPROTEIN STABILITY; PROTEIN EXPRESSION; ESTROGEN-RECEPTOR; CLINICAL TISSUE; INHIBITION; ANTIBODY	Phosphorylated signaling molecules are biomarkers of cancer pathophysiology and resistance to therapy, but because phosphoprotein analytes are often labile, poorly controlled clinical laboratory practices could prevent translation of research findings in this area from the bench to the bedside. We therefore compared multiple biomarker and phosphoprotein immunohistochemistry (IHC) results in 23 clinical colorectal carcinoma samples after either a novel, rapid tissue fixation protocol or a standard tissue fixation protocol employed by clinical laboratories, and we also investigated the effect of a defined post-operative "cold'' ischemia period on these IHC results. We found that a one-hour cold ischemia interval, allowed by ASCO/CAP guidelines for certain cancer biomarker assays, is highly deleterious to certain phosphoprotein analytes, specifically the phosphorylated epidermal growth factor receptor (pEGFR), but shorter ischemic intervals (less than 17 minutes) facilitate preservation of phosphoproteins. Second, we found that a rapid 4-hour, two temperature, formalin fixation yielded superior staining in several cases with select markers (pEGFR, pBAD, pAKT) compared to a standard overnight room temperature fixation protocol, despite taking less time. These findings indicate that the future research and clinical utilities of phosphoprotein IHC for assessing colorectal carcinoma pathophysiology absolutely depend upon attention to preanalytical factors and rigorously controlled tissue fixation protocols.	[Theiss, Abbey P.; Chafin, David; Bauer, Daniel R.; Grogan, Thomas M.] Ventana Med Syst Inc, Tucson, AZ USA; [Baird, Geoffrey S.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Baird, Geoffrey S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Roche Holding; Ventana Medical Systems, Inc.; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baird, GS (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	gbaird@u.washington.edu			Ventana Medical Systems, Inc.; University of Washington	Ventana Medical Systems, Inc.(Roche Holding); University of Washington(University of Washington)	This study was funded in part by a research grant to GSB from Ventana Medical Systems, Inc. There is no grant number associated with this contract research grant. This study was a collaborative effort between GSB's institution and Ventana, and hence Ventana employees were involved in all stages of this research (study design, data collection, analysis, decision to publish, and preparation of the manuscript). The remaining portion of this work was funded by internal University of Washington funds.	Bai YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079901; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Chafin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054138; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Espina V, 2008, MOL CELL PROTEOMICS, V7, P1998, DOI 10.1074/mcp.M700596-MCP200; Espina V, 2011, METHODS MOL BIOL, V785, P23, DOI 10.1007/978-1-61779-286-1_3; Guendisch S, 2012, J PROTEOME RES, V11, P5748, DOI 10.1021/pr300560y; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hewitt SM, 2011, ILA28A2 CLSI; Kim MR, 2007, DIGEST DIS SCI, V52, P2751, DOI 10.1007/s10620-007-9799-z; Kuan SF, 2014, HUM PATHOL, V45, P464, DOI 10.1016/j.humpath.2013.10.026; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Meric-Bernstam F, 2014, CLIN CANCER RES, V20, P3870, DOI 10.1158/1078-0432.CCR-13-1507; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Neumeister VM, 2012, JNCI-J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Sinicrope FA, 2013, CANCER-AM CANCER SOC, V119, P2765, DOI 10.1002/cncr.28133; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; True LD, 2008, HISTOCHEM CELL BIOL, V130, P473, DOI 10.1007/s00418-008-0481-0; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yang H, 2012, CANCER RES, V72, P779, DOI 10.1158/0008-5472.CAN-11-2941; Yildiz-Aktas IZ, 2012, MODERN PATHOL, V25, P1098, DOI 10.1038/modpathol.2012.59	23	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113608	10.1371/journal.pone.0113608	http://dx.doi.org/10.1371/journal.pone.0113608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409462	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200141
J	Vilela, B; Villalobos, F; Rodriguez, MA; Terribile, LC				Vilela, Bruno; Villalobos, Fabricio; Rodriguez, Miguel Angel; Terribile, Levi Carina			Body Size, Extinction Risk and Knowledge Bias in New World Snakes	PLOS ONE			English	Article							GEOGRAPHIC RANGE; BIODIVERSITY; PATTERNS; BIRDS; PHYLOGENY; RICHNESS; SQUAMATA; REPTILES; ECOLOGY; BIG	Extinction risk and body size have been found to be related in various vertebrate groups, with larger species being more at risk than smaller ones. We checked whether this was also the case for snakes by investigating extinction risk-body size relationships in the New World's Colubroidea species. We used the IUCN Red List risk categories to assign each species to one of two broad levels of threat (Threatened and Non-Threatened) or to identify it as either Data Deficient or Not-Evaluated by the IUCN. We also included the year of description of each species in our analysis as this could affect the level of threat assigned to it (earlier described species had more time to gather information about them, which might have facilitated their evaluation). Also, species detectability could be a function of body size, with larger species tending to be described earlier, which could have an impact in extinction risk-body size relationships. We found a negative relationship between body size and description year, with large-bodied species being described earlier. Description year also varied among risk categories, with Non-Threatened species being described earlier than Threatened species and both species groups earlier than Data Deficient species. On average, Data Deficient species also presented smaller body sizes, while no size differences were detected between Threatened and Non-Threatened species. So it seems that smaller body sizes are related with species detectability, thus potentially affecting both when a species is described (smaller species tend to be described more recently) as well as the amount of information gathered about it (Data Deficient species tend to be smaller). Our data also indicated that if Data Deficient species were to be categorized as Threatened in the future, snake body size and extinction risk would be negatively related, contrasting with the opposite pattern commonly observed in other vertebrate groups.	[Vilela, Bruno; Villalobos, Fabricio] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Vilela, Bruno; Rodriguez, Miguel Angel] Univ Alcala, Dept Ciencias Vida, Madrid, Spain; [Terribile, Levi Carina] Univ Fed Goias, Lab Macroecol, Jatai, Go, Brazil	Universidade Federal de Goias; Universidad de Alcala; Universidade Federal de Goias	Vilela, B (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil.	brunovilelasilva@hotmail.com	Rodriguez, Miguel A/A-3409-2011; Terribile, Levi Carina/AAW-1102-2021; Villalobos, Fabricio/J-6246-2012; Vilela, Bruno/L-1594-2015	Rodriguez, Miguel A/0000-0002-4082-2995; Terribile, Levi Carina/0000-0001-8420-9300; Villalobos, Fabricio/0000-0002-5230-2217; Vilela, Bruno/0000-0003-4072-0558	Spanish Ministry of Economy and Competitiveness [CGL2010-22119]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [473788/2009-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Spanish Ministry of Economy and Competitiveness(Spanish Government); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Spanish Ministry of Economy and Competitiveness (grant: CGL2010-22119), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Process n. 473788/2009-8) (http://www.cnpq.br/), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Boback SM, 2003, EVOLUTION, V57, P345; Bonner J.T., 2011, WHY SIZE MATTERS BAC; Brown J. H., 1995, MACROECOLOGY; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; Diniz JAF, 2001, EVOLUTION, V55, P1104, DOI 10.1111/j.0014-3820.2001.tb00630.x; Diniz JAF, 2012, ECOGRAPHY, V35, P239, DOI 10.1111/j.1600-0587.2011.06949.x; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Filippi E, 2000, BIOL CONSERV, V93, P219, DOI 10.1016/S0006-3207(99)00138-X; Fitzgerald LA, 2000, WILDLIFE SOC B, V28, P235; Freitas MA, 2007, HERPETOFAUNA CAATING; Freitas MA, 2005, HERPETOFAUNA MATA AT; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gonzalez-Suarez M, 2012, J ANIM ECOL, V81, P1211, DOI 10.1111/j.1365-2656.2012.01999.x; Harnik PG, 2011, P NATL ACAD SCI USA, V108, P13594, DOI 10.1073/pnas.1100572108; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2012, IUCN RED LIST THREAT; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Kohler G, 2003, REPTILES CENTROAMERI; Luisellil L, 2005, J ZOOL, V265, P207, DOI 10.1017/S0952836904006211; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Olalla-Tarraga MA, 2006, J BIOGEOGR, V33, P781, DOI 10.1111/j.1365-2699.2006.01435.x; Olden JD, 2007, GLOBAL ECOL BIOGEOGR, V16, P694, DOI 10.1111/j.1466-8238.2007.00337.x; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Payne JL, 2007, P NATL ACAD SCI USA, V104, P10506, DOI 10.1073/pnas.0701257104; Pereira-Filho GA, 2007, VERTEBRATE CONSERVAT, P143; Petchey OL, 2010, BIOL LETT; Pincheira-Donoso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059741; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pough F.H., 1983, P141; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; R Core Team, 2021, R LANGUAGE ENV STAT; Reed RN, 2002, GLOBAL ECOL BIOGEOGR, V11, P41, DOI 10.1046/j.1466-822X.2002.00260.x; Reed RN, 2003, ECOGRAPHY, V26, P107, DOI 10.1034/j.1600-0587.2003.03388.x; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Terribile LC, 2012, J ZOOL SYST EVOL RES, V50, P202, DOI 10.1111/j.1439-0469.2012.00658.x; Terribile LC, 2009, GLOBAL ECOL BIOGEOGR, V18, P123, DOI 10.1111/j.1466-8238.2008.00440.x; Uetz P., 2012, REPTILE DATABASE; Vilela B, 2014, LETSR TOOLS DATA HAN	54	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113429	10.1371/journal.pone.0113429	http://dx.doi.org/10.1371/journal.pone.0113429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409293	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200120
J	Zhang, CB; Teng, FM; Tu, J; Zhang, D				Zhang, Chunbing; Teng, Fengmeng; Tu, Juan; Zhang, Dong			Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine against Cerebral Ischemia/Reperfusion Injury	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; SUPEROXIDE-DISMUTASE; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; RAT-BLOOD; ISCHEMIA; STROKE; DRUG; REPERFUSION; DAMAGE	In traditional Chinese medicine, Ligusticum wallichii (Chuan Xiong) and its bioactive ingredient, tetramethylpyrazine (TMP), have been used to treat cardiovascular diseases and to relieve various neurological symptoms, such as those associated with ischemic injury. In the present study, we investigated whether ultrasound (US) exposure could enhance the protective effect of TMP against cerebral ischemia/reperfusion (I/R) injury. Glutamate-induced toxicity to pheochromocytoma (PC12) cells was used to model I/R injury. TMP was paired with US to examine whether this combination could alleviate glutamate-induced cytotoxicity. The administration of TMP effectively protected cells against glutamate-induced apoptosis, which could be further enhanced by US-mediated sonoporation. The anti-apoptotic effect of TMP was associated with the inhibition of oxidative stress and a change in the levels of apoptosis-related proteins, Bcl-2 and Bax. Furthermore, TMP reduced the expression of proinflammatory cytokines such as TNF-alpha and IL-8, which likely also contributes to its cytoprotective effects. Taken together, our findings suggest that ultrasound-enhanced TMP treatment might be a promising therapeutic strategy for ischemic stroke. Further study is required to optimize ultrasound treatment parameters.	[Zhang, Chunbing; Teng, Fengmeng] Jiangsu Prov TCM, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Chunbing] Nanjing Univ Chinese Med, Nanjing, Jiangsu, Peoples R China; [Tu, Juan; Zhang, Dong] Nanjing Univ, Key Lab Modern Acoust MOE, Inst Acoust, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University	Tu, J (corresponding author), Nanjing Univ, Key Lab Modern Acoust MOE, Inst Acoust, Nanjing 210008, Jiangsu, Peoples R China.	juantu@nju.edu.cn; dzhang@nju.edu.cn		Zhang, Chunbing/0000-0001-5576-7821	National Basic Research Program 973 from Ministry of Science and Technology, China [2011CB707900]; National Natural Science Foundation of China [81171659, 81127901, 81227004, 11374155, 11174141, 11104140, 11474001, 11161120324, 11474161]; National High-Tech Research and Development Program 863 [2012AA022702]	National Basic Research Program 973 from Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program 863(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program 973 (Grant no. 2011CB707900) from Ministry of Science and Technology, China, National Natural Science Foundation of China (Grant no's. 81171659, 81127901, 81227004, 11374155, 11174141, 11104140, 11474001, 11161120324 and 11474161), and the National High-Tech Research and Development Program 863 (2012AA022702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrouz R, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/839151; Cheng XR, 2007, CELL BIOL INT, V31, P438, DOI 10.1016/j.cellbi.2006.10.001; DAI XZ, 1985, J CARDIOVASC PHARM, V7, P841, DOI 10.1097/00005344-198509000-00005; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Genovese T, 2011, BRAIN RES, V1372, P92, DOI 10.1016/j.brainres.2010.11.088; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; Heo JM, 2007, BIOCHEM PHARMACOL, V74, P1361, DOI 10.1016/j.bcp.2007.07.023; HO WKK, 1989, STROKE, V20, P96, DOI 10.1161/01.STR.20.1.96; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ilan Z, 1994, NEUROSCI LETT, V170; Ito Y, 2010, CURR NEUROVASC RES, V7, P23, DOI 10.2174/156720210790820190; Kostulas N, 1998, STROKE, V29, P462, DOI 10.1161/01.STR.29.2.462; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Liang CC, 1999, J CHROMATOGR B, V724, P303, DOI 10.1016/S0378-4347(99)00010-9; Liao SL, 2004, NEUROSCI LETT, V372, P40, DOI 10.1016/j.neulet.2004.09.013; Liao SL, 2002, NEUROSCI LETT, V324, P133, DOI 10.1016/S0304-3940(02)00236-7; Lindsberg PJ, 1996, CIRCULATION, V94, P939, DOI 10.1161/01.CIR.94.5.939; Lui C., 1978, CLIN MED RES, V4, P24; Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613; May DJ, 2002, IEEE T ULTRASON FERR, V49, P1400, DOI 10.1109/TUFFC.2002.1041081; Mei D, 2008, EUR J PHARM BIOPHARM, V70, P874, DOI 10.1016/j.ejpb.2008.06.031; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Muzykantov VR, 2001, J CONTROL RELEASE, V71, P1, DOI 10.1016/S0168-3659(01)00215-2; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Nita DA, 2001, J CELL MOL MED, V5, P163, DOI 10.1111/j.1582-4934.2001.tb00149.x; Oto J, 2008, J ANESTH, V22, P207, DOI 10.1007/s00540-008-0639-x; Ou Y, 2010, PHARMAZIE, V65, P755, DOI 10.1691/ph.2010.0580; Pias EK, 2002, CELL DEATH DIFFER, V9, P1007, DOI 10.1038/sj.cdd.4401064; Qiu YY, 2010, J CONTROL RELEASE, V145, P40, DOI 10.1016/j.jconrel.2010.04.010; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Shih YH, 2002, NEUROREPORT, V13, P515, DOI 10.1097/00001756-200203250-00032; Tsai TH, 2001, INT J PHARMACEUT, V216, P61, DOI 10.1016/S0378-5173(01)00572-5; Tu XK, 2011, INFLAMMATION, V34, P463, DOI 10.1007/s10753-010-9254-8; TUTTLE RS, 1989, AM J OBSTET GYNECOL, V161, P1319, DOI 10.1016/0002-9378(89)90691-1; van Wamel A, 2006, J CONTROL RELEASE, V112, P149, DOI 10.1016/j.jconrel.2006.02.007; Virmani Renu, 2006, Neurosurgery, V59, pS219; Zarnitsyn V, 2008, BIOPHYS J, V95, P4124, DOI 10.1529/biophysj.108.131664; Zhang H, 2014, NEUROCHEM RES, V39, P276, DOI 10.1007/s11064-013-1219-5; Zhang ZH, 2003, LIFE SCI, V72, P2465, DOI 10.1016/S0024-3205(03)00139-5; Zhao H, 2003, BIORHEOLOGY, V40, P179	44	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113673	10.1371/journal.pone.0113673	http://dx.doi.org/10.1371/journal.pone.0113673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409029	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200143
J	Zhao, HX; Zheng, NG; Ribi, WA; Zheng, HQ; Xue, L; Gong, F; Zheng, XX; Hu, FL				Zhao, Huixia; Zheng, Nenggan; Ribi, Willi A.; Zheng, Huoqing; Xue, Lei; Gong, Fan; Zheng, Xiaoxiang; Hu, Fuliang			Neuromechanism Study of Insect-Machine Interface: Flight Control by Neural Electrical Stimulation	PLOS ONE			English	Article							OCTOPAMINERGIC MODULATION; NEURONS; PLASTICITY; SEROTONIN; DOPAMINE; HONEYBEE; MUSCLE	The insect-machine interface (IMI) is a novel approach developed for man-made air vehicles, which directly controls insect flight by either neuromuscular or neural stimulation. In our previous study of IMI, we induced flight initiation and cessation reproducibly in restrained honeybees (Apis mellifera L.) via electrical stimulation of the bilateral optic lobes. To explore the neuromechanism underlying IMI, we applied electrical stimulation to seven subregions of the honeybee brain with the aid of a new method for localizing brain regions. Results showed that the success rate for initiating honeybee flight decreased in the order: alpha-lobe (or beta-lobe), ellipsoid body, lobula, medulla and antennal lobe. Based on a comparison with other neurobiological studies in honeybees, we propose that there is a cluster of descending neurons in the honeybee brain that transmits neural excitation from stimulated brain areas to the thoracic ganglia, leading to flight behavior. This neural circuit may involve the higher-order integration center, the primary visual processing center and the suboesophageal ganglion, which is also associated with a possible learning and memory pathway. By pharmacologically manipulating the electrically stimulated honeybee brain, we have shown that octopamine, rather than dopamine, serotonin and acetylcholine, plays a part in the circuit underlying electrically elicited honeybee flight. Our study presents a new brain stimulation protocol for the honeybee-machine interface and has solved one of the questions with regard to understanding which functional divisions of the insect brain participate in flight control. It will support further studies to uncover the involved neurons inside specific brain areas and to test the hypothesized involvement of a visual learning and memory pathway in IMI flight control.	[Zhao, Huixia; Zheng, Huoqing; Hu, Fuliang] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Nenggan; Xue, Lei; Gong, Fan; Zheng, Xiaoxiang] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310003, Zhejiang, Peoples R China; [Ribi, Willi A.] Private Univ Liechtenstein, Triesen, Liechtenstein; [Xue, Lei; Gong, Fan; Zheng, Xiaoxiang] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Xiaoxiang] Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zheng, NG (corresponding author), Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310003, Zhejiang, Peoples R China.	zng@cs.zju.edu.cn; flhu@zju.edu.cn	Zheng, Huoqing/AAQ-3307-2021		National Natural Science Foundation of China [61031002, 61003150]; Modern Agroindustry Technology Research System from the Ministry of Agriculture of China [CARS-45]; Fundamental Research Funds for the Central Universities; Zhejiang Provincial Natural Science Foundation of China [LZ14F020002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agroindustry Technology Research System from the Ministry of Agriculture of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The author FLH received the funding from the National Natural Science Foundation of China (No. 61031002), and the Modern Agroindustry Technology Research System from the Ministry of Agriculture of China (CARS-45). The author XXZ received the funding from the National Natural Science Foundation of China (No. 61003150), and the Fundamental Research Funds for the Central Universities. This work is partially supported by Zhejiang Provincial Natural Science Foundation of China (LZ14F020002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari SA, 2006, PROG AEROSP SCI, V42, P129, DOI 10.1016/j.paerosci.2006.07.001; Augustin H, 2011, JOVE-J VIS EXP, DOI 10.3791/2412; BAO L, 2011, THE 5 IEEE EMBS CONF, P558; BENTLEY D, 1977, J COMP PHYSIOL, V116, P19, DOI 10.1007/BF00605514; BLONDEAU J, 1981, J EXP BIOL, V92, P143; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; CLAASSEN DE, 1986, J NEUROBIOL, V17, P1, DOI 10.1002/neu.480170102; Ejaz N, 2011, JOVE-J VIS EXP, V49, P11; EVANS PD, 1977, NATURE, V270, P257, DOI 10.1038/270257a0; GOLDSTEIN RS, 1991, J COMP PHYSIOL A, V168, P103, DOI 10.1007/BF00217108; Goodman L.J., 1987, P158; Holzer R., 1997, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robot and Systems. Innovative Robotics for Real-World Applications. IROS '97 (Cat. No.97CH36108), P1514, DOI 10.1109/IROS.1997.656559; HUBER F, 1960, Z VERGL PHYSIOL, V44, P60, DOI 10.1007/BF00297863; IBBOTSON MR, 1990, J EXP BIOL, V148, P255; IBBOTSON MR, 1991, J COMP PHYSIOL A, V168, P91, DOI 10.1007/BF00217107; Leitch B, 2003, J COMP NEUROL, V462, P55, DOI 10.1002/cne.10698; Matheson T, 1997, J EXP BIOL, V200, P1317; Mentel T, 2003, J NEUROSCI, V23, P1109, DOI 10.1523/JNEUROSCI.23-04-01109.2003; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; Oleskevich S, 1997, J NEUROPHYSIOL, V78, P528, DOI 10.1152/jn.1997.78.1.528; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; OTTO D, 1971, Z VERGL PHYSIOL, V74, P227, DOI 10.1007/BF00297729; Otto D., 1968, Verhandlungen der Deutschen Zoologischen Gesellschaft, V31, P585; Pines DJ, 2006, J AIRCRAFT, V43, P290, DOI 10.2514/1.4922; RAMIREZ JM, 1991, BRAIN RES, V549, P332, DOI 10.1016/0006-8993(91)90477-D; ROWELL CHF, 1963, J EXP BIOL, V40, P271; Sato H, 2009, PROC IEEE MICR ELECT, P216, DOI 10.1109/MEMSYS.2009.4805357; Sato H., 2008, SOL STAT SENS ACT WO, V4, P90, DOI [10.31438/TRF.HH2008.26, DOI 10.31438/TRF.HH2008.26]; Sato H, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00199; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Sato H, 2008, PROC IEEE MICR ELECT, P164, DOI 10.1109/MEMSYS.2008.4443618; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tsang W, 2008, 12 INT C MIN SYST CH, P1922; Tsang WM, 2012, J NEUROSCI METH, V204, P355, DOI 10.1016/j.jneumeth.2011.11.026; Tsang WM, 2010, PROC IEEE MICR ELECT, P39, DOI 10.1109/MEMSYS.2010.5442570; Tsang WM, 2010, IEEE T BIO-MED ENG, V57, P1757, DOI 10.1109/TBME.2010.2041778; WHIM MD, 1988, J EXP BIOL, V134, P247; Zuo DC, 2006, ADV ROBOTICS, V20, P807, DOI 10.1163/156855306777681393	39	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113012	10.1371/journal.pone.0113012	http://dx.doi.org/10.1371/journal.pone.0113012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409523	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200057
J	Zhao, L; Sun, LN; Nie, HB; Wang, XL; Guan, GJ				Zhao, Long; Sun, Li-Na; Nie, Hui-Bin; Wang, Xue-Ling; Guan, Guang-Ju			RETRACTED: Berberine Improves Kidney Function in Diabetic Mice via AMPK Activation (Retracted article. See vol.12, artn. e0190562, 2017)	PLOS ONE			English	Article; Retracted Publication							PROTEIN-KINASE; ENDOTHELIAL DYSFUNCTION; PATHWAY; SUPEROXIDE; INHIBITION; EXPRESSION; MEDICINE; INSIGHTS; OXIDASE	Diabetic nephropathy is a major cause of morbidity and mortality in diabetic patients. Effective therapies to prevent the development of this disease are required. Berberine (BBR) has several preventive effects on diabetes and its complications. However, the molecular mechanism of BBR on kidney function in diabetes is not well defined. Here, we reported that activation of AMP-activated protein kinase (AMPK) is required for BBR-induced improvement of kidney function in vivo. AMPK phosphorylation and activity, productions of reactive oxygen species (ROS), kidney function including serum blood urea nitrogen (BUN), creatinine clearance (Ccr), and urinary protein excretion, morphology of glomerulus were determined in vitro or in vivo. Exposure of cultured human glomerulus mesangial cells (HGMCs) to BBR time-or dose-dependently activates AMPK by increasing the thr172 phosphorylation and its activities. Inhibition of LKB1 by siRNA or mutant abolished BBR-induced AMPK activation. Incubation of cells with high glucose (HG, 30 mM) markedly induced the oxidative stress of HGMCs, which were abolished by 5-aminoimidazole-4-carboxamide ribonucleoside, AMPK gene overexpression or BBR. Importantly, the effects induced by BBR were bypassed by AMPK siRNA transfection in HG-treated HGMCs. In animal studies, streptozotocin-induced hyperglycemia dramatically promoted glomerulosclerosis and impaired kidney function by increasing serum BUN, urinary protein excretion, and decreasing Ccr, as well as increased oxidative stress. Administration of BBR remarkably improved kidney function in wildtype mice but not in AMPK alpha 2-deficient mice. We conclude that AMPK activation is required for BBR to improve kidney function in diabetic mice.	[Zhao, Long; Sun, Li-Na; Nie, Hui-Bin; Wang, Xue-Ling; Guan, Guang-Ju] Shandong Univ, Hosp 2, Nephrol Res Inst, Jinan, Shandong, Peoples R China	Shandong University	Guan, GJ (corresponding author), Shandong Univ, Hosp 2, Nephrol Res Inst, Jinan, Shandong, Peoples R China.	guangj@sdu.edu.cn			Ministry of Science and Technology of China [2011BA110B05]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China 2011BA110B05.	Cao SJ, 2013, J ETHNOPHARMACOL, V149, P576, DOI 10.1016/j.jep.2013.07.025; Chang WG, 2013, METABOLISM, V62, P1159, DOI 10.1016/j.metabol.2013.02.007; Chatuphonprasert W, 2013, PHARM BIOL; Cho BJ, 2005, MOL CELLS, V20, P429; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Fan LX, 2013, BBA-GEN SUBJECTS, V1830, P5175, DOI 10.1016/j.bbagen.2013.07.010; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Han YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015420; Homolya L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091921; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jha JC, 2014, ADV CHRONIC KIDNEY D, V21, P318, DOI 10.1053/j.ackd.2014.03.008; Li Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/289264; Liang KW, 2008, EUR J PHARMACOL, V590, P343, DOI 10.1016/j.ejphar.2008.06.034; Liang KW, 2006, BIOCHEM PHARMACOL, V71, P806, DOI 10.1016/j.bcp.2005.12.028; Liao J, 2010, NEPHRON EXP NEPHROL, V114, pE61, DOI 10.1159/000254567; Lv XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047351; Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116; Molitch ME., 2004, DIABETES CARE, V27, pS79, DOI [10.2337/diacare.27.2007.S79, DOI 10.2337/DIACARE.27.2007.S79]; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Shen N, 2012, EUR J PHARMACOL, V694, P120, DOI 10.1016/j.ejphar.2012.07.052; Shen Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095786, 10.1371/journal.pone.0087894]; Tang LQ, 2014, MOL BIOL REP, V41, P3339, DOI 10.1007/s11033-014-3196-4; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Wan X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059794; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025436; Wang SX, 2008, CARDIOVASC RES, V80, P255, DOI 10.1093/cvr/cvn179; Wang SX, 2008, HYPERTENSION, V52, P484, DOI 10.1161/HYPERTENSIONAHA.108.112094; Wang SX, 2011, HYPERTENSION, V57, P1010, DOI 10.1161/HYPERTENSIONAHA.110.168906; Wang SX, 2012, NAT MED, V18, P902, DOI 10.1038/nm.2711; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Yang Y, 2014, J RECEPT SIG TRANSD, V22, P1; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Zhang MZ, 2012, J ETHNOPHARMACOL, V141, P111, DOI 10.1016/j.jep.2012.02.007; Zhao HL, 2012, DIABETES, V61, P933, DOI 10.2337/db11-1164; Zhou LB, 2011, BBA-MOL BASIS DIS, V1812, P527, DOI 10.1016/j.bbadis.2010.10.001	38	30	34	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113398	10.1371/journal.pone.0113398	http://dx.doi.org/10.1371/journal.pone.0113398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409232	Green Published, gold			2022-12-27	WOS:000345533200109
J	Sorbye, SW; Fismen, S; Gutteberg, TJ; Mortensen, ES; Skjeldestad, FE				Sorbye, Sveinung Wergeland; Fismen, Silje; Gutteberg, Tore Jarl; Mortensen, Elin Synnove; Skjeldestad, Finn Egil			HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE DISTRIBUTION; ASC-US CYTOLOGY; INTRAEPITHELIAL NEOPLASIA; CANCER; RISK; ADOLESCENTS; PERFORMANCE; DIAGNOSIS; TESTS; PREDICTORS	Background: In Norway, repeat cytology and HPV testing comprise delayed triage of women with minor cytological lesions. The objective of this study was to evaluate HPV DNA and HPV mRNA testing in triage of women with an ASC-US/LSIL diagnosis. Materials and Methods: We used repeat cytology, HPV DNA testing (Cobas 4800) and HPV mRNA testing (PreTect HPV-Proofer) to follow up 311 women aged 25-69 years with ASC-US/LSIL index cytology. Results: Of 311 women scheduled for secondary screening, 30 women (9.6%) had ASC-H/HSIL cytology at triage and 281 women (90.4%) had ASC-US/LSIL or normal cytology. The HPV DNA test was positive in 92 (32.7%) of 281 instances, and 37 (13.2%) were mRNA positive. Of the 132 women with repeated ASC-US/LSIL, we received biopsies from 97.0% (65/67) of the DNA-positive and 92.9% (26/28) of the mRNA-positive cases. The positive predictive values for CIN2+ were 21.5% (14/65) for DNA positive and 34.6% (9/26) for mRNA positive (ns). The odds ratio for being referred to colposcopy in DNA-positive cases were 2.8 times (95% CI: 1.8-4.6) higher that of mRNA-positive cases. Compared to the mRNA test, the DNA test detected four more cases of CIN2 and one case of CIN3. Conclusions: The higher positivity rate of the DNA test in triage leads to higher referral rate for colposcopy and biopsy, and subsequent additional follow-up of negative biopsies. By following mRNA-negative women who had ASC-US/LSIL at triage with cytology, the additional cases of CIN2+ gained in DNA screening can be discovered. Our study indicates that in triage of repeated ASC-US/LSIL, HPV mRNA testing is more specific and is more relevant in clinical use than an HPV DNA test.	[Sorbye, Sveinung Wergeland; Fismen, Silje; Mortensen, Elin Synnove] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Sorbye, Sveinung Wergeland; Gutteberg, Tore Jarl] Arctic Univ Norway, Dept Med Biol, Fac Hlth Sci, Tromso, Norway; [Gutteberg, Tore Jarl; Mortensen, Elin Synnove] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Skjeldestad, Finn Egil] Arctic Univ Norway, Inst Clin Med, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sorbye, SW (corresponding author), Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway.	sveinung.sorbye@unn.no	Sorbye, Sveinung Wergeland/AAE-7208-2020	Sorbye, Sveinung Wergeland/0000-0002-8250-3992	University Hospital of North Norway	University Hospital of North Norway	This research was supported by the University Hospital of North Norway (http://www.unn.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Arbyn M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008054.pub2; Arbyn Marc, 2010, Evid Based Med, V15, P13, DOI 10.1136/ebm.15.1.13; Baandrup L, 2012, GYNECOL ONCOL, V124, P281, DOI 10.1016/j.ygyno.2011.10.020; Benevolo M, 2011, J CLIN MICROBIOL; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; Budal EB, 2014, CANCER MED-US, V3, P182, DOI 10.1002/cam4.171; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Castle PE, 2007, AM J CLIN PATHOL, V127, P805, DOI 10.1309/PT3PNC1QL2F4D2VL; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Cattani P, 2009, J CLIN MICROBIOL, V47, P3895, DOI 10.1128/JCM.01275-09; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Denton KJ, 2010, AM J CLIN PATHOL, V134, P12, DOI 10.1309/AJCP3CD9YKYFJDQL; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; Ho GYF, 2011, J LOW GENIT TRACT DI, V15, P268, DOI 10.1097/LGT.0b013e3182216fef; Howell-Jones R, 2010, BRIT J CANCER, V103, P209, DOI 10.1038/sj.bjc.6605747; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Koliopoulos G, 2012, ACTA OBSTET GYN SCAN, V91, P794, DOI 10.1111/j.1600-0412.2012.01414.x; Korfage IJ, 2010, EUR J CANCER, V46, P134, DOI 10.1016/j.ejca.2009.07.003; Massad LS, 2009, J LOW GENIT TRACT DI, V13, P137, DOI 10.1097/LGT.0b013e31819308d4; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Moscicki AB, 2010, OBSTET GYNECOL, V116, P1373, DOI 10.1097/AOG.0b013e3181fe777f; Moscicki Anna-Barbara, 2008, J Natl Compr Canc Netw, V6, P101; Moscicki AB, 2008, OBSTET GYN CLIN N AM, V35, P633, DOI 10.1016/j.ogc.2008.09.004; Moscicki AB, 2008, OBSTET GYNECOL, V112, P1335, DOI 10.1097/AOG.0b013e31818c9222; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Nygard M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003460; Powell N, 2013, J CLIN VIROL, V58, P571, DOI 10.1016/j.jcv.2013.08.020; Ratnam S, 2010, J CLIN MICROBIOL, V48, P2779, DOI 10.1128/JCM.00382-10; Reuschenbach M, 2010, GYNECOL ONCOL, V119, P98, DOI 10.1016/j.ygyno.2010.06.011; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P946; Siddiqui MT, 2008, ARCH PATHOL LAB MED, V132, P1648, DOI 10.1043/1543-2165(2008)132[1648:PCIAHH]2.0.CO;2; Skare GB, 2014, ANN REP 2012 CANC RE; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; Sorbye SW, 2010, J VIROL METHODS, V169, P219, DOI 10.1016/j.jviromet.2010.07.011; Sorbye SW, 2013, CURR PHARM DESIGN, V19, P1401; Sorbye SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012724; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Verdoodt F, 2013, CANCER CYTOPATHOL, V121, P675, DOI 10.1002/cncy.21325; Zuchna C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.033; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	49	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112934	10.1371/journal.pone.0112934	http://dx.doi.org/10.1371/journal.pone.0112934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405981	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300064
J	Zhang, Q; Liu, HZ; Soukup, GA; He, DZZ				Zhang, Qian; Liu, Huizhan; Soukup, Garrett A.; He, David Z. Z.			Identifying MicroRNAs Involved in Aging of the Lateral Wall of the Cochlear Duct	PLOS ONE			English	Article							ENDOCOCHLEAR POTENTIAL REDUCTION; LIFE-SPAN; DIFFERENTIAL EXPRESSION; HEARING-LOSS; RECEPTOR; PROTEIN; CELLS; OVEREXPRESSION; APOPTOSIS; GROWTH	Age-related hearing loss is a progressive sensorineural hearing loss that occurs during aging. Degeneration of the organ of Corti and atrophy of the lateral wall of the cochlear duct (or scala media) in the inner ear are the two primary causes. MicroRNAs (miRNAs), a class of short non-coding RNAs that regulate the expression of mRNA/protein targets, are important regulators of cellular senescence and aging. We examined miRNA gene expression profiles in the lateral wall of two mouse strains, along with exploration of the potential targets of those miRNAs that showed dynamic expression during aging. We show that 95 and 60 miRNAs exhibited differential expression in C57 and CBA mice during aging, respectively. A majority of downregulated miRNAs are known to regulate pathways of cell proliferation and differentiation, while all upregulated miRNAs are known regulators in the pro-apoptotic pathways. By using apoptosis-related gene array and bioinformatic approaches to predict miRNA targets, we identify candidate miRNA-regulated genes that regulate apoptosis pathways in the lateral wall of C57 and CBA mice during aging.	[Zhang, Qian; Liu, Huizhan; Soukup, Garrett A.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Creighton University	Soukup, GA (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	GarrettSoukup@creighton.edu; hed@creighton.edu		He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NIH [R01 DC004696, R01 DC 009025]; Creighton University School of Medicine; NCRR, NIH) [RR17417-01]; University of Nebraska Microarray Facility; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417, P20RR018788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696, R01DC009025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creighton University School of Medicine; NCRR, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Nebraska Microarray Facility; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported by NIH grant R01 DC004696 to DH. QZ has been supported by a graduate student scholarship from Creighton University School of Medicine. GS is supported by NIH grant R01 DC 009025 from the NIDCD. We acknowledge the use of the Integrated Biological Imaging Facility (supported by the Creighton University School of Medicine and C06 Grant RR17417-01 from the NCRR, NIH) and the University of Nebraska Microarray Facility (supported by P20 Grant RR 018788 from the NCRR, NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2013, PHARMACOL RES, V75, P28, DOI 10.1016/j.phrs.2013.04.003; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bates DJ, 2009, BBA-GEN SUBJECTS, V1790, P970, DOI 10.1016/j.bbagen.2009.03.028; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; CABLE J, 1993, PIGM CELL RES, V6, P215, DOI 10.1111/j.1600-0749.1993.tb00605.x; Cammarata G, 2010, AM J HEMATOL, V85, P331, DOI 10.1002/ajh.21667; Chen L, 2013, CELL MOL NEUROBIOL, V33, P651, DOI 10.1007/s10571-013-9927-6; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Devarajan P, 2002, HEARING RES, V174, P45, DOI 10.1016/S0378-5955(02)00634-2; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823; Dynoodt P, 2013, J INVEST DERMATOL, V133, P201, DOI 10.1038/jid.2012.266; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; GILAD O, 1979, J AM AUDITORY SOC, V4, P207; GILAD O, 1979, J AM AUDITORY SOC, V4, P195; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Habtemichael N, 2010, MOL CELL NEUROSCI, V45, P297, DOI 10.1016/j.mcn.2010.07.003; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hu BH, 2009, NEUROSCIENCE, V161, P915, DOI 10.1016/j.neuroscience.2009.03.072; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Hutcheson R, 2013, ARTERIOSCL THROM VAS, V33, P727, DOI 10.1161/ATVBAHA.112.301116; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Jakob P, 2012, CARDIOVASC RES, V93, P614, DOI 10.1093/cvr/cvr311; Jin CY, 2013, BIOMED PHARMACOTHER, V67, P321, DOI 10.1016/j.biopha.2012.11.005; Judice TN, 2002, BRAIN RES PROTOC, V9, P65, DOI 10.1016/S1385-299X(01)00138-6; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kaur P, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/870150; Khan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068753; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Knauer SK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.25; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055532; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Mao ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065565; McKenna DJ, 2010, J VIROL, V84, P10644, DOI 10.1128/JVI.00703-10; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Mun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057850; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Nelson PT, 2011, NUCLEIC ACIDS RES, V39, P8163, DOI 10.1093/nar/gkr532; Ni C, 2013, PIGM CELL MELANOMA R, V26, P78, DOI 10.1111/pcmr.12030; Niu YN, 2011, IMMUNOLOGY, V133, P8, DOI 10.1111/j.1365-2567.2010.03374.x; Noguchi S, 2012, J BIOL CHEM, V287, P11769, DOI 10.1074/jbc.M111.325027; Ohlemiller KK, 2006, HEARING RES, V220, P10, DOI 10.1016/j.heares.2006.06.012; Ohlemiller Kevin K, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P439, DOI 10.1097/01.moo.0000134450.99615.22; Ohlemiller KK, 2011, JARO-J ASSOC RES OTO, V12, P45, DOI 10.1007/s10162-010-0238-z; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pichiorri Flavia, 2011, Frontiers in Genetics, V2, P22, DOI 10.3389/fgene.2011.00022; Provost P, 2010, AGING-US, V2, P166, DOI 10.18632/aging.100131; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Santovito D, 2013, EXPERT OPIN THER TAR, V17, P217, DOI 10.1517/14728222.2013.745512; Schacht J, 2005, AUDIOL NEURO-OTOL, V10, P243, DOI 10.1159/000086524; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315; STEEL KP, 1989, DEVELOPMENT, V107, P453; Sun ZH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-276; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; Trivellin G, 2012, AM J PHYSIOL-ENDOC M, V303, pE708, DOI 10.1152/ajpendo.00546.2011; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wei L, 2010, NEUROSCIENCE, V168, P288, DOI 10.1016/j.neuroscience.2010.03.015; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391; Yang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065256; Yao JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015546; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062786; Zhou DH, 2013, HEPATOB PANCREAT DIS, V12, P94, DOI 10.1016/S1499-3872(13)60012-0	81	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112857	10.1371/journal.pone.0112857	http://dx.doi.org/10.1371/journal.pone.0112857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405349	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300059
J	Dobbs, C; Nitschke, CR; Kendal, D				Dobbs, Cynnamon; Nitschke, Craig R.; Kendal, Dave			Global Drivers and Tradeoffs of Three Urban Vegetation Ecosystem Services	PLOS ONE			English	Article							GREEN SPACE; CARBON STORAGE; POLITICAL-ECONOMY; ECOLOGY; IMPACT; COVER; FORM; URBANIZATION; INEQUALITY; BENEFITS	Our world is increasingly urbanizing which is highlighting that sustainable cities are essential for maintaining human wellbeing. This research is one of the first attempts to globally synthesize the effects of urbanization on ecosystem services and how these relate to governance, social development and climate. Three urban vegetation ecosystem services (carbon storage, recreation potential and habitat potential) were quantified for a selection of a hundred cities. Estimates of ecosystem services were obtained from the analysis of satellite imagery and the use of well-known carbon and structural habitat models. We found relationships between ecosystem services, social development, climate and governance, however these varied according to the service studied. Recreation potential was positively related to democracy and negatively related to population. Carbon storage was weakly related to temperature and democracy, while habitat potential was negatively related to democracy. We found that cities under 1 million inhabitants tended to have higher levels of recreation potential than larger cities and that democratic countries have higher recreation potential, especially if located in a continental climate. Carbon storage was higher in full democracies, especially in a continental climate, while habitat potential tended to be higher in authoritarian and hybrid regimes. Similar to other regional or city studies we found that the combination of environment conditions, socioeconomics, demographics and politics determines the provision of ecosystem services. Results from this study showed the existence of environmental injustice in the developing world.	[Dobbs, Cynnamon] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Dobbs, Cynnamon; Nitschke, Craig R.] Univ Melbourne, Melbourne Sch Land & Environm, Sch Forest Sci & Ecosyst, Melbourne, Vic, Australia; [Kendal, Dave] Univ Melbourne, Sch Bot, Royal Bot Gardens Melbourne, Australian Res Ctr Urban Ecol, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Dobbs, C (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic, Australia.	cdobbsbr@gmail.com		kendal, dave/0000-0003-2816-1722; Nitschke, Craig/0000-0003-2514-9744				Alberti M, 2003, BIOSCIENCE, V53, P1169, DOI 10.1641/0006-3568(2003)053[1169:IHIEOA]2.0.CO;2; Andersson E, 2006, ECOL SOC, V11; Angel S., 2005, DYNAMICS GLOBAL URBA; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Bastian O, 2012, ECOL INDIC, V21, P7, DOI 10.1016/j.ecolind.2011.03.014; Begon M., 2009, ECOLOGY INDIVIDUALS; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Bjerke Tore, 2006, Urban Forestry & Urban Greening, V5, P35, DOI 10.1016/j.ufug.2006.01.006; Bowler DE, 2010, LANDSCAPE URBAN PLAN, V97, P147, DOI 10.1016/j.landurbplan.2010.05.006; Camara de Comercio de Bogota, 2009, CAP 3 GEST ESP PUBL, P37; Cilliers S, 2013, URBAN ECOSYST, V16, P681, DOI 10.1007/s11252-012-0254-3; Congalton R. G., 2009, MATER CHARACT, DOI DOI 10.1016/J.MATCHAR.2009.07.002; Conway Tenley M., 2007, Urban Forestry & Urban Greening, V6, P181, DOI 10.1016/j.ufug.2007.07.003; Daily G, 1997, WHAT ARE ECOSYSTEM S; Davies ZG, 2011, J APPL ECOL, V48, P1125, DOI 10.1111/j.1365-2664.2011.02021.x; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Demsar U, 2013, ANN ASSOC AM GEOGR, V103, P106, DOI 10.1080/00045608.2012.689236; Dobbs C, 2011, LANDSCAPE URBAN PLAN, V99, P196, DOI 10.1016/j.landurbplan.2010.11.004; Economist Intelligence Unit, 2011, DEM IND 2011 DEM STR; Edmondson JL, 2014, SCI TOTAL ENVIRON, V472, P444, DOI 10.1016/j.scitotenv.2013.11.025; Eigenbrod F, 2010, J APPL ECOL, V47, P377, DOI 10.1111/j.1365-2664.2010.01777.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ernstson H, 2008, ECOL SOC, V13; Escobedo F., 2006, URBAN FOR URBAN GREE, V4, P105, DOI DOI 10.1016/J.UFUG.2005.12.002; Escobedo FJ, 2011, ENVIRON POLLUT, V159, P2078, DOI 10.1016/j.envpol.2011.01.010; Farzin YH, 2006, J DEV ECON, V81, P213, DOI 10.1016/j.jdeveco.2005.04.003; Fortin MJ, 2012, SPAT STAT-NETH, V1, P100, DOI 10.1016/j.spasta.2012.02.004; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haase D, 2012, ECOL SOC, V17, DOI 10.5751/ES-04853-170322; Heynen N.C., 2003, PUBLIC WORKS MANAGEM, V8, P33, DOI [10.1177/1087724X03008001004, DOI 10.1177/1087724X03008001004, 10.1177/1087724X03253604]; Heynen N, 2006, URBAN AFF REV, V42, P3, DOI 10.1177/1078087406290729; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Huang JG, 2007, LANDSCAPE URBAN PLAN, V82, P184, DOI 10.1016/j.landurbplan.2007.02.010; Huber A., 1995, URBAN ECOLOGY BASIS; Hutyra LR, 2011, GLOBAL CHANGE BIOL, V17, P783, DOI 10.1111/j.1365-2486.2010.02238.x; Imhoff ML, 2004, REMOTE SENS ENVIRON, V89, P434, DOI 10.1016/j.rse.2003.10.015; Jim CY, 2009, CITIES, V26, P187, DOI 10.1016/j.cities.2009.03.003; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kinzig AP, 2005, ECOL SOC, V10; Kitchen L, 2013, INT J URBAN REGIONAL, V37, P1968, DOI 10.1111/j.1468-2427.2012.01138.x; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kuchelmeister G., 1998, URBAN FORESTRY ASIA; Luck GW, 2011, CONSERV BIOL, V25, P816, DOI 10.1111/j.1523-1739.2011.01685.x; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; McDonald RI, 2008, FRONT ECOL ENVIRON, V6, P99, DOI 10.1890/070038; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Mikkelson GM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000444; Millenium Ecosystem Assessment, 2003, EC HUM WELL BEING EC, P85; Millenium Ecosystem Assessment, 2003, DRIV CHANG EC THEIR; Millenium Ecosystem Assessment, 2003, INTR CONC FRAM EC HU, P26; Myeong S, 2006, REMOTE SENS ENVIRON, V101, P277, DOI 10.1016/j.rse.2005.12.001; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Nowak David J., 2008, Arboriculture & Urban Forestry, V34, P347; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Pedlowski M.A., 2002, URBAN ECOSYST, V6, P9, DOI [DOI 10.1023/A:1025910528583, 10.1023/A:1025910528583]; Perkins HA, 2004, CITIES, V21, P291, DOI 10.1016/j.cities.2004.04.002; Potere D, 2009, INT J REMOTE SENS, V30, P6531, DOI 10.1080/01431160903121134; Poudyal NC, 2010, FOREST POLICY ECON, V12, P432, DOI 10.1016/j.forpol.2010.05.002; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Saura S, 2011, FOREST ECOL MANAG, V262, P150, DOI 10.1016/j.foreco.2011.03.017; Schneider A, 2008, URBAN STUD, V45, P659, DOI 10.1177/0042098007087340; Schwarz N, 2010, LANDSCAPE URBAN PLAN, V96, P29, DOI 10.1016/j.landurbplan.2010.01.007; Singh VS, 2010, URBAN FOREST OPEN GR; Strohbach MW, 2012, LANDSCAPE URBAN PLAN, V104, P220, DOI 10.1016/j.landurbplan.2011.10.013; Szantoi Z, 2012, GISCI REMOTE SENS, V49, P428, DOI 10.2747/1548-1603.49.3.428; Tannier C, 2012, LANDSCAPE URBAN PLAN, V105, P128, DOI 10.1016/j.landurbplan.2011.12.008; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; UN, 2011, AR WE BUILD COMP LIV; UNDP, 2011, HUM DEV REP 2011 BET; Van de Voorde T, 2008, SENSORS-BASEL, V8, P3880, DOI 10.3390/s8063880; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Wang T, 2006, GLOBAL CHANGE BIOL, V12, P2404, DOI 10.1111/j.1365-2486.2006.01271.x; Wang Xiao-Jun, 2009, Journal of Forestry Research (Harbin), V20, P79, DOI 10.1007/s11676-009-0014-2; Wickham JD, 2010, LANDSCAPE URBAN PLAN, V94, P186, DOI 10.1016/j.landurbplan.2009.10.003; Wilkinson C, 2013, URBANIZATION BIODIVE; Zhang JW, 2014, J ENVIRON PSYCHOL, V38, P55, DOI 10.1016/j.jenvp.2013.12.013; Zhu Z, 2012, REMOTE SENS ENVIRON, V117, P72, DOI 10.1016/j.rse.2011.07.020	84	60	64	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113000	10.1371/journal.pone.0113000	http://dx.doi.org/10.1371/journal.pone.0113000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25402184	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700091
J	Ricker, M; Ramirez, VMP; von Rosen, D				Ricker, Martin; Pena Ramirez, Victor M.; von Rosen, Dietrich			A New Method to Compare Statistical Tree Growth Curves: The PL-GMANOVA Model and Its Application with Dendrochronological Data	PLOS ONE			English	Article								Growth curves are monotonically increasing functions that measure repeatedly the same subjects over time. The classical growth curve model in the statistical literature is the Generalized Multivariate Analysis of Variance (GMANOVA) model. In order to model the tree trunk radius (r) over time (t) of trees on different sites, GMANOVA is combined here with the adapted PL regression model Q=A.T+E, where for b not equal 0 : Q=Ei[-b.r] - Ei[-b.r] and for b=0 : Q=Ln[r/r(1)], A = initial relative growth to be estimated, T=t-t(1), and E is an error term for each tree and time point. Furthermore, Ei[-b.r] = integral (Exp[b.r]/r)dr, b = -1/TPR, with TPR being the turning point radius in a sigmoid curve, and r(1) at t(1) is an estimated calibrating time-radius point. Advantages of the approach are that growth rates can be compared among growth curves with different turning point radiuses and different starting points, hidden outliers are easily detectable, the method is statistically robust, and heteroscedasticity of the residuals among time points is allowed. The model was implemented with dendrochronological data of 235 Pinus montezumae trees on ten Mexican volcano sites to calculate comparison intervals for the estimated initial relative growth (A) over cap. One site (at the Popocatepetl volcano) stood out, with (A) over cap being 3.9 times the value of the site with the slowest-growing trees. Calculating variance components for the initial relative growth, 34% of the growth variation was found among sites, 31% among trees, and 35% over time. Without the Popocatepetl site, the numbers changed to 7%, 42%, and 51%. Further explanation of differences in growth would need to focus on factors that vary within sites and over time.	[Ricker, Martin] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico; [Pena Ramirez, Victor M.] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico; [von Rosen, Dietrich] Swedish Univ Agr Sci, Dept Energy & Technol, Uppsala, Sweden	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Swedish University of Agricultural Sciences	Ricker, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico.	mricker@ib.unam.mx						[Anonymous], 2006, SAS MIXED MODELS; Belsley D. A., 1991, CONDITIONING DIAGNOS; Burkhart H. E., 2012, MODELING FOREST TREE; CONOVER W. J, 1980, PRACTICAL NONPARAMET; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Duncan T, 2006, INTRO LATENT VARIABL; Enders W., 2010, APPL ECONOMETRIC TIM, Vthird; Fisher RA., 1921, ANN APPL BIOL, DOI [10.1111/j.1744-7348.1921.tb05524.x, DOI 10.1111/J.1744-7348.1921.TB05524.X]; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; FLIGNER MA, 1981, J AM STAT ASSOC, V76, P162, DOI 10.2307/2287062; GABRIEL KR, 1978, J AM STAT ASSOC, V73, P724, DOI 10.2307/2286265; Golub GH., 2013, MATRIX COMPUTATIONS; HUI SL, 1984, BIOMETRICS, V40, P691, DOI 10.2307/2530912; Hunt R, 1982, PLANT GROWTH ANAL; Jeffrey A., 1995, HDB MATH FORMULAS IN; KHATRI CG, 1966, ANN I STAT MATH, V18, P75, DOI 10.1007/BF02869518; Kiviste A., 2002, FUNCIONES CRECIMIENT; Kollo T., 2005, MATH ITS APPL, V579; Kshirsagar A.M., 1995, GROWTH CURVES; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; LISKI EP, 1985, COMMUN STAT-SIMUL C, V14, P13, DOI 10.1080/03610918508812423; Maddala G. S., 2009, INTRO ECONOMETRICS; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Muller KE, 2006, LINEAR MODEL THEORY; Pan J., 2002, GROWTH CURVE MODELS; Pena Ramirez VM, 2013, THESIS U NACL AUTONO; Pinheiro J, 2001, MIXED EFFECTS MODELS; POTTHOFF RF, 1964, BIOMETRIKA, V51, P313, DOI [10.2307/2334137, 10.1093/biomet/51.3-4.313]; Ricker M, 2004, FOREST SCI, V50, P213; Ricker M, 2007, CAN J FOREST RES, V37, P977, DOI 10.1139/X06-304; Rohlf F.J., 2012, STAT TABLES; Ryan TP, 2009, MODERN REGRESSION AN; Sokal R. R., 2012, BIOMETRY; Speer JH, 2010, FUNDAMENTALS TREE RI; Srivastava M., 2002, METHODS MULTIVARIATE; Srivastava MS, 1999, STAT TEXTB MONOG, V159, P547; Stroup W. W., 2013, GEN LINEAR MIXED MOD; Timm NH, 2002, UNIVARIATE MULTIVARI; Verbeke G, 2000, LINEAR MIXED MODELS; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; VONROSEN D, 1995, ANN I STAT MATH, V47, P129, DOI 10.1007/BF00773417; VONROSEN D, 1991, COMMUN STAT THEORY, V20, P2791, DOI 10.1080/03610929108830668; Weerahandi S., 2004, GEN INFERENCE REPEAT; Weiskittel AR, 2011, FOREST GROWTH AND YIELD MODELING, P1, DOI 10.1002/9781119998518; Wenk G., 1990, WALDERTRAGSLEHRE	47	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112396	10.1371/journal.pone.0112396	http://dx.doi.org/10.1371/journal.pone.0112396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402427	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700043
J	Volpe, D; Giantin, MG; Fasano, A				Volpe, Daniele; Giantin, Maria Giulia; Fasano, Alfonso			A Wearable Proprioceptive Stabilizer (Equistasi (R)) for Rehabilitation of Postural Instability in Parkinson's Disease: A Phase II Randomized Double-Blind, Double-Dummy, Controlled Study	PLOS ONE			English	Article							TENDON VIBRATION; MUSCLE VIBRATION; CONTROLLED-TRIAL; GROUP IA; PEOPLE; RESPONSES; BALANCE; FALLS; EXERCISE; STANCE	Background: Muscle spindles endings are extremely sensitive to externally applied vibrations, and under such circumstances they convey proprioceptive inflows to the central nervous system that modulate the spinal reflexes excitability or the muscle responses elicited by postural perturbations. The aim of this pilot study is to test the feasibility and effectiveness of a balance training program in association with a wearable proprioceptive stabilizer (Equistasi) that emits focal mechanical vibrations in patients with PD. Methods: Forty patients with PD were randomly divided in two groups wearing an active or inactive device. All the patients received a 2-month intensive program of balance training. Assessments were performed at baseline, after the rehabilitation period (T1), and two more months after (T2). Posturographic measures were used as primary endpoint; secondary measures of outcome included the number of falls and several clinical scales for balance and quality of life. Results: Both groups improved at the end of the rehabilitation period and we did not find significant between-group differences in any of the principal posturographic measures with the exception of higher sway area and limit of stability on the instrumental functional reach test during visual deprivation at T1 in the Equistasi group. As for the secondary outcome, we found an overall better outcome in patients enrolled in the Equistasi group: 1) significant improvement at T1 on Berg Balance Scale (+45.0%, p = .026), Activities-specific Balance Confidence (+83.7, p = .004), Falls Efficacy Scale (-33.3%, p = .026) and PDQ-39 (-48.8%, p = .004); 2) sustained improvement at T2 in terms of UPDRS-III, Berg Balance Scales, Time Up and Go and PDQ-39; 3) significant and sustained reduction of the falls rate. Conclusions: This pilot trial shows that a physiotherapy program for training balance in association with focal mechanical vibration exerted by a wearable proprioceptive stabilizer might be superior than rehabilitation alone in improving patients' balance.	[Volpe, Daniele; Giantin, Maria Giulia] S Raffaele Arcangelo Fatebenefratelli Hosp, Dept Phys Med & Rehabil, Venice, Italy; [Fasano, Alfonso] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON M5T 2S8, Canada; [Fasano, Alfonso] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON M5T 2S8, Canada; [Fasano, Alfonso] Univ Toronto, Div Neurol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Volpe, D (corresponding author), S Raffaele Arcangelo Fatebenefratelli Hosp, Dept Phys Med & Rehabil, Venice, Italy.	dott.dvolpe@libero.it	Fasano, Alfonso/K-2558-2018	Fasano, Alfonso/0000-0001-5346-0180				Abdo WF, 2006, J NEUROL NEUROSUR PS, V77, P1367, DOI 10.1136/jnnp.2006.091322; Allen NE, 2011, MOVEMENT DISORD, V26, P1605, DOI 10.1002/mds.23790; Ashburn A, 2007, J NEUROL NEUROSUR PS, V78, P678, DOI 10.1136/jnnp.2006.099333; BECKLEY DJ, 1993, ELECTROEN CLIN NEURO, V89, P22, DOI 10.1016/0168-5597(93)90080-9; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Berardelli A, 2013, EUR J NEUROL, V20, P16, DOI 10.1111/ene.12022; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Bosco C, 1999, CLIN PHYSIOL, V19, P183; Bove M, 2003, J PHYSIOL-LONDON, V550, P617, DOI 10.1113/jphysiol.2003.043331; BURKE D, 1976, J PHYSIOL-LONDON, V261, P695, DOI 10.1113/jphysiol.1976.sp011581; Conte A, 2013, NAT REV NEUROL, V9, P687, DOI 10.1038/nrneurol.2013.224; CORDO P, 1995, J NEUROPHYSIOL, V74, P1675, DOI 10.1152/jn.1995.74.4.1675; Courtine G, 2007, J NEUROPHYSIOL, V97, P772, DOI 10.1152/jn.00764.2006; De Nunzio AM, 2010, CLIN NEUROPHYSIOL, V121, P240, DOI 10.1016/j.clinph.2009.10.018; De Nunzio AM, 2008, MOVEMENT DISORD, V23, P2186, DOI 10.1002/mds.22201; Demirci M, 1997, ANN NEUROL, V41, P781, DOI 10.1002/ana.410410614; DESMEDT JE, 1978, J PHYSIOL-LONDON, V285, P197, DOI 10.1113/jphysiol.1978.sp012567; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; EKLUND G, 1972, UPSALA J MED SCI, V77, P112, DOI 10.1517/03009734000000016; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Fasano A, 2012, NEUROL SCI, V33, P1215, DOI 10.1007/s10072-012-1126-6; Fiorio M, 2007, NEUROSCI LETT, V417, P312, DOI 10.1016/j.neulet.2007.02.050; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodwin VA, 2011, J NEUROL NEUROSUR PS, V82, P1232, DOI 10.1136/jnnp-2011-300919; Hirsch MA, 2003, ARCH PHYS MED REHAB, V84, P1109, DOI 10.1016/S0003-9993(03)00046-7; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HORAK FB, 1992, J NEUROL SCI, V111, P46, DOI 10.1016/0022-510X(92)90111-W; Ivanenko YP, 2000, J NEUROPHYSIOL, V84, P1737, DOI 10.1152/jn.2000.84.4.1737; Jacobs JV, 2006, NEUROSCIENCE, V141, P999, DOI 10.1016/j.neuroscience.2006.04.014; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; LACKNER JR, 1979, AVIAT SPACE ENVIR MD, V50, P346; Lamont RM, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/856237; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; MARSDEN CD, 1969, BRAIN, V92, P647, DOI 10.1093/brain/92.3.647; Menant JC, 2011, MOVEMENT DISORD, V26, P637, DOI 10.1002/mds.23547; Mohapatra S, 2012, EXP BRAIN RES, V217, P197, DOI 10.1007/s00221-011-2986-3; Morris ME, 2006, PHYS THER, V86, P1426, DOI 10.2522/ptj.20050277; Morris ME, 2010, PHYS THER, V90, P280, DOI 10.2522/ptj.20090091; Morris ME, 2009, MOVEMENT DISORD, V24, P64, DOI 10.1002/mds.22295; Munneke M, 2010, LANCET NEUROL, V9, P46, DOI 10.1016/S1474-4422(09)70327-8; Nanhoe-Mahabier W, 2012, PARKINSONISM RELAT D, V18, P1017, DOI 10.1016/j.parkreldis.2012.05.018; Nardone A, 2005, CLIN NEUROPHYSIOL, V116, P1370, DOI 10.1016/j.clinph.2005.01.015; Nardone A, 2006, MOVEMENT DISORD, V21, P1515, DOI 10.1002/mds.21015; Necking LE, 1996, J HAND SURG-BRIT EUR, V21B, P753, DOI 10.1016/S0266-7681(96)80180-X; Nieuwboer A, 2009, PARKINSONISM RELAT D, V15, pS53, DOI 10.1016/S1353-8020(09)70781-3; Nonnekes J, 2013, EXPERT REV NEUROTHER, V13, P1303, DOI 10.1586/14737175.2013.839231; Paul SS, 2012, GAIT POSTURE, V36, P639, DOI 10.1016/j.gaitpost.2012.04.013; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rocchi L, 2006, NEUROSCI LETT, V406, P128, DOI 10.1016/j.neulet.2006.07.027; Rochester L, 2010, MOVEMENT DISORD, V25, P906, DOI 10.1002/mds.22978; ROLL JP, 1982, EXP BRAIN RES, V47, P177; SCHIEPPATI M, 1991, BRAIN, V114, P1227, DOI 10.1093/brain/114.3.1227; SCHIEPPATI M, 1984, EXP BRAIN RES, V56, P448; SCHIEPPATI M, 1994, ELECTROEN CLIN NEURO, V93, P286, DOI 10.1016/0168-5597(94)90031-0; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Slijper H, 2004, BRAIN RES, V1015, P57, DOI 10.1016/j.brainres.2004.04.054; Smiley-Oyen AL, 2002, GAIT POSTURE, V16, P188, DOI 10.1016/S0966-6362(02)00005-X; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Tan D, 2012, PARKINSONISM RELAT D, V18, P117, DOI 10.1016/j.parkreldis.2011.07.014; Thompson Mary, 2007, J Geriatr Phys Ther, V30, P43; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Valkovic P, 2006, MOVEMENT DISORD, V21, P59, DOI 10.1002/mds.20679; Valkovic P, 2006, NEUROSCI LETT, V401, P92, DOI 10.1016/j.neulet.2006.02.073	69	22	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112065	10.1371/journal.pone.0112065	http://dx.doi.org/10.1371/journal.pone.0112065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401967	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700026
J	Xie, YY; Xue, W; Shao, XH; Che, XJ; Xu, WJ; Ni, ZH; Mou, S				Xie, Yuanyuan; Xue, Wei; Shao, Xinghua; Che, Xiajing; Xu, Weijia; Ni, Zhaohui; Mou, Shan			Analysis of a Urinary Biomarker Panel for Obstructive Nephropathy and Clinical Outcomes	PLOS ONE			English	Article							KIDNEY INJURY MOLECULE-1; ACID-BINDING PROTEIN; GELATINASE-ASSOCIATED LIPOCALIN; CARDIAC-SURGERY; RENAL-DISEASE; EXCRETION; KIM-1; MARKER; PERFORMANCE; PROGRESSION	Objectives: To follow up renal function changes in patients with obstructive nephropathy and to evaluate the predictive value of biomarker panel in renal prognosis. Methods: A total of 108 patients with obstructive nephropathy were enrolled in the study; 90 patients completed the follow-up. At multiple time points before and after obstruction resolution, urinary samples were prospectively collected in patients with obstructive nephropathy; the levels of urinary kidney injury molecule-1 (uKIM-1), liver-type fatty acid-binding protein (uL-FABP), and neutrophil gelatinase associated lipocalin (uNGAL) were determined by enzyme-linked immunosorbent assay (ELISA). After 1 year of follow-up, the predictive values of biomarker panel for determining the prognosis of obstructive nephropathy were evaluated. Results: uKIM-1 (r = 0.823), uL-FABP (r = 0.670), and uNGAL (r = 0.720) levels were positively correlated with the serum creatinine level (all P<0.01). The levels of uKIM-1, uL-FABP, and uNGAL were higher in the renal function deterioration group than in the renal function stable group. Cox regression analysis revealed that the 72-h postoperative uKIM-1 level and the preoperative and 72-h postoperative uL-FABP levels were all risk factors for renal function deterioration (all P<0.01). The area under the curve of Receiver Operating Characteristic(ROC-AUCs) of 72-h postoperative uKIM-1, preoperative uL-FABP, and 72-h postoperative uL-FABP were 0.786, 0.911, and 0.875, respectively. When the combined preoperative uKIM-1, uL-FABP, and uNGAL levels or combined 72-h postoperative uKIM-1, uL-FABP, and uNGAL levels were considered, the accuracy of prediction for renal prognosis was markedly increased, with an ROC-AUC of 0.967 or 0.964, respectively. Kaplan-Meier survival curve analysis demonstrated that a 72-h postoperative uKIM-1>96.69 pg/mg creatinine (Cr), a preoperative uL-FABP>154.62 ng/mg Cr, and a 72-h postoperative uL-FABP>99.86 ng/mg Cr were all positively correlated with poor prognosis (all P<0.01). Conclusion: Biomarker panel may be used as a marker for early screening of patients with obstructive nephropathy and for determining poor prognosis.	[Xie, Yuanyuan; Shao, Xinghua; Che, Xiajing; Xu, Weijia; Ni, Zhaohui; Mou, Shan] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nephrol,Mol Cell Lab Kidney Dis, Shanghai 200030, Peoples R China; [Xue, Wei] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xue, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Urol, Shanghai 200030, Peoples R China.	uroxuewei@163.com; shan_mou@126.com	shao, xinghua/GVU-8320-2022	mou, shan/0000-0003-4160-1681	National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China [2014DFT30090]; National Natural Science Foundation of China [81102700, 81373865, 81370794]; Science and Technology Commission of Shanghai Municipality, China [12401906400, 14140903200]; Shanghai Health Bureau [ZYSNXD012-RC-ZXY017]; Funding scheme for training young teachers in Colleges and universities in Shanghai	National Basic Research Program of China 973 Program(National Basic Research Program of China); Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Health Bureau; Funding scheme for training young teachers in Colleges and universities in Shanghai	This study was supported in part by the National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517602). The study was also sponsored by Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China (2014DFT30090), the National Natural Science Foundation of China (81102700, 81373865 and 81370794) and by grants 12401906400 and 14140903200 from the Science and Technology Commission of Shanghai Municipality, China, and ZYSNXD012-RC-ZXY017 from the Shanghai Health Bureau. Funding scheme for training young teachers in Colleges and universities in Shanghai was also included in the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavsar NA, 2012, AM J KIDNEY DIS, V60, P233, DOI 10.1053/j.ajkd.2012.02.336; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Butt MJ, 2007, KIDNEY INT, V72, P936, DOI 10.1038/sj.ki.5002457; Chaturvedi S, 2009, INT J BIOL SCI, V5, P128; Chevalier RL, 2010, PEDIATR NEPHROL, V25, P687, DOI 10.1007/s00467-009-1316-5; Dear JW, 2008, KIDNEY INT, V74, P7, DOI 10.1038/ki.2008.126; Fu Peng, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P641, DOI 10.3736/jcim20120607; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Kamijo A, 2005, J LAB CLIN MED, V145, P125, DOI 10.1016/j.lab.2004.12.003; Kamijo A, 2004, AM J PATHOL, V165, P1243, DOI 10.1016/S0002-9440(10)63384-6; KLAHR S, 1991, AM J KIDNEY DIS, V18, P689, DOI 10.1016/S0272-6386(12)80611-1; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Mou S, 2012, CLIN CHIM ACTA, V413, P187, DOI 10.1016/j.cca.2011.09.018; Nakamura T, 2006, AM J KIDNEY DIS, V47, P439, DOI 10.1053/j.ajkd.2005.11.006; Parikh CR, 2013, CLIN J AM SOC NEPHRO, V8, P1079, DOI 10.2215/CJN.10971012; Ponte B, 2008, NEPHROL DIAL TRANSPL, V23, P3859, DOI 10.1093/ndt/gfn398; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Shao XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084131; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Smith JM, 2007, PEDIATR TRANSPLANT, V11, P366, DOI 10.1111/j.1399-3046.2007.00704.x; Soni SS, 2009, BLOOD PURIFICAT, V28, P165, DOI 10.1159/000227785; Srisawat N, 2011, CLIN J AM SOC NEPHRO, V6, P1815, DOI 10.2215/CJN.11261210; Tang XJ, 2014, CURR OPIN NEPHROL HY, V23, P385, DOI 10.1097/01.mnh.0000447017.28852.52; Trnka P, 2012, CLIN J AM SOC NEPHRO, V7, P1567, DOI 10.2215/CJN.09640911; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Xie YY, 2014, BIOMARK MED, V8, P543, DOI 10.2217/bmm.13.136; Xue W, 2014, NEPHROLOGY, V19, P186, DOI 10.1111/nep.12173	31	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112865	10.1371/journal.pone.0112865	http://dx.doi.org/10.1371/journal.pone.0112865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402279	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700079
J	Wu, CH; Hung, TH; Chen, CC; Ke, CH; Lee, CY; Wang, PY; Chen, SF				Wu, Chun-Hu; Hung, Tai-Ho; Chen, Chien-Cheng; Ke, Chia-Hua; Lee, Chun-Yen; Wang, Pei-Yi; Chen, Szu-Fu			Post-Injury Treatment with 7,8-Dihydroxyflavone, a TrkB Receptor Agonist, Protects against Experimental Traumatic Brain Injury via PI3K/Akt Signaling	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; NEUROTROPHIC FACTOR; CEREBRAL-ISCHEMIA; NEURONAL INJURY; MOTOR FUNCTION; BLOOD-BRAIN; MOUSE MODEL; BDNF; PATHWAYS; KINASE	Tropomyosin-related kinase B (TrkB) signaling is critical for promoting neuronal survival following brain damage. The present study investigated the effects and underlying mechanisms of TrkB activation by the TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) on traumatic brain injury (TBI). Mice subjected to controlled cortical impact received intraperitoneal 7,8-DHF or vehicle injection 10 min post-injury and subsequently daily for 3 days. Behavioral studies, histology analysis and brain water content assessment were performed. Levels of TrkB signaling-related molecules and apoptosis-related proteins were analyzed. The protective effect of 7,8-DHF was also investigated in primary neurons subjected to stretch injury. Treatment with 20 mg/kg 7,8-DHF attenuated functional deficits and brain damage up to post-injury day 28. 7,8-DHF also reduced brain edema, neuronal death, and apoptosis at day 4. These changes were accompanied by a significant decrease in cleaved caspase-3 and increase in Bcl-2/Bax ratio. 7,8-DHF enhanced phosphorylation of TrkB, Akt (Ser473/Thr308), and Bad at day 4, but had no effect on Erk 1/2 phosphorylation. Moreover, 7,8-DHF increased brain-derived neurotrophic factor levels and promoted cAMP response element-binding protein (CREB) activation. This beneficial effect was attenuated by inhibition of TrkB or PI3K/Akt. 7,8-DHF also promoted survival and reduced apoptosis in cortical neurons subjected to stretch injury. Remarkably, delayed administration of 7,8-DHF at 3 h post-injury reduced brain tissue damage. Our study demonstrates that activation of TrkB signaling by 7,8-DHF protects against TBI via the PI3K/Akt but not Erk pathway, and this protective effect may be amplified via the PI3K/Akt-CREB cascades.	[Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan; [Wu, Chun-Hu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Chen, Chien-Cheng; Ke, Chia-Hua; Lee, Chun-Yen; Wang, Pei-Yi; Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Chang Gung Memorial Hospital; Chang Gung University; Cheng Hsin General Hospital	Chen, SF (corresponding author), Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan.	szufuchen@yahoo.com.tw	Hung, Tai-Ho/C-7584-2011; Hung, Tai-Ho/ABD-1800-2020; WU, CHUN-HU/P-3958-2018	Hung, Tai-Ho/0000-0003-2354-7060; WU, CHUN-HU/0000-0001-6851-7936	National Science Council of Taiwan, R.O.C. [NSC 101-2314-B-350-001-MY3]; Cheng Hsin General Hospital	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital	Funding provided by the National Science Council of Taiwan, R.O.C.(NSC 101-2314-B-350-001-MY3) and the Cheng Hsin General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Granado-Serrano AB, 2006, J NUTR, V136, P2715, DOI 10.1093/jn/136.11.2715; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen J, 2011, NEUROSCI LETT, V499, P181, DOI 10.1016/j.neulet.2011.05.054; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Han XH, 2014, NEUROCHEM INT, V64, P18, DOI 10.1016/j.neuint.2013.10.018; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Hung PL, 2013, STROKE, V44, P2275, DOI 10.1161/STROKEAHA.113.001552; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jeon SJ, 2011, NEUROSCI RES, V69, P214, DOI 10.1016/j.neures.2010.11.008; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; Jiang SN, 2013, MOL THER, V21, P1985, DOI 10.1038/mt.2013.183; Kim DH, 2004, J NEUROSURG, V100, P79, DOI 10.3171/jns.2004.100.1.0079; Kong ANT, 2000, ARCH PHARM RES, V23, P1, DOI 10.1007/BF02976458; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Park HY, 2012, INT J MOL MED, V29, P1146, DOI 10.3892/ijmm.2012.935; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Swart C, 2014, EXP GERONTOL, V58, P279, DOI 10.1016/j.exger.2014.09.003; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Tsai T, 2013, MOL CELL NEUROSCI; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang B, 2014, J MOL HISTOL, V45, P129, DOI 10.1007/s10735-013-9539-y; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005	49	60	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113397	10.1371/journal.pone.0113397	http://dx.doi.org/10.1371/journal.pone.0113397			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415296	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600045
J	Bu, ZQ; Chen, ZJ; Huang, GN; Zhang, HW; Wu, QF; Ma, YP; Shi, JZ; Xu, YW; Zhang, SY; Zhang, CL; Zhao, XM; Zhang, B; Huang, YH; Sun, ZY; Kang, YF; Wu, RR; Wu, XQ; Sun, HX; Sun, YP				Bu, Zhiqin; Chen, Zi-Jiang; Huang, Guoning; Zhang, Hanwang; Wu, Qiongfang; Ma, Yanping; Shi, Juanzi; Xu, Yanwen; Zhang, Songying; Zhang, Cuilian; Zhao, Xiaoming; Zhang, Bo; Huang, Yuanhua; Sun, Zhengyi; Kang, Yuefan; Wu, Riran; Wu, Xueqing; Sun, Haixiang; Sun, Yingpu			Live Birth Sex Ratio after In Vitro Fertilization and Embryo Transfer in China - An Analysis of 121,247 Babies from 18 Centers	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; BLASTOCYST TRANSFER; INFANTS BORN; IMPACT; STAGE	In order to study the impact of procedures of IVF/ICSI technology on sex ratio in China, we conducted this multi-center retrospective study including 121,247 babies born to 93,895 women in China. There were 62,700 male babies and 58,477 female babies, making the sex ratio being 51.8% (Male: Female = 107: 100). In univariate logistic regression analysis, sex ratio was imbalance toward females of 50.3% when ICSI was preformed compared to 47.7% when IVF was used (P < 0.01). The sex ratio in IVF/ICSI babies was significantly higher toward males in transfers of blastocyst (54.9%) and thawed embryo (52.4%) when compared with transfers of cleavage stage embryo (51.4%) and fresh embryo (51.5%), respectively. Multiple delivery was not associated with sex ratio. However, in multivariable logistic regression analysis after controlling for related factors, only ICSI (adjusted OR = 0.90, 95%CI: 0.88-0.93; P < 0.01) and blastocyst transfer (adjusted OR = 1.14, 95% CI: 1.09-1.20; P < 0.01) were associated with sex ratio in IVF/ICSI babies. In conclusion, the live birth sex ratio in IVF/ICSI babies was influenced by the use of ICSI, which may decrease the percentage of male offspring, or the use of blastocyst transfer, which may increase the percentage of male offspring.	[Bu, Zhiqin; Sun, Yingpu] Zhengzhou Univ, Reprod Med Ctr, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Sun, Haixiang] Nanjing Univ, Nanjing Drum Tower Hosp, Reprod Med Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Zi-Jiang] Shandong Univ, Ctr Reprod Med, Prov Hosp, Jinan 250100, Peoples R China; [Huang, Guoning] Chongqing Obstet & Gynecol Hosp, Chongqing Reprod & Genet Inst, Chongqing, Peoples R China; [Zhang, Hanwang] Huazhong Univ Sci & Technol, Reprod Med Ctr, Tongji Hosp, Wuhan 430074, Peoples R China; [Wu, Qiongfang] Women & Children Hosp Jiangxi Prov, Reprod Med Ctr, Nanchang, Peoples R China; [Ma, Yanping] First Peoples Hosp Yunnan Prov, Reprod Med Ctr, Kunming, Peoples R China; [Shi, Juanzi] Maternal & Child Hlth Care Hosp Shaanxi Prov, Reprod Med Ctr, Xian, Peoples R China; [Xu, Yanwen] Sun Yat Sen Univ, Reprod Med Ctr, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhang, Songying] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Reprod Med Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Cuilian] Henan Prov Peoples Hosp, Reprod Med Ctr, Zhengzhou, Peoples R China; [Zhao, Xiaoming] Shanghai Jiao Tong Univ, Reprod Med Ctr, Renji Hosp, Shanghai 200030, Peoples R China; [Zhang, Bo] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Reprod Med Ctr, Nanning, Peoples R China; [Huang, Yuanhua] Hainan Med Coll, Reprod Med Ctr, Affiliated Hosp, Haikou, Peoples R China; [Sun, Zhengyi] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100021, Peoples R China; [Sun, Zhengyi] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Kang, Yuefan] Maternal & Childrens Hlth Hosp Fujian Prov, Reprod Med Ctr, Fuzhou, Peoples R China; [Wu, Riran] Boai Hosp Zhongshan, Reprod Med Ctr, Zhongshan, Peoples R China; [Wu, Xueqing] Women & Childrens Hosp Shanxi Prov, Reprod Med Ctr, Taiyuan, Peoples R China	Zhengzhou University; Nanjing University; Shandong University; Huazhong University of Science & Technology; Sun Yat Sen University; Zhejiang University; Zhengzhou University; Shanghai Jiao Tong University; Hainan Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Shanxi Medical University	Sun, HX (corresponding author), Nanjing Univ, Nanjing Drum Tower Hosp, Reprod Med Ctr, Nanjing 210008, Jiangsu, Peoples R China.	stevensunz@163.com; syp2008@vip.sina.com	Yan, Junhao/AAH-8310-2019; Chen, Zi-Jiang/GOE-6119-2022; Li, Yuan/GXV-1310-2022	Wu, Qiongfang/0000-0002-8432-7240; Chen, Zi-Jiang/0000-0001-6637-6631				Blake DA, 2007, COCHRANE DB SYST REV, pD2118; Bonduelle M, 2002, HUM REPROD, V17, P671, DOI 10.1093/humrep/17.3.671; Chang HJ, 2009, FERTIL STERIL, V91, P2381, DOI 10.1016/j.fertnstert.2008.03.066; Dar S, 2013, HUM REPROD, V28, P924, DOI 10.1093/humrep/des448; Dar S, 2014, HUMAN REPROD UPDATE, pu1; Dean JH, 2010, BJOG-INT J OBSTET GY, V117, P1628, DOI 10.1111/j.1471-0528.2010.02731.x; Fernando D, 2012, FERTIL STERIL, V97, P579, DOI 10.1016/j.fertnstert.2011.12.032; Henman M, 2005, FERTIL STERIL, V84, P1620, DOI 10.1016/j.fertnstert.2005.05.064; Hunault CC, 2004, HUM REPROD, V19, P2019, DOI 10.1093/humrep/deh365; Ishihara O, 2014, FERTIL STERIL, V101, P128, DOI 10.1016/j.fertnstert.2013.09.025; James WH, 2012, J THEOR BIOL, V310, P183, DOI 10.1016/j.jtbi.2012.06.038; Kausche A, 2001, FERTIL STERIL, V76, P688, DOI 10.1016/S0015-0282(01)02010-6; Kurinczuk JJ, 2003, HUM REPROD, V18, P925, DOI 10.1093/humrep/deg217; Lin PY, 2009, FERTIL STERIL, V92, P1764, DOI 10.1016/j.fertnstert.2009.05.011; Luke B, 2009, FERTIL STERIL, V92, P1579, DOI 10.1016/j.fertnstert.2008.08.107; Luna M, 2007, FERTIL STERIL, V87, P519, DOI 10.1016/j.fertnstert.2006.06.058; MACMAHON B, 1954, AM J HUM GENET, V6, P284; MCMILLEN MM, 1979, SCIENCE, V204, P89, DOI 10.1126/science.571144; Menezo YJR, 1999, FERTIL STERIL, V72, P221, DOI 10.1016/S0015-0282(99)00256-3; Menezo YJ, 2006, REPROD BIOMED ONLINE, V12, P616, DOI 10.1016/S1472-6483(10)61188-1; Milki AA, 2003, J ASSIST REPROD GEN, V20, P323, DOI 10.1023/A:1024861624805; Pergament Eugene, 2002, Reprod Biomed Online, V5, P43; Rueness J, 2012, HUM REPROD, V27, P283, DOI 10.1093/humrep/der347; Wikland M, 2010, HUM REPROD, V25, P1699, DOI 10.1093/humrep/deq117; Zadzinska E, 2011, HOMO, V62, P218, DOI 10.1016/j.jchb.2011.03.002; Zhu WX, 2009, BMJ BRIT MED J OVERS, V338	26	36	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113522	10.1371/journal.pone.0113522	http://dx.doi.org/10.1371/journal.pone.0113522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412419	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000062
J	Wiechmann, AF; Ceresa, BP; Howard, EW				Wiechmann, Allan F.; Ceresa, Brian P.; Howard, Eric W.			Diurnal Variation of Tight Junction Integrity Associates Inversely with Matrix Metalloproteinase Expression in Xenopus laevis Corneal Epithelium: Implications for Circadian Regulation of Homeostatic Surface Cell Desquamation	PLOS ONE			English	Article							TISSUE INHIBITORS; E-CADHERIN; STIMULATES PRODUCTION; EXTRACELLULAR-MATRIX; RETINAL MELATONIN; IN-VITRO; MATRIX-METALLOPROTEINASE-9; OCCLUDIN; PROTEIN; MMP-9	Background and Objectives: The corneal epithelium provides a protective barrier against pathogen entrance and abrasive forces, largely due to the intercellular junctional complexes between neighboring cells. After a prescribed duration at the corneal surface, tight junctions between squamous surface cells must be disrupted to enable them to desquamate as a component of the tissue homeostatic renewal. We hypothesize that matrix metalloproteinase (MMPs) are secreted by corneal epithelial cells and cleave intercellular junctional proteins extracellularly at the epithelial surface. The purpose of this study was to examine the expression of specific MMPs and tight junction proteins during both the light and dark phases of the circadian cycle, and to assess their temporal and spatial relationships in the Xenopus laevis corneal epithelium. Methodology/Principal Findings: Expression of MMP-2, tissue inhibitor of MMP-2 (TIMP-2), membrane type 1-MMP (MT1-MMP) and the tight junction proteins occludin and claudin-4 were examined by confocal double-label immunohistochemistry on corneas obtained from Xenopus frogs at different circadian times. Occludin and claudin-4 expression was generally uniformly intact on the surface corneal epithelial cell lateral membranes during the daytime, but was frequently disrupted in small clusters of cells at night. Concomitantly, MMP-2 expression was often elevated in a mosaic pattern at nighttime and associated with clusters of desquamating surface cells. The MMP-2 binding partners, TIMP-2 and MT1-MMP were also localized to surface corneal epithelial cells during both the light and dark phases, with TIMP-2 tending to be elevated during the daytime. Conclusions/Significance: MMP-2 protein expression is elevated in a mosaic pattern in surface corneal epithelial cells during the nighttime in Xenopus laevis, and may play a role in homeostatic surface cell desquamation by disrupting intercellular junctional proteins. The sequence of MMP secretion and activation, tight junction protein cleavage, and subsequent surface cell desquamation and renewal may be orchestrated by nocturnal circadian signals.	[Wiechmann, Allan F.; Howard, Eric W.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA; [Wiechmann, Allan F.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK USA; [Ceresa, Brian P.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Louisville	Wiechmann, AF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	allan-wiechmann@ouhsc.edu			Oklahoma Center for the Advancement of Science and Technology [HR12-008]; University of Oklahoma College of Medicine Alumni Association; National Eye Institute [EY021497]; NATIONAL EYE INSTITUTE [R01EY021497] Funding Source: NIH RePORTER	Oklahoma Center for the Advancement of Science and Technology; University of Oklahoma College of Medicine Alumni Association; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Oklahoma Center for the Advancement of Science and Technology HR12-008 AFW, University of Oklahoma College of Medicine Alumni Association AFW, and National Eye Institute EY021497 BPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JS, 2002, J ANAT, V200, P561, DOI 10.1046/j.1469-7580.2002.00057.x; Ardan T, 2012, ACTA HISTOCHEM, V114, P540, DOI 10.1016/j.acthis.2011.10.004; Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; Barabino Stefano, 2007, Chem Immunol Allergy, V92, P176, DOI 10.1159/000099268; Brejchova K, 2009, MOL VIS, V15, P2364; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; CAHILL GM, 1991, J NEUROSCI, V11, P2959; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; CAHILL GM, 1990, J NEUROCHEM, V54, P716, DOI 10.1111/j.1471-4159.1990.tb01932.x; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Chen LZ, 2007, JPN J OPHTHALMOL, V51, P405, DOI 10.1007/s10384-007-0479-5; Chen W, 2008, INVEST OPHTH VIS SCI, V49, P1386, DOI 10.1167/iovs.07-0744; Chotikavanich S, 2009, INVEST OPHTH VIS SCI, V50, P3203, DOI 10.1167/iovs.08-2476; Clarke H, 2000, J CELL SCI, V113, P3187; Collier SA, 2000, CURR EYE RES, V21, P662, DOI 10.1076/0271-3683(200008)21:2;1-V;FT662; Cordenonsi M, 1999, EUR J BIOCHEM, V264, P374, DOI 10.1046/j.1432-1327.1999.00616.x; Covington MD, 2006, AM J PHYSIOL-RENAL, V290, pF43, DOI 10.1152/ajprenal.00179.2005; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dominguez-Rodriguez A, 2007, THROMB RES, V120, P361, DOI 10.1016/j.thromres.2006.10.010; Esposito E, 2008, J PINEAL RES, V45, P166, DOI 10.1111/j.1600-079X.2008.00572.x; Estil S, 2000, INVEST OPHTH VIS SCI, V41, P3360; Feng SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020599; FINI ME, 1992, CURR EYE RES, V11, P849, DOI 10.3109/02713689209033483; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; FOGLE JA, 1980, A GRAEF ARCH KLIN EX, V213, P143, DOI 10.1007/BF00410983; Fu LZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-81; FULLARD RJ, 1986, CURR EYE RES, V5, P847, DOI 10.3109/02713688609029236; Ganguly K, 2005, J PINEAL RES, V39, P307, DOI 10.1111/j.1600-079X.2005.00250.x; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Gordon GM, 2011, J CELL PHYSIOL, V226, P1461, DOI 10.1002/jcp.22306; Gorodeski GI, 2007, ENDOCRINOLOGY, V148, P218, DOI 10.1210/en.2006-1120; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354; HASKJOLD E, 1989, VIRCHOWS ARCH B, V58, P123, DOI 10.1007/BF02890063; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kenney MC, 1998, CURR EYE RES, V17, P238, DOI 10.1076/ceyr.17.3.238.5222; Kernacki KA, 2004, EXP EYE RES, V78, P1155, DOI 10.1016/j.exer.2003.12.005; Kim HS, 2004, EXP EYE RES, V79, P263, DOI 10.1016/j.exer.2004.05.003; Koval M, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24518; Krug SM, 2014, SEMIN CELL DEV BIOL; Li DQ, 2003, INVEST OPHTH VIS SCI, V44, P2928, DOI 10.1167/iovs.02-0874; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lomako J, 2005, J CELL PHYSIOL, V202, P115, DOI 10.1002/jcp.20101; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Lynch CC, 2010, J ONCOL, V2010, DOI 10.1155/2010/530745; Markoulli M, 2012, INVEST OPHTH VIS SCI, V53, P1479, DOI 10.1167/iovs.11-8365; MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; PARTRIDGE CA, 1993, AM J PHYSIOL, V265, pL438, DOI 10.1152/ajplung.1993.265.5.L438; PATERSON CA, 1994, INVEST OPHTH VIS SCI, V35, P677; Paul S, 2008, J PINEAL RES, V44, P439, DOI 10.1111/j.1600-079X.2007.00547.x; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; REFSUM SB, 1991, VIRCHOWS ARCH B, V60, P225, DOI 10.1007/BF02899550; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Ren HW, 1996, INVEST OPHTH VIS SCI, V37, P1017; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Scott RAH, 1997, EYE, V11, P607, DOI 10.1038/eye.1997.163; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Smith VA, 1999, BRIT J OPHTHALMOL, V83, P1376, DOI 10.1136/bjo.83.12.1376; Sobrin L, 2000, INVEST OPHTH VIS SCI, V41, P1703; SOKOL JL, 1990, INVEST OPHTH VIS SCI, V31, P294; Sounni NE, 2005, BIOCHIMIE, V87, P329, DOI 10.1016/j.biochi.2004.07.012; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; Swarnakar S, 2007, J PINEAL RES, V43, P56, DOI 10.1111/j.1600-079X.2007.00443.x; Ortiz-Melo MT, 2013, BIOL OPEN, V2, P132, DOI 10.1242/bio.20123145; Thomas J, 1997, IMMUNOL RES, V16, P375, DOI 10.1007/BF02786400; Van Itallie CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25247; Van Itallie CM, 2014, SEMIN CELL DEV BIOL; Wiechmann AF, 2009, MOL VIS, V15, P2384; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042; WOLOSIN JM, 1993, INVEST OPHTH VIS SCI, V34, P2655; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang YN, 2003, EXP EYE RES, V77, P227, DOI 10.1016/S0014-4835(03)00112-X; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Yoshida Y, 2009, INVEST OPHTH VIS SCI, V50, P2103, DOI 10.1167/iovs.08-3046; Yuan XY, 2009, INVEST OPHTH VIS SCI, V50, P737, DOI 10.1167/iovs.08-2390; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	91	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113810	10.1371/journal.pone.0113810	http://dx.doi.org/10.1371/journal.pone.0113810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412440	Green Submitted, gold, Green Published			2022-12-27	WOS:000345253000080
J	Abashidze, A; Gold, V; Anavi, Y; Greenspan, H; Weil, M				Abashidze, Anastasia; Gold, Veronica; Anavi, Yaron; Greenspan, Hayit; Weil, Miguel			Involvement of IKAP in Peripheral Target Innervation and in Specific JNK and NGF Signaling in Developing PNS Neurons	PLOS ONE			English	Article							B KINASE COMPLEX; FAMILIAL DYSAUTONOMIA; TRANSCRIPTIONAL ELONGATION; NEURITE OUTGROWTH; IKBKAP; GENE; EXPRESSION; PROTEIN; DIFFERENTIATION; MUTATION	A splicing mutation in the ikbkap gene causes Familial Dysautonomia (FD), affecting the IKAP protein expression levels and proper development and function of the peripheral nervous system (PNS). Here we attempted to elucidate the role of IKAP in PNS development in the chick embryo and found that IKAP is required for proper axonal outgrowth, branching, and peripheral target innervation. Moreover, we demonstrate that IKAP colocalizes with activated JNK (pJNK), dynein, and beta-tubulin at the axon terminals of dorsal root ganglia (DRG) neurons, and may be involved in transport of specific target derived signals required for transcription of JNK and NGF responsive genes in the nucleus. These results suggest the novel role of IKAP in neuronal transport and specific signaling mediated transcription, and provide, for the first time, the basis for a molecular mechanism behind the FD phenotype.	[Abashidze, Anastasia; Gold, Veronica; Weil, Miguel] Tel Aviv Univ, George S Wise Fac Life Sci, Sagol Sch Neurosci, Dept Cell Res & Immunol,Lab Neurodegenerat Dis &, IL-69978 Tel Aviv, Israel; [Anavi, Yaron] Tel Aviv Univ, Sch Math Sci, Dept Appl Math, IL-69978 Tel Aviv, Israel; [Greenspan, Hayit] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Weil, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Sagol Sch Neurosci, Dept Cell Res & Immunol,Lab Neurodegenerat Dis &, IL-69978 Tel Aviv, Israel.	miguelw@tauex.tau.ac.il			Israel Science Foundation (ISF grant) [1491/09]; FD research consortium (FD Hope); FD research consortium (FD Foundation Inc.); FD research consortium (FD Israel Foundation)	Israel Science Foundation (ISF grant); FD research consortium (FD Hope); FD research consortium (FD Foundation Inc.); FD research consortium (FD Israel Foundation)	This study was supported by the FD research consortium (FD Hope, FD Foundation Inc., FD Israel Foundation) and by the Israel Science Foundation (ISF grant 1491/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Avivi C, 1999, DEV BRAIN RES, V115, P89, DOI 10.1016/S0165-3806(99)00054-1; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Cheishvili D, 2011, HUM MOL GENET, V20, P1585, DOI 10.1093/hmg/ddr036; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Coffey ET, 2014, NAT REV NEUROSCI, V15, P285, DOI 10.1038/nrn3729; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Cohen-Kupiec R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019147; Corcoran J, 2000, J CELL SCI, V113, P2567; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dietrich P, 2012, HUM MOL GENET, V21, P5078, DOI 10.1093/hmg/dds354; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; George L, 2013, P NATL ACAD SCI USA, V110, P18698, DOI 10.1073/pnas.1308596110; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Hunnicutt BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032050; Jackson MZ, 2014, DEVELOPMENT, V141, P2452, DOI 10.1242/dev.107797; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; PEARSON J, 1974, ANN NY ACAD SCI, V228, P288, DOI 10.1111/j.1749-6632.1974.tb20517.x; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; RILEY CM, 1949, PEDIATRICS, V3, P468; Rosenberg SS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004259; Sakai D, 2005, CELLS TISSUES ORGANS, V179, P24, DOI 10.1159/000084506; Sakakibara A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130061; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Valensi-Kurtz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009290; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006	37	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113428	10.1371/journal.pone.0113428	http://dx.doi.org/10.1371/journal.pone.0113428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409162	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200119
J	Chatterjee, A; Sharma, A; Chen, M; Toy, R; Mottola, G; Conte, MS				Chatterjee, Anuran; Sharma, Anjali; Chen, Mian; Toy, Robert; Mottola, Giorgio; Conte, Michael S.			The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; OXIDATIVE STRESS; ADHESION MOLECULE-1; MICROARRAY ANALYSIS; HUMAN PHAGOCYTES; E-SELECTIN; EXPRESSION; CAMP; TRANSCRIPTION	Objective: Inflammation and its resolution are central to vascular injury and repair. Maresins comprise a new family of bioactive lipid mediators synthesized from docosahexaenoic acid, an omega-3 polyunsaturated fatty acid. They have been found to exert anti-inflammatory and pro-resolving responses in macrophages, neutrophils and bronchial epithelial cells and impart beneficial actions in murine models of peritonitis and colitis. We investigated the impact of maresin-1 (MaR1) on tumor necrosis factor alpha (TNF-alpha) induced inflammatory responses in human vascular endothelial (EC) and smooth muscle cells (VSMC). Methods: Primary cultures of human saphenous vein EC and VSMC were employed. We tested the naturally occurring MaR1 as modulator of TNF-alpha effects, with examination of monocyte adhesion, oxidant stress, and intracellular inflammatory signaling pathways. Results: MaR1 attenuated TNF-alpha induced monocyte adhesion and reactive oxygen species (ROS) generation in both EC and VSMC, associated with down-regulated expression (cell surface) of the adhesion molecule E-selectin (in EC) and NADPH-oxidases (NOX4, NOX1, NOX2). MaR1 attenuated TNF-alpha induced release of pro-inflammatory mediators by EC and VSMC. MaR1 caused an attenuation of TNF-a induced NF-kappa B activation in both cell types associated with inhibition of I-kappa Kinase (IKK) phosphorylation, I kappa B-alpha degradation and nuclear translocation of the NF-kappa B p65 subunit. MaR1 also caused a timedependent increase in intracellular cyclic AMP (cAMP) in both naive and TNF-alpha stimulated VSMC and EC. Conclusions: MaR1 has broad anti-inflammatory actions on EC and VSMC, which may be partly mediated through upregulation of cAMP and down-regulation of the transcription factor NF-kappa B. The results suggest that the pro-resolving lipid mediator MaR1 exerts homeostatic actions on vascular cells that counteract pro-inflammatory signals. These findings may have direct relevance for acute and chronic states of vascular inflammation.	[Chatterjee, Anuran] Univ Calif San Francisco, Cardiovasc Res Inst CVRI, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chatterjee, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst CVRI, San Francisco, CA 94143 USA.	anuran.chatterjee@ucsf.edu	Mottola, Giorgio/AAO-4375-2021	Mottola, Giorgio/0000-0003-0670-8619	American Heart Association [13SDG16940069]; National Institutes of Health- National Heart Lung and Blood Institute [HL119508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119508] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health- National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by American Heart Association- Scientist Development Grant (13SDG16940069) to AC, National Institutes of Health- National Heart Lung and Blood Institute (HL119508) to MSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Bandman O, 2002, ANN NY ACAD SCI, V975, P77, DOI 10.1111/j.1749-6632.2002.tb05943.x; Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Keulenaer GW, 1998, BIOCHEM J, V329, P653; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; GHERSA P, 1994, J BIOL CHEM, V269, P29129; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; Grabner R, 2000, CYTOMETRY, V40, P238, DOI 10.1002/1097-0320(20000701)40:3<238::AID-CYTO9>3.0.CO;2-3; Gusan S, 2013, AM J PHYSIOL-CELL PH, V304, pC1198, DOI 10.1152/ajpcell.00269.2012; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Lee CH, 2012, ARCH PHARM RES, V35, P3, DOI 10.1007/s12272-012-0121-z; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Martin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043545; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Moe KT, 2006, J CELL MOL MED, V10, P231, DOI 10.1111/j.1582-4934.2006.tb00304.x; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Nordgren TM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-51; Oldenburger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031574; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; PANETTIERI RA, 1995, J IMMUNOL, V154, P2358; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; POBER JS, 1993, J IMMUNOL, V150, P5114; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Sands WA, 2005, BIOCHEM SOC T, V33, P1126, DOI 10.1042/BST0331126; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Takamiya R, 2012, FEBS OPEN BIO, V2, P328, DOI 10.1016/j.fob.2012.10.001; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Wang GJ, 2005, ARTERIOSCL THROM VAS, V25, P2081, DOI 10.1161/01.ATV.0000183885.66153.8a; Zhao BT, 2003, AM J PHYSIOL-CELL PH, V284, pC1577, DOI 10.1152/ajpcell.00243.2002	40	51	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113480	10.1371/journal.pone.0113480	http://dx.doi.org/10.1371/journal.pone.0113480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409514	Green Submitted, gold, Green Published			2022-12-27	WOS:000345533200127
J	Drury-Stewart, DN; Lannert, KW; Chung, DW; Teramura, GT; Zimring, JC; Konkle, BA; Gammill, HS; Johnsen, JM				Drury-Stewart, Danielle N.; Lannert, Kerry W.; Chung, Dominic W.; Teramura, Gayle T.; Zimring, James C.; Konkle, Barbara A.; Gammill, Hilary S.; Johnsen, Jill M.			Complex Changes in von Willebrand Factor-Associated Parameters Are Acquired during Uncomplicated Pregnancy	PLOS ONE			English	Article							FACTOR-VIII COMPLEX; FACTOR PROPEPTIDE; VENOUS THROMBOEMBOLISM; ARTERIAL THROMBOSIS; VWF PROPEPTIDE; HEMOSTATIC CHANGES; PRE-ECLAMPSIA; DISEASE; RISK; PUERPERIUM	Background: The coagulation protein von Willebrand Factor (VWF) is known to be elevated in pregnancy. However, the timing and nature of changes in VWF and associated parameters throughout pregnancy are not well understood. Objectives: To better understand the changes in VWF provoked by pregnancy, we studied VWF-associated parameters in samples collected over the course of healthy pregnancies. Methods: We measured VWF antigen (VWF:Ag), VWF propeptide (VWFpp), Factor VIII (FVIII), and ADAMTS13 activity in samples collected from 46 women during pregnancy and at non-pregnant baseline. We also characterized pregnant vs. nonpregnant VWF multimer structure in 21 pregnancies, and performed isoelectric focusing (IEF) of VWF in two pregnancies which had samples from multiple trimesters. Results: VWF:Ag and FVIII levels were significantly increased during pregnancy. ADAMTS13 activity was unchanged. VWFpp levels increased much later in pregnancy than VWF:Ag, resulting in a progressive decrease in VWFpp:Ag ratios. FVIII:VWF ratios also decreased in pregnancy. Most pregnancies exhibited a clear loss of larger VWF multimers and altered VWF triplet structure. Further evidence of acquired VWF qualitative changes in pregnancy was found in progressive, reversible shifts in VWF IEF patterns over gestation. Conclusions: These data support a new view of pregnancy in which VWF can acquire qualitative changes associated with advancing gestational age. Modeling supports a scenario in which both increased VWF production and doubling of the VWF half-life would account for the data observed. We propose that gestation induces a prolongation in VWF survival, which likely contributes to increased total VWF levels and altered VWF structure.	[Drury-Stewart, Danielle N.; Lannert, Kerry W.; Chung, Dominic W.; Teramura, Gayle T.; Zimring, James C.; Konkle, Barbara A.; Johnsen, Jill M.] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA; [Zimring, James C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Konkle, Barbara A.; Johnsen, Jill M.] Univ Washington, Dept Med, Seattle, WA USA; [Gammill, Hilary S.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Gammill, Hilary S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Johnsen, JM (corresponding author), Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA.	jjohnsen@uw.edu	Teramura, Gayle/ABG-2749-2021; Konkle, Barbara/GPX-3325-2022; Sessum, Rachel/F-7312-2015; Konkle, Barbara A/AAD-7712-2022	Sessum, Rachel/0000-0002-2444-7056; Konkle, Barbara A/0000-0002-3959-8797; Zimring, James/0000-0002-1063-4010; Chung, Dominic/0000-0002-2645-5703	Puget Sound Blood Center Hemophilia Program; NIH [2 R01 HL39693-21]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD067221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039693] Funding Source: NIH RePORTER	Puget Sound Blood Center Hemophilia Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These efforts were supported by funding from the Puget Sound Blood Center Hemophilia Program, an unrestricted gift by Dr. Earl Davie, and NIH 2 R01 HL39693-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Blood Banks, 2008, FREQ ABO US POP; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bank I, 2005, J THROMB HAEMOST, V3, P79, DOI 10.1111/j.1538-7836.2004.01033.x; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Butenas S, 2009, J THROMB HAEMOST, V7, P132, DOI 10.1111/j.1538-7836.2008.03210.x; CAIRES D, 1984, ACTA OBSTET GYN SCAN, V63, P411, DOI 10.3109/00016348409156694; Casonato A, 2011, SEMIN THROMB HEMOST, V37, P456, DOI 10.1055/s-0031-1281029; Casonato A, 2010, TRANSL RES, V155, P200, DOI 10.1016/j.trsl.2009.12.003; Castaman G, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.052; Catto AJ, 1997, THROMB HAEMOSTASIS, V77, P1104; Defaus S, 2014, ANALYST, V139, P2944, DOI 10.1039/c3an02245e; Eikenboom J, 2013, BLOOD, V121, P2336, DOI 10.1182/blood-2012-09-455089; Favaloro EJ, 1997, CLIN APPL THROMB-HEM, V3, P110, DOI 10.1177/107602969700300208; Federici AB, 2006, BLOOD, V108, P3229, DOI 10.1182/blood-2006-09-043117; Fischer K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006745; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; FOURNIE A, 1981, BRIT J OBSTET GYNAEC, V88, P250, DOI 10.1111/j.1471-0528.1981.tb00977.x; Fuchs B, 2013, SEMIN THROMB HEMOST, V39, P306, DOI 10.1055/s-0032-1328971; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; Haberichter SL, 2006, BLOOD, V108, P3344, DOI 10.1182/blood-2006-04-015065; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Hovinga JAK, 2007, J THROMB HAEMOST, V5, P2284; HYTTEN F, 1985, CLIN HAEMATOL, V14, P601; Jenkins PV, 2012, BRIT J HAEMATOL, V157, P653, DOI 10.1111/j.1365-2141.2012.09134.x; Johnsen J, 2010, WILLIAMS HEMATOLOGY, P2069; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Lenting PJ, 2013, CURR VASC PHARMACOL, V11, P448; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Marik PE, 2008, NEW ENGL J MED, V359, P2025, DOI 10.1056/NEJMra0707993; Nossent AY, 2006, J THROMB HAEMOST, V4, P2556, DOI 10.1111/j.1538-7836.2006.02273.x; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; OGAWA T, 1983, BIOL RES PREG PERIN, V4, P155; Rosenkranz A, 2008, THROMB HAEMOSTASIS, V99, P331, DOI 10.1160/TH07-05-0359; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; Saha P, 2009, BJOG-INT J OBSTET GY, V116, P1602, DOI 10.1111/j.1471-0528.2009.02295.x; Sanchez-Luceros A, 2003, BLOOD COAGUL FIBRIN, V14, P647, DOI 10.1097/00001721-200310000-00005; Sanders YV, 2013, J THROMB HAEMOST, V11, P845, DOI 10.1111/jth.12194; Sie P, 2003, BRIT J HAEMATOL, V121, P897, DOI 10.1046/j.1365-2141.2003.04371.x; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Sonneveld MAH, 2014, BLOOD REV, V28, P167, DOI 10.1016/j.blre.2014.04.003; Stockschlaeder M, 2014, BLOOD COAGUL FIBRIN, V25, P206, DOI 10.1097/MBC.0000000000000065; Sztukowska M, 2008, BRIT J HAEMATOL, V143, P107, DOI 10.1111/j.1365-2141.2008.07311.x; THORNTON CA, 1977, BRIT J OBSTET GYNAEC, V84, P919, DOI 10.1111/j.1471-0528.1977.tb12521.x; TREFFERS PE, 1983, INT J GYNECOL OBSTET, V21, P327, DOI 10.1016/0020-7292(83)90024-3; van Mourik JA, 1999, BLOOD, V94, P179, DOI 10.1182/blood.V94.1.179.413k18_179_185; van Schie MC, 2011, J THROMB HAEMOST, V9, P899, DOI 10.1111/j.1538-7836.2011.04243.x; Whincup RH, 2002, EUR HEART J, V23, P1764, DOI 10.1053/euhj.2001.3237; Wu JJ, 2006, J THROMB HAEMOST, V4, P129, DOI 10.1111/j.1538-7836.2005.01677.x	52	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112935	10.1371/journal.pone.0112935	http://dx.doi.org/10.1371/journal.pone.0112935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409031	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200048
J	Jiang, X; Kanda, T; Wu, S; Nakamoto, S; Wakita, T; Shirasawa, H; Yokosuka, O				Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Nakamoto, Shingo; Wakita, Takaji; Shirasawa, Hiroshi; Yokosuka, Osamu			Hepatitis C Virus Nonstructural Protein 5A Inhibits Thapsigargin-Induced Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ANTI-FAS ANTIBODY; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; ER STRESS; MEDIATED APOPTOSIS; NS5A; GENE; INVOLVEMENT; PATHWAY	Background: We previously reported that the hepatitis C virus (HCV) nonstructural protein 5A (NS5A) down-regulates TLR4 signaling and lipopolysaccharide-induced apoptosis of hepatocytes. There have been several reports regarding the association between HCV infection and endoplasmic reticulum (ER) stress. Here, we examined the regulation of HCV NS5A on the apoptosis of hepatocytes induced by thapsigargin, an inducer of ER stress. Methods: The apoptotic response to thapsigargin and the expression of molecules involved in human hepatocyte apoptotic pathways were examined in the presence or absence of HCV NS5A expression. Results: HCV JFH1 infection induced ER stress in the Huh7 cell line. HCV NS5A protected HepG2 cells against thapsigargin-induced apoptosis, the effect of which was linked to the enhanced expression of the 78-kDa glucose-regulated protein/immunoglobulin heavy-chain binding protein (GRP78). Consistent with a conferred pro-survival advantage, HCV NS5A reduced poly(adenosine diphosphate-ribose) polymerase cleavage and activation of caspases-3, -7 and -9, and Bax expression, while increasing the expressions of the anti-apoptotic molecules XIAP and c-FLIP. HCV NS5A weakly interacts with GRP78 and enhances GRP78 expression in hepatocytes. Conclusion: HCV NS5A enhances GRP78 expression, resulting in the inhibition of apoptotic properties, and inhibits thapsigargin-induced apoptotic pathways in human hepatocytes, suggesting that disruption of ER stress-mediated apoptosis may have a role in the pathogenesis of HCV infection. Thus, HCV NS5A might engender the survival of HCV-infected hepatocytes contributing to the establishment of persistent infection.	[Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Nakamoto, Shingo; Shirasawa, Hiroshi] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Chiba University; Chiba University; National Institute of Infectious Diseases (NIID)	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590955]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a KAKEN Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24590955), awarded to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2010, VIRUSES-BASEL, V2, P2108, DOI 10.3390/v2092108; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Berthelet Jean, 2013, Cells, V2, P163, DOI 10.3390/cells2010163; Cecconi F, 1999, CELL DEATH DIFFER, V6, P1087, DOI 10.1038/sj.cdd.4400602; Cerella C, 2014, BIOTECHNOL ADV, V32, P1111, DOI 10.1016/j.biotechadv.2014.03.006; Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998; Christen V, 2007, HEPATOLOGY, V46, P558, DOI 10.1002/hep.21611; Chung YL, 2003, INT J CANCER, V107, P65, DOI 10.1002/ijc.11303; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gerotto M, 1999, J VIRAL HEPATITIS, V6, P367, DOI 10.1046/j.1365-2893.1999.00166.x; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Hofgartner WT, 1997, J MED VIROL, V53, P118, DOI 10.1002/(SICI)1096-9071(199710)53:2<118::AID-JMV3>3.0.CO;2-C; Jiang X, 2014, EXP CELL RES, V323, P326, DOI 10.1016/j.yexcr.2014.02.017; Jiang X, 2013, IMMUNOL LETT, V152, P8, DOI 10.1016/j.imlet.2013.03.006; Kanda T, 2006, J VIROL, V80, P4633, DOI 10.1128/JVI.80.9.4633-4639.2006; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; KANEKO Y, 1994, CANCER LETT, V79, P147, DOI 10.1016/0304-3835(94)90253-4; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Merola M, 2001, J VIROL, V75, P11205, DOI 10.1128/JVI.75.22.11205-11217.2001; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Nakamoto S, 2014, WORLD J GASTROENTERO, V20, P2902, DOI 10.3748/wjg.v20.i11.2902; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Rosebeck S, 2011, VIROLOGY, V417, P293, DOI 10.1016/j.virol.2011.06.010; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Safa A. R., 2012, Experimental Oncology, V34, P176; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Saito K, 2006, J VIROL, V80, P4372, DOI 10.1128/JVI.80.9.4372-4379.2006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Tamura R, 2011, J INFECT DIS, V204, P793, DOI 10.1093/infdis/jir381; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Waris G, 2002, BIOCHEM PHARMACOL, V64, P1425, DOI 10.1016/S0006-2952(02)01300-X; Yoo SA, 2012, J EXP MED, V209, P871, DOI 10.1084/jem.20111783	50	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113499	10.1371/journal.pone.0113499	http://dx.doi.org/10.1371/journal.pone.0113499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409163	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200129
J	Kruse, TN; Carter, RE; Rosedahl, JK; Joyner, MJ				Kruse, Timothy N.; Carter, Rickey E.; Rosedahl, Jordan K.; Joyner, Michael J.			Speed Trends in Male Distance Running	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; PERFORMANCE; PROGRESSION; MARATHON; RUNNERS; KENYAN; RACES; SPORT	The major cycling "Grand Tours'' have shown an attenuation of performance over the last decade. This has been interpreted as circumstantial evidence that newer anti-doping strategies have reduced the use of performance-enhancing drugs. To examine this idea under more controlled conditions, speed trends for world class 5000 m, 10000 m, and marathon performances by men from 1980 to 2013 were analyzed. We obtained comprehensive records from the International Association of Athletics Federations, Association of Road Racing Statisticians, and the Track and Field All-time Performances database webpages. The top 40 performances for each event and year were selected for regression analysis. For the three distances, we noted cumulative performance improvements in the 1990s thru the mid-2000s. After the peak speed years of the mid 2000 s, there has been limited improvement in the 5000 m and 10,000 m and world records set during that time remain in place today, marking the longest period of time between new records since the early 1940s. By contrast marathon speed continues to increase and the world record has been lowered four times since 2007, including in 2013. While the speed trends for 5000 m and 10000 m track results parallel those seen in elite cycling, the marathon trends do not. We discuss a number of explanations other than improved anti-doping strategies that might account for these divergent findings.	[Kruse, Timothy N.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Carter, Rickey E.; Rosedahl, Jordan K.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Joyner, Michael J.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA	University of Washington; University of Washington Seattle; Mayo Clinic; Mayo Clinic	Joyner, MJ (corresponding author), Mayo Clin, Dept Anesthesiol, 200 First St SW, Rochester, MN 55905 USA.	Joyner.Michael@Mayo.edu			National Institutes of Health [R25 GM075148, UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants R25 GM075148 and UL1 TR000135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Berthelot G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008800; Billat V, 2003, MED SCI SPORT EXER, V35, P297, DOI 10.1249/01.MSS.0000053556.59992.A9; Bourne ND, 2008, THESIS U TEXAS; Conti Andrea A, 2010, Med Secoli, V22, P181; D'Angelo C, 2010, J MED ETHICS, V36, P700, DOI 10.1136/jme.2009.034801; de Hon O, 2014, SPORTS MED; Delanghe JR, 2008, J APPL PHYSIOL, V105, P395, DOI 10.1152/japplphysiol.90746.2008; Denny MW, 2008, J EXP BIOL, V211, P3836, DOI 10.1242/jeb.024968; El Helou N, 2010, J SPORT SCI, V28, P789, DOI 10.1080/02640411003739654; Gaudard A, 2003, SPORTS MED, V33, P187, DOI 10.2165/00007256-200333030-00003; Haugen K. K., 2004, Journal of Sports Economics, V5, P67, DOI 10.1177/1527002503251712; Hill R, 2014, RACE CONVERSION; Hunter SK, 2011, MED SCI SPORT EXER, V43, P656, DOI 10.1249/MSS.0b013e3181fb4e00; International Olympic Committee, 2014, FIGHT DOP PROM ATHL; Jelkmann W, 2011, BLOOD, V118, P2395, DOI 10.1182/blood-2011-02-303271; Joyner MJ, 2011, J APPL PHYSIOL, V110, P275, DOI 10.1152/japplphysiol.00563.2010; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Joyner MJ, 2003, BRIT J SPORT MED, V37, P190, DOI 10.1136/bjsm.37.3.190; Larsson P, 2014, MENS STANDARD EVENTS; Lonnberg M, 2013, ANAL BIOANAL CHEM, V405, P9685, DOI 10.1007/s00216-013-6997-8; Lundby C, 2008, J APPL PHYSIOL, V105, P417, DOI 10.1152/japplphysiol.90529.2008; Martin D.M., 2007, WORLD PSYCHIAT J WOR, V6, P118; Miller T, 2001, GLOBALIZATION SPORTS; Noakes TD, 2004, NEW ENGL J MED, V351, P847, DOI 10.1056/NEJMp048208; Papagelopoulos PJ, 2004, ORTHOPEDICS, V27, P1226; Perneger TV, 2010, INT J SPORTS MED, V31, P261, DOI 10.1055/s-0030-1247593; Strelan P, 2006, J APPL SOC PSYCHOL, V36, P2909, DOI 10.1111/j.0021-9029.2006.00135.x; Thibault V, 2010, J SPORT SCI MED, V9, P214; Tokish JM, 2004, AM J SPORT MED, V32, P1543, DOI 10.1177/0363546504268041; Wilber RL, 2012, INT J SPORT PHYSIOL, V7, P92, DOI 10.1123/ijspp.7.2.92; World Anti-Doping Agency, 2010, BRIEF HIST ANT; Young K, 2014, YEARLY RANKINGS MARA	33	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112978	10.1371/journal.pone.0112978	http://dx.doi.org/10.1371/journal.pone.0112978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409192	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200054
J	Li, S; An, YZ; Ren, JY; Zhu, FX; Chen, H				Li, Shu; An, You-zhong; Ren, Jing-yi; Zhu, Feng-xue; Chen, Hong			Myocardial Injury after Surgery Is a Risk Factor for Weaning Failure from Mechanical Ventilation in Critical Patients Undergoing Major Abdominal Surgery	PLOS ONE			English	Article							NONINVASIVE VENTILATION; PNEUMONIA; DISEASE; IMPACT; CARE	Background: Myocardial injury after noncardiac surgery (MINS) is a newly proposed concept that is common among adults undergoing noncardiac surgery and associated with substantial mortality. We analyzed whether MINS was a risk factor for weaning failure in critical patients who underwent major abdominal surgery. Methods: This retrospective study was conducted in the Department of Critical Care Medicine of Peking University People's Hospital. The subjects were all critically ill patients who underwent major abdominal surgery between January 2011 and December 2013. Clinical and laboratory parameters during the perioperative period were investigated. Backward stepwise regression analysis was performed to evaluate MINS relative to the rate of weaning failure. Age, hypertension, chronic renal disease, left ventricular ejection fraction before surgery, Acute Physiologic and Chronic Health Evaluation II score, pleural effusion, pneumonia, acute kidney injury, duration of mechanical ventilation before weaning and the level of albumin after surgery were treated as independent variables. Results: This study included 381 patients, of whom 274 were successfully weaned. MINS was observed in 42.0% of the patients. The MINS incidence was significantly higher in patients who failed to be weaned compared to patients who were successfully weaned (56.1% versus 36.5%; P < 0.001). Independent predictive factors of weaning failure were MINS, age, lower left ventricular ejection fraction before surgery and lower serum albumin level after surgery. The MINS odds ratio was 4.098 (95% confidence interval, 1.07 to 15.6; P = 0.04). The patients who were successfully weaned had shorter hospital stay lengths and a higher survival rate than those who failed to be weaned. Conclusion: MINS is a risk factor for weaning failure from mechanical ventilation in critical patients who have undergone major abdominal surgery, independent of age, lower left ventricular ejection fraction before surgery and lower serum albumin levels after surgery.	[Li, Shu; An, You-zhong; Zhu, Feng-xue] Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing 100871, Peoples R China; [Ren, Jing-yi; Chen, Hong] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, H (corresponding author), Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing 100871, Peoples R China.	chenhong0418@aliyun.com						Ali ZA, 2008, EUR J VASC ENDOVASC, V35, P413, DOI 10.1016/j.ejvs.2007.10.007; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; Carroll K, 2003, J PUBLIC HEALTH MED, V25, P29, DOI 10.1093/pubmed/fdg007; Dunning J, 2003, EUR J CARDIO-THORAC, V24, P270, DOI 10.1016/S1010-7940(03)00269-0; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Epstein SK, 2009, RESP CARE, V54, P198; Glossop AJ, 2012, BRIT J ANAESTH, V109, P305, DOI 10.1093/bja/aes270; Gupta Barkha, 2010, J Clin Med Res, V2, P68, DOI 10.4021/jocmr2010.03.261e; Hadda V, 2014, LUNG INDIA, V31, P4, DOI 10.4103/0970-2113.125886; Mehta RH, 2008, CIRCULATION, V117, P876, DOI 10.1161/CIRCULATIONAHA.107.728147; Monnet X, 2007, CURR OPIN CRIT CARE, V13, P6, DOI 10.1097/MCC.0b013e328013c865; Naughton C, 2007, INT J CLIN PRACT, V61, P768, DOI 10.1111/j.1742-1241.2007.01304.x; Nozawa E, 2005, INT HEART J, V46, P819, DOI 10.1536/ihj.46.819; Pinsky MR, 2000, INTENS CARE MED, V26, P1164, DOI 10.1007/s001340000619; Porhomayon J, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/173527; Shi ZD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008367.pub2; Siddiqui MMA, 2012, CARDIOVASC DIAGN THE, V2, P192, DOI 10.3978/j.issn.2223-3652.2012.06.05; Teboul JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8852; Thille AW, 2013, AM J RESP CRIT CARE, V187, P1294, DOI 10.1164/rccm.201208-1523CI; TORRES A, 1995, AM J RESP CRIT CARE, V152, P137, DOI 10.1164/ajrccm.152.1.7599812; Zhu F, 2013, CHINESE MED J-PEKING, V126, P1337, DOI 10.3760/cma.j.issn.0366-6999.20121744	22	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113410	10.1371/journal.pone.0113410	http://dx.doi.org/10.1371/journal.pone.0113410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409182	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200114
J	Puspitasari, HP; Aslani, P; Krass, I				Puspitasari, Hanni P.; Aslani, Parisa; Krass, Ines			Challenges in the Care of Clients with Established Cardiovascular Disease: Lessons Learned from Australian Community Pharmacists	PLOS ONE			English	Article							PATIENT OUTCOMES; SECONDARY PREVENTION; PHARMACEUTICAL CARE; MANAGEMENT SERVICES; PART 1; INTERVENTIONS; METAANALYSIS; SENSITIVITY; FACILITATORS; AWARENESS	Background: As primary healthcare professionals, community pharmacists have both opportunity and potential to contribute to the prevention and progression of chronic diseases. Using cardiovascular disease (CVD) as a case study, we explored factors that influence community pharmacists' everyday practice in this area. We also propose a model to best illustrate relationships between influencing factors and the scope of community pharmacy practice in the care of clients with established CVD. Methods: In-depth, semi-structured interviews were conducted with 21 community pharmacists in New South Wales, Australia. All interviews were audio-recorded, transcribed ad verbatim, and analysed using a "grounded-theory'' approach. Results: Our model shows that community pharmacists work within a complex system and their practice is influenced by interactions between three main domains: the "people'' factors, including their own attitudes and beliefs as well as those of clients and doctors; the "environment'' within and beyond the control of community pharmacy; and outcomes of their professional care. Despite the complexity of factors and interactions, our findings shed some light on the interrelationships between these various influences. The overarching obstacle to maximizing the community pharmacists' contribution is the lack of integration within health systems. However, achieving better integration of community pharmacists in primary care is a challenge since the systems of remuneration for healthcare professional services do not currently support this integration. Conclusion: Tackling chronic diseases such as CVD requires mobilization of all sources of support in the community through innovative policies which facilitate inter-professional collaboration and team care to achieve the best possible healthcare outcomes for society.	[Puspitasari, Hanni P.; Aslani, Parisa; Krass, Ines] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Puspitasari, Hanni P.] Univ Airlangga, Fak Farm, Surabaya, Indonesia	University of Sydney; Airlangga University	Puspitasari, HP (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	hanni.puspitasari@sydney.edu.au	Puspitasari, Hanni/GQP-4205-2022	Krass, Ines/0000-0002-0466-9807				Amariles P, 2012, J MANAGE CARE PHARM, V18, P311, DOI 10.18553/jmcp.2012.18.4.311; Australian Government Department of Health and the Pharmacy Guild of Australia, 2010, 5 COMM PHARM AGR COM; Benson A, 2009, SOC SCI MED, V68, P2223, DOI 10.1016/j.socscimed.2009.03.012; BERBATIS CG, 2007, INT J PHARM PRACT, V15, P185, DOI DOI 10.1211/ijpp.15.3.0005; Bereznicki B, 2011, J CLIN PHARM THER, V36, P348, DOI 10.1111/j.1365-2710.2010.01187.x; Bissell P, 2008, HEALTH SOC CARE COMM, V16, P363, DOI 10.1111/j.1365-2524.2007.00749.x; Blake KB, 2010, ANN PHARMACOTHER, V44, P424, DOI 10.1345/aph.1M386; Browne S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093288; Bryant LJM, 2009, RES SOC ADMIN PHARM, V5, P347, DOI 10.1016/j.sapharm.2009.01.002; Chisholm-Burns MA, 2010, MED CARE, V48, P923, DOI 10.1097/MLR.0b013e3181e57962; Chui MA, 2012, RES SOC ADMIN PHARM, V8, P206, DOI 10.1016/j.sapharm.2011.06.001; Chung VCH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050022; Consumers' Health Forum of Australia, 2001, GUID CONS REPR; Creswell J. W., 2013, QUALITATIVE INQUIRY; D'Amour D, 2008, BMC HEALTH SERV RES, V8, DOI [10.1186/1472-6963-8-40, 10.1186/1472-6963-8-188]; DAMBOISE G, 1988, ACAD MANAGE REV, V13, P226, DOI 10.2307/258574; Doucette WR, 2012, RES SOC ADMIN PHARM, V8, P274, DOI 10.1016/j.sapharm.2011.07.002; Evans CD, 2011, ANN PHARMACOTHER, V45, P615, DOI 10.1345/aph.1P615; Feletto Eleonora, 2013, Int J Pharm Pract, V21, P28, DOI 10.1111/j.2042-7174.2012.00225.x; Gastelurrutia M, 2009, PHARM WORLD SCI, V31, P32, DOI 10.1007/s11096-008-9261-0; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Grindrod KA, 2009, CAN PHARM J, V142, P234, DOI 10.3821/1913-701X-142.5.234; Grover A, 2013, ACAD MED, V88, P1827, DOI 10.1097/ACM.0000000000000028; Hatah E, 2012, INT J CLIN PHARM-NET, V34, P364, DOI 10.1007/s11096-012-9617-3; Health Workforce Australia, 2014, AUSTR HLTH WORKF SER; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Holland RW, 1999, AM J HEALTH-SYST PH, V56, P1758, DOI 10.1093/ajhp/56.17.1758; Jacobs Sally, 2011, J Health Organ Manag, V25, P420; Kerner JF, 2008, J PUBLIC HEALTH MAN, V14, P193, DOI 10.1097/01.PHH.0000311899.11197.db; Labrunee M., 2012, Annals of Physical and Rehabilitation Medicine, V55, P322, DOI 10.1016/j.rehab.2012.04.003; Machado M, 2008, ANN PHARMACOTHER, V42, P1195, DOI 10.1345/aph.1K618; Machado M, 2007, ANN PHARMACOTHER, V41, P1770, DOI 10.1345/aph.1K311; Machado M, 2007, ANN PHARMACOTHER, V41, P1569, DOI 10.1345/aph.1K151; Mak Vivienne S L, 2012, Int J Pharm Pract, V20, P33, DOI 10.1111/j.2042-7174.2011.00160.x; Martin-Calero MJ, 2004, CURR PHARM DESIGN, V10, P3969, DOI 10.2174/1381612043382549; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Mossialos E, 2013, HEALTH POLICY, V111, P135, DOI 10.1016/j.healthpol.2013.04.003; Pharmaceutical Society of Australia, 2011, GUID PHARM HOM MED R; Pharmaceutical Society of Australia, 2012, GUID PHARM MED US RE; Pharmacy Guild of Australia, 2010, ROADM STRAT DIR COMM; Ponniah A, 2007, J CLIN PHARM THER, V32, P343, DOI 10.1111/j.1365-2710.2007.00827.x; Puspitasari HP, 2013, INT J CLIN PHARM-NET, V35, P1218, DOI 10.1007/s11096-013-9854-0; Roberts Alison S, 2005, Res Social Adm Pharm, V1, P546, DOI 10.1016/j.sapharm.2005.09.003; Robinson Jennifer G, 2009, Prev Cardiol, V12, P136, DOI 10.1111/j.1751-7141.2009.00037.x; Smith M, 2013, HEALTH AFFAIR, V32, P1963, DOI 10.1377/hlthaff.2013.0542; Sonnedecker G., 1976, KREMERS URDANGS HIST; Stergachis Andy, 2002, J Am Pharm Assoc (Wash), V42, P743, DOI 10.1331/108658002764653522; Swanson RC, 2012, HEALTH POLICY PLANN, V27, P54, DOI 10.1093/heapol/czs090; Sweeny K, 2007, 34 VICT U TECHN CTR; West MA, 2007, BLACKWELL ENCY SOCIO; White CM, 2014, ANN PHARMACOTHER, V48, P268, DOI 10.1177/1060028013511786; Wong FYY, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-121; World Health Organization, 2007, PREV CARD DIS POCK G; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zellmer WA, 2012, ANN PHARMACOTHER, V46, pS41, DOI 10.1345/aph.1Q805	55	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113337	10.1371/journal.pone.0113337	http://dx.doi.org/10.1371/journal.pone.0113337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409194	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200099
J	Ma, J; Stiller, J; Zhao, Q; Feng, Q; Cavanagh, C; Wang, PH; Gardiner, D; Choulet, F; Feuillet, C; Zheng, YL; Wei, YM; Yan, GJ; Han, B; Manners, JM; Liu, CJ				Ma, Jian; Stiller, Jiri; Zhao, Qiang; Feng, Qi; Cavanagh, Colin; Wang, Penghao; Gardiner, Donald; Choulet, Frederic; Feuillet, Catherine; Zheng, You-Liang; Wei, Yuming; Yan, Guijun; Han, Bin; Manners, John M.; Liu, Chunji			Transcriptome and Allele Specificity Associated with a 3BL Locus for Fusarium Crown Rot Resistance in Bread Wheat	PLOS ONE			English	Article							HEAD-BLIGHT RESISTANCE; MYCOTOXIN DEOXYNIVALENOL; DRAFT GENOME; GENE; EXPRESSION; DEFENSE; GRAMINEARUM; PROTEIN; QTL; OVEREXPRESSION	Fusarium pathogens cause two major diseases in cereals, Fusarium crown rot (FCR) and head blight (FHB). A large-effect locus conferring resistance to FCR disease was previously located to chromosome arm 3BL (designated as Qcrs-3B) and several independent sets of near isogenic lines (NILs) have been developed for this locus. In this study, five sets of the NILs were used to examine transcriptional changes associated with the Qcrs-3B locus and to identify genes linked to the resistance locus as a step towards the isolation of the causative gene(s). Of the differentially expressed genes (DEGs) detected between the NILs, 12.7% was located on the single chromosome 3B. Of the expressed genes containing SNP (SNP-EGs) detected, 23.5% was mapped to this chromosome. Several of the DEGs and SNP-EGs are known to be involved in host-pathogen interactions, and a large number of the DEGs were among those detected for FHB in previous studies. Of the DEGs detected, 22 were mapped in the Qcrs-3B interval and they included eight which were detected in the resistant isolines only. The enrichment of DEG, and not necessarily those containing SNPs between the resistant and susceptible isolines, around the Qcrs-3B locus is suggestive of local regulation of this region by the resistance allele. Functions for 13 of these DEGs are known. Of the SNP-EGs, 28 were mapped in the Qcrs-3B interval and biological functions for 16 of them are known. These results provide insights into responses regulated by the 3BL locus and identify a tractable number of target genes for fine mapping and functional testing to identify the causative gene(s) at this QTL.	[Ma, Jian; Stiller, Jiri; Gardiner, Donald; Manners, John M.; Liu, Chunji] CSIRO Agr Flagship, St Lucia, Qld, Australia; [Ma, Jian; Zheng, You-Liang; Wei, Yuming] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China; [Zhao, Qiang; Feng, Qi; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Gene Res, Shanghai, Peoples R China; [Cavanagh, Colin; Wang, Penghao] CSIRO Agr Flagship, Black Mt, ACT, Australia; [Choulet, Frederic; Feuillet, Catherine] INRA, UBP Joint Res Unit 1095, Genet Div & Ecophysiol Cereals, Clermont Ferrand, France; [Yan, Guijun; Liu, Chunji] Univ Western Australia, Fac Sci, Sch Plant Biol, Perth, WA 6009, Australia; [Yan, Guijun; Liu, Chunji] Univ Western Australia, Inst Agr, Perth, WA 6009, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Sichuan Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); INRAE; University of Western Australia; University of Western Australia	Liu, CJ (corresponding author), CSIRO Agr Flagship, St Lucia, Qld, Australia.	chunji.liu@csiro.au	Stiller, Jiri/E-1564-2012; Wang, Penghao/A-7482-2015; Ma, Jian/M-3639-2019; Liu, Chunji/B-5243-2009; Manners, John M/A-4922-2008; Gardiner, Donald/A-1297-2010; Yan, Guijun/A-9809-2011	Ma, Jian/0000-0001-6265-7911; Gardiner, Donald/0000-0002-2162-8716; Cavanagh, Colin/0000-0003-4341-4484; Choulet, Frederic/0000-0003-1788-7288; Wang, Penghao/0000-0002-3751-3921; Yan, Guijun/0000-0001-9628-1211	joint CAS/CSIRO project [R-1910-1]; ARC Linkage project [LP120200830]; Sichuan Agricultural University; China Scholarship Council	joint CAS/CSIRO project; ARC Linkage project(Australian Research Council); Sichuan Agricultural University; China Scholarship Council(China Scholarship Council)	This publication is based upon work supported by a joint CAS/CSIRO project (Project No R-1910-1) and an ARC Linkage project (Project No. LP120200830). JM is grateful to the Sichuan Agricultural University and the China Scholarship Council for funding his visit to CSIRO Agriculture Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Bovill WD, 2006, PLANT BREEDING, V125, P538, DOI 10.1111/j.1439-0523.2006.01251.x; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chakraborty S, 2006, AUSTRALAS PLANT PATH, V35, P643, DOI 10.1071/AP06068; Cho SH, 2012, J PLANT BIOL, V55, P64, DOI 10.1007/s12374-011-9190-7; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Collard BCY, 2005, PLANT BREEDING, V124, P532, DOI 10.1111/j.1439-0523.2005.01163.x; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; Desmond OJ, 2005, PHYSIOL MOL PLANT P, V67, P171, DOI 10.1016/j.pmpp.2005.12.007; Desmond OJ, 2008, PHYSIOL MOL PLANT P, V73, P40, DOI 10.1016/j.pmpp.2008.12.001; Dubin H.J., 1997, FUSARIUM HEAD SCAB G; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Gottwald S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-369; Hancock JT, 2002, PLANT PHYSIOL BIOCH, V40, P611, DOI 10.1016/S0981-9428(02)01403-1; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kugler KG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-728; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Li GL, 2008, CROP SCI, V48, P1888, DOI 10.2135/cropsci2008.02.0097; Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0; Li WL, 2001, THEOR APPL GENET, V102, P353, DOI 10.1007/s001220051653; Li X, 2010, PHYTOPATHOLOGY, V100, P183, DOI 10.1094/PHYTO-100-2-0183; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu SX, 2008, CEREAL RES COMMUN, V36, P195, DOI 10.1556/CRC.36.2008.Suppl.B.15; Liu YL, 2004, PLANT J, V38, P800, DOI 10.1111/j.1365-313X.2004.02085.x; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Lu W, 2001, WHEAT SCAB RES CHINA; Ma J, 2012, EUPHYTICA, V183, P147, DOI 10.1007/s10681-011-0414-1; Ma J, 2010, THEOR APPL GENET, V120, P1119, DOI 10.1007/s00122-009-1239-3; Ma J, 2013, PLANTA, V238, P1081, DOI 10.1007/s00425-013-1953-6; Ma J, 2013, GENETICA, V141, P227, DOI 10.1007/s10709-013-9721-x; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; MAUCH F, 1993, PLANT PHYSIOL, V102, P1193, DOI 10.1104/pp.102.4.1193; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Muhitch MJ, 2000, PLANT SCI, V157, P201, DOI 10.1016/S0168-9452(00)00282-X; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Yang XM, 2010, EUR J PLANT PATHOL, V128, P495, DOI 10.1007/s10658-010-9680-3; Zheng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096011, 10.1371/journal.pone.0090817]; Zhu XL, 2012, FUNCT INTEGR GENOMIC, V12, P481, DOI 10.1007/s10142-012-0286-z	54	26	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113309	10.1371/journal.pone.0113309	http://dx.doi.org/10.1371/journal.pone.0113309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405461	Green Published, gold			2022-12-27	WOS:000347121300102
J	Shahab, L; Beard, E; Brown, J; West, R				Shahab, Lion; Beard, Emma; Brown, Jamie; West, Robert			Prevalence of NRT Use and Associated Nicotine Intake in Smokers, Recent Ex-Smokers and Longer-Term Ex-Smokers	PLOS ONE			English	Article							REPLACEMENT THERAPY; SMOKING-CESSATION; TOBACCO DEPENDENCE; CIGARETTE; COTININE; DURATION; IMPACT; AID; GUM	Background: Nicotine replacement therapy (NRT) is used by smokers wanting to reduce their smoking and to quit. However, there are very little data on nicotine intake associated with NRT use in representative population samples. This study aimed to provide estimates for NRT use and associated nicotine exposure among smokers, recent and longer-term exsmokers in England, a country with a permissive regulatory regime for nicotine substitution. Methods: In the Smoking Toolkit Study, a monthly series of representative household surveys of adults aged 16+ in England, current and recent ex-smokers who agreed to be re-contacted were followed up 6 months later and standard socio-demographic and smoking characteristics assessed (N = 5,467, response rate 25.1%). A random sub-sample (N = 1,614; 29.5%) also provided saliva, analysed for cotinine. Results: The sample followed up was broadly representative of the original sample. At follow-up, 11.8% (95% CI 10.9-12.8, N = 565) of current smokers, 34.8% (95% CI 28.9-41.3, N = 77) of recent (<= 3 months) ex-smokers, and 7.8% (95% CI 5.6-10.6, N = 36) of longer-term (>3 months) ex-smokers reported using NRT. Smokers who used NRT had similar saliva cotinine concentrations to smokers who did not use NRT (mean +/- sd = 356.0 +/- 198.6 ng/ml vs. 313.1 +/- 178.4 ng/ml). Recent exsmokers who used NRT had levels that were somewhat lower, but not significantly so, than current smokers (216.7 +/- 179.3 ng/ml). Longer-term ex-smokers using NRT had still lower levels (157.3 +/- 227.1 ng/ml), which differed significantly from smokers using NRT (p = 0.024). Conclusions: Concurrent use of nicotine replacement therapy while smoking is relatively uncommon and is not associated with higher levels of nicotine intake. Among ex-smokers, NRT use is common in the short but not longer-term and among longer-term users is associated with lower nicotine intake than in smokers.	[Shahab, Lion; Beard, Emma; Brown, Jamie; West, Robert] UCL, Dept Epidemiol & Publ Hlth, London, England; [Brown, Jamie] UCL, Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London; University of London; University College London	Shahab, L (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	lion.shahab@ucl.ac.uk	Brown, Jamie/F-4413-2011; Shahab, Lion/B-5835-2009; West, Robert/B-5414-2009	Brown, Jamie/0000-0002-2797-5428; Shahab, Lion/0000-0003-4033-442X; West, Robert/0000-0001-6398-0921	Department of Health, Cancer Research UK; Pfizer; GlaxoSmithKline; Johnson and Johnson; Cancer Research UK [14135] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish	Department of Health, Cancer Research UK(Cancer Research UK); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Department of Health, Cancer Research UK, Pfizer, GlaxoSmithKline and Johnson and Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard E, 2013, TOB CONTROL, V22, P118, DOI 10.1136/tobaccocontrol-2011-050007; Beard E, 2011, PSYCHOPHARMACOLOGY, V218, P609, DOI 10.1007/s00213-011-2359-4; BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P368; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; Black A, 2012, ADDICTION, V107, P2037, DOI 10.1111/j.1360-0443.2012.03955.x; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Etter JF, 2009, ADDICT BEHAV, V34, P246, DOI 10.1016/j.addbeh.2008.10.018; Fagerstrom Karl Olov, 2002, Nicotine Tob Res, V4 Suppl 2, pS73; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; Fidler JA, 2011, PSYCHOPHARMACOLOGY, V217, P587, DOI 10.1007/s00213-011-2317-1; Fidler JA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-479; Fidler JA, 2011, ADDICTION, V106, P631, DOI 10.1111/j.1360-0443.2010.03226.x; FOULDS J, 1994, AM J PUBLIC HEALTH, V84, P1182, DOI 10.2105/AJPH.84.7.1182; Fucito LM, 2014, NICOTINE TOB RES, V16, P909, DOI 10.1093/ntr/ntu087; Hajek P, 2007, PREV MED, V44, P230, DOI 10.1016/j.ypmed.2006.10.005; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; Hubbard R, 2005, TOB CONTROL, V14, P416, DOI 10.1136/tc.2005.011387; Joseph AM, 2011, ARCH INTERN MED, V171, P1894, DOI 10.1001/archinternmed.2011.500; Kotz D, 2013, DRUG ALCOHOL DEPEN, V128, P15, DOI 10.1016/j.drugalcdep.2012.07.012; Le Houezec J, 2011, DRUG ALCOHOL REV, V30, P119, DOI 10.1111/j.1465-3362.2010.00264.x; Le Strat Y, 2011, TOB CONTROL, V20, P338, DOI 10.1136/tc.2010.038703; MHRA, 2009, MHRA PUBL ASS REP US; NICE, 2013, TOB HARM RED; Schnoll RA, 2010, ANN INTERN MED, V152, P144, DOI 10.7326/0003-4819-152-3-201002020-00005; Shahab L, 2013, CNS DRUGS, V27, P1007, DOI 10.1007/s40263-013-0116-4; Shahab L, 2009, ADDICTION, V104, P1420, DOI 10.1111/j.1360-0443.2009.02641.x; Shiffman S, 2008, HEALTH POLICY, V86, P17, DOI 10.1016/j.healthpol.2007.08.006; Silla K, 2014, NICOTINE TOB RES, V16, P1050, DOI 10.1093/ntr/ntu019; Sims TH, 2002, CNS DRUGS, V16, P653, DOI 10.2165/00023210-200216100-00001; Stratton S, 2001, CLEARING SMOKE ADDRE; Tonnesen P, 1999, EUR RESPIR J, V13, P238, DOI 10.1034/j.1399-3003.1999.13b04.x; Wang D, 2008, HEALTH TECHNOL ASSES, V12, piii, DOI DOI 10.3310/HTA12020; Wennike P, 2003, ADDICTION, V98, P1395, DOI 10.1046/j.1360-0443.2003.00489.x; West R, 2005, TOB CONTROL, V14, P166, DOI 10.1136/tc.2004.008649	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113045	10.1371/journal.pone.0113045	http://dx.doi.org/10.1371/journal.pone.0113045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405343	Green Published, gold			2022-12-27	WOS:000347121300073
J	Shan, GG; Young, D; Kang, L				Shan, Guogen; Young, Daniel; Kang, Le			A New Powerful Nonparametric Rank Test for Ordered Alternative Problem	PLOS ONE			English	Article							K-SAMPLE; END-POINTS; HOMOGENEITY; DESIGNS; TRENDS	We propose a new nonparametric test for ordered alternative problem based on the rank difference between two observations from different groups. These groups are assumed to be independent from each other. The exact mean and variance of the test statistic under the null distribution are derived, and its asymptotic distribution is proven to be normal. Furthermore, an extensive power comparison between the new test and other commonly used tests shows that the new test is generally more powerful than others under various conditions, including the same type of distribution, and mixed distributions. A real example from an anti-hypertensive drug trial is provided to illustrate the application of the tests. The new test is therefore recommended for use in practice due to easy calculation and substantial power gain.	[Shan, Guogen] Univ Nevada, Sch Community Hlth Sci, Dept Environm & Occupat Hlth, Epidemiol & Biostat Program, Las Vegas, NV 89154 USA; [Young, Daniel] Univ Nevada, Div Hlth Sci, Las Vegas, NV 89154 USA; [Kang, Le] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Virginia Commonwealth University	Shan, GG (corresponding author), Univ Nevada, Sch Community Hlth Sci, Dept Environm & Occupat Hlth, Epidemiol & Biostat Program, Las Vegas, NV 89154 USA.	guogen.shan@unlv.edu	Shan, Guogen/GQI-3293-2022; Daniel L. Young, PT/R-9920-2016; Kang, Le/ABD-1116-2022	Daniel L. Young, PT/0000-0002-3575-6049; Kang, Le/0000-0003-4262-2329				Alonzo TA, 2009, STAT MED, V28, P1144, DOI 10.1002/sim.3536; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dmitrienko A., 2006, PHARM STAT USING SAS; HAJEK J, 1961, ANN MATH STAT, V32, P506, DOI 10.1214/aoms/1177705057; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Kossler W, 2005, J NONPARAMETR STAT, V17, P777, DOI 10.1080/10485250500077254; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LE CT, 1988, BIOMETRICAL J, V30, P87, DOI 10.1002/bimj.4710300116; MACK GA, 1981, J AM STAT ASSOC, V76, P175, DOI 10.2307/2287064; MAHRER JM, 1995, STAT MED, V14, P863, DOI 10.1002/sim.4780140814; Mann H. B., 1947, ANN MATH STAT; Neuhauser M, 1998, BIOMETRICAL J, V40, P899, DOI 10.1002/(SICI)1521-4036(199812)40:8<899::AID-BIMJ899>3.0.CO;2-9; Randles R, 1979, INTRO THEORY NONPARA; Shan G, 2014, OPEN J STAT, V04, P495, DOI DOI 10.4236/OJS.2014.47047; Shan GG, 2014, STAT PROBABIL LETT, V85, P129, DOI 10.1016/j.spl.2013.11.010; Shan GG, 2012, PHARM STAT, V11, P287, DOI 10.1002/pst.1499; Shan GG, 2012, STAT MED, V31, P155, DOI 10.1002/sim.4411; Terpstra JT, 2003, J NONPARAMETR STAT, V15, P289, DOI 10.1080/1048525031000078349; Terpstra T, 1952, INDAGATIONES MATHEMA, V14, P327; TRYON PV, 1973, ANN STAT, V1, P1061, DOI 10.1214/aos/1176342557; Wilding GE, 2014, STAT MED, V33, P2998, DOI 10.1002/sim.6135; Wilding GE, 2012, CONTEMP CLIN TRIALS, V33, P332, DOI 10.1016/j.cct.2011.10.008; [No title captured]	26	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112924	10.1371/journal.pone.0112924	http://dx.doi.org/10.1371/journal.pone.0112924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405757	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300062
J	Merkes, CM; McCalla, SG; Jensen, NR; Gaikowski, MP; Amberg, JJ				Merkes, Christopher M.; McCalla, S. Grace; Jensen, Nathan R.; Gaikowski, Mark P.; Amberg, Jon J.			Persistence of DNA in Carcasses, Slime and Avian Feces May Affect Interpretation of Environmental DNA Data	PLOS ONE			English	Article							WATER; CONSERVATION; ERADICATION; PREDATION; BIOLOGY; RARE	The prevention of non-indigenous aquatic invasive species spreading into new areas is a goal of many resource managers. New techniques have been developed to survey for species that are difficult to capture with conventional gears that involve the detection of their DNA in water samples (eDNA). This technique is currently used to track the invasion of bigheaded carps (silver carp and bighead carp; Hypophthalmichthys molitrix and H. nobilis) in the Chicago Area Waterway System and Upper Mississippi River. In both systems DNA has been detected from silver carp without the capture of a live fish, which has led to some uncertainty about the source of the DNA. The potential contribution to eDNA by vectors and fomites has not been explored. Because barges move from areas with a high abundance of bigheaded carps to areas monitored for the potential presence of silver carp, we used juvenile silver carp to simulate the barge transport of dead bigheaded carp carcasses, slime residue, and predator feces to determine the potential of these sources to supply DNA to uninhabited waters where it could be detected and misinterpreted as indicative of the presence of live bigheaded carp. Our results indicate that all three vectors are feasible sources of detectable eDNA for at least one month after their deposition. This suggests that current monitoring programs must consider alternative vectors of DNA in the environment and consider alternative strategies to minimize the detection of DNA not directly released from live bigheaded carps.	[Merkes, Christopher M.] IAP Worldwide Serv Inc, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA; [Merkes, Christopher M.; McCalla, S. Grace; Jensen, Nathan R.; Gaikowski, Mark P.; Amberg, Jon J.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA	United States Department of the Interior; United States Geological Survey	Merkes, CM (corresponding author), IAP Worldwide Serv Inc, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA.	cmerkes@usgs.gov		McCalla, S. Grace/0000-0003-4292-8694; Gaikowski, Mark/0000-0002-6507-9341; Merkes, Christopher/0000-0001-8191-627X	U.S. Environmental Protection Agency - Great Lakes Restoration Initiative; IAP Worldwide Services	U.S. Environmental Protection Agency - Great Lakes Restoration Initiative; IAP Worldwide Services	Funding support for this work came from the U.S. Environmental Protection Agency - Great Lakes Restoration Initiative appropriated funds (http://greatlakesrestoration.us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Christopher M. Merkes was employed by IAP Worldwide Services at the time of the study. IAP Worldwide Services provided support in the form of salary for author Christopher M. Merkes but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	Banks SC, 2003, MOL ECOL, V12, P1663, DOI 10.1046/j.1365-294X.2003.01823.x; Bienert F, 2012, MOL ECOL, V21, P2017, DOI 10.1111/j.1365-294X.2011.05407.x; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Casper RM, 2007, J EXP MAR BIOL ECOL, V347, P144, DOI 10.1016/j.jembe.2007.04.002; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Dallas John F., 2000, Conservation Genetics, V1, P181, DOI 10.1023/A:1026551510861; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gross S, 2013, ARMY CORPS ENG OTHER; Hedmark E, 2004, CONSERV GENET, V5, P405, DOI 10.1023/B:COGE.0000031224.88778.f5; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Lamer JT, 2010, N AM J FISH MANAGE, V30, P1452, DOI 10.1577/M10-053.1; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Matsui K, 2001, AQUAT MICROB ECOL, V26, P95, DOI 10.3354/ame026095; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Oehm J, 2011, MOL ECOL RESOUR, V11, P620, DOI 10.1111/j.1755-0998.2011.03001.x; Palsboll PJ, 1997, NATURE, V388, P767, DOI 10.1038/42005; Piggott MP, 2003, WILDLIFE RES, V30, P1, DOI 10.1071/WR02077; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; U.S. Army Corps of Engineers, 2013, 2012 AS CARP MON RAP; U.S. Army Corps of Engineers, 2013, ENV DNA CAL STUD INT; U.S. Fish & Wildlife Service, 2013, BIGH SILV CARP EDNA; Williams CK, 2003, TLS-TIMES LIT SUPPL, P31	38	94	98	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113346	10.1371/journal.pone.0113346	http://dx.doi.org/10.1371/journal.pone.0113346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402206	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700130
J	Menard, S; Guzylack-Piriou, L; Lencina, C; Leveque, M; Naturel, M; Sekkal, S; Harkat, C; Gaultier, E; Olier, M; Garcia-Villar, R; Theodorou, V; Houdeau, E				Menard, Sandrine; Guzylack-Piriou, Laurence; Lencina, Corinne; Leveque, Mathilde; Naturel, Manon; Sekkal, Soraya; Harkat, Cherryl; Gaultier, Eric; Olier, Maiwenn; Garcia-Villar, Raphael; Theodorou, Vassilia; Houdeau, Eric			Perinatal Exposure to a Low Dose of Bisphenol A Impaired Systemic Cellular Immune Response and Predisposes Young Rats to Intestinal Parasitic Infection	PLOS ONE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; DEVELOPMENTAL IMMUNOTOXICOLOGY; ENDOCRINE DISRUPTOR; PROTECTIVE IMMUNITY; ANTIBODY; MICE; INFLAMMATION; NEUTROPHILS; ADULTHOOD; DISEASE	Perinatal exposure to the food contaminant bisphenol A (BPA) in rats induces long lasting adverse effects on intestinal immune homeostasis. This study was aimed at examining the immune response to dietary antigens and the clearance of parasites in young rats at the end of perinatal exposure to a low dose of BPA. Female rats were fed with BPA [5 mu g/kg of body weight/day] or vehicle from gestational day 15 to pup weaning. Juvenile female offspring (day (D) 25) were used to analyze immune cell populations, humoral and cellular responses after oral tolerance or immunization protocol to ovalbumin (OVA), and susceptibility to infection by the intestinal nematode Nippostrongylus brasiliensis (N. brasiliensis). Anti-OVA IgG titers following either oral tolerance or immunization were not affected after BPA perinatal exposure, while a sharp decrease in OVA-induced IFN gamma secretion occurred in spleen and mesenteric lymph nodes (MLN) of OVA-immunized rats. These results are consistent with a decreased number of helper T cells, regulatory T cells and dendritic cells in spleen and MLN of BPA-exposed rats. The lack of cellular response to antigens questioned the ability of BPA-exposed rats to clear intestinal infections. A 1.5-fold increase in N. brasiliensis living larvae was observed in the intestine of BPA-exposed rats compared to controls due to an inappropriate Th1/Th2 cytokine production in infected jejunal tissues. These results show that perinatal BPA exposure impairs cellular response to food antigens, and increases susceptibility to intestinal parasitic infection in the juveniles. This emphasized the maturing immune system during perinatal period highly sensitive to low dose exposure to BPA, altering innate and adaptative immune response capacities in early life.	[Menard, Sandrine; Lencina, Corinne; Leveque, Mathilde; Naturel, Manon; Harkat, Cherryl; Olier, Maiwenn; Theodorou, Vassilia] Res Ctr Food Toxicol, Neurogastroenterol & Nutr INRA, Toxalim UMR1331, Toulouse, France; [Guzylack-Piriou, Laurence; Sekkal, Soraya; Gaultier, Eric; Houdeau, Eric] Res Ctr Food Toxicol, Intestinal Dev Xenobiot & ImmunoToxicol INRA, Toxalim UMR1331, Toulouse, France; [Garcia-Villar, Raphael] INRA, Res Ctr Food Toxicol, Toxalim UMR1331, F-31931 Toulouse, France	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Menard, S (corresponding author), Res Ctr Food Toxicol, Neurogastroenterol & Nutr INRA, Toxalim UMR1331, Toulouse, France.	sandrine.menard@toulouse.inra.fr	Olier, Maïwenn/N-3383-2019; Olier, Maïwenn/C-4971-2015; Menard, Sandrine/ABF-8935-2021	Olier, Maïwenn/0000-0001-7214-1134; Olier, Maïwenn/0000-0001-7214-1134; Menard, Sandrine/0000-0001-8867-199X; GARCIA-VILLAR, Rafael/0000-0002-2118-4406; Leveque, Mathilde/0000-0003-1253-3798	Agence Nationale de la Recherche [ANR-10-CESA-005]; AP AlimH from Institut National de la Recherche Agronomique	Agence Nationale de la Recherche(French National Research Agency (ANR)); AP AlimH from Institut National de la Recherche Agronomique	Funding: This work was supported by grant ANR-10-CESA-005 from Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) (France) and AP AlimH 2008 from Institut National de la Recherche Agronomique (http://www.alimh.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Braniste V, 2010, P NATL ACAD SCI USA, V107, P448, DOI 10.1073/pnas.0907697107; Cabaton NJ, 2013, ENVIRON HEALTH PERSP, V121, P586, DOI 10.1289/ehp.1205588; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Dietert RR, 2010, METHODS MOL BIOL, V598, P17, DOI 10.1007/978-1-60761-401-2_2; Dietert RR, 2009, CHEM RES TOXICOL, V22, P17, DOI 10.1021/tx800198m; Dietert RR, 2008, BIRTH DEFECTS RES B, V83, P547, DOI 10.1002/bdrb.20170; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Heilmann C, 2006, PLOS MED, V3, P1352, DOI 10.1371/journal.pmed.0030311; Heilmann C, 2010, ENVIRON HEALTH PERSP, V118, P1434, DOI 10.1289/ehp.1001975; Houdeau E, 2005, AM J PHYSIOL-REG I, V288, pR630, DOI 10.1152/ajpregu.00482.2004; Lawrence BP, 2007, VIRAL IMMUNOL, V20, P231, DOI 10.1089/vim.2007.0013; Luebke RW, 2006, J TOXICOL ENV HEAL B, V9, P1, DOI 10.1080/15287390500194326; Menard S, 2014, FASEB J, V28, P4893, DOI 10.1096/fj.14-255380; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nel HJ, 2011, J IMMUNOL, V186, P4631, DOI 10.4049/jimmunol.1002995; OGILVIE BM, 1971, EXP PARASITOL, V29, P138, DOI 10.1016/0014-4894(71)90021-X; Ohshima Y, 2007, PEDIATR RES, V62, P60, DOI 10.1203/PDR.0b013e3180674dae; Pesce JT, 2008, J IMMUNOL, V180, P464, DOI 10.4049/jimmunol.180.1.464; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sharkhuu T, 2011, J IMMUNOTOXICOL, V8, P183, DOI 10.3109/1547691X.2011.568978; Sharkhuu T, 2010, TOXICOL LETT, V196, P12, DOI 10.1016/j.toxlet.2010.03.017; UCHIKAWA R, 1994, IMMUNOLOGY, V82, P427; URBAN JF, 1993, J IMMUNOL, V151, P7086; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Winans B, 2011, REPROD TOXICOL, V31, P327, DOI 10.1016/j.reprotox.2010.09.004; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829	34	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112752	10.1371/journal.pone.0112752	http://dx.doi.org/10.1371/journal.pone.0112752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415191	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600014
J	Liu, Y; Wu, B; Weinstock, G; Walker, DH; Yu, XJ				Liu, Yan; Wu, Bin; Weinstock, George; Walker, David H.; Yu, Xue-jie			Inactivation of SAM-Methyltransferase is the Mechanism of Attenuation of a Historic Louse Borne Typhus Vaccine Strain	PLOS ONE			English	Article							RICKETTSIA-PROWAZEKII STRAINS; EPIDEMIC TYPHUS; PROTEIN	Louse borne typhus (also called epidemic typhus) was one of man's major scourges, and epidemics of the disease can be reignited when social, economic, or political systems are disrupted. The fear of a bioterrorist attack using the etiologic agent of typhus, Rickettsia prowazekii, was a reality. An attenuated typhus vaccine, R. prowazekii Madrid E strain, was observed to revert to virulence as demonstrated by isolation of the virulent revertant Evir strain from animals which were inoculated with Madrid E strain. The mechanism of the mutation in R. prowazekii that affects the virulence of the vaccine was not known. We sequenced the genome of the virulent revertant Evir strain and compared its genome sequence with the genome sequences of its parental strain, Madrid E. We found that only a single nucleotide in the entire genome was different between the vaccine strain Madrid E and its virulent revertant strain Evir. The mutation is a single nucleotide insertion in the methyltransferase gene (also known as PR028) in the vaccine strain that inactivated the gene. We also confirmed that the vaccine strain E did not cause fever in guinea pigs and the virulent revertant strain Evir caused fever in guinea pigs. We concluded that a single nucleotide insertion in the methyltransferase gene of R. prowazekii attenuated the R. prowazekii vaccine strain E. This suggested that an irreversible insertion or deletion mutation in the methyl transferase gene of R. prowazekii is required for Madrid E to be considered a safe vaccine.	[Liu, Yan] Anhui Med Univ, Sch Basic Med Sci, Dept Microbiol, Hefei 230032, Anhui, Peoples R China; [Liu, Yan; Walker, David H.; Yu, Xue-jie] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Wu, Bin] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Weinstock, George] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Yu, Xue-jie] Shandong Univ, Sch Publ Hlth, Jinan 250012, Shandong, Peoples R China	Anhui Medical University; University of Texas System; University of Texas Medical Branch Galveston; Jiangsu Provincial Center for Disease Control & Prevention; Washington University (WUSTL); Shandong University	Yu, XJ (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	xuyu@utmb.edu	Yu, Xuejie/AAP-9246-2021; Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	Institute of National Health [U01AI71283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI071283] Funding Source: NIH RePORTER	Institute of National Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the Institute of National Health (U01AI71283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibek K, 1999, BIOHAZARD CHILLING T; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Ching W.M., 1993, TECHNIQUES PROTEIN C, P307; CHING WM, 1992, MOL IMMUNOL, V29, P95, DOI 10.1016/0161-5890(92)90161-P; Conlon JM, 2014, HIST IMPACT EPIDEMIC; DUMA RJ, 1981, JAMA-J AM MED ASSOC, V245, P2318, DOI 10.1001/jama.245.22.2318; FOX JP, 1957, J IMMUNOL, V79, P348; Harris S., 1992, ANN N Y ACAD SCI, V666, P21; PENKINA GA, 1995, ACTA VIROL, V39, P205; Raoult D, 2004, INFECT DIS CLIN N AM, V18, P127, DOI 10.1016/S0891-5520(03)00093-X; RODIONOV AV, 1991, ACTA VIROL, V35, P557; TURCO J, 1994, INFECT IMMUN, V62, P3172, DOI 10.1128/IAI.62.8.3172-3177.1994; Wisseman C L Jr, 1972, Adv Exp Med Biol, V31, P97; Zhang JZ, 2006, VACCINE, V24, P2317, DOI 10.1016/j.vaccine.2005.11.044; Zinsser H, 1933, NEW ENGL J MED, V209, P815, DOI 10.1056/NEJM193310262091701	16	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113285	10.1371/journal.pone.0113285	http://dx.doi.org/10.1371/journal.pone.0113285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412248	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000033
J	Okpechi, IG; Dlamini, TAL; Duffield, M; Rayner, BL; Moturi, G; Swanepoel, CR				Okpechi, Ikechi G.; Dlamini, Thandiwe A. L.; Duffield, Maureen; Rayner, Brian L.; Moturi, George; Swanepoel, Charles R.			Outcome of Patients with Primary Immune-Complex Type Mesangiocapillary Glomerulonephritis (MCGN) in Cape Town South Africa	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LONG-TERM PROGNOSIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; RENAL-DISEASES; EPIDEMIOLOGY; PROGRESSION; REGISTRY; HYGIENE	Background and Aim: Mesangiocapillary glomerulonephritis (MCGN) is a common cause of chronic kidney disease in developing countries. Data on the renal outcome of patients with idiopathic MCGN is limited. The aim of this study is to investigate the outcome of patients with idiopathic MCGN presenting to the Groote Schuur Hospital (GSH) Renal Unit in Cape Town. Materials and Methods: A retrospective study of patients with idiopathic MCGN followed up at our clinic. Seventy-nine patients with no identifiable cause of MCGN were included for analysis. A composite renal outcome of persistent doubling of serum creatinine or end stage renal disease (ESRD) was used. Kaplan Meier survival and Cox regression analysis were used to assess survival and identify factors predicting the outcome. Results: The mean age at biopsy was 33.9 +/- 13.6 years and 41.8% were black. Mean duration of follow up was 13.5 +/- 18.8 months. Twenty-three patients (34.2%) reached the composite endpoint. Overall, median renal survival was 38.7 +/- 11.7 months (95%CI 15.7-61.8) with 2-year and 5-year renal survival of 61% and 40.3% respectively. No significant difference was found for renal survival between males and females, treatment or non-treatment with immunosuppression, presence or absence of crescents or histological type of MCGN (p>0.05). On univariate Cox-regression analysis, factors found to be associated with the outcome were the estimated glomerular filtration rate at biopsy (OR 0.97 [95%CI: 0.95-0.99], p<0.0001), black race (OR 3.03 [95%CI: 1.27-7.21], p = 0.012) and presence of interstitial fibrosis in the biopsy (OR 2.64 [95%CI: 1.076.48], p = 0.034). Age, systolic blood pressure and attaining complete or partial remission approached significant values with the endpoint. Conclusions: The outcome of idiopathic MCGN in Cape Town is poor and requires further prospective studies to improve our understanding of this common disease.	[Okpechi, Ikechi G.; Dlamini, Thandiwe A. L.; Rayner, Brian L.; Swanepoel, Charles R.] Groote Schuur Hosp, Div Nephrol & Hypertens, Cape Town, South Africa; [Okpechi, Ikechi G.; Dlamini, Thandiwe A. L.; Rayner, Brian L.; Swanepoel, Charles R.] Univ Cape Town, ZA-7700 Rondebosch, South Africa; [Duffield, Maureen] Univ Cape Town, Natl Hlth & Lab Serv, Div Anat Pathol, ZA-7700 Rondebosch, South Africa; [Moturi, George] Aga Khan Univ Hosp, Dept Med, Nairobi, Kenya	University of Cape Town; University of Cape Town; University of Cape Town	Okpechi, IG (corresponding author), Groote Schuur Hosp, Div Nephrol & Hypertens, Cape Town, South Africa.	Ikechi.Okpechi@uct.ac.za	Rayner, Brian/AAA-3174-2021	Dlamini, Thandiwe/0000-0002-6614-2656; Rayner, Brian/0000-0002-0167-9591				Asinobi A O, 1999, West Afr J Med, V18, P203; Ayodele OE, 2013, INT UROL NEPHROL, V45, P1289, DOI 10.1007/s11255-012-0376-9; Barsoum R S, 2000, Saudi J Kidney Dis Transpl, V11, P421; Brantsma AH, 2007, J AM SOC NEPHROL, V18, P637, DOI 10.1681/ASN.2006070738; CAMERON JS, 1983, AM J MED, V74, P175, DOI 10.1016/0002-9343(83)90606-X; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Covic A, 2006, NEPHROL DIAL TRANSPL, V21, P419, DOI 10.1093/ndt/gfi207; DAMICO G, 1992, J AM SOC NEPHROL, V2, pS159; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fervenza FC, 2012, KIDNEY INT SUPPL, V2, P139, DOI [DOI 10.1038/KISUP.2012.9, 10.1038/kisup.2012.9]; Fervenza FC, 2012, NEPHROL DIAL TRANSPL, V27, P4288, DOI 10.1093/ndt/gfs288; Habib R, 1973, Perspect Nephrol Hypertens, V1 Pt 1, P491; Hanko JB, 2009, NEPHROL DIAL TRANSPL, V24, P3050, DOI 10.1093/ndt/gfp254; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Johnson RJ, 2003, AM J KIDNEY DIS, V42, P575, DOI 10.1016/S0272-6386(03)00801-1; Kawamura T, 2013, CLIN EXP NEPHROL, V17, P248, DOI 10.1007/s10157-012-0690-7; Khalifa Eman H, 2004, Saudi J Kidney Dis Transpl, V15, P176; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Liang MH, 2006, ARTHRITIS RHEUM-US, V54, P421, DOI 10.1002/art.21625; Little MA, 2000, RENAL FAILURE, V22, P445, DOI 10.1081/JDI-100100886; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; MCENERY PT, 1990, J PEDIATR-US, V116, pS109, DOI 10.1016/S0022-3476(05)82712-X; Naicker S, 2008, SEMIN NEPHROL, V28, P348, DOI 10.1016/j.semnephrol.2008.04.003; Okpechi I, 2011, NEPHROL DIAL TRANSPL, V26, P1853, DOI 10.1093/ndt/gfq655; Okpechi IG, 2012, NEPHROL DIAL TRANSPL, V27, P3509, DOI 10.1093/ndt/gfs122; Okpechi IG, 2010, J NATL MED ASSOC, V102, P1193, DOI 10.1016/S0027-9684(15)30774-4; Olowu WA, 2003, PEDIATR NEPHROL, V18, P1249, DOI 10.1007/s00467-003-1255-5; ORLOWSKI T, 1988, KLIN WOCHENSCHR, V66, P1019, DOI 10.1007/BF01733447; PEDERSEN RS, 1995, SCAND J UROL NEPHROL, V29, P265, DOI 10.3109/00365599509180574; Rychlik I, 2004, NEPHROL DIAL TRANSPL, V19, P3040, DOI 10.1093/ndt/gfh521; Schena FP, 1997, NEPHROL DIAL TRANSPL, V12, P418, DOI 10.1093/ndt/12.3.418; SCHMITT H, 1990, NEPHRON, V55, P242, DOI 10.1159/000185969; Sethi S, 2012, KIDNEY INT, V81, P434, DOI 10.1038/ki.2011.399; Sethi S, 2011, SEMIN NEPHROL, V31, P341, DOI 10.1016/j.semnephrol.2011.06.005; Sethi S, 2010, CLIN J AM SOC NEPHRO, V5, P770, DOI 10.2215/CJN.06760909; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; SWAINSON CP, 1983, J PATHOL, V141, P449, DOI 10.1002/path.1711410404; Zand L, 2013, AM J KIDNEY DIS, V62, P506, DOI 10.1053/j.ajkd.2013.02.370	39	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113302	10.1371/journal.pone.0113302	http://dx.doi.org/10.1371/journal.pone.0113302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411791	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000037
J	Wei, CY; Kim, IK; Li, L; Wu, LL; Gupta, S				Wei, Chuanyu; Kim, Il-Kwon; Li, Li; Wu, Liling; Gupta, Sudhiranjan			Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy	PLOS ONE			English	Article							ASPARTYL-LYSYL-PROLINE; HEPATIC STELLATE CELLS; FACTOR-KAPPA-B; ARTERIAL-HYPERTENSION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CARDIAC REPAIR; MIGRATION; PROMOTES; NOTCH	Pulmonary hypertension (PH) is a progressive vascular disease of pulmonary arteries that impedes ejection of blood by the right ventricle. As a result there is an increase in pulmonary vascular resistance and pulmonary arterial pressure causing right ventricular hypertrophy (RVH) and RV failure. The pathology of PAH involves vascular cell remodeling including pulmonary arterial endothelial cell (PAEC) dysfunction and pulmonary arterial smooth muscle cell (PASMC) proliferation. Current therapies are limited to reverse the vascular remodeling. Investigating a key molecule is required for development of new therapeutic intervention. Thymosin beta-4 (T beta 4) is a ubiquitous G-actin sequestering protein with diverse biological function and promotes wound healing and modulates inflammatory responses. However, it remains unknown whether T beta 4 has any protective role in PH. The purpose of this study is to evaluate the whether T beta 4 can be used as a vascular-protective agent. In monocrotaline (MCT)-induced PH mouse model, we showed that mice treated with T beta 4 significantly attenuated the systolic pressure and RVH, compared to the MCT treated mice. Our data revealed for the first time that T beta 4 selectively targets Notch3-Col 3A-CTGF gene axis in preventing MCT-induced PH and RVH. Our study may provide pre-clinical evidence for T beta 4 and may consider as vasculo-protective agent for the treatment of PH induced RVH.	[Wei, Chuanyu; Kim, Il-Kwon; Li, Li; Gupta, Sudhiranjan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Med, Div Mol Cardiol, Temple, TX 76508 USA; [Wei, Chuanyu; Kim, Il-Kwon; Li, Li; Gupta, Sudhiranjan] Scott & White Mem Hosp & Clin, Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Li, Li; Wu, Liling] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Scott & White Medical Center; Peking University	Gupta, S (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Med, Div Mol Cardiol, Temple, TX 76508 USA.	sgupta@medicine.tamhsc.edu	wei, chuanyu/H-3150-2016		Texas A & M Health Science Center, College of Medicine; American Heart Association [14GRNT 20490320]; Research Mentor Award by Scott & White Memorial Hospital; Texas AM; Natural National Science Foundation of China	Texas A & M Health Science Center, College of Medicine; American Heart Association(American Heart Association); Research Mentor Award by Scott & White Memorial Hospital; Texas AM; Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partly supported by startup funds from the Texas A & M Health Science Center, College of Medicine, by an American Heart Association- Grant-in-Aid (14GRNT 20490320), by Research Mentor Award by Scott & White Memorial Hospital and Texas A&M and Natural National Science Foundation of China to S. Gupta (SG) and Liling Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WK, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00149; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Conte E, 2013, EUR J CLIN INVEST, V43, P309, DOI 10.1111/eci.12048; De Santis M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-22; Dube KN, 2012, CURR PHARM DESIGN, V18, P799; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Evans MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3081; Goldstein AL, 2012, EXPERT OPIN BIOL TH, V12, P37, DOI 10.1517/14712598.2012.634793; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Hinkel R, 2008, CIRCULATION, V117, P2232, DOI 10.1161/CIRCULATIONAHA.107.758904; Ho JHC, 2008, BRIT J OPHTHALMOL, V92, P992, DOI 10.1136/bjo.2007.136747; Hong YM, 2014, KOREAN CIRC J, V44, P97, DOI 10.4070/kcj.2014.44.2.97; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Kumar S, 2012, AM J PHYSIOL-HEART C, V302, pH1655, DOI 10.1152/ajpheart.00756.2011; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Li L, 2014, HYPERTENSION, V63, P1260, DOI 10.1161/HYPERTENSIONAHA.114.03220; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Lv SM, 2013, MOL CELL BIOCHEM, V381, P283, DOI 10.1007/s11010-013-1713-8; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; O'Callaghan DS, 2011, NAT REV CARDIOL, V8, P526, DOI 10.1038/nrcardio.2011.104; Omata M, 2006, J AM SOC NEPHROL, V17, P674, DOI 10.1681/ASN.2005040385; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Rhaleb NE, 2001, CIRCULATION, V103, P3136, DOI 10.1161/01.CIR.103.25.3136; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Rossdeutsch A, 2012, CIRC RES, V111, pE89, DOI 10.1161/CIRCRESAHA.111.259846; Ruff D, 2010, ANN NY ACAD SCI, V1194, P223, DOI 10.1111/j.1749-6632.2010.05474.x; Selmi A, 2012, EXP CELL RES, V318, P1659, DOI 10.1016/j.yexcr.2012.04.009; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Sosne G, 2006, EXP EYE RES, V83, P502, DOI 10.1016/j.exer.2006.02.001; Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307; Stamm Jason A, 2011, Pulm Circ, V1, P138, DOI 10.4103/2045-8932.83444; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Veit F, 2013, ANTIOXID REDOX SIGN, V19, P2213, DOI 10.1089/ars.2012.4904; Wei CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042586; Xiao YT, 2014, CELL PHYSIOL BIOCHEM, V34, P356, DOI 10.1159/000363005; Young JD, 1999, NAT MED, V5, P1424; Zuo YQ, 2013, KIDNEY INT, V84, P1166, DOI 10.1038/ki.2013.209	41	7	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e110598	10.1371/journal.pone.0110598	http://dx.doi.org/10.1371/journal.pone.0110598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412097	Green Submitted, Green Published, gold			2022-12-27	WOS:000345253000004
J	von Saltzwedel, H; Maraun, M; Scheu, S; Schaefer, I				von Saltzwedel, Helge; Maraun, Mark; Scheu, Stefan; Schaefer, Ina			Evidence for Frozen-Niche Variation in a Cosmopolitan Parthenogenetic Soil Mite Species (Acari, Oribatida)	PLOS ONE			English	Article							ENEMY-FREE SPACE; GENETIC DIFFERENTIATION; CLONAL DIVERSITY; LIFE-HISTORY; BODY-SIZE; EVOLUTION; POPULATIONS; MICROARTHROPODS; RECOMBINATION; POECILIOPSIS	Parthenogenetic lineages may colonize marginal areas of the range of related sexual species or coexist with sexual species in the same habitat. Frozen-Niche-Variation and General-Purpose-Genotype are two hypotheses suggesting that competition and interclonal selection result in parthenogenetic populations being either genetically diverse or rather homogeneous. The cosmopolitan parthenogenetic oribatid mite Oppiella nova has a broad ecological phenotype and is omnipresent in a variety of habitats. Morphological variation in body size is prominent in this species and suggests adaptation to distinct environmental conditions. We investigated genetic variance and body size of five independent forest -grassland ecotones. Forests and grasslands were inhabited by distinct genetic lineages with transitional habitats being colonized by both genetic lineages from forest and grassland. Notably, individuals of grasslands were significantly larger than individuals in forests. These differences indicate the presence of specialized genetic lineages specifically adapted to either forests or grasslands which coexist in transitional habitats. Molecular clock estimates suggest that forest and grassland lineages separated 16-6 million years ago, indicating long-term persistence of these lineages in their respective habitat. Long-term persistence, and morphological and genetic divergence imply that drift and environmental factors result in the evolution of distinct parthenogenetic lineages resembling evolution in sexual species. This suggests that parthenogenetic reproduction is not an evolutionary dead end.	[von Saltzwedel, Helge; Maraun, Mark; Scheu, Stefan; Schaefer, Ina] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Ecol, D-37073 Gottingen, Germany	University of Gottingen	von Saltzwedel, H (corresponding author), Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Ecol, D-37073 Gottingen, Germany.	hsaltzw1@gwdg.de	Scheu, Stefan/H-7049-2015					Andersen HF, 2012, ECOL EVOL, V2, P247, DOI 10.1002/ece3.58; Avise John C., 1994, pi; Baker H. G., 1965, The genetics of colonizing species., P147; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Beerli Peter, 2009, V17, P42; Bell G, 1982, MASTERPIECE NATURE E; Birdsell JA, 2003, EVOL BIOL, V33, P27; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; Bronmark C, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P203; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Browne RA, 1990, EVOLUTION, V33, P848; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; CHRISTENSEN B, 1980, HEREDITAS, V92, P193; Cianciolo JM, 2006, EXP APPL ACAROL, V40, P1, DOI 10.1007/s10493-006-9016-3; Cooper WE, 2010, BEHAV ECOL, V21, P1278, DOI 10.1093/beheco/arq142; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Dahl, 2006, TIERWELT DEUTSCHLAND; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; East TL, 1999, J PLANKTON RES, V21, P1537, DOI 10.1093/plankt/21.8.1537; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Erdmann G, 2012, EXP APPL ACAROL, V57, P157, DOI 10.1007/s10493-012-9546-9; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher RA, 1930, GENETICAL THEORY NAT; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2008, J EVOLUTION BIOL, V21, P580, DOI 10.1111/j.1420-9101.2007.01472.x; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; Gray MM, 2001, CAN J FISH AQUAT SCI, V58, P1313, DOI 10.1139/cjfas-58-7-1313; Groot TVM, 2005, EXP APPL ACAROL, V36, P165, DOI 10.1007/s10493-005-3360-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hansen MM, 1998, HEREDITY, V81, P493, DOI 10.1046/j.1365-2540.1998.00408.x; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Heethoff M, 2004, PEDOBIOLOGIA, V48, P9, DOI 10.1016/j.pedobi.2003.04.001; Heethoff M, 2012, EXP APPL ACAROL, V56, P93, DOI 10.1007/s10493-011-9501-1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hotz H, 2008, J ZOOL SYST EVOL RES, V46, P56, DOI 10.1111/j.1439-0469.2007.00430.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTSON BR, 1980, J APPL ECOL, V17, P255, DOI 10.2307/2402323; Janssens TKS, 2009, INSECT SCI, V16, P3, DOI 10.1111/j.1744-7917.2009.00249.x; KANEKO N, 1988, ACAROLOGIA, V29, P215; Kempson D., 1963, Pedobiologia, V3, P1; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Laumann M, 2007, PEDOBIOLOGIA, V51, P111, DOI 10.1016/j.pedobi.2007.02.001; Lehmitz R, 2012, APPL SOIL ECOL, V55, P10, DOI 10.1016/j.apsoil.2011.12.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima NRW, 1998, BEHAVIOUR, V135, P83, DOI 10.1163/156853998793066410; Lindberg N, 2005, APPL SOIL ECOL, V28, P163, DOI 10.1016/j.apsoil.2004.07.003; LITVAITIS MK, 1994, MAR BIOL, V120, P437, DOI 10.1007/BF00680218; LYNCH M, 1985, EVOLUTION, V39, P804, DOI 10.1111/j.1558-5646.1985.tb00422.x; LYNCH M, 1987, AM NAT, V129, P283, DOI 10.1086/284635; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Maraun M, 2004, EXP APPL ACAROL, V33, P183, DOI 10.1023/B:APPA.0000032956.60108.6d; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2011, SOIL BIOL BIOCHEM, V43, P877, DOI 10.1016/j.soilbio.2011.01.003; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Norton Roy A., 1994, P99; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; Pantel JH, 2011, J EVOLUTION BIOL, V24, P723, DOI 10.1111/j.1420-9101.2010.02196.x; Penttinen R, 2008, INTEGRATIVE ACAROLOG, P237; Peschel K, 2006, SOIL BIOL BIOCHEM, V38, P2985, DOI 10.1016/j.soilbio.2006.04.035; Pinheiro J., 2019, NLME LINEAR NONLINEA; POSTHUMA L, 1990, J APPL ECOL, V27, P609, DOI 10.2307/2404306; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberger M, 2013, PEDOBIOLOGIA, V56, P79, DOI 10.1016/j.pedobi.2012.11.003; Sanders FH, 2004, J MORPHOL, V259, P119, DOI 10.1002/jmor.10183; Schaffer S, 2010, PEDOBIOLOGIA, V53, P203, DOI 10.1016/j.pedobi.2009.09.004; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Schneider K, 2009, SOIL BIOL BIOCHEM, V41, P170, DOI 10.1016/j.soilbio.2008.10.013; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; Siira-Pietikainen A, 2008, PEDOBIOLOGIA, V52, P111, DOI 10.1016/j.pedobi.2008.05.001; Stamatakis A, 2014, BIOINFORMATICS; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Van Doninck K, 2004, HEREDITY, V93, P154, DOI 10.1038/sj.hdy.6800486; Vrijenhoek R.C., 1984, P399; Vrijenhoek R. C, 1984, POPULATION BIOL EVOL, P217, DOI [DOI 10.1007/978-3-642-69646-6_18, 10.1007/978-3-642-69646-6_18]; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Wanner M, 2002, EUR J SOIL BIOL, V38, P137, DOI 10.1016/S1164-5563(02)01135-4; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Wetherington J.D., 1989, P259; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; WOAS S, 1986, Andrias, V5, P21; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	94	14	14	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113268	10.1371/journal.pone.0113268	http://dx.doi.org/10.1371/journal.pone.0113268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409516	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200087
J	Yang, F; Kerns, DL; Head, GP; Leonard, BR; Levy, R; Niu, Y; Huang, FN				Yang, Fei; Kerns, David L.; Head, Graham P.; Leonard, B. Rogers; Levy, Ronnie; Niu, Ying; Huang, Fangneng			A Challenge for the Seed Mixture Refuge Strategy in Bt Maize: Impact of Cross-Pollination on an Ear-Feeding Pest, Corn Earworm	PLOS ONE			English	Article							BORER LEPIDOPTERA CRAMBIDAE; RESISTANCE MANAGEMENT STRATEGY; FALL ARMYWORM LEPIDOPTERA; INSECT RESISTANCE; FIELD-RESISTANCE; TRANSGENIC CORN; PINK-BOLLWORM; MIX REFUGE; NOCTUIDAE; CROPS	To counter the threat of insect resistance, Bacillus thuringiensis (Bt) maize growers in the U.S. are required to plant structured non-Bt maize refuges. Concerns with refuge compliance led to the introduction of seed mixtures, also called RIB (refuge-in-the- bag), as an alternative approach for implementing refuge for Bt maize products in the U.S. Maize Belt. A major concern in RIB is cross-pollination of maize hybrids that can cause Bt proteins to be present in refuge maize kernels and negatively affect refuge insects. Here we show that a mixed planting of 5% nonBt and 95% Bt maize containing the SmartStax traits expressing Cry1A. 105, Cry2Ab2 and Cry1F did not provide an effective refuge for an important above-ground ear-feeding pest, the corn earworm, Helicoverpa zea (Boddie). Cross-pollination in RIB caused a majority (>90%) of refuge kernels to express >= one Bt protein. The contamination of Bt proteins in the refuge ears reduced neonate-to-adult survivorship of H. zea to only 4.6%, a reduction of 88.1% relative to larvae feeding on ears of pure non-Bt maize plantings. In addition, the limited survivors on refuge ears had lower pupal mass and took longer to develop to adults.	[Yang, Fei; Leonard, B. Rogers; Niu, Ying; Huang, Fangneng] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Kerns, David L.] Louisiana State Univ, Ctr Agr, Macon Ridge Res Stn, Winnsboro, LA 71295 USA; [Head, Graham P.] Monsanto Co, St Louis, MO 63167 USA; [Levy, Ronnie] Louisiana State Univ, Ctr Agr, Dean Lee Res Stn, Alexandria, LA 71302 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Monsanto; Louisiana State University System; Louisiana State University at Alexandria	Huang, FN (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	fhuang@agcenter.lsu.edu	Yang, Fei/Q-6498-2016		Monsanto; Louisiana Soybean and Feed Grain Promotion Board; USDA National Institute of Food and Agriculture	Monsanto; Louisiana Soybean and Feed Grain Promotion Board; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	F.H. received research funding related to this project from Monsanto, the Louisiana Soybean and Feed Grain Promotion Board, and the hatch funds from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that a funder (Monsanto) provided support in the form of salaries for a co-author [G.P.H.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors also confirm that this does not alter their adherence to PLOS ONE policies on sharing data and materials.	Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; Bannert M., 2006, THESIS SWISS FEDERAL; Burkness EC, 2011, J ECON ENTOMOL, V104, P1476, DOI 10.1603/EC11081; Burkness EC, 2010, GM CROP, V1, P1, DOI DOI 10.4161/GMCR.1.1.10948; Burkness EC, 2012, J ECON ENTOMOL, V105, P1773, DOI 10.1603/EC12128; Capinera J. L., 2001, HDB VEGETABLE PESTS, P396; Capinera JL, 2000, CORN EARWORM HELICOV; Carroll MW, 2013, CROP PROT, V49, P58, DOI 10.1016/j.cropro.2013.02.003; Carroll MW, 2012, CROP PROT, V38, P74, DOI 10.1016/j.cropro.2012.02.015; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Chilcutt CF, 2007, J ECON ENTOMOL, V100, P327, DOI 10.1603/0022-0493(2007)100[327:EOBTTC]2.0.CO;2; Davis PM, 2000, J ECON ENTOMOL, V93, P937, DOI 10.1603/0022-0493-93.3.937; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; DIFONZO C., 2012, HANDY BT TRAIT TABLE; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Goldstein JA, 2010, J ECON ENTOMOL, V103, P331, DOI 10.1603/EC09304; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Heuberger S, 2008, J ECON ENTOMOL, V101, P504, DOI 10.1603/0022-0493(2008)101[504:EORCBT]2.0.CO;2; Huang F, 2007, B ENTOMOL RES, V97, P1, DOI DOI 10.1787/HEMP-V19-ART3-EN; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Institute S.A.S., 2010, SAS STAT US; Ives AR, 2011, ECOL APPL, V21, P503, DOI 10.1890/09-1869.1; Kang J, 2012, ENVIRON ENTOMOL, V41, P200, DOI 10.1603/EN11133; LEAHY TC, 1994, ANN ENTOMOL SOC AM, V87, P342, DOI 10.1093/aesa/87.3.342; LINGREN PD, 1994, ENVIRON ENTOMOL, V23, P562, DOI 10.1093/ee/23.3.562; MALLET J, 1992, P ROY SOC B-BIOL SCI, V250, P165, DOI 10.1098/rspb.1992.0145; Marlay S., 2011, EXTERNAL PUBLICATION; Matten SR, 2012, US ENV PROTECTION AG, P175; NASS (National Agricultural Statistics Service), 2013, ACR; Niu Y, 2014, CROP PROT, V59, P22, DOI 10.1016/j.cropro.2014.01.005; Onstad DW, 2011, J ECON ENTOMOL, V104, P343, DOI 10.1603/EC10388; Ostlie KR., 1997, N CENTRAL REGIONAL E, V602; Poongothai S, 2013, INT J BIOL RES, V1, P49; Razze JM, 2012, J ECON ENTOMOL, V105, P1214, DOI 10.1603/EC11288; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Shantharam S, 2006, CURR SCI INDIA, V90, P1170; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; US EPA (U.S. Environmental Protection Agency), 2001, BIOP REG ACT DOC BAC; US EPA [United States Environmental Protection Agency], 2010, TERMS COND BT CORN R; US-EPA, 2010, BIOP REG ACT DOC BAC; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wangila DS, 2013, PEST MANAG SCI, V69, P1163, DOI 10.1002/ps.3484; Yang F, 2014, CROP PROT, V55, P127, DOI 10.1016/j.cropro.2013.10.012; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	49	32	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112962	10.1371/journal.pone.0112962	http://dx.doi.org/10.1371/journal.pone.0112962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409442	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200051
J	Deng, ZY; Uehara, T; Maeda, H; Hasegawa, M; Matayoshi, S; Kiyuna, A; Agena, S; Pan, XL; Zhang, CL; Yamashita, Y; Xie, MQ; Suzuki, M				Deng, Zeyi; Uehara, Takayuki; Maeda, Hiroyuki; Hasegawa, Masahiro; Matayoshi, Sen; Kiyuna, Asanori; Agena, Shinya; Pan, Xiaoli; Zhang, Chunlin; Yamashita, Yukashi; Xie, Minqiang; Suzuki, Mikio			Epstein-Barr Virus and Human Papillomavirus Infections and Genotype Distribution in Head and Neck Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; LATENT MEMBRANE-PROTEIN; MESSENGER-RNA EXPRESSION; LYTIC CYCLE REPLICATION; 30-BP DELETION VARIANT; NF-KAPPA-B; NASOPHARYNGEAL CARCINOMA; PHYSICAL STATUS; DNA LOAD; EBV	Objective: To investigate the prevalence, genotypes, and prognostic values of Epstein-Barr virus (EBV) and human papillomavirus (HPV) infections in Japanese patients with different types of head and neck cancer (HNC). Methods and Materials: HPV and EBV DNA, EBV genotypes and LMP-1 variants, and HPV mRNA expression were detected by PCR from fresh-frozen HNC samples. HPV genotypes were determined by direct sequencing, and EBV encoded RNA (EBER) was examined by in situ hybridization. Results: Of the 209 HNC patients, 63 (30.1%) had HPV infection, and HPV-16 was the most common subtype (86.9%). HPV E6/E7 mRNA expression was found in 23 of 60 (38.3%) HPV DNA-positive cases detected. The site of highest prevalence of HPV was the oropharynx (45.9%). Among 146 (69.9%) HNCs in which EBV DNA was identified, 107 (73.3%) and 27 (18.5%) contained types A and B, respectively, and 124 (84.9%) showed the existence of del-LMP-1. However, only 13 (6.2%) HNCs were positive for EBER, 12 (92.3%) of which derived from the nasopharynx. Co-infection of HPV and EBER was found in only 1.0% of HNCs and 10.0% of NPCs. Kaplan-Meier survival analysis showed significantly better disease-specific and overall survival in the HPV DNA+/mRNA+ oropharyngeal squamous cell carcinoma (OPC) patients than in the other OPC patients (P = 0.027 and 0.017, respectively). Multivariate analysis showed that stage T1-3 (P = 0.002) and HPV mRNA-positive status (P = 0.061) independently predicted better disease-specific survival. No significant difference in disease-specific survival was found between the EBER-positive and -negative NPC patients (P = 0.155). Conclusions: Our findings indicate that co-infection with HPV and EBV is rare in HNC. Oropharyngeal SCC with active HPV infection was related to a highly favorable outcome, while EBV status was not prognostic in the NPC cohort.	[Deng, Zeyi; Pan, Xiaoli; Zhang, Chunlin; Xie, Minqiang] Southern Med Univ, Zhujiang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Deng, Zeyi; Uehara, Takayuki; Maeda, Hiroyuki; Hasegawa, Masahiro; Matayoshi, Sen; Kiyuna, Asanori; Agena, Shinya; Pan, Xiaoli; Zhang, Chunlin; Yamashita, Yukashi; Suzuki, Mikio] Univ Ryukyus, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Nishihara, Okinawa 90301, Japan	Southern Medical University - China; University of the Ryukyus	Deng, ZY (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China.	jordandzy@hotmail.com; min_qiang_x@hotmail.com		Deng, Zeyi/0000-0003-1064-1031	KAKENHI (Japan Society for the Promotion of Science) [26462610, 26462611]; Okinawa Medical Science Research Foundation; Science and Technology Development Center, Ministry of Education of the People's Republic of China; Ryukyu Society for the Promotion of Oto-Rhino-Laryngology	KAKENHI (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Okinawa Medical Science Research Foundation; Science and Technology Development Center, Ministry of Education of the People's Republic of China; Ryukyu Society for the Promotion of Oto-Rhino-Laryngology	This study was supported by grant KAKENHI 26462610 (Japan Society for the Promotion of Science) to Dr. Suzuki, grant KAKENHI 26462611 (Japan Society for the Promotion of Science) to Dr. Deng, a grant from the Okinawa Medical Science Research Foundation to Dr. Deng, and a grant from the Science and Technology Development Center, Ministry of Education of the People's Republic of China to Dr. Deng. This study was also supported and conducted in cooperation with the Ryukyu Society for the Promotion of Oto-Rhino-Laryngology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2013, CLIN CANCER RES, V19, P2175, DOI 10.1158/1078-0432.CCR-12-2897; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Blake SMS, 2001, VIROLOGY, V282, P278, DOI 10.1006/viro.2001.0828; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Bussu F, 2013, BRIT J CANCER, V108, P1157, DOI 10.1038/bjc.2013.55; Chan KCA, 2013, CANCER-AM CANCER SOC, V119, P1838, DOI 10.1002/cncr.28001; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Cheung ST, 1996, INT J CANCER, V66, P711, DOI 10.1002/(SICI)1097-0215(19960529)66:5<711::AID-IJC21>3.0.CO;2-5; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Cmelak AJ, 2007, J CLIN ONCOL, V25, P3971, DOI 10.1200/JCO.2007.10.8951; Cohen JI, 1999, CURR OPIN IMMUNOL, V11, P365, DOI 10.1016/S0952-7915(99)80062-4; Correa RM, 2007, J MED VIROL, V79, P401, DOI 10.1002/jmv.20782; Correa RM, 2004, J MED VIROL, V73, P583, DOI 10.1002/jmv.20129; Dardari R, 2006, INT J CANCER, V118, P1977, DOI 10.1002/ijc.21595; de Boer MA, 2007, CLIN CANCER RES, V13, P132, DOI 10.1158/1078-0432.CCR-06-1568; Deng ZY, 2013, HEAD NECK-J SCI SPEC, V35, P800, DOI 10.1002/hed.23034; de Oliveira DE, 2006, AM J CLIN PATHOL, V126, P284, DOI [10.1039/UU2JADUEHDWATVM9, 10.1309/UU2JADUEHDWATVM9]; Fielding CA, 2001, J VIROL, V75, P9129, DOI 10.1128/JVI.75.19.9129-9141.2001; Goldenberg D, 2001, AM J OTOLARYNG, V22, P197, DOI 10.1053/ajot.2001.23429; Higa M, 2002, J CLIN PATHOL, V55, P414, DOI 10.1136/jcp.55.6.414; Hodge CW, 2007, INT J RADIAT ONCOL, V69, P1032, DOI 10.1016/j.ijrobp.2007.05.017; HORDING U, 1994, LARYNGOSCOPE, V104, P99; Hu LF, 2000, CANCER RES, V60, P5589; Huang CC, 2011, J CLIN PATHOL, V64, P571, DOI 10.1136/jcp.2010.087742; HUEN DS, 1995, ONCOGENE, V10, P549; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; Jalouli J, 2012, ANTICANCER RES, V32, P571; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon YK, 2004, HEAD NECK-J SCI SPEC, V26, P573, DOI 10.1002/hed.10370; Khanim F, 1996, BLOOD, V88, P3491, DOI 10.1182/blood.V88.9.3491.bloodjournal8893491; Kis A, 2009, EUR J ORAL SCI, V117, P536, DOI 10.1111/j.1600-0722.2009.00660.x; Koskinen WJ, 2003, INT J CANCER, V107, P401, DOI 10.1002/ijc.11381; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Laantri N, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-3; Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040767; Lin ZX, 2014, HEAD NECK-J SCI SPEC, V36, P709, DOI 10.1002/hed.23362; Lo EJ, 2010, LARYNGOSCOPE, V120, P1990, DOI 10.1002/lary.21089; Luo CW, 2007, INT J ORAL MAX SURG, V36, P153, DOI 10.1016/j.ijom.2006.09.005; MANOS MM, 1989, CANCER CEL, V7, P209; Mercader M, 2000, AM J PATHOL, V156, P1961, DOI 10.1016/S0002-9440(10)65069-9; Mirzamani N, 2006, EXP MOL PATHOL, V81, P231, DOI 10.1016/j.yexmp.2006.04.006; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; NICHOLLS JM, 1994, PATHOLOGY, V26, P94, DOI 10.1080/00313029400169281; Pai PC, 2004, HEAD NECK-J SCI SPEC, V26, P619, DOI 10.1002/hed.20057; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Rautava J, 2012, J CLIN VIROL, V53, P116, DOI 10.1016/j.jcv.2011.11.005; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Shimakage M, 1999, HUM PATHOL, V30, P1071, DOI 10.1016/S0046-8177(99)90225-3; SHU CH, 1992, J VIROL METHODS, V38, P123, DOI 10.1016/0166-0934(92)90175-D; Sidagis J, 1997, INT J CANCER, V72, P72, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;72::AID-IJC11&gt;3.0.CO;2-C; Singhi AD, 2012, HEAD NECK-J SCI SPEC, V34, P213, DOI 10.1002/hed.21714; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; Szkaradkiewicz A, 2002, CLIN EXP MED, V2, P137, DOI 10.1007/s102380200019; Tung Yi-Ching, 1999, Kaohsiung Journal of Medical Sciences, V15, P256; TYAN YS, 1993, J CLIN MICROBIOL, V31, P53, DOI 10.1128/JCM.31.1.53-56.1993; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Wiest T, 2002, ONCOGENE, V21, P1510, DOI 10.1038/sj.onc.1205214; Wong M, 2002, JNCI-J NATL CANCER I, V94, P1832, DOI 10.1093/jnci/94.24.1832; Yang HJ, 2001, HEAD NECK-J SCI SPEC, V23, P629, DOI 10.1002/hed.1089; Zhang XS, 2002, CANCER LETT, V176, P65, DOI 10.1016/S0304-3835(01)00733-9; Zheng Y, 2010, ANTICANCER RES, V30, P1233	66	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113702	10.1371/journal.pone.0113702	http://dx.doi.org/10.1371/journal.pone.0113702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405488	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300123
J	Lan, JM; Deng, Y; Chen, H; Lu, GW; Wang, W; Guo, XJ; Lu, ZZ; Gao, GF; Tan, WJ				Lan, Jiaming; Deng, Yao; Chen, Hong; Lu, Guangwen; Wang, Wen; Guo, Xiaojuan; Lu, Zhuozhuang; Gao, George F.; Tan, Wenjie			Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen	PLOS ONE			English	Article							SPIKE PROTEIN; S PROTEIN; IMMUNIZATION; PNEUMONIA; RESPONSES; TARGET; SAFETY	The development of an effective vaccine is critical for prevention of a Middle East respiratory syndrome coronavirus (MERS-CoV) pandemic. Some studies have indicated the receptor-binding domain (RBD) protein of MERS-CoV spike (S) is a good candidate antigen for a MERS-CoV subunit vaccine. However, highly purified proteins are typically not inherently immunogenic. We hypothesised that humoral and cell-mediated immunity would be improved with a modification of the vaccination regimen. Therefore, the immunogenicity of a novel MERS-CoV RBD-based subunit vaccine was tested in mice using different adjuvant formulations and delivery routes. Different vaccination regimens were compared in BALB/c mice immunized 3 times intramuscularly (i.m.) with a vaccine containing 10 mu g of recombinant MERS-CoV RBD in combination with either aluminium hydroxide (alum) alone, alum and polyriboinosinic acid (poly I:C) or alum and cysteine-phosphate-guanine (CpG) oligodeoxynucleotides (ODN). The immune responses of mice vaccinated with RBD, incomplete Freund's adjuvant (IFA) and CpG ODN by a subcutaneous (s.c.) route were also investigated. We evaluated the induction of RBD-specific humoral immunity (total IgG and neutralizing antibodies) and cellular immunity (ELISpot assay for IFN-gamma spot-forming cells and splenocyte cytokine production). Our findings indicated that the combination of alum and CpG ODN optimized the development of RBD-specific humoral and cellular immunity following subunit vaccination. Interestingly, robust RBD-specific antibody and T-cell responses were induced in mice immunized with the rRBD protein in combination with IFA and CpG ODN, but low level of neutralizing antibodies were elicited. Our data suggest that murine immunity following subunit vaccination can be tailored using adjuvant combinations and delivery routes. The vaccination regimen used in this study is promising and could improve the protection offered by the MERS-CoV subunit vaccine by eliciting effective humoral and cellular immune responses.	[Lan, Jiaming; Deng, Yao; Chen, Hong; Wang, Wen; Guo, Xiaojuan; Lu, Zhuozhuang; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing 102206, Peoples R China; [Lan, Jiaming] Hebei Med Univ, Dept Pathogen Biol, Shijiazhuang 050017, Peoples R China; [Lu, Guangwen; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Hebei Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn; tanwj28@163.com	Lu, Guangwen/HCH-9193-2022; Gao, George Fu/ABD-5229-2021		State Megaproject for Infectious Disease Research of China [2014ZX10004001-002, 2013ZX10004601]; National 973 Program of China [2011CB504704]	State Megaproject for Infectious Disease Research of China; National 973 Program of China(National Basic Research Program of China)	This work was supported by grants from the State Megaproject for Infectious Disease Research of China (2014ZX10004001-002, 2013ZX10004601) and National 973 Program of China (2011CB504704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chuai X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054126, DOI 10.1371/JOURNAL.PONE.0054126PONE-D-12-35157]; Conforti VA, 2008, VACCINE, V26, P907, DOI 10.1016/j.vaccine.2007.12.010; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; de Wit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069127; Du LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081587; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; Dychter SS, 2012, J INFUS MURS, V35, P154, DOI 10.1097/NAN.0b013e31824d2271; Gong MQ, 2012, VACCINE, V30, P7498, DOI 10.1016/j.vaccine.2012.10.054; Haining WN, 2004, J IMMUNOL, V173, P2578, DOI 10.4049/jimmunol.173.4.2578; Jiang SB, 2012, EXPERT REV VACCINES, V11, P1405, DOI [10.1586/ERV.12.126, 10.1586/erv.12.126]; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lau SKP, 2013, J VIROL, V87, P8638, DOI 10.1128/JVI.01055-13; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Lu L, 2013, MICROBES INFECT, V15, P625, DOI 10.1016/j.micinf.2013.06.003; Ma CQ, 2014, VACCINE, V32, P2100, DOI 10.1016/j.vaccine.2014.02.004; Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13; Munster VJ, 2013, NEW ENGL J MED, V368, P1560, DOI 10.1056/NEJMc1215691; Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Reusken CB, 2014, EURO SURVEILL, V19; Samara EM, 2014, MBIO, V5, DOI 10.1128/mBio.01430-14; Vallecillo MFS, 2014, BIOMATERIALS, V35, P2529, DOI 10.1016/j.biomaterials.2013.12.002; Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/erv.11.21, 10.1586/ERV.11.21]; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037019; World Health Organization, 2014, MIDDL E RESP SYNDR C; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao GY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-266; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111; Zhu XJ, 2013, J THORAC DIS, V5, pS142, DOI 10.3978/j.issn.2072-1439.2013.06.06	35	63	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112602	10.1371/journal.pone.0112602	http://dx.doi.org/10.1371/journal.pone.0112602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405618	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300040
J	Libran-Perez, M; Velasco, C; Lopez-Patino, MA; Miguez, JM; Soengas, JL				Libran-Perez, Marta; Velasco, Cristina; Lopez-Patino, Marcos A.; Miguez, Jesus M.; Soengas, Jose L.			Counter-Regulatory Response to a Fall in Circulating Fatty Acid Levels in Rainbow Trout. Possible Involvement of the Hypothalamus-Pituitary-Interrenal Axis	PLOS ONE			English	Article							SALMON SALMO-SALAR; VOLUNTARY FEED-INTAKE; ONCORHYNCHUS-MYKISS; FOOD-INTAKE; CORTISOL RESPONSE; GROWTH-HORMONE; INTERMEDIARY METABOLISM; GLUCOSENSING CAPACITY; LIPOSTATIC REGULATION; ENERGY HOMEOSTASIS	We hypothesize that a decrease in circulating levels of fatty acid (FA) in rainbow trout Oncorhynchus mykiss would result in the inhibition of putative hypothalamic FA sensing systems with concomitant changes in the expression of orexigenic and anorexigenic factors ultimately leading to a stimulation of food intake. To assess this hypothesis, we lowered circulating FA levels treating fish with SDZ WAG 994 (SDZ), a selective A1 adenosine receptor agonist that inhibits lipolysis. In additional groups, we also evaluated if the presence of intralipid was able to counteract changes induced by SDZ treatment, and the possible involvement of the hypothalamus-pituitary-interrenal (HPI) axis by treating fish with SDZ in the presence of metyrapone, which decreases cortisol synthesis in fish. The decrease in circulating levels of FA in rainbow trout induced a clear increase in food intake that was associated with the decrease of the anorexigenic potential in hypothalamus (decreased POMC-A1 and CART mRNA abundance), and with changes in several parameters related to putative FA-sensing mechanisms in hypothalamus. Intralipid treatment counteracted these changes. SDZ treatment also induced increased cortisol levels and the activation of different components of the HPI axis whereas these changes disappeared in the presence of intralipid or metyrapone. These results suggest that the HPI axis is involved in a counter-regulatory response in rainbow trout to restore FA levels in plasma.	[Libran-Perez, Marta; Velasco, Cristina; Lopez-Patino, Marcos A.; Miguez, Jesus M.; Soengas, Jose L.] Univ Vigo, Lab Fisioloxia Anim, Dept Bioloxia Func & Ciencias Saude, Fac Bioloxia, Vigo 36310, Spain	Universidade de Vigo	Soengas, JL (corresponding author), Univ Vigo, Lab Fisioloxia Anim, Dept Bioloxia Func & Ciencias Saude, Fac Bioloxia, Vigo 36310, Spain.	jsoengas@uvigo.es	Miguez, J.M./M-3705-2014; Soengas, José L/M-1898-2014; Velasco, Cristina/AAE-4604-2021	Miguez, J.M./0000-0002-3474-2139; Soengas, José L/0000-0002-6847-3993; Velasco Rubial, Cristina/0000-0001-7440-8998; Lopez-Patino, Marcos A./0000-0002-1038-7419	Ministerio de Ciencia e Innovacion and European Fund for Regional Development (FEDER) [AGL2013-46448-3-1-R]; Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia [CN 2012/004]; Ministerio de Ciencia e Innovacion (Predoctoral Fellowship, Program FPI)	Ministerio de Ciencia e Innovacion and European Fund for Regional Development (FEDER); Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia(Xunta de Galicia); Ministerio de Ciencia e Innovacion (Predoctoral Fellowship, Program FPI)	Ministerio de Ciencia e Innovacion and European Fund for Regional Development (AGL2013-46448-3-1-R and FEDER) to JLS. Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia, CN 2012/004) to JLS. Ministerio de Ciencia e Innovacion (Predoctoral Fellowship, Program FPI) to MLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Alderman SL, 2012, GEN COMP ENDOCR, V176, P79, DOI 10.1016/j.ygcen.2011.12.031; Aluru N, 2006, ENDOCRINOLOGY, V147, P1895, DOI 10.1210/en.2005-1143; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Bernier NJ, 2008, J ENDOCRINOL, V196, P637, DOI 10.1677/JOE-07-0568; Bernier NJ, 2005, AM J PHYSIOL-REG I, V289, pR982, DOI 10.1152/ajpregu.00668.2004; Bernier NJ, 2001, NEUROENDOCRINOLOGY, V73, P248, DOI 10.1159/000054642; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Clement L, 2002, PFLUG ARCH EUR J PHY, V445, P375, DOI 10.1007/s00424-002-0937-3; Conde-Sieira M, 2013, J EXP BIOL, V216, P554, DOI 10.1242/jeb.076505; Conde-Sieira M, 2011, J EXP BIOL, V214, P3887, DOI 10.1242/jeb.061564; Conde-Sieira M, 2010, J EXP BIOL, V213, P3858, DOI 10.1242/jeb.048439; Cox BF, 1997, J CARDIOVASC PHARM, V29, P417, DOI 10.1097/00005344-199703000-00017; De Pedro N, 1998, PEPTIDES, V19, P505, DOI 10.1016/S0196-9781(97)00469-5; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Dindia L, 2013, AM J PHYSIOL-ENDOC M, V304, pE1157, DOI 10.1152/ajpendo.00500.2012; Doyon C, 2006, GEN COMP ENDOCR, V146, P126, DOI 10.1016/j.ygcen.2005.10.003; Ducasse-Cabanot S, 2007, ANIMAL, V1, P1272, DOI 10.1017/S1751731107000596; Fabbri E, 1998, COMP BIOCHEM PHYS C, V120, P177, DOI 10.1016/S0742-8413(98)10017-8; Figueiredo-Silva AC, 2012, BRIT J NUTR, V107, P1714, DOI 10.1017/S0007114511004739; Figueiredo-Silva AC, 2012, PHYSIOL BEHAV, V106, P499, DOI 10.1016/j.physbeh.2012.03.027; Froiland E, 2012, GEN COMP ENDOCR, V178, P330, DOI 10.1016/j.ygcen.2012.06.017; Gelineau A, 2001, REPROD NUTR DEV, V41, P487, DOI 10.1051/rnd:2001103; Geslin M, 2004, GEN COMP ENDOCR, V135, P70, DOI 10.1016/S0016-6480(03)00283-1; Geurden I, 2007, AM J PHYSIOL-REG I, V292, pR2275, DOI 10.1152/ajpregu.00444.2006; HARMON JS, 1993, AM J PHYSIOL, V265, pR255, DOI 10.1152/ajpregu.1993.265.1.R255; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jeffrey JD, 2014, GEN COMP ENDOCR, V196, P8, DOI 10.1016/j.ygcen.2013.11.010; Johansen SJS, 2003, AQUAC RES, V34, P317; Johansen SJS, 2002, AQUAC RES, V33, P515, DOI 10.1046/j.1365-2109.2002.00736.x; KASHIWAGI A, 1995, DIABETES RES CLIN PR, V28, pS195, DOI 10.1016/0168-8227(95)01079-S; Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; Lansard M, 2009, BRIT J NUTR, V102, P1564, DOI 10.1017/S000711450999095X; LEACH GJ, 1980, GEN COMP ENDOCR, V42, P219, DOI 10.1016/0016-6480(80)90191-4; Libran-Perez M, 2014, PHYSIOL BEHAV, V129, P272, DOI 10.1016/j.physbeh.2014.02.061; Libran-Perez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059507; Libran-Perez M, 2013, COMP BIOCHEM PHYS A, V164, P241, DOI 10.1016/j.cbpa.2012.09.012; Libran-Perez M, 2012, AM J PHYSIOL-REG I, V302, pR1340, DOI 10.1152/ajpregu.00070.2012; Lopez M, 2007, BIOESSAYS, V29, P248, DOI 10.1002/bies.20539; Martinez-Rubio L, 2013, AQUACULTURE, V384, P94, DOI 10.1016/j.aquaculture.2012.12.010; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Milligan CL, 2003, J EXP BIOL, V206, P3167, DOI 10.1242/jeb.00538; OCONNOR PK, 1993, J COMP PHYSIOL B, V163, P427; Oh YT, 2014, ENDOCRINOLOGY, V155, P923, DOI 10.1210/en.2013-1700; Oh YT, 2012, ENDOCRINOLOGY, V153, P3587, DOI 10.1210/en.2012-1330; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polakof S, 2011, LIPIDS, V46, P189, DOI 10.1007/s11745-010-3521-1; Polakof S, 2010, DOMEST ANIM ENDOCRIN, V39, P26, DOI 10.1016/j.domaniend.2010.01.003; Polakof S, 2008, J COMP PHYSIOL A, V194, P829, DOI 10.1007/s00359-008-0354-y; Polakof S, 2008, AM J PHYSIOL-REG I, V295, pR478, DOI 10.1152/ajpregu.00176.2008; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; QUABBE HJ, 1983, J CLIN ENDOCR METAB, V57, P410, DOI 10.1210/jcem-57-2-410; Rasmussen RS, 2000, AQUACULT NUTR, V6, P17; Sangiao-Alvarellos S, 2006, COMP BIOCHEM PHYS A, V144, P491, DOI 10.1016/j.cbpa.2006.04.015; Saravanan S, 2013, J NUTR, V143, P781, DOI 10.3945/jn.112.173062; Schrama JW, 2012, BRIT J NUTR, V108, P277, DOI 10.1017/S0007114511005654; Shearer KD, 1997, COMP BIOCHEM PHYS A, V118, P1209, DOI 10.1016/S0300-9629(97)86801-6; Silverstein JT, 1999, AQUACULTURE, V177, P161, DOI 10.1016/S0044-8486(99)00076-9; Soengas JL, 2014, GEN COMP EN IN PRESS; Tang ZG, 2013, MOL CELL ENDOCRINOL, V376, P114, DOI 10.1016/j.mce.2013.06.020; Tripathi G, 2003, COMP BIOCHEM PHYS B, V136, P463, DOI 10.1016/S1096-4959(03)00249-5; Velasco-Santamaria YM, 2011, AQUAT TOXICOL, V105, P107, DOI 10.1016/j.aquatox.2011.05.018; Watt MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE120, DOI 10.1152/ajpendo.00542.2003	67	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113291	10.1371/journal.pone.0113291	http://dx.doi.org/10.1371/journal.pone.0113291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405879	Green Published, gold, Green Submitted			2022-12-27	WOS:000347121300098
J	Mehaffy, C; Guthrie, JL; Alexander, DC; Stuart, R; Rea, E; Jamieson, FB				Mehaffy, Carolina; Guthrie, Jennifer L.; Alexander, David C.; Stuart, Rebecca; Rea, Elizabeth; Jamieson, Frances B.			Marked Microevolution of a Unique Mycobacterium tuberculosis Strain in 17 Years of Ongoing Transmission in a High Risk Population	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; ALTERNATE SIGMA-FACTOR; ACTIVE TUBERCULOSIS; STRINGENT RESPONSE; MUTANT LACKING; UNITED-STATES; HOMELESS; DELETIONS; GENES; IDENTIFICATION	The transmission and persistence of Mycobacterium tuberculosis within high risk populations is a threat to tuberculosis (TB) control. In the current study, we used whole genome sequencing (WGS) to decipher the transmission dynamics and microevolution of M. tuberculosis ON-A, an endemic strain responsible for an ongoing outbreak of TB in an urban homeless/under-housed population. Sixty-one M. tuberculosis isolates representing 57 TB cases from 1997 to 2013 were subjected to WGS. Sequencing data was integrated with available epidemiological information and analyzed to determine how the M. tuberculosis ON-A strain has evolved during almost two decades of active transmission. WGS offers higher discriminatory power than traditional genotyping techniques, dividing the M. tuberculosis ON-A strain into 6 sub-clusters, each defined by unique single nucleotide polymorphism profiles. One sub-cluster, designated ON-A NM (Natural Mutant; 26 isolates from 24 cases) was also defined by a large, 15 kb genomic deletion. WGS analysis reveals the existence of multiple transmission chains within the same population/setting. Our results help validate the utility of WGS as a powerful tool for identifying genomic changes and adaptation of M. tuberculosis.	[Mehaffy, Carolina; Guthrie, Jennifer L.; Jamieson, Frances B.] Publ Hlth Ontario, Toronto, ON, Canada; [Mehaffy, Carolina; Jamieson, Frances B.] Univ Toronto, Toronto, ON, Canada; [Alexander, David C.] Saskatchewan Dis Control Lab, Regina, SK, Canada; [Stuart, Rebecca; Rea, Elizabeth] Toronto Publ Hlth, Toronto, ON, Canada	University of Toronto	Mehaffy, C (corresponding author), Colorado State Univ, Ft Collins, CO 80523 USA.	Carolina.mehaffy@colostate.edu	Guthrie, Jennifer/ABE-2378-2021	Guthrie, Jennifer/0000-0001-8565-203X	Lung Association/Ontario Thoracic Society	Lung Association/Ontario Thoracic Society	This study was supported by a grant-in-aid from The Lung Association/Ontario Thoracic Society (http://www.on.lung.ca) (CM, FBJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, INT J TUBERC LUNG D, V14, P1350; Alexander DC, 2009, J CLIN MICROBIOL, V47, P2651, DOI 10.1128/JCM.01946-08; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Benedetti A, 2010, AM J EPIDEMIOL, V172, P318, DOI 10.1093/aje/kwq124; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P904; Chen P, 2000, INFECT IMMUN, V68, P5575, DOI 10.1128/IAI.68.10.5575-5580.2000; Colangeli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091024; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Boer AS, 2000, J CLIN MICROBIOL, V38, P4478, DOI 10.1128/JCM.38.12.4478-4484.2000; Dobbins Claire, 2012, Morbidity and Mortality Weekly Report, V61, P186; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Fang Z, 1999, J BACTERIOL, V181, P1014, DOI 10.1128/JB.181.3.1014-1020.1999; Feske ML, 2013, AM J PUBLIC HEALTH, V103, P839, DOI 10.2105/AJPH.2012.300973; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Gambette P, 2008, IEEE ACM T COMPUT BI, V5, P472, DOI 10.1109/TCBB.2007.1046; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Haddad MB, 2005, JAMA-J AM MED ASSOC, V293, P2762, DOI 10.1001/jama.293.22.2762; Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11; Ho TBL, 2000, YEAST, V17, P272, DOI 10.1002/1097-0061(200012)17:4&lt;272::AID-YEA48&gt;3.0.CO;2-2; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Lofy KH, 2006, INT J TUBERC LUNG D, V10, P683; McAdam JM, 2009, EMERG INFECT DIS, V15, P1109, DOI 10.3201/eid1507.080410; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Parida BK, 2005, TUBERCULOSIS, V85, P347, DOI 10.1016/j.tube.2005.08.001; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Reyes A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-249; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sampson SL, 2004, J CLIN MICROBIOL, V42, P895, DOI 10.1128/JCM.42.2.895-898.2004; Schurch AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028365; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Torok ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Yesilkaya H, 2005, J BACTERIOL, V187, P6726, DOI 10.1128/JB.187.19.6726-6732.2005	52	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112928	10.1371/journal.pone.0112928	http://dx.doi.org/10.1371/journal.pone.0112928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405861	gold, Green Submitted, Green Published			2022-12-27	WOS:000347121300063
J	Radenbaugh, AJ; Ma, S; Ewing, A; Stuart, JM; Collisson, EA; Zhu, JC; Haussler, D				Radenbaugh, Amie J.; Ma, Singer; Ewing, Adam; Stuart, Joshua M.; Collisson, Eric A.; Zhu, Jingchun; Haussler, David			RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection	PLOS ONE			English	Article							GENOME BROWSER; FREQUENT MUTATIONS; POINT MUTATIONS; TP53 MUTATIONS; WHOLE GENOME; CANCER; ALIGNMENT; PATHWAY; EXOME; EVOLUTION	The detection of somatic single nucleotide variants is a crucial component to the characterization of the cancer genome. Mutation calling algorithms thus far have focused on comparing the normal and tumor genomes from the same individual. In recent years, it has become routine for projects like The Cancer Genome Atlas (TCGA) to also sequence the tumor RNA. Here we present RADIA (RNA and DNA Integrated Analysis), a novel computational method combining the patient-matched normal and tumor DNA with the tumor RNA to detect somatic mutations. The inclusion of the RNA increases the power to detect somatic mutations, especially at low DNA allelic frequencies. By integrating an individual's DNA and RNA, we are able to detect mutations that would otherwise be missed by traditional algorithms that examine only the DNA. We demonstrate high sensitivity (84%) and very high precision (98% and 99%) for RADIA in patient data from endometrial carcinoma and lung adenocarcinoma from TCGA. Mutations with both high DNA and RNA read support have the highest validation rate of over 99%. We also introduce a simulation package that spikes in artificial mutations to patient data, rather than simulating sequencing data from a reference genome. We evaluate sensitivity on the simulation data and demonstrate our ability to rescue back mutations at low DNA allelic frequencies by including the RNA. Finally, we highlight mutations in important cancer genes that were rescued due to the incorporation of the RNA.	[Radenbaugh, Amie J.; Ma, Singer; Ewing, Adam; Stuart, Joshua M.; Zhu, Jingchun; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Genom Inst, Santa Cruz, CA 95064 USA; [Collisson, Eric A.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Haussler, David] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Radenbaugh, AJ (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Genom Inst, Santa Cruz, CA 95064 USA.	aradenba@soe.ucsc.edu; haussler@soe.ucsc.edu	Ewing, Adam D/M-3164-2014	Ewing, Adam D/0000-0002-4544-994X; Stuart, Joshua/0000-0002-2171-565X	National Cancer Institute [U24CA143858, R01CA180778, R01CA194003, U24CA180951]; National Human Genome Research Institute [U01ES017154]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U24CA143858, U24CA180951, R01CA180778] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Cancer Institute [U24CA143858 to AJR, SM, AE, and JZ; R01CA180778 to JMS; R01CA194003 to EAC; and U24CA180951 to JZ]; the National Human Genome Research Institute [U01ES017154 to AJR]; a gift from Edward Schulak [to AE]; and the Howard Hughes Medical Institute [to DH]. The results published here are in whole or part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/, a project of the National Cancer Institute. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Alsner J, 2000, CLIN CANCER RES, V6, P3923; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andujar P, 2010, LUNG CANCER, V67, P23, DOI 10.1016/j.lungcan.2009.03.018; Baertsch R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-466; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Blons H, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-25; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Fernandez-Cuesta L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3179; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gartel AL, 2003, ONCOL RES, V13, P405; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim TH, 2009, MOL CANCER RES, V7, P1645, DOI 10.1158/1541-7786.MCR-09-0117; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Ku CS, 2012, EXPERT REV MOL DIAGN, V12, P241, DOI [10.1586/ERM.12.10, 10.1586/erm.12.10]; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Musumeci L, 2010, HUM MUTAT, V31, P67, DOI 10.1002/humu.21137; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagy E, 2003, EUR J CANCER, V39, P2298, DOI 10.1016/S0959-8049(03)00552-5; Pfaff E, 2010, J CLIN ONCOL, V28, P5188, DOI 10.1200/JCO.2010.31.1670; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Takahira T, 2004, CANCER SCI, V95, P651, DOI 10.1111/j.1349-7006.2004.tb03324.x; Ueki T, 2004, CLIN CANCER RES, V10, P1717, DOI 10.1158/1078-0432.CCR-1137-3; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	54	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111516	10.1371/journal.pone.0111516	http://dx.doi.org/10.1371/journal.pone.0111516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405470	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300011
J	Yamada, H; Abe, O; Shizukuishi, T; Kikuta, J; Shinozaki, T; Dezawa, K; Nagano, A; Matsuda, M; Haradome, H; Imamura, Y				Yamada, Haruyasu; Abe, Osamu; Shizukuishi, Takashi; Kikuta, Junko; Shinozaki, Takahiro; Dezawa, Ko; Nagano, Akira; Matsuda, Masayuki; Haradome, Hiroki; Imamura, Yoshiki			Efficacy of Distortion Correction on Diffusion Imaging: Comparison of FSL Eddy and Eddy_Correct Using 30 and 60 Directions Diffusion Encoding	PLOS ONE			English	Article							HUMAN CONNECTOME PROJECT; WEIGHTED MRI; SPIN-ECHO; PARAMETERS; REDUCTION; IMAGES; MOTION; BRAIN; EPI	Diffusion imaging is a unique noninvasive tool to detect brain white matter trajectory and integrity in vivo. However, this technique suffers from spatial distortion and signal pileup or dropout originating from local susceptibility gradients and eddy currents. Although there are several methods to mitigate these problems, most techniques can be applicable either to susceptibility or eddy-current induced distortion alone with a few exceptions. The present study compared the correction efficiency of FSL tools, "eddy_correct'' and the combination of "eddy'' and "topup'' in terms of diffusion-derived fractional anisotropy (FA). The brain diffusion images were acquired from 10 healthy subjects using 30 and 60 directions encoding schemes based on the electrostatic repulsive forces. For the 30 directions encoding, 2 sets of diffusion images were acquired with the same parameters, except for the phase-encode blips which had opposing polarities along the anteroposterior direction. For the 60 directions encoding, non-diffusion-weighted and diffusion-weighted images were obtained with forward phase-encoding blips and non-diffusion-weighted images with the same parameter, except for the phase-encode blips, which had opposing polarities. FA images without and with distortion correction were compared in a voxel-wise manner with tract-based spatial statistics. We showed that images corrected with eddy and topup possessed higher FA values than images uncorrected and corrected with eddy_correct with trilinear (FSL default setting) or spline interpolation in most white matter skeletons, using both encoding schemes. Furthermore, the 60 directions encoding scheme was superior as measured by increased FA values to the 30 directions encoding scheme, despite comparable acquisition time. This study supports the combination of eddy and topup as a superior correction tool in diffusion imaging rather than the eddy_correct tool, especially with trilinear interpolation, using 60 directions encoding scheme.	[Yamada, Haruyasu; Abe, Osamu; Shizukuishi, Takashi; Kikuta, Junko; Haradome, Hiroki] Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Shinozaki, Takahiro; Dezawa, Ko; Imamura, Yoshiki] Nihon Univ, Sch Dent, Dept Oral Diagnost Sci, Tokyo 101, Japan; [Nagano, Akira; Matsuda, Masayuki] Nihon Univ, Itabashi Hosp, Dept Radiol Technol, Tokyo, Japan	Nihon University; Nihon University; Nihon University	Abe, O (corresponding author), Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan.	abe.osamu27@nihon-u.ac.jp	KIKUTA, Junko/AAK-6545-2020; Jovicich, Jorge/D-2293-2010; KIKUTA, Junko/AAR-4743-2021	KIKUTA, Junko/0000-0003-1324-8614; KIKUTA, Junko/0000-0003-1324-8614; Abe, Osamu/0000-0002-1180-2629	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [24593065] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Andersson JLR, 2012, P INT SOC MAGN RES M; Bowtell R, 1994, P 2 ANN M SOC MAGN R; Embleton KV, 2010, HUM BRAIN MAPP, V31, P1570, DOI 10.1002/hbm.20959; Gallichan D, 2010, MAGN RESON MED, V64, P382, DOI 10.1002/mrm.22318; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Mangin JF, 2002, MED IMAGE ANAL, V6, P191, DOI 10.1016/S1361-8415(02)00079-8; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; O'Brien K, 2013, IEEE T MED IMAGING, V32, P1515, DOI 10.1109/TMI.2013.2259249; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Techavipoo U, 2009, MAGN RESON IMAGING, V27, P1281, DOI 10.1016/j.mri.2009.05.005; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Wan X, 1997, MAGNET RESON MED, V37, P932, DOI 10.1002/mrm.1910370619; Zeng HR, 2002, MAGN RESON MED, V48, P137, DOI 10.1002/mrm.10200; Zhu T, 2009, J MAGN RESON IMAGING, V29, P422, DOI 10.1002/jmri.21647; Zhuang JC, 2006, J MAGN RESON IMAGING, V24, P1188, DOI 10.1002/jmri.20727	25	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112411	10.1371/journal.pone.0112411	http://dx.doi.org/10.1371/journal.pone.0112411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405472	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300032
J	Casagrande, JC; Macorini, LFB; Antunes, KA; dos Santos, UP; Campos, JF; Dias, JM; Sangalli, A; Cardoso, CAL; Vieira, MD; Rabelo, LA; Paredes-Gamero, EJ; dos Santos, EL; Souza, KD				Casagrande, Junior Cesar; Benitez Macorini, Luis Fernando; Antunes, Katia Avila; dos Santos, Uilson Pereira; Campos, Jaqueline Ferreira; Dias-Junior, Nelson Miguel; Sangalli, Andreia; Lima Cardoso, Claudia Andrea; Vieira, Maria do Carmo; Rabelo, Luiza Antas; Paredes-Gamero, Edgar Julian; dos Santos, Edson Lucas; Souza, Kely de Picoli			Antioxidant and Cytotoxic Activity of Hydroethanolic Extract from Jacaranda decurrens Leaves	PLOS ONE			English	Article							OXIDATIVE DAMAGE; CELL-DEATH; LIPID-PEROXIDATION; URSOLIC ACID; FLAVONOIDS; MEMBRANE; PROPOLIS; TUMOR	Background and Purpose: Leaves of Jacaranda decurrens are used in traditional Brazilian medicine to treat metabolic diseases related to increased reactive oxygen species. The present study evaluated the antioxidant and cytotoxic potential of hydroethanolic extract from the leaves of Jacaranda decurrens subsp. symmetrifoliolata. Experimental Approach: Phenolic compounds, flavonoids and saponins were evaluated in an ethanol: water (80: 20, v/v) extract from the leaves of Jacaranda decurrens subsp. symmetrifoliolata (E-Jds). The antioxidant activity of E-Jds was investigated by assessing the following: 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity; protection against 2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced hemolysis of erythrocytes; in vitro and in vivo malondialdehyde dosage; and the ability to activate antioxidant enzymes. K562 leukemia cells were used for the cytotoxic evaluation of E-Jds and for the assessment of the cell death profile through flow cytometry. Key Results: Phenolic and flavonoid compounds were quantified as 14.38% and 2.15%, respectively, of E-Jds. These phenolic and flavonoid compounds proved to be able to scavenge DPPH free radicals with an IC50 of 9.3 +/- 3.3 mu g/mL, to protect up to 50% of erythrocytes against AAPH-induced hemolysis and to reduce in vitro and in vivo malondialdehyde levels up to 84% and 22%, respectively. E-Jds also increased glutathione peroxidase enzyme activity, with a concomitant decrease in superoxide dismutase and catalase activity, and exhibited dose-dependent cytotoxic activity on K562 erythroleukemia cells with cell death occurring via both late apoptosis and necrosis. Conclusions: E-Jds exhibits in vitro and in vivo antioxidant potential, which may be the mechanism mediating the metabolic activities reported in folk medicine. Furthermore, the cytotoxic activity identified in this study contributes with the knowledge of antiproliferative activities that have been described in the literature for the genus Jacaranda.	[Casagrande, Junior Cesar; Benitez Macorini, Luis Fernando; Antunes, Katia Avila; dos Santos, Uilson Pereira; Campos, Jaqueline Ferreira; Sangalli, Andreia; Vieira, Maria do Carmo; dos Santos, Edson Lucas; Souza, Kely de Picoli] Fed Univ Grande Dourados, Dourados, MS, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Dourados, MS, Brazil; [Dias-Junior, Nelson Miguel; Rabelo, Luiza Antas] Univ Fed Alagoas, Maceio, Alagoas, Brazil; [Paredes-Gamero, Edgar Julian] Univ Fed Sao Paulo, Sao Paulo, Brazil	Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Alagoas; Universidade Federal de Sao Paulo (UNIFESP)	Souza, KD (corresponding author), Fed Univ Grande Dourados, Dourados, MS, Brazil.	kelypicoli@gmail.com	de Picoli Souza, Kely/I-1248-2015; Paredes-Gamero, Edgar J/C-4791-2012; Rabêlo, Luiza A./S-4050-2019; Santos, Edson/C-6820-2014; de Picoli Souza, Kely/AAU-5978-2020; Cardoso, Claudia Andrea Lima/AAK-5578-2020; dos Santos, Edson Lucas/AAU-5857-2020; Dias-Júnior, Nelson Miguel/AAG-9506-2021; Vieira, Maria do Carmo MCV/D-4860-2016	de Picoli Souza, Kely/0000-0001-5764-2125; Paredes-Gamero, Edgar J/0000-0003-3686-8402; Santos, Edson/0000-0002-6557-7914; de Picoli Souza, Kely/0000-0001-5764-2125; Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; dos Santos, Edson Lucas/0000-0002-6557-7914; Ferreira Campos, Jaqueline/0000-0002-4981-238X	Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants of the Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Mato Grosso do Sul (FUNDECT), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ELS, CALC and MCV are CNPq research productivity fellows.	Abdollahzad H, 2009, INT J VITAM NUTR RES, V79, P281, DOI 10.1024/0300-9831.79.56.281; Ashokkumar P, 2008, BIOMED PHARMACOTHER, V62, P590, DOI 10.1016/j.biopha.2008.06.031; de Almeida MRA, 2013, PAK J PHARM SCI, V26, P881; Blatt CTT, 1998, PLANT SYST EVOL, V210, P289, DOI 10.1007/BF00985673; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Chaabane F, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-153; Chiste RC, 2014, LIFE SCI, V99, P52, DOI 10.1016/j.lfs.2014.01.059; Bieski IGC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/272749; Croft KD, 1998, ANN NY ACAD SCI, V854, P435, DOI 10.1111/j.1749-6632.1998.tb09922.x; Day BJ, 2009, BIOCHEM PHARMACOL, V77, P285, DOI 10.1016/j.bcp.2008.09.029; de Carvalho CA, 2009, REV BRAS FARMACOGN, V19, P592, DOI 10.1590/S0102-695X2009000400015; De Martino L, 2012, INT J MOL SCI, V13, P5406, DOI 10.3390/ijms13055406; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gasmi J, 2013, PHYTOMEDICINE, V20, P734, DOI 10.1016/j.phymed.2013.01.012; Ginsburg I, 2011, ARCH BIOCHEM BIOPHYS, V506, P12, DOI 10.1016/j.abb.2010.11.009; Gu Y, 2012, BIOCHEM PHARMACOL, V84, P468, DOI 10.1016/j.bcp.2012.06.002; Gupta D, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-13; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Iqbal Jamshed, 2012, ISRN Pharmacol, V2012, P563267, DOI 10.5402/2012/563267; Jo Y, 2005, ARCH PHARM RES, V28, P885, DOI 10.1007/BF02973871; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Katiyar SK, 2001, CARCINOGENESIS, V22, P287, DOI 10.1093/carcin/22.2.287; Kazi A, 2003, INT J MOL MED, V12, P879; Kuliaviene I, 2013, WORLD J GASTROENTERO, V19, P5678, DOI 10.3748/wjg.v19.i34.5678; Lee WL, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/925804; Liberio SA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-108; Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Massaoka MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038698; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Moraes VWR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.190; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; OGURA M, 1977, LLOYDIA, V40, P157; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Martucci MEP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093149; Rana A, 2013, NAT PROD RES, V27, P1167, DOI 10.1080/14786419.2012.717290; Rao CV, 2012, CURR DRUG TARGETS, V13, P1820; Sharif T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032526; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; VARANDA EM, 1992, J NAT PROD, V55, P800, DOI 10.1021/np50084a015; Wang Y, 2013, NUTRIENTS, V5, P2969, DOI 10.3390/nu5082969; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Yamasaki M, 2013, J OLEO SCI, V62, P925, DOI 10.5650/jos.62.925; Yin MC, 2007, J AGR FOOD CHEM, V55, P7177, DOI 10.1021/jf071242m	49	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112748	10.1371/journal.pone.0112748	http://dx.doi.org/10.1371/journal.pone.0112748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402205	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700067
J	Schilder, JD; IJzerman, H; Denissen, JJA				Schilder, Janneke D.; IJzerman, Hans; Denissen, Jaap J. A.			Physical Warmth and Perceptual Focus: A Replication of IJzerman and Semin (2009)	PLOS ONE			English	Article							ATTACHMENT; SENSITIVITY; PROXIMITY; CUES	With the changing of modal research practices in psychology, the grounded cognition perspective (sometimes categorized under the more popular term of "social priming'') has become heavily criticized. Specifically, LeBel and Campbell (2013) reported a failed replication of a study involving what some would call "social priming.'' We sought to replicate a study from our own lab (IJzerman & Semin, 2009), to investigate the reproducibility of the reported effect that physical warmth leads to a greater focus on perceptual relations. We also improved our methods to reduce potential experimenter's bias (cf. Doyen, Klein, Pichon, & Cleeremans, 2012). We successfully replicated the finding that a simple cue of physical warmth makes people more likely to adopt a relational focus.	[Schilder, Janneke D.; Denissen, Jaap J. A.] Tilburg Univ, Dept Dev Psychol, NL-5000 LE Tilburg, Netherlands; [Schilder, Janneke D.; IJzerman, Hans] Tilburg Univ, Dept Social Psychol, NL-5000 LE Tilburg, Netherlands	Tilburg University; Tilburg University	IJzerman, H (corresponding author), Tilburg Univ, Dept Dev Psychol, NL-5000 LE Tilburg, Netherlands.	h.ijzerman@uvt.nl	Denissen, Jaap/H-2180-2013	Denissen, Jaap/0000-0002-6282-4107; IJzerman, Hans/0000-0002-0990-2276				Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Brandt MJ, 2014, J EXP SOC PSYCHOL, V50, P217, DOI 10.1016/j.jesp.2013.10.005; Cohen J.E., 1988, STAT POWER ANAL BEHA; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fay AJ, 2012, J EXP SOC PSYCHOL, V48, P1369, DOI 10.1016/j.jesp.2012.05.017; Ijzerman H, 2013, EUR J PERSONALITY, V27, P128; IJzerman H, 2013, SOC PSYCHOL-GERMANY, V44, P160, DOI 10.1027/1864-9335/a000142; IJzerman H, 2011, PSYCHOL BULL, V137, P355, DOI 10.1037/a0022373; Ijzerman H, 2010, J EXP SOC PSYCHOL, V46, P867, DOI 10.1016/j.jesp.2010.07.015; IJzerman H, 2009, PSYCHOL SCI, V20, P1214, DOI 10.1111/j.1467-9280.2009.02434.x; KIMCHI R, 1982, J EXP PSYCHOL HUMAN, V8, P521, DOI 10.1037/0096-1523.8.4.521; Lakoff George., 1999, PHILOS FLESH EMBODIE; LeBel EP, 2013, PSYCHOL SCI, V24, P2128, DOI 10.1177/0956797613486983; SEARLE JR, 1980, BEHAV BRAIN SCI, V3, P417, DOI 10.1017/S0140525X00006038; Szymkow A, 2013, SOC PSYCHOL-GERMANY, V44, P167, DOI 10.1027/1864-9335/a000147; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Vess M, 2012, PSYCHOL SCI, V23, P472, DOI 10.1177/0956797611435919; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x	22	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112772	10.1371/journal.pone.0112772	http://dx.doi.org/10.1371/journal.pone.0112772			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25402343	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700068
J	Fan, YZ; Wang, Y; Jiang, HB; Yang, WW; Yu, M; Yan, WR; Diwan, VK; Xu, B; Dong, HJ; Palm, L; Nie, SF				Fan, Yunzhou; Wang, Ying; Jiang, Hongbo; Yang, Wenwen; Yu, Miao; Yan, Weirong; Diwan, Vinod K.; Xu, Biao; Dong, Hengjin; Palm, Lars; Nie, Shaofa			Evaluation of Outbreak Detection Performance Using Multi-Stream Syndromic Surveillance for Influenza-Like Illness in Rural Hubei Province, China: A Temporal Simulation Model Based on Healthcare-Seeking Behaviors	PLOS ONE			English	Article							ABERRATION DETECTION METHODS; PANDEMIC INFLUENZA; REPRODUCTION NUMBER; A H1N1; DISEASE; TRANSMISSION; SYSTEM; NOTIFICATION; ALGORITHMS; HISTORY	Background: Syndromic surveillance promotes the early detection of diseases outbreaks. Although syndromic surveillance has increased in developing countries, performance on outbreak detection, particularly in cases of multi-stream surveillance, has scarcely been evaluated in rural areas. Objective: This study introduces a temporal simulation model based on healthcare-seeking behaviors to evaluate the performance of multi-stream syndromic surveillance for influenza-like illness. Methods: Data were obtained in six towns of rural Hubei Province, China, from April 2012 to June 2013. A SusceptibleExposed-Infectious-Recovered model generated 27 scenarios of simulated influenza A (H1N1) outbreaks, which were converted into corresponding simulated syndromic datasets through the healthcare-behaviors model. We then superimposed converted syndromic datasets onto the baselines obtained to create the testing datasets. Outbreak performance of single-stream surveillance of clinic visit, frequency of over the counter drug purchases, school absenteeism, and multi-stream surveillance of their combinations were evaluated using receiver operating characteristic curves and activity monitoring operation curves. Results: In the six towns examined, clinic visit surveillance and school absenteeism surveillance exhibited superior performances of outbreak detection than over the counter drug purchase frequency surveillance; the performance of multistream surveillance was preferable to signal-stream surveillance, particularly at low specificity (Sp < 90%). Conclusions: The temporal simulation model based on healthcare-seeking behaviors offers an accessible method for evaluating the performance of multi-stream surveillance.	[Fan, Yunzhou; Wang, Ying; Jiang, Hongbo; Yang, Wenwen; Yu, Miao; Yan, Weirong; Nie, Shaofa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Yan, Weirong; Diwan, Vinod K.] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Xu, Biao] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Dong, Hengjin] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Palm, Lars] Future Posit X, Gavle, Sweden	Huazhong University of Science & Technology; Karolinska Institutet; Fudan University; Ruprecht Karls University Heidelberg	Nie, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	sf_nie@mails.tjmu.edu.cn	Fan, Yunzhou/P-8829-2014	Jiang, Hongbo/0000-0002-0631-4460	European Union [241900]	European Union(European Commission)	This work has received financial support from the European Union Framework Program 7 (grant no. 241900) (http://ec.europa.eu/research/participants/portal/desktop/en/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckeridge DL, 2007, J BIOMED INFORM, V40, P370, DOI 10.1016/j.jbi.2006.09.003; Buckeridge David L, 2005, MMWR Suppl, V54, P109; Buckeridge David L, 2004, MMWR Suppl, V53, P137; Buckeridge DL, 2005, J BIOMED INFORM, V38, P99, DOI 10.1016/j.jbi.2004.11.007; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Chowell G, 2013, BMC MED, V11, P214; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Edge Victoria L, 2006, Can J Infect Dis Med Microbiol, V17, P235; Heffernan Richard, 2004, MMWR Suppl, V53, P23; Hiller KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073832; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Hutwagner LC, 2005, STAT MED, V24, P543, DOI 10.1002/sim.2034; Kara EO, 2012, EPIDEMIOL INFECT, V140, P1328, DOI 10.1017/S0950268811002093; Kleinman Ken P, 2005, MMWR Suppl, V54, P101; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; Magruder Steven F, 2004, MMWR Suppl, V53, P117; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Moore KM, 2008, CAN J EMERG MED, V10, P114; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Nsoesie EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045414; O'Neill PD, 2010, STAT MED, V29, P2069, DOI 10.1002/sim.3968; Punpanich W, 2012, INT J INFECT DIS, V16, pE714, DOI 10.1016/j.ijid.2012.05.1025; Rha B, 2013, EMERG INFECT DIS, V19, P1214, DOI 10.3201/eid1908.130483; Sosin DM, 2003, J URBAN HEALTH, V80, pI8; Truscott J, 2012, J R SOC INTERFACE, V9, P304, DOI 10.1098/rsif.2011.0309; Uchida M, 2013, J INFECT CHEMOTHER, V19, P665, DOI 10.1007/s10156-012-0540-2; van den Wijngaard C, 2008, EMERG INFECT DIS, V14, P917, DOI 10.3201/eid1406.071467; van Dijk A, 2009, EMERG INFECT DIS, V15, P799, DOI 10.3201/eid1505.081174; Wang C, 2012, PUBLIC HEALTH, V126, P289, DOI 10.1016/j.puhe.2011.11.008; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Yan WR, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-4; Yan WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062749; Yang F, 2013, ANN EPIDEMIOL, V23, P301, DOI 10.1016/j.annepidem.2013.04.005; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040	41	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112255	10.1371/journal.pone.0112255	http://dx.doi.org/10.1371/journal.pone.0112255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409025	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200018
J	Gorczynski, RM; Chen, ZQ; Erin, N; Khatri, I; Podnos, A				Gorczynski, Reginald M.; Chen, Zhiqi; Erin, Nuray; Khatri, Ismat; Podnos, Anna			Comparison of Immunity in Mice Cured of Primary/Metastatic Growth of EMT6 or 4THM Breast Cancer by Chemotherapy or Immunotherapy	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-CELLS; PULMONARY METASTASIS; THERAPEUTIC TARGET; CD200 EXPRESSION; PROMOTES; INFLAMMATION; CD4(+)	Purpose: We have compared cure from local/metastatic tumor growth in BALB/c mice receiving EMT6 or the poorly immunogenic, highly metastatic 4THM, breast cancer cells following manipulation of immunosuppressive CD200:CD200R interactions or conventional chemotherapy. Methods: We reported previously that EMT6 tumors are cured in CD200R1KO mice following surgical resection and immunization with irradiated EMT6 cells and CpG oligodeoxynucleotide (CpG), while wild-type (WT) animals developed pulmonary and liver metastases within 30 days of surgery. We report growth and metastasis of both EMT6 and a highly metastatic 4THM tumor in WT mice receiving iv infusions of Fab anti-CD200R1 along with CpG/tumor cell immunization. Metastasis was followed both macroscopically (lung/liver nodules) and microscopically by cloning tumor cells at limiting dilution in vitro from draining lymph nodes (DLN) harvested at surgery. We compared these results with local/metastatic tumor growth in mice receiving 4 courses of combination treatment with anti-VEGF and paclitaxel. Results: In WT mice receiving Fab anti-CD200R, no tumor cells are detectable following immunotherapy, and CD4+ cells produced increased TNF alpha/IL-2/IFN gamma on stimulation with EMT6 in vitro. No long-term cure was seen following surgery/immunotherapy of 4THM, with both microscopic (tumors in DLN at limiting dilution) and macroscopic metastases present within 14 d of surgery. Chemotherapy attenuated growth/metastases in 4THM tumor-bearers and produced a decline in lung/liver metastases, with no detectable DLN metastases in EMT6 tumor-bearing mice-these latter mice nevertheless showed no significantly increased cytokine production after restimulation with EMT6 in vitro. EMT6 mice receiving immunotherapy were resistant to subsequent re-challenge with EMT6 tumor cells, but not those receiving curative chemotherapy. Anti-CD4 treatment caused tumor recurrence after immunotherapy, but produced no apparent effect in either EMT6 or 4THM tumor bearers after chemotherapy treatment. Conclusion: Immunotherapy, but not chemotherapy, enhances CD4+ immunity and affords long-term control of breast cancer growth and resistance to new tumor foci.	[Gorczynski, Reginald M.; Chen, Zhiqi; Khatri, Ismat; Podnos, Anna] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada; [Gorczynski, Reginald M.] Univ Toronto, Fac Med, Dept Immunol, Toronto, ON, Canada; [Gorczynski, Reginald M.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Erin, Nuray] Akdeniz Univ, Sch Med, Dept Med Pharmacol, TR-07058 Antalya, Turkey	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Akdeniz University	Gorczynski, RM (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada.	rgorczynski@uhnres.utoronto.ca	Erin, Nuray/B-8616-2012; Gorczynski, Reginald/AAA-1435-2019	Erin, Nuray/0000-0002-6116-1970; 	Canadian Cancer Society [RG-11]	Canadian Cancer Society(Canadian Cancer Society (CCS))	Supported by a grant (RG-11) to RMG from the Canadian Cancer Society (www.cancer.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi YM, 2013, J IMMUNOL, V190, P3806, DOI 10.4049/jimmunol.1202439; Anderson KS, 2009, CANCER INVEST, V27, P361, DOI 10.1080/07357900802574421; Assudani DP, 2007, CANCER IMMUNOL IMMUN, V56, P70, DOI 10.1007/s00262-006-0154-6; Baxevanis CN, 2006, CANCER IMMUNOL IMMUN, V55, P85, DOI 10.1007/s00262-005-0692-3; Beyer M, 2009, CANCER RES, V69, P4346, DOI 10.1158/0008-5472.CAN-08-3796; Calogero RA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1745; Campoli Michael, 2004, Breast Dis, V20, P105; Chaudhuri S, 2000, P NATL ACAD SCI USA, V97, P11451, DOI 10.1073/pnas.97.21.11451; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DISIS ML, 1994, CANCER RES, V54, P16; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Einav U, 2005, ONCOGENE, V24, P6367, DOI 10.1038/sj.onc.1208797; Erin N, 2014, ONCOGENE IN PRESS; Erin N, 2006, BREAST CANCER RES TR, V99, P351, DOI 10.1007/s10549-006-9219-7; Gorczynski RM, 2013, BREAST CANCER RES TR, V142, P271, DOI 10.1007/s10549-013-2735-3; Gorczynski RM, 2011, BREAST CANCER RES TR, V130, P49, DOI 10.1007/s10549-010-1259-3; Gorczynski RM, 2010, BREAST CANCER RES TR, V123, P405, DOI 10.1007/s10549-009-0667-8; HAMILTON G, 1988, J CANCER RES CLIN, V114, P191, DOI 10.1007/BF00417836; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; JEROME KR, 1993, J IMMUNOL, V151, P1654; Liang ZX, 2005, CANCER RES, V65, P967; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; McWhirter JR, 2006, P NATL ACAD SCI USA, V103, P1041, DOI 10.1073/pnas.0510081103; Menard S, 1997, CLIN CANCER RES, V3, P817; Moreaux J, 2008, BIOCHEM BIOPH RES CO, V366, P117, DOI 10.1016/j.bbrc.2007.11.103; Olkhanud PB, 2009, CANCER RES, V69, P5996, DOI 10.1158/0008-5472.CAN-08-4619; Pakala SB, 2013, CANCER RES, V73, P3761, DOI 10.1158/0008-5472.CAN-12-3998; Pandit TS, 2009, INT J ONCOL, V35, P297, DOI 10.3892/ijo_00000340; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Pfeffer U, 2009, CLIN EXP METASTAS, V26, P547, DOI 10.1007/s10585-009-9254-y; Podnos A, 2012, BREAST CANCER RES TR, V136, P117, DOI 10.1007/s10549-012-2258-3; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; Ramsey-Goldman R, 1998, J INVEST MED, V46, P217; Siva A, 2008, CANCER IMMUNOL IMMUN, V57, P987, DOI 10.1007/s00262-007-0429-6; Standish Leanna J, 2008, J Soc Integr Oncol, V6, P158; Takahashi M, 2009, CLIN EXP METASTAS, V26, P817, DOI 10.1007/s10585-009-9281-8; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; TICHATSCHEK E, 1988, CANCER IMMUNOL IMMUN, V27, P278; Tonks A, 2007, LEUKEMIA, V21, P566, DOI 10.1038/sj.leu.2404559; Tsavaris N, 2002, BRIT J CANCER, V87, P21, DOI 10.1038/sj.bjc.6600347; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zhou G, 2006, BLOOD, V107, P628, DOI 10.1182/blood-2005-07-2737	47	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113597	10.1371/journal.pone.0113597	http://dx.doi.org/10.1371/journal.pone.0113597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409195	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200139
J	Han, XM; Smyth, RL; Young, BE; Brooks, TM; de Lozada, AS; Bubb, P; Butchart, SHM; Larsen, FW; Hamilton, H; Hansen, MC; Turner, WR				Han, Xuemei; Smyth, Regan L.; Young, Bruce E.; Brooks, Thomas M.; de Lozada, Alexandra Sanchez; Bubb, Philip; Butchart, Stuart H. M.; Larsen, Frank W.; Hamilton, Healy; Hansen, Matthew C.; Turner, Will R.			A Biodiversity Indicators Dashboard: Addressing Challenges to Monitoring Progress towards the Aichi Biodiversity Targets Using Disaggregated Global Data	PLOS ONE			English	Article							FOREST CARBON STOCKS; RED LIST INDEXES; BIOLOGICAL DIVERSITY; CONSERVATION; SCIENCE; DECLINES; SERVICES; ECOLOGY; TRENDS; AREAS	Recognizing the imperiled status of biodiversity and its benefit to human well-being, the world's governments committed in 2010 to take effective and urgent action to halt biodiversity loss through the Convention on Biological Diversity's "Aichi Targets''. These targets, and many conservation programs, require monitoring to assess progress toward specific goals. However, comprehensive and easily understood information on biodiversity trends at appropriate spatial scales is often not available to the policy makers, managers, and scientists who require it. We surveyed conservation stakeholders in three geographically diverse regions of critical biodiversity concern (the Tropical Andes, the African Great Lakes, and the Greater Mekong) and found high demand for biodiversity indicator information but uneven availability. To begin to address this need, we present a biodiversity "dashboard'' - a visualization of biodiversity indicators designed to enable tracking of biodiversity and conservation performance data in a clear, user-friendly format. This builds on previous, more conceptual, indicator work to create an operationalized online interface communicating multiple indicators at multiple spatial scales. We structured this dashboard around the Pressure-State-Response-Benefit framework, selecting four indicators to measure pressure on biodiversity (deforestation rate), state of species (Red List Index), conservation response (protection of key biodiversity areas), and benefits to human populations (freshwater provision). Disaggregating global data, we present dashboard maps and graphics for the three regions surveyed and their component countries. These visualizations provide charts showing regional and national trends and lay the foundation for a web-enabled, interactive biodiversity indicators dashboard. This new tool can help track progress toward the Aichi Targets, support national monitoring and reporting, and inform outcome-based policy-making for the protection of natural resources.	[Han, Xuemei; Smyth, Regan L.; Young, Bruce E.; Brooks, Thomas M.; de Lozada, Alexandra Sanchez; Hamilton, Healy] NatureServe, Arlington, VA 22203 USA; [Han, Xuemei] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Brooks, Thomas M.] Int Union Conservat Nat, Gland, Switzerland; [Brooks, Thomas M.] Univ Philippines, World Agroforestry Ctr, Int Ctr Res Agroforestry, Los Banos, Laguna, Philippines; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia; [Bubb, Philip] United Nations Environm Programme World Conservat, Cambridge, England; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Larsen, Frank W.] European Environm Agcy, Copenhagen, Denmark; [Larsen, Frank W.; Turner, Will R.] Conservat Int, Arlington, VA USA; [Hansen, Matthew C.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA	Nature Conservancy; George Mason University; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University; University of Tasmania; BirdLife International; Conservation International; University System of Maryland; University of Maryland College Park	Han, XM (corresponding author), NatureServe, Arlington, VA 22203 USA.	xuemei_han@natureserve.org	Butchart, Stuart HM/Y-2711-2018; Butchart, Stuart/AAJ-1852-2021; Hansen, Matthew C/ABE-7226-2020	Butchart, Stuart/0000-0002-1140-4049; Brooks, Thomas/0000-0001-8159-3116; Han, Xuemei/0000-0001-7612-3216	John D. and Catherine T. MacArthur Foundation [11-98252-000-INP, 12-100096-000-INP];  [12-102962-000-INP]	John D. and Catherine T. MacArthur Foundation; 	This work was supported by awards from the John D. and Catherine T. MacArthur Foundation (URL: http://www.macfound.org/) to NatureServe addressing "Dashboard assessments: proof-of-concept and baselines" (Grant No. 11-98252-000-INP), "Moving graphical presentation of biodiversity conservation monitoring indicators from a static proof-of-concept to a dynamic prototype" (Grant No. 12-100096-000-INP), and the bridge grant between the two (Grant No. 12-102962-000-INP). The funders supported the concept development in study design phase, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2003, HYDROLOG SCI J, V48, P317, DOI 10.1623/hysj.48.3.317.45290; Andrew B., 2008, EC BIODIVERSITY ECOS; [Anonymous], 2005, NATURE, V438, P531, DOI 10.1038/438531a; Asner GP, 2012, BIOGEOSCIENCES, V9, P2683, DOI 10.5194/bg-9-2683-2012; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Bertzky M, 2009, J ENVIRON MANAGE, V90, P8, DOI 10.1016/j.jenvman.2007.11.001; Biala K., 2012, STREAMLINING EUROPEA; BirdLife Important Bird Area (IBA) Programme, 2011, BIRDLIFE IMP BIRD AR; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Bubb P, 2011, REPORT UNEP WCMC IUC; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Butchart SHM, 2010, SCIENCE, V329, P900, DOI 10.1126/science.329.5994.900-c; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calix M., 2018, EUROPEAN RED LIST SA; Carr ER, 2007, INT J SUST DEV WORLD, V14, P543, DOI 10.1080/13504500709469753; Chalakkal K, 2010, YB INT ENV LAW, V21, P301; Chandra A, 2011, BIODIVERS CONSERV, V20, P3295, DOI 10.1007/s10531-011-0141-x; Chavan VS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S2; CHENERY A, 2013, AICHI TARGETS PASSPO; Clua E, 2005, AQUAT LIVING RESOUR, V18, P199, DOI 10.1051/alr:2005026; Convention on Biological Diversity, 2011, REP AD HOC TECHN EXP; Convention on International Trade in Endangered Species of Wild Fauna and Flora, YB INT ENV LAW; Danielsen F, 2003, ORYX, V37, P412, DOI 10.1017/S0030605303000760; Danielsen F, 2003, ORYX, V37, P407, DOI 10.1017/S0030605303000735; Diversity CoB, 2010, C PART DEC 10 2 STRA; Dudley N., 2003, RUNNING PURE IMPORTA; Eckerson W.W., 2011, PERFORMANCE DASHBOAR, V2nd; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; ESA-UCLouvain, 2010, GLOBCOVER 2009 GLOB; ESRI, 2011, ARCGIS DESKT REL 10; Extinction AfZ, 2010, 2010 AZE UPD; FAO, 2010, GLOB FOR RES ASS; FAO GeoNetwork, 2009, HYDR BAS DER HYDR; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Few S., 2006, INFORM DASHBOARD DES; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hansen MC, 2010, GLOBAL FOREST MONITO; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Holland GJ, 2012, BIOL CONSERV, V145, P95, DOI 10.1016/j.biocon.2011.10.016; Hopkin M, 2006, NATURE, V444, P420, DOI 10.1038/444420a; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Larsen FW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036971; Larsen FW, 2011, CONSERV LETT, V4, P355, DOI 10.1111/j.1755-263X.2011.00183.x; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; MacArthur Foundation, 2011, CONS SUST DEV INT PR; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Maxim L, 2009, ECOL ECON, V69, P12, DOI 10.1016/j.ecolecon.2009.03.017; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NASA USGS, J APPL REMOTE SENSIN; *OAK RIDG NAT LAB, 2006, LANDSC GLOB POP DAT; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Pimm SL, 1991, BALANCE NATURE ECOLO; R Core Team, 2021, R LANGUAGE ENV STAT; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Roberts D, 2011, BMC BIOINFORMATICS, V12; Rodriguez JP, 2003, ORYX, V37, P411, DOI 10.1017/S0030605303000759; Rudd MA, 2011, CONSERV BIOL, V25, P476, DOI 10.1111/j.1523-1739.2010.01625.x; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Sparks TH, 2011, ORYX, V45, P411, DOI 10.1017/S003060531100024X; Stein B. A., 2000, PRECIOUS HERITAGE ST, P399; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tessier E., 2011, DEFINITION INDICATEU; Tscherning K, 2012, LAND USE POLICY, V29, P102, DOI 10.1016/j.landusepol.2011.05.009; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; U.S.Geological Survey, 2000, HYDRO1K EL DER DAT; UNEP-WCMC, 2009, INT EXP WORKSH 2010; Walpole M, 2009, ORYX, V43, P461; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; Yoccoz NG, 2003, ORYX, V37, P410, DOI 10.1017/S0030605303000747; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	86	23	25	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112046	10.1371/journal.pone.0112046	http://dx.doi.org/10.1371/journal.pone.0112046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409183	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200009
J	Jorgensen, AW; Lundstrom, LH; Wetterslev, J; Astrup, A; Gotzsche, PC				Jorgensen, Anders W.; Lundstrom, Lars H.; Wetterslev, Jorn; Astrup, Arne; Gotzsche, Peter C.			Comparison of Results from Different Imputation Techniques for Missing Data from an Anti-Obesity Drug Trial	PLOS ONE			English	Article							WEIGHT-LOSS; MULTIPLE IMPUTATION; OBESE; MAINTENANCE; TOPIRAMATE; OVERWEIGHT; STATE; DIET	Background: In randomised trials of medical interventions, the most reliable analysis follows the intention-to-treat (ITT) principle. However, the ITT analysis requires that missing outcome data have to be imputed. Different imputation techniques may give different results and some may lead to bias. In anti-obesity drug trials, many data are usually missing, and the most used imputation method is last observation carried forward (LOCF). LOCF is generally considered conservative, but there are more reliable methods such as multiple imputation (MI). Objectives: To compare four different methods of handling missing data in a 60-week placebo controlled anti-obesity drug trial on topiramate. Methods: We compared an analysis of complete cases with datasets where missing body weight measurements had been replaced using three different imputation methods: LOCF, baseline carried forward (BOCF) and MI. Results: 561 participants were randomised. Compared to placebo, there was a significantly greater weight loss with topiramate in all analyses: 9.5 kg (SE 1.17) in the complete case analysis (N = 86), 6.8 kg (SE 0.66) using LOCF (N = 561), 6.4 kg (SE 0.90) using MI (N = 561) and 1.5 kg (SE 0.28) using BOCF (N = 561). Conclusions: The different imputation methods gave very different results. Contrary to widely stated claims, LOCF did not produce a conservative (i.e., lower) efficacy estimate compared to MI. Also, LOCF had a lower SE than MI.	[Jorgensen, Anders W.; Gotzsche, Peter C.] Rigshosp, Dept 7811, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Lundstrom, Lars H.; Wetterslev, Jorn] Rigshosp, Dept 7812, Copenhagen Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2100 Copenhagen, Denmark; [Astrup, Arne] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Gotzsche, Peter C.] Univ Copenhagen, Fac Hlth Sci, Inst Med & Surg, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Gotzsche, PC (corresponding author), Rigshosp, Dept 7811, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk	Wetterslev, Jørn/ABF-1251-2020; Astrup, Arne/B-1407-2015	Wetterslev, Jørn/0000-0001-7778-1771; Astrup, Arne/0000-0001-8968-8996; Lundstrom, Lars/0000-0002-2179-1433	Johnson & Johnson Pharmaceutical Research and Development, LLP	Johnson & Johnson Pharmaceutical Research and Development, LLP	This trial was supported by Johnson & Johnson Pharmaceutical Research and Development, LLP, the producer of topiramate, to conduct the clinical trial from which the data for this paper originated (see reference 10). Arne Astrup is currently consultant or member of advisory boards for a number companies, including: Arena Pharmaceuticals Inc., USA; Basic Research, USA; BioCare Copenhagen, DenmarK; Boehringer Ingelheim Pharma, Germany; Gelesis, USA; Novo Nordisk, Denmark; Pathway Genomics Corporation, USA; S-Biotek, Denmark; Twinlab, USA; Vivus Inc., USA. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, GUIDELINE MISSING DA; Astrup A, 2004, OBES RES, V12, P1658, DOI 10.1038/oby.2004.206; Beunckens C, 2005, CLIN TRIALS, V2, P379, DOI 10.1191/1740774505cn119oa; Carpenter J, MISSING DATA RANDOMI; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Fabricatore AN, 2009, OBES REV, V10, P333, DOI 10.1111/j.1467-789X.2009.00567.x; FLETCHER SW, 1993, ANN INTERN MED, V119, P764, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00026; Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Kramer CK, 2011, OBES REV, V12, pe338, DOI 10.1111/j.1467-789X.2010.00846.x; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Molenberghs G., 2007, MISSING DATA CLIN ST; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Rock CL, 2010, JAMA-J AM MED ASSOC, V304, P1803, DOI 10.1001/jama.2010.1503; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; Sinharay S, 2001, PSYCHOL METHODS, V6, P317, DOI 10.1037//1082-989X.6.4.317; Smith IG, 2001, J FAM PRACTICE, V50, P505; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054	22	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111964	10.1371/journal.pone.0111964	http://dx.doi.org/10.1371/journal.pone.0111964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409438	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200006
J	Rusz, J; Saft, C; Schlegel, U; Hoffman, R; Skodda, S				Rusz, Jan; Saft, Carsten; Schlegel, Uwe; Hoffman, Rainer; Skodda, Sabine			Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease	PLOS ONE			English	Article							EARLY-STAGE; ONSET; VOICE	Purpose: Although dysphonia has been shown to be a common sign of Huntington disease (HD), the extent of phonatory dysfunction in gene positive premanifest HD individuals remains unknown. The aim of the current study was to explore the possible occurrence of phonatory abnormalities in prodromal HD. Method: Sustained vowel phonations were acquired from 28 premanifest HD individuals and 28 healthy controls of comparable age. Data were analysed acoustically for measures of several phonatory dimensions including airflow insufficiency, aperiodicity, irregular vibration of vocal folds, signal perturbations, increased noise, vocal tremor and articulation deficiency. A predictive model was built to find the best combination of acoustic features and estimate sensitivity/specificity for differentiation between premanifest HD subjects and controls. The extent of voice deficits according to a specific phonatory dimension was determined using statistical decision making theory. The results were correlated to global motor function, cognitive score, disease burden score and estimated years to disease onset. Results: Measures of aperiodicity and increased noise were able to significantly differentiate between premanifest HD individuals and controls (p < 0.01). The combination of these aspects of dysphonia led to a sensitivity of 91.5% and specificity of 79.2% to correctly distinguish speakers with premanifest HD from healthy individuals. Some form of disrupted phonatory function was revealed in 68% of our premanifest HD subjects, where 18% had one affected phonatory dimension and 50% showed impairment of two or more dimensions. A relationship between pitch control and cognitive score was also observed (r = 20.50, p = 0.007). Conclusions: Phonatory abnormalities are detectable even the in premotor stages of HD. Speech investigation may have the potential to provide functional biomarkers of HD and could be included in future clinical trials and therapeutic interventions.	[Rusz, Jan] Czech Tech Univ, Fac Elect Engn, Dept Circuit Theory, CR-16635 Prague, Czech Republic; [Rusz, Jan] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Rusz, Jan] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Saft, Carsten; Hoffman, Rainer] Ruhr Univ Bochum, St Josef Hosp, Huntington Ctr NRW, Dept Neurol, Bochum, Germany; [Schlegel, Uwe; Skodda, Sabine] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Neurol, Bochum, Germany	Czech Technical University Prague; Charles University Prague; Charles University Prague; Ruhr University Bochum; Ruhr University Bochum	Rusz, J (corresponding author), Czech Tech Univ, Fac Elect Engn, Dept Circuit Theory, CR-16635 Prague, Czech Republic.	rusz.mz@gmail.com	Rusz, Jan/S-2054-2018; Rusz, Jan/X-5427-2019	Rusz, Jan/0000-0002-1036-3054; Rusz, Jan/0000-0002-1036-3054; Saft, Carsten/0000-0002-3983-7292	Czech Science Foundation [GACR 102/12/2230]; Charles University in Prague [PRVOUK-P26/LF1/4]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University in Prague	This study was supported by the Czech Science Foundation (GACR 102/12/2230) and Charles University in Prague (PRVOUK-P26/LF1/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beste C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01797; Boersma Paul, 2002, GLOT INT, V5, P341; COLEMAN R, 1990, AM J MED GENET, V37, P36, DOI 10.1002/ajmg.1320370110; Duffy J. R., 2013, MOTOR SPEECH DISORDE; Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217; Gamboa J, 1998, J VOICE, V12, P444, DOI 10.1016/S0892-1997(98)80053-2; Hartelius L, 2003, J MED SPEECH-LANG PA, V11, P1; Kay Elemetrics Corp, 2003, MULT VOIC PROGR MDVP; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kirkwood SC, 2000, J NEUROL NEUROSUR PS, V69, P773, DOI 10.1136/jnnp.69.6.773; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; Novotny M, 2014, IEEE-ACM T AUDIO SPE, V22, P1366, DOI 10.1109/TASLP.2014.2329734; Peck KK, 2009, NEUROIMAGE, V44, P175, DOI 10.1016/j.neuroimage.2008.08.034; PENNEY JB, 1990, MOVEMENT DISORD, V5, P93, DOI 10.1002/mds.870050202; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; RAMIG LA, 1986, ANN OTO RHINOL LARYN, V95, P288, DOI 10.1177/000348948609500315; Rusz J, 2014, J NEURAL TRANSM, V121, P1529, DOI 10.1007/s00702-014-1229-8; Rusz J, 2014, J NEURAL TRANSM, V121, P655, DOI 10.1007/s00702-014-1158-6; Rusz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065881; Saft C, 2003, J NEUROL, V250, P1469, DOI 10.1007/s00415-003-0256-4; Saft C, 2006, MOVEMENT DISORD, V21, P1208, DOI 10.1002/mds.20939; Skodda S, 2014, J NEURAL TRANSM, V121, P399, DOI 10.1007/s00702-013-1115-9; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tsanas A, 2012, IEEE T BIO-MED ENG, V59, P1264, DOI 10.1109/TBME.2012.2183367; Garcia MJV, 2011, J VOICE, V25, P208, DOI 10.1016/j.jvoice.2009.08.007; Vogel AP, 2012, NEUROPSYCHOLOGIA, V50, P3273, DOI 10.1016/j.neuropsychologia.2012.09.011; Weir DW, 2011, LANCET NEUROL, V10, P573, DOI 10.1016/S1474-4422(11)70070-9	32	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113412	10.1371/journal.pone.0113412	http://dx.doi.org/10.1371/journal.pone.0113412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409322	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200115
J	Zablotska, IB; Frankland, A; Holt, M; de Wit, J; Brown, G; Maycock, B; Fairley, C; Prestage, G				Zablotska, Iryna B.; Frankland, Andrew; Holt, Martin; de Wit, John; Brown, Graham; Maycock, Bruce; Fairley, Christopher; Prestage, Garrett			Methodological Challenges in Collecting Social and Behavioural Data Regarding the HIV Epidemic among Gay and Other Men Who Have Sex with Men in Australia	PLOS ONE			English	Article							DRIVEN SAMPLING METHODOLOGY; SURVEILLANCE	Background: Behavioural surveillance and research among gay and other men who have sex with men (GMSM) commonly relies on non-random recruitment approaches. Methodological challenges limit their ability to accurately represent the population of adult GMSM. We compared the social and behavioural profiles of GMSM recruited via venue-based, online, and respondent-driven sampling (RDS) and discussed their utility for behavioural surveillance. Methods: Data from four studies were selected to reflect each recruitment method. We compared demographic characteristics and the prevalence of key indicators including sexual and HIV testing practices obtained from samples recruited through different methods, and population estimates from respondent-driven sampling partition analysis. Results: Overall, the socio-demographic profile of GMSM was similar across samples, with some differences observed in age and sexual identification. Men recruited through time-location sampling appeared more connected to the gay community, reported a greater number of sexual partners, but engaged in less unprotected anal intercourse with regular (UAIR) or casual partners (UAIC). The RDS sample overestimated the proportion of HIV-positive men and appeared to recruit men with an overall higher number of sexual partners. A single-website survey recruited a sample with characteristics which differed considerably from the population estimates with regards to age, ethnically diversity and behaviour. Data acquired through time-location sampling underestimated the rates of UAIR and UAIC, while RDS and online sampling both generated samples that underestimated UAIR. Simulated composite samples combining recruits from time-location and multi-website online sampling may produce characteristics more consistent with the population estimates, particularly with regards to sexual practices. Conclusion: Respondent-driven sampling produced the sample that was most consistent to population estimates, but this methodology is complex and logistically demanding. Time-location and online recruitment are more cost-effective and easier to implement; using these approaches in combination may offer the potential to recruit a more representative sample of GMSM.	[Zablotska, Iryna B.; Frankland, Andrew; Prestage, Garrett] Univ NSW Australia, Kirby Inst, Sydney, NSW, Australia; [Frankland, Andrew] Univ NSW Australia, Sch Psychiat, Sydney, NSW, Australia; [Frankland, Andrew; Holt, Martin] Univ NSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [Brown, Graham; Prestage, Garrett] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Brown, Graham; Maycock, Bruce] Curtin Univ, Perth, WA 6845, Australia; [Fairley, Christopher] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Fairley, Christopher] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; La Trobe University; Curtin University; Monash University	Zablotska, IB (corresponding author), Univ NSW Australia, Kirby Inst, Sydney, NSW, Australia.	izablotska@nchecr.unsw.edu.au	Holt, Martin/X-6482-2019	Holt, Martin/0000-0002-2586-8274; Prestage, Garrett/0000-0003-3917-8992; Brown, Graham/0000-0003-4901-0974; Christopher, Fairley/0000-0001-9081-1664	NSW Ministry of Health, in Victoria by Victoria Department of Health; NSW Ministry of Health, in Queensland by Queensland Health; National Health and Medical Research Council, Australia [NHMRC 630547]; Australian Government Department of Health and Ageing	NSW Ministry of Health, in Victoria by Victoria Department of Health; NSW Ministry of Health, in Queensland by Queensland Health; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	Gay Community Periodic Survey and PASH study in New South Wales (NSW), Australia, were funded by the NSW Ministry of Health, in Victoria by Victoria Department of Health, and in Queensland by Queensland Health. The CONNECT study was funded by the Project Grant from the National Health and Medical Research Council, Australia (NHMRC 630547). The Kirby Institute and the Centre for Social Research in Health receive funding from the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elford J, 2006, CURR OPIN INFECT DIS, V19, P26, DOI 10.1097/01.qco.0000199018.50451.e1; Elford J, 2009, EUROSURVEILL, V14; Garnett GP, 2006, SEX TRANSM INFECT, V82, pI57, DOI 10.1136/sti.2005.016543; Grulich AE, 2003, AUST NZ J PUBL HEAL, V27, P155, DOI 10.1111/j.1467-842X.2003.tb00803.x; Grulich Andrew, 2010, N S W Public Health Bull, V21, P96, DOI 10.1071/NB10028; Guo Y, 2011, AIDS CARE, V23, P1400, DOI 10.1080/09540121.2011.565029; Holt M, 2011, AIDS BEHAV, V15, P1128, DOI 10.1007/s10461-009-9645-8; Holt M, 2012, AIDS BEHAV, V16, P13, DOI 10.1007/s10461-010-9872-z; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Lyons A, 2012, AIDS BEHAV, V16, P1934, DOI 10.1007/s10461-012-0148-7; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; McCreesh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078402; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; McFarland W, 2001, AIDS, V15, pS23, DOI 10.1097/00002030-200104003-00004; Paquette D, 2008, HIV PREVALENCE ASS R; Paquette D, 2010, AIDS BEHAV, V14, P1252, DOI 10.1007/s10461-010-9743-7; Prestage G, 2012, SEX TRANSM DIS, V39, P167, DOI 10.1097/OLQ.0b013e31823e67a9; Rehle T, 2004, B WORLD HEALTH ORGAN, V82, P121; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P106, DOI 10.1111/j.1467-842X.2003.tb00797.x; The Kirby Institute The University of New South Wales, 2013, HIV VIR HEP SEX TRAN; World Health Organization, 2013, GUID 2 GEN HIV SURV; Zablotska I, 2013, WORLD J AIDS, V3, P320, DOI DOI 10.4236/wja.2013.34041; Zablotska IB, 2012, AIDS BEHAV, V16, P669, DOI 10.1007/s10461-011-9919-9; Zablotska IB, 2011, SEX HEALTH, V8, P272, DOI 10.1071/SH10125; Zablotska IB, 2011, AIDS BEHAV, V15, P607, DOI 10.1007/s10461-010-9675-2; Zablotska IB, 2010, AIDS, V24, P1955, DOI 10.1097/QAD.0b013e32833bf74a	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113167	10.1371/journal.pone.0113167	http://dx.doi.org/10.1371/journal.pone.0113167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409440	Green Published, gold			2022-12-27	WOS:000345533200076
J	Dong, YY; Luo, RS; Feng, HK; Wang, JH; Zhao, JL; Zhu, YN; Yang, GJ				Dong, Yingying; Luo, Ruisen; Feng, Haikuan; Wang, Jihua; Zhao, Jinling; Zhu, Yining; Yang, Guijun			Analysing and Correcting the Differences between Multi-Source and Multi-Scale Spatial Remote Sensing	PLOS ONE			English	Article							LAND-COVER; MODIS; CLASSIFICATION	Differences exist among analysis results of agriculture monitoring and crop production based on remote sensing observations, which are obtained at different spatial scales from multiple remote sensors in same time period, and processed by same algorithms, models or methods. These differences can be mainly quantitatively described from three aspects, i.e. multiple remote sensing observations, crop parameters estimation models, and spatial scale effects of surface parameters. Our research proposed a new method to analyse and correct the differences between multi-source and multi-scale spatial remote sensing surface reflectance datasets, aiming to provide references for further studies in agricultural application with multiple remotely sensed observations from different sources. The new method was constructed on the basis of physical and mathematical properties of multi-source and multi-scale reflectance datasets. Theories of statistics were involved to extract statistical characteristics of multiple surface reflectance datasets, and further quantitatively analyse spatial variations of these characteristics at multiple spatial scales. Then, taking the surface reflectance at small spatial scale as the baseline data, theories of Gaussian distribution were selected for multiple surface reflectance datasets correction based on the above obtained physical characteristics and mathematical distribution properties, and their spatial variations. This proposed method was verified by two sets of multiple satellite images, which were obtained in two experimental fields located in Inner Mongolia and Beijing, China with different degrees of homogeneity of underlying surfaces. Experimental results indicate that differences of surface reflectance datasets at multiple spatial scales could be effectively corrected over non-homogeneous underlying surfaces, which provide database for further multi-source and multi-scale crop growth monitoring and yield prediction, and their corresponding consistency analysis evaluation.	[Dong, Yingying; Feng, Haikuan; Zhao, Jinling; Yang, Guijun] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Dong, Yingying; Wang, Jihua] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Agr Stand & Testing, Beijing, Peoples R China; [Luo, Ruisen; Wang, Jihua] Zhejiang Univ, Inst Agr Remote Sensing & Informat Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Yining] Peking Univ, Sch Math Sci, LMAM, Beijing 100871, Peoples R China	Beijing Academy of Agriculture & Forestry; Beijing Academy of Agriculture & Forestry; Zhejiang University; Peking University	Yang, GJ (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China.	yanggj@nercita.org.cn		Feng, Haikuan/0000-0003-3312-6200; Yang, Guijun/0000-0002-6425-8321	National Key Basic Research and Development Program of China [2011CB311806]; National Natural Science Foundation of China [40901173, 41071228]; Beijing Natural Science Foundation [4141001]; Natural Science Foundation of China [41271345]; Beijing Municipal Talents Training Funded Project [2012D002020000007]; Beijing Academy of Agriculture and Forestry Sciences [KJCX20140417]; Open Funds of State Key Laboratory of Remote Sensing Science; Institute of Remote Sensing Applications of Chinese Academy of Sciences; Beijing Normal University [OFSLRSS201308]	National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Talents Training Funded Project; Beijing Academy of Agriculture and Forestry Sciences; Open Funds of State Key Laboratory of Remote Sensing Science; Institute of Remote Sensing Applications of Chinese Academy of Sciences(Chinese Academy of Sciences); Beijing Normal University	This research was supported by the National Key Basic Research and Development Program of China (Project No. 2011CB311806), the National Natural Science Foundation of China (Project No. 40901173 and 41071228), the Beijing Natural Science Foundation (Project No. 4141001), the Natural Science Foundation of China (Project No. 41271345), the Beijing Municipal Talents Training Funded Project (Project No. 2012D002020000007), the Special Funds for Technology innovation capacity building sponsored by the Beijing Academy of Agriculture and Forestry Sciences (Project No. KJCX20140417), and the Open Funds of State Key Laboratory of Remote Sensing Science, jointly sponsored by the Institute of Remote Sensing Applications of Chinese Academy of Sciences and Beijing Normal University (Project No. OFSLRSS201308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barany I, 2007, ANN PROBAB, V35, P1593, DOI 10.1214/009117906000000791; Bloschl G, 1999, HYDROL PROCESS, V13, P2149, DOI 10.1002/(SICI)1099-1085(199910)13:14/15<2149::AID-HYP847>3.0.CO;2-8; Braswell BH, 2003, REMOTE SENS ENVIRON, V87, P243, DOI 10.1016/j.rse.2003.06.002; Cooley T, 2002, INT GEOSCI REMOTE SE, P1414, DOI 10.1109/IGARSS.2002.1026134; Dong YY, 2012, ADV MATER RES-SWITZ, V356-360, P2833, DOI 10.4028/www.scientific.net/AMR.356-360.2833; Dong YY, 2013, THESIS ZHEJIANG U; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; He X, 2010, SENSOR LETT, V8, P2, DOI 10.1166/sl.2010.1191; Kallenberg O., 2002, FDN MODERN PROBABILI, DOI [10.1007/978-3-030-61871-1, DOI 10.1007/978-3-030-61871-1]; Li Xiang, 2005, Scientia Agricultura Sinica, V38, P1825; Liang SL, 2007, PROG PHYS GEOG, V31, P501, DOI 10.1177/0309133307084626; Liu JiaoDi, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P220; Liu M.L., 2001, J REMOTE SENSING, V5, P183; PERCIVAL DP, 1995, BIOMETRIKA, V82, P619, DOI 10.2307/2337538; Qi J, 2000, AGR FOREST METEOROL, V105, P55, DOI 10.1016/S0168-1923(00)00195-7; Rice J., 1995, MATH STAT DATA ANAL; Rosenqvist A, 2004, INT GEOSCI REMOTE SE, P4527; Tadono T, 2009, IEEE T GEOSCI REMOTE, V47, P4042, DOI 10.1109/TGRS.2009.2025270; Tarnavsky E, 2008, REMOTE SENS ENVIRON, V112, P535, DOI 10.1016/j.rse.2007.05.008; Vermote E. F., 1999, ATMOSPHERIC CORRECTI; Wang J., 2008, BASIS APPL AGR QUANT; Webster R., 2007, STAT PRACTICE; Wu H, 2010, THESIS I GEOGRAPHIC; Wu J., 2000, ANN GIS, V6, P6, DOI DOI 10.1080/10824000009480529; Yang CC, 2003, AGR SYST, V76, P1101, DOI 10.1016/S0308-521X(02)00051-3; Zhang T.B., 2006, J EARTH SCI ENV, V28, P79	27	0	0	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111642	10.1371/journal.pone.0111642	http://dx.doi.org/10.1371/journal.pone.0111642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405760	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300013
J	Itoh, A; Uchiyama, A; Taniguchi, S; Sagara, J				Itoh, Akihiro; Uchiyama, Atsushi; Taniguchi, Shunichiro; Sagara, Junji			Phactr3/Scapinin, a Member of Protein Phosphatase 1 and Actin Regulator (Phactr) Family, Interacts with the Plasma Membrane via Basic and Hydrophobic Residues in the N-Terminus	PLOS ONE			English	Article							BINDING-PROTEIN; PP1; CYTOSKELETON; SCAPININ; DYNAMICS; COFILIN; SPECIFICITY; MIGRATION; MOTILITY; CELLS	Proteins that belong to the protein phosphatase 1 and actin regulator (phactr) family are involved in cell motility and morphogenesis. However, the mechanisms that regulate the actin cytoskeleton are poorly understood. We have previously shown that phactr3, also known as scapinin, localizes to the plasma membrane, including lamellipodia and membrane ruffles. In the present study, experiments using deletion and point mutants showed that the basic and hydrophobic residues in the N-terminus play crucial roles in the localization to the plasma membrane. A BH analysis (http://helixweb.nih.gov/bhsearch) is a program developed to identify membrane-binding domains that comprise basic and hydrophobic residues in membrane proteins. We applied this program to phactr3. The results of the BH plot analysis agreed with the experimentally determined region that is responsible for the localization of phactr3 to the plasma membrane. In vitro experiments showed that the N-terminal itself binds to liposomes and acidic phospholipids. In addition, we showed that the interaction with the plasma membrane via the N-terminal membrane-binding sequence is required for phactr3-induced morphological changes in Cos7 cells. The membrane-binding sequence in the N-terminus is highly conserved in all members of the phactr family. Our findings may provide a molecular basis for understanding the mechanisms that allow phactr proteins to regulate cell morphogenesis.	[Itoh, Akihiro; Uchiyama, Atsushi; Sagara, Junji] Shinshu Univ, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan; [Taniguchi, Shunichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University	Sagara, J (corresponding author), Shinshu Univ, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan.	sagaraj@shinshu-u.ac.jp			Minister of Education, Science and Culture, Japan [16570156]	Minister of Education, Science and Culture, Japan	This work was supported by a Grant-in aid 16570156 to JS from the Minister of Education, Science and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Farghaian H, 2011, J BIOL CHEM, V286, P19724, DOI 10.1074/jbc.M110.205781; Favot L, 2005, FEBS LETT, V579, P100, DOI 10.1016/j.febslet.2004.11.054; Fils-Aime N, 2013, J BIOL CHEM, V288, P11807, DOI 10.1074/jbc.M112.430934; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Huet G, 2013, J CELL SCI, V126, P497, DOI 10.1242/jcs.113241; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Mouilleron S, 2012, STRUCTURE, V20, P1960, DOI 10.1016/j.str.2012.08.031; Niggli V, 2001, TRENDS BIOCHEM SCI, V26, P604, DOI 10.1016/S0968-0004(01)01927-2; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Sagara J, 2003, J BIOL CHEM, V278, P45611, DOI 10.1074/jbc.M305227200; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Solimini NL, 2013, P NATL ACAD SCI USA, V110, pE407, DOI 10.1073/pnas.1221385110; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wider C, 2009, NEUROSCI LETT, V453, P9, DOI 10.1016/j.neulet.2009.02.009; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhang Y, 2012, GENE DEV, V26, P69, DOI 10.1101/gad.179283.111	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113289	10.1371/journal.pone.0113289	http://dx.doi.org/10.1371/journal.pone.0113289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405772	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300097
J	Lima, ILB; Rodrigues, AFAC; Bergamaschi, CT; Campos, RR; Hirata, AE; Tufik, S; Xylaras, BDP; Visniauskas, B; Chagas, JR; Gomes, GN				Lima, Ingrid L. B.; Rodrigues, Aline F. A. C.; Bergamaschi, Cassia T.; Campos, Ruy R.; Hirata, Aparecida E.; Tufik, Sergio; Xylaras, Beatriz D. P.; Visniauskas, Bruna; Chagas, Jair R.; Gomes, Guiomar N.			Chronic Sleep Restriction during Pregnancy - Repercussion on Cardiovascular and Renal Functioning of Male Offspring	PLOS ONE			English	Article							SENSITIVE METHOD; ANGIOTENSIN-II; HEART-RATE; HYPERTENSION; RATS; DEPRIVATION; DISORDERS; DURATION; ASSOCIATION; PRINCIPLE	Changes in the maternal environment can induce fetal adaptations that result in the progression of chronic diseases in the offspring. The objective of the present study was to evaluate the effects of maternal chronic sleep restriction on blood pressure, renal function and cardiac baroreflex response on male offspring at adult age. Female 3-month-old Wistar rats were divided in two experimental groups: control (C) and chronic sleep restricted (CSR). Pregnancy was confirmed by vaginal smear. Chronic sleep restricted females were subjected to sleep restriction by the multiple platform technique for 20 h daily, between the 1st and 20th day of pregnancy. After birth, the litters were reduced to 6 rats per mother, and were designated as offspring from control (OC) and offspring from chronic sleep restricted (OCSR). Indirect blood pressure (BPi tail cuff) was measured by plethysmography in male offspring at 3 months old. Following, the renal function and cardiac baroreflex response were analyzed. Values of BPi in OCSR were significantly higher compared to OC [OC: 127 +/- 2.6 (19); OCSR: 144 +/- 2.5 (17) mmHg]. The baroreflex sensitivity to the increase of blood pressure was reduced in OCSR [Slope: OC: -2.6 +/- 0.15 (9); OCRS: -1.6 +/- 0.13 (9)]. Hypothalamic activity of ACE2 was significantly reduced in OCSR compared to OC [OC: 97.4 +/- 15 (18); OSR: 60.2 +/- 3.6 (16) UAF/min/protein mg]. Renal function alteration was noticed by the increase in glomerular filtration rate (GFR) observed in OCSR [OC: 6.4 +/- 0.2 (10); OCSR: 7.4 +/- 0.3 (7)]. Chronic sleep restriction during pregnancy caused in the offspring hypertension, altered cardiac baroreflex response, reduced ACE-2 activity in the hypothalamus and renal alterations. Our data suggest that the reduction of sleeping time along the pregnancy is able to modify maternal homeostasis leading to functional alterations in offspring.	[Lima, Ingrid L. B.; Rodrigues, Aline F. A. C.; Bergamaschi, Cassia T.; Campos, Ruy R.; Hirata, Aparecida E.; Gomes, Guiomar N.] Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil; [Tufik, Sergio; Xylaras, Beatriz D. P.; Visniauskas, Bruna; Chagas, Jair R.] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil; [Chagas, Jair R.] Univ Fed Sao Paulo, Dept Biociencias, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Gomes, GN (corresponding author), Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil.	guiomar.gomes@unifesp.br	Visniauskas, Bruna/F-2962-2018; Bergamaschi, Cassia/AAZ-9441-2020; Chagas, Jair Ribeiro/AFV-6501-2022; Gomes, Guiomar/GLS-9245-2022; Gomes, Guiomar N/E-6345-2013; Campos, Ruy R R/I-3691-2015; Campos, Ruy R/H-8339-2017; Chagas, Jair R/A-1701-2012	Visniauskas, Bruna/0000-0002-4525-2194; Chagas, Jair Ribeiro/0000-0002-0357-8276; Gomes, Guiomar/0000-0002-6687-9885; Campos, Ruy R R/0000-0002-9404-0817; Campos, Ruy R/0000-0002-9404-0817; Chagas, Jair R/0000-0002-0357-8276; Bergamaschi, Cassia/0000-0002-5741-6993	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP-10/51665-4]; Associacao Fundo de Incentivo a Pesquisa (AFIP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Fundo de Incentivo a Pesquisa (AFIP)	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) ILBL, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-10/51665-4) GNG, Associacao Fundo de Incentivo a Pesquisa (AFIP)JRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calegare BFA, 2010, PSYCHONEUROENDOCRINO, V35, P775, DOI 10.1016/j.psyneuen.2009.11.004; Aldabal Laila, 2011, Open Respir Med J, V5, P31, DOI 10.2174/1874306401105010031; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 1997, ACTA PAEDIATR, V86, P78; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; Caruso CC, 2006, IND HEALTH, V44, P531, DOI 10.2486/indhealth.44.531; Celsi G, 1998, PEDIATR RES, V44, P317, DOI 10.1203/00006450-199809000-00009; CHAPLEAU MW, 1995, HYPERTENSION, V26, P341, DOI 10.1161/01.HYP.26.2.341; Dall'Ago P, 2002, BRAZ J MED BIOL RES, V35, P843, DOI 10.1590/S0100-879X2002000700013; Rodrigues AFDC, 2013, AM J PHYSIOL-RENAL, V304, pF189, DOI 10.1152/ajprenal.00241.2012; DENTON KM, 1994, J PHYSIOL-LONDON, V475, P159, DOI 10.1113/jphysiol.1994.sp020057; FINK GD, 1987, HYPERTENSION, V9, P355, DOI 10.1161/01.HYP.9.4.355; Flores Mendoza I, 1979, J BRAS NEFROL, V1, P51; Martins PJF, 2010, AM J PHYSIOL-ENDOC M, V298, pE726, DOI 10.1152/ajpendo.00660.2009; Forty EJ, 2012, EXP PHYSIOL, V97, P785, DOI 10.1113/expphysiol.2011.063172; Franco MD, 2009, LIFE SCI, V85, P327, DOI 10.1016/j.lfs.2009.06.013; Franco M, 2009, CURR OPIN NEPHROL HY, V18, P63, DOI 10.1097/MNH.0b013e32831cf5d3; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; ITO S, 1993, J CLIN INVEST, V91, P2012, DOI 10.1172/JCI116423; JOUVET D, 1964, CR SOC BIOL, V158, P756; Kandasamy Y, 2012, AM J PERINAT, V29, P115, DOI 10.1055/s-0031-1295651; Kotronoulas G, 2009, HORM-INT J ENDOCRINO, V8, P232, DOI 10.14310/horm.2002.1239; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; LISHNER M, 1987, J AUTONOM NERV SYST, V19, P119, DOI 10.1016/0165-1838(87)90005-1; Lopes EA, 2004, ARQ NEURO-PSIQUIAT, V62, P217, DOI 10.1590/S0004-282X2004000200005; Lucas SRR, 2001, AM J KIDNEY DIS, V37, P467, DOI 10.1053/ajkd.2001.22088; Machado RB, 2008, PSYCHONEUROENDOCRINO, V33, P1211, DOI 10.1016/j.psyneuen.2008.06.007; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; National Sleep Foundation, 2007, SLEEP AM POLL; Nautiyal M, 2013, HYPERTENSION, V61, pE20, DOI 10.1161/HYPERTENSIONAHA.111.00571; Ofstad J, 2005, AM J PHYSIOL-RENAL, V288, pF665, DOI 10.1152/ajprenal.00226.2004; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Pedersen KB, 2011, AM J PHYSIOL-REG I, V301, pR1293, DOI 10.1152/ajpregu.00339.2011; Pien GW, 2004, SLEEP, V27, P1405, DOI 10.1093/sleep/27.7.1405; Plagemann A, 1999, DEV NEUROSCI-BASEL, V21, P58, DOI 10.1159/000017367; Rocha SO, 2005, PEDIATR RES, V58, P1274, DOI 10.1203/01.pdr.0000188698.58021.ff; Sahota PK, 2003, CURR OPIN PULM MED, V9, P477, DOI 10.1097/00063198-200311000-00005; Salgado H C, 1973, Clin Sci Mol Med Suppl, V45 Suppl 1, p123s; Schussler P, 2006, AM J PHYSIOL-ENDOC M, V291, pE549, DOI 10.1152/ajpendo.00641.2005; SIMPSON JB, 1981, NEUROENDOCRINOLOGY, V32, P248, DOI 10.1159/000123167; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Sriramula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063847; Stranges S, 2010, J HYPERTENS, V28, P896, DOI 10.1097/HJH.0b013e328335d076; Thomal JT, 2010, SLEEP, V33, P1357, DOI 10.1093/sleep/33.10.1357; Tzschentke B, 2006, WORLD POULTRY SCI J, V62, P626, DOI 10.1079/WPS2006117; Vetrivelan R, 2012, SLEEP, V35, P1511, DOI 10.5665/sleep.2200; Xia HJ, 2009, HYPERTENSION, V53, P210, DOI 10.1161/HYPERTENSIONAHA.108.123844	52	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113075	10.1371/journal.pone.0113075	http://dx.doi.org/10.1371/journal.pone.0113075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405471	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300074
J	Samia, DSM; Blumstein, DT				Samia, Diogo S. M.; Blumstein, Daniel T.			Phi Index: A New Metric to Test the Flush Early and Avoid the Rush Hypothesis	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; QUANTILE REGRESSION; HUMAN DISTURBANCE; PATTERNS; BIRDS; RISK; WILDLIFE; BEHAVIOR; ECOLOGY; RULE	Optimal escape theory states that animals should counterbalance the costs and benefits of flight when escaping from a potential predator. However, in apparent contradiction with this well-established optimality model, birds and mammals generally initiate escape soon after beginning to monitor an approaching threat, a phenomena codified as the ``Flush Early and Avoid the Rush'' (FEAR) hypothesis. Typically, the FEAR hypothesis is tested using correlational statistics and is supported when there is a strong relationship between the distance at which an individual first responds behaviorally to an approaching predator (alert distance, AD), and its flight initiation distance (the distance at which it flees the approaching predator, FID). However, such correlational statistics are both inadequate to analyze relationships constrained by an envelope (such as that in the AD-FID relationship) and are sensitive to outliers with high leverage, which can lead one to erroneous conclusions. To overcome these statistical concerns we develop the phi index (W), a distribution-free metric to evaluate the goodness of fit of a 1: 1 relationship in a constraint envelope (the prediction of the FEAR hypothesis). Using both simulation and empirical data, we conclude that W is superior to traditional correlational analyses because it explicitly tests the FEAR prediction, is robust to outliers, and it controls for the disproportionate influence of observations from large predictor values (caused by the constrained envelope in AD-FID relationship). Importantly, by analyzing the empirical data we corroborate the strong effect that alertness has on flight as stated by the FEAR hypothesis.	[Samia, Diogo S. M.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Universidade Federal de Goias; University of California System; University of California Los Angeles	Samia, DSM (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	diogosamia@gmail.com		Blumstein, Daniel/0000-0001-5793-9244				Agresti A, 2007, INTRO CATEGORICAL DA; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 2003, BIOL CONSERV, V110, P97, DOI 10.1016/S0006-3207(02)00180-5; BLUMSTEIN DT, 1992, ECOLOGY, V73, P1757, DOI 10.2307/1940027; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chamaille-Jammes S, 2012, BEHAV ECOL SOCIOBIOL, V66, P985, DOI 10.1007/s00265-012-1354-z; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooper WE, 2005, CAN J ZOOL, V83, P1045, DOI 10.1139/Z05-104; Cooper WE, 2003, BEHAV ECOL SOCIOBIOL, V54, P179, DOI 10.1007/s00265-003-0619-y; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Cooper WE, 2014, BEHAV ECOL, V25, P44, DOI 10.1093/beheco/art083; Diaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064634; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Dumont F, 2012, ETHOLOGY, V118, P1051, DOI 10.1111/eth.12006; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fernandez-Juricic E, 2005, BIOL CONSERV, V125, P225, DOI 10.1016/j.biocon.2005.03.020; Fernandez-Juricic E, 2002, CAN J ZOOL, V80, P1212, DOI 10.1139/Z02-104; Fernandez-Juricic E, 2001, ENVIRON CONSERV, V28, P263, DOI 10.1017/S0376892901000273; Frid A, 2002, CONSERV ECOL, V6; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Gulbransen D, 2006, ETHOLOGY, V112, P1056, DOI 10.1111/j.1439-0310.2006.01265.x; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Louis S, 2000, CAN J ZOOL, V78, P556, DOI 10.1139/cjz-78-4-556; Mao X, 2012, P IEEE VEH TECHN C, P1; Meiri S, 2005, J BIOGEOGR, V32, P369, DOI 10.1111/j.1365-2699.2005.01197.x; Moller AP, 2013, BEHAV ECOL, V24, P1211, DOI 10.1093/beheco/art054; Montgomery D.C., 2012, INTRO LINEAR REGRESS, Vfifith; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; RODGERS JA, 1995, CONSERV BIOL, V9, P89, DOI 10.1046/j.1523-1739.1995.09010089.x; Rodgers JA, 2002, CONSERV BIOL, V16, P216, DOI 10.1046/j.1523-1739.2002.00316.x; Samia DSM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0016; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Stephens PA, 2007, TRENDS ECOL EVOL, V22, P192, DOI 10.1016/j.tree.2006.12.003; TOKESHI M, 1993, ADV ECOL RES, V24, P111, DOI 10.1016/S0065-2504(08)60042-2; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zar ZH, 2010, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	50	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113134	10.1371/journal.pone.0113134	http://dx.doi.org/10.1371/journal.pone.0113134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405872	Green Submitted, gold, Green Published			2022-12-27	WOS:000347121300084
J	Wu, JL; Chen, Y; Luo, YJ				Wu, Jialin; Chen, Yu; Luo, Yongjun			Evaluation of the Visual Analog Score (VAS) to Assess Acute Mountain Sickness (AMS) in a Hypobaric Chamber	PLOS ONE			English	Article							ENVIRONMENTAL SYMPTOMS QUESTIONNAIRE; HIGH-ALTITUDE HEADACHE; PAIN SEVERITY; SCALE; HYPOXIA; RELIABILITY; VALIDATION; DIFFERENCE; EXPOSURE; EXERCISE	Objective: The visual analog score (VAS) is widely used in clinical medicine to evaluate the severity of subjective symptoms. There is substantial literature on the application of the VAS in medicine, especially in measuring pain, nausea, fatigue, and sleep quality. Hypobaric chambers are utilized to test and exercise the anaerobic endurance of athletes. To this end, we evaluated the degree of AMS using the visual analog scale (VAS) in a hypobaric chamber in which the equivalent altitude was increased from 300 to 3500 m. Methods: We observed 32 healthy young men in the hypobaric chamber (Guizhou, China) and increased the altitude from 300 to 3500 m. During the five hours of testing, we measured the resting blood oxygen saturation (SaO(2)) and heart rate (HR). Using the VAS, we recorded the subjects' ratings of their AMS symptom intensity that occurred throughout the phase of increasing altitude at 300 m, 1500 m, 2000 m, 2500 m, 3000 m, and 3500 m. Results: During the phase of increasing altitude in the hypobaric chamber, the patients' SaO(2) was 96.8 +/- 0.8% at 300 m and 87.5 +/- 4.1% at 3500 m (P<0.05) and their HR was 79.0 +/- 8.0 beats/minute at 300 m and 79.3 +/- 11.3 beats/minute at 3500 m. The incidence of symptoms significantly increased from 21.9% at an altitude of 1000 m to 65.6% at an altitude of 3500 m (P<0.05). The composite VAS score, which rated the occurrence of four symptoms (headache, dizziness, fatigue, and gastrointestinal discomfort), was significantly correlated with elevation (P<0.01). Conclusion: Based on the experimental data, the VAS can be used as an auxiliary diagnostic method of Lake Louise score to evaluate AMS and can show the changing severity of symptoms during the process of increased elevation in a hypobaric chamber; it also reflects a significant correlation with altitude.	[Wu, Jialin] Third Mil Med Univ, Chongqing, Peoples R China; [Wu, Jialin; Luo, Yongjun] Third Mil Med Univ, Coll High Altitude Mil Med, Dept Mil Med Geog, Chongqing, Peoples R China; [Wu, Jialin; Chen, Yu; Luo, Yongjun] Third Mil Med Univ, Key Lab High Altitude Med, Minist Educ, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Luo, YJ (corresponding author), Third Mil Med Univ, Coll High Altitude Mil Med, Dept Mil Med Geog, Chongqing, Peoples R China.	luoyongjun2011@gmail.com			National Natural Science Foundation of China [81372125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81372125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DM, 2006, J CEREBR BLOOD F MET, V26, P99, DOI 10.1038/sj.jcbfm.9600169; Baillie JK, 2009, QJM-INT J MED, V102, P341, DOI 10.1093/qjmed/hcp026; Beidleman BA, 2007, HIGH ALT MED BIOL, V8, P192, DOI 10.1089/ham.2007.1016; Castellani JW, 2010, J APPL PHYSIOL, V109, P1792, DOI 10.1152/japplphysiol.00517.2010; [陈国柱 Chen Guozhu], 2013, [重庆医学, Chongqing Medicine], V42, P3593; Dellasanta P, 2007, HIGH ALT MED BIOL, V8, P184, DOI 10.1089/ham.2007.8305; Gallagher EJ, 2002, AM J EMERG MED, V20, P287, DOI 10.1053/ajem.2002.33778; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Guo P, 2013, NEUROSCI LETT, V547, P82, DOI 10.1016/j.neulet.2013.05.008; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hendley GW, 2005, ANN EMERG MED, V45, P77, DOI 10.1016/j.annemergmed.2004.07.446; Hext F, 2011, HIGH ALT MED BIOL, V12, P329, DOI 10.1089/ham.2010.1055; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Hou XH, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-2; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Khanna D, 2008, J RHEUMATOL, V35, P2339, DOI 10.3899/jrheum.080375; KOBAYASHI S, 1992, CHEST, V102, P1893, DOI 10.1378/chest.102.6.1893; KOBRICK JL, 1979, AVIAT SPACE ENVIR MD, V50, P925; Lazio MP, 2009, WILD ENVIRON MED, V20, P393, DOI 10.1580/1080-6032-020.004.0393; Luo YJ, 2013, INT J CARDIOL, V169, P97, DOI 10.1016/j.ijcard.2013.08.059; Luo YJ, 2013, EUR J APPL PHYSIOL, V113, P223, DOI 10.1007/s00421-012-2414-9; Luo YJ, 2012, HIGH ALT MED BIOL, V13, P252, DOI 10.1089/ham.2012.1014; Maggiorini M, 1998, AVIAT SPACE ENVIR MD, V69, P1186; Niewinski P, 2014, EXP PHYSIOL, V99, P552, DOI 10.1113/expphysiol.2013.075580; Pradhan S, 2009, WILD ENVIRON MED, V20, P359, DOI 10.1580/1080-6032-020.004.0359; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roach R, 2007, HIGH ALT MED BIOL, V8, P171, DOI 10.1089/ham.2007.8301; SAMPSON JB, 1980, AVIAT SPACE ENVIR MD, V51, P872; SAMPSON JB, 1983, AVIAT SPACE ENVIR MD, V54, P1063; SAVOUREY G, 1995, AVIAT SPACE ENVIR MD, V66, P963; Serrano-Duenas M, 2005, CEPHALALGIA, V25, P1110, DOI 10.1111/j.1468-2982.2005.00968.x; Shen G, 2010, BIOMED ENG ONLINE, V11, P49; Tang E, 2014, INT J CARDIOLOGY; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Van Roo JD, 2011, WILD ENVIRON MED, V22, P7, DOI 10.1016/j.wem.2010.10.002; Vardy J, 2006, AVIAT SPACE ENVIR MD, V77, P742; Wagner DR, 2007, HIGH ALT MED BIOL, V8, P27, DOI 10.1089/ham.2006.0814; Wagner DR, 2012, HIGH ALT MED BIOL, V13, P245, DOI 10.1089/ham.2012.1030; Zisapel N, 2003, J SLEEP RES, V12, P291, DOI 10.1046/j.0962-1105.2003.00365.x	39	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113376	10.1371/journal.pone.0113376	http://dx.doi.org/10.1371/journal.pone.0113376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405765	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300111
J	Aharonson-Raz, K; Lichter-Peled, A; Tal, S; Gelman, B; Cohen, D; Klement, E; Steinman, A				Aharonson-Raz, Karin; Lichter-Peled, Anat; Tal, Shlomit; Gelman, Boris; Cohen, Daniel; Klement, Eyal; Steinman, Amir			Spatial and Temporal Distribution of West Nile Virus in Horses in Israel (1997-2013) - from Endemic to Epidemics	PLOS ONE			English	Article							SOUTHERN FRANCE; CENTRAL-EUROPE; LINEAGE 2; INFECTION; OUTBREAK; DISEASE; FEVER; TRANSMISSION; ANIMALS; SPREAD	With the rapid global spread of West Nile virus (WNV) and the endemic state it has acquired in new geographical areas, we hereby bring a thorough serological investigation of WNV in horses in a longstanding endemic region, such as Israel. This study evaluates the environmental and demographic risk factors for WNV infection in horses and suggests possible factors associated with the transition from endemic to epidemic state. West Nile virus seroprevalence in horses in Israel was determined throughout a period of more than a decade, before (1997) and after (2002 and 2013) the massive West Nile fever outbreak in humans and horses in 2000. An increase in seroprevalence was observed, from 39% (113/290) in 1997 to 66.1% (547/827) in 2002 and 85.5% (153/179) in 2013, with persistent significantly higher seroprevalence in horses situated along the Great Rift Valley (GRV) area, the major birds' migration route in Israel. Demographic risk factors included age and breed of the horse. Significantly lower spring precipitation was observed during years with increased human incidence rate that occurred between 1997-2007. Hence, we suggest referring to Israel as two WNV distinct epidemiological regions; an endemic region along the birds' migration route (GRV) and the rest of the country which perhaps suffers from cyclic epidemics. In addition, weather conditions, such as periods of spring drought, might be associated with the transition from endemic state to epidemic state of WNV.	[Aharonson-Raz, Karin; Lichter-Peled, Anat; Klement, Eyal; Steinman, Amir] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Tal, Shlomit; Cohen, Daniel] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, IL-39040 Tel Aviv, Israel; [Gelman, Boris] Kimron Vet Inst, IL-50250 Bet Dagan, Israel	Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Kimron Veterinary Institute	Steinman, A (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel.	amirst@savion.huji.ac.il	Klement, Eyal/H-8388-2019	Klement, Eyal/0000-0002-2384-2345; Steinman, Amir/0000-0003-0984-6822; Cohen, Daniel/0000-0003-2664-2303				Ahmadnejad F, 2011, EPIDEMIOL INFECT, V139, P1587, DOI 10.1017/S0950268811000173; AKOV Y, 1966, B WORLD HEALTH ORGAN, V34, P901; Anis E, 2013, J INFECT; Armstrong PM, 2013, NEW ENGL J MED, V368, P1670, DOI 10.1056/NEJMp1213696; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Banet-Noach C, 2003, AVIAN PATHOL, V32, P489, DOI 10.1080/0307945031000154080; Banet-Noach C, 2003, VIRUS GENES, V26, P135, DOI 10.1023/A:1023431328933; Barzon L, 2013, INT J ENV RES PUB HE, V10, P4669, DOI 10.3390/ijerph10104669; Beasley DWC, 2013, ANTIVIR RES, V99, P1, DOI 10.1016/j.antiviral.2013.04.015; Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049; Cabre O, 2006, EMERG INFECT DIS, V12, P1958; Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080; Chowers MY, 2005, EUR J CLIN MICROBIOL, V24, P851, DOI 10.1007/s10096-005-0061-3; Cohen D, 1999, Public Health Rev, V27, P217; Cohen DI, 2006, INFECTION, V34, P208, DOI 10.1007/s15010-006-6604-4; Epp T, 2007, CAN VET J, V48, P1137; Jansen CC, 2013, INT J ENV RES PUB HE, V10, P3735, DOI 10.3390/ijerph10083735; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P15, DOI 10.1089/vbz.2006.0543; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Leshem Y, 1998, IBIS, V140, P41, DOI 10.1111/j.1474-919X.1998.tb04539.x; Lindsey NP, 2013, AM J TROP MED HYG; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Monath TP, 2013, VACCINE, V31, P5321, DOI 10.1016/j.vaccine.2013.09.029; Murgue B, 2001, EMERG INFECT DIS, V7, P692; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Murgue B, 2002, CURR TOP MICROBIOL, V267, P195; NIR Y, 1969, AM J TROP MED HYG, V18, P416, DOI 10.4269/ajtmh.1969.18.416; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Paz S, 2006, INT J ENVIRON HEAL R, V16, P1, DOI 10.1080/09603120500392400; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Pradier S, 2012, REV SCI TECH OIE, V31, P829; Reiter P, 2010, EUROSURVEILLANCE, V15, P4; Rios LMV, 2009, MED VET ENTOMOL, V23, P357, DOI 10.1111/j.1365-2915.2009.00821.x; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Sanchini A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002184; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; SCHMIDT JR, 1963, ANN TROP MED PARASIT, V57, P415, DOI 10.1080/00034983.1963.11686194; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Shaman J, 2010, INT J ENV RES PUB HE, V7, P494, DOI 10.3390/ijerph7020494; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Stanke Carla, 2013, PLOS CURR-TREE LIFE, V1, P13, DOI 10.1371/currents. dis.7a2cee9e980f91ad7697b570bcc4b004.; Steinman A, 2002, VET REC, V151, P47, DOI 10.1136/vr.151.2.47; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38; Weinberger M, 2001, EMERG INFECT DIS, V7, P686, DOI 10.3201/eid0704.010416; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; Ziegler U, 2013, VIRUSES-BASEL, V5, P2469, DOI 10.3390/v5102469; Ziegler U, 2013, INT J ENV RES PUB HE, V10, P3112, DOI 10.3390/ijerph10083112	53	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113149	10.1371/journal.pone.0113149	http://dx.doi.org/10.1371/journal.pone.0113149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402217	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700118
J	Al-Dwairi, A; Brown, AR; Pabona, JMP; Van, TH; Hamdan, H; Mercado, CP; Quick, CM; Wight, PA; Simmen, RCM; Simmen, FA				Al-Dwairi, Ahmed; Brown, Adam R.; Pabona, John Mark P.; Van, Trang H.; Hamdan, Hamdan; Mercado, Charles P.; Quick, Charles M.; Wight, Patricia A.; Simmen, Rosalia C. M.; Simmen, Frank A.			Enhanced Gastrointestinal Expression of Cytosolic Malic Enzyme (ME1) Induces Intestinal and Liver Lipogenic Gene Expression and Intestinal Cell Proliferation in Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID SYNTHASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ADIPOSE-TISSUE; ILEAL AUTOTRANSPLANTATION; LIPID-METABOLISM; SKELETAL-MUSCLE; X-RECEPTOR; OBESITY	The small intestine participates in lipid digestion, metabolism and transport. Cytosolic malic enzyme 1 (ME1) is an enzyme that generates NADPH used in fatty acid and cholesterol biosynthesis. Previous work has correlated liver and adipose ME1 expression with susceptibility to obesity and diabetes; however, the contributions of intestine-expressed ME1 to these conditions are unknown. We generated transgenic (Tg) mice expressing rat ME1 in the gastrointestinal epithelium under the control of the murine villin1 promoter/enhancer. Levels of intestinal ME1 protein (endogenous plus transgene) were greater in Tg than wildtype (WT) littermates. Effects of elevated intestinal ME1 on body weight, circulating insulin, select adipocytokines, blood glucose, and metabolism-related genes were examined. Male Tg mice fed a high-fat (HF) diet gained significantly more body weight than WT male littermates and had heavier livers. ME1-Tg mice had deeper intestinal and colon crypts, a greater intestinal 5-bromodeoxyuridine labeling index, and increased expression of intestinal lipogenic (Fasn, Srebf1) and cholesterol biosynthetic (Hmgcsr, Hmgcs1), genes. The livers from HF diet-fed Tg mice also exhibited an induction of cholesterol and lipogenic pathway genes and altered measures (Irs1, Irs2, Prkce) of insulin sensitivity. Results indicate that gastrointestinal ME1 via its influence on intestinal epithelial proliferation, and lipogenic and cholesterologenic genes may concomitantly impact signaling in liver to modify this tissue's metabolic state. Our work highlights a new mouse model to address the role of intestine-expressed ME1 in whole body metabolism, hepatomegaly, and crypt cell proliferation. Intestinal ME1 may thus constitute a therapeutic target to reduce obesity-associated pathologies.	[Al-Dwairi, Ahmed; Brown, Adam R.; Pabona, John Mark P.; Van, Trang H.; Hamdan, Hamdan; Mercado, Charles P.; Wight, Patricia A.; Simmen, Rosalia C. M.; Simmen, Frank A.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Quick, Charles M.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Brown, Adam R.; Simmen, Rosalia C. M.; Simmen, Frank A.] Univ Arkansas Med Sci, Interdisciplinary Biomed Sci Program, Little Rock, AR 72205 USA; [Simmen, Rosalia C. M.; Simmen, Frank A.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Simmen, FA (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	simmenfranka@uams.edu		Al-Dwairi, Ahmed/0000-0002-8909-9275; Simmen, Frank/0000-0001-6842-7754; Hamdan, Hamdan/0000-0002-2029-6772	NIH [R01CA136493, F31CA165665]; UAMS Translational Research Institute [NIH UL1TR000039]; Arkansas Biosciences Institute; UAMS College of Medicine Research Council; NATIONAL CANCER INSTITUTE [R01CA136493, F31CA165665] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS Translational Research Institute; Arkansas Biosciences Institute; UAMS College of Medicine Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by NIH grants R01CA136493 (FAS, RCMS) and F31CA165665 (ARB). The UAMS Translational Research Institute (NIH UL1TR000039) also supported this research through the authors' use of the Experimental Pathology, Transgenic Mouse, and DNA Sequencing Cores. This work also received support from the Arkansas Biosciences Institute and the UAMS College of Medicine Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Al-Dwairi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046716; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x; BUTS JP, 1990, EUR J CLIN INVEST, V20, P441, DOI 10.1111/j.1365-2362.1990.tb01882.x; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Dave B, 2005, CARCINOGENESIS, V26, P1793, DOI 10.1093/carcin/bgi131; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; Desmarchelier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-84; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Dunel-Erb S, 2001, COMP BIOCHEM PHYS A, V129, P933, DOI 10.1016/S1095-6433(01)00360-9; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Ershow Abby G, 2007, J Diabetes Sci Technol, V1, P95; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; GOODRIDGE AG, 1976, J BIOL CHEM, V251, P3027; Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124; Hayashi H, 2002, AM J PHYSIOL-GASTR L, V282, pG69, DOI 10.1152/ajpgi.2002.282.1.G69; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; HOYUMPA AM, 1975, AM J DIG DIS, V20, P1142, DOI 10.1007/BF01070758; Istvan ES, 2002, AM HEART J, V144, pS27, DOI 10.1067/mhj.2002.130300; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; Kim HS, 2011, CLIN CANCER RES, V17, P1713, DOI 10.1158/1078-0432.CCR-10-2081; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kondo H, 2006, AM J PHYSIOL-ENDOC M, V291, pE1092, DOI 10.1152/ajpendo.00583.2005; Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI 10.1053/j.gastro.2008.01.075; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Olivecrona T, 1997, P NUTR SOC, V56, P723, DOI 10.1079/PNS19970072; Pakarinen M, 1997, HEPATOLOGY, V25, P1315, DOI 10.1002/hep.510250602; Pakarinen MP, 1998, LIPIDS, V33, P267, DOI 10.1007/s11745-998-0205-y; Pakarinen MP, 1997, SURGERY, V122, P950, DOI 10.1016/S0039-6060(97)90337-8; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; POPPER DA, 1985, AM J PHYSIOL, V249, pG161, DOI 10.1152/ajpgi.1985.249.2.G161; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; RAUL F, 1988, GUT, V29, P1557, DOI 10.1136/gut.29.11.1557; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Sugita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020467; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Thulesen J, 1999, GUT, V45, P672, DOI 10.1136/gut.45.5.672; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Voss MD, 2005, DIABETOLOGIA, V48, P2622, DOI 10.1007/s00125-005-0025-2; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wei XC, 2012, CELL HOST MICROBE, V11, P140, DOI 10.1016/j.chom.2011.12.006; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Wouters K, 2010, FEBS LETT, V584, P1001, DOI 10.1016/j.febslet.2010.01.046; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zhang YJ, 2006, BIOORG MED CHEM LETT, V16, P525, DOI 10.1016/j.bmcl.2005.10.065; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	68	24	25	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113058	10.1371/journal.pone.0113058	http://dx.doi.org/10.1371/journal.pone.0113058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402228	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700104
J	Bruun, J; Bearden, IG				Bruun, Jesper; Bearden, Ian G.			Time Development in the Early History of Social Networks: Link Stabilization, Group Dynamics, and Segregation	PLOS ONE			English	Article							COMPLEX NETWORKS; INFORMATION	Studies of the time development of empirical networks usually investigate late stages where lasting connections have already stabilized. Empirical data on early network history are rare but needed for a better understanding of how social network topology develops in real life. Studying students who are beginning their studies at a university with no or few prior connections to each other offers a unique opportunity to investigate the formation and early development of link patterns and community structure in social networks. During a nine week introductory physics course, first year physics students were asked to identify those with whom they communicated about problem solving in physics during the preceding week. We use these students' self reports to produce time dependent student interaction networks. We investigate these networks to elucidate possible effects of different student attributes in early network formation. Changes in the weekly number of links show that while roughly half of all links change from week to week, students also reestablish a growing number of links as they progress through their first weeks of study. Using the Infomap community detection algorithm, we show that the networks exhibit community structure, and we use non-network student attributes, such as gender and end-of-course grade to characterize communities during their formation. Specifically, we develop a segregation measure and show that students structure themselves according to gender and pre-organized sections (in which students engage in problem solving and laboratory work), but not according to end-of-coure grade. Alluvial diagrams of consecutive weeks' communities show that while student movement between groups are erratic in the beginnning of their studies, they stabilize somewhat towards the end of the course. Taken together, the analyses imply that student interaction networks stabilize quickly and that students establish collaborations based on who is immediately available to them and on observable personal characteristics.	[Bruun, Jesper; Bearden, Ian G.] Univ Copenhagen, Dept Sci Educ, Copenhagen, Denmark; [Bearden, Ian G.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Niels Bohr Institute	Bruun, J (corresponding author), Univ Copenhagen, Dept Sci Educ, Copenhagen, Denmark.	jbruun@ind.ku.dk	Bearden, Ian G/M-4504-2014; Bearden, Ian G./AAH-6265-2019	Bearden, Ian G/0000-0003-2784-3094; Bearden, Ian G./0000-0003-2784-3094				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bruun J, 2012, THESIS U COPENHAGEN; Bruun J, 2012, PHYS REV SPECIAL TOP; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Carrington P. J., 2011, SAGE HDB SOCIAL NETW, DOI 10.4135/9781446294413; Carrington P. J., 2011, SAGE HDB SOCIAL NETW, P370; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Esquivel AV, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021025; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Kim BJ, 2005, EUR PHYS J B, V43, P369, DOI 10.1140/epjb/e2005-00065-y; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Lambiotte R, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056107; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Liben-Nowell D., 2005, ALGORITHMIC APPROACH; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Newman M.E.J., 2010, NETWORKS INTRO; Niven R, 2005, ARXIVCONDMAT0512017; Pustejovsky JE, 2009, SOC NETWORKS, V31, P221, DOI 10.1016/j.socnet.2009.06.001; RCore Team, 2020, R LANG ENV STAT COMP; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rosvall M, 2006, EUROPHYS LETT, V74, P1109, DOI 10.1209/epl/i2006-10064-2; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Wasserman S, 1994, SOCIAL NETWORK ANAL	32	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112775	10.1371/journal.pone.0112775	http://dx.doi.org/10.1371/journal.pone.0112775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402449	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700069
J	Stirling, J; Lekkas, I; Sweetman, A; Djuranovic, P; Guo, QM; Pauw, B; Granwehr, J; Levy, R; Moriarty, P				Stirling, Julian; Lekkas, Ioannis; Sweetman, Adam; Djuranovic, Predrag; Guo, Quanmin; Pauw, Brian; Granwehr, Josef; Levy, Raphael; Moriarty, Philip			Critical Assessment of the Evidence for Striped Nanoparticles	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; PROTECTED GOLD NANOPARTICLE; LIGAND-SHELL; MICROSCOPY; QUANTUM; DOMAINS; SURFACE; DISCRIMINATION; RESOLUTION; ARTIFACTS	There is now a significant body of literature which reports that stripes form in the ligand shell of suitably functionalised Au nanoparticles. This stripe morphology has been proposed to strongly affect the physicochemical and biochemical properties of the particles. We critique the published evidence for striped nanoparticles in detail, with a particular focus on the interpretation of scanning tunnelling microscopy (STM) data (as this is the only technique which ostensibly provides direct evidence for the presence of stripes). Through a combination of an exhaustive re-analysis of the original data, in addition to new experimental measurements of a simple control sample comprising entirely unfunctionalised particles, we show that all of the STM evidence for striped nanoparticles published to date can instead be explained by a combination of well-known instrumental artefacts, or by issues with data acquisition/analysis protocols. We also critically re-examine the evidence for the presence of ligand stripes which has been claimed to have been found from transmission electron microscopy, nuclear magnetic resonance spectroscopy, small angle neutron scattering experiments, and computer simulations. Although these data can indeed be interpreted in terms of stripe formation, we show that the reported results can alternatively be explained as arising from a combination of instrumental artefacts and inadequate data analysis techniques.	[Stirling, Julian; Lekkas, Ioannis; Sweetman, Adam; Moriarty, Philip] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Djuranovic, Predrag] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Guo, Quanmin] Univ Birmingham, Sch Phys & Astron, Birmingham, W Midlands, England; [Pauw, Brian] NIMS, ICYS, Tsukuba, Ibaraki, Japan; [Granwehr, Josef] Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England; [Levy, Raphael] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Nottingham; Massachusetts Institute of Technology (MIT); University of Birmingham; National Institute for Materials Science; University of Nottingham; University of Liverpool	Stirling, J (corresponding author), Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.	Julian.Stirling@nottingham.ac.uk	Pauw, Brian/C-8392-2013; Levy, Raphael/D-1474-2009	Pauw, Brian/0000-0002-8605-838X; Levy, Raphael/0000-0001-5728-0531; Moriarty, Philip/0000-0002-9926-9004; Sweetman, Adam/0000-0002-7716-9045; Stirling, Julian/0000-0002-8270-9237	Engineering and Physical Sciences Research Council (EPSRC) [EP/G007837/1, EP/H046143/1]; Leverhulme Trust [F00/114 BI]; ACRITAS FP7 initial training network; Biotechnology and Biological Sciences Research Council [BB/D020638/1]; Medical Research Council [MR/K015931/1]; Engineering and Physical Sciences Research Council [EP/H046143/1, EP/G007837/1] Funding Source: researchfish; BBSRC [BB/D020638/1] Funding Source: UKRI; EPSRC [EP/G007837/1, EP/H046143/1] Funding Source: UKRI; MRC [MR/K015931/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); ACRITAS FP7 initial training network; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JS thanks the Engineering and Physical Sciences Research Council (EPSRC) for the award of a University of Nottingham Doctoral Training Grant studentship. PM and AS thank the Engineering and Physical Sciences Research Council (EPSRC) and the Leverhulme Trust, respectively, for fellowship and grant awards [EP/G007837/1, F00/114 BI]. IL is grateful for the award of a Marie Curie fellowship funded by the ACRITAS FP7 initial training network (www.acritas.eu). RL thanks the Biotechnology and Biological Sciences Research Council (David Phillips Fellowship 2006-11, BB/D020638/1), the Engineering and Physical Sciences Research Council (EP/H046143/1) and the Medical Research Council, (MR/K015931/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiadis O, 2007, J PHYS CHEM C, V111, P6380, DOI 10.1021/jp067347u; Alloyeau D, 2009, ULTRAMICROSCOPY, V109, P788, DOI 10.1016/j.ultramic.2009.02.002; ATAMNY F, 1995, SURF SCI, V323, pL314, DOI 10.1016/0039-6028(94)00752-7; Barnard VE, 2004, MON NOT R ASTRON SOC, V352, P961, DOI 10.1111/j.1365-2966.2004.07985.x; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNIG G, 1983, PHYS REV LETT, V50, P120, DOI 10.1103/PhysRevLett.50.120; Biscarini F, 2013, COMMUNICATION; Biscarini F, 2013, LANGMUIR, V29, P13723, DOI 10.1021/la403546c; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; Cesbron Y, 2012, SMALL, V8, P3714, DOI 10.1002/smll.201001465; Chiutu C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268302; Cho ES, 2012, NAT MATER, V11, P978, DOI [10.1038/NMAT3406, 10.1038/nmat3406]; CLEMMER CR, 1991, SCIENCE, V251, P640, DOI 10.1126/science.1992517; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; de Oteyza DG, 2013, SCIENCE, V340, P1434, DOI 10.1126/science.1238187; DIGGLE PJ, 1976, BIOMETRICS, V32, P659, DOI 10.2307/2529754; Duchesne L, 2008, CHEMBIOCHEM, V9, P2127, DOI 10.1002/cbic.200800326; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Ernst R. R., 1987, INT SERIES MONOGRAPH; Filippov SK, 2013, BIOMACROMOLECULES, V14, P4061, DOI 10.1021/bm401186z; Fischer D, 2003, LANGMUIR, V19, P3567, DOI 10.1021/la034013c; Foster KR, 2009, P ROY SOC B-BIOL SCI, V276, P31, DOI 10.1098/rspb.2008.0981; Frenkel D, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13010-8; Gackenheimer C, 2006, ULTRAMICROSCOPY, V106, P389, DOI 10.1016/j.ultramic.2005.11.006; Gao RX, 2011, WAVELETS: THEORY AND APPLICATIONS FOR MANUFACTURING, P17, DOI 10.1007/978-1-4419-1545-0_2; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Groot RD, 1997, J CHEM PHYS, V107, P4423, DOI 10.1063/1.474784; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Harris R., 1986, NUCL MAGNETIC RESONA; Henz BJ, 2007, PROCEEDINGS OF THE HPCMP USERS GROUP CONFERENCE 2007, P185; Herz M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045301; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hu Y., 2009, J SCANNING PROBE MIC, V4, P24; Hyvrinen A, 2009, NATURAL IMAGE STAT P, P114; Ionita P, 2008, ANAL CHEM, V80, P95, DOI 10.1021/ac071266s; Jackson AM, 2006, J AM CHEM SOC, V128, P11135, DOI 10.1021/ja061545h; Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116; Jadzinsky PD, 2007, SCIENCE, V318, P430, DOI 10.1126/science.1148624; Kim H, 2012, ADV MATER, V24, P3857, DOI 10.1002/adma.201200926; Lee HJ, 1999, SCIENCE, V286, P1719, DOI 10.1126/science.286.5445.1719; Lenihan TG, 1995, THIN SOLID FILMS, V270, P356, DOI 10.1016/0040-6090(95)06747-7; Li FS, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4806969; Liu X, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2155; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Maksymovych P, 2010, PROG SURF SCI, V85, P206, DOI 10.1016/j.progsurf.2010.05.001; Martin CP, 2004, NANO LETT, V4, P2389, DOI 10.1021/nl048536w; Mayoral A, 2010, NANOSCALE, V2, P335, DOI 10.1039/b9nr00287a; Mezour MA, 2014, ACS NANO; Moglianetti M, 2013, CHEM SCI; Moon CR, 2008, SCIENCE, V319, P782, DOI 10.1126/science.1151490; Moon CR, 2009, NAT NANOTECHNOL, V4, P167, DOI [10.1038/NNANO.2008.415, 10.1038/nnano.2008.415]; Moriarty P, 2013, NANOSCIENCE, VI; Moriarty PJ, 2010, SURF SCI REP, V65, P175, DOI 10.1016/j.surfrep.2010.08.001; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Muller DJ, 2011, TRENDS CELL BIOL, V21, P461, DOI 10.1016/j.tcb.2011.04.008; Necas D, 2011, CENTRAL EUROPEAN J P, V10; Nesheva D, 2000, SOLID STATE COMMUN, V114, P511, DOI 10.1016/S0038-1098(00)00100-9; O'Shea JN, 2003, J CHEM PHYS, V119, P13046, DOI 10.1063/1.1628225; Pauw BR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/38/383201; Polking MJ, 2012, NAT MATER, V11, P700, DOI [10.1038/nmat3371, 10.1038/NMAT3371]; Prestat E, 2013, SURF SCI, V609, P195, DOI 10.1016/j.susc.2012.12.014; Ong QK, 2013, ACS NANO, V7, P8529, DOI 10.1021/nn402414b; Rosalie J, 2014, ACTA MAT, V66; ROWLINGSON BS, 1993, COMPUT GEOSCI, V19, P627, DOI 10.1016/0098-3004(93)90099-Q; Schull G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.206803; SCHWARZ UD, 1994, J MICROSC-OXFORD, V173, P183, DOI 10.1111/j.1365-2818.1994.tb03441.x; Shermer M, 2008, SCI AM, V299, P48, DOI 10.1038/scientificamerican1208-48; Shevade AV, 2001, LANGMUIR, V17, P7566, DOI 10.1021/la0108151; Singh C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226106; Song YJ, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3520482; Stellaci F, 2013, COMMUNICATION; Stern A, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/16/164203; Stirling J, 2014, BEILSTEIN J NANOTECH, V5, P337, DOI 10.3762/bjnano.5.38; Stirling J, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4827076; Swart I, 2011, CHEM COMMUN, V47, P9011, DOI 10.1039/c1cc11404b; Sweetman AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4931; Sweetman A, 2012, BEILSTEIN J NANOTECH, V3, P25, DOI 10.3762/bjnano.3.3; Taylor MDR, 2000, APPL PHYS LETT, V77, P1144, DOI 10.1063/1.1289797; Tielens F, 2009, LANGMUIR, V25, P9980, DOI 10.1021/la901127g; Toomes RL, 2003, SURF SCI, V522, pL9, DOI 10.1016/S0039-6028(02)02355-5; Uzun O, 2008, CHEM COMMUN, P196, DOI 10.1039/b713143g; Varga P, 1999, APPL SURF SCI, V141, P287, DOI 10.1016/S0169-4332(98)00514-5; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; XU YS, 1994, IEEE T IMAGE PROCESS, V3, P747, DOI 10.1109/83.336245; Yu M, 2012, SMALL, V8, P3720, DOI 10.1002/smll.201202322; Zhachuk R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.077401; Zhang J, 2013, SCIENCE, V342, P611, DOI 10.1126/science.1242603	90	33	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e108482	10.1371/journal.pone.0108482	http://dx.doi.org/10.1371/journal.pone.0108482			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402426	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700001
J	Marjoram, RJ; Li, ZZ; He, L; Tollefsen, DM; Kunicki, TJ; Dickeson, SK; Santoro, SA; Zutter, MM				Marjoram, Robin J.; Li, Zhengzhi; He, Li; Tollefsen, Douglas M.; Kunicki, Thomas J.; Dickeson, S. Kent; Santoro, Samuel A.; Zutter, Mary M.			alpha 2 beta 1 Integrin, GPVI Receptor, and Common FcR gamma Chain on Mouse Platelets Mediate Distinct Responses to Collagen in Models of Thrombosis	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; VON-WILLEBRAND-FACTOR; GLYCOPROTEIN-VI; IN-VIVO; ARTERIAL THROMBOSIS; RHO GTPASES; MICE; ACTIVATION; DEFICIENT; ADHESION	Objective: Platelets express the alpha 2 beta 1 integrin and the glycoprotein VI (GPVI)/FcR gamma complex, both collagen receptors. Understanding platelet-collagen receptor function has been enhanced through use of genetically modified mouse models. Previous studies of GPVI/FcR gamma-mediated collagen-induced platelet activation were perfomed with mice in which the FcR gamma subunit was genetically deleted ( FcR gamma(-/-)) or the complex was depleted. The development of alpha 2 beta 1(-/-) and GPVI(-/-) mice permits side-by-side comparison to address contributions of these collagen receptors in vivo and in vitro. Approach and Results: To understand the different roles played by the a2b1 integrin, the GPVI receptor or FcR gamma subunit in collagen-stimulated hemostasis and thrombosis, we compared alpha 2 beta 1(-/-), FcR gamma(-/-), and GPVI(-/-) mice in models of endothelial injury and intravascular thrombosis in vivo and their platelets in collagen-stimulated activation in vitro. We demonstrate that both the alpha 2 beta 1 integrin and the GPVI receptor, but not the FcR gamma subunit influence carotid artery occlusion in vivo. In contrast, the GPVI receptor and the FcR gamma chain, but not the alpha 2 beta 1 integrin, play similar roles in intravascular thrombosis in response to soluble Type I collagen. FcR gamma(-/-) platelets showed less attenuation of tyrosine phosphorylation of several proteins including RhoGDI when compared to GPVI(-/-) and wild type platelets. The difference between FcR gamma(-/-) and GPVI(-/-) platelet phosphotyrosine levels correlated with the in vivo thrombosis findings. Conclusion: Our data demonstrate that genetic deletion of GPVI receptor, FcR gamma chain, or the alpha 2 beta 1 integrin changes the thrombotic potentials of these platelets to collagen dependent on the stimulus mechanism. The data suggest that the FcR gamma chain may provide a dominant negative effect through modulating signaling pathways in platelets involving several tyrosine phosphorylated proteins such as RhoGDI. In addition, these findings suggest a more complex signaling network downstream of the platelet collagen receptors than previously appreciated.	[Marjoram, Robin J.; Li, Zhengzhi; Dickeson, S. Kent; Santoro, Samuel A.; Zutter, Mary M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Kunicki, Thomas J.] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [He, Li; Tollefsen, Douglas M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Vanderbilt University; Childrens Hospital of Orange County; Washington University (WUSTL)	Zutter, MM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	mary.zutter@vanderbilt.edu			NIH [R01 HL086904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant R01 HL086904. The funders had no role in study design, data collection and analysis.	Aslan JE, 2013, J THROMB HAEMOST, V11, P35, DOI 10.1111/jth.12051; Bergmeier W, 2013, CURR OPIN HEMATOL, V20, P445, DOI 10.1097/MOH.0b013e3283642267; Berlanga O, 2002, EUR J BIOCHEM, V269, P2951, DOI 10.1046/j.1432-1033.2002.02969.x; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Boylan B, 2004, BLOOD, V104, P1350, DOI 10.1182/blood-2004-03-0896; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; Cheli Y, 2008, BLOOD, V111, P1266, DOI 10.1182/blood-2007-09-111369; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dubois C, 2006, BLOOD, V107, P3902, DOI 10.1182/blood-2005-09-3687; Dumont B, 2009, BLOOD, V114, P1900, DOI 10.1182/blood-2009-03-213504; FUJIOKA H, 1990, BIOCHEM BIOPH RES CO, V168, P1244, DOI 10.1016/0006-291X(90)91162-L; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Hermans C, 2009, J THROMB HAEMOST, V7, P1356, DOI 10.1111/j.1538-7836.2009.03520.x; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Kehrel B, 1998, BLOOD, V91, P491; Konstantinides S, 2006, J THROMB HAEMOST, V4, P2014, DOI 10.1111/j.1538-7836.2006.02086.x; KUNICKI TJ, 1993, BLOOD, V82, P2693; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Lockyer S, 2006, THROMB RES, V118, P371, DOI 10.1016/j.thromres.2005.08.001; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Marjoram RJ, 2009, J BIOL CHEM, V284, P34640, DOI 10.1074/jbc.M109.020990; Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490; Morancho B, 2012, ONCOGENE; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2001, J EXP MED, V193, P459, DOI 10.1084/jem.193.4.459; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nonne C, 2005, ARTERIOSCL THROM VAS, V25, P1293, DOI 10.1161/01.ATV.0000163184.02484.69; O'Connor MN, 2006, J BIOL CHEM, V281, P33505, DOI 10.1074/jbc.M606480200; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; SANIABADI AR, 1995, THROMB HAEMOSTASIS, V73, P868; Shida Y, 2014, BLOOD, V124, P1799, DOI 10.1182/blood-2013-09-521484; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; UENO H, 1993, J BIOL CHEM, V268, P22814; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106	45	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e114035	10.1371/journal.pone.0114035	http://dx.doi.org/10.1371/journal.pone.0114035			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415203	Green Published, gold			2022-12-27	WOS:000346906600086
J	Carlsen, M; Koehl, P; Rogen, P				Carlsen, Martin; Koehl, Patrice; Rogen, Peter			On the Importance of the Distance Measures Used to Train and Test Knowledge-Based Potentials for Proteins	PLOS ONE			English	Article							MODEL QUALITY PREDICTIONS; ENERGY FUNCTIONS; DECOY SET; STRUCTURE REFINEMENT; TERTIARY STRUCTURES; SCORING FUNCTIONS; SINGLE-PARAMETER; FORCE-FIELD; DYNAMICS; NETWORK	Knowledge-based potentials are energy functions derived from the analysis of databases of protein structures and sequences. They can be divided into two classes. Potentials from the first class are based on a direct conversion of the distributions of some geometric properties observed in native protein structures into energy values, while potentials from the second class are trained to mimic quantitatively the geometric differences between incorrectly folded models and native structures. In this paper, we focus on the relationship between energy and geometry when training the second class of knowledge-based potentials. We assume that the difference in energy between a decoy structure and the corresponding native structure is linearly related to the distance between the two structures. We trained two distance-based knowledge-based potentials accordingly, one based on all inter-residue distances (PPD), while the other had the set of all distances filtered to reflect consistency in an ensemble of decoys (PPE). We tested four types of metric to characterize the distance between the decoy and the native structure, two based on extrinsic geometry (RMSD and GTD-TS*), and two based on intrinsic geometry (Q* and MT). The corresponding eight potentials were tested on a large collection of decoy sets. We found that it is usually better to train a potential using an intrinsic distance measure. We also found that PPE outperforms PPD, emphasizing the benefits of capturing consistent information in an ensemble. The relevance of these results for the design of knowledge-based potentials is discussed.	[Carlsen, Martin; Rogen, Peter] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Technical University of Denmark; University of California System; University of California Davis; University of California System; University of California Davis	Rogen, P (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark.	prog@dtu.dk		Rogen, Peter/0000-0002-3588-8092	Technical University of Denmark; NIH	Technical University of Denmark; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The first author is financed by internal funding (public, no grant number) from the Technical University of Denmark. PK acknowledges support from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amautova Y, 2008, BIOPHYS J, V95, P2434; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; BOHR J, 1993, J MOL BIOL, V231, P861, DOI 10.1006/jmbi.1993.1332; Chopra G, 2010, PROTEINS, V78, P2668, DOI 10.1002/prot.22781; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Cozzetto D, 2009, PROTEINS, V77, P157, DOI 10.1002/prot.22534; de Boor C., 2001, APPL MATH SCI, V27; Eickholt J, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-38; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Handl J, 2009, BIOINFORMATICS, V25, P1271, DOI 10.1093/bioinformatics/btp150; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huang E, 1999, PACIFIC S BIOCOMPUTI, V4, P505; Kaindl K, 1997, ACTA CRYSTALLOGR A, V53, P809, DOI 10.1107/S0108767397010325; Keasar C, 2003, J MOL BIOL, V329, P159, DOI 10.1016/S0022-2836(03)00323-1; Kryshtafovych A, 2014, PROTEINS, V82, P112, DOI 10.1002/prot.24347; Kryshtafovych A, 2011, PROTEINS, V79, P91, DOI 10.1002/prot.23180; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MCLACHLAN AD, 1979, J MOL BIOL, V128, P49, DOI 10.1016/0022-2836(79)90308-5; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Park B, 1996, J MOL BIOL, V258, P367, DOI 10.1006/jmbi.1996.0256; Perez A, 2012, J CHEM THEORY COMPUT, V8, P3985, DOI 10.1021/ct300148f; Rajgaria R, 2006, PROTEINS, V65, P726, DOI 10.1002/prot.21149; Rogen P, 2013, PROTEINS, V81, P841, DOI 10.1002/prot.24242; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Samudrala R, 2000, PROTEIN SCI, V9, P1399, DOI 10.1110/ps.9.7.1399; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Summa CM, 2007, P NATL ACAD SCI USA, V104, P3177, DOI 10.1073/pnas.0611593104; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; TODA M, 1967, J PHYS SOC JPN, V22, P431, DOI 10.1143/JPSJ.22.431; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Xia Y, 2000, J MOL BIOL, V300, P171, DOI 10.1006/jmbi.2000.3835; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhu J, 2008, PROTEINS, V72, P1171, DOI 10.1002/prot.22005	50	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e109335	10.1371/journal.pone.0109335	http://dx.doi.org/10.1371/journal.pone.0109335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411785	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000001
J	Muls, N; Dang, HA; Sindic, CJM; van Pesch, V				Muls, Nathalie; Dang, Hong Anh; Sindic, Christian J. M.; van Pesch, Vincent			Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE SUPPRESSION; CENTRAL MEMORY; TH17 CELLS; FTY720; IL-22; EXPRESSION; EFFECTOR; DIFFERENTIATION	Background: Multiple sclerosis (MS) likely results from an imbalance between regulatory and inflammatory immune processes. CD39 is an ectoenzyme that cleaves ATP to AMP and has been suggested as a novel regulatory T cells (Treg) marker. As ATP has numerous proinflammatory effects, its degradation by CD39 has anti-inflammatory influence. The purpose of this study was to explore regulatory and inflammatory mechanisms activated in fingolimod treated MS patients. Methods and Findings: Peripheral blood mononuclear cells (PBMCs) were isolated from relapsing-remitting MS patients before starting fingolimod and three months after therapy start. mRNA expression was assessed in ex vivo PBMCs. The proportions of CD8, B cells, CD4 and CD39-expressing cells were analysed by flow cytometry. Treg proportion was quantified by flow cytometry and methylation-specific qPCR. Fingolimod treatment increased mRNA levels of CD39, AHR and CYP1B1 but decreased mRNA expression of IL-17, IL-22 and FOXP3 mRNA in PBMCs. B cells, CD4(+) cells and Treg proportions were significantly reduced by this treatment, but remaining CD4(+) T cells were enriched in FOXP3(+) cells and in CD39-expressing Tregs. Conclusions: In addition to the decrease in circulating CD4(+) T cells and CD19(+) B cells, our findings highlight additional immunoregulatory mechanisms induced by fingolimod.	[Muls, Nathalie; Dang, Hong Anh; Sindic, Christian J. M.; van Pesch, Vincent] Catholic Univ Louvain, Inst Neurosci, Neurochem Unit, B-1200 Brussels, Belgium; [Sindic, Christian J. M.; van Pesch, Vincent] Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	van Pesch, V (corresponding author), Catholic Univ Louvain, Inst Neurosci, Neurochem Unit, B-1200 Brussels, Belgium.	vincent.vanpesch@uclouvain.be	van Pesch, Vincent/AAK-9506-2020	van Pesch, Vincent/0000-0003-2885-9004	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Bayer educational grants; Belgian Charcot Foundation; Walloon Region "Desordres Inflammatoires dans les Affections Neurologiques" project	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Bayer educational grants(Fonds de la Recherche Scientifique - FNRS); Belgian Charcot Foundation; Walloon Region "Desordres Inflammatoires dans les Affections Neurologiques" project	This work was financially supported by the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Bayer educational grants (www.fnrs.be/), the Belgian Charcot Foundation (www.fondation-charcot.org/) and the Walloon Region "Desordres Inflammatoires dans les Affections Neurologiques" project (http://recherche-technologie.wallonie.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2012, NEUR M ABSTR; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kimss MG, 2011, NEPHROL DIAL TRANSPL, V26, P111; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; Miyazaki Y, 2014, CLIN IMMUNOL, V151, P127, DOI 10.1016/j.clim.2014.02.001; Muls N, 2012, J NEUROIMMUNOL, V243, P73, DOI 10.1016/j.jneuroim.2011.12.010; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Serpero LD, 2013, J NEUROIMMUNE PHARM, V8, P1106, DOI 10.1007/s11481-013-9465-5; Sun Y, 2011, AM J REPROD IMMUNOL, V66, P349, DOI 10.1111/j.1600-0897.2011.01010.x; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wolf AM, 2009, J IMMUNOL, V183, P3751, DOI 10.4049/jimmunol.0901011; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503	32	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113025	10.1371/journal.pone.0113025	http://dx.doi.org/10.1371/journal.pone.0113025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411844	Green Published, Green Submitted, gold			2022-12-27	WOS:000345253000020
J	Ortega, JD; Beck, ON; Roby, JM; Turney, AL; Kram, R				Ortega, Justus D.; Beck, Owen N.; Roby, Jaclyn M.; Turney, Aria L.; Kram, Rodger			Running for Exercise Mitigates Age-Related Deterioration of Walking Economy	PLOS ONE			English	Article							METABOLIC COST; ENERGY-COST; MECHANICAL WORK; SPEED; GAIT; HABITUATION	Introduction: Impaired walking performance is a key predictor of morbidity among older adults. A distinctive characteristic of impaired walking performance among older adults is a greater metabolic cost (worse economy) compared to young adults. However, older adults who consistently run have been shown to retain a similar running economy as young runners. Unfortunately, those running studies did not measure the metabolic cost of walking. Thus, it is unclear if running exercise can prevent the deterioration of walking economy. Purpose: To determine if and how regular walking vs. running exercise affects the economy of locomotion in older adults. Methods: 15 older adults (69 +/- 63 years) who walk >= 30 min, 3x/week for exercise, "walkers'' and 15 older adults (69 +/- 65 years) who run >= 30 min, 3x/week, "runners'' walked on a force-instrumented treadmill at three speeds (0.75, 1.25, and 1.75 m/s). We determined walking economy using expired gas analysis and walking mechanics via ground reaction forces during the last 2 minutes of each 5 minute trial. We compared walking economy between the two groups and to non-aerobically trained young and older adults from a prior study. Results: Older runners had a 7-10% better walking economy than older walkers over the range of speeds tested (p = .016) and had walking economy similar to young sedentary adults over a similar range of speeds (p = .237). We found no substantial biomechanical differences between older walkers and runners. In contrast to older runners, older walkers had similar walking economy as older sedentary adults (p = .461) and, similar to 26% worse walking economy than young adults (p < .0001). Conclusion: Running mitigates the age-related deterioration of walking economy whereas walking for exercise appears to have minimal effect on the age-related deterioration in walking economy.	[Ortega, Justus D.; Beck, Owen N.; Turney, Aria L.] Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA; [Beck, Owen N.; Roby, Jaclyn M.; Kram, Rodger] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	California State University System; California State Polytechnic University, Humboldt; University of Colorado System; University of Colorado Boulder	Ortega, JD (corresponding author), Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA.	Justus.Ortega@humboldt.edu		Ortega, Justus/0000-0002-9931-5605	California State University Program for Education and Research in Biotechnology New Investigator [HM531]; National Institutes of Health Clinical and Translational Science Award [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER	California State University Program for Education and Research in Biotechnology New Investigator; National Institutes of Health Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support was provided by the California State University Program for Education and Research in Biotechnology New Investigator [Grant #: HM531] (http://www.calstate.edu/csuperb/grants/). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by the National Institutes of Health Clinical and Translational Science Award [Grant #: UL1 TR000154] (http://www.ncats.nih.gov/research/cts/ctsa/funding/funding.html). This funder provided the facility where the data was collected.	Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Brisswalter J, 2014, EUR J APPL PHYSL, P1; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Conley KE, 2007, EXERC SPORT SCI REV, V35, P43; Finley JM, 2012, EXP BRAIN RES, V217, P53, DOI 10.1007/s00221-011-2972-9; Franz JR, 2013, GAIT POSTURE, V37, P378, DOI 10.1016/j.gaitpost.2012.08.004; Franz JR, 2012, J BIOMECH, V45, P257, DOI 10.1016/j.jbiomech.2011.10.034; Gottschall JS, 2005, J APPL PHYSIOL, V99, P23, DOI 10.1152/japplphysiol.01190.2004; Hakkinen K, 1998, J APPL PHYSIOL, V84, P1341, DOI 10.1152/jappl.1998.84.4.1341; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Malatesta D, 2003, J APPL PHYSIOL, V95, P2248, DOI 10.1152/japplphysiol.01106.2002; Malatesta D, 2010, EXP GERONTOL, V45, P427, DOI 10.1016/j.exger.2010.03.009; MARTIN PE, 1992, J APPL PHYSIOL, V73, P200; Mian OS, 2007, EUR J APPL PHYSIOL, V100, P499, DOI 10.1007/s00421-006-0141-9; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Monaco V, 2010, J NEUROPHYSIOL, V104, P2092, DOI 10.1152/jn.00525.2009; MURRAY MP, 1969, J GERONTOL, V24, P169, DOI 10.1093/geronj/24.2.169; Ortega JD, 2014, J ELECTROMYOGR KINES, V0; Ortega JD, 2007, J APPL PHYSIOL, V102, P2266, DOI 10.1152/japplphysiol.00583.2006; Ortega JD, 2008, J BIOMECH, V41, P3303, DOI 10.1016/j.jbiomech.2008.06.039; Peiffer JJ, 2008, J STRENGTH COND RES, V22, P1434, DOI 10.1519/JSC.0b013e318181a0d2; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Quinn TJ, 2011, J STRENGTH COND RES, V25, P2971, DOI 10.1519/JSC.0b013e318212dd0e; Sacchetti M, 2010, MED SCI SPORT EXER, V42, P2128, DOI 10.1249/MSS.0b013e3181e05526; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Thomas EE, 2007, J APPL PHYSIOL, V103, P1598, DOI 10.1152/japplphysiol.00399.2007; Trappe SW, 1996, J APPL PHYSIOL, V80, P285, DOI 10.1152/jappl.1996.80.1.285; Van de Putte M, 2006, BIO-MED MATER ENG, V16, P43; WALL JC, 1981, ERGONOMICS, V24, P531, DOI 10.1080/00140138108924874; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208	30	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113471	10.1371/journal.pone.0113471	http://dx.doi.org/10.1371/journal.pone.0113471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25411850	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000056
J	Fanslow, DA; Wirt, SE; Barker, JC; Connelly, JP; Porteus, MH; Dann, CT				Fanslow, Danielle A.; Wirt, Stacey E.; Barker, Jenny C.; Connelly, Jon P.; Porteus, Matthew H.; Dann, Christina Tenenhaus			Genome Editing in Mouse Spermatogonial Stem/Progenitor Cells Using Engineered Nucleases	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; GERMLINE STEM-CELLS; HOMOLOGOUS RECOMBINATION; GENE CORRECTION; DIRECT TRANSDIFFERENTIATION; PLURIPOTENT; CULTURE; TESTIS	Editing the genome to create specific sequence modifications is a powerful way to study gene function and promises future applicability to gene therapy. Creation of precise modifications requires homologous recombination, a very rare event in most cell types that can be stimulated by introducing a double strand break near the target sequence. One method to create a double strand break in a particular sequence is with a custom designed nuclease. We used engineered nucleases to stimulate homologous recombination to correct a mutant gene in mouse "GS'' (germline stem) cells, testicular derived cell cultures containing spermatogonial stem cells and progenitor cells. We demonstrated that gene-corrected cells maintained several properties of spermatogonial stem/progenitor cells including the ability to colonize following testicular transplantation. This proof of concept for genome editing in GS cells impacts both cell therapy and basic research given the potential for GS cells to be propagated in vitro, contribute to the germline in vivo following testicular transplantation or become reprogrammed to pluripotency in vitro.	[Fanslow, Danielle A.; Dann, Christina Tenenhaus] Indiana Univ, Dept Chem, Bloomington, IN USA; [Wirt, Stacey E.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Barker, Jenny C.; Connelly, Jon P.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA	Indiana University System; Indiana University Bloomington; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Porteus, MH (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	mporteus@stanford.edu; ctdann@indiana.edu		Barker, Jenny/0000-0002-1517-5124	Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R21HD062853]; University of Texas Southwestern Medical Scientist Training Program; PhRMA Foundation Paul Calabresi Medical Student Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071081] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062853] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Texas Southwestern Medical Scientist Training Program; PhRMA Foundation Paul Calabresi Medical Student Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	D. F. and C. T. D. were supported by a grant from Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R21HD062853), and J. B. was funded by the University of Texas Southwestern Medical Scientist Training Program and the PhRMA Foundation Paul Calabresi Medical Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Brenneman M, 1996, P NATL ACAD SCI USA, V93, P3608, DOI 10.1073/pnas.93.8.3608; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Chikhovskaya JV, 2012, HUM REPROD, V27, P210, DOI 10.1093/humrep/der383; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Dann Christina Tenenhaus, 2013, Methods Mol Biol, V927, P503; Dann CT, 2008, STEM CELLS; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Falciatori Ilaria, 2008, V450, P181, DOI 10.1007/978-1-60327-214-8_13; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Heim C, 2011, REPROD TOXICOL, V31, P454, DOI 10.1016/j.reprotox.2010.12.056; Heim CN, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101717; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Iwamori N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038914; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P236, DOI 10.1095/biolreprod.104.035659; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Lim JJ, 2010, CELL PROLIFERAT, V43, P405, DOI 10.1111/j.1365-2184.2010.00691.x; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Oatley JM, 2008, ANN REV CELL DEV BIO; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Quintarelli C, 2007, BLOOD, V110, P2793, DOI 10.1182/blood-2007-02-072843; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Simon L, 2009, STEM CELLS, V27, P1666, DOI 10.1002/stem.93; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang ZZ, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-67; Zheng Y, 2014, HUM REPROD IN PRESS; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	53	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112652	10.1371/journal.pone.0112652	http://dx.doi.org/10.1371/journal.pone.0112652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409432	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200031
J	Gandica, Y; Schwarz, T; Oliveira, O; Travasso, RDM				Gandica, Yerali; Schwarz, Tobias; Oliveira, Orlando; Travasso, Rui D. M.			Hypoxia in Vascular Networks: A Complex System Approach to Unravel the Diabetic Paradox	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; RETINAL BARRIER BREAKDOWN; ENDOTHELIAL GROWTH-FACTOR; FRACTAL ANALYSIS; BLOOD; ANGIOGENESIS; TRANSPORT; MODEL; ANGIOPOIETIN-2; QUANTIFICATION	In this work we model the extent of hypoxia in the diabetic retina as a function of the area affected by vessel disruption. We find two regimes that differ on the ratio between the area of disrupted vasculature and the area of tissue in hypoxia. In the first regime the hypoxia is localized in the vicinity of the vascular disruption, while in the second regime there is a generalized hypoxia in the affected tissue. The transition between these two regimes occurs when the tissue area affected by individual sites of vessel damage is on the order of the square of the characteristic irrigation length in the tissue (the maximum distance that an irrigated point in the tissue is from an existing vessel). We observe that very high levels of hypoxia are correlated with the rupture of larger vessels in the retina, and with smaller radii of individual sites of vessel damage. Based on this property of vascular networks, we propose a novel mechanism for the transition between the nonproliferative and the proliferative stages in diabetic retinopathy.	[Gandica, Yerali; Schwarz, Tobias; Oliveira, Orlando; Travasso, Rui D. M.] Univ Coimbra, Dept Phys, Ctr Computat Phys, Coimbra, Portugal; [Schwarz, Tobias] Heinz Brandt Schule, Berlin, Germany; [Travasso, Rui D. M.] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci, Ctr Ophthalmol & Vis Sci COCV, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Travasso, RDM (corresponding author), Univ Coimbra, Dept Phys, Ctr Computat Phys, Coimbra, Portugal.	rui@teor.fis.uc.pt	Travasso, Rui/B-8342-2018; GANDICA, YERALI/M-6261-2013; Oliveira, Orlando/M-3792-2013	Travasso, Rui/0000-0001-6078-0721; GANDICA, YERALI/0000-0002-6262-1801; Oliveira, Orlando/0000-0001-8266-3796	Fundos FEDER through Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e Tecnologia [FCOMP-01-0124-FEDER-015708, PEst-OE/FIS/UI0405/2014]; Fundacao para a Ciencia e Tecnologia through the Investigador FCT program	Fundos FEDER through Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia through the Investigador FCT program(Portuguese Foundation for Science and Technology)	Y.G., T.S. and R.D.M.T. acknowledge financial support from Fundos FEDER through Programa Operacional Factores de Competitividade - COMPETE and by Fundacao para a Ciencia e Tecnologia, through project FCOMP-01-0124-FEDER-015708. The authors acknowledge support from Fundacao para a Ciencia e Tecnologia through project PEst-OE/FIS/UI0405/2014. R.D.M.T. acknowledges financial support from Fundacao para a Ciencia e Tecnologia through the Investigador FCT program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2012, J MED SYST, V36, P2011, DOI 10.1007/s10916-011-9663-8; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Avakian A, 2002, CURR EYE RES, V24, P274, DOI 10.1076/ceyr.24.4.274.8411; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bearse MA, 2006, PROG RETIN EYE RES, V25, P425, DOI 10.1016/j.preteyeres.2006.07.001; Bento CF, 2010, EXP PHYSIOL, V95, P955, DOI 10.1113/expphysiol.2010.053561; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Costa C, 2011, VASCULOGENESIS ANGIO, P107; Dall'Asta L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/P04006; DAXER A, 1993, GRAEF ARCH CLIN EXP, V231, P681, DOI 10.1007/BF00919281; Fadini GP, 2006, DIABETES CARE, V29, P714, DOI 10.2337/diacare.29.03.06.dc05-1834; Flores J, 2010, J THEOR BIOL, V265, P599, DOI 10.1016/j.jtbi.2010.06.003; Flores J, 2013, J THEOR BIOL, V317, P257, DOI 10.1016/j.jtbi.2012.10.005; Formaggia Luca, 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P273, DOI 10.1080/10255840600857767; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gastner MT, 2006, EUR PHYS J B, V49, P247, DOI 10.1140/epjb/e2006-00046-8; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Guibert R, 2010, TRANSPORT POROUS MED, V83, P171, DOI 10.1007/s11242-009-9492-0; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hellums JD, 1996, ANN BIOMED ENG, V24, P1, DOI 10.1007/BF02770991; Herman AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022973; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Milde F, 2013, INTEGR BIOL-UK, V5, P1426, DOI 10.1039/c3ib40085a; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Paul G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056130; Paul G, 2004, EUR PHYS J B, V38, P187, DOI 10.1140/epjb/e2004-00112-3; Pittman R.N., 2011, REGULATION TISSUE OX; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Reiter C, 2005, DIABETES, V54, pA222; Secomb TW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002983; Secomb TW, 2004, ANN BIOMED ENG, V32, P1519, DOI 10.1114/B:ABME.0000049036.08817.44; Shih AY, 2012, NAT NEUROSCI, V16, P55; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sivakumar R, 2005, J BIOMED BIOTECHNOL, P20, DOI 10.1155/JBB.2005.20; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Travasso RDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019989; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a; VINORES SA, 1990, J HISTOCHEM CYTOCHEM, V38, P1341, DOI 10.1177/38.9.2117624; VINORES SA, 1989, AM J PATHOL, V134, P231; West GB, 2000, SFI S SCI C, P87; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yun WL, 2008, INFORM SCIENCES, V178, P106, DOI 10.1016/j.ins.2007.07.020	57	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113165	10.1371/journal.pone.0113165	http://dx.doi.org/10.1371/journal.pone.0113165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409306	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200075
J	Gebauer, F; Wicklein, D; Horst, J; Sundermann, P; Maar, H; Streichert, T; Tachezy, M; Izbicki, JR; Bockhorn, M; Schumacher, U				Gebauer, Florian; Wicklein, Daniel; Horst, Jennifer; Sundermann, Philipp; Maar, Hanna; Streichert, Thomas; Tachezy, Michael; Izbicki, Jakob R.; Bockhorn, Maximilian; Schumacher, Udo			Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer	PLOS ONE			English	Article							PERITONEAL CARCINOMATOSIS; ADJUVANT CHEMOTHERAPY; FOLINIC ACID; EXPRESSION; ADENOCARCINOMA; GEMCITABINE; RESECTION; THERAPY; MODEL; GENE	Background: Aim of this study was to assess the biological function in tumor progression and metastatic process carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 in pancreatic adenocarcinoma (PDAC). Experimental Design: CEACAM knock down cells were established and assessed in vitro and in a subcutaneous and intraperitoneal mouse xenograft model. Tissue and serum expression of patients with PDAC were assessed by immunohistochemistry (IHC) and by enzyme linked immunosorbent assays. Results: Presence of lymph node metastasis was correlated with CEACAM 5 and 6 expression (determined by IHC) and tumor recurrence exclusively with CEACAM 6. Patients with CEACAM 5 and 6 expression showed a significantly shortened OS in Kaplan-Meier survival analyses. Elevated CEACAM6 serum values showed a correlation with distant metastasis and. Survival analysis revealed a prolonged OS for patients with low serum CEACAM 1 values. In vitro proliferation and migration capacity was increased in CEACAM knock down PDAC cells, however, mice inoculated with CEACAM knock down cells showed a prolonged overall-survival (OS). The number of spontaneous pulmonary metastasis was increased in the CEACAM knock down group. Conclusion: The effects mediated by CEACAM expression in PDAC are complex, though overexpression is correlated with loco-regional aggressive tumor growth. However, loss of CEACAM can be considered as a part of epithelial-mesenchymal transition and is therefore of rather importance in the process of distant metastasis.	[Gebauer, Florian; Sundermann, Philipp; Tachezy, Michael; Izbicki, Jakob R.; Bockhorn, Maximilian] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Gebauer, Florian; Wicklein, Daniel; Horst, Jennifer; Maar, Hanna; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Gebauer, Florian; Wicklein, Daniel; Horst, Jennifer; Maar, Hanna; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gebauer, F (corresponding author), Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	fgebauer@uke.uni-hamburg.de	Tachezy, Michael/AAD-6759-2022					Alexakis N, 2004, BRIT J SURG, V91, P1410, DOI 10.1002/bjs.4794; Arabzadeh A., 2012, ONCOGENE; Beauchemin N, 1999, EXP CELL RES, V252, P243; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Chen ZG, 2011, J EXP MED, V208, P2633, DOI 10.1084/jem.20102575; Dancau AM, 2010, METHODS MOL BIOL, V576, P49, DOI 10.1007/978-1-59745-545-9_4; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; Duxbury MS, 2005, ANN SURG, V241, P491, DOI 10.1097/01.sla.0000154455.86404.e9; Duxbury MS, 2004, ANN SURG, V240, P667, DOI 10.1097/01.sla.0000140755.97224.9a; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Duxbury MS, 2004, ONCOGENE, V23, P5834, DOI 10.1038/sj.onc.1207775; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V317, P837, DOI 10.1016/j.bbrc.2004.03.128; Gebauer F, 2013, GUT, V62, P741, DOI 10.1136/gutjnl-2011-300629; Gebauer F, 2011, J SURG ONCOL, V104, P140, DOI 10.1002/jso.21957; Gerstel D, 2011, ONCOGENE, V30, P4275, DOI 10.1038/onc.2011.146; GOLD P, 1965, J EXP MED, V122, P467, DOI 10.1084/jem.122.3.467; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Heine M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028030; HOCKEY MS, 1984, BRIT J CANCER, V49, P129, DOI 10.1038/bjc.1984.24; Horst AK, 2004, HANDB EXP PHARM, V165, P283, DOI 10.1007/978-3-540-68170-0_10; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Huang SY, 1996, CLIN CANCER RES, V2, P1969; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Lange T, 2012, CLIN CANCER RES, V18, P1364, DOI 10.1158/1078-0432.CCR-11-2900; Loos M, 2008, ANN NY ACAD SCI, V1138, P169, DOI 10.1196/annals.1414.024; Nehmann N, 2010, ACTA HISTOCHEM, V112, P489, DOI 10.1016/j.acthis.2009.05.004; Neoptolemos JP, 2009, BRIT J CANCER, V100, P246, DOI 10.1038/sj.bjc.6604838; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; ONA FV, 1973, CANCER, V31, P324, DOI 10.1002/1097-0142(197302)31:2<324::AID-CNCR2820310208>3.0.CO;2-Y; Portilla AG, 1999, WORLD J SURG, V23, P23, DOI 10.1007/s002689900560; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; Serra S, 2009, APPL IMMUNOHISTO M M, V17, P286, DOI 10.1097/PAI.0b013e318196e13c; Simeone DM, 2007, PANCREAS, V34, P436, DOI 10.1097/MPA.0b013e3180333ae3; Simon R, 2010, METHODS MOL BIOL, V664, P113, DOI 10.1007/978-1-60761-806-5_12; Skubitz KM, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-78; Sperti C, 1997, WORLD J SURG, V21, P195, DOI 10.1007/s002689900215; STOFFEL A, 1993, J IMMUNOL, V150, P4978; Strickland LA, 2009, J PATHOL, V218, P380, DOI 10.1002/path.2545; Tachezy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039018; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Thom I, 2009, ANTICANCER RES, V29, P249; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Thompson JA, 1997, INT J CANCER, V72, P197, DOI 10.1002/(SICI)1097-0215(19970703)72:1<197::AID-IJC28>3.0.CO;2-F; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Wicklein Daniel, 2012, Methods Mol Biol, V878, P241, DOI 10.1007/978-1-61779-854-2_16; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wright P F, 1993, Rev Sci Tech, V12, P435; Xie SH, 1997, CANCER RES, V57, P2295; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	55	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113023	10.1371/journal.pone.0113023	http://dx.doi.org/10.1371/journal.pone.0113023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409014	Green Submitted, Green Published, gold			2022-12-27	WOS:000345533200058
J	Henning, Y; Vole, C; Begall, S; Bens, M; Broecker-Preuss, M; Sahm, A; Szafranski, K; Burda, H; Dammann, P				Henning, Yoshiyuki; Vole, Christiane; Begall, Sabine; Bens, Martin; Broecker-Preuss, Martina; Sahm, Arne; Szafranski, Karol; Burda, Hynek; Dammann, Philip			Unusual Ratio between Free Thyroxine and Free Triiodothyronine in a Long-Lived Mole-Rat Species with Bimodal Ageing	PLOS ONE			English	Article							CONE OPSIN EXPRESSION; THYROID-HORMONE; TRANSCRIPTIONAL REGULATION; MATERNAL HYPOTHYROXINEMIA; PHYLOGENETIC ANALYSIS; SUBTERRANEAN RODENTS; DWARF MICE; LONGEVITY; SENSITIVITY; ENERGETICS	Ansell's mole-rats (Fukomys anselli) are subterranean, long-lived rodents, which live in eusocial families, where the maximum lifespan of breeders is twice as long as that of non-breeders. Their metabolic rate is significantly lower than expected based on allometry, and their retinae show a high density of S-cone opsins. Both features may indicate naturally low thyroid hormone levels. In the present study, we sequenced several major components of the thyroid hormone pathways and analyzed free and total thyroxine and triiodothyronine in serum samples of breeding and non-breeding F. anselli to examine whether a) their thyroid hormone system shows any peculiarities on the genetic level, b) these animals have lower hormone levels compared to euthyroid rodents (rats and guinea pigs), and c) reproductive status, lifespan and free hormone levels are correlated. Genetic analyses confirmed that Ansell's mole-rats have a conserved thyroid hormone system as known from other mammalian species. Interspecific comparisons revealed that free thyroxine levels of F. anselli were about ten times lower than of guinea pigs and rats, whereas the free triiodothyronine levels, the main biologically active form, did not differ significantly amongst species. The resulting fT4:fT3 ratio is unusual for a mammal and potentially represents a case of natural hypothyroxinemia. Comparisons with total thyroxine levels suggest that mole-rats seem to possess two distinct mechanisms that work hand in hand to downregulate fT4 levels reliably. We could not find any correlation between free hormone levels and reproductive status, gender or weight. Free thyroxine may slightly increase with age, based on sub-significant evidence. Hence, thyroid hormones do not seem to explain the different ageing rates of breeders and non-breeders. Further research is required to investigate the regulatory mechanisms responsible for the unusual proportion of free thyroxine and free triiodothyronine.	[Henning, Yoshiyuki; Vole, Christiane; Begall, Sabine; Burda, Hynek; Dammann, Philip] Univ Duisburg Essen, Fac Biol, Dept Gen Zool, Essen, Germany; [Bens, Martin; Sahm, Arne; Szafranski, Karol] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Broecker-Preuss, Martina] Univ Duisburg Essen, Univ Hosp, Dept Endocrinol & Metab, Essen, Germany; [Broecker-Preuss, Martina] Univ Duisburg Essen, Univ Hosp, Div Lab Res, Essen, Germany; [Dammann, Philip] Univ Duisburg Essen, Univ Hosp, Cent Anim Lab, Essen, Germany	University of Duisburg Essen; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Henning, Y (corresponding author), Univ Duisburg Essen, Fac Biol, Dept Gen Zool, Essen, Germany.	yoshiyuki.henning@uni-due.de	Sahm, Arne/AAG-3842-2019	Sahm, Arne/0000-0002-7330-1790; Bens, Martin/0000-0001-7940-6668; Henning, Yoshiyuki/0000-0002-0166-2204	German Research Foundation (DFG) [DA 992/3-1]; "Publish Open Access''-Program of the University of Duisburg-Essen; German Research Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); "Publish Open Access''-Program of the University of Duisburg-Essen; German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant of the German Research Foundation to PD (DFG-grant DA 992/3-1) (http://www.dfg.de/). The publication fee was funded by the "Publish Open Access''-Program of the University of Duisburg-Essen and the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avivi A, 2005, FASEB J, V19, P1314, DOI 10.1096/fj.04-3414fje; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BAUCH K, 1986, ENDOCRINOL EXP, V20, P67; Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3; Becker NI, 2013, ECOL RES, V28, P249, DOI 10.1007/s11284-012-1010-0; Bianco AC, 2005, THYROID, V15, P777, DOI 10.1089/thy.2005.15.777; Bowers J, 2013, ENDOCR REV, V34, P556, DOI 10.1210/er.2012-1056; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2001, AM J PHYSIOL-REG I, V280, pR149, DOI 10.1152/ajpregu.2001.280.1.R149; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; CamposBarros A, 1997, J NEUROCHEM, V68, P795; Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P4128, DOI 10.1210/en.2012-1467; CRANTZ FR, 1980, J CLIN INVEST, V65, P935, DOI 10.1172/JCI109749; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Dammann P, 2011, J GERONTOL A-BIOL, V67, P573; Dammann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018757; Darras VM, 2009, GEN COMP ENDOCR, V163, P58, DOI 10.1016/j.ygcen.2008.11.014; DAVIES DT, 1993, COMP HAEMATOL INT, V3, P142, DOI 10.1007/BF00186098; Dong H, 2014, CEREBRAL CORTEX; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; Edward DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P137; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Gesing A, 2012, THYROID RES, V5, P1; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harvey CB, 2002, THYROID, V12, P441, DOI 10.1089/105072502760143791; Hoff J, 2000, LAB ANIMAL, V29, P47; Hood A, 1999, TOXICOL SCI, V49, P263, DOI 10.1093/toxsci/49.2.263; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P623, DOI 10.1016/B978-0-12-370491-7.00020-9; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Kelly G S, 2000, Altern Med Rev, V5, P306; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kott O, 2014, J ZOOL, V294, P67, DOI 10.1111/jzo.12152; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; LOVEGROVE BG, 1986, OECOLOGIA, V69, P551, DOI 10.1007/BF00410361; Ma C, 2009, NUCL MED COMMUN, V30, P586, DOI 10.1097/MNM.0b013e32832c79e0; MARHOLD S, 1995, J COMP PHYSIOL B, V164, P636, DOI 10.1007/BF00389805; Moeller LC, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S6; Moeller LC, 2005, MOL ENDOCRINOL, V19, P2955, DOI 10.1210/me.2004-0542; Monnier V.M., 1989, Progress in Clinical and Biological Research, V304, P1; Montero AG, 2015, VET ANAESTH ANALG, V42, P187, DOI 10.1111/vaa.12180; Moreno M, 1997, J PHYSIOL-LONDON, V505, P529, DOI 10.1111/j.1469-7793.1997.529bb.x; Muller K, 2009, VET CLIN PATH, V38, P507, DOI 10.1111/j.1939-165X.2009.00159.x; Negro R, 2011, ENDOCR PRACT, V17, P422, DOI 10.4158/EP10309.RA; OOKA H, 1983, MECH AGEING DEV, V22, P113, DOI 10.1016/0047-6374(83)90104-5; OOKA H, 1986, MECH AGEING DEV, V33, P275, DOI 10.1016/0047-6374(86)90052-7; Opazo MC, 2008, ENDOCRINOLOGY, V149, P5097, DOI 10.1210/en.2008-0560; Otto T, 2008, ENDOCRINOLOGY, V149, P2241, DOI 10.1210/en.2007-1238; Peeters RP, 2008, HORM-INT J ENDOCRINO, V7, P28, DOI 10.14310/horm.2002.1111035; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Pohlenz J, 1999, THYROID, V9, P1265, DOI 10.1089/thy.1999.9.1265; Refetoff S, 1996, J CLIN ENDOCR METAB, V81, P3335; Roman GC, 2013, ANN NEUROL, V74, P733, DOI 10.1002/ana.23976; Rozing MP, 2010, J CLIN ENDOCR METAB, V95, P4979, DOI 10.1210/jc.2010-0875; SAVU L, 1992, ACTA MED AUST, V19, P88; Schmidt CM, 2013, AFR ZOOL, V48, P193; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; SHUPNIK MA, 1985, J BIOL CHEM, V260, P2900; Storey NM, 2006, P NATL ACAD SCI USA, V103, P5197, DOI 10.1073/pnas.0600089103; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244; Visser WE, 2008, TRENDS ENDOCRIN MET, V19, P50, DOI 10.1016/j.tem.2007.11.003; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zelova J, 2007, COMP BIOCHEM PHYS A, V147, P412, DOI 10.1016/j.cbpa.2007.01.002; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439	77	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113698	10.1371/journal.pone.0113698	http://dx.doi.org/10.1371/journal.pone.0113698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409169	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200144
J	Hogfors, H; Motwani, NH; Hajdu, S; El-Shehawy, R; Holmborn, T; Vehmaa, A; Engstrom-Ost, J; Brutemark, A; Gorokhova, E				Hogfors, Hedvig; Motwani, Nisha H.; Hajdu, Susanna; El-Shehawy, Rehab; Holmborn, Towe; Vehmaa, Anu; Engstrom-Ost, Jonna; Brutemark, Andreas; Gorokhova, Elena			Bloom-Forming Cyanobacteria Support Copepod Reproduction and Development in the Baltic Sea	PLOS ONE			English	Article							NODULARIA-SPUMIGENA; EURYTEMORA-AFFINIS; ACARTIA-BIFILOSA; SECONDARY METABOLITES; TOXIC CYANOBACTERIUM; COMMUNITY STRUCTURE; NITROGEN-FIXATION; CALANOID COPEPODS; OXIDATIVE STRESS; N-2 FIXATION	It is commonly accepted that summer cyanobacterial blooms cannot be efficiently utilized by grazers due to low nutritional quality and production of toxins; however the evidence for such effects in situ is often contradictory. Using field and experimental observations on Baltic copepods and bloom-forming diazotrophic filamentous cyanobacteria, we show that cyanobacteria may in fact support zooplankton production during summer. To highlight this side of zooplankton-cyanobacteria interactions, we conducted: (1) a field survey investigating linkages between cyanobacteria, reproduction and growth indices in the copepod Acartia tonsa; (2) an experiment testing relationships between ingestion of the cyanobacterium Nodularia spumigena (measured by molecular diet analysis) and organismal responses (oxidative balance, reproduction and development) in the copepod A. bifilosa; and (3) an analysis of long term (1999-2009) data testing relationships between cyanobacteria and growth indices in nauplii of the copepods, Acartia spp. and Eurytemora affinis, in a coastal area of the northern Baltic proper. In the field survey, N. spumigena had positive effects on copepod egg production and egg viability, effectively increasing their viable egg production. By contrast, Aphanizomenon sp. showed a negative relationship with egg viability yet no significant effect on the viable egg production. In the experiment, ingestion of N. spumigena mixed with green algae Brachiomonas submarina had significant positive effects on copepod oxidative balance, egg viability and development of early nauplial stages, whereas egg production was negatively affected. Finally, the long term data analysis identified cyanobacteria as a significant positive predictor for the nauplial growth in Acartia spp. and E. affinis. Taken together, these results suggest that bloom forming diazotrophic cyanobacteria contribute to feeding and reproduction of zooplankton during summer and create a favorable growth environment for the copepod nauplii.	[Hogfors, Hedvig; Motwani, Nisha H.; Hajdu, Susanna; Gorokhova, Elena] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [El-Shehawy, Rehab] IMDEA Agua, Madrid, Spain; [Holmborn, Towe] Calluna AB, Stockholm, Sweden; [Vehmaa, Anu; Engstrom-Ost, Jonna; Brutemark, Andreas] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Vehmaa, Anu; Engstrom-Ost, Jonna; Brutemark, Andreas] Abo Akad Univ, Ekenas, Finland; [Vehmaa, Anu; Brutemark, Andreas] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University; Novia University of Applied Sciences; Abo Akademi University; University of Helsinki; Stockholm University	Gorokhova, E (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	elena.gorokhova@itm.su.se	Vehmaa, Anu/A-2671-2010; Gorokhova, Elena/E-7105-2018; Engström-Öst, Jonna/C-7373-2008	Vehmaa, Anu/0000-0003-4912-3258; Gorokhova, Elena/0000-0002-4192-6956; Engström-Öst, Jonna/0000-0003-1792-7702; El Shehawy, Rehab/0000-0003-4091-0810	Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management; Swedish Environmental Protection Agency; SYVAB (The Southwestern Stockholm Region Sewage Company); Ivar Bendixsons Stipendiefond; Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS); Academy of Finland [125251, 255566]; Maj and Tor Nessling Foundation; Walter and Andree de Nottbeck Foundation; Research and Development Institute ARONIA	Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management; Swedish Environmental Protection Agency; SYVAB (The Southwestern Stockholm Region Sewage Company); Ivar Bendixsons Stipendiefond; Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Academy of Finland(Academy of Finland); Maj and Tor Nessling Foundation; Walter and Andree de Nottbeck Foundation; Research and Development Institute ARONIA	This work was financially supported by Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management, the Swedish Environmental Protection Agency, SYVAB (The Southwestern Stockholm Region Sewage Company), Ivar Bendixsons Stipendiefond and the Swedish Research Council for the Environment, Agricultural Sciences and Spatial Planning (FORMAS), the Academy of Finland (projects 125251 and 255566), the Maj and Tor Nessling Foundation, Walter and Andree de Nottbeck Foundation, and the Research and Development Institute ARONIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LL, 2010, ENVIRON INT, V36, P226, DOI 10.1016/j.envint.2009.10.010; [Anonymous], ALGOLOGICAL STUDIES; Baud A, 2002, CAN J ZOOL, V80, P232, DOI 10.1139/Z01-219; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Guedes AC, 2013, MAR DRUGS, V11, P1256, DOI 10.3390/md11041256; Davis TW, 2011, J PLANKTON RES, V33, P415, DOI 10.1093/plankt/fbq109; de Kluijver A, 2012, LIMNOL OCEANOGR, V57, P1245, DOI 10.4319/lo.2012.57.4.1245; Degerholm J, 2008, MAR ECOL PROG SER, V360, P73, DOI 10.3354/meps07379; DEMOTT WR, 1991, ECOLOGY, V72, P1820, DOI 10.2307/1940981; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; El-Shehawy R, 2013, CYANOBACTERIA ECOLOG; Engstrom J, 2000, J PLANKTON RES, V22, P1403, DOI 10.1093/plankt/22.7.1403; Engstrom-Ost J, 2011, AQUAT MICROB ECOL, V62, P39, DOI 10.3354/ame01456; Forbes VE, 2000, FUNCT ECOL, V14, P12, DOI 10.1046/j.1365-2435.2000.00392.x; GIFFORD DJ, 1991, J PROTOZOOL, V38, P81, DOI 10.1111/j.1550-7408.1991.tb04806.x; Gilardi JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038293; Giraffa G, 2000, J MICROBIOL METH, V42, P175, DOI 10.1016/S0167-7012(00)00172-X; Gorokhova E, 2005, LIMNOL OCEANOGR-METH, V3, P143, DOI 10.4319/lom.2005.3.143; Gorokhova E, 2003, MAR ECOL PROG SER, V262, P163, DOI 10.3354/meps262163; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071385; Gorokhova E, 2010, LIMNOL OCEANOGR-METH, V8, P414, DOI 10.4319/lom.2010.8.414; Gorokhova E, 2009, J PLANKTON RES, V31, P1235, DOI 10.1093/plankt/fbp060; Gorokhova E, 2009, HARMFUL ALGAE, V8, P264, DOI 10.1016/j.hal.2008.06.006; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; Helsinki Commission (HELCOM), 2008, MAN MAR MON COMBINE; Holland DP, 2012, MAR ECOL PROG SER, V461, P47, DOI 10.3354/meps09843; Holmborn T, 2009, LIMNOL OCEANOGR-METH, V7, P785, DOI 10.4319/lom.2009.7.785; Hoppe HG, 1981, KIELER MEERESFORSCH, V5, P291; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Ibelings BW, 2008, ADV EXP MED BIOL, V619, P675, DOI 10.1007/978-0-387-75865-7_32; Jiang XD, 2010, LIMNOL OCEANOGR, V55, P1643, DOI 10.4319/lo.2010.55.4.1643; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; KIORBOE T, 1989, MAR ECOL PROG SER, V55, P229, DOI 10.3354/meps055229; Knuckey RM, 2005, AQUACULTURE, V249, P339, DOI 10.1016/j.aquaculture.2005.02.053; Koski M, 1999, MAR ECOL PROG SER, V186, P187, DOI 10.3354/meps186187; Koski M, 2002, LIMNOL OCEANOGR, V47, P878; Kozlowsky-Suzuki B, 2003, MAR ECOL PROG SER, V249, P237, DOI 10.3354/meps249237; Larsson U, 2001, LIMNOL OCEANOGR, V46, P811, DOI 10.4319/lo.2001.46.4.0811; Loick-Wilde N, 2012, LIMNOL OCEANOGR, V57, P199, DOI 10.4319/lo.2012.57.1.0199; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Meyer-Harms B, 1999, MAR ECOL PROG SER, V191, P243, DOI 10.3354/meps191243; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Motwani NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079230; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Oberholster PJ, 2006, HARMFUL ALGAE, V5, P705, DOI 10.1016/j.hal.2006.03.001; Ohlendieck U, 2000, J MARINE SYST, V25, P213, DOI 10.1016/S0924-7963(00)00016-6; Olenina I., 2006, BALT SEA ENV P, V106; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; Pandey U, 2009, BIOTECHNOL BIOPROC E, V14, P316, DOI [10.1007/s12257-008-0234-x, 10.1007/S12257-008-0234-X]; Parsons PA, 2001, Q REV BIOL, V76, P459, DOI 10.1086/420541; Peters J, 2006, MAR BIOL, V149, P1417, DOI 10.1007/s00227-006-0290-8; Pinho GLL, 2005, ECOTOX ENVIRON SAFE, V61, P353, DOI 10.1016/j.ecoenv.2004.11.014; Ploug H, 2011, ISME J, V5, P1549, DOI 10.1038/ismej.2011.20; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; Schmidt K, 1997, MAR ECOL PROG SER, V151, P1, DOI 10.3354/meps151001; Schmidt K, 2002, J PLANKTON RES, V24, P979, DOI 10.1093/plankt/24.10.979; Sellner K. G., 1996, Phycologia, V35, P177, DOI 10.2216/i0031-8884-35-6S-177.1; Sellner KG, 1997, LIMNOL OCEANOGR, V42, P1089, DOI 10.4319/lo.1997.42.5_part_2.1089; Singh S, 2005, CRIT REV BIOTECHNOL, V25, P73, DOI 10.1080/07388550500248498; Smith JL, 2008, AQUACULTURE, V280, P5, DOI 10.1016/j.aquaculture.2008.05.007; Stal LJ, 1999, AQUAT MICROB ECOL, V18, P165, DOI 10.3354/ame018165; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; Tuomainen J, 2006, MICROB ECOL, V52, P513, DOI 10.1007/s00248-006-9130-0; Vargas MA, 1998, J PHYCOL, V34, P812, DOI 10.1046/j.1529-8817.1998.340812.x; Vehmaa A, 2013, ECOL EVOL, V3, P4548, DOI 10.1002/ece3.839; VIITASALO M, 1994, HYDROBIOLOGIA, V293, P415; Wannicke N, 2013, J MARINE SYST, V117, P1, DOI 10.1016/j.jmarsys.2013.03.005; Wasmund N, 1997, INT REV GES HYDROBIO, V82, P169, DOI 10.1002/iroh.19970820205; Webster EK, 1978, LIMNOL OCEANOGR, V23, P1238; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Wilson AE, 2006, LIMNOL OCEANOGR, V51, P1915, DOI 10.4319/lo.2006.51.4.1915; Wilson SE, 2010, MAR ECOL PROG SER, V412, P11, DOI 10.3354/meps08648; Woodland RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067588	79	46	47	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112692	10.1371/journal.pone.0112692	http://dx.doi.org/10.1371/journal.pone.0112692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409500	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200032
J	Ju, JY; Li, RS; Gu, SC; Leader, JK; Wang, XH; Chen, YH; Zheng, B; Wu, SD; Gur, D; Sciurba, F; Pu, JT				Ju, Jieyang; Li, Ruosha; Gu, Suicheng; Leader, Joseph K.; Wang, Xiaohua; Chen, Yahong; Zheng, Bin; Wu, Shandong; Gur, David; Sciurba, Frank; Pu, Jiantao			Impact of Emphysema Heterogeneity on Pulmonary Function	PLOS ONE			English	Article							REGIONAL-DISTRIBUTION; LUNG; CT; COPD; PHYSIOLOGY	Objectives: To investigate the association between emphysema heterogeneity in spatial distribution, pulmonary function and disease severity. Methods and Materials: We ascertained a dataset of anonymized Computed Tomography (CT) examinations acquired on 565 participants in a COPD study. Subjects with chronic bronchitis (CB) and/or bronchodilator response were excluded resulting in 190 cases without COPD and 160 cases with COPD. Low attenuations areas (LAAs) (<= 950 Hounsfield Unit (HU)) were identified and quantified at the level of individual lobes. Emphysema heterogeneity was defined in a manner that ranged in value from -100% to 100%. The association between emphysema heterogeneity and pulmonary function measures (e. g., FEV1% predicted, RV/TLC, and DLco% predicted) adjusted for age, sex, and smoking history (pack-years) was assessed using multiple linear regression analysis. Results: The majority (128/160) of the subjects with COPD had a heterogeneity greater than zero. After adjusting for age, gender, smoking history, and extent of emphysema, heterogeneity in depicted disease in upper lobe dominant cases was positively associated with pulmonary function measures, such as FEV1 Predicted (p<.001) and FEV1/FVC (p<.001), as well as disease severity (p<0.05). We found a negative association between HI%, RV/TLC (p<0.001), and DLco% (albeit not a statistically significant one, p = 0.06) in this group of patients. Conclusion: Subjects with more homogeneous distribution of emphysema and/or lower lung dominant emphysema tend to have worse pulmonary function.	[Ju, Jieyang; Gu, Suicheng; Leader, Joseph K.; Wu, Shandong; Gur, David; Pu, Jiantao] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Li, Ruosha] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Wang, Xiaohua; Chen, Yahong] Peking Univ, Affiliated Hosp 3, Beijing 100871, Peoples R China; [Zheng, Bin] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA; [Sciurba, Frank] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Pu, Jiantao] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University; University of Oklahoma System; University of Oklahoma - Norman; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pu, JT (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	puj@upmc.edu	Sciurba, Frank/AAZ-9339-2021; Zheng, Bin/HGU-5316-2022	sciurba, frank/0000-0001-7468-2225; Zheng, Bin/0000-0002-7682-6648	National Institutes of Health [RO1 HL096613]; Bonnie J. Addario Lung Cancer Foundation; National Health and Family Planning Commission of the R.R. China [201402013]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bonnie J. Addario Lung Cancer Foundation; National Health and Family Planning Commission of the R.R. China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by grants from the National Institutes of Health (RO1 HL096613), the Bonnie J. Addario Lung Cancer Foundation, and the National Health and Family Planning Commission of the R.R. China (No. 201402013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Boschetto P, 2003, EUR RESPIR J, V21, P450, DOI 10.1183/09031936.03.00048703; Castaldi PJ, 2013, AM J RESP CRIT CARE, V188, P1083, DOI 10.1164/rccm.201305-0873OC; DeMeo DL, 2007, AM J RESP CRIT CARE, V176, P42, DOI 10.1164/rccm.200612-1797OC; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Gietema HA, 2010, RESP MED, V104, P76, DOI 10.1016/j.rmed.2009.08.004; GURNEY JW, 1992, RADIOLOGY, V183, P457, DOI 10.1148/radiology.183.2.1561350; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Haraguchi M, 1998, RESPIRATION, V65, P125, DOI 10.1159/000029243; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Holme J, 2007, CHEST, V132, P909, DOI 10.1378/chest.07-0341; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; LEOPOLD J. G., 1957, THORAX, V12, P219, DOI 10.1136/thx.12.3.219; Minai Omar A, 2008, Proc Am Thorac Soc, V5, P468, DOI 10.1513/pats.200802-018ET; Nakano Y, 2001, AM J RESP CRIT CARE, V164, P2195, DOI 10.1164/ajrccm.164.12.2012140; Parr DG, 2004, AM J RESP CRIT CARE, V170, P1172, DOI 10.1164/rccm.200406-761OC; Pauls S, 2010, CLIN IMAG, V34, P172, DOI 10.1016/j.clinimag.2009.05.004; Pu J, 2008, COMPUT MED IMAG GRAP, V32, P452, DOI 10.1016/j.compmedimag.2008.04.005; Pu JT, 2009, IEEE T MED IMAGING, V28, P1986, DOI 10.1109/TMI.2009.2027117; Pu JT, 2009, IEEE T MED IMAGING, V28, P710, DOI 10.1109/TMI.2008.2010441; Stolk J, 2011, AM J RESP CRIT CARE, V183, P1578, DOI 10.1164/rccm.201104-0615ED; Tanabe N, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-31; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Yuan R, 2009, THORAX, V64, P944, DOI 10.1136/thx.2008.112433; Zulueta JJ, 2012, CHEST, V141, P1216, DOI 10.1378/chest.11-0101	26	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113320	10.1371/journal.pone.0113320	http://dx.doi.org/10.1371/journal.pone.0113320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409328	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000345533200095
J	Khan, I; Suhasini, AN; Banerjee, T; Sommers, JA; Kaplan, DL; Kuper, J; Kisker, C; Brosh, RM				Khan, Irfan; Suhasini, Avvaru N.; Banerjee, Taraswi; Sommers, Joshua A.; Kaplan, Daniel L.; Kuper, Jochen; Kisker, Caroline; Brosh, Robert M., Jr.			Impact of Age-Associated Cyclopurine Lesions on DNA Repair Helicases	PLOS ONE			English	Article							XERODERMA-PIGMENTOSUM; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; TRANSLESION SYNTHESIS; ESCHERICHIA-COLI; DUPLEX DNA; REPLICATION; DAMAGE; 8,5'-CYCLOPURINE-2'-DEOXYNUCLEOSIDES; STRAND	8,5' cyclopurine deoxynucleosides (cPu) are locally distorting DNA base lesions corrected by nucleotide excision repair (NER) and proposed to play a role in neurodegeneration prevalent in genetically defined Xeroderma pigmentosum (XP) patients. In the current study, purified recombinant helicases from different classifications based on sequence homology were examined for their ability to unwind partial duplex DNA substrates harboring a single site-specific cPu adduct. Superfamily (SF) 2 RecQ helicases (RECQ1, BLM, WRN, RecQ) were inhibited by cPu in the helicase translocating strand, whereas helicases from SF1 (UvrD) and SF4 (DnaB) tolerated cPu in either strand. SF2 Fe-S helicases (FANCJ, DDX11 (ChlR1), DinG, XPD) displayed marked differences in their ability to unwind the cPu DNA substrates. Archaeal Thermoplasma acidophilum XPD (taXPD), homologue to the human XPD helicase involved in NER DNA damage verification, was impeded by cPu in the non-translocating strand, while FANCJ was uniquely inhibited by the cPu in the translocating strand. Sequestration experiments demonstrated that FANCJ became trapped by the translocating strand cPu whereas RECQ1 was not, suggesting the two SF2 helicases interact with the cPu lesion by distinct mechanisms despite strand-specific inhibition for both. Using a protein trap to simulate single-turnover conditions, the rate of FANCJ or RECQ1 helicase activity was reduced 10-fold and 4.5-fold, respectively, by cPu in the translocating strand. In contrast, single-turnover rates of DNA unwinding by DDX11 and UvrD helicases were only modestly affected by the cPu lesion in the translocating strand. The marked difference in effect of the translocating strand cPu on rate of DNA unwinding between DDX11 and FANCJ helicase suggests the two Fe-S cluster helicases unwind damaged DNA by distinct mechanisms. The apparent complexity of helicase encounters with an unusual form of oxidative damage is likely to have important consequences in the cellular response to DNA damage and DNA repair.	[Khan, Irfan; Suhasini, Avvaru N.; Banerjee, Taraswi; Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL USA; [Kuper, Jochen; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); State University System of Florida; Florida State University; University of Wurzburg	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Banerjee, Taraswi/AAC-6093-2020; Brosh, Robert/AAR-6124-2020; Kisker, Caroline/T-1724-2019	Kisker, Caroline/0000-0002-0216-6026; Kaplan, Daniel/0000-0003-2760-7745	Intramural Research program of the National Institutes of Health, National Institute on Aging; Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft [Forschungszentrum FZ82, KI-562/2]; NATIONAL INSTITUTE ON AGING [ZIAAG000753, ZIAAG000741] Funding Source: NIH RePORTER	Intramural Research program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research program of the National Institutes of Health, National Institute on Aging and by the Fanconi Anemia Research Fund (to R. M. B.) and through the Deutsche Forschungsgemeinschaft (Forschungszentrum FZ82 and KI-562/2 to C. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KM, 2006, CELL CYCLE, V5, P1240, DOI 10.4161/cc.5.11.2816; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Berquist BR, 2012, CANCER LETT, V327, P61, DOI 10.1016/j.canlet.2012.02.001; Bharti SK, 2014, CELL MOL LIFE SCI, V71, P2625, DOI 10.1007/s00018-014-1569-4; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Buechner CN, 2014, J BIOL CHEM, V289, P3613, DOI 10.1074/jbc.M113.523001; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2011, FUTURE ONCOL, V7, P253, DOI [10.2217/fon.10.191, 10.2217/FON.10.191]; D'Errico M, 2007, ONCOGENE, V26, P4336, DOI 10.1038/sj.onc.1210232; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Huang H, 2011, J AM CHEM SOC, V133, P20357, DOI 10.1021/ja207407n; Jaruga P, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh087; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Jaruga P, 2012, BIOCHEMISTRY-US, V51, P1822, DOI 10.1021/bi201912c; Jasti VP, 2011, BIOCHEMISTRY-US, V50, P3862, DOI 10.1021/bi2004944; Kamakura N, 2012, CHEM RES TOXICOL, V25, P2718, DOI 10.1021/tx300351p; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kirkali G, 2009, DNA REPAIR, V8, P274, DOI 10.1016/j.dnarep.2008.09.009; Klaue D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3024; Kuper J, 2013, ADV EXP MED BIOL, V973, P203, DOI 10.1007/978-1-4614-5037-5_10; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Kuraoka I, 2001, J BIOL CHEM, V276, P49283, DOI 10.1074/jbc.M107779200; Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Marietta C, 2002, DNA REPAIR, V1, P967, DOI 10.1016/S1568-7864(02)00148-9; Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932; Mathieu N, 2013, CURR BIOL, V23, P204, DOI 10.1016/j.cub.2012.12.032; Mathieu N, 2010, P NATL ACAD SCI USA, V107, P17545, DOI 10.1073/pnas.1004339107; Mazouzi A, 2013, P NATL ACAD SCI USA, V110, pE3071, DOI 10.1073/pnas.1305281110; Menoni H, 2012, J CELL BIOL, V199, P1037, DOI 10.1083/jcb.201205149; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pednekar V, 2014, CHEM RES TOXICOL, V27, P200, DOI 10.1021/tx4002786; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sontz PA, 2012, P NATL ACAD SCI USA, V109, P1856, DOI 10.1073/pnas.1120063109; Suhasini AN, 2012, J BIOL CHEM, V287, P19188, DOI 10.1074/jbc.M112.352757; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Suhasini AN, 2010, CELL CYCLE, V9, P2317, DOI 10.4161/cc.9.12.11902; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Swanson AL, 2012, CHEM RES TOXICOL, V25, P1682, DOI 10.1021/tx3001576; Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Xie J, 2010, ONCOGENE, V29, P2499, DOI 10.1038/onc.2010.18; Yodh JG, 2009, EMBO J, V28, P405, DOI 10.1038/emboj.2008.298; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Zaliznyak T, 2012, CHEM RES TOXICOL, V25, P2103, DOI 10.1021/tx300193k	66	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113293	10.1371/journal.pone.0113293	http://dx.doi.org/10.1371/journal.pone.0113293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409515	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200092
J	Liu, ZK; Liu, YH; Cai, BP				Liu, Zengkai; Liu, Yonghong; Cai, Baoping			Reliability Analysis of the Electrical Control System of Subsea Blowout Preventers Using Markov Models	PLOS ONE			English	Article							REDUNDANT-SYSTEMS	Reliability analysis of the electrical control system of a subsea blowout preventer (BOP) stack is carried out based on Markov method. For the subsea BOP electrical control system used in the current work, the 3-2-1-0 and 3-2-0 input voting schemes are available. The effects of the voting schemes on system performance are evaluated based on Markov models. In addition, the effects of failure rates of the modules and repair time on system reliability indices are also investigated.	[Liu, Zengkai; Liu, Yonghong; Cai, Baoping] China Univ Petr, Coll Mech & Elect Engn, Qingdao, Shandong, Peoples R China	China University of Petroleum	Liu, YH (corresponding author), China Univ Petr, Coll Mech & Elect Engn, Qingdao, Shandong, Peoples R China.	liuyhup@163.com		Liu, Yonghong/0000-0002-4339-6389; Liu, Zengkai/0000-0001-6475-7481	Key Laboratory of Oil & Gas Equipment, Ministry of Education (Southwest Petroleum University) [OGE201403-24]; National Natural Science Foundation of China [51309240]; Specialized Research Fund for the Doctoral Program of Higher Education [20130133120007]; Applied Basic Research Programs of Qingdao [14-2-4-68-jch]; Science and Technology Project of Huangdao District [2014-1-48]; National High-Technology Research and Development Program of China [2013AA09A220]; Incubation Program of Excellent Doctoral Dissertation of China University of Petroleum [2013-4]	Key Laboratory of Oil & Gas Equipment, Ministry of Education (Southwest Petroleum University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Applied Basic Research Programs of Qingdao; Science and Technology Project of Huangdao District; National High-Technology Research and Development Program of China(National High Technology Research and Development Program of China); Incubation Program of Excellent Doctoral Dissertation of China University of Petroleum	The study was financially supported by the financial support of Open Fund of Key Laboratory of Oil & Gas Equipment, Ministry of Education (Southwest Petroleum University) (NO. OGE201403-24), National Natural Science Foundation of China (No. 51309240), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130133120007), Applied Basic Research Programs of Qingdao (NO. 14-2-4-68-jch), Science and Technology Project of Huangdao District (No. 2014-1-48), National High-Technology Research and Development Program of China (No. 2013AA09A220), and Incubation Program of Excellent Doctoral Dissertation of China University of Petroleum (No. 2013-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	API, 2004, SPEC CONTR SYST DRIL; Azaron A, 2006, APPL MATH COMPUT, V173, P137, DOI 10.1016/j.amc.2005.02.051; Bucci P, 2008, RELIAB ENG SYST SAFE, V93, P1616, DOI 10.1016/j.ress.2008.01.008; Cai BP, 2012, J PETROL SCI ENG, V90-91, P18, DOI 10.1016/j.petrol.2012.04.007; Cai BP, 2012, ISA T, V51, P198, DOI 10.1016/j.isatra.2011.08.003; Childers MA, 2004, IADC SPE DRILL C DAL; Committee for Analysis of Causes of the Deepwater Horizon Explosion, 2011, FIR OIL SPILL ID MEA; Duan LL, 2011, COMMUN NONLINEAR SCI, V16, P2554, DOI 10.1016/j.cnsns.2010.09.012; Ellis M, 2014, COMPUT NETW, V70, P384, DOI 10.1016/j.comnet.2014.05.013; Fougere P, 1997, OIL GAS J, V95, P90; Fowler JH, 1994, SPE DRILL COMPLETION, V3, P193; Guo HT, 2008, RELIAB ENG SYST SAFE, V93, P829, DOI 10.1016/j.ress.2007.03.029; Harlow WF, 2011, PUBLIC RELAT REV, V37, P80, DOI 10.1016/j.pubrev.2010.11.005; Holand P., 2012, 20125202 EXPR TRONDH; Jiang JJ, 2011, SAFETY SCI, V49, P843, DOI 10.1016/j.ssci.2011.01.014; Karami-Horestani A, 2014, INT J ELEC POWER, V55, P305, DOI 10.1016/j.ijepes.2013.09.010; Kim H, 2005, RELIAB ENG SYST SAFE, V88, P291, DOI 10.1016/j.ress.2004.08.012; Lisnianski A, 2012, RELIAB ENG SYST SAFE, V98, P1, DOI 10.1016/j.ress.2011.10.008; Mendes AA, 2014, RELIAB ENG SYST SAFE, V131, P148, DOI 10.1016/j.ress.2014.06.021; Pil CK, 2008, RELIAB ENG SYST SAFE, V93, P1345, DOI 10.1016/j.ress.2006.11.005; Rausand M, 2003, SYSTEM RELIABILITY T, V2nd, DOI DOI 10.1002/9780470316900; Shanks E., 2003, OFFSH TECHN C, P1, DOI DOI 10.4043/15194-MS; Tanrioven M, 2006, RENEW ENERG, V31, P915, DOI 10.1016/j.renene.2005.05.004; Wang JJ, 2013, ENERGY, V61, P531, DOI 10.1016/j.energy.2013.09.018; Yu HY, 2007, RELIAB ENG SYST SAFE, V92, P1627, DOI 10.1016/j.ress.2006.09.015; Yuan L, 2012, APPL MATH COMPUT, V218, P11959, DOI 10.1016/j.amc.2012.06.006	26	5	5	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113525	10.1371/journal.pone.0113525	http://dx.doi.org/10.1371/journal.pone.0113525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409010	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200133
J	Rai, H; Parveen, F; Sudeep, K; Kapoor, A; Sinha, N				Rai, Himanshu; Parveen, Farah; Kumar, Sudeep; Kapoor, Aditya; Sinha, Nakul			Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms with Coronary Artery Disease: An Updated Meta-Analysis and Systematic Review	PLOS ONE			English	Review							ACUTE MYOCARDIAL-INFARCTION; MISSENSE GLU298ASP VARIANT; 27-BP REPEAT POLYMORPHISM; TYPE-2 DIABETES-MELLITUS; SOUTH INDIAN POPULATION; ISCHEMIC-HEART-DISEASE; ENOS GENE; TURKISH POPULATION; G894T POLYMORPHISM; EARLY-ONSET	Several association studies of endothelial nitric oxide synthase (NOS3) gene polymorphisms with respect to coronary artery disease (CAD) have been published in the past two decades. However, their association with the disease, especially among different ethnic subgroups, still remains controversial. This prompted us to conduct a systematic review and an updated structured meta-analysis, which is the largest so far (89 articles, 132 separate studies, and a sample size of 69,235), examining association of three polymorphic forms of the NOS3 gene (i.e. Glu298Asp, T786-C and 27bp VNTR b/a) with CAD. In a subgroup analysis, we tested their association separately among published studies originating predominantly from European, Middle Eastern, Asian, Asian-Indian and African ancestries. The pooled analysis confirmed the association of all the three selected SNP with CAD in three different genetic models transcending all ancestries worldwide. The Glu298Asp polymorphism showed strongest association (OR range = 1.28-1.52, and P<0.00001 for all comparisons), followed by T786-C (OR range = 1.34-1.42, and P<0.00001 for all comparisons) and 4b/a, (OR range = 1.19-1.41, and P <= 0.002 for all comparisons) in our pooled analysis. Subgroup analysis revealed that Glu298Asp (OR range = 1.54-1.87, and P<0.004 for all comparisons) and 4b/a (OR range = 1.71-3.02, and P<0.00001 for all comparisons) have highest degree of association amongst the Middle Easterners. On the other hand, T786-C and its minor allele seem to carry a highest risk for CAD among subjects of Asian ancestry (OR range = 1.61-1.90, and P <= 0.01 for all comparisons).	[Rai, Himanshu; Kumar, Sudeep; Kapoor, Aditya] Sanjay Gandhi Post Grad Inst Med Sci, Dept Cardiol, Lucknow, Uttar Pradesh, India; [Parveen, Farah] Sanjay Gandhi Post Grad Inst Med Sci, Dept Med Genet, Lucknow, Uttar Pradesh, India; [Sinha, Nakul] Sahara India Med Inst, Dept Cardiol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Rai, H (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Cardiol, Lucknow, Uttar Pradesh, India.	himanshurai1981@gmail.com; sudeepkum@yahoo.com	Rai, Himanshu/GRX-9608-2022; Rai, Himanshu/N-7726-2016	Rai, Himanshu/0000-0003-3917-1934; Rai, Himanshu/0000-0003-3917-1934				Abdel-Aziz TA, 2013, MOL BIOL REP, V40, P3065, DOI 10.1007/s11033-012-2380-7; Afrasyap L, 2004, ACTA BIOCH BIOPH SIN, V36, P661, DOI 10.1093/abbs/36.10.661; Agema WRP, 2004, CLIN SCI, V107, P255, DOI 10.1042/CS20030360; Agirbasli D, 2006, CORONARY ARTERY DIS, V17, P413, DOI 10.1097/00019501-200608000-00003; Agirbasli M, 2011, EUR J CARDIOV PREV R, V18, P803, DOI 10.1177/1741826711398806; Alkharfy KM, 2010, ARCH MED RES, V41, P134, DOI 10.1016/j.arcmed.2010.02.004; Alp E, 2009, DNA CELL BIOL, V28, P343, DOI 10.1089/dna.2009.0866; Alvarez R, 2001, NITRIC OXIDE-BIOL CH, V5, P343, DOI 10.1006/niox.2001.0351; Andrikopoulos GK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-43; Angeline T, 2010, EXP MOL PATHOL, V89, P205, DOI 10.1016/j.yexmp.2010.08.009; Antoniades C, 2005, J AM COLL CARDIOL, V46, P1101, DOI 10.1016/j.jacc.2005.05.072; Aras O, 2002, THROMB HAEMOSTASIS, V87, P347; Bae J, 2010, EXP THER MED, V1, P719, DOI 10.3892/etm_00000111; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berdeli A, 2005, CLIN CHIM ACTA, V351, P87, DOI 10.1016/j.cccn.2004.08.015; Bhanushali AA, 2010, J COMMUN GENET, V1, P55, DOI 10.1007/s12687-010-0005-1; Bor-Kucukatay M, 2010, MOL BIOL REP, V37, P171, DOI 10.1007/s11033-009-9572-9; Cai H, 1999, J MOL MED, V77, P511, DOI 10.1007/s001099900020; Cam SF, 2005, THROMB RES, V116, P287, DOI 10.1016/j.thromres.2004.12.002; Ciftci C, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-5; Cine N, 2002, CLIN GENET, V61, P66, DOI 10.1034/j.1399-0004.2002.610113.x; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Colombo MG, 2003, CLIN CHEM, V49, P389, DOI 10.1373/49.3.389; Colombo MG, 2002, HEART, V87, P525, DOI 10.1136/heart.87.6.525; Dafni C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-133; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dosenko Victor E, 2006, Exp Clin Cardiol, V11, P11; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekmekci A, 2013, ACTA CARDIOL, V68, P464, DOI 10.1080/AC.68.5.2994468; Piccoli JDE, 2012, ARCH MED RES, V43, P205, DOI 10.1016/j.arcmed.2012.03.011; Fatini C, 2004, AM HEART J, V147, P516, DOI 10.1016/j.ahj.2003.10.032; Fowkes FGR, 2000, ATHEROSCLEROSIS, V150, P179, DOI 10.1016/S0021-9150(99)00366-4; Gad MZ, 2012, GENET TEST MOL BIOMA, V16, P695, DOI 10.1089/gtmb.2011.0342; Gardemann A, 2002, ATHEROSCLEROSIS, V160, P167, DOI 10.1016/S0021-9150(01)00554-8; Gluba A, 2009, ANGIOLOGY, V60, P588, DOI 10.1177/0003319709335031; Granath B, 2001, J CARDIOVASC RISK, V8, P235, DOI 10.1097/00043798-200108000-00008; Gururajan P, 2011, BIOCHEM GENET, V49, P96, DOI 10.1007/s10528-010-9391-7; Han Y, 2010, PHARMACOLOGY, V85, P211, DOI 10.1159/000275135; Hibi K, 1998, HYPERTENSION, V32, P521, DOI 10.1161/01.HYP.32.3.521; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; HINGORANI AD, 1995, CLIN SCI, V88, P21, DOI 10.1161/01.cir.100.14.1515; Hooper WC, 1999, CHEST, V116, P880, DOI 10.1378/chest.116.4.880; Hwang JJ, 2002, CARDIOLOGY, V97, P67, DOI 10.1159/000057674; Hyndman ME, 2002, HYPERTENSION, V39, P919, DOI 10.1161/01.HYP.0000013703.07316.7F; Ichihara S, 1998, AM J CARDIOL, V81, P83, DOI 10.1016/S0002-9149(97)10806-2; Isordia-Salas I, 2010, CLIN CHIM ACTA, V411, P553, DOI 10.1016/j.cca.2010.01.013; Jaramillo PC, 2008, CLIN CHIM ACTA, V387, P105, DOI 10.1016/j.cca.2007.09.011; Jaramillo PC, 2006, CLIN CHIM ACTA, V371, P102, DOI 10.1016/j.cca.2006.02.030; Jaramillo PC, 2010, CLIN CHIM ACTA, V411, P258, DOI 10.1016/j.cca.2009.11.018; Jeerooburkhan N, 2001, HYPERTENSION, V38, P1054, DOI 10.1161/hy1101.092967; Jemaa R, 2007, CLIN CHEM LAB MED, V45, P1476, DOI 10.1515/CCLM.2007.312; Jo I, 2006, CLIN CHIM ACTA, V365, P86, DOI 10.1016/j.cca.2005.07.029; Kallel A, 2013, CYTOKINE, V64, P646, DOI 10.1016/j.cyto.2013.09.005; KELM M, 1991, CARDIOVASC RES, V25, P831, DOI 10.1093/cvr/25.10.831; Kerkeni M, 2006, CLIN CHEM, V52, P53, DOI 10.1373/clinchem.2005.057950; Kim IJ, 2007, THROMB RES, V119, P579, DOI 10.1016/j.thromres.2006.06.005; Kincl V, 2009, FOLIA BIOL-PRAGUE, V55, P187; Kumar ASA, 2013, MOL BIOL REP, V40, P1275, DOI 10.1007/s11033-012-2170-2; Lee WH, 2001, VASC MED, V6, P103, DOI 10.1191/135886301680223635; Letonja M, 2004, ACTA CARDIOL, V59, P618, DOI 10.2143/AC.59.6.2005244; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Li JY, 2010, CARDIOLOGY, V116, P271, DOI 10.1159/000316063; Lin NT, 2008, CHINESE J PHYSIOL, V51, P42; Liu D, 2013, GENE; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Mathew Jomal, 2008, Indian Heart J, V60, P223; Matyar S, 2005, CLIN CHIM ACTA, V354, P153, DOI 10.1016/j.cccn.2004.11.022; Meluzin J, 2009, HEART VESSELS, V24, P157, DOI 10.1007/s00380-008-1097-y; Milutinovic A, 2005, FOLIA BIOL-PRAGUE, V51, P47; Min BW, 2010, ACTA NEUROL BELG, V110, P255; Miyamoto Y, 2000, HUM MOL GENET, V9, P2629, DOI 10.1093/hmg/9.18.2629; Miyamoto Y, 1998, HYPERTENSION, V32, P3, DOI 10.1161/01.HYP.32.1.3; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Motawi T, 2011, ANGIOLOGY, V62, P191, DOI 10.1177/0003319710373094; Naber CK, 2001, AM J PHYSIOL-HEART C, V281, pH1908, DOI 10.1152/ajpheart.2001.281.5.H1908; Nakagami H, 1999, J THROMB THROMBOLYS, V8, P191, DOI 10.1023/A:1008954018658; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Narne P, 2013, J DIABETES COMPLICAT, V27, P255, DOI 10.1016/j.jdiacomp.2012.10.009; Nassar BA, 2001, AM HEART J, V142, P586, DOI 10.1067/mhj.2001.118113; Odawara M, 1998, DIABETOLOGIA, V41, P365, DOI 10.1007/s001250050917; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Park Jeong-Euy, 2000, Korean Journal of Internal Medicine, V15, P65; Persu A, 2002, HUM MOL GENET, V11, P229, DOI 10.1093/hmg/11.3.229; Philip I, 1999, CIRCULATION, V99, P3096, DOI 10.1161/01.CIR.99.24.3096; Poirier O, 1999, EUR J CLIN INVEST, V29, P284; Pulkkinen A, 2000, J MOL MED-JMM, V78, P372, DOI 10.1007/s001090000124; Ragia Georgia, 2010, Hum Genomics, V4, P375; Rahimi Z, 2012, ANGIOLOGY, V63, P131, DOI 10.1177/0003319711409741; Rai H, 2012, MOL BIOL REP, V39, P5995, DOI 10.1007/s11033-011-1412-z; Rankinen T, 2000, HYPERTENSION, V36, P885, DOI 10.1161/01.HYP.36.5.885; Rao S, 2005, ETHNIC DIS, V15, P191; Rios DLS, 2005, CLIN CHIM ACTA, V362, P138, DOI 10.1016/j.cccn.2005.06.012; Rios DLS, 2007, ATHEROSCLEROSIS, V193, P135, DOI 10.1016/j.atherosclerosis.2006.05.041; Rossi GP, 2003, J AM COLL CARDIOL, V41, P930, DOI 10.1016/S0735-1097(02)03012-7; Saini V, 2012, DIABETES METAB SYND, V6, P106, DOI 10.1016/j.dsx.2012.05.001; Saini V, 2011, DIS MARKERS, V31, P215, DOI [10.1155/2011/419708, 10.3233/DMA-2011-0819]; Salimi S, 2006, INDIAN J MED RES, V124, P683; Salimi Saeedeh, 2012, Pathophysiology, V19, P157, DOI 10.1016/j.pathophys.2012.04.003; Salimi S, 2010, ANN SAUDI MED, V30, P33, DOI [10.5144/0256-4947.59370, 10.4103/0256-4947.59370]; Salom MG, 2005, AM J PHYSIOL-REG I, V289, pR1459, DOI 10.1152/ajpregu.00746.2004; Sampalo MF, 2007, CLIN CHIM ACTA, V377, P154, DOI 10.1016/j.cca.2006.09.013; Sandrim VC, 2006, ATHEROSCLEROSIS, V189, P241, DOI 10.1016/j.atherosclerosis.2005.12.011; Savvidou MD, 2001, HYPERTENSION, V38, P1289, DOI 10.1161/hy1201.097305; Schmoelzer I, 2003, EUR J CLIN INVEST, V33, P191, DOI 10.1046/j.1365-2362.2003.01108.x; Shimasaki Y, 1998, J AM COLL CARDIOL, V31, P1506, DOI 10.1016/S0735-1097(98)00167-3; Sigusch HH, 2000, SCAND J CLIN LAB INV, V60, P229, DOI 10.1080/003655100750044884; Szperl M, 2008, MED SCI MONITOR, V14, pCR611; Takagi S, 2001, THROMB HAEMOSTASIS, V86, P1339; Tamemoto H, 2008, DIABETES RES CLIN PR, V80, P275, DOI 10.1016/j.diabres.2007.12.019; Tangurek B, 2006, HEART VESSELS, V21, P285, DOI 10.1007/s00380-005-0902-0; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Tian GX, 2013, MOL MED REP, V7, P1310, DOI 10.3892/mmr.2013.1301; Tsukada T, 1998, BIOCHEM BIOPH RES CO, V245, P190, DOI 10.1006/bbrc.1998.8267; Vasilakou M, 2008, ACTA CARDIOL, V63, P609, DOI 10.2143/AC.63.5.2033229; Wang CL, 2001, J FORMOS MED ASSOC, V100, P736; Wang XL, 2000, FEBS LETT, V471, P45, DOI 10.1016/S0014-5793(00)01356-9; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Wang XL, 1997, ARTERIOSCL THROM VAS, V17, P3147, DOI 10.1161/01.ATV.17.11.3147; Yang YJ, 2014, INT J MOL SCI, V15, P7987, DOI 10.3390/ijms15057987; Yoon Y, 2000, CLIN CHEM, V46, P1626; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785; Zhang K, 2012, THROMB RES, V130, P192, DOI 10.1016/j.thromres.2012.02.015; Zigra AM, 2013, DIS MARKERS, V34, P431, DOI [10.1155/2013/235056, 10.3233/DMA-130987]	126	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113363	10.1371/journal.pone.0113363	http://dx.doi.org/10.1371/journal.pone.0113363			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409023	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200103
J	Rohrich, WG; Hardiess, G; Mallot, HA				Roehrich, Wolfgang G.; Hardiess, Gregor; Mallot, Hanspeter A.			View-Based Organization and Interplay of Spatial Working and Long-Term Memories	PLOS ONE			English	Article							PATH-INTEGRATION; NEURAL BASIS; REPRESENTATION; NAVIGATION; PARAHIPPOCAMPAL; RECOGNITION; HIPPOCAMPUS; INSIGHTS; VISION; CORTEX	Space perception provides egocentric, oriented views of the environment from which working and long-term memories are constructed. "Allocentric'' (i.e. position-independent) long-term memories may be organized as graphs of recognized places or views but the interaction of such cognitive graphs with egocentric working memories is unclear. Here we present a simple coherent model of view-based working and long-term memories, together with supporting evidence from behavioral experiments. The model predicts (i) that within a given place, memories for some views may be more salient than others, (ii) that imagery of a target square should depend on the location where the recall takes place, and (iii) that recall favors views of the target square that would be obtained when approaching it from the current recall location. In two separate experiments in an outdoor urban environment, pedestrians were approached at various interview locations and asked to draw sketch maps of one of two well-known squares. Orientations of the sketch map productions depended significantly on distance and direction of the interview location from the target square, i. e. different views were recalled at different locations. Further analysis showed that location-dependent recall is related to the respective approach direction when imagining a walk from the interview location to the target square. The results are consistent with a view-based model of spatial long-term and working memories and their interplay.	[Roehrich, Wolfgang G.; Hardiess, Gregor; Mallot, Hanspeter A.] Univ Tubingen, Dept Biol, Cognit Neurosci Unit, Tubingen, Germany	Eberhard Karls University of Tubingen	Mallot, HA (corresponding author), Univ Tubingen, Dept Biol, Cognit Neurosci Unit, Tubingen, Germany.	hanspeter.mallot@uni-tuebingen.de	Mallot, Hanspeter A/H-7888-2016		Werner Reichardt Center for Integrative Neuroscience (CIN) at the University of Tubingen; Deutsche Forschungsgemeinschaft within the Excellence Initiative [EXC 307]; German Federal Ministry of Education and Research within the Tubingen Bernstein Center for Computational Neuroscience [01GQ1002A]	Werner Reichardt Center for Integrative Neuroscience (CIN) at the University of Tubingen; Deutsche Forschungsgemeinschaft within the Excellence Initiative(German Research Foundation (DFG)); German Federal Ministry of Education and Research within the Tubingen Bernstein Center for Computational Neuroscience	This work was carried out at the Department of Biology of the University of Tubingen. WGR received additional support from the Werner Reichardt Center for Integrative Neuroscience (CIN) at the University of Tubingen. The CIN is an Excellence Cluster funded by the Deutsche Forschungsgemeinschaft (www.dfg.de) within the Excellence Initiative under grant number EXC 307. Additional support was provided by the German Federal Ministry of Education and Research (www.bmbf.de) within the Tubingen Bernstein Center for Computational Neuroscience under grant number 01GQ1002A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basten K, 2012, SPATIAL COGNITION, V7463, P378; Batschelet E, 1981, CIRCULAR STAT BIOL; Berens P., 2009, J STAT SOFTW, V31; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; BULTHOFF HH, 1995, CEREB CORTEX, V5, P247, DOI 10.1093/cercor/5.3.247; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Carruthers P, 2013, P NATL ACAD SCI USA, V110, P10371, DOI 10.1073/pnas.1301195110; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Farrell MJ, 1998, J EXP PSYCHOL LEARN, V24, P227, DOI 10.1037/0278-7393.24.1.227; Franz MO, 1998, AUTON ROBOT, V5, P111, DOI 10.1023/A:1008821210922; Furuya Y, 2014, HIPPOCAMPUS, V24, P113, DOI 10.1002/hipo.22209; Gaussier P, 2002, BIOL CYBERN, V86, P15, DOI 10.1007/s004220100269; Gillner S, 2008, COGNITION, V109, P105, DOI 10.1016/j.cognition.2008.07.018; Giudice NA, 2013, SPAT COGN COMPUT, V13, P103, DOI 10.1080/13875868.2012.678522; Grusser O J, 1982, Hum Neurobiol, V1, P73; Hardiess G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018494; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Ison MJ, 2011, J NEUROPHYSIOL, V106, P1713, DOI 10.1152/jn.00576.2010; Klatzky R. L., 1998, Spatial Cognition. An Interdisciplinary Approach to Representing and Processing Spatial Knowledge, P1; Lambrey S, 2012, CEREB CORTEX, V22, P166, DOI 10.1093/cercor/bhr101; Land MF, 2014, PHILOS T R SOC B, V369; Loomis J. M., 2013, MULTISENSORY IMAGERY, P131, DOI [10.1007/978-1-4614-5879-1_8, DOI 10.1007/978-1-4614-5879-1_8]; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; Mallot HA, 2000, PERCEPTION, V29, P43, DOI 10.1068/p2865; Mallot HA, 2009, IMAGE VISION COMPUT, V27, P1658, DOI 10.1016/j.imavis.2008.09.001; Meilinger T, 2008, COGNITIVE SCI, V32, P755, DOI 10.1080/03640210802067004; Mellet E, 2002, CEREB CORTEX, V12, P1322, DOI 10.1093/cercor/12.12.1322; Moller R, 2010, AUTON ROBOT, V29, P253, DOI 10.1007/s10514-010-9195-y; Montello D. R., 1993, Spatial Information Theory. A Theoretical Basis for GIS. European Conference, COSIT '93 Proceedings, P312; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; Nasr S, 2013, NEUROIMAGE, V83, P892, DOI 10.1016/j.neuroimage.2013.07.030; Philbeck JW, 1997, J EXP PSYCHOL HUMAN, V23, P72, DOI 10.1037/0096-1523.23.1.72; Piccardi L, 2013, NEUROL SCI, V34, P971, DOI 10.1007/s10072-012-1175-x; Pickup LC, 2013, BIOL CYBERN, V107, P449, DOI 10.1007/s00422-013-0558-2; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Schindler A, 2013, CURR BIOL, V23, P177, DOI 10.1016/j.cub.2012.11.060; SCHOLKOPF B, 1995, ADAPT BEHAV, V3, P311, DOI 10.1177/105971239500300303; Tatler BW, 2011, PHILOS T R SOC B, V366, P596, DOI 10.1098/rstb.2010.0188; ULLMAN S, 1991, IEEE T PATTERN ANAL, V13, P992, DOI 10.1109/34.99234; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wang RF, 2002, TRENDS COGN SCI, V6, P376, DOI 10.1016/S1364-6613(02)01961-7; Wang RF, 2003, PSYCHON B REV, V10, P981, DOI 10.3758/BF03196562; Wang RXF, 2003, J EXP PSYCHOL LEARN, V29, P398, DOI 10.1037/0278-7393.29.3.398; Wiener JM., 2003, SPAT COGN COMPUT, V3, P331, DOI [10.1207/s15427633scc0304_5, DOI 10.1207/S15427633SCC0304_5]; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Wolbers T, 2007, J NEUROSCI, V27, P9408, DOI 10.1523/JNEUROSCI.2146-07.2007	50	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112793	10.1371/journal.pone.0112793	http://dx.doi.org/10.1371/journal.pone.0112793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409437	Green Published, gold, Green Submitted			2022-12-27	WOS:000345533200041
J	Ye, CT; Ji, GL; Li, L; Liang, C				Ye, Congting; Ji, Guoli; Li, Lei; Liang, Chun			detectIR: A Novel Program for Detecting Perfect and Imperfect Inverted Repeats Using Complex Numbers and Vector Calculation	PLOS ONE			English	Article							DNA PALINDROMES; CRUCIFORM STRUCTURES; GENOME; GENE; REPLICATION; EFFICIENT; SEQUENCE; EXPRESSION; ALGORITHM; PROMOTER	Inverted repeats are present in abundance in both prokaryotic and eukaryotic genomes and can form DNA secondary structures - hairpins and cruciforms that are involved in many important biological processes. Bioinformatics tools for efficient and accurate detection of inverted repeats are desirable, because existing tools are often less accurate and time consuming, sometimes incapable of dealing with genome-scale input data. Here, we present a MATLAB-based program called detectIR for the perfect and imperfect inverted repeat detection that utilizes complex numbers and vector calculation and allows genome-scale data inputs. A novel algorithm is adopted in detectIR to convert the conventional sequence string comparison in inverted repeat detection into vector calculation of complex numbers, allowing non-complementary pairs (mismatches) in the pairing stem and a non-palindromic spacer (loop or gaps) in the middle of inverted repeats. Compared with existing popular tools, our program performs with significantly higher accuracy and efficiency. Using genome sequence data from HIV-1, Arabidopsis thaliana, Homo sapiens and Zea mays for comparison, detectIR can find lots of inverted repeats missed by existing tools whose outputs often contain many invalid cases. detectIR is open source and its source code is freely available at: https://sourceforge.net/projects/detectir.	[Ye, Congting; Ji, Guoli; Li, Lei] Xiamen Univ, Dept Automat, Xiamen 361005, Fujian, Peoples R China; [Ye, Congting; Li, Lei; Liang, Chun] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Ji, Guoli] Xiamen Univ, Innovat Ctr Cell Biol, Xiamen 361005, Fujian, Peoples R China; [Liang, Chun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Xiamen University; University System of Ohio; Miami University; Xiamen University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Ji, GL (corresponding author), Xiamen Univ, Dept Automat, Xiamen 361005, Fujian, Peoples R China.	glji@xmu.edu.cn; liangc@miamioh.edu	Li, Lei/AGZ-4207-2022	Li, Lei/0000-0002-8828-5199; Ye, Congting/0000-0003-4803-2098	National Institutes of Health National Institute of General Medical Sciences grant [1R15GM94732-1 A1]; National Natural Science Foundation of China [61174161, 61375077, 61201358]; Natural Science Foundation of Fujian Province of China [2012J01154]; specialized Research Fund for the Doctoral Program of Higher Education of China [20130121130004, 20120121120038]; Fundamental Research Funds for the Central Universities in China [2013121025, 201412G009, CBX2014007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094732] Funding Source: NIH RePORTER	National Institutes of Health National Institute of General Medical Sciences grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities in China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported partially by National Institutes of Health National Institute of General Medical Sciences grant (1R15GM94732-1 A1 to CL), the National Natural Science Foundation of China (61174161, 61375077 and 61201358), the Natural Science Foundation of Fujian Province of China (2012J01154), the specialized Research Fund for the Doctoral Program of Higher Education of China (20130121130004 and 20120121120038), and the Fundamental Research Funds for the Central Universities in China (2013121025, 201412G009 and CBX2014007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLERS T, 1995, J MOL BIOL, V252, P70, DOI 10.1006/jmbi.1994.0476; Bhattacharya M, 2011, BIOCHEM BIOPH RES CO, V415, P17, DOI 10.1016/j.bbrc.2011.09.143; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Chasovskikh S, 2005, CYTOM PART A, V68A, P21, DOI 10.1002/cyto.a.20187; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Gupta R, 2006, SIGNAL PROCESS, V86, P2067, DOI 10.1016/j.sigpro.2005.10.008; Hily JM, 2007, J AM SOC HORTIC SCI, V132, P850, DOI 10.21273/JASHS.132.6.850; Howe KJ, 1997, P NATL ACAD SCI USA, V94, P12467, DOI 10.1073/pnas.94.23.12467; Hu LC, 2013, NATURE, V501, P569, DOI 10.1038/nature12500; Humphrey-Dixon EL, 2011, GENOME, V54, P934, DOI [10.1139/g11-058, 10.1139/G11-058]; LILLEY DMJ, 1980, P NATL ACAD SCI-BIOL, V77, P6468, DOI 10.1073/pnas.77.11.6468; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Lu L, 2007, FUNCT INTEGR GENOMIC, V7, P221, DOI 10.1007/s10142-007-0047-6; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Nakade K, 2011, MICROBIOL RES, V166, P484, DOI 10.1016/j.micres.2010.09.004; Nasim FUH, 2002, RNA, V8, P1078, DOI 10.1017/S1355838202024056; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Pelham C, 2013, BBA-GENE REGUL MECH, V1829, P1257, DOI 10.1016/j.bbagrm.2013.10.002; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Smith GR, 2008, GENE DEV, V22, P2612, DOI 10.1101/gad.1724708; Sreeskandarajan S, 2014, BIOINFORMATICS, V30, P887, DOI 10.1093/bioinformatics/btt651; Strawbridge EM, 2010, CURR GENET, V56, P321, DOI 10.1007/s00294-010-0302-6; Tulin A, 2003, CURR TOP DEV BIOL, V56, P55, DOI 10.1016/S0070-2153(03)01007-X; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yang GJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-186	26	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e0113349	10.1371/journal.pone.0113349	http://dx.doi.org/10.1371/journal.pone.0113349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409465	Green Published, Green Submitted, gold			2022-12-27	WOS:000345533200101
J	Mehta, RG; Hawthorne, M; Mehta, RR; Torres, KEO; Peng, XJ; McCormick, DL; Kopelovich, L				Mehta, Rajendra G.; Hawthorne, Michael; Mehta, Rajeshwari R.; Torres, Karen E. O.; Peng, Xinjian; McCormick, David L.; Kopelovich, Levy			Differential Roles of ER alpha and ER beta in Normal and Neoplastic Development in the Mouse Mammary Gland	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ESTROGEN-RECEPTORS; EXPRESSION; LIGAND; GPR30; GENE	The present experiments were performed to determine the roles of estrogen receptors alpha and beta (ER alpha and ER beta) in normal and neoplastic development in the mouse mammary gland. In wild-type mice, in vivo administration of estradiol (E) + progesterone (P) stimulated mammary ductal growth and alveolar differentiation. Mammary glands from mice in which the ER beta gene has been deleted (beta ERKO mice) demonstrated normal ductal growth and differentiation in response to E + P. By contrast, mammary glands from mice in which the ERa gene has been deleted (alpha ERKO mice) demonstrated only rudimentary ductal structures that did not differentiate in response to E + P. EGF demonstrates estrogen-like activity in the mammary glands of aERKO mice: treatment of alpha ERKO mice with EGF + P (without E) supported normal mammary gland development, induced expression of progesterone receptor (PR), and increased levels of G-protein-coupled receptor (GPR30) protein. Mammary gland development in beta ERKO mice treated with EGF + P was comparable to that of wild-type mice receiving EGF + P; EGF had no statistically significant effects on the induction of PR or expression of GPR30 in mammary glands harvested from either wild-type mice or beta ERKO mice. In vitro exposure of mammary glands to 7,12-imethylbenz[a] anthracene (DMBA) induced preneoplastic mammary alveolar lesions (MAL) in glands from wild-type mice and beta ERKO mice, but failed to induce MAL in mammary glands from alpha ERKO mice. Microarray analysis of DMBA-treated mammary glands identified 28 functional pathways whose expression was significantly different in alpha ERKO mice versus both beta ERKO and wild-type mice; key functions that were differentially expressed in alpha ERKO mice included cell division, cell proliferation, and apoptosis. The data demonstrate distinct roles for ER alpha and ER beta in normal and neoplastic development in the mouse mammary gland, and suggest that EGF can mimic the ER alpha-mediated effects of E in this organ.	[Mehta, Rajendra G.; Hawthorne, Michael; Mehta, Rajeshwari R.; Peng, Xinjian; McCormick, David L.] IIT Res Inst, Chicago, IL USA; [Torres, Karen E. O.] GenUs Biosyst, Northbrook, IL USA; [Kopelovich, Levy] NCI, Canc Prevent Div, Rockville, MD USA	Illinois Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mehta, RG (corresponding author), IIT Res Inst, Chicago, IL USA.	RMehta@iitri.org			Division of Cancer Prevention, National Cancer Institute (NCI), Bethesda, Maryland [NO1-CN-43301]; Division of Cancer Prevention Branch, NCI	Division of Cancer Prevention, National Cancer Institute (NCI), Bethesda, Maryland; Division of Cancer Prevention Branch, NCI	Funding provided by Division of Cancer Prevention, National Cancer Institute (NCI), Bethesda, Maryland NO1-CN-43301 (RGM) and LK, Division of Cancer Prevention Branch, NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Ankrapp DP, 1998, J CELL PHYSIOL, V174, P251, DOI 10.1002/(SICI)1097-4652(199802)174:2<251::AID-JCP12>3.0.CO;2-F; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; Cotrim CZ, 2013, ONCOGENE, V32, P2390, DOI 10.1038/onc.2012.261; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Daniel A.R., 2014, ONCOGENE; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Harrison H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3396; Heldering N, 2007, ESTROGEN RECEPTORS D, V37, P905; Higa GM, 2013, INT J CANCER, V284036, P2013; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; Jonsson P, 2014, ENDOCR-RELAT CANCER, V21, P143, DOI 10.1530/ERC-13-0444; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Leitman DC, 2012, SEMIN REPROD MED, V30, P14, DOI 10.1055/s-0031-1299593; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Mehta RG, 2008, CURR MED CHEM, V15, P2785, DOI 10.2174/092986708786242787; Mehta RG, 2000, J NATL CANCER I, V92, P418, DOI 10.1093/jnci/92.5.418; Mo ZQ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3581; Paige LA, 1997, P NATL ACAD SCI USA, V30, P3999; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Silva E, 2010, TOXICOL APPL PHARM, V45, P160; Skandalis SS, 2013, MATRIX BIOL, DOI 10.1016; Stope MB, 2010, BREAST CANCER RES TR, V120, P357, DOI 10.1007/s10549-009-0393-2; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Zhao C, 2008, NUCL RECEPTOR SIGNAL, DOI [10.1621/inrs.06003, DOI 10.1621/INRS.06003]	26	18	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113175	10.1371/journal.pone.0113175	http://dx.doi.org/10.1371/journal.pone.0113175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405629	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300089
J	Saeed, S; Waje-Andreassen, U; Fromm, A; Oygarden, H; Kokorina, MV; Naess, H; Gerdts, E				Saeed, Sahrai; Waje-Andreassen, Ulrike; Fromm, Annette; Oygarden, Halvor; Kokorina, Marina V.; Naess, Halvor; Gerdts, Eva			Early Vascular Aging in Young and Middle-Aged Ischemic Stroke Patients: The Norwegian Stroke in the Young Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; METABOLIC SYNDROME; AORTIC STIFFNESS; INDEPENDENT PREDICTOR; CLINICAL-APPLICATIONS; FOLLOW-UP; MORTALITY; ADULTS; GUIDELINES	Background: Ischemic stroke survivors have high risk of cardiovascular morbidity and mortality even at young age, suggesting that early arterial aging is common among such patients. Methods: We measured aortic stiffness by carotid-femoral pulse wave velocity (PWV) in 205 patients (69% men) aged 15-60 years with acute ischemic stroke in the prospective Norwegian Stroke in the Young Study. High for age carotid-femoral PWV was identified in the reference normogram. Results: Patients were on average 49610 years old, 34% had a history of hypertension and 37% had metabolic syndrome (MetS). In the total study population, higher PWV was associated with history of hypertension (beta = 0.18), higher age (beta = 0.34), systolic blood pressure (BP) (beta = 0.28) and serum creatinine (beta = 0.18) and lower high-density lipoprotein (HDL) cholesterol (beta = -0.10, all p< 0.01) in multivariate linear regression analysis (multiple R-2 = 0.42, p< 0.001). High for age PWV was found in 18% of patients. In univariate analyses, known hypertension was associated with a 6-fold, MetS with a 4-fold and presence of carotid plaque with a 3.7-fold higher risk for high for age PWV (all p, 0.01). In multiple logistic regression analysis higher systolic BP (odds ratio [OR] 1.04; 95% confidence interval [CI] 1.02-1.06; p, 0.01), history of hypertension (OR 3.59; 95% CI 1.52-8.51; p< 0.01), low HDL cholesterol (OR 3.03; 95% CI 1.00-9.09; p = 0.05) and higher serum creatinine (OR 1.04; 95% CI 1.01-1.06; p, 0.01) were associated with high for age PWV. Conclusions: Higher PWV is common in younger and middle-aged ischemic stroke patients and associated with a clustering of classical cardiovascular risk factors.	[Saeed, Sahrai; Kokorina, Marina V.] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Saeed, Sahrai; Gerdts, Eva] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Waje-Andreassen, Ulrike; Naess, Halvor] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Fromm, Annette; Oygarden, Halvor] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Saeed, S (corresponding author), Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway.	sahrai.saeed@helse-bergen.no	Fromm, Annette/I-1575-2019	Fromm, Annette/0000-0003-0621-570X	West-Norwegian Regional Health Authority; Simon Fougner Hartmann's Family Fund; university	West-Norwegian Regional Health Authority; Simon Fougner Hartmann's Family Fund; university	This study was financially supported by research grants from The West-Norwegian Regional Health Authority, the university, and Simon Fougner Hartmann's Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Agnoletti D, 2013, ATHEROSCLEROSIS, V230, P315, DOI 10.1016/j.atherosclerosis.2013.07.054; Casalnuovo G, 2012, AM J HYPERTENS, V25, P739, DOI 10.1038/ajh.2012.38; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Fromm A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-89; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gasecki D, 2012, ATHEROSCLEROSIS, V225, P348, DOI 10.1016/j.atherosclerosis.2012.09.024; Genuth S, 2003, DIABETES CARE, V26, P3160; Grabska K, 2009, CEREBROVASC DIS, V27, P187, DOI 10.1159/000185611; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mattsson N, 2008, EUR HEART J, V29, P784, DOI 10.1093/eurheartj/ehm576; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Nilsson PM, 2014, BLOOD PRESSURE, V23, P17, DOI 10.3109/08037051.2013.796142; Nilsson PM, 2013, J HYPERTENS, V31, P1517, DOI 10.1097/HJH.0b013e328361e4bd; Paini A, 2006, HYPERTENSION, V47, P371, DOI 10.1161/01.HYP.0000202052.25238.68; Putaala J, 2010, ANN NEUROL, V68, P661, DOI 10.1002/ana.22091; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Tuttolomondo A, 2012, ATHEROSCLEROSIS, V225, P216, DOI 10.1016/j.atherosclerosis.2012.08.027; Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3; Waje-Andreassen U, 2013, EUR J NEUROL, V20, P818, DOI 10.1111/ene.12073; Wang F, 2011, EUR J CLIN INVEST, V41, P929, DOI 10.1111/j.1365-2362.2011.02481.x	28	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112814	10.1371/journal.pone.0112814	http://dx.doi.org/10.1371/journal.pone.0112814			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405619	gold, Green Published			2022-12-27	WOS:000347121300054
J	Zanke, CD; Ling, J; Plieske, J; Kollers, S; Ebmeyer, E; Korzun, V; Argillier, O; Stiewe, G; Hinze, M; Neumann, K; Ganal, MW; Roder, MS				Zanke, Christine D.; Ling, Jie; Plieske, Joerg; Kollers, Sonja; Ebmeyer, Erhard; Korzun, Viktor; Argillier, Odile; Stiewe, Gunther; Hinze, Maike; Neumann, Kerstin; Ganal, Martin W.; Roeder, Marion S.			Whole Genome Association Mapping of Plant Height in Winter Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DWARFING GENE RHT8; GREEN-REVOLUTION; WIDE ASSOCIATION; CHROMOSOME 2D; KERNEL NUMBER; GRAIN-YIELD; GIBBERELLIN; RICE; BARLEY	The genetic architecture of plant height was investigated in a set of 358 recent European winter wheat varieties plus 14 spring wheat varieties based on field data in eight environments. Genotyping of diagnostic markers revealed the Rht-D1b mutant allele in 58% of the investigated varieties, while the Rht-B1b mutant was only present in 7% of the varieties. Rht-D1 was significantly associated with plant height by using a mixed linear model and employing a kinship matrix to correct for population stratification. Further genotyping data included 732 microsatellite markers, resulting in 770 loci, of which 635 markers were placed on the ITMI map plus a set of 7769 mapped SNP markers genotyped with the 90 k iSELECT chip. When Bonferroni correction was applied, a total of 153 significant marker-trait associations (MTAs) were observed for plant height and the SSR markers (-log(10) (P-value) >= 4.82) and 280 (-log(10) (P-value) >= 5.89) for the SNPs. Linear regression between the most effective markers and the BLUEs for plant height indicated additive effects for the MTAs of different chromosomal regions. Analysis of syntenic regions in the rice genome revealed closely linked rice genes related to gibberellin acid (GA) metabolism and perception, i.e. GA20 and GA2 oxidases orthologous to wheat chromosomes 1A, 2A, 3A, 3B, 5B, 5D and 7B, ent-kaurenoic acid oxidase orthologous to wheat chromosome 7A, ent-kaurene synthase on wheat chromosome 2B, as well as GA-receptors like DELLA genes orthologous to wheat chromosomes 4B, 4D and 7A and genes of the GID family orthologous to chromosomes 2B and 5B. The data indicated that besides the widely used GA-insensitive dwarfing genes Rht-B1 and Rht-D1 there is a wide spectrum of loci available that could be used for modulating plant height in variety development.	[Zanke, Christine D.; Ling, Jie; Neumann, Kerstin; Roeder, Marion S.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Plieske, Joerg; Ganal, Martin W.] TraitGenet GmbH, Gatersleben, Germany; [Kollers, Sonja; Ebmeyer, Erhard; Korzun, Viktor] KWS LOCHOW GMBH, Bergen, Germany; [Argillier, Odile] Syngenta France SAS, Orgerus, France; [Stiewe, Gunther; Hinze, Maike] Syngenta Seeds GmbH, Bad Salzuflen, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; KWS Saat AG; Syngenta; Syngenta	Roder, MS (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.	roder@ipk-gatersleben.de	Korzun, Viktor/U-6352-2019	Korzun, Viktor/0000-0003-0760-8249; Neumann, Kerstin/0000-0001-7451-7086; Roder, Marion/0000-0002-9313-0650; Ling, Jie/0000-0001-7054-5119	German Federal Ministry of Education and Research (BMBF) [0315067, 0315947]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was funded by the Plant Biotechnology program of the German Federal Ministry of Education and Research (BMBF) within the frame of the projects GABI-Wheat and VALID (project numbers 0315067 and 0315947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Barboza L, 2013, P NATL ACAD SCI USA, V110, P15818, DOI 10.1073/pnas.1314979110; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Borner A, 1997, THEOR APPL GENET, V95, P1133, DOI 10.1007/s001220050673; BORNER A, 1993, PLANT BREEDING, V111, P204, DOI 10.1111/j.1439-0523.1993.tb00631.x; Brown PJ, 2008, GENETICS, V180, P629, DOI 10.1534/genetics.108.092239; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chandler PM, 2013, J EXP BOT, V64, P1603, DOI 10.1093/jxb/ert022; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Ellis MH, 2005, THEOR APPL GENET, V111, P423, DOI 10.1007/s00122-005-2008-6; Ellis MH, 2004, FUNCT PLANT BIOL, V31, P583, DOI 10.1071/FP03207; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Griffiths S, 2012, MOL BREEDING, V29, P159, DOI 10.1007/s11032-010-9534-x; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jain M, 2006, GENOMICS, V88, P360, DOI 10.1016/j.ygeno.2006.04.008; Jia QJ, 2011, THEOR APPL GENET, V122, P1451, DOI 10.1007/s00122-011-1544-5; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Khlestkina EK, 2010, MOL BREEDING, V25, P251, DOI 10.1007/s11032-009-9326-3; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Kollers S, 2014, MOL BREEDING, V34, P363, DOI 10.1007/s11032-014-0039-x; Kollers S, 2013, MOL BREEDING, V32, P411, DOI 10.1007/s11032-013-9880-6; Kollers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057500; Korzun V, 1997, PLANT BREEDING, V116, P227, DOI 10.1111/j.1439-0523.1997.tb00987.x; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Linkiewicz AM, 2004, GENETICS, V168, P665, DOI 10.1534/genetics.104.034835; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matthies IE, 2009, MOL BREEDING, V23, P139, DOI 10.1007/s11032-008-9221-3; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Parvathaneni RK, 2013, G3-GENES GENOM GENET, V3, P563, DOI 10.1534/g3.113.005587; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pestsova E, 2002, THEOR APPL GENET, V106, P84, DOI 10.1007/s00122-002-0998-x; PESTSOVA EG, 2008, CEREAL RES COMMUN, V36, P235; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rebetzke GJ, 2000, AUST J AGR RES, V51, P235, DOI 10.1071/AR99043; Rebetzke GJ, 2001, AUST J AGR RES, V52, P1221, DOI 10.1071/AR01042; Roder MS, 1998, GENETICS, V149, P2007; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Spielmeyer W, 2004, THEOR APPL GENET, V109, P1303, DOI 10.1007/s00122-004-1745-2; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tosovic-Maric B., 2008, GENETIKA, V40, P31, DOI [10.2298/GENSR0801031T, DOI 10.2298/GENSR0801031T]; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Wilhelm EP, 2013, THEOR APPL GENET, V126, P2233, DOI 10.1007/s00122-013-2130-9; Wilhelm EP, 2013, THEOR APPL GENET, V126, P1733, DOI 10.1007/s00122-013-2088-7; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; WINKLER RG, 1995, PLANT CELL, V7, P1307, DOI 10.1105/tpc.7.8.1307; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zhang B, 2013, MOL BREEDING, V32, P327, DOI 10.1007/s11032-013-9873-5; Zhang JJ, 2013, MOL BREEDING, V32, P771, DOI 10.1007/s11032-013-9905-1; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1	73	108	111	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113287	10.1371/journal.pone.0113287	http://dx.doi.org/10.1371/journal.pone.0113287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405621	Green Published, Green Submitted, gold			2022-12-27	WOS:000347121300096
J	Dwivedi, S; Wahab, R; Khan, F; Mishra, YK; Musarrat, J; Al-Khedhairy, AA				Dwivedi, Sourabh; Wahab, Rizwan; Khan, Farheen; Mishra, Yogendra K.; Musarrat, Javed; Al-Khedhairy, Abdulaziz A.			Reactive Oxygen Species Mediated Bacterial Biofilm Inhibition via Zinc Oxide Nanoparticles and Their Statistical Determination	PLOS ONE			English	Article							ZNO; GROWTH	The formation of bacterial biofilm is a major challenge in clinical applications. The main aim of this study is to describe the synthesis, characterization and biocidal potential of zinc oxide nanoparticles (NPs) against bacterial strain Pseudomonas aeruginosa. These nanoparticles were synthesized via soft chemical solution process in a very short time and their structural properties have been investigated in detail by using X-ray diffraction and transmission electron microscopy measurements. In this work, the potential of synthesized ZnO-NPs (similar to 10-15 nm) has been assessed in-vitro inhibition of bacteria and the formation of their biofilms was observed using the tissue culture plate assays. The crystal violet staining on biofilm formation and its optical density revealed the effect on biofilm inhibition. The NPs at a concentration of 100 mg/mL significantly inhibited the growth of bacteria and biofilm formation. The biofilm inhibition by ZnO-NPs was also confirmed via bio-transmission electron microscopy (Bio-TEM). The Bio-TEM analysis of ZnO-NPs treated bacteria confirmed the deformation and damage of cells. The bacterial growth in presence of NPs concluded the bactericidal ability of NPs in a concentration dependent manner. It has been speculated that the antibacterial activity of NPs as a surface coating material, could be a feasible approach for controlling the pathogens. Additionally, the obtained bacterial solution data is also in agreement with the results from statistical analytical methods.	[Dwivedi, Sourabh; Wahab, Rizwan; Al-Khedhairy, Abdulaziz A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Khan, Farheen] Aligarh Muslim Univ, Dept Chem, Aligarh 202002, Uttar Pradesh, India; [Mishra, Yogendra K.] Univ Kiel, Inst Mat Sci, Kiel, Germany; [Musarrat, Javed] Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh 202002, Uttar Pradesh, India	King Saud University; Aligarh Muslim University; University of Kiel; Aligarh Muslim University	Wahab, R (corresponding author), King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia.	rwahab@ksu.edu.sa	Dwivedi, Sourabh/I-2060-2013; Al-Khedhairy, Abdulaziz A A/F-8327-2011; Wahab, Rizwan/ABF-3961-2020; Khan, Farheen/ABF-4968-2020; Mishra, Yogendra Kumar/G-6241-2010; Musarrat, Javed/N-4094-2019; Musarrat, Javed/I-1942-2013	Al-Khedhairy, Abdulaziz A A/0000-0002-1210-6262; Wahab, Rizwan/0000-0003-0340-3844; Mishra, Yogendra Kumar/0000-0002-8786-9379; dwivedi, sourabh/0000-0002-7591-5358; Wahab, Razak/0000-0002-7167-8201; Musarrat, Javed/0000-0001-5981-3813; Khan, Farheen/0000-0003-0158-0791	Deanship of Scientific Research at King Saud University [RGP-218]	Deanship of Scientific Research at King Saud University(King Saud University)	Rizwan Wahab would like to extend the appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project no. RGP-218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneesh PM, 2007, PROC SPIE, V6639, DOI 10.1117/12.730364; [Anonymous], HARM TRIP GUID VAL A; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Baghbamidi SE, 2012, J ANAL METHODS CHEM, V2012, DOI 10.1155/2012/305872; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Contado C, 2008, ANAL CHEM, V80, P7594, DOI 10.1021/ac8012626; Cullity B.D., 1978, ANSWERS PROBLEMS ELE; Dwivedi S, 2012, SCI TOTAL ENVIRON, V437, P331, DOI 10.1016/j.scitotenv.2012.08.004; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Eshed M, 2012, LANGMUIR, V28, P12288, DOI 10.1021/la301432a; FLETCHER M, 1988, J BACTERIOL, V170, P2027, DOI 10.1128/jb.170.5.2027-2030.1988; Hernandez-Sierra JF, 2008, NANOMED-NANOTECHNOL, V4, P237, DOI 10.1016/j.nano.2008.04.005; FRESTA M, 1995, J PHARM SCI, V84, P895, DOI 10.1002/jps.2600840721; Hamouda T, 1999, J INFECT DIS, V180, P1939, DOI 10.1086/315124; Hernandez-Delgadillo Rene, 2012, Int J Nanomedicine, V7, P2109, DOI 10.2147/IJN.S29854; Khan ST, 2013, ARCH ORAL BIOL, V58, P1804, DOI 10.1016/j.archoralbio.2013.09.011; Kierek-Pearscon K, 2005, ADV APPL MICROBIOL, V57, P79, DOI 10.1016/S0065-2164(05)57003-5; Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Ng SM, 2013, ANAL LETT, V46, P1278, DOI 10.1080/00032719.2012.760100; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Ravikumar S., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P92, DOI 10.1016/S2221-1691(11)60199-8; Segets D, 2009, ACS NANO, V3, P1703, DOI 10.1021/nn900223b; Wahab R, 2007, MATER RES BULL, V42, P1640, DOI 10.1016/j.materresbull.2006.11.035; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, COLLOID SURFACE B, V111, P211, DOI 10.1016/j.colsurfb.2013.06.003; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wahab R, 2013, CHEM ENG J, V226, P154, DOI 10.1016/j.cej.2013.02.128; Wahab R, 2010, NANOSCALE RES LETT, V5, P1675, DOI 10.1007/s11671-010-9694-y; Wahab R, 2010, APPL MICROBIOL BIOT, V87, P1917, DOI 10.1007/s00253-010-2692-2; Wahab R, 2009, SYNTHETIC MET, V159, P2443, DOI 10.1016/j.synthmet.2009.08.006; Yanez-Sedeno P, 2010, TRAC-TREND ANAL CHEM, V29, P939, DOI 10.1016/j.trac.2010.06.006	36	211	213	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111289	10.1371/journal.pone.0111289	http://dx.doi.org/10.1371/journal.pone.0111289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402188	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700014
J	Pang, YN; Liang, YW; Feng, TS; Zhao, S; Wu, H; Chai, YS; Lei, F; Ding, Y; Xing, DM; Du, LJ				Pang, Yu-Nong; Liang, Yin-Wen; Feng, Tian-Shi; Zhao, Shuang; Wu, Hao; Chai, Yu-Shuang; Lei, Fan; Ding, Yi; Xing, Dong-Ming; Du, Li-Jun			Transportation of Berberine into HepG2, HeLa and SY5Y Cells: A Correlation to Its Anti-Cancer Effect	PLOS ONE			English	Article							COPTIDIS-RHIZOMA EXTRACT; CANCER-CELLS; CEREBRAL-ISCHEMIA; APOPTOSIS; RESISTANCE; EXPRESSION; ARREST; DEATH	The anti-cancer activities of berberine (BBR) have been reported extensively in various cancer cell lines. However, the minimal inhibitory concentrations of BBR varied greatly among different cell lines and very few studies have been devoted to elucidate this aspect. In this study, we employed three cancer cell lines, HepG2, HeLa and SY5Y, to compare the transportation and distribution of BBR. HPLC results demonstrated that BBR was capable of penetrating all the cell lines whereas the cumulative concentrations were significantly different. HepG2 cells accumulated higher level of BBR for longer duration than the other two cell lines. Molecular docking studies revealed the BBR binding site on P-glycoprotein 1 (P-gp). In addition, we elucidated that BBR regulated P-gp at both mRNA and protein levels. BBR induced the transcription and translation of P-gp in HeLa and SY5Y cells, whereas BBR inhibited P-gp expression in HepG2 cells. Further study showed that BBR regulates P-gp expression depending on different mechanisms (or affected by different factors) in different cell lines. To summarize, our study has revealed several mechanistic aspects of BBR regulation on P-gp in different cancer cell lines and might shed some useful insights into the use of BBR in the anti-cancer drug development.	[Pang, Yu-Nong; Liang, Yin-Wen; Feng, Tian-Shi; Zhao, Shuang; Chai, Yu-Shuang; Lei, Fan; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Pang, Yu-Nong; Liang, Yin-Wen; Feng, Tian-Shi; Zhao, Shuang; Chai, Yu-Shuang; Lei, Fan; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wu, Hao] NGM Biopharmaceut Inc, San Francisco, CA USA; [Ding, Yi] Tsinghua Univ, Sch Life Sci, Drug Discovery Facil, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Du, LJ (corresponding author), Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	lijundu@mail.tsinghua.edu.cn	Liang, Yinwen/U-2734-2019		National Natural Science Foundation of China [81374006, 81073092]; National S&T Major Special Project for New Drug R&D Program of China [2012ZX09103-201-041, 2012ZX09102-201-008, 2011ZX09101-002-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project for New Drug R&D Program of China	This study was supported by the National Natural Science Foundation of China (81374006 and 81073092) and the National S&T Major Special Project for New Drug R&D Program of China (2012ZX09103-201-041, 2012ZX09102-201-008 and 2011ZX09101-002-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Chen YY, 2008, BIOMED CHROMATOGR, V22, P28, DOI 10.1002/bmc.889; [丁阳平 Ding Yangping], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P1765; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Kosztyu P, 2013, PHARMACOL RES, V67, P79, DOI 10.1016/j.phrs.2012.10.012; [来丽娜 LAI Lina], 2008, [中草药, Chinese Traditional and Herbal Drugs], V39, P244; Lawlor D, 2014, J PHARM SCI-US, V103, P1913, DOI 10.1002/jps.23952; Lin HL, 1999, BRIT J CANCER, V81, P416, DOI 10.1038/sj.bjc.6690710; Liu Shan-Wen, 2011, Shengli Xuebao, V63, P517; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Lu BA, 2010, TOXICOL IN VITRO, V24, P1482, DOI 10.1016/j.tiv.2010.07.017; Luo JY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/545898; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Moon PD, 2011, PHYTOTHER RES, V25, P844, DOI 10.1002/ptr.3353; Muralimanoharan SB, 2009, PROSTATE, V69, P494, DOI 10.1002/pros.20899; Park JJ, 2012, BIOCHEM BIOPH RES CO, V426, P461, DOI 10.1016/j.bbrc.2012.08.091; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; Prabhakar PK, 2011, THER ADV ENDOCRINOL, V2, P103, DOI 10.1177/2042018811411356; Shan YQ, 2013, BIOL PHARM BULL, V36, P1562, DOI 10.1248/bpb.b13-00272; Shigeta K, 2002, BIOSCI BIOTECH BIOCH, V66, P2491, DOI 10.1271/bbb.66.2491; Singh IP, 2013, EXPERT OPIN THER PAT, V23, P215, DOI 10.1517/13543776.2013.746314; Tan YL, 2006, MOL BIOSYST, V2, P250, DOI 10.1039/b517116d; UEDA K, 1987, J BIOL CHEM, V262, P17432; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wang XL, 2005, NEUROSCI LETT, V379, P132, DOI 10.1016/j.neulet.2004.12.050; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Zha WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054349; Zhao Qian, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P259	33	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112937	10.1371/journal.pone.0112937	http://dx.doi.org/10.1371/journal.pone.0112937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402492	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700083
J	Tamayo, T; Schipf, S; Meisinger, C; Schunk, M; Maier, W; Herder, C; Roden, M; Nauck, M; Peters, A; Volzke, H; Rathmann, W				Tamayo, Teresa; Schipf, Sabine; Meisinger, Christine; Schunk, Michaela; Maier, Werner; Herder, Christian; Roden, Michael; Nauck, Matthias; Peters, Annette; Voelzke, Henry; Rathmann, Wolfgang			Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors	PLOS ONE			English	Article							SOUTHERN GERMANY; KORA SURVEY; LIFE-STYLE; MELLITUS; METAANALYSIS; INDIVIDUALS; POPULATIONS; DISPARITIES; HEALTH; EAST	Background: We have previously found regional differences in the prevalence of known type 2 diabetes between northeastern and southern Germany. We aim to also provide prevalence estimates for prediabetes (isolated impaired fasting glucose (i-IFG), isolated glucose intolerance (i-IGT), combined IFG and IGT) and unknown type 2 diabetes for both regions. Methods: Prevalence (95% CI) of prediabetes (i-IFG: fasting glucose 5.6-6.9 mmol/l; i-IGT: 2 h postchallenge gluose 7.8-11.0 mmol/l, oral glucose tolerance test (OGTT), >= 8 h overnight fasting) and unknown diabetes were analyzed in two regional population-based surveys (age group 35-79 years): SHIP-TREND (Study of Health in Pomerania (northeast), 2008-2012) and KORA F4 (Cooperative Health Research in the region of Augsburg (south), 2006-2008). Both studies used similar methods, questionnaires, and identical protocols for OGTT. Overall, 1,980 participants from SHIP-TREND and 2,617 participants from KORA F4 were included. Results: Age-sex-standardized prevalence estimates (95% CI) of prediabetes and unknown diabetes were considerably higher in the northeast (SHIP-TREND: 43.1%; 40.9-45.3% and 7.1%; 5.9-8.2%) than in the south of Germany (KORA F4: 30.1%; 28.4-31.7% and 3.9%; 3.2-4.6%), respectively. In particular, i-IFG (26.4%; 24.5-28.3% vs. 17.2%; 15.7-18.6%) and IFG+IGT (11.2%; 9.8-12.6% vs. 6.6%; 5.7-7.5%) were more frequent in SHIP-TREND than in KORA. In comparison to normal glucose tolerance, the odds of having unknown diabetes (OR, 95% CI: 2.59; 1.84-3.65) or prediabetes (1.98; 1.70-2.31) was higher in the northeast than in the south after adjustment for known risk factors (obesity, lifestyle). Conclusions: The regional differences of prediabetes and unknown diabetes are in line with the geographical pattern of known diabetes in Germany. The higher prevalences in the northeast were not explained by traditional risk factors.	[Tamayo, Teresa; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Schipf, Sabine; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Meisinger, Christine; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Schunk, Michaela; Maier, Werner] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Roden, Michael] Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Herder, Christian; Roden, Michael; Peters, Annette] German Ctr Diabet Res DZD eV, Dusseldorf, Germany; [Herder, Christian; Roden, Michael; Peters, Annette] German Ctr Diabet Res DZD eV, Munich, Germany; [Peters, Annette; Voelzke, Henry] German Ctr Cardiovasc Res DZHK eV, Munich, Germany; [Peters, Annette; Voelzke, Henry] German Ctr Cardiovasc Res DZHK eV, Greifswald, Germany; [Tamayo, Teresa; Schipf, Sabine; Meisinger, Christine; Schunk, Michaela; Maier, Werner; Nauck, Matthias; Voelzke, Henry; Rathmann, Wolfgang] Fed Minist Educ & Res, Competence Network Diabet Mellitus, Dusseldorf, Germany; [Tamayo, Teresa; Schipf, Sabine; Meisinger, Christine; Schunk, Michaela; Maier, Werner; Nauck, Matthias; Voelzke, Henry; Rathmann, Wolfgang] Fed Minist Educ & Res, Competence Network Diabet Mellitus, Munich, Germany; [Tamayo, Teresa; Schipf, Sabine; Meisinger, Christine; Schunk, Michaela; Maier, Werner; Nauck, Matthias; Voelzke, Henry; Rathmann, Wolfgang] Fed Minist Educ & Res, Competence Network Diabet Mellitus, Greifswald, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Greifswald Medical School; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research	Tamayo, T (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.	teresa.tamayo@ddz.uni-duesseldorf.de	Peters, Annette/A-6117-2011; Meisinger, Christine/B-5358-2014; Roden, Michael/AAD-3843-2019	Peters, Annette/0000-0001-6645-0985; Maier, Werner/0000-0003-4356-7296; Schunk, Michaela/0000-0002-1200-1903; Meisinger, Christa/0000-0002-9026-6544	Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research [01GI1110D]; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation (DFG); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia	Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia	The project was funded by a grant of the Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research (support code 01GI1110D). The KORA research platform (KORA, Cooperative Health Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The KORA Diabetes Study was partly funded by a German Research Foundation (DFG) grant to WR from the German Diabetes Center. The German Diabetes Center is funded by grants of the German Federal Ministry of Health, and the Ministry of School, Science and Research of the State of North-Rhine-Westphalia. The Study of Health in Pomerania (SHIP-TREND) is part of the Community Medicine Research net (CMR) at the University of Greifswald, Germany. The CMR encompasses several research projects, which share data from the population-based SHIP project (http://ship.community-medicine.de). Oral glucose tolerance tests were funded by grants given to WR (German Diabetes Center, Dusseldorf, Germany). The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Bongaerts BWC, 2012, DIABETES CARE, V35, P1891, DOI 10.2337/dc11-2028; Chambless L, 1987, 3186 GSF; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133; Herder C, 2013, DIABETOLOGIA; Icks A, 2013, DIABETES CARE, V36, pE53, DOI 10.2337/dc12-0997; International Diabetes Federation, 2013, IDF DIABETES ATLAS; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Meisinger C, 2012, PLOS ONE, V7, P3; Mensink GBM, 2004, EUR J CLIN NUTR, V58, P1000, DOI 10.1038/sj.ejcn.1601923; Muller G, 2013, AM J EPIDEMIOL, V178, P221, DOI 10.1093/aje/kws466; Qiao Q, 2003, DIABETES CARE, V26, P688; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Robert Koch-Institut, 2012, BEITR GES BUND; Robert Koch-Institut, 2004, GBE SCHW GES KIND JU; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Schipf S, 2014, J EPIDEMIOL COMMUN H, V68, P1088, DOI 10.1136/jech-2014-203998; Schulze MB, 1999, ANN NUTR METAB, V43, P235, DOI 10.1159/000012790; Stang A, 2011, EUR J CARDIOV PREV R, V18, P106, DOI 10.1097/HJR.0b013e32833b3305; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Voigt M, 2013, Z GEBURTSH NEONATOL, V217, P24, DOI [10.1055/s-0033-1361096, 10.1055/s-0032-1333256]; Wiesner G, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P266, DOI 10.1007/s00103-003-0793-0; Wilke T, 2013, DEUT MED WOCHENSCHR, V138, P69, DOI 10.1055/s-0032-1327394	37	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113154	10.1371/journal.pone.0113154	http://dx.doi.org/10.1371/journal.pone.0113154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402347	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700119
J	Vaksman, Z; Fonville, NC; Tae, H; Garner, HR				Vaksman, Zalman; Fonville, Natalie C.; Tae, Hongseok; Garner, Harold R.			Exome-Wide Somatic Microsatellite Variation Is Altered in Cells with DNA Repair Deficiencies	PLOS ONE			English	Article							TANDEM REPEATS; FANCONI-ANEMIA; MUTATIONS; CANCER; INSTABILITY; RECOMBINATION; EVOLUTION; LINES; SEQUENCES; EVENTS	Microsatellites (MST), tandem repeats of 1-6 nucleotide motifs, are mutational hot-spots with a bias for insertions and deletions (INDELs) rather than single nucleotide polymorphisms (SNPs). The majority of MST instability studies are limited to a small number of loci, the Bethesda markers, which are only informative for a subset of colorectal cancers. In this paper we evaluate non-haplotype alleles present within next-gen sequencing data to evaluate somatic MST variation (SMV) within DNA repair proficient and DNA repair defective cell lines. We confirm that alleles present within next-gen data that do not contribute to the haplotype can be reliably quantified and utilized to evaluate the SMV without requiring comparisons of matched samples. We observed that SMV patterns found in DNA repair proficient cell lines without DNA repair defects, MCF10A, HEK293 and PD20 RV:D2, had consistent patterns among samples. Further, we were able to confirm that changes in SMV patterns in cell lines lacking functional BRCA2, FANCD2 and mismatch repair were consistent with the different pathways perturbed. Using this new exome sequencing analysis approach we show that DNA instability can be identified in a sample and that patterns of instability vary depending on the impaired DNA repair mechanism, and that genes harboring minor alleles are strongly associated with cancer pathways. The MST Minor Allele Caller used for this study is available at https://github.com/zalmanv/MST_minor_allele_caller.	[Vaksman, Zalman; Fonville, Natalie C.; Tae, Hongseok; Garner, Harold R.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Garner, Harold R.] Genomeon LLC, Floyd, VA 24091 USA	Virginia Polytechnic Institute & State University	Garner, HR (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	garner@vbi.vt.edu			Virginia Bioinformatics Institute Medical Informatics Systems Division; Virginia Bioinformatics Institute Genomics Research Lab Small Grant [CLF-1172]; National Science Foundation [OCI-1124123]; NSF S-STEM grant [DUE-0850198]; Virginia Tech; National Science Foundation (NSF)	Virginia Bioinformatics Institute Medical Informatics Systems Division; Virginia Bioinformatics Institute Genomics Research Lab Small Grant; National Science Foundation(National Science Foundation (NSF)); NSF S-STEM grant; Virginia Tech; National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by the Virginia Bioinformatics Institute Medical Informatics Systems Division director's funds, Virginia Bioinformatics Institute Genomics Research Lab Small Grant (CLF-1172), high performance computing was supported by a grant from the National Science Foundation (OCI-1124123) and NSF S-STEM grant (DUE-0850198). This work was supported by these 4 funds. The first two funds were internal university funds (Virginia Tech), and the latter two were from the National Science Foundation (NSF). None had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. These funds supported portions of author salaries and benefits, computer costs, laboratory supplies, sequencing services, publication costs, and overhead (indirect expenses to the university).	Ananda G, 2013, GENOME BIOL EVOL, V5, P606, DOI 10.1093/gbe/evs116; Bagshaw AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-49; Baptiste BA, 2013, G3-GENES GENOM GENET, V3, P451, DOI 10.1534/g3.112.005173; Barber LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021639; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; Budworth H, 2013, DNA REPAIR, V12, P672, DOI 10.1016/j.dnarep.2013.04.019; Butz J, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-11; CHEN TR, 1983, CANCER GENET CYTOGEN, V10, P351, DOI 10.1016/0165-4608(83)90092-4; Delagoutte E, 2008, J BIOL CHEM, V283, P13341, DOI 10.1074/jbc.M800153200; Eckert KA, 2002, BIOCHEMISTRY-US, V41, P10490, DOI 10.1021/bi025918c; Fonville NC, 2011, J MOL MICROB BIOTECH, V21, P36, DOI 10.1159/000332748; Fonville NC, GENOME BIOL UNPUB; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Grigorova M, 2004, CYTOGENET GENOME RES, V104, P333, DOI 10.1159/000077512; Gundry M, 2012, MUTAT RES-FUND MOL M, V729, P1, DOI [10.1016/j.mrfmmm.2011.10.001, 10.1016/mrfmmm.2011.10.001]; Harris RS, 1999, MUTAT RES-REV MUTAT, V436, P157, DOI 10.1016/S1383-5742(99)00003-4; Hile SE, 2008, NUCLEIC ACIDS RES, V36, P688, DOI 10.1093/nar/gkm1089; Holt JT, 2008, CANCER GENET CYTOGEN, V186, P85, DOI 10.1016/j.cancergencyto.2008.06.013; Hong SP, 2012, EUR J CANCER, V48, P1235, DOI 10.1016/j.ejca.2011.10.005; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Kunz C, 2009, CELL MOL LIFE SCI, V66, P1021, DOI 10.1007/s00018-009-8739-9; Lacroix-Triki M, 2011, INT J CLIN EXP PATHO, V4, P22; Leclercq S, 2010, GENOME BIOL EVOL, V2, P325, DOI 10.1093/gbe/evq023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McIver LJ, 2013, GENE, V516, P328, DOI 10.1016/j.gene.2012.12.068; McIver LJ, BREAST CANC RES TREA; Mestrovic N, 2006, MOL BIOL EVOL, V23, P2316, DOI 10.1093/molbev/msl119; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Ohashi A, 2005, J BIOL CHEM, V280, P14877, DOI 10.1074/jbc.M414669200; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Schor S L, 1995, EXS, V74, P273; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Sirivatanauksorn V, 2001, INT J CANCER, V91, P350, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1049>3.3.CO;2-3; Tae H, 2013, BIOINFORMATICS; Tae H, 2013, BIOINFORMATICS, V29, P1734, DOI 10.1093/bioinformatics/btt277; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Xiao H, 2013, AM J CLIN PATHOL, V140, P341, DOI 10.1309/AJCP8P2DYNKGRBVI; Yoon K, 2013, GENOME RES, V23, P1109, DOI 10.1101/gr.145706.112	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110263	10.1371/journal.pone.0110263	http://dx.doi.org/10.1371/journal.pone.0110263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402475	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700003
J	Bedwell, JS; Compton, MT; Jentsch, FG; Deptula, AE; Goulding, SM; Tone, EB				Bedwell, Jeffrey S.; Compton, Michael T.; Jentsch, Florian G.; Deptula, Andrew E.; Goulding, Sandra M.; Tone, Erin B.			Latent Factor Modeling of Four Schizotypy Dimensions with Theory of Mind and Empathy	PLOS ONE			English	Article							PSYCHOMETRIC SCHIZOTYPY; PSYCHOSIS CONTINUUM; SOCIAL ANHEDONIA; SCHIZOPHRENIA; PERSONALITY; RISK; METAANALYSIS; INDIVIDUALS; DISORDERS; COGNITION	Preliminary evidence suggests that theory of mind and empathy relate differentially to factors of schizotypy. The current study assessed 686 undergraduate students and used structural equation modeling to examine links between a four-factor model of schizotypy with performance on measures of theory of mind (Reading the Mind in the Eyes Test [MIE]) and empathy (Interpersonal Reactivity Index [IRI]). Schizotypy was assessed using three self-report measures which were simultaneously entered into the model. Results revealed that the Negative factor of schizotypy showed a negative relationship with the Empathy factor, which was primarily driven by the Empathic Concern subscale of the IRI and the No Close Friends and Constricted Affect subscales of the Schizotypal Personality Questionnaire. These findings are consistent with a growing body of literature suggesting a relatively specific relationship between negative schizotypy and empathy, and are consistent with several previous studies that found no relationship between MIE performance and schizotypy.	[Bedwell, Jeffrey S.; Jentsch, Florian G.; Deptula, Andrew E.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA; [Compton, Michael T.] Hofstra Univ, Hofstra North Shore LIJ Sch Med, Dept Psychiat, Hempstead, NY 11550 USA; [Goulding, Sandra M.] Emory Univ, Dept Psychol, Grad Sch Arts & Sci, Atlanta, GA 30322 USA; [Tone, Erin B.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA	State University System of Florida; University of Central Florida; Hofstra University; Northwell Health; Emory University; University System of Georgia; Georgia State University	Bedwell, JS (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	jeffrey.bedwell@ucf.edu		Bedwell, Jeffrey/0000-0002-1205-5792; Tone, Erin/0000-0003-4021-1673				Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barragan M, 2011, PSYCHIAT RES, V186, P225, DOI 10.1016/j.psychres.2010.07.051; Bzdok D, 2012, BRAIN STRUCT FUNCT, V217, P783, DOI 10.1007/s00429-012-0380-y; Calkins ME, 2004, SCHIZOPHRENIA BULL, V30, P317, DOI 10.1093/oxfordjournals.schbul.a007081; Chapman J. P., 1995, SCHIZOTYPAL PERSONAL, P79, DOI DOI 10.1017/CBO9780511759031.006; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; Chapman LJ, 1985, CONTROVERSIES SCHIZO; Compton MT, 2009, SCHIZOPHR RES, V111, P46, DOI 10.1016/j.schres.2009.02.012; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1994, J PERS, V62, P369, DOI 10.1111/j.1467-6494.1994.tb00302.x; Eckblad M.L., 1982, REVISED SOCIAL ANHED; Esterberg ML, 2009, CURR PSYCHIAT REP, V11, P179, DOI 10.1007/s11920-009-0028-7; Fogelson DL, 2007, SCHIZOPHR RES, V91, P192, DOI 10.1016/j.schres.2006.12.023; Gooding DC, 2005, J ABNORM PSYCHOL, V114, P170, DOI 10.1037/0021-843X.114.1.170; Gooding DC, 2011, PSYCHIAT RES, V188, P217, DOI 10.1016/j.psychres.2011.04.029; Gooding DC, 2010, PSYCHIAT RES, V178, P73, DOI 10.1016/j.psychres.2010.04.023; Henry JD, 2008, PSYCHIAT RES, V160, P15, DOI 10.1016/j.psychres.2007.04.014; Hirao K, 2008, SCHIZOPHR RES, V105, P165, DOI 10.1016/j.schres.2008.07.021; Hojat M, 2011, ACAD MED, V86, P989, DOI 10.1097/ACM.0b013e31822203d8; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P296, DOI 10.1001/archpsyc.1995.03950160046009; Lenzenweger M.F., 2010, SCHIZOTYPY SCHIZOPHR; LENZENWEGER MF, 1994, SCHIZOPHRENIA BULL, V20, P121, DOI 10.1093/schbul/20.1.121; Fernandez AM, 2011, EUR J PSYCHOL ASSESS, V27, P179, DOI 10.1027/1015-5759/a000065; Marjoram D, 2006, PSYCHIAT RES, V144, P29, DOI 10.1016/j.psychres.2006.01.008; McCleery A, 2012, J NERV MENT DIS, V200, P147, DOI 10.1097/NMD.0b013e3182439533; MERRITT RD, 1993, J PERS ASSESS, V60, P227, DOI 10.1207/s15327752jpa6002_2; Meyer J, 2006, J PSYCHOL, V140, P199, DOI 10.3200/JRLP.140.3.199-207; Mitchell JP, 2006, BRAIN RES, V1079, P66, DOI 10.1016/j.brainres.2005.12.113; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Nelson MT, 2013, NEUROSCI BIOBEHAV R, V37, P317, DOI 10.1016/j.neubiorev.2013.01.004; Pflum MJ, 2013, J NERV MENT DIS, V201, P394, DOI 10.1097/NMD.0b013e31828e1016; Pickup Graham J, 2006, Cogn Neuropsychiatry, V11, P177; Ragsdale KA, 2013, PSYCHIAT RES, V210, P1000, DOI 10.1016/j.psychres.2013.07.027; Ragsdale KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00482; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Raine A, 2006, ANNU REV CLIN PSYCHO, V2, P291, DOI 10.1146/annurev.clinpsy.2.022305.095318; Sacks SA, 2012, PSYCHIAT RES, V196, P115, DOI 10.1016/j.psychres.2011.09.019; Stefanis NC, 2004, SCHIZOPHRENIA BULL, V30, P335, DOI 10.1093/oxfordjournals.schbul.a007083; Thakkar KN, 2010, COGN NEUROPSYCHIATRY, V15, P477, DOI 10.1080/13546801003711350; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Wang Y, 2013, PSYCHIAT RES, V210, P62, DOI 10.1016/j.psychres.2013.03.015	42	17	17	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113853	10.1371/journal.pone.0113853	http://dx.doi.org/10.1371/journal.pone.0113853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MM	25415195	gold, Green Published			2022-12-27	WOS:000346906600080
J	Finucane, OM; Reynolds, CM; McGillicuddy, FC; Harford, KA; Morrison, M; Baugh, J; Roche, HM				Finucane, Orla M.; Reynolds, Clare M.; McGillicuddy, Fiona C.; Harford, Karen A.; Morrison, Martine; Baugh, John; Roche, Helen M.			Macrophage Migration Inhibitory Factor Deficiency Ameliorates High-Fat Diet Induced Insulin Resistance in Mice with Reduced Adipose Inflammation and Hepatic Steatosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; FACTOR MIF; ALTERNATIVE ACTIVATION; GLUCOSE-METABOLISM; OBESITY; TISSUE; EXPRESSION; CELLS; INFILTRATION	Macrophage infiltration is a critical determinant of high-fat diet induced adipose tissue inflammation and insulin resistance. The precise mechanisms underpinning the initiation of macrophage recruitment and activation are unclear. Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, displays chemokine-like properties. Circulating MIF levels are elevated during obesity however its role in high-fat diet induced adipose inflammation and insulin resistance remains elusive. Wildtype and MIF-/- C57Bl\6J mice were fed chow or high-fat diet. Body weight and food intake was assessed. Glucose homeostasis was monitored by glucose and insulin tolerance tests. Adipose tissue macrophage recruitment and adipose tissue insulin sensitivity was evaluated. Cytokine secretion from stromal vascular fraction, adipose explants and bone marrow macrophages was measured. Inflammatory signature and insulin sensitivity of 3T3-L1-adipocytes co-cultured with wildtype and MIF-/- macrophage was quantified. Hepatic triacylglyceride levels were assessed. MIF-/- exhibited reduced weight gain. Age and weight-matched obese MIF-/- mice exhibited improved glucose homeostasis coincident with reduced adipose tissue M1 macrophage infiltration. Obese MIF-/- stromal vascular fraction secreted less TNF alpha and greater IL-10 compared to wildtype. Activation of JNK was impaired in obese MIF-/- adipose, concomitant with pAKT expression. 3T3-L1-adipocytes cultured with MIF-/- macrophages had reduced pro-inflammatory cytokine secretion and improved insulin sensitivity, effects which were also attained with MIF inhibitor ISO-1. MIF-/- liver exhibited reduced hepatic triacyglyceride accumulation, enhanced pAKT expression and reduced NF kappa B activation. MIF deficiency partially protects from high-fat diet induced insulin resistance by attenuating macrophage infiltration, ameliorating adipose inflammation, which improved adipocyte insulin resistance ex vivo. MIF represents a potential therapeutic target for treatment of high-fat diet induced insulin resistance.	[Finucane, Orla M.] St James Hosp, Trinity Ctr Hlth Sci, Inst Mol Med, Sch Med, Dublin 8, Ireland; [Finucane, Orla M.; Reynolds, Clare M.; McGillicuddy, Fiona C.; Harford, Karen A.; Morrison, Martine; Roche, Helen M.] Univ Coll Dublin, UCD Conway Inst, Sch Publ Hlth & Populat Sci, Nutrigen Res Grp, Dublin 2, Ireland; [Reynolds, Clare M.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Baugh, John] Univ Coll Dublin, UCD Conway Inst, Sch Med & Med Sci, Dublin 4, Ireland	Trinity College Dublin; University College Dublin; University of Auckland; University College Dublin	Roche, HM (corresponding author), Univ Coll Dublin, UCD Conway Inst, Sch Publ Hlth & Populat Sci, Nutrigen Res Grp, Dublin 2, Ireland.	Helen.roche@ucd.ie	Roche, Helen M/AAF-4164-2019; Morrison, Martine C./C-3168-2014	Roche, Helen M/0000-0002-0628-3318; Morrison, Martine C./0000-0003-4996-943X; McGillicuddy, Fiona/0000-0003-3623-3503; Reynolds, Clare/0000-0001-5782-6303	Health Research Board (HRB) Ireland; Trinity College Dublin PhD Molecular Medicine Programme; Science Foundation Ireland PI Programme [06/IM.1/B105, 11/PI/1119]	Health Research Board (HRB) Ireland; Trinity College Dublin PhD Molecular Medicine Programme; Science Foundation Ireland PI Programme(Science Foundation Ireland)	Professor Helen Roche is the guarantor of this work, had full access to all the data, and takes full responsibility for the integrity of data and the accuracy of data analysis. This work was supported by Health Research Board (HRB) Ireland; Trinity College Dublin PhD Molecular Medicine Programme (http://www.hrb.ie/ research-strategy-funding/strategic-initiatives/capacity-building/phd-scholars-programmes) and Science Foundation Ireland PI Programme (06/IM.1/B105 & 11/PI/1119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abed Y, 2011, P NATL ACAD SCI USA, V108, P8224, DOI 10.1073/pnas.1017624108; Atsumi T, 2007, J IMMUNOL, V179, P5399, DOI 10.4049/jimmunol.179.8.5399; Bacher M, 1997, AM J PATHOL, V150, P235; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Chavey C, 2009, AGING-US, V1, P674, DOI 10.18632/aging.100064; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Church TS, 2005, INT J OBESITY, V29, P675, DOI 10.1038/sj.ijo.0802942; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; Finucane OM, 2012, P NUTR SOC, V71, P622, DOI 10.1017/S0029665112000730; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Herder C, 2008, ATHEROSCLEROSIS, V200, P380, DOI 10.1016/j.atherosclerosis.2007.12.025; Hirokawa J, 1997, BIOCHEM BIOPH RES CO, V235, P94, DOI 10.1006/bbrc.1997.6745; Hirokawa J, 1998, J BIOCHEM, V123, P733; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lin XC, 2005, SHOCK, V24, P556, DOI 10.1097/01.shk.0000183238.70374.a8; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sakaue S, 1999, MOL MED, V5, P361, DOI 10.1007/BF03402125; Saksida T, 2012, IMMUNOL CELL BIOL, V90, P688, DOI 10.1038/icb.2011.89; Serre-Beinier V, 2010, J ENDOCRINOL, V206, P297, DOI 10.1677/JOE-09-0342; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Straczkowski M, 2002, J CLIN ENDOCR METAB, V87, P4602, DOI 10.1210/jc.2002-020135; Toso C, 2008, DIABETOLOGIA, V51, P1937, DOI 10.1007/s00125-008-1063-3; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Vozarova B, 2002, DIABETOLOGIA, V45, P1739, DOI 10.1007/s00125-002-0896-4; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	51	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113369	10.1371/journal.pone.0113369	http://dx.doi.org/10.1371/journal.pone.0113369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412423	Green Published, gold, Green Submitted			2022-12-27	WOS:000345253000044
J	Jay-Russell, MT; Hake, AF; Bengson, Y; Thiptara, A; Nguyen, T				Jay-Russell, Michele T.; Hake, Alexis F.; Bengson, Yingjia; Thiptara, Anyarat; Tran Nguyen			Prevalence and Characterization of Escherichia coli and Salmonella Strains Isolated from Stray Dog and Coyote Feces in a Major Leafy Greens Production Region at the United States-Mexico Border	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; FRESH PRODUCE; O157 STRAINS; FOOD; CATS; RISK; RESTRICTION; PATHOGENS; OUTBREAKS; SAMPLES	In 2010, Romaine lettuce grown in southern Arizona was implicated in a multi-state outbreak of Escherichia coli O145: H28 infections. This was the first known Shiga toxin-producing E. coli (STEC) outbreak traced to the southwest desert leafy green vegetable production region along the United States-Mexico border. Limited information exists on sources of STEC and other enteric zoonotic pathogens in domestic and wild animals in this region. According to local vegetable growers, unleashed or stray domestic dogs and free-roaming coyotes are a significant problem due to intrusions into their crop fields. During the 2010-2011 leafy greens growing season, we conducted a prevalence survey of STEC and Salmonella presence in stray dog and coyote feces. Fresh fecal samples from impounded dogs and coyotes from lands near produce fields were collected and cultured using extended enrichment and serogroup-specific immunomagnetic separation (IMS) followed by serotyping, pulsed-field gel electrophoresis (PFGE), and antimicrobial susceptibility testing. A total of 461 fecal samples were analyzed including 358 domestic dog and 103 coyote fecals. STEC was not detected, but atypical enteropathogenic E. coli (aEPEC) strains comprising 14 different serotypes were isolated from 13 (3.6%) dog and 5 (4.9%) coyote samples. Salmonella was cultured from 33 (9.2%) dog and 33 (32%) coyote samples comprising 29 serovars with 58% from dogs belonging to Senftenberg or Typhimurium. PFGE analysis revealed 17 aEPEC and 27 Salmonella distinct pulsotypes. Four (22.2%) of 18 aEPEC and 4 (6.1%) of 66 Salmonella isolates were resistant to two or more antibiotic classes. Our findings suggest that stray dogs and coyotes in the desert southwest may not be significant sources of STEC, but are potential reservoirs of other pathogenic E. coli and Salmonella. These results underscore the importance of good agriculture practices relating to mitigation of microbial risks from animal fecal deposits in the produce production area.	[Jay-Russell, Michele T.; Hake, Alexis F.; Bengson, Yingjia; Thiptara, Anyarat; Tran Nguyen] Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA	University of California System; University of California Davis	Jay-Russell, MT (corresponding author), Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA.	mjay@ucdavis.edu			Center for Produce Safety; University of California Agriculture and Natural Resources (UCANR) United States Department of Agriculture/National Institute of Food and Agriculture [2010-34608-20768 (SA7670)]	Center for Produce Safety; University of California Agriculture and Natural Resources (UCANR) United States Department of Agriculture/National Institute of Food and Agriculture	Funding for this project was provided by the Center for Produce Safety (http://cps.ucdavis.edu) and University of California Agriculture and Natural Resources (UCANR) United States Department of Agriculture/National Institute of Food and Agriculture (http://www.csrees.usda.gov/) grant #2010-34608-20768 (SA7670). Additionally, JV Farms is a Center for Produce Safety contributor (https://cps.ucdavis.edu/campaign_contributors.php). Except JV Farms, the funders had no role in study design or data collection. JV Farms food safety staff assisted in enrolling local animal shelters and collecting fecal samples for shipment to the authors. All funders had no role in the analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CALIFORNIA LEAFY GRE; [Anonymous], 2008, M31A3 CLSI; [Anonymous], 2013, ARIZONA LEAFY GREEN; [Anonymous], 2008, M100S20 CLSI; [Anonymous], 2005, DRUG RESISTANT SALMO; [Anonymous], 2012, NATL ANTIMICROBIAL R; Barkocy-Gallagher GA, 2002, J FOOD PROTECT, V65, P1527, DOI 10.4315/0362-028X-65.10.1527; Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20; Behravesh CB, 2010, PEDIATRICS, V126, P477, DOI 10.1542/peds.2009-3273; Bentancor A, 2007, FEMS MICROBIOL LETT, V267, P251, DOI 10.1111/j.1574-6968.2006.00569.x; Bentancor A, 2010, REV ARGENT MICROBIOL, V42, P46, DOI 10.1590/S0325-75412010000100010; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Bielaszewska M, 2008, CLIN INFECT DIS, V47, P208, DOI 10.1086/589245; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Boriss H, 2012, PRODUCE PROFILE; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Crawford W, 2010, ENV ASSESSMENT NONO1; DebRoy Chitrita, 2011, Animal Health Research Reviews, V12, P169, DOI 10.1017/S1466252311000193; DebRoy Chitrita, 2001, Animal Health Research Reviews, V2, P129; Economou V, 2013, INT J HYG ENVIR HEAL, V216, P435, DOI 10.1016/j.ijheh.2012.07.004; Ferraro A., 2008, Morbidity and Mortality Weekly Report, V57, P521; Goffaux F, 2000, RES MICROBIOL, V151, P865, DOI 10.1016/S0923-2508(00)01153-0; Gorski L, 2013, FOODBORNE PATHOG DIS, V10, P540, DOI 10.1089/fpd.2012.1372; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Grimot P. A. D., 2007, ANTIGENIC FORMULAE S; Holland RE, 1999, VET MICROBIOL, V70, P261, DOI 10.1016/S0378-1135(99)00136-4; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jay-Russell M., 2013, CAB REV, V8, P040, DOI DOI 10.1079/PAVSNNR20138040; Joffe DJ, 2002, CAN VET J, V43, P441; Kanki M, 2009, J FOOD PROTECT, V72, P2065, DOI 10.4315/0362-028X-72.10.2065; Kataoka Y, 2010, J VET MED SCI, V72, P791, DOI 10.1292/jvms.09-0439; Kilonzo C, 2013, APPL ENVIRON MICROB, V79, P6337, DOI 10.1128/AEM.01503-13; Kimura R, 2000, APPL ENVIRON MICROB, V66, P2513, DOI 10.1128/AEM.66.6.2513-2519.2000; Lantz K, 2012, SALMONELLA SEROTYPES; Lenz J, 2009, CAN VET J, V50, P637; Leonard EK, 2011, ZOONOSES PUBLIC HLTH, V58, P140, DOI 10.1111/j.1863-2378.2009.01320.x; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Lynch Michael, 2006, Morbidity and Mortality Weekly Report, V55, P1; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; Mandrell RE, 2010, WOODHEAD PUBL FOOD S, P548; Marks SL, 2011, J VET INTERN MED, V25, P1195, DOI 10.1111/j.1939-1676.2011.00821.x; McKenzie E, 2010, J VET INTERN MED, V24, P97, DOI 10.1111/j.1939-1676.2009.0418.x; Moura RA, 2009, APPL ENVIRON MICROB, V75, P7399, DOI 10.1128/AEM.00636-09; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Partyka ML, 2014, J FOOD PROTECT, V77, P6, DOI 10.4315/0362-028X.JFP-13-249; Puno-Sarmiento J, 2013, VET MICROBIOL, V166, P676, DOI 10.1016/j.vetmic.2013.07.007; Renter DG, 2003, APPL ENVIRON MICROB, V69, P542, DOI 10.1128/AEM.69.1.542-547.2003; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rice DH, 2003, VET REC, V152, P82, DOI 10.1136/vr.152.3.82; Sasaki Y, 2011, VET MICROBIOL, V150, P140, DOI 10.1016/j.vetmic.2010.12.024; Selmi M, 2011, VET ITAL, V47, P183; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Sjolund-Karlsson M, 2011, ANTIMICROB AGENTS CH, V55, P3985, DOI 10.1128/AAC.00590-11; Staats JJ, 2003, VET MICROBIOL, V94, P303, DOI 10.1016/S0378-1135(03)00134-2; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P7618, DOI 10.1128/AEM.02831-13; Taylor EV, 2013, J FOOD PROTECT, V76, P939, DOI 10.4315/0362-028X.JFP-12-503; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Whichard JM, 2007, EMERG INFECT DIS, V13, P1681, DOI 10.3201/eid1311.061438; Wilkes G, 2011, WATER RES, V45, P5807, DOI 10.1016/j.watres.2011.06.021; WINSOR DK, 1981, APPL ENVIRON MICROB, V42, P1123, DOI 10.1128/AEM.42.6.1123-1124.1981	64	45	46	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113433	10.1371/journal.pone.0113433	http://dx.doi.org/10.1371/journal.pone.0113433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	25412333	gold, Green Published, Green Submitted			2022-12-27	WOS:000345253000052
J	Al-Hajoj, S; Memish, Z; Abuljadayel, N; AlHakeem, R; AlRabiah, F; Varghese, B				Al-Hajoj, Sahal; Memish, Ziad; Abuljadayel, Naila; AlHakeem, Raafat; AlRabiah, Fahad; Varghese, Bright			Molecular Confirmation of Bacillus Calmette Guerin Vaccine Related Adverse Events among Saudi Arabian Children	PLOS ONE			English	Article							BCG VACCINE; MYCOBACTERIUM-TUBERCULOSIS; LYMPHADENITIS; INFECTION; STRAIN; CONSANGUINITY; METAANALYSIS; MENINGITIS; DISORDERS; DISEASE	Background: Bacillus Calmette Guerin (BCG) is the only available vaccine for tuberculosis (TB). Low grade complications in healthy recipients and disseminated vaccine associated complications among immuno-suppressed individuals were noticed globally after administration. Recently a series of clinically suspected BCG associated suppurative and non-suppurative lymphadenitis cases were reported from different regions of Saudi Arabia. However a molecular confirmative analysis was lacking to prove these claims. Methodology: During 2009-2010, 42 Mycobacterium bovis BCG suspected clinical isolates from children diagnosed with suppurative lymphadenitis from different provinces of the country were collected and subjected to 24 loci based MIRU-VNTR typing, spoligotyping and first line anti-TB drugs susceptibility testing. Principal Findings: Of the total 42 cases, 41 (97.6%) were Saudi nationals and particularly male (64.3%). Majority of the cases were aged below 6 months (83.3%) with a median of age 4 months. All the enrolled subjects showed left axillary mass which suppurated in a median of 4 months after vaccination. Among the study subjects, 1 (2.4%) case was reactive to HIV antigen and 2 (4.8%) case had severe combined immunodeficiency. Genotyping results showed that, 41 (97.6%) isolates were identical to the vaccine strain Danish 1331 and one to Tokyo 172-1. Phylogenetic analysis revealed all the Danish 1331 isolates in a single cluster. Conclusion: Elevated proportion of suppurative lymphadenitis caused by M. bovis BCG reported in the country recently is majorly related to the vaccine strain Danish 1331. However lack of nationwide data on real magnitude of BCG related adverse events warrants population centric, long term future studies.	[Al-Hajoj, Sahal; Varghese, Bright] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Memish, Ziad; Abuljadayel, Naila; AlHakeem, Raafat] Minist Hlth, Prevent Med Directorate, Riyadh, Saudi Arabia; [AlRabiah, Fahad] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Ministry of Health - Saudi Arabia; King Faisal Specialist Hospital & Research Center	Al-Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia [AT-26/110]	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia	SA received a grant from King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia (www.kacst.edu.sa, grant code AT-26/110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bhlal LA, 2001, DIAGN CYTOPATHOL, V24, P333, DOI 10.1002/dc.1071; Al-Salem AH, 2012, SAUDI MED J, V33, P172; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Alrabiaah AA, 2012, ANN SAUDI MED, V32, P4, DOI 10.5144/0256-4947.2012.4; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Benamar F, 2001, THERAPIE, V56, P739; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brewer TF, 2000, CLIN INFECT DIS, V31, pS64, DOI 10.1086/314072; Bukhari E, 2012, INDIAN J PATHOL MICR, V55, P202, DOI 10.4103/0377-4929.97869; Calmette A, 1931, Proc R Soc Med, V24, P1481; CASANOVA JL, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91421-8; Casanova JL, 1996, PEDIATRICS, V98, P774; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; DeSimone JA, 2000, ANN INTERN MED, V133, P447, DOI 10.7326/0003-4819-133-6-200009190-00013; El Mouzan MI, 2008, ANN SAUDI MED, V28, P169, DOI 10.5144/0256-4947.2008.169; ELHAZMI MAF, 1995, J MED GENET, V32, P623, DOI 10.1136/jmg.32.8.623; GONZALEZ B, 1989, PEDIATR INFECT DIS J, V8, P201; Goraya JS, 2002, POSTGRAD MED J, V78, P327, DOI 10.1136/pmj.78.920.327; HENGSTER P, 1992, ARCH DIS CHILD, V67, P952, DOI 10.1136/adc.67.7.952; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lee PPW, 2008, PEDIATR INFECT DIS J, V27, P224, DOI 10.1097/INF.0b013e31815b494c; Lotte A, 1988, Bull Int Union Tuberc Lung Dis, V63, P47; Lotte A, 1984, Adv Tuberc Res, V21, P194; Lotte A, 1984, Adv Tuberc Res, V21, P107; Mansouri D, 2005, EUR J PEDIATR, V164, P753, DOI 10.1007/s00431-005-1689-9; Markey K, 2010, VACCINE, V28, P6964, DOI [10.1016/j.vaccine.2010.08.045, 10.1016/j.vaccine.2010.07.086]; Mazroa Mohammed A A I, 2012, PLoS One, V7, pe45919, DOI 10.1371/journal.pone.0045919; MILSTIEN JB, 1990, B WORLD HEALTH ORGAN, V68, P93; Mori T, 1996, TUBERCLE LUNG DIS, V77, P269, DOI 10.1016/S0962-8479(96)90012-X; Poyntz HC, 2014, TUBERCULOSIS, V94, P226, DOI 10.1016/j.tube.2013.12.006; Prando C, 2013, MEDICINE, V92, P109, DOI 10.1097/MD.0b013e31828a01f9; Ritz N, 2008, FEMS MICROBIOL REV, V32, P821, DOI 10.1111/j.1574-6976.2008.00118.x; Ritz N, 2009, ANTIMICROB AGENTS CH, V53, P316, DOI 10.1128/AAC.01302-08; RODRIGUES LC, 1990, T ROY SOC TROP MED H, V84, P739, DOI 10.1016/0035-9203(90)90172-B; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sadeghi-Shabestari M, 2009, INT J INFECT DIS, V13, pE420, DOI 10.1016/j.ijid.2009.02.008; Singla A, 2002, PEDIATR INFECT DIS J, V21, P446, DOI 10.1097/00006454-200205000-00026; Suliaman F, 2006, ALLERGY IMMUNOL, V19, P14; Suliaman Fawzi, 2009, Pediatric Asthma Allergy & Immunology, V22, P21, DOI 10.1089/pai.2008.0513; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; TARDIEU M, 1988, LANCET, V1, P440; Turnbull FM, 2002, CLIN INFECT DIS, V34, P447, DOI 10.1086/338462; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	44	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113472	10.1371/journal.pone.0113472	http://dx.doi.org/10.1371/journal.pone.0113472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409184	gold, Green Published, Green Submitted			2022-12-27	WOS:000345533200124
J	Hartstone-Rose, A; Selvey, H; Villari, JR; Atwell, M; Schmidt, T				Hartstone-Rose, Adam; Selvey, Hannah; Villari, Joseph R.; Atwell, Madeline; Schmidt, Tammy			The Three-Dimensional Morphological Effects of Captivity	PLOS ONE			English	Article							LION PANTHERA-LEO; CALIFORNIA SEA LIONS; ZALOPHUS-CALIFORNIANUS; CEREBELLAR HERNIATION; TIGRIS; SKULL; WILD; GROWTH; FELIDS; DIET	Many captive animals are fed diets that are drastically different in mechanical properties than their wild diet. Most captive pantherines are fed a nutritionally supplemented diet consisting almost entirely of ground meat. While many zoos supplement this diet with bones, the fact remains that large captive felids are fed diets that require substantially less masticatory effort than those of their wild counterparts. The osteological effects of this dietary difference have not been fully evaluated. To this end, we compared linear measurements and 3D geometric morphometric landmarks of captive and wild lions and tigers. Using Principal Component (PC) analysis of the linear measurements, not only were the sexes and species statistically distinct, but so too was the population clearly divisible in terms of captivity status. The 3D analysis supported these findings: although the most influential variable in the sample (PC1, 21.5% of the variation) separates the two species, the second most influential contributor (PC2) to the overall skull shape is driven not by the sex differences in these highly dimorphic species, but rather by their captivity status. In fact, captivity status drives nearly twice as much of the 3D variation as sexual dimorphism (14.8% vs. 8.0% for PC2 vs. PC3). Thus the shape is influenced nearly twice as much by whether the animal was captive or wild than by whether it was male or female. If a causal relationship can be demonstrated between dietary mechanical properties and morphology, people who oversee the diets of captive carnivores should consider modifying these diets to account for not only nutritional but also the mechanical properties of a carcass-based diet as well. In addition to the husbandry implications, our analyses show the ways in which captive specimens are different than their wild counterparts - findings that have implications for morphologists when considering anatomical samples.	[Hartstone-Rose, Adam] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Hartstone-Rose, Adam; Selvey, Hannah; Atwell, Madeline] Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA; [Villari, Joseph R.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Schmidt, Tammy] Zoo Atlanta, Mammals, Atlanta, GA USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; George Mason University	Hartstone-Rose, A (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	AdamHR@sc.edu	Hartstone-Rose, Adam/I-3503-2016; Hartstone-Rose, Adam/AAU-3332-2020	Hartstone-Rose, Adam/0000-0001-5307-5573; 	University of South Carolina School of Medicine; South Carolina Honors College Science Undergraduate Research Funding Program; Trio Programs at the University of South Carolina; Ronald E. McNair Post-Baccalaureate Achievement Program	University of South Carolina School of Medicine; South Carolina Honors College Science Undergraduate Research Funding Program; Trio Programs at the University of South Carolina; Ronald E. McNair Post-Baccalaureate Achievement Program	This work was supported by the University of South Carolina School of Medicine, the South Carolina Honors College Science Undergraduate Research Funding Program, the Trio Programs at the University of South Carolina, and the Ronald E. McNair Post-Baccalaureate Achievement Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1977, VET REC, V100, P154, DOI 10.1136/vr.100.8.154; Bowers K., 2014, CARCASS CONTROVERSY; Central Nebraska Packing Inc, 2013, PREM BEEF FEL DIET; Chandra AMS, 1999, J VET DIAGN INVEST, V11, P465, DOI 10.1177/104063879901100514; CORDY D R, 1957, Cornell Vet, V47, P480; CORRUCCINI RS, 1982, SCIENCE, V218, P74, DOI 10.1126/science.7123221; Crossley DA, 2001, ARCH ORAL BIOL, V46, P919, DOI 10.1016/S0003-9969(01)00055-3; De Rosa J., 2014, SPECIALIZING CAPTIVE; du Boulay G. H., 1968, Symposia of the Zoological Society of London, VNo. 21, P223; Duckler GL, 1997, J VERTEBR PALEONTOL, V17, P600, DOI 10.1080/02724634.1997.10011006; Duckler GL, 1998, ZOO BIOL, V17, P135, DOI 10.1002/(SICI)1098-2361(1998)17:2<135::AID-ZOO8>3.0.CO;2-A; Fitch H.M., 1982, Zoo Biology, V1, P295, DOI 10.1002/zoo.1430010403; Gawor JP, 2006, SURVEY CURRENT DENTA, p2021S; Glatt S. E., 2008, International Zoo Yearbook, V42, P206, DOI 10.1111/j.1748-1090.2007.00032.x; Gross-Tsubery R, 2010, VET RADIOL ULTRASOUN, V51, P34, DOI 10.1111/j.1740-8261.2009.01617.x; Groves C. P., 1966, Zeitschrift fuer Saugietierkunde, V31, P44; Groves C.P., 1982, Zoo Biology, V1, P251, DOI 10.1002/zoo.1430010309; Guthrie RD, 1984, CARNEGIE MUS NAT HIS, V8, P482; HABERSTROH LI, 1984, J ZOO ANIM MED, V15, P142, DOI 10.2307/20094710; Hartstone-Rose A, 2011, J ZOOL, V285, P119, DOI 10.1111/j.1469-7998.2011.00821.x; Hartstone-Rose Adam, 2013, South African Journal of Science, V109, P77; Hartstone-Rose A, 2012, ANAT REC, V295, P1336, DOI 10.1002/ar.22518; Hartstone-Rose A, 2008, CR PALEVOL, V7, P629, DOI 10.1016/j.crpv.2008.09.015; Hollister N., 1917, P US NATL MUS, V53, P177, DOI DOI 10.5479/SI.00963801.53-2196.177; Howell A. B., 1925, Journal of Mammalogy, V6, P163, DOI 10.2307/1373626; Kastelein RA, 2000, ZOO BIOL, V19, P143, DOI 10.1002/1098-2361(2000)19:2<143::AID-ZOO5>3.0.CO;2-O; Kimura T, 1996, PRIMATES, V37, P237, DOI 10.1007/BF02381856; Lieberman DE, 2004, J HUM EVOL, V46, P655, DOI 10.1016/j.jhevol.2004.03.005; Lyons J, 1997, ZOO BIOL, V16, P71; Mazak JH, 2004, MAMM BIOL, V69, P392, DOI 10.1078/1616-5047-00161; Mazak JH, 2010, MAMM BIOL, V75, P45, DOI 10.1016/j.mambio.2008.06.003; McPhee ME, 2004, J MAMMAL, V85, P1130, DOI 10.1644/BPR-017.1; McPhee ME, 2002, ZOO BIOL, V21, P37, DOI 10.1002/zoo.10033; McRoberts Seafood Sales Inc, 2008, ZOO AQ SPEC DIR; MEERS MB, 1996, 3 DIMENSIONAL ANAL D; Milliken Meats, 2014, TOR ZOO CARN DIETS, V21; Naples VL, 2012, MAMMALIA, V76, P99, DOI 10.1515/mammalia-2012-0504; O'Regan H, 2006, INT J OSTEOARCHAEOL, V16, P385, DOI 10.1002/oa.835; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; O'Regan HJ, 2002, MAMMAL REV, V32, P58, DOI 10.1046/j.1365-2907.2002.00093.x; O'Regan HJ, 2004, INTERFACE CONSERVATI, P90; Ohlsson T, 2001, PHYSIOL BIOCHEM ZOOL, V74, P212, DOI 10.1086/319657; PHILLIPSCONROY JE, 1988, AM J PRIMATOL, V15, P17, DOI 10.1002/ajp.1350150104; Resources SS, 2012, ZOOLOGICAL; Saragusty J, 2014, PLOS ONE, V9; Schaerlaeken V, 2012, J EXP ZOOL PART A, V317A, P371, DOI 10.1002/jez.1730; Schaller G. B., 1972, SERENGETI LION; Schwarts ND, 2014, NY TIMES, VA6; Shamir MH, 2008, J ZOO WILDLIFE MED, V39, P455, DOI 10.1638/2006-0064.1; Skibiel AL, 2007, ZOO BIOL, V26, P371, DOI 10.1002/zoo.20147; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; Sunquist ME, 2002, WILD CATS WORLD; Sweeney JM, 2011, MAR MAMMAL SCI, V27, pE279, DOI 10.1111/j.1748-7692.2010.00459.x; Triple A Brand Meat Company, 2006, FEL COMPL DIET SPECS; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; von Cramon-Taubadel N, 2007, AM J PHYS ANTHROPOL, V134, P24, DOI 10.1002/ajpa.20616; Yamaguchi N, 2009, BIOL J LINN SOC, V98, P85, DOI 10.1111/j.1095-8312.2009.01249.x; Zuccarelli Micah D., 2004, BIOS (Ocean Grove), V75, P131, DOI 10.1893/0005-3155(2004)075<0131:CMAOCV>2.0.CO;2	58	29	30	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113437	10.1371/journal.pone.0113437	http://dx.doi.org/10.1371/journal.pone.0113437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409498	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200122
J	Ngamphiw, C; Tongsima, S; Mutirangura, A				Ngamphiw, Chumpol; Tongsima, Sissades; Mutirangura, Apiwat			Roles of Intragenic and Intergenic L1s in Mouse and Human	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; LINE-1 ELEMENTS; HUMAN GENOME; RETROTRANSPOSON SUBFAMILY; REPEAT HYPOTHESIS; EVOLUTION; MAMMALS; EMBRYO; IMPACT; GENES	Long INterspersed Element-1 (LINE-1 or L1) is a retrotransposable element that has shaped the evolution of mammalian genomes. There is increasing evidence that transcriptionally active L1 could have been co-opted through evolution to play various roles including X-inactivation, homologous recombination and gene regulation. Here, we compare putatively active L1 distributions in the mouse with human. L1 density is higher in the mouse except for the Y-chromosome. L1 density is the highest in X-chromosome, implying an X-inactivation role. L1 is more common outside genes (intergenic) except for the Y-chromosome in both species. The structure of mouse L1 is distinguished from human L1 by the presence of a 200 bp repeat in the 5' UTR of the former. We found that mouse intragenic L1 has significantly higher repeat copy numbers than intergenic L1, suggesting that this is important for control of L1 expression. Furthermore, a significant association between the presence of intragenic L1s and down-regulated genes in early embryogenesis was found in both species. In conclusion, the distribution of L1 in the mouse genome points to biological roles of L1 in mouse similar to human.	[Ngamphiw, Chumpol] Chulalongkorn Univ, Fac Grad Sch, Interdept Program Biomed Sci, Bangkok 10330, Thailand; [Ngamphiw, Chumpol; Tongsima, Sissades] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Genome Technol Res Unit, Pathum Thani, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok 10330, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Mutirangura, A (corresponding author), Chulalongkorn Univ, Fac Med, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok 10330, Thailand.	apiwat.mutirangura@gmail.com	Ngamphiw, Chumpol/ABB-6488-2021; Tongsima, Sissades/F-4891-2011	Ngamphiw, Chumpol/0000-0002-8581-397X; Tongsima, Sissades/0000-0002-1491-1839	National Science and Technology Development Agency (NSTDA), Thailand; National Center for Genetic Engineering and Biotechnology (BIOTEC); Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University; BIOTEC; Chulalongkorn University	National Science and Technology Development Agency (NSTDA), Thailand; National Center for Genetic Engineering and Biotechnology (BIOTEC); Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University(Chulalongkorn University); BIOTEC; Chulalongkorn University(Chulalongkorn University)	This work is funded by the 2011 Research Chair Grant from the National Science and Technology Development Agency (NSTDA), Thailand. CN is partly supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC) and the Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University. ST and AM are partially supported by BIOTEC and Chulalongkorn University, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aporntewan C, 2011, ASIAN BIOMED, V5, P257, DOI 10.5372/1905-7415.0502.034; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Cantrell MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006252; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; dos Santos Silva I, 1999, CANC EPIDEMIOLOGY PR, P305; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hormozdiari F, 2013, P NATL ACAD SCI USA, V110, P13457, DOI 10.1073/pnas.1310914110; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Khowutthitham S, 2012, GENES GENOM, V34, P517, DOI 10.1007/s13258-012-0058-0; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030649; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Ovchinnikov I, 2002, P NATL ACAD SCI USA, V99, P10522, DOI 10.1073/pnas.152346799; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Scott LA, 2006, CYTOGENET GENOME RES, V112, P261, DOI 10.1159/000089880; SEVERYNSE DM, 1992, MAMM GENOME, V2, P41, DOI 10.1007/BF00570439; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Wanichnopparat W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-205; Waters PD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000158; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Zemojtel T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-392; Zimmerman DW, 1997, J EDUC BEHAV STAT, V22, P349, DOI 10.3102/10769986022003349	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113434	10.1371/journal.pone.0113434	http://dx.doi.org/10.1371/journal.pone.0113434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409429	gold, Green Submitted, Green Published			2022-12-27	WOS:000345533200121
J	Kennefick, M; Maslovat, D; Carlsen, AN				Kennefick, Michael; Maslovat, Dana; Carlsen, Anthony N.			The Time Course of Corticospinal Excitability during a Simple Reaction Time Task	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VOLUNTARY MOVEMENT; MOTOR; INHIBITION; HUMANS; SYSTEM	The production of movement in a simple reaction time task can be separated into two time periods: the foreperiod, which is thought to include preparatory processes, and the reaction time interval, which includes initiation processes. To better understand these processes, transcranial magnetic stimulation has been used to probe corticospinal excitability at various time points during response preparation and initiation. Previous research has shown that excitability decreases prior to the "go" stimulus and increases following the "go"; however these two time frames have been examined independently. The purpose of this study was to measure changes in CE during both the foreperiod and reaction time interval in a single experiment, relative to a resting baseline level. Participants performed a button press movement in a simple reaction time task and excitability was measured during rest, the foreperiod, and the reaction time interval. Results indicated that during the foreperiod, excitability levels quickly increased from baseline with the presentation of the warning signal, followed by a period of stable excitability leading up to the "go" signal, and finally a rapid increase in excitability during the reaction time interval. This excitability time course is consistent with neural activation models that describe movement preparation and response initiation.	[Kennefick, Michael; Carlsen, Anthony N.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Maslovat, Dana] Langara Coll, Dept Kinesiol, Vancouver, BC, Canada; [Maslovat, Dana] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada	University of Ottawa; University of British Columbia	Carlsen, AN (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	tony.carlsen@uottawa.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [RGPIN 418361-2012]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN 418361-2012; www.nserc-crsng.gc.ca/index_eng.asp) awarded to ANC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Carlsen AN, 2010, BRAIN RES, V1322, P38, DOI 10.1016/j.brainres.2010.01.076; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Deecke L, 1996, COGNITIVE BRAIN RES, V3, P59, DOI 10.1016/0926-6410(95)00046-1; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Hallett M., 2003, BEREITSCHAFTSPOTENTI; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hasbroucq T, 1997, COGNITIVE BRAIN RES, V5, P185, DOI 10.1016/S0926-6410(96)00069-9; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; NAZIR TA, 1991, PSYCHOL RES-PSYCH FO, V53, P281, DOI 10.1007/BF00920481; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; Requin J., 1991, HDB COGNITIVE PSYCHO, P357; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; ROSSINI PM, 1988, BRAIN RES, V458, P20, DOI 10.1016/0006-8993(88)90491-X; STARR A, 1988, ELECTROEN CLIN NEURO, V70, P26, DOI 10.1016/0013-4694(88)90191-5; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Thickbroom GW, 2000, BRAIN RES, V874, P233, DOI 10.1016/S0006-8993(00)02588-9; Touge T, 1998, ELECTROMYOGR MOTOR C, V109, P489, DOI 10.1016/S0924-980X(98)00050-2; WICKENS J, 1994, J MOTOR BEHAV, V26, P66, DOI 10.1080/00222895.1994.9941663	26	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113563	10.1371/journal.pone.0113563	http://dx.doi.org/10.1371/journal.pone.0113563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406079	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300121
J	Kumar, T; Sharma, GS; Singh, LR				Kumar, Tarun; Sharma, Gurumayum Suraj; Singh, Laishram Rajendrakumar			Existence of Molten Globule State in Homocysteine-Induced Protein Covalent Modifications	PLOS ONE			English	Article							TRANSFER RNA-SYNTHETASE; EGG-WHITE LYSOZYME; CYTOCHROME-C; N-HOMOCYSTEINYLATION; PATHOLOGICAL CONSEQUENCES; GUANIDINE-HYDROCHLORIDE; CARDIOVASCULAR-DISEASE; POSSIBLE MECHANISM; SULFHYDRYL-GROUPS; THIOLACTONE	Homocysteine thiolactone is a toxic metabolite produced from homocysteine by amino-acyl t-RNA synthetase in error editing reaction. The basic cause of toxicity of homocysteine thiolactone is believed to be due to the adduct formation with lysine residues (known as protein N-homocysteinylation) leading to protein aggregation and loss of enzyme function. There was no data available until now that showed the effect of homocysteine thiolactone on the native state structural changes that led to aggregate formation. In the present study we have investigated the time dependent structural changes due to homocysteine thiolactone induced modifications on three different proteins having different physico-chemical properties (cytochrome-c, lysozyme and alpha lactalbumin). We discovered that N-homocysteinylation leads to the formation of molten globule state-an important protein folding intermediate in the protein folding pathway. We also found that the formation of the molten globule state might be responsible for the appearance of aggregate formation. The study indicates the importance of protein folding intermediate state in eliciting the homocysteine thiolactone toxicity.	[Kumar, Tarun; Sharma, Gurumayum Suraj; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Singh, LR (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	lairksingh@gmail.com		Sharma, Gurumayum Suraj/0000-0002-7924-2031	University of Delhi (DRCH/RD); Council of Scientific and Industrial Research [09/045(1131)/2011-EMR-1]; Department of Science and Technology [SR/SO/BB-0003/2011]	University of Delhi (DRCH/RD); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	This work is supported by the grant provided by University of Delhi (DRCH/R&D). LRS, TK and GSS acknowledge Council of Scientific and Industrial Research (File No.: 09/045(1131)/2011-EMR-1) and Department of Science and Technology (Ref No.: SR/SO/BB-0003/2011) for the financial assistance provided in the form of research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2010, PROTEIN PEPTIDE LETT, V17, P11, DOI 10.2174/092986610789909502; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; BUTTERWORTH PH, 1967, ARCH BIOCHEM BIOPHYS, V118, P716, DOI 10.1016/0003-9861(67)90409-2; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fedunova D, 2006, BIOTECHNOL BIOENG, V93, P485, DOI 10.1002/bit.20733; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; Hameed M, 2007, J BIOCHEM, V141, P573, DOI 10.1093/jb/mvm057; Iram A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072075; Jacobsen DW, 1998, CLIN CHEM, V44, P1833; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, J BIOL CHEM, V275, P3957, DOI 10.1074/jbc.275.6.3957; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; JAKUBOWSKI H, 1991, EMBO J, V10, P593, DOI 10.1002/j.1460-2075.1991.tb07986.x; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jalili S, 2011, PROTEIN J, V30, P299, DOI 10.1007/s10930-011-9333-1; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Khazaei S, 2012, PROTEIN J, V31, P717, DOI 10.1007/s10930-012-9451-4; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Kuwajima K., 2002, PINSA-A (Proceedings of the Indian National Science Academy) Part A (Physical Sciences), V68, P333; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Naeem A, 2004, INT J BIOCHEM CELL B, V36, P2281, DOI 10.1016/j.biocel.2004.04.023; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Perla-Kajan J, 2007, BIOCHEMISTRY-US, V46, P6225, DOI 10.1021/bi602463m; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rabbani G, 2014, APPL MICROBIOL BIOT, V98, P2533, DOI 10.1007/s00253-013-5123-3; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Raman B, 1996, J BIOL CHEM, V271, P17067, DOI 10.1074/jbc.271.29.17067; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Stroylova YY, 2012, ARCH BIOCHEM BIOPHYS, V526, P29, DOI 10.1016/j.abb.2012.06.008; Stroylova YY, 2011, BBA-PROTEINS PROTEOM, V1814, P1234, DOI 10.1016/j.bbapap.2011.05.017; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x; Yousefi R, 2012, INT J BIOL MACROMOL, V51, P291, DOI 10.1016/j.ijbiomac.2012.05.021; Zang TZ, 2009, ANAL CHEM, V81, P9065, DOI 10.1021/ac9017132	45	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113566	10.1371/journal.pone.0113566	http://dx.doi.org/10.1371/journal.pone.0113566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405350	Green Submitted, Green Published, gold			2022-12-27	WOS:000347121300122
J	Triscoli, C; Ackerley, R; Sailer, U				Triscoli, Chantal; Ackerley, Rochelle; Sailer, Uta			Touch Satiety: Differential Effects of Stroking Velocity on Liking and Wanting Touch Over Repetitions	PLOS ONE			English	Article							SENSORY-SPECIFIC SATIETY; UNMYELINATED C FIBERS; HAIRY SKIN; CUTANEOUS MECHANORECEPTORS; TACTILE AFFERENTS; INSULAR CORTEX; FOOD REWARD; BRAIN; HUMANS; RESPONSES	A slow, gentle caress of the skin is a salient hedonic stimulus. Low threshold, unmyelinated C-tactile afferents fire preferentially to this type of touch, where slow (< 1 cm/s) and fast (> 10 cm/s) stroking velocities produce lower firing frequencies and are rated as less pleasant. The current aim was to investigate how the experience of tactile pleasantness changes with repeated exposure (satiety to touch). A further aim was to determine whether tactile satiety varied with different stroking velocities. The experimental paradigm used a controlled brush stroke to the forearm that was delivered repeatedly for similar to 50 minutes. In Experiment 1, brush strokes were administered at three different velocities (0.3 cm/s, 3 cm/s and 30 cm/s), which were presented in a pseudo-randomised order. In Experiment 2, brush strokes were applied using only one velocity (either 3 or 30 cm/s). After each stroke, the participants rated both subjective pleasantness (liking) and wanting (the wish to be further exposed to the same stimulus) for each tactile sensation. In Experiment 1, both pleasantness and wanting showed a small, but significant, decrease over repetitions during stroking at 3 cm/s only, where the mean values for pleasantness and wanting were similar. Conversely, slower (0.3 cm/s) and faster (30 cm/s) stroking showed no decrease in ratings over time, however pleasantness was rated higher than wanting. In Experiment 2, both pleasantness and wanting showed a significant decrease over repetitions for both applied velocities, with a larger decrease in ratings for stroking at 3 cm/s. In conclusion, satiety to touch occurred with a slow onset and progression, where pleasantness and wanting ratings to stroking at 3 cm/s were affected more than at the slower or faster velocities. Tactile satiety appears to differ compared to appetitive and olfactory satiety, because the hedonic and rewarding aspects of touch persist for some time.	[Triscoli, Chantal; Sailer, Uta] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden; [Triscoli, Chantal; Ackerley, Rochelle; Sailer, Uta] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Ackerley, Rochelle; Sailer, Uta] Univ Gothenburg, Dept Psychol, Inst Neurosci & Physiol, S-40020 Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Sailer, U (corresponding author), Univ Gothenburg, Dept Psychol, Box 14158, S-40020 Gothenburg, Sweden.	uta.sailer@psy.gu.se	Ackerley, Rochelle/Q-5719-2017	Ackerley, Rochelle/0000-0003-4621-7929	Swedish Research Council [2011-1529]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Swedish Research Council (grant 2011-1529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Ackerley R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00054; BARKER DJ, 1982, NEUROSCI LETT, V30, P117, DOI 10.1016/0304-3940(82)90282-8; Bellisle F, 2012, J NUTR, V142, p1149S, DOI 10.3945/jn.111.149583; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; CAIN WS, 1978, PERCEPTION, V7, P459, DOI 10.1068/p070459; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CORNELL CE, 1989, PHYSIOL BEHAV, V45, P695, DOI 10.1016/0031-9384(89)90281-3; Croy I, 2013, INT J PSYCHOPHYSIOL, V88, P104, DOI 10.1016/j.ijpsycho.2013.02.005; Dawson SJ, 2013, J SEX MED, V10, P990, DOI 10.1111/jsm.12032; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; GRICE GR, 1964, PSYCHOL REV, V71, P247, DOI 10.1037/h0047547; Guinard JX, 1998, APPETITE, V31, P141, DOI 10.1006/appe.1998.0159; Havermans RC, 2011, APPETITE, V57, P286, DOI 10.1016/j.appet.2011.05.310; Havermans RC, 2009, APPETITE, V52, P222, DOI 10.1016/j.appet.2008.09.020; Hetherington MM, 2006, PHYSIOL BEHAV, V87, P263, DOI 10.1016/j.physbeh.2005.10.012; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; IGGO A, 1977, J PHYSIOL-LONDON, V271, P549, DOI 10.1113/jphysiol.1977.sp012014; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Litman JA, 2005, COGNITION EMOTION, V19, P793, DOI 10.1080/02699930541000101; Loken LS, 2011, BRAIN RES, V1417, P9, DOI 10.1016/j.brainres.2011.08.011; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; McSweeney FK, 1998, PSYCHON B REV, V5, P428, DOI 10.3758/BF03208818; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Nasser J, 2001, Obes Rev, V2, P213, DOI 10.1046/j.1467-789X.2001.00039.x; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Raynor Hollie A, 2006, Eat Behav, V7, P1, DOI 10.1016/j.eatbeh.2005.05.005; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rolls BJ, 1998, AM J CLIN NUTR, V67, P1170, DOI 10.1093/ajcn/67.6.1170; ROLLS BJ, 1990, APPETITE, V15, P115, DOI 10.1016/0195-6663(90)90044-9; Rolls ET, 2007, EUR J NEUROSCI, V26, P1067, DOI 10.1111/j.1460-9568.2007.05724.x; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; Triscoli C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00526; Triscoli C, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00208; VALLBO A, 1993, BRAIN RES, V628, P301, DOI 10.1016/0006-8993(93)90968-S; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3	54	39	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113425	10.1371/journal.pone.0113425	http://dx.doi.org/10.1371/journal.pone.0113425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405620	gold, Green Published, Green Submitted			2022-12-27	WOS:000347121300117
J	Asano, K; Asano, Y; Ono, HK; Nakane, A				Asano, Krisana; Asano, Yoshiya; Ono, Hisaya K.; Nakane, Akio			Suppression of Starvation-Induced Autophagy by Recombinant Toxic Shock Syndrome Toxin-1 in Epithelial Cells	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; INDUCTION; PATHWAY; PROTEIN	Toxic shock syndrome toxin-1 (TSST-1), a superantigen produced from Staphylococcus aureus, has been reported to bind directly to unknown receptor(s) and penetrate into non-immune cells but its function is unclear. In this study, we demonstrated that recombinant TSST-1 suppresses autophagosomal accumulation in the autophagic-induced HeLa 229 cells. This suppression is shared by a superantigenic-deficient mutant of TSST-1 but not by staphylococcal enterotoxins, suggesting that autophagic suppression of TSST-1 is superantigenic-independent. Furthermore, we showed that TSST-1-producing S. aureus suppresses autophagy in the response of infected cells. Our data provides a novel function of TSST-1 in autophagic suppression which may contribute in staphylococcal persistence in host cells.	[Asano, Krisana; Ono, Hisaya K.; Nakane, Akio] Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan; [Asano, Yoshiya] Hirosaki Univ, Grad Sch Med, Dept Neuroanat Cell Biol & Histol, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Nakane, A (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan.	a27k03n0@cc.hirosaki-u.ac.jp	Ono, Hisaya/P-3595-2019	Asano, Yoshiya/0000-0002-8941-7659; , Akio/0000-0002-9583-8919	JSPS KAKENHI [23390100, 23790467]; Grant for Hirosaki University Institutional Research; Grants-in-Aid for Scientific Research [23390100] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant for Hirosaki University Institutional Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant number 23390100, 23790467 and Grant for Hirosaki University Institutional Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 1996, J DAIRY SCI, V79, P1021, DOI 10.3168/jds.S0022-0302(96)76454-8; Andrey DO, 2010, J BACTERIOL, V192, P6077, DOI 10.1128/JB.00146-10; Mestre MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002664; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003; Hu DL, 2003, J INFECT DIS, V188, P743, DOI 10.1086/377308; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; JUPIN C, 1988, J EXP MED, V167, P752, DOI 10.1084/jem.167.3.752; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kong XF, 2012, J NUTR BIOCHEM, V23, P1178, DOI 10.1016/j.jnutbio.2011.06.012; KUSHNARYOV VM, 1989, REV INFECT DIS, V11, pS282; KUSHNARYOV VM, 1984, INFECT IMMUN, V45, P566, DOI 10.1128/IAI.45.3.566-571.1984; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MARRACK P, 1990, SCIENCE, V248, P1066; Mauthe Mario, 2012, Int J Cell Biol, V2012, P179207, DOI 10.1155/2012/179207; Muthukrishnan G, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-221; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Narita K, 2008, FEMS IMMUNOL MED MIC, V52, P389, DOI 10.1111/j.1574-695X.2008.00384.x; Nuzzo I, 2000, FEMS IMMUNOL MED MIC, V27, P235, DOI 10.1111/j.1574-695X.2000.tb01435.x; Parsonnet J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-249; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Shupp JW, 2002, INFECT IMMUN, V70, P2178, DOI 10.1128/IAI.70.4.2178-2186.2002; Tang YL, 2015, AMINO ACIDS, V47, P2199, DOI 10.1007/s00726-014-1781-4; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Wang BN, 2006, CELL MICROBIOL, V8, P257, DOI 10.1111/j.1462-5822.2005.00618.x; Yang HS, 2012, CYTOKINE, V60, P646, DOI 10.1016/j.cyto.2012.07.033; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113018	10.1371/journal.pone.0113018	http://dx.doi.org/10.1371/journal.pone.0113018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402468	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700095
J	Gao, L; Edwards, EJ; Zeng, YB; Huang, YS				Gao, Li; Edwards, Erika J.; Zeng, Yongbo; Huang, Yongsong			Major Evolutionary Trends in Hydrogen Isotope Fractionation of Vascular Plant Leaf Waxes	PLOS ONE			English	Article							DELTA-D VALUES; N-ALKANES; COMPARATIVE BIOLOGY; WATER; CLIMATE; REGENERATION; VARIABILITY; HYDROLOGY; RECORD; FIELD	Hydrogen isotopic ratios of terrestrial plant leaf waxes (delta D) have been widely used for paleoclimate reconstructions. However, underlying controls for the observed large variations in leaf wax delta D values in different terrestrial vascular plants are still poorly understood, hampering quantitative paleoclimate interpretation. Here we report plant leaf wax and source water delta D values from 102 plant species grown in a common environment (New York Botanic Garden), chosen to represent all the major lineages of terrestrial vascular plants and multiple origins of common plant growth forms. We found that leaf wax hydrogen isotope fractionation relative to plant source water is best explained by membership in particular lineages, rather than by growth forms as previously suggested. Monocots, and in particular one clade of grasses, display consistently greater hydrogen isotopic fractionation than all other vascular plants, whereas lycopods, representing the earlier-diverging vascular plant lineage, display the smallest fractionation. Data from greenhouse experiments and field samples suggest that the changing leaf wax hydrogen isotopic fractionation in different terrestrial vascular plants may be related to different strategies in allocating photosynthetic substrates for metabolic and biosynthetic functions, and potential leaf water isotopic differences.	[Gao, Li; Huang, Yongsong] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Edwards, Erika J.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Zeng, Yongbo] Univ Rhode Isl, Dept Elect Comp & Biomed Engn, Kingston, RI 02881 USA	Brown University; Brown University; University of Rhode Island	Huang, YS (corresponding author), Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA.	yongsong_huang@brown.edu	Gao, Li/H-3747-2014	Gao, Li/0000-0003-0684-3570	NSF [0816739, 0902805, 1024144]; Brown University	NSF(National Science Foundation (NSF)); Brown University	This project is supported by NSF 0816739, 0902805 and 1024144 to Y. Huang and a Brown University Seed Grant to Y. Huang and EJ Edwards. Website for National Science Fundation: http://www.nsf.gov/. Website for Brown University Seed Grant: http://www.brown.edu/research/internal-funding-opportunities-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cernusak LA, 2002, PLANT CELL ENVIRON, V25, P893, DOI 10.1046/j.1365-3040.2002.00875.x; Dupont LM, 2013, EARTH PLANET SC LETT, V375, P408, DOI 10.1016/j.epsl.2013.06.005; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; Eriksson L., 1999, INTRO MULTI MEGAVARI; Feakins SJ, 2010, ORG GEOCHEM, V41, P1269, DOI 10.1016/j.orggeochem.2010.09.007; Gao L, 2014, GEOCHEM GEOPHY GEOSY, V15, P361, DOI 10.1002/2013GC005015; Gao L, 2013, OECOLOGIA, V172, P347, DOI 10.1007/s00442-012-2506-6; Gao L, 2012, RAPID COMMUN MASS SP, V26, P2241, DOI 10.1002/rcm.6348; Gao L, 2012, RAPID COMMUN MASS SP, V26, P115, DOI 10.1002/rcm.5313; Gao L, 2011, GEOCHIM COSMOCHIM AC, V75, P3781, DOI 10.1016/j.gca.2011.04.008; HELLBERG S, 1991, INT J PEPT PROT RES, V37, P414; Hou JZ, 2008, GEOCHIM COSMOCHIM AC, V72, P3503, DOI 10.1016/j.gca.2008.04.030; Hou JZ, 2007, ORG GEOCHEM, V38, P977, DOI 10.1016/j.orggeochem.2006.12.009; Huang YS, 2007, GEOLOGY, V35, P531, DOI 10.1130/G23666A.1; Kahmen A, 2013, GEOCHIM COSMOCHIM AC, V111, P50, DOI 10.1016/j.gca.2012.09.004; Kahmen A, 2013, GEOCHIM COSMOCHIM AC, V111, P39, DOI 10.1016/j.gca.2012.09.003; Kahmen A, 2011, PLANT CELL ENVIRON, V34, P1639, DOI 10.1111/j.1365-3040.2011.02360.x; KAPLAN DR, 1973, Q REV BIOL, V48, P437, DOI 10.1086/407703; Keun HC, 2003, ANAL CHIM ACTA, V490, P265, DOI 10.1016/S0003-2670(03)00094-1; Kuechler RR, 2013, QUATERNARY SCI REV, V82, P56, DOI 10.1016/j.quascirev.2013.10.013; Liu WG, 2008, GLOBAL CHANGE BIOL, V14, P2166, DOI 10.1111/j.1365-2486.2008.01608.x; McInerney FA, 2011, GEOCHIM COSMOCHIM AC, V75, P541, DOI 10.1016/j.gca.2010.10.022; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Polissar PJ, 2009, EARTH PLANET SC LETT, V287, P64, DOI 10.1016/j.epsl.2009.07.037; Rach O, 2014, NAT GEOSCI, V7, P109, DOI [10.1038/ngeo2053, 10.1038/NGEO2053]; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sachse D, 2012, ANNU REV EARTH PL SC, V40, P221, DOI 10.1146/annurev-earth-042711-105535; Schefuss E, 2011, NATURE, V480, P509, DOI 10.1038/nature10685; Shchepinov MS, 2007, BIOESSAYS, V29, P1247, DOI 10.1002/bies.20681; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Smith FA, 2006, GEOCHIM COSMOCHIM AC, V70, P1172, DOI 10.1016/j.gca.2005.11.006; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Tipple BJ, 2013, P NATL ACAD SCI USA, V110, P2659, DOI 10.1073/pnas.1213875110; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Zhuang GS, 2014, EARTH PLANET SC LETT, V390, P186, DOI 10.1016/j.epsl.2014.01.003	39	56	58	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112610	10.1371/journal.pone.0112610	http://dx.doi.org/10.1371/journal.pone.0112610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402476	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700057
J	Oelze, M; Kroller-Schon, S; Welschof, P; Jansen, T; Hausding, M; Mikhed, Y; Stamm, P; Mader, M; Zinssius, E; Agdauletova, S; Gottschlich, A; Steven, S; Schulz, E; Bottari, SP; Mayoux, E; Munzel, T; Daiber, A				Oelze, Matthias; Kroeller-Schoen, Swenja; Welschof, Philipp; Jansen, Thomas; Hausding, Michael; Mikhed, Yuliya; Stamm, Paul; Mader, Michael; Zinssius, Elena; Agdauletova, Saule; Gottschlich, Anna; Steven, Sebastian; Schulz, Eberhard; Bottari, Serge P.; Mayoux, Eric; Muenzel, Thomas; Daiber, Andreas			The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; ENDOTHELIAL DYSFUNCTION; SGLT-2 INHIBITOR; ORGANIC NITRATES; GLYCEMIC CONTROL; OXIDANT STRESS; BURST ACTIVITY; NADPH OXIDASE; NITRIC-OXIDE	Objective: In diabetes, vascular dysfunction is characterized by impaired endothelial function due to increased oxidative stress. Empagliflozin, as a selective sodium-glucose co-transporter 2 inhibitor (SGLT2i), offers a novel approach for the treatment of type 2 diabetes by enhancing urinary glucose excretion. The aim of the present study was to test whether treatment with empagliflozin improves endothelial dysfunction in type I diabetic rats via reduction of glucotoxicity and associated vascular oxidative stress. Methods: Type I diabetes in Wistar rats was induced by an intravenous injection of streptozotocin (60 mg/kg). One week after injection empagliflozin (10 and 30 mg/kg/d) was administered via drinking water for 7 weeks. Vascular function was assessed by isometric tension recording, oxidative stress parameters by chemiluminescence and fluorescence techniques, protein expression by Western blot, mRNA expression by RT-PCR, and islet function by insulin ELISA in serum and immunohistochemical staining of pancreatic tissue. Advanced glycation end products (AGE) signaling was assessed by dot blot analysis and mRNA expression of the AGE-receptor (RAGE). Results: Treatment with empagliflozin reduced blood glucose levels, normalized endothelial function (aortic rings) and reduced oxidative stress in aortic vessels (dihydroethidium staining) and in blood (phorbol ester/zymosan A-stimulated chemiluminescence) of diabetic rats. Additionally, the pro-inflammatory phenotype and glucotoxicity (AGE/RAGE signaling) in diabetic animals was reversed by SGLT2i therapy. Conclusions: Empagliflozin improves hyperglycemia and prevents the development of endothelial dysfunction, reduces oxidative stress and improves the metabolic situation in type 1 diabetic rats. These preclinical observations illustrate the therapeutic potential of this new class of antidiabetic drugs.	[Oelze, Matthias; Kroeller-Schoen, Swenja; Welschof, Philipp; Jansen, Thomas; Hausding, Michael; Mikhed, Yuliya; Stamm, Paul; Mader, Michael; Zinssius, Elena; Agdauletova, Saule; Gottschlich, Anna; Steven, Sebastian; Schulz, Eberhard; Muenzel, Thomas; Daiber, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Cardiol, Med Clin 2, D-55122 Mainz, Germany; [Bottari, Serge P.] Grenoble Alpes Univ, CHU Grenoble, Lab Fundamental & Appl, INSERM U1055, Grenoble, France; [Bottari, Serge P.] CHU Grenoble, Pole Biol, F-38043 Grenoble, France; [Mayoux, Eric] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany	Johannes Gutenberg University of Mainz; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Boehringer Ingelheim	Daiber, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Cardiol, Med Clin 2, D-55122 Mainz, Germany.	andreas.daiber@bioredox.com	Bottari, Serge/ABF-3990-2021; Steven, Sebastian/Z-1583-2019; Munzel, Thomas/A-2912-2014	Munzel, Thomas/0000-0001-5503-4150; Bottari, Serge P./0000-0002-4172-2400; Daiber, Andreas/0000-0002-2769-0094	vascular biology research grant from Boehringer Ingelheim Pharma GmbH Co. KG; Centre of Translational Vascular Biology (CTVB); Institute of Molecular Biology gGmbH, (Mainz, Germany) - Boehringer Ingelheim Foundation	vascular biology research grant from Boehringer Ingelheim Pharma GmbH Co. KG; Centre of Translational Vascular Biology (CTVB); Institute of Molecular Biology gGmbH, (Mainz, Germany) - Boehringer Ingelheim Foundation	The present work was supported by a vascular biology research grant from Boehringer Ingelheim Pharma GmbH & Co. KG (A. D. and T. M.) and by the Centre of Translational Vascular Biology (CTVB). Yuliya Miked holds a stipend from the International PhD Programme on the "Dynamics of Gene Regulation, Epigenetics and DNA Damage Response" from the Institute of Molecular Biology gGmbH, (Mainz, Germany) funded by the Boehringer Ingelheim Foundation. This paper contains results that are part of the doctoral thesis of Philipp Welschof. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. E. M. (Boehringer Ingelheim Pharma GmbH & Co. KG) was involved in the study design.	Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; CHANG FY, 1995, DIABETES RES CLIN PR, V29, P121, DOI 10.1016/0168-8227(95)01123-4; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; Cherney DZI, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-28; Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514; Daiber A, 2004, MOL PHARMACOL, V66, P1372, DOI 10.1124/mol.104.002600; Evans JL, 2013, DIABETES, V62, P346, DOI 10.2337/db12-1239; Ferrannini E, 2013, DIABETES OBES METAB, V15, P721, DOI 10.1111/dom.12081; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Forbes JM, 2002, DIABETES, V51, P3274, DOI 10.2337/diabetes.51.11.3274; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Hansen HH, 2014, J PHARMACOL EXP THER, V350, P657, DOI 10.1124/jpet.114.213454; Hausding M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0386-5; Hink U, 2001, CIRC RES, V88, pE14; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Kroller-Schon S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953; Kroller-Schon S, 2012, CARDIOVASC RES, V96, P140, DOI 10.1093/cvr/cvs246; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067009; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Loot AE, 2009, J EXP MED, V206, P2889, DOI 10.1084/jem.20090449; Luippold G, 2012, DIABETES OBES METAB, V14, P601, DOI 10.1111/j.1463-1326.2012.01569.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OELZE M, 2013, HYPERTENSION; Oelze M, 2006, HYPERTENSION, V48, P677, DOI 10.1161/01.HYP.0000239207.82326.29; Oelze M, 2011, J VASC RES, V48, P275, DOI 10.1159/000320627; Oelze M, 2011, J BIOL CHEM, V286, P8893, DOI 10.1074/jbc.M110.190017; Osar Z, 2004, EXP DIABESITY RES, V5, P155, DOI 10.1080/15438600490424244; Perkins BA, 2014, DIABETES CARE, V37, P1480, DOI 10.2337/dc13-2338; Pricci F, 2003, FREE RADICAL BIO MED, V35, P683, DOI 10.1016/S0891-5849(03)00401-5; Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF188, DOI 10.1152/ajprenal.00518.2013; Sarashina A, 2013, DRUG METAB PHARMACOK, V28, P213, DOI 10.2133/dmpk.DMPK-12-RG-082; Schuhmacher S, 2011, DIABETES, V60, P2608, DOI 10.2337/db10-1395; Schulz E, 2014, ANTIOXID REDOX SIGN, V20, P308, DOI 10.1089/ars.2012.4609; Shiryaeva YK, 2012, B EXP BIOL MED+, V153, P114, DOI 10.1007/s10517-012-1656-1; Sun M, 1998, INT J EXP PATHOL, V79, P207; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Vickers SP, 2014, DIABETES METAB SYNDR, V7, P265, DOI 10.2147/DMSO.S58786; Wang JL, 2011, MOL MED, V17, P172, DOI 10.2119/molmed.2010.00114; WAUTIER JL, 1994, P NATL ACAD SCI USA, V91, P7742, DOI 10.1073/pnas.91.16.7742; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Wenzel P, 2007, BRIT J PHARMACOL, V150, P526, DOI 10.1038/sj.bjp.0707116; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Wenzel P, 2008, ATHEROSCLEROSIS, V198, P65, DOI 10.1016/j.atherosclerosis.2007.10.003; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Yamamoto Y, 2000, ANN NY ACAD SCI, V902, P163; Yu YX, 2005, AM J MED SCI, V330, P227, DOI 10.1097/00000441-200511000-00005	50	185	192	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112394	10.1371/journal.pone.0112394	http://dx.doi.org/10.1371/journal.pone.0112394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402275	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700042
J	Rhodes, JR; Lunney, D; Callaghan, J; McAlpine, CA				Rhodes, Jonathan R.; Lunney, Daniel; Callaghan, John; McAlpine, Clive A.			A Few Large Roads or Many Small Ones? How to Accommodate Growth in Vehicle Numbers to Minimise Impacts on Wildlife	PLOS ONE			English	Article							NEW-SOUTH-WALES; OF-FIT TESTS; PHASCOLARCTOS-CINEREUS; PORT STEPHENS; HOME-RANGE; MORTALITY; CONSERVATION; POPULATION; KOALAS; MODELS	Roads and vehicular traffic are among the most pervasive of threats to biodiversity because they fragmenting habitat, increasing mortality and opening up new areas for the exploitation of natural resources. However, the number of vehicles on roads is increasing rapidly and this is likely to continue into the future, putting increased pressure on wildlife populations. Consequently, a major challenge is the planning of road networks to accommodate increased numbers of vehicles, while minimising impacts on wildlife. Nonetheless, we currently have few principles for guiding decisions on road network planning to reduce impacts on wildlife in real landscapes. We addressed this issue by developing an approach for quantifying the impact on wildlife mortality of two alternative mechanisms for accommodating growth in vehicle numbers: (1) increasing the number of roads, and (2) increasing traffic volumes on existing roads. We applied this approach to a koala (Phascolarctos cinereus) population in eastern Australia and quantified the relative impact of each strategy on mortality. We show that, in most cases, accommodating growth in traffic through increases in volumes on existing roads has a lower impact than building new roads. An exception is where the existing road network has very low road density, but very high traffic volumes on each road. These findings have important implications for how we design road networks to reduce their impacts on biodiversity.	[Rhodes, Jonathan R.; McAlpine, Clive A.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Rhodes, Jonathan R.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Rhodes, Jonathan R.; McAlpine, Clive A.] Univ Queensland, NERP Environm Decis Hub, Brisbane, Qld, Australia; [Lunney, Daniel] Off Environm & Heritage New South Wales, Hurstville, NSW, Australia; [Lunney, Daniel] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Callaghan, John] Australian Koala Fdn, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Office of Environment & Heritage - New South Wales; University of Sydney	Rhodes, JR (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	j.rhodes@uq.edu.au	Rhodes, Jonathan/C-4841-2008	Rhodes, Jonathan/0000-0001-6746-7412; Beale, Mathew/0000-0002-4740-3187; Fisher, Matthew/0000-0002-1862-6402; Rhodes, Johanna/0000-0002-1338-7860; McAlpine, Clive/0000-0003-0457-8144; Lunney, Dan/0000-0002-5771-0746	Australian Research Council [C00107594]	Australian Research Council(Australian Research Council)	This work was supported by funding from: An Australian Research Council Linkage Project with contributions from the Australian Koala Foundation and New South Wales Government (project number: C00107594, www.arc.gov.au). The Australian Research Council Centre of Excellence for Environmental Decisions (www.arc.gov.au). The National Environmental Research Program Environmental Decisions Hub (http://www.environment.gov.au/topics/science-and-research/national-environmental-research-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Callaghan J, 2011, WILDLIFE RES, V38, P89, DOI 10.1071/WR07177; Caswell, 2000, MATRIX POPULATION MO; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Cork SJ, 2000, CONSERV BIOL, V14, P660, DOI 10.1046/j.1523-1739.2000.99389.x; DECC, 2008, NSW 2008 KOAL REC PL; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Dovers SR, 1996, BIODIVERS CONSERV, V5, P1143, DOI 10.1007/BF00051569; Dudaniec RY, 2013, MOL ECOL, V22, P3752, DOI 10.1111/mec.12359; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; FAHRIG L, 1995, BIOL CONSERV, V73, P177, DOI 10.1016/0006-3207(94)00102-V; FAHRIG L, 2009, ECOL SOC, V14; Fields G, 2009, INT J SUSTAIN TRANSP, V3, P360, DOI 10.1080/15568310802260013; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Goosem Miriam, 1997, P241; Grosman PD, 2011, ECOL MODEL, V222, P1423, DOI 10.1016/j.ecolmodel.2011.01.022; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; HINDELL MA, 1985, AUST WILDLIFE RES, V12, P137; HINDELL MA, 1987, AUST WILDLIFE RES, V14, P349, DOI 10.1071/WR9870349; Hosmer DW, 1997, STAT MED, V16, P965; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Road Federation, 2011, WORLD ROAD STAT 2011; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Jaeger Jochen A.G., 2006, P151; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; Knott Tiffany, 1998, Pacific Conservation Biology, V4, P354; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Lunney D, 2000, CONSERV BIOL, V14, P669, DOI 10.1046/j.1523-1739.2000.99386.x; Lunney D, 2010, NATURAL HIST SYDNEY; Lunney D, PAC CONSERV IN PRESS; Lunney Daniel, 1998, Pacific Conservation Biology, V4, P186; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Melzer A, 1995, ASPECTS ECOLOGY KOAL; Mitchell P., 1990, P171; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Natural Resource Management Ministerial Council, 2009, NAT KOAL CONS MAN ST; OSIUS G, 1992, J AM STAT ASSOC, V87, P1145, DOI 10.2307/2290653; Phillips S, 2000, WILDLIFE RES, V27, P1, DOI 10.1071/WR98054; Pittman J, 1993, PROBABILITY; Polak T, J APPL ECOL IN PRESS; Port Stephens Council, 2001, PORT STEPH COUNC C 1; Ramp D, 2005, BIOL CONSERV, V126, P474, DOI 10.1016/j.biocon.2005.07.001; Ramp D, 2006, J WILDLIFE MANAGE, V70, P1615, DOI 10.2193/0022-541X(2006)70[1615:TEORFO]2.0.CO;2; Reed P.C., 1990, P55; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Rhodes JR, 2005, ECOLOGY, V86, P1199, DOI 10.1890/04-0912; Roger E, 2011, POPUL ECOL, V53, P215, DOI 10.1007/s10144-010-0209-6; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Slooten E, 2000, CONSERV BIOL, V14, P1264, DOI 10.1046/j.1523-1739.2000.00099-411.x; Spellerberg IF, 2002, ECOLOGICAL EFFECTS R, DOI DOI 10.1201/9781482279931; Stewart-Oaten Allan, 1996, P17, DOI 10.1016/B978-012627255-0/50004-5; Sushinsky JR, 2013, GLOBAL CHANGE BIOL, V19, P401, DOI 10.1111/gcb.12055; Taylor BD, 2003, WILDLIFE RES, V30, P529, DOI 10.1071/WR01062; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; van Langevelde F, 2004, LANDSCAPE ECOL, V19, P895, DOI 10.1007/s10980-004-0464-z; van Langevelde F, 1997, HABITAT FRAGMENTATIO, P171; van Langevelde F, 2009, ECOL SOC, V14; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Wade PR, 2002, POPULATION VIABILITY ANALYSIS, P213; White NA, 1999, WILDLIFE RES, V26, P731, DOI 10.1071/WR98002; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar J. H., 1996, BIOSTATISTICAL ANAL; [No title captured], DOI DOI 10.1016/j.jenvman.2010.11.027	74	56	58	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91093	10.1371/journal.pone.0091093	http://dx.doi.org/10.1371/journal.pone.0091093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646891	Green Published, gold			2022-12-27	WOS:000333348500024
